Page last updated: 2024-12-10

quercetin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID5284452
CHEMBL ID1520590
SCHEMBL ID22103
MeSH IDM0018327
PubMed CID16212154
CHEMBL ID1173475
SCHEMBL ID1658852
MeSH IDM0018327
PubMed CID5280343
CHEMBL ID50
CHEBI ID16243
SCHEMBL ID219729
SCHEMBL ID19723
MeSH IDM0018327

Synonyms (393)

Synonym
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4h-chromen-4-one dihydrate
quercetin dihydrate ,
PRESTWICK_541
6151-25-3
quercetine dihydrate
NCGC00017056-01
cas-6151-25-3
flavone, 3,3',4',5,7-pentahydroxy-, dihydrate
ccris 3304
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4h-1-benzopyran-4-one dihydrate
quercetin, dihydrate
3,3',4',5,7-pentahydroxyflavone dihydrate
BMK1-G2
HMS1569F15
A833274
AKOS004910448
HMS2096F15
53b03v78a6 ,
unii-53b03v78a6
tox21_201150
NCGC00258702-01
dtxcid401219
dtxsid9021219 ,
tox21_110761
QUERCETIN DIHYDRATE - SOPHORETIN
FT-0601606
S2347
CCG-208320
SCHEMBL22103
NCGC00015870-27
tox21_110761_1
quercetin dihydrate [mi]
quercetin dihydrate [who-dd]
quercetindihydrate
HB0543
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4h-1-benzopyran-4-one dihydrate; 3,3′,4′,5,7-pentahydroxyflavone dihydrate
CHEMBL1520590
HMS3403F09
c15h10o7.2h2o
mfcd00149487
F0001-1629
HMS3656A09
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4h-1-benzopyran-4-one dihydrate (quercetin dihydrate)
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one;dihydrate
SW148203-5
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4h-chromen-4-onedihydrate
BCP07318
quercetin dihydrate (sophoretin)
2-(3,4-dihydroxyphenyl)-3,5,7-
trihydroxy-4h-chromen-4-one dihydrate
quercetin,(s)
AS-13663
HMS3884N13
CS-0007880
quercetin (dihydrate)
HY-N0146
Q27261093
SY061661
B0005-465575
MLS002153851
quercetin hydrate, >=95%
smr000674606
MLS001074343
849061-97-8
CHEMBL1173475
AKOS002318957
HMS2234O11
REGID_FOR_CID_747934
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4h-chromen-4-one hydrate
HMS3370H12
REGID_FOR_CID_16212154
OKXFBEYCJRMINR-UHFFFAOYSA-N
SCHEMBL1658852
quercetin hydrate
mfcd03847906
quercetin, pharmaceutical secondary standard; certified reference material
1001001-36-0
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one;hydrate
quercetin hydrate
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4h-chromen-4-one xhydrate
quercetin (hydrate)
quercetin monohydrate
2(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4h-chromen-4-one monohydrate
D95379
A863909
BS-23834
7255-55-2
nsc-57655
BIDD:PXR0007
AC-19596
BIDD:ER0315
HMS3267M12
BRD-K97399794-001-02-1
BRD-K97399794-335-03-1
BRD-K97399794-001-07-0
brd-9794
brd9794
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4h-1-benzopyran-4-one
3,3',4',5,7-pentahydroxyflavone
CHEBI:16243 ,
2-(3,4-dihydroxy-phenyl)-3,5,7-trihydroxy-chromen-4-one
DIVK1C_000485
KBIO1_000485
NCI60_042036
3',4',5,7-tetrahydroxyflavon-3-ol
quer
lim-5662
c.i. natural red 1
lns-5662
SGCUT00001
EU-0100999
SPECTRUM_000124
PRESTWICK2_000507
BSPBIO_002243
c15h10o7
corvitin
quertine
nsc9219 ,
quercetol
sophoretin
flavone,3',4',5,7-pentahydroxy-
c.i. natural yellow 10
t-gelb bzw. grun 1
xanthaurine
meletin
3',5,7-tetrahydroxyflavan-3-ol
quercitin
nsc-9219
3,7,3',4'-pentahydroxyflavone
wln: t66 bo evj cr cq dq & dq gq iq
c.i. 75670
quercetine ,
3,4',5,7-pentahydroxyflavone
cyanidelonon 1522
K00029
quercetin; 3,3',4',5,7-pentahydroxyflavone
S00057
bdbm7460
NCGC00015870-02
BIO1_000858
BIO2_000854
chembl50 ,
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chromone;hydrate
NCGC00015870-03
tnp00089
BIO1_000369
NCGC00025016-01
BIO1_001347
BIO2_000374
lopac-q-0125
NCGC00015870-01
tocris-1125
tnp00070
LOPAC0_000999
MEGXP0_000381
ACON1_000560
SPECTRUM5_001389
IDI1_002129
IDI1_000485
SMP1_000252
BPBIO1_000477
BIOMOLKI2_000068
BSPBIO_001068
nsc58588
nsc324608
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chromen-4-one
nsc57655
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4h-chromen-4-one
3',4',5,7-tetrahydroxyflavan-3-ol
c.i. natural yellow 10 & 13
quertin
hsdb 3529
ccris 1639
flavone, 3,3',4',5,7-pentahydroxy-
flavone, 3,4',5,5',7-pentahydroxy-
flavin meletin
4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-
QUE ,
3,5,7-trihydroxy-2-(3,4-dihydroxyphenyl)-4h-chromen-4-on
quercetin content
ai3-26018
UPCMLD-DP081:001
nsc 9219
einecs 204-187-1
brn 0317313
kvercetin [czech]
nci-c60106
ci 75670
natural yellow 10
ci natural yellow 10
STK365650
C00389
117-39-5
3,5,7,3',4'-pentahydroxyflavone
3,3',4,5,7-pentahydroxyflavone
quercetin ,
TO_000078
CU-01000012502-3 ,
DB04216
UPCMLD-DP081
BSPBIO_000433
PRESTWICK3_000507
NCGC00025016-05
NCGC00025016-08
NCGC00025016-07
NCGC00025016-03
KBIO3_000776
KBIO3_001463
KBIO2_002976
KBIOSS_000584
KBIO2_000584
KBIOGR_001293
KBIO2_005720
KBIO2_005544
KBIO2_000408
KBIOGR_000408
KBIOSS_000408
MAYBRIDGE1_008992
KBIO2_003152
MIXCOM3_000183 ,
KBIO3_000775
PRESTWICK1_000507
SPECTRUM2_000059
SPECTRUM3_000642
NCIOPEN2_007628
NINDS_000485
PRESTWICK0_000507
SPBIO_000217
SPBIO_002354
NCIOPEN2_007882
SPECTRUM4_000807
SPECTRUM1500672
BIOMOLKI_000062
NCGC00025016-02
NCGC00168962-04
NCGC00168962-02
NCGC00025016-06
NCGC00025016-04
NCGC00168962-03
NCGC00168962-01
3,5,7-trihydroxy-2-(3,4-dihydroxyphenyl)-4h-chromen-4-one
dikvertin
LMPK12110004
NCGC00015870-05
Q 0125 ,
49643640-FD4C-4B93-BD28-0D7C2021CC52
HMS1990F09
3CF8
ksc-10-126
NCGC00015870-17
KUC104418N ,
AKOS000511724
ksc-23-76
KUC107684N ,
lipoflavon
cyanidenolon 1522
3'-hydroxykaempferol
korvitin
nsc 57655
ci-75670
ldn-0052529
quercetin (constituent of ginkgo)
ldn 0052529
HMS501I07
HMS1362F09
HMS1792F09
FT-0655108
P0042 ,
HMS1923O19
HMS3263G19
QUERCETIN_SATHISHKUMAR
enicostemma littorale blume
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one
dtxsid4021218 ,
dtxcid001218
tox21_300285
NCGC00254218-01
cas-117-39-5
NCGC00259857-01
tox21_202308
BBL005513
Q0025
QUERCETIN - SOPHORETIN
9ikm0i5t1e ,
5-18-05-00494 (beilstein handbook reference)
(+)-4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-
niosh/lk8760000
flavone, 3,3',4',5,7-pentahydroxy-, (+)-
unii-9ikm0i5t1e
LK87600000
(+)-3,3',4',5,7-pentahydroxyflavone
kvercetin
CCG-40054
NCGC00015870-19
NCGC00015870-13
NCGC00015870-11
NCGC00015870-06
NCGC00015870-09
NCGC00015870-15
NCGC00015870-08
NCGC00015870-23
NCGC00015870-10
NCGC00015870-21
NCGC00015870-24
NCGC00015870-12
NCGC00015870-16
NCGC00015870-18
NCGC00015870-22
NCGC00015870-07
NCGC00015870-14
BRD-K97399794-001-11-2
FT-0603318
LP00999
quercetin (constituent of ginkgo) [dsc]
quercetin [usp-rs]
quercetin [vandf]
quercetin [inci]
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4h-benzopyran-4-one
quercetin [who-dd]
quercetin [mi]
quercetin [hsdb]
quercetin [iarc]
quercetin [dsc]
S2391
gtpl5346
SCHEMBL219729
SCHEMBL19723
4DFU
tox21_500999
CS-3981
NCGC00261684-01
quercetin, sophoretin, meletin, quercetine
MLS006011766
smr000112559
Q-200333
74893-81-5
HB0542
3,5,7,3',4'-pentahydroxyflavon
ritacetin
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4h-chromen-4-one #
c.i. natural yellow 13
HY-18085
AC-29756
HMS3649D04
mfcd00006828
4MRA
SR-01000076098-1
sr-01000076098
HMS3656C15
3,4',5,5',7-pentahydroxy-flavone
3',4',5,7-tetrahydroxyflavonol
quercetin, >=95% (hplc), solid
SR-01000076098-7
SR-01000076098-3
SR-01000076098-8
4h-1-benzopyran-4-one,2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-, zirconium(2+) salt (1:1)
SW148203-4
NCGC00015870-25
quercetin2h2o
DS-3416
Q409478
SY057722
quercetin (sophoretin) ,
HMS3678J19
NCGC00015870-28
SR-01000076098-11
HMS3414J21
BRD-K97399794-001-09-6
SDCCGSBI-0050972.P003
NCGC00015870-48
quercetin 100 microg/ml in acetonitrile
NCGC00015870-04
nsc756660
nsc-756660
quercetin 1000 microg/ml in acetone
quercetin (gmp)
CS-0638666
HY-18085G
NCGC00015870-50
EN300-199773
meletin;sophoretin
ci natural red 1
3,4',5,5',7-pentahydroxyflavone
2-(3,4-dihydroxyphenyl)-4h-1-benzopyran-4-one
quercetin (iarc)
t-gelb bzw, grun 1
quercetin (usp-rs)
ci natural yellow 10 & 13
quercetin,
quercetin phenolic
quercetin1540
4h-1-benzopyran-4-one,2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-,zirconium(2+)salt(1:1)
Z57176222

Research Excerpts

Overview

Quercetin (Que) is a flavonoid abundant in fruits and vegetables that exhibits anti-oxidant activity. It is a plant-derived metabolite belonging to the flavonoids class which presents a range of beneficial effects including anti-inflammatory, cardioprotective and anti-obesity. QuercetIn is a natural compound capable of antagonizing esophagus carcinoma.

ExcerptReferenceRelevance
"Quercetin is a flavonoid natural product, that is, found in many foods and has been found to have a wide range of medicinal effects. "( Biotinylated quercetin as an intrinsic photoaffinity proteomics probe for the identification of quercetin target proteins.
Chen, J; Hunt, CR; Taylor, JS; Wang, RE, 2011
)
2.18
"Quercetin is a plant-derived flavonoid and its cytotoxic properties have been widely reported. "( Delineation of the role of glycosylation in the cytotoxic properties of quercetin using novel assays in living vertebrates.
Jung, DW; Kim, AR; Kim, HJ; Kim, KK; Park, SH; Shen, H; Shin, BA; Tyagi, N; Williams, DR; Yim, SH, 2014
)
2.08
"Quercetin (Que) is a flavonoid abundant in fruits and vegetables that exhibits anti-oxidant activity."( Quercetin antagonizes imidacloprid-induced mitochondrial apoptosis through PTEN/PI3K/AKT in grass carp hepatocytes.
Miao, Z; Shi, X; Wang, S; Xu, S, 2021
)
2.79
"Quercetin is a flavonoid with anti-oxidant, anti-cancer, anti-bacterial and anti-viral activities."( Quercetin as an antiviral agent inhibits the Pseudorabies virus in vitro and in vivo.
He, Q; Jiang, J; Li, C; Li, Z; Shangguan, A; Sun, Y; Zeng, W; Zhang, S, 2021
)
2.79
"Quercetin (Que) is a natural compound capable of antagonizing esophagus carcinoma (EC)."( Quercetin Antagonizes Esophagus Cancer by Modulating miR-1-3p/TAGLN2 Pathway-Dependent Growth and Metastasis.
Chen, X; Li, J; Wang, Y; Xia, C, 2022
)
2.89
"Quercetin (QCT) is an effective antioxidant, antifibrotic and wound healing agent. "( Quercetin loaded silver nanoparticles in hydrogel matrices for diabetic wound healing.
Badhwar, R; Khanna, K; Mangla, B; Neupane, YR; Popli, H, 2021
)
3.51
"Quercetin is a plant-derived metabolite belonging to the flavonoids class which presents a range of beneficial effects including anti-inflammatory, cardioprotective, anti-oxidant, anti-obesity, anti-carcinogenic, anti-atherosclerotic, anti-diabetic, anti-hypercholesterolemic, and anti-apoptotic activities."( Quercetin and its role in modulating endoplasmic reticulum stress: A review.
Eisvand, F; Seidel, V; Shakeri, A; Tabeshpour, J; Tajbakhsh, A; Zirak, MR, 2022
)
2.89
"Quercetin is a flavonoid compound rich in many natural plants with a wide range of pharmacological effects and nutritional value. "( Quercetin reverses chronic unpredictable mild stress-induced depression-like behavior in vivo by involving nuclear factor-E2-related factor 2.
Gong, M; Guan, Y; Li, B; Song, L; Wang, J; Wang, Y; Wu, X, 2021
)
3.51
"Quercetin (Q) is a potent flavonol that has neuroprotective effects on AD derangements."( Quercetin stimulates the non-amyloidogenic pathway via activation of ADAM10 and ADAM17 gene expression in aluminum chloride-induced Alzheimer's disease rat model.
Elfiky, AM; Elreedy, HA; Ghazy, MA; Ibrahim, KS; Mahmoud, AA, 2021
)
2.79
"Quercetin (Que) is a promising flavonoid with broad-spectrum anti-tumor activity against various cancers, including MM; however, the underlying mechanism is not yet understood."( Quercetin inhibits the proliferation of multiple myeloma cells by upregulating PTPRR expression.
Cheng, T; Li, J; Li, L; Ma, R; Shi, J; Wang, H; Wang, Y; Wu, H; Yu, D; Zhai, H; Zhang, H, 2021
)
2.79
"Quercetin is a natural flavonoid, which widely exists in nature, such as tea, coffee, apples, and onions. "( A review on pharmacological activities and synergistic effect of quercetin with small molecule agents.
Kamaraj, R; Pavek, P; Ye, H; Zhang, J; Zhang, T; Zou, H, 2021
)
2.3
"Quercetin is a flavonoid found in a great variety of foods such as vegetables and fruits. "( Morphological and mechanical changes induced by quercetin in human T24 bladder cancer cells.
Adami, BS; de Oliveira, JR; Diz, FM; Dutra, AP; Morrone, FB; Oliveira Gonçalves, GP; Papaléo, RM; Reghelin, CK; Scherer, M; Wieck, A; Xavier, LL, 2021
)
2.32
"Quercetin is a dietary flavonoid that can affect the balance between anti-oxidant defense system and oxidative stress. "( The roles of quercetin in diabetes mellitus and related metabolic disorders; special focus on the modulation of gut microbiota: A comprehensive review.
Askari, SF; Ayati, MH; Fazelian, S; Namazi, N; Roshanravan, N, 2023
)
2.72
"Quercetin is a flavonoid with described antitumoral effect in different types of cancer cell lines that could be a possible option in GCTB treatment."( Ultrastructural changes in giant cell tumor of bone cultured cells exposed to quercetin.
Delgado-Cedillo, A; Estrada-Villaseñor, E; Hernández-Pérez, A; Hidalgo-Bravo, A; Landa Solís, C; Meneses, A; Olivos Meza, A; Santamaría, M, 2021
)
1.57
"Quercetin is a naturally occurring phytochemical with good bioactivity, which mainly exists in the form of glycoside in vegetables, fruits, tea, and wine and exhibits beneficial health effects. "( [Research progress on therapeutic potential of quercetin].
Feng, YL; Li, H; Liu, J; Ruan, Z; Zhai, GY, 2021
)
2.32
"Quercetin is a flavonol that modifies many cellular processes. "( Quercetin and HSC70 coregulate the anti-inflammatory action of the ubiquitin-like protein MNSFβ.
Fukuma, Y; Kono, M; Nakamura, M; Notsu, K, 2022
)
3.61
"Quercetin (QUE) is a flavonol reported with anti-inflammatory and antioxidant activities, and previous results from the group of this study have demonstrated its neuroprotective effect against lipopolysaccharide-induced neuropsychiatric injuries. "( Protective effect of quercetin against the metabolic dysfunction of glucose and lipids and its associated learning and memory impairments in NAFLD rats.
Chen, Z; Fang, K; Gao, XR; Ge, JF; Xu, JX, 2021
)
2.38
"Quercetin is a polyphenolic molecule with a broad spectrum of biological activities derived from its antioxidant property. "( Quercetin induces lipid domain-dependent permeability.
Alvares, DS; Cabrera, MPDS; Leite, NB; Martins, DB, 2022
)
3.61
"Quercetin is a flavonoid that is widely found in food species and has anti-inflammatory, antioxidant, and anticancer activities."( Quercetin Prevents Radiation-Induced Oral Mucositis by Upregulating BMI-1.
Dong, Q; Dong, X; Feng, Y; Hong, Y; Jiang, Z; Li, H; Liu, H; Liuyang, Z; Tao, J; Wang, G; Wang, Y; Xie, A; Zhang, J, 2021
)
2.79
"Quercetin (Qct) is a flavonoid that belongs to the group of the most bioactive polyphenolic compounds. "( Cardioprotective and nephroprotective effects of Quercetin against different toxic agents.
Alasmari, AF, 2021
)
2.32
"Quercetin is a flavonol compound that exerts a control effect on plant virus diseases, but its poor solubility and stability limit the control efficiency."( Field application of nanoliposomes delivered quercetin by inhibiting specific hsp70 gene expression against plant virus disease.
Hao, K; Shen, L; Su, C; Wang, F; Wang, J; Yang, J; Yu, F, 2022
)
1.7
"Quercetin is a flavonoid in vegetables and fruits that has shown hepatoprotective potential, but little is known about its effects on HSCs activation."( Effect of Quercetin on the fructose-activated human hepatic stellate cells, LX-2, an in-vitro study.
Afarin, R; Akbari, R; Mohammadtaghvaei, N; Shakerian, E, 2022
)
1.85
"Quercetin is a natural flavonoid that is known to have numerous pharmacological activities such as antioxidative, anti-inflammatory, and neuroprotective effects against various neurological disorders. "( Quercetin ameliorates lipopolysaccharide-induced neuroinflammation and oxidative stress in adult zebrafish.
Kapil, L; Sahu, K; Singh, A; Singh, C; Singh, S, 2022
)
3.61
"Quercetin is a bioactive flavonoid in O."( Quercetin promotes cutaneous wound healing in mice through Wnt/β-catenin signaling pathway.
Hu, P; Lu, S; Ma, X; Mi, Y; Pan, Y; Wei, Z; Yan, B; Yang, G; Zhong, L, 2022
)
2.89
"Quercetin is a bioflavonoid compound with therapeutic benefits in metabolic diseases."( Quercetin attenuates the proliferation, inflammation, and oxidative stress of high glucose-induced human mesangial cells by regulating the miR-485-5p/YAP1 pathway.
Chen, S; Chen, X; Li, X; Pan, Q; Wan, H; Wang, Y; Yao, W,
)
2.3
"Quercetin, a flavonoid, is an anti-oxidative, anti-allergic, antiviral, anti-inflammatory, and anticancer compound."( Quercetin and Glioma: Which Signaling Pathways are Involved?
Aschner, M; Barati, E; Mirzaei, H; Razavi, ZS; Razzaghi, N; Tamtaji, OR, 2022
)
2.89
"Quercetin is a polyphenol found in plant and has neuroprotective effects against neurodegenerative diseases."( Quercetin ameliorates glutamate toxicity-induced neuronal cell death by controlling calcium-binding protein parvalbumin.
Kang, JB; Koh, PO; Park, DJ; Shah, MA, 2022
)
2.89
"Quercetin is a pharmacologically active polyphenol found in quinoa."( Quinoa Soluble Fiber and Quercetin Alter the Composition of the Gut Microbiome and Improve Brush Border Membrane Morphology In Vivo (
Agarwal, N; Even, C; Khen, N; Kolba, N; Koren, O; Tako, E; Turjeman, S, 2022
)
1.75
"Quercetin is a plant-derived polyphenol flavonoid that has been proven to be effective for many diseases. "( The potential biological effects of quercetin based on pharmacokinetics and multi-targeted mechanism
Amuti, S; Chen, D; Fu, J; Han, P; Jiang, JD; Keranmu, A; Liu, YF; Ma, SR; Pan, LB; Wang, MS; Wang, Y; Xing, NZ; Xu, H; Yang, FY; Yu, H; Zhang, ZW, 2022
)
2.44
"Quercetin is a polyphenolic flavonoid plant secondary metabolite with a well-characterized antioxidant activity."( A Comprehensive View on the Quercetin Impact on Colorectal Cancer.
Alaya, A; Maghiar, AM; Maghiar, TA; Mathe, E; Neamtu, AA; Neamtu, C; Olah, NK; Pelea, D; Totolici, BD; Turcus, V, 2022
)
1.74
"Quercetin is a flavonoid abundantly present in plant-based foods, with a possible impact on cardiovascular health."( Quercetin Mitigates Endothelial Activation in a Novel Intestinal-Endothelial-Monocyte/Macrophage Coculture Setup.
Boon, N; De Munck, J; Grootaert, C; Raes, K; Smagghe, G; Van Camp, J; Vissenaekens, H, 2022
)
2.89
"Quercetin is a natural flavonoid present in many vegetables and fruits and has immunomodulatory, anti-inflammatory, and antioxidant properties."( Quercetin-Ameliorated, Multi-Walled Carbon Nanotubes-Induced Immunotoxic, Inflammatory, and Oxidative Effects in Mice.
Abou El-Fotoh, MF; Ahmed, MM; Alshahrani, MY; El-Magd, MA; Ghamry, HI; Magdy, A; Sallam, AA, 2022
)
2.89
"Quercetin is a natural product with antioxidative, anti-inflammatory, and antiproliferative properties."( Quercetin attenuates the proliferation of arsenic-related lung cancer cells via a caspase-dependent DNA damage signaling.
Li, X; Wen, Q; Yang, P; Zhao, X, 2022
)
2.89
"Quercetin is a potent antioxidant which is currently being used in various pharmaceuticals."( Health Benefits of Quercetin in Age-Related Diseases.
Maurya, PK, 2022
)
1.77
"Quercetin (Quer) is a natural polyphenolic compound widely used in traditional Chinese medicine."( Quercetin regulates vascular endothelium function in chronic renal failure via modulation of Eph/Cav-1 signaling.
Chen, B; Chen, J; Yang, Y; Zhang, H, 2022
)
2.89
"Quercetin is a flavonoid present in the human diet with multiple health benefits. "( Structural, dynamic, and hydration properties of quercetin and its aggregates in solution.
Campo, MG; Corral, GM, 2022
)
2.42
"Quercetin is a potent anti-oxidative bioflavonoid."( Quercetin ameliorates oxidative stress‑induced cell apoptosis of seminal vesicles via activating Nrf2 in type 1 diabetic rats.
Chen, J; Chen, ZS; Dong, B; Dong, Y; Han, C; Shi, Z; Wu, W; Wu, ZX, 2022
)
2.89
"Quercetin is a phytochemical that has strong antioxidant properties and pro-apoptotic effects and has been investigated for many years."( Senescence-mediated anticancer effects of quercetin.
Becer, E; Özsoy Gökbilen, S; Vatansever, HS, 2022
)
1.71
"Quercetin is a flavonol compound that can be found in dietary fruits and vegetables."( Quercetin Mitigates Cisplatin-Induced Oxidative Damage and Apoptosis in Cardiomyocytes through Nrf2/HO-1 Signaling Pathway.
Chang, YC; Cheng, HC; Chou, WC; Huang, YT; Ou, HC; Tsai, KL; Wang, SH, 2022
)
2.89
"Quercetin is a natural flavonoid exhibiting antiviral activity against CMV by a mechanism distinct from GCV, but is poorly soluble, limiting its use as a therapeutic."( Poloxamer 188 - quercetin formulations amplify in vitro ganciclovir antiviral activity against cytomegalovirus.
Britt, DW; Kjar, A; Vargis, E; Wadsworth, I, 2022
)
1.79
"Quercetin is a flavonoid that is widely found in fruits and vegetables. "( Phytochemical quercetin alleviates hyperexcitability of trigeminal nociceptive neurons associated with inflammatory hyperalgesia comparable to NSAIDs.
Itou, H; Takeda, M; Toyota, R, 2022
)
2.52
"Quercetin is a potent, naturally occurring GLP-1 secretagogue."( Novel luciferase-based glucagon-like peptide 1 reporter assay reveals naturally occurring secretagogues.
Alexandru, PR; Anghel, SA; Badea, RA; Chiritoiu, G; Patriche, DS; Pena, F, 2022
)
1.44
"Quercetin is a flavonoid with a wide range of pharmacological activities, including anticancer, antioxidant, and anti-inflammatory effects. "( Quercetin Reduces the Development of 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Induced Cleft Palate in Mice by Suppressing CYP1A1 via the Aryl Hydrocarbon Receptor.
Ishii, T; Morikawa, T; Nishii, Y; Sakamoto, T; Satake, K, 2022
)
3.61
"Quercetin is a kind of flavonoid with important bioactivities, such as hypoglycemic, antioxidant, anti-inflammatory, and anti-allergic properties. "( Anti-Allergic Effects of Quercetin and Quercetin Liposomes in RBL-2H3 Cells.
Guan, R; Huang, H; Zhang, Y, 2023
)
2.66
"Quercetin (QUE) is a natural flavonoid that is ubiquitous in fruits and vegetables."( Pharmacological Aspects of Natural Quercetin in Rheumatoid Arthritis.
Ji, B; Li, F; Peng, W; Tang, M; Xie, X; Yang, Y; Zeng, Y, 2022
)
1.72
"Quercetin (QUR) is a natural compound of flavonoids found in a variety of foods and medicinal plants."( Potential Role of Quercetin in Polycystic Ovary Syndrome and Its Complications: A Review.
Chen, T; Jia, F; Liu, X; Wang, C; Yu, Y; Zhang, N; Zhang, W; Zhu, S, 2022
)
1.78
"Quercetin is a polyphenolic bioactive compound highly enriched in dietary fruits, vegetables, nuts, and berries. "( Therapeutic Potential of Quercetin and its Derivatives in Epilepsy: Evidence from Preclinical Studies.
Kumar, V; Prakash, C; Rabidas, SS; Sharma, D; Tyagi, J, 2023
)
2.66
"Quercetin is a privileged molecule that is known to interfere at different levels of inflammatory response."( Quercetin against Emerging RNA Viral Diseases: Potential and Challenges for Translation.
Subudhi, BB; Swain, RP, 2023
)
3.07
"Quercetin (QT) is an effective apoptosis inhibitor and antioxidant flavonoid, but its water solubility is poor and has no targeting."( A Water-Soluble Quercetin Conjugate with Triple Targeting Exerts Neuron-Protective Effect on Cerebral Ischemia by Mitophagy Activation.
Cen, J; Cui, J; Duan, S; Guo, Y; Zhang, C; Zhang, R; Zhang, X; Zhao, K; Zhao, T, 2022
)
1.79
"Quercetin (QUE) is a well-known natural product that can exert beneficial properties on human health. "( Comparative Interaction Studies of Quercetin with 2-Hydroxyl-propyl-β-cyclodextrin and 2,6-Methylated-β-cyclodextrin.
Cournia, Z; Diamantis, DA; Georgiou, N; Javornik, U; Mauromoustakos, T; Papadourakis, M; Papakyriakopoulou, P; Plavec, J; Tzakos, AG; Tzeli, D; Vakali, V; Valsami, G; Zoupanou, N, 2022
)
2.44
"Quercetin (QT) is a flavonoid that exhibits anti-oxidant and chemo-preventive activity. "( Development of surface modified bilosomes for the oral delivery of quercetin: optimization, characterization in-vitro antioxidant, antimicrobial, and cytotoxicity study.
Alnomasy, SF; Alomar, FA; Alquraini, A; Alruwaili, NK; Alsaidan, OA; Mostafa, EM; Rawaf, A; Yasir, M; Zafar, A, 2022
)
2.4
"Quercetin is a flavonoid widely found in numerous vegetables, fruits, and foods and is thought to have antioxidant and anti-inflammatory properties, which may be associated with improvement of chemotherapy sensitivity during pancreatic cancer treatment."( Quercetin improves pancreatic cancer chemo-sensitivity by regulating oxidative-inflammatory networks.
Hu, Y; Jin, J; Li, R; Ma, R; Wang, Y, 2022
)
2.89
"Quercetin (Qu) is a bioflavonoid with striking biological activities."( Protective effect of quercetin against 5-fluorouracil-induced cardiac impairments through activating Nrf2 and inhibiting NF-κB and caspase-3 activities.
Al Sberi, H; Albrakati, A; Alharthi, F; Alhazmi, A; Alsharif, KF; Althagafi, HA; Elhefny, MA; Gewaily, MS; Habotta, OA; Hassan, AA; Hawsawi, YM; Kassab, RB; Khafaga, AF; Lokman, MS; Mufti, AH; Theyab, A, 2023
)
1.95
"Quercetin is a widely distributed, bioactive flavonoid compound, which displays potential to inhibit fibrosis in several diseases. "( Quercetin inhibits the amphiregulin/EGFR signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in obstructive nephropathy.
Jiang, D; Li, X; Ma, Z; Wang, F; Wang, Q, 2023
)
3.8
"Quercetin is an organic flavonoid present in several fruits and vegetables. "( Sub-chronic oral toxicity screening of quercetin in mice.
Aladhami, A; Chatzistamou, I; Cunningham, P; Enos, RT; Fan, D; Madero, S; Murphy, EA; Patton, E; Unger, C; VanderVeen, BN; Velázquez, KT, 2022
)
2.43
"Quercetin is a flavonol ubiquitously present in fruits and vegetables that shows a potential therapeutic use in non-transmissible chronic diseases, such as cancer and diabetes. "( Cytotoxicity of quercetin is related to mitochondrial respiration impairment in Saccharomyces cerevisiae.
Arvizu-Medrano, SM; Canizal-Garcia, M; Carrillo-Garmendia, A; González-Hernández, JC; Gracida, J; Madrigal-Perez, LA; Martinez-Ortiz, C; Regalado-Gonzalez, C, 2022
)
2.51
"Quercetin (Que) is a natural bioflavonoid compound with anti-inflammatory and antioxidative properties that reportedly inhibits the NLRP3 inflammasome in sepsis-induced organ dysfunctions such as ALI."( Quercetin protects against LPS-induced lung injury in mice via SIRT1-mediated suppression of PKM2 nuclear accumulation.
Chen, LL; Dai, MH; Han, DD; Li, W; Li, Y; Lin, FY; Pan, PH; Song, C; Zhang, Y; Zhao, YH, 2022
)
2.89
"Quercetin is a flavonol-type antioxidant that may be found in many foods."( Quercetin and polycystic ovary syndrome; inflammation, hormonal parameters and pregnancy outcome: A randomized clinical trial.
Amidi, F; Amini, N; Moini, A; Parivr, K; Rudbari, NH; Vaez, S, 2023
)
3.07
"Quercetin (Qu) is a dietary antioxidant and a member of flavonoids in the plant polyphenol family. "( Anti-Inflammatory, Antioxidative, and Nitric Oxide-Scavenging Activities of a Quercetin Nanosuspension with Polyethylene Glycol in LPS-Induced RAW 264.7 Macrophages.
Do, GS; Kang, SG; Kwon, JB; Lee, GB; Oh, SY; Singh, M; Vinayagam, R; Yang, SJ, 2022
)
2.39
"Quercetin is a naturally occurring bioactive flavonoid abundant in many plants and fruits. "( Neuropharmacological interventions of quercetin and its derivatives in neurological and psychological disorders.
Agrawal, K; Arfin, S; Chakraborty, P; Das, SS; Dewanjee, S; Dey, A; Jafari, SM; Jha, NK; Jha, SK; Kumar, D; Mishra, PC; Moustafa, M, 2023
)
2.62
"Quercetin is a natural polyphenol, considered as nutraceutical agent which produce antioxidant effects."( Quercetin impact against psychological disturbances induced by fat rich diet.
Arshad, M; Farhan, M; Rafi, H; Rafiq, H; Rehman, S, 2022
)
2.89
"Quercetin is a natural polyphenol, which protects neurodegeneration, remarkably by suppressing oxidative stress and inflammation."( Quercetin Is An Active Agent in Berries against Neurodegenerative Diseases Progression through Modulation of Nrf2/HO1.
Bayazid, AB; Lim, BO, 2022
)
2.89
"Quercetin is a flavonoid that reduces MMP-2 activity and ameliorates hypertrophic vascular remodeling of hypertension."( Quercetin decreases cardiac hypertrophic mediators and maladaptive coronary arterial remodeling in renovascular hypertensive rats without improving cardiac function.
Bertozi, G; Castro, MM; da Rocha, EV; de Mello, MMB; Falchetti, F; Gomes, BQ; Nogueira, RC; Parente, JM; Pernomian, L; Sanches-Lopes, JM; Tanus-Santos, JE, 2023
)
3.07
"Quercetin (QT) is a multipurposed drug with reported bone-conserving properties."( Development and evaluation of local regenerative biomimetic bone-extracellular matrix scaffold loaded with nano-formulated quercetin for orthopedic fractures.
Abdallah, OY; Ali, MM; Aly, RG; Heikal, LA; Kamal, NH, 2023
)
1.84
"Quercetin (Que) is a potent anti-inflammatory and antioxidant flavonoid with cardioprotective potential. "( Quercetin alleviates diastolic dysfunction and suppresses adverse pro-hypertrophic signaling in diabetic rats.
Bartekova, M; Bartosova, L; Duris-Adameova, A; Ferenczyova, K; Galis, P; Horvath, C; Kalocayova, B; Rajtik, T; Szobi, A, 2022
)
3.61
"Quercetin (QCT) is a naturally occurring phenolic flavonoid compound with inbuilt characteristics of antioxidant, anti-inflammatory, and immune protection. "( Protective role of engineered extracellular vesicles loaded quercetin nanoparticles as anti-viral therapy against SARS-CoV-2 infection: A prospective review.
Agarwal, S; Giri, R; Jeong, GB; Kala, S; Raghav, A, 2022
)
2.41
"Quercetin is a natural flavonoid that exhibits anti-inflammatory and antioxidant properties, and its antioxidant activity is correlated with POI."( Quercetin alleviates cyclophosphamide-induced premature ovarian insufficiency in mice by reducing mitochondrial oxidative stress and pyroptosis in granulosa cells.
Chen, B; Chen, Y; Miao, C; Wang, R; Yang, L; Zhang, Q; Zhao, Y, 2022
)
2.89
"Quercetin is a popular flavonoid with lower adverse effects and has anti-tumor properties."( Quercetin Effects on Cell Cycle Arrest and Apoptosis and Doxorubicin Activity in T47D Cancer Stem Cells.
Atashpour, S; Azizi, E; Barzegar, E; Fouladdel, S; Ghahremani, MH; Komeili Movahhed, T; Modaresi, F; Ostad, SN, 2022
)
2.89
"Quercetin is a key ingredient of anti-HCC activity in Xihuang Pills by regulating macrophage polarization and promoting autophagy via the NF-κB pathway."( Quercetin, the Ingredient of Xihuang Pills, Inhibits Hepatocellular Carcinoma by Regulating Autophagy and Macrophage Polarization.
Chen, J; Tian, S; Tian, X; Wang, Y; Wu, R; Xiong, J; Zhang, Z; Zhou, T, 2022
)
3.61
"Quercetin is a kind of polyphenolic flavonoid compounds which has perfect antioxidant properties. "( Synthesis of Quercetin-Acid Esters and Its Reduction of H
Hui, AL; Li, JW; Li, SN; Lin, YT; Liu, H; Liu, QS; Wang, YC; Wu, ZY; Zhang, WC, 2023
)
2.72
"Quercetin is a natural flavonoid, can be present in natural foods and plants."( Protective effect of quercetin on pulmonary dysfunction in streptozotocin-induced diabetic rats via inhibition of NLRP3 signaling pathway.
El-Shaer, NO; Hegazy, AM; Muhammad, MH, 2023
)
1.95
"Quercetin is a natural flavonoid found in common food species, with the characteristics of antioxidative, anti-inflammatory, and anti-cancerous activity."( Quercetin Mitigates Radiation-Induced Intestinal Injury and Promotes Intestinal Regeneration via Nrf2-Mediated Antioxidant Pathway1.
Li, J; Li, Y; Liu, Y; Wu, L; Xu, Y; Yang, M; Yu, Z; Yue, L; Zhang, B; Zhang, Y; Zhou, X; Zhu, X, 2023
)
3.07
"Quercetin is a natural flavonoid compound found in many kinds of plants and foods."( Quercetin Induces Cell Cycle Arrest and Apoptosis in YD10B and YD38 Oral Squamous Cell Carcinoma Cells.
Kim, D; Son, HK, 2023
)
3.07
"Quercetin is a flavonoid with anti-inflammatory and antioxidant properties as well as neuroprotective effects."( Anticonvulsant effect of quercetin in pentylenetetrazole (PTZ)-induced seizures in male mice: The role of anti-neuroinflammatory and anti-oxidative stress.
Amini-Khoei, H; Korani, MS; Lorigooini, Z; Rahimi-Madiseh, M; Tahmasebi Dehkordi, H; Tavakoli, Z, 2023
)
1.93
"Quercetin is a flavonoid that can be found in a variety of foods, including fruits and vegetables."( Quercetin: A Functional Food-Flavonoid Incredibly Attenuates Emerging and Re-Emerging Viral Infections through Immunomodulatory Actions.
Chowdhury, MAH; Hossain, KH; Nisa, FY; Rahman, MA; Saha, S; Shorobi, FM; Srisuphanunt, M, 2023
)
3.07
"Quercetin is a cheap and easily accessible therapeutic option for COVID-19 patients."( Quercetin for the treatment of COVID-19 patients: A systematic review and meta-analysis.
Awan, RU; Cheema, HA; Chinnam, S; Fatima, A; Nashwan, AJ; Shahid, A; Shahzil, M; Sohail, A; Ur Rehman, ME, 2023
)
3.07
"Quercetin is a flavonoid with various cytoprotective effects. "( Decrease in cholesterol in the cell membrane is essential for Nrf2 activation by quercetin.
Hashimoto, N; Kawabe, T; Kusatsugu, Y; Matsushima, M; Nose, H; Ohdachi, T; Sato, M; Takekoshi, M; Taniguchi, H; Tsuzuki, H, 2023
)
2.58
"Quercetin is a naturally sourced flavonoid with anti-inflammatory and antioxidant activities."( Quercetin Reprograms Immunometabolism of Macrophages via the SIRT1/PGC-1α Signaling Pathway to Ameliorate Lipopolysaccharide-Induced Oxidative Damage.
Cui, D; Hao, B; He, J; Li, H; Liu, Y; Lv, Y; Peng, J; Pu, W; Shang, R; Wang, S; Wang, X; Yang, Z; Zhang, H, 2023
)
3.07
"Quercetin is a polyphenol flavonoid compound from natural plants with anti-inflammatory and antioxidant functions."( Quercetin alleviates gliotoxin-induced duckling tissue injury by inhibiting oxidative stress, inflammation and increasing heterophil extracellular traps release.
Chen, M; Gao, X; Hong, H; Jiang, L; Jiang, Y; Jin, Q; Jin, Z; Liu, Q; Liu, W; Qian, Y; Wei, Z; Xu, J, 2023
)
3.07
"Quercetin is a bioflavonoid with antioxidant, anti-inflammatory, anti-aging and anti-cancer properties."( Protective Effects of Querectin against MPP
Alimujiang, A; Huang, D; Jiang, Y; Xie, G; Xie, H; Yang, W; Yin, F, 2023
)
1.63
"Quercetin is a naturally existing plant pigment belonging to the flavonoid group; it is contained in a wide range of vegetables and fruits. "( Quercetin as a Dietary Supplementary Flavonoid Alleviates the Oxidative Stress Induced by Lead Toxicity in Male Wistar Rats.
Abd-Elwahab, MM; Al-Doaiss, AA; Al-Eissa, MS; Al-Zharani, M; Mubarak, M; Rudayni, HA, 2023
)
3.8
"Quercetin is a well-known plant flavanol that exhibits multiple biological activities, including antioxidant, anti-inflammatory and anticancer activities. "( The significance of quercetin-loaded advanced nanoformulations for the management of diabetic wounds.
Chaudhary, A; Imran, M; Mohammed, Y; Panthi, VK; Paudel, KR, 2023
)
2.68
"Quercetin (QT) is a very effective anticancer drug in combating breast cancer. "( Delivery of quercetin for breast cancer and targeting potentiation via hyaluronic nano-micelles.
Li, M; Lin, K; Liu, Z; Sun, J; Wang, W; Wang, Z; Zhang, S; Zhao, Y; Zhen, Y, 2023
)
2.73
"Quercetin is a flavonoid with antioxidant and anti-inflammatory properties. "( The therapeutic potential of quercetin for cigarette smoking-induced chronic obstructive pulmonary disease: a narrative review.
Chen, J; Ding, K; Jia, H; Jiang, W; Lei, M; Wang, Y; Xiong, C; Zhan, W,
)
1.87
"Quercetin is a plant flavonoid with a molecular formula C"( Dietary quercetin protects Cherax quadricarinatus against white spot syndrome virus infection.
Gong, J; Pan, X; Zhou, X; Zhu, F, 2023
)
2.79
"Quercetin is a plant flavonoid, mostly used as a constituent in dietary products."( Quercetin abrogates lipopolysaccharide-induced depressive-like symptoms by inhibiting neuroinflammation via microglial NLRP3/NFκB/iNOS signaling pathway.
Abubakar, B; Adeniyi, FR; Adeoluwa, GO; Adeoluwa, OA; Akinluyi, ET; Edem, EE; Eduviere, AT; Fafure, A; Nebo, K; Olayinka, JN, 2023
)
3.07
"Quercetin is an essential flavonoid mostly found in herbal plants, fruits, and vegetables, which exhibits anti-hypertension properties. "( Quercetin attenuates angiotensin II-induced proliferation of vascular smooth muscle cells and p53 pathway activation in vitro and in vivo.
Ali, F; Cheng, Y; Chu, J; Peng, J; Saleem, MZ; Shen, A; Wang, D; Wei, L; Wu, M; Xie, Y; Yan, M; Yang, Y,
)
3.02
"Quercetin (Que) is a hydrophobic flavanol that has the potential to prevent colon diseases. "( Preparation of core-shell hordein/pectin nanoparticles as quercetin delivery matrices: Physicochemical properties and colon-specific release analyses.
Luo, T; Sun, Y; Wei, Z; Xue, C; Zhang, X, 2023
)
2.6
"Quercetin (QT) is a natural dietary flavonoid with good safety and multifaceted pharmacological activities against inflammation."( Oral pectin/oligochitosan microspheres for colon-specific controlled release of quercetin to treat inflammatory bowel disease.
Chen, H; Fang, Y; Huang, Y; Jing, S; Liu, E; Muhitdinov, B; Shen, H; Zeng, F; Zhang, M, 2023
)
1.86
"Quercetin is a flavonol widely distributed in plants and has various described biological functions. "( Dopaminergic modulation by quercetin: In silico and in vivo evidence using Caenorhabditis elegans as a model.
Aschner, M; Ávila, DS; Carrazoni, T; Dal Belo, CA; Martins, CF; Mori, MA; Müller, RU; Paula, FR; Rios-Anjos, RM; Salgueiro, WG; Soares, MV, 2023
)
2.65
"Quercetin (QUE) is a plant polyphenol with anti-inflammatory and antioxidant properties."( Quercetin Alleviates Deoxynivalenol-Induced Intestinal Damage by Suppressing Inflammation and Ferroptosis in Mice.
Chen, Y; Fu, Y; Hong, X; Jiang, M; Sun, Y; Wang, J; Wang, X; Wu, H; Yang, Z; Ye, Y; Zhou, E, 2023
)
3.07
"Quercetin (Qu) is a powerful flavanol antioxidant that is naturally found in plants and is part of the flavonoid family. "( Neuroprotective effect of quercetin and nano-quercetin against cyclophosphamide-induced oxidative stress in the rat brain: Role of Nrf2/ HO-1/Keap-1 signaling pathway.
Abass, HI; AbdElrazek, DA; Farroh, KY; Hassan, NH; Hassanen, EI; Ibrahim, MA, 2023
)
2.65
"Quercetin is a natural flavonoid widely found in natural fruits and vegetables. "( Pharmacological Activity of Flavonoid Quercetin and Its Therapeutic Potential in Testicular Injury.
Gu, J; Lu, G; Tang, Y; Zhang, X, 2023
)
2.62
"Quercetin is a flavonoid compound, which has anti-inflammatory and antioxidant roles."( Quercetin mitigates depression-like behavior via the suppression of neuroinflammation and oxidative damage in corticosterone-induced mice.
Ge, C; Lei, L; Wang, S; Wu, X, 2023
)
3.07
"Quercetin (QUE) is a natural polyphenol known to have numerous pharmacological properties against infectious and non-infectious diseases. "( Quercetin inhibits Toxoplasma gondii tachyzoite proliferation and acts synergically with azithromycin.
Abugri, DA; Ayariga, JA; Napier, A; Robertson, BK; Sharma, HN; Wijerathne, SVT, 2023
)
3.8
"Quercetin (Que) is a natural compound that has demonstrated chemopreventive effects against different types of tumors."( Potential Therapeutic Targets of Quercetin in the Cutaneous Melanoma Model and Its Cellular Regulation Pathways: A Systematic Review.
Fernandes E Silva, E; Lopes, AC; Nascimento, MAD; Paiva, LS; Salgado, MTSF; Votto, APS, 2023
)
1.91
"Quercetin (QUER) is a natural polyphenolic compound endowed with beneficial properties for human health, with anti-aging effects. "( Sir2 and Glycerol Underlie the Pro-Longevity Effect of Quercetin during Yeast Chronological Aging.
Abbiati, F; Garagnani, SA; Orlandi, I; Vai, M, 2023
)
2.6
"Quercetin (QT) is a dietary flavonoid known for its anti-inflammatory effects and safe use in humans."( Cyclodextrin-Coordinated Liposome-in-Gel for Transcutaneous Quercetin Delivery for Psoriasis Treatment.
Chen, R; Gao, N; Gong, S; Huang, Y; Liu, E; Liu, L; Pan, L; Shen, H; Zhang, Y, 2023
)
1.87
"Quercetin is a vital flavonoid widely occurring in fruits and vegetables and has received significant interest as a prospective anti-inflammatory antioxidant."( Quercetin Alleviates Lipopolysaccharide-Induced Cell Oxidative Stress and Inflammatory Responses via Regulation of the TLR4-NF-κB Signaling Pathway in Bovine Rumen Epithelial Cells.
Huang, Y; Jiang, M; Wang, K; Yang, T; Zhan, K; Zhang, X; Zhao, G, 2023
)
3.07
"Quercetin is a bioactive flavonoid, but the effect of it on cardiometabolic factors has remained uncertain and previous findings from meta-analyses have been controversial."( The effects of Quercetin supplementation on cardiometabolic outcomes: An umbrella review of meta-analyses of randomized controlled trials.
Arabi, SM; Bahrami, LS; Chambari, M; Maleki, M; Sahebkar, A; Shahraki Jazinaki, M; Sukhorukov, VN, 2023
)
2.71
"Quercetin is an important source of free radical scavengers."( Investigation of the combined cytotoxicity induced by sodium butyrate and a flavonoid quercetin treatment on MCF-7 breast cancer cells.
Aksoy, O; Alimudin, J; Aydin, D; Betts, Z; Deveci Ozkan, A; Yanar, S; Yuksel, B, 2023
)
1.85
"Quercetin is a naturally occurring flavonoid, with numerous pharmaceutical activities like anti-oxidant, anti-inflammatory, and anti-tumor effects."( Anti-Inflammatory and Antioxidant Activity of Titanium Dioxide Nanotubes Conjugated with Quercetin.
Gulla, S; Lomada, D; Reddy, MC, 2023
)
1.85
"Quercetin (QC) is a naturally occurring flavonoid found in abundance in fruits and vegetables. "( Quercetin-loaded solid lipid nanoparticles exhibit antitumor activity and suppress the proliferation of triple-negative MDA-MB 231 breast cancer cells: implications for invasive breast cancer treatment.
Hatami, M; Kheirollah, A; Khorsandi, L; Kouchak, M; Rashidi, M, 2023
)
3.8
"Quercetin (Que) is a flavonol compound found in plants, which has a variety of biological activities. "( Quercetin Ameliorates Deoxynivalenol-Induced Intestinal Injury and Barrier Dysfunction Associated with Inhibiting Necroptosis Signaling Pathway in Weaned Pigs.
Chen, S; Guo, J; Liu, J; Liu, Y; Lv, Q; Qin, X; Xiao, K; Xu, Q; Xu, X; Zhao, J; Zhou, M, 2023
)
3.8
"Quercetin is a flavonol belonging to the flavonoid group of polyphenols. "( Quercetin induces pathogen resistance through the increase of salicylic acid biosynthesis in
An, J; Bahk, S; Chung, WS; Hong, JC; Kim, SH; Le Anh Pham, M; Lee, J; Park, J; Ramadany, Z, 2023
)
3.8
"The quercetin acts as an enzyme inducer by renewing the glutathione peroxidase activity and inhibiting the oxidation of proteins and hence decreases the oxidative stress. "( Extraction and Identification of Two Flavonoids in Phlomoides hyoscyamoides as an Endemic Plant of Iran: The Role of Quercetin in the Activation of the Glutathione Peroxidase, the Improvement of the Hydroxyproline and Protein Oxidation in Bile Duct-Ligate
Doustimotlagh, AH; Eftekhari, M; Mansourian, M; Taheri, S, 2020
)
1.33
"Quercetin is a bioflavonoid with well-known antidiabetic and antifibrotic properties."( Quercetin Mitigates Hepatic Insulin Resistance in Rats with Bile Duct Ligation Through Modulation of the STAT3/SOCS3/IRS1 Signaling Pathway.
Eshaghian, A; Khodarahmi, A; Moradi, A; Safari, F, 2019
)
2.68
"Quercetin is a widely used bioflavonoid found in onions, grapes, berries and citrus fruits. "( Quercetin-induced inactivation and conformational alterations of alpha-2-macroglobulin: multi-spectroscopic and calorimetric study.
Ahsan, H; Khan, FH; Siddiqui, T; Zia, MK, 2020
)
3.44
"Quercetin is a hydrophobic flavonoid with high antioxidant activity. "( Preparation and Characterization of Quercetin-Loaded Zein Nanoparticles by Electrospraying and Study of In Vitro Bioavailability.
Barreras-Urbina, CG; Carvajal-Millan, E; Castro-Enríquez, DD; Del-Toro-Sánchez, CL; Javier Cinco-Moroyoqui, F; Juárez, J; López-Ahumada, GA; Rodríguez-Félix, F; Ruiz-Cruz, S; Tapia-Hernández, JA, 2019
)
2.23
"Quercetin is a plant-derived chemical belonging to the family of flavonoids."( Autophagy as a molecular target of quercetin underlying its protective effects in human diseases.
Ahmadi, Z; Ashrafizadeh, M; Farkhondeh, T; Samarghandian, S, 2022
)
1.72
"Quercetin is a flavonoid extract of Ginkgo biloba leaves."( Systematic Investigation of Quercetin for Treating Cardiovascular Disease Based on Network Pharmacology.
Chen, C; Mao, W; Wu, XJ; Zhou, XB, 2019
)
1.53
"Quercetin is a natural flavonoid with important biological properties (anti-inflammatory, antihistamine and anti-oxidative actions)."( Supplementary prevention and management of asthma with quercetin phytosome: a pilot registry.
Belcaro, G; Cesarone, MR; Cotellese, R; Dugall, M; Feragalli, B; Hosoi, M; Hu, S; Ledda, A; Maione, C, 2019
)
1.48
"Quercetin is a flavonoid that is abundant in apples, grapes, red raspberry, and onions and has been reported to inhibit RAGE."( Quercetin facilitates cell death and chemosensitivity through RAGE/PI3K/AKT/mTOR axis in human pancreatic cancer cells.
Chen, SY; Kuo, CW; Lan, CY; Lu, CC; Yen, GC, 2019
)
2.68
"Quercetin is a plant flavonoid with great potential for the prevention and treatment of disease. "( Quercetin-Amino Acid Conjugates are Promising Anti-Cancer Agents in Drug Discovery Projects.
Atamaniuk, VP; Dobrydnev, AV; Popova, MV; Tkachuk, TM, 2020
)
3.44
"Quercetin is a bioactive flavonoid and has been shown to protect against HCC through its antioxidant activity."( Beyond its antioxidant properties: Quercetin targets multiple signalling pathways in hepatocellular carcinoma in rats.
Abdel-Rahman, N; El Gayyar, AM; El-Karef, A; Salama, YA, 2019
)
1.51
"Quercetin is a flavonol polyphenol widely found in many vegetables, grains, and fruits. "( Quercetin depletes intracellular Ca
Chan, P; Chen, CY; Hour, MJ; Leung, YM; Shiao, LR; So, EC; Wong, KL, 2020
)
3.44
"Quercetin is a flavonoid and is abundant in the plant kingdom. "( Green Synthetic Nanoarchitectonics of Gold and Silver Nanoparticles Prepared Using Quercetin and Their Cytotoxicity and Catalytic Applications.
Lee, YJ; Park, Y, 2020
)
2.23
"Quercetin is a naturally occurring polyphenol present in various fruits and vegetables. "( Quercetin Directly Targets JAK2 and PKCδ and Prevents UV-Induced Photoaging in Human Skin.
Byun, S; Hong, S; Lee, JS; Lim, TG; Shin, EJ, 2019
)
3.4
"Quercetin is a type of flavonoid compound that influences antioxidant and anti-inflammatory activities have protective and therapeutic effects for treating various diseases including diabetes mellitus and neuro-degenerative diseases."( The protective effect of quercetin in the alcohol-induced liver and lymphoid tissue injuries in newborns.
Ince, E, 2020
)
1.58
"Quercetin is a flavonoid that presents several biological activities, including anti-hRSV role."( Quercetin pentaacetate inhibits in vitro human respiratory syncytial virus adhesion.
Caruso, IP; da Costa, MF; da Silva, TF; de Araujo, GC; de Oliveira, J; de Souza, FP; Desideri, A; Falconi, M; Genova Ribeiro, A; Iacovelli, F; Kubo, LH; Lima, CS; Lopes, BRP; Regasini, LO; Toledo, KA, 2020
)
2.72
"Quercetin is a kind of flavonoid compounds that comes from nature and is widely existed in the daily diet. "( Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects.
Deng, XT; Ge, XX; Li, QP; Miao, L; Tang, SM; Zhou, J, 2020
)
2.27
"Quercetin is a flavonoid present in fruits, vegetables and plants with antioxidant, anti-inflammatory and anticancer properties. "( Antitumor Effects of Quercetin in Hepatocarcinoma In Vitro and In Vivo Models: A Systematic Review.
Fernández-Palanca, P; Fondevila, F; González-Gallego, J; Mauriz, JL; Méndez-Blanco, C; Tuñón, MJ, 2019
)
2.28
"Quercetin is a flavonoid that exhibits potential pharmacological activity on mental diseases."( Quercetin attenuates acute predator stress exposure-evoked innate fear and behavioral perturbation.
Anggreini, P; Ardianto, C; Khotib, J; Rahmadi, M, 2019
)
2.68
"Quercetin is a bioactive flavonoid which abundantly exists in vegetables and fruits. "( Quercetin Attenuates Decrease of Thioredoxin Expression Following Focal Cerebral Ischemia and Glutamate-induced Neuronal Cell Damage.
Jin, YB; Kang, JB; Koh, PO; Park, DJ; Shah, FA, 2020
)
3.44
"Quercetin is a flavonoid with notable pharmacological effects and promising therapeutic potential. "( Neuroprotective Effects of Quercetin in Alzheimer's Disease.
Akkol, EK; Aschner, M; Cheang, WS; Khan, H; Ullah, H, 2019
)
2.25
"Quercetin is a kind of distinctive bioactive flavonoid that has potent anti-oxidant, anti-inflammatory and anti-diabetic properties. "( Quercetin attenuates high glucose-induced injury in human retinal pigment epithelial cell line ARPE-19 by up-regulation of miR-29b.
Li, H; Shi, J; Wang, H; Wang, X, 2020
)
3.44
"Quercetin is a natural flavonoid with potential anti-cancer properties without significant cytotoxicity in normal tissues."( Quercetin pretreatment enhances the radiosensitivity of colon cancer cells by targeting Notch-1 pathway.
Cai, Y; He, GQ; Jin, J; Li, SH; Li, Y; Wang, J; Wang, Z; Zhu, SX, 2020
)
2.72
"Quercetin is a flavonoid which has potent anti-inflammatory, antibacterial, and antioxidant effect. "( Quercetin Decreased Alveolar Bone Loss and Apoptosis in Experimentally Induced Periodontitis Model in Wistar Rats.
Gevrek, F; Taskan, MM, 2020
)
3.44
"Quercetin is an herbal bioactive flavonoid commonly used for the treatment of metabolic and inflammatory disorders."( Quercetin and polycystic ovary syndrome, current evidence and future directions: a systematic review.
Alizadeh, M; Hajizadeh-Sharafabad, F; Jafari-Vayghan, H; Maleki, V; Pourteymour Fard Tabrizi, F; Vaezi, M, 2020
)
2.72
"Quercetin is a natural product that has been shown to induce tumor apoptosis and necrosis through multiple mechanisms. "( Quercetin promotes the survival of granulocytic myeloid-derived suppressor cells via the ESR2/STAT3 signaling pathway.
Hu, C; Ma, Z; Xia, Y; Yi, H; Yu, M, 2020
)
3.44
"Quercetin is a flavonoid possessing neuroprotective effects."( Quercetin is protective against short-term dietary advanced glycation end products intake induced cognitive dysfunction in aged ICR mice.
Chen, LH; Li, RY; Shen, QL; Wan, Z; Wang, G; Yang, S; Zhang, XJ; Zhang, YH; Zhong, XH; Zhou, H, 2020
)
2.72
"Quercetin is a plant flavonoid and has potent antioxidant and anti-inflammatory properties. "( Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease.
Barreto, TA; Comstock, AT; Han, MK; Martinez, FJ; Sajjan, US, 2020
)
2.25
"Quercetin is a plant flavonoid and has antioxidative properties. "( Quercetin alleviates hyperthyroidism-induced liver damage via Nrf2 Signaling pathway.
Hou, Q; Hu, Z; Ma, W; Tian, Z; Zang, L; Zhao, P, 2020
)
3.44
"Quercetin is a flavonoid belonging to phytoestrogens family and may be useful in treatment of reproductive disorders."( Ameliorative effects of quercetin on the preimplantation embryos development in diabetic pregnant mice.
Alaee, S; Bolouki, A; Zal, F, 2020
)
1.59
"Quercetin (QCT) is a natural polyphenolic compound enriched in human food, mainly in vegetables, fruits and berries. "( Potential Implications of Quercetin and its Derivatives in Cardioprotection.
Bartekova, M; Ferenczyova, K; Kalocayova, B, 2020
)
2.3
"Quercetin is a key nutraceutical with topical antioxidant and anti-inflammatory properties which was reported to be effective in the treatment of different dermatological diseases, however, its topical therapeutic activity is hindered by its poor skin penetration."( Nanotechnological Innovations Enhancing the Topical Therapeutic Efficacy of Quercetin: A Succinct Review.
Al-Karaki, R; Nasr, M, 2020
)
1.51
"Quercetin is a flavonol from the flavonoid group of polyphenols, which positively affects human health due to its anti-cancer, anti-inflammatory, anti-microbial and cardioprotective effects. "( Quercetin-Mediated Apoptosis and Cellular Senescence in Human Colon Cancer.
Becer, E; Kabadayı, H; Özsoy, S; Vatansever, HS; Yücecan, S, 2020
)
3.44
"Quercetin (Que) is a kind of flavonoid that can protect many tissues from the toxic effect of heavy metals."( Protective effect of quercetin on rat testes against cadmium toxicity by alleviating oxidative stress and autophagy.
Liu, Z; Wang, J; Wang, K; Yang, Z; Zhu, H, 2020
)
1.6
"Quercetin is a dietary antioxidant with strong redox modulating capacities that is suggested to exert part of its antioxidative effects via activation of the redox-sensitive transcription factor Nrf2 that regulates endogenous antioxidant levels."( The dietary antioxidant quercetin reduces hallmarks of bleomycin-induced lung fibrogenesis in mice.
Albrecht, C; Bartholome, R; Bast, A; Boots, AW; Claessen, SMH; Drittij, MJ; Jonkers, L; Rosenbruch, M; Schins, RPF; van Schooten, FJ; Veith, C, 2020
)
1.59
"Quercetin is a flavonoid with high anti-tumour activity against different cancers that can be used with cisplatin to enhance its efficacy and also are seen to sensitise cancer cells into chemotherapy."( Dual role of quercetin in enhancing the efficacy of cisplatin in chemotherapy and protection against its side effects: a review.
Ashrafizadeh, M; Najafi, M; Tavakol, S; Zarrabi, A, 2022
)
1.81
"Quercetin is a part of natural flavonoids in plant polyphenols."( Quercetin for myocardial ischemia reperfusion injury: A protocol for systematic review and meta-analysis.
Kong, Y; Li, L; Lu, L; Ma, X; Wang, J; Yang, W; Zheng, J, 2020
)
2.72
"Quercetin is a well-known flavonoid whose antiviral properties have been investigated in numerous studies."( Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19).
Berrill, M; Catravas, JD; Colunga Biancatelli, RML; Marik, PE, 2020
)
2.72
"Quercetin is a flavonoid commonly found in vegetables and fruits and has been reported to exert numerous pharmacological activities such as enhancing antioxidant capacity or suppressing inflammation."( Dietary Quercetin Alleviated DSS-induced Colitis in Mice Through Several Possible Pathways by Transcriptome Analysis.
Dong, Y; Lei, J; Zhang, B, 2020
)
1.71
"Quercetin is a potent antioxidant flavonoid widely distributed in fruits and vegetables and has shown protective effects against dexamethasone-induced skeletal muscle atrophy."( Effect of Quercetin on Dexamethasone-Induced C2C12 Skeletal Muscle Cell Injury.
Chen, C; Chen, FA; Chen, HC; Chiu, YJ; Chung, MI; Lu, CC; Wu, YT; Yang, JS, 2020
)
1.68
"Quercetin is a flavonoid, its glycosides and aglycone are found in significant amounts in several plants and dietary supplements. "( Inhibitory Effects of Quercetin and Its Main Methyl, Sulfate, and Glucuronic Acid Conjugates on Cytochrome P450 Enzymes, and on OATP, BCRP and MRP2 Transporters.
Fliszár-Nyúl, E; Kroon, PA; Kuffa, K; Mohos, V; Needs, PW; Özvegy-Laczka, C; Poór, M; Telbisz, Á; Ungvári, O, 2020
)
2.32
"Quercetin is a plant-derived flavonoid suggested to have potent anticancer properties."( Quercetin Inhibits Proliferation and Induces Apoptosis of B16 Melanoma Cells
Berry, IM; Kumari, D; Moore, TC; Soll, F; Ternent, C,
)
2.3
"Quercetin is a phytoestrogen reported to accelerate skin wound healing, but its effect on EpSCs is unknown."( Quercetin promotes human epidermal stem cell proliferation through the estrogen receptor/β-catenin/c-Myc/cyclin A2 signaling pathway.
Feng, J; Fu, Y; Hou, R; Jin, G; Ju, J; Le, Y; Liu, J; Su, H; Wan, D; Wang, Z; Zhang, G; Zhang, P; Zhao, Q, 2020
)
2.72
"Quercetin is a flavonoid contained in subarctic trees with freeze resistance and is known to be a strong antioxidant."( Effect of quercetin on the motility of cryopreserved canine spermatozoa.
Harakawa, S; Kawasaki, Y; Sakurai, D; Suzuki, H; Tsuchida, M; Yoshihara, T, 2020
)
1.68
"Quercetin is a yellow pigment that is found in many common dietary plants, and that protects against oxidative stress, inflammation, and arteriosclerosis. "( Quercetin enhances motility in aged and heat-stressed Caenorhabditis elegans nematodes by modulating both HSF-1 activity, and insulin-like and p38-MAPK signalling.
Sakamoto, K; Sugawara, T, 2020
)
3.44
"Quercetin is a kind of typical flavonoid, mainly found in various vegetables, fruits and Chinese herbs that are consumed daily, with the functions of anti-oxidation, anti-tumor, prevention and treatment of cardiovascular and cerebrovascular diseases. "( [Research progress on antitumor activity of quercetin derivatives].
Feng, YL; Lu, LP; Zhai, GY, 2020
)
2.26
"Quercetin is a flavonoid abundantly found in fruits and vegetables. "( Quercetin as an Agent for Protecting the Bone: A Review of the Current Evidence.
Chin, KY; Ima-Nirwana, S; Wong, SK, 2020
)
3.44
"Quercetin is a natural flavonoid that occurs in fruits and vegetables. "( The protective effect of quercetin on retinal inflammation in mice: the involvement of tumor necrosis factor/nuclear factor-κB signaling pathways.
Ho, TY; Hsiang, CY; Liao, YF; Lin, KA; Liu, IC; Lo, HY; Lo, YC, 2020
)
2.3
"Quercetin (Que) is a flavonoid associated with high oxygen radical scavenging activity and potential neuroprotective activity against Alzheimer's disease. "( Preparation and Biophysical Characterization of Quercetin Inclusion Complexes with β-Cyclodextrin Derivatives to be Formulated as Possible Nose-to-Brain Quercetin Delivery Systems.
Andreadelis, I; Athanasiadou, I; Banella, S; Chatziathanasiadou, MV; Chountoulesi, M; Colombo, G; Dallas, P; Demetzos, C; Diamantis, DA; Javornik, U; Manta, K; Mavromoustakos, T; Moschovou, K; Naziris, N; Papakyriakopoulou, P; Plavec, J; Rekkas, DM; Spaneas, D; Tzakos, AG; Vakali, V; Valsami, G, 2020
)
2.26
"Quercetin is a natural flavonoid which has been reported to be analgesic in different animal models of pain. "( Inhibition of hyperpolarization-activated cyclic nucleotide-gated channels with natural flavonoid quercetin.
Cao, Y; Liang, Y; Pang, J; Wu, X; Xu, Z; Zhou, P, 2020
)
2.22
"Quercetin is a flavonol that is known to have numerous beneficial biological effects such as an anti-fibrotic effect. "( Suppressive effect of quercetin against bleomycin-induced epithelial-mesenchymal transition in alveolar epithelial cells.
Deguchi, J; Izumi, M; Kawami, M; Senoo, S; Takano, M; Yumoto, R, 2020
)
2.32
"Quercetin is a flavonoid produced as a defense by plants. "( Effects of Quercetin on the Growth and Expression of Immune-Pathway-Related Genes in Silkworm (Lepidoptera: Bombycidae).
Guo, P; Kang, Z; Ren, F; Shi, G; Zhou, Y, 2020
)
2.39
"Quercetin is a flavonoid that displays antioxidant and anti-inflammatory activities in liver diseases."( Protective Effects of Quercetin on Livers from Mice Exposed to Long-Term Cigarette Smoke.
Araújo, NPS; Bezerra, FS; Cangussú, SD; Castro, TF; Costa, GP; Machado-Junior, PA; Matos, NA; Oliveira, M; Souza, ABF; Talvani, A; Vieira, PMA, 2020
)
1.59
"Quercetin is a natural substance that has multiple pharmacological properties, such as anti-inflammatory action, and is used as a dietary supplement."( Mechanistic Aspects and Therapeutic Potential of Quercetin against COVID-19-Associated Acute Kidney Injury.
Diniz, LRL; Duarte, ABS; Sousa, DP; Souza, MTS, 2020
)
1.53
"Quercetin is a flavonoid exclusively found in different vegetables, herbs, and fruits."( Quercetin in Attenuation of Ischemic/Reperfusion Injury: A Review.
Ashrafizadeh, M; Entezari, M; Esmaeili, H; Hushmandi, K; Najafi, M; Raei, M; Saleki, H; Samarghandian, S; Shahinozzaman, M; Zabolian, A; Zarrabi, A, 2021
)
2.79
"Quercetin is a bioflavonoid with potential antioxidant properties. "( Protective Effect of Quercetin against H
Cheng, X; Hu, Y; Peng, W; Tong, X; Yang, J; Yi, M; Yi, P; Zhang, Z, 2020
)
2.32
"Quercetin is a compound belonging to the flavonols class and has shown therapeutic effects against influenza virus."( Quercetin as a Natural Therapeutic Candidate for the Treatment of Influenza Virus.
Ghavami, S; Hudy, D; Markowski, J; Mehrbod, P; Shyntum, D; Łos, MJ, 2020
)
2.72
"Quercetin is a polyhydroxy flavone compound with activities such as anti-cancer, anti-inflammatory, antibacterial, antiviral, hypoglycemic and anti-hypertensive, immunomodulation and cardiovascular protection."( [Interaction between quercetin and DNA].
Wang, Y, 2020
)
1.6
"Quercetin is a plant-derived flavonoid with several pharmacological activities."( Enlightening the neuroprotective effect of quercetin in epilepsy: From mechanism to therapeutic opportunities.
Akyuz, E; Angelopoulou, E; Dundar, HE; Paudel, YN; Polat, AK, 2021
)
1.61
"Quercetin is a flavonoid compound widely present in plants and exhibits a variety of biological activities. "( Quercetin: Its Main Pharmacological Activity and Potential Application in Clinical Medicine.
Li, P; Long, M; Wang, T; Yang, D, 2020
)
3.44
"Quercetin is a natural flavonol antioxidant found in various plant sources and food samples. "( The therapeutic use of quercetin in ophthalmology: recent applications.
Du, X; Wang, H; Zhao, L, 2021
)
2.37
"Quercetin is a natural flavonoid with beneficial effects in the diabetic animal model, but data related to its effect on histological change and adiponectin system in the placenta of GDM are limited."( Quercetin improved histological structure and upregulated adiponectin and adiponectin receptors in the placenta of rats with gestational diabetes mellitus.
Khazaeel, K; Mahabady, MK; Ranjbar, R; Shamsi, MM; Tabandeh, MR, 2021
)
2.79
"Quercetin (QC) is a flavonoid with antioxidant activity, however, high liposolubility makes it difficult to remain in the viable skin layer."( A topical formulation containing quercetin-loaded microcapsules protects against oxidative and inflammatory skin alterations triggered by UVB irradiation: enhancement of activity by microencapsulation.
Baracat, MM; Casagrande, R; da Rocha, C; Georgetti, SR; Lopez, RFV; Martinez, RM; Medeiros, DC; Sfeir, N; Vale, DL; Verri, WA; Vicentini, FTMC, 2021
)
1.62
"Quercetin is a polyphenolic flavonoid that has reported to block the binding of adenosine to A1 receptors at central nervous system and increase calcium release from the sarcoplasmic reticulum at skeletal muscle. "( Quercetin ingestion modifies human motor unit firing patterns and muscle contractile properties.
Holobar, A; Watanabe, K, 2021
)
3.51
"Quercetin is a flavonoid that is found in many plant materials, including commonly eaten fruits and vegetables. "( Synthesis, Antiproliferative Activity and Radical Scavenging Ability of 5-
Barker, D; Fedrizzi, B; Leung, E; Lo, S, 2021
)
2.06
"Quercetin is a well-known antioxidant and a plant polyphenolic of flavonoid group found in many fruits, leaves, and vegetables. "( Inhibitory Effect of Quercetin on Propionibacterium acnes-induced Skin Inflammation.
Jeon, YD; Jin, JS; Kang, SH; Lim, HJ; Song, YJ, 2021
)
2.38
"Quercetin (QC) is a dietary bioflavonoid that can be conjugated with nanoparticles to facilitate its brain bioavailability. "( Quercetin‑conjugated superparamagnetic iron oxide nanoparticles modulate glucose metabolism-related genes and miR-29 family in the hippocampus of diabetic rats.
Dehghanian, F; Dini, S; Ebrahimpour, S; Esmaeili, A; Zakeri, M, 2021
)
3.51
"Quercetin is an inhibitor of the PI3K pathway; however, its protective effects against chemotherapy-induced follicle loss in mice have not been established."( Quercetin prevents primordial follicle loss via suppression of PI3K/Akt/Foxo3a pathway activation in cyclophosphamide-treated mice.
Cong, Y; Gao, H; Kuang, Y; Li, J; Long, H; Lyu, Q; Yu, S, 2021
)
2.79
"Quercetin is a flavonoid present in a wide variety of plant resources. "( Design and optimization of quercetin-based functional foods.
Lai, WF; Wong, WT, 2022
)
2.46
"Quercetin is a well-known plant flavonoid with neuroprotective properties. "( Quercetin relieves D-amphetamine-induced manic-like behaviour through activating TREK-1 potassium channels in mice.
Bai, Z; Guo, B; Li, R; Liu, H; Mao, H; Ren, K; Wang, W; Wu, S; Xue, Q; Yao, H, 2021
)
3.51
"Quercetin is a member of the flavonoid group of compounds, which is abundantly present in various dietary sources. "( Effect of Quercetin on ABCC6 Transporter: Implication in HepG2 Migration.
Abruzzese, V; Bisaccia, F; Carmosino, M; Koshal, P; Martinelli, F; Matera, I; Milella, L; Ostuni, A, 2021
)
2.47
"Quercetin (QCT) is a substance with preventive effects in treatment of cardiovascular diseases and diabetes."( Matrix Metalloproteinases and Their Role in Mechanisms Underlying Effects of Quercetin on Heart Function in Aged Zucker Diabetic Fatty Rats.
Barančík, M; Barteková, M; Boťanská, B; Ferenczyová, K; Fogarassyová, M; Kindernay, L, 2021
)
1.57
"Quercetin is a well-studied natural product with multiple pharmacological properties. "( Dual effects of quercetin on protein digestion and absorption in the digestive tract.
Chen, D; Cheng, Y; Huang, M; Liao, CK; Lin, H; Liu, Y; Xu, P; Yu, S; Zhou, Y, 2021
)
2.41
"Quercetin is a natural flavonoid compound that can be found in many foods."( Quercetin inhibits invasion and angiogenesis of esophageal cancer cells.
Cheng, D; Li, CL; Liu, KD; Liu, Y; Sun, ZQ; Xu, QQ, 2021
)
2.79
"Quercetin (Que) is a major active flavonoid component isolated from HT and is one of the quality control indexes of HT."( Quercetin-mediated SIRT1 activation attenuates collagen-induced mice arthritis.
Ba, X; Chen, Z; Han, L; Huang, Y; Lin, W; Qin, K; Shen, P; Tu, S, 2021
)
2.79
"Quercetin is a flavonoid with significant pharmacological effects and promising therapeutic potential."( Mechanistic insights and perspectives involved in neuroprotective action of quercetin.
Abdel-Daim, MM; Akhtar, MF; Albadrani, GM; Grewal, AK; Kamel, M; Najda, A; Rahman, MH; Saleem, A; Sharma, D; Sharma, V; Singh, M; Singh, TG; Walasek-Janusz, M, 2021
)
1.57
"Quercetin is a poorly water-soluble flavonoid with many benefits to human health. "( Solid Lipid Nanoparticles Produced via a Coacervation Method as Promising Carriers for Controlled Release of Quercetin.
Consumi, M; Leone, G; Magnani, A; Talarico, L; Tamasi, G, 2021
)
2.28
"Quercetin is a powerful antioxidant, so it potently provides plant tolerance against several biotic and abiotic stresses."( The role of quercetin in plants.
Arif, Y; Bajguz, A; Hayat, S; Singh, P, 2021
)
1.72
"Quercetin (QCT) is a dietary flavonoid with many beneficial effects (e.g., antioxidant, antiaging, antidiabetic, antifungal effects, and regulation of gastrointestinal motor activity in human); furthermore, it induces apoptosis, cell cycle arrest, and differentiation."( Is Quercetin Beneficial for Colon Cancer? A Cell Culture Study, Using the Apoptosis Pathways.
Armağan, İ; Bayram, D; Özgöçmen, M; Şenol, N; Sevimli, M; Türel, GY, 2022
)
2.79
"Quercetin is a flavonoid existing in different herbs, fruits, seeds, nuts and tea. "( The impact of the phytotherapeutic agent quercetin on expression of genes and activity of signaling pathways.
Ayatollahi, SA; Ghafouri-Fard, S; Khanbabapour Sasi, A; Shoorei, H; Taheri, M, 2021
)
2.33
"Quercetin is a flavonoid compound with a variety of biological properties that is widely distributed throughout the plant kingdom. "( Toxicity of thioacetamide and protective effects of quercetin in zebrafish (Danio rerio) larvae.
Cheng, B; Deng, Y; Guo, J; Huang, Y; Liu, Y; Lu, H; Meng, Y; Wang, K; Xiong, G; Zhang, J; Zhong, K, 2021
)
2.31
"Quercetin is a natural flavonoid that is widely present in fruits, herbs, and vegetables."( Potential Implications of Quercetin in Autoimmune Diseases.
Ba, X; Chen, Z; Deng, X; Han, L; Huang, Y; Lin, W; Qin, K; Shen, P; Tu, S, 2021
)
1.64
"Quercetin is a polyphenolic flavonoid occurring in leaves, stems, flowers and fruits of many plants. "( Quercetin affects uterine smooth muscle contractile activity in gilts.
Burmańczuk, A; Grabowski, T; Jaroszewski, JJ; Markiewicz, W; Vyniarska, A; Zygmuntowicz, A, 2021
)
3.51
"Quercetin is a flavonoid agent detected in fruits and vegetables with anti-inflammatory, antioxidant, and anticancer effects. "( Emerging impact of quercetin in the treatment of prostate cancer.
Abak, A; Basiri, A; Ghafouri-Fard, S; Karimi, A; Shabestari, FA; Shoorei, H; Taheri, M; Vaezi, S, 2021
)
2.39
"Quercetin is a polyphenolic compound, the effects of which raise scientists' doubts. "( Advantageous/Unfavorable Effect of Quercetin on the Membranes of SK-N-SH Neuroblastoma Cells.
Barbasz, A; Dyba, B; Kreczmer, B; Rudolphi-Szydło, E, 2021
)
2.34
"Quercetin is a natural product that is sold as a supplement in health food stores. "( Quercetin, a natural product supplement, impairs mitochondrial bioenergetics and locomotor behavior in larval zebrafish (Danio rerio).
Denslow, ND; Laurence Souders, C; Martyniuk, CJ; Zhang, JL, 2017
)
3.34
"Quercetin is a typical flavonol with atheroprotective effects, but the effect of quercetin on dendritic cell (DC) maturation in relation to atherosclerosis has not yet been clearly defined. "( Quercetin protects against atherosclerosis by inhibiting dendritic cell activation.
Lin, W; Ling, W; Wang, D; Wang, W, 2017
)
3.34
"Quercetin is a plant-based flavonoid with inhibitory effects on P-glycoprotein (P-gp) and CYP3A4 and also antioxidant properties."( Mechanistically elucidating the in vitro safety and efficacy of a novel doxorubicin derivative.
Alrushaid, S; Anderson, HD; Chaboyer, K; Davies, NM; El-Kadi, AOS; Forrest, ML; Maayah, ZH; Sayre, CL; Senadheera, SN; Zhao, Y, 2017
)
1.18
"Quercetin is a bioactive compound with anti-inflammatory, antioxidant and anticancer properties. "( Differential cytotoxic activity of Quercetin on colonic cancer cells depends on ROS generation through COX-2 expression.
Devaraj, H; Devaraj, SN; Kasinathan, NK; Murali, MR; P, A; Raja, SB; Rajendiran, V; Venkatabalasubramanian, S, 2017
)
2.17
"Quercetin (QC) is a dietary flavonoid abundant in many natural plants. "( Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-κB pathway.
Chen, H; Han, L; Liu, H; Lu, C; Wang, M; Yan, Y; Zhao, H, 2017
)
3.34
"Quercetin is a flavonoid that has been shown to have anti-oxidation, anti-inflammation, anti-allergic, anti-viral, and anti-cancer activities. "( Effects of quercetin on proliferation and migration of human glioblastoma U251 cells.
Li, CL; Lin, Y; Liu, Y; Lv, W; Qu, XG; Tang, ZG; Wang, GB, 2017
)
2.29
"Quercetin is an abundant flavonoid in fruits, vegetables such as onion, tea leaves, cranberry, radish leaves etc. "( Solvent effect in the synthesis of hydrophobic drug-loaded polymer nanoparticles.
Pal, S; Saha, C, 2017
)
1.9
"Quercetin is a flavonoid with many beneficial uses."( A Study of the Modulating Action of Quercetin on Biochemical and Histological Alterations Induced by Lead Exposure in the Liver and Kidney of Rats.
Elsawy, H; Mohammed, GM; Sedky, A, 2017
)
1.45
"Quercetin is a bioflavonoid found ubiquitously in fruits and vegetables, and has antioxidative activity."( Protective Effect of Quercetin against Oxidative Stress-Induced Cytotoxicity in Rat Pheochromocytoma (PC-12) Cells.
Bao, D; Liu, H; Pang, X; Wang, J, 2017
)
1.5
"Quercetin is a redox-active plant-derived flavonoid with potential anticancer effects, stemming largely from its interaction with a number of proteins, and in particular from inhibition of pro-life kinases. "( Potential anti-cancer activity of 7-O-pentyl quercetin: Efficient, membrane-targeted kinase inhibition and pro-oxidant effect.
Biasutto, L; Espina, V; Liotta, L; Mattarei, A; Paradisi, C; Sassi, N; Zoratti, M, 2017
)
2.16
"Quercetin is a flavonoid widely studied as a chemopreventive agent in different types of cancer. "( Quercetin Reverses Rat Liver Preneoplastic Lesions Induced by Chemical Carcinogenesis.
Baltiérrez-Hoyos, R; Carrasco-Torres, G; Martínez-Guerra, AA; Monroy-Ramírez, HC; Romero-Tlalolini, MLÁ; Sánchez-Chino, X; Vásquez-Garzón, VR; Villa-Treviño, S, 2017
)
3.34
"Quercetin is a flavonoid that exhibits powerful antioxidant activity."( Quercetin ameliorates learning and memory via the Nrf2-ARE signaling pathway in d-galactose-induced neurotoxicity in mice.
Dong, F; Fan, H; Jiang, J; Qu, X; Wang, S; Wang, Y; Wu, D; Yang, X; Yao, R, 2017
)
2.62
"Quercetin is a flavonoid with antioxidant properties."( Effects of ciprofloxacin on fetal rat liver during pregnancy and protective effects of quercetin.
Cetin, A; Demirtas, S; Dogan, Z; Elbe, H; Soysal, H; Taslidere, E, 2017
)
1.4
"Quercetin is a fragile bioactive compound. "( Fluorescence Lifetime and UV-Vis Spectroscopy to Evaluate the Interactions Between Quercetin and Its Yeast Microcapsule.
Pham-Hoang, BN; Waché, Y; Winckler, P, 2018
)
2.15
"Quercetin is a vital dietary flavonoid that has been shown to have a variety of anticancer effects, as it induces cell cycle arrest, apoptosis, and differentiation and is involved in cell adhesion, metastasis and angiogenesis."( Quercetin Inhibits Cell Migration and Invasion in Human Osteosarcoma Cells.
Bai, B; Fan, P; Hong, W; Lan, H; Qian, D; Zhu, J, 2017
)
2.62
"Quercetin is a major dietary flavonoid that has been shown to induce cell growth inhibition and apoptosis in human lung cancer cell lines."( Interactions of quercetin with receptor tyrosine kinases associated with human lung carcinoma.
Antony, P; Baby, B; Vijayan, R, 2018
)
1.55
"Quercetin is a flavonoid with high antioxidant activity that provides benefits to health."( Production of Cornstarch Granules Enriched with Quercetin Liposomes by Aggregation of Particulate Binary Mixtures Using High Shear Process.
Dacanal, GC; Galeskas, H; Pinho, SC; Toniazzo, T, 2017
)
1.43
"Quercetin is a common flavonoid which is found in many fruits and red wine."( Quercetin-Induced AMP-Activated Protein Kinase Activation Attenuates Vasoconstriction Through LKB1-AMPK Signaling Pathway.
Choi, HC; Kim, JR; Kim, SG, 2018
)
2.64
"Quercetin (Q1) is a flavonoid widely present in plants and endowed with several pharmacological properties mostly due to its antioxidant potential. "( New insights for the use of quercetin analogs in cancer treatment.
Caruso, A; Ceramella, J; Grande, F; Iacopetta, D; Mordocco, RA; Muià, N; Plutino, MR; Puoci, F; Rosano, C; Saturnino, C; Scrivano, L; Sinicropi, MS, 2017
)
2.19
"Quercetin is a flavonoid that has roles in both cytoprotection and cytotoxicity. "( Effect of quercetin on cell protection via erythropoietin and cell injury of HepG2 cells.
Matsumoto, R; Nakagawa, H; Nishimura, K; Yonezawa, Y, 2017
)
2.3
"Isoquercetin is a glycoside derivative with antihistamine properties of quercetin, a natural polyphenol flavonoid found in many plants."( Use of Isoquercetin in the Treatment of Prurigo Nodularis.
Basak, SA; Marks, AG; Neely, J; Pennesi, CM, 2017
)
1.37
"Quercetin is a polyphenol found in food that has numerous health benefits. "( Quercetin metabolism by fecal microbiota from healthy elderly human subjects.
Hoshi, C; Kobori, M; Nishihira, J; Nishimura, M; Takahashi, S; Tamura, M; Tomita, J, 2017
)
3.34
"Quercetin is a flavonoid presenting cytotoxicity against different cancer cell lines. "( Amplifying and broadening the cytotoxic profile of quercetin in cancer cell lines through bioconjugation.
Bellou, S; Chatziathanasiadou, MV; Geromichalos, GD; Geromichalou, EG; Katsikoudi, A; Sayyad, N; Stylos, E; Tzakos, AG; Vrettos, EI, 2018
)
2.18
"Quercetin (QUE) is a naturally occurring flavonoid compound."( Quercetin inhibits okadaic acid-induced tau protein hyperphosphorylation through the Ca2+‑calpain‑p25‑CDK5 pathway in HT22 cells.
He, F; Li, S; Luo, T; Shen, XY; Ting, OY; Wang, HQ; Xu, J, 2018
)
2.64
"Quercetin is a polyphenol that has been reported to be an active oxygen scavenger as well as a functional adenosine monophosphate-activated protein kinase (AMPK) activator."( Quercetin restores corticosteroid sensitivity in cells from patients with chronic obstructive pulmonary disease.
Azam, A; Barnes, PJ; Ito, K; Mercado, N; Mitani, A; Vuppusetty, C,
)
2.3
"Quercetin (QCT) is a flavonol present in many vegetables, it is proved to show chemo preventive effect against lung, cervical, prostate, breast and colon cancer due to its anti-inflammatory, anti-tumor and anti-oxidant property. "( Antitumor effect of Quercetin on Y79 retinoblastoma cells via activation of JNK and p38 MAPK pathways.
Liu, H; Zhou, M, 2017
)
2.22
"Quercetin is a member of flavonoid with strong antioxidant properties, and our results indicate that the use of ciprofloxacin in pregnancy can result damage to fetal brain tissue."( Effects of ciprofloxacin and quercetin on fetal brain development: a biochemical and histopathological study.
Cetin, A; Dogan, Z; Elibol, E; Turkoz, Y; Vardi, N, 2019
)
1.53
"Quercetin is a dietary flavonoid which has an effect on inflammation, angiogenesis and vascular inflammation. "( Quercetin decrease somatic cells count in mastitis of dairy cows.
Burmańczuk, A; Grabowski, T; Hola, P; Kowalski, C; Milczak, A; Piech, T; Wojciechowska, B, 2018
)
3.37
"Quercetin is a flavonoid with antioxidant, antiangiogenic, and chemoprotective properties but the mitochondrial effects are less characterized."( Quercetin exerts an inhibitory effect on cellular bioenergetics of the B164A5 murine melanoma cell line.
Ancușa, S; Danciu, C; Dehelean, C; Duicu, O; Muntean, D; Pavel, I; Sturza, A, 2018
)
2.64
"Quercetin is a ubiquitous flavonoid found in many plants. "( Effect of quercetin on the brain-derived neurotrophic factor gene expression in the rat brain.
Mashayekhi, FJ; Owji, AA; Rahvar, M, 2018
)
2.33
"As quercetin is an important flavonoid with significant antioxidant effects, the hypothesis here is that quercetin will reduce increased MMP-2 activity by decreasing oxidative stress in aortas of hypertensive rats and then ameliorate hypertension-induced vascular remodeling."( Quercetin decreases the activity of matrix metalloproteinase-2 and ameliorates vascular remodeling in renovascular hypertension.
Belo, VA; Castro, MM; Ceron, CS; do Vale, GT; Gonzaga, NA; Mendes, AS; Parente, JM; Pereira, SC; Tanus-Santos, JE; Tirapelli, CR, 2018
)
2.44
"Quercetin is a typical flavonoid that is commonly found in fruits and vegetables and has versatile biological effects."( Quercetin and iron metabolism: What we know and what we need to know.
Luo, G; Tang, Y; Xiao, L; Yao, P, 2018
)
2.64
"Quercetin is a well-known flavonoid naturally occurring in most of the plant foods and is often found in the human diet. "( MicroRNAs as molecular targets of quercetin and its derivatives underlying their biological effects: A preclinical strategy.
Li, D; Li, F; Sun-Waterhouse, D; Wang, D; Xin, L, 2019
)
2.24
"Quercetin is a major flavonoid in various plants. "( Therapeutic evaluation of solid lipid nanoparticle of quercetin in pentylenetetrazole induced cognitive impairment of zebrafish.
Muthuraman, A; Rishitha, N, 2018
)
2.17
"Quercetin is a flavonoid with strong antioxidant and antiinflammatory activities considered as a potential drug candidate for skin exogenous supplementation. "( Liposomes, lipid nanocapsules and smartCrystals®: A comparative study for an effective quercetin delivery to the skin.
Bégu, S; Devoisselle, JM; Hatahet, T; Hommoss, A; Morille, M; Müller, RH, 2018
)
2.15
"Quercetin is a flavonoid compound that is abundant in vegetables and fruits."( Quercetin attenuates neuronal cells damage in a middle cerebral artery occlusion animal model.
Koh, PO; Park, DJ; Shah, FA, 2018
)
2.64
"Quercetin is a major flavonoid, present as its glycosidic forms in plant foods. "( Lymphatic metabolites of quercetin after intestinal administration of quercetin-3-glucoside and its aglycone in rats.
Hamada, M; Ikushiro, S; Kato, Y; Kinjo, C; Murota, K; Nakajima, N; Nakamura, T; Nakamura, Y; Nishikawa, M, 2018
)
2.23
"Quercetin is a plant polyphenol from the flavonoid group that plays a fundamental role in controlling homeostasis due to its potent antioxidant properties. "( Quercetin conjugated with silica nanoparticles inhibits tumor growth in MCF-7 breast cancer cell lines.
Aghapour, F; Barari, L; Kani, SNM; Kazemi, S; Moghadamnia, AA; Morakabati, P; Nicolini, A; Rezazadeh, L, 2018
)
3.37
"Quercetin is a flavonoid that has anti‑inflammatory, anti‑oxidant and lipid metabolic effects. "( Quercetin protects against ox‑LDL‑induced injury via regulation of ABCAl, LXR‑α and PCSK9 in RAW264.7 macrophages.
Cao, H; Chen, C; Jia, Q; Li, S; Shen, D; Xing, SL, 2018
)
3.37
"Quercetin is a bioflavonoid substance that acts an antioxidant agent and exerts a neuroprotective effect against cerebral ischemia."( Identification of Proteins Differentially Expressed by Quercetin Treatment in a Middle Cerebral Artery Occlusion Model: A Proteomics Approach.
Koh, PO; Park, DJ; Shah, FA, 2018
)
1.45
"Quercetin is a potential antioxidant and free radical scavenger that is widely found in fruits, vegetables, and leaves."( Quercetin increases the antioxidant capacity of the ovary in menopausal rats and in ovarian granulosa cell culture in vitro.
Gao, Q; Jin, H; Lv, C; Qian, X; Wang, J; Xu, J; Zhu, H, 2018
)
2.64
"Quercetin is a flavonoid found in a variety of herbs with anti-fibrosis function."( Quercetin ameliorates pulmonary fibrosis by inhibiting SphK1/S1P signaling.
Cai, Y; Chen, X; Zhang, W; Zhang, X, 2018
)
2.64
"Quercetin is a bioactive flavonoid in the class of polyphenols with a free-radical scavenging ability and anti-inflammatory activity."( Targeting heme oxygenase-1 by quercetin ameliorates alcohol-induced acute liver injury via inhibiting NLRP3 inflammasome activation.
Chai, G; Liu, S; Tian, L; Wang, B; Wen, B, 2018
)
1.49
"Quercetin is a flavonoid compound that is widely present in food and drink. "( Quercetin‑3‑O‑β‑D‑glucoside decreases the bioavailability of cyclosporin A through regulation of drug metabolizing enzymes, transporters and nuclear receptors in rats.
Huang, X; Liu, Y; Shi, S; Wan, J; Yang, C; Yang, T; Zhang, R; Zhang, Y; Zhou, J, 2018
)
3.37
"Quercetin is a naturally-occurring flavonoid claimed to exert many beneficial health effects. "( The effect of quercetin on the electrical properties of model lipid membranes and human glioblastoma cells.
Cechowska-Pasko, M; Gál, M; Kotyńska, J; Krętowski, R; Kruszewski, M; Kusaczuk, M; Naumowicz, M, 2018
)
2.28
"Quercetin (Que) is a polyphenolic compound that shows good anti-cancer, anti-inflammation and anti-oxidation effects."( Effects of Quercetin on Proliferation and H₂O₂-Induced Apoptosis of Intestinal Porcine Enterocyte Cells.
Chen, H; Chen, Z; Lei, H; Su, J; Xu, G; Yuan, Q, 2018
)
1.59
"Quercetin (QCT) is a flavonoid, abundantly present in plants and has gained considerable interest for its antioxidant property and chemo preventive activity. "( In vitro and in vivo anticancer efficacy potential of Quercetin loaded polymeric nanoparticles.
Baksi, R; Borse, SP; Nivsarkar, M; Rana, R; Sharma, V; Singh, DP, 2018
)
2.17
"Quercetin is a flavonoid with many physiological effects. "( Simultaneous collection of the portal and superior vena cava blood in conscious rats defined that intestinal epithelium is the major site of glucuronidation, but not sulfation and methylation, of quercetin.
Hara, H; Ikushiro, S; Nishikawa, M; Oyama, M; Tanaka, S, 2018
)
2.11
"Quercetin is a dietary flavonoid that exerts anti-oxidant, anti-inflammatory, and anti-cancer properties."( Quercetin preferentially induces apoptosis in KRAS-mutant colorectal cancer cells via JNK signaling pathways.
Chen, D; Liao, S; Ma, Q; Wang, T; Wang, Y; Yang, Y; Zhang, J; Zheng, Y, 2019
)
2.68
"Both quercetin, which is a phosphoinositide 3-kinase inhibitor, and the phospholipase C inhibitor U-73122 reduced oxytocin-induced elevation of intracellular calcium concentration."( Projection length stimulated by oxytocin is modulated by the inhibition of calcium signaling in U-87MG cells.
Alanazi, M; Bacova, Z; Bakos, J; Castejon, AM; Kiss, A; Lestanova, Z; Ostatnikova, D; Puerta, F; Reichova, A; Zatkova, M, 2018
)
0.94
"Quercetin is a phenolic compound occurring in many food plants and agricultural crops. "( Enhanced bioactivity and efficient delivery of quercetin through nanoliposomal encapsulation using rice bran phospholipids.
Almeda, RA; Reyes, CT; Rodriguez, EB; Vidallon, MLP, 2019
)
2.21
"Quercetin (QR) is a multipotent flavonoid that functions as an antioxidant and protects against inflammation and neurodegeneration."( Protective effects of quercetin against brain injury in a rat model of lipopolysaccharide-induced fetal brain injury.
Liu, C; Wang, Q, 2018
)
1.52
"Quercetin (Que) is an effective antioxidant and free radical scavenger against oxidative/nitrosative stress."( Protective effects of quercetin from oxidative/nitrosative stress under intermittent hypobaric hypoxia exposure in the rat's heart.
Baltaru, D; Chiş, IC; Coseriu, A; Dumitrovici, A; Moldovan, R; Mureşan, A; Radu, BC, 2018
)
1.52
"Quercetin (Qu), is a flavonoid known to have anti-diabetic effects owing to its antioxidant property, thus promoting regeneration of the pancreatic islets, ultimately increasing insulin secretion. "( Design, optimization, characterization and in-vivo evaluation of Quercetin enveloped Soluplus®/P407 micelles in diabetes treatment.
Ajmal, G; Mishra, B; Mittal, P; Singh, J; Vasant Bonde, G, 2018
)
2.16
"Quercetin (QC) is a phyto-derived bioactive flavone with numerous beneficial activities."( Effect of quercetin-conjugated superparamagnetic iron oxide nanoparticles on diabetes-induced learning and memory impairment in rats.
Beheshti, S; Ebrahimpour, S; Esmaeili, A, 2018
)
1.6
"Quercetin is a flavonoid widely found in plants and marketed to the public as a supplement. "( Quercetin Attenuates Neuropathic Pain in Rats with Spared Nerve Injury.
Arakawa, K; Kaku, R; Kurita, M; Matsuoka, Y; Morimatsu, H; Muto, N; Omiya, H; Taniguchi, A, 2018
)
3.37
"Quercetin (Q) is a natural polyphenol with high radical scavenging capacity, but low in vivo bioavailability. "( Effects of conjugation metabolism on radical scavenging and transport properties of quercetin - In silico study.
Amić, A; Lučić, B; Marković, Z; Matić, S; Milenković, D; Stepanić, V, 2019
)
2.18
"Quercetin is a well-known plant flavonoid that is reported to have anticancer actions in vitro and in vivo."( Potential of the Flavonoid Quercetin to Prevent and Treat Cancer - Current Status of Research.
Břetislav, G; Jana, N; Pavel, S; Pavla, U,
)
1.15
"Quercetin is a direct inhibitor of mTOR but did not influence the activity of Akt at the tested concentration range."( Enhancing TFEB-Mediated Cellular Degradation Pathways by the mTORC1 Inhibitor Quercetin.
Cai, J; Chen, Y; Goldfine, H; Huang, Y; Shaw, AM; Tian, J, 2018
)
1.43
"Quercetin acts as a GLP-1R PAM and DPP-4 inhibitor, and therefore, might be considered as a pioneering agent with a dual mechanism of action, in terms of GLP-1R positive allosteric modulation and DPP-4 inhibition for potentiating GLP-1 dependent effects."( An Overview, Advantages and Therapeutic Potential of Nonpeptide Positive Allosteric Modulators of Glucagon-Like Peptide-1 Receptor.
Anastasijevic, M; Anderluh, M; Jukic, M; Kocic, G; Lazarevic, J; Smelcerovic, A; Tomovic, K, 2019
)
1.24
"Quercetin (Que) is a flavonoid that possesses anti-oxidative activities, exerts myocardial protection."( Quercetin protects cardiomyocytes against doxorubicin-induced toxicity by suppressing oxidative stress and improving mitochondrial function via 14-3-3γ.
Chen, X; He, H; He, M; Luo, Y; Peng, X; Xu, Q; Yin, D; You, J, 2019
)
2.68
"Quercetin is a flavonoid present in fruits and vegetables which possess anticancer properties."( Quercetin inhibits human metastatic ovarian cancer cell growth and modulates components of the intrinsic apoptotic pathway in PA-1 cell line.
Elayapillai, SP; Jagadeesan, A; Teekaraman, D; Viswanathan, MP, 2019
)
2.68
"Quercetin is a flavonoid polyphenolic compound present in fruits and vegetables that has proven anti-inflammatory activity. "( Anti-inflammatory property of quercetin through downregulation of ICAM-1 and MMP-9 in TNF-α-activated retinal pigment epithelial cells.
Cheng, CY; Cheng, SC; Huang, TH; Huang, WC; Pang, JS; Wu, YH, 2019
)
2.25
"Quercetin is a plant polyphenol with biological activities such as anti-inflammatory, anticancer, antidiabetic, neuroprotective and anti-allergic. "( Antidiabetic effect of quercetin: A systematic review and meta-analysis of animal studies.
Abdollahi, M; Abdurahman, A; Amini, M; Bule, M; Nikfar, S, 2019
)
2.27
"Quercetin is a polyphenolic flavonoid, which is frequently found in fruits and vegetables. "( Application of quercetin in neurological disorders: from nutrition to nanomedicine.
Amanzadeh, E; Esmaeili, A; Nourbakhshnia, M; Rahgozar, S, 2019
)
2.31
"Quercetin is a member of the flavonoid family and has antioxidant and anti-inflammatory properties in degenerative diseases."( Quercetin attenuates oxidative stress-induced apoptosis via SIRT1/AMPK-mediated inhibition of ER stress in rat chondrocytes and prevents the progression of osteoarthritis in a rat model.
Chen, Z; Feng, K; Pengcheng, L; Wang, X; Zhang, S, 2019
)
2.68
"Quercetin is a flavonoid compound widely found in vegetables, fruits, and medicinal plants. "( ESI-TOF MS analysis of complexes formed between quercetin and five metal ions in hot water and a study into their DNA cleavage activity.
Liang, P; Lixia, H; Manman, H; Min, C; Weilan, C; Zhimin, L, 2019
)
2.21
"Quercetin is a bioactive compound that is widely used in botanical medicine and traditional Chinese medicine due to its potent antioxidant activity. "( Antioxidant Activities of Quercetin and Its Complexes for Medicinal Application.
Cui, YL; Hu, MJ; Wang, YQ; Xu, D, 2019
)
2.26
"Quercetin is a common Chinese herbal medicine and has been reported to inhibit TGF‑β signaling pathway activation."( Quercetin suppresses glomerulosclerosis and TGF‑β signaling in a rat model.
Dai, E; Liu, Y; Yang, J, 2019
)
2.68
"Quercetin is a dietary bioflavonoid used widely as a food supplement and is generally recognized as safe. "( Dietary bioflavonoid quercetin modulates porcine ovarian granulosa cell functions
Galik, B; Halenar, M; Klinerova, B; Kolesarova, A; Kopcekova, J; Michalcova, K; Mnahoncakova, E; Packova, D; Roychoudhury, S, 2019
)
2.28
"Quercetin is a well-known flavonoid abundant in vegetables, fruits, grains, leaves, and red onions."( Quercetin suppresses the proliferation and metastasis of metastatic osteosarcoma cells by inhibiting parathyroid hormone receptor 1.
Li, S; Liu, F; Pei, Y; Wang, W; Zhang, X; Zheng, K, 2019
)
2.68
"Quercetin (QE) is an attractive natural compound for cancer prevention due to its beneficial anti-oxidative and anti-proliferative effects. "( Size-Dependent Biological Effects of Quercetin Nanocrystals.
Gao, J; Liu, Q; Sun, J; Yang, X; Yu, F; Zhang, H; Zheng, A, 2019
)
2.23
"Quercetin (QE) is an antioxidant, anti-inflammatory, flavonoid compound. "( Quercetin Enhances the Function and Reduces Apoptosis of Mouse Islets.
Jang, HJ; Kim, SS; Oh, MY, 2019
)
3.4
"Quercetin is a polyphenolic flavonoid with approved anti-tumor effect."( Synthesis and biological evaluation of quercetin-zinc (II) complex for anti-cancer and anti-metastasis of human bladder cancer cells.
Lee, YH; Tuyet, PT, 2019
)
1.5
"Quercetin is a plant flavonoid that has anti-oxidant, anti-inflammatory, anti-cancer, and anti-ischemic properties. "( Quercetin alleviates the injury-induced decrease of protein phosphatase 2A subunit B in cerebral ischemic animal model and glutamate-exposed HT22 cells.
Kang, JB; Koh, PO; Park, DJ; Shah, MA, 2019
)
3.4
"Quercetin is a bioflavonoid which has anti-oxidant and reno-protective abilities."( Ameliorative effects of pre-eclampsia by quercetin supplement to aspirin in a rat model induced by L-NAME.
Ma, Y; Shi, X; Song, L; Yang, S; Zhao, N, 2019
)
1.5
"Quercetin is an abundant flavonoid in nature and is used in several dietary supplements. "( Inhibitory Effects of Quercetin and Its Human and Microbial Metabolites on Xanthine Oxidase Enzyme.
Fliszár-Nyúl, E; Hetényi, C; Kroon, PA; Mladěnka, P; Mohos, V; Needs, PW; Pánovics, A; Pethő, G; Poór, M; Schilli, G, 2019
)
2.27
"Quercetin (Qc) is a flavonoid found in fruits and vegetables that has several biological properties."( Preventive Effect of Quercetin in a Triple Transgenic Alzheimer's Disease Mice Model.
Angelica Maria, SG; Gloria Patricia, CG; Luis, CH; Paula, PC, 2019
)
1.55
"Quercetin is a phytochemical with disease prevention and health promotion activities that has attracted significant research attention. "( Application of Natural Deep Eutectic Solvents in the Extraction of Quercetin from Vegetables.
Dai, Y; Row, KH, 2019
)
2.19
"Quercetin is a natural bioflavonoid present in fruits, vegetables, seeds, berries, and tea."( Quercetin Loaded Nanoparticles in Targeting Cancer: Recent Development.
Maurya, AK; Vinayak, M, 2019
)
2.68
"Quercetin is a polyphenol of great interest given its antioxidant activity and involvement in the immune response. "( Genome-wide localization of the polyphenol quercetin in human monocytes.
Atrahimovich, D; Barsheshet, Y; Khatib, S; Reuveni, E; Samson, AO; Vaya, J, 2019
)
2.22
"Quercetin is an abundant dietary flavonoid that selectively clears inhibiting PI3K/AKT and p53/p21/serpines and inducing apoptosis."( Increased renal cellular senescence in murine high-fat diet: effect of the senolytic drug quercetin.
Ahmed, L; Chen, X; Hickson, LJ; Jiang, K; Kim, SR; Kirkland, JL; Lerman, LO; Lohmeier, H; Ogrodnik, M; Tang, H; Tchkonia, T; Zhu, XY, 2019
)
1.46
"Quercetin can acts as a prooxidant at high intake levels."( Quercetin reduces serum homocysteine level in rats fed a methionine-enriched diet.
Gao, W; Guo, C; Meng, B; Pu, L; Wei, J; Wu, J; Yang, J, 2013
)
2.55
"So, quercetin appears to be a semi-specific fluorescent probe for the activity of ryanodine receptors, which in our Jurkat (clone E6.1) cell preparations probably reports the type 3 RyR activity."( Quercetin as a fluorescent probe for the ryanodine receptor activity in Jurkat cells.
Baran, I; Ganea, C; Katona, E, 2013
)
2.31
"Quercetin (Qu) is a principal flavonoid compound and an excellent free-radical-scavenging antioxidant that promotes apoptosis."( Reappraisal of the anticancer efficacy of quercetin in oral cancer cells.
Chang, YC; Chen, SF; Lin, YS; Liu, CL; Nien, S; Wu, CH, 2013
)
1.38
"Quercetin (QC) is a typical plant flavonoid, possesses diverse pharmacologic effects including antiinflammatory, antioxidant, anti-cancer, anti-anaphylaxis effects and against aging. "( Bioavailability of quercetin: problems and promises.
Cai, X; Dou, J; Fang, Z; Yu, A; Zhai, G, 2013
)
2.16
"Quercetin is a natural polyphenolic flavonoid that displays anti-diabetic properties in vivo. "( Quercetin induces insulin secretion by direct activation of L-type calcium channels in pancreatic beta cells.
Bardy, G; Bertrand, G; Cros, G; Dalle, S; Magous, R; Oiry, C; Quignard, JF; Ravier, MA; Richard, S; Virsolvy, A, 2013
)
3.28
"Quercetin is an effective antioxidant and free radical scavenger against oxidative stress."( Quercetin potentially attenuates cadmium induced oxidative stress mediated cardiotoxicity and dyslipidemia in rats.
Milton Prabu, S; Muthumani, M; Shagirtha, K, 2013
)
2.55
"Quercetin is a plant-derived flavonoid that can induce apoptosis in prostate cancer cells."( Quercetin synergizes with 2-methoxyestradiol inhibiting cell growth and inducing apoptosis in human prostate cancer cells.
Song, L; Wang, G; Wang, H; Xing, N, 2013
)
2.55
"Quercetin is an important flavonoid with antioxidant and anti-inflammatory activity."( Quercetin protects against diabetes-induced exaggerated vasoconstriction in rats: effect on low grade inflammation.
El Bassossy, HM; Fahmy, A; Hassan, NA; Mahmoud, MF, 2013
)
2.55
"Quercetin is a major bioflavonoid widely present in fruits and vegetables. "( Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
Cho, JY; Endale, M; Kim, S; Kim, SH; Park, SC; Rhee, MH; Yang, Y, 2013
)
3.28
"Quercetin is a common flavonoid polyphenol which has been shown to exert neuroprotective actions in vitro and in vivo. "( Modulation of paraoxonase 2 (PON2) in mouse brain by the polyphenol quercetin: a mechanism of neuroprotection?
Cole, TB; Costa, LG; Dao, K; de Laat, R; Furlong, CE; Giordano, G; Pellacani, C; Tait, L, 2013
)
2.07
"Quercetin is a ubiquitous flavonoid found in vegetable foods. "( The effects of quercetin protect cardiomyocytes from A/R injury is related to its capability to increasing expression and activity of PKCε protein.
He, M; Liu, Y; Luo, Y; Peng, Y; Tang, L; Xu, T; Yi, X; Yin, D, 2013
)
2.19
"Quercetin is a naturally derived PDE4-selective inhibitor found in fruits, vegetables, and tea."( Quercetin acutely relaxes airway smooth muscle and potentiates β-agonist-induced relaxation via dual phosphodiesterase inhibition of PLCβ and PDE4.
Emala, CW; Townsend, EA, 2013
)
2.55
"Quercetin is a promising chemopreventive agent against cancer that inhibits tumor progression by inducing cell cycle arrest and promoting apoptotic cell death. "( Regulation of Wnt signaling activity for growth suppression induced by quercetin in 4T1 murine mammary cancer cells.
Ganbold, B; Kang, YH; Kim, H; Lee, SS; Nam, JS; Park, J; Seo, EM; Sharma, AR; Sharma, G; Song, DK, 2013
)
2.07
"Quercetin is a natural flavonoid widely distributed in plants that acts as a neuroprotective agent and modulates the activity of different synaptic receptors and ion channels, including the ionotropic GABA receptors. "( Quercetin antagonism of GABAAρ₁ receptors is prevented by ascorbic acid through a redox-independent mechanism.
Alvarez, S; Beltrán González, AN; Calero, CI; Calvo, DJ; Evelson, P; Gasulla, J, 2013
)
3.28
"Quercetin is a major flavonoid compound found in red wine at a much higher concentration than the phytoalexin resveratrol. "( Quercetin suppresses invasion and migration of H-Ras-transformed MCF10A human epithelial cells by inhibiting phosphatidylinositol 3-kinase.
Chung, MY; Jang, TS; Kang, NJ; Lee, HJ; Lee, KW; Seo, SG; Song, NR, 2014
)
3.29
"Quercetin is a flavonoid possessing potential chemopreventive properties."( Quercetin: a pleiotropic kinase inhibitor against cancer.
Bilotto, S; Iannitti, R; Palumbo, R; Russo, GL; Russo, M; Spagnuolo, C; Tedesco, I, 2014
)
2.57
"Quercetin (QU) is a kind of natural flavonoids, with lipid-lowering, anti-inflammatory and other pharmacological activities, and minor toxic side effects."( Quercetin: a potential natural drug for adjuvant treatment of rheumatoid arthritis.
Diao, YP; Huang, SS; Ji, JJ; Li, K; Lin, Y; Zhang, HL, 2013
)
2.55
"Quercetin is a widely distributed flavonoid in edible plants which prevented atherosclerosis in an animal model."( Quercetin-3-O-glucuronide induces ABCA1 expression by LXRα activation in murine macrophages.
Ohara, K; Shindo, K; Taniguchi, Y; Wakabayashi, H; Yajima, H; Yoshida, A, 2013
)
2.55
"Quercetin (QT) is a potential chemotherapeutic drug with low solubility that seriously limits its clinical use. "( Comparing different sterol containing solid lipid nanoparticles for targeted delivery of quercetin in hepatocellular carcinoma.
Jafarian, A; Salehi, G; Varshosaz, J; Zolfaghari, B, 2014
)
2.07
"Quercetin is a plant-based antioxidant traditionally used as a treatment for hepatic injury, but its poor solubility affects its bioavailability."( Protective effects of quercetin and quercetin-5',8-disulfonate against carbon tetrachloride-caused oxidative liver injury in mice.
Cui, Y; Han, Y; Sun, Y; Yang, X; Zhao, Y, 2013
)
1.43
"Quercetin is a dietary flavonoid with known antitumor effects against several types of cancers by promoting apoptotic cell death and inducing cell cycle arrest. "( Quercetin induces mitochondrial mediated apoptosis and protective autophagy in human glioblastoma U373MG cells.
Ahn, KS; Cho, SK; Kim, H; Moon, JY, 2013
)
3.28
"Quercetin is a dietary flavonoid with potential chemoprotective effects, but has low bioavailability because of poor aqueous solubility and low intestinal absorption. "( Quercetin-containing self-nanoemulsifying drug delivery system for improving oral bioavailability.
Bruno, RS; Guo, Y; Lu, X; Song, D; Tran, TH, 2014
)
3.29
"Quercetin is a natural flavonoid that exhibits antioxidant properties."( Quercetin enhances exercise-mediated neuroprotective effects in brain ischemic rats.
Chang, HC; Wang, PS; Wang, RY; Yang, YR, 2014
)
2.57
"Quercetin (QE) is a flavonoid that can eliminate reactive oxygen species (ROS) and elicit anti-inflammatory and anti-apoptotic effects."( Regulatory effect of quercetin on hazardous microcystin-LR-induced apoptosis of Carassius auratus lymphocytes in vitro.
Fang, W; Wang, D; Wu, Y; Zhang, H, 2014
)
1.44
"Quercetin is a flavonoid, which acts on estrogen receptors and causes the development of estrogen-related diseases."( Effects of quercetin on CYP450 and cytokines in Aroclor 1254 injured endometrial cells of the pregnant rats.
Lu, L; Ma, Y; Qin, J; Sun, L; Xu, L; Zhong, X, 2014
)
1.51
"Quercetin is a natural flavonoid found in high quantities in fruits and vegetables, and may be a potential antioxidant and free radical scavenger."( Anti-apoptotic and anti-oxidative roles of quercetin after traumatic brain injury.
Cheng, L; Gu, JW; Kong, B; Kuang, YQ; Shu, HF; Xia, X; Yang, T; Yang, WT, 2014
)
1.39
"Quercetin is an effective Hsp27 inhibitor and has been reported to facilitate tumor cell apoptosis. "( Quercetin sensitizes human glioblastoma cells to temozolomide in vitro via inhibition of Hsp27.
Lan, Q; Li, RJ; Sang, DP, 2014
)
3.29
"Quercetin (QUE) is a flavonoid with antioxidant/anti-inflammatory properties, poorly absorbed when orally administered."( Chitosan-xanthan gum microparticle-based oral tablet for colon-targeted and sustained delivery of quercetin.
Caddeo, C; Díez-Sales, O; Fadda, AM; Manconi, M; Merino-Sanjuán, M; Nácher, A, 2014
)
2.06
"Quercetin is a plant-derived flavonoid that is widely distributed in nature. "( Quercetin prevents pyrrolizidine alkaloid clivorine-induced liver injury in mice by elevating body defense capacity.
Cai, Z; Ji, L; Ma, Y; Pang, C; Wang, Z, 2014
)
3.29
"Quercetin is a natural polyphenolic flavonoid and acts as a quencher for reactive oxygen species generated by any physical or chemical action. "( Protective effect of quercetin on hyperglycemia, oxidative stress and DNA damage in alloxan induced type 2 diabetic mice.
Alam, MM; Meerza, D; Naseem, I, 2014
)
2.16
"Quercetin is an abundant dietary flavonoid with well-known radical scavenging properties being often used as a reference compound in many antioxidant tests."( Dependence of DPPH radical scavenging activity of dietary flavonoid quercetin on reaction environment.
Sak, K, 2014
)
1.36
"Quercetin is a potential chemopreventive agent."( Cytotoxicity comparison of quercetin and its metabolites from in vitro fermentation of several gut bacteria.
Liu, L; Ou, S; Peng, X; Wang, Y; Zhang, N; Zhang, Z, 2014
)
1.42
"Quercetin is a flavonoid, of the subclass flavonols, possessing potential anticancer properties. "( The pleiotropic flavonoid quercetin: from its metabolism to the inhibition of protein kinases in chronic lymphocytic leukemia.
Russo, GL; Russo, M; Spagnuolo, C, 2014
)
2.15
"Quercetin is a plant-derived bioflavonoid that was recently shown to have multiple anticancer activities in various solid tumors. "( Quercetin induces mitochondrial-derived apoptosis via reactive oxygen species-mediated ERK activation in HL-60 leukemia cells and xenograft.
Chang, JL; Cheng, CW; Chien, MH; Chow, JM; Hsiao, M; Lee, LM; Lee, WJ; Lin, KH; Lin, YW; Liu, CC; Tseng, TH; Yang, SF, 2015
)
3.3
"Quercetin is a kind of antioxidant that has neuroprotective effects and potent7ial pro-oxidant effects as well."( Differential effects of quercetin on hippocampus-dependent learning and memory in mice fed with different diets related with oxidative stress.
Cheng, XR; Le, GW; Li, LR; Qiao, Y; Shi, YH; Tang, X; Xia, SF; Xie, ZX, 2015
)
1.45
"Quercetin is a dietary flavonoid which exerts vasodilator, antiplatelet and antiproliferative effects and reduces blood pressure, oxidative status and end-organ damage in humans and animal models of systemic hypertension. "( The flavonoid quercetin reverses pulmonary hypertension in rats.
Barreira, B; Cogolludo, A; Duarte, J; Galindo, P; Jimenez, R; Menendez, C; Moral-Sanz, J; Morales-Cano, D; Moreno, E; Moreno, L; Pandolfi, R; Perez-Vizcaino, F, 2014
)
2.21
"Quercetin is a dietary flavonol that has poor and highly variable bioavailability. "( Endogenous and exogenous mediators of quercetin bioavailability.
Bruno, RS; Guo, Y, 2015
)
2.13
"Quercetin is a flavonol shown to have anti-carcinogenic actions."( Dose-dependent benefits of quercetin on tumorigenesis in the C3(1)/SV40Tag transgenic mouse model of breast cancer.
Altomare, D; Carson, J; Creek, K; Davis, J; Enos, R; Fayad, R; McClellan, J; Murphy, E; Nagarkatti, M; Nagarkatti, P; Steiner, J, 2014
)
1.42
"Quercetin is a polyphenol of growing interest that is present in many foods. "( Comparison of methods for rapid analysis of quercetin.
Lage-Yusty, MA; Lago-Crespo, M; López-Hernández, J; Pardo-Barrela, J, 2015
)
2.12
"Quercetin is a flavonol with anti-inflammatory and antioxidant effects and is also an activator of peroxisome proliferator-activated receptor γ coactivator 1α capable of antioxidant upregulation, mitochondrial biogenesis and prevention of cardiac complications."( Histological and biochemical outcomes of cardiac pathology in mdx mice with dietary quercetin enrichment.
Amin, R; Ballmann, C; Hollinger, K; Quindry, JC; Selsby, JT, 2015
)
1.36
"Quercetin is a plant flavonoid phytochemical exhibiting a broad spectrum of properties i.a. "( [Health--promoting effect of quercetin in human diet].
Janas, KM; Kobylińska, A, 2015
)
2.15
"Quercetin is a typical flavonoid ubiquitously contained in vegetables and fruits with several biological effects demonstrated in vitro and in vivo including antioxidative, anti-inflammatory, anticancer, and antidiabetic activities."( Quercetin and related polyphenols: new insights and implications for their bioactivity and bioavailability.
Ishisaka, A; Kawabata, K; Mukai, R, 2015
)
2.58
"Quercetin is a natural flavonoid compound that has attracted increased interest and attention due to its anticancer activity."( Quercetin in prostate cancer: Chemotherapeutic and chemopreventive effects, mechanisms and clinical application potential (Review).
Song, L; Wang, H; Wang, J; Xing, N; Xu, Z; Yang, F, 2015
)
2.58
"Quercetin is a promising food component, which can prevent lifestyle related diseases. "( Estimated daily intake and seasonal food sources of quercetin in Japan.
Akasaka, H; Ippoushi, K; Kobori, M; Matsunaga, I; Nagata, T; Naito, S; Nishimuro, H; Ohnishi, H; Ohnishi-Kameyama, M; Oike, H; Saitoh, S; Sato, M; Shimamoto, K, 2015
)
2.11
"Quercetin is an antioxidant belongs to flavonoid group."( Beneficial effects of quercetin on renal injury and oxidative stress caused by ciprofloxacin in rats: A histological and biochemical study.
Cetin, A; Dogan, Z; Elbe, H; Taslidere, E; Turkoz, Y, 2016
)
1.47
"Quercetin is a dietary flavonoid that exerts anti-metastatic effect in various types of cancer including melanoma."( Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion.
Cao, HH; Cheng, CY; Fu, XQ; Guo, H; Kwan, HY; Li, T; Su, T; Tse, AK; Yu, H; Yu, ZL, 2015
)
2.58
"Quercetin is a plant flavonol that is available from both daily diet and nutraceuticals. "( The Influence of Single-Dose and Short-Term Administration of Quercetin on the Pharmacokinetics of Midazolam in Humans.
Langguth, P; Nguyen, MA; Staubach, P; Wolffram, S, 2015
)
2.1
"Quercetin is a potent cancer therapeutic agent and dietary antioxidant present in fruit and vegetables. "( Quercetin-induced autophagy flux enhances TRAIL-mediated tumor cell death.
Eo, SK; Lee, JH; Moon, JH; Park, SY, 2015
)
3.3
"Quercetin is a bioflavonoid known for antioxidation and antiproliferation activities. "( Quercetin Enhances Chemosensitivity to Gemcitabine in Lung Cancer Cells by Inhibiting Heat Shock Protein 70 Expression.
Hur, GY; In, KH; Kang, KH; Kim, JH; Lee, EJ; Lee, SH; Lee, SY; Min, KH; Shim, JJ; Shin, C, 2015
)
3.3
"Quercetin is a bioflavonoid with antiproliferative and proapoptotic activity in various cancer cells. "( Quercetin Enhances Chemosensitivity to Gemcitabine in Lung Cancer Cells by Inhibiting Heat Shock Protein 70 Expression.
Hur, GY; In, KH; Kang, KH; Kim, JH; Lee, EJ; Lee, SH; Lee, SY; Min, KH; Shim, JJ; Shin, C, 2015
)
3.3
"Quercetin (QT) is a potential bioflavonol and antioxidant with poor bioavailability and very low distribution in the brain. "( Poly(n-butylcyanoacrylate) nanoparticles for oral delivery of quercetin: preparation, characterization, and pharmacokinetics and biodistribution studies in Wistar rats.
Bagad, M; Khan, ZA, 2015
)
2.1
"Quercetin is a classic flavonoid that inhibits the epithelial-mesenchymal transition (EMT) of tumor cells. "( Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy.
Ji, XJ; Liu, YQ; Lu, Q; Yao, XQ; Yin, XX; Zhang, F; Zhou, YX, 2015
)
3.3
"Quercetin is a ubiquitous flavonoid present in beverages, food and plants that has been demonstrated to have a role in the prevention of neurodegenerative and cerebrovascular diseases. "( Quercetin in brain diseases: Potential and limits.
Abin-Carriquiry, JA; Arredondo, F; Blasina, F; Dajas, F; Echeverry, C; Martínez, M; Rivera, F; Vaamonde, L, 2015
)
3.3
"Quercetin is a competitive inhibitor of MMP-9 and could downregulate the expression of MMP-9 and TGF-β1, which plays an important role in A549 apoptosis."( [Mechanisms for quercetin in prevention of lung cancer cell growth and metastasis].
Zhang, J; Zhao, X, 2015
)
2.21
"Quercetin is a flavonoid found in fruits, vegetables, leaves and grains. "( The inhibitory effects of quercetin on obesity and obesity-induced inflammation by regulation of MAPK signaling.
Hwang, JH; Kim, KJ; Lee, BY; Lee, YJ; Seo, MJ, 2015
)
2.16
"Quercetin (Que) is a member of flavonoids with anti-oxidant effects."( Protection of Quercetin against Triptolide-induced apoptosis by suppressing oxidative stress in rat Leydig cells.
Chen, X; Gao, P; Hu, J; Ji, J; Jiang, Z; Ren, Y; Shao, S; Yan, M; Yu, Q; Zhang, L; Zhao, F, 2015
)
1.5
"Quercetin (QUE) is a naturally occurring dietary flavonoid having antioxidant properties."( Anticarcinogenic action of quercetin by downregulation of phosphatidylinositol 3-kinase (PI3K) and protein kinase C (PKC) via induction of p53 in hepatocellular carcinoma (HepG2) cell line.
Maurya, AK; Vinayak, M, 2015
)
1.44
"Quercetin is a flavonoid with antioxidant/anti-inflammatory properties, poorly absorbed when administered orally. "( Cross-linked chitosan/liposome hybrid system for the intestinal delivery of quercetin.
Caddeo, C; Carbone, C; Díez-Sales, O; Ennas, G; Fadda, AM; Manconi, M; Pons, R; Puglisi, G, 2016
)
2.11
"Quercetin is a dietary flavonoid which exerts anti-oxidant, anti-inflammatory and anti-cancer properties. "( Quercetin Suppresses Twist to Induce Apoptosis in MCF-7 Breast Cancer Cells.
Halagowder, D; Ranganathan, S; Sivasithambaram, ND, 2015
)
3.3
"Quercetin is a flavonol believed to have beneficial effects on human health. "( Isolation and characterization of human intestinal Enterococcus avium EFEL009 converting rutin to quercetin.
Han, NS; Kim, TJ; Lee, YB; Li, L; Moon, JS; Shin, NR; Shin, SY, 2016
)
2.09
"Quercetin is a member of the flavonoids family reported to have better cytoprotective abilities, stronger inhibition of lipopolysaccharide-induced nitric oxide production, and better chemoprevention than rutin. "( Isolation and characterization of human intestinal Enterococcus avium EFEL009 converting rutin to quercetin.
Han, NS; Kim, TJ; Lee, YB; Li, L; Moon, JS; Shin, NR; Shin, SY, 2016
)
2.09
"Quercetin is a free radical scavenger and antioxidant."( Quercetin protection against ciprofloxacin induced liver damage in rats.
Cetin, A; Dogan, Z; Elbe, H; Taslidere, E; Turkoz, Y; Vardi, N, 2016
)
2.6
"Quercetin is a dietary flavonoid whose role in the regulation of the activity of insulin remains controversial. "( Quercetin oppositely regulates insulin-mediated glucose disposal in skeletal muscle under normal and inflammatory conditions: The dual roles of AMPK activation.
Huang, F; Kou, J; Li, J; Liu, B; Liu, K; Mei, F; Qi, LW; Wang, Y; Xiao, N; Yang, L, 2016
)
3.32
"Quercetin is a flavonoid compound that widely exists in the nature."( Quercetin inhibits angiogenesis through thrombospondin-1 upregulation to antagonize human prostate cancer PC-3 cell growth in vitro and in vivo.
Jiang, X; Mei, Z; Song, L; Wang, H; Xing, N; Xu, Z; Yang, F, 2016
)
2.6
"Quercetin is a natural plant flavonoid that has been reported to possess a wide range of beneficial health effects, including anti-cancer and anti-inflammatory activities. "( The immunostimulating activity of quercetin 3-O-xyloside in murine macrophages via activation of the ASK1/MAPK/NF-κB signaling pathway.
Choi, JW; Lee, J; Pandey, RP; Park, YI; Sohng, JK, 2016
)
2.16
"Quercetin is an important flavonoid that is ubiquitously present in the diet in a variety of fruits and vegetables. "( Quercetin and the mitochondria: A mechanistic view.
Ahmed, T; Braidy, N; de Oliveira, MR; Nabavi, SF; Nabavi, SM; Setzer, WN,
)
3.02
"Quercetin is a major constituent of various dietary products and recently its anti-cancer potential has been extensively explored, revealing its anti-proliferative effect on different cancer cell lines, both in vitro and in vivo."( Application of Bioactive Quercetin in Oncotherapy: From Nutrition to Nanomedicine.
Chakraborty, C; Lee, SS; Nam, JS; Nguyen, LT; Sharma, AR; Sharma, G, 2016
)
1.46
"Quercetin (Quer) is a polyphenol present in berries and other commodities which exhibits these effects."( Role of quercetin on Caco-2 cells against cytotoxic effects of alternariol and alternariol monomethyl ether.
Fernández-Blanco, C; Font, G; Ruiz, MJ, 2016
)
1.59
"Quercetin (QCT) is a natural flavonoid compound that has attracted increasing interest due to its anticancer activity."( Quercetin-loaded nanomicelles to circumvent human castration-resistant prostate cancer in vitro and in vivo.
Cheng, Q; Duan, X; Huo, S; Liang, XJ; Liu, J; Ma, X; Wei, T; Zhang, C; Zhang, Y; Zhao, J, 2016
)
2.6
"Quercetin (QU) is a polyphenol that has an antioxidant effect in vitro, but due to its high lipophilicity, it has low bioavailability in vivo."( Protective role of free and quercetin-loaded nanoemulsion against damage induced by intracerebral haemorrhage in rats.
Antunes, MF; Barros, DM; Cordeiro, MF; Dora, CL; Galho, AR; Hädrich, G; Horn, AP; Lima, JV; Luz, DC; Marques, MS; Muccillo-Baisch, AL; Ribeiro, SA, 2016
)
1.45
"Quercetin is a major flavonoid that has anti-oxidant, anti-cancer and anti-inflammatory properties."( Quercetin Protects against Okadaic Acid-Induced Injury via MAPK and PI3K/Akt/GSK3β Signaling Pathways in HT22 Hippocampal Neurons.
He, F; Jiang, W; Li, S; Luo, T; Shen, XY; Wang, HQ; Xu, J; Zhou, Y, 2016
)
2.6
"Quercetin is a major dietary flavonoid in fruits and vegetables. "( Preventive effect of dietary quercetin on disuse muscle atrophy by targeting mitochondria in denervated mice.
Fujikura, Y; Hirasaka, K; Horikawa, M; Hou, DX; Iwasa, K; Kanzaki, N; Matsui, N; Matsumoto, N; Mukai, R; Nikawa, T; Shibata, H; Terao, J, 2016
)
2.17
"Quercetin is a flavonoid known for its neuroprotective and antioxidant effects."( Ameliorative Effect of Quercetin on Neurochemical and Behavioral Deficits in Rotenone Rat Model of Parkinson's Disease: Modulating Autophagy (Quercetin on Experimental Parkinson's Disease).
El-Horany, HE; El-Latif, RN; ElBatsh, MM; Emam, MN, 2016
)
1.47
"Quercetin (QUE) is a natural flavonol-type flavonoid with antibacterial, anti-inflammatory and anti-aggregatory properties. "( Protective Effects of Quercetin on Selected Oxidative Biomarkers in Bovine Spermatozoa Subjected to Ferrous Ascorbate.
Kováčik, A; Libová, Ľ; Lukáč, N; Paál, D; Tušimová, E; Tvrdá, E, 2016
)
2.19
"Quercetin is a plant flavonoid having hepatoprotective and antioxidative potential and the ability to reduce liver lipid accumulation in monogastric animals."( Effects of a six-week intraduodenal supplementation with quercetin on liver lipid metabolism and oxidative stress in peripartal dairy cows.
Esatbeyoglu, T; Metges, CC; Mielenz, M; Nürnberg, G; Rimbach, G; Sauerwein, H; Starke, A; Stoldt, AK; Wagner, AE; Wolffram, S, 2016
)
1.4
"Quercetin (QT) is a natural flavonoid with various biological activities and pharmacological actions. "( Development of quercetin-phospholipid complex to improve the bioavailability and protection effects against carbon tetrachloride-induced hepatotoxicity in SD rats.
Chen, X; Gu, L; Hu, G; Jia, J; Liu, Z; Zhang, K; Zhang, M; Zhang, Y, 2016
)
2.23
"Quercetin is a natural compound that has several biological activities including anticancer activity. "( Oral Delivery of a High Quercetin Payload Nanosized Emulsion: In Vitro and In Vivo Activity Against B16-F10 Melanoma.
Assreuy, J; Baischl, AL; Dora, CL; Fernandes, D; Lemos-Senna, E; Maioral, MF; Mazzarino, L; Pacheco, LK; Santos-Silva, MC; Silva, LF; Siqueira, JM, 2016
)
2.18
"Quercetin is a flavonoid reported as anti-allergic, anti-inflammatory, antiplatelet, anti-microbial, antioxidant, antineurodegenerative and antitumoral. "( Bovine Serum Albumin Nanoparticles Containing Quercetin: Characterization and Antioxidant Activity.
Antônio, E; Khalil, NM; Mainardes, RM, 2016
)
2.14
"Quercetin (Quer) is a naturally occurring flavonol present in many commonly consumed food items."( Molecular mechanisms of action of quercetin in cancer: recent advances.
Kashyap, D; Mittal, S; Sak, K; Singhal, P; Tuli, HS, 2016
)
1.43
"Quercetin is an important dietary flavonoid present in fruits and vegetables and has attracted attention because of its anti-inflammatory and anti-oxidative properties. "( Protective Effect of Quercetin on Posttraumatic Cardiac Injury.
Bi, Y; Cao, T; Chen, X; Jing, Z; Li, S; Li, X; Wang, Z; Yu, D; Zhou, J; Zhu, L, 2016
)
2.2
"Quercetin is a known antioxidant and protein kinase C (PKC) inhibitor. "( Quercetin reduces manic-like behavior and brain oxidative stress induced by paradoxical sleep deprivation in mice.
Acco, A; Andreatini, R; Barcaro, IMR; Dos Reis Lívero, FA; Hocayen, PAS; Kanazawa, LKS; Stipp, MC; Vecchia, DD; Wendler, EM, 2016
)
3.32
"Quercetin is a flavonoid occurring in many plant foods commonly consumed as part of a regular diet."( Neuroprotective Effects of Quercetin: From Chemistry to Medicine.
Barreca, D; Bellocco, E; D'Onofrio, G; Daglia, M; Nabavi, SF; Nabavi, SM; Rastrelli, L, 2016
)
1.45
"Quercetin is a natural flavonoid, which has been shown to have anti hepatitis C virus (HCV) properties. "( Effect of Quercetin on Hepatitis C Virus Life Cycle: From Viral to Host Targets.
Bartosch, B; Bautista, JD; Clement, S; Del Campo, JA; García-Valdecasas, M; Gil-Gómez, A; Lemasson, M; Negro, F; Ranchal, I; Rojas, Á; Romero-Gómez, M; Rosenberg, AR, 2016
)
2.28
"Quercetin is a flavonoid with very pronounced effective antioxidant and antiinflammatory activities, and thus a candidate of first choice for such skin supplementation."( Quercetin topical application, from conventional dosage forms to nanodosage forms.
Bégu, S; Devoisselle, JM; Hatahet, T; Hommoss, A; Morille, M; Müller, RH, 2016
)
2.6
"Quercetin (QR), is a polyphenolic flavonoid compound which is found in large amounts in certain foods, and protects against oxidative stress. "( Hepatoprotective effect of Quercetin supplementation against Acrylamide-induced DNA damage in wistar rats.
Abudawood, M; Ansar, S; Ganaie, MA; Siddiqi, NJ; Zargar, S, 2016
)
2.17
"Quercetin is a potent cancer therapeutic agent presented in fruit and vegetables, preventing tumor proliferation, and is a well known cancer therapeutic agent and autophagy mediator."( Quercetin nanoparticles induced autophagy and apoptosis through AKT/ERK/Caspase-3 signaling pathway in human neuroglioma cells: In vitro and in vivo.
Feng, FQ; Ji, PG; Li, BF; Liu, JH; Lou, M; Wang, L; Yang, C; Zhang, LN, 2016
)
2.6
"Quercetin is a ubiquitous flavonoid reported to have all-natural myriad of health benefits."( Role of Quercetin Benefits in Neurodegeneration.
Elumalai, P; Lakshmi, S, 2016
)
1.59
"Quercetin (Que) is an abundant flavonoid in the human diet and high-concentration food supplement with reported pro- and anti-carcinogenic activities. "( Quercetin alters the DNA damage response in human hematopoietic stem and progenitor cells via TopoII- and PI3K-dependent mechanisms synergizing in leukemogenic rearrangements.
Aqaqe, N; Biechonski, S; Elad, D; Gourevich, D; Grisaru, D; Jaffa, AJ; Milyavsky, M; Olender, L; Rall, M; Raz, Y; Trakhtenbrot, L; Wiesmuller, L; Yassin, M; Zipin-Roitman, A, 2017
)
3.34
"Quercetin is considered to be an anti-oxidant with healing effects on many experimental toxic injuries."( Quercetin attenuates, indomethacin-induced acute gastric ulcer in rats.
Alkushi, AGR; Elsawy, NAM, 2017
)
2.62
"Quercetin is a major dietary flavonoid found in a various fruits, vegetables, and grains. "( Inhibitory effect of quercetin on colorectal lung metastasis through inducing apoptosis, and suppression of metastatic ability.
Han, YH; Hong, SH; Jeong, MY; Kee, JY; Kim, DS; Mun, JG; Park, J; Um, JY, 2016
)
2.2
"Quercetin is a naturally occurring compound with strong antioxidant action and can successfully scavenge free radicals."( Protective effects of quercetin on UVB irradiation‑induced cytotoxicity through ROS clearance in keratinocyte cells.
Chen, H; Ding, L; Li, N; Shi, X; Wang, Y; Yu, Y; Zhu, X, 2017
)
1.49
"Quercetin is a flavonol which inhibits some virus infectivity and replication."( Biophysical characterization of the interaction between M2-1 protein of hRSV and quercetin.
Caruso, ÍP; Fossey, MA; Lopes, BR; Regasini, LO; Souza, FP; Teixeira, TS; Toledo, KA, 2017
)
1.4
"Quercetin (QCT) is a dietary flavonoid and has been demonstrated to be antifungal against C."( Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
Gao, M; Wang, H; Zhu, L, 2016
)
2.6
"Quercetin is a dietary flavonoid compound extracted from various plants, such as apple and onions. "( Quercetin attenuates high fructose feeding-induced atherosclerosis by suppressing inflammation and apoptosis via ROS-regulated PI3K/AKT signaling pathway.
Lu, XL; Yao, XL; Zhang, H; Zhao, CH, 2017
)
3.34
"Quercetin (Q) is a bioactive flavonol with potential to benefit human health. "( Novel cellulose-based amorphous solid dispersions enhance quercetin solution concentrations in vitro.
Arca, HC; Edgar, KJ; Gilley, AD; Mosquera-Giraldo, LI; Neilson, AP; Nichols, BLB; Taylor, LS, 2017
)
2.14
"Quercetin is an anti‑diabetic and cardiovascular protective agent that has previously been demonstrated to reduce ER stress in human umbilical vein endothelial cells (HUVECs)."( Quercetin alleviates cell apoptosis and inflammation via the ER stress pathway in vascular endothelial cells cultured in high concentrations of glucosamine.
Bao, L; Cai, X; Dai, X; Ding, Y; Li, Y; Zhang, Z, 2017
)
2.62
"Quercetin is a polyphenol, which is a derivative of plants, and has been shown"( Therapeutic Effects of Quercetin on Inflammation, Obesity, and Type 2 Diabetes.
Chen, S; Fang, J; Jiang, H; Wu, X, 2016
)
1.47
"Quercetin is a plant flavonoid with strong antioxidant and antiinflammatory properties interesting for skin protection. "( Dermal quercetin lipid nanocapsules: Influence of the formulation on antioxidant activity and cellular protection against hydrogen peroxide.
Aubert-Pouëssel, A; Bégu, S; Devoisselle, JM; Hatahet, T; Morille, M; Shamseddin, A, 2017
)
2.35
"Quercetin is a dietary antioxidant."( Quercetin promotes the apoptosis of fibroblast-like synoviocytes in rheumatoid arthritis by upregulating lncRNA MALAT1.
Lv, H; Pan, F; Pei, C; Zhu, L, 2016
)
2.6
"Quercetin is a common flavonol that has been shown to have potent antioxidant, anti-inflammatory, and anti-fibrotic activities both in vitro and in vivo in various tissues."( Quercetin and the ocular surface: What we know and where we are going.
Karamichos, D; McKay, TB, 2017
)
2.62
"Quercetin is an ubiquitous bioactive antioxidant rich in vegetables and beverages."( Quercetin Attenuates Cell Survival, Inflammation, and Angiogenesis via Modulation of AKT Signaling in Murine T-Cell Lymphoma.
Maurya, AK; Vinayak, M, 2017
)
2.62
"Quercetin is a bioactive compound exerting therapeutic effects on in vivo animal models of neurodegeneration or neurotoxicity. "( Quercetin-3-O-glucuronide promotes the proliferation and migration of neural stem cells.
Baral, S; Kim, J; Lee, HS; Pariyar, R; Seo, J, 2017
)
3.34
"Quercetin is a flavonoid with antifibrotic, and hepatoprotective properties."( Quercetin protects liver injury induced by bile duct ligation via attenuation of Rac1 and NADPH oxidase1 expression in rats.
Eskandari-Nasab, E; Ghoreshi, ZA; Kabirifar, R; Karimollah, A; Moradi, A; Safari, F, 2017
)
2.62
"Quercetin is a dietary flavonoid which has anti-inflammatory effects. "( Effects of Quercetin Treatment on Epithelium-derived Cytokines and Epithelial Cell Apoptosis in Allergic Airway Inflammation Mice Model.
Anal, O; Arikan Ayyildiz, Z; Bagriyanik, A; Caglayan Sozmen, S; Cilaker Micili, S; Isik, S; Karaman, M; Karaman, O; Uzuner, N, 2016
)
2.27
"Quercetin (Q) is a flavonoid widely distributed in the plant kingdom and well-known for its ability to exert antioxidant, prooxidant and anticarcinogenic activities in several tumor cells. "( Quercetin derivatives as potent inducers of selective cytotoxicity in glioma cells.
Dell'Albani, P; Di Marco, B; Foti, MC; Grasso, S; Rocco, C, 2017
)
3.34
"Quercetin is a well-known flavonoid, has pharmacokinetic interaction with ester drugs due to its capability of esterase inhibition in the gut and liver. "( Enhancement of oral bioavailability of rivastigmine with quercetin nanoparticles by inhibiting CYP3A4 and esterases.
Neerati, P; Palle, S, 2017
)
2.14
"Quercetin is a major component of the plant Glycyrrhiza uralensis, which is largely used as a traditional medicine in Asia. "( The anti-HSV-1 effect of quercetin is dependent on the suppression of TLR-3 in Raw 264.7 cells.
Cho, H; Kang, H; Lee, HH; Lee, S; Shin, YS, 2017
)
2.2
"Quercetin is a potent cancer therapeutic agent and dietary antioxidant present in fruit and vegetables. "( Quercetin nanoparticles display antitumor activity via proliferation inhibition and apoptosis induction in liver cancer cells.
Han, XW; Li, YH; Li, ZM; Lu, HB; Ren, JZ; Ren, KW; Wu, G, 2017
)
3.34
"Quercetin is a potent antioxidant compound."( Protective Effect of Quercetin Against Oxidative Stress-induced Toxicity Associated With Doxorubicin and Cyclophosphamide in Rat Kidney and Liver Tissue.
Dogan, Z; Erdemli, E; Kocahan, S; Taskin, E, 2017
)
1.5
"Quercetin is a most promising compound for disease prevention and therapy; however, many of the effects still need confirmation by human intervention trials."( Quercetin: potentials in the prevention and therapy of disease.
Bischoff, SC, 2008
)
3.23
"Quercetin is a flavonoid found ubiquitously in nature. "( Quercetin is able to demethylate the p16INK4a gene promoter.
Cui, Y; Lu, C; Ma, X; Shi, X; Tan, S; Wang, C; Zhao, B, 2009
)
3.24
"Quercetin is a herbal flavonoid derived from various foods of plant origin and widely used as a major constituent of nutritional supplements. "( Quercetin inhibits IL-1 beta-induced ICAM-1 expression in pulmonary epithelial cell line A549 through the MAPK pathways.
Chen, L; Cheng, D; Fan, H; Hu, X; Liu, D; Lu, X; Song, X; Wang, T; Wei, Y; Wen, F; Xu, D; Yang, T; Ying, B, 2009
)
3.24
"Quercetin is a flavonoid present in many vegetables, fruits, and beverages. "( Effects of low dose quercetin: cancer cell-specific inhibition of cell cycle progression.
An, JY; Jeong, JH; Kwon, YT; Lee, YJ; Rhee, JG, 2009
)
2.12
"Quercetin is a natural flavonoid with many important therapeutic properties. "( Fluorescence quenching study of quercetin interaction with bovine milk xanthine oxidase.
Jabary, HN; Naseri, A; Rashidi, MR; Rasoulzadeh, F, 2009
)
2.08
"Quercetin is a natural flavonoid with pro-apoptotic and antiproliferative properties. "( Different sensitivity of neurons and neuroblastoma cells to quercetin treatment.
Gawron, A; Glowniak, K; Jakubowicz-Gil, J; Piersiak, T; Rzeski, W; Weiksza, K; Zdzisińska, B, 2008
)
2.03
"Quercetin is a flavonoid with anti-carcinogenic and antioxidant properties."( Inhibition of reactive oxygen species and pre-neoplastic lesions by quercetin through an antioxidant defense mechanism.
Aparicio-Rautista, DI; Arellanes-Robledo, J; García-Román, R; Vásquez-Garzón, VR; Villa-Treviño, S, 2009
)
1.31
"Quercetin (Qu) is a dietary flavonoid and a known inhibitor of PI3K."( Stabilization of quercetin paradoxically reduces its proapoptotic effect on UVB-irradiated human keratinocytes.
Bowden, GT; Dong, Z; Melton, T; Olson, ER, 2008
)
1.41
"Quercetin is a well-investigated antioxidant known to protect cells against oxidative nuclear DNA damage. "( Effect of quercetin on oxidative nuclear and mitochondrial DNA damage.
Calcabrini, C; Cucchiarini, L; Dachà, M; De Bellis, R; Mancini, U; Potenza, L, 2008
)
2.19
"Quercetin is a major dietary flavonoid found in onions and other vegetables, and potentially has beneficial effects on disease prevention. "( Dietary quercetin inhibits bone loss without effect on the uterus in ovariectomized mice.
Inakuma, T; Kato, S; Kawai, Y; Mizuha, Y; Sato, T; Takeda, E; Taketani, Y; Terao, J; Tsuji, M; Yamamoto, H, 2009
)
2.23
"Quercetin is a food component that may ameliorate the diabetic symptoms. "( Dietary quercetin alleviates diabetic symptoms and reduces streptozotocin-induced disturbance of hepatic gene expression in mice.
Akimoto, Y; Kobori, M; Masumoto, S; Takahashi, Y, 2009
)
2.23
"Quercetin is a flavonoid of interest because of its proposed health-promoting effects."( The flavonoid quercetin protects and prevents against potassium dichromate-induced systemic peroxidation of lipids and diminution in renal clearance of para-aminohippuric acid and inulin in the rat.
Becerra-Torres, SL; Jaramillo-Juárez, F; Medina-Ramírez, IE; Rodríguez-Vázquez, ML, 2009
)
1.43
"Quercetin (QC) is a poorly water-soluble and degradation-prone bioflavonoid."( Production and characterization of a spray-dried hydroxypropyl-beta-cyclodextrin/quercetin complex.
Chow, AH; Zheng, Y, 2009
)
2.02
"Quercetin is a major natural polyphenol that is known to protect cells from UVA-induced damage."( Essential role of Nrf2 in keratinocyte protection from UVA by quercetin.
Ishii, T; Ishii, Y; Itoh, K; Kawachi, Y; Kimura, S; Ma, D; Warabi, E; Yanagawa, T, 2009
)
1.31
"Quercetin is a flavonoid compound found in a number of medicinal plants that are often prescribed in Chinese clinics for the treatment of cardiovascular diseases. "( Quercetin improves cognitive deficits in rats with chronic cerebral ischemia and inhibits voltage-dependent sodium channels in hippocampal CA1 pyramidal neurons.
Han, DD; Yang, Z; Yao, Y; Zhang, T, 2010
)
3.25
"Quercetin is a dietary bioflavonoid which has been shown to inhibit lens opacification in a number of models of cataract. "( Hypoxia-inducible factor-1 (HIF-1) pathway activation by quercetin in human lens epithelial cells.
Kroon, PA; Mithen, RF; Radreau, P; Rhodes, JD; Sanderson, J, 2009
)
2.04
"Quercetin is a bioflavonoid abundant in onions, apples, tea and red wine and one of the most studied flavonoids. "( Flavonoid quercetin protects against swimming stress-induced changes in oxidative biomarkers in the hypothalamus of rats.
Haleagrahara, N; Kumar, P; Lee, N; Radhakrishnan, A, 2009
)
2.2
"Quercetin is a plant-derived flavonoid widely known by its anti-oxidant and anti-inflammatory properties, but its oral bioavailability is very poor and this becomes difficult to assess its therapeutic potential. "( Anti-inflammatory effect of quercetin-loaded microemulsion in the airways allergic inflammatory model in mice.
Andrade, EL; Calixto, JB; Chaves, JS; Dora, CL; Lemos-Senna, E; Rogerio, AP; Silva, LF, 2010
)
2.1
"Quercetin is a flavonoid found in many foods including apples, onions and tea."( Inhibitory effect of quercetin on periodontal pathogens in vitro.
Geoghegan, F; Rabie, AB; Wong, RW, 2010
)
1.4
"Quercetin is a major flavonoid that contributes to the reduced risk of cardiovascular disease associated with dietary ingestion of fruits and vegetables. "( Quercetin and its major metabolites selectively modulate cyclic GMP-dependent relaxations and associated tolerance in pig isolated coronary artery.
Hughes, DA; Kroon, PA; Liu, XH; Needs, PW; Rayment, S; Suri, S; Taylor, MA; Tribolo, S; Wilson, VG, 2010
)
3.25
"Quercetin is a naturally occurring flavonoid with anti-oxidant and anti-inflammatory properties. "( Effect of quercetin supplementation on maximal oxygen uptake in men and women.
Armstrong, LE; Ballard, KD; Ganio, MS; Johnson, EC; Kaushik, D; Klau, JF; Maresh, CM; Michniak-Kohn, B, 2010
)
2.21
"Quercetin (QR) is a strong antioxidant and has been shown to reduce oxidative stress in the long-term treatment of streptozotocin (STZ)-induced diabetes in animal models. "( Beneficial effects of quercetin on sperm parameters in streptozotocin-induced diabetic male rats.
Ahmadi, P; Fathiazad, F; Khaki, A; Khamnei, HJ; Maleki, NA; Nouri, M, 2010
)
2.12
"Quercetin is a potent antioxidant and has been extensively used as a therapy intervention to prevent age-associated diseases. "( Quercetin-induced H(2)O(2) mediates the pathogen resistance against Pseudomonas syringae pv. Tomato DC3000 in Arabidopsis thaliana.
Dong, H; Gou, Z; Jia, Z; Ma, H; Qiu, J; Song, S; Wang, X; Zou, B, 2010
)
3.25
"Quercetin is a bioflavonoid reported to produce variety of behavioral effects like anxiolytic, antidepressant, etc. "( Reversal by quercetin of corticotrophin releasing factor induced anxiety- and depression-like effect in mice.
Bansod, K; Bhutada, P; Mundhada, D; Mundhada, Y; Quazi, M; Ubgade, A; Umathe, S, 2010
)
2.18
"Quercetin is a naturally occurring dietary flavonol and several reports have shown that quercetin substantially affects cognitive function in disease models, which suggests that quercetin might be a useful agent for treatment of memory dysfunction. "( Quercetin impairs learning and memory in normal mice via suppression of hippocampal phosphorylated cyclic AMP response element-binding protein expression.
Jung, WY; Kim, DH; Kim, JM; Park, DH; Park, SJ; Ryu, JH, 2010
)
3.25
"Quercetin is a potential chemopreventive and chemotherapeutic agent for pancreatic and other cancers. "( Quercetin aglycone is bioavailable in murine pancreas and pancreatic xenografts.
Angst, E; Dawson, DW; Eibl, G; Go, VL; Hines, OJ; Lu, QY; Moro, A; Park, JL; Reber, HA; Zhang, L, 2010
)
3.25
"Quercetin is an excellent antioxidant that has a variety of side effects. "( Quercetin accumulation by chronic administration causes the caspase-3 activation in liver and brain of mice.
Choi, EJ; Kim, GH,
)
3.02
"Quercetin is a plant derived flavonoid and popular nutritional supplement proposed to prevent memory loss and altitude sickness among other ailments, although its precise mechanism(s) of action has been unclear. "( Quercetin targets cysteine string protein (CSPalpha) and impairs synaptic transmission.
Braun, JE; Gibbs, S; Johnson, JN; Proft, J; Syed, N; Winkfein, B; Xu, F, 2010
)
3.25
"Quercetin is a plant-derived bioflavonoid with potentially beneficial effects on the cardiovascular system. "( Acute treatment with polyphenol quercetin improves postischemic recovery of isolated perfused rat hearts after global ischemia.
Barteková, M; Breier, A; Carnická, S; Ondrejcáková, M; Pancza, D; Ravingerová, T, 2010
)
2.09
"Quercetin is a unique dietary polyphenol because it can exert biphasic dose-responses on cells depending on its concentration. "( Hormesis and synergy: pathways and mechanisms of quercetin in cancer prevention and management.
Burd, R; Vargas, AJ, 2010
)
2.06
"Quercetin is a flavonoid naturally present in food and beverages belonging to the large class of phytochemicals with potential anti-cancer properties. "( Quercetin induced apoptosis in association with death receptors and fludarabine in cells isolated from chronic lymphocytic leukaemia patients.
Mupo, A; Russo, GL; Russo, M; Spagnuolo, C; Tedesco, I; Volpe, S, 2010
)
3.25
"Quercetin is a low molecular weight flavonoid found in dietary fruits and vegetables. "( Effects of quercetin on human α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor-mediated ion currents.
Choi, SH; Han, YS; Hwang, SH; Kim, BR; Kim, HC; Lee, BH; Lee, JH; Lee, SM; Nah, SY; Park, JH; Pyo, MK; Rhim, H; Shin, TJ, 2010
)
2.19
"Quercetin is a useful therapeutic agent for the treatment of colitis and gastric ulcer."( Management of aphthous ulceration with topical quercetin: a randomized clinical trial.
Hamdy, AA; Ibrahem, MA, 2010
)
1.34
"Quercetin is a safe, well-tolerated, and highly effective promising new, adjunctive treatment for healing common aphthous ulcers."( Management of aphthous ulceration with topical quercetin: a randomized clinical trial.
Hamdy, AA; Ibrahem, MA, 2010
)
2.06
"Quercetin is a flavonoid with anticancer properties. "( The flavonoid quercetin transiently inhibits the activity of taxol and nocodazole through interference with the cell cycle.
Fadlalla, K; Samuel, T; Turner, T; Yehualaeshet, TE, 2010
)
2.16
"Quercetin is a flavonoid with a wide variety of cytoprotective and modulatory functions. "( Attenuation of transforming growth factor-β-stimulated collagen production in fibroblasts by quercetin-induced heme oxygenase-1.
Hasegawa, Y; Hashimoto, N; Hayashi, Y; Imaizumi, K; Kawabe, T; Matsushima, M; Nakamura, T; Shibasaki, M; Shimokata, K, 2011
)
2.03
"Quercetin is an antioxidant flavonoid, found ubiquitously in nature and extensively used in herbal medicines and food additives. "( Quercetin inhibits diethylnitrosamine-induced hepatic preneoplastic lesions in rats.
Gupta, C; Jena, GB; Ramarao, P; Tripathi, DN; Vikram, A, 2011
)
3.25
"Quercetin is a potent dietary antioxidant that also displays anti-inflammatory activities."( Quercetin reduces markers of oxidative stress and inflammation in sarcoidosis.
Bast, A; Boots, AW; de Boer, VC; Drent, M; Haenen, GR, 2011
)
2.53
"Quercetin is a flavonoid found in plant foods and herbal medicines. "( Effect of quercetin and glucuronide metabolites on the monoamine oxidase-A reaction in mouse brain mitochondria.
Hara, A; Ishisaka, A; Kawabata, K; Kawai, Y; Sakakibara, H; Terao, J; Tokumura, A; Yoshino, S,
)
1.98
"Quercetin acts as an anti-oxidant to protect retinal pigment epithelial cells (RPE) from damaged by oxidative stress, but its effect on formation of choroidal neovascularization (CNV) in AMD is unclear."( Effect of quercetin on formation of choroidal neovascularization (CNV) in age-related macular degeneration(AMD).
Chiou, GC; Lin, BQ; Shen, Y; Zhang, WY; Zhuang, P, 2011
)
1.49
"Quercetin (Que) is a flavonoid widely distributed in vegetables and fruits and exhibits strong antioxidant activity, but the poor stability of Que limits its function and application. "( Bovine serum albumin nanoparticle promotes the stability of quercetin in simulated intestinal fluid.
Fang, R; Hao, R; Jing, H; Leng, X; Li, Q; Wu, X, 2011
)
2.05
"Quercetin, a flavonoid, is an inhibitor of P-glycoprotein-mediated efflux transport, and its oxidative metabolism is catalyzed by CYP enzymes. "( Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin.
Choi, JS; Kang, KW; Piao, YJ, 2011
)
2.2
"Quercetin is a dietary flavonoid purported to improve human endurance exercise capacity. "( Quercetin and endurance exercise capacity: a systematic review and meta-analysis.
Kressler, J; Millard-Stafford, M; Warren, GL, 2011
)
3.25
"Quercetin is a flavonoids that recently has raised many issues and shown evidence about its action as a potential drug to allergy."( Quercetin as a potential anti-allergic drug: which perspectives?
Chirumbolo, S, 2011
)
2.53
"Quercetin, a flavonoid is a safe and potent neuroprotective antioxidant."( Polychlorinated biphenyl (PCBs)-induced oxidative stress plays a critical role on cerebellar dopaminergic receptor expression: ameliorative role of quercetin.
Arunakaran, J; Bavithra, S; Krishnamoorthy, G; Pratheepa Kumari, R; Selvakumar, K; Venkataraman, P, 2012
)
1.3
"Quercetin is a ubiquitous plant-derived flavonoid with well documented anti-inflammatory properties, in part, a consequence of its capacity to downmodulate the NF-κB signal transduction pathway."( Quercetin, a potent suppressor of NF-κB and Smad activation in osteoblasts.
Weitzmann, MN; Yamaguchi, M, 2011
)
2.53
"Quercetin is a typical anti-oxidative flavonoid ubiquitously distributed in vegetables. "( Conjugated quercetin glucuronides as bioactive metabolites and precursors of aglycone in vivo.
Kawai, Y; Murota, K; Terao, J, 2011
)
2.2
"Quercetin is a major flavonoid in the human diet and the most commonly used in studies of biological activity. "( Effects of O-methylated metabolites of quercetin on oxidative stress, thermotolerance, lifespan and bioavailability on Caenorhabditis elegans.
Cabello, J; Dueñas, M; Gómez-Orte, E; González-Manzano, S; González-Paramás, AM; Santos-Buelga, C; Surco-Laos, F, 2011
)
2.08
"Quercetin is a flavonol modifying a number of cell processes in different cell lines. "( Quercetin accumulates in nuclear structures and triggers specific gene expression in epithelial cells.
Alexaki, VI; Castanas, E; Kampa, M; Nifli, AP; Notas, G; Pelekanou, V; Theodoropoulos, P; Vercauteren, J, 2012
)
3.26
"Quercetin is a major flavonoid that is found in most plants; it can intercalate with DNA. "( 125I-labeled quercetin as a novel DNA-targeted radiotracer.
Hosseinimehr, SJ; Stenerlöw, B; Tolmachev, V, 2011
)
2.18
"Quercetin is an active constituent of Hippophae rhamnoides L. "( Modulatory effects of quercetin on hypobaric hypoxic rats.
Gao, Y; Zeng, S; Zhou, J; Zhou, S, 2012
)
2.14
"Quercetin is a mixed inhibitor, whereas quercitrin and isoquercitrin are uncompetitive inhibitors of L."( The leishmanicidal flavonols quercetin and quercitrin target Leishmania (Leishmania) amazonensis arginase.
da Silva, ER; Magalhães, PP; Maquiaveli, Cdo C, 2012
)
1.39
"Quercetin is a proven antioxidant that might have decreased the oxidative stress produced by chronic alcoholism."( Evaluation of ameliorative effect of quercetin in experimental model of alcoholic neuropathy in rats.
Bodhankar, SL; Ghosh, P; Ghule, AE; Kandhare, AD; Raygude, KS, 2012
)
1.37
"Quercetin is a flavonol that appears to be protective against several cancers, but its possible role in prevention of colorectal cancer is not yet well studied. "( Association of dietary quercetin with reduced risk of proximal colon cancer.
Djuric, Z; Kato, I; Severson, RK, 2012
)
2.13
"Quercetin is a natural compound that has shown several biological activities. "( Poly(ethylene glycol) hydroxystearate-based nanosized emulsions: effect of surfactant concentration on their formation and ability to solubilize quercetin.
Borsali, R; Dora, CL; Lemos-Senna, E; Nishiyama, Y; Pignot-Paintrand, I; Putaux, JL; Silva, LF, 2012
)
2.02
"Quercetin is a popular flavonoid in plant foods, herbs, and dietary supplement. "( Hydroxyl radical scavenging mechanism of human erythrocytes by quercetin-germanium (IV) complex.
Cai, HH; Cai, JY; Li, SP; Xie, WL; Yang, PH, 2012
)
2.06
"Quercetin (QU) is a potent anti-inflammatory agent; however, its poor water solubility restricts its clinical application."( Treating acute cystitis with biodegradable micelle-encapsulated quercetin.
Gao, X; Gou, ML; Huang, MJ; Huang, N; Men, K; Qian, ZY; Qiu, J; Wang, BL; Wei, YQ; Yang, B; Zhao, X, 2012
)
1.34
"Quercetin is a P-gp inhibitor and may be an inhibitor of CYP3A4."( Pharmacokinetic interaction study between quercetin and valsartan in rats and in vitro models.
Babu, PR; Challa, SR; Challa, VR; Johnson, B; Maheswari, C, 2013
)
1.38
"Quercetin is a potent anti-inflammatory flavonoid, but its capacity to modulate insulin sensitivity in obese insulin resistant conditions is unknown. "( Quercetin decreases inflammatory response and increases insulin action in skeletal muscle of ob/ob mice and in L6 myotubes.
Anhê, FF; Anhê, GF; Bordin, S; Hirabara, SM; Kinote, A; Lellis-Santos, C; Lima, GA; Machado, UF; Okamoto, MM; Sollon, C; Velloso, LA, 2012
)
3.26
"Quercetin is a plant-derived flavonoid known to possess anti-inflammatory property, but its use as a chemopreventive substance has been reviewed quite recently. "( Quercetin in cancer prevention and therapy.
Chirumbolo, S, 2013
)
3.28
"Quercetin was observed to be a more potent antioxidative and anti-inflammatory agent."( Quercetin as a prophylactic measure against high altitude cerebral edema.
Bansal, A; Mathew, T; Patir, H; Sarada, SK; Singh, B; Singh, S, 2012
)
2.54
"Quercetin is an inhibitor of CYP3A4 and P-gp."( Influence of quercetin on the pharmacokinetics of ranolazine in rats and in vitro models.
Babu, KN; Babu, PJ; Babu, PR; Peter, PL; Rajesh, K, 2013
)
1.48
"Quercetin is a ubiquitous flavonoid that is present in numerous plants that are utilized in many different cultures for their nervous system and anticancer effects. "( Life or death: neuroprotective and anticancer effects of quercetin.
Dajas, F, 2012
)
2.07
"Quercetin is a bioflavonoid that exhibits several biological functions in vitro and in vivo. "( Quercetin 3-O-methyl ether protects FL83B cells from copper induced oxidative stress through the PI3K/Akt and MAPK/Erk pathway.
Chen, CY; Hsu, HY; Huang, LH; Li, CJ; Lin, CN; Tsai, CH; Tseng, HL, 2012
)
3.26
"Quercetin is a major flavonoid in a wide range of fruits and vegetables. "( Quercetin and its metabolites improve vessel function by inducing eNOS activity via phosphorylation of AMPK.
Croft, KD; Hodgson, JM; Kyle, R; Lee, IL; Shen, Y; Stocker, R; Wang, Y; Ward, NC, 2012
)
3.26
"Quercetin (Q) is a bioactive compound with excellent antioxidant activity. "( Competition between ascorbate and glutathione for the oxidized form of methylated quercetin metabolites and analogues: tamarixetin, 4'O-methylquercetin, has the lowest thiol reactivity.
Bast, A; Haenen, GR; Moalin, M; van Strijdonck, GP, 2012
)
2.05
"Quercetin is a well known aglycone flavonoid that is widely found in different food sources."( Mitigating role of quercetin against sodium fluoride-induced oxidative stress in the rat brain.
Habtemariam, S; Latifi, AM; Mirzaei, M; Moghaddam, AH; Nabavi, SF; Nabavi, SM, 2012
)
2.15
"Quercetin is a naturally occurring flavonoid that is known to form complexes with metals; a process that reduces the environmental availability of toxic metals such as chromium. "( Reduction of hexavalent chromium using naturally-derived flavonoids.
Chong, J; Doetschman, D; Knipfing, MT; Mwilu, S; Noah, N; Okello, VA; Sadik, OA; Zhou, A, 2012
)
1.82
"Quercetin is a member of the flavonoid family and has been previously shown to have a variety of anti-cancer activities. "( Rapid dimerization of quercetin through an oxidative mechanism in the presence of serum albumin decreases its ability to induce cytotoxicity in MDA-MB-231 cells.
Bortolazzo, A; Pham, A; White, JB, 2012
)
2.14
"Quercetin is a naturally occurring flavonol with antioxidant, anticancer and anti-ageing properties. "( Quercetin protects Saccharomyces cerevisiae against oxidative stress by inducing trehalose biosynthesis and the cell wall integrity pathway.
Amorim, MA; Carreto, L; Costa, V; de Freitas, V; Mateus, N; Mendes, MV; Mendes, V; Moradas-Ferreira, P; Vilaça, R, 2012
)
3.26
"Quercetin (QU) is a hydrophobic agent with potential anticancer activity."( Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer.
Gao, X; Gou, M; Guo, G; Huang, M; Huang, N; Men, K; Qian, Z; Wang, B; Wei, X; Wei, Y; Zheng, F; Zheng, Y; Zhou, Y, 2012
)
1.34
"Quercetin is a natural flavonoid possessing a number of health beneficial effects. "( Vitamin C inhibits staphylococcus aureus growth and enhances the inhibitory effect of quercetin on growth of Escherichia coli in vitro.
Jaakkola, M; Kallio, J; Kilpeläinen, P; Mäki, M; Virtanen, V, 2012
)
2.04
"Quercetin is a well-known antioxidant. "( Quercetin improves baroreflex sensitivity in spontaneously hypertensive rats.
Alves, NF; Braga, VA; França-Silva, MS; Monteiro, MM; Porpino, SK, 2012
)
3.26
"Quercetin is a natural flavonoid that has been shown to have the highest anti-radical activity, along with the ability to act as a scavenger of free radicals and an inhibitor of lipid peroxidation."( Formulation optimization and topical delivery of quercetin from solid lipid based nanosystems.
Bose, S; Du, Y; Michniak-Kohn, B; Takhistov, P, 2013
)
1.37
"Quercetin is an abundant micronutrient in our daily diet. "( Inhibition of mTOR signaling by quercetin in cancer treatment and prevention.
Bruning, A, 2013
)
2.12
"Quercetin (1) is an anti-inflammatory and antioxidant flavonoid. "( Quercetin-loaded microcapsules ameliorate experimental colitis in mice by anti-inflammatory and antioxidant mechanisms.
Baracat, MM; Casagrande, R; Colombo, BB; Fattori, V; Georgetti, SR; Guazelli, CF; Verri, WA; Vicentini, FT, 2013
)
3.28
"Quercetin is a plant-derived flavonoid found in fruits or vegetables that has antioxidant properties and acts as a free radical scavenger. "( Quercetin improves the in vitro development of porcine oocytes by decreasing reactive oxygen species levels.
Jang, G; Kang, JT; Kim, SJ; Koo, OJ; Kwon, DK; Lee, BC; Moon, JH; Park, SJ, 2013
)
3.28
"Quercetin is an inhibitor of CYP3A4 and a modulator of Pgp."( Quercetin significantly decreased cyclosporin oral bioavailability in pigs and rats.
Chao, PD; Hou, YC; Hsiu, SL; Su, SF; Tsao, CW; Wang, YH, 2002
)
2.48
"Quercetin is a potent inhibitor of apomorphine sulfation and may inhibit the sulfation of apomorphine in human brain in vivo."( Quercetin inhibits the sulfation of r(-)-apomorphine in human brain.
Cantini, R; Pacifici, GM; Vaglini, F; Vietri, M, 2003
)
2.48
"Quercetin is a naturally occurring L-type Ca(2+) channel agonist. "( Effects of quercetin and rutin on vascular preparations: a comparison between mechanical and electrophysiological phenomena.
Fusi, F; Gorelli, B; Pessina, F; Saponara, S; Sgaragli, G, 2003
)
2.15
"Quercetin is a flavonoid molecule ubiquitous in nature and functions as an anti-oxidant and anti-inflammatory agent with little toxicity in vivo and in vitro. "( Quercetin suppresses proinflammatory cytokines production through MAP kinases andNF-kappaB pathway in lipopolysaccharide-stimulated macrophage.
Bok, SH; Cho, SY; Choi, WY; Do, SH; Jeong, KS; Jeong, TS; Jeong, WI; Kwon, MJ; Lee, CS; Park, SJ; Ryu, SY; Song, JC, 2003
)
3.2
"Quercetin is a bioflavonoid with strong antioxidant properties."( Reversal of haloperidol-induced orofacial dyskinesia by quercetin, a bioflavonoid.
Kulkarni, SK; Naidu, PS; Singh, A, 2003
)
1.29
"Quercetin is a naturally occurring flavonoid that exerts multiple pharmacological effects. "( The study of the quercetin action on human erythrocyte membranes.
Gawron, A; Gruszecki, WI; Misiak, LE; Pawlikowska-Pawlega, B, 2003
)
2.1
"Quercetin is a typical flavonoid ubiquitously present in fruits and vegetables, and its antioxidant effect is implied to be helpful for human health. "( Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism.
Murota, K; Terao, J, 2003
)
2.07
"Quercetin is a bioflavonoid with strong antioxidant properties."( Reversal of reserpine-induced orofacial dyskinesia and cognitive dysfunction by quercetin.
Kulkarni, SK; Naidu, PS; Singh, A, 2004
)
1.27
"Quercetin is an ubiquitous antioxidant flavonoid."( Lethal quercetin-digoxin interaction in pigs.
Chao, PD; Hou, YC; Hsiu, SL; Wang, YH; Wen, KC, 2004
)
1.5
"Quercetin is a bioflavonoid with strong antioxidant properties."( Reversal of aging and chronic ethanol-induced cognitive dysfunction by quercetin a bioflavonoid.
Kulkarni, SK; Naidu, PS; Singh, A, 2003
)
1.27
"Quercetin is a typical antioxidative flavonoid found in vegetables, which is more commonly present as its glucosides, quercetin-3-glucoside (Q3G) and quercetin-4'-glucoside (Q4'G). "( Quercetin-4'-glucoside is more potent than quercetin-3-glucoside in protection of rat intestinal mucosa homogenates against iron ion-induced lipid peroxidation.
Ichikawa, M; Mitsukuni, Y; Miyamoto, S; Murota, K; Terao, J; Tsushida, T, 2004
)
3.21
"Quercetin is an important dietary flavonoid with putative beneficial effects in the prevention of cancer and CVD. "( The type of sugar moiety is a major determinant of the small intestinal uptake and subsequent biliary excretion of dietary quercetin glycosides.
Arts, IC; Faassen-Peters, M; Hollman, PC; Sesink, AL, 2004
)
1.97
"Quercetin is a major dietary flavonoid consumed with a diet rich in onions, tea, and apples."( Protein expression profiling identifies molecular targets of quercetin as a major dietary flavonoid in human colon cancer cells.
Daniel, H; Herzog, A; Kuntz, S; Wenzel, U, 2004
)
1.29
"Quercetin is a flavonoid that can inhibit proliferation of tumor cells and reduce the number of aberrant crypt foci, although increase of number of colon tumors was also reported."( Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro.
Aarts, JM; Roepman, P; Stierum, RH; van Bladeren, PJ; van der Lende, TR; van Erk, MJ; van Ommen, B, 2005
)
1.29
"Quercetin is a dietary anticancer chemical that is capable of inducing apoptosis in tumor cells. "( Selective effects of quercetin on the cell growth and antioxidant defense system in normal versus transformed mouse hepatic cell lines.
Jang, YS; Jeon, YM; Kim, JG; Kook, SH; Lee, JC; Lee, KY; Son, YO, 2004
)
2.09
"Quercetin is an important dietary flavonoid with in vitro antioxidant activity. "( Properties of quercetin conjugates: modulation of LDL oxidation and binding to human serum albumin.
Janisch, KM; Needs, P; Plumb, GW; Williamson, G, 2004
)
2.13
"Quercetin is a common antioxidant flavonoid found in vegetables, which is usually present in glycosylated forms, such as quercitrin (3-rhamnosylquercetin). "( In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway.
Ballester, I; Camuesco, D; Comalada, M; Gálvez, J; Sierra, S; Xaus, J; Zarzuelo, A, 2005
)
2.01
"Quercetin is a bioactive flavonoid widely used as a health supplement. "( Physicochemical and structural characterization of quercetin-beta-cyclodextrin complexes.
Chow, AH; Chow, MS; Haworth, IS; Zheng, Y; Zuo, Z, 2005
)
2.02
"Quercetin-4'-glucoside is a major flavonol in onions, and this study investigated the absorption and fate of radiolabeled quercetin-4'-glucoside in rats. "( Disposition and metabolism of [2-14C]quercetin-4'-glucoside in rats.
Caldwell, ST; Crozier, A; Duthie, GG; Edwards, CA; Graf, BA; Hartley, RC; Lean, ME; Mullen, W, 2005
)
2.04
"Quercetin is an abundant flavonoid in the human diet with numerous biological activities, which may contribute to the prevention of human disease but also may be potentially harmful. "( Covalent binding of the flavonoid quercetin to human serum albumin.
Kaldas, MI; McMillan, JM; van der Woude, H; Walle, T; Walle, UK, 2005
)
2.05
"Quercetin is a dietary polyphenolic compound with potentially beneficial effects on health. "( Tissue distribution of quercetin in rats and pigs.
Alink, GM; Arts, IC; de Boer, VC; Dihal, AA; Hollman, PC; Keijer, J; Rietjens, IM; van der Woude, H; Wolffram, S, 2005
)
2.08
"Quercetin is a novel antitumor and antioxidant, whose molecular mechanism involved in cell cycle arrest in androgen independent prostate cancer cells remains unclear."( Quercetin-induced growth inhibition and cell death in prostatic carcinoma cells (PC-3) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression.
Aruldhas, MM; Arunakaran, J; Arunkumar, A; Ilangovan, R; Kanagaraj, P; Vijayababu, MR, 2005
)
2.49
"Quercetin is a major flavonoid in plant foods and potentially has beneficial effects on disease prevention. "( Quercetin appears in the lymph of unanesthetized rats as its phase II metabolites after administered into the stomach.
Murota, K; Terao, J, 2005
)
3.21
"Quercetin is a potent oxygen free radical scavenger and a metal chelator."( Effect of quercetin on metallothionein, nitric oxide synthases and cyclooxygenase-2 expression on experimental chronic cadmium nephrotoxicity in rats.
Jerkic, M; López-Novoa, JM; Morales, AI; Pérez-Barriocanal, F; Sánchez-González, PD; Santiago, JM; Vicente-Sánchez, C, 2006
)
1.46
"Quercetin is a widely distributed plant flavonoid possessing a variety of chemical and biological activities, including chelation, free-radical scavenging, and antioxidant activity. "( Quercetin reduces chromosome aberrations induced by atrazine in the Allium cepa test.
Bolle, P; Carratù, MR; Evandri, MG; Mastrangelo, S; Tomassetti, M, 2006
)
3.22
"Quercetin is a herbal flavonoid derived from various foods of plant origin and plays a role in anti-inflammation. "( The inhibitory effect of quercetin on IL-6 production by LPS-stimulated neutrophils.
He, T; He, Y; Li, J; Li, X; Liu, J; Yue, Y, 2005
)
2.07
"Quercetin is a kind of flavonoid which has been proved to exhibit anti-tumor activity. "( Spectroscopic studies of the interaction between quercetin and G-quadruplex DNA.
Sun, H; Tang, Y; Xiang, J; Xu, G; Xu, L; Zhang, H; Zhang, Y, 2006
)
2.03
"Quercetin is a flavonoid and widely used as an antioxidant and recent studies have revealed its pleiotropic anticancer and antiproliferative capabilities."( Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3).
Arunakaran, J; Arunkumar, A; Kanagaraj, P; Krishnamoorthy, G; Venkataraman, P; Vijayababu, MR, 2006
)
2.5
"Quercetin is a potent chemotherapeutic drug. "( Liposomal quercetin efficiently suppresses growth of solid tumors in murine models.
Chen, LJ; Diao, P; Du, XB; Fan, LY; Tang, MH; Wang, GQ; Wang, R; Wei, YQ; Wu, HB; Yang, GL; Yang, HS; Yao, WX; Ye, B; Yuan, ZP; Zhang, W; Zhao, QM; Zhao, X, 2006
)
2.18
"Quercetin is a potent oxygen free radicals scavenger and a metal chelator."( Protective effect of quercetin on experimental chronic cadmium nephrotoxicity in rats is based on its antioxidant properties.
Arévalo, MA; Egido, J; Fernández-Tagarro, M; López-Novoa, JM; Mayoral, P; Morales, AI; Pérez-Barriocanal, F; Sandoval, JM; Vicente-Sánchez, C, 2006
)
1.37
"Quercetin is a potential chemotherapeutic drug with many biological activities. "( [Nanoliposomal quercetin inhibits formation of malignant ascites of hepatocellular carcinoma].
Chen, LJ; Fan, LY; Tang, MH; Wei, YQ; Yang, GL; Yuan, ZP, 2006
)
2.13
"Quercetin is a typical flavonol-type flavonoid and is present in a variety of vegetables, and their antioxidant effect implies their possible role in the prevention of oxidative stress related chronic diseases. "( Effects of quercetin and quercetin 3-glucuronide on the expression of bone sialoprotein gene.
Arai, M; Araki, S; Kawai, Y; Kim, DS; Mezawa, M; Murota, K; Ogata, Y; Takai, H; Terao, J, 2007
)
2.17
"Quercetin is a flavonoid ubiquitously found in nature. "( Quercetin induces cell cycle G1 arrest through elevating Cdk inhibitors p21 and p27 in human hepatoma cell line (HepG2).
Jia, P; Li, X; Liu, H; Liu, X; Mu, C; Yan, Z, 2007
)
3.23
"Quercetin is a naturally occurring flavonoid that has a lot of beneficial properties to human health. "( Modification of membranes by quercetin, a naturally occurring flavonoid, via its incorporation in the polar head group.
Gawron, A; Gruszecki, WI; Misiak, L; Paduch, R; Pawelec, J; Pawlikowska-Pawlega, B; Piersiak, T; Zarzyka, B, 2007
)
2.07
"Quercetin is a substance of low molecular weight found in vascular plants with a wide range of biological activities including antioxidative and anti-inflammatory activities. "( Quercetin subunit specifically reduces GlyR-mediated current in rat hippocampal neurons.
Cheng, XP; Jiang, P; Sun, H; You-Ye, Z; Zhou, JN, 2007
)
3.23
"Quercetin is a naturally-occurring flavonol (a member of the flavonoid family of compounds) that has a long history of consumption as part of the normal human diet. "( A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties.
Borzelleca, JF; Danielewska-Nikiel, B; Flamm, GW; Harwood, M; Lines, TC; Williams, GM, 2007
)
2.03
"Quercetin is a major dietary flavonoid found in onions and other vegetables. "( Antioxidant capacity of albumin-bound quercetin metabolites after onion consumption in humans.
Hayashi, H; Hotta, A; Ido, H; Inakuma, T; Kawai, Y; Moon, JH; Murota, K; Sekido, K; Terao, J, 2007
)
2.05
"Quercetin is a well-investigated antioxidant and known to be able to protect against cellular oxidative DNA damage."( Discriminative protection against hydroxyl and superoxide anion radicals by quercetin in human leucocytes in vitro.
Briedé, JJ; Kleinjans, JC; Moonen, EJ; Wilms, LC, 2008
)
1.3
"Quercetin was shown to be a strong radical scavenger possibly explaining the observed down-regulation of mitochondrial manganese superoxide dismutase by a reduced need for this antioxidant enzyme for maintenance of cellular redox homeostasis."( Increase of stress resistance and lifespan of Caenorhabditis elegans by quercetin.
Chovolou, Y; Kampkötter, A; Proksch, P; Ruhl, S; Timpel, C; Wätjen, W; Zurawski, RF, 2008
)
1.3
"Quercetin is an important member of dietary flavonoid family and widely present in red wine and Mediterranean diet. "( Dietary polyphenol quercetin protects rat hearts during reperfusion: enhanced antioxidant capacity with chronic treatment.
Dernek, S; Erkasap, N; Ikizler, M; Kaygisiz, Z; Kural, T, 2007
)
2.11
"Quercetin is a natural substance found abundantly in grapes, red wine and other food products. "( Quercetin inhibits choroidal and retinal angiogenesis in vitro.
Cao, XG; Chen, Y; Li, XX; Xing, NZ, 2008
)
3.23
"Quercetin is a bioflavonoid found in red wine, grapefruit, onions, apples, black tea, and, in lesser amounts, in leafy green vegetables and beans."( Role of quercetin (a natural herbal compound) in allergy and inflammation.
Caraffa, A; Castellani, ML; Cerulli, G; Conti, F; De Lutiis, MA; Madhappan, B; Perrella, A; Salini, V; Shaik, YB; Tete, S; Vecchiet, J,
)
1.29
"Quercetin is a flavonoid compound that has been demonstrated to be a potent antioxidant in vitro. "( Chronic quercetin ingestion and exercise-induced oxidative damage and inflammation.
Dibarnardi, A; Dumke, CL; Henson, DA; Hosick, PA; Hudson, MH; McAnulty, LS; McAnulty, SR; Milne, GL; Morrow, JD; Nieman, DC; Quindry, JC; Still, L; Triplett, NT; Utter, AC, 2008
)
2.22
"Quercetin is a flavonoid reported to have health-promoting properties. "( Activation of EpRE-mediated gene transcription by quercetin glucuronides depends on their deconjugation.
Aarts, JM; Lee-Hilz, YY; Rietjens, IM; Stolaki, M; van Berkel, WJ, 2008
)
2.04
"Quercetin is a flavonol, also a phytoestrogen, available commonly in onions and apples. "( Effect of quercetin on bone formation.
Rabie, AB; Wong, RW, 2008
)
2.19
"Quercetin is a flavonoid and a well-known AhR antagonist, while onion contains many flavonoids, including quercetin."( Alleviative effects of quercetin and onion on male reproductive toxicity induced by diesel exhaust particles.
Aizawa, K; Inakuma, T; Izawa, H; Kohara, M; Sagai, M; Suganuma, H; Taya, K; Watanabe, G, 2008
)
1.38
"Quercetin is an anti-oxidative flavonoid widely distributed in the plant kingdom. "( Multitargeted cancer prevention by quercetin.
Ashida, H; Murakami, A; Terao, J, 2008
)
2.07
"Quercetin is a popular flavonoid compound that is biosynthesized by plants; it is suggested to modulate a variety of inflammatory responses of macrophages and T lymphocytes. "( Regulatory mechanisms of IL-2 and IFNgamma suppression by quercetin in T helper cells.
An, SY; Hong, JH; Hwang, ES; Min, HJ; Won, HY; Yu, ES, 2008
)
2.03
"Quercetin is a naturally occurring flavonoid, chemically related to cromolyn. "( Quercetin inhibition of the induction and function of cytotoxic T lymphocytes.
Middleton, E; Schwartz, A; Sutton, SL, 1982
)
3.15
"Quercetin is a dietary antioxidant that prevents oxidation of low-density lipoproteins in vitro. "( Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers.
de Vries, JH; Hollman, PC; Katan, MB; Mengelers, MJ; van Leeuwen, SD, 1995
)
2.05
"Quercetin is a dietary antioxidant that prevents oxidation of low-density lipoproteins in vitro by scavenging to free oxygen radicals. "( Absorption and disposition kinetics of the dietary antioxidant quercetin in man.
de Vries, JH; Hollman, PC; Katan, MB; Mengelers, MJ; van Trijp, JM; vd Gaag, M, 1996
)
1.98
"Quercetin is a powerful antioxidant which is widely distributed in edible plants, mainly as glycosides such as rutin. "( Bioavailability of rutin and quercetin in rats.
Demigné, C; Manach, C; Morand, C; Régérat, F; Rémésy, C; Texier, O, 1997
)
2.03
"Quercetin is a strong antioxidant and a major dietary flavonoid. "( Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man.
Buysman, MN; de Vries, JH; Hollman, PC; Katan, MB; Mengelers, MJ; van der Gaag, MS; van Trijp, JM, 1997
)
1.99
"Quercetin is a flavonoid well known to inhibit growth and heat shock protein (HSP) synthesis of cancer cells. "( Effects of quercetin and sunphenon on responses of cancer cells to heat shock damage.
Asano, G; Kudo, M; Naito, Z; Yokoyama, M, 1999
)
2.14
"Quercetin is a potent antioxidant in vitro, and protection against the oxidative damage to LDL implicated in atherogenesis has been suggested as a possible mechanism."( The bioavailability of non-nutrient plant factors: dietary flavonoids and phyto-oestrogens.
Wiseman, H, 1999
)
1.02
"Quercetin is a bioflavonoid with antioxidant and anti-inflammatory activity. "( Effect of an antioxidant (quercetin) on sodium-lauryl-sulfate-induced skin irritation.
Armenaka, M; Davoy, E; Katsarou, A; Theoharides, TC; Xenos, K, 2000
)
2.05
"Quercetin is a plant polyphenol which is present in the diet as an aglycone and as sugar conjugates. "( High-performance liquid chromatographic determination of quercetin and isorhamnetin in rat tissues using beta-glucuronidase and acid hydrolysis.
Duthie, GG; Morrice, PC; Wood, SG, 2000
)
1.99
"Quercetin-3-rutinoside is an important form of quercetin in foods, but its bioavailability in humans is only 20% of that of quercetin-4'-glucoside."( Bioavailabilities of quercetin-3-glucoside and quercetin-4'-glucoside do not differ in humans.
Hollman, PC; Katan, MB; Olthof, MR; Vree, TB, 2000
)
1.35
"Quercetin is a flavonoid molecule ubiquitous in nature. "( Antioxidants and cancer, part 3: quercetin.
Brignall, MS; Lamson, DW, 2000
)
2.03
"Quercetin is a typical flavonoid present mostly as glycosides in plant foods; it has attracted much attention for its potential beneficial effects in disease prevention. "( Accumulation of quercetin conjugates in blood plasma after the short-term ingestion of onion by women.
Inakuma, T; Moon, JH; Nakata, R; Oshima, S; Terao, J, 2000
)
2.1
"Quercetin is a flavonoid found in red wine and many other dietary sources. "( The effect of quercetin, a widely distributed flavonoid in food and drink, on cytosolic aldehyde dehydrogenase: a comparison with the effect of diethylstilboestrol.
Kitson, KE; Kitson, TM, 2000
)
2.11
"Quercetin is a flavonoid with a wide range of biological activities. "( Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers.
Alfthan, G; Aro, A; Erlund, I; Kenraali, J; Kosonen, T; Mäenpää, J; Parantainen, J; Perttunen, K, 2000
)
2.07
"Quercetin is a very common flavonoid widely distributed in many plants. "( The effect of quercetin on apoptosis and necrosis induction in human colon adenocarcinoma cell line LS180.
Gawron, A; Jakubowicz-Gil, J; Pawlikowska-Pawlega, B; Rzymowska, J, 2001
)
2.11
"1. Quercetin is a natural flavonoid present in vegetables, fruit and wine, and is known to inhibit sulphotransferase. "( Differential inhibition of human liver and duodenum sulphotransferase activities by quercetin, a flavonoid present in vegetables, fruit and wine.
De Santi, C; Marchetti, F; Mosca, F; Pacifici, GM; Pietrabissa, A; Spisni, R; Vietri, M, 2001
)
1.16
"Quercetin is a naturally occurring chemical found in our daily diet in fruits and vegetables. "( Toxicity and carcinogenicity studies of quercetin, a natural component of foods.
Dunnick, JK; Hailey, JR, 1992
)
1.99
"Quercetin is an effective inhibitor of human myeloperoxidase (MPO) activity, both with purified enzyme (IC50 = 3.5 microM) and in a system using stimulated human neutrophils. "( Human myeloperoxidase activity is inhibited in vitro by quercetin. Comparison with three related compounds.
de Bruyn-Dister, M; Deby, C; Goutier, R; Pincemail, J; Thirion, A, 1988
)
1.96
"Quercetin was shown to be a potent inhibitor of iron-induced lipid peroxidation with a I50 of 0.2 mM."( Lipid antioxidant properties of quercetin in vitro.
Das, M; Ray, PK, 1988
)
1.28
"Quercetin is an equally good inhibitor of xanthine oxidase (type O, oxygen-reducing enzyme) and xanthine dehydrogenase (type D, NAD+-reducing enzyme) activity of a preparation of the xanthine-oxidizing enzyme partially purified from rat liver. "( Inhibitory action of quercetin on xanthine oxidase and xanthine dehydrogenase activity.
Bindoli, A; Cavallini, L; Valente, M, 1985
)
2.03

Effects

Quercetin has a variety of biological activities and pharmacological effects. Its clinical application is limited due to its low water solubility, low bioavailability and poor chemical stability. QuercetIn has a potential to modulate P-gp in rodents, but its effects on P-GP modulation in chicken are still unclear.

Isoquercetin (Iso) has been found to have neuroprotective effects against cerebral ischemic stroke. QuercetIn (Que) has anti-tumor activity in addition to its protective effects on various cells.

ExcerptReferenceRelevance
"Quercetin has a hydrophilic surface region that preferentially establishes donor hydrogen bonds with water molecules with relative frequencies from 0.12 to 0.46 at infinite dilution."( Structural, dynamic, and hydration properties of quercetin and its aggregates in solution.
Campo, MG; Corral, GM, 2022
)
1.7
"Quercetin has a wide range of potential health benefits, working as a direct or indirect agent or an adjuvant following different principles. "( Quercetin as a cancer chemopreventive or chemotherapeutic agent: Where we stand.
Boretti, A, 2023
)
3.8
"Quercetin has an ideal therapeutic effect on islet function improvement in type 2 diabetes mellitus (T2DM). "( Controlled SPION-Exosomes Loaded with Quercetin Preserves Pancreatic Beta Cell Survival and Function in Type 2 Diabetes Mellitus.
Chen, Y; Lv, X; Qin, D; Rao, L; Xia, H; Xiao, S; Yang, J; Zhu, C; Zhuang, M, 2023
)
2.62
"Quercetin has a theoretical, but significant, capability to interfere with SARS-CoV-2 replication, with the results showing this to be the fifth best compound out of 18 candidates."( A role for quercetin in coronavirus disease 2019 (COVID-19).
D'Angelo, A; Derosa, G; Di Pierro, F; Maffioli, P, 2021
)
1.73
"Quercetin has a potential to modulate P-gp in rodents, however, its effects on P-gp modulation in chicken are still unclear."( Use of quercetin in animal feed: effects on the P-gp expression and pharmacokinetics of orally administrated enrofloxacin in chicken.
Bhutto, ZA; Guo, T; He, F; Huang, J; Wang, L; Yang, J; Zloh, M, 2018
)
1.66
"Quercetin has a variety of biological activities and pharmacological effects, but its clinical application is limited due to its low water solubility, low bioavailability and poor chemical stability. "( [Research and application of quercetin-loaded nano drug delivery system].
Du, Q; Li, SJ; Liao, YF, 2018
)
2.21
"Quercetin has a dose-dependent effect on the fluidity and local order of the lipid membranes, whilst epigallocatechin-3-gallate action is not dose-dependent, the differences being attributable to the hydrophobic/hydrophilic character of the substances."( Quercetin and epigallocatechin-3-gallate effect on the anisotropy of model membranes with cholesterol.
Ganea, C; Iftime, A; Ilie, M; Ionescu, D; Margină, D, 2013
)
2.55
"Quercetin has a wide range of biological properties. "( Isolation and identification of quercetin degrading bacteria from human fecal microbes.
Li, S; Peng, X; Wang, Y; Wei, H; Zhang, N; Zhang, Z, 2014
)
2.13
"Quercetin has a small beneficial effect for exercise of longer duration (>100 min), but it is unclear whether this benefits athletes."( Impact of Dietary Antioxidants on Sport Performance: A Review.
Braakhuis, AJ; Hopkins, WG, 2015
)
1.14
"Quercetin has a substantial anticancer effect on various human cancer cells."( Quercetin-induced apoptosis of HT-29 colon cancer cells via inhibition of the Akt-CSN6-Myc signaling axis.
Dong, X; Gu, H; Guo, S; Hisamitsu, T; Liu, Y; Qian, Y; Wang, H; Wang, M; Yang, L, 2016
)
2.6
"Quercetin has a strengthening effect on the differentiation of rat bone marrow mesenchymal stem cells into β-cells and increases insulin secretion from the differentiated β-cells in vitro."( Quercetin potentiates transdifferentiation of bone marrow mesenchymal stem cells into the beta cells in vitro.
Khoshdel, Z; Miladpour, B; Mostafavipour, Z; Noorafshan, A; Owji, AA; Rasti, M; Zal, F, 2017
)
3.34
"Quercetin has a wide range of biological functions and health-promoting effects."( Quercetin inhibits human sperm functions by reducing sperm [Ca2+]i and tyrosine phosphorylation.
Liang, X; Wang, Y; Xia, Z; Xue, S; Yan, J; Zhang, X, 2016
)
2.6
"1) Quercetin has a higher reduction potential compared with curcumin at three different pH settings and is comparable to Trolox at pH 7-9.5; 2) its TAC is 3.5 fold higher than curcumin; 3) it reduced LPS-induced ROS to near normal levels; 4) it reduced LPS-induced NO production. "( Antioxidant properties of quercetin.
Cao, Y; Howell, R; Ju, S; Keng, PC; Liu, C; Okunieff, P; Olek, DJ; Schwartz, L; Swarts, M; Swarts, SG; Tian, Y; Yang, S; Yin, L; Zhang, K; Zhang, L; Zhang, M; Zhang, SB, 2011
)
1.29
"Quercetin has an inhibitory effect on Aa and Pg."( Inhibitory effect of quercetin on periodontal pathogens.
Geoghegan, F; Rabie, AB; Tsui, VW; Wong, RW, 2008
)
2.11
"Quercetin has an antioxidant and anti-inflammatory activity and prevents cancer."( Role of quercetin (a natural herbal compound) in allergy and inflammation.
Caraffa, A; Castellani, ML; Cerulli, G; Conti, F; De Lutiis, MA; Madhappan, B; Perrella, A; Salini, V; Shaik, YB; Tete, S; Vecchiet, J,
)
1.29
"Quercetin has an inhibitory effect on urinary crystal deposit formation."( Reduction of oxidative stress in cultured renal tubular cells and preventive effects on renal stone formation by the bioflavonoid quercetin.
Choi, EY; Jeong, BC; Kim, BS; Kim, HH; Kim, JI; Park, HK; Park, MY; Sung, MK, 2008
)
1.99
"Quercetin, which has a better than Ipriflavone water-solubility seems as promising as Ipriflavone in the control of the otosclerotic bone-remodelling disturbance."( Flavonoids alter bone-remodelling in auditory ossicle organ cultures.
Ribári, O; Sziklai, I, 1995
)
1.01
"Quercetin, however, has a strong affinity for protein and provides no direct protective effect during LDL oxidation."( Absorption and antioxidant effects of quercetin from onions, in man.
McAnlis, GT; McEneny, J; Pearce, J; Young, IS, 1999
)
1.3
"Quercetin has been described as a pro-oxidant that induces the production of reactive oxygen species, which can cause cell death."( Reactive oxygen species production by quercetin causes the death of Leishmania amazonensis intracellular amastigotes.
Almeida-Amaral, EE; Canto-Cavalheiro, MM; Fonseca-Silva, F; Inacio, JD, 2013
)
1.38
"Quercetin also has anti-cancer activity, and can be used as an adjuvant to decrease resistance to cancer chemotherapy."( Quercetin and its role in modulating endoplasmic reticulum stress: A review.
Eisvand, F; Seidel, V; Shakeri, A; Tabeshpour, J; Tajbakhsh, A; Zirak, MR, 2022
)
2.89
"Quercetin has been extensively studied for its anti-diabetic, anti-hypertensive, anti-Alzheimer's disease, anti-arthritic, anti-influenza virus, anti-microbial infection, anti-aging, autophagy-regulating, and cardiovascular protective effects."( [Research progress on therapeutic potential of quercetin].
Feng, YL; Li, H; Liu, J; Ruan, Z; Zhai, GY, 2021
)
1.6
"Quercetin has been preliminarily proven to serve as a potential agent for the treatment of osteoarthritis (OA). "( Effects of quercetin on apoptosis and extracellular matrix degradation of chondrocytes induced by oxidative stress-mediated pyroptosis.
Ji, Y; Wang, Q; Wei, B; Xu, Y; Ying, L, 2022
)
2.55
"Quercetin has demonstrated antioxidant, anti-inflammatory, hypoglycemic, and hypolipidemic activities, suggesting therapeutic potential against type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD). "( Mechanism of quercetin therapeutic targets for Alzheimer disease and type 2 diabetes mellitus.
Han, T; Huang, H; Li, L; Sun, K; Zu, G; Zu, X, 2021
)
2.43
"Quercetin (Que) has been proved to have various biological activities, including anti-oxidation, anti-inflammation and anti-virus, showing great potential in liver protection. "( Quercetin loaded liposomes modified with galactosylated chitosan prevent LPS/D-GalN induced acute liver injury.
Fan, Y; Liu, H; Nie, H; Wang, L; Wei, X; Xing, Z; Yang, D; Zhao, C, 2021
)
3.51
"Quercetin (Que) has been proven to possess strong antioxidant activity, and therefore we investigated whether it had potential protective effect against AC-induced cardiotoxicity."( Quercetin attenuates the cardiotoxicity of doxorubicin-cyclophosphamide regimen and potentiates its chemotherapeutic effect against triple-negative breast cancer.
Li, K; Li, S; Zhang, J; Zhang, P; Zhao, L, 2022
)
2.89
"Quercetin (Que) has many pharmacological activities, such as anticancer, antioxidant, cardiovascular protection, antihypertensive and lipid-lowering activities. "( Encapsulating quercetin in cyclodextrin metal-organic frameworks improved its solubility and bioavailability.
Hua, C; Jiang, H; Jiang, Y; Ma, Y; Wang, R; Wang, Z; Wu, Y; Xu, Q; Zhou, F, 2022
)
2.52
"Quercetin has been reported to have antitumor activity of a wide range of cancers, including breast, lung, colon, prostate. "( Quercetin Inhibits Glioblastoma Growth and Prolongs Survival Rate through Inhibiting Glycolytic Metabolism.
Ji, S; Liu, Z; Wang, L; Zhao, J, 2022
)
3.61
"Quercetin, has many biological effects in the prevention and treatment of cancer."( Quercetin's effects on colon cancer cells apoptosis and proliferation in a rat model of disease.
Abdolazimi, H; Fallah, A; Nazari Robati, F; Talaei, B; Tezerji, S, 2022
)
2.89
"Quercetin has been shown to inhibit the growth of different Gram-positive and Gram-negative bacteria as well as fungi and viruses."( Antimicrobial Activity of Quercetin: An Approach to Its Mechanistic Principle.
Bhattacharya, D; Nguyen, TLA, 2022
)
1.74
"Quercetin has anti-oxidative, anti-inflammatory, anti-proliferative, anti-carcinogenic, anti-diabetic, and anti-viral properties."( Health Benefits of Quercetin in Age-Related Diseases.
Maurya, PK, 2022
)
1.77
"Quercetin has significant anti-diabetic effects and may be helpful in lowering blood sugar and increasing insulin sensitivity."( Quercetin: an effective polyphenol in alleviating diabetes and diabetic complications.
Asemi, Z; Malakoti, F; Moein, S; Qujeq, D; Vaghari-Tabari, M; Yan, L; Yousefi, B, 2023
)
3.07
"Quercetin has a hydrophilic surface region that preferentially establishes donor hydrogen bonds with water molecules with relative frequencies from 0.12 to 0.46 at infinite dilution."( Structural, dynamic, and hydration properties of quercetin and its aggregates in solution.
Campo, MG; Corral, GM, 2022
)
1.7
"Quercetin has been proved to exert anti-inflammation in ALI."( Quercetin attenuates sepsis-induced acute lung injury via suppressing oxidative stress-mediated ER stress through activation of SIRT1/AMPK pathways.
Li, X; Sang, A; Song, X; Wang, Q; Wang, S; Wang, X; Wang, Y, 2022
)
2.89
"Quercetin has been a focal point in recent years due to its versatile health-promoting benefits and high pharmacological values."( The Targeting of Noncoding RNAs by Quercetin in Cancer Prevention and Therapy.
Chang, W; Chen, X; Wang, M; Yu, F; Zhang, L; Zhang, Y, 2022
)
1.72
"Quercetin has anti-inflammation, antioxidant, antifibrosis activity in the CKD cells model. "( Quercetin prevents chronic kidney disease on mesangial cells model by regulating inflammation, oxidative stress, and TGF-β1/SMADs pathway.
Afifah, E; Arumwardana, S; Kusuma, HSW; Maulana, MA; Onggowidjaja, P; Prahastuti, S; Rizal, R; Tjokropranoto, R; Widowati, W, 2022
)
3.61
"Quercetin (Que) has been used to treat cardiovascular diseases such as arrhythmias."( Mechanisms of Quercetin against atrial fibrillation explored by network pharmacology combined with molecular docking and experimental validation.
Chen, Y; Gao, Q; Geng, J; Kang, P; Li, X; Tan, X; Tang, B; Wang, H; Wang, Q; Xian, W, 2022
)
1.8
"Quercetin has been reported to alleviate radiation-induced salivary gland damage, yet the effect of quercetin on SS-caused salivary gland damage remains unclear."( Quercetin ameliorates salivary gland apoptosis and inflammation in primary Sjögren's syndrome through regulation of the leptin/OB-R signaling.
Chang, L; Chen, P; Guo, Y; Kong, A; Sun, Y; Wang, X; Zhang, J, 2022
)
2.89
"Quercetin has multiple protective effects against cardiometabolic diseases, but the biological mechanisms underlying the benefits in diabetic cardiomyopathy (DCM) are unclear. "( Quercetin ameliorated cardiac injury
Chen, L; Gao, C; Jiang, C; Li, D; Liu, Y; Mei, G; Tang, Y; Yang, Y; Yao, P; Zhao, Y, 2022
)
3.61
"Quercetin has shown prominent inhibitory effects on the JAK-STAT pathway in terms of anti-inflammatory and antitumor activity, as well as control of neurodegenerative diseases."( Quercetin as a JAK-STAT inhibitor: a potential role in solid tumors and neurodegenerative diseases.
Dana, VG; Farahighasreaboonasr, F; Forghaniesfidvajani, R; Nabi-Afjadi, M; Pakizeh, F; Seif, F; Tavakol, C; Zalpoor, H, 2022
)
2.89
"Quercetin has been shown to have a wide range of beneficial effects, such as anti-inflammation, anti-oxidation and immunomodulation. "( Quercetin protects rat BMSCs from oxidative stress via ferroptosis.
Lan, D; Li, X; Liu, H; Qi, S; Wang, D; Wang, Y; Yao, C, 2022
)
3.61
"Yet, quercetin has the potential to reduce the side effects of crude oil vapor on the male reproductive system."( Potential protective effect of quercetin on the male reproductive system against exposure of Wistar rats to crude oil vapor: Genetic, biochemical, and histopathological evidence.
Basir, Z; Daaj, SAZ; Khazaeel, K; Sadeghi, A; Tabandeh, MR, 2022
)
1.46
"Quercetin has been demonstrated as anti-cancer role in cancer development."( Quercetin Mediated TET1 Expression Through MicroRNA-17 Induced Cell Apoptosis in Melanoma Cells.
Ding, D; Feng, Y; Gao, Y; Hou, R; Li, C; Li, J; Lin, C; Wang, D; Xia, Q; Xue, T, 2023
)
3.07
"Quercetin has gained recognition over the years because of its anti-cancer effect with minimal toxicity."( Quercetin induces autophagy-associated death in HL-60 cells through CaMKKβ/AMPK/mTOR signal pathway.
Huang, K; Li, Y; Liu, H; Liu, X; Nie, D; Wang, J; Xiao, J; Xie, S; Yang, W; Yin, S; Zhang, B; Zhang, G, 2022
)
2.89
"Quercetin (QCT) has antioxidant, anti-inflammatory, anti-tumor and other important pharmacological activities, but the poor water solubility limits its application. "( Dual-grafted dextran based nanomicelles: Higher antioxidant, anti-inflammatory and cellular uptake efficiency for quercetin.
Chen, S; Chen, Y; He, Z; Huang, G; Li, P; Liu, Y; Song, S; Wang, C; Wang, H; Yang, Z; Zhou, C, 2023
)
2.56
"Quercetin has been shown to be preventative against many forms of neuronal cell death resulting from glutamate excitotoxicity, such as oncosis, intrinsic apoptosis, mitochondrial permeability transition, ferroptosis, phagoptosis, lysosomal cell death, parthanatos, and death by reactive oxygen species (ROS)/reactive nitrogen species (RNS) generation."( Quercetin's Effects on Glutamate Cytotoxicity.
Lenard, NR; Riche, K, 2022
)
2.89
"Quercetin has a wide range of potential health benefits, working as a direct or indirect agent or an adjuvant following different principles. "( Quercetin as a cancer chemopreventive or chemotherapeutic agent: Where we stand.
Boretti, A, 2023
)
3.8
"Quercetin has long been used as a natural medicine but its photoactivity has been neglected."( Phytochemicals-based edible coating for photodynamic preservation of fresh-cut apples.
Du, T; Li, X; Su, Z; Sun, H; Wang, J; Wang, S; Zhang, W, 2023
)
1.63
"Quercetin has been proven to be effective for cancer treatment, including nasopharyngeal carcinoma (NPC). "( Quercetin acts as a novel anti-cancer drug to suppress cancer aggressiveness and cisplatin-resistance in nasopharyngeal carcinoma (NPC) through regulating the yes-associated protein/Hippo signaling pathway.
Li, T; Li, Y, 2023
)
3.8
"Quercetin has the potential to ameliorate diabetes induced pulmonary dysfunction by targeting NLRP3."( Protective effect of quercetin on pulmonary dysfunction in streptozotocin-induced diabetic rats via inhibition of NLRP3 signaling pathway.
El-Shaer, NO; Hegazy, AM; Muhammad, MH, 2023
)
1.95
"Quercetin has been reported to be a modulator of proliferation and survival in various types of cancers due to its cytotoxic effects."( Quercetin Induces Cell Cycle Arrest and Apoptosis in YD10B and YD38 Oral Squamous Cell Carcinoma Cells.
Kim, D; Son, HK, 2023
)
3.07
"Quercetin has been shown to reduce the loss of striatal neurons, which may enhance motor capabilities and protect against agents that cause the production of reactive oxygen species (ROS)."( Inhibition of drug induced Parkinsonism by chronic supplementation of quercetin in haloperidol-treated wistars.
Arshad, M; Farhan, M; Rafi, H; Rafiq, H; Rehman, S; Shakeel, S, 2022
)
1.68
"Quercetin has been studied extensively for its anti-Alzheimer's disease (AD) and anti-aging effects. "( A Diet Containing Rutin Ameliorates Brain Intracellular Redox Homeostasis in a Mouse Model of Alzheimer's Disease.
Benedí, J; Bermejo-Bescós, P; Jiménez-Aliaga, KL; Martín-Aragón, S, 2023
)
2.35
"Quercetin has anti-allergic biological activity in AR."( Quercetin improves the imbalance of Th1/Th2 cells and Treg/Th17 cells to attenuate allergic rhinitis.
Chen, Z; Hong, S; Kang, H; Ke, X; Wang, X, 2023
)
3.07
"Quercetin (QC) has been shown to affect CSC viability, but its low bioavailability limits its clinical use."( Effective inhibition of breast cancer stem cell properties by quercetin-loaded solid lipid nanoparticles via reduction of Smad2/Smad3 phosphorylation and β-catenin signaling pathway in triple-negative breast cancer.
Hatami, M; Kheirollah, A; Khorsandi, L; Kouchak, M; Rashidi, M, 2023
)
1.87
"Quercetin has potentially beneficial therapeutic effects for several diseases, including cigarette smoking-induced chronic obstructive pulmonary disease (CS-COPD)."( The therapeutic potential of quercetin for cigarette smoking-induced chronic obstructive pulmonary disease: a narrative review.
Chen, J; Ding, K; Jia, H; Jiang, W; Lei, M; Wang, Y; Xiong, C; Zhan, W,
)
1.14
"Quercetin (QR) has significant anti-respiratory syncytial virus (RSV) effects. "( Integrating metabolomics and network pharmacology to assess the effects of quercetin on lung inflammatory injury induced by human respiratory syncytial virus.
Hu, CC; Jiang, MC; Li, XM; Sun, YL; Tao, JL; Yuan, B; Zhao, PP; Zhu, CB, 2023
)
2.58
"Quercetin has shown beneficial effects on cartilage during OA across animal species. "( Therapeutic potential of senolytic agent quercetin in osteoarthritis: A systematic review and meta-analysis of preclinical studies.
Bahney, C; Huard, J; Nelson, AL; Nishimura, H; Philippon, MJ; Ravuri, SK; Rutledge, JC; Yamaura, K, 2023
)
2.62
"Quercetin has also been demonstrated to exert a striking antiinflammatory effect mainly by inhibiting the production of cytokines, reducing the expression of cyclooxygenase and lipoxygenase, and preserving the integrity of mast cells."( Advance in the pharmacological effects of quercetin in modulating oxidative stress and inflammation related disorders.
Dong, G; Lu, Y; Qian, C; Song, M; Tang, Y; Wang, A; Yang, C; Zhang, T; Zhao, Y; Zheng, W; Zhong, C; Zhou, Y, 2023
)
1.9
"Quercetin, a flavonoid, has demonstrated various therapeutic properties, such as antioxidant, anti-diabetic, anti-hypertensive, and anti-carcinogenic activities."( Drug design strategies that aim to improve the low solubility and poor bioavailability conundrum in quercetin derivatives.
Alizadeh, SR; Ebrahimzadeh, MA; Savadkouhi, N,
)
1.07
"Quercetin has been studied extensively when used with various nanodelivery systems for enhancing quercetin bioavailability."( Nano Drug Delivery Strategies for an Oral Bioenhanced Quercetin Formulation.
Attar, ES; Chaudhari, VH; Deokar, CG; Devarajan, PV; Dyawanapelly, S, 2023
)
1.88
"Quercetin (Que) has been proven to enhance the chemosensitivity of multiple cancers, including colon cancer (CC). "( Quercetin reverses 5-fluorouracil resistance in colon cancer cells by modulating the NRF2/HO-1 pathway.
Chen, Y; Liu, B; Tang, Z; Wang, H; Wang, L; Wang, R; Zhang, S; Zheng, X, 2023
)
3.8
"Both quercetin and leucine have been shown to exert moderately beneficial effects in preventing muscle atrophy induced by cancers or chemotherapy. "( The combination of quercetin and leucine synergistically improves grip strength by attenuating muscle atrophy by multiple mechanisms in mice exposed to cisplatin.
Hsu, TH; Huang, CS; Liao, JW; Tai, YA; Wu, TJ; Yeh, SL, 2023
)
1.75
"Quercetin has an ideal therapeutic effect on islet function improvement in type 2 diabetes mellitus (T2DM). "( Controlled SPION-Exosomes Loaded with Quercetin Preserves Pancreatic Beta Cell Survival and Function in Type 2 Diabetes Mellitus.
Chen, Y; Lv, X; Qin, D; Rao, L; Xia, H; Xiao, S; Yang, J; Zhu, C; Zhuang, M, 2023
)
2.62
"Quercetin has been widely found to exhibit anticancer activity with low toxicity and prevalence in foods. "( Prediction of new targets and mechanisms for quercetin in the treatment of pancreatic cancer, colon cancer, and rectal cancer.
Jiang, C; Jin, H; Liu, Y; Lu, Y; Pang, B; Shao, D; Shi, J; Xu, X; Yang, R, 2019
)
2.22
"Quercetin has valuable biological and therapeutic effects such as anti-tumor, antioxidant, anti-inflammatory, anti-diabetic, hepatoprotective, and cardioprotective."( Autophagy as a molecular target of quercetin underlying its protective effects in human diseases.
Ahmadi, Z; Ashrafizadeh, M; Farkhondeh, T; Samarghandian, S, 2022
)
1.72
"Quercetin has multiple intracellular targets in a cancer cell."( Quercetin as an innovative therapeutic tool for cancer chemoprevention: Molecular mechanisms and implications in human health.
Bhagat, M; Rather, RA, 2020
)
2.72
"Quercetin has been shown to inhibit proliferation and invasion of various glioma cells and is regarded as a potential anticancer agent against glioma."( Quercetin depletes intracellular Ca
Chan, P; Chen, CY; Hour, MJ; Leung, YM; Shiao, LR; So, EC; Wong, KL, 2020
)
2.72
"Quercetin has pharmacological functions in PD by controlling different molecular pathways."( The Therapeutic Potential of Quercetin in Parkinson's Disease: Insights into its Molecular and Cellular Regulation.
Asemi, Z; Behnam, M; Fallah, M; Hadinezhad, T; Shahmirzadi, AR; Taghizadeh, M; Tamtaji, OR, 2020
)
1.57
"Bulk quercetin has low bioavailability and thus, from obtained data we suggest that LA-Q-ORMOSIL nanoparticles provide high therapeutic value in protecting experimental animals against CP-induced liver injury."( Lactobionic Acid Conjugated Quercetin Loaded Organically Modified Silica Nanoparticles Mitigates Cyclophosphamide Induced Hepatocytotoxicity.
Flora, SJ; Naqvi, S; Sharma, H, 2019
)
1.26
"Quercetin has excellent antioxidant properties and preventative effects."( Quercetin Reduces Ischemic Brain Injury by Preventing Ischemia-induced Decreases in the Neuronal Calcium Sensor Protein Hippocalcin.
Jeon, SJ; Kang, JB; Koh, PO; Park, DJ, 2020
)
2.72
"Quercetin has been certified with the effect on improving diabetes mellitus (DM) and cognitive impairment."( Quercetin protects against diabetic encephalopathy via SIRT1/NLRP3 pathway in db/db mice.
Chen, QB; Chen, YB; Hu, T; Liu, XQ; Lu, XY; Shi, JJ; Wang, Q; Zhang, SJ, 2020
)
2.72
"Quercetin (Qc) has shown great potential as a chemopreventive agent and has been widely studied for the treatment of diseases such as bladder cancer."( New quercetin-coated titanate nanotubes and their radiosensitization effect on human bladder cancer.
Alban, L; Diz, FM; Ligabue, R; Miranda, GM; Monteiro, WF; Morrone, FB; Scheid, CM; Zotti, ER, 2020
)
1.84
"Quercetin has been reported to be effective in improving cognitive dysfunction in DE."( Quercetin ameliorates diabetic encephalopathy through SIRT1/ER stress pathway in db/db mice.
Chen, YB; Fang, J; Hu, T; Shi, JJ; Wang, Q; Zhang, SJ, 2020
)
2.72
"Quercetin Dihydrate has been studied in cardiovascular disease, but its effect on myocardial fibrosis is not clear."( Quercetin Dihydrate inhibition of cardiac fibrosis induced by angiotensin II in vivo and in vitro.
An, X; Tan, A; Wang, L; Xia, Y; Xie, Y, 2020
)
2.72
"Quercetin(Que) has multiple pharmacological properties, and is regarded as a potential protective agent against a variety of organ injuries."( Quercetin attenuates NLRP3 inflammasome activation and apoptosis to protect INH-induced liver injury via regulating SIRT1 pathway.
Gao, H; Qu, X; Song, Y; Sun, J; Tao, L; Zhai, J; Zhang, J; Zhang, Y, 2020
)
2.72
"Quercetin has pleiotropic action like anti-oxidant, regulation cell cycle &vascular integrity, and preventive effect of neuroinflammation."( Therapeutic investigation of quercetin nanomedicine in a zebrafish model of diabetic retinopathy.
Du, S; Wang, S; Wang, W; Zhang, F, 2020
)
1.57
"Quercetin has no demonstrable toxicity in humans, further supporting the possibility of using quercetin therapeutically."( Quercetin Inhibits Proliferation and Induces Apoptosis of B16 Melanoma Cells
Berry, IM; Kumari, D; Moore, TC; Soll, F; Ternent, C,
)
2.3
"Quercetin has various biological activities, but its poor water solubility and stability limit its applications. "( Characterization and bacteriostatic effects of β-cyclodextrin/quercetin inclusion compound nanofilms prepared by electrospinning.
Li, F; Liu, L; Shen, W; Wang, M; Wang, Z; Zou, W, 2021
)
2.3
"Quercetin has a theoretical, but significant, capability to interfere with SARS-CoV-2 replication, with the results showing this to be the fifth best compound out of 18 candidates."( A role for quercetin in coronavirus disease 2019 (COVID-19).
D'Angelo, A; Derosa, G; Di Pierro, F; Maffioli, P, 2021
)
1.73
"Quercetin has been in the spotlight over the years because of its high pharmacological values and substantial evidence has demonstrated its anti-proliferative effect against various types of cancers."( Quercetin and MicroRNA Interplay in Apoptosis Regulation in Ovarian Cancer.
Cho, WC; Javed, Z; Khan, K; Luparello, C; Sadia, H; Sharifi-Rad, J, 2021
)
2.79
"Quercetin has been proved to have high medicinal value, and as a type of flavonol, has been found in many plants. "( Borate-modified carbon dots as a probe for quercetin in plants.
Gao, M; He, M; Wang, X; Wang, Z; Xing, R, 2021
)
2.33
"Quercetin has potential against the Multidrug Resistance (MDR) phenotype, but with low bioavailability. "( Anti-MDR Effects of Quercetin and its Nanoemulsion in Multidrug-Resistant Human Leukemia Cells.
Araújo, GS; Cañedo, AD; Carrett-Dias, M; da Silva Alves, B; da Silva Júnior, FMR; de Oliveira, BS; de Souza Votto, AP; Dora, CL; Fernandes E Silva, E; Filgueira, DMVB; Machado, AP; Marques, MB; Santos, PA, 2021
)
2.39
"Quercetin has potential value in treating cardiovascular diseases, but it is not suitable for clinical application due to its own water solubility. "( Effect of Quercetin-Loaded Mesoporous Silica Nanoparticles on Myocardial Ischemia-Reperfusion Injury in Rats and Its Mechanism.
Hu, YM; Liu, CJ; Yao, L; Zhao, BT, 2021
)
2.47
"Quercetin has been also reported to modulate the activity of some members of the multidrug-resistance transporters family, such as P-gp, ABCC1, ABCC2, and ABCG2, and the activity of ecto-5'-nucleotidase (NT5E/CD73), a key regulator in some tumor processes such as invasion, migration, and metastasis."( Effect of Quercetin on ABCC6 Transporter: Implication in HepG2 Migration.
Abruzzese, V; Bisaccia, F; Carmosino, M; Koshal, P; Martinelli, F; Matera, I; Milella, L; Ostuni, A, 2021
)
1.75
"Quercetin has been shown to have anti-obesity effects, but it is unknown whether these effects can be transmitted from mothers to their progeny. "( Maternal Quercetin Consumption during Pregnancy May Help Regulate Total Cholesterol/HDL-Cholesterol Ratio without Effect on Cholesterol Levels in Male Progeny Consuming High-Fat Diet.
Matsuyama, H; Sakakibara, H; Tajiri, H; Takashima, M; Tanaka, W, 2021
)
2.48
"Quercetin (QUR) has been used as model lipophilic drug in this study."( Exploring role of polysaccharides present in Ganoderma lucidium extract powder and probiotics as solid carriers in development of liquisolid formulation loaded with quercetin: A novel study.
Chellappan, DK; Dua, K; Gulati, M; Gupta, G; Jha, NK; Kapoor, B; Kapoor, DN; Karri, VVSR; Khursheed, R; Mondal, S; Pandey, NK; Pattanayak, P; Sharni, A; Singh, SK; Wadhwa, S, 2021
)
1.54
"Quercetin (QUE) has chemo-preventive effect against a variety of cancers."( Quercetin Inhibits the Epithelial to Mesenchymal Transition through Suppressing Akt Mediated Nuclear Translocation of β-Catenin in Lung Cancer Cell Line.
Elumalai, P; Ezhilarasan, D; Raghunandhakumar, S, 2022
)
2.89
"Quercetin has been investigated as an agent to treat rheumatoid arthritis. "( Low dose of quercetin-loaded pectin/casein microparticles reduces the oxidative stress in arthritic rats.
Bracht, A; Bracht, L; Carvalho, AS; Comar, JF; Gonçalves, OH; Moreira, LS; Oliveira, BPM; Sá-Nakanishi, AB; Silva, BT; Silva, PS; Souza, KS; Verri, WA; Zanoni, JN, 2021
)
2.44
"Quercetin has better cytoprotective effect than SnPP."( Quercetin and tin protoporphyrin attenuate hepatic ischemia reperfusion injury: role of HO-1.
Abdel-Mottaleb, Y; Atef, Y; El-Fayoumi, HM; Mahmoud, MF, 2017
)
2.62
"Quercetin (Qu) intake has been associated with reduced incidence and slow development of GC, probably due to its anti-proliferative and apoptotic effects, but it is unclear whether Qu can inhibit the metastatic activity."( Quercetin Has Antimetastatic Effects on Gastric Cancer Cells via the Interruption of uPA/uPAR Function by Modulating NF-κb, PKC-δ, ERK1/2, and AMPKα.
Chen, C; Li, H, 2018
)
2.64
"Quercetin has been found to be very efficacious against many different types of cancer cells. "( Quercetin induces apoptosis and necroptosis in MCF-7 breast cancer cells.
Abbaspour, MR; Khodadadi, A; Khorsandi, L; Mansouri, E; Niazvand, F; Orazizadeh, M,
)
3.02
"Quercetin (Que) has been confirmed to have a neuro-protective effect during nerve damage processes."( Quercetin reduces neural tissue damage and promotes astrocyte activation after spinal cord injury in rats.
Jin, D; Li, G; Li, W; Lin, C; Luo, J; Wang, M; Wang, Y; Zhou, X, 2018
)
2.64
"Quercetin has been shown to induce expression of hypoxia-inducible factor, a protein that is known to regulate transcription of the erythropoietin (EPO) gene, and EPO is known to have a cytoprotective effect."( Effect of quercetin on cell protection via erythropoietin and cell injury of HepG2 cells.
Matsumoto, R; Nakagawa, H; Nishimura, K; Yonezawa, Y, 2017
)
1.58
"Quercetin (QU) has been shown obvious anti-arthritic property in pre-clinical studies or clinical studies. "( Quercetin attenuates collagen-induced arthritis by restoration of Th17/Treg balance and activation of Heme Oxygenase 1-mediated anti-inflammatory effect.
Wu, X; Xu, M; Yang, Y; Zhang, X; Zhao, C; Zhao, F, 2018
)
3.37
"Quercetin has been demonstrated to quench production of intracellular free iron-induced -OH, but the effect of quercetin in ethanol-induced cardiac damage remains unclear."( Quercetin Attenuates Ethanol-Induced Iron Uptake and Myocardial Injury by Regulating the Angiotensin II-L-Type Calcium Channel.
Chen, M; Dong, Z; Gao, C; Guo, X; Liu, J; Liu, P; Tang, Y; Yao, P; Zeng, H; Zhang, J; Zhou, F; Zhu, X, 2018
)
2.64
"Quercetin, a flavonoid, has been reported to ameliorate cardiovascular diseases, such as cardiac hypertrophy. "( Quercetin Prevents In Vivo and In Vitro Myocardial Hypertrophy Through the Proteasome-GSK-3 Pathway.
Chen, K; Li, S; Liu, Y; Luo, J; Rekep, M; Tian, J; Wei, W; Wu, Q; Xiao, Q; Xue, Q; Yi, Q; Zhang, G, 2018
)
3.37
"Isoquercetin (Iso) has been found to have neuroprotective effects against cerebral ischemic stroke. "( Isoquercetin attenuates oxidative stress and neuronal apoptosis after ischemia/reperfusion injury via Nrf2-mediated inhibition of the NOX4/ROS/NF-κB pathway.
Dai, Y; Yan, M; Zhang, H; Zhang, J, 2018
)
1.72
"Quercetin (Que) has anti-tumor activity in addition to its protective effects on various cells."( Quercetin enhances chemotherapeutic effect of doxorubicin against human breast cancer cells while reducing toxic side effects of it.
Li, K; Li, S; Wang, B; Wang, X; Yuan, S; Zhao, Q, 2018
)
2.64
"Quercetin has a potential to modulate P-gp in rodents, however, its effects on P-gp modulation in chicken are still unclear."( Use of quercetin in animal feed: effects on the P-gp expression and pharmacokinetics of orally administrated enrofloxacin in chicken.
Bhutto, ZA; Guo, T; He, F; Huang, J; Wang, L; Yang, J; Zloh, M, 2018
)
1.66
"Quercetin has been reported to improve the symptoms of CP/CPPS patients."( Quercetin protects against chronic prostatitis in rat model through NF-κB and MAPK signaling pathways.
Chen, D; Chen, DX; Cheng, WL; He, QB; Ma, LX; Meng, LQ; Shi, BK; Wang, MS; Xing, NZ; Yang, FY; Zhou, Q, 2018
)
2.64
"Quercetin has specific protective effect on CP/CPPS, which is mediated by anti-inflammation, anti-oxidation, and at least partly through NF-κB and MAPK signaling pathways."( Quercetin protects against chronic prostatitis in rat model through NF-κB and MAPK signaling pathways.
Chen, D; Chen, DX; Cheng, WL; He, QB; Ma, LX; Meng, LQ; Shi, BK; Wang, MS; Xing, NZ; Yang, FY; Zhou, Q, 2018
)
3.37
"Quercetin conjugates have been detected in plasma and in urine, but their presence in the small intestine has not been assessed."( Intestinal disposition of quercetin and its phase-II metabolites after oral administration in healthy volunteers.
Augustijns, P; Chalet, C; Duchateau, GS; Rubbens, J; Tack, J, 2018
)
1.5
"Quercetin has been reported to exert many beneficial effects on the protection against various diseases, such as diabetes, cancer, and inflammation. "( The effects of biodegradable poly(lactic-co-glycolic acid)-based microspheres loaded with quercetin on stemness, viability and osteogenic differentiation potential of stem cell spheroids.
Jeong, JH; Kim, M; Lee, H; Nguyen, TT; Park, JB, 2018
)
2.14
"Quercetin (Que) has consistently been reported to be useful cytotoxic compound in vivo and in vitro, but little is known on its metabolites. "( Differential Effects of Quercetin and Two of Its Derivatives, Isorhamnetin and Isorhamnetin-3-glucuronide, in Inhibiting the Proliferation of Human Breast-Cancer MCF-7 Cells.
Kroon, PA; Needs, PW; Shao, H; Wu, Q; Yang, X, 2018
)
2.23
"Quercetin has a variety of biological activities and pharmacological effects, but its clinical application is limited due to its low water solubility, low bioavailability and poor chemical stability. "( [Research and application of quercetin-loaded nano drug delivery system].
Du, Q; Li, SJ; Liao, YF, 2018
)
2.21
"Quercetin (QCT) has been known as a potential therapeutic strategy for gastrointestinal diseases because it contributes to the stabilization of mast cells, the prevention of histamine release and modulation of CaCC chloride channel."( Quercetin promotes gastrointestinal motility and mucin secretion in loperamide-induced constipation of SD rats through regulation of the mAChRs downstream signal.
Choi, JY; Choi, YW; Hong, JT; Hwang, DY; Kim, JE; Kim, KM; Lee, MR; Park, JJ; Son, HJ; Song, BR, 2018
)
3.37
"Quercetin has been shown to inhibit PhIP formation by trapping phenylacetaldehyde to form two human beneficial adducts 6-C-(E-phenylethenyl)quercetin (6-CEPQ) and 8-C-(E-phenylethenyl)quercetin (8-CEPQ)."( A comparison of mutagenic PhIP and beneficial 8-C-(E-phenylethenyl)quercetin and 6-C-(E-phenylethenyl)quercetin formation under microwave and conventional heating.
Cheng, KW; Fan, D; Li, L; Wang, M; Wang, Q; Yan, B; Zhang, H; Zhang, N; Zhao, J; Zhao, Y, 2018
)
1.44
"Quercetin has important biological activities related to the improvement of the wound healing process."( Quercetin and its Natural Sources in Wound Healing Management.
Aiello, F; Badolato, M; Carullo, G; Perri, F; Polerà, N, 2019
)
2.68
"Quercetin has several pharmacological effects in the nervous system as a neuroprotective agent."( Quercetin in Food: Possible Mechanisms of Its Effect on Memory.
Babaei, F; Mirzababaei, M; Nassiri-Asl, M, 2018
)
2.64
"Quercetin has attracted considerable attention because of its amazingly high pharmacological value."( Quercetin-mediated regulation of signal transduction cascades and microRNAs: Natural weapon against cancer.
Attar, R; Farooqi, AA; Jabeen, S; Xu, B; Yaylim, I, 2018
)
2.64
"Quercetin has multiple intracellular molecular targets with the potential to reverse treatment resistance and affect pleiotropic signaling processes that are altered in cancer cells."( Potential of the Flavonoid Quercetin to Prevent and Treat Cancer - Current Status of Research.
Břetislav, G; Jana, N; Pavel, S; Pavla, U,
)
1.15
"Quercetin has been reported to suppress protein glycation or the formation of advanced glycation end-products (AGEs), but the inhibition mechanism related to protein structure and glycation sites and the influence on physicochemical properties remain unclear. "( Insights into the Mechanism of Quercetin against BSA-Fructose Glycation by Spectroscopy and High-Resolution Mass Spectrometry: Effect on Physicochemical Properties.
Chen, J; Lu, Y; Tu, ZC; Wang, H; Wang, HH; Yang, SH; Ye, YH; Yuan, T; Zhang, L, 2019
)
2.24
"Quercetin (Q) has rapid metabolism, which may make it worthwhile to focus on the potential activity of its metabolites. "( Effects of Quercetin Metabolites on Triglyceride Metabolism of 3T3-L1 Preadipocytes and Mature Adipocytes.
Eseberri, I; González-Manzano, S; Lasa, A; Miranda, J; Mosqueda-Solís, A; Portillo, MP; Santos-Buelga, C, 2019
)
2.35
"Quercetin has strong binding affinity towards CD4, CD8 and CD28, CD45 receptors and protects the thymocytes and splenocytes against DLM-induced apoptotic signaling pathways."( Deltamethrin-Induced Immunotoxicity and its Protection by Quercetin: An Experimental Study.
Gupta, M; Kumar, A; Sharma, N; Sharma, R, 2020
)
2.25
"Quercetin (QCT) has important functions such as antioxidant, anti-inflammatory and anticancer. "( Self-assembled amphiphilic chitosan nanomicelles to enhance the solubility of quercetin for efficient delivery.
Chen, Y; He, Z; Li, P; Li, S; Liu, X; Wang, C; Wang, H; Yang, Z; Zhou, C, 2019
)
2.18
"Quercetin (QCT) has been shown to have anticancer activities associated with apoptosis and autophagy induction. "( Quercetin inhibits growth of hepatocellular carcinoma by apoptosis induction in part via autophagy stimulation in mice.
Ji, Y; Li, L; Li, WT; Ma, YX; Wu, MH; Zhou, JR; Zhu, HZ, 2019
)
3.4
"Quercetin has been shown to display intensive antioxidant activity against ROS-mediated damage in chilled semen, and the effects and molecular mechanisms of Quercetin on sperm function in the infertile patients with leukocytospermia remain largely unknown."( In vitro antioxidation effect of Quercetin on sperm function from the infertile patients with leukocytospermia.
Cai, X; Diao, R; Duan, YG; Gan, H; Song, X; Tian, F; Zhen, W, 2019
)
2.24
"Quercetin has potential pharmacological values in various carcinomas including oral squamous cell carcinoma (OSCC). "( Quercetin suppresses the tumorigenesis of oral squamous cell carcinoma by regulating microRNA-22/WNT1/β-catenin axis.
Hao, Y; Liu, P; Sun, Y; Zhang, C, 2019
)
3.4
"Quercetin has good anti-inflammatory effects and immunomodulatory activities."( Quercetin reduces TNF-α-induced mesangial cell proliferation and inhibits PTX3 production: Involvement of NF-κB signaling pathway.
Fan, H; Huang, Y; Ji, K; Li, X; Liu, Y; Qi, D; Wang, X; Wang, Y; Xie, H; Yu, C, 2019
)
2.68
"Quercetin has a dose-dependent effect on the fluidity and local order of the lipid membranes, whilst epigallocatechin-3-gallate action is not dose-dependent, the differences being attributable to the hydrophobic/hydrophilic character of the substances."( Quercetin and epigallocatechin-3-gallate effect on the anisotropy of model membranes with cholesterol.
Ganea, C; Iftime, A; Ilie, M; Ionescu, D; Margină, D, 2013
)
2.55
"Quercetin a flavonoid, has been reported to lower the risk of several cancers."( Anti-cancer activity of quercetin in neuroblastoma: an in vitro approach.
Arunakaran, J; Arunkumar, R; Bavithra, S; Brindha Mercy, A; Elumalai, P; Raja Singh, P; Selvakumar, K; Sugantha Priya, E, 2014
)
1.43
"And quercetin has effect on intracellular Ca2+ releasing via IP3 of sarcoplasmic reticulum."( [Influences of quercetin on contraction of small intestine smooth muscle of rabbits in vitro and its mechanism].
Gao, Y; Shao, ZW; Wang, QY; Zhang, J, 2013
)
1.22
"Quercetin has been shown to be a potent antioxidant, acts hepatoprotectively, and affects glucose and lipid metabolism in monogastrics. "( Influence of 4-week intraduodenal supplementation of quercetin on performance, glucose metabolism, and mRNA abundance of genes related to glucose metabolism and antioxidative status in dairy cows.
Gohlke, A; Görs, S; Hammon, HM; Ingelmann, CJ; Metges, CC; Nürnberg, G; Starke, A; Weitzel, JM; Wolffram, S, 2013
)
2.08
"Quercetin has been shown to modulate obesity-induced inflammation, but the mechanism of its action remains unclear."( Quercetin suppresses MIP-1α-induced adipose inflammation by downregulating its receptors CCR1/CCR5 and inhibiting inflammatory signaling.
Choe, SY; Hong, SM; Kang, JH; Kim, CS; Noh, HJ; Park, JY; Park, T; Yoo, H; Yu, R, 2014
)
2.57
"Quercetin has been shown to inhibit intestinal P-glycoprotein-mediated drug efflux. "( Effect of single-dose and short-term administration of quercetin on the pharmacokinetics of talinolol in humans - Implications for the evaluation of transporter-mediated flavonoid-drug interactions.
Langguth, P; Nguyen, MA; Staubach, P; Wolffram, S, 2014
)
2.09
"Quercetin has been demonstrated to play an important role in altering the progression of ischemic brain injuries and neurodegenerative diseases by protecting against oxidative stress. "( Protective effect of quercetin against oxidative stress and brain edema in an experimental rat model of subarachnoid hemorrhage.
Dong, YS; Feng, DY; Gao, GD; Li, C; Qin, HZ; Wang, JL; Wen, H; Yin, ZM, 2014
)
2.16
"Quercetin has the potential as functional feed additive in animal production."( Effects of dietary supplementation of quercetin on performance, egg quality, cecal microflora populations, and antioxidant status in laying hens.
Feng, XA; Hu, LL; Jin, F; Li, Y; Liu, HN; Liu, Y; Suo, YL; Teng, N; Zhang, L, 2014
)
1.39
"Quercetin has a wide range of biological properties. "( Isolation and identification of quercetin degrading bacteria from human fecal microbes.
Li, S; Peng, X; Wang, Y; Wei, H; Zhang, N; Zhang, Z, 2014
)
2.13
"Quercetin has many pharmaceutical applications, many of which arise from its potent antioxidant properties."( Intracellular ROS protection efficiency and free radical-scavenging activity of quercetin and quercetin-encapsulated liposomes.
Barzegar, A; Eidi, A; Rezaei-Sadabady, R; Zarghami, N, 2016
)
1.38
"Quercetin (QUR) has been shown to induce anti-, as well as, pro-oxidant effects depending on the dose and on the redox state of the cell. "( Dual effects of quercetin in doxorubicin-induced nephrotoxicity in rats and its modulation of the cytotoxic activity of doxorubicin on human carcinoma cells.
Heeba, GH; Mahmoud, ME, 2016
)
2.22
"Quercetin has been demonstrated to exhibit cytoprotective effects through the induction of heme oxygenase (HO)-1."( Protective effects of intratracheally administered quercetin on lipopolysaccharide-induced acute lung injury.
Hasegawa, Y; Hashimoto, K; Hashimoto, N; Kawabe, T; Matsushima, M; Nose, H; Sato, M; Takashima, K, 2014
)
1.38
"Quercetin has been confirmed to possess antihistamine, anti-inflammatory, antiviral, immunomodulatory, and antioxidant properties. "( Quercetin inhibits proliferation and drug resistance in KB/VCR oral cancer cells and enhances its sensitivity to vincristine.
Hu, Z; Huang, Y; Sun, S; Wang, H; Wu, B; Yao, F; Yuan, Z, 2015
)
3.3
"Quercetin has several biological effects including antioxidative, anti-inflammatory, and anti-allergic effects."( Effect of topical application of quercetin-3-O-(2″-gallate)-α-l-rhamnopyranoside on atopic dermatitis in NC/Nga mice.
Jeong, MS; Joo, SS; Kim, JY; Lee, MW; Park, EJ; Park, KH; Park, KY; Seo, SJ, 2015
)
1.42
"Quercetin has a small beneficial effect for exercise of longer duration (>100 min), but it is unclear whether this benefits athletes."( Impact of Dietary Antioxidants on Sport Performance: A Review.
Braakhuis, AJ; Hopkins, WG, 2015
)
1.14
"Quercetin, a flavonoid, has been tried in traditional medicine for treating many disorders and reported to have inhibitory action on PI3 kinase."( Phosphatidylinositide 3-kinase inhibition: A new potential target for the treatment of polycystic ovarian syndrome.
Patel, SS; Shah, KN, 2016
)
1.88
"Quercetin has been reported to exhibit a wide range of biological activities related to their antibacterial activity and acetylcholine as a neurotransmitter, which can combine with the receptor on the bacterial cell."( Investigation of functional selenium nanoparticles as potent antimicrobial agents against superbugs.
Chen, Q; Chen, X; Huang, X; Liu, J; Sun, D; Yu, Q, 2016
)
1.16
"Quercetin has potent anti-oxidative activities, but poor bioavailability limits its therapeutic application."( Quercetin phospholipid complex significantly protects against oxidative injury in ARPE-19 cells associated with activation of Nrf2 pathway.
Ding, SH; Hang, L; Xu, XR; Yang, XW; Yang, Y; Yu, HT, 2016
)
2.6
"Quercetin has slightly affected it."( Phloretin modulates the rate of channel formation by polyenes.
Chulkov, EG; Ostroumova, OS, 2016
)
1.16
"Quercetin also has known anti-inflammatory effects on lipopolysaccharide-induced macrophages."( Anti-Inflammatory Effect of Quercetin on RAW 264.7 Mouse Macrophages Induced with Polyinosinic-Polycytidylic Acid.
Kim, YJ; Park, W, 2016
)
1.45
"Quercetin has good potential to be applied in oral biological materials."( [Inhibitory effect of quercetin on the biofilm formation of Streptococcus mutans].
Han, L; Huang, C; Song, FF; Yang, HY; Yue, JX; Zhu, MY, 2016
)
1.47
"Quercetin has benefits for liver fibrosis, but the mechanisms are unknown."( Quercetin stimulates mitochondrial apoptosis dependent on activation of endoplasmic reticulum stress in hepatic stellate cells.
Fan, F; He, L; Hou, X; Wu, H, 2016
)
2.6
"Quercetin has the special ability of scavenging highly reactive species, such as hydrogen peroxide, superoxide anion, and hydroxyl radicals."( Molecular Targets Underlying the Anticancer Effects of Quercetin: An Update.
Abdollahi, M; Bishayee, A; Ismail Hassan, F; Khan, F; Maqbool, F; Nabavi, SM; Nagulapalli Venkata, KC; Niaz, K, 2016
)
1.4
"Quercetin has multiple potential to control various cell function keeping our body condition healthy. "( Quercetin is a Useful Medicinal Compound Showing Various Actions Including Control of Blood Pressure, Neurite Elongation and Epithelial Ion Transport.
Hosogi, S; Ikeuchi, Y; Kanamura, N; Kashio, M; Kogiso, H; Marunaka, R; Marunaka, Y; Miyazaki, H; Nakahari, T; Nakajima, KI; Niisato, N; Okui, M; Sun, H; Taruno, A; Yamamoto, T, 2018
)
3.37
"Quercetin has been reported to have the activities of antioxidant, anti-inflammatory, anti-virus, anti-cancer and so on. "( Quercetin upregulates ABCA1 expression through liver X receptor alpha signaling pathway in THP-1 macrophages.
Jia, YP; Lu, Y, 2016
)
3.32
"Quercetin has a substantial anticancer effect on various human cancer cells."( Quercetin-induced apoptosis of HT-29 colon cancer cells via inhibition of the Akt-CSN6-Myc signaling axis.
Dong, X; Gu, H; Guo, S; Hisamitsu, T; Liu, Y; Qian, Y; Wang, H; Wang, M; Yang, L, 2016
)
2.6
"Quercetin has also been well reported for its ability to reverse cognitive impairment and memory enhancement during aging."( Bioactive effects of quercetin in the central nervous system: Focusing on the mechanisms of actions.
Braidy, N; Devi, KP; Nabavi, SF; Nabavi, SM; Suganthy, N, 2016
)
1.47
"Quercetin has been identified as a promising compound with a neuroprotective potential against age-related neurodegenerative diseases such as Alzheimer's disease (AD). "( Effect of the oral administration of nanoencapsulated quercetin on a mouse model of Alzheimer's disease.
Irache, JM; Moreno, LCGEI; Puerta, E; Ramirez, MJ; Santos-Magalhães, NS; Suárez-Santiago, JE, 2017
)
2.15
"Quercetin has a strengthening effect on the differentiation of rat bone marrow mesenchymal stem cells into β-cells and increases insulin secretion from the differentiated β-cells in vitro."( Quercetin potentiates transdifferentiation of bone marrow mesenchymal stem cells into the beta cells in vitro.
Khoshdel, Z; Miladpour, B; Mostafavipour, Z; Noorafshan, A; Owji, AA; Rasti, M; Zal, F, 2017
)
3.34
"Quercetin has shown neuroprotective and antidiabetic effects, besides modulating cognition and insulin signaling."( Quercetin ameliorates chronic unpredicted stress-mediated memory dysfunction in male Swiss albino mice by attenuating insulin resistance and elevating hippocampal GLUT4 levels independent of insulin receptor expression.
Mehta, V; Parashar, A; Sharma, A; Singh, TR; Udayabanu, M, 2017
)
2.62
"Quercetin has a wide range of biological functions and health-promoting effects."( Quercetin inhibits human sperm functions by reducing sperm [Ca2+]i and tyrosine phosphorylation.
Liang, X; Wang, Y; Xia, Z; Xue, S; Yan, J; Zhang, X, 2016
)
2.6
"Quercetin has been reported to have several biological activities, which include anti-viral and anti-inflammatory effects."( The anti-HSV-1 effect of quercetin is dependent on the suppression of TLR-3 in Raw 264.7 cells.
Cho, H; Kang, H; Lee, HH; Lee, S; Shin, YS, 2017
)
1.48
"Quercetin has been shown to have anti-inflammatory properties and can play a role in anti-inflammatory procedure."( Quercetin inhibits IL-1 beta-induced ICAM-1 expression in pulmonary epithelial cell line A549 through the MAPK pathways.
Chen, L; Cheng, D; Fan, H; Hu, X; Liu, D; Lu, X; Song, X; Wang, T; Wei, Y; Wen, F; Xu, D; Yang, T; Ying, B, 2009
)
2.52
"Quercetin has demonstrated significant anti-inflammatory activity because of direct inhibition of several initial processes of inflammation."( Quercetin regulates Th1/Th2 balance in a murine model of asthma.
Ahn, SC; Chang, JH; Choi, IW; Chun, SH; Jeong, YI; Jung, ID; Kim, MJ; Lee, CM; Lee, JS; Park, HJ; Park, YM; Shin, YK; Yeom, SR, 2009
)
2.52
"Quercetin has been shown to induce a progressive, dose-dependent and sustained reduction in blood pressure when given chronically in several rat models of hypertension, including spontaneously hypertensive rats, L-NAME-treated rats, DOCA-salt hypertensive rats, two-kidney one-clip Goldblatt rats, rats with aortic constriction and Dahl salt-sensitive hypertensive rats."( Antihypertensive effects of the flavonoid quercetin.
Duarte, J; Jimenez, R; Osuna, A; Perez-Vizcaino, F; Santos-Buelga, C,
)
1.12
"Quercetin has strong antioxidant potency. "( Quercetin metabolites and protection against peroxynitrite-induced oxidative hepatic injury in rats.
Crozier, A; Kawai, Y; Kumazawa, S; Matsui, A; Sakakibara, H; Shimoi, K; Terao, J; Yokoyama, A, 2009
)
3.24
"Quercetin has been shown to possess beneficial pharmacological properties in treatment of heart disease, but lack of stability and bioavailability limits its clinical use. "( 3,3',4',5,7-Pentamethylquercetin reduces angiotensin II-induced cardiac hypertrophy and apoptosis in rats.
Du, X; Liang, Y; Mao, Z; Sun, Z, 2009
)
2.11
"Quercetin has been shown to enhance tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of prostate cancer cells via mechanisms that include upregulation of death receptor (DR) 5, a protein reported to play an important role in sensitizing cancer cells to apoptosis. "( Quercetin enhances TRAIL-induced apoptosis in prostate cancer cells via increased protein stability of death receptor 5.
Heo, J; Jung, YH; Kim, YH; Kwon, TK; Lee, YJ, 2010
)
3.25
"Quercetin has been studied extensively. "( Changes of metabolic profiles in urine after oral administration of quercetin in rats.
An, D; Dong, F; Guo, C; Wei, J; Wu, S; Yan, X; Yang, J; Zhang, Q, 2010
)
2.04
"Quercetin has been described as having a wide range of beneficial effects in humans, ranging from anti-carcinogenic properties to reducing the risk of CVD. "( Quercetin supplementation and its effect on human monocyte gene expression profiles in vivo.
Boomgaarden, I; Döring, F; Egert, S; Müller, MJ; Rimbach, G; Wolffram, S, 2010
)
3.25
"Quercetin (Qt) has anti-inflammatory properties through its ability to inhibits nitric oxide production and iNOS expression in different cellular types."( Quercetin tetraacetyl derivative inhibits LPS-induced nitric oxide synthase (iNOS) expression in J774A.1 cells.
Cabrera, JL; Chiabrando, GA; Ortega, MG; Saragusti, AC, 2010
)
2.52
"Quercetin has antioxidants properties which may increase nitric oxide (NO) bioavailability. "( Quercetin restores plasma nitrite and nitroso species levels in renovascular hypertension.
Castro, MM; Ceron, CS; Dias-Junior, CA; Gomes, VA; Kanashiro, A; Montenegro, MF; Neto-Neves, EM; Tanus-Santos, JE, 2010
)
3.25
"Quercetin has been reported to be an efficient antioxidant which protects chicken spermatogonial cells from oxidative damage through increasing intracellular antioxidants and decreasing lipid peroxidation. "( Quercetin protects hamster spermatogenic cells from oxidative damage induced by diethylstilboestrol.
Li, G; Ma, A; Shi, W; Zhong, X, 2010
)
3.25
"Quercetin has shown a biphasic behavior in basophils at nanomolar doses and hence its action on cells involved in allergic inflammation is here described."( The role of quercetin, flavonols and flavones in modulating inflammatory cell function.
Chirumbolo, S, 2010
)
1.46
"Quercetin has attracted much attention recently because of its antioxidant capacity and potential in the prevention of chronic degenerative diseases. "( Cholesterol metabolism is modulated by quercetin in rats.
Gao, W; Guo, C; Wang, Y; Wei, J; Wu, J; Yang, J; Zhao, L, 2011
)
2.08
"Quercetin has generated considerable interest as a pharmaceutical compound with a wide range of therapeutic activities."( Reactive oxygen species production and mitochondrial dysfunction contribute to quercetin induced death in Leishmania amazonensis.
Almeida-Amaral, EE; Canto-Cavalheiro, MM; Fonseca-Silva, F; Inacio, JD, 2011
)
1.32
"Quercetin has been described as a pro-oxidant, generating ROS which are responsible for cell death in some cancer cells."( Reactive oxygen species production and mitochondrial dysfunction contribute to quercetin induced death in Leishmania amazonensis.
Almeida-Amaral, EE; Canto-Cavalheiro, MM; Fonseca-Silva, F; Inacio, JD, 2011
)
1.32
"1) Quercetin has a higher reduction potential compared with curcumin at three different pH settings and is comparable to Trolox at pH 7-9.5; 2) its TAC is 3.5 fold higher than curcumin; 3) it reduced LPS-induced ROS to near normal levels; 4) it reduced LPS-induced NO production. "( Antioxidant properties of quercetin.
Cao, Y; Howell, R; Ju, S; Keng, PC; Liu, C; Okunieff, P; Olek, DJ; Schwartz, L; Swarts, M; Swarts, SG; Tian, Y; Yang, S; Yin, L; Zhang, K; Zhang, L; Zhang, M; Zhang, SB, 2011
)
1.29
"Quercetin has been shown to be an adenosine-receptor antagonist and may reduce oxidative stress via inhibition of the enzyme xanthine oxidase (XO)."( Effect of quercetin supplementation on repeated-sprint performance, xanthine oxidase activity, and inflammation.
Abbey, EL; Rankin, JW, 2011
)
1.49
"Quercetin has potentially beneficial effects on disease prevention, including cancer. "( The pro-apoptotic effect of quercetin in cancer cell lines requires ERβ-dependent signals.
Acconcia, F; Bolli, A; Bulzomi, P; Galluzzo, P; Leone, S; Marino, M, 2012
)
2.12
"Quercetin and rutin have been reported to exert numerous pharmacological activities, such as free-radical scavenging, effects on immune and inflammatory cell functions, and could have benefits in Alzheimer's disease (AD) by mitigating cellular damage induced by reactive oxygen species (ROS). "( Quercetin and rutin exhibit antiamyloidogenic and fibril-disaggregating effects in vitro and potent antioxidant activity in APPswe cells.
Benedí, J; Bermejo-Bescós, P; Jiménez-Aliaga, K; Martín-Aragón, S, 2011
)
3.25
"Quercetin has an inhibitory effect on Aa and Pg."( Inhibitory effect of quercetin on periodontal pathogens.
Geoghegan, F; Rabie, AB; Tsui, VW; Wong, RW, 2008
)
2.11
"Quercetin has been shown to induce apoptosis in a number of cancer cell lines, but a quercetin-loaded nanoliposomal formulation with enhanced antitumor activity in C6 glioma cells and its effect on cancer cell death has not been well studied. "( Effects of quercetin nanoliposomes on C6 glioma cells through induction of type III programmed cell death.
Chen, JY; Du, SM; Feng, JB; Li, DS; Li, RM; Wang, G; Wang, JJ; Yang, GY; Ye, F; Yuan, SH; Zeng, N, 2012
)
2.21
"Quercetin has been demonstrated to be effective in increasing physical endurance in mice and humans. "( Quercetin alters energy metabolism in swimming mice.
Gao, W; Guo, C; Pu, L; Wei, J; Wu, J; Yang, J, 2012
)
3.26
"Quercetin has renal protective effects partly through reducing NF-κB p65 expression."( [Effects of quercetin on nuclear factor-κB p65 expression in renal ubiquitin-proteasome system of diabetic rats].
Chen, JB; Chen, P; Chen, WY; Wang, YQ; Xu, XJ; Zheng, QL, 2012
)
1.48
"Quercetin has also been shown to undergo oxidation."( Rapid dimerization of quercetin through an oxidative mechanism in the presence of serum albumin decreases its ability to induce cytotoxicity in MDA-MB-231 cells.
Bortolazzo, A; Pham, A; White, JB, 2012
)
1.41
"Quercetin has been reported to protect testicular cells from oxidative damage induced by environmental chemicals. "( Quercetin decreases steroidogenic enzyme activity, NF-κB expression, and oxidative stress in cultured Leydig cells exposed to atrazine.
Abarikwu, SO; Farombi, EO; Pant, AB, 2013
)
3.28
"Quercetin has therapeutic potential as an anticancer drug, but has poor solubility and low bioavailability."( Co-encapsulation of biodegradable nanoparticles with silicon quantum dots and quercetin for monitored delivery.
Ahire, J; Bao, Y; Chao, Y; Wang, Q, 2013
)
1.34
"Quercetin has demonstrated protective effects against Aβ-induced toxicity on both neurons and endothelial cells. "( Quercetin protects against the Aβ(25-35)-induced amnesic injury: involvement of inactivation of rage-mediated pathway and conservation of the NVU.
Bai, XY; Du, GH; Huang, C; Li, L; Liu, R; Meng, FR; Song, JK; Wu, CX; Zhang, TT; Zhou, D; Zhou, WL, 2013
)
3.28
"Quercetin has been reported to possess many important biological properties. "( Quercetin modulates Na(+)/K(+) ATPase and sodium hydrogen exchanger in type 2 diabetic erythrocytes.
Mishra, N; Rizvi, SI, 2012
)
3.26
"Quercetin has antioxidant, anti-inflammatory, antiproliferative and anticarcinogenic properties. "( Intestinal uptake of quercetin-3-glucoside in rats involves hydrolysis by lactase phlorizin hydrolase.
Arts, IC; Faassen-Peters, M; Hollman, PC; Sesink, AL, 2003
)
2.08
"Quercetin has been shown to act as a hyperthermia sensitizer by inhibiting the synthesis of heat shock protein 70 (HSP70) in a variety of tumour cell lines. "( Quercetin sensitizes cells in a tumour-like low pH environment to hyperthermia.
Bhala, A; Bobyock, SB; Burd, R; Leeper, DB; Owen, CS; Rifat, SB; Wachsberger, PR; Wahl, ML,
)
3.02
"Quercetin has certain counter-effect against the influence of microgravity."( [Image analysis of cardiac muscle cytoskeleton under simulated microgravity based on gray-level co-occurrence matrix (GLCM)].
Xiong, JH; Yan, H; Yao, YH, 2003
)
1.04
"Quercetin has chemoprotective properties in experimental colon cancer models, and in vitro studies have demonstrated that quercetin inhibits HT-29 colon cancer cell growth. "( Quercetin decreases the expression of ErbB2 and ErbB3 proteins in HT-29 human colon cancer cells.
Bang, MH; Cho, HJ; Jung, KC; Kang, NE; Kim, ES; Kim, WK; Park, JH, 2005
)
3.21
"Quercetin has been suggested to exert its pharmacological effects, at least in part, via its metabolites, such as glucuronides. "( Quantitative regioselectivity of glucuronidation of quercetin by recombinant UDP-glucuronosyltransferases 1A9 and 1A3 using enzymatic kinetic parameters.
Chen, SQ; Chen, YK; Li, X; Zeng, S,
)
1.82
"Quercetin has therapeutic potential as an anti-cancer drug."( Reactive oxygen species production is involved in quercetin-induced apoptosis in human hepatoma cells.
Chang, YF; Chi, CW; Wang, JJ, 2006
)
1.31
"Quercetin has many beneficial effects on the cardiovascular system, but it is unknown whether it provides protection against homocysteine-injured vascular endothelial cells."( Protective effect of quercetin on the homocysteine-injured human umbilical vein vascular endothelial cell line (ECV304).
Ding, C; Gan, W; Lin, R; Liu, J, 2007
)
1.38
"Quercetin has provided increased preservation in myocardial recovery in both chronic and acute treatment protocols compared to non-treated group. "( Dietary polyphenol quercetin protects rat hearts during reperfusion: enhanced antioxidant capacity with chronic treatment.
Dernek, S; Erkasap, N; Ikizler, M; Kaygisiz, Z; Kural, T, 2007
)
2.11
"Quercetin has been shown to act as an anticarcinogen in experimental colorectal cancer (CRC). "( Transcriptome and proteome profiling of colon mucosa from quercetin fed F344 rats point to tumor preventive mechanisms, increased mitochondrial fatty acid degradation and decreased glycolysis.
Alink, GM; Burgers, PC; Charif, H; de Boer, VC; Dekker, LJ; Dihal, AA; Hendriksen, PJ; Ijsselstijn, L; Rietjens, IM; Stierum, RH; van der Woude, H; Woutersen, RA, 2008
)
2.03
"Quercetin has an antioxidant and anti-inflammatory activity and prevents cancer."( Role of quercetin (a natural herbal compound) in allergy and inflammation.
Caraffa, A; Castellani, ML; Cerulli, G; Conti, F; De Lutiis, MA; Madhappan, B; Perrella, A; Salini, V; Shaik, YB; Tete, S; Vecchiet, J,
)
1.29
"Quercetin has an inhibitory effect on urinary crystal deposit formation."( Reduction of oxidative stress in cultured renal tubular cells and preventive effects on renal stone formation by the bioflavonoid quercetin.
Choi, EY; Jeong, BC; Kim, BS; Kim, HH; Kim, JI; Park, HK; Park, MY; Sung, MK, 2008
)
1.99
"Quercetin aglycone has also been shown to modulate several signal transduction pathways involving MEK/ERK and Nrf2/keap1, which are associated with the processes of inflammation and carcinogenesis."( Multitargeted cancer prevention by quercetin.
Ashida, H; Murakami, A; Terao, J, 2008
)
1.34
"Quercetin has been shown to inhibit antigen- and mitogen-induced histamine release from rat mast cells and basophils of subjects with hay fever, to increase cyclic adenosine monophosphate (AMP) in Ehrlich ascites tumor cells and to inhibit phosphodiesterase and certain adenosine triphosphatase (ATPase) systems."( Quercetin inhibition of the induction and function of cytotoxic T lymphocytes.
Middleton, E; Schwartz, A; Sutton, SL, 1982
)
2.43
"Quercetin, which has a better than Ipriflavone water-solubility seems as promising as Ipriflavone in the control of the otosclerotic bone-remodelling disturbance."( Flavonoids alter bone-remodelling in auditory ossicle organ cultures.
Ribári, O; Sziklai, I, 1995
)
1.01
"Quercetin has been the subject of numerous studies on its genetic toxicity and carcinogenicity. "( On the mechanisms of genotoxicity and metabolism of quercetin.
Costa, S; Gaspar, J; Laires, A; Monteiro, C; Monteiro, MJ; Rodrigues, A; Rueff, J; Silva, F, 1994
)
1.98
"Quercetin has been shown to induce the translocation of tryptophanyls and tyrosyls from membrane protein inner regions to their surface."( [Structural rearrangement in leukocyte membranes under the effect of quercetin and linoleic acid hydroxamate].
Lebed', OI; Luĭk, AI; Zhirnov, VV,
)
1.09
"Quercetin has antiproliferative activity in vitro and is known to inhibit signal transduction targets including tyrosine kinases, protein kinase C, and phosphatidyl inositol-3 kinase."( Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition.
Anderson, D; Baker, J; deTakats, PG; Ferry, DR; Fyfe, DW; Kerr, DJ; Malkhandi, J; Smith, A, 1996
)
1.28
"Quercetin, however, has a strong affinity for protein and provides no direct protective effect during LDL oxidation."( Absorption and antioxidant effects of quercetin from onions, in man.
McAnlis, GT; McEneny, J; Pearce, J; Young, IS, 1999
)
1.3
"Quercetin has radical scavenging effects on both sides of the membrane, because it prevents PC-OOH production by AMVN or AAPH."( [Effect of antioxidants on radical-initiated peroxidation of retinal homogenate].
Armstrong, D; Chida, M; Higa, A; Kan, K; Koide, R; Matsuishi, M; Suzuki, K; Ueda, T; Yamamoto, Y; Yasuhara, H, 2000
)
1.03
"Quercetin has nonspecific effects on normal human T cells, but luteolin appears nontoxic."( Luteolin, an abundant dietary component is a potent anti-leishmanial agent that acts by inducing topoisomerase II-mediated kinetoplast DNA cleavage leading to apoptosis.
Bandyopadhyay, S; Chowdhury, AR; Majumder, HK; Mandal, S; Mittra, B; Mukhopadhyay, S; Pal, C; Saha, A, 2000
)
1.03
"Quercetin has been reported to have carcinogenic effects. "( Distinct mechanisms of DNA damage in apoptosis induced by quercetin and luteolin.
Kawanishi, S; Yamashita, N, 2000
)
1.99
"Quercetin has been known to have anti-tumor and anti-oxidation activities. "( Quercetin inhibits the invasion and mobility of murine melanoma B16-BL6 cells through inducing apoptosis via decreasing Bcl-2 expression.
Saiki, I; Xu, Q; Zhang, X, 2000
)
3.19
"Quercetin has been reported to be an agent that inhibits hsp70 expression."( Effects of quercetin on the heat-induced cytotoxicity of prostate cancer cells.
Deguchi, N; Hirata, R; Iida, M; Nakanoma, T; Ueno, M, 2001
)
1.42
"Quercetin has been extensively studied in various short-term assays for genotoxicity. "( Oxygen species and the genotoxicity of quercetin.
Borba, H; Gaspar, J; Laires, A; Rodrigues, A; Rueff, J, 1992
)
2
"Quercetin (Q) has been shown to inhibit Ca2+-dependent processes. "( Selectivity of quercetin inhibition on stimulated amylase release in rat pancreatic acini.
Cumella, JC; Lee, PC; Rossi, TM; Shimizu, K, 1988
)
2.07

Actions

Quercetin did not cause any significant changes on the plasma TC, TG and liver fat at weeks 4, 7 and 10. It did, however, inhibit ATPase activity of plasma membrane, suggesting that this unidentified ATPase may contribute to the formation of ADP and Pi required for lactate production by the intact cell.

ExcerptReferenceRelevance
"Quercetin promotes the proliferation of H9C2 cells, while inhibiting inflammation, oxidative stress, and cell apoptosis, and alleviating the structural and functional dysfunction of mitochondria. "( Quercetin regulates inflammation, oxidative stress, apoptosis, and mitochondrial structure and function in H9C2 cells by promoting PVT1 expression.
Chen, H; Li, D; Li, F; Liu, J; Tang, S; Yan, J; Yan, X, 2021
)
3.51
"Quercetin can inhibit glycolysis and cell proliferation of oral squamous cell carcinoma, apparently by inhibiting the G3BP1/YWHAZ axis."( Quercetin acts via the G3BP1/YWHAZ axis to inhibit glycolysis and proliferation in oral squamous cell carcinoma.
Chen, L; Hu, M; Song, HY, 2023
)
3.07
"Quercetin and OC-20 inhibit airway inflammation response, airway fibrosis, and airway hyperreactivity."( Quercetin Alleviates Asthma-Induced Airway Inflammation and Remodeling through Downregulating Periostin via Blocking TGF-β1/Smad Pathway.
Fang, Y; Guo, Z; Hao, J; Jin, W, 2023
)
3.07
"Quercetin plays a protective role in mouse A. "( Quercetin protects against Aspergillus fumigatus keratitis by reducing fungal load and inhibiting TLR-4 induced inflammatory response.
Lin, J; Luan, J; Peng, X; Tian, X; Xu, Q; Zhan, L; Zhang, Y; Zhao, G; Zhu, Y, 2023
)
3.8
"Quercetin could inhibit the activity of CYP3A to down-regulate AA metabolites EETs, consequently hampering p-Stat3 and nuclear translocation, thus impeding BC development."( Quercetin inhibits the metabolism of arachidonic acid by inhibiting the activity of CYP3A4, thereby inhibiting the progression of breast cancer.
Fu, Q; Kuang, Y; Peng, B; Tang, H; Wu, W, 2023
)
3.8
"Quercetin may lower the death rate from READ by targeting SLCO1B1 and producing enhanced effects from use of this compound, inhibiting cell growth, and inducing apoptosis in tumor cells."( Prediction of new targets and mechanisms for quercetin in the treatment of pancreatic cancer, colon cancer, and rectal cancer.
Jiang, C; Jin, H; Liu, Y; Lu, Y; Pang, B; Shao, D; Shi, J; Xu, X; Yang, R, 2019
)
1.49
"Quercetin can inhibit the proliferation of primary leukemia cells in a time-dependent manner. "( [Efficacy of Quercetin-sensitized Adriamycin for Treatment of Refractory Acute Leukemia].
DU, H; Han, YQ; Shi, YX; Su, XT, 2019
)
2.33
"Quercetin can inhibit platelet apoptosis by increasing the ratio of apoptosis-related protein BCL-2/BAX in a concentration-dependent manner."( [Effect of Quercetin on Apoptosis of Platelets and Its Mechanism].
Chen, XY; Jiang, LX; Jiang, YF; Ouyang, Q; Wu, YQ; Xiao, Q, 2019
)
2.35
"Quercetin can inhibit the formation of foam cells induced by ox-LDL and delay senescence. "( Quercetin Suppresses the Progression of Atherosclerosis by Regulating MST1-Mediated Autophagy in ox-LDL-Induced RAW264.7 Macrophage Foam Cells.
Cao, H; Chen, C; Jia, Q; Shen, D; Xing, S; Yan, L, 2019
)
3.4
"Quercetin was found to inhibit both AGEs production and amyloid formation."( Non-enzymatic glycation of protein induces cancer cell proliferation and its inhibition by quercetin: Spectroscopic, cytotoxicity and molecular docking studies.
Al-Okail, MS; AlAjmi, MF; Bhat, SA; Husain, FM; Khan, MS; Rehman, TM; Shaik, GM; Tabrez, S, 2021
)
1.56
"Quercetin did not suppress HGF- or TGF-α-induced p38 MAPK phosphorylation."( Quercetin suppresses the migration of hepatocellular carcinoma cells stimulated by hepatocyte growth factor or transforming growth factor-α: Attenuation of AKT signaling pathway.
Kozawa, O; Matsushima-Nishiwaki, R; Yamada, N, 2020
)
2.72
"Quercetin could increase the survival rate and proliferation rate of PC12 cells; reduce the levels of LDH, AChE, MDA, and HO-1 protein; and increase the levels of SOD, GSH-Px, CAT, T-AOC, sirtuin1, and Nrf2 protein."( Effect of Quercetin on PC12 Alzheimer's Disease Cell Model Induced by A
Li, Y; Mu, X; Yu, X, 2020
)
1.68
"Quercetin can increase the survival rate of PC12 injured by A"( Effect of Quercetin on PC12 Alzheimer's Disease Cell Model Induced by A
Li, Y; Mu, X; Yu, X, 2020
)
2.4
"Quercetin was shown to inhibit RANKL-mediated osteoclastogenesis, osteoblast apoptosis, oxidative stress and inflammatory response while promoting osteogenesis, angiogenesis, antioxidant expression, adipocyte apoptosis and osteoclast apoptosis."( Quercetin as an Agent for Protecting the Bone: A Review of the Current Evidence.
Chin, KY; Ima-Nirwana, S; Wong, SK, 2020
)
2.72
"Quercetin can inhibit the proliferation of EESCs in adenomyosis and reduce their mobility and invasiveness. "( Quercetin Inhibits Adenomyosis by Attenuating Cell Proliferation, Migration and Invasion of Ectopic Endometrial Stromal Cells.
Li, K; Song, Y; Xu, W; Zhang, B; Zhu, X, 2020
)
3.44
"Quercetin can inhibit gingipains, hemolytic, hemagglutination activities and biofilm formation at sub-MIC concentrations."( Quercetin inhibits virulence properties of Porphyromas gingivalis in periodontal disease.
Chang, H; He, Z; Li, L; Li, S; Song, Z; Zhang, X; Zhou, W, 2020
)
2.72
"Quercetin might enhance the antitumor effect of cisplatin via inhibiting proliferation, migration and invasion and elevating apoptosis through weakening MMP2, ezrin, METTL3 and P-Gp expression of cancer cells."( Effects of Quercetin on the Efficacy of Various Chemotherapeutic Drugs in Cervical Cancer Cells.
Chen, X; Pan, S; Qian, H; Xie, S; Xu, W; Zhu, X, 2021
)
1.73
"Quercetin can increase the antioxidant capacity of PDLCs and reduce OS damage by activating the NRF2 signaling pathway, which alleviates alveolar bone loss in periodontitis."( Quercetin Prevents Oxidative Stress-Induced Injury of Periodontal Ligament Cells and Alveolar Bone Loss in Periodontitis.
Fu, J; Ma, P; Ren, L; Wei, Y; Wu, J; Wu, W; Yi, Z, 2021
)
3.51
"quercetins) from its flower petal."( Clitoria ternatea flower petals: Effect on TNFR1 neutralization via downregulation of synovial matrix metalloproteases.
Adhikary, R; Bishayi, B; Sultana, S, 2018
)
1.2
"Quercetin could inhibit the proliferation and promote the apoptosis of BIU-87 cells."( [Mechanism in growth inhibition of quercetin on human bladder cancer cell line].
Liu, XH; Tan, DQ, 2017
)
1.45
"Quercetin plays a protective role against intestinal barrier disruption and inflammation in ANP, probably partly by inhibiting TLR4/MyD88/p38 MAPK and ERS activation."( Quercetin protects against intestinal barrier disruption and inflammation in acute necrotizing pancreatitis through TLR4/MyD88/p38 MAPK and ERS inhibition.
Chunlan, H; Hui, X; Junjie, F; Junyuan, Z; Lihong, L; Qixiang, M; Xingpeng, W; Yingying, L; Yue, Z, 2018
)
3.37
"Quercetin promotes HOKs proliferation and oral re-epithelialization in vitro."( Effects of quercetin on human oral keratinocytes during re-epithelialization: An in vitro study.
Chi, M; Hujiahemaiti, M; Li, C; Li, X; Lv, H; Qi, M; Sun, X; Zhou, J; Zhou, Y, 2018
)
2.31
"Quercetin flavonoids inhibit PDI activity and block platelet accumulation and fibrin generation at the site of a vascular injury in mouse models, but the clinical effect of targeting extracellular PDI in humans has not been studied."( Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer.
Aggarwal, A; Bauer, KA; Caughey, T; Flaumenhaft, R; Furie, B; Hidalgo, M; Kuemmerle, N; Liebman, HA; McLaughlin, M; Neuberg, D; Puligandla, M; Schlechter, BL; Stopa, JD; Wong, E; Wun, T; Zwicker, JI, 2019
)
1.48
"Quercetin was found to increase the number of proliferating neural stem/progenitor cells."( Quercetin promotes learning and memory performance concomitantly with neural stem/progenitor cell proliferation and neurogenesis in the adult rat dentate gyrus.
Bagheri, HS; Ghanadian, M; Karimipour, M; Mahmoudi, J; Rahbarghazi, R; Shimia, M; Tayefi, H, 2019
)
2.68
"Quercetin promotes the apoptosis of multiform glioblastoma U87 cells mediated by caspase-3 and influences the feedback balance of MDM2-p53."( [Effect of quercetin on glioma cell U87 apoptosis and feedback regulation of MDM2-p53].
Chen, Z; Hu, Z; Wang, H; Wu, B; Yao, F; Yuan, Z, 2014
)
2.23
"Quercetin also could increase p53 and Caspase-3 expression."( Effects of quercetin on hedgehog signaling in chronic myeloid leukemia KBM7 cells.
Li, W; Tao, B; Zhang, Y; Zhao, Y, 2014
)
1.51
"Quercetin could inhibit Hh signaling and its downstream targets in the KBM7 cells. "( Effects of quercetin on hedgehog signaling in chronic myeloid leukemia KBM7 cells.
Li, W; Tao, B; Zhang, Y; Zhao, Y, 2014
)
2.23
"Quercetin may inhibit HSP27 expression in PC-3 cell."( [Effect of quercetin on heat shock protein 27 expression in prostate cancer cells].
Di, YC; Jiang, LL; Yu, F, 2014
)
1.51
"Quercetin could activate caspase-3 and promote leukemic cell apoptosis."( [Quercetin enhances the anti-leukemic effect of adriamycin].
Han, YQ; Hong, Y; Su, XL; Wang, JR, 2014
)
2.03
"Quercetin can suppress osteosarcoma cell growth and metastasis. "( Quercetin Enhances Cisplatin Sensitivity of Human Osteosarcoma Cells by Modulating microRNA-217-KRAS Axis.
Chen, J; Chen, Z; Guo, Q; Zhang, X, 2015
)
3.3
"Quercetin also displays a different UV-protective effect depending on its location in the membranes, as the effect is more pronounced at pH 8.4 when it is located at the membrane surface."( Damage and protection of the photosynthetic apparatus from UV-B radiation. II. Effect of quercetin at different pH.
Apostolova, EL; Dobrikova, AG, 2015
)
1.36
"Quercetin can inhibit cell viability and induce autophagy of U87 and U251 glioma cells in a dose-dependent manner."( Inhibition of autophagy induced by quercetin at a late stage enhances cytotoxic effects on glioma cells.
Bi, Y; Gao, D; Hou, X; Li, C; Liu, H; Liu, Y; Liu, Z; Peng, F; Shen, C; Shi, C; Wang, K; Wang, X; Wu, J; Zhang, J; Zhao, B; Zhao, S; Zheng, Z; Zhong, C; Zou, H, 2016
)
1.43
"Quercetin acts to increase survival in the face of ischemia via an increase of SENP3 expression, the possible inactivation of SENPs 1/2, and via a decrease in KEAP1 levels (thereby increasing Nrf2 stability)."( Global SUMOylation facilitates the multimodal neuroprotection afforded by quercetin against the deleterious effects of oxygen/glucose deprivation and the restoration of oxygen/glucose.
Bernstock, JD; Hallenbeck, JM; Ko, B; Lee, YJ; Nagaraja, N, 2016
)
1.39
"Quercetin could inhibit Ang II induced apoptosis of human umbilical vein endothelial cells via the mitochondrial pathway."( Quercetin inhibits angiotensin II induced apoptosis via mitochondrial pathway in human umbilical vein endothelial cells.
Guo, BB; Jia, YP; Lu, Y; Wang, RH, 2016
)
3.32
"Quercetin prevented the increase in total plasma cholesterol, but only partially prevented the high cholesterol diet-induced alterations in lipid profile."( The deleterious effect of cholesterol and protection by quercetin on mitochondrial bioenergetics of pancreatic β-cells, glycemic control and inflammation: In vitro and in vivo studies.
Borges, K; Carrasco-Pozo, C; Cires, MJ; De La Jara, N; Garcia-Diaz, DF; Llanos, P; Ngo, ST; Reyes-Farias, M; Tan, KN, 2016
)
1.4
"Quercetin could increase ABCA1 expression and cholesterol efflux through LXRα pathway to eventually promote RCT in the THP-1 macrophage."( Quercetin upregulates ABCA1 expression through liver X receptor alpha signaling pathway in THP-1 macrophages.
Jia, YP; Lu, Y, 2016
)
3.32
"Quercetin (Qe) plays an important role in inflammation, antibacterial, anticancer, and aging. "( Quercetin loading CdSe/ZnS nanoparticles as efficient antibacterial and anticancer materials.
Cai, Y; Li, N; Lin, Y; Mou, Z; Sun, D; Wang, W; Yang, X; Zhang, W; Zhao, Z, 2017
)
3.34
"Quercetin did not cause cytotoxicity 24 h after treatment."( Quercetin promotes degradation of survivin and thereby enhances death-receptor-mediated apoptosis in glioma cells.
Habel, A; Rami, A; Reuss, DE; Siegelin, MD; von Deimling, A, 2009
)
2.52
"Quercetin can enhance the inhibitory effect of cisplatin on HeLa cell adhesion, migration and invasion."( [Effects of quercetin and quercetin in combination with cisplatin on adhesion, migration and invasion of HeLa cells].
Chen, XM; Luo, RY; Zhang, FL; Zhang, W, 2008
)
1.45
"Quercetin can inhibit breeding of HeLa cells and induce apoptosis of the cells. "( Effects of quercetin on proliferation, apoptosis, adhesion and migration, and invasion of HeLa cells.
Zhang, F; Zhang, W, 2009
)
2.19
"Quercetin plays a cardiovascular protective role because of its antioxidant capacity and ability to modulate dyslipidemia. "( Quercetin inhibits fatty acid and triacylglycerol synthesis in rat-liver cells.
Gnoni, GV; Paglialonga, G; Siculella, L, 2009
)
3.24
"The quercetin-induced increase and nuclear translocation of HIF-1alpha was reversed by addition of excess iron (100 microM)."( Hypoxia-inducible factor-1 (HIF-1) pathway activation by quercetin in human lens epithelial cells.
Kroon, PA; Mithen, RF; Radreau, P; Rhodes, JD; Sanderson, J, 2009
)
1.08
"Quercetin did not increase reactive oxygen species generation but increased cytosolic Ca(2+) levels and reduced the mitochondrial membrane potential (DeltaPsi(m))."( Quercetin-induced apoptosis acts through mitochondrial- and caspase-3-dependent pathways in human breast cancer MDA-MB-231 cells.
Chen, DR; Chien, SY; Chung, JG; Kuo, SJ; Lu, HF; Tsou, MF; Wood, WG; Wu, YC; Yang, JS, 2009
)
2.52
"Quercetin may allow for dissection of the viral life cycle and has potential therapeutic use to reduce virus production with low associated toxicity."( The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production.
Arumugaswami, V; Dasgupta, A; Fontanes, V; French, SW; Gonzalez, O; Loo, J; Loo, R; Raychaudhuri, S; Sun, R, 2009
)
2.08
"Quercetin was found to enhance the photostability of the two UV filters in a concentration-dependent way."( Photostabilization effect of quercetin on the UV filter combination, butyl methoxydibenzoylmethane-octyl methoxycinnamate.
Mezzena, M; Scalia, S,
)
1.14
"Quercetin plays a very important role in ameliorating reproductive toxicity induced by environmental oestrogens."( Quercetin protects hamster spermatogenic cells from oxidative damage induced by diethylstilboestrol.
Li, G; Ma, A; Shi, W; Zhong, X, 2010
)
2.52
"Quercetin is known to inhibit tyrosinase activity and melanin production in melanocytes. "( Quercetin inhibits α-MSH-stimulated melanogenesis in B16F10 melanoma cells.
Jeon, YM; Lee, JC; Lee, SA; Son, YO; Yang, YM, 2011
)
3.25
"Quercetin can inhibit the proliferation and induce the apoptosis of human PC-3 cells, but its action mechanism remains to be further investigated."( [Quercetin induces the apoptosis of human PC-3 cells].
Gu, XJ; Hu, R; Huang, WZ; Liu, L; Ma, L; Yuan, L; Zhu, QY, 2011
)
2.72
"Quercetin could inhibit the Proliferation of MGC-803 cells. "( [Quercetin affects leptin and its receptor in human gastric cancer MGC-803 cells and JAK-STAT pathway].
Chen, Y; He, LY; Qin, Y; Wang, WY; Wu, MY; Zhao, XH, 2012
)
2.73
"Quercetin was found to inhibit basal and insulin-induced phosphorylation of Akt (Ser473), a downstream target of PI3K, in HT-22 cells, whereas naringenin and curcumin had no effect."( The dietary flavonoids naringenin and quercetin acutely impair glucose metabolism in rodents possibly via inhibition of hypothalamic insulin signalling.
Ganjam, GK; Heldmaier, G; Hoggard, N; Koch, CE; Legler, K; Schumacher, D; Steger, J; Stöhr, S; Tups, A, 2013
)
1.38
"Quercetin was found to suppress proliferation of human HCC cell lines BEL-7402, HuH-7 and HLE, with peak suppression at 50 micromol/L quercetin. "( Synergetic anticancer effect of combined quercetin and recombinant adenoviral vector expressing human wild-type p53, GM-CSF and B7-1 genes on hepatocellular carcinoma cells in vitro.
Shi, M; Wang, FS; Wu, ZZ, 2003
)
2.03
"Quercetin was found to inhibit several important steps of angiogenesis including proliferation, migration, and tube formation of human microvascular dermal endothelial cells in a dose-dependent manner."( Quercetin, a dietary-derived flavonoid, possesses antiangiogenic potential.
Ding, J; Li, MH; Lin, LP; Tan, WF; Tong, YG; Xiao, D; Zhang, YX, 2003
)
2.48
"Quercetin was found to inhibit H(2)O(2)- or xanthine (X)/xanthine oxidase (XO)-induced oxidative neuronal cell injury, with an estimated IC(50) of 4-5 micro g/ml."( Neuroprotective effects of antioxidative flavonoids, quercetin, (+)-dihydroquercetin and quercetin 3-methyl ether, isolated from Opuntia ficus-indica var. saboten.
Cho, J; Dok-Go, H; Jin, C; Kim, HJ; Lee, EH; Lee, J; Lee, KH; Lee, YH; Lee, YS; Song, YS, 2003
)
1.29
"4. Quercetin did not inhibit glucose transport into cells but decreased intracellular sequestration of [5-(3)H]glucose under conditions of net glucose release."( Action of quercetin on glycogen catabolism in the rat liver.
Bracht, A; Bracht, L; Constantin, J; Gasparin, FR; Ishii-Iwamoto, EL; Salgueiro-Pagadigorria, CL, 2003
)
1.24
"Quercetin can inhibit the growth of transplantation tumor of breast cancer cell line MCF-7 in nude mice."( [Effects of quercetin on the proliferation and apoptosis in transplantation tumor of breast cancer in nude mice].
He, S; Kong, L; Ma, S; Wu, K; Zhong, X, 2003
)
2.14
"Quercetin-induced increase in nociceptive threshold was reversed by naloxone (2 mg/kg i.p.), an opioid receptor antagonist."( Quercetin, a bioflavonoid, attenuates thermal hyperalgesia in a mouse model of diabetic neuropathic pain.
Anjaneyulu, M; Chopra, K, 2003
)
2.48
"Quercetin can inhibit the intestinal movement and reduce capillary permeability in the abdominal cavity, which may be the antidiarrheal mechanism of Psidium guajava L extract."( [Mechanism of quercetin as an antidiarrheal agent].
Chen, BT; Mo, ZX; Wang, CY; Zhang, WJ; Zhu, QH, 2003
)
2.12
"Quercetin at lower doses was found to be more effective."( Quercetin allievates oxidative stress in streptozotocin-induced diabetic rats.
Mahesh, T; Menon, VP, 2004
)
2.49
"Quercetin (QU) displays antioxidant and cell protective effects in most cell culture models, yet in some studies it is reported that QU shows prooxidant and cytotoxic effects. "( Coadjustment of quercetin and hydrogen peroxide: the role of ROS in the cytotoxicity of quercetin.
Chen, J; Da, WM; Kang, JH; Ou, YX, 2004
)
2.11
"Quercetin inhibited the increase of tartrate-resistant acid phosphatase (TRAP) activity of mononuclear preosteoclasts (pOCs) induced by receptor activator of nuclear factor-kappaB (NF-kappaB) ligand (RANKL) in both MD and RAW cell cultures."( Quercetin suppresses bone resorption by inhibiting the differentiation and activation of osteoclasts.
Hagiwara, H; Lee, IS; Nagai, K; Nakagawa, H; Notoya, M; Ohnishi, M; Udagawa, N; Woo, JT; Yonezawa, T, 2004
)
2.49
"Quercetin can enhance acyclovir intestinal absorption by inhibiting the function of P-gp."( [Effect of quercetin on the acyclovir intestinal absorption].
Li, XD; Lv, WL; Meng, H; Yang, ZG; Zhang, Q; Zhang, X, 2004
)
2.16
"Quercetin induces an increase followed by a decrease in |DeltaPsim| value depending on its concentration."( Spontaneous mitochondrial membrane potential change during apoptotic induction by quercetin in K562 and K562/adr cells.
Dechsupa, S; Kothan, S; Leger, G; Mankhetkorn, S; Moretti, JL; Vergote, J, 2004
)
1.27
"Quercetin could suppress LPS- and IFN-gamma-induced NO production and inducible nitric oxide synthase (iNOS) gene transcription, while quercetin-3'-sulfate had no effect."( Inhibition of iNOS gene expression by quercetin is mediated by the inhibition of IkappaB kinase, nuclear factor-kappa B and STAT1, and depends on heme oxygenase-1 induction in mouse BV-2 microglia.
Chen, CP; Chen, JC; Ho, FM; Hsu, HB; Jeng, KC; Lee, ST; Lin, WW, 2005
)
1.32
"Quercetin did not activate transcription through p53-binding sites in HeLa cells, although it up-regulated gadd45 in p53-inactivated tumor cells."( Quercetin induces gadd45 expression through a p53-independent pathway.
Horinaka, M; Maeda, A; Nakata, S; Sakai, T; Shiraishi, T; Wakada, M; Yogosawa, S; Yoshida, T, 2005
)
2.49
"Quercetin can inhibit the growth and induce apoptosis of MGC-803 cells in a dose- and time-dependent manner. "( [Quercetin inhibits growth and induces apoptosis of human gastric carcinoma cells].
Chen, Y; Cheng, CL; Guo, LM; He, LY; Wang, HY; Wu, MY; Zhao, XH, 2006
)
2.69
"Quercetin was found to increase osteogenic differentiation in a dose-dependent manner."( Quercetin, a flavonoid, inhibits proliferation and increases osteogenic differentiation in human adipose stromal cells.
Bae, YC; Jung, JS; Kim, YJ; Suh, KT, 2006
)
2.5
"Quercetin-induced increase in cAMP-stimulated progesterone secretion was reversed by ICI 182,780, an estrogen receptor (ER) antagonist."( Effects of genistein, resveratrol, and quercetin on steroidogenesis and proliferation of MA-10 mouse Leydig tumor cells.
Chen, YC; Lin, T; Nagpal, ML; Stocco, DM, 2007
)
1.33
"Quercetin did not inhibit and rather enhanced 0.1 mM H2O2-induced cell death."( Quercetin-induced PC12 cell death accompanied by caspase-mediated DNA fragmentation.
Horie, S; Kashiwayanagi, M; Murayama, T; Nakamura, H; Saito, T; Sasaki, M; Tsuchiya, S, 2007
)
2.5
"Quercetinases catalyze the 2,4-dioxygenolytic cleavage of 3,5,7,3',4'-pentahydroxyflavone to 2-protocatechuoylphloroglucinol carboxylic acid and carbon monoxide."( A new monocupin quercetinase of Streptomyces sp. FLA: identification and heterologous expression of the queD gene and activity of the recombinant enzyme towards different flavonols.
Fetzner, S; Merkens, H; Rose, K; Sielker, S, 2007
)
1.41
"Quercetin was shown to produce hydrogen peroxide in aqueous solutions at pH 7.5, this resulting in the oxidation of the cysteine residues of the enzyme."( Antioxidant and prooxidant effects of quercetin on glyceraldehyde-3-phosphate dehydrogenase.
Firuzi, O; Muronetz, VI; Saso, L; Schmalhausen, EV; Shalova, IN; Zhlobek, EB, 2007
)
1.33
"Quercetin was able to inhibit the ecto-5'-NT/CD73 activity and modulate its expression."( Ecto-5'-nucleotidase/CD73 inhibition by quercetin in the human U138MG glioma cell line.
Battastini, AM; Bernardi, A; Braganhol, E; Tamajusuku, AS; Wink, MR, 2007
)
1.33
"Quercetin was found to inhibit HSP expression depleting heat shock factor 1 (HSF1) cellular stores."( Inhibition of heat shock proteins (HSP) expression by quercetin and differential doxorubicin sensitization in neuroblastoma and Ewing's sarcoma cell lines.
Bisaro, B; Carta, F; Crescenzio, N; di Montezemolo, LC; Doria, A; Foglia, L; Giribaldi, G; Mandili, G; Timeus, F; Turrini, F; Zanini, C, 2007
)
1.31
"Quercetin did not increase reactive oxygen species (ROS) generation and the quercetin-induced cell death was also not affected by antioxidants, suggesting that ROS generation is not involved in loss of cell viability."( Underlying mechanism of quercetin-induced cell death in human glioma cells.
Choi, CH; Kang, SK; Kim, EJ; Kim, YK; Park, JY, 2008
)
1.37
"Quercetin can activate the expression of Caspase-3 and induce the apoptosis of HEN1 cells through mitochondrion-depended pathway."( [Effect of quercetin on proliferation and apoptosis of human nasopharyngeal carcinoma HEN1 cells].
Cao, P; Cui, Y; Zhang, F, 2007
)
2.17
"Quercetin seems to inhibit the transcription by interaction with the enzyme."( Inhibition by flavonoids of RNA synthesis in permeable WI-38 cells and of transcription by RNA polymerase II.
Nose, K, 1984
)
0.99
"Quercetin was found to inhibit hsp70 synthesis for a period of 3-6 h after PGA1 treatment."( Modulation of prostaglandin A1-induced thermotolerance by quercetin in human leukemic cells: role of heat shock protein 70.
Amici, C; Elia, G; Rossi, A; Santoro, MG, 1996
)
1.26
"The quercetin-induced increase in Isc was inhibited by the Cl- channel blocker 5-nitro-2-(3-phenylpropylamino)-benzoic acid."( Dietary flavonol quercetin induces chloride secretion in rat colon.
Cermak, R; Föllmer, U; Wolffram, S, 1998
)
1.12
"Quercetin induced an increase in short-circuit current (Isc), which was largely independent of submucosal neurons, as it was not affected by the neurotoxin tetrodotoxin."( The secretory response of the rat colon to the flavonol quercetin is dependent on Ca2+-calmodulin.
Cermak, R; Kuhn, G; Vujicic, Z; Wolffram, S, 2000
)
1.27
"Quercetin failed to increase Luc activity in cells transfected with a reporter vector containing a mutated ARE."( Induction of human NAD(P)H:quinone oxidoreductase (NQO1) gene expression by the flavonol quercetin.
Kepa, JK; Pickwell, GV; Quattrochi, LC; Valerio, LG, 2001
)
1.25
"Quercetin and tamoxifen inhibit melanoma cell growth."( Quercetin and tamoxifen sensitize human melanoma cells to hyperthermia.
Castrilli, G; Larocca, LM; Maggiano, N; Natali, PG; Piantelli, M; Ranelletti, FO; Savini, F; Tatone, D, 2001
)
2.47
"Quercetin inhibited an increase of hsp70 expression after heat treatment and increased the number of subG1 cells with lower levels of hsp70 in JCA-1 and LNcap cells."( Effects of quercetin on the heat-induced cytotoxicity of prostate cancer cells.
Deguchi, N; Hirata, R; Iida, M; Nakanoma, T; Ueno, M, 2001
)
1.42
"Quercetin did not cause tumors at other sites."( Toxicity and carcinogenicity studies of quercetin, a natural component of foods.
Dunnick, JK; Hailey, JR, 1992
)
1.27
"Quercetin did not increase the thermosensitivity of non-tolerant cells."( Quercetin, an inhibitor of heat shock protein synthesis, inhibits the acquisition of thermotolerance in a human colon carcinoma cell line.
Abe, M; Hiraoka, M; Hirayoshi, K; Hosokawa, N; Koishi, M; Nagata, K; Nakai, A; Sato, M, 1992
)
2.45
"Quercetin did not cause any significant changes on the plasma TC, TG and liver fat at weeks 4, 7 and 10."( Effects of polyphenolic natural products on the lipid profiles of rats fed high fat diets.
Das, NP; Tan, BK; Teh, M; Yugarani, T, 1992
)
1
"Quercetin may inhibit the promotive effect of the NP on histamine release and the secretion of the NP while ketotifen and isoproterenol have no influence on this promotive effect."( [Effects of neutrophils on histamine release from mast cells].
Bian, RL; Wang, YC; Zhou, HL, 1990
)
1
"Quercetin did, however, inhibit ATPase activity of plasma membrane, suggesting that this unidentified ATPase may contribute to the formation of ADP and Pi required for lactate production by the intact cell."( Motility, heat, and lactate production in ejaculated bovine sperm.
Hammerstedt, RH; Racker, E; Volonté, C, 1988
)
1

Treatment

Quercetin pretreatment could antagonize such machinery to protect the kidney against DEP. QuercetIn and vitamin E treatment reversed these effects, suggestive of their anti-apoptotic effect.

ExcerptReferenceRelevance
"Quercetin pretreatment could antagonize such machinery to protect the kidney against DEP."( The biomechanistic aspects of renal cortical injury induced by diesel exhaust particles in rats and the renoprotective contribution of quercetin pretreatment: Histological and biochemical study.
Alasmari, WA; Faruk, EM; Fouad, H; Morsi, AA, 2022
)
1.65
"Quercetin pretreatment attenuated the acquisition and reinstatement. "( Evaluation of the effects of quercetin on the rewarding property of ethanol in mice.
Yunusoğlu, O, 2022
)
2.46
"Quercetin pretreatment alleviated reactive oxygen species generation, NF-"( Quercetin Prevents Radiation-Induced Oral Mucositis by Upregulating BMI-1.
Dong, Q; Dong, X; Feng, Y; Hong, Y; Jiang, Z; Li, H; Liu, H; Liuyang, Z; Tao, J; Wang, G; Wang, Y; Xie, A; Zhang, J, 2021
)
2.79
"Quercetin and vitamin E treatment reversed these effects, suggestive of their anti-apoptotic effect."( Quercetin and vitamin E ameliorate cardio-apoptotic risks in diabetic rats.
Obaidu, IM; Obigade, OC; Ojo, OO; Olorunsogo, OO, 2022
)
2.89
"Quercetin treatment helps to prevent oxidative damage and neuroinflammation in LPS treated adult zebrafish."( Quercetin ameliorates lipopolysaccharide-induced neuroinflammation and oxidative stress in adult zebrafish.
Kapil, L; Sahu, K; Singh, A; Singh, C; Singh, S, 2022
)
3.61
"The quercetin-EGCG co-treatment reduced glucose production through targeting FOXO1 and inhibiting the transcription of gluconeogenic enzymes."( Enhanced alleviation of insulin resistance via the IRS-1/Akt/FOXO1 pathway by combining quercetin and EGCG and involving miR-27a-3p and miR-96-5p.
Guan, H; Jiang, Y; Li, D; Li, F; Liu, H; Sun-Waterhouse, D; Tan, X, 2022
)
1.42
"Post quercetin treatment improved liver function parameters in the hepatotoxic Wistar rats by augmenting bilirubin content, SGOT and SGPT activity."( Nonlinear molecular dynamics of quercetin in Gynocardia odorata and Diospyros malabarica fruits: Its mechanistic role in hepatoprotection.
Alkahtani, S; Baishya, D; Ghosh, A; Mishra, R; Mukerjee, N; Patel, H; Sarmah, P; Varma, RS, 2022
)
1.46
"Quercetin co-treatment enhanced activities of antioxidant enzymes, inhibited myeloperoxidase (MPO) activity, lowered levels of nitric oxide, interferon-Υ (IFN-Υ), and interleukin-6 (IL-6), and reduced kynurenine concentration as well as IDO/TDO activities."( Abatement of cyclophosphamide-induced splenic immunosuppressive indoleamine 2, 3-dioxygenase and altered hematological indices in Wister rats by dietary quercetin.
Kalu, WO; Olachi Obasi, D; Peter Ebokaiwe, A, 2022
)
1.64
"Quercetin treatment decreases NOX expression and thus exerts antioxidant and anti-inflammatory effects in the Achilles tendons of diabetic rats. "( Quercetin treatment protects the Achilles tendons of rats from oxidative stress induced by hyperglycemia.
Inui, A; Kuroda, R; Mifune, Y; Mukohara, S; Nishimoto, H; Shinohara, I; Yamaura, K; Yoshikawa, T, 2022
)
3.61
"Quercetin treatment also significantly reduced the increased serum leptin (LP) levels in NOD/Ltj mice."( Quercetin ameliorates salivary gland apoptosis and inflammation in primary Sjögren's syndrome through regulation of the leptin/OB-R signaling.
Chang, L; Chen, P; Guo, Y; Kong, A; Sun, Y; Wang, X; Zhang, J, 2022
)
2.89
"Quercetin pretreatment alleviates seizure-like behaviors and cognitive impairment in KA-induced epileptic mice."( Quercetin alleviates kainic acid-induced seizure by inhibiting the Nrf2-mediated ferroptosis pathway.
Bentley, R; Hu, G; Jiang, X; Lowe, S; Mei, H; Sun, C; Wu, Y; Xie, R; Zhao, W, 2022
)
2.89
"Quercetin treatment also restored the increased expression of GFAP and decreased expression of occludin and doublecortin in the frontal cortex and hippocampus of rmTBI mice."( Involvement of Microbiome Gut-Brain Axis in Neuroprotective Effect of Quercetin in Mouse Model of Repeated Mild Traumatic Brain Injury.
Balasubramanian, R; Bazaz, MR; Dandekar, MP; Pasam, T; Samanthula, G; Sharief, N; Velip, L, 2023
)
1.87
"Quercetin (40 mg/kg) treated improved some behavioral disorders."( Preventive effect of quercetin-Loaded nanophytosome against autistic-like damage in maternal separation model: The possible role of Caspase-3, Bax/Bcl-2 and Nrf2.
Eslami, A; Hasantabar, V; Jelodar, SK; Moghaddam, AH; Ranjbar, M, 2023
)
1.95
"Quercetin-pretreated mice significantly reduced radiation-induced DNA damage and intestinal epithelium cell apoptosis."( Quercetin Mitigates Radiation-Induced Intestinal Injury and Promotes Intestinal Regeneration via Nrf2-Mediated Antioxidant Pathway1.
Li, J; Li, Y; Liu, Y; Wu, L; Xu, Y; Yang, M; Yu, Z; Yue, L; Zhang, B; Zhang, Y; Zhou, X; Zhu, X, 2023
)
3.07
"Quercetin-treated groups were treated with intragastric quercetin once a day for 28 days."( Quercetin prevents osteoarthritis progression possibly via regulation of local and systemic inflammatory cascades.
Gu, J; Hao, B; Hong, W; Jaspers, RT; Lan, H; Li, H; Pathak, JL; Peng, G; Qian, D; Shao, M; Wang, H; Wu, G; Yan, Y; Zeng, J, 2023
)
3.07
"Quercetin treatment inhibits MPEs-induced oxidative testicular damage in rats possibly by direct scavenging of free radicals to lower testicular oxidative stress and restore the regulation of the Nrf2 signaling pathway."( [Mechanisms mediating the inhibitory effects of quercetin against phthalates-induced testicular oxidative damage in rats].
Deng, R; Gao, H; Lin, M; Liu, L; Xia, L; Zhou, W, 2023
)
2.61
"Quercetin treatment reversed the molecular, functional and morphological abnormalities brought on due to letrozole in pathological and physiological setting, particularly the issues of reproduction connected to PCOS. "( Effect of quercetin on steroidogenesis and folliculogenesis in ovary of mice with experimentally-induced polycystic ovarian syndrome.
Al-Jafary, MA; Al-Qhtani, MH; Al-Suhaimi, EA; Ansari, MA; Bashir, SM; Ganie, MA; Homeida, AM; Mir, MA; Rather, GA; Shafi, M; Shah, MZUH; Sheikh, WM; Shrivastva, VK, 2023
)
2.76
"Quercetin treatment markedly suppressed amiodarone induced toxicity in the pulmonary tissues."( Pulmonary Responses Following Quercetin Administration in Rats After Intratracheal Instillation of Amiodarone.
Oka, VO; Okon, UE; Osim, EE, 2019
)
1.52
"Quercetin treatment is suggested to reduce the risk factors for obesity."( Quercetin Actions on Lipid Profiles in Overweight and Obese Individuals: A Systematic Review and Meta-Analysis.
Gong, X; Guo, W; Li, M, 2019
)
2.68
"Quercetin treatment suppressed body weight gains and reduced the extent of atherosclerotic lesions in the aortic sinus."( Quercetin reduces atherosclerotic lesions by altering the gut microbiota and reducing atherogenic lipid metabolites.
Du, X; Nie, J; Zhang, L; Zhao, G, 2019
)
2.68
"Oral quercetin treatment may represent a new approach to mitigating the onset and development of atherosclerosis."( Quercetin reduces atherosclerotic lesions by altering the gut microbiota and reducing atherogenic lipid metabolites.
Du, X; Nie, J; Zhang, L; Zhao, G, 2019
)
2.47
"Quercetin treatment attenuated rotenone- and iron supplement-induced motor deficits and biochemical and neurotransmitter alterations in experimental rats."( Neuroprotective Effect of Quercetin in Combination with Piperine Against Rotenone- and Iron Supplement-Induced Parkinson's Disease in Experimental Rats.
Raj, K; Sharma, S; Singh, S, 2020
)
1.58
"Quercetin treatment alleviated necroptosis of OLs partially by inhibiting M1 macrophages/microglia polarization after SCI. "( Quercetin prevents necroptosis of oligodendrocytes by inhibiting macrophages/microglia polarization to M1 phenotype after spinal cord injury in rats.
Chen, X; Chen, Z; Fan, H; Hao, DJ; Huang, DG; Liu, SC; Shan, LQ; Tang, HB; Yang, H; Yang, M; Yin, XH, 2019
)
3.4
"Quercetin treatment attenuated the increase of caspase-3."( Quercetin Reduces Ischemic Brain Injury by Preventing Ischemia-induced Decreases in the Neuronal Calcium Sensor Protein Hippocalcin.
Jeon, SJ; Kang, JB; Koh, PO; Park, DJ, 2020
)
2.72
"Quercetin treatment led to significantly higher levels of p-PI3K, p-AKT, p-JAK1, and p-STAT3."( Quercetin protects human oral keratinocytes from lipopolysaccharide-induced injury by downregulating microRNA-22.
Ke, Y; Wang, F; Wang, FJ; Yang, L, 2020
)
2.72
"Quercetin treatment also resulted in reduced nuclear beta-catenin and reduced Pax2 expression."( Quercetin treatment reduces the severity of renal dysplasia in a beta-catenin dependent manner.
Ask, A; Bridgewater, D; Cunanan, J; Cunanan, K; Deacon, E; Morikawa, L; Todorova, E; Yang, Z, 2020
)
2.72
"Quercetin treatment also decreases Bcl-2 and increases Bax protein expression, and increases miR-197 mRNA while reducing IGFBP5 mRNA expression."( Quercetin induces apoptosis in meningioma cells through the miR-197/IGFBP5 cascade.
Cheng, J; Hu, SA; Zhao, HY; Zhao, WH, 2020
)
2.72
"Quercetin treatment reversed these effects."( Quercetin alleviates kidney fibrosis by reducing renal tubular epithelial cell senescence through the SIRT1/PINK1/mitophagy axis.
Chen, X; Liu, T; Qin, R; Shan, W; Yang, Q; Zhang, H; Zhang, X, 2020
)
2.72
"Quercetin treatment also inhibited the expression of COX-2 and hypoxia-inducible factor 1"( Quercetin Downregulates Cyclooxygenase-2 Expression and HIF-1
Chen, J; Jing, H; Liu, X; Luo, L; Qin, T; Shen, Z; Wang, L; Wu, H; Xiong, L; Yang, N; Zhu, X, 2020
)
2.72
"Quercetin treatment increased the expressions of IL-10, VEGF, TGF-β"( Quercetin accelerated cutaneous wound healing in rats by modulation of different cytokines and growth factors.
Jangir, BL; Kant, V; Kumar, V; Nigam, A; Sharma, V, 2020
)
2.72
"Quercetin pretreatment ameliorates DMH-induced proliferation, activities of detoxifying enzymes, and putative early markers (mucin depletion and goblet cell disintegration) in colonic tissue."( Quercetin ameliorates reactive oxygen species generation, inflammation, mucus depletion, goblet disintegration, and tumor multiplicity in colon cancer: Probable role of adenomatous polyposis coli, β-catenin.
Islam, J; Shree, A; Sultana, S, 2021
)
2.79
"Quercetin-treatment decreased the sharp increase in RNA expression of BAX and MPO in both cisplatin-toxicated testes and after MNU carcinogenesis induction."( Efficacy of Quercetin-Sensitized Cisplatin against N-Nitroso-NMethylurea Induced Testicular Carcinogenesis in Wistar Rats.
El-Diasty, HH; El-Ghaweet, HA; El-Sayyad, H; Refaat, S, 2021
)
1.72
"Quercetin treatment at 50 μM and 75 μM concentration inhibit human metastatic ovarian cancer PA-1 cell survival and proliferation via inactivating PI3k/Akt, Ras/Raf pathways and EGFR expression."( Quercetin attenuates metastatic ability of human metastatic ovarian cancer cells via modulating multiple signaling molecules involved in cell survival, proliferation, migration and adhesion.
Arunakaran, J; Dhanaraj, T; Mohan, M, 2021
)
2.79
"Quercetin treatment attenuated cortical inflammatory responses and oxidative stress induced by TBI insults."( Protective effects of quercetin on traumatic brain injury induced inflammation and oxidative stress in cortex through activating Nrf2/HO-1 pathway.
Cui, S; Du, G; Gao, X; Liu, B; Song, J; Wu, H; Yang, Z, 2021
)
1.66
"Quercetin pretreatment partially alleviated the decrease of cell viability, the increase of apoptosis, and the release of inflammatory cytokines (IL-10, IL-6, and IL-17A) induced by TNF-α."( Quercetin Efficiently Alleviates TNF-α-Stimulated Injury by Signal Transducer and Activator of Transcription 1 and Mitogen-Activated Protein Kinase Pathway in H9c2 Cells: A Protective Role of Quercetin in Myocarditis.
An, Y; Li, S; Yang, B; Zhang, R; Zhao, C; Zheng, CY, 2021
)
2.79
"Quercetin treatment significantly reduced cell viability in two GBM cell lines of U87MG and U373MG while keeping 85% of normal astrocytes alive."( Quercetin Induces Apoptosis in Glioblastoma Cells by Suppressing Axl/IL-6/STAT3 Signaling Pathway.
Choi, YJ; Kim, HI; Kim, MJ; Kim, TY; Ko, SG; Lee, SJ, 2021
)
2.79
"All quercetin-treated rats had a daily single dose of 25, 50 or 100 mg/kg intraperitoneally administered quercetin for 21 days, and the last dose was given 30 min before the penicillin injection."( Chronic effects of different quercetin doses in penicillin-induced focal seizure model.
Aygun, H; Sumbul, O, 2021
)
1.39
"Quercetin pretreatments of 25, 50 and 100 mg/kg significantly increased the duration of latency (initial spike activity) and decreased spike frequency of the epileptiform activity compared to the control group (p < 0.05). "( Chronic effects of different quercetin doses in penicillin-induced focal seizure model.
Aygun, H; Sumbul, O, 2021
)
2.36
"Quercetin treatment increased mitochondrial biogenesis, caused hypertrophy in pancreatic β cells and activated mTOR signaling with a transient change in mitochondrial membrane potential and AMP/ATP."( Quercetin improves oxidative stress-induced pancreatic beta cell alterations via mTOR-signaling.
Dhanya, R; Kartha, CC, 2021
)
2.79
"Quercetin treatment in the GBH+Quer group allowed partial or total improvement in behavioral tests (EPM and FST) and in the levels of oxidative stress markers (RS and GSH)."( A subchronic low-dose exposure of a glyphosate-based herbicide induces depressive and anxious-like behavior in mice: quercetin therapeutic approach.
Bicca, DF; Cibin, FWS; Ramalho, JB; Soares, MB; Spiazzi, CC, 2021
)
1.55
"Quercetin treatment protects bladder tissue contractility against acute I/R injury by decreasing oxidative stress and apoptosis induced by I/R."( Antioxidant Agent Quercetin Prevents Impairment of Bladder Tissue Contractility and Apoptosis in a Rat Model of Ischemia/Reperfusion Injury.
Cadirci, S; Cetinel, S; Cevik, O; Sener, G; Sener, TE; Tarcan, T; Tinay, I; Toklu, H, 2017
)
2.23
"Quercetin treatment reduced aging-induced morphological changes and reactive oxygen species accumulation."( Quercetin delays postovulatory aging of mouse oocytes by regulating SIRT expression and MPF activity.
Jo, YJ; Kim, NH; Oh, JS; Wang, H, 2017
)
2.62
"Quercetin treatment also induced apoptosis via deregulating the expression of apoptotic genes, including Bax and Bcl-2, and arrested cell cycle at G2/M phases."( Effects of quercetin on proliferation and migration of human glioblastoma U251 cells.
Li, CL; Lin, Y; Liu, Y; Lv, W; Qu, XG; Tang, ZG; Wang, GB, 2017
)
1.57
"The quercetin treated with the plasma for 20 min showed rapidly increased α-glucosidase inhibitory and radical scavenging activities compared to those of parent quercetin."( Plasma-Induced Degradation of Quercetin Associated with the Enhancement of Biological Activities.
Jo, C; Kim, HJ; Kim, TH; Lee, J, 2017
)
1.22
"Quercetin treatment significantly improvement stress-mediated behavior dysfunction as indicated by improved locomotion, lesser immobility time and greater frequency of upward turning in TST and FST and increased transfer latency on the day 2 (short-term memory) and day 5 (long-term memory) in PASD test."( Quercetin ameliorates chronic unpredicted stress-induced behavioral dysfunction in male Swiss albino mice by modulating hippocampal insulin signaling pathway.
Mehta, V; Singh, TR; Udayabanu, M, 2017
)
2.62
"Quercetin treatment reduced the lipid peroxidation in the diabetic rats, meanwhile increased the total antioxidant capacity in the pancreas from diabetic rats."( Quercetin improves endothelial function in diabetic rats through inhibition of endoplasmic reticulum stress-mediated oxidative stress.
Chatterjee, S; Dornadula, S; Mohanram, RK; Suganya, N, 2018
)
2.64
"Quercetin treatment decreased the levels of intracellular signalling proteins in PKD mouse kidneys, including phosphorylated protein kinase B (also known as AKT) and phosphorylated extracellular signal-regulated kinase (ERK), which are upregulated and promote cyst development in ADPKD."( Quercetin inhibits renal cyst growth in vitro and via parenteral injection in a polycystic kidney disease mouse model.
Du, L; Guo, H; Sun, Y; Teng, T; Wang, H; Yang, B; Yin, X; Zhu, Y, 2018
)
2.64
"Quercetin pretreatment significantly alleviated LPS-induced cardiac abnormalities in mice."( Quercetin exerts cardiovascular protective effects in LPS-induced dysfunction in vivo by regulating inflammatory cytokine expression, NF-κB phosphorylation, and caspase activity.
Li, C; Meng, X; Shen, F; Wei, X; Yang, J; Yuan, Y, 2018
)
2.64
"Quercetin treatment at a dose of 10 mg/kg failed to cause any significant changes in the levels of BDNF mRNA CONCLUSION: Our findings suggest that the neuroprotective effects of quercetin may be at least partly due to its inducing effects on the expression levels of the BDNF mRNA (Fig."( Effect of quercetin on the brain-derived neurotrophic factor gene expression in the rat brain.
Mashayekhi, FJ; Owji, AA; Rahvar, M, 2018
)
1.6
"Quercetin or rutin co-treatment with SASP significantly reversed organ weights, preserved sperm integrity, restored plasma hormone levels and increased cholesterol levels, 3β-HSD and 17β-HSD activities in testis."( Quercetin and rutin ameliorates sulphasalazine-induced spermiotoxicity, alterations in reproductive hormones and steroidogenic enzyme imbalance in rats.
Farombi, EO; Osawe, SO, 2018
)
2.64
"In quercetin-treated groups, serum AST, ALT, MDA levels, and tissue MDA concentration were decreased as inversely with increasing quercetin dose."( Quercetin dose affects the fate of hepatic ischemia and reperfusion injury in rats: An experimental research.
Alataş, İÖ; Şahin, A; Şahintürk, V; Uylaş, MU, 2018
)
2.44
"Quercetin treatment improved the wound healing process in I/R lesions by suppressing MAPK pathway."( Topical application of quercetin improves wound healing in pressure ulcer lesions.
Wang, X; Wang, Z; Yin, G, 2018
)
1.51
"Quercetin-3-glucoside treatment also alleviated of endoplasmic reticulum stress in the embryos of diabetic mice (P < .05)."( Modulation of nuclear factor-κB signaling and reduction of neural tube defects by quercetin-3-glucoside in embryos of diabetic mice.
Meng, F; Reece, EA; Tan, C; Zhao, Z, 2018
)
1.43
"Quercetin-treated model rats had reduced serum levels of parathyroid hormone (PTH), inorganic phosphate, increased urine protein-to-creatinine ratio, increased urine antioxidants, serum lactate dehydrogenase (LDH), and interleukin (IL)-8 when compared with the untreated model group and the control group."( Quercetin Treatment Improves Renal Function and Protects the Kidney in a Rat Model of Adenine-Induced Chronic Kidney Disease.
Li, R; Liang, YN; Song, Y; Yang, H, 2018
)
2.64
"Quercetin treatment significantly attenuated Ox-LDL-induced VSMC calcification, reduced ALP activity, down-regulated the expression levels of Msx2, BMP2 and Osterix, and up-regulated the expressions of vascular smooth muscle contractile proteins SMA and SM22a."( [Quercetin attenuates Ox-LDL-induced calcification in vascular smooth muscle cells by regulating ROS-TLR4 signaling pathway].
Chen, Y; Li, C; Liang, Q; Lu, L, 2018
)
2.11
"Quercetin treatment significantly augmented SOD, GSH, catalase and 5 HT levels."( A Natural Phenolic Compound Quercetin Showed the Usefulness by Targeting Inflammatory, Oxidative Stress Markers and Augment 5-HT Levels in One of the Animal Models of Depression in Mice.
Akhtar, M; Khan, K; Najmi, AK, 2019
)
1.53
"Quercetin treatment at 37°C induced mitochondrial fragmentation and decreased membrane potential (ΔΨ"( Astaxanthin but not quercetin preserves mitochondrial integrity and function, ameliorates oxidative stress, and reduces heat-induced skeletal muscle injury.
Chen, Y; Deuster, PA; Dohl, J; Gasier, HG; Yu, T, 2019
)
1.56
"Quercetin treatment (0-200 μM) for 24h decreases PA-1 cells viability in a dose-dependent manner."( Quercetin inhibits human metastatic ovarian cancer cell growth and modulates components of the intrinsic apoptotic pathway in PA-1 cell line.
Elayapillai, SP; Jagadeesan, A; Teekaraman, D; Viswanathan, MP, 2019
)
2.68
"Quercetin cotreatment enhanced activity as well gene expression in F2 generation."( Cadmium level in brain correlates with memory impairment in F1 and F2 generation mice: improvement with quercetin.
Banerjee, BD; Bhattacharya, SK; Chakraborty, S; Halder, S; Kar, R; Mediratta, PK, 2019
)
1.45
"Quercetintreated rats exhibited in liver significantly less steatosis without significant changes in inflammation and fibrosis features (S1A1F2; NAS - 2, fibrosis - 2) compared with rats of the 2nd group."( [Effect of quercetin on morphological changes in nonalcoholic fatty liver disease in high fructose-fed rats].
Kuznetsov, SL; Nikitin, NS,
)
1.24
"Quercetin treatment significantly induced the inhibition of root growth and the reduction of H₂O₂ and O₂"( RNA-Seq Transcriptome Analysis of Rice Primary Roots Reveals the Role of Flavonoids in Regulating the Rice Primary Root Growth.
Wang, L; Xu, M; Xu, Y; Zheng, H; Zong, X; Zou, J, 2019
)
1.24
"Quercetin treatment was found to significantly reduce anxiety-like behaviors in mTBI-induced mice."( Quercetin mitigates anxiety-like behavior and normalizes hypothalamus-pituitary-adrenal axis function in a mouse model of mild traumatic brain injury.
Ghorbanihaghjo, A; Kosari-Nasab, M; Mesgari-Abbasi, M; Salari, AA; Shokouhi, G, 2019
)
2.68
"Quercetin pretreatment can protect mice against LPSinduced AKI by inhibiting TLR4/NF-κB signaling pathway."( [Quercetin alleviates lipopolysaccharide-induced acute kidney injury in mice by suppressing TLR4/NF-κB pathway].
He, J; Qin, W; Tan, J; Zhao, L, 2019
)
2.87
"Quercetin treatment also increased renal cortical oxygenation and decreased plasma creatinine levels in obese mice, whereas body weight and cholesterol levels were unaltered."( Increased renal cellular senescence in murine high-fat diet: effect of the senolytic drug quercetin.
Ahmed, L; Chen, X; Hickson, LJ; Jiang, K; Kim, SR; Kirkland, JL; Lerman, LO; Lohmeier, H; Ogrodnik, M; Tang, H; Tchkonia, T; Zhu, XY, 2019
)
1.46
"Quercetin treatment in arthritis groups decreased the elevated levels of cytokines in the arthritis control group."( Effect of quercetin on E-NTPDase/E-ADA activities and cytokine secretion of complete Freund adjuvant-induced arthritic rats.
Abdalla, FH; Adefegha, SA; Becker, LV; Casali, EA; Castilhos, LG; Coelho, APV; da Silveira, KL; da Silveira, LL; Leal, DBR; Manzoni, AG; Martins, NMB; Oliveira, JS; Saccol, RDSP, 2019
)
1.64
"Quercetin pretreatment blocked the stress-induced corticosterone release and alleviated the brain oxidative stress with the maternal anxiety measures being slightly attenuated, whereas its effects on the offspring immune cell counts were mostly revealed at birth."( Quercetin alleviates predator stress-induced anxiety-like and brain oxidative signs in pregnant rats and immune count disturbance in their offspring.
Baudin, B; Merzoug, S; Tahraoui, A; Toumi, ML, 2013
)
2.55
"Quercetin  was pretreated along with Cd for four weeks to assess its cardioprotective effect against Cd intoxication."( Quercetin potentially attenuates cadmium induced oxidative stress mediated cardiotoxicity and dyslipidemia in rats.
Milton Prabu, S; Muthumani, M; Shagirtha, K, 2013
)
2.55
"The quercetin cotreatment along with lindane for 30 days reversed these biochemical alterations in lipids induced by lindane."( Effect of quercetin against lindane induced alterations in the serum and hepatic tissue lipids in wistar rats.
Baskaran, R; Lalitha, G; Padma, VV; Shirony, NP, 2012
)
1.26
"Quercetin treatment suppressed cell growth by inducing G2 arrest and apoptosis in EGFR-overexpressing HSC-3 and TW206 oral cancer cells."( Quercetin induces growth arrest through activation of FOXO1 transcription factor in EGFR-overexpressing oral cancer cells.
Chan, CY; Chou, IT; Huang, CY; Hung, HC; Lee, MF; Lien, CH, 2013
)
2.55
"Quercetin treatment reduces levels of inflammatory cytokines and improves lipid peroxidation and IR in NAFLD rats, and its beneficial effects appear to increase with higher dosage."( [Effects of quercetin on serum levels of resistin and IL-18 and on insulin resistance in nonalcoholic fatty liver disease rats].
Li, SL; Liang, ZQ; Qin, Q; Tang, L; Zhang, MH; Zhou, DS, 2013
)
2.21
"The quercetin treatments were administered for eight weeks after model establishment and control groups received simultaneous gavages of isotonic saline, with continuation of the respective diets."( [Therapeutic efficacy and mechanisms of quercetin in a rat model of nonalcoholic fatty liver disease].
Li, SL; Liang, ZQ; Qin, Q; Zhang, MH; Zhou, DS, 2013
)
1.14
"Quercetin treatment may help to delay the progression of NAFLD, possibly by adjusting the balance of inflammatory cytokines."( [Therapeutic efficacy and mechanisms of quercetin in a rat model of nonalcoholic fatty liver disease].
Li, SL; Liang, ZQ; Qin, Q; Zhang, MH; Zhou, DS, 2013
)
1.38
"Quercetin treatment prevented the cadmium-induced increase in NTPDase, 5-nucleotidase, and ADA activities in Cd/ethanol group when compared to saline/ethanol group."( Neuroprotective effect of quercetin in ectoenzymes and acetylcholinesterase activities in cerebral cortex synaptosomes of cadmium-exposed rats.
Abdalla, FH; Cardoso, AM; Fiorenza, AM; Gonçalves, JF; Gutierres, JM; Mazzanti, CM; Morsch, VM; Pereira, LB; Pimentel, VC; Schetinger, MR; Schmatz, R; Serres, JD; Stefanello, N; Vieira, JM; Zanini, D, 2013
)
1.41
"Quercetin treatment significantly reduced hind limb contracture, collagen accumulation and expression of TGF-β in irradiated skin."( Quercetin inhibits radiation-induced skin fibrosis.
Chung, EJ; Citrin, D; Gonzalez, F; Horton, JA; Hudak, K; Krausz, K; Li, F; White, A, 2013
)
2.55
"Quercetin treatment reduced oxysterol content (P<0.05) after 7 days of refrigerated storage of fresh meat, but did not affect significantly (P>0.05) the level of lipid-derived volatiles in the headspace of the light-exposed stored cooked meat."( The effect of quercetin dietary supplementation on meat oxidation processes and texture of fattening lambs.
Andrés, S; Bodas, R; Giráldez, FJ; Huerga, L; Mateo, J; Morán, L; Prieto, N; Rotolo, L; Tejido, ML, 2014
)
1.48
"Quercetin treatment decreased AAA incidence and inhibited the reactive oxygen species generation, nitrotyrosine formation and lipid peroxidation production in the aortic tissue during AAA development."( Quercetin reduces oxidative stress and inhibits activation of c‑Jun N‑terminal kinase/activator protein‑1 signaling in an experimental mouse model of abdominal aortic aneurysm.
Cheng, X; Jing, H; Li, H; Lu, H; Qiu, F; Shen, Y; Wang, B; Wang, L; Wang, Y; Wu, H; Yang, N, 2014
)
2.57
"Quercetin pretreatment evidently alleviated mitochondrial oxidative stress by inhibiting glutathione depletion and aconitase inactivation, ROS over-generation, and lipid peroxidation in cardiac mitochondria of intense exercise mice."( Myocardial mitochondrial oxidative stress and dysfunction in intense exercise: regulatory effects of quercetin.
Chen, S; Chen, X; Gao, C; Li, J; Li, Y; Liu, L; Tang, Y; Yao, P; Yu, H, 2014
)
1.34
"Quercetin treatment alone and with CdF2 also caused a significant increase in total Hyp and total collagen in mice liver."( Effect of quercetin on cadmium fluoride-induced alterations in hydroxyproline/collagen content in mice liver.
Siddiqi, NJ; Zargar, S, 2014
)
1.53
"Quercetin treatment before CCK application exerted no protection on MMP but increased ATP to a normal level, leading to a continuous decrease in the dehydrogenase activity."( Beneficial effect of the bioflavonoid quercetin on cholecystokinin-induced mitochondrial dysfunction in isolated rat pancreatic acinar cells.
Jonas, L; Krüger, B; Wakileh, M; Weber, H, 2014
)
1.39
"Quercetin (0.02%) treatment was administered in the food 3 days prior to 5-FU administration and for the duration of the experiment (ie, days -2 to 14)."( Dietary quercetin reduces chemotherapy-induced fatigue in mice.
Davis, JM; Mahoney, SE; McClellan, JL; Murphy, EA; Pena, MM, 2014
)
1.56
"Quercetin pre-treatment at 25 and 50 μm had a cytoprotective effect on cells against TUN-induced toxicity. "( Quercetin ameliorates tunicamycin-induced endoplasmic reticulum stress in endothelial cells.
Bhakkiyalakshmi, E; Paulmurugan, R; Ramkumar, KM; Suganya, N; Suriyanarayanan, S, 2014
)
3.29
"Quercetin treatment did not improve treadmill run-time-to-fatigue, hyperglycemia, or hyperlipidemia in cachectic Apc(Min/+) mice."( Quercetin supplementation attenuates the progression of cancer cachexia in ApcMin/+ mice.
Carson, JA; Davis, JM; Enos, RT; Murphy, EA; Narsale, AA; Puppa, MJ; Velázquez, KT, 2014
)
2.57
"Quercetin (50mg/kg) treatment during restraint stress (21 days) markedly decreased escape latency and increased time spent in target quadrant during Morris water maze task."( Chronic administration of quercetin prevent spatial learning and memory deficits provoked by chronic stress in rats.
Abrari, K; Elahdadi Salmani, M; Goudarzi, I; Lashkarbolouki, T; Mohammadi, HS, 2014
)
1.42
"Quercetin treatment downregulated USP10 and promoted T-bet degradation in a proteasome dependent way."( Deubiquitination and stabilization of T-bet by USP10.
Chen, C; Chen, Z; Li, B; Li, D; Pan, L; Shi, G; Wan, H; Wang, L, 2014
)
1.12
"Quercetin treatment at various concentrations was examined in combination with Cisplatin, taxol, Pirarubicin and 5-Fu in human epithelial ovarian cancer C13* and SKOV3 cells. "( Low concentration of quercetin antagonizes the cytotoxic effects of anti-neoplastic drugs in ovarian cancer.
Chen, G; Li, N; Ma, D; Sun, C; Weng, D; Xing, H; Zhou, B, 2014
)
2.16
"Quercetin treatment resulted in an increased cell arrest in G1 phase of the cell cycle, with pronounced decrease in CDK2, CDK6, cyclin D, cyclin E, and cyclin A proteins, decreased Rb phosphorylation and increased p21 and p27 expression."( Multitarget effects of quercetin in leukemia.
Calgarotto, AK; Filho, PL; Franchi, GC; Maso, V; Nowill, AE; Saad, ST; Vassallo, J, 2014
)
1.43
"Quercetin treatment down-regulated the expression of the PI3K and p-Akt."( Quercetin suppresses HeLa cells by blocking PI3K/Akt pathway.
Fang, Y; Wang, SX; Xiang, T, 2014
)
2.57
"Quercetin treatment caused a reduction in polyuria (~45%) and glycemia (~35%), abolished the hypertriglyceridemia and had significant effects on renal function including, decreased proteinuria and high plasma levels of uric acid, urea and creatinine, which were accompanied by beneficial effects on the structural changes of the kidney including glomerulosclerosis. "( Renoprotective, anti-oxidative and anti-apoptotic effects of oral low-dose quercetin in the C57BL/6J model of diabetic nephropathy.
Campagnaro, BP; Gomes, IB; Meyrelles, SS; Pereira, TM; Porto, ML; Santos, MC; Vasquez, EC, 2014
)
2.08
"Also quercetin treatment resulted in a marked increase in plasma and testicular testosterone concentrations."( Alleviative effect of quercetin on rat testis against arsenic: a histological and biochemical study.
Hussain, I; Iftikhar, N; Jahan, S; Rukh, G; Ullah, H, 2015
)
1.19
"Quercetin treatment attenuated the development of AD-like skin lesions."( Modulation of HMGB1 translocation and RAGE/NFκB cascade by quercetin treatment mitigates atopic dermatitis in NC/Nga transgenic mice.
Afrin, R; Arumugam, S; Harima, M; Karuppagounder, V; Miyashita, S; Nakamura, M; Nomoto, M; Pitchaimani, V; Sreedhar, R; Suzuki, H; Suzuki, K; Thandavarayan, RA; Watanabe, K, 2015
)
1.38
"Quercetin cotreatment significantly improved the testicular antioxidant status, decreased DNA fragmentation and restored the testicular histology, thus demonstrating the protective effect of quercetin in PCBs-treated rats."( Quercetin ameliorates polychlorinated biphenyls-induced testicular DNA damage in rats.
Adedara, IA; Barbisan, F; Costabeber, IB; da Cruz, IB; da Rocha, MI; Dalberto, M; de Oliveira, CR; Lovato, FL; Marroni, NP; Moreira, KL, 2016
)
2.6
"Quercetin treatment inhibited cell growth and led to upregulation of Nrf2 at both the mRNA and protein levels without altering the ubiquitination and extending the half-life of the Nrf2 protein."( Nrf2 Expression and Apoptosis in Quercetin-treated Malignant Mesothelioma Cells.
Lee, DM; Lee, SH; Lee, YJ, 2015
)
1.42
"Quercetin treatment dose-dependently decreased the p62 protein expression and increased GFP-LC3B."( Quercetin-induced autophagy flux enhances TRAIL-mediated tumor cell death.
Eo, SK; Lee, JH; Moon, JH; Park, SY, 2015
)
2.58
"Quercetin pretreatment significantly improved the cardiac function of LPS-challenged mice (P<0.05), and attenuated LPS-induced increment in myocardial iNOS expression and decrement in eNOS level. "( [Quercetin protects against lipopolysaccharide-induced cardiac injury in mice].
Deng, H; Dong, X; Li, J; Yang, F; Zhang, J, 2015
)
2.77
"Quercetin pretreatment significantly reduced the ConA-induced elevations in plasma aminotransferase concentrations and liver necrosis, as well as reducing serum concentrations of the pro-inflammatory cytokines tumor necrosis factor (TNF)-α, interferon-γ, and interleukin-4."( Quercetin Protects Mice from ConA-Induced Hepatitis by Inhibiting HMGB1-TLR Expression and Down-Regulating the Nuclear Factor Kappa B Pathway.
Li, X; Liu, HC; Tu, CT; Xu, BL; Yao, QY; Zhang, SC, 2016
)
2.6
"quercetin-treated group)."( Modulation of BV-2 microglia functions by novel quercetin pivaloyl ester.
Kuniaková, M; Mrvová, N; Račková, L; Škandík, M, 2015
)
1.39
"Quercetin treatment did not significantly alter the pharmacokinetic parameters of atorvastatin like AUC(0-24), AUC(0-α) , T(max), C(max) and T(½) in both single dose and multiple dose studies of Atorvastatin Calcium."( Quercetin does not alter the oral bioavailability of Atorvastatin in rats.
Babu, N; Challa, SR; Devi, R; Geddam, LB; Koritala, R; Ragam, SK; Sattenapalli, S; Venkatesh Reddy Challa, VR, 2015
)
2.58
"In quercetin treated group an increase in the mitochondrial DNA copy number and mitochondrial content in both the regions of rat brain was observed."( Quercetin protects against aluminium induced oxidative stress and promotes mitochondrial biogenesis via activation of the PGC-1α signaling pathway.
Bal, A; Gill, KD; Priyanka, K; Sharma, DR; Sharma, RK; Sunkaria, A; Verma, D; Wani, WY, 2015
)
2.37
"Quercetin treatment significantly prevented tissue deposition of arsenic within the testis."( Ameliorative effect of quercetin against arsenic-induced sperm DNA damage and daily sperm production in adult male rats.
Ain, QU; Iqbal, T; Jahan, S; Munawar, A; Rehman, S; Ullah, H, 2016
)
1.47
"Quercetin treatment resulted in restoration of spermatogenesis and reversal of histological damage."( Therapeutic effects of quercetin against bisphenol A induced testicular damage in male Sprague Dawley rats.
Ain, QU; Jahan, S; Ullah, H, 2016
)
1.47
"Quercetin treatment decreased the levels of Nos2 expression, protein nitrosylation, and protein nitration, alleviating nitrosative stress."( Amelioration of intracellular stress and reduction of neural tube defects in embryos of diabetic mice by phytochemical quercetin.
Cao, L; Liu, P; Meng, F; Reece, EA; Tan, C; Zhao, Z, 2016
)
1.36
"Quercetin treatment increased SUMOylation levels in both SHSY5Y cells and rat cortical neurons in a dose and time-dependent manner, possibly via the direct inactivation of certain SENPs (SUMO-specific isopeptidases)."( Global SUMOylation facilitates the multimodal neuroprotection afforded by quercetin against the deleterious effects of oxygen/glucose deprivation and the restoration of oxygen/glucose.
Bernstock, JD; Hallenbeck, JM; Ko, B; Lee, YJ; Nagaraja, N, 2016
)
1.39
"Quercetin pretreatment alleviated the stress-induced behavioural and haematological impairments in dams but failed to attenuate the haematological changes in neonates."( Effects of quercetin on predator stress-related hematological and behavioral alterations in pregnant rats and their offspring.
Merzoug, S; Tahraoui, A; Toumi, ML, 2016
)
1.55
"Quercetin treatment induced the myocardial expression of Prx-3 but not Prx-5 both in control and STZ rats."( Mitochondrial Peroxiredoxin-3 protects against hyperglycemia induced myocardial damage in Diabetic cardiomyopathy.
Arkat, S; Singh, S; Sitasawad, SL; Umbarkar, P, 2016
)
1.16
"Quercetin pretreatment (20 mg/kg i.p.; 0.5 h before trauma) significantly improved posttraumatic cardiomyocyte apoptosis and cardiac dysfunction."( Protective Effect of Quercetin on Posttraumatic Cardiac Injury.
Bi, Y; Cao, T; Chen, X; Jing, Z; Li, S; Li, X; Wang, Z; Yu, D; Zhou, J; Zhu, L, 2016
)
1.47
"Quercetin pretreatment showed protective effects on heart by significantly attenuating the ISO-induced oxidative stress, inflammation, protecting heart architecture, and by downregulation of the expression of calpain."( Molecular and biochemical evidence on the protective effects of quercetin in isoproterenol-induced acute myocardial injury in rats.
Bodduluru, LN; Kasala, ER; Kumar, M; Kumar, V; Lahkar, M, 2017
)
1.42
"Quercetin treatment resulted in an upregulation of Nrf2 expression and cytochrome c, malondialdehyde (MDA) and superoxide dismutase (SOD) levels were restored by quercetin treatment."( Protective Effects of Quercetin on Mitochondrial Biogenesis in Experimental Traumatic Brain Injury via the Nrf2 Signaling Pathway.
Fan, Y; Gao, Y; Li, L; Li, X; Mao, L; Tang, C; Wang, H; Wen, G; Zhou, M; Zhou, Y, 2016
)
1.47
"Quercetin pre-treatment was observed to suppress the expression of Hsp70 as well the protective function of co-enzyme Q10 at 5 h of heat stress."( Hsp70 expression induced by Co-Enzyme Q10 protected chicken myocardial cells from damage and apoptosis under in vitro heat stress.
Bao, E; Song, E; Tang, S; Wu, D; Xu, J; Yin, B, 2017
)
1.18
"Quercetin treatment also reduced the expression levels of glucose‑regulated protein 78, phosphorylated protein kinase‑like ER kinase, phosphorylated c‑Jun N‑terminal kinase and C/EBP homologous protein."( Quercetin alleviates cell apoptosis and inflammation via the ER stress pathway in vascular endothelial cells cultured in high concentrations of glucosamine.
Bao, L; Cai, X; Dai, X; Ding, Y; Li, Y; Zhang, Z, 2017
)
2.62
"Quercetin treatment alleviated memory dysfunction and rescued neurons from CUS-mediated damage."( Quercetin ameliorates chronic unpredicted stress-mediated memory dysfunction in male Swiss albino mice by attenuating insulin resistance and elevating hippocampal GLUT4 levels independent of insulin receptor expression.
Mehta, V; Parashar, A; Sharma, A; Singh, TR; Udayabanu, M, 2017
)
2.62
"Quercetin treatment significantly lowered oxidative and inflammatory stress and prevented neural damage."( Quercetin prevents chronic unpredictable stress induced behavioral dysfunction in mice by alleviating hippocampal oxidative and inflammatory stress.
Mehta, V; Parashar, A; Udayabanu, M, 2017
)
2.62
"Quercetin treatment led to lower epithelial thickness, subepithelial smooth muscle thickness, goblet and mast cell numbers compared to untreated  mice with allergic airway inflammation (p<0.05)."( Effects of Quercetin Treatment on Epithelium-derived Cytokines and Epithelial Cell Apoptosis in Allergic Airway Inflammation Mice Model.
Anal, O; Arikan Ayyildiz, Z; Bagriyanik, A; Caglayan Sozmen, S; Cilaker Micili, S; Isik, S; Karaman, M; Karaman, O; Uzuner, N, 2016
)
1.55
"Quercetin treatment suppressed the accumulation of malondialdehyde and increased glutathione peroxidase levels during doxorubicin and cyclophosphamide treatment (P <.05) Conclusions."( Protective Effect of Quercetin Against Oxidative Stress-induced Toxicity Associated With Doxorubicin and Cyclophosphamide in Rat Kidney and Liver Tissue.
Dogan, Z; Erdemli, E; Kocahan, S; Taskin, E, 2017
)
1.5
"Quercetin pretreatment and following UVA exposure resulted in increased reactive oxygen species production and intracellular glutathione level depletion in human dermal fibroblasts."( The Phototoxic Potential of the Flavonoids, Taxifolin and Quercetin.
Kosina, P; Psotová, M; Rajnochová Svobodová, A; Ryšavá, A; Ulrichová, J; Vostálová, J; Zálešák, B, 2017
)
1.42
"Quercetin pre-treatment resulted in increased irinotecan C(max) and area under curve (AUC) with a concomitant decrease in t(max), plasma clearance and volume of distribution (p<0.05)."( Pre-clinical evidence for altered absorption and biliary excretion of irinotecan (CPT-11) in combination with quercetin: possible contribution of P-glycoprotein.
Awasthi, A; Bansal, T; Jaggi, M; Khar, RK; Talegaonkar, S, 2008
)
1.28
"Quercetin treatment also significantly reduced hypoxia-induced secretion of VEGF."( Quercetin suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha) through inhibiting protein synthesis.
Lee, DH; Lee, YJ, 2008
)
2.51
"and quercetin treatments for 14 days significantly reduced (p=0.000) the serum uric acid levels of hyperuricemic rats in a time-dependent manner."( Hypouricemic and antioxidant activities of Allium cepa Lilliaceae and quercetin in normal and hyperuricemic rats.
Eshraghian, MR; Haidari, F; Keshavarz, SA; Mahboob, SA; Rashidi, MR; Shahi, MM, 2008
)
1.06
"Quercetin treatment reduced circulating levels of HMGB1 in animals with established endotoxemia."( Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function.
Kang, R; Lotze, MT; Tang, D; Wang, H; Xiao, W; Xiao, X; Zhang, H, 2009
)
2.52
"Quercetin pretreatment strongly suppressed UVA-induced apoptosis in human keratinocyte HaCaT cells, markedly increased protein levels of the transcription factor Nrf2, induced the expression of antioxidative genes, and dramatically reduced the production of reactive oxygen species following UVA irradiation."( Essential role of Nrf2 in keratinocyte protection from UVA by quercetin.
Ishii, T; Ishii, Y; Itoh, K; Kawachi, Y; Kimura, S; Ma, D; Warabi, E; Yanagawa, T, 2009
)
1.31
"Quercetin co-treatment significantly blocked both PCB77 and PCB126 induction of CYP1A1, vascular cell adhesion molecule 1 (VCAM-1), E-selectin and P-selectin."( Quercetin blocks caveolae-dependent pro-inflammatory responses induced by co-planar PCBs.
Arzuaga, X; Caraballo, A; Choi, YJ; Hennig, B; Kluemper, CT; Toborek, M, 2010
)
2.52
"Quercetin treatment markedly attenuated the Cd-induced biochemical alterations in serum, urine and renal tissue."( Quercetin protects against oxidative stress-related renal dysfunction by cadmium in rats.
Prabu, SM; Renugadevi, J, 2010
)
2.52
"Quercetin treatment also caused a measurable increase in the mRNA expression of human 8-oxoguanine DNA glycosylase (hOGG1) at 0 and 4h after H2O2 treatment (measured using RT-PCR)."( Quercetin inhibits hydrogen peroxide-induced DNA damage and enhances DNA repair in Caco-2 cells.
Ebeler, SE; Min, K, 2009
)
2.52
"Quercetin treatment promoted activation of caspase-3, -8 and -9 in MDA-MB-231 cells."( Quercetin-induced apoptosis acts through mitochondrial- and caspase-3-dependent pathways in human breast cancer MDA-MB-231 cells.
Chen, DR; Chien, SY; Chung, JG; Kuo, SJ; Lu, HF; Tsou, MF; Wood, WG; Wu, YC; Yang, JS, 2009
)
2.52
"No quercetin treatment effect was observed for any of the outcome measures in this study."( Quercetin's effect on cycling efficiency and substrate utilization.
Dumke, CL; McAnulty, LS; McAnulty, SR; Nieman, DC; Quindry, JC; Rigby, MD; Triplett, NT; Utter, AC, 2009
)
2.31
"Quercetin treatment enhanced TRAIL-induced activation proteins in the caspase pathway, such as poly (ADP-ribose) polymerase (PARP), caspase-3, and caspase-9."( Quercetin enhances TRAIL-induced apoptosis in prostate cancer cells via increased protein stability of death receptor 5.
Heo, J; Jung, YH; Kim, YH; Kwon, TK; Lee, YJ, 2010
)
2.52
"Quercetin pretreatment significantly (P<0.05) lowered ST-segment elevation and decreased the levels of lipid peroxidation products in plasma and heart in isoproterenol treated cardiotoxic rats."( Pretreatment with quercetin ameliorates lipids, lipoproteins and marker enzymes of lipid metabolism in isoproterenol treated cardiotoxic male Wistar rats.
Prince, PS; Sathya, B, 2010
)
1.42
"Quercetin treatment protected ARPE-19 cells from H(2)O(2)-induced oxidative injury, enhanced BCL-2 transcript levels, increased the BCL-2/BAX ratio, suppressed the transcription of pro-apoptotic factors such as BAX, FADD, CASPASE-3 and CASPASE-9, inhibited the transcription of inflammatory factors such as TNF-alpha, COX-2 and INOS, and decreased the levels of COX and NO in the culture medium."( The effects of quercetin in cultured human RPE cells under oxidative stress and in Ccl2/Cx3cr1 double deficient mice.
Cao, X; Chan, CC; Liu, M; Shen, D; Tuo, J, 2010
)
1.43
"The quercetin-treated K562, SNU1, and SNU-C4 cells showed an enhanced susceptibility to NK-92 cells through induction of NKG2D ligands."( Quercetin enhances susceptibility to NK cell-mediated lysis of tumor cells through induction of NKG2D ligands and suppression of HSP70.
Bae, JH; Chang, SH; Chung, JS; Kang, CD; Kim, JY; Kim, MJ; Kim, SH; Lee, EY; Park, SJ; Park, YS; Son, CH, 2010
)
2.28
"Quercetin treatment induced no significant changes in the hypertensive responses to angiotensin I and angiotensin II, as well in the hypotensive responses to bradykinin (all p>0.05)."( Chronic treatment with quercetin does not inhibit angiotensin-converting enzyme in vivo or in vitro.
Dias-Junior, CA; Kanashiro, A; Montenegro, MF; Neto-Neves, EM; Spiller, F; Tanus-Santos, JE, 2010
)
1.39
"Quercetin treatment for 30min enhanced relaxation of rat aortic ring segments."( Dietary flavonoid quercetin stimulates vasorelaxation in aortic vessels.
Constance, C; Inoue, T; Khoo, NK; Parks, DA; Patel, RP; Pozzo-Miller, L; White, CR; Zhou, F, 2010
)
1.42
"In quercetin-treated animals, MPO activity was significantly decreased in tissue at 12 and 24 h and in serum at 6, 12 and 24 h after injury, compared with saline controls. "( Quercetin attenuates inflammatory processes after spinal cord injury in an animal model.
Griebel, RW; Juurlink, BH; Schültke, E, 2010
)
2.42
"Quercetin-treated groups (10, 20, or 40 mg/kg, p.o.) also showed significant memory impairments compared with the control group in the Y-maze task (P < 0.05)."( Quercetin impairs learning and memory in normal mice via suppression of hippocampal phosphorylated cyclic AMP response element-binding protein expression.
Jung, WY; Kim, DH; Kim, JM; Park, DH; Park, SJ; Ryu, JH, 2010
)
2.52
"Quercetin pretreatment increased total GSH levels, but did not increase Trx2."( After cellular internalization, quercetin causes Nrf2 nuclear translocation, increases glutathione levels, and prevents neuronal death against an oxidative insult.
Abin-Carriquiry, JA; Antúnez, K; Arredondo, F; Blasina, F; Dajas, F; Echeverry, C; Go, YM; Jones, DP; Liang, YL, 2010
)
1.37
"Quercetin treatment of K-562 cells was accompanied by cell cycle arrest in G2/M and apoptosis with caspase-3 activation."( Apoptosis and content of mobile lipid domains in human leukemia K-562 cells induced to differentiate by quercetin or dimethyl sulfoxide.
Kuyava, LM; Mikhailenko, VM; Philchenkov, AA; Zavelevich, MP,
)
1.07
"Quercetin treatment restored plasma nitrite and nitroso species levels to those found in the sham-vehicle group (P < 0.05)."( Quercetin restores plasma nitrite and nitroso species levels in renovascular hypertension.
Castro, MM; Ceron, CS; Dias-Junior, CA; Gomes, VA; Kanashiro, A; Montenegro, MF; Neto-Neves, EM; Tanus-Santos, JE, 2010
)
2.52
"Quercetin treatment also markedly suppressed the histological changes such as pancreatic edema, inflammatory cell infiltration, acinar cell necrosis, and the expression of TNF-alpha."( The natural flavonoid quercetin ameliorates cerulein-induced acute pancreatitis in mice.
Carvalho, KM; de Andrade, GM; de Castro Brito, GA; de Melo, TS; Morais, TC; Rao, VS; Santos, FA, 2010
)
1.4
"Quercetin-treated, elastase/LPS-exposed mice showed improved elastic recoil and decreased alveolar chord length compared to vehicle-treated controls. "( Quercetin prevents progression of disease in elastase/LPS-exposed mice by negatively regulating MMP expression.
Burgess, JR; Chattoraj, A; Chattoraj, SS; Comstock, AT; Curtis, JL; Faris, AN; Ganesan, S; Hershenson, MB; Martinez, FJ; Sajjan, US; Zick, S, 2010
)
3.25
"Quercetin treatment markedly reduced ischemia-induced up-regulation of MMP-9 at 24 and 48 h after ischemic injury. "( Quercetin reduces the elevated matrix metalloproteinases-9 level and improves functional outcome after cerebral focal ischemia in rats.
Jang, JW; Kim, HS; Kim, SH; Kwak, HJ; Lee, JK; Piao, MS, 2011
)
3.25
"Quercetin treatment (30mg/kg body weight) over 14 consecutive days markedly increased the striatal dopamine and antioxidant enzyme levels compared with similar measurements in the group treated with 6-OHDA alone."( Neuroprotective effect of bioflavonoid quercetin in 6-hydroxydopamine-induced oxidative stress biomarkers in the rat striatum.
Haleagrahara, N; Kumari, M; Mitra, NK; Siew, CJ, 2011
)
1.36
"Quercetin pretreated lymphocytes showed a significant protection against the cytotoxic effects inducted by Dimethoate on the studied parameters."( Protective effect of quercetin against oxidative stress caused by dimethoate in human peripheral blood lymphocytes.
Abdallah, FB; Elfekih, A; Gargouri, B; Khaled, H; Lassoued, S; Mansour, RB, 2011
)
1.41
"Quercetin treatment caused significant decreases in lipid peroxide levels in the TAA-treated rats, with some changes in antioxidant enzymes superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx)."( Role of quercetin in preventing thioacetamide-induced liver injury in rats.
Bona, S; de David, C; González-Gallego, J; Marroni, NP; Meurer, L; Rodrigues, G; Tuñón, MJ, 2011
)
1.52
"Quercetin treatment improved viability of P19 neurons exposed to both types of oxidative injury."( Neuroprotective effect of quercetin against hydrogen peroxide-induced oxidative injury in P19 neurons.
Erhardt, J; Jazvinšćak Jembrek, M; Oršolić, N; Puhović, J; Vuković, L, 2012
)
1.4
"Quercetin treatment also attenuated RV-induced airway cholinergic hyperresponsiveness."( Quercetin inhibits rhinovirus replication in vitro and in vivo.
Comstock, AT; Faris, AN; Ganesan, S; Hershenson, MB; Nanua, S; Sajjan, US; Wang, Q, 2012
)
2.54
"Quercetin treatment reversed the effects of high glucose in a dose-dependent manner."( Quercetin suppresses NF-κB and MCP-1 expression in a high glucose-induced human mesangial cell proliferation model.
Chen, P; Chen, W; Shi, Q; Wang, H; Wang, Y; Xu, X, 2012
)
2.54
"Quercetin treatment improved whole body insulin sensitivity by increasing GLUT4 expression and decreasing JNK phosphorylation, and TNFα and iNOS expression in skeletal muscle."( Quercetin decreases inflammatory response and increases insulin action in skeletal muscle of ob/ob mice and in L6 myotubes.
Anhê, FF; Anhê, GF; Bordin, S; Hirabara, SM; Kinote, A; Lellis-Santos, C; Lima, GA; Machado, UF; Okamoto, MM; Sollon, C; Velloso, LA, 2012
)
2.54
"Quercetin treatment can improve memory and learning ability as well as cognitive ability in neonates with WMD, suggesting that quercetin protects against WMD resulting from hypoxia-ischemia."( [Effects of quercetin on the learning and memory ability of neonatal rats with hypoxic-ischemic brain damage].
Huang, JJ; Liu, X; Qi, DS; Wang, XQ; Yang, LH; Yao, RQ, 2012
)
2.2
"Quercetin treatment attenuated oedema in a dose-dependent manner and decreased histological signs of acute inflammation in the treated animals. "( Therapeutic properties of quercetin on monosodium urate crystal-induced inflammation in rat.
Chen, J; Huang, J; Li, S; Sun, W; Tao, Y; Wang, S; Zhu, M, 2012
)
2.12
"Quercetin treatment induced the apoptosis of A2780S cells associated with activating caspase-3 and caspase-9."( Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer.
Gao, X; Gou, M; Guo, G; Huang, M; Huang, N; Men, K; Qian, Z; Wang, B; Wei, X; Wei, Y; Zheng, F; Zheng, Y; Zhou, Y, 2012
)
1.34
"Quercetin treatment also attenuated the expression of both TNF-alpha (TNF-α) and interleukin-10 (IL-10) and lowered the serum levels of inflammatory cytokine (P < 0.05)."( Protective roles of quercetin in acute myocardial ischemia and reperfusion injury in rats.
Jin, HB; Li, YR; Song, YL; Yang, YB; Zhang, YC, 2012
)
1.42
"Quercetin pretreatment reduced the ROS generation stimulated by either CSE or H(2)O(2) in preadipocyte OFs."( Cigarette smoke extract-induced adipogenesis in Graves' orbital fibroblasts is inhibited by quercetin via reduction in oxidative stress.
Chae, MK; Lee, EJ; Lee, HJ; Lee, SY; Yoon, JS, 2013
)
1.33
"Quercetin pretreatment ameliorated these alterations."( Modulatory role of quercetin against gamma radiation-mediated biochemical and morphological alterations of red blood cells.
Bhattacharjee, S; Chakraborty, A; Das, DK; Dey, S; Manna, K; Mukherjee, D; Sinha, M, 2013
)
1.44
"Quercetin treatment did not improve oocyte nuclear maturation, but significantly higher blastocyst rates (p < 0.05) of parthenogenetically activated oocytes were achieved when the IVM medium was supplemented with an adequate concentration of quercetin (1 µg/mL)."( Quercetin improves the in vitro development of porcine oocytes by decreasing reactive oxygen species levels.
Jang, G; Kang, JT; Kim, SJ; Koo, OJ; Kwon, DK; Lee, BC; Moon, JH; Park, SJ, 2013
)
2.55
"Quercetin pre-treatment (88.7 micromol/kg p.o., 45 min; 14.7 micromol/kg i.v., 5 min) significantly potentiated the hypotensive effect of bradykinin (10 nmol/kg i.v.)."( Inhibition of angiotesin-converting enzyme by quercetin alters the vascular response to brandykinin and angiotensin I.
Cuttle, G; Dovichi, SS; Häckl, LP; Lima-Landman, MT; Nicolau, M, 2002
)
1.29
"Quercetin treatment raised blood glucose concentrations in normal and diabetic rats, whereas treatment with coenzyme Q(10) did not."( Effects of combined quercetin and coenzyme Q(10) treatment on oxidative stress in normal and diabetic rats.
Coldiron, AD; Sanders, RA; Watkins, JB, 2002
)
1.36
"Quercetin-treated strains showed by 13-20% fewer nodules than untreated controls."( Preincubation of Mesorhizobium ciceri with flavonoids improves its nodule occupancy.
Kamboj, DV; Kukreja, K; Sharma, PK; Upadhyay, KK, 2002
)
1.04
"Quercetin treatment significantly increased GSH levels and activities of these enzymes when compared to the I/R group (p<0.05, p<0.01, p<0.05, respectively)."( Protective effect of quercetin on renal ischemia/reperfusion injury in rats.
Erkasap, N; Kahraman, A; Köken, T; Serteser, M,
)
1.17
"Quercetin treatment did not induce oxidative damage, but protected mouse thymocytes from glucose oxidase (GO)-mediated apoptosis in a dose-dependent manner."( The antioxidant, rather than prooxidant, activities of quercetin on normal cells: quercetin protects mouse thymocytes from glucose oxidase-mediated apoptosis.
Chung, GH; Jang, YS; Kim, J; Lee, JC; Park, JK, 2003
)
1.29
"Quercetin treatment reduced the beta-hexosaminidase release response to concanavalin A."( Effects of water-soluble cigarette smoke extracts upon the release of beta-hexosaminidase from RBL-2H3 basophilic leukaemia cells in response to substance P, compound 48/80, concanavalin A and antigen stimulation.
Fowler, CJ; Sandberg, M; Tiger, G, 2003
)
1.04
"Quercetin treatment decreased the glutathione concentration and glutathione reductase activity (40 and 34%, respectively) in the liver significantly and to a similar extent in vitamin E-deprived and -undeprived rats."( Anti- and prooxidant effects of chronic quercetin administration in rats.
Chee, KM; Choi, EJ; Lee, BH, 2003
)
1.31
"Quercetin and verapamil treatments reduced the endothelium-independent hyper-reactivity to KCl observed in the aorta of DOCA-salt-hypertensive rats, but only quercetin increased the contractile responses to angiotensin II, improved endothelial dysfunction and restored basal aortic Cu/Zn SOD expression, altered in DOCA-salt-treated rats."( Effects of quercetin treatment on vascular function in deoxycorticosterone acetate-salt hypertensive rats. Comparative study with verapamil.
Duarte, J; Galisteo, M; García-Saura, MF; Jiménez, R; Vargas, F; Villar, IC; Wangensteen, R; Zarzuelo, A, 2004
)
1.43
"Quercetin treatment attenuated the functional, histological and immunohistochemical alterations induced by cisplatin."( Protective effect of quercetin on the evolution of cisplatin-induced acute tubular necrosis.
Bianchi, Mde L; Coimbra, TM; Costa, RS; Francescato, HD, 2004
)
2.09
"Quercetin and verapamil treatments reduced systolic blood pressure of DOCA-salt rats in approximately 67.6 and 63.3% respectively, producing no effect in control animals."( Effects of chronic quercetin treatment on antioxidant defence system and oxidative status of deoxycorticosterone acetate-salt-hypertensive rats.
Duarte, J; Galisteo, M; García-Saura, MF; Jiménez, R; Vargas, F; Villar, IC; Zarzuelo, A, 2004
)
1.37
"Quercetin treatment, by abolishing the NF-kappaB signal transduction pathway, may block the production of noxious mediators involved in the pathogenesis of portal hypertensive gastropathy."( Quercetin prevents oxidative stress and NF-kappaB activation in gastric mucosa of portal hypertensive rats.
Alonso, M; Collado, PS; Fraga, C; González-Gallego, J; Marroni, C; Marroni, N; Moreira, AJ; Zetller, C, 2004
)
2.49
"Quercetin treatment of the SW480 human colon cancer cells was found to result in the decreased expression of three proteins and the increased expression of one protein. "( The effects of quercetin on SW480 human colon carcinoma cells: a proteomic study.
Grider, A; Hargrove, JL; Kolli, K; Mouat, MF; Orlando, R, 2005
)
2.12
"Quercetin treatment (30 microM, 1.5 month) increased CH(2)/CH(3) ratio by 2.1 fold."( Analysis of 1H NMR-detectable mobile lipid domains for assessment of apoptosis induced by inhibitors of DNA synthesis and replication.
Mikhailenko, VM; Philchenkov, AA; Zavelevich, MP, 2005
)
1.05
"Quercetin treatment reduced systolic blood pressure of GB rats, producing no effect in control animals."( Effects of chronic quercetin treatment in experimental renovascular hypertension.
Bermejo, A; Duarte, J; Galisteo, M; García-Saura, MF; Vargas, F; Villar, IC; Zarzuelo, A, 2005
)
1.38
"Quercetin and rutin treatment did not influence the echocardiographical and histo logical parameters in normal animals."( Partial reversal by rutin and quercetin of impaired cardiac function in streptozotocin-induced diabetic rats.
Annapurna, A; Chalam, CR; Gopal, GS; Krishna, KM; Kumar, VK; Madan, K; Prakash, GJ, 2005
)
1.34
"Quercetin pretreatment significantly reversed the decrease in caspase-1, -6, and -8 activities and the antiapoptotic effect of MG132 on IFN-gamma-treated LECs."( Upregulation of heat shock protein expression by proteasome inhibition: an antiapoptotic mechanism in the lens.
Awasthi, N; Wagner, BJ, 2005
)
1.05
"In quercetin-treated mice, delayed neuronal damage was significantly decreased compared with vehicle-treated mice."( Protective effect of quercetin, a natural flavonoid against neuronal damage after transient global cerebral ischemia.
Cho, JY; Jang, YH; Kim, AR; Kim, IS; Lee, SR, 2006
)
1.17
"Quercetin treatment obviously relieved the degree of hepatic fibrosis, significantly reduced the expression of immediate early gene, tissue inhibitor of metalloproteinase 1 (TIMP 1), types I and III collagen compared to the control."( [Inhibition of quercetin on liver fibrosis due to Schistosoma japonicum infection and on the expression of immediate early gene and metalloproteinase 1 inhibitor in liver tissue of mice].
Han, CR; He, SS; Xu, B, 2006
)
1.41
"In quercetin-treated PC-3 cells, an increase in Bax protein expression and a decrease in Bcl-x(L) protein and Bcl-2 protein were observed."( Quercetin induces p53-independent apoptosis in human prostate cancer cells by modulating Bcl-2-related proteins: a possible mediation by IGFBP-3.
Arunakaran, J; Arunkumar, A; Dharmarajan, A; Ilangovan, R; Kanagaraj, P; Vijayababu, MR, 2006
)
2.29
"Quercetin pretreatment administered prior to the induction of differentiation also exerted stimulatory effects on the osteogenic differentiation of hADSC."( Quercetin, a flavonoid, inhibits proliferation and increases osteogenic differentiation in human adipose stromal cells.
Bae, YC; Jung, JS; Kim, YJ; Suh, KT, 2006
)
2.5
"Quercetin treatment of cells caused a significant time- and dose-dependent increase in the caspase-3 activity."( Induction of cell apoptosis in 3T3-L1 pre-adipocytes by flavonoids is associated with their antioxidant activity.
Hsu, CL; Yen, GC, 2006
)
1.06
"Quercetin treatment of hepatoma cells resulted in changes of cell cycle progression."( Reactive oxygen species production is involved in quercetin-induced apoptosis in human hepatoma cells.
Chang, YF; Chi, CW; Wang, JJ, 2006
)
1.31
"Quercetin treatment reduced blood glucose level in diabetic rats."( Quercetin, a flavonoid antioxidant, modulates endothelium-derived nitric oxide bioavailability in diabetic rat aortas.
Achike, FI; Machha, A; Mustafa, AM; Mustafa, MR, 2007
)
2.5
"Quercetin treatment and HSF1 silencing increased the pro-apoptotic effect of doxorubicin."( Inhibition of heat shock proteins (HSP) expression by quercetin and differential doxorubicin sensitization in neuroblastoma and Ewing's sarcoma cell lines.
Bisaro, B; Carta, F; Crescenzio, N; di Montezemolo, LC; Doria, A; Foglia, L; Giribaldi, G; Mandili, G; Timeus, F; Turrini, F; Zanini, C, 2007
)
1.31
"Quercetin treatment reduced the inflammation-induced over-expression of VCAM-1 and ICAM-1 (protein and transcript) in HUVECs."( Comparative effects of quercetin and its predominant human metabolites on adhesion molecule expression in activated human vascular endothelial cells.
Connor, C; Hughes, DA; Kroon, PA; Lodi, F; Needs, PW; Suri, S; Taylor, MA; Tribolo, S; Wilson, VG, 2008
)
1.38
"Quercetin treatment also led to a translocation of the C."( Increase of stress resistance and lifespan of Caenorhabditis elegans by quercetin.
Chovolou, Y; Kampkötter, A; Proksch, P; Ruhl, S; Timpel, C; Wätjen, W; Zurawski, RF, 2008
)
1.3
"All quercetin treatment groups produced increases in the GSH:GSSG ratio and decreases in mixed disulfide levels in hepatic tissue."( Influence of dietary quercetin on glutathione redox status in mice.
Meyers, KJ; Mitchell, AE; Rudolf, JL, 2008
)
1.15
"Quercetin pretreatment increased AUC(0-infinity) of pioglitazone after oral administration by 75% and AUC(0-infinity) after intravenous administration by 25% suggesting decreased metabolism, which could be due to inhibition of CYP3A by quercetin."( Quercetin pretreatment increases the bioavailability of pioglitazone in rats: involvement of CYP3A inhibition.
Bansod, KU; Dixit, PV; Kumar, V; Umathe, SN; Wanjari, MM, 2008
)
2.51
"Quercetin treatment did not show any notable effect on intracellular levels of glutathione in either used concentration of quercetin."( The protective effect of quercetin against oxidative stress in the human RPE in vitro.
Kampik, A; Kook, D; Neubauer, AS; Priglinger, SG; Welge-Lüssen, UC; Wolf, AH; Yu, AL, 2008
)
1.37
"Quercetin treatment (100 microM) also caused a decrease in Ser136 phosphorylation of Bad, which is a downstream target of Akt."( Role of Bax in quercetin-induced apoptosis in human prostate cancer cells.
Lee, DH; Lee, YJ; Szczepanski, M, 2008
)
1.42
"Quercetin treatment produced differential regulation of Cyp1A1 and Cyp1B1 mRNA expression in a time- and dose-dependent manner."( Preferential induction of cytochrome P450 1A1 over cytochrome P450 1B1 in human breast epithelial cells following exposure to quercetin.
Bhat, HK; Chhabra, J; Mense, SM, 2008
)
1.27
"Some quercetin-treated groups showed a significant decrease in the average weight of day-20 foetuses compared with the corresponding control weight."( Teratogenic potential of quercetin in the rat.
Willhite, CC, 1982
)
1.02
"Quercetin-treated tumor cells were not induced to show aggregation of HSP70 in the nuclei and nucleolus in response to heat shock, resulting in apoptosis."( Induction of apoptosis by quercetin: involvement of heat shock protein.
Fukata, H; Kariya, Y; Teshigawara, K; Uchida, A; Wei, YQ; Zhao, X, 1994
)
1.31
"Quercetin treatments also caused a small but significant reduction (17-18%) in DLP relative gland weights (gland wt/body wt) in T + E2-treated animals."( In vitro and in vivo inhibition of nuclear type II estrogen binding sites in the dorsolateral prostate of noble rats.
Ho, SM; Viccione, T; Yu, M, 1993
)
1.01
"Quercetin treatment significantly decreased FI630nm and increased the ratio FI520nm/FI630nm when compared with DMBA-induced lesions."( Inhibitory effect of dietary flavonol quercetin on 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis.
Balasubramanian, S; Govindasamy, S, 1996
)
1.29
"Quercetin-treated cells did not show any differentiation but showed 68% apoptosis as compared to 7% in control."( Down-modulation of P210bcr/abl induces apoptosis/differentiation in K562 leukemic blast cells.
Deora, AB; Miranda, MB; Rao, SG,
)
0.85
"In quercetin-treated animals, the decrease in nitric oxide concentration was slower, such that substantial amounts (60(20) nmol/l) accumulated during reperfusion."( Bioflavonoid quercetin scavenges superoxide and increases nitric oxide concentration in ischaemia-reperfusion injury: an experimental study.
Brovkovych, V; Huk, I; Malinski, T; Nanobash Vili, J; Neumayer, C; Partyka, L; Patton, S; Weigel, G, 1998
)
1.18
"Quercetin treatment mollified ischaemia-reperfusion injury to skeletal muscle by scavenging destructive superoxide and enhancing the cytoprotective nitric oxide concentration."( Bioflavonoid quercetin scavenges superoxide and increases nitric oxide concentration in ischaemia-reperfusion injury: an experimental study.
Brovkovych, V; Huk, I; Malinski, T; Nanobash Vili, J; Neumayer, C; Partyka, L; Patton, S; Weigel, G, 1998
)
2.11
"Quercetin treated animals did not show increased oxidation of LDL (and VLDL in rabbits) and cholesterol levels were not decreased."( Probucol selectively increases oxidation of atherogenic lipoproteins in cholesterol-fed mice and in Watanabe heritable hyperlipidemic rabbits.
Lauridsen, ST; Mortensen, A, 1999
)
1.02
"Quercetin treatment downregulated both PMA- and TNF-alpha-induced surface expression, as well as the ICAM-1 mRNA levels, in ECV cells in a dose-dependent (10-50 microM) manner."( Quercetin inhibits inducible ICAM-1 expression in human endothelial cells through the JNK pathway.
Kobuchi, H; Nguyen, HG; Packer, L; Roy, S; Sen, CK, 1999
)
2.47
"Quercetin-treated RBL-2H3 cells in which expression of G(alphai2) and G(alphai3) is enhanced more than 7-fold respond to the G(i) stimulant compound 48/80 with the activation of PLD, a transient activation of phospholipase C, and enhanced membrane GTPase activity."( Compound 48/80 activates mast cell phospholipase D via heterotrimeric GTP-binding proteins.
Beaven, MA; Chahdi, A; Fraundorfer, PF, 2000
)
1.03
"Quercetin treatment alone slightly enhanced binding of AP-1 complexes to this site."( Differential effects of flavonoid compounds on tumor promoter-induced activation of the human CYP1A2 enhancer.
Pickwell, GV; Quattrochi, LC; Shih, H, 2000
)
1.03
"With quercetin treatment, these proteins were significantly reduced."( Quercetin inhibits c-fos, heat shock protein, and glial fibrillary acidic protein expression in injured astrocytes.
Wu, BY; Yu, AC, 2000
)
2.2
"Quercetin treatment of diabetic rats reversed only the diabetic effects on brain oxidized glutathione concentration and on hepatic glutathione peroxidase activity."( Effects of quercetin on antioxidant defense in streptozotocin-induced diabetic rats.
Rauscher, FM; Sanders, RA; Watkins, JB, 2001
)
1.42
"Quercetin treatment resulted in the accumulation of cells specifically at G2/M phase of the cell cycle."( Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin.
Choi, JA; Kang, CM; Kim, JY; Kim, TW; Kwon, HJ; Lee, JY; Lee, SJ; Lee, YS; Yoo, YD, 2001
)
1.26
"Quercetin pretreatment significantly inhibited NO production in an LPS-stimulated RAW 264.7 murine macrophage cell line."( The inhibitory action of quercetin on lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophage cells.
Chakravortty, D; Koide, N; Mori, I; Mu, MM; Sugiyama, T; Takahashi, K; Yokochi, T; Yoshida, T, 2001
)
1.34
"Quercetin treatment, however, resulted in a moderate increase in Cip1/p21 with no change in Kip1/p27 and a decrease in CDK4 and cyclin D1."( Differential responses of skin cancer-chemopreventive agents silibinin, quercetin, and epigallocatechin 3-gallate on mitogenic signaling and cell cycle regulators in human epidermoid carcinoma A431 cells.
Agarwal, C; Agarwal, R; Bhatia, N, 2001
)
1.26
"Quercetin-treated female medaka had a significantly increased number of atretic ovarian follicles, but no significant differences in the extent of apoptosis in intestine, liver or kidney."( Increased cellular apoptosis after chronic aqueous exposure to nonylphenol and quercetin in adult medaka (Oryzias latipes).
Hwang, GS; Janz, DM; Kiparissis, Y; Metcalfe, CD; Niimi, AJ; Weber, LP, 2002
)
1.26
"Quercetin treatment suppressed the JNK activity and ameliorated apoptosis induced by H2O2."( Inhibition of c-Jun N-terminal kinase ameliorates apoptosis induced by hydrogen peroxide in the kidney tubule epithelial cells (NRK-52E).
Araki, I; Matsushita, K; Takeda, M; Wang, L, 2002
)
1.04
"Quercetin treatment could decrease JNK activity and ameliorate H2O2-induced apoptosis."( Inhibition of c-Jun N-terminal kinase ameliorates apoptosis induced by hydrogen peroxide in the kidney tubule epithelial cells (NRK-52E).
Araki, I; Matsushita, K; Takeda, M; Wang, L, 2002
)
1.04
"Quercetin treatment, which enhanced rather than inhibited motility, depressed heat and lactate production by 50-60%."( Motility, heat, and lactate production in ejaculated bovine sperm.
Hammerstedt, RH; Racker, E; Volonté, C, 1988
)
1
"Treatment with quercetin dihydrate promoted the killing activity of T cells on MDA-MB-231 and NCI-H460 cancer cells."( Quercetin inhibiting the PD-1/PD-L1 interaction for immune-enhancing cancer chemopreventive agent.
Diao, A; Jing, L; Li, Y; Lin, J; Liu, Z; Tao, L; Yang, Y; Zhao, Q, 2021
)
2.4
"Treatment with quercetin led to an increased in"( Effect of quercetin on the pharmacokinetics of selexipag and its active metabolite in beagles.
Chen, YA; Fan, C; Gu, EM; Luo, SB; Xu, RA; Zhou, SC, 2022
)
1.46
"Pretreatment with quercetin was effective at attenuating histopathologic changes in hepatic and renal tissues by regulating the immunoexpression of caspase-3 and Bcl-2 to return them to more normal values."( Gibberellic acid-induced hepatorenal dysfunction and oxidative stress: Mitigation by quercetin through modulation of antioxidant, anti-inflammatory, and antiapoptotic activities.
Abdelhadi, AA; Alsanie, WF; Elbadawy, M; Gaber, A; Metwally, MMM; Mohamed, WA; Shukry, M; Soliman, MM, 2022
)
1.27
"Treatment with quercetin in vitro increased PON2 protein levels and prevented oxidative stress from different types of stimuli."( Airway epithelial Paraoxonase-2 in obese asthma.
Cooney, R; Holguin, F; Liu, C; Monzon, A; Saal, M; Sharma, S; Vladar, EK; Winnica, DE; Ye, S, 2022
)
1.06
"Pretreatment with quercetin, TNF-α antagonist, PP1, U0126, or Bay 11-7082 reduced TNF-α-induced p65 phosphorylation and translocation and p65-Luc activity in a dose- and time-dependent manner."( Quercetin exerts anti-inflammatory effects
Cheng, LC; Chu, MY; Hsieh, HL; Huang, TH; Tsai, MM; Yeh, TS; Yu, MC, 2022
)
2.49
"Treatment with quercetin reversed lysosomal dysfunction and promoted autophagosome-lysosome fusion, which restored defective autophagic flux and provoked autophagy."( Quercetin protects against palmitate-induced pancreatic β-cell apoptosis by restoring lysosomal function and autophagic flux.
Guan, L; Guo, L; Li, P; Liu, H; Lyu, K; Peng, L; Qiao, Y; Wang, H; Wang, Z; Yan, X; Zhai, Y; Zhang, H; Zhao, J; Zhou, W, 2022
)
2.5
"Co-treatment with quercetin and/or curcumin decreased the warfarin-induced CYP3A protein expression."( Curcumin and quercetin modify warfarin-induced regulation of porcine CYP1A2 and CYP3A expression and activity
Burkina, V; Rasmussen, MK; Zamaratskaia, G, 2022
)
1.41
"Co-treatment of quercetin 30 mg/kg/day through oral gavage for 60 days along with rotenone significantly reversed all these adverse effects, suggesting that quercetin could reduce neuroinflammation, and improve memory, and cognitive function."( Neuroprotective effect of quercetin against rotenone-induced neuroinflammation and alterations in mice behavior.
Biswas, P; Hasan, W; Jain, J; Jat, D; Yadav, RS, 2022
)
1.36
"Treatment with quercetin abrogated HFrD-induced oxidative stress, along with attenuation of NLRP3 activation in the liver."( Convergence of Fructose-Induced NLRP3 Activation with Oxidative Stress and ER Stress Leading to Hepatic Steatosis.
Ahmad, I; Ahmad, S; Gulzar, F; Guru, B; Kumar, P; Sharma, A; Singh, S; Tamrakar, AK, 2023
)
1.25
"Treatment of quercetin efficiently decreased the senescence markers in senescent BMSCs models."( Bone-targeted delivery of senolytics to eliminate senescent cells increases bone formation in senile osteoporosis.
Gao, X; Huang, H; Li, M; Liang, C; Liao, L; Ma, S; Tan, L; Tang, Q; Tian, W; Xing, X; Xu, X; Yang, J; Zou, J, 2023
)
1.26
"Treatment with quercetin, a purified product from traditional Chinese medicine (TCM) that shows effective treatment of COVID-19 patients, can significantly inhibit SARS-CoV-2 N protein-induced AKI in diabetic mice with or without underlying DKD."( Treatment with quercetin inhibits SARS-CoV-2 N protein-induced acute kidney injury by blocking Smad3-dependent G1 cell-cycle arrest.
Chen, J; Huang, XR; Lan, HY; Liang, L; Wang, W; Wang, X; Wei, B; Wu, W; Yu, X, 2023
)
1.6
"The treatment with quercetin inhibited cell proliferation of colon cancer cells in a dose-dependent manner."( A Comprehensive Study on the Anti-cancer Effects of Quercetin and Its Epigenetic Modifications in Arresting Progression of Colon Cancer Cell Proliferation.
Banerjee, A; Bhatiya, M; Duttaroy, AK; Jothimani, G; Pathak, S, 2023
)
1.48
"Treatment with quercetin-incorporated collagen matrix showed a significant decrease in thymidine phosphorylase level compared with the untreated and collagen-treated groups."( Thymidine phosphorylase as a molecular target for quercetin-incorporated collagen matrix in the prevention of hand-foot syndrome induced by capecitabine in rats.
Abdin, AA; Hedya, SE; Kotb, HM; Mashaly, ME, 2023
)
1.5
"A pretreatment with quercetin (1-1000 nM) did not effectively protect Neuroscreen-1 cells from death induced by serum starvation."( Flavonoid quercetin and its glucuronide and sulfate conjugates bind to 67-kDa laminin receptor and prevent neuronal cell death induced by serum starvation.
Aguilar, J; Gopalakrishna, R; Hou, L; Lee, E; Li, A; Mack, WJ; Oh, A, 2023
)
1.63
"Treatment with quercetin, naringenin, or rutin increased the expression and interaction of the microRNAs' hsa-miR-34a-5p, hsa-miR-30b-5p, hsa-let-7a-5p, and hsa-miR-26a-1-3p."( Evaluation of the Possible Pathways Involved in the Protective Effects of Quercetin, Naringenin, and Rutin at the Gene, Protein and miRNA Levels Using In-Silico Multidimensional Data Analysis.
Alkahtani, HM; Altwaijry, N; Wani, TA; Zargar, S, 2023
)
1.48
"Treatment with quercetin dose- and time-dependently inhibited the proliferation of HSC-T6 cells and significantly increased the total cell apoptosis rate ("( [Quercetin induces hepatic stellate cell apoptosis by inhibiting the PI3K/Akt signaling pathway
Gao, X; Jin, R; Ma, Y; Yan, Y; Zhang, C; Zhao, X, 2023
)
2.17
"Treatment with quercetin suppressed UV-induced matrix metalloproteinase-1 (MMP-1) and cyclooxygenase-2 (COX-2) expression and prevented UV-mediated collagen degradation in human skin tissues."( Quercetin Directly Targets JAK2 and PKCδ and Prevents UV-Induced Photoaging in Human Skin.
Byun, S; Hong, S; Lee, JS; Lim, TG; Shin, EJ, 2019
)
2.3
"Pre-treatment with quercetin (25 and 50 mg/kg, p.o.), piperine (2.5 mg/kg, p.o.) alone, quercetin (25 mg/kg, p.o.) in combination with piperine (2.5 mg/kg), and ropinirole (0.5 mg/kg, i.p.) was administered for 28 days 1 h prior to rotenone and iron supplement administration."( Neuroprotective Effect of Quercetin in Combination with Piperine Against Rotenone- and Iron Supplement-Induced Parkinson's Disease in Experimental Rats.
Raj, K; Sharma, S; Singh, S, 2020
)
1.18
"Treatment with quercetin increased the adiponectin level and expression of adipoR1 and nesfatin-1 and decreased both the expression of aromatase and the oestradiol level."( The phytoestrogen, quercetin, in serum, uterus and ovary as a potential treatment for dehydroepiandrosterone-induced polycystic ovary syndrome in the rat.
Jafari Khorchani, M; Neisy, A; Zal, F, 2020
)
1.23
"Treatment with quercetin 50 mg/kg attenuated the freezing, anxiety-like and depressive-like behaviors."( Quercetin attenuates acute predator stress exposure-evoked innate fear and behavioral perturbation.
Anggreini, P; Ardianto, C; Khotib, J; Rahmadi, M, 2019
)
2.3
"Pretreatment with quercetin did not influence the responses to phenylephrine and tamsulosin, in neither WKY nor SHR. "( Haemodynamic effects of the flavonoid quercetin in rats revisited.
Bast, A; Janssen, BJ; Opperhuizen, A; van Essen, H; Vrolijk, MF, 2020
)
1.16
"Co-treatment with quercetin and low dose of radiation significantly reduced the expressions of all five proteins of γ-secretase complex in HT-29 and DLD-1 cells."( Quercetin pretreatment enhances the radiosensitivity of colon cancer cells by targeting Notch-1 pathway.
Cai, Y; He, GQ; Jin, J; Li, SH; Li, Y; Wang, J; Wang, Z; Zhu, SX, 2020
)
2.32
"Rats treated with quercetin showed no changes in the protein levels of citrate synthase or cytochrome C oxidase IV or those of sirtuin 1, peroxisome proliferator-activated receptor gamma coactivator-1α or phosphorylated AMPK."( Effect of Quercetin Treatment on Mitochondrial Biogenesis and Exercise-Induced AMP-Activated Protein Kinase Activation in Rat Skeletal Muscle.
Honda, A; Koshinaka, K; Masuda, H; Sato, A, 2020
)
1.28
"Pre-treatment with quercetin significantly reversed the LPS-induced upregulation of pro-fibrotic factors (IL-6, IL-8, COL-1, COL-3, LC3) and fibrotic signaling mediators (mTOR and AKT), and it induced the downregulation of ATG5 in the WI-38 cells. "( Anti-fibrosis activity of quercetin attenuates rabbit tracheal stenosis via the TGF-β/AKT/mTOR signaling pathway.
Chen, A; Huang, G; Liu, G; Luo, L; Qin, C; Wei, P; Xiao, Y; Zhang, T; Zhou, L, 2020
)
1.19
"Treatment with quercetin showed a decrease in the inflammatory status and an increase in the oxidative status of adipose cells, thereby exhibiting its anti-inflammatory and anti-oxidative properties."( Effect of the anti-retroviral drug, rilpivirine, on human subcutaneous adipose cells and its nutritional management using quercetin.
Adem, A; Behl, S; Hussain, A; Singh, J, 2020
)
1.11
"Co-treatment with quercetin reduces pyruvate concentrations compared to TNFα-only treated controls."( Anti-Inflammatory Effects of Quercetin on High-Glucose and Pro-Inflammatory Cytokine Challenged Vascular Endothelial Cell Metabolism.
Kroon, PA; Le Gall, G; Needs, PW; Ozyel, B, 2021
)
1.24
"Treatment with quercetin and/or cisplatin was performed after 2 months of MNU induced testicular carcinogenesis."( Efficacy of Quercetin-Sensitized Cisplatin against N-Nitroso-NMethylurea Induced Testicular Carcinogenesis in Wistar Rats.
El-Diasty, HH; El-Ghaweet, HA; El-Sayyad, H; Refaat, S, 2021
)
1.34
"Treatment of quercetin with PA-1 cells also downregulates the tight junctional molecules such as Claudin-4 and Claudin-11 while upregulates the expression of occludin."( Quercetin attenuates metastatic ability of human metastatic ovarian cancer cells via modulating multiple signaling molecules involved in cell survival, proliferation, migration and adhesion.
Arunakaran, J; Dhanaraj, T; Mohan, M, 2021
)
2.42
"Treatment with quercetin improved the PCOS related disturbances in estrous cycle, lipid profile, serum levels of testosterone, estradiol and progesterone, and IR."( Therapeutic potential of quercetin in an animal model of PCOS: Possible involvement of AMPK/SIRT-1 axis.
Khadem-Ansari, MH; Mihanfar, A; Nouri, M; Roshangar, L, 2021
)
1.26
"Treatment with quercetin markedly reduced ear thickness and swelling."( Inhibitory Effect of Quercetin on Propionibacterium acnes-induced Skin Inflammation.
Jeon, YD; Jin, JS; Kang, SH; Lim, HJ; Song, YJ, 2021
)
1.28
"Treatment with quercetin and vitamin E resulted in 34% decrease of apoptogenic cytochrome c release."( Quercetin and vitamin E attenuate diabetes-induced testicular anomaly in Wistar rats via the mitochondrial-mediated apoptotic pathway.
Ojo, OO; Olorunsogo, OO, 2021
)
2.4
"Pre-treatment with quercetin and rottlerin, PKCδ signaling inhibitors, significantly suppressed the PMA-induced elevation of glucagon secretion."( Protein kinase C-δ signaling regulates glucagon secretion from pancreatic islets.
Fukui, H; Kobayashi, M; Mizuguchi, H; Sato, Y; Tamaki, M; Tokashiki, N; Yamamoto, K; Yamauchi, A, 2017
)
0.77
"Treatment with quercetin was used 15 days after the induction of preneoplastic lesions."( Quercetin Reverses Rat Liver Preneoplastic Lesions Induced by Chemical Carcinogenesis.
Baltiérrez-Hoyos, R; Carrasco-Torres, G; Martínez-Guerra, AA; Monroy-Ramírez, HC; Romero-Tlalolini, MLÁ; Sánchez-Chino, X; Vásquez-Garzón, VR; Villa-Treviño, S, 2017
)
2.24
"Treatment with quercetin significantly attenuated cell migration and invasion in HOS and MG63 cells compared with treatment with control medium."( Quercetin Inhibits Cell Migration and Invasion in Human Osteosarcoma Cells.
Bai, B; Fan, P; Hong, W; Lan, H; Qian, D; Zhu, J, 2017
)
2.24
"Pretreatment with quercetin significantly restored LPS-suppressed bone mineralization and the mRNA and protein expression levels of osteoblast-specific genes such as Osterix (OSX), runt-related transcription factor 2 (Runx2), alkaline phosphatase (ALP) and osteocalcin (OCN) in a dose-dependent manner. "( Protective Effects of Pretreatment with Quercetin Against Lipopolysaccharide-Induced Apoptosis and the Inhibition of Osteoblast Differentiation via the MAPK and Wnt/β-Catenin Pathways in MC3T3-E1 Cells.
Guo, C; Jang, K; Liu, YZ; Yang, RJ; Zhou, XL, 2017
)
1.06
"72-h treatment with quercetin induced a dose-dependent decrease of all OCR parameters (basal respiration, proton leak, ATP turnover, maximal respiration, reserve capacity) as well as of ECAR."( Quercetin exerts an inhibitory effect on cellular bioenergetics of the B164A5 murine melanoma cell line.
Ancușa, S; Danciu, C; Dehelean, C; Duicu, O; Muntean, D; Pavel, I; Sturza, A, 2018
)
2.24
"Treatment with quercetin resulted in the alleviation of cadmium-induced behavioral and neurochemical alterations."( Involvement of PKA/DARPP-32/PP1α and β- arrestin/Akt/GSK-3β Signaling in Cadmium-Induced DA-D2 Receptor-Mediated Motor Dysfunctions: Protective Role of Quercetin.
Dhuriya, YK; Gupta, R; Khanna, VK; Pandey, A; Pant, AB; Sharma, T; Shukla, RK; Siddiqi, MI; Singh, MP; Srivastava, P, 2018
)
1.02
"Treatment with quercetin and green tea induced conversion of LC3-I to LC3-II as well as activation of autophagy proteins, suggesting that quercetin and green tea initiate the autophagic progression."( Antitumor activities of Quercetin and Green Tea in xenografts of human leukemia HL60 cells.
Calgarotto, AK; Filho, PL; Junior, GCF; Maso, V; Nowill, AE; Saad, STO; Vassallo, J, 2018
)
1.13
"Treatment with quercetin in the pristane-induced LN mice model was nephroprotective, decreasing proteinuria levels and significantly lowering tissue expression of IL-6, TNF-α, TGF-β1, Bax and TBARS."( Protective effects of quercetin treatment in a pristane-induced mouse model of lupus nephritis.
Bona, SR; Bonomini, F; Dos Santos, M; Favero, G; Marroni, NP; Montanari, CC; Poletti, PT; Rezzani, R; Stacchiotti, A; Veronese, FV, 2018
)
1.14
"Treatment with quercetin-3-glucoside (suspended in water) significantly decreased neural tube defect rate and apoptosis in the embryos of diabetic mice, compared with those in the water-treated diabetic group (3.1% vs. "( Modulation of nuclear factor-κB signaling and reduction of neural tube defects by quercetin-3-glucoside in embryos of diabetic mice.
Meng, F; Reece, EA; Tan, C; Zhao, Z, 2018
)
1.06
"Treatment with quercetin significantly inhibited ROS generation, inflammation and MMP‑2 protein expression in the rat model CPR."( Quercetin protects against inflammation, MMP‑2 activation and apoptosis induction in rat model of cardiopulmonary resuscitation through modulating Bmi‑1 expression.
Jiang, XM; Liu, XL; Lou, X; Wang, D; Yang, C; Zhang, N, 2018
)
2.26
"Treatment with quercetin‑3‑methyl ether alone markedly suppressed the levels of tri‑methyl histone H3 (Lys27), but had no effect on the expression of enhancer of zeste homolog 2."( Quercetin‑3‑methyl ether suppresses human breast cancer stem cell formation by inhibiting the Notch1 and PI3K/Akt signaling pathways.
Cao, L; Li, C; Li, J; Liang, T; Lin, B; Yang, Y; Ye, Z; Zeng, J; Zhou, K, 2018
)
2.26
"Pretreatment with quercetin, rottlerin, SP600125, or Bay 11-7082 attenuated TNF-α-induced NF-κB (p65) phosphorylation, translocation and RelA/p65-Luc activity."( Anti-inflammatory property of quercetin through downregulation of ICAM-1 and MMP-9 in TNF-α-activated retinal pigment epithelial cells.
Cheng, CY; Cheng, SC; Huang, TH; Huang, WC; Pang, JS; Wu, YH, 2019
)
1.13
"The treatment of quercetin supplement to aspirin rescued the declined survival rate and weight of pups caused by L-NAME-induced pre-eclampsia."( Ameliorative effects of pre-eclampsia by quercetin supplement to aspirin in a rat model induced by L-NAME.
Ma, Y; Shi, X; Song, L; Yang, S; Zhao, N, 2019
)
1.11
"Oral treatments of quercetin and αOR at this dosage exhibited no anti-allergic effect, and IQC showed less effect than EMIQ."( Anti-allergic effects of enzymatically modified isoquercitrin (α-oligoglucosyl quercetin 3-O-glucoside), quercetin 3-O-glucoside, α-oligoglucosyl rutin, and quercetin, when administered orally to mice.
Kanemaru, M; Makino, T; Mizukami, H; Okuyama, S; Shimizu, R; Tanaka, H, 2013
)
0.94
"Co-treatment with quercetin (2.5, 5, and 10 mmol/L) dose-dependently decreased HG-induced caspase-3 activation and apoptosis."( Quercetin protects rat dorsal root ganglion neurons against high glucose-induced injury in vitro through Nrf-2/HO-1 activation and NF-κB inhibition.
Liang, XC; Qu, L; Shi, Y; Sun, Q; Wu, QL; Zhang, H, 2013
)
2.16
"Treatment with quercetin prevented the increase in AChE activity when compared to Cd/ethanol group."( Neuroprotective effect of quercetin in ectoenzymes and acetylcholinesterase activities in cerebral cortex synaptosomes of cadmium-exposed rats.
Abdalla, FH; Cardoso, AM; Fiorenza, AM; Gonçalves, JF; Gutierres, JM; Mazzanti, CM; Morsch, VM; Pereira, LB; Pimentel, VC; Schetinger, MR; Schmatz, R; Serres, JD; Stefanello, N; Vieira, JM; Zanini, D, 2013
)
1.03
"Treatment with quercetin-containing drugs, particularly, water-soluble corvitin and tableted quertin exerted favourable effect on cardiac hemodynamics, normalized systolic and diastolic function in cardiac remodeling, induced by sustained beta-adrenergic stimulation."( [Experimental therapy of cardiac remodeling with quercetin-containing drugs].
Dosenko, VE; Kuzmenko, MA; Moybenko, AA; Pavlyuchenko, VB; Tumanovskaya, LV,
)
0.73
"Treatment with quercetin rather than cisplatin resulted in a marked elevation of p16 expression in HepG2 cells."( Synergistic growth-suppressive effects of quercetin and cisplatin on HepG2 human hepatocellular carcinoma cells.
Jiao, HJ; Zhao, J; Zhao, JL, 2014
)
1.01
"Pre-treatment with quercetin ameliorated ROS and calcium release as well as NF-κB induction and expression."( Quercetin modulates OTA-induced oxidative stress and redox signalling in HepG2 cells - up regulation of Nrf2 expression and down regulation of NF-κB and COX-2.
Krishnaswamy, R; Padma, VV; Ramyaa, P, 2014
)
2.16
"Pretreatment with quercetin decreased cell viability only at the highest concentration of 37 microg/mL 2, 24, and 48 h after the treatment. "( Inhibitive effect on phagocytosis of Candida albicans induced by pretreatment with quercetin via actin cytoskeleton interference.
Bo, P; Cui, S; Qian, J, 2013
)
0.95
"Pretreatment with quercetin induced an anti-inflammatory effect against Candida albicans infection in macrophages."( Inhibitive effect on phagocytosis of Candida albicans induced by pretreatment with quercetin via actin cytoskeleton interference.
Bo, P; Cui, S; Qian, J, 2013
)
0.95
"Treatment with quercetin decreased the number of caspase-3 and TUNEL positive cells."( The protective effect of quercetin on IMA levels and apoptosis in experimental ovarian ischemia-reperfusion injury.
Coşar, E; Demirtaş, S; Gencer, M; Güngör, AN; Hacıvelioğlu, SÖ; Hancı, V; Karaca, T; Korkmaz, F; Turkon, H; Uysal, A, 2014
)
1.05
"Co-treatment with quercetin prevented reduction in T-SH, GSH, and GR activities and the rise of GST activity."( Quercetin protects the impairment of memory and anxiogenic-like behavior in rats exposed to cadmium: Possible involvement of the acetylcholinesterase and Na(+),K(+)-ATPase activities.
Abdalla, FH; Baldissarelli, J; Barbisan, F; Cardoso, AM; Carvalho, FB; da Cruz, IB; de Oliveira, JS; Dressler, VL; Gonçalves Nunes, MA; Gonçalves, JF; Mazzanti, CM; Morsch, VM; Pereira, LB; Rosa, MM; Rubin, MA; Schetinger, MR; Schmatz, R, 2014
)
2.17
"The treatment with quercetin 25 and 50 mg/kg prevented this increase in the ATP and ADP hydrolysis, while the treatment with quercetin 5, 25, and 50 mg/kg prevented the increase in the ADA activity."( Protective effect of quercetin in ecto-enzymes, cholinesterases, and myeloperoxidase activities in the lymphocytes of rats exposed to cadmium.
Abdalla, FH; Baldissarelli, J; Cardoso, AM; da Costa, P; de Oliveira, LS; Gonçalves, JF; Lhamas, CL; Martins, CC; Mazzanti, CM; Morsch, VM; Pereira, LB; Pimentel, VC; Schetinger, MR; Schmatz, R; Zanini, D, 2014
)
1.04
"Treatment with quercetin significantly decreased the levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST)."( Inhibitory effect of liposomal quercetin on acute hepatitis and hepatic fibrosis induced by concanavalin A.
Chen, LJ; Chen, XC; Tang, MH; Wan, Y; Wang, YS; Wei, YQ, 2014
)
1.03
"Treatment with quercetin reduced AKT phosphorylation, and oxidative/nitrosative stress, inflammation and lipid metabolism-related genes displayed a tendency to normalize in both in vivo and in vitro models."( Quercetin ameliorates dysregulation of lipid metabolism genes via the PI3K/AKT pathway in a diet-induced mouse model of nonalcoholic fatty liver disease.
Benet, M; Fernández, A; García-Mediavilla, MV; González-Gallego, J; Jover, R; Martínez-Ferreras, Á; Martínez-Flórez, S; Olcoz, JL; Pisonero-Vaquero, S; Sánchez-Campos, S, 2015
)
2.2
"Treatment with quercetin aglycone and PAC DP-9, which exhibited the strongest activity, induced apoptosis, led to caspase-3 activation and PARP deactivation, and increased sensitivity to cisplatin."( The cranberry flavonoids PAC DP-9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells.
Chen, E; Chichester, CO; Han, A; Moore, RG; Singh, AP; Singh, RK; Vorsa, N; Wang, Y, 2015
)
1.03
"Pre‑treatment with quercetin (5 or 10 mg/kg orally (p.o.); once daily) induced a dose‑dependent reduction in I/R‑induced hippocampal neuron cell loss, with 10 mg/kg/day being the lowest dose that achieved maximal neuroprotection."( Neuroprotective effects of quercetin in a mouse model of brain ischemic/reperfusion injury via anti-apoptotic mechanisms based on the Akt pathway.
Chao, H; Lei, X; Li, F; Li, S; Li, Z; Lv, J; Wei, H; Xue, R; Zhang, Z, 2015
)
1.03
"Treatment with quercetin decreased body weight, serum insulin, and ceruloplasmin levels as compared with untreated mice."( Quercetin Affects Erythropoiesis and Heart Mitochondrial Function in Mice.
Barreto, M; Elorza, AA; Jensen, E; Quintanilla, RA; Ruiz, LM; Ruiz, PA; Salazar, C; Tiznado, W, 2015
)
2.2
"Treatment with quercetin, quercetin 3-O-glucoside, and quercetin 7-O-glucoside differentially suppressed epidermal growth factor-induced migration activity of human pancreatic cancer cells."( Quercetin 3-O-glucoside suppresses epidermal growth factor-induced migration by inhibiting EGFR signaling in pancreatic cancer cells.
Han, SI; Kim, JH; Lee, J; Yun, JH, 2015
)
2.2
"Treatment with quercetin alleviated the decline in renal function, and the progression of renal fibrosis and inhibited mTORC1/p70S6K activation in the diabetic renal cortex."( Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy.
Ji, XJ; Liu, YQ; Lu, Q; Yao, XQ; Yin, XX; Zhang, F; Zhou, YX, 2015
)
2.2
"Pretreatment with quercetin or hydroxytyrosol attenuated the phosphorylation of MAPKAPK-2 and cleaved caspase-3 in X/XO-exposed cells (p < 0.01, vs."( Quercetin and hydroxytyrosol attenuates xanthine/xanthine oxidase-induced toxicity in H9c2 cardiomyocytes by regulation of oxidative stress and stress-sensitive signaling pathways.
Bali, EB; Karasu, C; Ozbek, N, 2015
)
2.18
"The treatment with quercetin did not modify body weight gain but uterine (296.7 ± 5.11 versus 263.0 ± 8.60 mg) and ovary weights (49.5 ± 1.93 versus 37.8 ± 3.43 mg) were found to be decreased significantly (p <0.05) as compared with the PCOS control group. "( Phosphatidylinositide 3-kinase inhibition: A new potential target for the treatment of polycystic ovarian syndrome.
Patel, SS; Shah, KN, 2016
)
0.76
"Co-treatment with quercetin (all doses) also exhibited enhanced acquisition and retention memory compared to control."( Quercetin Modulates the Effects of Chromium Exposure on Learning, Memory and Antioxidant Enzyme Activity in F1 Generation Mice.
Banerjee, BD; Bhattacharya, SK; Halder, S; Kar, R; Mediratta, PK; Mehta, AK, 2016
)
2.2
"Treatment of quercetin-3-O-glucoside suppressed the migratory activity induced by TGF-β and VEGF-A even at relatively low dosages in CFPAC-1, but not in bFGF-activated SNU-213 cells."( Quercetin-3-O-glucoside suppresses pancreatic cancer cell migration induced by tumor-deteriorated growth factors in vitro.
Kim, JH; Kim, SJ; Lee, J, 2016
)
2.23
"Treatment with quercetin caused DNA damage in HepG2, Hep3B2.1-7, and TFK-1 cell lines."( New Approach for Treatment of Primary Liver Tumors: The Role of Quercetin.
Abrantes, AM; Botelho, MF; Brito, AF; Casalta-Lopes, JE; Gonçalves, AC; Laranjo, M; Mamede, AC; Ribeiro, M; Sarmento-Ribeiro, AB; Tralhão, JG, 2016
)
1.01
"Treatment of quercetin with CP (7.5 mg/kg) prevents the CP-induced nephrotoxicity along with enhance the anticancer activity confirmed by the reduction of aberrant crypt foci number."( Enhanced therapeutic efficacy and amelioration of cisplatin-induced nephrotoxicity by quercetin in 1,2-dimethyl hydrazine-induced colon cancer in rats.
Hu, GR; Li, QC; Liang, Y; Tian, Y,
)
0.71
"Treatment with quercetin at 15μM had a similar effect as the RQC combination in the inhibition of BC cell proliferation, apoptosis, and migration."( Anti-Breast Cancer Potential of Quercetin via the Akt/AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Cascade.
Castillo-Pichardo, L; Dharmawardhane, S; Gerena, Y; Rivera Rivera, A, 2016
)
1.06
"Treatment with quercetin did not significantly alter HIF-1α levels, but did reduce AaPO2 as well as lung tissue NF-κB activity, VEGFA gene and protein levels, Akt activity, and angiogenesis."( Quercetin alleviates pulmonary angiogenesis in a rat model of hepatopulmonary syndrome.
Chen, Y; Li, X; Liu, A; Shang, G; Wang, L; Zhang, C; Zhang, H; Zhao, Z, 2016
)
2.22
"Pretreatment with quercetin (20 μM; 24 h before trauma plasma addition) significantly attenuated trauma-induced viability decreases, TNF-α increases, ROS overproduction and [Ca(2+)]i overload in H9c2 cells."( Protective Effect of Quercetin on Posttraumatic Cardiac Injury.
Bi, Y; Cao, T; Chen, X; Jing, Z; Li, S; Li, X; Wang, Z; Yu, D; Zhou, J; Zhu, L, 2016
)
1.08
"Pretreatment with quercetin (3, 10, 30 μmol/L) dose-dependently inhibited excessive histamine release from paclitaxel-stimulated RBL-2H3 cells in vitro, and quercetin administration significantly suppressed the high plasma histamine levels in paclitaxel-treated rats. "( Quercetin ameliorates paclitaxel-induced neuropathic pain by stabilizing mast cells, and subsequently blocking PKCε-dependent activation of TRPV1.
Gao, W; Hu, XY; Huang, F; Wang, ZJ; Zan, Y, 2016
)
2.21
"Pretreatment with quercetin and simvastatin treatment in the hyperlipidemic groups significantly (P<0.05) increased AChE activity compared with the hyperlipidemic group."( Neuroprotective effects of pretreatment with quercetin as assessed by acetylcholinesterase assay and behavioral testing in poloxamer-407 induced hyperlipidemic rats.
Adefegha, SA; Braun, JBS; Castilhos, LG; Coelho, APV; de Andrade, CM; Dornelles, GL; Leal, DBR; Oliveira, JS; Rubin, MA; Ruchel, JB; Signor, C; Trelles, KB, 2017
)
1.04
"Treatment with quercetin nanoparticle effectively inhibited the liver cancer cell proliferation, cell migration and colony formation, thus suppressing liver cancer progression."( Quercetin nanoparticles display antitumor activity via proliferation inhibition and apoptosis induction in liver cancer cells.
Han, XW; Li, YH; Li, ZM; Lu, HB; Ren, JZ; Ren, KW; Wu, G, 2017
)
2.24
"Treatment with quercetin in patients receiving doxorubicin and cyclophosphamide results in therapeutic restoration of homeostatic expression of the antioxidant parameters, reducing oxidative damage to the liver and kidney."( Protective Effect of Quercetin Against Oxidative Stress-induced Toxicity Associated With Doxorubicin and Cyclophosphamide in Rat Kidney and Liver Tissue.
Dogan, Z; Erdemli, E; Kocahan, S; Taskin, E, 2017
)
1.11
"Treatment with quercetin dose-dependently upregulated the expression of HO-1 mRNA in the bone marrow cells."( The changes of antioxidant defense system caused by quercetin administration do not lead to DNA damage and apoptosis in the spleen and bone marrow cells of rats.
Bzowska, M; Cierniak, A; Jozkowicz, A; Krzysciak, W; Papiez, MA; Piskula, M; Taha, HM, 2008
)
0.94
"Pretreatment with quercetin (20 and 40 mg/kg, i.p.) significantly reversed immobilized stress-induced anxiety and analgesia and reduced locomotor activity."( Quercetin protects against acute immobilization stress-induced behaviors and biochemical alterations in mice.
Goyal, R; Kumar, A, 2008
)
2.11
"Upon treatment with quercetin, the protein level of survivin was strongly suppressed in U87-MG, U251, and A172 but not in U373 glioma cells."( Quercetin promotes degradation of survivin and thereby enhances death-receptor-mediated apoptosis in glioma cells.
Habel, A; Rami, A; Reuss, DE; Siegelin, MD; von Deimling, A, 2009
)
2.11
"Treatment with quercetin can induce p53 target genes such as PUMA and p21."( Isolation of a chemical inhibitor against K-Ras-induced p53 suppression through natural compound screening.
Chung, HY; Jung, YS; Lee, SH; Lee, SJ; Park, BJ, 2009
)
0.69
"Pretreatment with quercetin alone and alpha-tocopherol alone showed significant effect in all the biochemical parameters in myocardial infarcted rats."( Combined effects of quercetin and alpha-tocopherol on lipids and glycoprotein components in isoproterenol induced myocardial infarcted Wistar rats.
Prince, PS; Punithavathi, VR, 2009
)
1
"Treatment of quercetin (5 mg/kg i.p."( Quercetin improves cognitive deficits in rats with chronic cerebral ischemia and inhibits voltage-dependent sodium channels in hippocampal CA1 pyramidal neurons.
Han, DD; Yang, Z; Yao, Y; Zhang, T, 2010
)
2.16
"Treatment with Quercetin reduced infectious particle production at nontoxic concentrations."( The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production.
Arumugaswami, V; Dasgupta, A; Fontanes, V; French, SW; Gonzalez, O; Loo, J; Loo, R; Raychaudhuri, S; Sun, R, 2009
)
0.97
"Pretreatment with quercetin resulted in the reduction of arsenite-induced expression of COX-2 and production of PGE(2)."( Protective effect of quercetin against arsenite-induced COX-2 expression by targeting PI3K in rat liver epithelial cells.
Hwang, MK; Lee, DE; Lee, HJ; Lee, KM; Lee, KW, 2010
)
1
"Pretreatment with quercetin (10 micromol/L; 30 minutes) prior to H(2)O(2) prevented the loss of ZO-1 and occludin."( Protective effect of quercetin on hydrogen peroxide-induced tight junction disruption.
Chuenkitiyanon, S; Jianmongkol, S; Pengsuparp, T, 2010
)
1
"Treatment with quercetin promoted lymphocyte proliferation and regulated Th1/Th2 cytokine imbalance."( Dietary quercetin combining intratumoral doxorubicin injection synergistically induces rejection of established breast cancer in mice.
Du, G; Han, G; Ji, L; Lin, H; Lu, L; Wang, M; Wu, X; Yang, Y; Yu, L; Zhang, S, 2010
)
1.13
"Treatment with quercetin (5-20 mg/kg, p.o., twice daily, 30 days) in streptozotocin-induced diabetic rats prevented the changes in blood glucose, body weight, and performance in Morris water and elevated plus maze tasks."( Ameliorative effect of quercetin on memory dysfunction in streptozotocin-induced diabetic rats.
Bansod, K; Bhutada, C; Bhutada, P; Dixit, P; Mundhada, D; Mundhada, Y; Tawari, S, 2010
)
1.01
"Pretreatment with quercetin or thalidomide significantly attenuated the severity of cerulein-induced acute pancreatitis as evidenced by effective reductions in the pancreatic wet weight/body weight ratio, biochemical indices, proinflammatory cytokines, myeloperoxidase activity, malondialdehyde formation, and an increase in antiinflammatory cytokine IL-10."( The natural flavonoid quercetin ameliorates cerulein-induced acute pancreatitis in mice.
Carvalho, KM; de Andrade, GM; de Castro Brito, GA; de Melo, TS; Morais, TC; Rao, VS; Santos, FA, 2010
)
1
"Pretreatment with quercetin offered neuroprotection against 6-OHDA-induced PC12 cell death."( Quercetin exerts a neuroprotective effect through inhibition of the iNOS/NO system and pro-inflammation gene expression in PC12 cells and in zebrafish.
Cheang, LC; Lee, SM; Wang, MW; Zhang, ZJ, 2011
)
2.14
"Pre-treatment with quercetin significantly reduced the frequency of mitomycin C (MMC) induced MN as well as CA, but no clear correlation between the dose and effect could be observed."( Role of quercetin on mitomycin C induced genotoxicity: analysis of micronucleus and chromosome aberrations in vivo.
Giri, A; Giri, S; Mazumdar, M, 2011
)
1.12
"Co-treatment with quercetin partially prevented all the renal effects of cisplatin, whereas it did not impair its anti-tumour activity. "( Quercetin reduces cisplatin nephrotoxicity in rats without compromising its anti-tumour activity.
Lopez-Hernandez, FJ; Lopez-Novoa, JM; Morales, AI; Perez-Barriocanal, F; Sanchez-Gonzalez, PD, 2011
)
2.15
"Pretreatment with quercetin, rutin or okra extract prevented the reduction in NMDA receptor expression."( Neuroprotective effects of quercetin, rutin and okra (Abelmoschus esculentus Linn.) in dexamethasone-treated mice.
Chantiratikul, P; Govitrapong, P; Kongbuntad, W; Pakdeenarong, N; Ruksee, N; Tongjaroenbuangam, W, 2011
)
0.99
"Pretreatment with quercetin (70 mg/kg/day/6 weeks) and its coadministration with acrylonitrile prevented acrylonitrile-induced alterations in hepatic lipid peroxides and enzymatic antioxidants as well as serum aminotransferases and bilirubin."( Hepatoprotective activity of quercetin against acrylonitrile-induced hepatotoxicity in rats.
Abd-Ellah, MF; Abo-Salem, OM; Ghonaim, MM,
)
0.75
"Treatment with quercetin improved these parameters except blood glucose."( Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-β1 and connective tissue growth factor in streptozotocin-induced diabetic rats.
Lai, PB; Yang, LY; Zhang, L, 2012
)
2.16
"Cotreatment of quercetin along with lindane significantly decreased the lindane induced alteration in histology, serum hepatic and renal markers and MDA and also improved the cellular antioxidant status."( Quercetin attenuates lindane induced oxidative stress in Wistar rats.
Baskaran, R; Padma, VV; Poornima, P; Roopesh, RS, 2012
)
2.16
"Cotreatment of quercetin with pyrrolidine dithiocarbamate (PDTC), an inhibitor of NF-κB activation, suggest that the effects of quercetin are partially mediated by NF-κB signaling."( Quercetin suppresses NF-κB and MCP-1 expression in a high glucose-induced human mesangial cell proliferation model.
Chen, P; Chen, W; Shi, Q; Wang, H; Wang, Y; Xu, X, 2012
)
2.16
"The treatment of quercetin and allopurinol regulated renal urate transport-related proteins to reduce hyperuricemia, and lipid metabolism-related genes to alleviate kidney lipid accumulation in STZ-treated rats."( Quercetin and allopurinol ameliorate kidney injury in STZ-treated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation.
Kong, LD; Pan, Y; Wang, C; Wang, FM; Zhang, QY, 2012
)
2.15
"Mice treated with quercetin exhibited a 32.7% reduction in aortic size compared with vehicle-treated controls."( Quercetin, a flavonoid with anti-inflammatory activity, suppresses the development of abdominal aortic aneurysms in mice.
Jing, H; Li, H; Liu, X; Lu, H; Qiu, F; Wang, B; Wang, G; Wang, L; Wu, H; Xiong, L; Xu, Y, 2012
)
2.15
"Treatment with quercetin either before or after LPS preserved the vascular function, as blood pressure, heart rate, vascular responsiveness were restored to near normal values, particularly when quercetin was given as a preventive regimen."( Preventive and therapeutic effects of quercetin on lipopolysaccharide-induced oxidative stress and vascular dysfunction in mice.
Donpunha, W; Kukongviriyapan, U; Kukongviriyapan, V; Pannangpetch, P; Sompamit, K, 2012
)
0.99
"Treatment with quercetin reduces oxidation and inflammation and also prevents liver fibrosis, through induction of HSC apoptosis and activation of MMPs."( Quercetin improves hepatic fibrosis reducing hepatic stellate cells and regulating pro-fibrogenic/anti-fibrogenic molecules balance.
Alcántar-Díaz, BE; Armendariz-Borunda, J; Bueno-Topete, M; Hernández-Ortega, LD; Ruiz-Corro, LA; Salazar-Montes, AM; Sandoval-Rodriguez, A, 2012
)
2.17
"Co-treatment with quercetin (60 mg/kg bw) and BPA (low dose and high dose) alleviates the changes in body weight, as well as absolute and relative organ weights of mice."( Testing the efficacy of quercetin in mitigating bisphenol A toxicity in liver and kidney of mice.
Sangai, NP; Trivedi, MH; Verma, RJ, 2014
)
1.03
"Treatment with quercetin partially reversed these changes."( Aberrantly activated EGFR contributes to enhanced IL-8 expression in COPD airways epithelial cells via regulation of nuclear FoxO3A.
Angel, KA; Comstock, AT; Ganesan, S; Mancuso, P; Martinez, FJ; Sajjan, US; Unger, BL, 2013
)
0.73
"Pre-treatment with quercetin for 3weeks suppressed TDI-induced nasal allergy-like symptoms and elevation of H1R mRNA in the nasal mucosa of TDI-sensitized rats."( Quercetin inhibits transcriptional up-regulation of histamine H1 receptor via suppressing protein kinase C-δ/extracellular signal-regulated kinase/poly(ADP-ribose) polymerase-1 signaling pathway in HeLa cells.
Baba, Y; Fukui, H; Hattori, M; Kitamura, Y; Kobayashi, M; Mizuguchi, H; Nakano, T; Ono, S; Sasaki, Y; Takeda, N; Zhang, Q, 2013
)
2.15
"Treatment with quercetin resulted in a significant decrease in prostaglandin E2 and cyclooxygenase-2 levels as well as inducible nitric oxide synthase-mediated nitric oxide production induced by lipopolysaccharide."( Quercetin negatively regulates TLR4 signaling induced by lipopolysaccharide through Tollip expression.
Byun, EB; Byun, EH; Choi, HG; Sin, SJ; Song, DS; Sung, NY; Yang, MS, 2013
)
2.17
"Treatment of quercetin showed potent inhibitory effects on the DNA synthesis of cultured HASMC in the presence of TNF-alpha."( Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of ERK1/2, cell-cycle regulation, and matrix metalloproteinase-9.
Cho, GO; Gal, SW; Jung, SY; Kim, CH; Kwon, TK; Lee, YC; Madamanchi, NR; Moon, SK, 2003
)
2.11
"Pretreatment with quercetin significantly enhanced cell survival (LDH release, 5.4 +/- 2.7% for UW and 8.4 +/- 4.2% for EC) in a concentration dependent manner."( Bioflavonoids attenuate renal proximal tubular cell injury during cold preservation in Euro-Collins and University of Wisconsin solutions.
Ahlenstiel, T; Burkhardt, G; Köhler, H; Kuhlmann, MK, 2003
)
0.64
"Pretreatment by quercetin suppressed the arginase activity in the liver (p < 0.05) and plasma levels of urea (p < 0.01)."( Role of quercetin on hepatic urea production in acute renal failure.
Cvetković, T; Nikolić, J; Sokolović, D, 2003
)
1.09
"Treatment with quercetin during 3 weeks improved liver histology and reduced collagen content, iNOS expression, and lipid peroxidation."( Effects of quercetin on liver damage in rats with carbon tetrachloride-induced cirrhosis.
González-Gallego, J; Llesuy, S; Marroni, CA; Marroni, N; Pavanato, A; Sánchez-Campos, S; Tuñón, MJ, 2003
)
1.05
"Pretreatment (quercetin 25, 50 and 75 mg/kg body weight for 15 d+co-treatment of ethanol 18%+quercetin for 15 d and ethanol 18% for the 15 d) increased the activities of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (GR), and glutathione (GSH) in comparison to the ethanol group."( Quercetin, a flavonoid antioxidant, prevents and protects against ethanol-induced oxidative stress in mouse liver.
Benedi, J; Iglesias, I; Molina, MF; Sanchez-Reus, I, 2003
)
2.11
"Pretreatment with quercetin significantly alleviated this increase."( Effect of quercetin on daunorubicin-induced heart mitochondria changes in rats.
Chavková, Z; Dubayová, K; Guzy, J; Kusnír, J; Mareková, M; Mirossay, L; Mojzis, J; Mojzisová, G, 2003
)
1.04
"Treatment with quercetin significantly attenuated renal dysfunction and oxidative stress in diabetic rats."( Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats.
Anjaneyulu, M; Chopra, K, 2004
)
2.11
"Pretreatment with quercetin dose-dependently (25-100 mg/kg p.o.) reduced the catalepsy score in haloperidol-treated animals."( Quercetin, a bioflavonoid, reverses haloperidol-induced catalepsy.
Kulkarni, SK; Naidu, PS, 2004
)
2.09
"Treatment with Quercetin enhanced cytotoxicity of Topotecan as 1.4-fold in MCF-7 and 1.3-fold in MDA-MB-231 cell line."( The effect of quercetin on topotecan cytotoxicity in MCF-7 and MDA-MB 231 human breast cancer cells.
Akbas, SH; Ozben, T; Timur, M, 2005
)
1.03
"Pretreatment with quercetin (10microM, 20min) increased ACh-induced relaxation and decreased PE-induced contraction in diabetic, but did not affect euglycemic rat aortic ring responses."( Effect of quercetin on altered vascular reactivity in aortas isolated from streptozotocin-induced diabetic rats.
Achike, FI; Ajay, M; Mustafa, AM; Mustafa, MR, 2006
)
1.06
"Pretreatment with quercetin and the PI 3-kinase inhibitor LY294002 each reduced TNF-alpha-induced IL-8 and monocyte chemoattractant protein (MCP)-1 (also called CCL2) expression in cultured human airway epithelial cells."( Quercetin blocks airway epithelial cell chemokine expression.
Andrade, JE; Burgess, JR; Hershenson, MB; Lukacs, NW; Nanua, S; Sajjan, US; Zick, SM, 2006
)
2.1
"Mice treated with quercetin showed attenuated brain MMP-9 activity."( Protective effect of quercetin, a natural flavonoid against neuronal damage after transient global cerebral ischemia.
Cho, JY; Jang, YH; Kim, AR; Kim, IS; Lee, SR, 2006
)
0.98
"Treatment with quercetin attenuated these alterations."( Comparative study of multiple dosage of quercetin against cisplatin-induced nephrotoxicity and oxidative stress in rat kidneys.
Antunes, LM; Behling, EB; Bianchi, Mde L; Costa, RS; Francescato, HD; Sendão, MC,
)
0.74
"Treatment with quercetin significantly improved arterial blood pressure and peripheral vascular resistance."( Protective effects of quercetin against phenylhydrazine-induced vascular dysfunction and oxidative stress in rats.
Kukongviriyapan, U; Kukongviriyapan, V; Luangaram, S; Pakdeechote, P; Pannangpetch, P, 2007
)
0.99
"Treatment with quercetin and catechin could eliminate reactive oxygen species (ROS) to reduce oxidative stress stimulated by S100B in THP-1 cells."( Effects of flavonoids on the expression of the pro-inflammatory response in human monocytes induced by ligation of the receptor for AGEs.
Huang, SM; Wu, CH; Yen, GC, 2006
)
0.67
"Treatment with quercetin resulted in a significant decrease in Na+ and Ca2+ and aldose reductase levels and an increase in K+ and protein levels in galactosemic cataractous lenses."( Defensive role of quercetin against imbalances of calcium, sodium, and potassium in galactosemic cataract.
Kumar, VV; Raju, TN; Ramana, BV; Reddy, PU, 2007
)
1.01
"Treatment with quercetin and kaempferol prevented the production of peroxides, superoxide anion and nitric oxide induced by CM."( Differential effects of dietary flavonoids on reactive oxygen and nitrogen species generation and changes in antioxidant enzyme expression induced by proinflammatory cytokines in Chang Liver cells.
Almar, M; Crespo, I; García-Mediavilla, MV; González, P; González-Gallego, J; Sánchez-Campos, S; Tuñón, MJ, 2008
)
0.69
"Oral treatment with quercetin protected ABD2F1/Jena mice significantly against intraperitoneal encephalomyocarditis, Col, SK, MM, Mengo M,L and MengoM virus infections, but not against intracerebral challenge with MengoM virus. "( Mechanism of antiviral action of quercetin against cardiovirus infection in mice.
Pusztai, R; Veckenstedt, A, 1981
)
0.87
"Treatment with quercetin of K562, Molt-4, Raji, and MCAS tumor cell lines resulted in morphological changes, including propidium iodide-stained condensed nuclei (intact or fragmented), condensation of nuclear chromatin, and nuclear fragmentation."( Induction of apoptosis by quercetin: involvement of heat shock protein.
Fukata, H; Kariya, Y; Teshigawara, K; Uchida, A; Wei, YQ; Zhao, X, 1994
)
0.93
"Treatment with quercetin caused a dose-dependent increase in the yield of AOM-induced tumors in the colon from 0.06 +/- 0.04 adenocarcinoma/rat to 0.64 +/- 0.12 and 1.14 +/- 0.17 for the low and high dose groups, respectively."( Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats.
Barnes, LH; Eto, I; Grubbs, CJ; Juliana, M; Kelloff, GJ; Li, H; Lubet, RA; Olson, GR; Pereira, MA; Steele, VE; Whitaker, LM, 1996
)
0.89
"Pretreatment with quercetin protected mesangial cells from hydrogen peroxide (H2O2)-induced apoptosis."( Unexpected protection of glomerular mesangial cells from oxidant-triggered apoptosis by bioflavonoid quercetin.
Kitamura, M; Yokoo, T, 1997
)
0.84
"Pretreatment with quercetin or curcumin resulted in preservation of histological integrity, with a decrease in tubular damage and interstitial inflammation. "( Effect of bioflavonoids quercetin and curcumin on ischemic renal injury: a new class of renoprotective agents.
Shoskes, DA, 1998
)
0.94
"Treatment by quercetin (5 mg/kg i.v.) of intact and ischemia-reperfusion groups did not significantly change the signal amplitude in the cerebellum, but did double it in the cortex (to 76% of control) for the ischemia-reperfusion group (P < 0.05)."( Influence of the antioxidant quercetin in vivo on the level of nitric oxide determined by electron paramagnetic resonance in rat brain during global ischemia and reperfusion.
Berthet, F; Girard, P; Henry, Y; Pinard, E; Potier, P; Sercombe, R; Seylaz, J; Shutenko, Z, 1999
)
0.95
"Pretreatment with quercetin provided protection from structural and functional cell damage in a concentration-dependent manner (10-100 microM)."( Inhibition of oxidant-induced lipid peroxidation in cultured renal tubular epithelial cells (LLC-PK1) by quercetin.
Burkhardt, G; Horsch, E; Köhler, H; Kuhlmann, MK; Wagner, M, 1998
)
0.84
"Pretreatment with quercetin (200 mg x kg(-1)per os) 2 h before LPS injection diminished the shock-induced increases in brain MDA, and NO(x)levels while elevating the reduced brain phospholipids' and serum SH groups' content."( Quercetin, coenzyme Q10, and L-canavanine as protective agents against lipid peroxidation and nitric oxide generation in endotoxin-induced shock in rat brain.
Abd El-Gawad, HM; Khalifa, AE, 2001
)
2.08
"Post-treatment with quercetin partially inhibited NO production."( The inhibitory action of quercetin on lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophage cells.
Chakravortty, D; Koide, N; Mori, I; Mu, MM; Sugiyama, T; Takahashi, K; Yokochi, T; Yoshida, T, 2001
)
0.93
"Treatment with quercetin alone resulted in an apparent decrease of hsp70-positive cells and an increase of subG1 cells in JCA-1 and LNcap cells. "( Effects of quercetin on the heat-induced cytotoxicity of prostate cancer cells.
Deguchi, N; Hirata, R; Iida, M; Nakanoma, T; Ueno, M, 2001
)
1.05
"Treatment with quercetin inhibited the binding of HSF to the HSE in whole-cell extracts activated in vivo by heat shock and in cytoplasmic extracts activated in vitro by elevated temperature or by urea."( Inhibition of the activation of heat shock factor in vivo and in vitro by flavonoids.
Aoike, A; Hirayoshi, K; Hosokawa, N; Kawai, K; Kudo, H; Nagata, K; Takechi, H, 1992
)
0.62
"Pretreatment with quercetin improved coronary stenosis, removing the second phase (15-60 min) of capacity vessel dilatation reaction (blood deposition)."( [Role of leukotrienes in shock of immune origin].
Sagach, VF, 1986
)
0.59

Toxicity

Quercetin and myricetin, both of which produce superoxide on autoxidation, appeared to be more toxic than kaempferol. Tamarixetin quinone prefers to pass reactivity to the antioxidant network, i.e. rather than adduction to CK.

ExcerptReferenceRelevance
" At interim evaluations at 6 and 15 months, treatment-related toxic lesions were not observed, but at 2 years toxic and neoplastic lesions were seen in the kidney of male rats, including increased severity of chronic nephropathy, hyperplasia, and neoplasia of the renal tubular epithelium."( Toxicity and carcinogenicity studies of quercetin, a natural component of foods.
Dunnick, JK; Hailey, JR, 1992
)
0.55
" In addition, as assessed by trypan blue exclusion, quercetin and myricetin, both of which produce superoxide on autoxidation, appeared to be more toxic than kaempferol."( The toxicity of flavonoids to guinea pig enterocytes.
Canada, AT; Nguyen, TD; Watkins, WD, 1989
)
0.53
"Bracken fern (Pteridium aquilinum) causes acute and chronic toxicity in animals and is associated with a high incidence of stomach and esophageal tumors in humans in countries where it is consumed as food, yet the toxic constituent(s) has not been unequivocally identified."( Genotoxicity studies of quercetin and shikimate in vivo in the bone marrow of mice and gastric mucosal cells of rats.
Jones, RS; Ngomuo, AJ, 1996
)
0.6
" In in vitro experiments, it was demonstrated that estradiol protects cells against the toxic effects of beta-amyloid, the major component of plaques in brains of AD patients."( Phytoestrogen kaempferol (3,4',5,7-tetrahydroxyflavone) protects PC12 and T47D cells from beta-amyloid-induced toxicity.
Hertel, C; Roth, A; Schaffner, W, 1999
)
0.3
" Morphological observation by phase contrast microscopy revealed that both crocetin and quercetin caused intense damage only on the malignant (RD) cells, whereas mild toxic effect was seen with cisplatin also on normal (Vero) cells."( In vitro studies on the selective cytotoxic effect of crocetin and quercetin.
Gunasekaran, P; Jagadeeswaran, R; Ramamurty, N; Sakthisekaran, D; Thirunavukkarasu, C, 2000
)
0.77
"Amyloid beta protein (Abeta) elicits a toxic effect on neurons in vitro and in vivo."( The neuroprotective effects of phytoestrogens on amyloid beta protein-induced toxicity are mediated by abrogating the activation of caspase cascade in rat cortical neurons.
Chen, CF; Chi, CW; Lin, YL; Shiao, YJ; Wang, CN, 2001
)
0.31
" It is primarily considered as a neurotoxin but its other toxic manifestations are also well documented."( Pharmacological interventions of cyanide-induced cytotoxicity and DNA damage in isolated rat thymocytes and their protective efficacy in vivo.
Bhattacharya, R; Lakshmana Rao, PV, 2001
)
0.31
"Cadmium chloride at concentrations of 10-50mM and acetaldehyde (AA) at 1-5mM showed synergistic toxic effects on V79 cells in vitro."( Synergistic effect of cadmium chloride and acetaldehyde on cytotoxicity and its prevention by quercetin and glycyrrhizin.
Chen, WK; Hu, CC; Lee, YJ; Liao, PH; Yu, WC, 2001
)
0.53
" With the exception of 5-O-PN, all the other naringenins showed only weak toxic effects at concentrations below 50 micromol/l."( Toxicity and cell cycle effects of synthetic 8-prenylnaringenin and derivatives in human cells.
Gutzeit, HO; Henker, Y; Metz, P; Schwab, P; Tokalov, SV, 2004
)
0.32
" Safety was assessed through concomitant medications, adverse events, laboratory evaluations, and physical examinations."( A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy. A preliminary report.
Farez, C; Khodabandehlou, T; Le Devehat, C; LeFante, C; Richard, JL; Rosenbloom, RA; Valensi, P,
)
0.13
" Eleven patients in the QR-333 group reported 23 adverse events (all mild or moderate); 4 in the placebo group reported 5 events (all moderate)."( A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy. A preliminary report.
Farez, C; Khodabandehlou, T; Le Devehat, C; LeFante, C; Richard, JL; Rosenbloom, RA; Valensi, P,
)
0.13
" These data indicate that heat shock protects cells from the toxic effect of MPP(+) and paraquat."( Heat shock proteins protect both MPP(+) and paraquat neurotoxicity.
Donaire, V; Fuentes, JM; García, L; González-Polo, RA; Morán, JM; Niso, M; Soler, G, 2005
)
0.33
" For these agents, normal dietary intake, doses used in clinical trials, efficacious doses in rodents, and where available, toxic doses are compared."( Putative cancer chemopreventive agents of dietary origin-how safe are they?
Gescher, AJ; Steward, WP; Verschoyle, RD, 2007
)
0.34
"Diesel exhaust particles (DEPs) are particulate matter from diesel exhaust that contain many toxic compounds, such as polyaromatic hydrocarbons (PAHs)."( Alleviative effects of quercetin and onion on male reproductive toxicity induced by diesel exhaust particles.
Aizawa, K; Inakuma, T; Izawa, H; Kohara, M; Sagai, M; Suganuma, H; Taya, K; Watanabe, G, 2008
)
0.66
" We detected a time-dependent action of quercetin and distinguished an early protective effect from a late toxic one."( Time-dependent protective and harmful effects of quercetin on 6-OHDA-induced toxicity in neuronal SH-SY5Y cells.
Kääräinen, TM; Männistö, PT; Ossola, B; Raasmaja, A, 2008
)
0.87
" On oxidation, polyphenols with B-ring catechol functionality form toxic alkylating quinones that are normally inactivated by cellular antioxidant defense and redox maintenance systems, including reduction by ascorbate and NAD(P)H:quinone oxidoreductase 1 (NQO1)."( Polyphenol cytotoxicity induced by the bacterial toxin pyocyanin: role of NQO1.
Muller, M, 2009
)
0.35
"Q proved to be toxic and did not exert complete protection against As, and only S was able to protect cells from As-induced oxidative death, which started after 4h with caspase activation and phosphatidylserine exteriorization on the outer cellular membrane."( Cytoprotective effects of silymarin on epithelial cells against arsenic-induced apoptosis in contrast with quercetin cytotoxicity.
Bongiovanni, GA; Eynard, AR; Soria, EA, 2010
)
0.57
" Based on the above findings, the no observed adverse effect level (NOAEL) was estimated to be 1% in both sexes (542."( Fifty-two week chronic toxicity of enzymatically decomposed rutin in Wistar rats.
Hayashi, M; Kasahara, H; Kobayashi, S; Kuroda, J; Mitsumori, K; Muto, S; Nagasawa, T; Okuhara, Y; Onozato, T; Tamura, T,
)
0.13
" It is obvious that hawthorn, particularly flavonoids constituents with antioxidative activity, reduced the oxidative stress and genotoxicity induced by toxic compounds."( Protective effect of hawthorn extract against genotoxicity induced by methyl methanesulfonate in human lymphocytes.
Azadbakht, M; Hosseinimehr, SJ; Mahmodzadeh, A; Mohammadifar, S; Tanha, M, 2011
)
0.37
"Cadmium is a toxic heavy metal that is widely distributed in the environment."( Protective effect of quercetin on cadmium-induced oxidative toxicity on germ cells in male mice.
Bu, T; Mi, Y; Zeng, W; Zhang, C, 2011
)
0.69
" In conclusion, TCDD caused an adverse effect on rat's liver."( Effects of quercetin and chrysin on 2,3,7,8-tetrachlorodibenzo-p-dioxin induced hepatotoxicity in rats.
Ciftci, O; Ozdemir, I; Vardi, N, 2013
)
0.78
" In H2O2 plus quercetin co-treated groups, both 75 and 100 μM quercetin attenuated toxic effect of H2O2 by 15%."( Quercetin both partially attenuates hydrogen peroxide-induced toxicity and decreases viability of rat glial cells.
Durmaz, R; Kabadere, S; Oztopcu-Vatan, P; Uyar, R, 2011
)
2.17
" These results suggest that LTC exerts its toxic effect by increasing lipid peroxidation, altering the antioxidant enzyme activities and DNA damage."( Caffeic acid and quercetin protect erythrocytes against the oxidative stress and the genotoxic effects of lambda-cyhalothrin in vitro.
Abdallah, FB; Fakhfakh, F; Fetoui, H; Keskes, L, 2012
)
0.72
" In contrast, Q and CH significantly prevented toxic effects of TCDD via increased GSH, CAT, GPx and SOD levels but decreased formation of TBARS."( Ameliorating effects of quercetin and chrysin on 2,3,7,8-tetrachlorodibenzo- p-dioxin-induced nephrotoxicity in rats.
Beytur, A; Ciftci, O; Oguz, F; Ozdemir, I; Vardi, N, 2012
)
0.69
"To observe the toxicity of hyperoside in rat embryo-fetal development, in order to provide preference for safe use of drugs during gestation period."( [Study on toxicity of hyperoside in rat embryo-fetal development].
Ai, G; Huang, Z; Liu, Z; Wang, D, 2012
)
0.38
" The study revealed that there were no significant treatment related adverse effects in rats exposed to Longevinex for 28 days and considered safe at the given dose where compared to plain Resveratrol."( Sub-acute toxicity profile of a modified resveratrol supplement.
Sali, VK; Sangeetha, MK; Thanka, J; Vallabi, DE; Vasanthi, HR, 2013
)
0.39
"The aim of this study was to investigate the toxic impacts of titanium dioxide nanoparticles (TiO₂-NPs) on rat kidneys and the possible prophylactic role of either quercetin or idebenone."( Potential impact of quercetin and idebenone against immuno- inflammatory and oxidative renal damage induced in rats by titanium dioxide nanoparticles toxicity.
Abdel Baky, NA; Al-Rasheed, NM; Faddah, LM; Mohamed, AM; Mohammad, RA, 2013
)
0.91
" These toxic effects were also regulated by high-dose quercetin."( Effect of quercetin against dichlorvos induced nephrotoxicity in rats.
Hou, Y; Li, S; Qi, L; Sun, C; Wang, H; Xu, W; Zeng, Y; Zhao, X, 2014
)
1.05
" The adverse effect of Fe2O3 NPs is not so significant at lower doses but at higher doses Fe2O3 NPs causes significant damage to cells."( Iron oxide nanoparticles mediated cytotoxicity via PI3K/AKT pathway: role of quercetin.
Sarkar, A; Sil, PC, 2014
)
0.63
" Taken together, potent MDR-modulating activity along with intracellular conversion into the natural flavonoid quercetin warrants development of the quercetin-amino acid conjugates as safe MDR modulators."( Water-soluble and cleavable quercetin-amino acid conjugates as safe modulators for P-glycoprotein-based multidrug resistance.
Chong, Y; Choo, H; Kim, MK, 2014
)
0.91
"There is an urgent need to make cisplatin (cDDP) more effective and less toxic in the treatment of ovarian cancer for its systemic side effects and high resistance rate."( Quercetin induces endoplasmic reticulum stress to enhance cDDP cytotoxicity in ovarian cancer: involvement of STAT3 signaling.
Chen, G; Gao, Q; Gong, C; Liao, J; Liu, Y; Ma, D; Sun, C; Wei, X; Yang, Z; Zhang, T; Zhou, X, 2015
)
1.86
" In conclusion, our present data suggests that HNE is highly toxic to serum-starved ARPE-19 cells but quercetin is able to reverse these adverse effects even when administered after an oxidative insult."( Quercetin alleviates 4-hydroxynonenal-induced cytotoxicity and inflammation in ARPE-19 cells.
Honkakoski, P; Hytti, M; Kaarniranta, K; Kauppinen, A; Piippo, N; Salminen, A, 2015
)
2.08
" The As-HAE induced cytotoxicity on PBMCs determined by trypan blue dye exclusion (CC50 = 653 μg/mL) and MTT (CC50 = 588 μg/mL) assays being more toxic than cold extract."( In Vitro and In Vivo Cytogenotoxic Effects of Hot Aqueous Extract of Achyrocline satureioides (Lam.) DC.
Bacchetti, R; Cariddi, LN; Comini, LR; Escobar, FM; Merckis, C; Montironi, I; Núñez Montoya, S; Reinoso, EB; Sabini, LI; Sabini, MC; Zanon, SM, 2015
)
0.42
" From the present findings, it can be evaluated that quercetin may protect against adverse effects resulted from multi-organophosphorous pesticides with significant high levels of uptake in man provided."( Effect of quercetin against mixture of four organophosphate pesticides induced nephrotoxicity in rats.
Cao, C; Li, S; Qi, L; Shi, H; Sun, C; Yang, S; Zhao, X, 2016
)
1.09
" However, QR administration ameliorated FNT-induced toxic effects."( Quercetin mitigates fenitrothion-induced testicular toxicity in rats.
Abd El-Aziz, RM; Ali, HA; Saber, TM, 2016
)
1.88
" Treatment of MGO for 24 h significantly enhanced 3-h OGD-induced HBMEC toxic effect, which was inhibited by pretreatment of isorhamnetin (100 μmol/L)."( The protective role of isorhamnetin on human brain microvascular endothelial cells from cytotoxicity induced by methylglyoxal and oxygen-glucose deprivation.
Chen, Z; Dai, H; He, P; Li, W; Yan, M, 2016
)
0.43
" Rats-administered querectin along with ZnONPs showed less toxic effects on all studied reproductive traits and mRNA transcripts."( Querectin Alleviates Zinc Oxide Nanoreprotoxicity in Male Albino Rats.
Ahmed, MM; Ali, HA; Hussein, MM; Saadeldin, IM, 2016
)
0.43
"The present study aims to investigate the protective effect of quercetin against the joint toxic action induced by the mixture of four organophosphate pesticides (mixture-OPs) (dimethoate, acephate, dichlorvos, and phorate) at their corresponding no observed adverse effect level (NOAEL) using metabonomics."( Metabonomic analysis of the protective effect of quercetin on the toxicity induced by mixture of organophosphate pesticides in rat urine.
Cao, C; Chen, S; Hu, L; Qi, L; Sun, C; Zhao, X, 2017
)
0.95
" Based on a favorable safety profile, it has been confirmed as generally recognized as safe (GRAS) compound by the FDA."( Ninety-day toxicity and single-dose toxicokinetics study of alpha-glycosyl isoquercitrin in Sprague-Dawley rats.
Davis, JP; Hayashi, SM; Jokinen, MP; Koyanagi, M; Maronpot, RR; Nyska, A; Ramot, Y, 2016
)
0.43
" Several studies have reported of toxic effects of Q against glioma cell lines."( Quercetin derivatives as potent inducers of selective cytotoxicity in glioma cells.
Dell'Albani, P; Di Marco, B; Foti, MC; Grasso, S; Rocco, C, 2017
)
1.9
"Repeated Mn administration induces toxic effects in several rat brain structures and treatment with R and QCT may be a potential therapeutic strategy to attenuate the metal neurotoxicity."( Manganese neurotoxicity and protective effects of resveratrol and quercetin in preclinical research.
Filip, M; Gawlik, M; Gawlik, MB; Smaga, I, 2017
)
0.69
" We hypothesized that quercetin administration would ameliorate the toxic effects of doxorubicin and cyclophosphamide prior to pregnancy."( Protective Effect of Quercetin Against Oxidative Stress-induced Toxicity Associated With Doxorubicin and Cyclophosphamide in Rat Kidney and Liver Tissue.
Dogan, Z; Erdemli, E; Kocahan, S; Taskin, E, 2017
)
1.09
" Direct toxic effects on renal cells, possibly mediated by reactive oxygen species, have been postulated as contributing to CI-AKI."( Quercetin protects against radiocontrast medium toxicity in human renal proximal tubular cells.
Andreucci, M; De Sarro, G; Faga, T; Michael, A; Pisani, A; Russo, D; Serra, R, 2018
)
1.92
"Doxorubicin (Dox) is an efficient drug for breast cancer chemotherapy, however, its toxic side effects on non-tumor tissues, especially on myocardial cells, sometimes limit its clinical application."( Quercetin enhances chemotherapeutic effect of doxorubicin against human breast cancer cells while reducing toxic side effects of it.
Li, K; Li, S; Wang, B; Wang, X; Yuan, S; Zhao, Q, 2018
)
1.92
" Interestingly, co-administration with low dose QT or different doses of LC succeeded to counteract the negative toxic effects of ATZ on serum oxidative stress indicators, serum testosterone levels, testicular IgA level and improved testicular CYP17A1 mRNA expression."( Dose- dependent ameliorative effects of quercetin and l-Carnitine against atrazine- induced reproductive toxicity in adult male Albino rats.
Abdel Aziz, RL; Abdel-Wahab, A; Abo El-Ela, FI; El-Nahass, ES; Hassan, NEY; Ibrahim, MA; Khalil, AAY, 2018
)
0.75
"Recent studies have demonstrated that bisphenol A (BPA) has an adverse or toxic effect on the kidney."( The ameliorative effect of quercetin on bisphenol A-induced toxicity in mitochondria isolated from rats.
Alizadeh, S; Dehghani, MA; Mahdavinia, M; Shirani, M, 2019
)
0.81
" As a result, CPF was found to exert a significant toxic effect on BV2 cells that was characterized by rounded cell body, atrophic synapse, poor adhesion, cell aggregation, inflammation, oxidative reaction, and autophagy."( Protective mechanism of Taxifolin for chlorpyrifos neurotoxicity in BV2 cells.
Dai, H; Deng, Y; Zhan, J; Zhang, C; Zhao, L; Zhao, M; Zhou, W, 2019
)
0.51
" Treatment of TAA intoxicated rats (G4) with MOLE ameliorated the toxic effects of TAA on hepatic tissue structure and function."( Protective effect of Moringa oleifera leaves ethanolic extract against thioacetamide-induced hepatotoxicity in rats via modulation of cellular antioxidant, apoptotic and inflammatory markers.
El Sabagh, HS; El-Gansh, HAI; Eldaim, MAA; Mohamed, MAE; Morsi, AH; Mousa, AA, 2019
)
0.51
" There were no toxic chemicals involved during the synthesis."( Green Synthetic Nanoarchitectonics of Gold and Silver Nanoparticles Prepared Using Quercetin and Their Cytotoxicity and Catalytic Applications.
Lee, YJ; Park, Y, 2020
)
0.78
"Acute renal failure induced by a toxic dose of acetaminophen (also known as paracetamol, or APAP) is common in both humans and experimental animal models."( Suppression of glomerular damage and apoptosis and biomarkers of acute kidney injury induced by acetaminophen toxicity using a combination of resveratrol and quercetin.
Abdel Kader, DH; Al-Ani, B; Dallak, M; Dawood, AF; Eid, RA; Haidara, MA; Kamar, SS; Shams Eldeen, AM, 2022
)
0.92
"Patients had no study drug-related severe adverse events based on blood tests, which included both complete blood counts and evaluation of comprehensive metabolic panel."( Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease.
Barreto, TA; Comstock, AT; Han, MK; Martinez, FJ; Sajjan, US, 2020
)
0.81
" Endosulfan, a highly toxic organochlorine insecticide, causes cytotoxic cell death by inducing oxidative stress."( Oxidative stress-mediated cytotoxicity of Endosulfan is causally linked to the inhibition of NADH dehydrogenase and Na
Carvalho, MS; Murali, M; Shivanandappa, T, 2020
)
0.56
" The data reported here support the hypothesis that QUE rescues the toxic effects of DON or 15ADON due to the similar mechanisms of DON and 15ADON toxicity."( Metabolomic profiling reveals similar cytotoxic effects and protective functions of quercetin during deoxynivalenol- and 15-acetyl deoxynivalenol-induced cell apoptosis.
Jia, BX; Liu, N; Wu, A; Yang, YX; Yu, S, 2020
)
0.78
"Cadmium (Cd), a highly toxic heavy metal, adversely affects human and animal health."( Protective effect of quercetin on rat testes against cadmium toxicity by alleviating oxidative stress and autophagy.
Liu, Z; Wang, J; Wang, K; Yang, Z; Zhu, H, 2020
)
0.88
" Administration of quercetin is advantageous in reducing the adverse effects of cisplatin without compromising its anti-tumour activity."( Dual role of quercetin in enhancing the efficacy of cisplatin in chemotherapy and protection against its side effects: a review.
Ashrafizadeh, M; Najafi, M; Tavakol, S; Zarrabi, A, 2022
)
1.42
" In the present study, we examined the toxic effects of lead acetate (Pb) on testicular structure and the possible effect of quercetin on mitigating these effects."( Protective Effect of Quercetin on Testis Structure and Apoptosis Against Lead Acetate Toxicity: an Stereological Study.
Alaee, S; Azarpira, N; Bordbar, H; Dolati, P; Jamhiri, I; Khodabandeh, Z; Mehrabani, D; Zamiri, MJ, 2021
)
1.15
"Previous studies have demonstrated the toxic impacts of zinc oxide nanoparticles (ZO-NPs) on male reproductive cells."( Quercetin ameliorates cytotoxic effects of zinc oxide nanoparticles on sertoli cells by enhancing autophagy and suppressing oxidative stress.
Karimi, S; Khorsandi, L; Zeinvand-Lorestani, M, 2021
)
2.06
" Thus, GlukvamineTM is a promising effective and safe drug for pharmacological correction of the hepatotoxicity of MTX."( The hepatoprotective effect of the combination of glucosamine derivatives with quercetin against methotrexate-induced liver toxicity.
Sakharova, TS; Vietrova, KV; Zupanets, IA, 2020
)
0.79
" Its most common dose-limiting adverse effect is nephrotoxicity."( Effect of taxifolin/dapagliflozin combination on colistin-induced nephrotoxicity in rats.
Kabel, AM; Salama, SA, 2021
)
0.62
" The aim of the present study was to examine the toxic effects of lead acetate on fertility in male mice and their offspring, and the potential effect of quercetin on mitigating the likely effects."( Reproductive and embryological toxicity of lead acetate in male mice and their offspring and mitigation effects of quercetin.
Akhlaghi, A; Atashi, H; Dolati, P; Jamhiri, I; Khodabandeh, Z; Mehrabani, D; Zamiri, MJ, 2021
)
1.03
" The findings suggest that sub-lethal concentration of cypermethrin is toxic to fish."( Cassia fistula ameliorates chronic toxicity of cypermethrin in Catla catla.
Faggio, C; Jindal, R; Sharma, R, 2021
)
0.62
"Cadmium (Cd), an environmental toxic heavy metal, has been reported to cause testicular toxicity, which contributes to the recent decline in male fertility worldwide."( Quercetin mediated attenuation of cadmium-induced oxidative toxicity and apoptosis of spermatogenic cells in caprine testes in vitro.
Bhardwaj, JK; Panchal, H, 2021
)
2.06
"Various natural compounds have been successfully tested for preventing or counteracting the toxic effects of exposure to heavy metals."( Quercetin Protects Human Thyroid Cells against Cadmium Toxicity.
Bulotta, S; Capriglione, F; Celano, M; Damante, G; Maggisano, V; Maiuolo, J; Russo, D, 2021
)
2.06
"Lead (Pb) is a common toxic heavy metal pollutant in the environment that seriously endangers the health of animals."( Quercetin and Allicin Can Alleviate the Hepatotoxicity of Lead (Pb) through the PI3K Signaling Pathway.
Bai, Y; Bian, J; Cai, P; Cao, Q; Gu, J; Liu, X; Liu, Z; Yuan, Y; Zhu, Q; Zou, H, 2021
)
2.06
" This study aimed to explore the potential of the quercetin (QUR) loaded magnetic nano-micelles for improving drug bioavailability while reducing the drug adverse effects."( Self-assembled magnetic polymeric micelles for delivery of quercetin: Toxicity evaluation on isolated rat liver mitochondria.
Hosseini, MJ; Kermanian, M; Rahmati, MA; Rashidzadeh, H; Sadighian, S, 2022
)
1.22
"Doxorubicin combined with cyclophosphamide (AC) is the most commonly used regimen for triple-negative breast cancer (TNBC) chemotherapy; however, its clinical application is severely limited by its serious adverse effect on cardiomyocytes."( Quercetin attenuates the cardiotoxicity of doxorubicin-cyclophosphamide regimen and potentiates its chemotherapeutic effect against triple-negative breast cancer.
Li, K; Li, S; Zhang, J; Zhang, P; Zhao, L, 2022
)
2.16
" In our study, first, toxic doses of acrylamide, nontoxic doses of thymoquinone and quercetin in C6 cells for 24 h were determined by MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) colorimetric test."( The effects of thymoquinone and quercetin on the toxicity of acrylamide in rat glioma cells.
Kacar, S; Kutlu, HM; Sahinturk, V; Tomsuk, O, 2022
)
1.23
" No serious adverse events or toxicity were reported in the clinical or experimental animal studies we reviewed."( United States Pharmacopeia comprehensive safety review of Styphnolobium japonicum flower and flower bud.
Calderón, AI; Madden, E; McLachlan, C; Oketch-Rabah, H, 2022
)
0.72
" Schizophrenia (SZ) is one of the neuropsychiatric disorders in human beings with rapid mortality and intense morbidity which can be treated with antipsychotics, but these commercial drugs exert adverse effects and have less efficacy to treat the full spectrum of SZ."( Reversal of oxidative stress, cytokine toxicity and DNA fragmentation by quercetin in dizocilpine-induced animal model of Schizophrenia.
Afzal, A; Batool, Z; Haider, S; Shahzad, S, 2022
)
0.95
" LA could be precisely released in the acidic tumor microenvironment for activating nontoxic QU successfully to produce toxic oxidized quercetin (OQU), and the LA was steady loaded on the LA@ZIF-8 under physiological conditions (pH∼7."( The safe Laccase@ZIF-8-prodrug system with GSH redox cycle for effective targeted cancer therapy with low off-target toxicity.
He, Z; Qi, W; Su, R; Wang, Y; Yan, X; You, S; Zhang, C; Zhang, J; Zhou, Y, 2022
)
0.92
" Overall, TEGDMA induces various toxic effects in macrophages, including cytotoxicity, apoptosis, and genotoxicity."( Protective Effect of Rutin on Triethylene Glycol Dimethacrylate-Induced Toxicity through the Inhibition of Caspase Activation and Reactive Oxygen Species Generation in Macrophages.
Chang, YC; Huang, FM; Kuan, YH; Su, NY; Yang, LC; Yeh, KL, 2022
)
0.72
" The main purpose of this study was to determine if quercetin has any toxic properties in mice at doses that have shown efficacy in pre-clinical studies regarding cancer, cancer therapy, and their off-target effects."( Sub-chronic oral toxicity screening of quercetin in mice.
Aladhami, A; Chatzistamou, I; Cunningham, P; Enos, RT; Fan, D; Madero, S; Murphy, EA; Patton, E; Unger, C; VanderVeen, BN; Velázquez, KT, 2022
)
1.24
"In summary, our study establishes that quercetin is safe for use in both female and male CD2F1 mice when given at ~ 12."( Sub-chronic oral toxicity screening of quercetin in mice.
Aladhami, A; Chatzistamou, I; Cunningham, P; Enos, RT; Fan, D; Madero, S; Murphy, EA; Patton, E; Unger, C; VanderVeen, BN; Velázquez, KT, 2022
)
1.26
" Interestingly, quercetin displays toxic properties against phylogenetically distant organisms such as bacteria and eukaryotic cells, suggesting that its molecular target resides on a highly conserved pathway."( Cytotoxicity of quercetin is related to mitochondrial respiration impairment in Saccharomyces cerevisiae.
Arvizu-Medrano, SM; Canizal-Garcia, M; Carrillo-Garmendia, A; González-Hernández, JC; Gracida, J; Madrigal-Perez, LA; Martinez-Ortiz, C; Regalado-Gonzalez, C, 2022
)
1.41
" The interactions between QC and nanoparticles caused the nanocomposite pH-responsive behavior that assists in minimizing the side effect of the anticancer agent by controlling the burst release of QC at neutral conditions."( Development of chitosan/halloysite/graphitic‑carbon nitride nanovehicle for targeted delivery of quercetin to enhance its limitation in cancer therapy: An in vitro cytotoxicity against MCF-7 cells.
Khadiv-Parsi, P; Pourmadadi, M; Rashedi, H; Sabzini, M; Yazdian, F, 2023
)
1.13
" However, compounds QMJ-2, QMJ-5, and NMJ-1 were cardiotoxic and the concentration needs to be reduced to prevent toxic effects on cardiomyocytes."( An efficient human stem cells derived cardiotoxicity testing platform for testing oncotherapeutic analogues of quercetin and cinnamic acid.
Biswas, S; Gamit, N; Mandal, S; Rao, CM; Sethi, G; Warrier, S, 2022
)
0.93
" The addition of dietary polyphenols did not increase adverse events."( Efficacy and safety of dietary polyphenols in rheumatoid arthritis: A systematic review and meta-analysis of 47 randomized controlled trials.
Chen, Y; Deng, Y; Guo, H; He, Q; Huang, Z; Li, H; Long, Z; Wei, H; Xiang, W; Xiao, W; Yang, K; Yuan, M; Yuan, X; Zeng, L, 2023
)
0.91
" Hence, man faces the risk of exposure to ZnO-NPs and the consequent adverse health effects."( Protective effect of quercetin and thymoquinone against genotoxicity and oxidative stress induced by ZnO nanoparticles in the Wistar rat model.
Ahmad, MF; Akbarsha, MA; Ansari, MO; Latif Wani, AB; Parveen, N; Shadab, GGHA,
)
0.45

Pharmacokinetics

A nanodroplet formulation was prepared and loaded with a novel class of chemotherapeutic drug. Time to reach Cmax (tmax) was significantly shorter after the quercetin aglycone treatment than after the rutin treatment. The pharmacokinetic model fitted well the observed data of quercetus and its conjugates.

ExcerptReferenceRelevance
" The median elimination half-life times of hypericin were 24."( Pharmacokinetics of hypericin and pseudohypericin after oral intake of the hypericum perforatum extract LI 160 in healthy volunteers.
Brockmöller, J; Kerb, R; Ploch, M; Roots, I; Staffeldt, B, 1994
)
0.29
"A double-blind, randomized, placebo-controlled parallel-group trial (phase I) was performed to evaluate the central pharmacodynamic effects of two hypericum extracts with different contents of hyperforin (0."( Pharmacodynamic effects of two different hypericum extracts in healthy volunteers measured by quantitative EEG.
Dimpfel, W; Sauer, S; Schellenberg, R, 1998
)
0.3
" The pharmacokinetic parameters following intravenous injection were determined in two studies."( Pharmacokinetics and bioavailability of the flavonol quercetin in humans.
Derendorf, H; Graefe, EU; Veit, M, 1999
)
0.55
" However, time to reach Cmax (tmax) was significantly shorter after the quercetin aglycone treatment than after the rutin treatment (1."( Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers.
Alfthan, G; Aro, A; Erlund, I; Kenraali, J; Kosonen, T; Mäenpää, J; Parantainen, J; Perttunen, K, 2000
)
0.86
" There was no significant difference in the bioavailability and pharmacokinetic parameters between the onion supplement and quercetin-4'-O-glucoside."( Pharmacokinetics and bioavailability of quercetin glycosides in humans.
Derendorf, H; Drewelow, B; Graefe, EU; Jacobasch, G; Mueller, S; Pforte, H; Riethling, AK; Uehleke, B; Veit, M; Wittig, J, 2001
)
0.78
" Pharmacokinetic parameters of camptothecin were assessed using a non-compartmental model."( Effect of P-glycoprotein modulators on the pharmacokinetics of camptothecin using microdialysis.
Lee, CH; Tsai, TH; Yeh, PH, 2001
)
0.31
" The present pharmacokinetic study was designed to find out whether the improved water solubility in the presence of procyanidin B2 or hyperoside is correlated to increased plasma levels of hypericin."( Plasma levels of hypericin in presence of procyanidin B2 and hyperoside: a pharmacokinetic study in rats.
Butterweck, V; Liefländer-Wulf, U; Nahrstedt, A; Winterhoff, H, 2003
)
0.32
" Pharmacokinetic parameters of verapamil and norverapamil were determined after the oral administration of verapamil (10 mg kg(-1)) to rabbits in the presence and absence of quercetin (5."( The effect of quercetin on the pharmacokinetics of verapamil and its major metabolite, norverapamil, in rabbits.
Choi, JS; Han, HK, 2004
)
0.88
"To determine the pharmacokinetics of quercetin and its glucuronide/sulfate conjugates and to develop a pharmacokinetic model to simultaneously describe their disposition after intravenous and oral administration in rats."( Pharmacokinetics and modeling of quercetin and metabolites.
Chen, X; Chow, MS; Yin, OQ; Zuo, Z, 2005
)
0.88
" The pharmacokinetic model fitted well the observed data of quercetin and its conjugates."( Pharmacokinetics and modeling of quercetin and metabolites.
Chen, X; Chow, MS; Yin, OQ; Zuo, Z, 2005
)
0.85
" The pharmacokinetic model appears to be suitable for describing the absorption and disposition of the quercetin and its conjugates and may be applicable to other flavonoids that undergo similar pharmacokinetic pathways."( Pharmacokinetics and modeling of quercetin and metabolites.
Chen, X; Chow, MS; Yin, OQ; Zuo, Z, 2005
)
0.82
" Therefore, the objective of the two open phase I clinical trials was to obtain pharmacokinetic data of these constituents from a hypericum extract containing tablet: hypericin, pseudohypericin, hyperforin, the flavonoid aglycone quercetin, and its methylated form isorhamnetin."( Investigation of pharmacokinetic data of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin revealed from single and multiple oral dose studies with a hypericum extract containing tablet in healthy male volunteers.
Bässler, D; Schulz, HU; Schürer, M; Weiser, D, 2005
)
0.73
" In the present study, we have investigated the pharmacokinetic profiles of isorhamnetin after oral application in rats equipped with a jugular catheter."( Quantitative determination of isorhamnetin, quercetin and kaempferol in rat plasma by liquid chromatography with electrospray ionization tandem mass spectrometry and its application to the pharmacokinetic study of isorhamnetin.
He, J; Jiang, X; Lan, K, 2007
)
0.6
"Little is known regarding pharmacokinetic (PK) or pharmacodynamic interactions of flavonoids with each other: this is of significance since multiple flavonoids are present in the diet and in dietary supplements."( Pharmacokinetics and bioavailability of the bioflavonoid biochanin A: effects of quercetin and EGCG on biochanin A disposition in rats.
Moon, YJ; Morris, ME,
)
0.36
" The validated method was successfully applied to pharmacokinetic studies of the two analytes in rat plasma after the oral administration of Hypericum japonicum thunb."( HPLC analysis and pharmacokinetic study of quercitrin and isoquercitrin in rat plasma after administration of Hypericum japonicum thunb. extract.
Bi, KS; Chen, XH; Li, J; Liu, X; Wang, ZW; Zhang, L, 2008
)
0.35
"The purpose of this study was to examine the pharmacokinetics of quercetin aglycone as well as its conjugated metabolites and to develop a population pharmacokinetic model for quercetin that incorporates enterohepatic recirculation."( Quercetin pharmacokinetics in humans.
DiCenzo, R; Moon, YJ; Morris, ME; Wang, L, 2008
)
2.03
" pharmacokinetic data on 670 drugs representing, to our knowledge, the largest publicly available set of human clinical pharmacokinetic data."( Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Lombardo, F; Obach, RS; Waters, NJ, 2008
)
0.35
" A reliable sensitive reversed-phase high-performance liquid chromatography (RP-HPLC) method with UV detection for the pharmacokinetic study of taxifolin in rabbit plasma after enzymatic hydrolysis was developed and validated for the first time."( Determination and pharmacokinetic study of taxifolin in rabbit plasma by high-performance liquid chromatography.
Karlina, MV; Kosman, VM; Makarov, VG; Makarova, MN; Pozharitskaya, ON; Shikov, AN, 2009
)
0.35
" Plasma and urinary fexofenadine concentrations were measured, and pharmacokinetic differences between placebo and quercetin phases were assessed."( Short-term effect of quercetin on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein, in healthy volunteers.
Kim, KA; Park, JY; Park, PW, 2009
)
0.88
" The area under the time versus concentration curve (AUC) of plasma fexofenadine was increased by 55% by quercetin (2,005."( Short-term effect of quercetin on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein, in healthy volunteers.
Kim, KA; Park, JY; Park, PW, 2009
)
0.89
" Treatment with rutin significantly decreased the elimination half-life of S-warfarin by 37% as a result of the 69% increase in unbound clearance of the S-enantiomer."( Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats.
Chan, E; Chen, X; Hegde, A, 2009
)
0.35
"Concurrent rutin administration is likely to reduce the anticoagulant effect of racemic warfarin, reflecting a significant decrease in the elimination half-life of the more potent S-enantiomer."( Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats.
Chan, E; Chen, X; Hegde, A, 2009
)
0.35
" Pharmacokinetic parameters were calculated using the software WinNonlin Standard Edition Version."( Lymphatic absorption of quercetin and rutin in rat and their pharmacokinetics in systemic plasma.
Chen, IL; Huang, CM; Tsai, TH; Tsai, YJ, 2010
)
0.67
"The pharmacokinetic parameters of diazepam and one of its metabolites, N-demethyldiazepam, were compared after oral administration of diazepam (10 mg) in the absence or presence of oral GBE (120 mg bid, for 28 days) in 12 healthy volunteers."( Effects of Ginkgo biloba extracts on diazepam metabolism: a pharmacokinetic study in healthy Chinese male subjects.
Chen, BM; Dai, LL; Jia, SJ; Li, J; Liu, SK; Yang, GP; Yuan, H; Zhang, BK; Zhang, J; Zhou, LY; Zuo, XC, 2010
)
0.36
"The 90% confidence intervals (CIs) of the ratios of mean pharmacokinetic parameters of diazepam presence and absence of GBE were well within the 80-125% bioequivalence range, indicating no pharmacokinetic interaction."( Effects of Ginkgo biloba extracts on diazepam metabolism: a pharmacokinetic study in healthy Chinese male subjects.
Chen, BM; Dai, LL; Jia, SJ; Li, J; Liu, SK; Yang, GP; Yuan, H; Zhang, BK; Zhang, J; Zhou, LY; Zuo, XC, 2010
)
0.36
"A simple and specific high-performance liquid chromatographic (HPLC) method was developed for the pharmacokinetic study of hyperoside (HP, isolated from the leaves of Crataegus pinnatifida Bge."( LC determination and pharmacokinetic study of hyperoside in rat plasma after intravenous administration.
Kang, TG; Liu, X; Meng, XS; Wang, D; Wang, SY; Ying, XX; Zhang, WJ, 2010
)
0.36
" Then we studied the pharmacokinetic characteristics and bioavailability in rats."( Comparative pharmacokinetics and bioavailability studies of quercetin, kaempferol and isorhamnetin after oral administration of Ginkgo biloba extracts, Ginkgo biloba extract phospholipid complexes and Ginkgo biloba extract solid dispersions in rats.
Cai, BC; Cai, H; Chen, HX; Chen, J; Chen, ZP; Liu, D; Sun, J; Xiao, YY, 2010
)
0.6
"The chirality of flavonoids has been overlooked in the majority of pharmacokinetic studies of homoeriodictyol, isosakuranetin, and taxifolin."( Stereospecific pharmacokinetics of racemic homoeriodictyol, isosakuranetin, and taxifolin in rats and their disposition in fruit.
Andrews, PK; Davies, NM; Ohgami, Y; Remsberg, CM; Takemoto, JK; Vega-Villa, KR; Yáñez, JA, 2011
)
0.37
" To investigate the pharmacokinetic profile of total quercetin after a single oral dose of tartary buckwheat extract in rats, a sensitive, simple, and accurate HPLC-UV method was developed to determine total quercertin following plasma enzyme hydrolysis with glucuronidase/sulfatase."( Pharmacokinetic profile of total quercetin after single oral dose of tartary buckwheat extracts in rats.
Hu, H; Hu, Y; Peng, L; Wang, Z; Zhao, G; Zou, L, 2011
)
0.9
" The developed-method was successfully applied for the pharmacokinetic study of PMQ and its metabolite TMQ in dogs following a single oral dose."( Simultaneous determination of 3,3',4',5,7-pentamethylquercetin and its possible metabolite 3,3',4',7-tetramethylquercetin in dog plasma by liquid chromatography-tandem mass spectrometry and its application to preclinical pharmacokinetic study.
Chen, X; Hu, Y; Jin, M; Li, D; Peng, K; Zheng, H; Zhou, L, 2011
)
0.62
" The main pharmacokinetic parameters were as follows: T(1/2z) was 92."( [Study on determination and pharmacokinetics of metabolites from Folium Mori extract in rats].
Jiang, LD; Lou, XF; Xuan, GD; Zhao, L; Zhu, YF, 2011
)
0.37
"The method established in this study is accurate, reliable and reproducible, and can be applied for determination of total quercetin, kaempferol and isorhamnetin in rat plasma after oral administration of FME; the pharmacokinetic studies showed that the distribution of drugs is rapid and elimination is very slow."( [Study on determination and pharmacokinetics of metabolites from Folium Mori extract in rats].
Jiang, LD; Lou, XF; Xuan, GD; Zhao, L; Zhu, YF, 2011
)
0.58
" Quercetin significantly increases the plasma concentration of valsartan and peak concentration (70."( Pharmacokinetic interaction study between quercetin and valsartan in rats and in vitro models.
Babu, PR; Challa, SR; Challa, VR; Johnson, B; Maheswari, C, 2013
)
1.56
" The results of this study indicated the SD formulations on the improvement of pharmacokinetic properties of isorhamnetin, quercetin and kaempferol in TFH were much better than those of SE formulations."( Effects of solid dispersion and self-emulsifying formulations on the solubility, dissolution, permeability and pharmacokinetics of isorhamnetin, quercetin and kaempferol in total flavones of Hippophae rhamnoides L.
Duan, J; Li, G; Lin, G; Luo, H; Xie, Y; Yuan, X; Zhao, G, 2013
)
0.8
" Quercetin increased the peak concentration (Cmax) of ranolazine from 254 ± 8."( Influence of quercetin on the pharmacokinetics of ranolazine in rats and in vitro models.
Babu, KN; Babu, PJ; Babu, PR; Peter, PL; Rajesh, K, 2013
)
1.67
" Pharmacokinetic parameters were determined by noncompartmental modeling using Kinetica software."( Comparison of quercetin pharmacokinetics following oral supplementation in humans.
Clarkson, PM; Conca, KR; Dunne, CP; Kaushik, D; Michniak-Kohn, B; O'Fallon, K, 2012
)
0.74
"In this study, we investigated pharmacokinetic drug interactions of clopidogrel with P-gp inhibitors in rats and dogs."( Pharmacokinetic interactions of clopidogrel with quercetin, telmisartan, and cyclosporine A in rats and dogs.
Lee, JH; Lee, YJ; Oh, JH; Shin, YJ, 2012
)
0.63
"To establish a method to determine the concentration of formononetin, calycosin and isorhamnetin from Astragalus mongholicus in rats' plasma using LC-MS/MS and calculate their pharmacokinetic parameters."( [Simultaneous determination of formononetin, calycosin and isorhamnetin from Astragalus mongholicus in rat plasma by LC-MS/MS and application to pharmacokinetic study].
Li, Y; Lin, Q; Tan, XM; Yao, XC, 2013
)
0.39
" The pharmacokinetic parameter, t(1/2beta), of formononetin, calycosin and isorhamnetin was (10."( [Simultaneous determination of formononetin, calycosin and isorhamnetin from Astragalus mongholicus in rat plasma by LC-MS/MS and application to pharmacokinetic study].
Li, Y; Lin, Q; Tan, XM; Yao, XC, 2013
)
0.39
"A sensitive, accuracy and suitable LC-MS/MS method for determination of formononetin, calycosin and isorhamnetin is developed and successfully applied to the pharmacokinetic study of 10 g/kg Astragalus mongholicus after oral administration in rats."( [Simultaneous determination of formononetin, calycosin and isorhamnetin from Astragalus mongholicus in rat plasma by LC-MS/MS and application to pharmacokinetic study].
Li, Y; Lin, Q; Tan, XM; Yao, XC, 2013
)
0.39
"6% in 5 subjects and cmax was decreased by 29."( Effect of single-dose and short-term administration of quercetin on the pharmacokinetics of talinolol in humans - Implications for the evaluation of transporter-mediated flavonoid-drug interactions.
Langguth, P; Nguyen, MA; Staubach, P; Wolffram, S, 2014
)
0.65
" Pharmacokinetic study was investigated in the two groups of rats (n = 6) for pharmacokinetic interactions between the Quercetin and Rutin (2."( Comparative pharmacokinetic interactions of Quercetin and Rutin in rats after oral administration of European patented formulation containing Hipphophae rhamnoides and Co-administration of Quercetin and Rutin.
Agrawal, A; Chintala, J; Dubey, GP; Kaliappan, I; Kammalla, AK; Ramasamy, MK, 2015
)
0.89
" The pharmacokinetic results showed that C max of isorhamnetin and quercetin in TFH solid dispersion (TFH-SD) and TFH self-emulsifying (TFH-SE) preparations was significantly enhanced than that in TFH preparations (p < 0."( A comparison of the pharmacokinetics of three different preparations of total flavones of Hippophae rhamnoides in beagle dogs after oral administration.
Dang, Y; Duan, J; Li, G; Ma, P; Meng, H; Wang, H; Wu, T; Xie, Y, 2016
)
0.67
" In this study, a nanodroplet formulation was prepared and loaded with a novel class of chemotherapeutic drug, ie, quercetin, to observe its pharmacokinetic properties and ultrasonic bioimaging of specific sites, namely the abdominal vein and bladder."( Pharmacokinetics of quercetin-loaded nanodroplets with ultrasound activation and their use for bioimaging.
Chang, LW; Hou, ML; Hung, SH; Lin, LC; Tsai, TH, 2015
)
0.95
" The validated method has been successfully applied to pharmacokinetic studies of the three analytes following intragastric administration of Eupatorium lindleyanum extract at a single dose of 100, 250, and 625mg/kg to Sprague-Dawley rats, respectively."( Pharmacokinetics of eupalinolide A, eupalinolide B and hyperoside from Eupatorium lindleyanum in rats by LC/MS/MS.
Lu, X; Yu, X; Zhang, J; Zhao, F; Zheng, G, 2015
)
0.42
" Pretreatment with verapamil increased the peak concentration and area under the concentration-time curve of hyperin, which were significantly higher than the control values."( Simultaneous quantification of hyperin, reynoutrin and guaijaverin in mice plasma by LC-MS/MS: application to a pharmacokinetic study.
Guo, J; Li, Z; Meng, F; Peng, S; Sun, L; Yu, L; Zhang, Y; Zhang, Z, 2016
)
0.43
"A rapid and sensitive LC-MS/MS method with good accuracy and precision was developed and validated for the pharmacokinetic study of quercetin-3-O-β-d-glucopyranosyl-7-O-β-d-gentiobioside (QGG) in Sprague-Dawley rats."( A rapid and sensitive LC-MS/MS method for quantification of quercetin-3-O-β-d-glucopyranosyl-7-O-β-d-gentiobioside in plasma and its application to a pharmacokinetic study.
Gao, H; He, X; Li, K; Sun, L; Tao, G; Zhang, Y, 2016
)
0.88
"Xiebai in Gualou Xiebai decoction has a remarkable effect on pharmacokinetic character of quercetin in Gualou, it can promote the absorption and distribution and reduce the elimination of quercetin, in vivo, as well as increase the bioavailability of quercetin."( [Influence of the Compatibility of Gualou and Xiebai on Pharmacokinetics of Quercetin in Gualou].
Chen, XJ; Huang, X; Wei, ML; Yan, HY; Zhang, YH; Zou, CC, 2015
)
0.87
" For quercetin, the pharmacokinetic parameter t(½β), AUC(0-∞), MRT(0."( [Determination of plasma concentration of quercetin, kaempferid and isorhamnetin in Hippophae rhamnoides extract by HPLC-MS/MS and pharmacokinetics in rats].
Liu, Y; Meng, XL; Tuo, YL; Wang, P; Wei, T; Yang, J; Zeng, Y, 2015
)
1.2
" The present LC-MS/MS method was successfully applied to pharmacokinetic studies of taxifolin after intravenous administration of taxifolin, oral administration of its physical mixture and nanodispersion."( UHPLC-MS/MS Determination, Pharmacokinetic, and Bioavailability Study of Taxifolin in Rat Plasma after Oral Administration of its Nanodispersion.
Gao, MJ; Kuang, HX; Lv, JN; Meng, YH; Mi, YY; Wang, ZB; Yang, BY; Yang, CJ, 2016
)
0.43
" An in vivo pharmacokinetic study demonstrated that Que-LMPMs had higher area under the concentration-time curve and a longer half-life, leading to better bioavailability compared to a free Que injection."( Development and characterization of self-assembling lecithin-based mixed polymeric micelles containing quercetin in cancer treatment and an in vivo pharmacokinetic study.
Chen, LC; Chen, YC; Ho, HO; Hong, CS; Sheu, MT; Su, CY, 2016
)
0.65
"The aim of the present study was to evaluate whether quercetin (Que) modulates the mRNA and protein expression levels of drug‑metabolizing enzymes (DMEs) and drug transporters (DTs) in the small intestine and liver, and thus modifies the pharmacokinetic profile of cyclosporine (CsA) in rats."( Impact of quercetin‑induced changes in drug‑metabolizing enzyme and transporter expression on the pharmacokinetics of cyclosporine in rats.
Liu, Y; Luo, X; Shi, S; Yang, C; Yang, T; Zhou, J, 2016
)
1.09
" The difference in outcomes was vivid in pharmacokinetic studies, where nanoparticles, esp."( Promises of a biocompatible nanocarrier in improved brain delivery of quercetin: Biochemical, pharmacokinetic and biodistribution evidences.
Katare, OP; Kumar, P; Kumar, R; Malik, R; Raza, K; Sharma, G; Singh, B, 2016
)
0.67
" By considering pharmacokinetic aspects, the present study was undertaken to evaluate the effects of caffeic acid and quercetin on Caco-2 cells permeability, metabolism, CYP1A inhibition in vitro assay systems and a single dose pharmacokinetics of melatonin in vivo rats."( Effects of Caffeic Acid and Quercetin on In Vitro Permeability, Metabolism and In Vivo Pharmacokinetics of Melatonin in Rats: Potential for Herb-Drug Interaction.
Jana, S; Rastogi, H, 2017
)
0.96
" Derivatives of imidazole, 1,3-thiazole and pyrimidine proved to be more potent than febuxostat while also displaying/possessing favorable predicted physico-chemical, pharmacokinetic and toxicological properties."( Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity.
Anderluh, M; Jakopin, Ž; Kocić, G; Petronijević, Ž; Šmelcerović, A; Šmelcerović, Ž; Tomašič, T; Tomović, K, 2017
)
0.46
" An 8-h pharmacokinetic study was performed."( Influence of diabetes on plasma pharmacokinetics and brain bioavailability of grape polyphenols and their phase II metabolites in the Zucker diabetic fatty rat.
Chen, TY; Cooper, B; Ferruzzi, MG; Ho, L; Janle, EM; Pasinetti, GM; Simon, JE; Talcott, ST; Todd, G; Wang, J; Wu, QL, 2017
)
0.46
" The method was validated and successfully applied to everted sac and pharmacokinetic studies in rats."( HPLC Estimation, Ex vivo Everted Sac Permeability and In Vivo Pharmacokinetic Studies of Darunavir.
Sangave, PC; Suvarna, VM, 2018
)
0.48
"To estabish ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method for simultaneous determination of quercetin(QCT), isorhamnetin(ISR), kaempferol(KMF), ginkgolide A(GA), ginkgolide B(GB), ginkgolide C(GC) and bilobalide(BB) in rat plasma and investigate the pharmacokinetic process of seven compounds after oral administration of Yindan Xinnaotong Ruanjiaonang, The results indicated that all calibrations curves showed good linearity (r≥0."( [Simultaneous determination of seven bioactive compounds and pharmacokinetics in rat plasma after oral administration of Yindan Xinnaotong Ruanjiaonang by UPLC-MS/MS].
Gong, LL; Liang, RX; Wang, L; Xu, HY; Yang, HJ; Yin, XJ; Yuan, HJ, 2017
)
0.66
" Quercetin altered pharmacokinetic of enrofloxacin by decreasing area under curve, peak concentration, and time to reach peak concentration and by increasing clearance rate."( Use of quercetin in animal feed: effects on the P-gp expression and pharmacokinetics of orally administrated enrofloxacin in chicken.
Bhutto, ZA; Guo, T; He, F; Huang, J; Wang, L; Yang, J; Zloh, M, 2018
)
1.85
"To study the pharmacokinetic and tissue distribution of quercetin injection and submicron emulsion after intravenous administration in mice."( [Study on Pharmacokinetics and Tissue Distribution of Quercetin Submicroemulsion in Mice].
Duan, X; Guo, QT; Song, X; Tang, ZS; Wang, CL; Zhao, P, 2016
)
0.93
"Quercetin submicron emulsion significantly alters the plasma pharmacokinetic characteristics of quercetin after intravenous administration in mice."( [Study on Pharmacokinetics and Tissue Distribution of Quercetin Submicroemulsion in Mice].
Duan, X; Guo, QT; Song, X; Tang, ZS; Wang, CL; Zhao, P, 2016
)
2.13
"To develop a sensitive and reliable ultra performance liquid chromatography tandem mass spectrometry ( UPLC-MS / MS) method for simultaneous determination and pharmacokinetics of protocatechuic acid, kaempferol biotin glucoside and quercitrin in rat plasma, and study their pharmacokinetic characteristics in rats."( [Simultaneous Determination of Protocatechuic Acid,Kaempferol Biotin Glucoside and Quercitrin in Rat Plasma and Pharmacokinetics By UPLC-MS/MS].
Chen, SY; Li, YJ; Sun, J; Xiang, WY; Yang, W; Zheng, L, 2016
)
0.43
"The established method is specific,rapid,accurate and sensitive,and is proved to meet the requirements of biological sample analyses,and is suitable for the concentration determination of protocatechuic acid, kaempferol biotin glucoside and quercitrin in rat plasma, three compounds are all best fitted to the two-compartment open pharmacokinetic model."( [Simultaneous Determination of Protocatechuic Acid,Kaempferol Biotin Glucoside and Quercitrin in Rat Plasma and Pharmacokinetics By UPLC-MS/MS].
Chen, SY; Li, YJ; Sun, J; Xiang, WY; Yang, W; Zheng, L, 2016
)
0.43
" The current study aimed to investigate the impact of co-administration of pomegranate peel and guava leaves extracts, including their quality markers namely; ellagic acid and quercetin, respectively, on warfarin's in vivo dynamic activity and pharmacokinetic actions, in addition to potential in vitro cytochrome P450 enzymes (CYP) inhibition."( Critical pharmacokinetic and pharmacodynamic drug-herb interactions in rats between warfarin and pomegranate peel or guava leaves extracts.
Alnaqeeb, M; Ghanim, BY; Idkaidek, N; Mallah, EM; Mansor, KA; Qinna, NA, 2019
)
0.71
"Influence of mentioned extracts and their key constituents on warfarin pharmacodynamic and kinetic actions and CYP activity were evaluated."( Critical pharmacokinetic and pharmacodynamic drug-herb interactions in rats between warfarin and pomegranate peel or guava leaves extracts.
Alnaqeeb, M; Ghanim, BY; Idkaidek, N; Mallah, EM; Mansor, KA; Qinna, NA, 2019
)
0.51
" This developed and validated method was successfully applied in the pharmacokinetic study of CUR, THC, QR, and PF in rats."( Simultaneous determination of curcumin, tetrahydrocurcumin, quercetin, and paeoniflorin by UHPLC-MS/MS in rat plasma and its application to a pharmacokinetic study.
Cai, D; Gan, H; Guan, Y; Jiang, F; Lao, B; Liu, X; Wen, D; Yu, W; Zheng, J; Zhong, G, 2019
)
0.76
" The aim of the current study was to characterize pharmacokinetic properties of DOPAC and 3-HPAA after intravenous bolus application in rats."( Single dose pharmacokinetics of intravenous 3,4-dihydroxyphenylacetic acid and 3-hydroxyphenylacetic acid in rats.
Butterweck, V; Hamburger, M; Oufir, M; Sampath, C; Zabela, V, 2020
)
0.56
"To develop and validate a sensitive and reliable ultra-high-performance liquid chromatography- tandem mass spectrometry (UHPLC-MS/MS) method for the quantitative determination of quercitrin levels in rat plasma, and test its application in a pharmacokinetic investigation after the oral administration of Polygoni cuspidati folium capsules (HC)."( Quantitative Determination of Quercitrin Levels in Rat Plasma Using UHPLC-MS/MS and its Application in a Pharmacokinetic Study after the Oral Administration of Polygoni cuspidati Folium Capsules.
Bi, XL; Feng, CT; Ma, ST; Zhang, N; Zhang, XY, 2022
)
0.72
" The pharmacokinetic parameters suggested that quercitrin may be present in the peripheral tissues of rats."( Quantitative Determination of Quercitrin Levels in Rat Plasma Using UHPLC-MS/MS and its Application in a Pharmacokinetic Study after the Oral Administration of Polygoni cuspidati Folium Capsules.
Bi, XL; Feng, CT; Ma, ST; Zhang, N; Zhang, XY, 2022
)
0.72
"In this study, the pharmacokinetic profiles of the bioactive components in the leaf extract of the medicinal herb, Cudrania tricuspidate, were investigated using an MS/MS-based molecular networking system."( Molecular networking-guided strategy for the pharmacokinetic study of herbal medicines: Cudrania tricuspidata leaf extracts.
Lee, EK; Park, KB; Seo, JI; Yoo, HH; Yu, JS, 2022
)
0.72
" Nevertheless, no study has been performed on the exposure differences of the pharmacodynamic material basis in vivo caused by different extraction methods."( Integrated metabolism, network pharmacology, and pharmacokinetics to explore the exposure differences of the pharmacodynamic material basis in vivo caused by different extraction methods for Saussurea involucrata.
Chen, B; Liu, M; Lyu, H; Ma, C; Tu, S; Wu, C; Xu, X; Yang, L; Yiming, A, 2022
)
0.72
"Based on the integrated strategy of metabolism, network pharmacology, and pharmacokinetics, we aimed to reveal exposure differences in pharmacodynamic substances caused by different extraction methods."( Integrated metabolism, network pharmacology, and pharmacokinetics to explore the exposure differences of the pharmacodynamic material basis in vivo caused by different extraction methods for Saussurea involucrata.
Chen, B; Liu, M; Lyu, H; Ma, C; Tu, S; Wu, C; Xu, X; Yang, L; Yiming, A, 2022
)
0.72
" Twenty-three prototype components were analyzed by network pharmacology, and seven critical active components were selected as representative markers for the pharmacokinetic study."( Integrated metabolism, network pharmacology, and pharmacokinetics to explore the exposure differences of the pharmacodynamic material basis in vivo caused by different extraction methods for Saussurea involucrata.
Chen, B; Liu, M; Lyu, H; Ma, C; Tu, S; Wu, C; Xu, X; Yang, L; Yiming, A, 2022
)
0.72
" This research aimed to provide the basis of metabolism in vivo for further studying these pharmacodynamic differences."( Integrated metabolism, network pharmacology, and pharmacokinetics to explore the exposure differences of the pharmacodynamic material basis in vivo caused by different extraction methods for Saussurea involucrata.
Chen, B; Liu, M; Lyu, H; Ma, C; Tu, S; Wu, C; Xu, X; Yang, L; Yiming, A, 2022
)
0.72
" This review discusses and reviews the pharmacological activity, pharmacokinetic characteristics, and targeted delivery nanosystems of quercetin in protecting against cerebral ischemic injury, and provides information on various downstream signaling pathways regulated by quercetin, such as PI3k/Akt, MAPK, and Sirt1."( Protective effects of dietary quercetin on cerebral ischemic injury: pharmacology, pharmacokinetics and bioavailability-enhancing nanoformulations.
Fu, K; Gong, L; Li, Y; Ma, C; Peng, C; Wang, C; Xue, X; Zhang, Y; Zhou, H, 2023
)
1.4
" The pharmacokinetic characteristics of Hyperoside-2-hydroxypropyl-β-cyclodextrin inclusion complex in rats were evaluated."( Pharmacokinetic studies of hyperoside-2-hydroxypropyl-β-cyclodextrin inclusion complex and ameliorated DSS-induced colitis in mice.
Cao, S; Chu, X; Ding, Y; Fu, X; Li, X; Li, Y; Liu, C; Su, J; Wang, X; Xue, J; Zhang, R; Zhang, X, 2023
)
0.91

Compound-Compound Interactions

Quercetin in combination with Testosterone and Estradiol contributed to stabilization of eNOS and nNOs expression already at early observation phases, and reduced the level of iNOS expression with its further disappearance in later observation period.

ExcerptReferenceRelevance
"The effect of acetylsalicylic acid in combination with quercetin on blood serum biochemiluminescence in the hypoxic syndrome was studied."( [A biochemiluminescent analysis of the pharmacotherapeutic activity of acetylsalicylic acid in combination with quercetin in a hypoxic syndrome].
Luk'ianchuk, VD; Savchenkova, LV; Semenova, IA,
)
0.59
"The effects of the anticancer drug irinotecan combined with ethanolic extract of propolis (EEP), a water-soluble derivate of propolis (WSDP), quercetin and naringin on the growth of Ehrlich ascites tumor (EAT) and the life span of tumor-bearing Swiss albino mice were studied."( Enhanced antitumor activity of irinotecan combined with propolis and its polyphenolic compounds on Ehrlich ascites tumor in mice.
Basic, I; Benkovic, V; Bevanda, M; Brozovic, G; Dikic, D; Horvat Knezevic, A; Knezevic, F; Orsolic, N, 2007
)
0.54
"To explore the effects of quercetin and quercetin in combination with cisplatin on adhesion, migration and invasion of HeLa cells."( [Effects of quercetin and quercetin in combination with cisplatin on adhesion, migration and invasion of HeLa cells].
Chen, XM; Luo, RY; Zhang, FL; Zhang, W, 2008
)
1.03
"Adhesion, migration and invasion of HeLa cells treated with quercetin and quercetin in combination with cisplatin were measured by adhesion assay, wound healing assay, and transwell chamber method respectively."( [Effects of quercetin and quercetin in combination with cisplatin on adhesion, migration and invasion of HeLa cells].
Chen, XM; Luo, RY; Zhang, FL; Zhang, W, 2008
)
0.97
"The results showed that quercetin and quercetin in combination with cisplatin could inhibit adhesion, migration and invasion of HeLa cells."( [Effects of quercetin and quercetin in combination with cisplatin on adhesion, migration and invasion of HeLa cells].
Chen, XM; Luo, RY; Zhang, FL; Zhang, W, 2008
)
1.03
"Quercetin and quercetin in combination with cisplatin can inhibit adhesion and migration and invasion of HeLa cells."( [Effects of quercetin and quercetin in combination with cisplatin on adhesion, migration and invasion of HeLa cells].
Chen, XM; Luo, RY; Zhang, FL; Zhang, W, 2008
)
2.17
"The article presents the data about clinical course and treatment of patients with chronic nonalcoholic steatohepatitis in combination with bowel diseases."( [Clinical and biochemical characteristics of clinical course and management of patients with chronic nonalcoholic steatohepatitis in combination with intestinal diseases].
Kharchenko, VV,
)
0.13
" Quercetin also induced polynucleation in aggressive tumor cells, which was maintained in combination with doxorubicin."( Drug combinations with quercetin: doxorubicin plus quercetin in human breast cancer cells.
Idrizi, E; Juillerat-Jeanneret, L; Kenzaoui, BH; Staedler, D, 2011
)
1.59
" Thus, we investigated whether quercetin supplementation suppresses the harmful effects of benzo[a]pyrene (BaP) alone or combined with β-carotene in the lungs of Mongolian gerbils."( Quercetin supplementation suppresses the secretion of pro-inflammatory cytokines in the lungs of Mongolian gerbils and in A549 cells exposed to benzo[a]pyrene alone or in combination with β-carotene: in vivo and ex vivo studies.
Chan, ST; Chuang, CH; Liao, JW; Liu, KL; Tseng, MJ; Yeh, CL; Yeh, SL, 2012
)
2.11
" The present study was carried out to compare the effect of a novel agent glucosamine alendronate (GA) alone and is combination with dihydroquercetin (DHQ) against the effect of a known drug alendronate (ALN) in the senescence-accelerated OXYS rats as model of osteoporosis."( Efficacy of glucosamine alendronate alone & in combination with dihydroquercetin for treatment of osteoporosis in animal model.
Kolosova, NG; Muraleva, NA; Ofitserov, EN; Tikhonov, VP, 2012
)
0.81
"The hepatic organic anion transporting polypeptides (OATPs) influence the pharmacokinetics of several drug classes and are involved in many clinical drug-drug interactions."( Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR, 2012
)
0.38
" In this study the polyphenol flavonoid quercetin (Q) or sodium butyrate (B) suppressed human esophageal 9706 cancer cell growth in dose dependent manner, and Q combined with B (Q+B) could further inhibit Eca9706 cell proliferation than that induced by Q or B alone, compared with untreated control group (C) in MTT assay."( Aberrant epigenetic alteration in Eca9706 cells modulated by nanoliposomal quercetin combined with butyrate mediated via epigenetic-NF-κB signaling.
Wang, JL; Wu, JL; Yang, SL; Zheng, NG, 2014
)
0.9
" Apoptotic effects of liposomal quercetin (LQ, with cytomembrane-philia) combined with CD133 antiserum were also detected by CD133 immunocytochemistry combined with TUNEL assay."( Anti-CSC effects in human esophageal squamous cell carcinomas and Eca109/9706 cells induced by nanoliposomal quercetin alone or combined with CD 133 antiserum.
Li, JP; Mo, SJ; Wu, JL; Zheng, NG, 2014
)
0.9
" In this study, leaves of Myrcia palustris were investigated by high-resolution α-glucosidase inhibition profiling combined with HPLC-HRMS-SPE-NMR."( High-resolution bioactivity profiling combined with HPLC-HRMS-SPE-NMR: α-Glucosidase inhibitors and acetylated ellagic acid rhamnosides from Myrcia palustris DC. (Myrtaceae).
Brighente, IMC; Moresco, HH; Staerk, D; Tahtah, Y; Wubshet, SG, 2015
)
0.42
"With the idea that platinum compounds that bind with DNA differently than cisplatin may be better-able to overcome platinum resistance in ovarian tumor, the monofunctional platinum complex tris(imidazo(1,2-α)pyridine) chloroplatinum(II) chloride (coded as LH6) has been synthesized and investigated for its activity, alone and in combination with the phytochemicals curcumin and quercetin, against human ovarian A2780, A2780(cisR) and A2780(ZD0473R) cancer cell lines."( Monofunctional Platinum-containing Pyridine-based Ligand Acts Synergistically in Combination with the Phytochemicals Curcumin and Quercetin in Human Ovarian Tumour Models.
Arzuman, L; Beale, P; Huq, F; Yu, JQ, 2015
)
0.79
"The present study was carried out to investigate the influence of dietary quercetin in combination with α-tocopherol on growth performance, antioxidant potential, lipid stability and fatty acid composition in breast meat of birds."( Lipid stability, antioxidant potential and fatty acid composition of broilers breast meat as influenced by quercetin in combination with α-tocopherol enriched diets.
Butt, MS; Shabbir, MA; Shahid, M; Sohaib, M, 2015
)
0.86
"Studied oxygen independent reaction and phagocytic activity of macrophage cells of patients with chronic obstructive pulmonary disease (COPD) II-III stage when combined with coronary heart disease (CHD)."( [EFFICIENCY OF COMBINATION OF ROFLUMILAST AND QUERCETIN FOR CORRECTION OXYGEN- INDEPENDENT MECHANISMS AND PHAGOCYTIC ACTIVITY OF MACROPHAGE CELLS OF PATIENTS WITH ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WHEN COMBINED WITH CORONARY HEAR
Gerych, P; Yatsyshyn, R,
)
0.39
" While the drug-drug interaction potential between flavonoids and co-ingested drugs still remain an issue, opportunities exist for the combination of flavonoids with suitable anti-cancer drugs to enhance the bioavailability of anti-cancer drugs and thereby reduce the dose size of the anti-cancer drugs and improve its therapeutic index."( Recent trends in preclinical drug-drug interaction studies of flavonoids--Review of case studies, issues and perspectives.
Srinivas, NR, 2015
)
0.42
"To detect the effects of quercetin (Que) combined with 2-methoxyestradiol (2-ME) on the proliferation of androgen-dependent LNCaP human prostate cancer cells line and androgen-independent PC-3 human prostate cancer cells line, and to evaluate the antitumor effects of different combos of the two drugs."( [Effect of 2-methoxyestradiol combined with quercetin on prostate cancer in vitro].
Song, LM; Wang, GD; Wang, HP; Xing, NZ, 2016
)
1
" T2DM was induced in Wistar rats by intraperitoneal administration of nicotinamide and streptozotocin and combination with high fructose diets for 8 weeks."( Quercetin-Rich Guava (Psidium guajava) Juice in Combination with Trehalose Reduces Autophagy, Apoptosis and Pyroptosis Formation in the Kidney and Pancreas of Type II Diabetic Rats.
Chen, TY; Chien, CT; Kuo, YT; Lin, CF, 2016
)
1.88
" Overall, combination with chemometrics and quantitative analysis would provide a useful and simple method for quality control of FCP in the future."( Combination with Chemometrics and Quantification for Quality Evaluation and Variety Identification of Flos Chimonanthi Praecocis by HPLC.
Gu, BR; Su, JH; Sun, L; Xing, YW; Zhang, C, 2016
)
0.43
"Previous research found Potentilla fruticosa leaf extracts (PFE) combined with green tea polyphenols (GTP) showed obvious synergistic effects based on chemical mechanisms."( Synergistic effects and related bioactive mechanisms of Potentilla fruticosa Linn. leaves combined with green tea polyphenols studied with microbial test system (MTS).
Ji, X; Li, DW; Liu, ZH; Luo, ZW; Wang, DM, 2018
)
0.48
" The aim of our research was the synthesis of a nanocarrier of quercetin combined with temozolomide, to enhance the specificity and efficacy of this anticancer drug commonly used in glioblastoma treatment."( Novel nanohydrogel of hyaluronic acid loaded with quercetin alone and in combination with temozolomide as new therapeutic tool, CD44 targeted based, of glioblastoma multiforme.
Armenia, E; Barbarisi, A; Barbarisi, M; De Sena, G; Iaffaioli, RV; Quagliariello, V; Schiavo, L; Tafuto, S, 2018
)
0.97
" Quercetin (QC) in combination with piperine (bioenhancer) acts as potential antioxidant, anti-inflammatory and neuroprotective against 6-OHDA rat model of PD."( Piperine in combination with quercetin halt 6-OHDA induced neurodegeneration in experimental rats: Biochemical and neurochemical evidences.
Kumar, P; Singh, S, 2018
)
1.68
" The purpose of this study was to investigate the therapeutic effect of quercetin combined with irinotecan/SN-38 in the AGS human gastric cancer cell line in vitro and in vivo."( Effects of quercetin combined with anticancer drugs on metastasis-associated factors of gastric cancer cells: in vitro and in vivo studies.
Hou, YC; Lei, CS; Lin, MT; Pai, MH; Yeh, SL, 2018
)
1.1
" Our findings showed that metformin in combination with quercetin synergistically inhibited the growth, migration and invasion of both PC-3 and LNCaP cells."( Metformin combined with quercetin synergistically repressed prostate cancer cells via inhibition of VEGF/PI3K/Akt signaling pathway.
Gong, F; Liu, P; Miao, Q; Sun, S, 2018
)
1.03
" We determined the effects of SR alone or in combination with the antioxidant α-glycosyl isoquercitrin (AGIQ) on hyperlipidemia- and steatosis-related precancerous lesions in high-fat diet (HFD)-fed rats subjected to a two-stage hepatocarcinogenesis model."( Spironolactone in Combination with α-glycosyl Isoquercitrin Prevents Steatosis-related Early Hepatocarcinogenesis in Rats through the Observed NADPH Oxidase Modulation.
Eguchi, A; Hayashi, SM; Kawashima, M; Kimura, M; Koyanagi, M; Makino, E; Maronpot, RR; Mizukami, S; Murayama, H; Nagahara, R; Nakamura, M; Ohtsuka, R; Shibutani, M; Takahashi, N; Yoshida, T, 2018
)
0.48
" In contrast to Spasmex, Mirabegron and Quercetin in combination with Testosterone and Estradiol contributed to stabilization of eNOS and nNOs expression already at early observation phases, and reduced the level of iNOS expression with its further disappearance in the later observation period."( MORPHOLOGICAL ASSESSMENT OF NO-SYNTHASE DISTRIBUTION IN OVERACTIVE BLADDER AND STRESS URINE INCONTINENCE IN ANIMAL MODELS ADMINISTERED WITH EXPERIMENTAL PHARMACOCORRECTION REGIMENS.
Iatsyna, O; Kostyev, F; Vernygorodskyi, S, 2018
)
0.75
" Therefore, we hypothesized the improved anticancer efficacy of QUE in combination with isoenzyme inhibitors-rottlerin (ROT-PKCδ inhibitor), G0 6983 (PKCα inhibitor), and PI-103 (p110α-class I PI3K inhibitor) in MCF-7 and RAW 264."( Improved synergistic anticancer efficacy of quercetin in combination with PI-103, rottlerin, and G0 6983 against MCF-7 and RAW 264.7 cells.
Maurya, AK; Vinayak, M, 2019
)
0.78
" The aim: The present study was designed to evaluate the indices of nitric oxide (NO) system in blood serum and a colon tissue supernatant of rats with chronic enterocolitis combined with streptozotocin-induced diabetes."( The effect of flavonoid quercetine on the indices of nitric oxide system in rats with chronic enterocolitis combined with streptozotocin-induced diabetes.
Krynytska, І; Kushynska, M; Marushchak, M; Pavlenko, I,
)
0.44
" Herewith more pronounced intensification of nitroxydergic processes was observed in rats with chronic enterocolitis combined with streptozotocin-induced diabetes."( The effect of flavonoid quercetine on the indices of nitric oxide system in rats with chronic enterocolitis combined with streptozotocin-induced diabetes.
Krynytska, І; Kushynska, M; Marushchak, M; Pavlenko, I,
)
0.44
" This study was carried out to investigate the effect of piperine and quercetin alone or in combination with marbofloxacin on CYP3A37 and MDR1 mRNA expression levels in liver and intestine of broiler chicken."( Effect of piperine and quercetin alone or in combination with marbofloxacin on CYP3A37 and MDR1 mRNA expression levels in broiler chickens.
Mathapati, BS; Modi, CM; Patel, HB; Patel, UD, 2019
)
1.06
" Therefore, the present study was designed to evaluate the neuroprotective effect of quercetin in combination with piperine against rotenone- and iron supplement-induced model of PD."( Neuroprotective Effect of Quercetin in Combination with Piperine Against Rotenone- and Iron Supplement-Induced Parkinson's Disease in Experimental Rats.
Raj, K; Sharma, S; Singh, S, 2020
)
1.08
" To test whether Zynamite®, a mango leaf extract rich in the natural polyphenol mangiferin, administered in combination with quercetin facilitates recovery after EIMD, 24 women and 33 men were randomly assigned to two treatment groups matched by sex and 5 km running performance, and ran a 10 km race followed by 100 drop jumps to elicit EIMD."( Supplementation with a Mango Leaf Extract (Zynamite®) in Combination with Quercetin Attenuates Muscle Damage and Pain and Accelerates Recovery after Strenuous Damaging Exercise.
Arteaga-Ortiz, R; Calbet, JAL; Dorado, C; Gallego-Selles, A; Galvan-Alvarez, V; Gelabert-Rebato, M; Lopez-Rios, L; Martin-Rincon, M; Martin-Rodriguez, S; Martinez-Canton, M; Morales-Alamo, D; Perez-Regalado, S; Santana, A; Wiebe, JC, 2020
)
1
" In this work, we constructed a nano-system using microbubbles to promote the crossing of drugs across the BBB, where microbubbles in combination with focused ultrasound were used to mediate the transient opening of the BBB and delivery of nanomedicines."( Microbubbles in combination with focused ultrasound for the delivery of quercetin-modified sulfur nanoparticles through the blood brain barrier into the brain parenchyma and relief of endoplasmic reticulum stress to treat Alzheimer's disease.
Chen, X; Gong, Y; Huang, A; Liu, J; Liu, Y; Qin, X; Xie, W; Yuan, X; Zhou, H; Zhu, X, 2020
)
0.79
" The synergistic scavenging effect and mechanism of curcumin combined with quercetin on ACR was analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS)."( Trapping of Acrolein by Curcumin and the Synergistic Inhibition Effect of Curcumin Combined with Quercetin.
Jiang, X; Lu, Y; Lv, H; Lv, L, 2021
)
1.07
" Therefore, a drug-drug cocrystal of two antithrombotic agents with poor solubility was developed, which exhibited greatly improved solubility, bioavailability and superior stability, indicating a novel method to overcome the shortages of drug combination."( Cocrystal of Apixaban-Quercetin: Improving Solubility and Bioavailability of Drug Combination of Two Poorly Soluble Drugs.
Du, G; Jiao, L; Kong, D; Lu, Y; Song, J; Wang, H; Yang, D; Yang, H; Yang, S; Zhang, L; Zhao, X, 2021
)
0.94
" These results indicated that quercetin combined with BmNPV could inhibit the activities of protective enzymes and lead to oxidative damage to silkworm."( The effects of quercetin combined with nucleopolyhedrovirus on the growth and immune response in the silkworm (Bombyx mori).
Kang, Z; Liu, H; Ren, F; Shi, G; Zhou, Y, 2021
)
1.26
"In this study, the therapeutic efficacy of quercetin in combination with remdesivir and favipiravir, were evaluated in severe hospitalized COVID-19 patients."( The therapeutic efficacy of quercetin in combination with antiviral drugs in hospitalized COVID-19 patients: A randomized controlled trial.
Abolnezhadian, F; Alavi, SM; Ghafourian, M; Khodadadi, A; Mahmoudian-Sani, MR; Nashibi, R; Sharhani, A; Shohan, M, 2022
)
1.28
"To study the therapeutic effect of lycopene combined with quercetin and curcumin on chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS) in rats and its underlying mechanism."( [Lycopene combined with quercetin and curcumin for chronic prostatitis/chronic pelvic pain syndrome in rats: Effect and mechanism].
Chen, D; Xing, NZ; Yang, FY; Zhao, QX, 2021
)
1.17
" Conclusions: Lycopene combined with quercetin and curcumin is more effective than any of the three drugs used alone in the treatment of CP/CPPS, which may be associated with its alleviation of inflammatory response and oxidative stress by interaction between the NF-κB, MAPKs and Nrf2 signaling pathways."( [Lycopene combined with quercetin and curcumin for chronic prostatitis/chronic pelvic pain syndrome in rats: Effect and mechanism].
Chen, D; Xing, NZ; Yang, FY; Zhao, QX, 2021
)
1.2
" The aim of this study is identifying its possible therapeutic targets and to evaluate the effects of AM in combination with a PARP inhibitor (olaparib) in the treatment of BRCA wild-type ovarian cancer."( Anticancer Effect of Active Component of Astragalus Membranaceus Combined with Olaparib on Ovarian Cancer Predicted by Network-Based Pharmacology.
Guo, Z; Jiang, J; Lang, F; Li, J; Liu, Y, 2023
)
0.91
" A collagenase I-induced ICH mice model was established and randomly separated into the model group (Model), quercetin gavage group (Quercetin), MSCs transplantation group (MSCs), and MSCs transplantation combined with IronQ group (MSCs + IronQ) after 24 h."( Mesenchymal stem cells transplantation combined with IronQ attenuates ICH-induced inflammation response via Mincle/syk signaling pathway.
Bai, X; Dechsupa, N; Huang, B; Kantapan, J; Mazhar, M; Wang, H; Wang, L; Yang, G; Yang, S; Zou, Y, 2023
)
1.12
"In this study, cultured MCF7 and MDA-MB-231 cells were treated with different concentrations of quercetin/fisetin individually and in combination with naringenin."( Naringenin in combination with quercetin/fisetin shows synergistic anti-proliferative and migration reduction effects in breast cancer cell lines.
Jalalpour Choupanan, M; Reiisi, S; Shahbazi, S, 2023
)
1.41
"Our results indicate that quercetin/fisetin enhances the anti-proliferative and anti-migratory activities in combination with naringenin in MCF7 and MDA-MB-231 human breast cancer cell lines."( Naringenin in combination with quercetin/fisetin shows synergistic anti-proliferative and migration reduction effects in breast cancer cell lines.
Jalalpour Choupanan, M; Reiisi, S; Shahbazi, S, 2023
)
1.5
" The present study employed network pharmacology and molecular docking to determine the mechanism of action and the key active components of BYHWD of Tetrandrine in combination with BYHWD for silicosis."( Unraveling the mechanism of tetrandrine combined with Buyang Huanwu Decoction against silicosis using network pharmacology and molecular docking analyses.
He, S; Jiang, H; Li, Y; Lyu, Z; Zhao, Y, 2023
)
0.91
"Gleditsiae sinensis fructus Pills (GF) is a famous classical prescription, that is regularly combined with Jujubae fructus (JF) for the treatment of chronic bronchitis (CB) in the clinic."( Gleditsiae sinensis fructus Pills combined with Jujubae fructus attenuate chronic bronchitis via regulation of AGE-RAGE signaling pathway.
Kang, L; Li, HW; Li, K; Peng, X; Wang, CC; Zhou, N; Zuo, BL, 2024
)
1.44
"To elucidate the mechanisms of action of Gleditsiae sinensis fructus Pills combined with Jujubae fructus (GF&JF) against CB based on network pharmacology and experimental verification."( Gleditsiae sinensis fructus Pills combined with Jujubae fructus attenuate chronic bronchitis via regulation of AGE-RAGE signaling pathway.
Kang, L; Li, HW; Li, K; Peng, X; Wang, CC; Zhou, N; Zuo, BL, 2024
)
1.44

Bioavailability

Quercetin (Q) has low bioavailability due to poor water solubility, low absorption, and rapid excretion from the body. After oral administration of TFH-PC in rats, the bioavailability of isorhamnetin, kaempferol, and quercetins was 223%, 172%, and 242% respectively.

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
" bioavailability of the dihydropyridine calcium antagonists nifedipine and felodipine."( Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice.
Edgar, B; Eriksson, UG; Lundahl, J; Miniscalco, A; Regårdh, CG, 1992
)
0.28
"We studied the bioavailability and the plasma transport of flavonols in rats fed quercetin or rutin diets."( Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin.
Agullo, G; Demigné, C; Favier, ML; Manach, C; Morand, C; Régérat, F; Rémésy, C; Texier, O, 1995
)
1.96
"1 microgram/ml, suggesting that the negative in vivo results may have been due to limited bioavailability of the compound."( Genotoxicity studies of quercetin and shikimate in vivo in the bone marrow of mice and gastric mucosal cells of rats.
Jones, RS; Ngomuo, AJ, 1996
)
0.6
" However, flavonoids are poorly absorbed from the gut and are subject to degradation by intestinal micro-organisms."( Review of the biology of Quercetin and related bioflavonoids.
Formica, JV; Regelson, W, 1995
)
0.59
" The relative bioavailability of quercetin from apples and rutinoside was one-third of that from onions."( Bioavailability of the dietary antioxidant flavonol quercetin in man.
de Vries, JH; Hollman, PC; Katan, MB; Mengelers, MJ; van Trijp, JM, 1997
)
0.83
" Bioavailability of quercetin from apples and of pure quercetin rutinoside was both 30% relative to onions."( Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man.
Buysman, MN; de Vries, JH; Hollman, PC; Katan, MB; Mengelers, MJ; van der Gaag, MS; van Trijp, JM, 1997
)
0.87
" However, there is limited knowledge on the oral bioavailability of these natural products."( Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells.
Walgren, RA; Walle, T; Walle, UK, 1998
)
0.67
"The bioavailability in human subjects of non-nutrient plant factors, including dietary flavonoids and phyto-oestrogens, is of great importance relative to their reported health protective effects."( The bioavailability of non-nutrient plant factors: dietary flavonoids and phyto-oestrogens.
Wiseman, H, 1999
)
0.3
" However, in-vivo-data on absorption, bioavailability and metabolism after oral intake are scarce and contradictory."( Urinary metabolites of flavonoids and hydroxycinnamic acids in humans after application of a crude extract from Equisetum arvense.
Graefe, EU; Veit, M, 1999
)
0.3
" The bioavailability of the rutinoside was only 20% of that of the glucoside."( The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man.
Bijsman, MN; Cnossen, EP; de Vries, JH; Hollman, PC; Katan, MB; van Gameren, Y, 1999
)
0.3
" It is essential to know the bioavailability of flavonoids involving intestinal absorption, metabolic conversion and urinary excretion, in order to evaluate their in vivo antioxidant activity after intake."( Dietary flavonoids as antioxidants in vivo: conjugated metabolites of (-)-epicatechin and quercetin participate in antioxidative defense in blood plasma.
Terao, J, 1999
)
0.52
"Diet-mediated induction of intestinal UGT may be important for the bioavailability of carcinogens and other toxic chemicals as well as therapeutic drugs."( Induction of UDP-glucuronosyltransferase by the flavonoids chrysin and quercetin in Caco-2 cells.
Galijatovic, A; Walle, T; Walle, UK, 2000
)
0.54
" The sugar moiety in quercetin glycosides affects their bioavailability in humans."( Bioavailabilities of quercetin-3-glucoside and quercetin-4'-glucoside do not differ in humans.
Hollman, PC; Katan, MB; Olthof, MR; Vree, TB, 2000
)
0.94
" In the present study, we have investigated the bioavailability of the flavonol quercetin after intravenous and oral application in pigs equipped with a permanent jugular catheter."( Bioavailability and metabolism of the flavonol quercetin in the pig.
Ader, P; Wessmann, A; Wolffram, S, 2000
)
0.79
" It is present in the diet, and the hepatic and duodenal sulphation might limit the bioavailability of this compound."( Sulphation of resveratrol, a natural product present in grapes and wine, in the human liver and duodenum.
De Santi, C; Mosca, F; Pacifici, GM; Pietrabissa, A; Spisni, R, 2000
)
0.31
" However, the bioavailability of these compounds is questionable."( Quercetin glucosides are completely hydrolyzed in ileostomy patients before absorption.
Otake, Y; Walle, T; Walle, UK; Wilson, FA, 2000
)
1.75
" Resveratrol is sulphated, and the hepatic and duodenal sulphation might limit the bioavailability of this compound."( Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoids.
De Santi, C; Mosca, F; Pacifici, GM; Pietrabissa, A; Spisni, R, 2000
)
0.31
"In clinical trials, studying the effects of quercetin from rutin, bioavailability must be taken into consideration and plasma quercetin concentrations monitored."( Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers.
Alfthan, G; Aro, A; Erlund, I; Kenraali, J; Kosonen, T; Mäenpää, J; Parantainen, J; Perttunen, K, 2000
)
0.89
" Glucuronidation may reduce the bioavailability of this compound however, flavonoids inhibit resveratrol glucuronidation and such an inhibition might improve the bioavailability of resveratrol."( Glucuronidation of resveratrol, a natural product present in grape and wine, in the human liver.
de Santi, C; Mosca, F; Pacifici, GM; Pietrabissa, A, 2000
)
0.31
" However, data on the bioavailability of flavonols from wine are lacking."( Red wine is a poor source of bioavailable flavonols in men.
de Vries, JH; Hollman, PC; Katan, MB; Olthof, MR; van Amersfoort, I, 2001
)
0.31
" We conclude that flavonols are absorbed from tea and that their bioavailability is not affected by addition of milk."( Addition of milk does not affect the absorption of flavonols from tea in man.
Hollman, PC; Katan, MB; Tijburg, LB; Van Het Hof, KH, 2001
)
0.31
" However, data on the bioavailability of quercetin after oral intake are scarce and contradictory."( Pharmacokinetics and bioavailability of quercetin glycosides in humans.
Derendorf, H; Drewelow, B; Graefe, EU; Jacobasch, G; Mueller, S; Pforte, H; Riethling, AK; Uehleke, B; Veit, M; Wittig, J, 2001
)
0.84
"The grapefruit juice component bergamottin is known to inactivate cytochrome P450 3A4, with grapefruit juice consumption causing increased absorption and enhanced oral bioavailability of many cytochrome P450 3A4 substrates."( Inhibition of P-glycoprotein transport function by grapefruit juice psoralen.
Casciano, CN; Clement, RP; Johnson, WW; Wang, EJ, 2001
)
0.31
" Inhibition of P-gp by citrus psoralens could present ways both to enhance bioavailability of therapies without increasing the dose and to diminish drug resistance in refractory cells."( Inhibition of P-glycoprotein transport function by grapefruit juice psoralen.
Casciano, CN; Clement, RP; Johnson, WW; Wang, EJ, 2001
)
0.31
"-) generation, thus the bioavailability of (*)NO was increased."( A flavonoid-rich diet increases nitric oxide production in rat aorta.
Benito, S; Buxaderas, S; Lopez, D; Mitjavila, MT; Puig-Parellada, P; Sáiz, MP; Sánchez, J, 2002
)
0.31
" On the length basis, the absorption rate of quercetin was colon > ileum > duodenum > jejunum."( [Study on the absorption of quercetin and rutin at different segments of intestine].
Guo, C; Su, J; Wei, J; Yang, J, 2002
)
0.87
" This in vitro study allowed selection of compounds which are able to increase the moxidectin bioavailability in lambs."( Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: quercetin.
Alvinerie, M; Dupuy, J; Larrieu, G; Lespine, A; Sutra, JF, 2003
)
0.55
" On the other hand, quercetin presented only as glucuronides and sulfates in the blood, indicating negligible bioavailability of quercetin, and the metabolites showed linear pharmacokinetics at the two doses studied."( Profound difference in pharmacokinetics between morin and its isomer quercetin in rats.
Chao, PD; Ho, HJ; Hou, YC; Hsiu, SL; Wen, CC, 2003
)
0.88
" Both compounds increased the oral bioavailability of hypericin by ca."( Plasma levels of hypericin in presence of procyanidin B2 and hyperoside: a pharmacokinetic study in rats.
Butterweck, V; Liefländer-Wulf, U; Nahrstedt, A; Winterhoff, H, 2003
)
0.32
" However, adequate intakes and absorption rate of phenolic compounds are necessary for these beneficial effects."( Influence of cooking process on phenolic marker compounds of vegetables.
Andlauer, W; Fürst, P; Hubert, M; Rings, A; Stumpf, C, 2003
)
0.32
" Urinary excretions of major phenols were measured to affirm bioavailability of dietary phenols."( Effects of phenol-depleted and phenol-rich diets on blood markers of oxidative stress, and urinary excretion of quercetin and kaempferol in healthy volunteers.
Kim, HY; Kim, OH; Sung, MK, 2003
)
0.53
" The bioavailability of quercetin glycosides should be clarified, because dietary quercetin is mostly present as its glycoside form."( Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism.
Murota, K; Terao, J, 2003
)
0.93
"Recent investigations suggest that the bioavailability of quercetin depends on the glycoside moiety of the quercetin glycosides present in the diet."( The bioavailability of quercetin in pigs depends on the glycoside moiety and on dietary factors.
Cermak, R; Landgraf, S; Wolffram, S, 2003
)
0.87
" However, the absolute water insolubility of quercetin is a key step that may limit its bioavailability and, thus, its 'in vivo' employment as a photoprotective agent."( 'In vitro' antioxidant and photoprotective properties and interaction with model membranes of three new quercetin esters.
Bonina, FP; Castelli, F; Messina, C; Nicolosi, G; Pellegrino, ML; Rocco, C; Saija, A; Tita, B; Tomaino, A; Trombetta, D, 2003
)
0.79
" The results showed the elimination rate constant k and the absorption rate constant ka of quercetin were slightly more than that of kaempferol; and the absorption half-life (t(1/2a)), the elimination half-life (t(1/2)) and t(max) of quercetin were less than that of kaempferol, the differences were, however, not statistically significant."( Disposition of quercetin and kaempferol in human following an oral administration of Ginkgo biloba extract tablets.
Wang, FM; Yao, TW; Zeng, S,
)
0.7
" These results indicate that co-ingested lipids and emulsifiers could enhance the bioavailability of quercetin glucosides in onion."( Enhancing effect of lipids and emulsifiers on the accumulation of quercetin metabolites in blood plasma after the short-term ingestion of onion by rats.
Azuma, K; Horie, H; Ippoushi, K; Ito, H; Terao, J, 2003
)
0.77
" These results, indicating a flow of quercetin from albumin to haemoglobin, and vice versa, are therefore consistent with the possibility that human RBC play a pivotal role in the distribution and bioavailability of circulating flavonoids."( Human red blood cells as a natural flavonoid reservoir.
Accorsi, A; Cantoni, O; Fiorani, M, 2003
)
0.59
"The present study investigates the bioavailability of resveratrol and quercetin in humans, mice, and rats after oral ingestion of grape juice preparations or pure aglycones."( Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice.
Lee, MJ; Lu, H; Maliakal, P; Meng, X; Yang, CS, 2004
)
0.82
"The aim of this study was to investigate the effect of quercetin on the bioavailability of paclitaxel after the oral administration of paclitaxel or a prodrug to rats pretreated with quercetin."( Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin.
Choi, JS; Jo, BW; Kim, YC, 2004
)
0.78
" In this study, the influence of dietary fat on oral bioavailability of quercetin was investigated."( Bioavailability of quercetin in pigs is influenced by the dietary fat content.
Cermak, R; Lesser, S; Wolffram, S, 2004
)
0.88
" The poor bioavailability of important dietary quercetin glycosides has implications for their in vivo bioactivities."( The type of sugar moiety is a major determinant of the small intestinal uptake and subsequent biliary excretion of dietary quercetin glycosides.
Arts, IC; Faassen-Peters, M; Hollman, PC; Sesink, AL, 2004
)
0.79
" However, there is limited knowledge on the bioavailability of specific phytochemicals from whole fruits and vegetables."( Uptake of quercetin and quercetin 3-glucoside from whole onion and apple peel extracts by Caco-2 cell monolayers.
Boyer, J; Brown, D; Liu, RH, 2004
)
0.73
" More in-depth studies on bioavailability should facilitate correlation of mechanisms determined in vitro with in vivo situations, increase our understanding of dose-response relationships, and facilitate extrapolation of results from animal studies to human situations."( Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations.
Hong, J; Lambert, JD; Liao, J; Yang, CS; Yang, GY, 2005
)
0.33
" These compounds have a wide range of potential health benefits, and understanding the bioavailability of flavonoids from foods is becoming increasingly important."( In vitro digestion and lactase treatment influence uptake of quercetin and quercetin glucoside by the Caco-2 cell monolayer.
Boyer, J; Brown, D; Liu, RH, 2005
)
0.57
" Despite the loss of quercetin from the digested shallot, the bioavailability of quercetin aglycone to the Caco-2 cells was the same in both the digested and non-digested shallot."( In vitro digestion and lactase treatment influence uptake of quercetin and quercetin glucoside by the Caco-2 cell monolayer.
Boyer, J; Brown, D; Liu, RH, 2005
)
0.89
"The increase in quercetin uptake following treatment with lactase suggests that dietary supplementation with lactase may increase quercetin bioavailability in lactose intolerant humans."( In vitro digestion and lactase treatment influence uptake of quercetin and quercetin glucoside by the Caco-2 cell monolayer.
Boyer, J; Brown, D; Liu, RH, 2005
)
0.92
" Flavonol-albumin binding is expected to modulate the bioavailability of flavonols."( Flavonoid-serum albumin complexation: determination of binding constants and binding sites by fluorescence spectroscopy.
Dangles, O; Dufour, C, 2005
)
0.33
"The objective of these two open phase I clinical trials was the investigation of the bioavailability of five constituents from a hypericum extract containing tablet, which are discussed as the components contributing to the antidepressant action."( Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet.
Bässler, D; Schulz, HU; Schürer, M; Weiser, D, 2005
)
0.55
" Being sparingly soluble and chemically unstable in aqueous intestinal fluids, quercetin is poorly absorbed orally."( Physicochemical and structural characterization of quercetin-beta-cyclodextrin complexes.
Chow, AH; Chow, MS; Haworth, IS; Zheng, Y; Zuo, Z, 2005
)
0.81
"The aim of this study was to investigate the effect of quercetin on the bioavailability of diltiazem after administering diltiazem (15 mg/kg) orally to rabbits either co-administered or pretreated with quercetin (2, 10, 20 mg/kg)."( Enhanced diltiazem bioavailability after oral administration of diltiazem with quercetin to rabbits.
Choi, JS; Li, X, 2005
)
0.8
" Great differences emerge as far as ingested doses, bioavailability and liver ability to accumulate the various compounds."( Dietary antioxidant compounds and liver health.
Caporaso, N; Fogliano, V; Morisco, F; Vitaglione, P, 2004
)
0.32
" The P-gp type efflux pump might limit the bioavailability of Ginkgo flavonols."( Involvement of P-glycoprotein in regulating cellular levels of Ginkgo flavonols: quercetin, kaempferol, and isorhamnetin.
Cao, J; Wang, Y; Zeng, S, 2005
)
0.55
" The aim of the present study was to bring data on the bioavailability of quercetin and catechin when administered simultaneously."( Co-administration of quercetin and catechin in rats alters their absorption but not their metabolism.
Manach, C; Morand, C; Remesy, C; Scalbert, A; Silberberg, M, 2005
)
0.88
" However, the actual bioavailability of these compounds in vivo, especially in the prevalent glycosidic form, remains a controversial point in making an assessment of their biological importance."( Absorption of quercetin and rutin in rat small intestine.
Carbonaro, M; Grant, G,
)
0.49
"The bioavailability of quercetin and rutin (quercetin-3-rutinoside) was assessed in vivo, with single-meal experiments with rats and by an in vitro method with ligated loops of rat small intestine."( Absorption of quercetin and rutin in rat small intestine.
Carbonaro, M; Grant, G,
)
0.8
" An early protective action by dietary antioxidants in the gastro-intestinal tract is plausible, especially for poorly bioavailable antioxidants such as polyphenols."( Inhibition of the metmyoglobin-induced peroxidation of linoleic acid by dietary antioxidants: Action in the aqueous vs. lipid phase.
Caris-Veyrat, C; Dangles, O; Goupy, P; Vulcain, E, 2005
)
0.33
" Factors that influence the bioavailability of this group of polyphenolic compounds are therefore important."( Red wine alcohol promotes quercetin absorption and directs its metabolism towards isorhamnetin and tamarixetin in rat intestine in vitro.
Bennett, R; Dragoni, S; Gee, J; Sgaragli, G; Valoti, M, 2006
)
0.63
" This study investigated the effect of quercetin, a dual inhibitor of CYP3A4 and P-gp, on the bioavailability and pharmacokinetics of tamoxifen and one of its metabolites, 4-hydroxytamoxifen, in rats."( Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats.
Choi, JS; Li, X; Shin, SC, 2006
)
0.83
" All phytochemicals tend to increase the therapeutic effect by blocking one or more targets of the signal transduction pathway, by increasing the bioavailability of the other drug or, by stabilizing the other drug in the system."( Potential synergism of natural products in the treatment of cancer.
Doble, M; HemaIswarya, S, 2006
)
0.33
"Our data indicated that pegylated liposomal quercetin can significantly improve the solubility and bioavailability of quercetin and can be a potential application in the treatment of tumor."( Liposomal quercetin efficiently suppresses growth of solid tumors in murine models.
Chen, LJ; Diao, P; Du, XB; Fan, LY; Tang, MH; Wang, GQ; Wang, R; Wei, YQ; Wu, HB; Yang, GL; Yang, HS; Yao, WX; Ye, B; Yuan, ZP; Zhang, W; Zhao, QM; Zhao, X, 2006
)
1
" Our previous study reported that quercetin significantly decreased the bioavailability of cyclosporin, a substrate for CYP3A4 and Pgp, in rats and pigs."( Marked decrease of cyclosporin bioavailability caused by coadministration of ginkgo and onion in rats.
Chao, PD; Hou, YC; Hsiu, SL; Tsai, SY; Wen, KC; Yang, CY, 2006
)
0.61
" In this article, the results of three intervention studies investigating the bioavailability of quercetin from berries are reviewed."( Bioavailability of quercetin from berries and the diet.
Alfthan, G; Erlund, I; Freese, R; Hakala, P; Marniemi, J, 2006
)
0.88
" The bioavailability of RGJ polyphenols was assessed in healthy subjects."( Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects.
Castilla, P; Cerrato, F; Dávalos, A; Echarri, R; Gómez-Coronado, D; Lasunción, MA; Lucas, MF; Ortega, H; Ortuño, J; Teruel, JL, 2006
)
0.33
" The bioavailability of flavonoids is influenced by the metabolism of the microflora in the intestine."( Metabolism of quercetin and rutin by the pig caecal microflora prepared by freeze-preservation.
Hein, EM; Humpf, HU; Keppler, K, 2006
)
0.69
"It is essential to have a thorough knowledge of the bioavailability and metabolism of dietary flavonols to understand their role in disease prevention."( Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions.
Crozier, A; Edwards, CA; Mullen, W, 2006
)
0.55
" Flavonols at two dosages in oatmeal porridge were rapidly absorbed, and a relatively small amount of sea buckthorn oil added to the porridge seemed to have increased the bioavailability of sea buckthorn flavonols consumed at the higher dose."( Absorption of flavonols derived from sea buckthorn (Hippophaë rhamnoides L.) and their effect on emerging risk factors for cardiovascular disease in humans.
Ahotupa, M; Kallio, H; Suomela, JP; Vasankari, T; Yang, B, 2006
)
0.33
"We have shown recently that dietary fat content influences the bioavailability of the flavonol quercetin."( The fatty acid pattern of dietary fat influences the oral bioavailability of the flavonol quercetin in pigs.
Cermak, R; Lesser, S; Wolffram, S, 2006
)
0.77
" Such processing techniques may have an impact on the flavonoid structure, resulting in changes of the bioavailability and activity of the flavonoids."( Thermal degradation of onion quercetin glucosides under roasting conditions.
Buchner, N; Driemel, G; Kroh, LW; Rauser, M; Rohn, S, 2007
)
0.63
"The elaboration of novel techniques for flavonoid intracellular tracing would elucidate the compounds' absorption and bioavailability and assist molecular and pharmacological approaches, as they are promising candidates for drug development."( Quercetin exhibits a specific fluorescence in cellular milieu: a valuable tool for the study of its intracellular distribution.
Castagnino, C; Castanas, E; Katerinopoulos, HE; Munier, S; Nifli, AP; Roussakis, E; Theodoropoulos, PA; Vercauteren, J, 2007
)
1.78
" The advantages of TFH SLNs are the improved oral bioavailability of TFH and the prolonged mean retention time and drug release time."( Preparation and characterization of solid lipid nanoparticles loaded with total flavones of Hippophae rhamnoides (TFH).
Cuia, F; Li, X; Wang, D; Zhao, P,
)
0.13
" Such disparity may reflect an inability of semiquantitative assessment to consider how infusion time and addition of milk affect the bioavailability of potentially beneficial antioxidant polyphenols."( Effects of infusion time and addition of milk on content and absorption of polyphenols from black tea.
Duthie, GG; Kyle, JA; McNeill, G; Morrice, PC, 2007
)
0.34
" From the present study, it can be concluded that quercetin administration to diabetic rats restores vascular function, probably through enhancement in the bioavailability of endothelium-derived nitric oxide coupled to reduced blood glucose level and oxidative stress."( Quercetin, a flavonoid antioxidant, modulates endothelium-derived nitric oxide bioavailability in diabetic rat aortas.
Achike, FI; Machha, A; Mustafa, AM; Mustafa, MR, 2007
)
2.04
" We now report the use of quercetin-hamster serum albumin combination to increase the bioavailability of quercetin."( Albumin-quercetin combination offers a therapeutic advantage in the prevention of reduced survival of erythrocytes in visceral leishmaniasis.
Biswas, D; Biswas, T; Ray, M; Sen, G,
)
0.87
" In conclusion, various beverages, especially teas, inhibit the function of SULT1A3, and therefore may have the potential to increase the bioavailability of orally administered substrates of SULT1A3, such as beta(2) agonists."( Inhibitory effects of various beverages on human recombinant sulfotransferase isoforms SULT1A1 and SULT1A3.
Hiratsuka, A; Nishimuta, H; Ogura, K; Ohtani, H; Sawada, Y; Tsujimoto, M, 2007
)
0.34
" Our objective was to determine the effect of quercetin and (-)-epigallocatechin-3-gallate (EGCG), major flavonoids present in the diet, on the PK and bioavailability of biochanin A, a flavonoid with chemopreventive properties."( Pharmacokinetics and bioavailability of the bioflavonoid biochanin A: effects of quercetin and EGCG on biochanin A disposition in rats.
Moon, YJ; Morris, ME,
)
0.62
" Pectin might thus enhance the bioavailability of quercetin from rutin by altering the metabolic activity of the intestinal flora and/or gut physiological function."( Effect of pectin enhancement on plasma quercetin and fecal flora in rutin-supplemented mice.
Hirayama, K; Itoh, K; Nakagawa, H; Tamura, M; Tsushida, T, 2007
)
0.86
" However, the bioavailability of quercetin depends on the food source and type of glycosidic moiety linked to the molecule."( Influence of dietary quercetin on glutathione redox status in mice.
Meyers, KJ; Mitchell, AE; Rudolf, JL, 2008
)
0.95
" Our data provide a new insight into the bioavailability of dietary flavonoids and the mechanism for the prevention of cardiovascular diseases."( Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: implication in the anti-atherosclerotic mechanism of dietary flavonoids.
Kanayama, M; Kawai, Y; Kobayashi, M; Murota, K; Nishikawa, T; Saito, S; Shiba, Y; Shibata, N; Terao, J; Uchida, K, 2008
)
0.65
" We focused on quercetin (3,3',4',5,7- pentahydroxyflavone), a major flavonoid in onion, and its anti-atherosclerotic effect was examined from the aspect of the bioavailability and translocation to the target site."( Vegetable flavonoids and cardiovascular disease.
Kawai, Y; Murota, K; Terao, J, 2008
)
0.7
"As the bioavailability of flavonoids is influenced by intestinal metabolism, we have investigated the microbial deconjugation and degradation of several flavonols and flavonol glycosides using the pig cecum in vitro model system developed in our group."( Deconjugation and degradation of flavonol glycosides by pig cecal microbiota characterized by Fluorescence in situ hybridization (FISH).
Friedrich, AW; Hein, EM; Humpf, HU; Rose, K; van't Slot, G, 2008
)
0.35
" Hence, it was speculated that quercetin may influence the bioavailability of pioglitazone, which could be particularly crucial, as any increment in its plasma levels may raise safety concerns."( Quercetin pretreatment increases the bioavailability of pioglitazone in rats: involvement of CYP3A inhibition.
Bansod, KU; Dixit, PV; Kumar, V; Umathe, SN; Wanjari, MM, 2008
)
2.07
" Assuming that low bioavailability of quercetin aglycone provided to humans as a pure substance is the result of its low solubility in the digestive tract, we studied its bioavailability from dietary sources in which quercetin was dispersed in the food matrix."( Quercetin from shallots (Allium cepa L. var. aggregatum) is more bioavailable than its glucosides.
Bucinski, A; Honke, J; Piskula, MK; Romaszko, J; Szawara-Nowak, D; Wiczkowski, W; Zielinski, H, 2008
)
2.06
" The absolute bioavailability (F) of irinotecan control was 33%, which was increased to 43% (1."( Pre-clinical evidence for altered absorption and biliary excretion of irinotecan (CPT-11) in combination with quercetin: possible contribution of P-glycoprotein.
Awasthi, A; Bansal, T; Jaggi, M; Khar, RK; Talegaonkar, S, 2008
)
0.56
"Although the flavonol quercetin is intensively investigated, our knowledge about its bioavailability and possible target organs is far from being complete."( Tissue distribution of quercetin in pigs after long-term dietary supplementation.
Bieger, J; Blank, R; Cermak, R; de Boer, VC; Hollman, PC; Kamphues, J; Wolffram, S, 2008
)
0.97
" It is concluded that quercetin increases the bioavailability of the pro-carcinogen PhIP in rats pointing at a potential adverse effect of this supposed beneficial food ingredient."( Quercetin increases the bioavailability of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rats.
Alink, GM; Freidig, AP; Groten, JP; Rietjens, IM; Schutte, ME; Spenkelink, B; Vaessen, JC; van de Sandt, JJ, 2008
)
2.1
" We have analyzed the vasorelaxant effects and the role on NO bioavailability and endothelial function of quercetin and its conjugated metabolites (quercetin-3-glucuronide, isorhamnetin-3-glucuronide and quercetin-3'-sulfate) in rat aorta."( Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta.
Cogolludo, A; Duarte, J; Gonzalez-Paramas, A; Hughes, DA; Jimenez, R; Kroon, PA; Lodi, F; Lopez-Sepulveda, R; Moreno, L; Needs, PW; Perez-Vizcaino, F; Santos-Buelga, C, 2009
)
0.81
"Quercetin bioavailability has been underestimated in the past and can be improved by food matrix components or particular delivery forms."( Quercetin: potentials in the prevention and therapy of disease.
Bischoff, SC, 2008
)
3.23
" The relative bioavailability of QT-SLNs to quercetin suspension was 571."( Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles.
Li, H; Li, L; Lou, H; Ma, Y; Zhai, G; Zhao, X, 2009
)
0.87
"85 h) show that oral bioavailability is improved evidently compared with that of quercetin."( Preparation and prodrug studies of quercetin pentabenzensulfonate.
Deng, Z; Peng, Y; Wang, C, 2008
)
0.85
" The study reveals that as it passes through the gastrointestinal tract, almost all of the of [2-(14)C]quercetin-4'-glucoside is converted to phenolic acids, compounds not monitored in previous flavonol bioavailability studies with model animal systems, some of which have used exceedingly high doses of the aglycone quercetin (500 mg/kg body weight), which is not a normal dietary component."( Bioavailability of [2-(14)C]quercetin-4'-glucoside in rats.
Auger, C; Caldwell, ST; Crozier, A; Edwards, CA; Hartley, RC; Lean, ME; Mullen, W; Rouanet, JM; Teissèdre, PL, 2008
)
0.85
"The use of a high quercetin dose to demonstrate its absorption and bioavailability does not reflect the real dietary situation because quercetin glycosides are usually present in small amounts in the human diet."( Phenylacetic acids were detected in the plasma and urine of rats administered with low-dose mulberry leaf extract.
Cheng, HM; Lee, CY; Sim, SM, 2008
)
0.68
" The absolute bioavailability of taxifolin after oral administration of lipid solution was 36%."( Determination and pharmacokinetic study of taxifolin in rabbit plasma by high-performance liquid chromatography.
Karlina, MV; Kosman, VM; Makarov, VG; Makarova, MN; Pozharitskaya, ON; Shikov, AN, 2009
)
0.35
" It was concluded that suppression of degrading quercetin aglycone in the large intestine has a major role for increasing alpha G-rutin bioavailability by DFA III and FOS feedings."( Oligosaccharide promotes bioavailability of a water-soluble flavonoid glycoside, alpha G-rutin, in rats.
Chiji, H; Hara, H; Matsukawa, N; Matsumoto, M, 2009
)
0.61
"The bioavailability of polyphenols in human and rodents has been discussed regarding their biological activity."( Different profiles of quercetin metabolites in rat plasma: comparison of two administration methods.
Ishisaka, A; Kawai, Y; Murota, K; Nishikawa, T; Saito, S; Terao, J, 2009
)
0.67
"The effect of apple pectin (AP) on quercetin and rutin bioavailability was investigated."( Chronic ingestion of apple pectin can enhance the absorption of quercetin.
Iwai, K; Matsue, H; Nishijima, T; Saito, Y; Takida, Y, 2009
)
0.87
"01) increased the absolute bioavailability (AB) of etoposide to 12."( Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats.
Choi, JS; Li, X, 2009
)
0.74
"The dietary bioavailability of the isoflavone genistein is decreased in older rats compared to young adults."( The kinetic basis for age-associated changes in quercetin and genistein glucuronidation by rat liver microsomes.
Blumberg, JB; Bolling, BW; Chen, CY; Court, MH, 2010
)
0.62
" These results indicated that P-glycoprotein and Multidrug Resistance Protein 2 might play important roles in limiting the bioavailability of those compounds."( Permeation of astilbin and taxifolin in Caco-2 cell and their effects on the P-gp.
Gao, LB; Liu, T; Meng, MX; Wang, XD; Xu, Q; Zeng, S, 2009
)
0.35
"Epigallocatechin gallate (EGCG), a main anticancer component in green tea, has a poor bioavailability in rats and humans due to oxidation, metabolism and its efflux."( Studies on the effects of oral administration of nutrient mixture, quercetin and red onions on the bioavailability of epigallocatechin gallate from green tea extract.
Gawande, S; Ivanov, V; Kale, A; Kotwal, S; Netke, S; Niedzwiecki, A; Rath, M; Roomi, W, 2010
)
0.6
" The data suggest that quercetin acts as a protective agent in mouse corpus cavernosum, increasing the bioavailability of exogenous nitric oxide by protecting it from superoxide anion (O(2)(-))."( Protective effect of quercetin, a polyphenolic compound, on mouse corpus cavernosum.
Ertuğ, PU; Oğülener, N; Olguner, AA; Singirik, E, 2010
)
0.99
" In vivo, these effects could result in reduced activation of procarcinogens and/or in drug bioavailability limitation."( CYP1A1 and CYP3A4 modulation by dietary flavonoids in human intestinal Caco-2 cells.
Dupont, I; Larondelle, Y; Pussemier, L; Schneider, YJ; Scippo, ML; Sergent, T; Van der Heiden, E, 2009
)
0.35
"Quercetin has been shown to possess beneficial pharmacological properties in treatment of heart disease, but lack of stability and bioavailability limits its clinical use."( 3,3',4',5,7-Pentamethylquercetin reduces angiotensin II-induced cardiac hypertrophy and apoptosis in rats.
Du, X; Liang, Y; Mao, Z; Sun, Z, 2009
)
2.11
" We conclude that chronic ingestion of high doses of the flavonol quercetin will decrease the bioavailability of simvastatin to a significant extent."( Effects of the flavonol quercetin on the bioavailability of simvastatin in pigs.
Cermak, R; Langguth, P; Wein, S; Wolffram, S, 2009
)
0.9
"Contribution of intestinal bacterial degradation of quercetin aglycone to the promotive effects of fructooligosaccharides and di-D-fructose anhydride III (DFAIII) on quercetin-3-O-beta-glucoside (Q3G) bioavailability was examined."( Nondigestible saccharides suppress the bacterial degradation of quercetin aglycone in the large intestine and enhance the bioavailability of quercetin glucoside in rats.
Hagio, M; Hara, H; Inoue, R; Matsukawa, N; Matsumoto, M; Shinoki, A, 2009
)
0.84
" These results demonstrate the feasibility of developing a diet-based combinatorial approach for CaP prevention and treatment and raise the possibility that serum added to culture medium might affect uptake, bioavailability and biological efficacy of dietary phytochemicals."( Targeting CWR22Rv1 prostate cancer cell proliferation and gene expression by combinations of the phytochemicals EGCG, genistein and quercetin.
Hsieh, TC; Wu, JM, 2009
)
0.56
"Quercetin is a plant-derived flavonoid widely known by its anti-oxidant and anti-inflammatory properties, but its oral bioavailability is very poor and this becomes difficult to assess its therapeutic potential."( Anti-inflammatory effect of quercetin-loaded microemulsion in the airways allergic inflammatory model in mice.
Andrade, EL; Calixto, JB; Chaves, JS; Dora, CL; Lemos-Senna, E; Rogerio, AP; Silva, LF, 2010
)
2.1
" However, their bioavailability and, in particular, their intestinal absorption mechanism have not yet been clearly identified."( Quercetin and naringenin transport across human intestinal Caco-2 cells.
Al Ahmad, A; Muller, CD; Nait Chabane, M; Peluso, J; Ubeaud, G, 2009
)
1.8
"In our experimental conditions, quercetin and naringenin were poorly absorbed by Caco-2 cells."( Quercetin and naringenin transport across human intestinal Caco-2 cells.
Al Ahmad, A; Muller, CD; Nait Chabane, M; Peluso, J; Ubeaud, G, 2009
)
2.08
" However, low oral bioavailability of quercetin due to insolubility in water has limited its use as a food additive or dietary supplement."( Enzymatically modified isoquercitrin, alpha-oligoglucosyl quercetin 3-O-glucoside, is absorbed more easily than other quercetin glycosides or aglycone after oral administration in rats.
Kanemaru, M; Makino, T; Mizukami, H; Moriwaki, M; Shimizu, R; Suzuki, Y, 2009
)
0.87
"The bioavailability and urinary excretion of three dietary flavonoids, quercetin, hesperetin and naringenin, were investigated."( Relative bioavailability of the flavonoids quercetin, hesperetin and naringenin given simultaneously through diet.
Bredsdorff, L; Haraldsdóttir, J; Knuthsen, P; Krogholm, KS; Rasmussen, SE, 2010
)
0.86
" The relative bioavailability of DHQ after the administration of Flamena D amounted to 159% in comparison to that of the parent substance of DHQ."( [Comparative pharmacokinetics of dihydroquercetin in rats upon peroral administration of a parent compound and liposomal flamen D].
Gekkiev, BI; Gorlov, VV; Grigor'ev, AM; Kolyvanov, GB; Litvin, AA; Sariev, AK; Viglinskaia, AO; Zherdev, VP, 2010
)
0.63
"Although the flavonol quercetin is used as a supplement in commercial dog food, data on quercetin bioavailability in dogs are not available."( Oral bioavailability of quercetin from different quercetin glycosides in dogs.
Abraham, G; Cermak, R; Reinboth, M; Ungemach, FR; Wolffram, S, 2010
)
0.98
" Co-effectors in the extract improve the bioavailability of active constituents such as hypericin (1) (pharmacokinetic synergy)."( Lessons learned from herbal medicinal products: the example of St. John's Wort (perpendicular).
Butterweck, V; Nahrstedt, A, 2010
)
0.36
" These results demonstrate that quercetin-mediated stimulation of eNOS phosphorylation increases NO bioavailability in endothelial cells and can thus play a role in the vascular protective effects associated with improved endothelial cell function."( Dietary flavonoid quercetin stimulates vasorelaxation in aortic vessels.
Constance, C; Inoue, T; Khoo, NK; Parks, DA; Patel, RP; Pozzo-Miller, L; White, CR; Zhou, F, 2010
)
0.98
" Our data show that the regiospecific glucosylation of flavonoids by the quercetin 5-O-glucosyltransferase can greatly affect the overall bioavailability of flavonoids in animals."( The silkworm Green b locus encodes a quercetin 5-O-glucosyltransferase that produces green cocoons with UV-shielding properties.
Daimon, T; Hirayama, C; Kanai, M; Katsuma, S; Kosegawa, E; Meng, Y; Nakamura, M; Ruike, Y; Shimada, T; Tsujimoto, G, 2010
)
0.87
" Recently, the clinical use of temozolomide (TMZ) has become the more commonly used analog of DTIC-related oral agents because of its greater bioavailability and ability to cross the blood brain barrier."( Quercetin abrogates chemoresistance in melanoma cells by modulating deltaNp73.
Burd, R; Limesand, KH; Mendoza, EE; Mitchell, GC; Radhakrishnan, VM; Sittadjody, S; Thangasamy, T, 2010
)
1.8
" However, flavonoid bioavailability is often poor probably due to their interaction with plasma proteins."( Flavonoid binding to human serum albumin.
Ascenzi, P; Bolli, A; Fanali, G; Fasano, M; Marino, M; Rimbach, G, 2010
)
0.36
" However, bioavailability of quercetin is a concern for such treatment."( Formulation and evaluation of quercetin polycaprolactone microspheres for the treatment of rheumatoid arthritis.
Krithica, N; Madhan, B; Natarajan, V; Sehgal, PK, 2011
)
0.95
" We examined the effect of alpha-oligoglucosylation of the sugar moiety of quercetin monoglucoside on its bioavailability in humans."( alpha-Oligoglucosylation of a sugar moiety enhances the bioavailability of quercetin glucosides in humans.
Fujikura, Y; Kashino, Y; Kato, Y; Koda, T; Matsuda, N; Murota, K; Nakamura, T; Okuyama, S; Sekido, K; Shimizu, R; Tanaka, H; Terao, J, 2010
)
0.82
" The findings presented in this work provide evidence concerning the bioavailability of almond skin polyphenols considering the effects of both phase II and microbial metabolism."( Targeted analysis of conjugated and microbial-derived phenolic metabolites in human urine after consumption of an almond skin phenolic extract.
Andrés-Lacueva, C; Bartolomé, B; Garrido, I; Gómez-Cordovés, C; Llorach, R; Martín-Alvarez, PJ; Monagas, M; Urpi-Sarda, M, 2010
)
0.36
" Since their low bioavailability is a major obstacle to biomedical applications, efforts are being made to improve their absorption and slow down phase II metabolism."( Determination of quercetin and resveratrol in whole blood--implications for bioavailability studies.
Biasutto, L; Garbisa, S; Marotta, E; Paradisi, C; Zoratti, M, 2010
)
0.7
"The flavonol quercetin in plants and foods occurs predominantly in the form of glycoside whose sugar moiety affects the bioavailability and the mechanism of its biological activities."( Transformation of rutin to antiproliferative quercetin-3-glucoside by Aspergillus niger.
Ahn, HJ; Ji, GE; You, HJ, 2010
)
0.99
" The ATP-binding cassette efflux transporter, breast cancer resistance protein (Bcrp, Abcg2), is involved in the transport of quercetin and represents a possible mechanism for the low bioavailability of quercetin."( The bioflavonoid kaempferol is an Abcg2 substrate and inhibits Abcg2-mediated quercetin efflux.
An, G; Gallegos, J; Morris, ME, 2011
)
0.8
" Although bioavailability was variable depending on the source, a healthy diet contains amounts of quercetin that might give sufficient amounts in brain to induce, by monoamine oxidase A inhibition, a small decrease in neurotransmitter breakdown."( Dietary inhibitors of monoamine oxidase A.
Dixon Clarke, SE; Ramsay, RR, 2011
)
0.59
" The results demonstrated that the tricin-alanine-glutamic acid conjugate exhibited enhanced permeability, stability in MDCK cells, and excellent bioavailability after oral administration in Crl:CD (SD) male rats."( Increased bioavailability of tricin-amino acid derivatives via a prodrug approach.
Koketsu, M; Muto, Y; Ninomiya, M; Tanaka, K; Tsuchida, Y; Watanabe, K, 2011
)
0.37
"With the aim to enhance dissolution rate and oral bioavailability of quercetin, a poorly water-soluble drug, quercetin loaded nanosuspension (QT-NS) was fabricated by a tandem of nano-precipitation (NP) and high pressure homogenization (HPH) method."( Development of nanosuspension formulation for oral delivery of quercetin.
Cao, F; Gao, Y; Guo, C; Li, H; Pei, Y; Sun, M; Yu, A; Zhai, G, 2010
)
0.83
" Future studies should be designed to account for a disease process in which the pathogenic factors may take place for years before disease manifestations take place, the possibly limited bioavailability of polyphenols, and the potential need to provide combinations or modifications of polyphenols."( Polyphenols: planting the seeds of treatment for the metabolic syndrome.
Cherniack, EP, 2011
)
0.37
" Quercetin significantly decreased bioavailability of enrofloxacin and its transformation to ciprofloxacin."( Pharmacokinetic-pharmacodynamic indices of enrofloxacin in Escherichia coli O78/H12 infected chickens.
Haritova, A; Lashev, L; Lutckanov, M; Petrov, V; Urumova, V, 2011
)
1.28
" In conclusion, quercetin and rutin decreased the bioavailability of CSP through activating P-gp and CYP3A."( Quercetin and rutin reduced the bioavailability of cyclosporine from Neoral, an immunosuppressant, through activating P-glycoprotein and CYP 3A4.
Chao, PD; Chen, CT; Hou, YC; Lin, SP; Tsai, SY; Wu, PP; Yu, CP, 2011
)
2.16
" The purpose of this study was to investigate the effect of oral quercetin on the bioavailability and pharmacokinetics of orally and intravenously administered doxorubicin in rats."( Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin.
Choi, JS; Kang, KW; Piao, YJ, 2011
)
1
" The absorption rate of flavonoid glycoside was lower than that of aglycone; the flavonoids from Abelmoschus manihot flowers could be absorbed in all of the intestinal segments."( [Absorption of flavonoids from Abelmoschus manihot extract by in situ intestinal perfusion].
Duan, JA; Guo, JM; Qian, DW; Shu, Y; Xue, CF, 2011
)
0.37
" The bioavailability of quercetin in humans may be influenced by the food matrix in which it is consumed as well as by its chemical and physical form."( Enriched cereal bars are more effective in increasing plasma quercetin compared with quercetin from powder-filled hard capsules.
Adolphi, B; Bosy-Westphal, A; Egert, S; Hubbermann, EM; Langguth, P; Müller, MJ; Rimbach, G; Schulze, B; Schwarz, K; Wolffram, S, 2012
)
0.93
" The cocrystals outperformed QUE dihydrate with increases in bioavailability up to nearly 10-fold."( Cocrystals of quercetin with improved solubility and oral bioavailability.
Kavuru, P; Shytle, RD; Smith, AJ; Wojtas, L; Zaworotko, MJ, 2011
)
0.73
"In current study, a self-nanoemulsifying drug delivery system (SNEDDS) of persimmon (Diospyros kaki) leaf extract (PLE) was developed and characterized to compare its in vitro dissolution and relative bioavailability with commercially available tablets (Naoxinqing tablets)."( Self-nanoemulsifying drug delivery system of persimmon leaf extract: Optimization and bioavailability studies.
Chen, S; Li, W; Wang, Z; Xie, J; Xin, S; Yi, S; Zhao, C, 2011
)
0.37
" In addition, the bioavailability of quercetin to the lens is considered."( Eye lens in aging and diabetes: effect of quercetin.
Karasu, C; Stefek, M, 2011
)
0.91
" Antioxidant flavonoids such as quercetin have been reported to be beneficial to human health, but their low water solubility and bioavailability limit their enteric administration."( Study of quercetin-loaded liposomes as potential drug carriers: in vitro evaluation of human complement activation.
Caleiro Seixas Azzolini, AE; Chrysostomo, TN; de Oliveira, CA; Landi-Librandi, AP; Lucisano-Valim, YM; Marzocchi-Machado, CM, 2012
)
1.08
" The concurrent targeting of quercetin's multiple bioactivities presents a potent chemopreventative strategy, but because bioavailability of quercetin is poor it will be necessary to develop quercetin analogs to maximize the full chemopreventative potential of the compound."( Quercetin as a systemic chemopreventative agent: structural and functional mechanisms.
Burd, R; Mendoza, EE, 2011
)
2.1
" We conclude that NQC with greater bioavailability offers significantly higher potency in downregulating MMP-9 and NOS-2 as well as oxidative stress in blocking ethanol-induced gastric ulcer."( The use of nano-quercetin to arrest mitochondrial damage and MMP-9 upregulation during prevention of gastric inflammation induced by ethanol in rat.
Chakraborty, S; Choudhury, ST; Das, N; Ghosh, S; Stalin, S; Swarnakar, S, 2012
)
0.72
" The effect of quercetin on bioavailability and metabolism of GTPs was confirmed in vivo."( Quercetin increased bioavailability and decreased methylation of green tea polyphenols in vitro and in vivo.
Heber, D; Henning, SM; Wang, P, 2012
)
2.17
" Consumption of the OP led to faster absorption, higher concentration, and greater bioavailability as compared to the AP."( Pharmacokinetics of quercetin absorption from apples and onions in healthy humans.
Lee, J; Mitchell, AE, 2012
)
0.7
"Our results suggest that the mechanisms through ISQ and extracts of Tropaeolum majus increase diuresis in SHR rats are mainly related to ACE inhibition, increased bioavailability of bradykinin, PGI2, and nitric oxide, besides an inhibitory effect on Na(+)/K(+)-ATPase."( Mechanisms underlying the diuretic effects of Tropaeolum majus L. extracts and its main component isoquercitrin.
Da Silva-Santos, JE; Gasparotto Junior, A; Gasparotto, FM; Kassuya, CA; Leme, Tdos S; Lourenço, EL; Marques, MC; Prando, TB; Rattmann, YD, 2012
)
0.38
") bioavailability of glucosamine."( Absorption and bioavailability of glucosamine in the rat.
Aghazadeh-Habashi, A; Gilzad-kohan, MH; Ibrahim, A; Jamali, F, 2012
)
0.38
" The bioavailability of isorhamnetin, quercetin and kaempferol in rats remarkably increased after oral administration of TFH SD formulations compared to TFH, but there was no significant increase after oral administration of TFH SE formulations."( Effects of solid dispersion and self-emulsifying formulations on the solubility, dissolution, permeability and pharmacokinetics of isorhamnetin, quercetin and kaempferol in total flavones of Hippophae rhamnoides L.
Duan, J; Li, G; Lin, G; Luo, H; Xie, Y; Yuan, X; Zhao, G, 2013
)
0.86
"Glycosylation is an important method for the structural modification of various flavonols, resulting in the glycosides with increased solubility, stability and bioavailability compared with the corresponding aglycone."( Synthesis of flavonol 3-O-glycoside by UGT78D1.
Fang, Q; Hou, J; Liu, X; Ren, G; Sun, H; Wang, PG; Zhang, L, 2012
)
0.38
"The aim of our study was to enhance the bioavailability of ranolazine by using herbal-bioenhancer quercetin in rats and to study the role of P-glycoprotein (P-gp) in vitro models."( Influence of quercetin on the pharmacokinetics of ranolazine in rats and in vitro models.
Babu, KN; Babu, PJ; Babu, PR; Peter, PL; Rajesh, K, 2013
)
0.98
" This is in part due to low bioavailability in plasma and in the brain, as well as the nature of the actual active molecules."( Life or death: neuroprotective and anticancer effects of quercetin.
Dajas, F, 2012
)
0.62
" Although quercetin and quercetin-containing plants exhibit potential as therapeutic modalities in neuropathology and in cancer, the data collectively highlight the need to elucidate issues such as bioavailability as well as its correlation with effectiveness at biomarkers in vivo."( Life or death: neuroprotective and anticancer effects of quercetin.
Dajas, F, 2012
)
1.03
" High-performance liquid chromatography coupled to time-of-flight mass spectrometry (HPLC-ESI-TOF-MS) was used for the bioavailability study."( Bioavailability study of a polyphenol-enriched extract from Hibiscus sabdariffa in rats and associated antioxidant status.
Barrajón-Catalán, E; Beltrán-Debón, R; Borrás-Linares, I; Fernández-Arroyo, S; Fernández-Gutiérrez, A; Herranz-López, M; Joven, J; Micol, V; Segura-Carretero, A, 2012
)
0.38
"The bioavailability of quercetin has been intensively investigated in monogastric species, but knowledge about its bioavailability in ruminants does not exist."( Bioavailability of the flavonol quercetin in cows after intraruminal application of quercetin aglycone and rutin.
Berger, LM; Blank, R; Metges, CC; Wein, S; Wolffram, S, 2012
)
0.97
" Direct antioxidant effect of flavonoids in vivo was not apparent probably due to low bioavailability although indirect redox effects through stimulation of the antioxidant response element cannot be excluded."( Antioxidant capacity of flavonoids in hepatic microsomes is not reflected by antioxidant effects in vivo.
Duthie, G; Morrice, P, 2012
)
0.38
" A single dose of Q aglycone reduces BP in hypertensive men through a mechanism that is independent of changes in ACE activity, ET-1, or nitric oxide bioavailability and without affecting vascular reactivity."( Acute, quercetin-induced reductions in blood pressure in hypertensive individuals are not secondary to lower plasma angiotensin-converting enzyme activity or endothelin-1: nitric oxide.
Bruno, RS; Guo, Y; Ives, S; Jalili, T; Larson, A; Richardson, RS; Symons, JD; Witman, MA, 2012
)
0.83
" The bioavailability and pharmacokinetic properties of quercetin are influenced by the type of sugars attached to the molecule."( Production of 3-O-xylosyl quercetin in Escherichia coli.
Kim, BG; Malla, S; Pandey, RP; Simkhada, D; Sohng, JK, 2013
)
0.94
") should be further investigated and be explored to obtain higher bioavailability and better activity for hyperoside."( Application of microdialysis for elucidating the existing form of hyperoside in rat brain: comparison between intragastric and intraperitoneal administration.
Duan, JA; Guo, JM; Lin, P; Qian, DW; Shang, EX; Tang, YP, 2012
)
0.38
" In order to maximize the bioavailability of quercetin for its use in efficacy studies, it is important to determine its ideal oral carrier system and route for its delivery."( Comparison of quercetin pharmacokinetics following oral supplementation in humans.
Clarkson, PM; Conca, KR; Dunne, CP; Kaushik, D; Michniak-Kohn, B; O'Fallon, K, 2012
)
1
" Following the oral administration of clopidogrel with or without the P-gp inhibitors, quercetin (250 mg/kg), telmisartan (8 mg/kg), and cyclosporine A (10 mg/kg), in rats and dogs, the plasma concentration-time profiles of clopidogrel carboxylic acid, a surrogate marker for the bioavailability of clopidogrel, were determined."( Pharmacokinetic interactions of clopidogrel with quercetin, telmisartan, and cyclosporine A in rats and dogs.
Lee, JH; Lee, YJ; Oh, JH; Shin, YJ, 2012
)
0.86
"Many bioactive compounds are hydrophobic materials that are crystalline at ambient and body temperatures, which reduces their bioavailability and poses challenges to their successful incorporation into pharmaceuticals and functional foods."( Encapsulation and release of hydrophobic bioactive components in nanoemulsion-based delivery systems: impact of physical form on quercetin bioaccessibility.
McClements, DJ; Mendoza, S; Pool, H; Xiao, H, 2013
)
0.59
"Since it is known that dietary fats improve the bioavailability of the flavonol quercetin, we purposed to investigate whether this effect is due to increased lymphatic transport of quercetin."( Influence of fatty acid patterns on the intestinal absorption pathway of quercetin in thoracic lymph duct-cannulated rats.
Cermak, R; Murota, K; Terao, J; Wolffram, S, 2013
)
0.85
" Our findings of the effective reduction of amyloid aggregation of lysozyme by polyphenol mixtures in vitro are of the utter physiological relevance considering the bioavailability and low toxicity of tested phenols."( Amyloid aggregation of lysozyme: the synergy study of red wine polyphenols.
Gazova, Z; Kurin, E; Mučaji, P; Nagy, M; Siposova, K, 2013
)
0.39
"Epidemiologic evidence supports that dietary quercetin reduces cardiovascular disease (CVD) risk, but its oral bioavailability is paradoxically low."( Dietary fat increases quercetin bioavailability in overweight adults.
Bruno, RS; Chun, OK; Davis, CG; Ferruzzi, MG; Guo, Y; Jalili, T; Mah, E, 2013
)
0.96
"Dietary fat improves quercetin bioavailability by increasing its absorption, likely by enhancing its micellarization at the small intestine."( Dietary fat increases quercetin bioavailability in overweight adults.
Bruno, RS; Chun, OK; Davis, CG; Ferruzzi, MG; Guo, Y; Jalili, T; Mah, E, 2013
)
1.02
" Furthermore, dietary sugars and flavonoids in fruits and vegetables may modulate Asc bioavailability via inhibition of small intestinal GLUT2 and GLUT8."( Intestinal dehydroascorbic acid (DHA) transport mediated by the facilitative sugar transporters, GLUT2 and GLUT8.
Al-Hasani, H; Corpe, CP; Eck, P; Levine, M; Wang, J, 2013
)
0.39
" It has been shown recently that bioavailability of quercetin is low after ruminal administration in cows because of degradation by the ruminal microbiota."( Bioavailability of quercetin from its aglycone and its glucorhamnoside rutin in lactating dairy cows after intraduodenal administration.
Gohlke, A; Ingelmann, CJ; Metges, CC; Nürnberg, G; Starke, A; Wolffram, S, 2013
)
0.97
" However, the low water solubility of quercetin limits its bioavailability to exhibit activity in vivo."( Anti-allergic effects of enzymatically modified isoquercitrin (α-oligoglucosyl quercetin 3-O-glucoside), quercetin 3-O-glucoside, α-oligoglucosyl rutin, and quercetin, when administered orally to mice.
Kanemaru, M; Makino, T; Mizukami, H; Okuyama, S; Shimizu, R; Tanaka, H, 2013
)
0.89
" To improve the bioavailability of QC, numerous approaches have been undertaken, involving the use of promising drug delivery systems such as inclusion complexes, liposomes, nanoparticles or micelles, which appear to provide higher solubility and bioavailability."( Bioavailability of quercetin: problems and promises.
Cai, X; Dou, J; Fang, Z; Yu, A; Zhai, G, 2013
)
0.72
" It was concluded that the inclusion complex could improve the aqueous solubility and bioavailability of ACADFE."( Encapsulation of a flavonoid-rich Allium cepa L. var. agrogatum don extract in β-cyclodextrin for transdermal drug delivery.
Ding, Z; Guo, Q; Wu, M; Yang, X; Zhang, B, 2013
)
0.39
" The bioavailability and efficacy of antioxidants in human corneal limbal epithelial (HCLE) cells were measured to determine whether antioxidants might be beneficial constituents of lubricant eye drops."( Bioavailability of antioxidants applied to stratified human corneal epithelial cells.
Koetje, LR; Mitchell, AK; Schotanus, MP; Stoddard, AR; Ubels, JL, 2013
)
0.39
"Quercetin (QT) was formulated into a novel self-emulsifying drug delivery system (SEDDS) to improve its oral bioavailability and antioxidant potential compared to free drug."( Novel self-emulsifying formulation of quercetin for improved in vivo antioxidant potential: implications for drug-induced cardiotoxicity and nephrotoxicity.
Jain, AK; Jain, S; Pohekar, M; Thanki, K, 2013
)
2.1
" Further studies are needed to determine the bioavailability of these compounds and their possible beneficial health effects when taken by moderate beer consumption."( Beer and beer compounds: physiological effects on skin health.
Becker, T; Chen, W; Qian, F; Ring, J, 2014
)
0.4
" Bioflavonoids like quercetin are reported to have poor bioavailability and limited therapeutic potential against stress induced neurological disorders."( Quercetin along with piperine prevents cognitive dysfunction, oxidative stress and neuro-inflammation associated with mouse model of chronic unpredictable stress.
Kumar, A; Rinwa, P, 2017
)
2.22
" Finally, the challenges of developing flavonoid delivery systems that improve flavonoid bioavailability and their anticancer therapy potentials were summarized."( Delivering flavonoids into solid tumors using nanotechnologies.
Chen, M; Wang, S; Wang, Y; Zhang, J, 2013
)
0.39
" Here, we aimed to estimate the effect of prenylation on the bioavailability of dietary quercetin (Q)."( Prenylation enhances quercetin uptake and reduces efflux in Caco-2 cells and enhances tissue accumulation in mice fed long-term.
Fujikura, Y; Kawamura, T; Matsui, N; Minekawa, S; Mukai, R; Murota, K; Nemoto, H; Terao, J; Uehara, M, 2013
)
0.93
" At the same time, higher Caco-2 cell uptake revealed its potential for oral delivery, which was well corroborated with in vivo pharmacokinetics, which suggested ∼ 5-fold and ∼ 3-fold increase in oral bioavailability as compared to the free Tmx citrate and free QT, respectively."( Co-encapsulation of tamoxifen and quercetin in polymeric nanoparticles: implications on oral bioavailability, antitumor efficacy, and drug-induced toxicity.
Jain, AK; Jain, S; Thanki, K, 2013
)
0.67
" These effects are associated with improvements in nitric oxide bioavailability and are critically related to arterial induction of HO-1."( Dietary quercetin attenuates oxidant-induced endothelial dysfunction and atherosclerosis in apolipoprotein E knockout mice fed a high-fat diet: a critical role for heme oxygenase-1.
Croft, KD; Hodgson, JM; Maghzal, GJ; Puddey, IB; Shen, Y; Stocker, R; Wang, Y; Ward, NC; Zhang, D, 2013
)
0.82
" These data suggest that the inhibition of SULTs by flavonoids and in vivo flavonoid conjugates may modify the bioavailability of dietary hydroxycinnamic acids by suppressing their conversion to sulfated metabolites."( Inhibition of hydroxycinnamic acid sulfation by flavonoids and their conjugated metabolites.
Williamson, G; Wong, CC,
)
0.13
" Quercetin glucosides, which are enzymatically trans-glycosylated isoquercitrin, have high water-solubility and bioavailability compared with quercetin."( Quercetin glucosides promote ischemia-induced angiogenesis, but do not promote tumor growth.
Ohki, T; Sata, M; Shibata, H; Sumi, M; Tateishi, N, 2013
)
2.74
"Quercetin (Q), a common dietary flavonoid, has gained research attention in cancer chemo-prevention, but its low level of aqueous solubility, stability, cellular bioavailability has limited its application."( Quercetin-nanostructured lipid carriers: characteristics and anti-breast cancer activities in vitro.
Fan, Z; Nie, S; Pan, X; Sun, M; Wang, S; Zhang, R, 2014
)
3.29
"The chemopreventive activity of green tea (GT) is limited by the low bioavailability and extensive methylation of GT polyphenols (GTPs) in vivo."( Enhanced inhibition of prostate cancer xenograft tumor growth by combining quercetin and green tea.
Doan, N; Heber, D; Henning, SM; Magyar, CE; Said, JW; Vadgama, JV; Wang, P, 2014
)
0.63
"The biochemical activities of plant flavonoids and stilbenoids point to many health-related applications, hampered however by a low bioavailability associated with rapid metabolic modification."( Prodrugs of quercetin and resveratrol: a strategy under development.
Biasutto, L; Zoratti, M, 2014
)
0.78
" More research is needed to overcome the issues of poor water solubility and relatively low bioavailability of quercetin as the major obstacles limiting its clinical use."( Site-specific anticancer effects of dietary flavonoid quercetin.
Sak, K, 2014
)
0.86
" However, the generally low solubility, stability, bioavailability and target specificity, together with the side effects seen when used at high levels, have limited their application."( Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals.
Moustaid-Moussa, N; Nie, S; Su, R; Sun, M; Wang, S; Wu, D; Zhang, J, 2014
)
0.4
"This study aims to improve the drug oral bioavailability by co-administration with flavonoid inhibitors of the CYP2C isozyme and to establish qualitative and quantitative (QSAR) structure-activity relationships (SAR) between flavonoids and CYP2C."( Dietary flavonoids modulate CYP2C to improve drug oral bioavailability and their qualitative/quantitative structure-activity relationship.
Hsiong, CH; Hu, OY; Lee, MS; Pao, LH; Shih, TY; Wang, HJ, 2014
)
0.4
" However, poor oral bioavailability of these flavonoids limits the clinical applications of TFH."( Phytic acid enhances the oral absorption of isorhamnetin, quercetin, and kaempferol in total flavones of Hippophae rhamnoides L.
Duan, J; Hong, C; Ji, G; Li, G; Luo, H; Ma, P; Wu, T; Xie, Y; Zhang, T, 2014
)
0.65
"The oral bioavailability of isorhamnetin, kaempferol, and quercetin in TFH was enhanced by the co-administration of IP6."( Phytic acid enhances the oral absorption of isorhamnetin, quercetin, and kaempferol in total flavones of Hippophae rhamnoides L.
Duan, J; Hong, C; Ji, G; Li, G; Luo, H; Ma, P; Wu, T; Xie, Y; Zhang, T, 2014
)
0.89
"Quercetin is a dietary flavonoid with potential chemoprotective effects, but has low bioavailability because of poor aqueous solubility and low intestinal absorption."( Quercetin-containing self-nanoemulsifying drug delivery system for improving oral bioavailability.
Bruno, RS; Guo, Y; Lu, X; Song, D; Tran, TH, 2014
)
3.29
" Isorhamnetin was poorly absorbed by both passive diffusion and active transport mechanisms."( Transport characteristics of isorhamnetin across intestinal Caco-2 cell monolayers and the effects of transporters on it.
Duan, J; Li, G; Luo, H; Wu, T; Xie, Y; Zhang, T, 2014
)
0.4
"Biological activities of flavonoids in vivo are ultimately dependent on the systemic bioavailability of the aglycones as well as their metabolites."( A physiologically based kinetic (PBK) model describing plasma concentrations of quercetin and its metabolites in rats.
Boonpawa, R; Punt, A; Rietjens, IM; Spenkelink, A, 2014
)
0.63
" Our results suggest that polyphenolic compounds might be potential structural bases and source to find and project nature-based, safe, orally bioavailable direct thrombin inhibitors."( Thrombin inhibitory activity of some polyphenolic compounds.
Bijak, M; Krotkiewski, H; Nowak, P; Pawlaczyk, I; Ponczek, M; Saluk, J; Wachowicz, B; Ziewiecki, R, 2014
)
0.4
" Isoquercitrin has higher bioavailability than quercetin and displays a number of chemoprotective effects both in vitro and in vivo, against oxidative stress, cancer, cardiovascular disorders, diabetes and allergic reactions."( Isoquercitrin: pharmacology, toxicology, and metabolism.
Bancířová, M; Křen, V; Ulrichová, J; Valentová, K; Vrba, J, 2014
)
0.66
" These nanocrystalline drugs have enhanced solubility in neutral aqueous medium at room temperature and thus exhibit better bioavailability than their commercially available microcrystalline form."( A lucid build-up of nanostructured curcumin, quercetin and their interaction with DNA.
Annaraj, J; Rajasekaran, M, 2014
)
0.66
" The goal of loading quercetin into nanoparticles was to improve its permeation across the blood-brain barrier into the brain, and its bioavailability to reach target cells."( Loading into nanoparticles improves quercetin's efficacy in preventing neuroinflammation induced by oxysterols.
Badilli, U; Biasi, F; Calfapietra, S; Cavalli, R; Gamba, P; Gargiulo, S; Guina, T; Leonarduzzi, G; Maina, M; Poli, G; Testa, G, 2014
)
1
"The current review emphasizes on the herbal bioenhancers which themselves do not possess inherent pharmacological activity of their own but when co-administered with Active Pharmaceutical Ingredients (API), enhances their bioavailability and efficacy."( Role of herbal bioactives as a potential bioavailability enhancer for Active Pharmaceutical Ingredients.
Alexander, A; Kumari, L; Qureshi, A; Saraf, S; Sharma, M; Vaishnav, P, 2014
)
0.4
" However, its low bioavailability is a major obstacle for biomedical applications, so the experiment is designed to prepare taxifolin nanoparticles by liquid antisolvent precipitation (LAP) to improve its bioavailability."( Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.
Li, Y; Wang, W; Wu, W; Zhang, Y; Zhao, X; Zhong, C; Zu, Y, 2014
)
0.4
" The bioavailability of Quercetin was lowered from the polyherbal formulation when compared with the co-administration, whereas the Rutin bioavailability has increased from the polyherbal formulation when compared with the co-administration."( Comparative pharmacokinetic interactions of Quercetin and Rutin in rats after oral administration of European patented formulation containing Hipphophae rhamnoides and Co-administration of Quercetin and Rutin.
Agrawal, A; Chintala, J; Dubey, GP; Kaliappan, I; Kammalla, AK; Ramasamy, MK, 2015
)
0.99
" However, the bioavailability of flavonoids across the blood-brain barrier and the localization in the brain remain controversial."( Specific localization of quercetin-3-O-glucuronide in human brain.
Ishisaka, A; Kawai, Y; Mukai, R; Shibata, N; Terao, J, 2014
)
0.71
"Quercetin (QUE) is a flavonoid with antioxidant/anti-inflammatory properties, poorly absorbed when orally administered."( Chitosan-xanthan gum microparticle-based oral tablet for colon-targeted and sustained delivery of quercetin.
Caddeo, C; Díez-Sales, O; Fadda, AM; Manconi, M; Merino-Sanjuán, M; Nácher, A, 2014
)
2.06
"To prepare chitosan/xanthan gum microparticles to increase QUE oral bioavailability and optimize its release in the colon."( Chitosan-xanthan gum microparticle-based oral tablet for colon-targeted and sustained delivery of quercetin.
Caddeo, C; Díez-Sales, O; Fadda, AM; Manconi, M; Merino-Sanjuán, M; Nácher, A, 2014
)
0.62
"An amphiphilic carboxymethyl chitosan-quercetin (CQ) conjugate was designed and synthesized for oral delivery of paclitaxel (PTX) to improve its oral bioavailability by increasing its water solubility and bypassing the P-gp drug efflux pumps."( Amphiphilic carboxymethyl chitosan-quercetin conjugate with P-gp inhibitory properties for oral delivery of paclitaxel.
Chen, Y; Dahmani, FZ; Wang, X; Yao, J; Yin, L; Zhou, J, 2014
)
0.95
" Their efficacy has been tested in tumor xenografted mice and considerable experimental findings have stimulated researchers to further improve the bioavailability of these nutraceuticals."( Targeting cancer with nano-bullets: curcumin, EGCG, resveratrol and quercetin on flying carpets.
Aras, A; Farooqi, AA; Hechenleitner, AA; Khokhar, AR; Pineda, EA; Qureshi, MZ; Silva, MF; Sobczak-Kupiec, A, 2014
)
0.64
" The present work is aimed to enhance the bioavailability of etoposide by co-administering it with quercetin (a P-gp inhibitor) in dual-loaded polymeric nanoparticle formulation."( Novel flavonoid-based biodegradable nanoparticles for effective oral delivery of etoposide by P-glycoprotein modulation: an in vitro, ex vivo and in vivo investigations.
Fatma, S; Goswami, DG; Iqbal, Z; Negi, LM; Panda, AK; Talegaonkar, S; Tariq, M, 2016
)
0.65
" Our data indicated that liposomal quercetin can significantly improve the solubility and bioavailability of quercetin and can be used as an effective antioxidant for ROS protection within the polar cytoplasm, and the nano-sized quercetin encapsulated by liposomes enhanced the cellular uptake (cancer cell human MCF_7)."( Intracellular ROS protection efficiency and free radical-scavenging activity of quercetin and quercetin-encapsulated liposomes.
Barzegar, A; Eidi, A; Rezaei-Sadabady, R; Zarghami, N, 2016
)
0.94
" Derivatives are under development with the aim of improving their bioavailability and/or bioefficacy."( Improving the efficacy of plant polyphenols.
Azzolini, M; Biasutto, L; Mattarei, A; Paradisi, C; Romio, M; Sassi, N; Zoratti, M, 2014
)
0.4
" Our study highlights a novel mechanism for the regulation of iron bioavailability by dietary polyphenols."( Quercetin inhibits intestinal iron absorption and ferroportin transporter expression in vivo and in vitro.
Balesaria, S; Debnam, ES; Hoque, R; Lesjak, M; Sharp, PA; Skinner, V; Srai, SK, 2014
)
1.85
" In this context, we reviewed the sometimes paradoxical antioxidant properties of quercetin and the functional role of its glucuronide and/or sulfate conjugates to discuss the low bioavailability of the molecule measured in vivo."( The pleiotropic flavonoid quercetin: from its metabolism to the inhibition of protein kinases in chronic lymphocytic leukemia.
Russo, GL; Russo, M; Spagnuolo, C, 2014
)
0.93
" The knowledge of this process would be useful to understand the bioavailability of these compounds."( Stability of iron-quercetin complexes in synthetic wine under in vitro digestion conditions.
Altamirano, JC; Camargo, AB; Escudero, LB; Fusari, CM; Wuilloud, RG, 2014
)
0.74
"Proanthocyanidins (PCs) with poor bioavailability were argued for their health benefits."( Characterisation of water-soluble proanthocyanidins of Pyracantha fortuneana fruit and their improvement in cell bioavailable antioxidant activity of quercetin.
Lei, DJ; Song, GH; Xu, H; Yu, LJ; Zhang, H; Zhao, CF, 2015
)
0.62
" Considering the low bioavailability of quercetin, appropriate regulation of MATE1 expression may optimize cellular quercetin concentrations and promote health benefits."( Multidrug and toxic compound extrusion protein-1 (MATE1/SLC47A1) is a novel flavonoid transporter.
Jun, HJ; Kim, Y; Lee, H; Lee, JE; Lee, JH; Lee, SJ, 2014
)
0.67
"Quercetin bioavailability exhibits high interindividual variation for reasons that remain unclear."( Quercetin bioavailability is associated with inadequate plasma vitamin C status and greater plasma endotoxin in adults.
Bruno, RS; Guo, Y; Mah, E,
)
3.02
" Greater quercetin absorption and bioavailability may be associated with poor vitamin C status and increased intestinal permeability in healthy adults."( Quercetin bioavailability is associated with inadequate plasma vitamin C status and greater plasma endotoxin in adults.
Bruno, RS; Guo, Y; Mah, E,
)
1.99
"This study selected γ-cyclodextrin (γ-CD) as the inclusion material and prepared inclusion complex of taxifolin-γ-CD by the emulsion solvent evaporation and the freeze drying combination method to achieve the improvement of the solubility and oral bioavailability of taxifolin."( The high water solubility of inclusion complex of taxifolin-γ-CD prepared and characterized by the emulsion solvent evaporation and the freeze drying combination method.
Li, Y; Wu, W; Zhang, Y; Zhao, X; Zhong, C; Zu, Y, 2014
)
0.4
" Concurrently, investigations aimed at improvement of the bioavailability of Q and further elucidation of its metabolism after application in combination with anthracyclines are needed."( The flavonoid quercetin: possible solution for anthracycline-induced cardiotoxicity and multidrug resistance.
Czepas, J; Gwoździński, K, 2014
)
0.76
" Bioavailability of dietary constituents is a critical mediator of their health benefits."( Endogenous and exogenous mediators of quercetin bioavailability.
Bruno, RS; Guo, Y, 2015
)
0.69
" After oral administration of TFH-PC in rats, the bioavailability of isorhamnetin, kaempferol, and quercetin in TFH-PC relative to TFH was 223%, 172%, and 242%, respectively."( A phospholipid complex to improve the oral bioavailability of flavonoids.
Cui, Y; Deng, B; Fu, Q; Li, G; Wang, H; Wu, T; Xie, Y; Yang, J, 2015
)
0.63
" In vivo oral bioavailability study was conducted for 1:2 binary amorphous form by using pure RTV as a control."( Fabrication, solid state characterization and bioavailability assessment of stable binary amorphous phases of Ritonavir with Quercetin.
Bhat, K; Dengale, SJ; Gautham Shenoy, G; Hussen, SS; Krishna, BS; Musmade, PB, 2015
)
0.62
" These findings suggested that the oral bioavailability of isorhamnetin and quercetin in beagle dogs can be significantly increased in TFH-SD and TFH-SE preparations compared to TFH preparations, which was helpful to explore the new forms for oral administration TFH and explain their in vivo processes."( A comparison of the pharmacokinetics of three different preparations of total flavones of Hippophae rhamnoides in beagle dogs after oral administration.
Dang, Y; Duan, J; Li, G; Ma, P; Meng, H; Wang, H; Wu, T; Xie, Y, 2016
)
0.66
"Despite their strong role in human health, poor bioavailability of flavonoids limits their biological effects in vivo."( Antiproliferative activity of long chain acylated esters of quercetin-3-O-glucoside in hepatocellular carcinoma HepG2 cells.
Rupasinghe, HV; Sudan, S, 2015
)
0.66
"The physiological functions and bioavailability of flavonoids have been widely investigated since their bioactivities were identified about 80 years ago."( Quercetin and related polyphenols: new insights and implications for their bioactivity and bioavailability.
Ishisaka, A; Kawabata, K; Mukai, R, 2015
)
1.86
" The aim of this study was to investigate the oral bioavailability of the flavonol quercetin, applied either as quercetin aglycone (QA) or as its glucorhamnoside rutin (RU), in newborn dairy calves."( Bioavailability of the flavonol quercetin in neonatal calves after oral administration of quercetin aglycone or rutin.
Bruckmaier, RM; Hammon, HM; Kanitz, E; Maciej, J; Schäff, CT; Tuchscherer, A; Wolffram, S, 2015
)
0.93
" We conducted a two-period, two-sequence crossover study to compare the bioavailability of quercetin when administered in the form of a fresh red onion meal (naturally glycosylated quercetin) or dietary supplement (aglycone quercetin) under fasting conditions."( Comparison of the urinary excretion of quercetin glycosides from red onion and aglycone from dietary supplements in healthy subjects: a randomized, single-blinded, cross-over study.
Shi, Y; Williamson, G, 2015
)
0.91
" Therefore, a strategy to improve the solubility of quercetin in water and/or enhance the bioavailability is desired."( Enhancing the anti-colon cancer activity of quercetin by self-assembled micelles.
Gao, X; Gong, D; Gou, H; Huang, N; Ren, L; Shi, H; Xu, G, 2015
)
0.93
" In addition, a scope of the new insights concerning quercetin pharmacokinetics, pharmacodynamics and bioavailability are presented."( Cardiovascular Disease: A Target for the Pharmacological Effects of Quercetin.
Gormaz, JG; Quintremil, S; Rodrigo, R, 2015
)
0.9
"38-fold increase in relative bioavailability as compared with quercetin suspension (C(max), 369."( LC-ESI-MS/MS analysis of quercetin in rat plasma after oral administration of biodegradable nanoparticles.
Singh, SK; V, DK; Verma, PR; Viswanathan, S, 2015
)
0.96
" Integration of these complexes into liposomes may increase their bioavailability and therapeutic effect."( Integration of Quercetin-Iron Complexes into Phosphatidylcholine or Phosphatidylethanolamine Liposomes.
Kim, YA; Kuznetsova, SM; Muzafarov, EN; Tarahovsky, YS; Yagolnik, EA, 2015
)
0.77
"Quercetin (QT) is a potential bioflavonol and antioxidant with poor bioavailability and very low distribution in the brain."( Poly(n-butylcyanoacrylate) nanoparticles for oral delivery of quercetin: preparation, characterization, and pharmacokinetics and biodistribution studies in Wistar rats.
Bagad, M; Khan, ZA, 2015
)
2.1
" These NPs were observed to improve the drugs' oral bioavailability and enhance their transport to the brain."( Poly(n-butylcyanoacrylate) nanoparticles for oral delivery of quercetin: preparation, characterization, and pharmacokinetics and biodistribution studies in Wistar rats.
Bagad, M; Khan, ZA, 2015
)
0.66
" The blood and brain bioavailability of free quercetin after ingestion is a complex and controversial process that produces final low concentrations, a fact that has led to suggestions that metabolites would be active by themselves and/or as pro-drugs that would release the active aglycone in the brain."( Quercetin in brain diseases: Potential and limits.
Abin-Carriquiry, JA; Arredondo, F; Blasina, F; Dajas, F; Echeverry, C; Martínez, M; Rivera, F; Vaamonde, L, 2015
)
2.12
" These polymeric systems can serve as prodrug carriers for the delivery of bioactive compounds which suffer from poor aqueous solubility, low bioavailability and are biologically unstable, such as the antioxidant, quercetin."( Quercetin conjugated poly(β-amino esters) nanogels for the treatment of cellular oxidative stress.
Authimoolam, SP; Dziubla, TD; Gupta, P; Hilt, JZ, 2015
)
2.05
" In this study, two kinds of QC-loaded self-aggregates based on O-carboxymethyl chitosan-cholic acid conjugates (CMCA) were developed to improve the drug bioavailability in which glycyrrhetinic acid (GA) modification was utilized in the nanocarrier fabrication (QC-GA-CMCA) or not (QC-CMCA)."( The role of glycyrrhetinic acid modification on preparation and evaluation of quercetin-loaded chitosan-based self-aggregates.
Du, H; Liu, M; Yang, X; Zhai, G, 2015
)
0.65
" While the drug-drug interaction potential between flavonoids and co-ingested drugs still remain an issue, opportunities exist for the combination of flavonoids with suitable anti-cancer drugs to enhance the bioavailability of anti-cancer drugs and thereby reduce the dose size of the anti-cancer drugs and improve its therapeutic index."( Recent trends in preclinical drug-drug interaction studies of flavonoids--Review of case studies, issues and perspectives.
Srinivas, NR, 2015
)
0.42
" The implications for improved bioavailability of the NP formulations were supported by cytotoxicity results that showed a similar efficacy to free dual drug formulations and even enhanced anti-cancer effects in the recovery condition."( Dual drug delivery of tamoxifen and quercetin: Regulated metabolism for anticancer treatment with nanosponges.
Beezer, DB; Harth, E; Kravitz, A; Lockhart, JN; Stevens, DM, 2015
)
0.69
" The bioavailability of flavonoids from fruits and vegetables is frequently affected by the manufacturing process and related conditions."( Effect of Processed Onions on the Plasma Concentration of Quercetin in Rats and Humans.
Hamano, T; Kashino, Y; Matsuda, N; Mukai, R; Murota, K; Terao, J; Tomotake, M, 2015
)
0.66
" The present study estimated the effect of food processing on the bioavailability of onion quercetin aglycone and its glucosides provided through the consumption of onion products."( Effect of Processed Onions on the Plasma Concentration of Quercetin in Rats and Humans.
Hamano, T; Kashino, Y; Matsuda, N; Mukai, R; Murota, K; Terao, J; Tomotake, M, 2015
)
0.88
"Quercetin is a flavonoid with antioxidant/anti-inflammatory properties, poorly absorbed when administered orally."( Cross-linked chitosan/liposome hybrid system for the intestinal delivery of quercetin.
Caddeo, C; Carbone, C; Díez-Sales, O; Ennas, G; Fadda, AM; Manconi, M; Pons, R; Puglisi, G, 2016
)
2.11
" Quercetin does not alter the oral bioavailability of Atorvastatin Calcium in rats."( Quercetin does not alter the oral bioavailability of Atorvastatin in rats.
Babu, N; Challa, SR; Devi, R; Geddam, LB; Koritala, R; Ragam, SK; Sattenapalli, S; Venkatesh Reddy Challa, VR, 2015
)
2.77
"Biological activities of flavonoids in vivo ultimately depend on the systemic bioavailability of the aglycones and their metabolites."( Use of physiologically based kinetic (PBK) modeling to study interindividual human variation and species differences in plasma concentrations of quercetin and its metabolites.
Boonpawa, R; Moradi, N; Punt, A; Rietjens, IM; Spenkelink, A, 2015
)
0.62
" Despite the potential use of Qu in clinical trials, low water solubility, stability problems and the scarcity of cellular bioavailability limit its applications."( Characterization and Antioxidant Activity of Quercetin/Methyl-β-Cyclodextrin Complexes.
Demirel, M; Güleç, K, 2016
)
0.69
" However, the oral bioavailability of this compound is very low due to the high pre-systemic metabolism in the colon and liver and its low water solubility."( Lipid-based nanocarrier for quercetin delivery: system characterization and molecular interactions studies.
Bidone, J; de Lima, VR; Dora, CL; Hädrich, G; Monteiro, SO; Muccillo-Baisch, AL; Putaux, JL; Rodrigues, MR; Teixeira, HF, 2016
)
0.73
" However, the clinical application of this flavonol is limited by its poor bioavailability and low stability in aqueous medium."( Quercetin derivatives as novel antihypertensive agents: Synthesis and physiological characterization.
Angelone, T; Brancale, A; Cantafio, P; Cerra, MC; Ferla, S; Grande, F; Mordocco, RA; Parisi, OI; Puoci, F; Quintieri, AM; Rocca, C; Saturnino, C; Scrivano, L; Sinicropi, MS, 2016
)
1.88
" Quercetin has potent anti-oxidative activities, but poor bioavailability limits its therapeutic application."( Quercetin phospholipid complex significantly protects against oxidative injury in ARPE-19 cells associated with activation of Nrf2 pathway.
Ding, SH; Hang, L; Xu, XR; Yang, XW; Yang, Y; Yu, HT, 2016
)
2.79
" Problems like low oral bioavailability and poor aqueous solubility make quercetin an unreliable candidate for therapeutic purposes."( Application of Bioactive Quercetin in Oncotherapy: From Nutrition to Nanomedicine.
Chakraborty, C; Lee, SS; Nam, JS; Nguyen, LT; Sharma, AR; Sharma, G, 2016
)
0.97
" While senolytic treatment significantly improved vasomotor function (isolated organ chamber baths) in both groups of mice, this was due to increases in nitric oxide bioavailability in aged mice and increases in sensitivity to NO donors in hypercholesterolemic mice."( Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice.
Casaclang-Verzosa, G; Hagler, M; Jurk, D; Kirkland, JL; Miller, JD; Ogrodnik, MB; Palmer, AK; Pirtskhalava, T; Roos, CM; Schafer, MJ; Smith, LA; Tchkonia, T; Thalji, NM; Zhang, B; Zhu, Y, 2016
)
0.43
" However, its poor bioavailability and moderate potency hinder its advancement into clinical therapy."( Synthesis and Anti-Proliferative Effects of Quercetin Derivatives.
Al-Jabban, SM; Chen, G; Chen, QH; Mekuria, EA; Rakotondraibe, LH; Zhang, X, 2015
)
0.68
" We also briefly discuss the approaches to improve the bioavailability of quercetin."( Molecular targets of quercetin with anti-inflammatory properties in atopic dermatitis.
Arumugam, S; Giridharan, VV; Karuppagounder, V; Sreedhar, R; Thandavarayan, RA; Watanabe, K, 2016
)
0.98
"A strategy to circumvent the poor polyphenols bioavailability is to load these compounds into liposomes."( Effect of Quercetin-loaded liposomes on induced oxidative stress in human spermatozoa.
Bonechi, C; Collodel, G; Iacoponi, F; Mazzi, L; Moretti, E; Rossi, C; Salvatici, MC, 2016
)
0.84
"Xiebai in Gualou Xiebai decoction has a remarkable effect on pharmacokinetic character of quercetin in Gualou, it can promote the absorption and distribution and reduce the elimination of quercetin, in vivo, as well as increase the bioavailability of quercetin."( [Influence of the Compatibility of Gualou and Xiebai on Pharmacokinetics of Quercetin in Gualou].
Chen, XJ; Huang, X; Wei, ML; Yan, HY; Zhang, YH; Zou, CC, 2015
)
0.87
" Quercetin (QU) is a polyphenol that has an antioxidant effect in vitro, but due to its high lipophilicity, it has low bioavailability in vivo."( Protective role of free and quercetin-loaded nanoemulsion against damage induced by intracerebral haemorrhage in rats.
Antunes, MF; Barros, DM; Cordeiro, MF; Dora, CL; Galho, AR; Hädrich, G; Horn, AP; Lima, JV; Luz, DC; Marques, MS; Muccillo-Baisch, AL; Ribeiro, SA, 2016
)
1.64
" This review focuses on the physicochemical properties, dietary sources, absorption, bioavailability and metabolism of quercetin, especially main effects of quercetin on inflammation and immune function."( Quercetin, Inflammation and Immunity.
Chaudhry, MT; Han, C; Li, Y; Liu, H; Wang, S; Yang, J; Yao, J; Yin, Y, 2016
)
2.09
"The aim of this study was to develop hyperoside (Hyp) nanocrystals to enhance its dissolution rate, oral bioavailability and anti-HBV activity."( Hyperoside nanocrystals for HBV treatment: process optimization, in vitro and in vivo evaluation.
Han, J; Lu, Y; Shen, B; Shen, C; Wang, Y; Wu, N; Wu, W; Wu, Y; Xu, P; Yuan, H; Zhang, F; Zhang, L, 2016
)
0.43
" These activities, associated to a good predictive bioavailability and a lack of cytotoxicity, design it as a promising hit for further in vivo investigation."( Novel benzylidenephenylpyrrolizinones with pleiotropic activities potentially useful in Alzheimer's disease treatment.
Corvaisier, S; Cresteil, T; Dallemagne, P; El Kihel, L; Jourdan, JP; Lecoutey, C; Legay, R; Malzert-Fréon, A; Rochais, C; Since, M; Sopkova-de Oliveira Santos, J, 2016
)
0.43
" The aim of this study was to develop a lecithin-based mixed polymeric micelle (LMPM) delivery system to improve the solubility and bioavailability of Que."( Development and characterization of self-assembling lecithin-based mixed polymeric micelles containing quercetin in cancer treatment and an in vivo pharmacokinetic study.
Chen, LC; Chen, YC; Ho, HO; Hong, CS; Sheu, MT; Su, CY, 2016
)
0.65
" Certain flavonoids, in particular quercetin, have been shown to ameliorate endothelial dysfunction and reduce blood pressure (BP), possibly by increasing the bioavailability of the potent vasodilator nitric oxide (NO)."( Acute effects of quercetin-3-O-glucoside on endothelial function and blood pressure: a randomized dose-response study.
Bondonno, CP; Bondonno, NP; Croft, KD; Hodgson, JM; Mas, E; Rich, L; Shinde, S; Ward, NC, 2016
)
1.05
" Flavonoid bioavailability and bioactivity depend on structure, conjugation and the cell type to which they are presented."( Flow Cytometric Method for the Detection of Flavonoids in Cell Lines.
Gonzales, GB; Grootaert, C; Raes, K; Smagghe, G; Van Camp, J; Van de Wiele, T; Vissenaekens, H, 2016
)
0.43
"Plant polyphenols showed useful biochemical characteristics in vitro; however, the assessments of their clinical applications in vivo are restricted by their limited bioavailability due to their strong resistance to 1st-pass effects during absorption."( Esterification of Quercetin Increases Its Transport Across Human Caco-2 Cells.
Chen, F; Deng, ZY; He, Y; Hu, JN; Zou, XG, 2016
)
0.77
"The tranquillizing effects of quercetin on allergic asthma are promising, but its poor water solubility and bioavailability is still a bottleneck."( Reversion of Asthmatic Complications and Mast Cell Signalling Pathways in BALB/c Mice Model Using Quercetin Nanocrystals.
Chaudhari, BP; Das, M; Dwivedi, PD; Gupta, K; Gupta, RK; Kumar, S; Sharma, A; Singh, SP; Stalin, K; Verma, AK, 2016
)
0.94
" Hence, in order to enhance the bioavailability of curcumin, we combined it with the bioavailability enhancers like piperine and quercetin."( Influence of piperine and quercetin on antidiabetic potential of curcumin.
Chintamaneni, M; Invally, M; Kaur, G, 2016
)
0.94
" Low aqueous solubility of quercetin limits its bioavailability and hence therapeutic effects."( Development and evaluation of PLGA polymer based nanoparticles of quercetin.
Al-Mansoor, MA; Al-Shdefat, R; Ansari, MN; Anwer, MK; Jamil, S; Shakeel, F, 2016
)
0.97
" However, poor water solubility as well as less bioavailability has confined its use as a suitable anti-cancer drug."( Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells.
Chowdhury, S; Ghosh, S; Pandey, B; Sarkar, A; Sil, PC, 2016
)
0.75
"MSN-FA-Q facilitates higher cellular uptake and allows more drug bioavailability to the breast cancer cells with over-expressed folate receptors."( Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells.
Chowdhury, S; Ghosh, S; Pandey, B; Sarkar, A; Sil, PC, 2016
)
0.75
" However, the bioavailability of QT is relatively low due to its low solubility which severely limits its use."( Development of quercetin-phospholipid complex to improve the bioavailability and protection effects against carbon tetrachloride-induced hepatotoxicity in SD rats.
Chen, X; Gu, L; Hu, G; Jia, J; Liu, Z; Zhang, K; Zhang, M; Zhang, Y, 2016
)
0.79
" These results suggest that an improvement in the oral bioavailability of quercetin occurred when this compound was dissolved in the oily phase of a nanosized emulsion, indicating that it might have a potential application in the treatment of melanoma."( Oral Delivery of a High Quercetin Payload Nanosized Emulsion: In Vitro and In Vivo Activity Against B16-F10 Melanoma.
Assreuy, J; Baischl, AL; Dora, CL; Fernandes, D; Lemos-Senna, E; Maioral, MF; Mazzarino, L; Pacheco, LK; Santos-Silva, MC; Silva, LF; Siqueira, JM, 2016
)
0.97
" It was demonstrated that Que was able to reduce the bioavailability of CsA following multiple concomitant doses in rats."( Impact of quercetin‑induced changes in drug‑metabolizing enzyme and transporter expression on the pharmacokinetics of cyclosporine in rats.
Liu, Y; Luo, X; Shi, S; Yang, C; Yang, T; Zhou, J, 2016
)
0.84
" To provide a complete picture of QE, its distribution, chemistry, biosynthesis and bioavailability are reported."( Hepatoprotective effect of quercetin: From chemistry to medicine.
Alavian, SM; Daglia, M; Miltonprabu, S; Nabavi, SF; Nabavi, SM; Rastrelli, L; Skalicka-Woźniak, K; Tomczyk, M, 2017
)
0.75
"Zein nanoparticles were evaluated as nanocarriers to promote the oral bioavailability of quercetin and, thus, improve its anti-inflammatory effect on a mouse model of induced endotoxemia."( Zein nanoparticles for oral delivery of quercetin: Pharmacokinetic studies and preventive anti-inflammatory effects in a mouse model of endotoxemia.
Esparza, I; Gamazo, C; González-Navarro, CJ; Irache, JM; Penalva, R, 2017
)
0.94
" Initial studies suggested poor bioavailability of quercetin."( The Antidiabetic Potential of Quercetin: Underlying Mechanisms.
Eid, HM; Haddad, PS, 2017
)
1
" The absorption of quercetin and its in vivo bioavailability were significantly improved by proliposome, which was evidenced by the in situ intestinal absorption and pharmacokinetic study."( Quercetin-containing self-assemble proliposome preparation and evaluation.
Du, Q; Fang, Z; Jiang, L; Ren, J, 2017
)
2.23
" To improve bypassing P-gp drug efflux pumps and oral bioavailability of doxorubicin hydrochloride (DOX), Multilayer micro-dispersing system (MMS) was constructed by co-immobilization of DOX loaded chitosan/carboxymethyl chitosan nanogels (DOX:CS/CMCS-NGs), along with quercetin (Qu) in the core of multilayer sodium alginate beads (DOX:NGs/Qu-M-ALG-Beads)."( Multilayer micro-dispersing system as oral carriers for co-delivery of doxorubicin hydrochloride and P-gp inhibitor.
Chen, XG; Cheng, XJ; Feng, C; Kong, M; Li, J; Li, Y; Liu, Y; Mu, Y; Raja, MA, 2017
)
0.63
" Quercetin glycosides have also received some attention due to their high bioavailability and activity against various diseases including cancer."( Structural insights into the polypharmacological activity of quercetin on serine/threonine kinases.
Al Halabi, W; Al Homedi, Z; Antony, P; Baby, B; Vijayan, R, 2016
)
1.59
" NLCs substantially enhanced the relative bioavailability (approx."( Promises of a biocompatible nanocarrier in improved brain delivery of quercetin: Biochemical, pharmacokinetic and biodistribution evidences.
Katare, OP; Kumar, P; Kumar, R; Malik, R; Raza, K; Sharma, G; Singh, B, 2016
)
0.67
" Quercetin and quercetin-rich foods have been reported to have wide range of health promoting effects, especially in the prevention and management of several diseases; however, the subject of its solubility and bioavailability has limited its use."( Quercetin and Its Role in Chronic Diseases.
Ademosun, AO; Oboh, G; Ogunsuyi, OB, 2016
)
2.79
" The aim of this work was to evaluate the capability of nanoencapsulated quercetin in zein nanoparticles (NPQ), that significantly improves the oral absorption and bioavailability of the flavonoid, as potential oral treatment for AD."( Effect of the oral administration of nanoencapsulated quercetin on a mouse model of Alzheimer's disease.
Irache, JM; Moreno, LCGEI; Puerta, E; Ramirez, MJ; Santos-Magalhães, NS; Suárez-Santiago, JE, 2017
)
0.94
" However, Q bioavailability is relatively low, due to its poor aqueous solubility and extensive phase-II metabolism."( Novel cellulose-based amorphous solid dispersions enhance quercetin solution concentrations in vitro.
Arca, HC; Edgar, KJ; Gilley, AD; Mosquera-Giraldo, LI; Neilson, AP; Nichols, BLB; Taylor, LS, 2017
)
0.7
" The rapid gastrointestinal digestion of quercetin is also a major obstacle for its clinical implementation due to low bioavailability and poor aqueous solubility."( 3',5-dihydroxy-3,4',7-trimethoxyflavone-induces ER-stress-associated HCT-116 programmed cell death via redox signaling.
Han, J; Kang, SC; Singh, MP, 2017
)
0.72
"A set of O-substituted quercetin derivatives was prepared with the aim to optimize bioavailability and redox properties of quercetin, a known agent with multiple health beneficial effects."( Novel quercetin derivatives: From redox properties to promising treatment of oxidative stress related diseases.
Horakova, L; Prnova, M; Rackova, L; Stefek, M; Zizkova, P, 2017
)
1.25
" These results, together with the innate properties of quercetin, contribute to an understanding of the low bioavailability of quercetin."( Towards an Understanding of the Low Bioavailability of Quercetin: A Study of Its Interaction with Intestinal Lipids.
Buchweitz, M; Kroon, PA; Rich, GT; Wilde, PJ; Winterbone, MS, 2017
)
0.95
" However, the slow dissolution rate leading to poor bioavailability constitutes a barrier to being further developed for nutritional products."( Preparation and characterization of quercetin/dietary fiber nanoformulations.
Chan, KP; Dong, Y; Khor, CM; Ng, WK, 2017
)
0.73
"The results revealed that enhanced bioavailability of rivastigmine might be caused by the combination of their effects due to CYP3A and esterase inhibition, Therefore, concomitant administration of NQC influences the bioavailability of rivastigmine and also has synergetic effect in the treatment of Alzheimer's disease."( Enhancement of oral bioavailability of rivastigmine with quercetin nanoparticles by inhibiting CYP3A4 and esterases.
Neerati, P; Palle, S, 2017
)
0.7
" Numerous attempts are taken for improving the bioavailability of polyphenols in order to increase their use in the body."( Polyphenols in preventing endothelial dysfunction.
Biegańska-Hensoldt, S; Rosołowska-Huszcz, D, 2017
)
0.46
" However, the optimum intake of flavonoids from supplements or diet has not been clarified yet, because a number of exogenous and endogenous factors modulating their bioavailability affect their vascular function."( Factors modulating bioavailability of quercetin-related flavonoids and the consequences of their vascular function.
Terao, J, 2017
)
0.73
" This quercetin nanoparticle with a particle size of around 35 nm significantly improved the bioavailability and metabolic stability of the parent quercetin."( Quercetin Remodels the Tumor Microenvironment To Improve the Permeation, Retention, and Antitumor Effects of Nanoparticles.
Goodwin, TJ; Hu, K; Huang, L; Li, J; Liu, Q; Miao, L, 2017
)
2.38
" Different types of formulations have been designed for the improvement of bioavailability of these compounds, nanonization being one of the most notable approaches among them."( Polyphenol nanoformulations for cancer therapy: experimental evidence and clinical perspective.
Abdollahi, M; Bahramsoltani, R; Davatgaran-Taghipour, Y; Farzaei, MH; Karimi-Soureh, Z; Masoomzadeh, S; Rahimi, R, 2017
)
0.46
"Quercetin, a dietary flavonol phytoestrogen, has many health benefits but it is poorly absorbed when administered orally."( Enhanced therapeutic benefit of quercetin-loaded phytosome nanoparticles in ovariectomized rats.
Abd El-Fattah, AI; Ali, ZY; El-Garawany, AEA; Fathy, MM; Mohamed, EK, 2017
)
2.18
" DoxQ provides a novel therapeutic approach to mitigate the cardiotoxicity and poor oral bioavailability of doxorubicin."( Mechanistically elucidating the in vitro safety and efficacy of a novel doxorubicin derivative.
Alrushaid, S; Anderson, HD; Chaboyer, K; Davies, NM; El-Kadi, AOS; Forrest, ML; Maayah, ZH; Sayre, CL; Senadheera, SN; Zhao, Y, 2017
)
0.46
" Concurrent administration of RES and QUR was able to enhance the bioavailability of RES."( Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction.
Kandasamy, R; Muthusamy, S; Natesan, S; Palanichamy, R; Pandian, S; Ponnusamy, C, 2017
)
0.74
"The effect of diabetes on the pharmacokinetics, bioavailability and brain distribution of grape polyphenols and select metabolites was studied in the Zucker diabetic fatty (ZDF) rat model."( Influence of diabetes on plasma pharmacokinetics and brain bioavailability of grape polyphenols and their phase II metabolites in the Zucker diabetic fatty rat.
Chen, TY; Cooper, B; Ferruzzi, MG; Ho, L; Janle, EM; Pasinetti, GM; Simon, JE; Talcott, ST; Todd, G; Wang, J; Wu, QL, 2017
)
0.46
"Diabetes may alter the overall bioavailability of some polyphenols in plasma and brain in part due to higher urinary clearance."( Influence of diabetes on plasma pharmacokinetics and brain bioavailability of grape polyphenols and their phase II metabolites in the Zucker diabetic fatty rat.
Chen, TY; Cooper, B; Ferruzzi, MG; Ho, L; Janle, EM; Pasinetti, GM; Simon, JE; Talcott, ST; Todd, G; Wang, J; Wu, QL, 2017
)
0.46
" To evaluate the extent of bioavailability for QMNE via post-intranasal (i."( Intranasal delivery of quercetin-loaded mucoadhesive nanoemulsion for treatment of cerebral ischaemia.
Abdur Rub, R; Ahmad, FJ; Ahmad, N; Ahmad, R; Alam, MA; Ashafaq, M; Naqvi, AA, 2018
)
0.79
" However, a key problem is their short half-life and low bioavailability under in vivo conditions."( Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
Benlloch, M; Castellano, G; Dellinger, RW; Estrela, JM; Mena, S; Obrador, E; Salvador, R, 2017
)
0.46
" Quite often however their instability, extensive metabolization, low bioavailability and poor solubility limit their application in cancer prevention and therapy."( Nanoparticle formulations to enhance tumor targeting of poorly soluble polyphenols with potential anticancer properties.
Bonferoni, MC; Ferrari, F; Rossi, S; Sandri, G, 2017
)
0.46
" However low oral bioavailability and poor cell membrane permeability restrict its therapeutic efficacy."( Triphenyl phosphonium coated nano-quercetin for oral delivery: Neuroprotective effects in attenuating age related global moderate cerebral ischemia reperfusion injury in rats.
Choudhury, ST; Das, N; Ghosh, S; Ghosh, T; Sarkar, S, 2017
)
0.73
"We hypothesized that metabolites of dietary flavonoids attenuate impairments in nitric oxide (NO) bioavailability evoked by glucotoxic conditions mimicking Type 1 or 2 diabetes."( Metabolites of flavonoid compounds preserve indices of endothelial cell nitric oxide bioavailability under glucotoxic conditions.
Babu, PVA; Jalili, T; Qian, Y; Symons, JD, 2017
)
0.46
"Drug nanosuspension is one of the established methods to improve the bioavailability of poorly soluble drugs."( Production of drug nanosuspensions: effect of drug physical properties on nanosizing efficiency.
Liu, T; Möschwitzer, JP; Müller, RH, 2018
)
0.48
" On the other hand, Q1 is poorly soluble in water and unstable in physiological systems, and its bioavailability is very low."( New insights for the use of quercetin analogs in cancer treatment.
Caruso, A; Ceramella, J; Grande, F; Iacopetta, D; Mordocco, RA; Muià, N; Plutino, MR; Puoci, F; Rosano, C; Saturnino, C; Scrivano, L; Sinicropi, MS, 2017
)
0.75
"The results showed that the top 5 active compounds with a relatively higher bioavailability that interacted with 23 therapeutic targets were identified in Vernonia anthelmintica (L."( Network pharmacological mechanisms of Vernonia anthelmintica (L.) in the treatment of vitiligo: Isorhamnetin induction of melanogenesis via up-regulation of melanin-biosynthetic genes.
Chen, H; Chen, HY; Tang, Y; Wang, JY; Wang, XQ; Wang, YY; Zhang, B; Zhang, M, 2017
)
0.46
" These biological effects suggest that FA and Qu display outstanding bioavailability and bioactivity and could be used for treatment of some metabolic syndromes, such as inflammatory bowel diseases and obesity."( Metabolomics Reveals that Dietary Ferulic Acid and Quercetin Modulate Metabolic Homeostasis in Rats.
Dong, M; Tang, H; Wang, Y; Zhang, L, 2018
)
0.73
" INS-LCNPs demonstrated approximately 20% relative bioavailability compared with subcutaneously administered INS."( Insulin- and quercetin-loaded liquid crystalline nanoparticles: implications on oral bioavailability, antidiabetic and antioxidant efficacy.
Agrawal, AK; Jain, S; Kushwah, V; Singh, S, 2018
)
0.85
" Herein, we aimed to formulate marrubiin loaded solid lipid nanoparticles (SLNs) to improve its pharmacokinetics and bioavailability and also to investigate free drug and formulation's protective impact against intracellular reactive oxygen species (ROS) generation in HUVECs."( Marrubiin-loaded solid lipid nanoparticles' impact on TNF-α treated umbilical vein endothelial cells: A study for cardioprotective effect.
Barar, J; Eskandani, M; Garjani, A; Ghafari, S; Nakhlband, A; Omidi, Y; Saeedi, N, 2018
)
0.48
" Absorption rate constant and apparent permeability coefficient of rhodamine 123 were decreased, reflecting efflux function of P-gp in chicken intestine increased by quercetin."( Use of quercetin in animal feed: effects on the P-gp expression and pharmacokinetics of orally administrated enrofloxacin in chicken.
Bhutto, ZA; Guo, T; He, F; Huang, J; Wang, L; Yang, J; Zloh, M, 2018
)
1.13
" Quercetin-3-glucoside, a naturally occurring polyphenol that has high bioavailability and low toxicity, is a promising candidate agent to prevent birth defects in diabetic pregnancies."( Modulation of nuclear factor-κB signaling and reduction of neural tube defects by quercetin-3-glucoside in embryos of diabetic mice.
Meng, F; Reece, EA; Tan, C; Zhao, Z, 2018
)
1.62
" However, their bioavailability is hampered due to their poor aqueous solubility."( Exploring the oxidation and iron binding profile of a cyclodextrin encapsulated quercetin complex unveiled a controlled complex dissociation through a chemical stimulus.
Chatzigiannis, CM; Degano, I; Diamantis, DA; Galaris, D; Gerogianni, PS; Gerothanassis, IP; Karadima, KE; Mavromoustakos, T; Perikleous, S; Ramesova, S; Rekkas, D; Sokolova, R; Tzakos, AG; Valsami, G, 2018
)
0.71
"Quercetin has a variety of biological activities and pharmacological effects, but its clinical application is limited due to its low water solubility, low bioavailability and poor chemical stability."( [Research and application of quercetin-loaded nano drug delivery system].
Du, Q; Li, SJ; Liao, YF, 2018
)
2.21
"5, 5 or 10 mg/kg) for 7 consecutive days reduced the bioavailability of oral CsA."( Quercetin‑3‑O‑β‑D‑glucoside decreases the bioavailability of cyclosporin A through regulation of drug metabolizing enzymes, transporters and nuclear receptors in rats.
Huang, X; Liu, Y; Shi, S; Wan, J; Yang, C; Yang, T; Zhang, R; Zhang, Y; Zhou, J, 2018
)
1.92
" Bioavailability of QCT is very low due to its poor aqueous solubility and instability."( In vitro and in vivo anticancer efficacy potential of Quercetin loaded polymeric nanoparticles.
Baksi, R; Borse, SP; Nivsarkar, M; Rana, R; Sharma, V; Singh, DP, 2018
)
0.73
" 3-O-(N,N-Dibutylamino)propyl-3',4'-dimethoxyflavonol (42) emerged as the most promising derivative due to its substantially improved potency in cell models, superior bioavailability in rats, and good selectivity of inhibiting prostate cancer cell proliferation over non-neoplastic human epithelial cell proliferation."( Structure-activity relationship and pharmacokinetic studies of 3-O-substitutedflavonols as anti-prostate cancer agents.
Chen, G; Chen, QH; Fong, R; Gonzalez, A; Guo, S; Lee, M; Li, X; Rajaram, P; Wang, G; Zhang, C; Zhang, Q; Zheng, S, 2018
)
0.48
"The aim of the present study was to investigate the bioavailability of quercetin from onion bulb (OB) and onion skin (OS) extracts in ruminants."( Bioavailability of Quercetin from Onion Extracts after Intraruminal Application in Cows.
Beyer, B; Blank, RH; Wein, S; Wolffram, S; Zimmermann, BF, 2018
)
1.04
" Moreover, folic acid-bovine serum albumin (FA-BSA) conjugates are applied to stabilize the CuS@ZIF-8-QT to promote the bioavailability of quercetin and realize active-targeting drug delivery."( CuS@MOF-Based Well-Designed Quercetin Delivery System for Chemo-Photothermal Therapy.
Garg, S; Jiang, W; Li, Z; Luan, Y; Wu, J; Zhai, G; Zhang, H, 2018
)
0.98
" However, the low absorption rate of QT, especially through the blood-brain barrier, restricts its bioactivity in the body."( Using superparamagnetic iron oxide nanoparticles to enhance bioavailability of quercetin in the intact rat brain.
Beheshti, S; Enteshari Najafabadi, R; Esmaeili, A; Kazemipour, N; Nazifi, S, 2018
)
0.71
"The results of this study confirm that SPION as a targeted drug delivery system enhances the bioavailability of quercetin in the brain about ten folds higher than free quercetin and could be used for the treatment of neurodegenerative disorders."( Using superparamagnetic iron oxide nanoparticles to enhance bioavailability of quercetin in the intact rat brain.
Beheshti, S; Enteshari Najafabadi, R; Esmaeili, A; Kazemipour, N; Nazifi, S, 2018
)
0.92
" However, the poor bioavailability of quercetin, due to its low aqueous solubility and its degradation during digestion, limits its nutraceutical applications."( Enhanced bioactivity and efficient delivery of quercetin through nanoliposomal encapsulation using rice bran phospholipids.
Almeda, RA; Reyes, CT; Rodriguez, EB; Vidallon, MLP, 2019
)
1.04
"In this study, quercetin-chitosan conjugate (QT-CS) was synthesized for oral delivery of doxorubicin (DOX) to improve its oral bioavailability by increasing its water solubility, opening tight junction and bypassing the P-glycoprotein (P-gp)."( Multifunctional quercetin conjugated chitosan nano-micelles with P-gp inhibition and permeation enhancement of anticancer drug.
Chen, X; Feng, C; Fu, Y; Kong, M; Li, J; Li, Y; Mu, Y; Wang, Y; Wu, X; Yu, X; Zhang, K, 2019
)
1.21
" But the therapeutic application of Qu is hampered by its low oral bioavailability and its unfavourable physicochemical characteristics."( Design, optimization, characterization and in-vivo evaluation of Quercetin enveloped Soluplus®/P407 micelles in diabetes treatment.
Ajmal, G; Mishra, B; Mittal, P; Singh, J; Vasant Bonde, G, 2018
)
0.72
" However, its poor stability in the upper gastro-intestinal tract and low bioavailability compromised its benefits."( A colon-specific delivery system for quercetin with enhanced cancer prevention based on co-axial electrospinning.
Hu, TG; Li, L; Wen, P; Wu, H; Zong, MH, 2018
)
0.75
" Enzymatically modified IQ (EMIQ) is a mixture of transglycosylated IQs that have better solubility and bioavailability than do quercetin and IQ."( High-efficiency enzymatic production of α-isoquercitrin glucosides by amylosucrase from Deinococcus geothermalis.
Choi, JM; Jung, YS; Kim, DO; Kim, ER; Ko, MJ; Park, CS; Rha, CS; Seo, DH, 2019
)
0.72
"5-fold increase in bioavailability of DTX was achieved with improved antitumor efficacy and reduced in vivo toxicity."( Chemosensitizer and docetaxel-loaded albumin nanoparticle: overcoming drug resistance and improving therapeutic efficacy.
Desale, JP; Jain, S; Katiyar, SS; Kushwah, V; Swami, R, 2018
)
0.48
" Current studies are focused on nano-formulations to overcome the low bioavailability of natural quercetin, which limits its clinical use as an antitumor agent."( Potential of the Flavonoid Quercetin to Prevent and Treat Cancer - Current Status of Research.
Břetislav, G; Jana, N; Pavel, S; Pavla, U,
)
0.65
" However, the instability, low water solubility and low bioavailability of QT remain to be solved."( Nanoformulations of quercetin and cellulose nanofibers as healthcare supplements with sustained antioxidant activity.
Chen, W; Li, X; Liu, Y; Yu, H; Yu, Y, 2019
)
0.84
" This work investigated the effects of combined cereal 3-deoxyflavonoids (apigenin, naringenin) and pulse flavonols (quercetin), along with natural extracts, on their bioavailability and underlying mechanisms using Caco-2 monolayer model."( Combined cereal and pulse flavonoids show enhanced bioavailability by downregulating phase II metabolism and ABC membrane transporter function in Caco-2 model.
Agah, S; Awika, J; Kim, H; Ravisankar, S; Talcott, S; Wu, C, 2019
)
0.72
" Low bioavailability of quercetin has also led researchers to construct various quercetin-involved nanoparticles."( Application of quercetin in neurological disorders: from nutrition to nanomedicine.
Amanzadeh, E; Esmaeili, A; Nourbakhshnia, M; Rahgozar, S, 2019
)
1.17
" However, their bioavailability is low."( Quercetin and its metabolite isorhamnetin promote glucose uptake through different signalling pathways in myotubes.
Ashida, H; Croft, K; Jiang, H; Nakamura, A; Yamashita, Y, 2019
)
1.96
" This study aimed to examine: (1) the extent to which quercetin altered the starch digestion and the glycemic potential of the fortified western baked bread as well as oriental steamed bread, (2) the matrix effects of bread on the potential bioaccessibility and bioavailability of quercetin."( In vitro bioaccessibility and bioavailability of quercetin from the quercetin-fortified bread products with reduced glycemic potential.
Leong, LP; Lin, J; Teo, LM; Zhou, W, 2019
)
1.02
"Glycosylation is a key modification for most molecules including plant natural products, for example, flavonoids and isoflavonoids, and can enhance the bioactivity and bioavailability of the natural products."( Crystal structures of rhamnosyltransferase UGT89C1 from Arabidopsis thaliana reveal the molecular basis of sugar donor specificity for UDP-β-l-rhamnose and rhamnosylation mechanism.
Fei, S; Gao, Y; Li, J; Liu, X; Shen, Y; Wang, X; Yang, X; Zong, G, 2019
)
0.51
" However, different preclinical and clinical studies have noted significant shortcomings, such as nonspecific tumor targeting and low bioavailability which limit their usage in therapeutics."( Targeted delivery of quercetin via pH-responsive zinc oxide nanoparticles for breast cancer therapy.
Chatterjee, S; Das, J; Ghosh, N; Kundu, M; Manna, P; Sadhukhan, P; Sil, PC, 2019
)
0.83
" However, QE is poorly soluble in water and slightly soluble in oil, which results in its low oral bioavailability and limits its application in the clinic."( Size-Dependent Biological Effects of Quercetin Nanocrystals.
Gao, J; Liu, Q; Sun, J; Yang, X; Yu, F; Zhang, H; Zheng, A, 2019
)
0.79
" Superparamagnetic iron oxide nanoparticle (SPION) is a novel drug delivery system that enhances the bioavailability of quercetin."( Quercetin conjugated with superparamagnetic iron oxide nanoparticles improves learning and memory better than free quercetin via interacting with proteins involved in LTP.
Abadi, REN; Amanzadeh, E; Beheshti, S; Esmaeili, A; Kazemipour, N; Pahlevanneshan, Z, 2019
)
2.16
"To investigate the effects of water-soluble dietary fibers (pectin, soybean fiber, and guar gum) on the bioavailability of quercetin glucoside mixture (Q3GM) comprising quercetin-3-O-glucoside (Q3G, 31."( Water-soluble dietary fibers enhance bioavailability of quercetin and a fiber derived from soybean is most effective after long-term feeding in rats.
Hara, H; Hira, T; Mizuta, E; Tanaka, S; Trakooncharoenvit, A, 2020
)
1.01
"Water-soluble dietary fibers, especially soybean fiber, enhanced quercetin bioavailability after chronic feeding and may promote beneficial effects of quercetin on disease prevention."( Water-soluble dietary fibers enhance bioavailability of quercetin and a fiber derived from soybean is most effective after long-term feeding in rats.
Hara, H; Hira, T; Mizuta, E; Tanaka, S; Trakooncharoenvit, A, 2020
)
1.04
"The poor water solubility and oral bioavailability of many lipophilic polyphenols can be improved through the use of colloidal delivery systems."( Encapsulation of Lipophilic Polyphenols into Nanoliposomes Using pH-Driven Method: Advantages and Disadvantages.
Liu, C; Liu, W; McClements, DJ; Peng, S; Zhou, W; Zou, L, 2019
)
0.51
" Finally, the study of theoretical physicochemical properties, the observation of low toxicity (hemolysis assay), and the evaluation of oral bioavailability of the TP derivative showed that it is a possible anti-inflammatory drug candidate."(
Castro, RI; Morales-Quintana, L; Valenzuela-Riffo, F, 2019
)
0.51
" Numerous nanoformulations, including solid lipid nanoparticles, polymeric nanoparticles, micelles, and liposomes, have been formulated to enhance the bioavailability and stability, as well as the therapeutic efficacy of polyphenols."( Pharmaceutical Topical Delivery of Poorly Soluble Polyphenols: Potential Role in Prevention and Treatment of Melanoma.
Ashby, CR; Chauhan, H; Heenatigala Palliyage, G; Singh, S; Tiwari, AK, 2019
)
0.51
"Quercetin possesses various health beneficial functions, but its poor bioavailability limits these functions."( Enzymatically modified isoquercitrin promotes energy metabolism through activating AMPKα in male C57BL/6 mice.
Ashida, H; Croft, KD; Horiuchi, Y; Jiang, H; Yamashita, Y; Yoshioka, Y; Yuan, S, 2019
)
1.96
" Glycosylation is a significant method for the structural modification of various flavanols, resulting in glycosides with increased solubility, stability, and bioavailability compared with the corresponding aglycone."( Natural Product Glycosylation: Biocatalytic Synthesis of Quercetin-3,4'-O-diglucoside.
Cai, R; Chen, K; Chen, L; Jia, H; Li, Y; Sun, P; Yan, M, 2020
)
0.8
" Also the ability of each classification system to predict and determine the extent of absorption of the Chinese herbal compound was investigated based on the absolute bioavailability of representative components."( Establishment of modified biopharmaceutics classification system absorption model for oral Traditional Chinese Medicine (Sanye Tablet).
Cao, X; Dou, Z; Li, H; Liu, T; Liu, Y; Ren, X; Wang, M, 2019
)
0.51
" Nuciferine is the best of the five components, with absolute bioavailability reaching 61."( Establishment of modified biopharmaceutics classification system absorption model for oral Traditional Chinese Medicine (Sanye Tablet).
Cao, X; Dou, Z; Li, H; Liu, T; Liu, Y; Ren, X; Wang, M, 2019
)
0.51
"The five representative components (except for nuciferine) are all class III/IV, which correlates well with the absolute bioavailability results and demonstrates that they are poorly absorbed substances."( Establishment of modified biopharmaceutics classification system absorption model for oral Traditional Chinese Medicine (Sanye Tablet).
Cao, X; Dou, Z; Li, H; Liu, T; Liu, Y; Ren, X; Wang, M, 2019
)
0.51
" Thus, the relative oral bioavailability of quercetin when administered as casein nanoparticles (close to 37%) was found to be about 9-times higher than the oral solution of the flavonoid in a mixture of PEG 400 and water."( Casein nanoparticles in combination with 2-hydroxypropyl-β-cyclodextrin improves the oral bioavailability of quercetin.
Esparza, I; González-Navarro, CJ; Irache, JM; Larrañeta, E; Morales-Gracia, J; Peñalva, R, 2019
)
0.99
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
" Herein, we prepared a biodegradable super paramagnetic starch-based hydrogel grafted onto fumaric acid for increasing Quer bioavailability and controlling its release."( Enhancing quercetin bioavailability by super paramagnetic starch-based hydrogel grafted with fumaric acid: An in vitro and in vivo study.
Doosti, M; Hosseini, SH; Mousavi, SN; Rasoulifard, MH; Seyed Dorraji, MS, 2019
)
0.92
" Naturally available phyto chemicals like piperine and quercetin as well as some floroquinolones are known to inhibit MDR1 and CYP3A37 activity and increases bioavailability of co-administered drugs."( Effect of piperine and quercetin alone or in combination with marbofloxacin on CYP3A37 and MDR1 mRNA expression levels in broiler chickens.
Mathapati, BS; Modi, CM; Patel, HB; Patel, UD, 2019
)
1.07
" However, for biological applications, the bioavailability of quercetin is low due to physiological barriers."( Preparation and Characterization of Quercetin-Loaded Zein Nanoparticles by Electrospraying and Study of In Vitro Bioavailability.
Barreras-Urbina, CG; Carvajal-Millan, E; Castro-Enríquez, DD; Del-Toro-Sánchez, CL; Javier Cinco-Moroyoqui, F; Juárez, J; López-Ahumada, GA; Rodríguez-Félix, F; Ruiz-Cruz, S; Tapia-Hernández, JA, 2019
)
1.03
" This article aims to review the current literature on the bioavailability of quercetin and kaempferol from food sources and evaluate the potential cardiovascular effects in humans."( Dietary Quercetin and Kaempferol: Bioavailability and Potential Cardiovascular-Related Bioactivity in Humans.
Dabeek, WM; Marra, MV, 2019
)
1.18
" Nonetheless, their low bioavailability forecasts controversy about mechanisms on their in vivo scavenging activity against reactive oxygen species (ROS)."( Antioxidant effect of phenolic compounds (PC) at different concentrations in IEC-6 cells: A spectroscopic analysis.
Alvarez-Parrilla, E; Barraza-Garza, G; Castillo-Michel, H; Cotte, M; de la Rosa, LA; Martinez-Martinez, A; Pérez-León, JA, 2020
)
0.56
"We recently showed that quercetin-conjugated iron oxide nanoparticles (QNPs) promoted the bioavailability of quercetin (Qu) in the brain of rats and improved the learning and memory of diabetic rats."( The antitoxic effects of quercetin and quercetin-conjugated iron oxide nanoparticles (QNPs) against H
Esmaeili, A; Ghaedi, K; Rahgozar, S; Yarjanli, Z; Zarrabi, A, 2019
)
1.12
" Bulk quercetin has low bioavailability and thus, from obtained data we suggest that LA-Q-ORMOSIL nanoparticles provide high therapeutic value in protecting experimental animals against CP-induced liver injury."( Lactobionic Acid Conjugated Quercetin Loaded Organically Modified Silica Nanoparticles Mitigates Cyclophosphamide Induced Hepatocytotoxicity.
Flora, SJ; Naqvi, S; Sharma, H, 2019
)
1.29
" Enzymatically modified isoquercitrin (EMIQ®) has a bioavailability 17-fold higher than quercetin aglycone and has shown potential CVD moderating effects in animal studies."( Enzymatically modified isoquercitrin improves endothelial function in volunteers at risk of cardiovascular disease.
Bondonno, CP; Bondonno, NP; Croft, KD; Hodgson, JM; Ward, NC; Woodman, RJ, 2020
)
0.78
" The strategy plays the solubility advantage of INH to improve the bioavailability of the insoluble QCT, thereby significantly enhancing the QCT's hepatoprotective effects."( A new cocrystal of isoniazid-quercetin with hepatoprotective effect: The design, structure, and in vitro/in vivo performance evaluation.
Li, YT; Liu, F; Wang, LY; Wu, ZY; Yan, CW; Yu, MC, 2020
)
0.85
" Its bioavailability is, however, low and, therefore, its metabolites could rather be responsible for this effect."( A Mixture of Phenolic Metabolites of Quercetin Can Decrease Elevated Blood Pressure of Spontaneously Hypertensive Rats Even in Low Doses.
Mladěnka, P; Najmanová, I; Pourová, J, 2020
)
0.83
"Quercetin, a pigment (flavonoid) found in many plants and foods, has good effects on protecting liver function but poor solubility and bioavailability in vivo."( Protective and therapeutic effects of nanoliposomal quercetin on acute liver injury in rats.
Hu, Y; Liao, M; Liu, L; Liu, X; Pan, Y; Yang, P; Zhang, Y, 2020
)
2.25
" The nanoliposomal quercetin showed high bioactivity and bioavailability in rat liver and markedly attenuated the liver index and pathologic changes in injured liver tissue."( Protective and therapeutic effects of nanoliposomal quercetin on acute liver injury in rats.
Hu, Y; Liao, M; Liu, L; Liu, X; Pan, Y; Yang, P; Zhang, Y, 2020
)
1.14
"Liposomal nanoparticles may improve the solubility and bioavailability of quercetin in liver."( Protective and therapeutic effects of nanoliposomal quercetin on acute liver injury in rats.
Hu, Y; Liao, M; Liu, L; Liu, X; Pan, Y; Yang, P; Zhang, Y, 2020
)
1.04
" These molecules have poor bioavailability that may remain as the limiting factor in their clinical effects."( Natural polyphenols in preclinical models of epilepsy.
Dhir, A, 2020
)
0.56
"05) antioxidant activity of consumers' blood compared to control bread consumption, indicating good bioavailability of flavonols."( Thermal stability and bioavailability of bioactive compounds after baking of bread enriched with different onion by-products.
Bedrníček, J; Jirotková, D; Kadlec, J; Laknerová, I; Samková, E; Smetana, P; Tříska, J; Vrchotová, N, 2020
)
0.56
"In this study, whey protein isolate (WPI)-quercetin (Que)-lotus root amylopectin (LRA) hydrogels (WPI-QUE-LRA) was developed to improve the solubility, stability and bioavailability of quercetin."( The hydrogel of whey protein isolate coated by lotus root amylopectin enhance the stability and bioavailability of quercetin.
Li, QM; Liu, K; Luo, JP; Pan, LH; Shen, WD; Zha, XQ, 2020
)
1.03
" However, the hydrophobic nature, poor bioavailability and low cellular uptake of most natural agents limit their therapeutic effectiveness."( Efficient synergistic combination effect of Quercetin with Curcumin on breast cancer cell apoptosis through their loading into Apo ferritin cavity.
Alberti, D; Bitonto, V; Geninatti Crich, S; Khoee, S; Mansourizadeh, F; Sepehri, H; Tripepi, M, 2020
)
0.82
" Apart from the promising therapeutic activities of QT molecule, their applications have been limited due to some major concerns, including low oral bioavailability and poor aqueous solubility."( Recent Advances in Liposomal Drug Delivery System of Quercetin for Cancer Targeting: A Mechanistic Approach.
Alshehri, S; Altamimi, MA; Das, SS; Hussain, A; Imam, SS; Singh, SK; Verma, PRP, 2020
)
0.81
"We evaluated if chronic consumption of quercetin (Q) with green tea extract (GTE) enhances the bioavailability of GT polyphenols (GTPs) and reduces methylation activity as previously observed in mouse xenograft tumors."( Prospective randomized trial evaluating blood and prostate tissue concentrations of green tea polyphenols and quercetin in men with prostate cancer.
Aronson, WJ; Grogan, T; Grojean, EM; Heber, D; Henning, SM; Hsu, M; Husari, G; Lee, RP; Li, Z; Ly, A; Trang, A; Wang, P; Yang, J, 2020
)
1.04
" Our results showed that Exo-Que improved brain targeting of Que as well as significantly enhanced bioavailability of Que."( Brain delivery of quercetin-loaded exosomes improved cognitive function in AD mice by inhibiting phosphorylated tau-mediated neurofibrillary tangles.
Guo, L; Jiang, Y; Qi, Y; Shi, Y; Sui, H; Zhao, L, 2020
)
0.89
" In conclusion, the results showed that quercetin supplementation increased the bioavailability of NO in the jejunum in euglycemic and mitigate the effects of diabetes on nNOS-IR neurons and VIP-IR varicosities in the myenteric plexus of diabetic rats."( Quercetin increases bioavailability of nitric oxide in the jejunum of euglycemic and diabetic rats and induces neuronal plasticity in the myenteric plexus.
Armani, ALC; Barili, E; Bossolani, GDP; Cecchini, R; de Souza Melo, CG; de Souza Neto, FP; de Souza, SRG; Frez, FCV; Guarnier, FA; Martins-Perles, JVC; Zanoni, JN; Zignani, I, 2020
)
2.27
" Besides, considering the low bioavailability of quercetin, great efforts have been made in its drug delivery systems to address the problem of limited application."( Drug delivery based pharmacological enhancement and current insights of quercetin with therapeutic potential against oral diseases.
Li, C; Sun, J; Sun, Y; Tao, B; Wan, Y; Wang, L; Wang, Y, 2020
)
1.04
" The low bioavailability and poor solubility of QT have also led researchers to make various QT-involved nanoparticles (NPs) to overcome these limitations."( Crosstalk between obesity, diabetes, and alzheimer's disease: Introducing quercetin as an effective triple herbal medicine.
Ebrahimpour, S; Esmaeili, A; Zakeri, M, 2020
)
0.79
"Numerous studies document an increased production of reactive oxygen species (ROS) with a subsequent decrease in nitric oxide (NO) bioavailability in different cardiovascular diseases, including hypertension, atherosclerosis, and heart failure."( Therapeutic Potential of Polyphenols-Loaded Polymeric Nanoparticles in Cardiovascular System.
Cebova, M; Dayar, E; Pechanova, O, 2020
)
0.56
" Recent strategies in drug delivery significantly contribute to overcoming the low bioavailability of flavonoids."( Antiviral Properties of Flavonoids and Delivery Strategies.
Antonelli, A; Magnani, M; Ninfali, P; Scarpa, ES, 2020
)
0.56
" Due to its low bioavailability and poor water solubility, quercetin has limitations in clinical application."( [Research progress on antitumor activity of quercetin derivatives].
Feng, YL; Lu, LP; Zhai, GY, 2020
)
1.06
" Que's oral bioavailability is limited by its low water solubility and extended peripheral metabolism; thus, nasal administration may be a promising alternative to achieve effective Que concentrations in the brain."( Preparation and Biophysical Characterization of Quercetin Inclusion Complexes with β-Cyclodextrin Derivatives to be Formulated as Possible Nose-to-Brain Quercetin Delivery Systems.
Andreadelis, I; Athanasiadou, I; Banella, S; Chatziathanasiadou, MV; Chountoulesi, M; Colombo, G; Dallas, P; Demetzos, C; Diamantis, DA; Javornik, U; Manta, K; Mavromoustakos, T; Moschovou, K; Naziris, N; Papakyriakopoulou, P; Plavec, J; Rekkas, DM; Spaneas, D; Tzakos, AG; Vakali, V; Valsami, G, 2020
)
0.81
" The likely antiviral properties of quercetin are anyway challenged by its very poor oral bioavailability profile and any attempt to overcome this limit should be welcome."( Quercetin Phytosome® as a potential candidate for managing COVID-19.
Bertuccioli, A; Derosa, G; Devrajani, BR; DI Pierro, F; Khan, A; Khan, BA; Khan, S; Maffioli, P; Nigar, R; Ujjan, I, 2021
)
2.34
" Guided by the increased bioavailability of quercetin in its encapsulated form, further evaluation of the biological activity of the magnetic as well as non-magnetic core-shell nanoparticles, pertaining to their anti-amyloid and antioxidant potential, revealed interference with the aggregation of β-amyloid peptide (Aβ) in Alzheimer's disease, reduction of Aβ cellular toxicity and minimization of Aβ-induced Reactive Oxygen Species (ROS) generation."( Modified magnetic core-shell mesoporous silica nano-formulations with encapsulated quercetin exhibit anti-amyloid and antioxidant activity.
Boukos, N; Halevas, E; Litsardakis, G; Mavroidi, B; Nday, CM; Pelecanou, M; Salifoglou, A; Smith, GC; Tang, J, 2020
)
1.04
" The purpose of the present study was to propose a drug delivery system to enhance the oral bioavailability of combined quercetin and resveratrol."( Enhanced Oral Bioavailability and Improved Biological Activities of a Quercetin/Resveratrol Combination Using a Liquid Self-Microemulsifying Drug Delivery System.
Chusri, S; Jaisamut, P; Limsuwan, S; Wanna, S; Wiwattanapatapee, R; Wiwattanawongsa, K, 2021
)
1.06
" However, its bioavailability is poor due to the low absorption and P-gp efflux."( Natural P-gp inhibitor EGCG improves the acteoside absorption in Caco-2 cell monolayers and increases the oral bioavailability of acteoside in rats.
Chen, Q; Huang, W; Liu, X; Lu, B; Peng, J; Wu, L; Xu, T; Zhou, F, 2020
)
0.56
" In addition, studies on the bioavailability of quercetin and its capacity to cross the blood-brain barrier and how this capacity and bioavailability can be increased were given."( Cholinesterase Inhibitory Potential of Quercetin towards Alzheimer's Disease - A Promising Natural Molecule or Fashion of the Day? - A Narrowed Review.
Orhan, IE, 2021
)
1.15
" Previous treatments existed some limitations of poor bioavailability and targeting the efficiency of drugs."( Glycyrrhizin mediated liver-targeted alginate nanogels delivers quercetin to relieve acute liver failure.
Cui, YL; Wang, GF; Wang, QS; Xu, D; Zhang, HY; Zhao, FQ, 2021
)
0.86
" Nanoparticles have been applied for the delivery of quercetin, enhancing its bioavailability and efficacy in the alleviation of I/R injury."( Quercetin in Attenuation of Ischemic/Reperfusion Injury: A Review.
Ashrafizadeh, M; Entezari, M; Esmaeili, H; Hushmandi, K; Najafi, M; Raei, M; Saleki, H; Samarghandian, S; Shahinozzaman, M; Zabolian, A; Zarrabi, A, 2021
)
2.31
"Quercetin-loaded microcapsules (QLM) promote controlled release and higher bioavailability of quercetin, an antioxidant and neuroprotective agent."( Protective effects of quercetin-loaded microcapsules on the enteric nervous system of diabetic rats.
Baracat, MM; Blegniski, FP; Bossolani, GDP; Guarnier, FA; Hermes-Uliana, C; Lima, MM; Martins, HA; Perles, JVCM; Sehaber-Sierakowski, CC; Vieira-Frez, FC; Zanoni, JN, 2021
)
2.38
"Based on oral bioavailability and drug-likeness, the main active components of Simiao powder were screened using the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP)."( Network Pharmacology Approach to Uncover the Mechanism Governing the Effect of Simiao Powder on Knee Osteoarthritis.
Huang, Z; Li, X; Mao, J; Shi, X; Wang, P; Wu, P; Xing, R; Zhang, L; Zhang, N, 2020
)
0.56
" The increase in the bioavailability can be obtained with nanostructures."( Anti-MDR Effects of Quercetin and its Nanoemulsion in Multidrug-Resistant Human Leukemia Cells.
Araújo, GS; Cañedo, AD; Carrett-Dias, M; da Silva Alves, B; da Silva Júnior, FMR; de Oliveira, BS; de Souza Votto, AP; Dora, CL; Fernandes E Silva, E; Filgueira, DMVB; Machado, AP; Marques, MB; Santos, PA, 2021
)
0.94
" PPs have structural diversity which impacts their bioavailability as they accumulate in the large intestine and are extensively metabolized through gut microbiota (GM)."( Curcumin, Quercetin, Catechins and Metabolic Diseases: The Role of Gut Microbiota.
Chelliah, R; Daliri, EB; Javed, A; Oh, DH; Rubab, M; Shabbir, U, 2021
)
1.02
" The aim of this work was to study, in rats, the bioavailability and nephroprotective efficacy of a micellar formulation of Pluronic F127-encapsulated quercetin (P-quercetin), with improved hydrosolubility."( A Micellar Formulation of Quercetin Prevents Cisplatin Nephrotoxicity.
Casanova, AG; Colino, CI; de Paz, E; Gutiérrez-Millán, C; López-Hernández, FJ; Martín, Á; Morales, AI; Prieto, M; Ruszkowska-Ciastek, B, 2021
)
1.12
" In addition, a network pharmacology approach, including bioactive compounds, was used with oral bioavailability (OB) and drug-likeness (DL) evaluation."( Uncovering the Key miRNAs and Targets of the Liuwei Dihuang Pill in Diabetic Nephropathy-Related Osteoporosis based on Weighted Gene Co-Expression Network and Network Pharmacology Analysis.
Cheng, J; Geng, R; Hua, Z; Huang, GC; Liu, MM; Lv, NN; Ma, Y; Xu, HY, 2022
)
0.72
" Poor solubility and low bioavailability of Q as a bioflavonoid with potent antioxidant activity, limit its therapeutic application."( Quercetin-loaded F127 nanomicelles: Antioxidant activity and protection against renal injury induced by gentamicin in rats.
Beyzaei, H; Bilal, M; Hasanein, P; Kyzas, GZ; Rahdar, A, 2021
)
2.06
" Moreover, in order to enhance quercetin bioavailability and capacity to target the brain, we discuss an innovative drug delivery system."( The Potential Neuroprotective Role of Free and Encapsulated Quercetin Mediated by miRNA against Neurological Diseases.
Benameur, T; Porro, C; Soleti, R, 2021
)
1.15
"This study examined the effects of a combination of soybean fiber and α-glycosyl-isoquercitrin (AGIQ) on improving quercetin bioavailability and glucose metabolism in rats fed an obesogenic diet."( Combination of α-Glycosyl-Isoquercitrin and Soybean Fiber Promotes Quercetin Bioavailability and Glucagon-like Peptide-1 Secretion and Improves Glucose Homeostasis in Rats Fed a High-Fat High-Sucrose Diet.
Hara, H; Hira, T; Trakooncharoenvit, A, 2021
)
1.07
" However, the oral bioavailability of nutraceuticals encapsulated in Pickering emulsions was not well established."( Bioavailability of quercetin in zein-based colloidal particles-stabilized Pickering emulsions investigated by the in vitro digestion coupled with Caco-2 cell monolayer model.
Huang, XN; Ma, JJ; Yang, XQ; Yin, SW; Yu, YG, 2021
)
0.95
" In this work, novel cocrystals, consisting of two antithrombotic drugs with poor solubility and low bioavailability in vivo, namely, apixaban (Apx) and quercetin (Que), were developed to discover a potential method to improve the poor solubility and internal absorption of the drug combination."( Cocrystal of Apixaban-Quercetin: Improving Solubility and Bioavailability of Drug Combination of Two Poorly Soluble Drugs.
Du, G; Jiao, L; Kong, D; Lu, Y; Song, J; Wang, H; Yang, D; Yang, H; Yang, S; Zhang, L; Zhao, X, 2021
)
1.13
" Besides the natural food resources that may provide Quercetin, the interest in delivery systems that could enhance its bioavailability in the human body has seen growth in recent years."( Solid Lipid Nanoparticles Produced via a Coacervation Method as Promising Carriers for Controlled Release of Quercetin.
Consumi, M; Leone, G; Magnani, A; Talarico, L; Tamasi, G, 2021
)
1.08
" Moreover, the implications of digestion on the putative benefits of dietary PC against COVID-19 are presented by addressing the bioavailability and biotransformation of PC by the gut microbiota."( Bioactivity, bioavailability, and gut microbiota transformations of dietary phenolic compounds: implications for COVID-19.
Augusti, PR; Bronze, MR; Conterato, GMM; Denardin, CC; Emanuelli, T; Prazeres, ID; Serra, AT, 2021
)
0.62
"Flavonoid bioavailability and bioactivity is associated with interindividual variability, which is partially due to differences in health status."( Intracellular quercetin accumulation and its impact on mitochondrial dysfunction in intestinal Caco-2 cells.
Boon, N; Criel, H; De Schutter, K; Goeminne, G; Grootaert, C; Raes, K; Rajkovic, A; Smagghe, G; Van Camp, J; Vissenaekens, H, 2021
)
0.98
"Quercetin-loaded nanosuspensions (Que-NSps) added metabolic inhibitors were evaluated as drug delivery system to promote the oral bioavailability of quercetin."( Enhancement of oral bioavailability of quercetin by metabolic inhibitory nanosuspensions compared to conventional nanosuspensions.
Ao, H; Fu, J; Li, H; Li, M; Wang, W; Wang, X, 2021
)
2.33
" Problems like poor solubility, bioavailability and stability, short half-life and weak tumor-targeting biodistribution make quercetin an unreliable candidate for cancer therapy."( Quercetin nanoformulations: a promising strategy for tumor therapy.
Chen, X; Cheng, M; Zang, X; Zhang, X, 2021
)
2.27
"Hyperoside (HYP) has various potential benefits, however, its low water-solubility and poor bioavailability have restricted its application."( Fabrication and characterization of zein-tea polyphenols-pectin ternary complex nanoparticles as an effective hyperoside delivery system: Formation mechanism, physicochemical stability, and in vitro release property.
Jin, Y; Li, F; Li, M; Liu, F; Lou, X; Peng, F; Wang, J; Wang, X; Xu, H, 2021
)
0.62
"Ticagrelor is a first-line clinical drug for the treatment of acute coronary syndrome, but its oral bioavailability is relatively low."( Untargeted metabolomics reveals the mechanism of quercetin enhancing the bioavailability of ticagrelor.
Sun, Y; Tang, Y; Wei, B; Wei, S; Xu, X; Zhang, W, 2021
)
0.88
" The discrepancy between the in vitro and in vivo studies was probably due to a poor bioavailability of flavonoids in the intestine."( Rutin and Quercetin Decrease Cholesterol in HepG2 Cells but Not Plasma Cholesterol in Hamsters by Oral Administration.
Chen, ZY; Hao, W; He, WS; He, Z; Kwek, E; Li, YM; Liang, N; Liu, J; Ma, KY; Zhao, Y; Zhu, H, 2021
)
1.02
" Despite the good characteristics of quercetin, like many flavonoids, it is characterized by reduced bioavailability due to limited absorption."( Substantiation of attention around antioxidants of plant origin for use in complex pharmacotherapy of diseases of the oral cavity.
Chornij, N; Kritsak, M; Pavliuk, B; Prokopovych, O; Stechyshyn, I, 2021
)
0.89
" Moreover, another important issue that needs to be resolved in future research is to improve the bioavailability of quercetin."( The Therapeutic Effects and Mechanisms of Quercetin on Metabolic Diseases: Pharmacological Data and Clinical Evidence.
Du, L; Fan, G; Kuang, T; Peng, H; Wu, X; Xu, X; Yi, H; Zhang, J, 2021
)
1.09
" Besides, due to the low bioavailability of QUR innovative drug delivery strategies (QUR loaded gel, QUR polymeric micelle, QUR nanoparticles, glucan-QUR conjugate, and QUR loaded mucoadhesive nanoemulsions) have been proposed to improve its bioavailability and providing novel therapeutic approaches."( Novel extraction, rapid assessment and bioavailability improvement of quercetin: A review.
Aadil, RM; Hussain, A; Khan, S; Manzoor, MF; Sahar, A; Sameen, A; Siddique, R; Xu, B, 2021
)
0.86
" Two lipophilic drugs, curcumin and quercetin were used in this study due to their dissolution rate limited oral bioavailability and poor permeability."( Development of mushroom polysaccharide and probiotics based solid self-nanoemulsifying drug delivery system loaded with curcumin and quercetin to improve their dissolution rate and permeability: State of the art.
Chellappan, DK; Dua, K; Gowthamarajan, K; Gulati, M; Gupta, G; Gupta, PK; Jain, SK; Jha, NK; Kapoor, B; Khursheed, R; Singh, SK; Wadhwa, S; Zacconi, F, 2021
)
1.1
" A marked cell bioavailability increase was demonstrated for the artemetin C-prenylated derivative."( Effects of quercetin and artemetin prenylation on bioavailability and bioactivity.
Bombardelli, E; Khalili, A; Nieddu, M; Pollastro, F; Rosa, A; Salamone, S; Sansaro, A, 2021
)
1.01
" This study aimed to explore the potential of the quercetin (QUR) loaded magnetic nano-micelles for improving drug bioavailability while reducing the drug adverse effects."( Self-assembled magnetic polymeric micelles for delivery of quercetin: Toxicity evaluation on isolated rat liver mitochondria.
Hosseini, MJ; Kermanian, M; Rahmati, MA; Rashidzadeh, H; Sadighian, S, 2022
)
1.22
" However, the hindrances in their absorption, specificity, and bioavailability can be overcome using nanotechnology."( Nanoencapsulation of Polyphenols as Drugs and Supplements for Enhancing Therapeutic Profile - A Review.
Ansari, MT; Hafiz, AK; Hasnain, MS; Kalam, N; Khatoon, S; Shaikh, MF, 2022
)
0.72
", Quercetin (QUR) for improving the bioavailability of the SEL in the brain via the oral route."( Lipid nanocarrier of selegiline augmented anti-Parkinson's effect via P-gp modulation using quercetin.
Ali, A; Ali, J; Ashhar, MU; Baboota, S; Qamar, Z; Qizilibash, FF; Sahoo, PK, 2021
)
1.56
", curcumin and quercetin), at specific concentrations, in dosage forms could improve the bioavailability of the BCS Class III and IV drugs that are substrates of CYP3A4 and p-glycoprotein."( Determination of effective concentrations of drug absorption enhancers using in vitro and ex vivo models.
Enslin, GM; Kheoane, PS; Tarirai, C, 2021
)
0.97
" However, poor solubility and low bioavailability of QC have also led researchers to make various QC-involved nanoparticles to overcome these limitations."( Quercetin attenuates neurotoxicity induced by iron oxide nanoparticles.
Bardestani, A; Ebrahimpour, S; Esmaeili, A, 2021
)
2.06
" The bioavailability of EGCG was higher in the hydrogel beads than those in the double emulsions, while the quercetin bioavailability was not significantly different expect for the ratio of 3:7."( Co-encapsulation of (-)-epigallocatechin-3-gallate and quercetin in double emulsion hydrogel beads: Microstructures, functional properties, and digestion behaviors.
Du, X; Hu, M; Li, Y; Liu, G; Qi, B; Zhang, W, 2022
)
1.18
" However, it is poorly absorbed in the upper gastrointestinal tract during oral intake but rather is metabolized by the intestinal microbiota into various phenolic acids."( 3-(3-Hydroxyphenyl)propionic acid, a microbial metabolite of quercetin, inhibits monocyte binding to endothelial cells via modulating E-selectin expression.
Feng, J; Ge, C; Li, R; Li, W, 2022
)
0.96
"57-folds increase in bioavailability was observed for curcumin and quercetin respectively, upon loading into SNEDDS pellets."( Self-nanoemulsifying composition containing curcumin, quercetin, Ganoderma lucidum extract powder and probiotics for effective treatment of type 2 diabetes mellitus in streptozotocin induced rats.
A, A; Awasthi, A; Chitranshi, N; Corrie, L; Dua, K; Gulati, M; Gupta, PK; Jha, NK; K R, A; Kaur, J; Khursheed, R; Kumar, A; Kumar, B; Kumar, R; Mustafa, G; Singh, SK; Vishwas, S; Wadhwa, S; Zacconi, F, 2022
)
1.21
" However further studies are needed to improve the bioavailability and to establish a dosing regimen for Quercetin."( Quercetin for managing type 2 diabetes and its complications, an insight into multitarget therapy.
Dhanya, R, 2022
)
2.38
" However, the low solubility and poor bioavailability of quercetin have limited its applications; therefore, the researchers have tried to design and synthesize many new derivatives of quercetin through different strategies to modify quercetin restrictions and improve its biological activities."( O-Glycoside quercetin derivatives: Biological activities, mechanisms of action, and structure-activity relationship for drug design, a review.
Alizadeh, SR; Ebrahimzadeh, MA, 2022
)
1.35
" However, quercetin's low solubility and poor bioavailability have restricted its applicability; as a result, researchers have attempted to design and synthesize numerous novel quercetin derivatives using various methodologies in order to modify quercetin's constraints; the physico-chemical properties of quercetin's molecular scaffold make it appealing for drug development; low molecular mass and chemical groups are two of these characteristics."( Quercetin derivatives: Drug design, development, and biological activities, a review.
Alizadeh, SR; Ebrahimzadeh, MA, 2022
)
2.57
" This study provides a new strategy for designing quercetin-loaded nanoparticles based on natural polysaccharides to improve the bioavailability of quercetin."( Hohenbuehelia serotina polysaccharides self-assembled nanoparticles for delivery of quercetin and their anti-proliferative activities during gastrointestinal digestion in vitro.
Feng, R; Li, X; Luo, Z; Wang, L; Zhou, P, 2022
)
1.2
"Although quercetin (Que) has many beneficial therapeutic effects on the human body, its oral bioavailability is poor because of its low water solubility."( Enhanced water dispersibility and Caco-2 cell monolayer permeability of quercetin by complexation with casein hydrolysate.
Inada, A; Oshima, T; Sawao, A; Takahashi, K, 2022
)
1.37
" In normal and DMH-induced rats, a pharmacokinetic study demonstrated that polyherbal nanoparticles had a typical sustained release profile with a fourfold increase in bioavailability when compared to polyherbal extract."( Improving gallic acid and quercetin bioavailability by polymeric nanoparticle formulation.
Killedar, S; Patil, P, 2021
)
0.92
"Quercetin, a flavonoid with promising therapeutic potential, has been shown to protect from cisplatin nephrotoxicity in rats following intraperitoneal injection, but its low bioavailability curtails its prospective clinical utility in oral therapy."( Protective Effect of Quercetin 3-
Casanova, AG; González-Paramás, AM; López-Hernández, FJ; Martín, Á; Morales, AI; Muñoz-Reyes, D; Prieto, M; Santos-Buelga, C, 2022
)
2.48
" However, the poor gastrointestinal absorption and low bioavailability of quercetin curtail its clinical applications."( Research Progress of Quercetin Delivery Systems.
Deng, Y; Li, Y; Liao, L; Peng, C; Xue, X; Zhao, X; Zhou, M, 2022
)
1.27
"The bioavailability of quercetin can be improved through the application of delivery systems technologies, such as microparticle delivery systems, solid dispersions, encapsulation, phospholipid complexes, and hydrogels."( Research Progress of Quercetin Delivery Systems.
Deng, Y; Li, Y; Liao, L; Peng, C; Xue, X; Zhao, X; Zhou, M, 2022
)
1.35
"Quercetin (QUE)-loaded poly(lipoic acid) nanoparticles (QUE/pLA) were developed to improve chemical stability in the gastrointestinal (GI) tract, oral bioavailability (BA), and pharmacological properties of QUE."( Development of Poly(lipoic acid) Nanoparticles with Improved Oral Bioavailability and Hepatoprotective Effects of Quercetin.
Banik, S; Onoue, S; Sato, H; Yamada, K, 2022
)
2.37
" However, low water solubility and bioavailability are the limitations of quercetin for its clinical applications."( Therapeutic effect of quercetin polymeric nanoparticles on ischemia/reperfusion-induced acute kidney injury in mice.
Chang, Y; Chiang, CK; Ho, FM; Huang, KT; Liu, SH; Wu, CT, 2022
)
1.27
" Antioxidants' bioavailability has become one of the main research topics in bio-nanomedicine."( Plant-Derived Nanoscale-Encapsulated Antioxidants for Oral and Topical Uses: A Brief Review.
Kim, SH; Lee, YC, 2022
)
0.72
"To improve the water solubility, stability and bioavailability of quercetin, the quercetin (Que)-quinoa protein (QP)-lotus root amylopectin (LRA) nanomicelles (Que-QP-LRA) were constructed via self-assembly in the present study."( The nanomicelles consisting of lotus root amylopectin and quinoa protein: Construction and encapsulation for quercetin.
Li, QM; Liu, K; Luo, JP; Pan, LH; Zha, XQ; Zhang, HL, 2022
)
1.17
" This limitation was solved by developing a nanoparticles formulation that improves the solubility and bioavailability of several bioactive compounds."( Nanoparticles Formulation Improves the Antifibrogenic Effect of Quercetin on an Adenine-Induced Model of Chronic Kidney Disease.
Bastidas-Ramírez, BE; Gasca-Lozano, LE; Gurrola-Díaz, CM; Hernández-Ortega, LD; Martínez-Limón, FJ; Mena-Enríquez, M; Salazar-Montes, AM; Sánchez-Jaramillo, EA; Vargas-Guerrero, B; Vera-Cruz, JM, 2022
)
0.96
" Therefore, to overcome these challenges, an inhalable quercetin-alginate nanogel (QU-Nanogel) was fabricated, and by this special "material-drug" structure, the solubility and bioavailability of quercetin were significantly enhanced, which could further increase the activity of quercetin and provide a promising therapy for ALI."( A novel inhalable quercetin-alginate nanogel as a promising therapy for acute lung injury.
Chen, YB; Cui, YL; Kaur, P; Wang, YL; Yang, BG; Ye, L; Zhang, YB; Zhu, Y, 2022
)
1.3
" Therefore, it is important to urgently find a method to improve the oral bioavailability of TAX."( Modification of taxifolin particles with an enteric coating material promotes repair of acute liver injury in mice through modulation of inflammation and autophagy signaling pathway.
Chen, K; Ding, C; Ding, Q; Liu, S; Liu, W; Liu, X; Sun, S; Zhang, J; Zhang, Y; Zhao, Y, 2022
)
0.72
"Herein, we designed novel glycocholic acid (GCA)-functionalized double layer nanoparticles (GCA-NPs), which can act via an endogenous pathway and in a temporally controlled manner in the intestine, to enhance the oral bioavailability of hydrophobic chemotherapeutic drugs such as paclitaxel (PTX)."( Biomimetic and temporal-controlled nanocarriers with ileum transporter targeting for achieving oral administration of chemotherapeutic drugs.
Chen, L; Gao, Z; Han, Y; Huang, W; Jin, J; Jin, M; Liu, C; Liu, W; Liu, Y; Xin, X; Zhang, X, 2022
)
0.72
" Besides, quercetin could serve as a prodrug, and the bioavailability of quercetin is improved through chemical modifications or the utilization of effective drug delivery systems."( Biological Activities Underlying the Therapeutic Effect of Quercetin on Inflammatory Bowel Disease.
Li, JY; Lyu, YL; Sun, F; Wang, FX; Yang, J; Zhou, HF, 2022
)
1.37
" Driven by the need to enhance quercetin bioavailability and bioactivity through metal ion complexation, synthetic efforts led to a unique ternary Ce(III)-quercetin-(1,10-phenanthroline) (1) compound."( A unique ternary Ce(III)-quercetin-phenanthroline assembly with antioxidant and anti-inflammatory properties.
Geromichalou, E; Halevas, E; Hatzidimitriou, A; Katsipis, G; Litsardakis, G; Matsia, S; Pantazaki, A; Papadopoulos, TA; Salifoglou, A, 2022
)
1.31
" In this review, we have discussed the approaches of improving solubilization and bioavailability of QCT with the use of nanoformulations."( Advances on nanoformulation approaches for delivering plant-derived antioxidants: A case of quercetin.
Arya, S; Bahadur, P; Kanike, S; Rathod, S; Shah, SA; Tiwari, S, 2022
)
0.94
" However, due to its low solubility its bioavailability is limited."( Comparative Interaction Studies of Quercetin with 2-Hydroxyl-propyl-β-cyclodextrin and 2,6-Methylated-β-cyclodextrin.
Cournia, Z; Diamantis, DA; Georgiou, N; Javornik, U; Mauromoustakos, T; Papadourakis, M; Papakyriakopoulou, P; Plavec, J; Tzakos, AG; Tzeli, D; Vakali, V; Valsami, G; Zoupanou, N, 2022
)
1
"Flavonoids are associated with health benefits, but most of them have poor oral bioavailability due to their extremely low aqueous solubility."( Discovery of a novel phosphotransferase from Bacillus subtilis that phosphorylates a broad spectrum of flavonoids.
Chang, CF; Hsu, C; Su, NW; Tsai, HY; Yang, CC, 2023
)
0.91
" Combined meals of sweet potato and onion may lower the bioavailability of onion quercetin glucosides."( Lowering effect of combined sweet potato and onion intake on plasma quercetin concentration and underlying mechanism involving intestinal β-glucosidase activity.
Kawabata, K; Mukai, R; Nayama, C; Nishijima, H; Nuka, E; Okitsu, M; Sogawa, R; Takahashi, M; Terao, J, 2022
)
1.18
"The simultaneous improvement of quercetin (QUE) processing stability and bioavailability has always presented a technical challenge during food processing."( Improving effect of oleic acid-mediated sodium caseinate-based encapsulation in an ultrasound field on the thermal stability and bioaccessibility of quercetin.
Guo, Z; Li, J; Liu, Y; Wang, S, 2022
)
1.2
"Improving bioavailability of orally delivered drugs is still challenging, as conventional drug delivery systems suffer from non-specific drug delivery in the gastrointestinal (GI) tract and limited drug absorption efficiency."( Microencapsulation of Ionic Liquid by Interfacial Self-Assembly of Metal-Phenolic Network for Efficient Gastric Absorption of Oral Drug Delivery.
Chen, Y; Feng, J; Ge, S; Li, J; Li, K; Shen, L; Xu, W; Yang, X; Zhang, Y; Zhao, Y, 2022
)
0.72
" This is due to their antioxidant and anti-inflammatory properties, despite their low bioavailability which often limits their use in clinical practice."( Flavonoids bridging the gut and the brain: Intestinal metabolic fate, and direct or indirect effects of natural supporters against neuroinflammation and neurodegeneration.
Ceruti, S; Magni, G; Petroni, K; Riboldi, B, 2022
)
0.72
" Quercetin (QUE), a bioflavonoid, may modify the bioavailability of drugs used concurrently by inhibiting CYP3A4, CYP2C8, CYP2C9, CYP1A2, and Pglycoprotein (P-gp)."( Influence of Quercetin Pretreatment on Pharmacokinetics of Warfarin in Rats.
Afzal, H; Ahmad, E; Bano, S; Bukhari, NI; Ismail, MA; Jahangir, M; Shamim, R, 2023
)
2.19
"Intravenous route of drug administration has maximum bioavailability, which shows 100% of the drug reaches blood circulation, whereas the oral administration of drugs, are readily undergoing pre-systemic metabolism, which means the poor bioavailability of the drug and limited amount of drug reaches the target site."( A Recent Review on Bio-availability Enhancement of Poorly Water-soluble Drugs by using Bioenhancer and Nanoparticulate Drug Delivery System.
Kumar, A; Kumar, D; Kumar, M; Kumar, S; Mandal, UK, 2022
)
0.72
"Bioenhancers are substances having medicinal entities which enhance the bioavailability and efficacy of the active constituents of drugs."( A Recent Review on Bio-availability Enhancement of Poorly Water-soluble Drugs by using Bioenhancer and Nanoparticulate Drug Delivery System.
Kumar, A; Kumar, D; Kumar, M; Kumar, S; Mandal, UK, 2022
)
0.72
"Bioenhancers are crucial to amplifying the bioavailability of many synthetic drugs."( A Recent Review on Bio-availability Enhancement of Poorly Water-soluble Drugs by using Bioenhancer and Nanoparticulate Drug Delivery System.
Kumar, A; Kumar, D; Kumar, M; Kumar, S; Mandal, UK, 2022
)
0.72
" The laboratory data and clinical trials have demonstrated that the bioavailability and bioactivity of curcumin are influenced by the feature of the curcumin molecular complex types."( Strategies for Improving Bioavailability, Bioactivity, and Physical-Chemical Behavior of Curcumin.
Avram, A; Barbu, I; Mocanu, A; Pop, LC; Racz, CP; Racz, LZ; Roman, I; Sárközi, M; Toma, VA; Tomoaia, G; Tomoaia-Cotisel, M, 2022
)
0.72
" However, quercetin has low bioavailability due to poor water solubility, low absorption, and rapid excretion from the body."( Anti-Inflammatory, Antioxidative, and Nitric Oxide-Scavenging Activities of a Quercetin Nanosuspension with Polyethylene Glycol in LPS-Induced RAW 264.7 Macrophages.
Do, GS; Kang, SG; Kwon, JB; Lee, GB; Oh, SY; Singh, M; Vinayagam, R; Yang, SJ, 2022
)
1.35
" Quercetin's bioavailability may limit its use clinically, however."( Quercetin's Effects on Glutamate Cytotoxicity.
Lenard, NR; Riche, K, 2022
)
3.07
" However, low bioavailability and potential side effects of senolytics restrict clinical application."( Bone-targeted delivery of senolytics to eliminate senescent cells increases bone formation in senile osteoporosis.
Gao, X; Huang, H; Li, M; Liang, C; Liao, L; Ma, S; Tan, L; Tang, Q; Tian, W; Xing, X; Xu, X; Yang, J; Zou, J, 2023
)
0.91
" The review includes a characterization of the mechanism of action of flavonoids, as well as insight into the physicochemical parameters determining their bioavailability in vitro."( Why Do Dietary Flavonoids Have a Promising Effect as Enhancers of Anthracyclines? Hydroxyl Substituents, Bioavailability and Biological Activity.
Golonko, A; Lewandowski, W; Olichwier, AJ; Swislocka, R; Szczerbinski, L, 2022
)
0.72
" These findings indicated that QNP due to its high bioavailability was more effective than quercetin can be reduced autistic-like behavior, oxidative and apoptotic damages in the model of MS rats."( Preventive effect of quercetin-Loaded nanophytosome against autistic-like damage in maternal separation model: The possible role of Caspase-3, Bax/Bcl-2 and Nrf2.
Eslami, A; Hasantabar, V; Jelodar, SK; Moghaddam, AH; Ranjbar, M, 2023
)
1.45
" Quercetin may be of benefit in COVID-19 patients, especially if administered in its phytosome formulation which greatly enhances its bioavailability but large-scale RCTs are needed to confirm these findings."( Quercetin for the treatment of COVID-19 patients: A systematic review and meta-analysis.
Awan, RU; Cheema, HA; Chinnam, S; Fatima, A; Nashwan, AJ; Shahid, A; Shahzil, M; Sohail, A; Ur Rehman, ME, 2023
)
3.26
" Here, we investigated the beneficial role of QUE and its derivative Q2, which demonstrates improved bioavailability and chemical stability, in cardiac lipotoxicity."( Quercetin and Its Derivative Counteract Palmitate-Dependent Lipotoxicity by Inhibiting Oxidative Stress and Inflammation in Cardiomyocytes.
Angelone, T; Ceramella, J; De Bartolo, A; Granieri, MC; Macchia, PE; Mariconda, A; Nettore, IC; Rago, V; Rocca, C; Romeo, N; Sinicropi, MS; Ungaro, P, 2023
)
2.35
" The therapeutic properties of quercetin include antioxidant, antibacterial and anti-cancer potential, but its therapeutic value is limited by its hydrophobic nature, low bioavailability and fast metabolism."( Improvement of Therapeutic Value of Quercetin with Chitosan Nanoparticle Delivery Systems and Potential Applications.
Lawson, MK, 2023
)
1.47
" These results indicate that carboxymethyl dextrin-coated zein nanoparticles can significantly improve the bioavailability of hydrophobic nutrient molecules such as quercetin and provide a valuable reference for their application in the field of biological delivery of energy drinks and food."( Physicochemical stability, antioxidant activity, and antimicrobial activity of quercetin-loaded zein nanoparticles coated with dextrin-modified anionic polysaccharides.
Chen, L; Hu, Y; Ji, H; Jiao, A; Jin, Z; Julian McClements, D; Li, X; Lin, Q; Long, J; Qiu, C; Sang, S; Xu, X; Zhang, Z, 2023
)
1.33
" This review also emphasizes the significance of the co-delivery vehicles-based nanoparticles of such bioactive phytochemicals that could improve their bioavailability and reduce their systemic dose."( Co-administration of curcumin with other phytochemicals improves anticancer activity by regulating multiple molecular targets.
Asoodeh, A; Ghobadi, N, 2023
)
0.91
" The components of AM were analyzed using the Traditional Chinese Medicine System Pharmacology (TCMSP) database to screen the active ingredients of AM based on their oral bioavailability and drug similarity index."( Anticancer Effect of Active Component of Astragalus Membranaceus Combined with Olaparib on Ovarian Cancer Predicted by Network-Based Pharmacology.
Guo, Z; Jiang, J; Lang, F; Li, J; Liu, Y, 2023
)
0.91
" However, the low bioavailability of quercetin and the presence of the BBB structure limit the therapeutic efficacy."( Protective effects of dietary quercetin on cerebral ischemic injury: pharmacology, pharmacokinetics and bioavailability-enhancing nanoformulations.
Fu, K; Gong, L; Li, Y; Ma, C; Peng, C; Wang, C; Xue, X; Zhang, Y; Zhou, H, 2023
)
1.47
"The synergistic effect of epigallocatechin-3-gallate (E) and quercetin (Q) enhances the therapeutic efficacy on related diseases; however, the instability and lower bioavailability of E and Q limited their application."( The synergistic effect of epigallocatechin-3-gallate and quercetin co-loaded hydrogel beads on inflammatory bowel disease.
Du, X; Hu, M; Huang, Y; Li, Y; Liu, G; Qi, B, 2023
)
1.4
"An inclusion complex formation with cyclodextrin is a promising method to improve the bioavailability of water-insoluble drugs."( Pharmacokinetic studies of hyperoside-2-hydroxypropyl-β-cyclodextrin inclusion complex and ameliorated DSS-induced colitis in mice.
Cao, S; Chu, X; Ding, Y; Fu, X; Li, X; Li, Y; Liu, C; Su, J; Wang, X; Xue, J; Zhang, R; Zhang, X, 2023
)
0.91
" However, the physicochemical properties, such as solubility and permeability, of this compound are low, which ultimately limits its bioavailability on the target site."( The significance of quercetin-loaded advanced nanoformulations for the management of diabetic wounds.
Chaudhary, A; Imran, M; Mohammed, Y; Panthi, VK; Paudel, KR, 2023
)
1.23
" Quercetin (QC) has been shown to affect CSC viability, but its low bioavailability limits its clinical use."( Effective inhibition of breast cancer stem cell properties by quercetin-loaded solid lipid nanoparticles via reduction of Smad2/Smad3 phosphorylation and β-catenin signaling pathway in triple-negative breast cancer.
Hatami, M; Kheirollah, A; Khorsandi, L; Kouchak, M; Rashidi, M, 2023
)
2.06
"Our findings demonstrate that SLNs improve the cytotoxic effect of QC in MDA-MB231 cells by increasing its bioavailability and inhibiting epithelial-mesenchymal transition (EMT), thereby effectively inhibiting CSC generation."( Effective inhibition of breast cancer stem cell properties by quercetin-loaded solid lipid nanoparticles via reduction of Smad2/Smad3 phosphorylation and β-catenin signaling pathway in triple-negative breast cancer.
Hatami, M; Kheirollah, A; Khorsandi, L; Kouchak, M; Rashidi, M, 2023
)
1.15
" However, it has several disadvantages such as poor water solubility, low bioavailability and low targeting, which seriously restrict its clinical application."( Delivery of quercetin for breast cancer and targeting potentiation via hyaluronic nano-micelles.
Li, M; Lin, K; Liu, Z; Sun, J; Wang, W; Wang, Z; Zhang, S; Zhao, Y; Zhen, Y, 2023
)
1.29
" Given the importance of the active ingredient, dose selection and the improvement of quercetin's bioavailability remain to be explored."( Mechanism of action of quercetin in rheumatoid arthritis models: meta-analysis and systematic review of animal studies.
Gao, Y; Liu, X; Tao, T; Wang, F; Yao, H; Zheng, H, 2023
)
1.44
" In the nutraceutical sector, natural flavonoids low bioavailability and solubility necessitate the application of delivery systems to enhance their efficacy."( Protective role of flavonoids quercetin and silymarin in the viral-associated inflammatory bowel disease: an updated review.
Abdulabbas, HT; Barbaresi, S; Ghasemian, A; Kareem, AS; Kouhpayeh, SA; Mazarzaei, A; Najafipour, S; Sotoudeh, M; Zarenezhad, E, 2023
)
1.2
"In this study, the ability of zein nanospheres (NS) and zein nanocapsules containing wheat germ oil (NC) to enhance the bioavailability and efficacy of quercetin was evaluated."( Zein-based nanospheres and nanocapsules for the encapsulation and oral delivery of quercetin.
Campión, R; Collantes, M; Cristina Martínez-Oharriz, M; Gonzalez-Navarro, CJ; Irache, JM; Luisa Martínez López, A; Matías, C; Peñuelas, I; Sáiz-Abajo, MJ, 2023
)
1.33
" However, little is known about the influence of dietary bioactive compounds on the bioavailability of PFOA and HFPO-TA."( Influence of dietary bioactive compounds on the bioavailability and excretion of PFOA and its alternative HFPO-TA: Mechanism exploration.
Chen, Y; Cui, X; Wu, H, 2023
)
0.91
" Recent research suggests that using nanoformulations can help quercetin to overcome its hydrophobicity while also enhancing its stability and cellular bioavailability both in vitro and in vivo."( Nanoformulations of quercetin for controlled delivery: a review of preclinical anticancer studies.
Aggarwal, D; Chhabra, RS; Gupta, DS; Gupta, M; Joshi, H; Kaur, G; Ramniwas, S; Saini, AK; Sak, K; Singh, T; Tuli, HS, 2023
)
1.47
" The attachment of a glucose unit impacts the stability and solubility of flavonoids and often determines their bioavailability and bioactivity."( Glycosylation of Quercetin by Selected Entomopathogenic Filamentous Fungi and Prediction of Its Products' Bioactivity.
Dymarska, M; Janeczko, T; Kozłowska, E; Piegza, M; Stępień, Ł; Tronina, T; Urbaniak, M; Łużny, M, 2023
)
1.25
" However, quercetin's bioavailability is frequently low due to its low water solubility, molecular stability, and absorption characteristics."( Drug design strategies that aim to improve the low solubility and poor bioavailability conundrum in quercetin derivatives.
Alizadeh, SR; Ebrahimzadeh, MA; Savadkouhi, N,
)
0.75
") were discussed to improve water solubility and bioavailability of quercetin."( Drug design strategies that aim to improve the low solubility and poor bioavailability conundrum in quercetin derivatives.
Alizadeh, SR; Ebrahimzadeh, MA; Savadkouhi, N,
)
0.58
" To enhance its oral bioavailability and efficacy, various quercetin-loaded nanosystems such as nanosuspensions, polymer nanoparticles, metal nanoparticles, emulsions, liposomes or phytosomes, micelles, solid lipid nanoparticles, and other lipid-based nanoparticles have been investigated in in-vitro cells, in-vivo animal models, and humans."( Nano Drug Delivery Strategies for an Oral Bioenhanced Quercetin Formulation.
Attar, ES; Chaudhari, VH; Deokar, CG; Devarajan, PV; Dyawanapelly, S, 2023
)
1.4
" All compounds were obtained from the traditional Chinese medicine systems pharmacology (TCMSP) database, and active ingredients were selected by their oral bioavailability and drug-likeness index."( Active ingredients Isorhamnetin of Croci Srigma inhibit stomach adenocarcinomas progression by MAPK/mTOR signaling pathway.
Cai, T; Fu, YD; Li, Y; Liao, ZY; Shi, XF; Wang, KB; Yu, Q; Zhang, S, 2023
)
0.91
" However, biomedical applications of Q are limited due to its low bioavailability and hydrophilicity."( Electrospun fiber-based micro- and nano-system for delivery of high concentrated quercetin to cancer cells.
Baranowska-Korczyc, A; Betlej, G; Cieślak, M; Deręgowska, A; Hudecki, A; Hudecki, J; Kęsik-Brodacka, M; Kolano-Burian, A; Krzemiński, P; Lewińska, A; Likus, W; Moskal, A; Rzeszutek, I; Warski, T; Wnuk, M; Wojnarowska-Nowak, R; Łyko-Morawska, D, 2023
)
1.14
" This study provides new knowledge about key molecular mechanisms involved in QUE-mediated protection against AFB1 toxicity and encourages in vivo studies to assess QUE's bioavailability and beneficial effects on aflatoxicosis."( Discovering the Protective Effects of Quercetin on Aflatoxin B1-Induced Toxicity in Bovine Foetal Hepatocyte-Derived Cells (BFH12).
Barbarossa, A; Bardhi, A; Bassan, I; Dacasto, M; Giantin, M; Montanucci, L; Pauletto, M; Tolosi, R; Zaghini, A, 2023
)
1.18
" Quercetin (QUR), as a flavonoid substance found in plants and fruits, has good anticancer and medicinal effects on brain tumors, but its low stability and bioavailability as well as the blood-brain barrier (BBB), prevent it from reaching brain tumors."( Co-biopolymer of chitosan/carboxymethyl cellulose hydrogel improved by zinc oxide and graphene quantum dots nanoparticles as pH-sensitive nanocomposite for quercetin delivery to brain cancer treatment.
Ostovar, S; Pourmadadi, M; Zaker, MA, 2023
)
2.02
" Its anti-cancer and anti-inflammatory properties have been previously demonstrated, but its low bioavailability hampers its clinical use."( Quercetin-loaded solid lipid nanoparticles exhibit antitumor activity and suppress the proliferation of triple-negative MDA-MB 231 breast cancer cells: implications for invasive breast cancer treatment.
Hatami, M; Kheirollah, A; Khorsandi, L; Kouchak, M; Rashidi, M, 2023
)
2.35
" Quercetin nanogels in the thermosensitive gel achieved sustained and controlled release of BDNF with non-Fick's diffusion, exhibited rapid brain distribution, and achieved nearly 50-fold enhanced bioavailability compared to oral quercetin."( Enhanced antidepressant effects of BDNF-quercetin alginate nanogels for depression therapy.
Chen, YB; Cui, YL; Dong, QW; Gao, LN; Song, XJ; Wang, Q; Xu, D, 2023
)
2.09
" However, the therapeutic benefit of quercetin is hindered by its poor bioavailability and limited concentration in pancreatic islets."( Controlled SPION-Exosomes Loaded with Quercetin Preserves Pancreatic Beta Cell Survival and Function in Type 2 Diabetes Mellitus.
Chen, Y; Lv, X; Qin, D; Rao, L; Xia, H; Xiao, S; Yang, J; Zhu, C; Zhuang, M, 2023
)
1.45
" However, the low bioavailability of AR-C17 due to its low water solubility restricts its application."( Quercetin Enhances the Availability of 5-Heptadecylresorcinol by Inhibiting the Expression of P-gp.
Fan, M; Jiang, L; Li, Y; Pan, W; Qian, H; Wang, L; Zhang, K, 2023
)
2.35
" Moreover, the number of hydrogen bond acceptors/donors, solubility, polar surface area and bioavailability score of the vanillic acid and three flavonoids were acceptable compared to Lipinski's Rule of Five."( Antioxidant activity, anti-tyrosinase activity, molecular docking studies, and molecular dynamic simulation of active compounds found in nipa palm vinegar.
Chatatikun, M; Chuaijit, S; Klangbud, WK; Mudpan, A; Palachum, W; Pattaranggoon, NC; Pruksaphanrat, S; Sohbenalee, S; Tedasen, A; Yamasaki, K, 2023
)
0.91
" Clinical studies investigating the safety and bioavailability of QUE are also discussed."( Advances in Quercetin for Drug-Resistant Cancer Therapy: Mechanisms, Applications, and Delivery Systems.
Kundrapu, DB; Malla, RR, 2023
)
1.29

Dosage Studied

Model ApoE KO mice were fed with either a normal chow diet or a high fat diet (HFD) supplemented with or without dosed quercetin for 24 weeks. Concentration/time curves were determined for hypericin, pseudohypericin and hyperforin. Dose-response study suggested 1 μmol/L quercETin for in vivo study.

ExcerptRelevanceReference
" The level of kinase induction correlated well with dose-response curves for two characteristic IL-1-induced responses, PGE2 and IL-6 production."( Evidence that MAP (mitogen-activated protein) kinase activation may be a necessary but not sufficient signal for a restricted subset of responses in IL-1-treated epidermoid cells.
Bird, TA; Delaney, PB; Dower, SK; Schule, HD; Sims, JE; Thoma, B, 1992
)
0.28
" Dose-response studies indicated that phosphorylation of the 67 kilodalton protein was particularly sensitive to inhibition by quercetin at concentrations that also inhibit neutrophil degranulation and superoxide production."( The bioflavonoid quercetin inhibits neutrophil degranulation, superoxide production, and the phosphorylation of specific neutrophil proteins.
Blackburn, WD; Heck, LW; Wallace, RW, 1987
)
0.82
" Dose-response curves for mutagenicity of quercetin with or without AAF (5 micrograms/plate) were examined."( The effect of quercetin on the mutagenicity of 2-acetylaminofluorene and benzo[alpha]pyrene in Salmonella typhimurium strains.
Fukui, S; Hirai, K; Hirayama, T; Nohara, M; Ogawa, S; Tokuda, M, 1985
)
0.89
" There were no significant differences between control and treated groups with regard to the number of dead implantations at any dosage level at any stage of the study in mice and rats."( Studies on germinal effects of quercetin, a naturally occurring flavonoid.
Aravindakshan, M; Chauhan, PS; Sundaram, K, 1985
)
0.56
" The therapy lasted for 4 weeks; the dosage was 300 mg three times daily."( Hypericum treatment of mild depressions with somatic symptoms.
Hübner, WD; Lande, S; Podzuweit, H, 1994
)
0.29
" The dosage was 3 x 300 mg hypericum extract LI 160 or 3 x 25 mg imipramine daily."( Effectiveness and tolerance of the hypericum extract LI 160 in comparison with imipramine: randomized double-blind study with 135 outpatients.
Arnoldt, KH; Hübner, WD; Vorbach, EU, 1994
)
0.29
" During long-term dosing (3 x 300 mg/day), a steady-state was reached after 4 days."( Pharmacokinetics of hypericin and pseudohypericin after oral intake of the hypericum perforatum extract LI 160 in healthy volunteers.
Brockmöller, J; Kerb, R; Ploch, M; Roots, I; Staffeldt, B, 1994
)
0.29
" The dosage was typically 300 to 900 mg total extract daily; the therapy duration was 2 to 6 weeks."( Clinical investigation of the antidepressant effectiveness of hypericum.
Harrer, G; Schulz, V, 1994
)
0.29
" Many supplements are potent drugs that lack sufficient data on safety, dose-response relationships, drug interactions, and purity."( Over-the-counter psychotropics: a review of melatonin, St John's wort, valerian, and kava-kava.
Guenther, G; Heiligenstein, E, 1998
)
0.3
" The dosage schedule was elaborated for the application of identical amounts of hyperforin in both extracts in each dosing group."( Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).
Dimpfel, W; Mannel, M; Schober, F, 1998
)
0.3
" After 3 weeks of treatment, dosage in 128 patients (21."( St. John's Wort for depressive disorders: results of an outpatient study with the Hypericum preparation HYP 811.
Mueller, BM,
)
0.13
" After 3 weeks of treatment, the dosage could be reduced to one capsule per day in 35."( Effects of hypericum extract HYP 811 in patients with psychovegetative disorders.
Mueller, BM,
)
0.13
" They also received the experimental diets containing one of test compounds (500 ppm) for 5 weeks, starting one week before the first dosing of AOM."( Inhibition of azoxymethane-induced aberrant crypt foci in rats by natural compounds, caffeine, quercetin and morin.
Honjo, S; Kawabata, K; Kohno, H; Matsunaga, K; Murakami, M; Shimada, R; Shimizu, M; Tanaka, T; Yamada, Y,
)
0.35
"The observed p53 concentration changes upon stimulation by polyphenols are relatively small, do not follow a uniform pattern in the four cell lines tested, and do not exhibit a dose-response effect."( Do wine polyphenols modulate p53 gene expression in human cancer cell lines?
Diamandis, EP; Goldberg, DM; Grass, L; Levesque, M; Soleas, GJ, 2001
)
0.31
" The antioxidant capacity of Gala apples and seven phenolic standards, determined by both ABTS(*)(-) and DPPH(*) scavenging assays, showed a dose-response of the first-order."( Vitamin C equivalent antioxidant capacity (VCEAC) of phenolic phytochemicals.
Kim, DO; Lee, CY; Lee, HJ; Lee, KW, 2002
)
0.31
" After oral dosing of morin, both the parent form, morin, and its glucuronides and sulfates were present in the bloodstream."( Profound difference in pharmacokinetics between morin and its isomer quercetin in rats.
Chao, PD; Ho, HJ; Hou, YC; Hsiu, SL; Wen, CC, 2003
)
0.55
" Inhibition of genotoxicity by spinach and peaches was not caused by any delay in maturation of micronucleated erythrocytes as shown by experiments with sampling times of 24, 48, and 72 h after dosing of BaP."( Inhibition of clastogenicity of benzo[a]pyrene and of its trans-7,8-dihydrodiol in mice in vivo by fruits, vegetables, and flavonoids.
Edenharder, R; Köttgen, V; Krieg, H; Platt, KL, 2003
)
0.32
" Dose-response studies indicated that the prenylated flavonoids were effective inhibitors of lipoprotein oxidation with IC50 values <1 microM and had similar inhibitory potency compared to quercetin, but was not directly related to Cu binding."( Antioxidant activity of prenylated flavonoids from the West African medicinal plant Dorstenia mannii.
Abegaz, BM; Croft, KD; Dufall, KG; Ngadjui, BT; Simeon, KF, 2003
)
0.51
" MRI studies using the relaxation of the T1 proton signal caused by Fe(2+) ions and the dose-dependent reversal of this effect by addition of quercetin in aqueous solution were used to guide us to the dosage of quercetin to be used in animal experimentations."( Quercetin promotes functional recovery following acute spinal cord injury.
Ghong, Z; Griebel, RW; Juurlink, BH; Kamencic, H; Kendall, E; Schültke, E, 2003
)
1.96
" Dose-response (D-R) curves and kinetic measurements of GABA rho(1) currents were carried out in the presence or absence of antagonists."( Studies on the mechanisms of action of picrotoxin, quercetin and pregnanolone at the GABA rho 1 receptor.
Calvo, DJ; Goutman, JD, 2004
)
0.58
"The current research provides a simplified sample preparation procedure for the accurate estimation of quercetin in pure and in the pharmaceutical dosage form."( Direct spectrophotometric determination of quercetin in the presence of ascorbic acid.
Kuntic, V; Micic, S; Pejic, N; Vujic, Z, 2004
)
0.8
" Body weight gain was reduced from week 10 to the end of the experiment in the 5% dosed males as compared to the 0% controls."( Evaluation of the toxicity of enzymatically decomposed rutin with 13-weeks dietary administration to Wistar rats.
Hasumura, M; Hirose, M; Imai, T; Mitsumori, K; Tamura, T; Yasuhara, K, 2004
)
0.32
" dosage forms."( Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin.
Choi, JS; Jo, BW; Kim, YC, 2004
)
0.54
" After dose-response studies, doses of 80 microM T3, 80 microM T4, 300 microM NA and 175 microM DES, which produced DNA damage but retained good cell viability, were chosen for further experiments with the antioxidant catalase and the flavonoids kaempferol and quercetin."( Antioxidants modulate thyroid hormone- and noradrenaline-induced DNA damage in human sperm.
Anderson, D; Baumgartner, A; Dobrzyńska, MM, 2004
)
0.5
" Oral treatment of quercitrin (1 or 5 mg kg(-1) day(-1)) to colitic rats ameliorated the evolution of the inflammatory process induced when administered in a preventative dosing protocol."( The intestinal anti-inflammatory effect of quercitrin is associated with an inhibition in iNOS expression.
Camuesco, D; Comalada, M; Concha, A; Gálvez, J; Lorente, MD; Nieto, A; Rodríguez-Cabezas, ME; Zarzuelo, A, 2004
)
0.32
" Interestingly, in both prostate and breast cancer cells, a remarkable dose-response parallelism was observed between flavonoid-induced inhibition of fatty acid synthesis, inhibition of cell growth, and induction of apoptosis."( Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity.
Brusselmans, K; Swinnen, JV; Verhoeven, G; Vrolix, R, 2005
)
0.33
"This paper describes a validated high-performance liquid chromatographic (HPLC) - photodiode array (PDA) detection method to quantitate five flavonol components as markers; rutin, quercitrin, quercetin, kaempferol and isorhamnetin for use in the quality control of Ginkgo biloba dosage forms."( High-performance liquid chromatographic determination of selected flavonols in Ginkgo biloba solid oral dosage forms.
Dubber, MJ; Kanfer, I, 2004
)
0.51
"A suitable method was developed to identify and quantitate five relevant flavonol marker compounds and was successfully used to assay some commercially available solid oral dosage forms of Ginkgo biloba ."( High-performance liquid chromatographic determination of selected flavonols in Ginkgo biloba solid oral dosage forms.
Dubber, MJ; Kanfer, I, 2004
)
0.32
" More in-depth studies on bioavailability should facilitate correlation of mechanisms determined in vitro with in vivo situations, increase our understanding of dose-response relationships, and facilitate extrapolation of results from animal studies to human situations."( Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations.
Hong, J; Lambert, JD; Liao, J; Yang, CS; Yang, GY, 2005
)
0.33
" Concentration/time curves were determined for hypericin, pseudohypericin, hyperforin, the flavonoid aglycone quercetin, and its methylated form isorhamnetin for 48 h after single dosing and for 24 h on day 14 at the end of 2 weeks of continuous daily dosing."( Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet.
Bässler, D; Schulz, HU; Schürer, M; Weiser, D, 2005
)
0.76
" These flavonols suppressed intracellular calcium ion elevations in a dose-response manner, with morin being the weakest; they also inhibited phosphorylation of the calcium-insensitive protein kinase C theta (PKC theta)."( Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells.
Boucher, W; Cao, J; Cetrulo, CL; Christodoulou, S; Kempuraj, D; Madhappan, B; Papadopoulou, N; Theoharides, TC, 2005
)
0.33
" Concentration/time curves were determined for the five constituents, for 48 h after single dosing and for 24 h on day 14 at the end of 2 weeks of continuous daily dosing."( Investigation of pharmacokinetic data of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin revealed from single and multiple oral dose studies with a hypericum extract containing tablet in healthy male volunteers.
Bässler, D; Schulz, HU; Schürer, M; Weiser, D, 2005
)
0.55
" Dose-response curves were established for each flavonol in the presence and absence of external metabolizing systems."( In vitro basal and metabolism-mediated cytotoxicity of flavonoids.
Raddi, MS; Soares, VC; Varanda, EA, 2006
)
0.33
" There seems to be a need for a better definition of the concept itself and reconsideration of whether all biphasic dose-response curves should be considered representative for hormesis."( The definition of hormesis and its implications for in vitro to in vivo extrapolation and risk assessment.
Alink, GM; Rietjens, IM; van der Woude, H, 2005
)
0.33
" In dose-response study, the ENRD activities in kaempferol (0."( [Effects of kaempferol and quercetin on cytochrome 450 activities in primarily cultured rat hepatocytes].
Shen, XY; Zhang, FF; Zheng, YF; Zhu, HJ; Zhu, XQ, 2006
)
0.63
" If the results are further confirmed in the clinical trials, the tamoxifen dosage should be adjusted when tamoxifen is administered with quercetin or quercetin-containing dietary supplements in order to avoid potential drug interactions."( Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats.
Choi, JS; Li, X; Shin, SC, 2006
)
0.76
" Finally, QuerVO stimulated the ERK phosphorylation in a dose-response manner and this activation seems to be involved as one of the possible mechanisms for the biological effects of the complex."( Synthesis, characterization, antitumoral and osteogenic activities of quercetin vanadyl(IV) complexes.
Barrio, DA; Correa, MJ; Etcheverry, SB; Ferrer, EG; Lezama, L; Naso, L; Rojo, T; Salinas, MV; Williams, PA, 2006
)
0.57
"On days 4 and 11, nine blood samples and four peripheral blood mononuclear cell samples were drawn during a steady-state dosing interval."( Effect of quercetin on the plasma and intracellular concentrations of saquinavir in healthy adults.
Chen, A; DiCenzo, R; Frerichs, V; Larppanichpoonphol, P; Morris, M; Predko, L; Reichman, R, 2006
)
0.74
" The concentrations required to result in a 50% reduction in cell death (EC(50) value) were calculated from their dose-response curves."( Free radical scavenging and cytoprotective activities of phenolic antioxidants.
Adaim, A; Melton, LD; Skinner, MA; Stanley, RA; Zhang, J, 2006
)
0.33
" After oral dosing of isorhamnetin, the mean values (n = 10) of C(max) were 57."( Quantitative determination of isorhamnetin, quercetin and kaempferol in rat plasma by liquid chromatography with electrospray ionization tandem mass spectrometry and its application to the pharmacokinetic study of isorhamnetin.
He, J; Jiang, X; Lan, K, 2007
)
0.6
" In this study quercetin inhibits, in a dose-response manner, tryptase and MCP-1."( Inhibitory effect of quercetin on tryptase and MCP-1 chemokine release, and histidine decarboxylase mRNA transcription by human mast cell-1 cell line.
Castellani, ML; Conti, P; Frydas, S; Kempuraj, D; Simeonidou, I; Theoharides, TC; Vecchiet, J, 2006
)
1.01
"10 g x kg(-1) x d(-1) dosage groups of hyperoside (P<0."( In vivo and in vitro antiviral activity of hyperoside extracted from Abelmoschus manihot (L) medik.
Huang, ZM; Liu, HZ; Wu, GX; Wu, LL; Yang, XB, 2007
)
0.34
" These 8 matrixes consisted primarily of simple dosage forms (e."( Evaluation of a method to determine flavonol aglycones in Ginkgo biloba dietary supplement crude materials and finished products by high-performance liquid chromatography: collaborative study.
Gray, D; LeVanseler, K; Meide, P; Waysek, EH,
)
0.13
" The dose-response study showed that the IC50 values for ECG and Q3G on glucose uptake in BLMV were 294+/-89 microM and 357+/-52 microM, respectively."( Interaction of flavonoids and intestinal facilitated glucose transporters.
Chen, CH; Hsu, HJ; Huang, YJ; Lin, CJ, 2007
)
0.34
" Optimal dosage of genistein, quercetin and in combination with chemicals for leukemia cells were determined by experiments."( [Synergistic antileukemic effect of phytoestrogens and chemotherapeutic drugs on leukemic cell lines in vitro].
Chen, CS; Shen, J; Tai, YC; Wong, CH; Xie, Z; Zhang, WJ, 2008
)
0.63
" The luc induction was determined in different tissues 8h after dosing the ER-luc male mice intraperitoneally (IP) or 14h after oral dosing."( Food-associated estrogenic compounds induce estrogen receptor-mediated luciferase gene expression in transgenic male mice.
Murk, AJ; Rietjens, IM; Ter Veld, MG; van den Berg, JH; van der Saag, PT; Zawadzka, E, 2008
)
0.35
" Administered orally to male rats at dose levels of up to 2000 mg/kg body weight, quercetin did not increase the number of micronucleated polychromatic erythrocytes (MN-PCE) 24 or 48 h following dosing in the micronucleus assay."( Evaluation of the potential in vivo genotoxicity of quercetin.
Broschard, TH; Danielewska-Nikiel, B; Dasenbrock, J; Feige, K; Harwood, M; Lines, TC; Utesch, D, 2008
)
0.82
" A dose-response study suggested that quercetin showed protective effects against Abeta(1-42) toxicity by modulating oxidative stress at lower doses, but higher doses were not only non-neuroprotective but also toxic."( Protective effect of quercetin in primary neurons against Abeta(1-42): relevance to Alzheimer's disease.
Abdul, HM; Ansari, MA; Butterfield, DA; Joshi, G; Opii, WO, 2009
)
0.94
"45 micromol PhIP/kg bw and 30 micromol quercetin/kg bw significantly increased the blood AUC(0-8h) of PhIP in rats to 131+/-14% of the AUC(0-8h) for rats dosed with PhIP alone."( Quercetin increases the bioavailability of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rats.
Alink, GM; Freidig, AP; Groten, JP; Rietjens, IM; Schutte, ME; Spenkelink, B; Vaessen, JC; van de Sandt, JJ, 2008
)
2.06
" The dosage regimen of etoposide in cancer therapy should take drug interaction into consideration when etoposide is administered with quercetin or dietary supplements containing quercetin."( Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats.
Choi, JS; Li, X, 2009
)
0.95
" Further considerations for dose-response relationships, duration of supplementation, and susceptible biomarkers are required."( Effects of antioxidant supplements intervention on the level of plasma inflammatory molecules and disease severity of rheumatoid arthritis patients.
Bae, SC; Jung, WJ; Lee, EJ; Sung, MK; Yu, R, 2009
)
0.35
" Since EGb 761 is a composition of various components, it is important to identify which components are responsible for its anticancer effects to reduce the total dosage and to avoid toxicity."( Kaempferol and quercetin, components of Ginkgo biloba extract (EGb 761), induce caspase-3-dependent apoptosis in oral cavity cancer cells.
Kang, JW; Kim, JH; Kim, KS; Kim, SH; Song, K; Yoon, JH, 2010
)
0.71
"This study suggests that Ambrotose AO(R) capsules appear to be safe and most effective at a dosage of 4 capsules/day."( A forced titration study of the antioxidant and immunomodulatory effects of Ambrotose AO supplement.
Brooks, L; Cheras, PA; Conellan, P; Morris, C; Myers, SP; O'Connor, J; Rolfe, M; Stevenson, L, 2010
)
0.36
" Depending on the duration and dosage of these modulators, 12."( Quercetin and ethanol attenuate the progression of atherosclerotic plaques with concomitant up regulation of paraoxonase1 (PON1) gene expression and PON1 activity in LDLR-/- mice.
Garige, M; Gong, M; Lakshman, RM; Leckey, LC; Nagata, T; Spurney, CF; Varatharajalu, R, 2010
)
1.8
" On the other side, studied flavonol augmented action of cytostatic drug in case of sensitive tumour cells what suggest, that it might allow to decrease dosage of cytostatic drugs and reduce negative side effects of the treatment."( Antiproliferative and pro-apoptotic effects of quercetin on human pancreatic carcinoma cell lines EPP85-181P and EPP85-181RDB.
Borska, S; Drag-Zalesinska, M; Dumanska, M; Dziegiel, P; Sopel, M; Wysocka, T; Zabel, M, 2010
)
0.62
" The implementation of this assay to the screening of a highly diverse academic chemical library of 14,300 molecules yielded, after secondary assays and generation of dose-response curves, the identification of two natural product inhibitors, cyanidin and delphinidin."( Identification by high-throughput screening of inhibitors of Schistosoma mansoni NAD(+) catabolizing enzyme.
Haiech, J; Hibert, M; Kellenberger, E; Kuhn, I; Lobstein, A; Muller-Steffner, H; Rognan, D; Said-Hassane, F; Schuber, F; Villa, P, 2010
)
0.36
" From this active fraction, seven compounds have been isolated and four compounds (pinosylvin, galangin, quercetin and methyl gallate) have been examined for their dose-response effect on the viability of A549 cells and on TNF-α inhibitory activity."( Bioactivity guided isolation of anticancer constituents from leaves of Alnus sieboldiana (Betulaceae).
Asakawa, Y; Kuzuhara, T; Ludwiczuk, A; Saha, A, 2011
)
0.58
" Therefore, it appears that the development of oral doxorubicin preparations is possible, which will be more convenient than the intravenous dosage forms."( Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin.
Choi, JS; Kang, KW; Piao, YJ, 2011
)
0.76
" The better results of lowering serum uric acid and protecting against renal failure were at the dosage of Que between 10 and 20 mg/kg."( [Preventive and therapeutic effects of quercetin on hyperuricemia and renal injury in rats].
Fu, R; He, W; Yao, F; Zhang, R, 2011
)
0.64
" Across all studies, subject presupplementation VO(2max) ranged from 41 to 64 mL·kg(-1)·min(-1) (median = 46), and median treatment duration was 11 d with a median dosage of 1000 mg·d(-1)."( Quercetin and endurance exercise capacity: a systematic review and meta-analysis.
Kressler, J; Millard-Stafford, M; Warren, GL, 2011
)
1.81
" It is possible that a different dosing regimen, a combination of antioxidants or a different form of quercetin supplementation, may be needed to produce an increase in soldier performance."( Effects of short-term quercetin supplementation on soldier performance.
Hendrickson, NR; McClung, HL; Michniak-Kohn, BB; Nindl, BC; Sharp, MA; Staab, JS, 2012
)
0.91
" The observed effect may be beneficial to develop oral valsartan dosage forms using safe P-gp inhibitor (quercetin) to improve its oral bioavailability."( Pharmacokinetic interaction study between quercetin and valsartan in rats and in vitro models.
Babu, PR; Challa, SR; Challa, VR; Johnson, B; Maheswari, C, 2013
)
0.87
" DHQ was more effective in restraining soy bean oil oxidation, and a dose-response relationship was observed."( Extraction of dihydroquercetin from Larix gmelinii with ultrasound-assisted and microwave-assisted alternant digestion.
Ma, C; Wang, W; Yang, F; Yang, L; Zhao, C; Zu, Y, 2012
)
0.7
" Single and 14-day repeat dosing in rats and dogs had no influence on body weight, feed consumption, blood chemistry, and haematology at any dose level."( Production, composition and toxicology studies of Enzogenol® Pinus radiata bark extract.
Frampton, CM; Frevel, MA; Gilchrist, NL; Grigsby, WJ; Pipingas, A, 2012
)
0.38
" Furthermore, the duration of benefit and the influence of different dosing regimens remain unclear."( Treatment with quercetin and 3',4'-dihydroxyflavonol inhibits platelet function and reduces thrombus formation in vivo.
Jackson, DE; Linden, MD; Mosawy, S; Woodman, OL, 2013
)
0.74
" The results showed no statistically significant difference in quercetin absorption among groups due to high variability within groups receiving quercetin from same dosage form."( Comparison of quercetin pharmacokinetics following oral supplementation in humans.
Clarkson, PM; Conca, KR; Dunne, CP; Kaushik, D; Michniak-Kohn, B; O'Fallon, K, 2012
)
0.98
" We assessed accumulations of polyphenols in the rat brain following oral dosage with a Cabernet Sauvignon red wine and tested brain-targeted polyphenols for potential beneficial AD disease-modifying activities."( Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer's disease.
Chen, TY; Cooper, B; Ferruzzi, MG; Gong, B; Ho, L; Janle, EM; Lobo, J; Pasinetti, GM; Percival, SS; Simon, JE; Talcott, ST; Wang, J; Wu, QL, 2013
)
0.64
" These data show that nanocapsulated quercetin possesses the potential bioactivity to reduce the drug dosage frequency, as well as increase patient compliance."( Co-encapsulation of biodegradable nanoparticles with silicon quantum dots and quercetin for monitored delivery.
Ahire, J; Bao, Y; Chao, Y; Wang, Q, 2013
)
0.89
" However, the pre-treatment of Quercetin in a dose-response manner prevented these changes and restored the expansion of neurospheres preferably by neutralizing the oxidative conditions and thereby reducing peroxynitrite formation, protein nitration and PK-M2 depletion."( Quercetin prevents protein nitration and glycolytic block of proliferation in hydrogen peroxide insulted cultured neuronal precursor cells (NPCs): Implications on CNS regeneration.
Arora, R; Khan, HA; Sajad, M; Sharma, J; Umar, S; Zargan, J; Zargar, MA, 2013
)
2.12
" Oral treatments of quercetin and αOR at this dosage exhibited no anti-allergic effect, and IQC showed less effect than EMIQ."( Anti-allergic effects of enzymatically modified isoquercitrin (α-oligoglucosyl quercetin 3-O-glucoside), quercetin 3-O-glucoside, α-oligoglucosyl rutin, and quercetin, when administered orally to mice.
Kanemaru, M; Makino, T; Mizukami, H; Okuyama, S; Shimizu, R; Tanaka, H, 2013
)
0.94
" The Cd-treated group was injected subcutaneously with cadmium chloride (CdCl2) dissolved in saline at a dose of 2 ml/kg/day for 30 days, resulting in a dosage of 1 mg/kg Cd."( Role of quercetin in cadmium-induced oxidative stress, neuronal damage, and apoptosis in rats.
Aktas, C; Erboga, M; Kanter, M; Unsal, C, 2015
)
0.85
" QUE, specially at the dosage of 50mg/kg, can act as an antioxidant and anti-inflammatory agent, becoming a promising adjuvant in the treatment of diabetes mellitus."( Antioxidant and anti-inflammatory effects of quercetin in functional and morphological alterations in streptozotocin-induced diabetic rats.
Abdala, FH; Costa, MM; Danesi, CC; Duarte, MM; Felin, DV; França, RT; Graça, DL; Lopes, ST; Maciel, RM; Martins, DB; Mazzanti, CM; Paim, FC; Palma, HE; Schetinger, MR; Schmatz, R; Stefanello, N; Zimpel, CK, 2013
)
0.65
" This study examines the dose-response of DNA-damage pathway to these compounds in HT1080 cells (a human cell line with wild-type p53) at doses relevant to human exposure."( Assessing dose-dependent differences in DNA-damage, p53 response and genotoxicity for quercetin and curcumin.
Andersen, ME; Carmichael, PL; Clewell, RA; Dent, M; Ross, SM; Sun, B; Trask, OJ; White, A, 2013
)
0.61
" Quercetin was administered by gavage daily for 10 days at dosage 50 mg kg(-1) ."( Evaluation of the protective effect of quercetin against cisplatin-induced renal and testis tissue damage and sperm parameters in rats.
Aldemir, M; Avcı, A; Ener, K; Evirgen, O; Gürleyik, E; Kösemehmetoğlu, K; Okulu, E; Topal, F, 2014
)
1.58
" In vivo evaluation and histopatholgical study of the selected QT SNEDDSs were achieved after administration of paracetamol over dosage to albino rats."( Design and optimization of self-nanoemulsifying delivery system to enhance quercetin hepatoprotective activity in paracetamol-induced hepatotoxicity.
Ahmed, OA; Ahmed, TA; Badr, JM; Badr-Eldin, SM; El-Say, KM; Tawfik, MK, 2014
)
0.63
"Microparticle tablets represent a promising dosage form for QUE delivery to the colon in the oral therapy of inflammatory-based disorders."( Chitosan-xanthan gum microparticle-based oral tablet for colon-targeted and sustained delivery of quercetin.
Caddeo, C; Díez-Sales, O; Fadda, AM; Manconi, M; Merino-Sanjuán, M; Nácher, A, 2014
)
0.62
" A multidisciplinary approach has been employed herein, in an effort to reveal its mode of action including dose-response antiproliferative activity and induced apoptosis effect, biochemical and physicochemical assays, and computational calculations."( Direct binding of Bcl-2 family proteins by quercetin triggers its pro-apoptotic activity.
Briasoulis, E; Chatziathanasiadou, MV; Chi, SW; Gerothanassis, IP; Hatzimichael, E; Karali, E; Kolettas, E; Kostaras, E; Mantzaris, MD; Primikyri, A; Shin, JS; Tzakos, AG, 2014
)
0.67
" Our results suggest that rutin may be useful in the management of inflammatory bowel disease in appropriate dosage conditions."( Rutin has intestinal antiinflammatory effects in the CD4+ CD62L+ T cell transfer model of colitis.
Aranda, C; de Medina, FS; Marín, JJ; Martínez-Augustin, O; Mascaraque, C; Monte, MJ; Ocón, B; Suárez, MD; Zarzuelo, A, 2014
)
0.4
" In conclusion, QUR protected against DOX-induced nephrotoxicity with a provision to dosage adjustment."( Dual effects of quercetin in doxorubicin-induced nephrotoxicity in rats and its modulation of the cytotoxic activity of doxorubicin on human carcinoma cells.
Heeba, GH; Mahmoud, ME, 2016
)
0.78
" Although significant advances have been made in understanding determinants of quercetin bioavailability, additional research in controlled trials is needed to more comprehensively examine dose-response effects, whether its cardioprotective activities improve in response to its greater bioavailability, and if the putative health benefits of quercetin are mediated directly or indirectly from one or more of its metabolites generated during xenobiotic metabolism."( Endogenous and exogenous mediators of quercetin bioavailability.
Bruno, RS; Guo, Y, 2015
)
0.92
"The aim of this work was to prepare a combined drug dosage form of famotidine (FAM) and quercetin (QRT) to augment treatment of gastric ulcer."( Evaluation of combined famotidine with quercetin for the treatment of peptic ulcer: in vivo animal study.
Abourehab, MA; Ahmed, OA; Khaled, KA; Sarhan, HA, 2015
)
0.91
" graveolens produced rightward parallel displacement of carbachol dose-response curves and reduced over 35 % of the maximum smooth muscle contraction."( Relaxant effects of a hydroalcoholic extract of Ruta graveolens on isolated rat tracheal rings.
Águila, L; de Campos, RR; Mansilla, K; Ordenes, J; Romero, F; Ruedlinger, J; Salvatici, R, 2015
)
0.42
" However, concurrent dosing of these natural products with ADR is limited due to their low solubility, and low oral bioavailability."( Combinatorial resveratrol and quercetin polymeric micelles mitigate doxorubicin induced cardiotoxicity in vitro and in vivo.
Alani, AWG; Carlson, LJ; Cote, B; Rao, DA, 2015
)
0.71
"With increasing dosage of quercetin, significant decrease in proliferation and increase in apoptosis was observed."( Quercetin reverses tamoxifen resistance in breast cancer cells.
Chen, T; Feng, D; Kong, H; Lin, Q; Qi, K; Tao, L; Wang, H; Wei, W; Zhang, H,
)
1.87
"Proliferation inhibition and apoptosis in MCF-7Ca/TAM-R cells increase with increasing dosage of quercetin."( Quercetin reverses tamoxifen resistance in breast cancer cells.
Chen, T; Feng, D; Kong, H; Lin, Q; Qi, K; Tao, L; Wang, H; Wei, W; Zhang, H,
)
1.79
" On the 30th day, hormonal dosing was performed to confirm hypothyroidism, and the animals were subsequently treated with 10 or 25 mg/kg quercetin for 60 days."( Hypothyroidism Enhanced Ectonucleotidases and Acetylcholinesterase Activities in Rat Synaptosomes can be Prevented by the Naturally Occurring Polyphenol Quercetin.
Abdalla, FH; Baldissarelli, J; Calgaroto, NS; Cardoso, AM; Dias, GR; Loro, VL; Martins, CC; Morsch, VM; Pelinson, LP; Reichert, KP; Santi, A; Schetinger, MR; Schmatz, R, 2017
)
0.86
" In conclusion, QPTN could be used as a potential intravenous dosage form for the treatment of liver cancer owing to the enhanced pharmacological effects of QT with increased liver targeting."( Quercetin-loaded poly (lactic-co-glycolic acid)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for the targeted treatment of liver cancer.
Deng, S; Gao, D; Gao, M; Guan, X; Liu, H; Lv, L; Tian, Y; Xu, H; Zhang, C, 2016
)
1.88
" Oral quercetin supplementation protected respiratory function for 4-6 months during a 12 month dosing regimen."( Oral quercetin administration transiently protects respiratory function in dystrophin-deficient mice.
Ballmann, CG; Quindry, JC; Ross, JW; Selsby, JT; Spaulding, HR, 2016
)
1.43
"The results indicate that quercetin has not only a positive dose-response on qualitative and quantitative histological characteristics of the compact bone of female rabbits as it would be expected."( Structural changes in femoral bone microstructure of female rabbits after intramuscular administration of quercetin.
Adamkovicova, M; Babosova, R; Capcarova, M; Duranova, H; Grosskopf, B; Kovacova, V; Martiniakova, M; Omelka, R, 2016
)
0.95
" The cadmium-treated group was injected subcutaneously with cadmium chloride (CdCl2) dissolved in saline at a dose of 2 mL/kg/ day for 30 days, resulting in a dosage of 1 mg/kg cadmium."( Role of Quercetin in Cadmium-Induced Oxidative Stress, Testicular Damage, and Apoptosis in Rats.
Aktas, C; Aktoz, T; Kanter, B; Kanter, M; Ozen, F; Yarali, O, 2016
)
0.87
" Dose-response curves were generated to evaluate the protective effect on hair cells."( Quercetin protects against hair cell loss in the zebrafish lateral line and guinea pig cochlea.
Hashimoto, M; Hirose, Y; Kanagawa, E; Sugahara, K; Takemoto, Y; Yamashita, H, 2016
)
1.88
" Model ApoE KO mice were fed with either a normal chow diet or a high fat diet (HFD) supplemented with or without dosed quercetin for 24 weeks."( Quercetin attenuates high fat diet-induced atherosclerosis in apolipoprotein E knockout mice: A critical role of NADPH oxidase.
Guo, X; Liu, L; Tang, Y; Wang, J; Xiao, L; Yao, P; Zhang, S; Zhou, F, 2017
)
2.11
" Intraperitoneal administration of 4-pentenoic acid was performed once daily during seven days, the used dosage was 20mg/kg."( [ACTION OF L-CARNITINE, CORVITIN AND THEIR COMBINATION ON FUNCTIONAL STATE OF LIVER IN EXPERIMENTAL MODEL OF REYE SYNDROME IN RATS].
Antelava, N; Ghonghadze, M; Liluashvili, K; Okujava, M; Pachkoria, K, 2017
)
0.46
" In the subgroup analysis, a significant reducing effect was observed in trials with ⩾500 mg/day dosage (WMD: -0."( Effects of supplementation with quercetin on plasma C-reactive protein concentrations: a systematic review and meta-analysis of randomized controlled trials.
Firoozi, D; Ghorbani, M; Mazloom, Z; Mohammadi-Sartang, M; Sherafatmanesh, S, 2017
)
0.74
"(ZDF) rats and their lean controls (LN) were dosed with a Standardized Grape Polyphenol (SGP) Mixture consisting of grape seed extract, Concord grape juice and resveratrol (RES) by oral gavage for 10 days."( Influence of diabetes on plasma pharmacokinetics and brain bioavailability of grape polyphenols and their phase II metabolites in the Zucker diabetic fatty rat.
Chen, TY; Cooper, B; Ferruzzi, MG; Ho, L; Janle, EM; Pasinetti, GM; Simon, JE; Talcott, ST; Todd, G; Wang, J; Wu, QL, 2017
)
0.46
" The mice dosed with tamoxifen were divided into four groups: high‑ or low‑quercetin group, valproic acid (VPA) group and untreated group."( Quercetin alleviates generalized hyperalgesia in mice with induced adenomyosis.
Liu, X; Nie, J, 2017
)
2.13
" QU at a dosage of 150 mg/kg was administered orally in collagen-induced arthritis rats and then the clinical symptoms were monitored."( Quercetin attenuates collagen-induced arthritis by restoration of Th17/Treg balance and activation of Heme Oxygenase 1-mediated anti-inflammatory effect.
Wu, X; Xu, M; Yang, Y; Zhang, X; Zhao, C; Zhao, F, 2018
)
1.92
" The proposed formulation design can significantly help in reduction of dose and dosing frequency, which ultimately enhance patient compliance with decreased drug toxicity."( Artesunate-quercetin/luteolin dual drug nanofacilitated synergistic treatment for malaria: A plausible approach to overcome artemisinin combination therapy resistance.
Kumar, RS; Puttappa, N; Yamjala, K, 2017
)
0.84
"The major objective of this study was to develop and validate a high-performance liquid chromatography (HPLC) method for the determination of TAX in a semisolid dosage forms and then to evaluate ex vivo permeations across porcine vaginal mucosa and human skin."( Taxifolin: Evaluation Through Ex vivo Permeations on Human Skin and Porcine Vaginal Mucosa.
Alves, MC; Bhering, CAP; Brandao, MAF; de Almeida, PA; de O Ferreira, A; Polonini, HC; Raposo, NRB, 2018
)
0.48
" dosage highly unlikely to have an effect on nocturia or any other pharmacologically significant effect in humans."( Investigations on the constituents of SagaPro tablets, a food supplement manufactured from
Eyjolfsson, R; Kowal, NM; Olafsdottir, ES, 2017
)
0.46
" The results demonstrated accelerated wound-healing with significant decrease in wound closure time compared to conventional dosage form."( In vitro and In vivo characterization of quercetin loaded multiphase hydrogel for wound healing application.
Jangde, R; Singh, D; Singh, MR; Srivastava, S, 2018
)
0.75
" Dose-response study suggested 1 μmol/L quercetin for in vivo study."( Topical application of quercetin improves wound healing in pressure ulcer lesions.
Wang, X; Wang, Z; Yin, G, 2018
)
1.06
" Despite the lack of effectiveness in preventing bone loss, a significant dose-response trend was observed in the phytochemical-rich diets in bone adipocyte number compared to ovariectomized control rats."( Synergistic Phytochemicals Fail to Protect Against Ovariectomy Induced Bone Loss in Rats.
Ambati, S; Baile, CA; Bass, EF; Della-Fera, MA; Hartzell, DL; Hohos, NM; Kelso, EW; Miller, CN; Rayalam, S; Trunnell, ER; Yang, JY, 2018
)
0.48
"We conducted a multicenter phase II trial of sequential dosing cohorts to evaluate the efficacy of targeting PDI with isoquercetin to reduce hypercoagulability in cancer patients at high risk for thrombosis."( Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer.
Aggarwal, A; Bauer, KA; Caughey, T; Flaumenhaft, R; Furie, B; Hidalgo, M; Kuemmerle, N; Liebman, HA; McLaughlin, M; Neuberg, D; Puligandla, M; Schlechter, BL; Stopa, JD; Wong, E; Wun, T; Zwicker, JI, 2019
)
0.96
" Naringenin, naringenin chalcone, and quercetin all showed strong antiallergic activity after intravenous dosing (0."( In Vivo Anti-inflammatory and Antiallergic Activity of Pure Naringenin, Naringenin Chalcone, and Quercetin in Mice.
Boix Montañés, A; Escribano-Ferrer, E; Garcia-Sala, X; Lamuela-Raventos, RM; Queralt Regué, J, 2019
)
1
" At the end of this period, the animals were killed with a high dosage of thiopental anaesthesia (50 mg/kg)."( The Effect of Taxifolin on Cisplatin-Induced Pulmonary Damage in Rats: A Biochemical and Histopathological Evaluation.
Cimen, FK; Kuzucu, M; Olmez, H; Suleyman, Z; Tosun, M; Unver, E, 2019
)
0.51
" Co-administration of mRQ with ADR can reduce ADR dosing through chemosensitization while being cardioprotective."( Chemosensitization and mitigation of Adriamycin-induced cardiotoxicity using combinational polymeric micelles for co-delivery of quercetin/resveratrol and resveratrol/curcumin in ovarian cancer.
Alani, AWG; Cote, B; Fatease, AA; LeBlanc, N; Nguyen, DX; Rao, DA; Shah, V, 2019
)
0.72
" Admistration of quercetin at the dosage of 15 and 20 mg/kg to septic rats caused significant reduction in the ROS levels."( Quercetin Exerted Protective Effects in a Rat Model of Sepsis via Inhibition of Reactive Oxygen Species (ROS) and Downregulation of High Mobility Group Box 1 (HMGB1) Protein Expression.
Cui, W; Hu, G; Liu, J; Mu, L; Peng, J; Qiao, L, 2019
)
2.3
" The role of UV-B rays in inducing secondary plant metabolites is enhanced by new plastic films, which, as a result of their optical properties, permit the necessary dosage of UV-B to be transmitted into the greenhouse to stimulate such metabolites without altering the harvest."( Use of greenhouse-covering films with tailored UV-B transmission dose for growing 'medicines' through plants: rocket salad case.
Graziani, G; Mormile, P; Rippa, M; Ritieni, A, 2019
)
0.51
" However, it is possible that a lower dosage from plant sources could be effective due to of its higher bioavailability compared to the aglycone form."( Dietary Quercetin and Kaempferol: Bioavailability and Potential Cardiovascular-Related Bioactivity in Humans.
Dabeek, WM; Marra, MV, 2019
)
0.95
" Partial least squares discriminant analysis showed significant differences in chemical content in the dosed rats."( Plasma metabolomics analysis of endogenous and exogenous metabolites in the rat after administration of Lonicerae Japonicae Flos.
Chen, L; Li, L; Ma, S; Wang, D; Wang, X, 2020
)
0.56
" The developed quercetin nanorod/MCC formulation could be used for further pharmaceutical dosage or food supplements processing."( Preparation of quercetin nanorod/microcrystalline cellulose formulation via fluid bed coating crystallization for dissolution enhancement.
Cheng, S; Chow, PS; Dong, Y; Guo, L; Hu, J; Sheng, F, 2020
)
1.26
" The oral administration of quercetin at the dosage of 25 and 50 mg/kg for 28 days remarkably reduced the level of blood glucose, glycosylated hemoglobin (Hb), and hepatic glycogen but enhanced plasma Hb concentration."( Quercetin modulates hyperglycemia by improving the pancreatic antioxidant status and enzymes activities linked with glucose metabolism in type 2 diabetes model of rats: In silico studies of molecular interaction of quercetin with hexokinase and catalase.
Adeyemi, OT; Aiyegoro, OA; Chukwuma, CI; Matsabisa, MG; Nwaogu, G; Oyedemi, SO; Swain, SS, 2020
)
2.29
"5, and VPA (800 mg/kg) was administered orally in a single dosage on gestational day 12."( Quercetin prevents alterations of behavioral parameters, delta-aminolevulinic dehydratase activity, and oxidative damage in brain of rats in a prenatal model of autism.
Baldissarelli, J; de Mattos, BDS; de Souza, AA; Gamaro, GD; Pedra, NS; Soares, MSP; Spanevello, RM; Spohr, L; Stefanello, FM; Teixeira, FC, 2020
)
2
" Also, rapid gastrointestinal digestion of QT seems to be a key barrier for its clinical translations for oral drug delivery in conventional dosage form."( Recent Advances in Liposomal Drug Delivery System of Quercetin for Cancer Targeting: A Mechanistic Approach.
Alshehri, S; Altamimi, MA; Das, SS; Hussain, A; Imam, SS; Singh, SK; Verma, PRP, 2020
)
0.81
" As results, quercetin showed contrasting dose-response to cellular behaviors dependent on the ROS-regulated p53 signaling pathways."( Quercetin exerts bidirectional regulation effects on the efficacy of tamoxifen in estrogen receptor-positive breast cancer therapy: An in vitro study.
Huang, B; Pan, X; Xia, X; Xu, Z; Zhao, D; Zheng, X, 2020
)
2.37
" A dose-response curve was generated by the cumulative addition of acetylcholine (ACh) or sodium nitroprusside (SNP)."( Quercetin improves vascular endothelial function through promotion of autophagy in hypertensive rats.
Fan, Y; Han, T; Lin, X; Wang, C; Wang, F; Wu, S, 2020
)
2
" The use of NSAIDs together with an overall reduction of their dosage and time of assumption has been reduced as well."( Effectiveness of the integration of quercetin, turmeric, and N-acetylcysteine in reducing inflammation and pain associated with endometriosis. In-vitro and in-vivo studies.
Accardi, M; Baietti, MG; Fadin, M; Fratter, A; Nicoletti, MC; Pellizzato, M, 2020
)
0.83
" Longer term and especially dose-response studies on mildly insulin resistant participants are required to establish the extent to which (poly)phenols and (poly)phenol-rich foods may improve insulin resistance in compromised groups."( Effects of Polyphenols on Insulin Resistance.
Sheedy, K; Williamson, G, 2020
)
0.56
" Dose-response effects showed an L-shaped curve between the total intake of five flavonoids and the risk of the MetS."( The association of dietary flavonoids, magnesium and their interactions with the metabolic syndrome in Chinese adults: a prospective cohort study.
Han, T; Jia, Y; Jin, S; Liu, J; Na, L; Sun, C; Zhao, X, 2021
)
0.62
" This may be related to factors such as the population and the dosage and time of taking natural products involved in different studies."( Natural products: The role and mechanism in low-density lipoprotein oxidation and atherosclerosis.
Chen, W; Feng, X; Li, L; Xu, S; Zhang, L; Zhang, S, 2021
)
0.62
" A modern pharmacy has proposed a number of dosage forms that improve bioavailability, including dental films or chips, which are intended for topical use and belong to the transdermal therapeutic systems and are applied by application to the mucous membrane of the mouth and periodontium."( Substantiation of attention around antioxidants of plant origin for use in complex pharmacotherapy of diseases of the oral cavity.
Chornij, N; Kritsak, M; Pavliuk, B; Prokopovych, O; Stechyshyn, I, 2021
)
0.62
" This paper investigated different concentrations of selected commercially sourced analytical-grade pure chemicals as potential drug absorption enhancers in vitro and ex vivo to determine the lowest effective concentrations for optimizing drug absorption in oral dosage forms."( Determination of effective concentrations of drug absorption enhancers using in vitro and ex vivo models.
Enslin, GM; Kheoane, PS; Tarirai, C, 2021
)
0.62
", curcumin and quercetin), at specific concentrations, in dosage forms could improve the bioavailability of the BCS Class III and IV drugs that are substrates of CYP3A4 and p-glycoprotein."( Determination of effective concentrations of drug absorption enhancers using in vitro and ex vivo models.
Enslin, GM; Kheoane, PS; Tarirai, C, 2021
)
0.97
" However further studies are needed to improve the bioavailability and to establish a dosing regimen for Quercetin."( Quercetin for managing type 2 diabetes and its complications, an insight into multitarget therapy.
Dhanya, R, 2022
)
2.38
" Orally dosed QUE/pLA (50 mg QUE/kg) in rats exhibited significantly prolonged systemic exposure, possibly due to the sustained release of QUE."( Development of Poly(lipoic acid) Nanoparticles with Improved Oral Bioavailability and Hepatoprotective Effects of Quercetin.
Banik, S; Onoue, S; Sato, H; Yamada, K, 2022
)
0.93
" Further investigations based on the results of interaction index and isobologram analysis showed that the antioxidant activity (DPPH, ABTS, and reducing power) of the combination of caffeic acid with SAC presented an increase with the raising of their individual concentrations in their mixture and along with a dose-response manner."( Antioxidant Interactions between S-allyl-L-cysteine and Polyphenols Using Interaction Index and Isobolographic Analysis.
Dong, C; Duan, S; Liu, J; Qiu, F; Tao, L; Wang, B; Wang, S; Zhao, G, 2022
)
0.72
" Dose/time-response images predicted a modest association between Qu dosage consumption/administration length and therapeutic efficacy, with the optimal dosage at 90-150 mg/kg/d and administration length ranging from 8 weeks to 12 weeks."( Effective dose/duration of natural flavonoid quercetin for treatment of diabetic nephropathy: A systematic review and meta-analysis of rodent data.
Deng, H; Feng, X; Guo, X; Li, Q; Li, Z; Lu, C; Ma, X; Wang, J; Yan, S; Zeng, J; Zhao, Z, 2022
)
0.98
"Seventy-two women with PCOS were randomly allocated to one of two intervention groups, and each received a daily dosage of 500 mg of Quercetin for the intervention group or a placebo for the control group for a period of 40 days from the start of the menstrual cycle until the day of ovulation."( Quercetin and polycystic ovary syndrome; inflammation, hormonal parameters and pregnancy outcome: A randomized clinical trial.
Amidi, F; Amini, N; Moini, A; Parivr, K; Rudbari, NH; Vaez, S, 2023
)
2.56
" All of the extracts revealed significant antioxidant capacities along a dosage gradient."( Appraisal of the Antioxidant Activity, Polyphenolic Content, and Characterization of Selected Himalayan Herbs: Anti-Proliferative Potential in HepG2 Cells.
Almaghrabi, S; Baothman, BK; Hjazi, A; Jamous, YF; Kauts, S; Khan, AA; Minocha, T; Mujalli, A; Obaid, AA; Shabir, S; Singh, MP; Singh, SK; Vamanu, E; Yousuf, S, 2022
)
0.72
" The poor water solubility of this flavanonol at ambient conditions inhibits its implementation in clinical practice as an injectable dosage form."( Solubility Enhancement of Dihydroquercetin via "Green" Phase Modification.
Beloborodov, VL; Bogdanov, AG; Davidovich, GN; Dzuban, AV; Ilyasov, IR; Pankov, DI; Saverina, EA; Selivanova, IA; Shilov, GV; Terekhov, RP; Utenyshev, AN; Zhevlakova, AK, 2022
)
1
"All participants completed the scheduled drug dosing regimen (108/108 doses) and planned assessments (60/60)."( Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability.
Gelfond, J; Goros, M; Hashmi, S; Justice, J; Kellogg, D; Kirkland, J; Kritchevsky, S; LeBrasseur, N; Limper, A; Masternak, M; Musi, N; Nambiar, A; Pascual, R; Prata, L; Tchkonia, T, 2023
)
1.21
" It is suggested that a single dosage of Quercetin have a reno-protective impact in the case of renal I/R injury."( The Effects of Quercetin on Apoptosis and Antioxidant Activity in a Renal Ischemia/Reperfusion Injury Animal Model.
Aria, N; Bagheri, A; Bagheri, Y; Ghiabi, S; Khajenouri, M; Radman, G; Rezaei, F, 2023
)
1.53
"Transdermal penetration of therapeutic moieties from topical dosage forms always remains a challenge due to the presence of permeation impeding keratin which should be addressed."( Exploring the Potent Combination of Quercetin-Boronic Acid, Epalrestat, and Urea Containing Nanoethosomal Keratolytic Gel for the Treatment of Diabetic Neuropathic Pain: In Vitro and In Vivo Studies.
Abid, S; Ameer, N; Azeem, M; Danish, Z; Hanif, M; Khan, M; Khurshid, U; Mahmood, K; Pandey, K; Qaiser, M; Razaque, G; Sajid Chughtai, FR; Usman Abid, HM, 2023
)
1.19
" From 4-13 months of age, C57BL/6 male and female mice received monthly oral dosing of either 100 mg/kg Fisetin or a 5 mg/kg Dasatinib (D) plus 50 mg/kg Quercetin (Q) cocktail."( Sexual dimorphic metabolic and cognitive responses of C57BL/6 mice to Fisetin or Dasatinib and quercetin cocktail oral treatment.
Bartke, A; Fang, Y; Hascup, ER; Hascup, KN; McFadden, S; Medina, D; Peck, MR; Quinn, K; Stockwell, R, 2023
)
1.33
" To investigate the mechanism of action, conducted assays of antioxidant activity, measured the dosage of inflammatory cytokines, quantified mucus, treated with inhibitors (IND, L-NAME, glibenclamide, and yohimbine), performed histopathological analysis, and measured gastric acid secretion."( Antiulcer activity and mechanism of action of the hydroethanolic extract of leaves of Terminalia argentea Mart. In different in vivo and in vitro experimental models.
Arunachalam, K; Damazo, AS; Figueiredo, FF; Martins, DTO; Muller, JAI; Oliveira, DM; Serio, BFD; Silva, MJD; Venturini, CL, 2024
)
1.44
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (101 Product(s))

Product Categories

Product CategoryProducts
Other4
Milchprodukte, Fermentierte Lebensmittel, Fermentierte Milch, Käse, Schmelzkäse1
Vitamins & Supplements65
Professional Supplements21
Active Lifestyle & Fitness5
Pet Supplies2
Herbs, Botanicals & Homeopathy1
Beauty & Personal Care2

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
1Life Science NAD+ Longevity Cardiovascular Support -- 60 Veggie Caps1Life ScienceVitamins & SupplementsApigenin, Fisetin, Vitamin B9, NAD +, Vitamin B3, NMN, Vitamin B6, Quercetin, Vitamin B62024-11-29 10:47:42
Allergy Research Group Quercetin 300 -- 300 mg - 60 CapsulesAllergy Research GroupProfessional SupplementsVitamin C, Vitamin E, Vitamin E, Quercetin2024-11-29 10:47:42
Amazing Grass Greens Blend Antioxidant Powder Sweet Berry -- 100 ServingsAmazing GrassVitamins & SupplementsVitamin C, Chlorophyll, Iodine, Manganese, Vitamin B6, Quercetin, Vitamin A, Riboflavin, Selenium, Vitamin B12, Vitamin B6, Vitamin K2024-11-29 10:47:42
Amazing Nutrition Amazing Formulas Quercetin -- 500 mg - 120 Veggie CapsulesAmazing NutritionVitamins & SupplementsQuercetin2024-11-29 10:47:42
Amazing Nutrition Amazing Formulas Quercetin Berberine -- 500 mg - 180 Veggie CapsulesAmazing NutritionVitamins & SupplementsQuercetin2024-11-29 10:47:42
Amazing Nutrition Amazing Formulas Quercetin Berberine -- 500 mg - 90 Veggie CapsulesAmazing NutritionVitamins & SupplementsQuercetin2024-11-29 10:47:42
Amazing Nutrition Amazing Formulas Quercetin Bromelain -- 965 mg - 120 Veggie CapsulesAmazing NutritionVitamins & SupplementsQuercetin2024-11-29 10:47:42
AMEN Vitamin C+ Zinc Rosehips Quercetin & Citrus Bioflavonoids -- 120 CapsulesAMENVitamins & SupplementsVitamin C, Quercetin Dihydrate2024-11-29 10:47:42
Animal Flex Joint Support -- 44 PacketsAnimalActive Lifestyle & FitnessVitamin C, cetyl myristoleate, cetyl palmitate, Vitamin E, Methylsulfonylmethane, Vitamin E, Glucosamine, HCl, Manganese, cetyl oleate, Quercetin, Selenium2024-11-29 10:47:42
Animal Stak All-in-1 Pill Packs -- 21 PacketsAnimalActive Lifestyle & FitnessDiindolylmethane, Astaxanthin, Coenzyme Q10, L-Glutamine, Glycine, Vitamin B6, Quercetin Dihydrate, Alpha-Lipoic Acid, Vitamin B62024-11-29 10:47:42
Bark & Whiskers Seasonal Allergy Support Powder for Dogs & Cats -- 3.17 ozBark & WhiskersPet SuppliesVitamin C, Quercetin2024-11-29 10:47:42
Best Naturals Quercetin -- 1000 mg - 120 Vegetarian CapsulesBest NaturalsVitamins & SupplementsQuercetin Dihydrate2024-11-29 10:47:42
BioSchwartz Glutathione Complex -- 60 CapsulesBioSchwartzVitamins & SupplementsVitamin C, Quercetin, Selenium, Alpha-Lipoic Acid2024-11-29 10:47:42
BioSchwartz Respiratory & Immune Support -- 60 CapsulesBioSchwartzVitamins & Supplements Ascorbyl Palmitate, Vitamin C, Calcium Ascorbate, Vitamin D3, Quercetin Dihydrate2024-11-29 10:47:42
Bluebonnet Nutrition Super Quercetin -- 90 Vegetable CapsulesBluebonnet NutritionVitamins & SupplementsVitamin C, Hesperidin, Quercetin, Rutin2024-11-29 10:47:42
Chew + Heal Allergy Aid Immune Boost Supplement for Dogs -- 90 Soft ChewsChew + HealPet SuppliesEPA, Quercetin2024-11-29 10:47:42
Codeage Liposomal Vitamin C 1500 mg - Immune System Support Formula - Bioflavonoids -- 180 Capsules Each / Pack of 2CodeageProfessional SupplementsVitamin C, Quercetin Dihydrate, Alpha-Lipoic Acid2024-11-29 10:47:42
Codeage Liposomal Vitamin C 1500 mg Supplement with Zinc Elderberry Quercetin -- 180 CapsulesCodeageProfessional SupplementsVitamin C, Quercetin Dihydrate, Alpha-Lipoic Acid2024-11-29 10:47:42
Codeage Wonder-C Liposomal Liquid Vitamin C 1000 mg with D3 Zinc Rose Hips & Quercetin -- 16 fl ozCodeageProfessional SupplementsVitamin C, Vitamin E, Vitamin E, Quercetin2024-11-29 10:47:42
Country Life Aller-Max™ -- 100 Vegetarian CapsulesCountry LifeVitamins & SupplementsN-Acetyl Cysteine, Vitamin C, calcium ascorbate, L-Histidine, Pantothenic Acid, Quercetin, Vitamin A2024-11-29 10:47:42
Cymbiotika Allergy Defense Alpha-Glycosyl Isoquercitrin -- 60 CapsulesCymbiotikaVitamins & SupplementsIsoquercitrin, Bioperine, Quercetin2024-11-29 10:47:42
DaVinci Laboratories Aller-DMG™ Chewable Orange Cream -- 120 Chewable TabletsDaVinci LaboratoriesProfessional SupplementsVitamin C, N, Quercetin2024-11-29 10:47:42
DaVinci Laboratories Healthy Eyes -- 90 CapsulesDaVinci LaboratoriesProfessional SupplementsVitamin C, Vitamin E, Vitamin E, Lutein, Lycopene, Quercetin, Vitamin A, Riboflavin, Selenium, Taurine, Alpha-Lipoic Acid, Vitamin B12, Zeaxanthin2024-11-29 10:47:42
Designs for Sport Hydration Complex - NSF Certified for Sport Lemon-Orange -- 30 ServingsDesigns for SportProfessional SupplementsVitamin C, Calcium Ascorbate, Chloride, Potassium Bicarbonate, Quercetin, D-Ribose, Rutin, Taurine2024-11-29 10:47:42
Designs for Sport Multi + Phyto - NSF Certified for Sport -- 120 Vegetarian CapsulesDesigns for SportProfessional SupplementsVitamin C, Benfotiamine, Biotin, Boron, Chromium, Folate, Lycopene, Manganese, MK-7, MK-9, Molybdenum, Niacin, Pantothenic Acid, Vitamin B6, Quercetin, Trans-Resveratrol, Vitamin A, Riboflavin, Selenium, Thiamin, Vanadium, Vitamin B12, Vitamin B6, Vitamin K2024-11-29 10:47:42
Designs for Sport Power Pack - NSF Certified for Sport -- 30 PacketsDesigns for SportProfessional SupplementsVitamin C, Benfotiamine, Biotin, Boron, Chromium, Folate, Lycopene, Manganese, MK-7, MK-9, Molybdenum, Niacin, Pantothenic Acid, Vitamin B6, Quercetin, Trans-Resveratrol, Vitamin A, Riboflavin, Selenium, Thiamin, Vanadium, Vitamin B12, Vitamin B6, Vitamin K2024-11-29 10:47:42
Double Wood Supplements Quercetin with Bromelain -- 1200 mg - 120 CapsulesDouble Wood SupplementsProfessional SupplementsQuercetin2024-11-29 10:47:42
Douglas Laboratories Cysto Renew -- 120 CapsulesDouglas LaboratoriesProfessional SupplementsQuercetin Dihydrate2024-11-29 10:47:42
Eclectic Institute Nettle Quercetin -- 350 mg - 90 Vegetarian CapsulesEclectic InstituteVitamins & SupplementsQuercetin dihydrate2024-11-29 10:47:42
Eclectic Institute Sinus Support -- 310 mg - 45 VegCapsEclectic InstituteHerbs, Botanicals & HomeopathyQuercetin dihydrate2024-11-29 10:47:42
Evlution Nutrition FlexMode Advanced Joint Support -- 90 Veggie CapsulesEvlution NutritionActive Lifestyle & FitnessMethylsulfonylmethane, Quercetin, Black Pepper2024-11-29 10:47:42
Force Factor Collagen Boosting Superfoods Tropical Fruit -- 60 Soft ChewsForce FactorVitamins & SupplementsVitamin C, Biotin, Vitamin E, Vitamin E, Maltodextrin, Niacin, Quercetin2024-11-29 10:47:42
ForestLeaf Quercetin Bromelain + Stinging Nettle & Vitamin C -- 90 Vegetable CapsulesForestLeafVitamins & SupplementsVitamin C, Quercetin Dihydrate2024-11-29 10:47:42
Greens First Female - MenoSolve Plus Probiotics Powder Original Mint -- 30 ServingsGreens FirstVitamins & SupplementsChromium, Vitamin E, Vitamin E, Niacin, Quercetin Dihydrate2024-11-29 10:47:42
Greens First Pro Capsules -- 180 CapsulesGreens FirstVitamins & SupplementsQuercetin Dihydrate2024-11-29 10:47:42
Greens First Super Food Powder Chocolate -- 28.74 ozGreens FirstVitamins & SupplementsQuercetin Dihydrate2024-11-29 10:47:42
Greens First Superfood Drink Mix Chocolate -- 1437 ozGreens FirstVitamins & Supplements Lipase, Cellulase, Quercetin Dihydrate2024-11-29 10:47:42
Greens First The Original Greens Powder Mint -- 19.72 ozGreens FirstVitamins & Supplements Citric acid, Citric acid, Quercetin Dihydrate, rebaudioside A2024-11-29 10:47:42
Greens First The Original Greens Powder Mint -- 9.86 ozGreens FirstVitamins & Supplements lipase, Citric acid, cellulase, Citric acid, Quercetin Dihydrate, rebaudioside A2024-11-29 10:47:42
HealFast Post-Surgery Nutrition -- 100 CapsulesHealFastProfessional SupplementsVitamin C, Vitamin D3, Vitamin B9, L-Glutamine, Vitamin B3, Vitamin B5, Vitamin B6, Quercetin, Vitamin A, Vitamin B2, Selenium, Vitamin B1, Vitamin B12, Vitamin B62024-11-29 10:47:42
Healths Harmony Respiratory Support Blend - lung support boosts respiratory health with essential ingredients to clear mucus enhance oxyg -- 120 CapsHealths HarmonyVitamins & SupplementsVitamin C, Quercetin2024-11-29 10:47:42
Healths Harmony Respiratory Support Blend - lung support boosts respiratory health with essential ingredients to clear mucus enhance oxyg -- 180 CapsHealths HarmonyVitamins & SupplementsVitamin C, Quercetin2024-11-29 10:47:42
Healths Harmony Respiratory Support Blend - lung support boosts respiratory health with essential ingredients to clear mucus enhance oxyg -- 60 CapsuHealths HarmonyVitamins & SupplementsVitamin C, Quercetin2024-11-29 10:47:42
Innate Response Formulas C Complete Powder -- 2.9 ozInnateProfessional Supplements Citric acid, Vitamin C, beta carotene, calcium ascorbate, Citric acid, Quercetin Dihydrate, Rutin2024-11-29 10:47:42
Integrative Therapeutics Vitamin C with Quercetin -- 180 CapsulesIntegrative TherapeuticsProfessional SupplementsVitamin C, Cellulose, Quercetin Dihydrate2024-11-29 10:47:42
Irwin Naturals Prosta-Strong -- 180 Liquid SoftgelsIrwin NaturalsVitamins & Supplementsglycerin, Quercetin2024-11-29 10:47:42
Irwin Naturals Prosta-Strong -- 90 Liquid SoftgelsIrwin NaturalsVitamins & Supplementsglycerin, Quercetin2024-11-29 10:47:42
Jarrow Formulas Quercetin -- 500 mg - 100 Veggie CapsulesJarrow FormulasVitamins & Supplementsmicrocrystalline cellulose, Quercetin2024-11-29 10:47:42
Jarrow Formulas Quercetin -- 500 mg - 200 Veggie CapsulesJarrow FormulasVitamins & Supplementsmicrocrystalline cellulose, Quercetin2024-11-29 10:47:42
Kaged Pre-Kaged Pre-Workout - Informed Sport Certified Krisp Apple -- 20 ServingsKagedActive Lifestyle & Fitnesscitric acid, citric acid, L-Isoleucine, Malic acid, N-Acetyl-L-Tyrosine, Niacin, Vitamin B6, quercetin, stevia, Taurine, sucralose, L-Valine, Vitamin B12, Vitamin B62024-11-29 10:47:42
KAL Quercetin -- 60 TabletsKALVitamins & SupplementsQuercetin2024-11-29 10:47:42
KAL Uric Acid Flush™ -- 60 VegCapsKALVitamins & SupplementsVitamin C, cellulose, maltodextrin, Quercetin2024-11-29 10:47:42
Little DaVinci Kids Enz-flame Kids Powdered Drink Mix Natural Orange -- 30 ServingsLittle DaVinciProfessional Supplementscitric acid, Cetyl Myristoleate, citric acid, Pepsin, Luteolin, Quercetin, Rutin, tricalcium phosphate2024-11-29 10:47:42
Mad Hippie Luminizing Facial Mineral Sunscreen SPF 29+ -- 2 fl ozMad HippieBeauty & Personal Carecaprylyl glycol, citric acid, bisabolol, cetearyl alcohol, citric acid, tocopherol, behenyl alcohol, ethyl ferulate, tocopherol, sodium gluconate, glycerin, microcrystalline cellulose, niacinamide, propanediol, quercetin, resveratrol, squalane, titanium dioxide2024-11-29 10:47:42
Mad Hippie Ultra Sheer Body SPF 40 -- 4 fl ozMad HippieBeauty & Personal Carecaprylyl glycol, citric acid, bisabolol, cetearyl alcohol, cetyl alcohol, citric acid, tocopherol, behenyl alcohol, tocopherol, sodium gluconate, glycerin, microcrystalline cellulose, quercetin, squalane2024-11-29 10:47:42
Momentous Essential Multivitamin - NSF Certified for Sport - 30 Servings -- 120 Vegetarian CapsulesMomentousProfessional SupplementsVitamin C, Benfotiamine, Biotin, Boron, Chromium, Folate, microcrystalline cellulose, Lycopene, Manganese, MK-7, MK-9, Molybdenum, Niacin, Pantethine, Pantothenic Acid, Vitamin B6, Quercetin, Trans-Resveratrol, Vitamin A, Riboflavin, Selenium, Thiamin, Vanadium, Vitamin B12, Vitamin B6, Vitamin K2024-11-29 10:47:42
Mt Angel Vitamins Joint Solution Advanced -- 60 CapsulesMt Angel VitaminsProfessional SupplementsQuercetin2024-11-29 10:47:42
Mt Angel Vitamins Quercetin Nettle+ -- 60 Vegetarian TabletsMt Angel VitaminsProfessional SupplementsVitamin C, Cellulose, Pantothenic Acid, Quercetin2024-11-29 10:47:42
Mt Angel Vitamins Quercetin Zinc -- 300 Vegetarian CapsulesMt Angel VitaminsProfessional SupplementsVitamin C, Cellulose, Vitamin D3, Quercetin, calcium phosphate2024-11-29 10:47:42
Natrol Quercetin Complex Immune Health -- 50 CapsulesNatrolVitamins & SupplementsVitamin C, Quercetin2024-11-29 10:47:42
Nutrex Hawaii BioAstin EyeAstin Hawaiian Astaxanthin -- 6 mg - 60 SoftgelsNutrex HawaiiVitamins & Supplementsvitamin E, vitamin E, glycerin, Lutein, Quercetin, Zeaxanthin2024-11-29 10:47:42
NutriCology Ocudyne II -- 200 CapsulesNutriCologyVitamins & SupplementsN-Acetyl L-Cysteine, Vitamin C, Boron, Vitamin D3, Chromium, Vitamin E, Folic Acid, Vitamin E, Glutamic Acid, Glycine, microcrystalline cellulose, Iodine, Lutein, Lycopene, Manganese, Molybdenum, Niacin, Pantothenic Acid, Vitamin B6, Quercetin, Vitamin A, Riboflavin, Selenium, Taurine, Thiamin, Alpha-Lipoic Acid, Vitamin B12, Vitamin B6, Zeaxanthin2024-11-29 10:47:42
NutriCology Quercetin 300 -- 60 CapsulesNutriCologyVitamins & SupplementsVitamin C, Vitamin E, Vitamin E, Quercetin2024-11-29 10:47:42
NutriCology Quercetin Bioflavonoids -- 100 Vegetarian CapsulesNutriCologyVitamins & Supplementscellulose, Hesperidin, Quercetin, Rutin2024-11-29 10:47:42
Nutricost Quercetin with Bromnelain -- 880 mg - 240 CapsulesNutricostVitamins & Supplementscellulose, microcrystalline cellulose, Quercetin2024-11-29 10:47:42
Olympian Labs Prosplex for Men -- 60 Vegetarian CapsulesOlympian LabsVitamins & Supplementsascorbyl palmitate, Microcrystalline cellulose, Tomato Lycopene, IP-6, Quercetin, Selenium2024-11-29 10:47:42
Paradise Herbs Orac Energy Greens -- 120 Vegetarian CapsulesParadise HerbsVitamins & SupplementsVitamin C, Quercetin, Vitamin A2024-11-29 10:47:42
Paradise Herbs ORAC-Energy Protein & Greens Original Unflavored -- 16 ozParadise HerbsActive Lifestyle & FitnessAlanine, Arginine, Aspartic Acid, Cystine, Glutamic Acid, Glycine, Histidine, Isoleucine, Leucine, Lysine, Methionine, Phenylalanine, Proline, Quercetin, Serine, Threonine, Tryptophan, Tyrosine, Valine2024-11-29 10:47:42
Solaray Mega Quercetin -- 600 mg - 60 VegCapsSolarayVitamins & SupplementsVitamin C, maltodextrin, Quercetin Dihydrate2024-11-29 10:47:42
Solaray QBC Plex™ -- 120 Vegetarian CapsulesSolarayVitamins & SupplementsVitamin C, Quercetin Dihydrate2024-11-29 10:47:42
Solaray Quercetin -- 500 mg - 90 VegCapsSolarayVitamins & SupplementsQuercetin2024-11-29 10:47:42
Solgar Quercetin Complex with Ester-C® Plus -- 100 Vegetable CapsulesSolgarVitamins & SupplementsVitamin C, calcium ascorbate, microcrystalline cellulose, Quercetin, Rutin2024-11-29 10:47:42
Source Naturals Life Force™ Multiple No Iron -- 180 CapsulesSource NaturalsVitamins & SupplementsN-Acetyl L-Cysteine, Vitamin C, Astaxanthin, Biotin, Boron, Vitamin D3, Choline, Chromium, Coenzyme Q10, Vitamin E, DMAE, Folate, Vitamin E, microcrystalline cellulose, Inositol, Iodine, calcium carbonate, Lutein, Lycopene, Manganese, Molybdenum, N-Acetyl-L-Tyrosine, Niacin, Pantethine, Pantothenic Acid, Vitamin B6, Quercetin, Vitamin A, Riboflavin, Rutin, Selenium, Thiamin, Vitamin B12, Vitamin B6, Vitamin K12024-11-29 10:47:42
Sunwarrior Collagen Protector -- 30 Vegan CapsulesSunwarriorVitamins & Supplements Quercetin2024-11-29 10:47:42
Titan Nutrition Joints -- 120 CapsulesTitan NutritionVitamins & SupplementsMethylsulfonylmethane, Quercetin Dihydrate2024-11-29 10:47:42
Trace Minerals Research Liquid Zinc + Quercetin Orange Mango -- 16 fl ozTrace Minerals ResearchVitamins & Supplementsorange, citric acid, citric acid, Glycerol, Quercetin2024-11-29 10:47:42
Tropical Oasis Adult Multi-Vitamin Mineral -- 16 fl ozTropical OasisVitamins & SupplementsVitamin C, Biotin, Vitamin E, Folic Acid, Vitamin E, Niacin, Pantothenic Acid, Vitamin B6, Quercetin, Vitamin A, Riboflavin, Thiamin Hydrochloride, Vitamin B12, Vitamin B6, xylitol2024-11-29 10:47:42
Tropical Oasis Mega Premium Multi-Vitamin -- 32 fl ozTropical OasisVitamins & SupplementsPABA, Vitamin C, Biotin, Choline, CoQ10, Vitamin E, Folate, Vitamin E, Inositol, Vitamin B3, PABA, Pantothenic Acid, Vitamin B6, Quercetin, Vitamin A, Vitamin B2, Vitamin B1, Vitamin B12, Vitamin B6, xylitol2024-11-29 10:47:42
Twinlab OcuGuard Plus -- 120 Veggie CapsulesTwinlabVitamins & SupplementsVitamin C, Chromium, Vitamin E, eriocitrin, Vitamin E, hesperidin, Lutein, Quercetin Dihydrate, Vitamin A, Riboflavin, Rutin, Selenium, Taurine2024-11-29 10:47:42
Twinlab OcuGuard® Plus -- 60 Veggie CapsTwinlabVitamins & SupplementsN-Acetyl L-Cysteine, Vitamin C, Chromium, Vitamin E, eriocitrin, Vitamin E, Lutein, naringin, Quercetin Dihydrate, Vitamin A, Riboflavin, Rutin, Selenium, Taurine, Zeaxanthin2024-11-29 10:47:42
Vitacost Quercetin & Bromelain -- 250 CapsulesVitacost BrandVitamins & Supplements Maltodextrin, Quercetin, GDU2024-11-29 10:47:42
Vitacost-Synergy 3000 Multivitamin -- 180 CapsulesVitacost-SynergyVitamins & SupplementsVitamin C, d-beta tocopherol, Biotin, Boron, calcium citrate, cholecalciferol, Chromium, Coenzyme Q10, Vitamin E, d-delta tocopherol, Folate, Vitamin E, Iodine, Lutein, Manganese, Molybdenum, Niacin, Pantothenic Acid, Vitamin B6, Quercetin, retinyl palmitate, Vitamin A, Riboflavin, Selenium, Thiamin, Alpha Lipoic Acid, Vitamin B12, Vitamin B6, phytonadione, Vitamin K, Zeaxanthin2024-11-29 10:47:42
Vitacost-Synergy Advan-C® 1,000 mg per serving with Quercetin & Bioflavonoids -- 1000 mg - 90 CapsulesVitacost-SynergyVitamins & SupplementsVitamin C, dicalcium phosphate, microcrystalline cellulose, Quercetin2024-11-29 10:47:42
Vitacost-Synergy Basic® Multivitamin -- 60 CapsulesVitacost-SynergyVitamins & Supplementsd-alpha tocopheryl succinate, Vitamin C, d-beta tocopherol, Biotin, dicalcium phosphate, Chromium, Coenzyme Q10, Vitamin E, d-delta tocopherol, Folate, Vitamin E, Iodine, Lutein, Manganese, Molybdenum, Niacin, Pantothenic Acid, Vitamin B6, Quercetin, Vitamin A, Riboflavin, Selenium, Thiamin, Alpha Lipoic Acid, Vitamin B12, Vitamin B6, phytonadione, Vitamin K, Zeaxanthin2024-11-29 10:47:42
Vitacost-Synergy Eye Defense Formula† -- 120 CapsulesVitacost-SynergyVitamins & SupplementsN-Acetyl L-Cysteine, Vitamin C, Chromium, Vitamin E, Vitamin E, Lutein, Quercetin Dihydrate, Vitamin A, Riboflavin, Rutin, Selenium, Taurine, Zeaxanthin2024-11-29 10:47:42
Vitacost-Synergy Once Daily® Multivitamin -- 60 CapsulesVitacost-SynergyVitamins & SupplementsVitamin C, Biotin, Chromium, Coenzyme Q10, Vitamin E, Folate, Vitamin E, microcrystalline cellulose, Iodine, Lutein, Manganese, Molybdenum, Niacin, Pantothenic Acid, Vitamin B6, Quercetin, Vitamin A, Riboflavin, Selenium, Thiamin, Alpha Lipoic Acid, Vitamin B12, Vitamin B6, Vitamin K, Zeaxanthin2024-11-29 10:47:42
Vitacost-Synergy Synergy Advan-C® including Quercetin & Bioflavonoids -- 1000 mg - 180 CapsulesVitacost-SynergyVitamins & SupplementsVitamin C, dicalcium phosphate, microcrystalline cellulose, Quercetin2024-11-29 10:47:42
Vitacost-Synergy Vitamin C-1000 including L-Lysine & L-Proline -- 240 CapsulesVitacost-SynergyVitamins & SupplementsVitamin C, microcrystalline cellulose, L-Lysine, Quercetin2024-11-29 10:47:42
Vital Nutrients Aller-C Isoquercitrin C & Bioflavonoids -- 200 Vegetarian CapsulesVital NutrientsProfessional SupplementsVitamin C, Quercetin Dihydrate2024-11-29 10:47:42
Vital Nutrients BCQ - Supports a Healthy Inflammatory Response -- 60 CapsulesVital NutrientsProfessional SupplementsQuercetin dihydrate2024-11-29 10:47:42
Vitanica Dopamine Assist™ -- 60 Vegetarian CapsulesVitanicaVitamins & SupplementsFolate, Vitamin B6, Quercetin, Vitamin B62024-11-29 10:47:42
Viteyes Optic Nerve Support -- 90 TabletsViteyesVitamins & SupplementsN-Acetyl Cysteine, Vitamin C, Dicalcium phosphate, Coenzyme Q10, Vitamin E, Folate, Vitamin E, microcrystalline cellulose, Quercetin Dihydrate, stearic acid, Taurine, Alpha-Lipoic Acid, Vitamin B122024-11-29 10:47:42
Zahler Multivitamin Beauty -- 60 CapsulesZahlerVitamins & SupplementsVitamin C, Astaxanthin, Biotin, Vitamin D3, Chromium, Vitamin E, Folate, Vitamin E, Iodine, Manganese, Vitamin K2, Vitamin K2, Molybdenum, Niacin, Pantethine, Vitamin B6, Quercetin, Vitamin A, Riboflavin, Selenium, Thiamin, Vitamin B12, Vitamin B62024-11-29 10:47:42
Zahler Multivitamin Brainfood -- 60 CapsulesZahlerVitamins & SupplementsVitamin C, Vitamin D3, Choline, Chromium, Vitamin E, Folate, Vitamin E, Iodine, Lutein, Manganese, Vitamin K2, Vitamin K2, Molybdenum, Niacin, Vitamin B6, Quercetin, Vitamin A, Riboflavin, Selenium, Thiamin, Vitamin B12, Vitamin B62024-11-29 10:47:42
Zahler Multivitamin Metabolism -- 60 CapsulesZahlerVitamins & SupplementsVitamin C, Vitamin D3, Choline, Chromium, Vitamin E, Folate, Vitamin E, Iodine, Manganese, Vitamin K2, Vitamin K2, Molybdenum, Niacin, Pantethine, Vitamin B6, Quercetin, Vitamin A, Riboflavin, Selenium, Thiamin, Vitamin B12, Vitamin B62024-11-29 10:47:42
Zahler Multivitamin One Daily -- 60 CapsulesZahlerVitamins & SupplementsVitamin C, Vitamin D3, Chromium, Vitamin E, Folate, Vitamin E, Iodine, Manganese, Vitamin K2, Vitamin K2, Molybdenum, Niacin, Pantethine, Vitamin B6, Quercetin, Vitamin A, Riboflavin, Selenium, Thiamin, Vitamin B12, Vitamin B62024-11-29 10:47:42

Roles (11)

RoleDescription
antibacterial agentA substance (or active part thereof) that kills or slows the growth of bacteria.
antioxidantA substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
protein kinase inhibitorAn EC 2.7.* (P-containing group transferase) inhibitor that interferes with the action of protein kinases.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitorAn EC 1.10.99.* (oxidoreductases acting on diphenols and related substances as donors, other acceptors) inhibitor that interferes with the action of ribosyldihydronicotinamide dehydrogenase (quinone), EC 1.10.99.2.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
phytoestrogenAny compound produced by a plant that happens to have estrogenic activity.
radical scavengerA role played by a substance that can react readily with, and thereby eliminate, radicals.
chelatorA ligand with two or more separate binding sites that can bind to a single metallic central atom, forming a chelate.
Aurora kinase inhibitorAny protein kinase inhibitor that inhibits the action of an Aurora kinase (a group of serine/threonine kinases that are essential for cell proliferation).
geroprotectorAny compound that supports healthy aging, slows the biological aging process, or extends lifespan.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
pentahydroxyflavoneA hydroxyflavone substituted by five hydroxy groups.
7-hydroxyflavonolAny flavonol carrying a 7-hydroxy substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (8)

PathwayProteinsCompounds
Digestion and absorption1724
Digestion1223
Flavone and Flavonol Biosynthesis627
CAMKK2 pathway011
Quercetin and Nf-kB / AP-1 induced apoptosis09
Flavonoid biosynthesis019
AtMetExpress overview0109
Quercetin and Nf-kB / AP-1 induced cell apoptosis09

Protein Targets (378)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency0.63100.003245.467312,589.2998AID2517
Chain A, HADH2 proteinHomo sapiens (human)Potency5.25060.025120.237639.8107AID886; AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency5.25060.025120.237639.8107AID886; AID893
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency7.07950.177814.390939.8107AID2147
Chain A, ATP-DEPENDENT DNA HELICASE Q1Homo sapiens (human)Potency0.95690.125919.1169125.8920AID2549; AID2708
Chain A, CruzipainTrypanosoma cruziPotency12.58930.002014.677939.8107AID1476
LuciferasePhotinus pyralis (common eastern firefly)Potency29.39080.007215.758889.3584AID1224835; AID624030
15-lipoxygenase, partialHomo sapiens (human)Potency1.58490.012610.691788.5700AID887
phosphopantetheinyl transferaseBacillus subtilisPotency39.81070.141337.9142100.0000AID1490
RAR-related orphan receptor gammaMus musculus (house mouse)Potency61.19270.006038.004119,952.5996AID1159523
SMAD family member 2Homo sapiens (human)Potency19.52480.173734.304761.8120AID1346859
USP1 protein, partialHomo sapiens (human)Potency56.23410.031637.5844354.8130AID504865
GALC proteinHomo sapiens (human)Potency31.622828.183828.183828.1838AID1159614
SMAD family member 3Homo sapiens (human)Potency19.52480.173734.304761.8120AID1346859
TDP1 proteinHomo sapiens (human)Potency29.85540.000811.382244.6684AID686979
GLI family zinc finger 3Homo sapiens (human)Potency28.70490.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency28.35430.000221.22318,912.5098AID1259243; AID1259247; AID743036; AID743042; AID743054; AID743063
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)Homo sapiens (human)Potency1.99530.00137.762544.6684AID914; AID915
thyroid stimulating hormone receptorHomo sapiens (human)Potency15.84890.001318.074339.8107AID926; AID938
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency26.60320.000657.913322,387.1992AID1259377
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency38.62540.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency22.05960.000417.946075.1148AID1346795
cytochrome P450 family 3 subfamily A polypeptide 4Homo sapiens (human)Potency27.54040.01237.983543.2770AID1645841
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency32.76890.003041.611522,387.1992AID1159552; AID1159553; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency23.51350.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
pregnane X nuclear receptorHomo sapiens (human)Potency30.97020.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency29.01870.000229.305416,493.5996AID1259383; AID743069; AID743075; AID743077; AID743078; AID743079
GVesicular stomatitis virusPotency13.80290.01238.964839.8107AID1645842
cytochrome P450 2D6Homo sapiens (human)Potency38.90180.00108.379861.1304AID1645840
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency5.95530.001019.414170.9645AID743191
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency2.23870.035520.977089.1251AID504332
aryl hydrocarbon receptorHomo sapiens (human)Potency42.20900.000723.06741,258.9301AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency12.20960.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency48.60710.001628.015177.1139AID1259385
activating transcription factor 6Homo sapiens (human)Potency10.68220.143427.612159.8106AID1159516
Histone H2A.xCricetulus griseus (Chinese hamster)Potency35.48690.039147.5451146.8240AID1224845; AID1224896
cellular tumor antigen p53 isoform aHomo sapiens (human)Potency1.58490.316212.443531.6228AID902
cytochrome P450 2C9 precursorHomo sapiens (human)Potency1.00000.00636.904339.8107AID883
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency68.65940.000323.4451159.6830AID743065; AID743067
histone deacetylase 9 isoform 3Homo sapiens (human)Potency20.91160.037617.082361.1927AID1259364; AID1259388
ubiquitin carboxyl-terminal hydrolase 2 isoform aHomo sapiens (human)Potency2.51190.65619.452025.1189AID927
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency8.93460.000627.21521,122.0200AID743202; AID743219
DNA polymerase kappa isoform 1Homo sapiens (human)Potency0.23780.031622.3146100.0000AID588579
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency12.58930.031610.279239.8107AID884; AID885
lethal factor (plasmid)Bacillus anthracis str. A2012Potency5.01190.020010.786931.6228AID912
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Polyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)Potency10.00000.316212.765731.6228AID881
Interferon betaHomo sapiens (human)Potency13.80290.00339.158239.8107AID1645842
HLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)Potency13.80290.01238.964839.8107AID1645842
Cellular tumor antigen p53Homo sapiens (human)Potency41.04930.002319.595674.0614AID651631
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Histamine H2 receptorCavia porcellus (domestic guinea pig)Potency4.60000.00638.235039.8107AID881; AID883
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Disintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)Potency2.51191.584913.004325.1189AID927
GABA theta subunitRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Inositol hexakisphosphate kinase 1Homo sapiens (human)Potency13.80290.01238.964839.8107AID1645842
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
cytochrome P450 2C9, partialHomo sapiens (human)Potency13.80290.01238.964839.8107AID1645842
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency0.47440.003245.467312,589.2998AID2517
Chain A, Beta-lactamaseEscherichia coli K-12Potency5.70630.044717.8581100.0000AID485294; AID485341
Chain A, JmjC domain-containing histone demethylation protein 3AHomo sapiens (human)Potency4.46680.631035.7641100.0000AID504339
Chain A, Ferritin light chainEquus caballus (horse)Potency35.48135.623417.292931.6228AID485281
LuciferasePhotinus pyralis (common eastern firefly)Potency33.80780.007215.758889.3584AID588342
WRNHomo sapiens (human)Potency2.18630.168331.2583100.0000AID651768; AID720497
phosphopantetheinyl transferaseBacillus subtilisPotency50.11870.141337.9142100.0000AID1490
ATAD5 protein, partialHomo sapiens (human)Potency1.83490.004110.890331.5287AID504467
USP1 protein, partialHomo sapiens (human)Potency112.20200.031637.5844354.8130AID743255
TDP1 proteinHomo sapiens (human)Potency6.91040.000811.382244.6684AID686978; AID686979
bromodomain adjacent to zinc finger domain 2BHomo sapiens (human)Potency39.81070.707936.904389.1251AID504333
P53Homo sapiens (human)Potency50.11870.07319.685831.6228AID504706
IDH1Homo sapiens (human)Potency18.35640.005210.865235.4813AID686970
Bloom syndrome protein isoform 1Homo sapiens (human)Potency1.07870.540617.639296.1227AID720503
lysosomal alpha-glucosidase preproproteinHomo sapiens (human)Potency7.94330.036619.637650.1187AID2100
parathyroid hormone/parathyroid hormone-related peptide receptor precursorHomo sapiens (human)Potency50.11873.548119.542744.6684AID743266
transcriptional regulator ERG isoform 3Homo sapiens (human)Potency11.22020.794321.275750.1187AID624246
DNA polymerase betaHomo sapiens (human)Potency0.56230.022421.010289.1251AID485314
flap endonuclease 1Homo sapiens (human)Potency2.23870.133725.412989.1251AID588795
histone-lysine N-methyltransferase 2A isoform 2 precursorHomo sapiens (human)Potency70.79460.010323.856763.0957AID2662
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)Potency44.66840.425612.059128.1838AID504891
DNA polymerase eta isoform 1Homo sapiens (human)Potency6.35170.100028.9256213.3130AID588591; AID720502
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency8.00150.050127.073689.1251AID588590; AID720496
urokinase-type plasminogen activator precursorMus musculus (house mouse)Potency7.94330.15855.287912.5893AID540303
plasminogen precursorMus musculus (house mouse)Potency7.94330.15855.287912.5893AID540303
urokinase plasminogen activator surface receptor precursorMus musculus (house mouse)Potency7.94330.15855.287912.5893AID540303
gemininHomo sapiens (human)Potency0.92000.004611.374133.4983AID624296
DNA polymerase kappa isoform 1Homo sapiens (human)Potency1.94240.031622.3146100.0000AID588579; AID720501
muscleblind-like protein 1 isoform 1Homo sapiens (human)Potency19.95260.00419.962528.1838AID2675
Rap guanine nucleotide exchange factor 3Homo sapiens (human)Potency7.07956.309660.2008112.2020AID720709
phosphoglycerate kinaseTrypanosoma brucei brucei TREU927Potency5.37310.07578.474229.0628AID602233; AID686980
ATP-dependent phosphofructokinaseTrypanosoma brucei brucei TREU927Potency2.68550.060110.745337.9330AID485367
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency3.38930.003245.467312,589.2998AID1705; AID2517
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency26.65140.004023.8416100.0000AID485290
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency15.81140.140911.194039.8107AID2451
Chain A, HADH2 proteinHomo sapiens (human)Potency1.89580.025120.237639.8107AID886; AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency1.89580.025120.237639.8107AID886; AID893
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency10.48760.177814.390939.8107AID2147
Chain A, ATP-DEPENDENT DNA HELICASE Q1Homo sapiens (human)Potency1.61820.125919.1169125.8920AID2353; AID2549
Chain A, CruzipainTrypanosoma cruziPotency20.98450.002014.677939.8107AID1476; AID1478
LuciferasePhotinus pyralis (common eastern firefly)Potency35.73390.007215.758889.3584AID1224835
Nrf2Homo sapiens (human)Potency20.59620.09208.222223.1093AID624149
thioredoxin reductaseRattus norvegicus (Norway rat)Potency23.77810.100020.879379.4328AID588453
15-lipoxygenase, partialHomo sapiens (human)Potency0.79430.012610.691788.5700AID887
phosphopantetheinyl transferaseBacillus subtilisPotency60.35100.141337.9142100.0000AID1490
RAR-related orphan receptor gammaMus musculus (house mouse)Potency50.38690.006038.004119,952.5996AID1159521; AID1159523
SMAD family member 2Homo sapiens (human)Potency15.48450.173734.304761.8120AID1346924
ATAD5 protein, partialHomo sapiens (human)Potency20.58780.004110.890331.5287AID493107
USP1 protein, partialHomo sapiens (human)Potency56.23410.031637.5844354.8130AID504865
NFKB1 protein, partialHomo sapiens (human)Potency5.62340.02827.055915.8489AID895; AID928
GLS proteinHomo sapiens (human)Potency0.44670.35487.935539.8107AID624146
SMAD family member 3Homo sapiens (human)Potency15.48450.173734.304761.8120AID1346924
TDP1 proteinHomo sapiens (human)Potency16.51220.000811.382244.6684AID686978; AID686979
GLI family zinc finger 3Homo sapiens (human)Potency23.91890.000714.592883.7951AID1259369; AID1259392
Microtubule-associated protein tauHomo sapiens (human)Potency8.55050.180013.557439.8107AID1460; AID1468
AR proteinHomo sapiens (human)Potency21.85850.000221.22318,912.5098AID1259243; AID1259247; AID743035; AID743042; AID743054
signal transducer and activator of transcription 6, interleukin-4 inducedHomo sapiens (human)Potency2.51192.51199.410115.8489AID922; AID935
Smad3Homo sapiens (human)Potency35.48130.00527.809829.0929AID588855
DNA polymerase III, partialBacillus subtilisPotency10.62131.062114.152826.6795AID485295
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency32.58610.011212.4002100.0000AID1030
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)Homo sapiens (human)Potency10.00000.00137.762544.6684AID914; AID915
thyroid stimulating hormone receptorHomo sapiens (human)Potency24.61130.001318.074339.8107AID926; AID938
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency25.93240.000657.913322,387.1992AID1259377
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency47.67680.001022.650876.6163AID1224838; AID1224839
progesterone receptorHomo sapiens (human)Potency14.57600.000417.946075.1148AID1346795
regulator of G-protein signaling 4Homo sapiens (human)Potency11.91730.531815.435837.6858AID504845
EWS/FLI fusion proteinHomo sapiens (human)Potency15.82070.001310.157742.8575AID1259252; AID1259253; AID1259255; AID1259256
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency49.39190.000214.376460.0339AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency28.08060.003041.611522,387.1992AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency15.97430.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency29.73400.001530.607315,848.9004AID1224819; AID1224820; AID1224821; AID1224842; AID1224848; AID1224849; AID1259403
pregnane X nuclear receptorHomo sapiens (human)Potency65.13930.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency18.93750.000229.305416,493.5996AID1259383; AID743069; AID743075; AID743077; AID743078; AID743079
67.9K proteinVaccinia virusPotency25.51540.00018.4406100.0000AID720579
glucocerebrosidaseHomo sapiens (human)Potency22.92870.01268.156944.6684AID2101
ParkinHomo sapiens (human)Potency6.68650.819914.830644.6684AID720572; AID720573
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency44.02060.001024.504861.6448AID743215
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency55.41860.001019.414170.9645AID743191
arylsulfatase AHomo sapiens (human)Potency33.80781.069113.955137.9330AID720538
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency20.38650.035520.977089.1251AID504332
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)Homo sapiens (human)Potency50.11870.016525.307841.3999AID602332
aryl hydrocarbon receptorHomo sapiens (human)Potency48.44120.000723.06741,258.9301AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency25.87270.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency61.81540.001628.015177.1139AID1224843; AID1259385
activating transcription factor 6Homo sapiens (human)Potency3.11640.143427.612159.8106AID1159516
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency61.64480.057821.109761.2679AID1159526
Histone H2A.xCricetulus griseus (Chinese hamster)Potency45.65000.039147.5451146.8240AID1224845; AID1224896
Bloom syndrome protein isoform 1Homo sapiens (human)Potency30.00820.540617.639296.1227AID2364; AID2528
cytochrome P450 2D6 isoform 1Homo sapiens (human)Potency35.71680.00207.533739.8107AID891
galactokinaseHomo sapiens (human)Potency42.12850.943115.289453.0367AID2015
peripheral myelin protein 22 isoform 1Homo sapiens (human)Potency47.754823.934123.934123.9341AID1967
cellular tumor antigen p53 isoform aHomo sapiens (human)Potency1.75590.316212.443531.6228AID902; AID924
polyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)Potency1.06101.000012.232631.6228AID1452
cytochrome P450 2C19 precursorHomo sapiens (human)Potency15.84890.00255.840031.6228AID899
cytochrome P450 2C9 precursorHomo sapiens (human)Potency11.94640.00636.904339.8107AID883
D(1A) dopamine receptorHomo sapiens (human)Potency4.28800.02245.944922.3872AID488982; AID488983
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency17.08410.001815.663839.8107AID894
chromobox protein homolog 1Homo sapiens (human)Potency44.66840.006026.168889.1251AID488953
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency44.66840.010039.53711,122.0200AID1479
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency60.83540.000323.4451159.6830AID743065; AID743067
histone deacetylase 9 isoform 3Homo sapiens (human)Potency24.51630.037617.082361.1927AID1259364; AID1259388
DNA polymerase betaHomo sapiens (human)Potency0.19950.022421.010289.1251AID485314
mitogen-activated protein kinase 1Homo sapiens (human)Potency35.71680.039816.784239.8107AID1454; AID995
flap endonuclease 1Homo sapiens (human)Potency14.85540.133725.412989.1251AID488816; AID588795
ubiquitin carboxyl-terminal hydrolase 2 isoform aHomo sapiens (human)Potency25.05780.65619.452025.1189AID463106; AID927
tyrosine-protein kinase YesHomo sapiens (human)Potency15.41030.00005.018279.2586AID686947
histone-lysine N-methyltransferase 2A isoform 2 precursorHomo sapiens (human)Potency22.38720.010323.856763.0957AID2662
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)Potency2.68550.425612.059128.1838AID504536
DNA polymerase eta isoform 1Homo sapiens (human)Potency0.79430.100028.9256213.3130AID588591
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency39.99760.050127.073689.1251AID588590
DNA polymerase kappa isoform 1Homo sapiens (human)Potency0.85920.031622.3146100.0000AID588579
survival motor neuron protein isoform dHomo sapiens (human)Potency35.48130.125912.234435.4813AID1458
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency6.30960.031610.279239.8107AID884; AID885
M-phase phosphoprotein 8Homo sapiens (human)Potency39.81070.177824.735279.4328AID488949
muscleblind-like protein 1 isoform 1Homo sapiens (human)Potency28.18380.00419.962528.1838AID2675
muscarinic acetylcholine receptor M1Rattus norvegicus (Norway rat)Potency11.55750.00106.000935.4813AID943; AID944
lamin isoform A-delta10Homo sapiens (human)Potency14.12540.891312.067628.1838AID1487
neuropeptide S receptor isoform AHomo sapiens (human)Potency0.15850.015812.3113615.5000AID1461
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency6.30961.000012.224831.6228AID885
Polyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)Potency14.21910.316212.765731.6228AID881
Cellular tumor antigen p53Homo sapiens (human)Potency56.13690.002319.595674.0614AID651631; AID720552
Integrin beta-3Homo sapiens (human)Potency2.51190.316211.415731.6228AID924
Integrin alpha-IIbHomo sapiens (human)Potency2.51190.316211.415731.6228AID924
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency6.30961.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency6.30961.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency6.30961.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency6.30961.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency6.30961.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency6.30961.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency6.30961.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency6.30961.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency6.30961.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency6.30961.000012.224831.6228AID885
Histamine H2 receptorCavia porcellus (domestic guinea pig)Potency12.64570.00638.235039.8107AID881; AID883
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency6.30961.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency6.30961.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency6.30961.000012.224831.6228AID885
Disintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)Potency31.62281.584913.004325.1189AID927
Inositol monophosphatase 1Rattus norvegicus (Norway rat)Potency11.26981.000010.475628.1838AID1457
GABA theta subunitRattus norvegicus (Norway rat)Potency6.30961.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency6.30961.000012.224831.6228AID885
phosphoglycerate kinaseTrypanosoma brucei brucei TREU927Potency7.56860.07578.474229.0628AID504547
ATP-dependent phosphofructokinaseTrypanosoma brucei brucei TREU927Potency6.74560.060110.745337.9330AID485368
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Glucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)IC50 (µMol)31.02005.18007.32009.4000AID1757376
integrase, partialHuman immunodeficiency virus 1IC50 (µMol)2.92120.07953.52039.9390AID1053171; AID1053172
lens epithelium-derived growth factor p75Homo sapiens (human)IC50 (µMol)2.92120.07953.52039.9390AID1053171; AID1053172
M18 aspartyl aminopeptidasePlasmodium falciparum 3D7IC50 (µMol)0.38510.385113.0782100.0000AID2195
large T antigenBetapolyomavirus macacaeIC50 (µMol)16.14000.160024.9724100.0000AID1903
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydrataseHelicobacter pyloriKi12.70000.90009.500014.9000AID977610
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydrataseHelicobacter pyloriKi12.70000.90009.500014.9000AID977610
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydrataseHelicobacter pyloriKi12.70000.90009.500014.9000AID977610
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydrataseHelicobacter pyloriKi12.70000.90009.500014.9000AID977610
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydrataseHelicobacter pyloriKi12.70000.90009.500014.9000AID977610
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydrataseHelicobacter pyloriKi12.70000.90009.500014.9000AID977610
Chain A, APH(2')-IdEnterococcus casseliflavusKi25.100025.100025.100025.1000AID977610
Neuraminidase Influenza A virus (A/Wilson-Smith/1933(H1N1))IC50 (µMol)53.92500.00000.503510.0000AID366284; AID366285; AID366286; AID455703
Neuraminidase Influenza A virus (A/Wilson-Smith/1933(H1N1))Ki3.80000.00011.78687.7000AID455703
hexokinaseTrypanosoma brucei brucei TREU927IC50 (µMol)22.37800.20084.602422.3780AID2230
Polyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)IC50 (µMol)100.00000.03201.46494.8000AID309801
ATP-binding cassette sub-family C member 3Homo sapiens (human)IC50 (µMol)133.00000.63154.45319.3000AID1473740
Multidrug resistance-associated protein 4Homo sapiens (human)IC50 (µMol)20.80000.20005.677410.0000AID1473741
Polyphenol oxidase 2Agaricus bisporusIC50 (µMol)135.50000.03403.987110.0000AID1505136; AID462349
Maltase-glucoamylase, intestinalHomo sapiens (human)IC50 (µMol)9.30000.04003.46529.0000AID1370805; AID1830872
Carbonic anhydrase 12Homo sapiens (human)Ki9.39000.00021.10439.9000AID462279
NUAK family SNF1-like kinase 1Homo sapiens (human)IC50 (µMol)5.09000.00130.29185.0900AID1063051
Lysine-specific histone demethylase 1AHomo sapiens (human)IC50 (µMol)1.26000.00312.16029.6000AID1515260
B2 bradykinin receptorCavia porcellus (domestic guinea pig)IC50 (µMol)4.00000.00112.58648.0000AID43124; AID43125
G2/mitotic-specific cyclin-B2Homo sapiens (human)IC50 (µMol)75.00000.00251.817210.0000AID241206
Bile salt export pumpHomo sapiens (human)IC50 (µMol)134.00000.11007.190310.0000AID1443980; AID1473738
Arginase Leishmania amazonensisIC50 (µMol)4.00001.60002.28004.0000AID1066694
Glutathione reductase, mitochondrialHomo sapiens (human)IC50 (µMol)218.00001.00004.55008.1000AID75433
Epidermal growth factor receptorHomo sapiens (human)IC50 (µMol)68.60000.00000.536910.0000AID1394726; AID420262; AID69720
Pancreatic triacylglycerol lipaseSus scrofa (pig)IC50 (µMol)70.00000.00401.10246.5000AID1204217
ProthrombinHomo sapiens (human)IC50 (µMol)15.75000.00000.710710.0000AID768890; AID768929
Prothrombin Bos taurus (cattle)IC50 (µMol)28.75000.00890.88576.0000AID1803131
Urokinase-type plasminogen activatorHomo sapiens (human)IC50 (µMol)25.42000.03703.385910.0000AID1803131; AID768888
Cationic trypsinBos taurus (cattle)IC50 (µMol)24.42000.00003.479210.0000AID1803131; AID214874
Chymotrypsinogen ABos taurus (cattle)IC50 (µMol)292.50000.98004.05607.2000AID1510602; AID1510604
Chymotrypsin-like elastase family member 1Sus scrofa (pig)IC50 (µMol)28.75002.18525.171310.0000AID1803131
Beta-lactamaseEscherichia coli K-12IC50 (µMol)58.00000.01502.46578.0000AID218575; AID218683; AID43124; AID43125
Carbonic anhydrase 1Homo sapiens (human)Ki29.91380.00001.372610.0000AID1799599; AID1803140; AID1803217; AID462270
Carbonic anhydrase 2Homo sapiens (human)Ki29.89630.00000.72369.9200AID1799599; AID1803140; AID1803217; AID462271
Protein E6Human papillomavirus 16IC50 (µMol)20.00000.85002.42504.0000AID654746
NeuraminidaseInfluenza A virus (A/Puerto Rico/8/1934(H1N1))IC50 (µMol)7.75000.00050.976710.0000AID1656375
Interstitial collagenaseHomo sapiens (human)IC50 (µMol)1.49000.00020.850210.0000AID1803286
Phospholipase A2Homo sapiens (human)IC50 (µMol)2.00000.00300.91223.9000AID325766
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1Oryctolagus cuniculus (rabbit)IC50 (µMol)9.00000.00022.81679.0000AID1605043
Cytochrome P450 1A1Homo sapiens (human)IC50 (µMol)8.43640.00791.24789.9000AID1372144; AID1372149; AID1372158; AID1446938; AID502474
Cytochrome P450 1A1Homo sapiens (human)Ki0.66000.01200.94693.8000AID598341
Amyloid-beta precursor proteinHomo sapiens (human)IC50 (µMol)40.78500.00053.889510.0000AID1269368; AID1336867; AID1484013; AID1802376
MyeloperoxidaseHomo sapiens (human)IC50 (µMol)1.69750.02001.88117.6800AID1446226; AID1446231; AID1514844; AID701372
Cytochrome P450 1A2Homo sapiens (human)IC50 (µMol)14.69900.00011.774010.0000AID1372146; AID1372151; AID502473
Beta-lactamaseEnterobacter cloacaeIC50 (µMol)269.66670.10001.87457.7000AID1510602; AID1510604; AID1510617
Tyrosine-protein kinase LckHomo sapiens (human)IC50 (µMol)13.00000.00021.317310.0000AID213412; AID378681
Cyclin-dependent kinase 1Homo sapiens (human)IC50 (µMol)28.86250.00041.345210.0000AID241206; AID365954; AID511076; AID53359
Glycogen phosphorylase, liver formHomo sapiens (human)IC50 (µMol)4.80000.08201.16594.8000AID1186739
Epoxide hydrolase 1 Homo sapiens (human)IC50 (µMol)7.00000.04002.98007.0000AID1617366
Carbonic anhydrase 3Homo sapiens (human)Ki8.10000.00022.010210.0000AID462272
Trypsin-1Homo sapiens (human)IC50 (µMol)15.40000.00351.532110.0000AID768889
Trypsin-2Homo sapiens (human)IC50 (µMol)15.40000.00351.58464.4000AID768889
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)IC50 (µMol)6.64170.00041.877310.0000AID34804; AID34969; AID34976; AID385353; AID95258
Tyrosine-protein kinase YesHomo sapiens (human)Ki0.47200.47204.38057.9000AID1649932
Proto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)IC50 (µMol)78.10000.00010.34843.5970AID1394718
Insulin-like growth factor 1 receptorHomo sapiens (human)IC50 (µMol)0.30000.00030.43088.0000AID1063046
ATP-dependent translocase ABCB1Homo sapiens (human)IC50 (µMol)52.50000.00022.318510.0000AID681162
Neutrophil elastaseHomo sapiens (human)IC50 (µMol)18.33900.00632.073422.3780AID1502927; AID2230
Neutrophil elastaseHomo sapiens (human)Ki11.90000.00201.28669.5499AID1502928
72 kDa type IV collagenaseHomo sapiens (human)IC50 (µMol)6.68000.00001.284810.0000AID670311
Stromelysin-1Homo sapiens (human)IC50 (µMol)5.57000.00001.148410.0000AID670312
Hepatocyte growth factor receptorHomo sapiens (human)IC50 (µMol)0.58000.00040.372210.0000AID1063044
Cytochrome P450 3A4Homo sapiens (human)IC50 (µMol)15.66670.00011.753610.0000AID1372147; AID1372152; AID1617366
Polyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)IC50 (µMol)6.95800.00011.68479.3200AID1063904; AID1596712; AID1603728; AID286228; AID288326
Enoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12IC50 (µMol)20.00000.00501.576510.0000AID277584
Replicase polyprotein 1abSevere acute respiratory syndrome-related coronavirusIC50 (µMol)26.42500.00402.92669.9600AID1805801; AID430139; AID430140; AID537123
Replicase polyprotein 1abSevere acute respiratory syndrome-related coronavirusKi7.40000.00753.00839.1100AID1805801
Adenosine receptor A3Homo sapiens (human)Ki30.00000.00000.930610.0000AID34885
Calmodulin-1Homo sapiens (human)IC50 (µMol)12.97005.17006.81008.0000AID550024
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2IC50 (µMol)23.80000.00022.45859.9600AID1805801
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2Ki7.40000.00001.63079.0000AID1805801
Alpha-amylase 1A Homo sapiens (human)IC50 (µMol)21.40000.50004.02039.6400AID1798320; AID404692
Lysosomal alpha-glucosidaseHomo sapiens (human)IC50 (µMol)7.80000.06002.28897.8000AID1370805
SialidaseClostridium perfringensIC50 (µMol)9.92000.00102.45729.8000AID417656; AID455702; AID480945; AID502478; AID622873
Malate dehydrogenaseThermus thermophilusIC50 (µMol)6.00000.70004.90008.0000AID106657
Cytochrome P450 2C8Homo sapiens (human)IC50 (µMol)13.50000.00081.88487.9000AID1614066; AID1617366
Cytochrome P450 2D6Homo sapiens (human)IC50 (µMol)20.00000.00002.015110.0000AID1372148; AID1372153
Serine/threonine-protein kinase pim-1Homo sapiens (human)IC50 (µMol)0.76860.00040.887110.0000AID1063041; AID1798717; AID257081; AID418378; AID706714
AromataseHomo sapiens (human)IC50 (µMol)6.00600.00001.290410.0000AID1250230; AID479369
Cytochrome P450 2C9 Homo sapiens (human)Ki27.00000.00031.684210.0000AID54410
Cyclin-dependent kinase 4Homo sapiens (human)IC50 (µMol)61.00000.00060.570610.0000AID54030
Polyunsaturated fatty acid 5-lipoxygenaseRattus norvegicus (Norway rat)IC50 (µMol)1.95000.00462.018210.0000AID179757; AID6809; AID6820; AID6855; AID7079; AID7096
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)IC50 (µMol)18.71500.11003.26419.0330AID286229; AID630874
Proto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)IC50 (µMol)7.56000.00020.533510.0000AID1063039; AID420260
Sucrase-isomaltase, intestinalHomo sapiens (human)IC50 (µMol)7.80000.04902.72947.8000AID1370805
G2/mitotic-specific cyclin-B1Homo sapiens (human)IC50 (µMol)38.33330.00131.451810.0000AID241206; AID365954; AID53359
TyrosinaseHomo sapiens (human)IC50 (µMol)44.38000.02304.459310.0000AID1891160
Matrix metalloproteinase-9Homo sapiens (human)IC50 (µMol)0.89190.00000.705310.0000AID1767576; AID670313
Urease subunit alphaHelicobacter pylori 26695IC50 (µMol)11.13330.29003.87606.7000AID1871940; AID745311; AID771082
Urease subunit alphaHelicobacter pylori 26695Ki9.34000.22603.40579.3400AID1871940
Serine/threonine-protein kinase B-rafHomo sapiens (human)IC50 (µMol)7.58900.00010.28007.5890AID1416480
Aldo-keto reductase family 1 member B1Homo sapiens (human)IC50 (µMol)2.21410.00101.191310.0000AID1161379; AID1800258; AID322413; AID388742; AID568209; AID639825
G2/mitotic-specific cyclin-BMarthasterias glacialis (spiny starfish)IC50 (µMol)31.27500.00402.10939.4000AID1796044
Cytochrome P450 11B1, mitochondrialRattus norvegicus (Norway rat)IC50 (µMol)50.00000.49503.52895.0000AID179759
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)IC50 (µMol)39.90000.00021.874210.0000AID35134
Polyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)IC50 (µMol)2.20000.04002.099810.0000AID309799
Aldo-keto reductase family 1 member B1Bos taurus (cattle)IC50 (µMol)17.75400.00702.589210.0000AID34200; AID34338; AID35134; AID480503; AID760688
Chymotrypsinogen BHomo sapiens (human)IC50 (µMol)100.000010.000010.000010.0000AID52462
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)IC50 (µMol)23.30000.00053.49849.7600AID165000; AID414643
Polyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)IC50 (µMol)0.44000.10002.452310.0000AID309798
Glycogen synthase kinase-3 betaRattus norvegicus (Norway rat)IC50 (µMol)31.27500.00401.51657.2000AID1796044
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)IC50 (µMol)4.00000.00031.38338.4000AID43124
Casein kinase II subunit alpha'Homo sapiens (human)IC50 (µMol)1.65000.00031.432010.0000AID1247842; AID1572646; AID587344; AID673629; AID779050
Casein kinase II subunit alpha'Homo sapiens (human)Ki1.18000.00020.90117.6700AID1750468
Amine oxidase [flavin-containing] AHomo sapiens (human)IC50 (µMol)2.62000.00002.37899.7700AID1459578; AID461721
Amine oxidase [flavin-containing] A Bos taurus (cattle)IC50 (µMol)0.01000.00290.10380.3802AID377654
5'-nucleotidaseRattus norvegicus (Norway rat)Ki0.04530.00090.25600.8700AID461575
D(4) dopamine receptorHomo sapiens (human)Ki7.84600.00000.436210.0000AID478694
AcetylcholinesteraseHomo sapiens (human)Ki38.30000.00001.27869.7300AID441660
Carbonic anhydrase 4Homo sapiens (human)Ki6.75330.00021.97209.9200AID1803140; AID1803217; AID462273
Carbonic anhydrase 6Homo sapiens (human)Ki4.95000.00011.47109.9200AID1803217; AID462276
Sodium-dependent dopamine transporterRattus norvegicus (Norway rat)IC50 (µMol)20.00000.00070.97749.7000AID1372144
Sodium- and chloride-dependent GABA transporter 1Rattus norvegicus (Norway rat)IC50 (µMol)50.00000.00132.22068.3000AID179759
G1/S-specific cyclin-D1Homo sapiens (human)IC50 (µMol)61.00000.00060.54799.5000AID54030
Cyclin-dependent kinase 2Homo sapiens (human)IC50 (µMol)40.00000.00041.044410.0000AID298693
C-X-C chemokine receptor type 1Homo sapiens (human)IC50 (µMol)35.37800.00102.022710.0000AID729310; AID729312
Adenosine receptor A1Rattus norvegicus (Norway rat)Ki8.90000.00011.20929.9700AID462275; AID462279; AID462281
Amine oxidase [flavin-containing] BHomo sapiens (human)IC50 (µMol)64.33000.00001.89149.5700AID1459579; AID461722
Dipeptidyl peptidase 4Homo sapiens (human)IC50 (µMol)66.46000.00010.444410.0000AID1395903; AID365675
Phosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)IC50 (µMol)3.80000.00000.683210.0000AID325654
Proteasome subunit beta type-5Homo sapiens (human)IC50 (µMol)2.75000.00050.939410.0000AID1633137; AID1633138
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)IC50 (µMol)37.90006.00006.83338.2000AID603318
Nitric oxide synthase, inducibleMus musculus (house mouse)IC50 (µMol)16.40000.00103.39119.6000AID735304
Vasopressin V2 receptorHomo sapiens (human)IC50 (µMol)20.32820.00001.12137.0000AID729307; AID729308; AID729309
Tyrosine-protein kinase receptor UFOHomo sapiens (human)IC50 (µMol)0.96000.00070.41169.1000AID1063050
Adenosine receptor A2aRattus norvegicus (Norway rat)Ki5.12500.00021.494010.0000AID462277; AID462281
Substance-P receptorCavia porcellus (domestic guinea pig)IC50 (µMol)58.40000.00002.751810.0000AID366285
Sodium- and chloride-dependent GABA transporter 2Rattus norvegicus (Norway rat)IC50 (µMol)50.00000.00321.79008.3000AID179759
Sodium- and chloride-dependent GABA transporter 3Rattus norvegicus (Norway rat)IC50 (µMol)50.00000.00321.54318.3000AID179759
Sodium-dependent serotonin transporterRattus norvegicus (Norway rat)IC50 (µMol)1.00000.00030.81978.4900AID1372145
RAC-alpha serine/threonine-protein kinaseHomo sapiens (human)IC50 (µMol)5.39000.00020.738710.0000AID1063052
Multidrug resistance-associated protein 1 Homo sapiens (human)Ki5.25000.07002.20208.1000AID427748; AID679336
Bifunctional epoxide hydrolase 2Homo sapiens (human)IC50 (µMol)20.27000.00000.54509.1000AID1126472; AID1617366
Trypsin-3Homo sapiens (human)IC50 (µMol)15.40000.00351.58464.4000AID768889
Carbonic anhydrase 5A, mitochondrialHomo sapiens (human)Ki6.81000.00001.27259.9000AID462274
Prostaglandin G/H synthase 2Homo sapiens (human)IC50 (µMol)28.60000.00010.995010.0000AID286230
Prostaglandin G/H synthase 2 Rattus norvegicus (Norway rat)IC50 (µMol)50.00000.00291.786810.0000AID161024; AID179759
Vascular endothelial growth factor receptor 2Homo sapiens (human)IC50 (µMol)0.97000.00000.48308.8000AID1063038; AID1394724
Receptor-type tyrosine-protein kinase FLT3Homo sapiens (human)IC50 (µMol)0.59000.00010.32759.5480AID730328
17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)IC50 (µMol)1.54000.09603.94009.9000AID1364654; AID406997
Alpha-synucleinHomo sapiens (human)IC50 (µMol)20.00000.19003.82049.8000AID1695729
Macrophage metalloelastaseHomo sapiens (human)IC50 (µMol)10.23000.00022.721710.0000AID670314
Kappa-type opioid receptorCavia porcellus (domestic guinea pig)IC50 (µMol)1.00000.00030.71237.0700AID95258
Glutathione reductaseSaccharomyces cerevisiae S288CIC50 (µMol)48.80003.67003.67003.6700AID75438
Carbonic anhydrase 7Homo sapiens (human)Ki4.84000.00021.37379.9000AID462277
Tyrosine-protein kinase SYKHomo sapiens (human)IC50 (µMol)20.00000.00010.826010.0000AID701071
Collagenase 3Homo sapiens (human)IC50 (µMol)8.46000.00000.767510.0000AID670315
1-deoxy-D-xylulose 5-phosphate reductoisomeraseEscherichia coli K-12IC50 (µMol)1.90000.02000.74213.5000AID1801043
Xanthine dehydrogenase/oxidaseHomo sapiens (human)IC50 (µMol)3.04000.00132.81389.8200AID1310994; AID336485; AID399340
Xanthine dehydrogenase/oxidaseHomo sapiens (human)Ki0.28000.00011.38097.3000AID1185463
Sodium- and chloride-dependent betaine transporterRattus norvegicus (Norway rat)IC50 (µMol)50.00000.00321.54318.3000AID179759
Prolyl endopeptidaseHomo sapiens (human)IC50 (µMol)13.00000.00111.98969.7500AID365674
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)IC50 (µMol)8.79500.00030.660710.0000AID1185177; AID1797363
Glycogen synthase kinase-3 alphaHomo sapiens (human)IC50 (µMol)2.10000.00101.22499.1000AID240981
Glycogen synthase kinase-3 betaHomo sapiens (human)IC50 (µMol)2.10000.00060.801310.0000AID240981
Aldo-keto reductase family 1 member A1Sus scrofa (pig)IC50 (µMol)38.40000.00051.66804.0000AID367704
Aldo-keto reductase family 1 member A1Rattus norvegicus (Norway rat)IC50 (µMol)2.32000.02801.13782.3200AID34198
C-C chemokine receptor type 4Homo sapiens (human)IC50 (µMol)47.24090.20004.542410.0000AID729313; AID729314; AID729315
Serine/threonine-protein kinase Nek2Homo sapiens (human)IC50 (µMol)5.73000.15802.51608.0000AID1063045
Oligo-1,6-glucosidase IMA1Saccharomyces cerevisiae S288CIC50 (µMol)530.00009.37009.37009.3700AID735123
Serine/threonine-protein kinase PLK1Homo sapiens (human)IC50 (µMol)34.87500.00010.77349.0000AID1063042; AID387406
Death-associated protein kinase 1Homo sapiens (human)IC50 (µMol)8.90000.00052.284510.0000AID1247840
Mitogen-activated protein kinase 10Homo sapiens (human)IC50 (µMol)2.88000.00201.703510.0000AID1799639
Monocarboxylate transporter 1Rattus norvegicus (Norway rat)IC50 (µMol)14.00000.28100.28100.2810AID681133
Amine oxidase [flavin-containing] BBos taurus (cattle)IC50 (µMol)20.00001.00001.00001.0000AID377655
Beta-secretase 1Homo sapiens (human)IC50 (µMol)7.64000.00061.619410.0000AID1230141; AID1486117; AID483707
Beta-secretase 1Homo sapiens (human)Ki14.00000.00031.35248.0000AID483708
Anthrax toxin receptor 2Homo sapiens (human)IC50 (µMol)300.00000.30000.45350.6070AID725981
Casein kinase II subunit betaHomo sapiens (human)IC50 (µMol)1.65000.00031.487510.0000AID1247842; AID1572646; AID587344; AID673629; AID779050
Casein kinase II subunit betaHomo sapiens (human)Ki1.18000.00021.11247.6700AID1750468
Casein kinase II subunit alphaHomo sapiens (human)IC50 (µMol)1.65000.00051.333210.0000AID1247842; AID1572646; AID587344; AID673629; AID779050
Casein kinase II subunit alphaHomo sapiens (human)Ki1.18000.00041.09847.6700AID1539764; AID1750468; AID1796664; AID435763
Urease subunit betaHelicobacter pylori 26695IC50 (µMol)11.13330.29003.87606.7000AID1871940; AID745311; AID771082
Urease subunit betaHelicobacter pylori 26695Ki9.34000.22603.40579.3400AID1871940
LactoperoxidaseBos taurus (cattle)IC50 (µMol)6.10000.40002.42506.1000AID1446235
Aldo-keto reductase family 1 member B1Sus scrofa (pig)IC50 (µMol)50.10000.01500.61352.5000AID354608
Xanthine dehydrogenase/oxidaseBos taurus (cattle)IC50 (µMol)31.90000.00303.10159.8000AID1485278
Xanthine dehydrogenase/oxidaseBos taurus (cattle)Ki1.20000.00010.83862.6000AID424726
Cyclin-dependent kinase 6Homo sapiens (human)IC50 (µMol)30.02000.00190.86547.2000AID1796044; AID242481
Cyclin-dependent-like kinase 5 Homo sapiens (human)IC50 (µMol)29.62000.00021.183210.0000AID1796044; AID241232
Heat shock factor protein 1Homo sapiens (human)IC50 (µMol)50.00000.00700.60351.2000AID1242158
Sorbitol dehydrogenaseHomo sapiens (human)IC50 (µMol)106.30000.24000.49531.0000AID203728; AID203731
Cyclin homologHerpesvirus saimiri (strain 11)IC50 (µMol)31.27500.08002.47007.2000AID1796044
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1BRattus norvegicus (Norway rat)IC50 (µMol)275.00000.10000.20000.3000AID220159
Dual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)IC50 (µMol)10.00000.00020.68139.7000AID1063047
Lactoylglutathione lyaseHomo sapiens (human)IC50 (µMol)3.20000.56003.59608.5000AID381802
Lactoylglutathione lyaseHomo sapiens (human)Ki15.13560.00122.59479.1400AID74123
Focal adhesion kinase 1Homo sapiens (human)IC50 (µMol)1.20000.00020.54168.3000AID1063048
Calcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)IC50 (µMol)3.00000.00011.032010.0000AID673630
ELAV-like protein 3Homo sapiens (human)IC50 (µMol)1.80000.20000.96001.8000AID1450465
Cyclin-dependent kinase 5 activator 1Homo sapiens (human)IC50 (µMol)29.62000.00101.289810.0000AID1796044; AID241232
ELAV-like protein 1Homo sapiens (human)IC50 (µMol)1.40000.06800.53901.4000AID1450466
Serine/threonine-protein kinase N1Homo sapiens (human)IC50 (µMol)5.80000.00101.11575.8000AID1063040
Mitogen-activated protein kinase 14Homo sapiens (human)IC50 (µMol)2.88000.00010.72667.8000AID1799639
Cytochrome P450 1B1Homo sapiens (human)IC50 (µMol)1.11080.00130.86969.9000AID1372145; AID1372150; AID1372154; AID1446939; AID502475
Cytochrome P450 1B1Homo sapiens (human)Ki0.02300.00300.97417.4600AID1452994; AID598342
Carbonic anhydrase 9Homo sapiens (human)Ki7.00000.00010.78749.9000AID462278
Probable maltase-glucoamylase 2Homo sapiens (human)IC50 (µMol)7.80000.54004.02447.8000AID1370805
Carbonic anhydrase 3Bos taurus (cattle)Ki6.52600.11303.88159.7100AID1803140; AID1803217
Monocarboxylate transporter 2Rattus norvegicus (Norway rat)IC50 (µMol)5.00005.00007.00009.0000AID681123
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1CRattus norvegicus (Norway rat)IC50 (µMol)275.00000.10000.20000.3000AID220159
Prostaglandin G/H synthase 1 Rattus norvegicus (Norway rat)IC50 (µMol)50.00000.00291.823210.0000AID161024; AID179759
Substance-K receptorCavia porcellus (domestic guinea pig)IC50 (µMol)58.40000.01500.01500.0150AID366285
Integrase Human immunodeficiency virus 1IC50 (µMol)13.16000.00051.544310.0000AID1152249; AID1152250; AID1152254; AID93507; AID93508
Casein kinase II subunit alpha 3Homo sapiens (human)IC50 (µMol)0.55000.00151.966410.0000AID1572646
Casein kinase II subunit alpha 3Homo sapiens (human)Ki1.18000.00041.86517.6700AID1750468
Inositol polyphosphate multikinaseHomo sapiens (human)IC50 (µMol)2.30001.10003.78337.2000AID1572025
G2/mitotic-specific cyclin-B3Homo sapiens (human)IC50 (µMol)75.00000.00251.817210.0000AID241206
Aldo-keto reductase family 1 member C21Mus musculus (house mouse)IC50 (µMol)6.90006.90006.90006.9000AID322409
Canalicular multispecific organic anion transporter 1Homo sapiens (human)IC50 (µMol)133.00002.41006.343310.0000AID1473739
Enoyl-acyl-carrier protein reductase Plasmodium falciparum (malaria parasite P. falciparum)IC50 (µMol)1.83330.06601.549910.0000AID265759; AID277583; AID494830
Enoyl-acyl-carrier protein reductase Plasmodium falciparum (malaria parasite P. falciparum)Ki0.52830.00000.57785.5000AID277585; AID277586; AID277587
3-oxoacyl-acyl-carrier protein reductase Plasmodium falciparum (malaria parasite P. falciparum)IC50 (µMol)5.40000.30003.772710.0000AID265760
Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein)Plasmodium falciparum (malaria parasite P. falciparum)IC50 (µMol)1.50000.03002.94428.0000AID265758
Aurora kinase BHomo sapiens (human)IC50 (µMol)2.43500.00030.96349.8000AID1063049; AID1801097
Carbonic anhydrase 13Mus musculus (house mouse)Ki9.03000.00021.39749.9000AID462280
Cyclin-dependent kinase 1Oryzias latipes (Japanese medaka)IC50 (µMol)31.27500.00402.10939.4000AID1796044
Phosphodiesterase Rattus norvegicus (Norway rat)IC50 (µMol)275.00000.10000.20000.3000AID220159
G-protein coupled receptor 35Homo sapiens (human)IC50 (µMol)15.40000.03001.39804.6600AID663960
Serine/threonine-protein kinase Nek6Homo sapiens (human)IC50 (µMol)4.23001.06502.64754.2300AID1063043
NADPH oxidase 4Homo sapiens (human)IC50 (µMol)0.68000.07080.87881.3400AID510244
Hypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)IC50 (µMol)10.20008.60008.60008.6000AID455764
Inositol hexakisphosphate kinase 2Homo sapiens (human)IC50 (µMol)0.70000.50002.35567.1000AID1572024
Short transient receptor potential channel 5Homo sapiens (human)IC50 (µMol)6.50000.30002.78756.5000AID1578735
Carbonic anhydrase 14Homo sapiens (human)Ki5.41000.00021.50999.9000AID462281
ALK tyrosine kinase receptorHomo sapiens (human)IC50 (µMol)3.32000.00010.310710.0000AID1063053
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)IC50 (µMol)7.25000.00401.966610.0000AID578759; AID578760
Carbonic anhydrase 5B, mitochondrialHomo sapiens (human)Ki11.90000.00001.34129.9700AID462275
Sialidase-2Homo sapiens (human)IC50 (µMol)160.00003.90006.73337.8000AID466938
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
glycogen synthase kinase-3 beta isoform 1Homo sapiens (human)EC50 (µMol)10.06000.212522.156283.9400AID434954
serine/threonine-protein kinase 33 isoform aHomo sapiens (human)EC50 (µMol)12.36000.769114.609644.8900AID2821
large T antigenBetapolyomavirus macacaeEC50 (µMol)50.00000.100035.489650.0000AID2102
Spike glycoproteinBetacoronavirus England 1EC50 (µMol)83.40000.00304.57559.8200AID1804127
Replicase polyprotein 1abBetacoronavirus England 1EC50 (µMol)83.40000.00304.57559.8200AID1804127
Transmembrane protease serine 2Homo sapiens (human)EC50 (µMol)83.40000.00304.51689.8200AID1804127
ProthrombinHomo sapiens (human)Kd0.03870.00000.01010.0387AID768894
Cytochrome P450 1A1Homo sapiens (human)EC50 (µMol)8.80001.80004.60008.8000AID1372157
Procathepsin LHomo sapiens (human)EC50 (µMol)83.40000.00304.48749.8200AID1804127
ATP-dependent translocase ABCB1Homo sapiens (human)Kd7.07950.07305.798110.0000AID615921
5-hydroxytryptamine receptor 1AHomo sapiens (human)EC50 (µMol)100.00000.00010.25718.0000AID380503
Heterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)Kd5.30000.08273.56098.9000AID1802891
Replicase polyprotein 1aSevere acute respiratory syndrome-related coronavirusEC50 (µMol)83.40000.00304.61369.8200AID1804126; AID1804127
Replicase polyprotein 1abHuman coronavirus 229EEC50 (µMol)83.40000.00304.61369.8200AID1804126; AID1804127
Replicase polyprotein 1abSevere acute respiratory syndrome-related coronavirusEC50 (µMol)83.40000.00304.45549.8200AID1804126; AID1804127
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2EC50 (µMol)83.40000.00304.11059.8200AID1804127
Serine/threonine-protein kinase pim-1Homo sapiens (human)Kd0.02500.00101.139319.3160AID257082
Tyrosine-protein kinase SYKHomo sapiens (human)EC50 (µMol)35.00000.00200.62905.0000AID701064
Spike glycoproteinSevere acute respiratory syndrome-related coronavirusEC50 (µMol)83.40000.00304.57559.8200AID1804127
Cytochrome P450 1B1Homo sapiens (human)EC50 (µMol)1.10001.10003.10005.1000AID1372155
Angiotensin-converting enzyme 2 Homo sapiens (human)EC50 (µMol)83.40000.00304.57559.8200AID1804127
G-protein coupled receptor 35Homo sapiens (human)EC50 (µMol)6.97500.00202.50079.8000AID663955; AID663956
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)EC50 (µMol)0.19530.00540.42203.2000AID1447895; AID1479734; AID1501277
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LMP1 [Human herpesvirus 4]human gammaherpesvirus 4 (Epstein-Barr virus)AC50233.01000.068039.9389277.4300AID588398
interferon gamma precursorHomo sapiens (human)AC5016.69000.128015.173038.6100AID1259418; AID1259420
Seed linoleate 13S-lipoxygenase-1Glycine max (soybean)Vmax0.00700.00500.00820.0120AID1063897; AID1063899
Xanthine dehydrogenase/oxidaseBos taurus (cattle)Km65.30001.80002.78003.7000AID424718; AID424719; AID424720; AID424721
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (1961)

Processvia Protein(s)Taxonomy
lipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
phospholipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
apoptotic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell population proliferationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of macrophage derived foam cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell migrationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
prostate gland developmentPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
regulation of epithelial cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of chemokine productionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of peroxisome proliferator activated receptor signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of keratinocyte differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell cyclePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of growthPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
hepoxilin biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
endocannabinoid signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cannabinoid biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxin A4 biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid oxidationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxygenase pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell activation involved in immune responseInterferon betaHomo sapiens (human)
cell surface receptor signaling pathwayInterferon betaHomo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to virusInterferon betaHomo sapiens (human)
positive regulation of autophagyInterferon betaHomo sapiens (human)
cytokine-mediated signaling pathwayInterferon betaHomo sapiens (human)
natural killer cell activationInterferon betaHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylation of STAT proteinInterferon betaHomo sapiens (human)
cellular response to interferon-betaInterferon betaHomo sapiens (human)
B cell proliferationInterferon betaHomo sapiens (human)
negative regulation of viral genome replicationInterferon betaHomo sapiens (human)
innate immune responseInterferon betaHomo sapiens (human)
positive regulation of innate immune responseInterferon betaHomo sapiens (human)
regulation of MHC class I biosynthetic processInterferon betaHomo sapiens (human)
negative regulation of T cell differentiationInterferon betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIInterferon betaHomo sapiens (human)
defense response to virusInterferon betaHomo sapiens (human)
type I interferon-mediated signaling pathwayInterferon betaHomo sapiens (human)
neuron cellular homeostasisInterferon betaHomo sapiens (human)
cellular response to exogenous dsRNAInterferon betaHomo sapiens (human)
cellular response to virusInterferon betaHomo sapiens (human)
negative regulation of Lewy body formationInterferon betaHomo sapiens (human)
negative regulation of T-helper 2 cell cytokine productionInterferon betaHomo sapiens (human)
positive regulation of apoptotic signaling pathwayInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell differentiationInterferon betaHomo sapiens (human)
natural killer cell activation involved in immune responseInterferon betaHomo sapiens (human)
adaptive immune responseInterferon betaHomo sapiens (human)
T cell activation involved in immune responseInterferon betaHomo sapiens (human)
humoral immune responseInterferon betaHomo sapiens (human)
positive regulation of T cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
adaptive immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independentHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of T cell anergyHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
defense responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
detection of bacteriumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-12 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-6 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protection from natural killer cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
innate immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of dendritic cell differentiationHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class IbHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
pentose-phosphate shuntGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
lipid metabolic processGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
cholesterol biosynthetic processGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
NADP metabolic processGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
NADPH regenerationGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
glutathione metabolic processGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
pentose-phosphate shunt, oxidative branchGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
response to iron(III) ionGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
negative regulation of protein glutathionylationGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
response to organic cyclic compoundGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
pentose biosynthetic processGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
substantia nigra developmentGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
response to foodGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
cellular response to oxidative stressGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
erythrocyte maturationGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
regulation of neuron apoptotic processGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
response to ethanolGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
ribose phosphate biosynthetic processGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
glucose 6-phosphate metabolic processGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
negative regulation of cell growth involved in cardiac muscle cell developmentGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channelGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
negative regulation of reactive oxygen species metabolic processGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
glucose metabolic processGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
positive regulation of epidermal growth factor receptor signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
response to hypoxiaDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
neutrophil mediated immunityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
germinal center formationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of leukocyte chemotaxisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
proteolysisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
membrane protein ectodomain proteolysisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cell adhesionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
Notch receptor processingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of cell population proliferationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
response to xenobiotic stimulusDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of T cell chemotaxisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
protein processingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
signal releaseDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
B cell differentiationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of cell growthDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of cell migrationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
response to lipopolysaccharideDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of chemokine productionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of tumor necrosis factor productionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
regulation of mast cell apoptotic processDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
T cell differentiation in thymusDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cell adhesion mediated by integrinDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
wound healing, spreading of epidermal cellsDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
amyloid precursor protein catabolic processDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of blood vessel endothelial cell migrationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of cyclin-dependent protein serine/threonine kinase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of epidermal growth factor-activated receptor activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of epidermal growth factor receptor signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
spleen developmentDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cell motilityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
defense response to Gram-positive bacteriumDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cellular response to high density lipoprotein particle stimulusDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
commissural neuron axon guidanceDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
negative regulation of cold-induced thermogenesisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of tumor necrosis factor-mediated signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of vascular endothelial cell proliferationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
Notch signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
inositol phosphate metabolic processInositol hexakisphosphate kinase 1Homo sapiens (human)
phosphatidylinositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
negative regulation of cold-induced thermogenesisInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
adaptive immune responseRap guanine nucleotide exchange factor 3Homo sapiens (human)
signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 3Homo sapiens (human)
associative learningRap guanine nucleotide exchange factor 3Homo sapiens (human)
Rap protein signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of actin cytoskeleton organizationRap guanine nucleotide exchange factor 3Homo sapiens (human)
negative regulation of syncytium formation by plasma membrane fusionRap guanine nucleotide exchange factor 3Homo sapiens (human)
intracellular signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of GTPase activityRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of protein export from nucleusRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of stress fiber assemblyRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of syncytium formation by plasma membrane fusionRap guanine nucleotide exchange factor 3Homo sapiens (human)
establishment of endothelial barrierRap guanine nucleotide exchange factor 3Homo sapiens (human)
cellular response to cAMPRap guanine nucleotide exchange factor 3Homo sapiens (human)
Ras protein signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of insulin secretionRap guanine nucleotide exchange factor 3Homo sapiens (human)
lipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
phospholipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
apoptotic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell population proliferationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of macrophage derived foam cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell migrationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
prostate gland developmentPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
regulation of epithelial cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of chemokine productionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of peroxisome proliferator activated receptor signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of keratinocyte differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell cyclePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of growthPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
hepoxilin biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
endocannabinoid signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cannabinoid biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxin A4 biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid oxidationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxygenase pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
viral translationTransmembrane protease serine 2Homo sapiens (human)
proteolysisTransmembrane protease serine 2Homo sapiens (human)
protein autoprocessingTransmembrane protease serine 2Homo sapiens (human)
positive regulation of viral entry into host cellTransmembrane protease serine 2Homo sapiens (human)
xenobiotic metabolic processATP-binding cassette sub-family C member 3Homo sapiens (human)
xenobiotic transmembrane transportATP-binding cassette sub-family C member 3Homo sapiens (human)
bile acid and bile salt transportATP-binding cassette sub-family C member 3Homo sapiens (human)
glucuronoside transportATP-binding cassette sub-family C member 3Homo sapiens (human)
xenobiotic transportATP-binding cassette sub-family C member 3Homo sapiens (human)
transmembrane transportATP-binding cassette sub-family C member 3Homo sapiens (human)
leukotriene transportATP-binding cassette sub-family C member 3Homo sapiens (human)
monoatomic anion transmembrane transportATP-binding cassette sub-family C member 3Homo sapiens (human)
transport across blood-brain barrierATP-binding cassette sub-family C member 3Homo sapiens (human)
prostaglandin secretionMultidrug resistance-associated protein 4Homo sapiens (human)
cilium assemblyMultidrug resistance-associated protein 4Homo sapiens (human)
platelet degranulationMultidrug resistance-associated protein 4Homo sapiens (human)
xenobiotic metabolic processMultidrug resistance-associated protein 4Homo sapiens (human)
xenobiotic transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
bile acid and bile salt transportMultidrug resistance-associated protein 4Homo sapiens (human)
prostaglandin transportMultidrug resistance-associated protein 4Homo sapiens (human)
urate transportMultidrug resistance-associated protein 4Homo sapiens (human)
glutathione transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
cAMP transportMultidrug resistance-associated protein 4Homo sapiens (human)
leukotriene transportMultidrug resistance-associated protein 4Homo sapiens (human)
monoatomic anion transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
export across plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
transport across blood-brain barrierMultidrug resistance-associated protein 4Homo sapiens (human)
guanine nucleotide transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
maltose catabolic processMaltase-glucoamylase, intestinalHomo sapiens (human)
starch catabolic processMaltase-glucoamylase, intestinalHomo sapiens (human)
dextrin catabolic processMaltase-glucoamylase, intestinalHomo sapiens (human)
estrous cycleCarbonic anhydrase 12Homo sapiens (human)
chloride ion homeostasisCarbonic anhydrase 12Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 12Homo sapiens (human)
protein phosphorylationNUAK family SNF1-like kinase 1Homo sapiens (human)
DNA damage responseNUAK family SNF1-like kinase 1Homo sapiens (human)
cell adhesionNUAK family SNF1-like kinase 1Homo sapiens (human)
regulation of cell adhesionNUAK family SNF1-like kinase 1Homo sapiens (human)
regulation of myosin-light-chain-phosphatase activityNUAK family SNF1-like kinase 1Homo sapiens (human)
regulation of cell population proliferationNUAK family SNF1-like kinase 1Homo sapiens (human)
regulation of signal transduction by p53 class mediatorNUAK family SNF1-like kinase 1Homo sapiens (human)
regulation of cellular senescenceNUAK family SNF1-like kinase 1Homo sapiens (human)
regulation of double-strand break repair via homologous recombinationLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of protein ubiquitinationLysine-specific histone demethylase 1AHomo sapiens (human)
regulation of protein localizationLysine-specific histone demethylase 1AHomo sapiens (human)
cellular response to UVLysine-specific histone demethylase 1AHomo sapiens (human)
cellular response to gamma radiationLysine-specific histone demethylase 1AHomo sapiens (human)
DNA repair-dependent chromatin remodelingLysine-specific histone demethylase 1AHomo sapiens (human)
negative regulation of transcription by RNA polymerase IILysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of neuroblast proliferationLysine-specific histone demethylase 1AHomo sapiens (human)
regulation of transcription by RNA polymerase IILysine-specific histone demethylase 1AHomo sapiens (human)
protein demethylationLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of epithelial to mesenchymal transitionLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of neuron projection developmentLysine-specific histone demethylase 1AHomo sapiens (human)
cerebral cortex developmentLysine-specific histone demethylase 1AHomo sapiens (human)
negative regulation of protein bindingLysine-specific histone demethylase 1AHomo sapiens (human)
neuron maturationLysine-specific histone demethylase 1AHomo sapiens (human)
negative regulation of DNA bindingLysine-specific histone demethylase 1AHomo sapiens (human)
negative regulation of DNA-binding transcription factor activityLysine-specific histone demethylase 1AHomo sapiens (human)
negative regulation of DNA damage response, signal transduction by p53 class mediatorLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of cell sizeLysine-specific histone demethylase 1AHomo sapiens (human)
negative regulation of DNA-templated transcriptionLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of transcription by RNA polymerase IILysine-specific histone demethylase 1AHomo sapiens (human)
guanine metabolic processLysine-specific histone demethylase 1AHomo sapiens (human)
muscle cell developmentLysine-specific histone demethylase 1AHomo sapiens (human)
regulation of androgen receptor signaling pathwayLysine-specific histone demethylase 1AHomo sapiens (human)
response to fungicideLysine-specific histone demethylase 1AHomo sapiens (human)
cellular response to cAMPLysine-specific histone demethylase 1AHomo sapiens (human)
regulation of DNA methylation-dependent heterochromatin formationLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of cold-induced thermogenesisLysine-specific histone demethylase 1AHomo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of neural precursor cell proliferationLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of stem cell proliferationLysine-specific histone demethylase 1AHomo sapiens (human)
chromatin remodelingLysine-specific histone demethylase 1AHomo sapiens (human)
in utero embryonic developmentG2/mitotic-specific cyclin-B2Homo sapiens (human)
spindle assembly involved in female meiosis IG2/mitotic-specific cyclin-B2Homo sapiens (human)
G2/MI transition of meiotic cell cycleG2/mitotic-specific cyclin-B2Homo sapiens (human)
regulation of growthG2/mitotic-specific cyclin-B2Homo sapiens (human)
T cell homeostasisG2/mitotic-specific cyclin-B2Homo sapiens (human)
thymus developmentG2/mitotic-specific cyclin-B2Homo sapiens (human)
cell divisionG2/mitotic-specific cyclin-B2Homo sapiens (human)
regulation of cyclin-dependent protein serine/threonine kinase activityG2/mitotic-specific cyclin-B2Homo sapiens (human)
mitotic cell cycle phase transitionG2/mitotic-specific cyclin-B2Homo sapiens (human)
fatty acid metabolic processBile salt export pumpHomo sapiens (human)
bile acid biosynthetic processBile salt export pumpHomo sapiens (human)
xenobiotic metabolic processBile salt export pumpHomo sapiens (human)
xenobiotic transmembrane transportBile salt export pumpHomo sapiens (human)
response to oxidative stressBile salt export pumpHomo sapiens (human)
bile acid metabolic processBile salt export pumpHomo sapiens (human)
response to organic cyclic compoundBile salt export pumpHomo sapiens (human)
bile acid and bile salt transportBile salt export pumpHomo sapiens (human)
canalicular bile acid transportBile salt export pumpHomo sapiens (human)
protein ubiquitinationBile salt export pumpHomo sapiens (human)
regulation of fatty acid beta-oxidationBile salt export pumpHomo sapiens (human)
carbohydrate transmembrane transportBile salt export pumpHomo sapiens (human)
bile acid signaling pathwayBile salt export pumpHomo sapiens (human)
cholesterol homeostasisBile salt export pumpHomo sapiens (human)
response to estrogenBile salt export pumpHomo sapiens (human)
response to ethanolBile salt export pumpHomo sapiens (human)
xenobiotic export from cellBile salt export pumpHomo sapiens (human)
lipid homeostasisBile salt export pumpHomo sapiens (human)
phospholipid homeostasisBile salt export pumpHomo sapiens (human)
positive regulation of bile acid secretionBile salt export pumpHomo sapiens (human)
regulation of bile acid metabolic processBile salt export pumpHomo sapiens (human)
transmembrane transportBile salt export pumpHomo sapiens (human)
cellular oxidant detoxificationGlutathione reductase, mitochondrialHomo sapiens (human)
cellular response to oxidative stressGlutathione reductase, mitochondrialHomo sapiens (human)
glutathione metabolic processGlutathione reductase, mitochondrialHomo sapiens (human)
cell redox homeostasisGlutathione reductase, mitochondrialHomo sapiens (human)
cell surface receptor signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
epidermal growth factor receptor signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
positive regulation of cell population proliferationEpidermal growth factor receptorHomo sapiens (human)
MAPK cascadeEpidermal growth factor receptorHomo sapiens (human)
ossificationEpidermal growth factor receptorHomo sapiens (human)
embryonic placenta developmentEpidermal growth factor receptorHomo sapiens (human)
positive regulation of protein phosphorylationEpidermal growth factor receptorHomo sapiens (human)
hair follicle developmentEpidermal growth factor receptorHomo sapiens (human)
translationEpidermal growth factor receptorHomo sapiens (human)
signal transductionEpidermal growth factor receptorHomo sapiens (human)
epidermal growth factor receptor signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
activation of phospholipase C activityEpidermal growth factor receptorHomo sapiens (human)
salivary gland morphogenesisEpidermal growth factor receptorHomo sapiens (human)
midgut developmentEpidermal growth factor receptorHomo sapiens (human)
learning or memoryEpidermal growth factor receptorHomo sapiens (human)
circadian rhythmEpidermal growth factor receptorHomo sapiens (human)
positive regulation of cell population proliferationEpidermal growth factor receptorHomo sapiens (human)
diterpenoid metabolic processEpidermal growth factor receptorHomo sapiens (human)
peptidyl-tyrosine phosphorylationEpidermal growth factor receptorHomo sapiens (human)
cerebral cortex cell migrationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of cell growthEpidermal growth factor receptorHomo sapiens (human)
lung developmentEpidermal growth factor receptorHomo sapiens (human)
positive regulation of cell migrationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of superoxide anion generationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationEpidermal growth factor receptorHomo sapiens (human)
response to cobalaminEpidermal growth factor receptorHomo sapiens (human)
response to hydroxyisoflavoneEpidermal growth factor receptorHomo sapiens (human)
cellular response to reactive oxygen speciesEpidermal growth factor receptorHomo sapiens (human)
peptidyl-tyrosine autophosphorylationEpidermal growth factor receptorHomo sapiens (human)
ERBB2-EGFR signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
negative regulation of epidermal growth factor receptor signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
negative regulation of protein catabolic processEpidermal growth factor receptorHomo sapiens (human)
vasodilationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of phosphorylationEpidermal growth factor receptorHomo sapiens (human)
ovulation cycleEpidermal growth factor receptorHomo sapiens (human)
hydrogen peroxide metabolic processEpidermal growth factor receptorHomo sapiens (human)
negative regulation of apoptotic processEpidermal growth factor receptorHomo sapiens (human)
positive regulation of MAP kinase activityEpidermal growth factor receptorHomo sapiens (human)
tongue developmentEpidermal growth factor receptorHomo sapiens (human)
positive regulation of cyclin-dependent protein serine/threonine kinase activityEpidermal growth factor receptorHomo sapiens (human)
positive regulation of DNA repairEpidermal growth factor receptorHomo sapiens (human)
positive regulation of DNA replicationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of bone resorptionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of DNA-templated transcriptionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of vasoconstrictionEpidermal growth factor receptorHomo sapiens (human)
negative regulation of mitotic cell cycleEpidermal growth factor receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIEpidermal growth factor receptorHomo sapiens (human)
regulation of JNK cascadeEpidermal growth factor receptorHomo sapiens (human)
symbiont entry into host cellEpidermal growth factor receptorHomo sapiens (human)
protein autophosphorylationEpidermal growth factor receptorHomo sapiens (human)
astrocyte activationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of fibroblast proliferationEpidermal growth factor receptorHomo sapiens (human)
digestive tract morphogenesisEpidermal growth factor receptorHomo sapiens (human)
positive regulation of smooth muscle cell proliferationEpidermal growth factor receptorHomo sapiens (human)
neuron projection morphogenesisEpidermal growth factor receptorHomo sapiens (human)
epithelial cell proliferationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of epithelial cell proliferationEpidermal growth factor receptorHomo sapiens (human)
regulation of peptidyl-tyrosine phosphorylationEpidermal growth factor receptorHomo sapiens (human)
protein insertion into membraneEpidermal growth factor receptorHomo sapiens (human)
response to calcium ionEpidermal growth factor receptorHomo sapiens (human)
regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of synaptic transmission, glutamatergicEpidermal growth factor receptorHomo sapiens (human)
positive regulation of glial cell proliferationEpidermal growth factor receptorHomo sapiens (human)
morphogenesis of an epithelial foldEpidermal growth factor receptorHomo sapiens (human)
eyelid development in camera-type eyeEpidermal growth factor receptorHomo sapiens (human)
response to UV-AEpidermal growth factor receptorHomo sapiens (human)
positive regulation of mucus secretionEpidermal growth factor receptorHomo sapiens (human)
regulation of ERK1 and ERK2 cascadeEpidermal growth factor receptorHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeEpidermal growth factor receptorHomo sapiens (human)
cellular response to amino acid stimulusEpidermal growth factor receptorHomo sapiens (human)
cellular response to mechanical stimulusEpidermal growth factor receptorHomo sapiens (human)
cellular response to cadmium ionEpidermal growth factor receptorHomo sapiens (human)
cellular response to epidermal growth factor stimulusEpidermal growth factor receptorHomo sapiens (human)
cellular response to estradiol stimulusEpidermal growth factor receptorHomo sapiens (human)
cellular response to xenobiotic stimulusEpidermal growth factor receptorHomo sapiens (human)
cellular response to dexamethasone stimulusEpidermal growth factor receptorHomo sapiens (human)
positive regulation of canonical Wnt signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
liver regenerationEpidermal growth factor receptorHomo sapiens (human)
cell-cell adhesionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of protein kinase C activityEpidermal growth factor receptorHomo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleEpidermal growth factor receptorHomo sapiens (human)
positive regulation of non-canonical NF-kappaB signal transductionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of prolactin secretionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of miRNA transcriptionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of protein localization to plasma membraneEpidermal growth factor receptorHomo sapiens (human)
negative regulation of cardiocyte differentiationEpidermal growth factor receptorHomo sapiens (human)
neurogenesisEpidermal growth factor receptorHomo sapiens (human)
multicellular organism developmentEpidermal growth factor receptorHomo sapiens (human)
positive regulation of kinase activityEpidermal growth factor receptorHomo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
positive regulation of protein phosphorylationProthrombinHomo sapiens (human)
proteolysisProthrombinHomo sapiens (human)
acute-phase responseProthrombinHomo sapiens (human)
cell surface receptor signaling pathwayProthrombinHomo sapiens (human)
G protein-coupled receptor signaling pathwayProthrombinHomo sapiens (human)
blood coagulationProthrombinHomo sapiens (human)
positive regulation of cell population proliferationProthrombinHomo sapiens (human)
regulation of cell shapeProthrombinHomo sapiens (human)
response to woundingProthrombinHomo sapiens (human)
negative regulation of platelet activationProthrombinHomo sapiens (human)
platelet activationProthrombinHomo sapiens (human)
regulation of blood coagulationProthrombinHomo sapiens (human)
positive regulation of blood coagulationProthrombinHomo sapiens (human)
positive regulation of cell growthProthrombinHomo sapiens (human)
positive regulation of insulin secretionProthrombinHomo sapiens (human)
positive regulation of collagen biosynthetic processProthrombinHomo sapiens (human)
fibrinolysisProthrombinHomo sapiens (human)
negative regulation of proteolysisProthrombinHomo sapiens (human)
positive regulation of receptor signaling pathway via JAK-STATProthrombinHomo sapiens (human)
negative regulation of astrocyte differentiationProthrombinHomo sapiens (human)
positive regulation of release of sequestered calcium ion into cytosolProthrombinHomo sapiens (human)
regulation of cytosolic calcium ion concentrationProthrombinHomo sapiens (human)
cytolysis by host of symbiont cellsProthrombinHomo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionProthrombinHomo sapiens (human)
negative regulation of fibrinolysisProthrombinHomo sapiens (human)
antimicrobial humoral immune response mediated by antimicrobial peptideProthrombinHomo sapiens (human)
neutrophil-mediated killing of gram-negative bacteriumProthrombinHomo sapiens (human)
positive regulation of lipid kinase activityProthrombinHomo sapiens (human)
negative regulation of cytokine production involved in inflammatory responseProthrombinHomo sapiens (human)
positive regulation of protein localization to nucleusProthrombinHomo sapiens (human)
positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathwayProthrombinHomo sapiens (human)
ligand-gated ion channel signaling pathwayProthrombinHomo sapiens (human)
positive regulation of reactive oxygen species metabolic processProthrombinHomo sapiens (human)
proteolysisProthrombin Bos taurus (cattle)
acute-phase responseProthrombin Bos taurus (cattle)
positive regulation of blood coagulationProthrombin Bos taurus (cattle)
protein polymerizationProthrombin Bos taurus (cattle)
positive regulation of cell migrationUrokinase-type plasminogen activatorHomo sapiens (human)
response to hypoxiaUrokinase-type plasminogen activatorHomo sapiens (human)
proteolysisUrokinase-type plasminogen activatorHomo sapiens (human)
chemotaxisUrokinase-type plasminogen activatorHomo sapiens (human)
signal transductionUrokinase-type plasminogen activatorHomo sapiens (human)
blood coagulationUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of signaling receptor activityUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of plasminogen activationUrokinase-type plasminogen activatorHomo sapiens (human)
negative regulation of plasminogen activationUrokinase-type plasminogen activatorHomo sapiens (human)
smooth muscle cell migrationUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of smooth muscle cell migrationUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of cell adhesionUrokinase-type plasminogen activatorHomo sapiens (human)
plasminogen activationUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of cell adhesion mediated by integrinUrokinase-type plasminogen activatorHomo sapiens (human)
urokinase plasminogen activator signaling pathwayUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of cell population proliferationUrokinase-type plasminogen activatorHomo sapiens (human)
fibrinolysisUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of fibrinolysisUrokinase-type plasminogen activatorHomo sapiens (human)
negative regulation of fibrinolysisUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of wound healingUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of smooth muscle cell-matrix adhesionUrokinase-type plasminogen activatorHomo sapiens (human)
proteolysisCationic trypsinBos taurus (cattle)
digestionCationic trypsinBos taurus (cattle)
digestionChymotrypsinogen ABos taurus (cattle)
antibiotic catabolic processBeta-lactamaseEscherichia coli K-12
response to antibioticBeta-lactamaseEscherichia coli K-12
one-carbon metabolic processCarbonic anhydrase 1Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 2Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 2Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 2Homo sapiens (human)
angiotensin-activated signaling pathwayCarbonic anhydrase 2Homo sapiens (human)
regulation of monoatomic anion transportCarbonic anhydrase 2Homo sapiens (human)
secretionCarbonic anhydrase 2Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 2Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 2Homo sapiens (human)
positive regulation of dipeptide transmembrane transportCarbonic anhydrase 2Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 2Homo sapiens (human)
carbon dioxide transportCarbonic anhydrase 2Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 2Homo sapiens (human)
viral release from host cellNeuraminidaseInfluenza A virus (A/Puerto Rico/8/1934(H1N1))
proteolysisInterstitial collagenaseHomo sapiens (human)
protein metabolic processInterstitial collagenaseHomo sapiens (human)
extracellular matrix disassemblyInterstitial collagenaseHomo sapiens (human)
collagen catabolic processInterstitial collagenaseHomo sapiens (human)
positive regulation of protein-containing complex assemblyInterstitial collagenaseHomo sapiens (human)
cellular response to UV-AInterstitial collagenaseHomo sapiens (human)
extracellular matrix organizationInterstitial collagenaseHomo sapiens (human)
positive regulation of interleukin-8 productionPhospholipase A2Homo sapiens (human)
positive regulation of MAP kinase activityPhospholipase A2Homo sapiens (human)
innate immune response in mucosaPhospholipase A2Homo sapiens (human)
neutrophil mediated immunityPhospholipase A2Homo sapiens (human)
fatty acid biosynthetic processPhospholipase A2Homo sapiens (human)
actin filament organizationPhospholipase A2Homo sapiens (human)
signal transductionPhospholipase A2Homo sapiens (human)
positive regulation of cell population proliferationPhospholipase A2Homo sapiens (human)
positive regulation of calcium ion transport into cytosolPhospholipase A2Homo sapiens (human)
lipid catabolic processPhospholipase A2Homo sapiens (human)
leukotriene biosynthetic processPhospholipase A2Homo sapiens (human)
antibacterial humoral responsePhospholipase A2Homo sapiens (human)
neutrophil chemotaxisPhospholipase A2Homo sapiens (human)
activation of phospholipase A2 activityPhospholipase A2Homo sapiens (human)
cellular response to insulin stimulusPhospholipase A2Homo sapiens (human)
intracellular signal transductionPhospholipase A2Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIPhospholipase A2Homo sapiens (human)
regulation of glucose importPhospholipase A2Homo sapiens (human)
phosphatidylcholine metabolic processPhospholipase A2Homo sapiens (human)
phosphatidylglycerol metabolic processPhospholipase A2Homo sapiens (human)
positive regulation of fibroblast proliferationPhospholipase A2Homo sapiens (human)
arachidonic acid secretionPhospholipase A2Homo sapiens (human)
positive regulation of protein secretionPhospholipase A2Homo sapiens (human)
positive regulation of immune responsePhospholipase A2Homo sapiens (human)
defense response to Gram-positive bacteriumPhospholipase A2Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activityPhospholipase A2Homo sapiens (human)
antimicrobial humoral immune response mediated by antimicrobial peptidePhospholipase A2Homo sapiens (human)
positive regulation of podocyte apoptotic processPhospholipase A2Homo sapiens (human)
phospholipid metabolic processPhospholipase A2Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cellular response to organic cyclic compoundCytochrome P450 1A1Homo sapiens (human)
response to hypoxiaCytochrome P450 1A1Homo sapiens (human)
long-chain fatty acid metabolic processCytochrome P450 1A1Homo sapiens (human)
lipid hydroxylationCytochrome P450 1A1Homo sapiens (human)
fatty acid metabolic processCytochrome P450 1A1Homo sapiens (human)
steroid biosynthetic processCytochrome P450 1A1Homo sapiens (human)
porphyrin-containing compound metabolic processCytochrome P450 1A1Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1A1Homo sapiens (human)
steroid metabolic processCytochrome P450 1A1Homo sapiens (human)
estrogen metabolic processCytochrome P450 1A1Homo sapiens (human)
amine metabolic processCytochrome P450 1A1Homo sapiens (human)
response to nematodeCytochrome P450 1A1Homo sapiens (human)
response to herbicideCytochrome P450 1A1Homo sapiens (human)
ethylene metabolic processCytochrome P450 1A1Homo sapiens (human)
coumarin metabolic processCytochrome P450 1A1Homo sapiens (human)
flavonoid metabolic processCytochrome P450 1A1Homo sapiens (human)
response to iron(III) ionCytochrome P450 1A1Homo sapiens (human)
insecticide metabolic processCytochrome P450 1A1Homo sapiens (human)
dibenzo-p-dioxin catabolic processCytochrome P450 1A1Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1A1Homo sapiens (human)
response to foodCytochrome P450 1A1Homo sapiens (human)
response to lipopolysaccharideCytochrome P450 1A1Homo sapiens (human)
response to vitamin ACytochrome P450 1A1Homo sapiens (human)
response to immobilization stressCytochrome P450 1A1Homo sapiens (human)
vitamin D metabolic processCytochrome P450 1A1Homo sapiens (human)
retinol metabolic processCytochrome P450 1A1Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 1A1Homo sapiens (human)
9-cis-retinoic acid biosynthetic processCytochrome P450 1A1Homo sapiens (human)
camera-type eye developmentCytochrome P450 1A1Homo sapiens (human)
nitric oxide metabolic processCytochrome P450 1A1Homo sapiens (human)
response to arsenic-containing substanceCytochrome P450 1A1Homo sapiens (human)
digestive tract developmentCytochrome P450 1A1Homo sapiens (human)
tissue remodelingCytochrome P450 1A1Homo sapiens (human)
hydrogen peroxide biosynthetic processCytochrome P450 1A1Homo sapiens (human)
response to hyperoxiaCytochrome P450 1A1Homo sapiens (human)
maternal process involved in parturitionCytochrome P450 1A1Homo sapiens (human)
hepatocyte differentiationCytochrome P450 1A1Homo sapiens (human)
cellular response to copper ionCytochrome P450 1A1Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1A1Homo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleCytochrome P450 1A1Homo sapiens (human)
response to 3-methylcholanthreneCytochrome P450 1A1Homo sapiens (human)
regulation of gene expressionAmyloid-beta precursor proteinHomo sapiens (human)
cognitionAmyloid-beta precursor proteinHomo sapiens (human)
G2/M transition of mitotic cell cycleAmyloid-beta precursor proteinHomo sapiens (human)
microglial cell activationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of protein phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
suckling behaviorAmyloid-beta precursor proteinHomo sapiens (human)
astrocyte activation involved in immune responseAmyloid-beta precursor proteinHomo sapiens (human)
regulation of translationAmyloid-beta precursor proteinHomo sapiens (human)
protein phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
intracellular copper ion homeostasisAmyloid-beta precursor proteinHomo sapiens (human)
endocytosisAmyloid-beta precursor proteinHomo sapiens (human)
response to oxidative stressAmyloid-beta precursor proteinHomo sapiens (human)
cell adhesionAmyloid-beta precursor proteinHomo sapiens (human)
regulation of epidermal growth factor-activated receptor activityAmyloid-beta precursor proteinHomo sapiens (human)
Notch signaling pathwayAmyloid-beta precursor proteinHomo sapiens (human)
axonogenesisAmyloid-beta precursor proteinHomo sapiens (human)
learning or memoryAmyloid-beta precursor proteinHomo sapiens (human)
learningAmyloid-beta precursor proteinHomo sapiens (human)
mating behaviorAmyloid-beta precursor proteinHomo sapiens (human)
locomotory behaviorAmyloid-beta precursor proteinHomo sapiens (human)
axo-dendritic transportAmyloid-beta precursor proteinHomo sapiens (human)
cholesterol metabolic processAmyloid-beta precursor proteinHomo sapiens (human)
negative regulation of cell population proliferationAmyloid-beta precursor proteinHomo sapiens (human)
adult locomotory behaviorAmyloid-beta precursor proteinHomo sapiens (human)
visual learningAmyloid-beta precursor proteinHomo sapiens (human)
regulation of gene expressionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of gene expressionAmyloid-beta precursor proteinHomo sapiens (human)
negative regulation of gene expressionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of peptidyl-threonine phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of G2/M transition of mitotic cell cycleAmyloid-beta precursor proteinHomo sapiens (human)
microglia developmentAmyloid-beta precursor proteinHomo sapiens (human)
axon midline choice point recognitionAmyloid-beta precursor proteinHomo sapiens (human)
neuron remodelingAmyloid-beta precursor proteinHomo sapiens (human)
dendrite developmentAmyloid-beta precursor proteinHomo sapiens (human)
regulation of Wnt signaling pathwayAmyloid-beta precursor proteinHomo sapiens (human)
extracellular matrix organizationAmyloid-beta precursor proteinHomo sapiens (human)
forebrain developmentAmyloid-beta precursor proteinHomo sapiens (human)
neuron projection developmentAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of chemokine productionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of interleukin-1 beta productionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of interleukin-6 productionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of tumor necrosis factor productionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
ionotropic glutamate receptor signaling pathwayAmyloid-beta precursor proteinHomo sapiens (human)
regulation of multicellular organism growthAmyloid-beta precursor proteinHomo sapiens (human)
negative regulation of neuron differentiationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of glycolytic processAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of mitotic cell cycleAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of JNK cascadeAmyloid-beta precursor proteinHomo sapiens (human)
astrocyte activationAmyloid-beta precursor proteinHomo sapiens (human)
regulation of long-term neuronal synaptic plasticityAmyloid-beta precursor proteinHomo sapiens (human)
collateral sprouting in absence of injuryAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of inflammatory responseAmyloid-beta precursor proteinHomo sapiens (human)
regulation of peptidyl-tyrosine phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
regulation of synapse structure or activityAmyloid-beta precursor proteinHomo sapiens (human)
synapse organizationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of calcium-mediated signalingAmyloid-beta precursor proteinHomo sapiens (human)
neuromuscular process controlling balanceAmyloid-beta precursor proteinHomo sapiens (human)
synaptic assembly at neuromuscular junctionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of protein metabolic processAmyloid-beta precursor proteinHomo sapiens (human)
neuron apoptotic processAmyloid-beta precursor proteinHomo sapiens (human)
smooth endoplasmic reticulum calcium ion homeostasisAmyloid-beta precursor proteinHomo sapiens (human)
neuron cellular homeostasisAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeAmyloid-beta precursor proteinHomo sapiens (human)
response to interleukin-1Amyloid-beta precursor proteinHomo sapiens (human)
modulation of excitatory postsynaptic potentialAmyloid-beta precursor proteinHomo sapiens (human)
NMDA selective glutamate receptor signaling pathwayAmyloid-beta precursor proteinHomo sapiens (human)
regulation of spontaneous synaptic transmissionAmyloid-beta precursor proteinHomo sapiens (human)
cytosolic mRNA polyadenylationAmyloid-beta precursor proteinHomo sapiens (human)
negative regulation of long-term synaptic potentiationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of long-term synaptic potentiationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of non-canonical NF-kappaB signal transductionAmyloid-beta precursor proteinHomo sapiens (human)
cellular response to amyloid-betaAmyloid-beta precursor proteinHomo sapiens (human)
regulation of presynapse assemblyAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of amyloid fibril formationAmyloid-beta precursor proteinHomo sapiens (human)
amyloid fibril formationAmyloid-beta precursor proteinHomo sapiens (human)
neuron projection maintenanceAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of T cell migrationAmyloid-beta precursor proteinHomo sapiens (human)
central nervous system developmentAmyloid-beta precursor proteinHomo sapiens (human)
negative regulation of low-density lipoprotein receptor activityIntegrin beta-3Homo sapiens (human)
positive regulation of protein phosphorylationIntegrin beta-3Homo sapiens (human)
positive regulation of endothelial cell proliferationIntegrin beta-3Homo sapiens (human)
positive regulation of cell-matrix adhesionIntegrin beta-3Homo sapiens (human)
cell-substrate junction assemblyIntegrin beta-3Homo sapiens (human)
cell adhesionIntegrin beta-3Homo sapiens (human)
cell-matrix adhesionIntegrin beta-3Homo sapiens (human)
integrin-mediated signaling pathwayIntegrin beta-3Homo sapiens (human)
embryo implantationIntegrin beta-3Homo sapiens (human)
blood coagulationIntegrin beta-3Homo sapiens (human)
positive regulation of endothelial cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of gene expressionIntegrin beta-3Homo sapiens (human)
negative regulation of macrophage derived foam cell differentiationIntegrin beta-3Homo sapiens (human)
positive regulation of fibroblast migrationIntegrin beta-3Homo sapiens (human)
negative regulation of lipid storageIntegrin beta-3Homo sapiens (human)
response to activityIntegrin beta-3Homo sapiens (human)
smooth muscle cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of smooth muscle cell migrationIntegrin beta-3Homo sapiens (human)
platelet activationIntegrin beta-3Homo sapiens (human)
positive regulation of vascular endothelial growth factor receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
cell-substrate adhesionIntegrin beta-3Homo sapiens (human)
activation of protein kinase activityIntegrin beta-3Homo sapiens (human)
negative regulation of lipid transportIntegrin beta-3Homo sapiens (human)
regulation of protein localizationIntegrin beta-3Homo sapiens (human)
regulation of actin cytoskeleton organizationIntegrin beta-3Homo sapiens (human)
cell adhesion mediated by integrinIntegrin beta-3Homo sapiens (human)
positive regulation of cell adhesion mediated by integrinIntegrin beta-3Homo sapiens (human)
positive regulation of osteoblast proliferationIntegrin beta-3Homo sapiens (human)
heterotypic cell-cell adhesionIntegrin beta-3Homo sapiens (human)
substrate adhesion-dependent cell spreadingIntegrin beta-3Homo sapiens (human)
tube developmentIntegrin beta-3Homo sapiens (human)
wound healing, spreading of epidermal cellsIntegrin beta-3Homo sapiens (human)
cellular response to platelet-derived growth factor stimulusIntegrin beta-3Homo sapiens (human)
apolipoprotein A-I-mediated signaling pathwayIntegrin beta-3Homo sapiens (human)
wound healingIntegrin beta-3Homo sapiens (human)
apoptotic cell clearanceIntegrin beta-3Homo sapiens (human)
regulation of bone resorptionIntegrin beta-3Homo sapiens (human)
positive regulation of angiogenesisIntegrin beta-3Homo sapiens (human)
positive regulation of bone resorptionIntegrin beta-3Homo sapiens (human)
symbiont entry into host cellIntegrin beta-3Homo sapiens (human)
platelet-derived growth factor receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
positive regulation of fibroblast proliferationIntegrin beta-3Homo sapiens (human)
mesodermal cell differentiationIntegrin beta-3Homo sapiens (human)
positive regulation of smooth muscle cell proliferationIntegrin beta-3Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationIntegrin beta-3Homo sapiens (human)
negative regulation of lipoprotein metabolic processIntegrin beta-3Homo sapiens (human)
negative chemotaxisIntegrin beta-3Homo sapiens (human)
regulation of release of sequestered calcium ion into cytosolIntegrin beta-3Homo sapiens (human)
regulation of serotonin uptakeIntegrin beta-3Homo sapiens (human)
angiogenesis involved in wound healingIntegrin beta-3Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeIntegrin beta-3Homo sapiens (human)
platelet aggregationIntegrin beta-3Homo sapiens (human)
cellular response to mechanical stimulusIntegrin beta-3Homo sapiens (human)
cellular response to xenobiotic stimulusIntegrin beta-3Homo sapiens (human)
positive regulation of glomerular mesangial cell proliferationIntegrin beta-3Homo sapiens (human)
blood coagulation, fibrin clot formationIntegrin beta-3Homo sapiens (human)
maintenance of postsynaptic specialization structureIntegrin beta-3Homo sapiens (human)
regulation of postsynaptic neurotransmitter receptor internalizationIntegrin beta-3Homo sapiens (human)
regulation of postsynaptic neurotransmitter receptor diffusion trappingIntegrin beta-3Homo sapiens (human)
positive regulation of substrate adhesion-dependent cell spreadingIntegrin beta-3Homo sapiens (human)
positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
regulation of trophoblast cell migrationIntegrin beta-3Homo sapiens (human)
regulation of extracellular matrix organizationIntegrin beta-3Homo sapiens (human)
cellular response to insulin-like growth factor stimulusIntegrin beta-3Homo sapiens (human)
negative regulation of endothelial cell apoptotic processIntegrin beta-3Homo sapiens (human)
positive regulation of T cell migrationIntegrin beta-3Homo sapiens (human)
cell migrationIntegrin beta-3Homo sapiens (human)
hydrogen peroxide catabolic processMyeloperoxidaseHomo sapiens (human)
response to yeastMyeloperoxidaseHomo sapiens (human)
hypochlorous acid biosynthetic processMyeloperoxidaseHomo sapiens (human)
respiratory burst involved in defense responseMyeloperoxidaseHomo sapiens (human)
defense responseMyeloperoxidaseHomo sapiens (human)
response to oxidative stressMyeloperoxidaseHomo sapiens (human)
response to mechanical stimulusMyeloperoxidaseHomo sapiens (human)
removal of superoxide radicalsMyeloperoxidaseHomo sapiens (human)
response to foodMyeloperoxidaseHomo sapiens (human)
response to lipopolysaccharideMyeloperoxidaseHomo sapiens (human)
low-density lipoprotein particle remodelingMyeloperoxidaseHomo sapiens (human)
hydrogen peroxide catabolic processMyeloperoxidaseHomo sapiens (human)
negative regulation of apoptotic processMyeloperoxidaseHomo sapiens (human)
defense response to fungusMyeloperoxidaseHomo sapiens (human)
response to gold nanoparticleMyeloperoxidaseHomo sapiens (human)
defense response to bacteriumMyeloperoxidaseHomo sapiens (human)
steroid catabolic processCytochrome P450 1A2Homo sapiens (human)
porphyrin-containing compound metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1A2Homo sapiens (human)
cholesterol metabolic processCytochrome P450 1A2Homo sapiens (human)
estrogen metabolic processCytochrome P450 1A2Homo sapiens (human)
toxin biosynthetic processCytochrome P450 1A2Homo sapiens (human)
post-embryonic developmentCytochrome P450 1A2Homo sapiens (human)
alkaloid metabolic processCytochrome P450 1A2Homo sapiens (human)
regulation of gene expressionCytochrome P450 1A2Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 1A2Homo sapiens (human)
dibenzo-p-dioxin metabolic processCytochrome P450 1A2Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
lung developmentCytochrome P450 1A2Homo sapiens (human)
methylationCytochrome P450 1A2Homo sapiens (human)
monocarboxylic acid metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 1A2Homo sapiens (human)
retinol metabolic processCytochrome P450 1A2Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 1A2Homo sapiens (human)
cellular respirationCytochrome P450 1A2Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 1A2Homo sapiens (human)
hydrogen peroxide biosynthetic processCytochrome P450 1A2Homo sapiens (human)
oxidative demethylationCytochrome P450 1A2Homo sapiens (human)
cellular response to cadmium ionCytochrome P450 1A2Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
protein phosphorylationTyrosine-protein kinase LckHomo sapiens (human)
intracellular zinc ion homeostasisTyrosine-protein kinase LckHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processTyrosine-protein kinase LckHomo sapiens (human)
response to xenobiotic stimulusTyrosine-protein kinase LckHomo sapiens (human)
peptidyl-tyrosine phosphorylationTyrosine-protein kinase LckHomo sapiens (human)
hemopoiesisTyrosine-protein kinase LckHomo sapiens (human)
platelet activationTyrosine-protein kinase LckHomo sapiens (human)
T cell differentiationTyrosine-protein kinase LckHomo sapiens (human)
T cell costimulationTyrosine-protein kinase LckHomo sapiens (human)
positive regulation of heterotypic cell-cell adhesionTyrosine-protein kinase LckHomo sapiens (human)
intracellular signal transductionTyrosine-protein kinase LckHomo sapiens (human)
peptidyl-tyrosine autophosphorylationTyrosine-protein kinase LckHomo sapiens (human)
Fc-gamma receptor signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
T cell receptor signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
positive regulation of T cell receptor signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
positive regulation of T cell activationTyrosine-protein kinase LckHomo sapiens (human)
leukocyte migrationTyrosine-protein kinase LckHomo sapiens (human)
release of sequestered calcium ion into cytosolTyrosine-protein kinase LckHomo sapiens (human)
regulation of lymphocyte activationTyrosine-protein kinase LckHomo sapiens (human)
positive regulation of leukocyte cell-cell adhesionTyrosine-protein kinase LckHomo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
innate immune responseTyrosine-protein kinase LckHomo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
B cell receptor signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
G1/S transition of mitotic cell cycleCyclin-dependent kinase 1Homo sapiens (human)
G2/M transition of mitotic cell cycleCyclin-dependent kinase 1Homo sapiens (human)
microtubule cytoskeleton organizationCyclin-dependent kinase 1Homo sapiens (human)
DNA replicationCyclin-dependent kinase 1Homo sapiens (human)
DNA repairCyclin-dependent kinase 1Homo sapiens (human)
chromatin remodelingCyclin-dependent kinase 1Homo sapiens (human)
regulation of transcription by RNA polymerase IICyclin-dependent kinase 1Homo sapiens (human)
protein phosphorylationCyclin-dependent kinase 1Homo sapiens (human)
apoptotic processCyclin-dependent kinase 1Homo sapiens (human)
DNA damage responseCyclin-dependent kinase 1Homo sapiens (human)
mitotic nuclear membrane disassemblyCyclin-dependent kinase 1Homo sapiens (human)
centrosome cycleCyclin-dependent kinase 1Homo sapiens (human)
pronuclear fusionCyclin-dependent kinase 1Homo sapiens (human)
response to xenobiotic stimulusCyclin-dependent kinase 1Homo sapiens (human)
response to toxic substanceCyclin-dependent kinase 1Homo sapiens (human)
positive regulation of gene expressionCyclin-dependent kinase 1Homo sapiens (human)
negative regulation of gene expressionCyclin-dependent kinase 1Homo sapiens (human)
positive regulation of G2/M transition of mitotic cell cycleCyclin-dependent kinase 1Homo sapiens (human)
regulation of Schwann cell differentiationCyclin-dependent kinase 1Homo sapiens (human)
response to amineCyclin-dependent kinase 1Homo sapiens (human)
response to activityCyclin-dependent kinase 1Homo sapiens (human)
cell migrationCyclin-dependent kinase 1Homo sapiens (human)
peptidyl-serine phosphorylationCyclin-dependent kinase 1Homo sapiens (human)
peptidyl-threonine phosphorylationCyclin-dependent kinase 1Homo sapiens (human)
chromosome condensationCyclin-dependent kinase 1Homo sapiens (human)
epithelial cell differentiationCyclin-dependent kinase 1Homo sapiens (human)
animal organ regenerationCyclin-dependent kinase 1Homo sapiens (human)
protein localization to kinetochoreCyclin-dependent kinase 1Homo sapiens (human)
positive regulation of protein import into nucleusCyclin-dependent kinase 1Homo sapiens (human)
regulation of circadian rhythmCyclin-dependent kinase 1Homo sapiens (human)
negative regulation of apoptotic processCyclin-dependent kinase 1Homo sapiens (human)
response to ethanolCyclin-dependent kinase 1Homo sapiens (human)
positive regulation of DNA replicationCyclin-dependent kinase 1Homo sapiens (human)
regulation of embryonic developmentCyclin-dependent kinase 1Homo sapiens (human)
response to cadmium ionCyclin-dependent kinase 1Homo sapiens (human)
response to copper ionCyclin-dependent kinase 1Homo sapiens (human)
symbiont entry into host cellCyclin-dependent kinase 1Homo sapiens (human)
fibroblast proliferationCyclin-dependent kinase 1Homo sapiens (human)
rhythmic processCyclin-dependent kinase 1Homo sapiens (human)
response to axon injuryCyclin-dependent kinase 1Homo sapiens (human)
cell divisionCyclin-dependent kinase 1Homo sapiens (human)
ventricular cardiac muscle cell developmentCyclin-dependent kinase 1Homo sapiens (human)
positive regulation of cardiac muscle cell proliferationCyclin-dependent kinase 1Homo sapiens (human)
positive regulation of mitotic sister chromatid segregationCyclin-dependent kinase 1Homo sapiens (human)
protein-containing complex assemblyCyclin-dependent kinase 1Homo sapiens (human)
cellular response to hydrogen peroxideCyclin-dependent kinase 1Homo sapiens (human)
ERK1 and ERK2 cascadeCyclin-dependent kinase 1Homo sapiens (human)
cellular response to organic cyclic compoundCyclin-dependent kinase 1Homo sapiens (human)
Golgi disassemblyCyclin-dependent kinase 1Homo sapiens (human)
positive regulation of protein localization to nucleusCyclin-dependent kinase 1Homo sapiens (human)
regulation of attachment of mitotic spindle microtubules to kinetochoreCyclin-dependent kinase 1Homo sapiens (human)
microtubule cytoskeleton organization involved in mitosisCyclin-dependent kinase 1Homo sapiens (human)
positive regulation of mitochondrial ATP synthesis coupled electron transportCyclin-dependent kinase 1Homo sapiens (human)
mitotic G2 DNA damage checkpoint signalingCyclin-dependent kinase 1Homo sapiens (human)
protein deubiquitinationCyclin-dependent kinase 1Homo sapiens (human)
glycogen metabolic processGlycogen phosphorylase, liver formHomo sapiens (human)
5-phosphoribose 1-diphosphate biosynthetic processGlycogen phosphorylase, liver formHomo sapiens (human)
response to bacteriumGlycogen phosphorylase, liver formHomo sapiens (human)
glucose homeostasisGlycogen phosphorylase, liver formHomo sapiens (human)
necroptotic processGlycogen phosphorylase, liver formHomo sapiens (human)
glycogen catabolic processGlycogen phosphorylase, liver formHomo sapiens (human)
xenobiotic metabolic processEpoxide hydrolase 1 Homo sapiens (human)
response to toxic substanceEpoxide hydrolase 1 Homo sapiens (human)
response to organic cyclic compoundEpoxide hydrolase 1 Homo sapiens (human)
arachidonic acid metabolic processEpoxide hydrolase 1 Homo sapiens (human)
catabolic processEpoxide hydrolase 1 Homo sapiens (human)
epoxide metabolic processEpoxide hydrolase 1 Homo sapiens (human)
response to bacteriumCarbonic anhydrase 3Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 3Homo sapiens (human)
digestionTrypsin-1Homo sapiens (human)
extracellular matrix disassemblyTrypsin-1Homo sapiens (human)
proteolysisTrypsin-1Homo sapiens (human)
proteolysisTrypsin-2Homo sapiens (human)
digestionTrypsin-2Homo sapiens (human)
antimicrobial humoral responseTrypsin-2Homo sapiens (human)
extracellular matrix disassemblyTrypsin-2Homo sapiens (human)
positive regulation of cell growthTrypsin-2Homo sapiens (human)
collagen catabolic processTrypsin-2Homo sapiens (human)
positive regulation of cell adhesionTrypsin-2Homo sapiens (human)
adaptive immune responseProcathepsin LHomo sapiens (human)
proteolysisProcathepsin LHomo sapiens (human)
protein autoprocessingProcathepsin LHomo sapiens (human)
fusion of virus membrane with host plasma membraneProcathepsin LHomo sapiens (human)
receptor-mediated endocytosis of virus by host cellProcathepsin LHomo sapiens (human)
antigen processing and presentationProcathepsin LHomo sapiens (human)
antigen processing and presentation of exogenous peptide antigen via MHC class IIProcathepsin LHomo sapiens (human)
collagen catabolic processProcathepsin LHomo sapiens (human)
zymogen activationProcathepsin LHomo sapiens (human)
enkephalin processingProcathepsin LHomo sapiens (human)
fusion of virus membrane with host endosome membraneProcathepsin LHomo sapiens (human)
CD4-positive, alpha-beta T cell lineage commitmentProcathepsin LHomo sapiens (human)
symbiont entry into host cellProcathepsin LHomo sapiens (human)
antigen processing and presentation of peptide antigenProcathepsin LHomo sapiens (human)
proteolysis involved in protein catabolic processProcathepsin LHomo sapiens (human)
elastin catabolic processProcathepsin LHomo sapiens (human)
macrophage apoptotic processProcathepsin LHomo sapiens (human)
cellular response to thyroid hormone stimulusProcathepsin LHomo sapiens (human)
positive regulation of apoptotic signaling pathwayProcathepsin LHomo sapiens (human)
positive regulation of peptidase activityProcathepsin LHomo sapiens (human)
immune responseProcathepsin LHomo sapiens (human)
negative regulation of inflammatory response to antigenic stimulusTyrosine-protein kinase YesHomo sapiens (human)
regulation of glucose transmembrane transportTyrosine-protein kinase YesHomo sapiens (human)
T cell costimulationTyrosine-protein kinase YesHomo sapiens (human)
cellular response to platelet-derived growth factor stimulusTyrosine-protein kinase YesHomo sapiens (human)
protein modification processTyrosine-protein kinase YesHomo sapiens (human)
Fc-gamma receptor signaling pathway involved in phagocytosisTyrosine-protein kinase YesHomo sapiens (human)
regulation of vascular permeabilityTyrosine-protein kinase YesHomo sapiens (human)
positive regulation of transcription by RNA polymerase IITyrosine-protein kinase YesHomo sapiens (human)
ephrin receptor signaling pathwayTyrosine-protein kinase YesHomo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationTyrosine-protein kinase YesHomo sapiens (human)
leukocyte migrationTyrosine-protein kinase YesHomo sapiens (human)
cellular response to retinoic acidTyrosine-protein kinase YesHomo sapiens (human)
cellular response to transforming growth factor beta stimulusTyrosine-protein kinase YesHomo sapiens (human)
innate immune responseTyrosine-protein kinase YesHomo sapiens (human)
cell differentiationTyrosine-protein kinase YesHomo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayTyrosine-protein kinase YesHomo sapiens (human)
protein phosphorylationTyrosine-protein kinase YesHomo sapiens (human)
MAPK cascadeProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
ureteric bud developmentProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
neural crest cell migrationProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
embryonic epithelial tube formationProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
protein phosphorylationProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
homophilic cell adhesion via plasma membrane adhesion moleculesProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
neuron cell-cell adhesionProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
signal transductionProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
axon guidanceProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
posterior midgut developmentProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
response to xenobiotic stimulusProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
positive regulation of gene expressionProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
positive regulation of neuron projection developmentProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
positive regulation of neuron maturationProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
regulation of cell adhesionProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
positive regulation of cell migrationProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylation of STAT proteinProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
membrane protein proteolysisProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
positive regulation of cell adhesion mediated by integrinProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
ureter maturationProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
glial cell-derived neurotrophic factor receptor signaling pathwayProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
neuron maturationProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
positive regulation of MAPK cascadeProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
positive regulation of cell sizeProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
positive regulation of DNA-templated transcriptionProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
response to painProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
enteric nervous system developmentProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
regulation of axonogenesisProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
retina development in camera-type eyeProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
innervationProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
Peyer's patch morphogenesisProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
cellular response to retinoic acidProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
positive regulation of metanephric glomerulus developmentProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
lymphocyte migration into lymphoid organsProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
GDF15-GFRAL signaling pathwayProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
positive regulation of extrinsic apoptotic signaling pathway in absence of ligandProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
positive regulation of kinase activityProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
multicellular organism developmentProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
peptidyl-tyrosine autophosphorylationInsulin-like growth factor 1 receptorHomo sapiens (human)
cardiac atrium developmentInsulin-like growth factor 1 receptorHomo sapiens (human)
immune responseInsulin-like growth factor 1 receptorHomo sapiens (human)
signal transductionInsulin-like growth factor 1 receptorHomo sapiens (human)
axonogenesisInsulin-like growth factor 1 receptorHomo sapiens (human)
positive regulation of cell population proliferationInsulin-like growth factor 1 receptorHomo sapiens (human)
insulin receptor signaling pathwayInsulin-like growth factor 1 receptorHomo sapiens (human)
negative regulation of muscle cell apoptotic processInsulin-like growth factor 1 receptorHomo sapiens (human)
cerebellum developmentInsulin-like growth factor 1 receptorHomo sapiens (human)
hippocampus developmentInsulin-like growth factor 1 receptorHomo sapiens (human)
establishment of cell polarityInsulin-like growth factor 1 receptorHomo sapiens (human)
positive regulation of cell migrationInsulin-like growth factor 1 receptorHomo sapiens (human)
positive regulation of cytokinesisInsulin-like growth factor 1 receptorHomo sapiens (human)
response to vitamin EInsulin-like growth factor 1 receptorHomo sapiens (human)
positive regulation of osteoblast proliferationInsulin-like growth factor 1 receptorHomo sapiens (human)
cellular response to zinc ion starvationInsulin-like growth factor 1 receptorHomo sapiens (human)
response to nicotineInsulin-like growth factor 1 receptorHomo sapiens (human)
negative regulation of apoptotic processInsulin-like growth factor 1 receptorHomo sapiens (human)
positive regulation of protein-containing complex disassemblyInsulin-like growth factor 1 receptorHomo sapiens (human)
response to alkaloidInsulin-like growth factor 1 receptorHomo sapiens (human)
negative regulation of MAPK cascadeInsulin-like growth factor 1 receptorHomo sapiens (human)
phosphatidylinositol 3-kinase/protein kinase B signal transductionInsulin-like growth factor 1 receptorHomo sapiens (human)
estrous cycleInsulin-like growth factor 1 receptorHomo sapiens (human)
transcytosisInsulin-like growth factor 1 receptorHomo sapiens (human)
response to ethanolInsulin-like growth factor 1 receptorHomo sapiens (human)
regulation of JNK cascadeInsulin-like growth factor 1 receptorHomo sapiens (human)
protein autophosphorylationInsulin-like growth factor 1 receptorHomo sapiens (human)
insulin-like growth factor receptor signaling pathwayInsulin-like growth factor 1 receptorHomo sapiens (human)
positive regulation of smooth muscle cell proliferationInsulin-like growth factor 1 receptorHomo sapiens (human)
positive regulation of axon regenerationInsulin-like growth factor 1 receptorHomo sapiens (human)
positive regulation of DNA metabolic processInsulin-like growth factor 1 receptorHomo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionInsulin-like growth factor 1 receptorHomo sapiens (human)
cellular response to mechanical stimulusInsulin-like growth factor 1 receptorHomo sapiens (human)
cellular response to estradiol stimulusInsulin-like growth factor 1 receptorHomo sapiens (human)
cellular response to progesterone stimulusInsulin-like growth factor 1 receptorHomo sapiens (human)
cellular response to testosterone stimulusInsulin-like growth factor 1 receptorHomo sapiens (human)
cellular response to dexamethasone stimulusInsulin-like growth factor 1 receptorHomo sapiens (human)
cellular response to transforming growth factor beta stimulusInsulin-like growth factor 1 receptorHomo sapiens (human)
positive regulation of steroid hormone biosynthetic processInsulin-like growth factor 1 receptorHomo sapiens (human)
cellular senescenceInsulin-like growth factor 1 receptorHomo sapiens (human)
dendritic spine maintenanceInsulin-like growth factor 1 receptorHomo sapiens (human)
amyloid-beta clearanceInsulin-like growth factor 1 receptorHomo sapiens (human)
positive regulation of cold-induced thermogenesisInsulin-like growth factor 1 receptorHomo sapiens (human)
response to L-glutamateInsulin-like growth factor 1 receptorHomo sapiens (human)
negative regulation of hepatocyte apoptotic processInsulin-like growth factor 1 receptorHomo sapiens (human)
cellular response to aldosteroneInsulin-like growth factor 1 receptorHomo sapiens (human)
negative regulation of cholangiocyte apoptotic processInsulin-like growth factor 1 receptorHomo sapiens (human)
cellular response to angiotensinInsulin-like growth factor 1 receptorHomo sapiens (human)
cellular response to amyloid-betaInsulin-like growth factor 1 receptorHomo sapiens (human)
cellular response to insulin-like growth factor stimulusInsulin-like growth factor 1 receptorHomo sapiens (human)
multicellular organism developmentInsulin-like growth factor 1 receptorHomo sapiens (human)
positive regulation of kinase activityInsulin-like growth factor 1 receptorHomo sapiens (human)
cellular response to glucose stimulusInsulin-like growth factor 1 receptorHomo sapiens (human)
positive regulation of MAPK cascadeInsulin-like growth factor 1 receptorHomo sapiens (human)
G2/M transition of mitotic cell cycleATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic metabolic processATP-dependent translocase ABCB1Homo sapiens (human)
response to xenobiotic stimulusATP-dependent translocase ABCB1Homo sapiens (human)
phospholipid translocationATP-dependent translocase ABCB1Homo sapiens (human)
terpenoid transportATP-dependent translocase ABCB1Homo sapiens (human)
regulation of response to osmotic stressATP-dependent translocase ABCB1Homo sapiens (human)
transmembrane transportATP-dependent translocase ABCB1Homo sapiens (human)
transepithelial transportATP-dependent translocase ABCB1Homo sapiens (human)
stem cell proliferationATP-dependent translocase ABCB1Homo sapiens (human)
ceramide translocationATP-dependent translocase ABCB1Homo sapiens (human)
export across plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
transport across blood-brain barrierATP-dependent translocase ABCB1Homo sapiens (human)
positive regulation of anion channel activityATP-dependent translocase ABCB1Homo sapiens (human)
carboxylic acid transmembrane transportATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic detoxification by transmembrane export across the plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic transport across blood-brain barrierATP-dependent translocase ABCB1Homo sapiens (human)
regulation of chloride transportATP-dependent translocase ABCB1Homo sapiens (human)
proteolysisNeutrophil elastaseHomo sapiens (human)
negative regulation of transcription by RNA polymerase IINeutrophil elastaseHomo sapiens (human)
response to yeastNeutrophil elastaseHomo sapiens (human)
leukocyte migration involved in inflammatory responseNeutrophil elastaseHomo sapiens (human)
biosynthetic process of antibacterial peptides active against Gram-negative bacteriaNeutrophil elastaseHomo sapiens (human)
proteolysisNeutrophil elastaseHomo sapiens (human)
intracellular calcium ion homeostasisNeutrophil elastaseHomo sapiens (human)
response to UVNeutrophil elastaseHomo sapiens (human)
extracellular matrix disassemblyNeutrophil elastaseHomo sapiens (human)
protein catabolic processNeutrophil elastaseHomo sapiens (human)
response to lipopolysaccharideNeutrophil elastaseHomo sapiens (human)
negative regulation of chemokine productionNeutrophil elastaseHomo sapiens (human)
negative regulation of interleukin-8 productionNeutrophil elastaseHomo sapiens (human)
positive regulation of interleukin-8 productionNeutrophil elastaseHomo sapiens (human)
defense response to bacteriumNeutrophil elastaseHomo sapiens (human)
positive regulation of MAP kinase activityNeutrophil elastaseHomo sapiens (human)
positive regulation of smooth muscle cell proliferationNeutrophil elastaseHomo sapiens (human)
negative regulation of inflammatory responseNeutrophil elastaseHomo sapiens (human)
positive regulation of immune responseNeutrophil elastaseHomo sapiens (human)
negative regulation of chemotaxisNeutrophil elastaseHomo sapiens (human)
pyroptosisNeutrophil elastaseHomo sapiens (human)
neutrophil-mediated killing of gram-negative bacteriumNeutrophil elastaseHomo sapiens (human)
neutrophil-mediated killing of fungusNeutrophil elastaseHomo sapiens (human)
positive regulation of leukocyte tethering or rollingNeutrophil elastaseHomo sapiens (human)
phagocytosisNeutrophil elastaseHomo sapiens (human)
acute inflammatory response to antigenic stimulusNeutrophil elastaseHomo sapiens (human)
angiogenesis72 kDa type IV collagenaseHomo sapiens (human)
ovarian follicle development72 kDa type IV collagenaseHomo sapiens (human)
ovulation from ovarian follicle72 kDa type IV collagenaseHomo sapiens (human)
luteinization72 kDa type IV collagenaseHomo sapiens (human)
blood vessel maturation72 kDa type IV collagenaseHomo sapiens (human)
intramembranous ossification72 kDa type IV collagenaseHomo sapiens (human)
proteolysis72 kDa type IV collagenaseHomo sapiens (human)
negative regulation of cell adhesion72 kDa type IV collagenaseHomo sapiens (human)
heart development72 kDa type IV collagenaseHomo sapiens (human)
embryo implantation72 kDa type IV collagenaseHomo sapiens (human)
parturition72 kDa type IV collagenaseHomo sapiens (human)
response to xenobiotic stimulus72 kDa type IV collagenaseHomo sapiens (human)
response to mechanical stimulus72 kDa type IV collagenaseHomo sapiens (human)
peripheral nervous system axon regeneration72 kDa type IV collagenaseHomo sapiens (human)
response to activity72 kDa type IV collagenaseHomo sapiens (human)
protein metabolic process72 kDa type IV collagenaseHomo sapiens (human)
extracellular matrix disassembly72 kDa type IV collagenaseHomo sapiens (human)
protein catabolic process72 kDa type IV collagenaseHomo sapiens (human)
positive regulation of cell migration72 kDa type IV collagenaseHomo sapiens (human)
collagen catabolic process72 kDa type IV collagenaseHomo sapiens (human)
response to retinoic acid72 kDa type IV collagenaseHomo sapiens (human)
cellular response to reactive oxygen species72 kDa type IV collagenaseHomo sapiens (human)
response to nicotine72 kDa type IV collagenaseHomo sapiens (human)
endodermal cell differentiation72 kDa type IV collagenaseHomo sapiens (human)
response to hydrogen peroxide72 kDa type IV collagenaseHomo sapiens (human)
response to estrogen72 kDa type IV collagenaseHomo sapiens (human)
negative regulation of vasoconstriction72 kDa type IV collagenaseHomo sapiens (human)
ephrin receptor signaling pathway72 kDa type IV collagenaseHomo sapiens (human)
macrophage chemotaxis72 kDa type IV collagenaseHomo sapiens (human)
response to electrical stimulus72 kDa type IV collagenaseHomo sapiens (human)
response to hyperoxia72 kDa type IV collagenaseHomo sapiens (human)
face morphogenesis72 kDa type IV collagenaseHomo sapiens (human)
bone trabecula formation72 kDa type IV collagenaseHomo sapiens (human)
prostate gland epithelium morphogenesis72 kDa type IV collagenaseHomo sapiens (human)
cellular response to amino acid stimulus72 kDa type IV collagenaseHomo sapiens (human)
cellular response to interleukin-172 kDa type IV collagenaseHomo sapiens (human)
cellular response to estradiol stimulus72 kDa type IV collagenaseHomo sapiens (human)
cellular response to UV-A72 kDa type IV collagenaseHomo sapiens (human)
cellular response to fluid shear stress72 kDa type IV collagenaseHomo sapiens (human)
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway72 kDa type IV collagenaseHomo sapiens (human)
response to amyloid-beta72 kDa type IV collagenaseHomo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferation72 kDa type IV collagenaseHomo sapiens (human)
extracellular matrix organization72 kDa type IV collagenaseHomo sapiens (human)
response to hypoxia72 kDa type IV collagenaseHomo sapiens (human)
tissue remodeling72 kDa type IV collagenaseHomo sapiens (human)
proteolysisStromelysin-1Homo sapiens (human)
extracellular matrix disassemblyStromelysin-1Homo sapiens (human)
protein catabolic processStromelysin-1Homo sapiens (human)
regulation of cell migrationStromelysin-1Homo sapiens (human)
collagen catabolic processStromelysin-1Homo sapiens (human)
positive regulation of protein-containing complex assemblyStromelysin-1Homo sapiens (human)
cellular response to reactive oxygen speciesStromelysin-1Homo sapiens (human)
innate immune responseStromelysin-1Homo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionStromelysin-1Homo sapiens (human)
cellular response to lipopolysaccharideStromelysin-1Homo sapiens (human)
cellular response to amino acid stimulusStromelysin-1Homo sapiens (human)
cellular response to UV-AStromelysin-1Homo sapiens (human)
cellular response to nitric oxideStromelysin-1Homo sapiens (human)
regulation of neuroinflammatory responseStromelysin-1Homo sapiens (human)
response to amyloid-betaStromelysin-1Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processStromelysin-1Homo sapiens (human)
extracellular matrix organizationStromelysin-1Homo sapiens (human)
positive regulation of leukocyte migrationIntegrin alpha-IIbHomo sapiens (human)
cell-matrix adhesionIntegrin alpha-IIbHomo sapiens (human)
integrin-mediated signaling pathwayIntegrin alpha-IIbHomo sapiens (human)
angiogenesisIntegrin alpha-IIbHomo sapiens (human)
cell-cell adhesionIntegrin alpha-IIbHomo sapiens (human)
cell adhesion mediated by integrinIntegrin alpha-IIbHomo sapiens (human)
endothelial cell morphogenesisHepatocyte growth factor receptorHomo sapiens (human)
signal transductionHepatocyte growth factor receptorHomo sapiens (human)
cell surface receptor signaling pathwayHepatocyte growth factor receptorHomo sapiens (human)
negative regulation of autophagyHepatocyte growth factor receptorHomo sapiens (human)
positive regulation of microtubule polymerizationHepatocyte growth factor receptorHomo sapiens (human)
negative regulation of Rho protein signal transductionHepatocyte growth factor receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIHepatocyte growth factor receptorHomo sapiens (human)
hepatocyte growth factor receptor signaling pathwayHepatocyte growth factor receptorHomo sapiens (human)
branching morphogenesis of an epithelial tubeHepatocyte growth factor receptorHomo sapiens (human)
positive chemotaxisHepatocyte growth factor receptorHomo sapiens (human)
negative regulation of stress fiber assemblyHepatocyte growth factor receptorHomo sapiens (human)
excitatory postsynaptic potentialHepatocyte growth factor receptorHomo sapiens (human)
establishment of skin barrierHepatocyte growth factor receptorHomo sapiens (human)
negative regulation of thrombin-activated receptor signaling pathwayHepatocyte growth factor receptorHomo sapiens (human)
semaphorin-plexin signaling pathwayHepatocyte growth factor receptorHomo sapiens (human)
negative regulation of hydrogen peroxide-mediated programmed cell deathHepatocyte growth factor receptorHomo sapiens (human)
negative regulation of guanyl-nucleotide exchange factor activityHepatocyte growth factor receptorHomo sapiens (human)
positive regulation of endothelial cell chemotaxisHepatocyte growth factor receptorHomo sapiens (human)
liver developmentHepatocyte growth factor receptorHomo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayHepatocyte growth factor receptorHomo sapiens (human)
phagocytosisHepatocyte growth factor receptorHomo sapiens (human)
multicellular organism developmentHepatocyte growth factor receptorHomo sapiens (human)
neuron differentiationHepatocyte growth factor receptorHomo sapiens (human)
positive regulation of kinase activityHepatocyte growth factor receptorHomo sapiens (human)
cell migrationHepatocyte growth factor receptorHomo sapiens (human)
pancreas developmentHepatocyte growth factor receptorHomo sapiens (human)
nervous system developmentHepatocyte growth factor receptorHomo sapiens (human)
lipid hydroxylationCytochrome P450 3A4Homo sapiens (human)
lipid metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid catabolic processCytochrome P450 3A4Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid metabolic processCytochrome P450 3A4Homo sapiens (human)
cholesterol metabolic processCytochrome P450 3A4Homo sapiens (human)
androgen metabolic processCytochrome P450 3A4Homo sapiens (human)
estrogen metabolic processCytochrome P450 3A4Homo sapiens (human)
alkaloid catabolic processCytochrome P450 3A4Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 3A4Homo sapiens (human)
calcitriol biosynthetic process from calciolCytochrome P450 3A4Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D metabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D catabolic processCytochrome P450 3A4Homo sapiens (human)
retinol metabolic processCytochrome P450 3A4Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 3A4Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 3A4Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 3A4Homo sapiens (human)
oxidative demethylationCytochrome P450 3A4Homo sapiens (human)
behavioral fear response5-hydroxytryptamine receptor 1AHomo sapiens (human)
G protein-coupled receptor signaling pathway5-hydroxytryptamine receptor 1AHomo sapiens (human)
adenylate cyclase-inhibiting serotonin receptor signaling pathway5-hydroxytryptamine receptor 1AHomo sapiens (human)
serotonin receptor signaling pathway5-hydroxytryptamine receptor 1AHomo sapiens (human)
gamma-aminobutyric acid signaling pathway5-hydroxytryptamine receptor 1AHomo sapiens (human)
positive regulation of cell population proliferation5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of serotonin secretion5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of vasoconstriction5-hydroxytryptamine receptor 1AHomo sapiens (human)
exploration behavior5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of dopamine metabolic process5-hydroxytryptamine receptor 1AHomo sapiens (human)
serotonin metabolic process5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of hormone secretion5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of behavior5-hydroxytryptamine receptor 1AHomo sapiens (human)
chemical synaptic transmission5-hydroxytryptamine receptor 1AHomo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of alternative mRNA splicing, via spliceosomeHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
mRNA splicing, via spliceosomeHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
RNA export from nucleusHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
positive regulation of telomere maintenance via telomeraseHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
cellular response to glucose starvationHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
regulation of RNA splicingHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
mRNA transportHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
nuclear exportHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
import into nucleusHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
cellular response to sodium arseniteHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
negative regulation of endothelial cell proliferationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukocyte chemotaxis involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukocyte migration involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene production involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene metabolic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
humoral immune responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of angiogenesisPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
lipoxygenase pathwayPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
positive regulation of bone mineralizationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
dendritic cell migrationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
glucose homeostasisPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
long-chain fatty acid biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of fat cell differentiationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of insulin secretionPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of vascular wound healingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of wound healingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of inflammatory response to woundingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of cytokine production involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of cellular response to oxidative stressPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene A4 biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of reactive oxygen species biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of response to endoplasmic reticulum stressPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of sprouting angiogenesisPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
positive regulation of leukocyte adhesion to arterial endothelial cellPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
lipoxin biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
arachidonic acid metabolic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
lipid oxidationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
lipid biosynthetic processEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
fatty acid elongationEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
protein homotetramerizationEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
fatty acid biosynthetic processEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
biotin biosynthetic processEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
fatty acid elongationEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
response to antibioticEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
symbiont-mediated perturbation of host ubiquitin-like protein modificationReplicase polyprotein 1aSevere acute respiratory syndrome-related coronavirus
symbiont-mediated perturbation of host ubiquitin-like protein modificationReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
inflammatory responseAdenosine receptor A3Homo sapiens (human)
signal transductionAdenosine receptor A3Homo sapiens (human)
activation of adenylate cyclase activityAdenosine receptor A3Homo sapiens (human)
regulation of heart contractionAdenosine receptor A3Homo sapiens (human)
negative regulation of cell population proliferationAdenosine receptor A3Homo sapiens (human)
response to woundingAdenosine receptor A3Homo sapiens (human)
regulation of norepinephrine secretionAdenosine receptor A3Homo sapiens (human)
negative regulation of cell migrationAdenosine receptor A3Homo sapiens (human)
negative regulation of NF-kappaB transcription factor activityAdenosine receptor A3Homo sapiens (human)
presynaptic modulation of chemical synaptic transmissionAdenosine receptor A3Homo sapiens (human)
G protein-coupled adenosine receptor signaling pathwayAdenosine receptor A3Homo sapiens (human)
G2/M transition of mitotic cell cycleCalmodulin-1Homo sapiens (human)
regulation of heart rateCalmodulin-1Homo sapiens (human)
detection of calcium ionCalmodulin-1Homo sapiens (human)
G protein-coupled receptor signaling pathwayCalmodulin-1Homo sapiens (human)
positive regulation of peptidyl-threonine phosphorylationCalmodulin-1Homo sapiens (human)
negative regulation of peptidyl-threonine phosphorylationCalmodulin-1Homo sapiens (human)
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulumCalmodulin-1Homo sapiens (human)
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ionCalmodulin-1Homo sapiens (human)
autophagosome membrane dockingCalmodulin-1Homo sapiens (human)
substantia nigra developmentCalmodulin-1Homo sapiens (human)
positive regulation of protein autophosphorylationCalmodulin-1Homo sapiens (human)
regulation of cytokinesisCalmodulin-1Homo sapiens (human)
positive regulation of phosphoprotein phosphatase activityCalmodulin-1Homo sapiens (human)
positive regulation of protein dephosphorylationCalmodulin-1Homo sapiens (human)
cellular response to interferon-betaCalmodulin-1Homo sapiens (human)
positive regulation of receptor signaling pathway via JAK-STATCalmodulin-1Homo sapiens (human)
regulation of calcium-mediated signalingCalmodulin-1Homo sapiens (human)
positive regulation of cyclic-nucleotide phosphodiesterase activityCalmodulin-1Homo sapiens (human)
response to calcium ionCalmodulin-1Homo sapiens (human)
regulation of cardiac muscle contractionCalmodulin-1Homo sapiens (human)
regulation of ryanodine-sensitive calcium-release channel activityCalmodulin-1Homo sapiens (human)
negative regulation of ryanodine-sensitive calcium-release channel activityCalmodulin-1Homo sapiens (human)
positive regulation of ryanodine-sensitive calcium-release channel activityCalmodulin-1Homo sapiens (human)
cellular response to type II interferonCalmodulin-1Homo sapiens (human)
positive regulation of protein serine/threonine kinase activityCalmodulin-1Homo sapiens (human)
regulation of cardiac muscle cell action potentialCalmodulin-1Homo sapiens (human)
organelle localization by membrane tetheringCalmodulin-1Homo sapiens (human)
negative regulation of high voltage-gated calcium channel activityCalmodulin-1Homo sapiens (human)
regulation of cell communication by electrical coupling involved in cardiac conductionCalmodulin-1Homo sapiens (human)
negative regulation of calcium ion export across plasma membraneCalmodulin-1Homo sapiens (human)
mitochondrion-endoplasmic reticulum membrane tetheringCalmodulin-1Homo sapiens (human)
oligosaccharide metabolic processAlpha-amylase 1A Homo sapiens (human)
carbohydrate metabolic processAlpha-amylase 1A Homo sapiens (human)
maltose metabolic processLysosomal alpha-glucosidaseHomo sapiens (human)
regulation of the force of heart contractionLysosomal alpha-glucosidaseHomo sapiens (human)
diaphragm contractionLysosomal alpha-glucosidaseHomo sapiens (human)
heart morphogenesisLysosomal alpha-glucosidaseHomo sapiens (human)
glycogen catabolic processLysosomal alpha-glucosidaseHomo sapiens (human)
sucrose metabolic processLysosomal alpha-glucosidaseHomo sapiens (human)
glucose metabolic processLysosomal alpha-glucosidaseHomo sapiens (human)
lysosome organizationLysosomal alpha-glucosidaseHomo sapiens (human)
locomotory behaviorLysosomal alpha-glucosidaseHomo sapiens (human)
tissue developmentLysosomal alpha-glucosidaseHomo sapiens (human)
aorta developmentLysosomal alpha-glucosidaseHomo sapiens (human)
vacuolar sequesteringLysosomal alpha-glucosidaseHomo sapiens (human)
muscle cell cellular homeostasisLysosomal alpha-glucosidaseHomo sapiens (human)
neuromuscular process controlling postureLysosomal alpha-glucosidaseHomo sapiens (human)
neuromuscular process controlling balanceLysosomal alpha-glucosidaseHomo sapiens (human)
cardiac muscle contractionLysosomal alpha-glucosidaseHomo sapiens (human)
glycophagyLysosomal alpha-glucosidaseHomo sapiens (human)
lipid hydroxylationCytochrome P450 2C8Homo sapiens (human)
organic acid metabolic processCytochrome P450 2C8Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2C8Homo sapiens (human)
steroid metabolic processCytochrome P450 2C8Homo sapiens (human)
estrogen metabolic processCytochrome P450 2C8Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2C8Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2C8Homo sapiens (human)
retinol metabolic processCytochrome P450 2C8Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 2C8Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 2C8Homo sapiens (human)
icosanoid biosynthetic processCytochrome P450 2C8Homo sapiens (human)
oxidative demethylationCytochrome P450 2C8Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 2C8Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2D6Homo sapiens (human)
steroid metabolic processCytochrome P450 2D6Homo sapiens (human)
cholesterol metabolic processCytochrome P450 2D6Homo sapiens (human)
estrogen metabolic processCytochrome P450 2D6Homo sapiens (human)
coumarin metabolic processCytochrome P450 2D6Homo sapiens (human)
alkaloid metabolic processCytochrome P450 2D6Homo sapiens (human)
alkaloid catabolic processCytochrome P450 2D6Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2D6Homo sapiens (human)
isoquinoline alkaloid metabolic processCytochrome P450 2D6Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2D6Homo sapiens (human)
retinol metabolic processCytochrome P450 2D6Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 2D6Homo sapiens (human)
negative regulation of bindingCytochrome P450 2D6Homo sapiens (human)
oxidative demethylationCytochrome P450 2D6Homo sapiens (human)
negative regulation of cellular organofluorine metabolic processCytochrome P450 2D6Homo sapiens (human)
arachidonic acid metabolic processCytochrome P450 2D6Homo sapiens (human)
carbohydrate metabolic processSolute carrier family 2, facilitated glucose transporter member 2Homo sapiens (human)
fructose transmembrane transportSolute carrier family 2, facilitated glucose transporter member 2Homo sapiens (human)
galactose transmembrane transportSolute carrier family 2, facilitated glucose transporter member 2Homo sapiens (human)
positive regulation of insulin secretion involved in cellular response to glucose stimulusSolute carrier family 2, facilitated glucose transporter member 2Homo sapiens (human)
dehydroascorbic acid transportSolute carrier family 2, facilitated glucose transporter member 2Homo sapiens (human)
glucose transmembrane transportSolute carrier family 2, facilitated glucose transporter member 2Homo sapiens (human)
glucose importSolute carrier family 2, facilitated glucose transporter member 2Homo sapiens (human)
protein phosphorylationSerine/threonine-protein kinase pim-1Homo sapiens (human)
apoptotic processSerine/threonine-protein kinase pim-1Homo sapiens (human)
regulation of transmembrane transporter activitySerine/threonine-protein kinase pim-1Homo sapiens (human)
negative regulation of apoptotic processSerine/threonine-protein kinase pim-1Homo sapiens (human)
negative regulation of DNA-binding transcription factor activitySerine/threonine-protein kinase pim-1Homo sapiens (human)
negative regulation of innate immune responseSerine/threonine-protein kinase pim-1Homo sapiens (human)
positive regulation of DNA-templated transcriptionSerine/threonine-protein kinase pim-1Homo sapiens (human)
protein autophosphorylationSerine/threonine-protein kinase pim-1Homo sapiens (human)
protein stabilizationSerine/threonine-protein kinase pim-1Homo sapiens (human)
positive regulation of cardiac muscle cell proliferationSerine/threonine-protein kinase pim-1Homo sapiens (human)
vitamin D receptor signaling pathwaySerine/threonine-protein kinase pim-1Homo sapiens (human)
cellular response to type II interferonSerine/threonine-protein kinase pim-1Homo sapiens (human)
positive regulation of brown fat cell differentiationSerine/threonine-protein kinase pim-1Homo sapiens (human)
regulation of hematopoietic stem cell proliferationSerine/threonine-protein kinase pim-1Homo sapiens (human)
positive regulation of TORC1 signalingSerine/threonine-protein kinase pim-1Homo sapiens (human)
positive regulation of cardioblast proliferationSerine/threonine-protein kinase pim-1Homo sapiens (human)
cellular detoxificationSerine/threonine-protein kinase pim-1Homo sapiens (human)
negative regulation of chronic inflammatory responseAromataseHomo sapiens (human)
steroid biosynthetic processAromataseHomo sapiens (human)
estrogen biosynthetic processAromataseHomo sapiens (human)
androgen catabolic processAromataseHomo sapiens (human)
syncytium formationAromataseHomo sapiens (human)
negative regulation of macrophage chemotaxisAromataseHomo sapiens (human)
sterol metabolic processAromataseHomo sapiens (human)
female genitalia developmentAromataseHomo sapiens (human)
mammary gland developmentAromataseHomo sapiens (human)
uterus developmentAromataseHomo sapiens (human)
prostate gland growthAromataseHomo sapiens (human)
testosterone biosynthetic processAromataseHomo sapiens (human)
positive regulation of estradiol secretionAromataseHomo sapiens (human)
female gonad developmentAromataseHomo sapiens (human)
response to estradiolAromataseHomo sapiens (human)
xenobiotic metabolic processCytochrome P450 2C9 Homo sapiens (human)
steroid metabolic processCytochrome P450 2C9 Homo sapiens (human)
cholesterol metabolic processCytochrome P450 2C9 Homo sapiens (human)
estrogen metabolic processCytochrome P450 2C9 Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2C9 Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2C9 Homo sapiens (human)
urea metabolic processCytochrome P450 2C9 Homo sapiens (human)
monocarboxylic acid metabolic processCytochrome P450 2C9 Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2C9 Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 2C9 Homo sapiens (human)
amide metabolic processCytochrome P450 2C9 Homo sapiens (human)
icosanoid biosynthetic processCytochrome P450 2C9 Homo sapiens (human)
oxidative demethylationCytochrome P450 2C9 Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 2C9 Homo sapiens (human)
G1/S transition of mitotic cell cycleCyclin-dependent kinase 4Homo sapiens (human)
protein phosphorylationCyclin-dependent kinase 4Homo sapiens (human)
positive regulation of cell population proliferationCyclin-dependent kinase 4Homo sapiens (human)
response to xenobiotic stimulusCyclin-dependent kinase 4Homo sapiens (human)
regulation of gene expressionCyclin-dependent kinase 4Homo sapiens (human)
positive regulation of G2/M transition of mitotic cell cycleCyclin-dependent kinase 4Homo sapiens (human)
positive regulation of fibroblast proliferationCyclin-dependent kinase 4Homo sapiens (human)
cell divisionCyclin-dependent kinase 4Homo sapiens (human)
regulation of cell cycleCyclin-dependent kinase 4Homo sapiens (human)
regulation of transcription initiation by RNA polymerase IICyclin-dependent kinase 4Homo sapiens (human)
regulation of type B pancreatic cell proliferationCyclin-dependent kinase 4Homo sapiens (human)
cellular response to lipopolysaccharideCyclin-dependent kinase 4Homo sapiens (human)
cellular response to interleukin-4Cyclin-dependent kinase 4Homo sapiens (human)
cellular response to phorbol 13-acetate 12-myristateCyclin-dependent kinase 4Homo sapiens (human)
cellular response to ionomycinCyclin-dependent kinase 4Homo sapiens (human)
response to organic substanceCyclin-dependent kinase 4Homo sapiens (human)
regulation of G2/M transition of mitotic cell cycleCyclin-dependent kinase 4Homo sapiens (human)
signal transductionCyclin-dependent kinase 4Homo sapiens (human)
peptidyl-tyrosine phosphorylationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
primary ovarian follicle growthProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of cytokine productionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
stimulatory C-type lectin receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of inflammatory response to antigenic stimulusProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
signal transductionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
signal complex assemblyProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
epidermal growth factor receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
transforming growth factor beta receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
integrin-mediated signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
spermatogenesisProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
learning or memoryProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
response to xenobiotic stimulusProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
response to mechanical stimulusProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
response to acidic pHProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of gene expressionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of epithelial cell migrationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of epithelial cell migrationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of glucose metabolic processProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of protein processingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
skeletal muscle cell proliferationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of smooth muscle cell migrationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
macroautophagyProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
peptidyl-tyrosine phosphorylationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of cell-cell adhesionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
platelet activationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
forebrain developmentProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
T cell costimulationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of protein-containing complex assemblyProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
protein destabilizationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
response to nutrient levelsProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of telomere maintenance via telomeraseProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to insulin stimulusProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of intracellular estrogen receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of integrin activationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of toll-like receptor 3 signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
adherens junction organizationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
substrate adhesion-dependent cell spreadingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of dephosphorylationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of hippo signalingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
intracellular signal transductionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
entry of bacterium into host cellProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
osteoclast developmentProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to platelet-derived growth factor stimulusProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
Fc-gamma receptor signaling pathway involved in phagocytosisProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
ERBB2 signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
angiotensin-activated signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
odontogenesisProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of apoptotic processProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of apoptotic processProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of vascular permeabilityProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
stress fiber assemblyProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of cysteine-type endopeptidase activity involved in apoptotic processProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
transcytosisProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of bone resorptionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
bone resorptionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of Notch signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of bone resorptionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of Ras protein signal transductionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of insulin receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
protein autophosphorylationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
platelet-derived growth factor receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
vascular endothelial growth factor receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
neurotrophin TRK receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
ephrin receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
focal adhesion assemblyProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
oogenesisProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
progesterone receptor signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
leukocyte migrationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of small GTPase mediated signal transductionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of protein transportProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
response to mineralocorticoidProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
myoblast proliferationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
response to electrical stimulusProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of focal adhesion assemblyProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of mitochondrial depolarizationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of telomerase activityProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
uterus developmentProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
branching involved in mammary gland duct morphogenesisProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of cell projection assemblyProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
intestinal epithelial cell developmentProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
interleukin-6-mediated signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to hydrogen peroxideProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
response to interleukin-1Proto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to lipopolysaccharideProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to peptide hormone stimulusProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to progesterone stimulusProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to fatty acidProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to hypoxiaProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to fluid shear stressProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of podosome assemblyProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
DNA biosynthetic processProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of protein serine/threonine kinase activityProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of heart rate by cardiac conductionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of canonical Wnt signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cell-cell adhesionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of protein localization to nucleusProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of non-membrane spanning protein tyrosine kinase activityProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of TORC1 signalingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cellular response to prolactinProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of male germ cell proliferationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of ovarian follicle developmentProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of lamellipodium morphogenesisProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
positive regulation of platelet-derived growth factor receptor-beta signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of early endosome to late endosome transportProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of anoikisProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathwayProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
regulation of caveolin-mediated endocytosisProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cell differentiationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cell adhesionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
innate immune responseProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
protein phosphorylationProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
symbiont entry into host cellProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cholesterol biosynthetic processCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
vesicle docking involved in exocytosisCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
bicarbonate transportCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
cholesterol transportCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
response to endoplasmic reticulum stressCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
transepithelial water transportCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
positive regulation of insulin secretion involved in cellular response to glucose stimulusCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
positive regulation of exocytosisCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
sperm capacitationCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
multicellular organismal-level water homeostasisCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
intracellular pH elevationCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
establishment of localization in cellCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
transmembrane transportCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
membrane hyperpolarizationCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
positive regulation of enamel mineralizationCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
cellular response to cAMPCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
amelogenesisCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
positive regulation of cyclic nucleotide-gated ion channel activityCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
chloride transmembrane transportCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
positive regulation of voltage-gated chloride channel activityCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
cellular response to forskolinCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
sucrose catabolic processSucrase-isomaltase, intestinalHomo sapiens (human)
polysaccharide digestionSucrase-isomaltase, intestinalHomo sapiens (human)
G2/M transition of mitotic cell cycleG2/mitotic-specific cyclin-B1Homo sapiens (human)
in utero embryonic developmentG2/mitotic-specific cyclin-B1Homo sapiens (human)
mitotic spindle organizationG2/mitotic-specific cyclin-B1Homo sapiens (human)
mitotic metaphase chromosome alignmentG2/mitotic-specific cyclin-B1Homo sapiens (human)
positive regulation of G2/M transition of mitotic cell cycleG2/mitotic-specific cyclin-B1Homo sapiens (human)
positive regulation of mitotic cell cycleG2/mitotic-specific cyclin-B1Homo sapiens (human)
positive regulation of fibroblast proliferationG2/mitotic-specific cyclin-B1Homo sapiens (human)
cell divisionG2/mitotic-specific cyclin-B1Homo sapiens (human)
positive regulation of attachment of spindle microtubules to kinetochoreG2/mitotic-specific cyclin-B1Homo sapiens (human)
regulation of mitotic cell cycle spindle assembly checkpointG2/mitotic-specific cyclin-B1Homo sapiens (human)
positive regulation of mitochondrial ATP synthesis coupled electron transportG2/mitotic-specific cyclin-B1Homo sapiens (human)
regulation of cyclin-dependent protein serine/threonine kinase activityG2/mitotic-specific cyclin-B1Homo sapiens (human)
mitotic cell cycle phase transitionG2/mitotic-specific cyclin-B1Homo sapiens (human)
melanin biosynthetic process from tyrosineTyrosinaseHomo sapiens (human)
eye pigment biosynthetic processTyrosinaseHomo sapiens (human)
visual perceptionTyrosinaseHomo sapiens (human)
cell population proliferationTyrosinaseHomo sapiens (human)
response to UVTyrosinaseHomo sapiens (human)
response to blue lightTyrosinaseHomo sapiens (human)
response to vitamin DTyrosinaseHomo sapiens (human)
melanin biosynthetic processTyrosinaseHomo sapiens (human)
thymus developmentTyrosinaseHomo sapiens (human)
response to cAMPTyrosinaseHomo sapiens (human)
pigmentationTyrosinaseHomo sapiens (human)
skeletal system developmentMatrix metalloproteinase-9Homo sapiens (human)
positive regulation of protein phosphorylationMatrix metalloproteinase-9Homo sapiens (human)
proteolysisMatrix metalloproteinase-9Homo sapiens (human)
apoptotic processMatrix metalloproteinase-9Homo sapiens (human)
embryo implantationMatrix metalloproteinase-9Homo sapiens (human)
cell migrationMatrix metalloproteinase-9Homo sapiens (human)
extracellular matrix disassemblyMatrix metalloproteinase-9Homo sapiens (human)
macrophage differentiationMatrix metalloproteinase-9Homo sapiens (human)
collagen catabolic processMatrix metalloproteinase-9Homo sapiens (human)
cellular response to reactive oxygen speciesMatrix metalloproteinase-9Homo sapiens (human)
endodermal cell differentiationMatrix metalloproteinase-9Homo sapiens (human)
positive regulation of apoptotic processMatrix metalloproteinase-9Homo sapiens (human)
negative regulation of apoptotic processMatrix metalloproteinase-9Homo sapiens (human)
positive regulation of DNA bindingMatrix metalloproteinase-9Homo sapiens (human)
positive regulation of epidermal growth factor receptor signaling pathwayMatrix metalloproteinase-9Homo sapiens (human)
ephrin receptor signaling pathwayMatrix metalloproteinase-9Homo sapiens (human)
positive regulation of keratinocyte migrationMatrix metalloproteinase-9Homo sapiens (human)
cellular response to lipopolysaccharideMatrix metalloproteinase-9Homo sapiens (human)
cellular response to cadmium ionMatrix metalloproteinase-9Homo sapiens (human)
cellular response to UV-AMatrix metalloproteinase-9Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaMatrix metalloproteinase-9Homo sapiens (human)
regulation of neuroinflammatory responseMatrix metalloproteinase-9Homo sapiens (human)
positive regulation of receptor bindingMatrix metalloproteinase-9Homo sapiens (human)
response to amyloid-betaMatrix metalloproteinase-9Homo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferationMatrix metalloproteinase-9Homo sapiens (human)
negative regulation of epithelial cell differentiation involved in kidney developmentMatrix metalloproteinase-9Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathwayMatrix metalloproteinase-9Homo sapiens (human)
negative regulation of cation channel activityMatrix metalloproteinase-9Homo sapiens (human)
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathwayMatrix metalloproteinase-9Homo sapiens (human)
extracellular matrix organizationMatrix metalloproteinase-9Homo sapiens (human)
MAPK cascadeSerine/threonine-protein kinase B-rafHomo sapiens (human)
myeloid progenitor cell differentiationSerine/threonine-protein kinase B-rafHomo sapiens (human)
protein phosphorylationSerine/threonine-protein kinase B-rafHomo sapiens (human)
epidermal growth factor receptor signaling pathwaySerine/threonine-protein kinase B-rafHomo sapiens (human)
visual learningSerine/threonine-protein kinase B-rafHomo sapiens (human)
animal organ morphogenesisSerine/threonine-protein kinase B-rafHomo sapiens (human)
positive regulation of gene expressionSerine/threonine-protein kinase B-rafHomo sapiens (human)
negative regulation of fibroblast migrationSerine/threonine-protein kinase B-rafHomo sapiens (human)
positive regulation of glucose transmembrane transportSerine/threonine-protein kinase B-rafHomo sapiens (human)
synaptic vesicle exocytosisSerine/threonine-protein kinase B-rafHomo sapiens (human)
thyroid gland developmentSerine/threonine-protein kinase B-rafHomo sapiens (human)
T cell differentiation in thymusSerine/threonine-protein kinase B-rafHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationSerine/threonine-protein kinase B-rafHomo sapiens (human)
substrate adhesion-dependent cell spreadingSerine/threonine-protein kinase B-rafHomo sapiens (human)
somatic stem cell population maintenanceSerine/threonine-protein kinase B-rafHomo sapiens (human)
regulation of cell population proliferationSerine/threonine-protein kinase B-rafHomo sapiens (human)
negative regulation of apoptotic processSerine/threonine-protein kinase B-rafHomo sapiens (human)
stress fiber assemblySerine/threonine-protein kinase B-rafHomo sapiens (human)
CD4-positive, alpha-beta T cell differentiationSerine/threonine-protein kinase B-rafHomo sapiens (human)
CD4-positive or CD8-positive, alpha-beta T cell lineage commitmentSerine/threonine-protein kinase B-rafHomo sapiens (human)
response to peptide hormoneSerine/threonine-protein kinase B-rafHomo sapiens (human)
negative regulation of neuron apoptotic processSerine/threonine-protein kinase B-rafHomo sapiens (human)
regulation of T cell differentiationSerine/threonine-protein kinase B-rafHomo sapiens (human)
thymus developmentSerine/threonine-protein kinase B-rafHomo sapiens (human)
positive regulation of axon regenerationSerine/threonine-protein kinase B-rafHomo sapiens (human)
positive regulation of axonogenesisSerine/threonine-protein kinase B-rafHomo sapiens (human)
T cell receptor signaling pathwaySerine/threonine-protein kinase B-rafHomo sapiens (human)
positive regulation of stress fiber assemblySerine/threonine-protein kinase B-rafHomo sapiens (human)
response to cAMPSerine/threonine-protein kinase B-rafHomo sapiens (human)
long-term synaptic potentiationSerine/threonine-protein kinase B-rafHomo sapiens (human)
head morphogenesisSerine/threonine-protein kinase B-rafHomo sapiens (human)
face developmentSerine/threonine-protein kinase B-rafHomo sapiens (human)
ERK1 and ERK2 cascadeSerine/threonine-protein kinase B-rafHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeSerine/threonine-protein kinase B-rafHomo sapiens (human)
cellular response to calcium ionSerine/threonine-protein kinase B-rafHomo sapiens (human)
cellular response to xenobiotic stimulusSerine/threonine-protein kinase B-rafHomo sapiens (human)
endothelial cell apoptotic processSerine/threonine-protein kinase B-rafHomo sapiens (human)
establishment of protein localization to membraneSerine/threonine-protein kinase B-rafHomo sapiens (human)
positive regulation of substrate adhesion-dependent cell spreadingSerine/threonine-protein kinase B-rafHomo sapiens (human)
cellular response to nerve growth factor stimulusSerine/threonine-protein kinase B-rafHomo sapiens (human)
negative regulation of synaptic vesicle exocytosisSerine/threonine-protein kinase B-rafHomo sapiens (human)
negative regulation of endothelial cell apoptotic processSerine/threonine-protein kinase B-rafHomo sapiens (human)
retinoid metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
epithelial cell maturationAldo-keto reductase family 1 member B1Homo sapiens (human)
renal water homeostasisAldo-keto reductase family 1 member B1Homo sapiens (human)
carbohydrate metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
C21-steroid hormone biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
L-ascorbic acid biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
regulation of urine volumeAldo-keto reductase family 1 member B1Homo sapiens (human)
retinol metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
negative regulation of apoptotic processAldo-keto reductase family 1 member B1Homo sapiens (human)
daunorubicin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
doxorubicin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
fructose biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
cellular hyperosmotic salinity responseAldo-keto reductase family 1 member B1Homo sapiens (human)
metanephric collecting duct developmentAldo-keto reductase family 1 member B1Homo sapiens (human)
ossificationPolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
negative regulation of adaptive immune responsePolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
lipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
phosphatidylethanolamine biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
inflammatory responsePolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
positive regulation of cell-substrate adhesionPolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
arachidonic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
lipoxygenase pathwayPolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
fatty acid oxidationPolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
bone mineralizationPolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
positive regulation of actin filament polymerizationPolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
response to endoplasmic reticulum stressPolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
regulation of peroxisome proliferator activated receptor signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
cellular response to interleukin-13Polyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
wound healingPolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
long-chain fatty acid biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
apoptotic cell clearancePolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
linoleic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
regulation of inflammatory responsePolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
hepoxilin biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadePolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
cellular response to calcium ionPolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
regulation of engulfment of apoptotic cellPolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
lipoxin A4 biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
lipid oxidationPolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
retinoid metabolic processAldo-keto reductase family 1 member B1Bos taurus (cattle)
prostaglandin metabolic processAldo-keto reductase family 1 member B1Bos taurus (cattle)
retinol metabolic processAldo-keto reductase family 1 member B1Bos taurus (cattle)
digestionChymotrypsinogen BHomo sapiens (human)
proteolysisChymotrypsinogen BHomo sapiens (human)
positive regulation of JUN kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
actin cytoskeleton organizationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of endocytosisTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of vascular endothelial growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulum unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of intracellular protein transportTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cellular response to unfolded proteinTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
platelet-derived growth factor receptor-beta signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor recyclingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of MAP kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of type I interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
growth hormone receptor signaling pathway via JAK-STATTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of protein tyrosine kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of hepatocyte growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of PERK-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of receptor catabolic processTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
linoleic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
leukotriene A4 metabolic processPolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
lipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
negative regulation of muscle cell apoptotic processPolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
arachidonic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
lipoxygenase pathwayPolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
fatty acid oxidationPolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
unsaturated fatty acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
superoxide anion generationPolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
linoleic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
hepoxilin biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
establishment of skin barrierPolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
negative regulation of platelet aggregationPolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
leukotriene A4 metabolic processPolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
lipoxin A4 biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
lipoxin B4 biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
lipid oxidationPolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
double-strand break repairCasein kinase II subunit alpha'Homo sapiens (human)
apoptotic processCasein kinase II subunit alpha'Homo sapiens (human)
spermatogenesisCasein kinase II subunit alpha'Homo sapiens (human)
Wnt signaling pathwayCasein kinase II subunit alpha'Homo sapiens (human)
cerebral cortex developmentCasein kinase II subunit alpha'Homo sapiens (human)
negative regulation of proteasomal ubiquitin-dependent protein catabolic processCasein kinase II subunit alpha'Homo sapiens (human)
liver regenerationCasein kinase II subunit alpha'Homo sapiens (human)
regulation of mitophagyCasein kinase II subunit alpha'Homo sapiens (human)
positive regulation of protein targeting to mitochondrionCasein kinase II subunit alpha'Homo sapiens (human)
regulation of chromosome separationCasein kinase II subunit alpha'Homo sapiens (human)
negative regulation of apoptotic signaling pathwayCasein kinase II subunit alpha'Homo sapiens (human)
peptidyl-threonine phosphorylationCasein kinase II subunit alpha'Homo sapiens (human)
peptidyl-serine phosphorylationCasein kinase II subunit alpha'Homo sapiens (human)
biogenic amine metabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
positive regulation of signal transductionAmine oxidase [flavin-containing] AHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
catecholamine metabolic processAmine oxidase [flavin-containing] A Bos taurus (cattle)
positive regulation of MAP kinase activityD(4) dopamine receptorHomo sapiens (human)
behavioral fear responseD(4) dopamine receptorHomo sapiens (human)
synaptic transmission, dopaminergicD(4) dopamine receptorHomo sapiens (human)
response to amphetamineD(4) dopamine receptorHomo sapiens (human)
intracellular calcium ion homeostasisD(4) dopamine receptorHomo sapiens (human)
adenylate cyclase-inhibiting dopamine receptor signaling pathwayD(4) dopamine receptorHomo sapiens (human)
dopamine receptor signaling pathwayD(4) dopamine receptorHomo sapiens (human)
adult locomotory behaviorD(4) dopamine receptorHomo sapiens (human)
positive regulation of sodium:proton antiporter activityD(4) dopamine receptorHomo sapiens (human)
positive regulation of kinase activityD(4) dopamine receptorHomo sapiens (human)
response to histamineD(4) dopamine receptorHomo sapiens (human)
social behaviorD(4) dopamine receptorHomo sapiens (human)
regulation of dopamine metabolic processD(4) dopamine receptorHomo sapiens (human)
dopamine metabolic processD(4) dopamine receptorHomo sapiens (human)
fear responseD(4) dopamine receptorHomo sapiens (human)
regulation of circadian rhythmD(4) dopamine receptorHomo sapiens (human)
positive regulation of MAP kinase activityD(4) dopamine receptorHomo sapiens (human)
behavioral response to cocaineD(4) dopamine receptorHomo sapiens (human)
behavioral response to ethanolD(4) dopamine receptorHomo sapiens (human)
rhythmic processD(4) dopamine receptorHomo sapiens (human)
arachidonic acid secretionD(4) dopamine receptorHomo sapiens (human)
negative regulation of protein secretionD(4) dopamine receptorHomo sapiens (human)
positive regulation of dopamine uptake involved in synaptic transmissionD(4) dopamine receptorHomo sapiens (human)
inhibitory postsynaptic potentialD(4) dopamine receptorHomo sapiens (human)
regulation of postsynaptic neurotransmitter receptor internalizationD(4) dopamine receptorHomo sapiens (human)
negative regulation of voltage-gated calcium channel activityD(4) dopamine receptorHomo sapiens (human)
adenylate cyclase-inhibiting serotonin receptor signaling pathwayD(4) dopamine receptorHomo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerD(4) dopamine receptorHomo sapiens (human)
chemical synaptic transmissionD(4) dopamine receptorHomo sapiens (human)
acetylcholine catabolic process in synaptic cleftAcetylcholinesteraseHomo sapiens (human)
regulation of receptor recyclingAcetylcholinesteraseHomo sapiens (human)
osteoblast developmentAcetylcholinesteraseHomo sapiens (human)
acetylcholine catabolic processAcetylcholinesteraseHomo sapiens (human)
cell adhesionAcetylcholinesteraseHomo sapiens (human)
nervous system developmentAcetylcholinesteraseHomo sapiens (human)
synapse assemblyAcetylcholinesteraseHomo sapiens (human)
receptor internalizationAcetylcholinesteraseHomo sapiens (human)
negative regulation of synaptic transmission, cholinergicAcetylcholinesteraseHomo sapiens (human)
amyloid precursor protein metabolic processAcetylcholinesteraseHomo sapiens (human)
positive regulation of protein secretionAcetylcholinesteraseHomo sapiens (human)
retina development in camera-type eyeAcetylcholinesteraseHomo sapiens (human)
acetylcholine receptor signaling pathwayAcetylcholinesteraseHomo sapiens (human)
positive regulation of cold-induced thermogenesisAcetylcholinesteraseHomo sapiens (human)
bicarbonate transportCarbonic anhydrase 4Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 4Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of bitter tasteCarbonic anhydrase 6Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 6Homo sapiens (human)
G1/S transition of mitotic cell cycleG1/S-specific cyclin-D1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIG1/S-specific cyclin-D1Homo sapiens (human)
re-entry into mitotic cell cycleG1/S-specific cyclin-D1Homo sapiens (human)
positive regulation of protein phosphorylationG1/S-specific cyclin-D1Homo sapiens (human)
DNA damage responseG1/S-specific cyclin-D1Homo sapiens (human)
lactationG1/S-specific cyclin-D1Homo sapiens (human)
response to xenobiotic stimulusG1/S-specific cyclin-D1Homo sapiens (human)
positive regulation of G2/M transition of mitotic cell cycleG1/S-specific cyclin-D1Homo sapiens (human)
Wnt signaling pathwayG1/S-specific cyclin-D1Homo sapiens (human)
neuron differentiationG1/S-specific cyclin-D1Homo sapiens (human)
negative regulation of epithelial cell differentiationG1/S-specific cyclin-D1Homo sapiens (human)
endoplasmic reticulum unfolded protein responseG1/S-specific cyclin-D1Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingG1/S-specific cyclin-D1Homo sapiens (human)
mammary gland epithelial cell proliferationG1/S-specific cyclin-D1Homo sapiens (human)
positive regulation of mammary gland epithelial cell proliferationG1/S-specific cyclin-D1Homo sapiens (human)
negative regulation of neuron apoptotic processG1/S-specific cyclin-D1Homo sapiens (human)
response to leptinG1/S-specific cyclin-D1Homo sapiens (human)
fat cell differentiationG1/S-specific cyclin-D1Homo sapiens (human)
positive regulation of cyclin-dependent protein serine/threonine kinase activityG1/S-specific cyclin-D1Homo sapiens (human)
cell divisionG1/S-specific cyclin-D1Homo sapiens (human)
mammary gland alveolus developmentG1/S-specific cyclin-D1Homo sapiens (human)
response to UV-AG1/S-specific cyclin-D1Homo sapiens (human)
liver regenerationG1/S-specific cyclin-D1Homo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleG1/S-specific cyclin-D1Homo sapiens (human)
regulation of cyclin-dependent protein serine/threonine kinase activityG1/S-specific cyclin-D1Homo sapiens (human)
G1/S transition of mitotic cell cycleCyclin-dependent kinase 2Homo sapiens (human)
G2/M transition of mitotic cell cycleCyclin-dependent kinase 2Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICyclin-dependent kinase 2Homo sapiens (human)
DNA replicationCyclin-dependent kinase 2Homo sapiens (human)
DNA repairCyclin-dependent kinase 2Homo sapiens (human)
chromatin remodelingCyclin-dependent kinase 2Homo sapiens (human)
DNA-templated transcriptionCyclin-dependent kinase 2Homo sapiens (human)
protein phosphorylationCyclin-dependent kinase 2Homo sapiens (human)
potassium ion transportCyclin-dependent kinase 2Homo sapiens (human)
centriole replicationCyclin-dependent kinase 2Homo sapiens (human)
Ras protein signal transductionCyclin-dependent kinase 2Homo sapiens (human)
regulation of mitotic cell cycleCyclin-dependent kinase 2Homo sapiens (human)
positive regulation of cell population proliferationCyclin-dependent kinase 2Homo sapiens (human)
peptidyl-serine phosphorylationCyclin-dependent kinase 2Homo sapiens (human)
positive regulation of heterochromatin formationCyclin-dependent kinase 2Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCyclin-dependent kinase 2Homo sapiens (human)
positive regulation of DNA-templated DNA replication initiationCyclin-dependent kinase 2Homo sapiens (human)
telomere maintenance in response to DNA damageCyclin-dependent kinase 2Homo sapiens (human)
post-translational protein modificationCyclin-dependent kinase 2Homo sapiens (human)
positive regulation of DNA replicationCyclin-dependent kinase 2Homo sapiens (human)
positive regulation of DNA-templated transcriptionCyclin-dependent kinase 2Homo sapiens (human)
centrosome duplicationCyclin-dependent kinase 2Homo sapiens (human)
cell divisionCyclin-dependent kinase 2Homo sapiens (human)
meiotic cell cycleCyclin-dependent kinase 2Homo sapiens (human)
cellular response to nitric oxideCyclin-dependent kinase 2Homo sapiens (human)
cellular senescenceCyclin-dependent kinase 2Homo sapiens (human)
regulation of anaphase-promoting complex-dependent catabolic processCyclin-dependent kinase 2Homo sapiens (human)
regulation of G2/M transition of mitotic cell cycleCyclin-dependent kinase 2Homo sapiens (human)
signal transductionCyclin-dependent kinase 2Homo sapiens (human)
regulation of gene expressionCyclin-dependent kinase 2Homo sapiens (human)
response to organic substanceCyclin-dependent kinase 2Homo sapiens (human)
dendritic cell chemotaxisC-X-C chemokine receptor type 1Homo sapiens (human)
cell surface receptor signaling pathwayC-X-C chemokine receptor type 1Homo sapiens (human)
G protein-coupled receptor signaling pathwayC-X-C chemokine receptor type 1Homo sapiens (human)
receptor internalizationC-X-C chemokine receptor type 1Homo sapiens (human)
interleukin-8-mediated signaling pathwayC-X-C chemokine receptor type 1Homo sapiens (human)
chemokine-mediated signaling pathwayC-X-C chemokine receptor type 1Homo sapiens (human)
calcium-mediated signalingC-X-C chemokine receptor type 1Homo sapiens (human)
immune responseC-X-C chemokine receptor type 1Homo sapiens (human)
neutrophil chemotaxisC-X-C chemokine receptor type 1Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationC-X-C chemokine receptor type 1Homo sapiens (human)
response to xenobiotic stimulusAmine oxidase [flavin-containing] BHomo sapiens (human)
response to toxic substanceAmine oxidase [flavin-containing] BHomo sapiens (human)
response to aluminum ionAmine oxidase [flavin-containing] BHomo sapiens (human)
response to selenium ionAmine oxidase [flavin-containing] BHomo sapiens (human)
negative regulation of serotonin secretionAmine oxidase [flavin-containing] BHomo sapiens (human)
phenylethylamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
substantia nigra developmentAmine oxidase [flavin-containing] BHomo sapiens (human)
response to lipopolysaccharideAmine oxidase [flavin-containing] BHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to ethanolAmine oxidase [flavin-containing] BHomo sapiens (human)
positive regulation of dopamine metabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
hydrogen peroxide biosynthetic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to corticosteroneAmine oxidase [flavin-containing] BHomo sapiens (human)
behavioral fear responseDipeptidyl peptidase 4Homo sapiens (human)
response to hypoxiaDipeptidyl peptidase 4Homo sapiens (human)
proteolysisDipeptidyl peptidase 4Homo sapiens (human)
cell adhesionDipeptidyl peptidase 4Homo sapiens (human)
positive regulation of cell population proliferationDipeptidyl peptidase 4Homo sapiens (human)
negative regulation of extracellular matrix disassemblyDipeptidyl peptidase 4Homo sapiens (human)
peptide hormone processingDipeptidyl peptidase 4Homo sapiens (human)
receptor-mediated endocytosis of virus by host cellDipeptidyl peptidase 4Homo sapiens (human)
T cell costimulationDipeptidyl peptidase 4Homo sapiens (human)
regulation of cell-cell adhesion mediated by integrinDipeptidyl peptidase 4Homo sapiens (human)
locomotory exploration behaviorDipeptidyl peptidase 4Homo sapiens (human)
psychomotor behaviorDipeptidyl peptidase 4Homo sapiens (human)
T cell activationDipeptidyl peptidase 4Homo sapiens (human)
endothelial cell migrationDipeptidyl peptidase 4Homo sapiens (human)
symbiont entry into host cellDipeptidyl peptidase 4Homo sapiens (human)
receptor-mediated virion attachment to host cellDipeptidyl peptidase 4Homo sapiens (human)
negative chemotaxisDipeptidyl peptidase 4Homo sapiens (human)
membrane fusionDipeptidyl peptidase 4Homo sapiens (human)
negative regulation of neutrophil chemotaxisDipeptidyl peptidase 4Homo sapiens (human)
glucagon processingDipeptidyl peptidase 4Homo sapiens (human)
intracellular glucose homeostasisPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
negative regulation of cell-matrix adhesionPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
positive regulation of leukocyte migrationPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
transcription by RNA polymerase IIPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
protein import into nucleusPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
immune responsePhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
extrinsic apoptotic signaling pathway via death domain receptorsPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damagePhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
positive regulation of lamellipodium assemblyPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
cytokine-mediated signaling pathwayPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
B cell differentiationPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
T cell differentiationPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
osteoclast differentiationPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
positive regulation of tumor necrosis factor productionPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
cellular response to insulin stimulusPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
positive regulation of RNA splicingPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
regulation of toll-like receptor 4 signaling pathwayPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
substrate adhesion-dependent cell spreadingPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
cellular response to UVPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
response to endoplasmic reticulum stressPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
interleukin-18-mediated signaling pathwayPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
natural killer cell mediated cytotoxicityPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
positive regulation of protein import into nucleusPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
negative regulation of apoptotic processPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
phosphatidylinositol 3-kinase/protein kinase B signal transductionPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
negative regulation of osteoclast differentiationPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
positive regulation of glucose importPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
phosphatidylinositol phosphate biosynthetic processPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
insulin-like growth factor receptor signaling pathwayPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
positive regulation of smooth muscle cell proliferationPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
protein stabilizationPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
positive regulation of filopodium assemblyPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
negative regulation of stress fiber assemblyPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
growth hormone receptor signaling pathwayPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
myeloid leukocyte migrationPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
positive regulation of focal adhesion disassemblyPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
positive regulation of endoplasmic reticulum unfolded protein responsePhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
positive regulation of protein localization to plasma membranePhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
insulin receptor signaling pathwayPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
proteolysisProteasome subunit beta type-5Homo sapiens (human)
response to oxidative stressProteasome subunit beta type-5Homo sapiens (human)
proteasome-mediated ubiquitin-dependent protein catabolic processProteasome subunit beta type-5Homo sapiens (human)
response to hypoxiaADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
signal transductionADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
female pregnancyADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
response to xenobiotic stimulusADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
negative regulation of neuron projection developmentADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
artery smooth muscle contractionADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
NAD metabolic processADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
positive regulation of cell growthADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
positive regulation of B cell proliferationADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
positive regulation of insulin secretionADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
response to estradiolADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
response to retinoic acidADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
response to progesteroneADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
response to hydroperoxideADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
B cell proliferationADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
negative regulation of apoptotic processADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
negative regulation of bone resorptionADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
negative regulation of DNA-templated transcriptionADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
positive regulation of DNA-templated transcriptionADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
positive regulation of vasoconstrictionADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
B cell receptor signaling pathwayADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
long-term synaptic depressionADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
response to interleukin-1ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
apoptotic signaling pathwayADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
positive regulation of systemic arterial blood pressureVasopressin V2 receptorHomo sapiens (human)
renal water retentionVasopressin V2 receptorHomo sapiens (human)
adenylate cyclase-modulating G protein-coupled receptor signaling pathwayVasopressin V2 receptorHomo sapiens (human)
activation of adenylate cyclase activityVasopressin V2 receptorHomo sapiens (human)
hemostasisVasopressin V2 receptorHomo sapiens (human)
positive regulation of cell population proliferationVasopressin V2 receptorHomo sapiens (human)
negative regulation of cell population proliferationVasopressin V2 receptorHomo sapiens (human)
positive regulation of gene expressionVasopressin V2 receptorHomo sapiens (human)
telencephalon developmentVasopressin V2 receptorHomo sapiens (human)
response to cytokineVasopressin V2 receptorHomo sapiens (human)
positive regulation of intracellular signal transductionVasopressin V2 receptorHomo sapiens (human)
cellular response to hormone stimulusVasopressin V2 receptorHomo sapiens (human)
positive regulation of vasoconstrictionVasopressin V2 receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayVasopressin V2 receptorHomo sapiens (human)
regulation of systemic arterial blood pressure by vasopressinVasopressin V2 receptorHomo sapiens (human)
neuron migrationTyrosine-protein kinase receptor UFOHomo sapiens (human)
positive regulation of cytokine-mediated signaling pathwayTyrosine-protein kinase receptor UFOHomo sapiens (human)
blood vessel remodelingTyrosine-protein kinase receptor UFOHomo sapiens (human)
phagocytosisTyrosine-protein kinase receptor UFOHomo sapiens (human)
inflammatory responseTyrosine-protein kinase receptor UFOHomo sapiens (human)
signal transductionTyrosine-protein kinase receptor UFOHomo sapiens (human)
spermatogenesisTyrosine-protein kinase receptor UFOHomo sapiens (human)
negative regulation of macrophage cytokine productionTyrosine-protein kinase receptor UFOHomo sapiens (human)
forebrain cell migrationTyrosine-protein kinase receptor UFOHomo sapiens (human)
animal organ regenerationTyrosine-protein kinase receptor UFOHomo sapiens (human)
negative regulation of type II interferon productionTyrosine-protein kinase receptor UFOHomo sapiens (human)
negative regulation of tumor necrosis factor productionTyrosine-protein kinase receptor UFOHomo sapiens (human)
positive regulation of natural killer cell differentiationTyrosine-protein kinase receptor UFOHomo sapiens (human)
secretion by cellTyrosine-protein kinase receptor UFOHomo sapiens (human)
erythrocyte homeostasisTyrosine-protein kinase receptor UFOHomo sapiens (human)
substrate adhesion-dependent cell spreadingTyrosine-protein kinase receptor UFOHomo sapiens (human)
cellular response to interferon-alphaTyrosine-protein kinase receptor UFOHomo sapiens (human)
ovulation cycleTyrosine-protein kinase receptor UFOHomo sapiens (human)
negative regulation of neuron apoptotic processTyrosine-protein kinase receptor UFOHomo sapiens (human)
innate immune responseTyrosine-protein kinase receptor UFOHomo sapiens (human)
symbiont entry into host cellTyrosine-protein kinase receptor UFOHomo sapiens (human)
vascular endothelial growth factor receptor signaling pathwayTyrosine-protein kinase receptor UFOHomo sapiens (human)
cell maturationTyrosine-protein kinase receptor UFOHomo sapiens (human)
positive regulation of pinocytosisTyrosine-protein kinase receptor UFOHomo sapiens (human)
response to axon injuryTyrosine-protein kinase receptor UFOHomo sapiens (human)
negative regulation of lymphocyte activationTyrosine-protein kinase receptor UFOHomo sapiens (human)
neuron apoptotic processTyrosine-protein kinase receptor UFOHomo sapiens (human)
establishment of localization in cellTyrosine-protein kinase receptor UFOHomo sapiens (human)
vagina developmentTyrosine-protein kinase receptor UFOHomo sapiens (human)
cellular response to hydrogen peroxideTyrosine-protein kinase receptor UFOHomo sapiens (human)
cellular response to lipopolysaccharideTyrosine-protein kinase receptor UFOHomo sapiens (human)
dendritic cell differentiationTyrosine-protein kinase receptor UFOHomo sapiens (human)
neutrophil clearanceTyrosine-protein kinase receptor UFOHomo sapiens (human)
positive regulation of viral life cycleTyrosine-protein kinase receptor UFOHomo sapiens (human)
negative regulation of dendritic cell apoptotic processTyrosine-protein kinase receptor UFOHomo sapiens (human)
platelet activationTyrosine-protein kinase receptor UFOHomo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionTyrosine-protein kinase receptor UFOHomo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayTyrosine-protein kinase receptor UFOHomo sapiens (human)
natural killer cell differentiationTyrosine-protein kinase receptor UFOHomo sapiens (human)
cell migrationTyrosine-protein kinase receptor UFOHomo sapiens (human)
positive regulation of kinase activityTyrosine-protein kinase receptor UFOHomo sapiens (human)
nervous system developmentTyrosine-protein kinase receptor UFOHomo sapiens (human)
multicellular organism developmentTyrosine-protein kinase receptor UFOHomo sapiens (human)
negative regulation of apoptotic processTyrosine-protein kinase receptor UFOHomo sapiens (human)
protein phosphorylationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
activation-induced cell death of T cellsRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
intracellular signal transductionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
osteoblast differentiationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
maternal placenta developmentRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of protein phosphorylationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of endothelial cell proliferationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cell migration involved in sprouting angiogenesisRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
sphingosine-1-phosphate receptor signaling pathwayRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
glycogen biosynthetic processRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
regulation of glycogen biosynthetic processRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
glucose metabolic processRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
regulation of translationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
protein phosphorylationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of protein kinase activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
protein import into nucleusRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
nitric oxide biosynthetic processRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
inflammatory responseRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
response to oxidative stressRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
signal transductionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
epidermal growth factor receptor signaling pathwayRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
G protein-coupled receptor signaling pathwayRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
canonical NF-kappaB signal transductionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cell population proliferationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
insulin receptor signaling pathwayRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
apoptotic mitochondrial changesRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
response to heatRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
gene expressionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of autophagyRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of endothelial cell migrationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of gene expressionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of gene expressionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of long-chain fatty acid import across plasma membraneRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
fibroblast migrationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of fibroblast migrationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of sodium ion transportRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of glucose metabolic processRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of endopeptidase activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
regulation of neuron projection developmentRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of macroautophagyRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
phosphorylationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
protein ubiquitinationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
peptidyl-serine phosphorylationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
peptidyl-threonine phosphorylationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
virus-mediated perturbation of host defense responseRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cytokine-mediated signaling pathwayRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
mammalian oogenesis stageRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cell differentiationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of cell growthRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
regulation of cell migrationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of cell migrationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
T cell costimulationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of protein ubiquitinationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
regulation of myelinationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
lipopolysaccharide-mediated signaling pathwayRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
TOR signalingRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of fatty acid beta-oxidationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of endodeoxyribonuclease activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of protein bindingRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
response to foodRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
peripheral nervous system myelin maintenanceRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of proteasomal ubiquitin-dependent protein catabolic processRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cellular response to insulin stimulusRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
response to fluid shear stressRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cellular response to reactive oxygen speciesRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
interleukin-18-mediated signaling pathwayRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cellular response to vascular endothelial growth factor stimulusRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cellular response to decreased oxygen levelsRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
non-canonical NF-kappaB signal transductionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
glucose homeostasisRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
regulation of apoptotic processRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of apoptotic processRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of cysteine-type endopeptidase activity involved in apoptotic processRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
proteasome-mediated ubiquitin-dependent protein catabolic processRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
anoikisRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
regulation of mRNA stabilityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
phosphatidylinositol 3-kinase/protein kinase B signal transductionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of blood vessel endothelial cell migrationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of nitric oxide biosynthetic processRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of fat cell differentiationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of glycogen biosynthetic processRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of cyclin-dependent protein serine/threonine kinase activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of Notch signaling pathwayRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of proteolysisRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of DNA-templated transcriptionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of glucose importRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of organ growthRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
protein autophosphorylationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of lipid biosynthetic processRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
insulin-like growth factor receptor signaling pathwayRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
behavioral response to painRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of smooth muscle cell proliferationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of nitric-oxide synthase activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of DNA-binding transcription factor activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
striated muscle cell differentiationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of protein metabolic processRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
excitatory postsynaptic potentialRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
response to growth hormoneRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
mammary gland epithelial cell differentiationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
labyrinthine layer blood vessel developmentRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
response to UV-ARAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
response to growth factorRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cellular response to cadmium ionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cellular response to tumor necrosis factorRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cellular response to epidermal growth factor stimulusRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cellular response to prostaglandin E stimulusRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of protein serine/threonine kinase activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
establishment of protein localization to mitochondrionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
maintenance of protein location in mitochondrionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of release of cytochrome c from mitochondriaRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cellular response to granulocyte macrophage colony-stimulating factor stimulusRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
execution phase of apoptosisRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
regulation of postsynapse organizationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
regulation of tRNA methylationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cellular response to oxidised low-density lipoprotein particle stimulusRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of protein localization to lysosomeRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of cGAS/STING signaling pathwayRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of protein localization to nucleusRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cellular response to peptideRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
regulation of signal transduction by p53 class mediatorRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of cilium assemblyRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathwayRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of leukocyte cell-cell adhesionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of protein localization to plasma membraneRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of I-kappaB phosphorylationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of TORC1 signalingRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of protein localization to endoplasmic reticulumRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cellular response to nerve growth factor stimulusRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
response to insulin-like growth factor stimulusRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
positive regulation of protein localization to cell surfaceRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
regulation of type B pancreatic cell developmentRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of lymphocyte migrationRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway in absence of ligandRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
intracellular signal transductionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
leukotriene metabolic processMultidrug resistance-associated protein 1 Homo sapiens (human)
xenobiotic metabolic processMultidrug resistance-associated protein 1 Homo sapiens (human)
response to xenobiotic stimulusMultidrug resistance-associated protein 1 Homo sapiens (human)
cobalamin transportMultidrug resistance-associated protein 1 Homo sapiens (human)
sphingolipid biosynthetic processMultidrug resistance-associated protein 1 Homo sapiens (human)
cellular response to oxidative stressMultidrug resistance-associated protein 1 Homo sapiens (human)
heme catabolic processMultidrug resistance-associated protein 1 Homo sapiens (human)
xenobiotic transportMultidrug resistance-associated protein 1 Homo sapiens (human)
phospholipid translocationMultidrug resistance-associated protein 1 Homo sapiens (human)
positive regulation of inflammatory responseMultidrug resistance-associated protein 1 Homo sapiens (human)
transmembrane transportMultidrug resistance-associated protein 1 Homo sapiens (human)
cell chemotaxisMultidrug resistance-associated protein 1 Homo sapiens (human)
transepithelial transportMultidrug resistance-associated protein 1 Homo sapiens (human)
cyclic nucleotide transportMultidrug resistance-associated protein 1 Homo sapiens (human)
leukotriene transportMultidrug resistance-associated protein 1 Homo sapiens (human)
monoatomic anion transmembrane transportMultidrug resistance-associated protein 1 Homo sapiens (human)
sphingolipid translocationMultidrug resistance-associated protein 1 Homo sapiens (human)
export across plasma membraneMultidrug resistance-associated protein 1 Homo sapiens (human)
transport across blood-brain barrierMultidrug resistance-associated protein 1 Homo sapiens (human)
cellular response to amyloid-betaMultidrug resistance-associated protein 1 Homo sapiens (human)
carboxylic acid transmembrane transportMultidrug resistance-associated protein 1 Homo sapiens (human)
xenobiotic transport across blood-brain barrierMultidrug resistance-associated protein 1 Homo sapiens (human)
glutathione transmembrane transportMultidrug resistance-associated protein 1 Homo sapiens (human)
response to toxic substanceBifunctional epoxide hydrolase 2Homo sapiens (human)
positive regulation of gene expressionBifunctional epoxide hydrolase 2Homo sapiens (human)
dephosphorylationBifunctional epoxide hydrolase 2Homo sapiens (human)
cholesterol homeostasisBifunctional epoxide hydrolase 2Homo sapiens (human)
stilbene catabolic processBifunctional epoxide hydrolase 2Homo sapiens (human)
phospholipid dephosphorylationBifunctional epoxide hydrolase 2Homo sapiens (human)
regulation of cholesterol metabolic processBifunctional epoxide hydrolase 2Homo sapiens (human)
epoxide metabolic processBifunctional epoxide hydrolase 2Homo sapiens (human)
proteolysisTrypsin-3Homo sapiens (human)
digestionTrypsin-3Homo sapiens (human)
antimicrobial humoral responseTrypsin-3Homo sapiens (human)
zymogen activationTrypsin-3Homo sapiens (human)
endothelial cell migrationTrypsin-3Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
response to oxidative stressProstaglandin G/H synthase 2Homo sapiens (human)
embryo implantationProstaglandin G/H synthase 2Homo sapiens (human)
learningProstaglandin G/H synthase 2Homo sapiens (human)
memoryProstaglandin G/H synthase 2Homo sapiens (human)
regulation of blood pressureProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell population proliferationProstaglandin G/H synthase 2Homo sapiens (human)
response to xenobiotic stimulusProstaglandin G/H synthase 2Homo sapiens (human)
response to nematodeProstaglandin G/H synthase 2Homo sapiens (human)
response to fructoseProstaglandin G/H synthase 2Homo sapiens (human)
response to manganese ionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vascular endothelial growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cyclooxygenase pathwayProstaglandin G/H synthase 2Homo sapiens (human)
bone mineralizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fever generationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic plasticityProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of synaptic transmission, dopaminergicProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin secretionProstaglandin G/H synthase 2Homo sapiens (human)
response to estradiolProstaglandin G/H synthase 2Homo sapiens (human)
response to lipopolysaccharideProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylationProstaglandin G/H synthase 2Homo sapiens (human)
response to vitamin DProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to heatProstaglandin G/H synthase 2Homo sapiens (human)
response to tumor necrosis factorProstaglandin G/H synthase 2Homo sapiens (human)
maintenance of blood-brain barrierProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of protein import into nucleusProstaglandin G/H synthase 2Homo sapiens (human)
hair cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of apoptotic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of nitric oxide biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vasoconstrictionProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
decidualizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle cell proliferationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of inflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
response to glucocorticoidProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of calcium ion transportProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic transmission, glutamatergicProstaglandin G/H synthase 2Homo sapiens (human)
response to fatty acidProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to mechanical stimulusProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to lead ionProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to ATPProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to hypoxiaProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to non-ionic osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to fluid shear stressProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of transforming growth factor beta productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of cell migration involved in sprouting angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fibroblast growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of platelet-derived growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cellular oxidant detoxificationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of neuroinflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to homocysteineProstaglandin G/H synthase 2Homo sapiens (human)
response to angiotensinProstaglandin G/H synthase 2Homo sapiens (human)
branching involved in blood vessel morphogenesisVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of macroautophagyVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of mitochondrial depolarizationVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of mitochondrial fissionVascular endothelial growth factor receptor 2Homo sapiens (human)
angiogenesisVascular endothelial growth factor receptor 2Homo sapiens (human)
ovarian follicle developmentVascular endothelial growth factor receptor 2Homo sapiens (human)
vasculogenesisVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of protein phosphorylationVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of endothelial cell proliferationVascular endothelial growth factor receptor 2Homo sapiens (human)
lymph vessel developmentVascular endothelial growth factor receptor 2Homo sapiens (human)
cell migration involved in sprouting angiogenesisVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of mesenchymal cell proliferationVascular endothelial growth factor receptor 2Homo sapiens (human)
epithelial cell maturationVascular endothelial growth factor receptor 2Homo sapiens (human)
endocardium developmentVascular endothelial growth factor receptor 2Homo sapiens (human)
endothelium developmentVascular endothelial growth factor receptor 2Homo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of cell population proliferationVascular endothelial growth factor receptor 2Homo sapiens (human)
regulation of cell shapeVascular endothelial growth factor receptor 2Homo sapiens (human)
mesenchymal cell proliferationVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of endothelial cell migrationVascular endothelial growth factor receptor 2Homo sapiens (human)
negative regulation of gene expressionVascular endothelial growth factor receptor 2Homo sapiens (human)
peptidyl-tyrosine phosphorylationVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of cell migrationVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of BMP signaling pathwayVascular endothelial growth factor receptor 2Homo sapiens (human)
embryonic hemopoiesisVascular endothelial growth factor receptor 2Homo sapiens (human)
cellular response to vascular endothelial growth factor stimulusVascular endothelial growth factor receptor 2Homo sapiens (human)
vascular endothelial growth factor receptor-2 signaling pathwayVascular endothelial growth factor receptor 2Homo sapiens (human)
peptidyl-tyrosine autophosphorylationVascular endothelial growth factor receptor 2Homo sapiens (human)
vascular endothelial growth factor signaling pathwayVascular endothelial growth factor receptor 2Homo sapiens (human)
surfactant homeostasisVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of MAPK cascadeVascular endothelial growth factor receptor 2Homo sapiens (human)
negative regulation of neuron apoptotic processVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of blood vessel endothelial cell migrationVascular endothelial growth factor receptor 2Homo sapiens (human)
cell fate commitmentVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of angiogenesisVascular endothelial growth factor receptor 2Homo sapiens (human)
protein autophosphorylationVascular endothelial growth factor receptor 2Homo sapiens (human)
vascular endothelial growth factor receptor signaling pathwayVascular endothelial growth factor receptor 2Homo sapiens (human)
lung alveolus developmentVascular endothelial growth factor receptor 2Homo sapiens (human)
post-embryonic camera-type eye morphogenesisVascular endothelial growth factor receptor 2Homo sapiens (human)
epithelial cell proliferationVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of positive chemotaxisVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of nitric-oxide synthase biosynthetic processVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of focal adhesion assemblyVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionVascular endothelial growth factor receptor 2Homo sapiens (human)
calcium ion homeostasisVascular endothelial growth factor receptor 2Homo sapiens (human)
blood vessel endothelial cell differentiationVascular endothelial growth factor receptor 2Homo sapiens (human)
vascular wound healingVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeVascular endothelial growth factor receptor 2Homo sapiens (human)
semaphorin-plexin signaling pathwayVascular endothelial growth factor receptor 2Homo sapiens (human)
stem cell proliferationVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of cell migration involved in sprouting angiogenesisVascular endothelial growth factor receptor 2Homo sapiens (human)
regulation of hematopoietic progenitor cell differentiationVascular endothelial growth factor receptor 2Homo sapiens (human)
regulation of bone developmentVascular endothelial growth factor receptor 2Homo sapiens (human)
cellular response to hydrogen sulfideVascular endothelial growth factor receptor 2Homo sapiens (human)
negative regulation of endothelial cell apoptotic processVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of stem cell proliferationVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of endothelial cell chemotaxisVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of vasculogenesisVascular endothelial growth factor receptor 2Homo sapiens (human)
regulation of MAPK cascadeVascular endothelial growth factor receptor 2Homo sapiens (human)
multicellular organism developmentVascular endothelial growth factor receptor 2Homo sapiens (human)
cell migrationVascular endothelial growth factor receptor 2Homo sapiens (human)
endothelial cell differentiationVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of kinase activityVascular endothelial growth factor receptor 2Homo sapiens (human)
hemopoiesisReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
leukocyte homeostasisReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
myeloid progenitor cell differentiationReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
pro-B cell differentiationReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
positive regulation of cell population proliferationReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
response to organonitrogen compoundReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
peptidyl-tyrosine phosphorylationReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
cytokine-mediated signaling pathwayReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
B cell differentiationReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
animal organ regenerationReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
common myeloid progenitor cell proliferationReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
vascular endothelial growth factor signaling pathwayReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
positive regulation of tyrosine phosphorylation of STAT proteinReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
regulation of apoptotic processReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
positive regulation of MAP kinase activityReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
positive regulation of MAPK cascadeReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
lymphocyte proliferationReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
protein autophosphorylationReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
cellular response to cytokine stimulusReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
cellular response to glucocorticoid stimulusReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
dendritic cell differentiationReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
positive regulation of kinase activityReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
multicellular organism developmentReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
in utero embryonic development17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
placenta development17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
estrogen biosynthetic process17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
androgen metabolic process17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
response to retinoic acid17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
steroid metabolic process17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
calcium ion homeostasisAlpha-synucleinHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIAlpha-synucleinHomo sapiens (human)
microglial cell activationAlpha-synucleinHomo sapiens (human)
positive regulation of receptor recyclingAlpha-synucleinHomo sapiens (human)
positive regulation of neurotransmitter secretionAlpha-synucleinHomo sapiens (human)
negative regulation of protein kinase activityAlpha-synucleinHomo sapiens (human)
fatty acid metabolic processAlpha-synucleinHomo sapiens (human)
neutral lipid metabolic processAlpha-synucleinHomo sapiens (human)
phospholipid metabolic processAlpha-synucleinHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processAlpha-synucleinHomo sapiens (human)
mitochondrial membrane organizationAlpha-synucleinHomo sapiens (human)
adult locomotory behaviorAlpha-synucleinHomo sapiens (human)
response to xenobiotic stimulusAlpha-synucleinHomo sapiens (human)
response to iron(II) ionAlpha-synucleinHomo sapiens (human)
regulation of phospholipase activityAlpha-synucleinHomo sapiens (human)
negative regulation of platelet-derived growth factor receptor signaling pathwayAlpha-synucleinHomo sapiens (human)
regulation of glutamate secretionAlpha-synucleinHomo sapiens (human)
regulation of dopamine secretionAlpha-synucleinHomo sapiens (human)
synaptic vesicle exocytosisAlpha-synucleinHomo sapiens (human)
synaptic vesicle primingAlpha-synucleinHomo sapiens (human)
regulation of transmembrane transporter activityAlpha-synucleinHomo sapiens (human)
negative regulation of microtubule polymerizationAlpha-synucleinHomo sapiens (human)
receptor internalizationAlpha-synucleinHomo sapiens (human)
protein destabilizationAlpha-synucleinHomo sapiens (human)
response to magnesium ionAlpha-synucleinHomo sapiens (human)
negative regulation of transporter activityAlpha-synucleinHomo sapiens (human)
response to lipopolysaccharideAlpha-synucleinHomo sapiens (human)
negative regulation of monooxygenase activityAlpha-synucleinHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationAlpha-synucleinHomo sapiens (human)
response to type II interferonAlpha-synucleinHomo sapiens (human)
cellular response to oxidative stressAlpha-synucleinHomo sapiens (human)
SNARE complex assemblyAlpha-synucleinHomo sapiens (human)
positive regulation of SNARE complex assemblyAlpha-synucleinHomo sapiens (human)
regulation of locomotionAlpha-synucleinHomo sapiens (human)
dopamine biosynthetic processAlpha-synucleinHomo sapiens (human)
mitochondrial ATP synthesis coupled electron transportAlpha-synucleinHomo sapiens (human)
regulation of macrophage activationAlpha-synucleinHomo sapiens (human)
positive regulation of apoptotic processAlpha-synucleinHomo sapiens (human)
negative regulation of apoptotic processAlpha-synucleinHomo sapiens (human)
negative regulation of cysteine-type endopeptidase activity involved in apoptotic processAlpha-synucleinHomo sapiens (human)
negative regulation of neuron apoptotic processAlpha-synucleinHomo sapiens (human)
positive regulation of endocytosisAlpha-synucleinHomo sapiens (human)
negative regulation of exocytosisAlpha-synucleinHomo sapiens (human)
positive regulation of exocytosisAlpha-synucleinHomo sapiens (human)
regulation of long-term neuronal synaptic plasticityAlpha-synucleinHomo sapiens (human)
synaptic vesicle endocytosisAlpha-synucleinHomo sapiens (human)
synaptic vesicle transportAlpha-synucleinHomo sapiens (human)
positive regulation of inflammatory responseAlpha-synucleinHomo sapiens (human)
regulation of acyl-CoA biosynthetic processAlpha-synucleinHomo sapiens (human)
protein tetramerizationAlpha-synucleinHomo sapiens (human)
positive regulation of release of sequestered calcium ion into cytosolAlpha-synucleinHomo sapiens (human)
neuron apoptotic processAlpha-synucleinHomo sapiens (human)
dopamine uptake involved in synaptic transmissionAlpha-synucleinHomo sapiens (human)
negative regulation of dopamine uptake involved in synaptic transmissionAlpha-synucleinHomo sapiens (human)
negative regulation of serotonin uptakeAlpha-synucleinHomo sapiens (human)
regulation of norepinephrine uptakeAlpha-synucleinHomo sapiens (human)
negative regulation of norepinephrine uptakeAlpha-synucleinHomo sapiens (human)
excitatory postsynaptic potentialAlpha-synucleinHomo sapiens (human)
long-term synaptic potentiationAlpha-synucleinHomo sapiens (human)
positive regulation of inositol phosphate biosynthetic processAlpha-synucleinHomo sapiens (human)
negative regulation of thrombin-activated receptor signaling pathwayAlpha-synucleinHomo sapiens (human)
response to interleukin-1Alpha-synucleinHomo sapiens (human)
cellular response to copper ionAlpha-synucleinHomo sapiens (human)
cellular response to epinephrine stimulusAlpha-synucleinHomo sapiens (human)
positive regulation of protein serine/threonine kinase activityAlpha-synucleinHomo sapiens (human)
supramolecular fiber organizationAlpha-synucleinHomo sapiens (human)
negative regulation of mitochondrial electron transport, NADH to ubiquinoneAlpha-synucleinHomo sapiens (human)
positive regulation of glutathione peroxidase activityAlpha-synucleinHomo sapiens (human)
positive regulation of hydrogen peroxide catabolic processAlpha-synucleinHomo sapiens (human)
regulation of synaptic vesicle recyclingAlpha-synucleinHomo sapiens (human)
regulation of reactive oxygen species biosynthetic processAlpha-synucleinHomo sapiens (human)
positive regulation of protein localization to cell peripheryAlpha-synucleinHomo sapiens (human)
negative regulation of chaperone-mediated autophagyAlpha-synucleinHomo sapiens (human)
regulation of presynapse assemblyAlpha-synucleinHomo sapiens (human)
amyloid fibril formationAlpha-synucleinHomo sapiens (human)
synapse organizationAlpha-synucleinHomo sapiens (human)
chemical synaptic transmissionAlpha-synucleinHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIMacrophage metalloelastaseHomo sapiens (human)
proteolysisMacrophage metalloelastaseHomo sapiens (human)
protein import into nucleusMacrophage metalloelastaseHomo sapiens (human)
extracellular matrix disassemblyMacrophage metalloelastaseHomo sapiens (human)
collagen catabolic processMacrophage metalloelastaseHomo sapiens (human)
positive regulation of interferon-alpha productionMacrophage metalloelastaseHomo sapiens (human)
wound healing, spreading of epidermal cellsMacrophage metalloelastaseHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIMacrophage metalloelastaseHomo sapiens (human)
lung alveolus developmentMacrophage metalloelastaseHomo sapiens (human)
regulation of defense response to virus by hostMacrophage metalloelastaseHomo sapiens (human)
positive regulation of epithelial cell proliferation involved in wound healingMacrophage metalloelastaseHomo sapiens (human)
elastin catabolic processMacrophage metalloelastaseHomo sapiens (human)
negative regulation of type I interferon-mediated signaling pathwayMacrophage metalloelastaseHomo sapiens (human)
positive regulation of type I interferon-mediated signaling pathwayMacrophage metalloelastaseHomo sapiens (human)
bronchiole developmentMacrophage metalloelastaseHomo sapiens (human)
cellular response to virusMacrophage metalloelastaseHomo sapiens (human)
response to amyloid-betaMacrophage metalloelastaseHomo sapiens (human)
negative regulation of endothelial cell-matrix adhesion via fibronectinMacrophage metalloelastaseHomo sapiens (human)
extracellular matrix organizationMacrophage metalloelastaseHomo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 7Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 7Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 7Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 7Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 7Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 7Homo sapiens (human)
protein import into nucleusTyrosine-protein kinase SYKHomo sapiens (human)
regulation of DNA-binding transcription factor activityTyrosine-protein kinase SYKHomo sapiens (human)
angiogenesisTyrosine-protein kinase SYKHomo sapiens (human)
cell activationTyrosine-protein kinase SYKHomo sapiens (human)
lymph vessel developmentTyrosine-protein kinase SYKHomo sapiens (human)
positive regulation of receptor internalizationTyrosine-protein kinase SYKHomo sapiens (human)
stimulatory C-type lectin receptor signaling pathwayTyrosine-protein kinase SYKHomo sapiens (human)
adaptive immune responseTyrosine-protein kinase SYKHomo sapiens (human)
macrophage activation involved in immune responseTyrosine-protein kinase SYKHomo sapiens (human)
neutrophil activation involved in immune responseTyrosine-protein kinase SYKHomo sapiens (human)
leukocyte activation involved in immune responseTyrosine-protein kinase SYKHomo sapiens (human)
serotonin secretion by plateletTyrosine-protein kinase SYKHomo sapiens (human)
negative regulation of inflammatory response to antigenic stimulusTyrosine-protein kinase SYKHomo sapiens (human)
protein phosphorylationTyrosine-protein kinase SYKHomo sapiens (human)
leukocyte cell-cell adhesionTyrosine-protein kinase SYKHomo sapiens (human)
integrin-mediated signaling pathwayTyrosine-protein kinase SYKHomo sapiens (human)
animal organ morphogenesisTyrosine-protein kinase SYKHomo sapiens (human)
regulation of platelet activationTyrosine-protein kinase SYKHomo sapiens (human)
regulation of tumor necrosis factor-mediated signaling pathwayTyrosine-protein kinase SYKHomo sapiens (human)
peptidyl-tyrosine phosphorylationTyrosine-protein kinase SYKHomo sapiens (human)
leukotriene biosynthetic processTyrosine-protein kinase SYKHomo sapiens (human)
calcium-mediated signalingTyrosine-protein kinase SYKHomo sapiens (human)
platelet activationTyrosine-protein kinase SYKHomo sapiens (human)
B cell differentiationTyrosine-protein kinase SYKHomo sapiens (human)
neutrophil chemotaxisTyrosine-protein kinase SYKHomo sapiens (human)
positive regulation of protein-containing complex assemblyTyrosine-protein kinase SYKHomo sapiens (human)
receptor internalizationTyrosine-protein kinase SYKHomo sapiens (human)
positive regulation of type I interferon productionTyrosine-protein kinase SYKHomo sapiens (human)
positive regulation of granulocyte macrophage colony-stimulating factor productionTyrosine-protein kinase SYKHomo sapiens (human)
positive regulation of interleukin-10 productionTyrosine-protein kinase SYKHomo sapiens (human)
positive regulation of interleukin-12 productionTyrosine-protein kinase SYKHomo sapiens (human)
positive regulation of interleukin-3 productionTyrosine-protein kinase SYKHomo sapiens (human)
positive regulation of interleukin-4 productionTyrosine-protein kinase SYKHomo sapiens (human)
positive regulation of interleukin-6 productionTyrosine-protein kinase SYKHomo sapiens (human)
positive regulation of interleukin-8 productionTyrosine-protein kinase SYKHomo sapiens (human)
positive regulation of tumor necrosis factor productionTyrosine-protein kinase SYKHomo sapiens (human)
positive regulation of mast cell cytokine productionTyrosine-protein kinase SYKHomo sapiens (human)
regulation of superoxide anion generationTyrosine-protein kinase SYKHomo sapiens (human)
positive regulation of superoxide anion generationTyrosine-protein kinase SYKHomo sapiens (human)
positive regulation of cell adhesion mediated by integrinTyrosine-protein kinase SYKHomo sapiens (human)
intracellular signal transductionTyrosine-protein kinase SYKHomo sapiens (human)
collagen-activated tyrosine kinase receptor signaling pathwayTyrosine-protein kinase SYKHomo sapiens (human)
Fc-epsilon receptor signaling pathwayTyrosine-protein kinase SYKHomo sapiens (human)
Fc-gamma receptor signaling pathway involved in phagocytosisTyrosine-protein kinase SYKHomo sapiens (human)
interleukin-3-mediated signaling pathwayTyrosine-protein kinase SYKHomo sapiens (human)
gamma-delta T cell differentiationTyrosine-protein kinase SYKHomo sapiens (human)
defense response to bacteriumTyrosine-protein kinase SYKHomo sapiens (human)
positive regulation of cysteine-type endopeptidase activity involved in apoptotic processTyrosine-protein kinase SYKHomo sapiens (human)
mast cell degranulationTyrosine-protein kinase SYKHomo sapiens (human)
positive regulation of mast cell degranulationTyrosine-protein kinase SYKHomo sapiens (human)
regulation of neutrophil degranulationTyrosine-protein kinase SYKHomo sapiens (human)
beta selectionTyrosine-protein kinase SYKHomo sapiens (human)
positive regulation of MAPK cascadeTyrosine-protein kinase SYKHomo sapiens (human)
innate immune responseTyrosine-protein kinase SYKHomo sapiens (human)
positive regulation of B cell differentiationTyrosine-protein kinase SYKHomo sapiens (human)
positive regulation of gamma-delta T cell differentiationTyrosine-protein kinase SYKHomo sapiens (human)
positive regulation of bone resorptionTyrosine-protein kinase SYKHomo sapiens (human)
positive regulation of alpha-beta T cell differentiationTyrosine-protein kinase SYKHomo sapiens (human)
positive regulation of alpha-beta T cell proliferationTyrosine-protein kinase SYKHomo sapiens (human)
blood vessel morphogenesisTyrosine-protein kinase SYKHomo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationTyrosine-protein kinase SYKHomo sapiens (human)
regulation of phagocytosisTyrosine-protein kinase SYKHomo sapiens (human)
positive regulation of calcium-mediated signalingTyrosine-protein kinase SYKHomo sapiens (human)
B cell receptor signaling pathwayTyrosine-protein kinase SYKHomo sapiens (human)
positive regulation of killing of cells of another organismTyrosine-protein kinase SYKHomo sapiens (human)
regulation of ERK1 and ERK2 cascadeTyrosine-protein kinase SYKHomo sapiens (human)
cellular response to molecule of fungal originTyrosine-protein kinase SYKHomo sapiens (human)
cellular response to lipidTyrosine-protein kinase SYKHomo sapiens (human)
cellular response to low-density lipoprotein particle stimulusTyrosine-protein kinase SYKHomo sapiens (human)
positive regulation of monocyte chemotactic protein-1 productionTyrosine-protein kinase SYKHomo sapiens (human)
regulation of arachidonic acid secretionTyrosine-protein kinase SYKHomo sapiens (human)
regulation of platelet aggregationTyrosine-protein kinase SYKHomo sapiens (human)
positive regulation of cold-induced thermogenesisTyrosine-protein kinase SYKHomo sapiens (human)
positive regulation of TORC1 signalingTyrosine-protein kinase SYKHomo sapiens (human)
cellular response to lectinTyrosine-protein kinase SYKHomo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayTyrosine-protein kinase SYKHomo sapiens (human)
cell differentiationTyrosine-protein kinase SYKHomo sapiens (human)
endochondral ossificationCollagenase 3Homo sapiens (human)
growth plate cartilage developmentCollagenase 3Homo sapiens (human)
proteolysisCollagenase 3Homo sapiens (human)
extracellular matrix disassemblyCollagenase 3Homo sapiens (human)
bone mineralizationCollagenase 3Homo sapiens (human)
collagen catabolic processCollagenase 3Homo sapiens (human)
bone morphogenesisCollagenase 3Homo sapiens (human)
response to amyloid-betaCollagenase 3Homo sapiens (human)
extracellular matrix organizationCollagenase 3Homo sapiens (human)
isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway1-deoxy-D-xylulose 5-phosphate reductoisomeraseEscherichia coli K-12
isoprenoid biosynthetic process1-deoxy-D-xylulose 5-phosphate reductoisomeraseEscherichia coli K-12
isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway1-deoxy-D-xylulose 5-phosphate reductoisomeraseEscherichia coli K-12
isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway involved in terpenoid biosynthetic process1-deoxy-D-xylulose 5-phosphate reductoisomeraseEscherichia coli K-12
allantoin metabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of protein phosphorylationXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of endothelial cell proliferationXanthine dehydrogenase/oxidaseHomo sapiens (human)
guanine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
inosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyinosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
adenosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyadenosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyguanosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
AMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
IMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
lactationXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
xanthine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of gene expressionXanthine dehydrogenase/oxidaseHomo sapiens (human)
iron-sulfur cluster assemblyXanthine dehydrogenase/oxidaseHomo sapiens (human)
amide catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of endothelial cell differentiationXanthine dehydrogenase/oxidaseHomo sapiens (human)
GMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
dGMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
dAMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionXanthine dehydrogenase/oxidaseHomo sapiens (human)
positive regulation of p38MAPK cascadeXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of vascular endothelial growth factor signaling pathwayXanthine dehydrogenase/oxidaseHomo sapiens (human)
positive regulation of reactive oxygen species metabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of vasculogenesisXanthine dehydrogenase/oxidaseHomo sapiens (human)
proteolysisProlyl endopeptidaseHomo sapiens (human)
phosphorylationPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
angiogenesisPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
positive regulation of cytokine productionPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
adaptive immune responsePhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
dendritic cell chemotaxisPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
positive regulation of acute inflammatory responsePhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
respiratory burst involved in defense responsePhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
sphingosine-1-phosphate receptor signaling pathwayPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
endocytosisPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
inflammatory responsePhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
immune responsePhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
G protein-coupled receptor signaling pathwayPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
positive regulation of endothelial cell migrationPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
T cell chemotaxisPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
negative regulation of triglyceride catabolic processPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
neutrophil chemotaxisPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
secretory granule localizationPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
regulation of cell adhesion mediated by integrinPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
positive regulation of Rac protein signal transductionPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
natural killer cell chemotaxisPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
T cell proliferationPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
T cell activationPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
mast cell degranulationPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
positive regulation of MAP kinase activityPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
phosphatidylinositol 3-kinase/protein kinase B signal transductionPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
innate immune responsePhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
regulation of angiogenesisPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
phosphatidylinositol phosphate biosynthetic processPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
negative regulation of cardiac muscle contractionPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
platelet aggregationPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
cellular response to cAMPPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
neutrophil extravasationPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
hepatocyte apoptotic processPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
regulation of calcium ion transmembrane transportPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
negative regulation of fibroblast apoptotic processPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
cell migrationPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
phosphatidylinositol-mediated signalingPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
phosphatidylinositol-3-phosphate biosynthetic processPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
regulation of systemic arterial blood pressureGlycogen synthase kinase-3 alphaHomo sapiens (human)
cardiac left ventricle morphogenesisGlycogen synthase kinase-3 alphaHomo sapiens (human)
glycogen metabolic processGlycogen synthase kinase-3 alphaHomo sapiens (human)
protein phosphorylationGlycogen synthase kinase-3 alphaHomo sapiens (human)
dopamine receptor signaling pathwayGlycogen synthase kinase-3 alphaHomo sapiens (human)
nervous system developmentGlycogen synthase kinase-3 alphaHomo sapiens (human)
insulin receptor signaling pathwayGlycogen synthase kinase-3 alphaHomo sapiens (human)
positive regulation of autophagyGlycogen synthase kinase-3 alphaHomo sapiens (human)
positive regulation of gene expressionGlycogen synthase kinase-3 alphaHomo sapiens (human)
positive regulation of peptidyl-threonine phosphorylationGlycogen synthase kinase-3 alphaHomo sapiens (human)
negative regulation of UDP-glucose catabolic processGlycogen synthase kinase-3 alphaHomo sapiens (human)
Wnt signaling pathwayGlycogen synthase kinase-3 alphaHomo sapiens (human)
cell migrationGlycogen synthase kinase-3 alphaHomo sapiens (human)
peptidyl-threonine phosphorylationGlycogen synthase kinase-3 alphaHomo sapiens (human)
viral protein processingGlycogen synthase kinase-3 alphaHomo sapiens (human)
positive regulation of protein ubiquitinationGlycogen synthase kinase-3 alphaHomo sapiens (human)
negative regulation of TOR signalingGlycogen synthase kinase-3 alphaHomo sapiens (human)
positive regulation of proteasomal ubiquitin-dependent protein catabolic processGlycogen synthase kinase-3 alphaHomo sapiens (human)
cellular response to insulin stimulusGlycogen synthase kinase-3 alphaHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationGlycogen synthase kinase-3 alphaHomo sapiens (human)
cellular response to interleukin-3Glycogen synthase kinase-3 alphaHomo sapiens (human)
proteasome-mediated ubiquitin-dependent protein catabolic processGlycogen synthase kinase-3 alphaHomo sapiens (human)
negative regulation of glycogen biosynthetic processGlycogen synthase kinase-3 alphaHomo sapiens (human)
positive regulation of protein catabolic processGlycogen synthase kinase-3 alphaHomo sapiens (human)
positive regulation of heart contractionGlycogen synthase kinase-3 alphaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIGlycogen synthase kinase-3 alphaHomo sapiens (human)
negative regulation of glucose importGlycogen synthase kinase-3 alphaHomo sapiens (human)
negative regulation of insulin receptor signaling pathwayGlycogen synthase kinase-3 alphaHomo sapiens (human)
excitatory postsynaptic potentialGlycogen synthase kinase-3 alphaHomo sapiens (human)
negative regulation of cell growth involved in cardiac muscle cell developmentGlycogen synthase kinase-3 alphaHomo sapiens (human)
cellular response to lithium ionGlycogen synthase kinase-3 alphaHomo sapiens (human)
cellular response to glucocorticoid stimulusGlycogen synthase kinase-3 alphaHomo sapiens (human)
positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathwayGlycogen synthase kinase-3 alphaHomo sapiens (human)
negative regulation of canonical Wnt signaling pathwayGlycogen synthase kinase-3 alphaHomo sapiens (human)
extrinsic apoptotic signaling pathwayGlycogen synthase kinase-3 alphaHomo sapiens (human)
extrinsic apoptotic signaling pathway in absence of ligandGlycogen synthase kinase-3 alphaHomo sapiens (human)
positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathwayGlycogen synthase kinase-3 alphaHomo sapiens (human)
autosome genomic imprintingGlycogen synthase kinase-3 alphaHomo sapiens (human)
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathwayGlycogen synthase kinase-3 alphaHomo sapiens (human)
regulation of mitophagyGlycogen synthase kinase-3 alphaHomo sapiens (human)
positive regulation of amyloid-beta formationGlycogen synthase kinase-3 alphaHomo sapiens (human)
positive regulation of protein targeting to mitochondrionGlycogen synthase kinase-3 alphaHomo sapiens (human)
negative regulation of glycogen synthase activity, transferring glucose-1-phosphateGlycogen synthase kinase-3 alphaHomo sapiens (human)
negative regulation of type B pancreatic cell developmentGlycogen synthase kinase-3 alphaHomo sapiens (human)
negative regulation of glycogen (starch) synthase activityGlycogen synthase kinase-3 alphaHomo sapiens (human)
positive regulation of glycogen (starch) synthase activityGlycogen synthase kinase-3 alphaHomo sapiens (human)
cell differentiationGlycogen synthase kinase-3 alphaHomo sapiens (human)
regulation of microtubule cytoskeleton organizationGlycogen synthase kinase-3 alphaHomo sapiens (human)
regulation of neuron projection developmentGlycogen synthase kinase-3 alphaHomo sapiens (human)
positive regulation of gene expressionGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of gene expressionGlycogen synthase kinase-3 betaHomo sapiens (human)
ER overload responseGlycogen synthase kinase-3 betaHomo sapiens (human)
peptidyl-serine phosphorylationGlycogen synthase kinase-3 betaHomo sapiens (human)
intracellular signal transductionGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of apoptotic processGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of protein export from nucleusGlycogen synthase kinase-3 betaHomo sapiens (human)
epithelial to mesenchymal transitionGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of cell-matrix adhesionGlycogen synthase kinase-3 betaHomo sapiens (human)
glycogen metabolic processGlycogen synthase kinase-3 betaHomo sapiens (human)
protein phosphorylationGlycogen synthase kinase-3 betaHomo sapiens (human)
mitochondrion organizationGlycogen synthase kinase-3 betaHomo sapiens (human)
dopamine receptor signaling pathwayGlycogen synthase kinase-3 betaHomo sapiens (human)
circadian rhythmGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of autophagyGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of gene expressionGlycogen synthase kinase-3 betaHomo sapiens (human)
peptidyl-serine phosphorylationGlycogen synthase kinase-3 betaHomo sapiens (human)
peptidyl-threonine phosphorylationGlycogen synthase kinase-3 betaHomo sapiens (human)
viral protein processingGlycogen synthase kinase-3 betaHomo sapiens (human)
hippocampus developmentGlycogen synthase kinase-3 betaHomo sapiens (human)
establishment of cell polarityGlycogen synthase kinase-3 betaHomo sapiens (human)
maintenance of cell polarityGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of cell migrationGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of axon extensionGlycogen synthase kinase-3 betaHomo sapiens (human)
neuron projection developmentGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of protein-containing complex assemblyGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of protein-containing complex assemblyGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of protein ubiquitinationGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of protein bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of proteasomal ubiquitin-dependent protein catabolic processGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of phosphoprotein phosphatase activityGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of microtubule-based processGlycogen synthase kinase-3 betaHomo sapiens (human)
intracellular signal transductionGlycogen synthase kinase-3 betaHomo sapiens (human)
cellular response to interleukin-3Glycogen synthase kinase-3 betaHomo sapiens (human)
regulation of circadian rhythmGlycogen synthase kinase-3 betaHomo sapiens (human)
proteasome-mediated ubiquitin-dependent protein catabolic processGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of GTPase activityGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of cell differentiationGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of osteoblast differentiationGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of glycogen biosynthetic processGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of cilium assemblyGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of protein catabolic processGlycogen synthase kinase-3 betaHomo sapiens (human)
protein autophosphorylationGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of protein export from nucleusGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of dendrite morphogenesisGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of axonogenesisGlycogen synthase kinase-3 betaHomo sapiens (human)
canonical Wnt signaling pathwayGlycogen synthase kinase-3 betaHomo sapiens (human)
excitatory postsynaptic potentialGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of microtubule cytoskeleton organizationGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of calcineurin-NFAT signaling cascadeGlycogen synthase kinase-3 betaHomo sapiens (human)
superior temporal gyrus developmentGlycogen synthase kinase-3 betaHomo sapiens (human)
cellular response to retinoic acidGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of canonical Wnt signaling pathwayGlycogen synthase kinase-3 betaHomo sapiens (human)
extrinsic apoptotic signaling pathwayGlycogen synthase kinase-3 betaHomo sapiens (human)
extrinsic apoptotic signaling pathway in absence of ligandGlycogen synthase kinase-3 betaHomo sapiens (human)
presynaptic modulation of chemical synaptic transmissionGlycogen synthase kinase-3 betaHomo sapiens (human)
neuron projection organizationGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of microtubule anchoring at centrosomeGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of cellular response to heatGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of protein localization to nucleusGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of long-term synaptic potentiationGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathwayGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of protein acetylationGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway via death domain receptorsGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of protein localization to ciliumGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of dopaminergic neuron differentiationGlycogen synthase kinase-3 betaHomo sapiens (human)
cellular response to amyloid-betaGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of protein localization to centrosomeGlycogen synthase kinase-3 betaHomo sapiens (human)
beta-catenin destruction complex disassemblyGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of type B pancreatic cell developmentGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of glycogen (starch) synthase activityGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of mesenchymal stem cell differentiationGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of TOR signalingGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of neuron projection developmentGlycogen synthase kinase-3 betaHomo sapiens (human)
cell differentiationGlycogen synthase kinase-3 betaHomo sapiens (human)
insulin receptor signaling pathwayGlycogen synthase kinase-3 betaHomo sapiens (human)
tolerance inductionC-C chemokine receptor type 4Homo sapiens (human)
chemotaxisC-C chemokine receptor type 4Homo sapiens (human)
inflammatory responseC-C chemokine receptor type 4Homo sapiens (human)
response to bacteriumC-C chemokine receptor type 4Homo sapiens (human)
homeostasis of number of cellsC-C chemokine receptor type 4Homo sapiens (human)
positive regulation of positive chemotaxisC-C chemokine receptor type 4Homo sapiens (human)
chemokine-mediated signaling pathwayC-C chemokine receptor type 4Homo sapiens (human)
interneuron migrationC-C chemokine receptor type 4Homo sapiens (human)
cell chemotaxisC-C chemokine receptor type 4Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationC-C chemokine receptor type 4Homo sapiens (human)
immune responseC-C chemokine receptor type 4Homo sapiens (human)
calcium-mediated signalingC-C chemokine receptor type 4Homo sapiens (human)
mitotic cell cycleSerine/threonine-protein kinase Nek2Homo sapiens (human)
blastocyst developmentSerine/threonine-protein kinase Nek2Homo sapiens (human)
protein phosphorylationSerine/threonine-protein kinase Nek2Homo sapiens (human)
chromosome segregationSerine/threonine-protein kinase Nek2Homo sapiens (human)
regulation of mitotic nuclear divisionSerine/threonine-protein kinase Nek2Homo sapiens (human)
positive regulation of telomere maintenance via telomeraseSerine/threonine-protein kinase Nek2Homo sapiens (human)
regulation of mitotic centrosome separationSerine/threonine-protein kinase Nek2Homo sapiens (human)
protein autophosphorylationSerine/threonine-protein kinase Nek2Homo sapiens (human)
spindle assemblySerine/threonine-protein kinase Nek2Homo sapiens (human)
centrosome separationSerine/threonine-protein kinase Nek2Homo sapiens (human)
cell divisionSerine/threonine-protein kinase Nek2Homo sapiens (human)
meiotic cell cycleSerine/threonine-protein kinase Nek2Homo sapiens (human)
positive regulation of telomerase activitySerine/threonine-protein kinase Nek2Homo sapiens (human)
regulation of attachment of spindle microtubules to kinetochoreSerine/threonine-protein kinase Nek2Homo sapiens (human)
mitotic spindle assemblySerine/threonine-protein kinase Nek2Homo sapiens (human)
negative regulation of centriole-centriole cohesionSerine/threonine-protein kinase Nek2Homo sapiens (human)
positive regulation of telomere cappingSerine/threonine-protein kinase Nek2Homo sapiens (human)
establishment of protein localizationSerine/threonine-protein kinase PLK1Homo sapiens (human)
mitotic sister chromatid segregationSerine/threonine-protein kinase PLK1Homo sapiens (human)
G2/M transition of mitotic cell cycleSerine/threonine-protein kinase PLK1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IISerine/threonine-protein kinase PLK1Homo sapiens (human)
establishment of mitotic spindle orientationSerine/threonine-protein kinase PLK1Homo sapiens (human)
mitotic cell cycleSerine/threonine-protein kinase PLK1Homo sapiens (human)
mitotic cytokinesisSerine/threonine-protein kinase PLK1Homo sapiens (human)
microtubule bundle formationSerine/threonine-protein kinase PLK1Homo sapiens (human)
double-strand break repairSerine/threonine-protein kinase PLK1Homo sapiens (human)
protein phosphorylationSerine/threonine-protein kinase PLK1Homo sapiens (human)
mitotic spindle organizationSerine/threonine-protein kinase PLK1Homo sapiens (human)
sister chromatid cohesionSerine/threonine-protein kinase PLK1Homo sapiens (human)
mitotic chromosome condensationSerine/threonine-protein kinase PLK1Homo sapiens (human)
mitotic nuclear membrane disassemblySerine/threonine-protein kinase PLK1Homo sapiens (human)
metaphase/anaphase transition of mitotic cell cycleSerine/threonine-protein kinase PLK1Homo sapiens (human)
mitotic spindle assembly checkpoint signalingSerine/threonine-protein kinase PLK1Homo sapiens (human)
mitotic G2 DNA damage checkpoint signalingSerine/threonine-protein kinase PLK1Homo sapiens (human)
centrosome cycleSerine/threonine-protein kinase PLK1Homo sapiens (human)
regulation of mitotic cell cycleSerine/threonine-protein kinase PLK1Homo sapiens (human)
positive regulation of peptidyl-threonine phosphorylationSerine/threonine-protein kinase PLK1Homo sapiens (human)
female meiosis chromosome segregationSerine/threonine-protein kinase PLK1Homo sapiens (human)
protein ubiquitinationSerine/threonine-protein kinase PLK1Homo sapiens (human)
peptidyl-serine phosphorylationSerine/threonine-protein kinase PLK1Homo sapiens (human)
regulation of mitotic metaphase/anaphase transitionSerine/threonine-protein kinase PLK1Homo sapiens (human)
protein destabilizationSerine/threonine-protein kinase PLK1Homo sapiens (human)
positive regulation of proteasomal ubiquitin-dependent protein catabolic processSerine/threonine-protein kinase PLK1Homo sapiens (human)
regulation of cytokinesisSerine/threonine-protein kinase PLK1Homo sapiens (human)
negative regulation of apoptotic processSerine/threonine-protein kinase PLK1Homo sapiens (human)
regulation of protein bindingSerine/threonine-protein kinase PLK1Homo sapiens (human)
homologous chromosome segregationSerine/threonine-protein kinase PLK1Homo sapiens (human)
negative regulation of cyclin-dependent protein serine/threonine kinase activitySerine/threonine-protein kinase PLK1Homo sapiens (human)
positive regulation of proteolysisSerine/threonine-protein kinase PLK1Homo sapiens (human)
Golgi inheritanceSerine/threonine-protein kinase PLK1Homo sapiens (human)
nuclear membrane disassemblySerine/threonine-protein kinase PLK1Homo sapiens (human)
positive regulation of ubiquitin-protein transferase activitySerine/threonine-protein kinase PLK1Homo sapiens (human)
regulation of cell cycleSerine/threonine-protein kinase PLK1Homo sapiens (human)
synaptonemal complex disassemblySerine/threonine-protein kinase PLK1Homo sapiens (human)
protein localization to chromatinSerine/threonine-protein kinase PLK1Homo sapiens (human)
protein localization to nuclear envelopeSerine/threonine-protein kinase PLK1Homo sapiens (human)
double-strand break repair via alternative nonhomologous end joiningSerine/threonine-protein kinase PLK1Homo sapiens (human)
positive regulation of protein localization to nucleusSerine/threonine-protein kinase PLK1Homo sapiens (human)
regulation of mitotic spindle assemblySerine/threonine-protein kinase PLK1Homo sapiens (human)
regulation of mitotic cell cycle phase transitionSerine/threonine-protein kinase PLK1Homo sapiens (human)
positive regulation of ubiquitin protein ligase activitySerine/threonine-protein kinase PLK1Homo sapiens (human)
regulation of protein localization to cell cortexSerine/threonine-protein kinase PLK1Homo sapiens (human)
regulation of anaphase-promoting complex-dependent catabolic processSerine/threonine-protein kinase PLK1Homo sapiens (human)
negative regulation of double-strand break repair via homologous recombinationSerine/threonine-protein kinase PLK1Homo sapiens (human)
apoptotic processDeath-associated protein kinase 1Homo sapiens (human)
defense response to tumor cellDeath-associated protein kinase 1Homo sapiens (human)
regulation of response to tumor cellDeath-associated protein kinase 1Homo sapiens (human)
protein phosphorylationDeath-associated protein kinase 1Homo sapiens (human)
apoptotic processDeath-associated protein kinase 1Homo sapiens (human)
extrinsic apoptotic signaling pathway via death domain receptorsDeath-associated protein kinase 1Homo sapiens (human)
regulation of autophagyDeath-associated protein kinase 1Homo sapiens (human)
positive regulation of autophagyDeath-associated protein kinase 1Homo sapiens (human)
negative regulation of translationDeath-associated protein kinase 1Homo sapiens (human)
intracellular signal transductionDeath-associated protein kinase 1Homo sapiens (human)
regulation of apoptotic processDeath-associated protein kinase 1Homo sapiens (human)
positive regulation of apoptotic processDeath-associated protein kinase 1Homo sapiens (human)
negative regulation of apoptotic processDeath-associated protein kinase 1Homo sapiens (human)
positive regulation of cysteine-type endopeptidase activity involved in apoptotic processDeath-associated protein kinase 1Homo sapiens (human)
protein autophosphorylationDeath-associated protein kinase 1Homo sapiens (human)
cellular response to type II interferonDeath-associated protein kinase 1Homo sapiens (human)
cellular response to hydroperoxideDeath-associated protein kinase 1Homo sapiens (human)
apoptotic signaling pathwayDeath-associated protein kinase 1Homo sapiens (human)
positive regulation of autophagic cell deathDeath-associated protein kinase 1Homo sapiens (human)
regulation of NMDA receptor activityDeath-associated protein kinase 1Homo sapiens (human)
protein phosphorylationMitogen-activated protein kinase 10Homo sapiens (human)
signal transductionMitogen-activated protein kinase 10Homo sapiens (human)
JNK cascadeMitogen-activated protein kinase 10Homo sapiens (human)
response to light stimulusMitogen-activated protein kinase 10Homo sapiens (human)
Fc-epsilon receptor signaling pathwayMitogen-activated protein kinase 10Homo sapiens (human)
regulation of circadian rhythmMitogen-activated protein kinase 10Homo sapiens (human)
rhythmic processMitogen-activated protein kinase 10Homo sapiens (human)
cellular senescenceMitogen-activated protein kinase 10Homo sapiens (human)
proteolysisBeta-secretase 1Homo sapiens (human)
membrane protein ectodomain proteolysisBeta-secretase 1Homo sapiens (human)
response to lead ionBeta-secretase 1Homo sapiens (human)
protein processingBeta-secretase 1Homo sapiens (human)
amyloid-beta formationBeta-secretase 1Homo sapiens (human)
amyloid precursor protein catabolic processBeta-secretase 1Homo sapiens (human)
positive regulation of neuron apoptotic processBeta-secretase 1Homo sapiens (human)
amyloid-beta metabolic processBeta-secretase 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painBeta-secretase 1Homo sapiens (human)
prepulse inhibitionBeta-secretase 1Homo sapiens (human)
cellular response to copper ionBeta-secretase 1Homo sapiens (human)
cellular response to manganese ionBeta-secretase 1Homo sapiens (human)
presynaptic modulation of chemical synaptic transmissionBeta-secretase 1Homo sapiens (human)
signaling receptor ligand precursor processingBeta-secretase 1Homo sapiens (human)
cellular response to amyloid-betaBeta-secretase 1Homo sapiens (human)
amyloid fibril formationBeta-secretase 1Homo sapiens (human)
signal transductionCasein kinase II subunit betaHomo sapiens (human)
negative regulation of cell population proliferationCasein kinase II subunit betaHomo sapiens (human)
Wnt signaling pathwayCasein kinase II subunit betaHomo sapiens (human)
peptidyl-threonine phosphorylationCasein kinase II subunit betaHomo sapiens (human)
negative regulation of proteasomal ubiquitin-dependent protein catabolic processCasein kinase II subunit betaHomo sapiens (human)
positive regulation of activin receptor signaling pathwayCasein kinase II subunit betaHomo sapiens (human)
adiponectin-activated signaling pathwayCasein kinase II subunit betaHomo sapiens (human)
negative regulation of blood vessel endothelial cell migrationCasein kinase II subunit betaHomo sapiens (human)
regulation of DNA bindingCasein kinase II subunit betaHomo sapiens (human)
positive regulation of SMAD protein signal transductionCasein kinase II subunit betaHomo sapiens (human)
endothelial tube morphogenesisCasein kinase II subunit betaHomo sapiens (human)
protein-containing complex assemblyCasein kinase II subunit betaHomo sapiens (human)
symbiont-mediated disruption of host cell PML bodyCasein kinase II subunit betaHomo sapiens (human)
negative regulation of viral life cycleCasein kinase II subunit betaHomo sapiens (human)
double-strand break repairCasein kinase II subunit alphaHomo sapiens (human)
protein phosphorylationCasein kinase II subunit alphaHomo sapiens (human)
apoptotic processCasein kinase II subunit alphaHomo sapiens (human)
DNA damage responseCasein kinase II subunit alphaHomo sapiens (human)
signal transductionCasein kinase II subunit alphaHomo sapiens (human)
positive regulation of cell population proliferationCasein kinase II subunit alphaHomo sapiens (human)
Wnt signaling pathwayCasein kinase II subunit alphaHomo sapiens (human)
negative regulation of translationCasein kinase II subunit alphaHomo sapiens (human)
peptidyl-serine phosphorylationCasein kinase II subunit alphaHomo sapiens (human)
peptidyl-threonine phosphorylationCasein kinase II subunit alphaHomo sapiens (human)
positive regulation of Wnt signaling pathwayCasein kinase II subunit alphaHomo sapiens (human)
positive regulation of cell growthCasein kinase II subunit alphaHomo sapiens (human)
negative regulation of proteasomal ubiquitin-dependent protein catabolic processCasein kinase II subunit alphaHomo sapiens (human)
negative regulation of cysteine-type endopeptidase activity involved in apoptotic processCasein kinase II subunit alphaHomo sapiens (human)
positive regulation of protein catabolic processCasein kinase II subunit alphaHomo sapiens (human)
rhythmic processCasein kinase II subunit alphaHomo sapiens (human)
protein stabilizationCasein kinase II subunit alphaHomo sapiens (human)
chaperone-mediated protein foldingCasein kinase II subunit alphaHomo sapiens (human)
symbiont-mediated disruption of host cell PML bodyCasein kinase II subunit alphaHomo sapiens (human)
positive regulation of aggrephagyCasein kinase II subunit alphaHomo sapiens (human)
regulation of chromosome separationCasein kinase II subunit alphaHomo sapiens (human)
negative regulation of double-strand break repair via homologous recombinationCasein kinase II subunit alphaHomo sapiens (human)
negative regulation of apoptotic signaling pathwayCasein kinase II subunit alphaHomo sapiens (human)
regulation of cell cycleCasein kinase II subunit alphaHomo sapiens (human)
positive regulation of epidermal growth factor receptor signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
response to hypoxiaDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
neutrophil mediated immunityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
germinal center formationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of leukocyte chemotaxisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
proteolysisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
membrane protein ectodomain proteolysisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cell adhesionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
Notch receptor processingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of cell population proliferationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
response to xenobiotic stimulusDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of T cell chemotaxisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
protein processingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
signal releaseDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
B cell differentiationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of cell growthDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of cell migrationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
response to lipopolysaccharideDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of chemokine productionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of tumor necrosis factor productionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
regulation of mast cell apoptotic processDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
T cell differentiation in thymusDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cell adhesion mediated by integrinDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
wound healing, spreading of epidermal cellsDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
amyloid precursor protein catabolic processDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of blood vessel endothelial cell migrationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of cyclin-dependent protein serine/threonine kinase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of epidermal growth factor-activated receptor activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of epidermal growth factor receptor signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
spleen developmentDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cell motilityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
defense response to Gram-positive bacteriumDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cellular response to high density lipoprotein particle stimulusDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
commissural neuron axon guidanceDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
negative regulation of cold-induced thermogenesisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of tumor necrosis factor-mediated signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of vascular endothelial cell proliferationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
Notch signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
response to oxidative stressLactoperoxidaseBos taurus (cattle)
thiocyanate metabolic processLactoperoxidaseBos taurus (cattle)
antibacterial humoral responseLactoperoxidaseBos taurus (cattle)
hydrogen peroxide catabolic processLactoperoxidaseBos taurus (cattle)
cellular oxidant detoxificationLactoperoxidaseBos taurus (cattle)
xanthine catabolic processXanthine dehydrogenase/oxidaseBos taurus (cattle)
G1/S transition of mitotic cell cycleCyclin-dependent kinase 6Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICyclin-dependent kinase 6Homo sapiens (human)
positive regulation of cell-matrix adhesionCyclin-dependent kinase 6Homo sapiens (human)
type B pancreatic cell developmentCyclin-dependent kinase 6Homo sapiens (human)
protein phosphorylationCyclin-dependent kinase 6Homo sapiens (human)
Notch signaling pathwayCyclin-dependent kinase 6Homo sapiens (human)
negative regulation of cell population proliferationCyclin-dependent kinase 6Homo sapiens (human)
response to virusCyclin-dependent kinase 6Homo sapiens (human)
regulation of gene expressionCyclin-dependent kinase 6Homo sapiens (human)
positive regulation of gene expressionCyclin-dependent kinase 6Homo sapiens (human)
astrocyte developmentCyclin-dependent kinase 6Homo sapiens (human)
dentate gyrus developmentCyclin-dependent kinase 6Homo sapiens (human)
lateral ventricle developmentCyclin-dependent kinase 6Homo sapiens (human)
T cell differentiation in thymusCyclin-dependent kinase 6Homo sapiens (human)
gliogenesisCyclin-dependent kinase 6Homo sapiens (human)
cell dedifferentiationCyclin-dependent kinase 6Homo sapiens (human)
negative regulation of cell differentiationCyclin-dependent kinase 6Homo sapiens (human)
negative regulation of myeloid cell differentiationCyclin-dependent kinase 6Homo sapiens (human)
regulation of erythrocyte differentiationCyclin-dependent kinase 6Homo sapiens (human)
negative regulation of monocyte differentiationCyclin-dependent kinase 6Homo sapiens (human)
negative regulation of osteoblast differentiationCyclin-dependent kinase 6Homo sapiens (human)
negative regulation of cell cycleCyclin-dependent kinase 6Homo sapiens (human)
positive regulation of fibroblast proliferationCyclin-dependent kinase 6Homo sapiens (human)
generation of neuronsCyclin-dependent kinase 6Homo sapiens (human)
negative regulation of epithelial cell proliferationCyclin-dependent kinase 6Homo sapiens (human)
cell divisionCyclin-dependent kinase 6Homo sapiens (human)
regulation of cell cycleCyclin-dependent kinase 6Homo sapiens (human)
hematopoietic stem cell differentiationCyclin-dependent kinase 6Homo sapiens (human)
regulation of hematopoietic stem cell differentiationCyclin-dependent kinase 6Homo sapiens (human)
regulation of cell motilityCyclin-dependent kinase 6Homo sapiens (human)
negative regulation of cellular senescenceCyclin-dependent kinase 6Homo sapiens (human)
regulation of G2/M transition of mitotic cell cycleCyclin-dependent kinase 6Homo sapiens (human)
response to organic substanceCyclin-dependent kinase 6Homo sapiens (human)
signal transductionCyclin-dependent kinase 6Homo sapiens (human)
microtubule cytoskeleton organizationCyclin-dependent-like kinase 5 Homo sapiens (human)
neuron migrationCyclin-dependent-like kinase 5 Homo sapiens (human)
synaptic transmission, dopaminergicCyclin-dependent-like kinase 5 Homo sapiens (human)
protein phosphorylationCyclin-dependent-like kinase 5 Homo sapiens (human)
intracellular protein transportCyclin-dependent-like kinase 5 Homo sapiens (human)
cell-matrix adhesionCyclin-dependent-like kinase 5 Homo sapiens (human)
chemical synaptic transmissionCyclin-dependent-like kinase 5 Homo sapiens (human)
synapse assemblyCyclin-dependent-like kinase 5 Homo sapiens (human)
skeletal muscle tissue developmentCyclin-dependent-like kinase 5 Homo sapiens (human)
motor neuron axon guidanceCyclin-dependent-like kinase 5 Homo sapiens (human)
visual learningCyclin-dependent-like kinase 5 Homo sapiens (human)
Schwann cell developmentCyclin-dependent-like kinase 5 Homo sapiens (human)
synaptic vesicle exocytosisCyclin-dependent-like kinase 5 Homo sapiens (human)
regulation of macroautophagyCyclin-dependent-like kinase 5 Homo sapiens (human)
phosphorylationCyclin-dependent-like kinase 5 Homo sapiens (human)
peptidyl-serine phosphorylationCyclin-dependent-like kinase 5 Homo sapiens (human)
peptidyl-threonine phosphorylationCyclin-dependent-like kinase 5 Homo sapiens (human)
sensory perception of painCyclin-dependent-like kinase 5 Homo sapiens (human)
cerebellar cortex formationCyclin-dependent-like kinase 5 Homo sapiens (human)
hippocampus developmentCyclin-dependent-like kinase 5 Homo sapiens (human)
layer formation in cerebral cortexCyclin-dependent-like kinase 5 Homo sapiens (human)
central nervous system neuron developmentCyclin-dependent-like kinase 5 Homo sapiens (human)
corpus callosum developmentCyclin-dependent-like kinase 5 Homo sapiens (human)
neuron differentiationCyclin-dependent-like kinase 5 Homo sapiens (human)
regulation of cell migrationCyclin-dependent-like kinase 5 Homo sapiens (human)
negative regulation of axon extensionCyclin-dependent-like kinase 5 Homo sapiens (human)
neuron projection developmentCyclin-dependent-like kinase 5 Homo sapiens (human)
negative regulation of protein ubiquitinationCyclin-dependent-like kinase 5 Homo sapiens (human)
negative regulation of synaptic plasticityCyclin-dependent-like kinase 5 Homo sapiens (human)
receptor catabolic processCyclin-dependent-like kinase 5 Homo sapiens (human)
synaptic transmission, glutamatergicCyclin-dependent-like kinase 5 Homo sapiens (human)
protein localization to synapseCyclin-dependent-like kinase 5 Homo sapiens (human)
regulation of apoptotic processCyclin-dependent-like kinase 5 Homo sapiens (human)
receptor clusteringCyclin-dependent-like kinase 5 Homo sapiens (human)
positive regulation of neuron apoptotic processCyclin-dependent-like kinase 5 Homo sapiens (human)
negative regulation of cell cycleCyclin-dependent-like kinase 5 Homo sapiens (human)
negative regulation of proteolysisCyclin-dependent-like kinase 5 Homo sapiens (human)
negative regulation of DNA-templated transcriptionCyclin-dependent-like kinase 5 Homo sapiens (human)
positive regulation of calcium ion-dependent exocytosisCyclin-dependent-like kinase 5 Homo sapiens (human)
negative regulation of protein export from nucleusCyclin-dependent-like kinase 5 Homo sapiens (human)
behavioral response to cocaineCyclin-dependent-like kinase 5 Homo sapiens (human)
regulation of synaptic plasticityCyclin-dependent-like kinase 5 Homo sapiens (human)
synaptic vesicle endocytosisCyclin-dependent-like kinase 5 Homo sapiens (human)
rhythmic processCyclin-dependent-like kinase 5 Homo sapiens (human)
axon extensionCyclin-dependent-like kinase 5 Homo sapiens (human)
oligodendrocyte differentiationCyclin-dependent-like kinase 5 Homo sapiens (human)
dendrite morphogenesisCyclin-dependent-like kinase 5 Homo sapiens (human)
cell divisionCyclin-dependent-like kinase 5 Homo sapiens (human)
neuron apoptotic processCyclin-dependent-like kinase 5 Homo sapiens (human)
regulation of cell cycleCyclin-dependent-like kinase 5 Homo sapiens (human)
regulation of synaptic transmission, glutamatergicCyclin-dependent-like kinase 5 Homo sapiens (human)
excitatory postsynaptic potentialCyclin-dependent-like kinase 5 Homo sapiens (human)
regulation of dendritic spine morphogenesisCyclin-dependent-like kinase 5 Homo sapiens (human)
calcium ion importCyclin-dependent-like kinase 5 Homo sapiens (human)
positive regulation of protein targeting to membraneCyclin-dependent-like kinase 5 Homo sapiens (human)
regulation of protein localization to plasma membraneCyclin-dependent-like kinase 5 Homo sapiens (human)
regulation of synaptic vesicle recyclingCyclin-dependent-like kinase 5 Homo sapiens (human)
cellular response to amyloid-betaCyclin-dependent-like kinase 5 Homo sapiens (human)
axonogenesisCyclin-dependent-like kinase 5 Homo sapiens (human)
synaptic vesicle transportCyclin-dependent-like kinase 5 Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIHeat shock factor protein 1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIHeat shock factor protein 1Homo sapiens (human)
MAPK cascadeHeat shock factor protein 1Homo sapiens (human)
DNA repairHeat shock factor protein 1Homo sapiens (human)
regulation of transcription by RNA polymerase IIHeat shock factor protein 1Homo sapiens (human)
mRNA processingHeat shock factor protein 1Homo sapiens (human)
defense responseHeat shock factor protein 1Homo sapiens (human)
response to nutrientHeat shock factor protein 1Homo sapiens (human)
positive regulation of gene expressionHeat shock factor protein 1Homo sapiens (human)
negative regulation of gene expressionHeat shock factor protein 1Homo sapiens (human)
negative regulation of cardiac muscle cell apoptotic processHeat shock factor protein 1Homo sapiens (human)
response to activityHeat shock factor protein 1Homo sapiens (human)
negative regulation of protein-containing complex assemblyHeat shock factor protein 1Homo sapiens (human)
response to testosteroneHeat shock factor protein 1Homo sapiens (human)
cellular response to heatHeat shock factor protein 1Homo sapiens (human)
cellular response to unfolded proteinHeat shock factor protein 1Homo sapiens (human)
cellular response to potassium ionHeat shock factor protein 1Homo sapiens (human)
positive regulation of tyrosine phosphorylation of STAT proteinHeat shock factor protein 1Homo sapiens (human)
positive regulation of macrophage differentiationHeat shock factor protein 1Homo sapiens (human)
positive regulation of mitotic cell cycleHeat shock factor protein 1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIHeat shock factor protein 1Homo sapiens (human)
mRNA transportHeat shock factor protein 1Homo sapiens (human)
positive regulation of DNA-binding transcription factor activityHeat shock factor protein 1Homo sapiens (human)
positive regulation of stress granule assemblyHeat shock factor protein 1Homo sapiens (human)
protein-containing complex assemblyHeat shock factor protein 1Homo sapiens (human)
cellular response to hydrogen peroxideHeat shock factor protein 1Homo sapiens (human)
cellular response to lipopolysaccharideHeat shock factor protein 1Homo sapiens (human)
cellular response to cadmium ionHeat shock factor protein 1Homo sapiens (human)
cellular response to copper ionHeat shock factor protein 1Homo sapiens (human)
cellular response to estradiol stimulusHeat shock factor protein 1Homo sapiens (human)
cellular response to xenobiotic stimulusHeat shock factor protein 1Homo sapiens (human)
cellular response to gamma radiationHeat shock factor protein 1Homo sapiens (human)
cellular response to diamideHeat shock factor protein 1Homo sapiens (human)
negative regulation of inclusion body assemblyHeat shock factor protein 1Homo sapiens (human)
positive regulation of inclusion body assemblyHeat shock factor protein 1Homo sapiens (human)
positive regulation of cold-induced thermogenesisHeat shock factor protein 1Homo sapiens (human)
regulation of cellular response to heatHeat shock factor protein 1Homo sapiens (human)
response to peptideHeat shock factor protein 1Homo sapiens (human)
positive regulation of apoptotic DNA fragmentationHeat shock factor protein 1Homo sapiens (human)
cellular response to sodium arseniteHeat shock factor protein 1Homo sapiens (human)
cellular response to angiotensinHeat shock factor protein 1Homo sapiens (human)
cellular response to nitroglycerinHeat shock factor protein 1Homo sapiens (human)
cellular response to L-glutamineHeat shock factor protein 1Homo sapiens (human)
response to hypobaric hypoxiaHeat shock factor protein 1Homo sapiens (human)
response to psychosocial stressHeat shock factor protein 1Homo sapiens (human)
negative regulation of double-strand break repair via nonhomologous end joiningHeat shock factor protein 1Homo sapiens (human)
glucose metabolic processSorbitol dehydrogenaseHomo sapiens (human)
sorbitol catabolic processSorbitol dehydrogenaseHomo sapiens (human)
glucuronate catabolic process to xylulose 5-phosphateSorbitol dehydrogenaseHomo sapiens (human)
flagellated sperm motilitySorbitol dehydrogenaseHomo sapiens (human)
fructose biosynthetic processSorbitol dehydrogenaseHomo sapiens (human)
L-xylitol catabolic processSorbitol dehydrogenaseHomo sapiens (human)
L-xylitol metabolic processSorbitol dehydrogenaseHomo sapiens (human)
chemotaxisDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
signal transductionDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
heart developmentDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
negative regulation of cell population proliferationDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
positive regulation of gene expressionDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
Schwann cell developmentDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
cerebellar cortex formationDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
keratinocyte differentiationDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
thyroid gland developmentDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
regulation of stress-activated MAPK cascadeDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
endodermal cell differentiationDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
ERBB2-ERBB3 signaling pathwayDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
myelinationDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
type B pancreatic cell proliferationDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
positive regulation of DNA-templated transcriptionDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
insulin-like growth factor receptor signaling pathwayDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
thymus developmentDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
regulation of axon regenerationDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
cell motilityDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
positive regulation of axonogenesisDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
Bergmann glial cell differentiationDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
face developmentDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
trachea formationDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
epithelial cell proliferation involved in lung morphogenesisDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
placenta blood vessel developmentDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
labyrinthine layer developmentDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
ERK1 and ERK2 cascadeDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
positive regulation of protein serine/threonine kinase activityDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
regulation of Golgi inheritanceDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
cellular senescenceDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
positive regulation of endodermal cell differentiationDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
regulation of early endosome to late endosome transportDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
neuron differentiationDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
MAPK cascadeDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
carbohydrate metabolic processLactoylglutathione lyaseHomo sapiens (human)
regulation of transcription by RNA polymerase IILactoylglutathione lyaseHomo sapiens (human)
glutathione metabolic processLactoylglutathione lyaseHomo sapiens (human)
methylglyoxal metabolic processLactoylglutathione lyaseHomo sapiens (human)
osteoclast differentiationLactoylglutathione lyaseHomo sapiens (human)
negative regulation of apoptotic processLactoylglutathione lyaseHomo sapiens (human)
positive regulation of macrophage chemotaxisFocal adhesion kinase 1Homo sapiens (human)
positive regulation of macrophage proliferationFocal adhesion kinase 1Homo sapiens (human)
angiogenesisFocal adhesion kinase 1Homo sapiens (human)
placenta developmentFocal adhesion kinase 1Homo sapiens (human)
regulation of protein phosphorylationFocal adhesion kinase 1Homo sapiens (human)
positive regulation of protein phosphorylationFocal adhesion kinase 1Homo sapiens (human)
heart morphogenesisFocal adhesion kinase 1Homo sapiens (human)
signal complex assemblyFocal adhesion kinase 1Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayFocal adhesion kinase 1Homo sapiens (human)
integrin-mediated signaling pathwayFocal adhesion kinase 1Homo sapiens (human)
axon guidanceFocal adhesion kinase 1Homo sapiens (human)
positive regulation of cell population proliferationFocal adhesion kinase 1Homo sapiens (human)
regulation of cell shapeFocal adhesion kinase 1Homo sapiens (human)
regulation of endothelial cell migrationFocal adhesion kinase 1Homo sapiens (human)
regulation of epithelial cell migrationFocal adhesion kinase 1Homo sapiens (human)
positive regulation of epithelial cell migrationFocal adhesion kinase 1Homo sapiens (human)
positive regulation of epithelial to mesenchymal transitionFocal adhesion kinase 1Homo sapiens (human)
positive regulation of fibroblast migrationFocal adhesion kinase 1Homo sapiens (human)
cell migrationFocal adhesion kinase 1Homo sapiens (human)
peptidyl-tyrosine phosphorylationFocal adhesion kinase 1Homo sapiens (human)
negative regulation of cell-cell adhesionFocal adhesion kinase 1Homo sapiens (human)
establishment of cell polarityFocal adhesion kinase 1Homo sapiens (human)
positive regulation of cell migrationFocal adhesion kinase 1Homo sapiens (human)
regulation of cell adhesion mediated by integrinFocal adhesion kinase 1Homo sapiens (human)
detection of muscle stretchFocal adhesion kinase 1Homo sapiens (human)
netrin-activated signaling pathwayFocal adhesion kinase 1Homo sapiens (human)
Fc-gamma receptor signaling pathway involved in phagocytosisFocal adhesion kinase 1Homo sapiens (human)
regulation of cell population proliferationFocal adhesion kinase 1Homo sapiens (human)
negative regulation of apoptotic processFocal adhesion kinase 1Homo sapiens (human)
regulation of GTPase activityFocal adhesion kinase 1Homo sapiens (human)
regulation of osteoblast differentiationFocal adhesion kinase 1Homo sapiens (human)
positive regulation of protein kinase activityFocal adhesion kinase 1Homo sapiens (human)
protein autophosphorylationFocal adhesion kinase 1Homo sapiens (human)
vascular endothelial growth factor receptor signaling pathwayFocal adhesion kinase 1Homo sapiens (human)
ephrin receptor signaling pathwayFocal adhesion kinase 1Homo sapiens (human)
cell motilityFocal adhesion kinase 1Homo sapiens (human)
regulation of cytoskeleton organizationFocal adhesion kinase 1Homo sapiens (human)
regulation of focal adhesion assemblyFocal adhesion kinase 1Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionFocal adhesion kinase 1Homo sapiens (human)
growth hormone receptor signaling pathwayFocal adhesion kinase 1Homo sapiens (human)
positive regulation of wound healingFocal adhesion kinase 1Homo sapiens (human)
regulation of substrate adhesion-dependent cell spreadingFocal adhesion kinase 1Homo sapiens (human)
positive regulation of ubiquitin-dependent protein catabolic processFocal adhesion kinase 1Homo sapiens (human)
negative regulation of anoikisFocal adhesion kinase 1Homo sapiens (human)
protein phosphorylationFocal adhesion kinase 1Homo sapiens (human)
epidermal growth factor receptor signaling pathwayFocal adhesion kinase 1Homo sapiens (human)
regulation of cell adhesionFocal adhesion kinase 1Homo sapiens (human)
protein phosphorylationCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
signal transductionCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
nervous system developmentCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
positive regulation of neuron projection developmentCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
regulation of skeletal muscle adaptationCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
cell differentiationCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
protein autophosphorylationCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
regulation of long-term neuronal synaptic plasticityCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
regulation of synapse structural plasticityCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
regulation of calcium ion transportCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
regulation of dendritic spine developmentCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
positive regulation of dendritic spine morphogenesisCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
positive regulation of synapse maturationCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
regulation of neuron migrationCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
nervous system developmentELAV-like protein 3Homo sapiens (human)
cell differentiationELAV-like protein 3Homo sapiens (human)
regulation of cyclin-dependent protein serine/threonine kinase activityCyclin-dependent kinase 5 activator 1Homo sapiens (human)
microtubule cytoskeleton organizationCyclin-dependent kinase 5 activator 1Homo sapiens (human)
neuron migrationCyclin-dependent kinase 5 activator 1Homo sapiens (human)
neuron cell-cell adhesionCyclin-dependent kinase 5 activator 1Homo sapiens (human)
G protein-coupled acetylcholine receptor signaling pathwayCyclin-dependent kinase 5 activator 1Homo sapiens (human)
axon guidanceCyclin-dependent kinase 5 activator 1Homo sapiens (human)
axonal fasciculationCyclin-dependent kinase 5 activator 1Homo sapiens (human)
brain developmentCyclin-dependent kinase 5 activator 1Homo sapiens (human)
embryo development ending in birth or egg hatchingCyclin-dependent kinase 5 activator 1Homo sapiens (human)
regulation of macroautophagyCyclin-dependent kinase 5 activator 1Homo sapiens (human)
peptidyl-serine phosphorylationCyclin-dependent kinase 5 activator 1Homo sapiens (human)
peptidyl-threonine phosphorylationCyclin-dependent kinase 5 activator 1Homo sapiens (human)
cerebellum developmentCyclin-dependent kinase 5 activator 1Homo sapiens (human)
superior olivary nucleus maturationCyclin-dependent kinase 5 activator 1Homo sapiens (human)
hippocampus developmentCyclin-dependent kinase 5 activator 1Homo sapiens (human)
layer formation in cerebral cortexCyclin-dependent kinase 5 activator 1Homo sapiens (human)
neuron differentiationCyclin-dependent kinase 5 activator 1Homo sapiens (human)
positive regulation of microtubule polymerizationCyclin-dependent kinase 5 activator 1Homo sapiens (human)
neuron projection developmentCyclin-dependent kinase 5 activator 1Homo sapiens (human)
regulation of actin cytoskeleton organizationCyclin-dependent kinase 5 activator 1Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayCyclin-dependent kinase 5 activator 1Homo sapiens (human)
positive regulation of neuron apoptotic processCyclin-dependent kinase 5 activator 1Homo sapiens (human)
regulation of neuron differentiationCyclin-dependent kinase 5 activator 1Homo sapiens (human)
negative regulation of DNA-templated transcriptionCyclin-dependent kinase 5 activator 1Homo sapiens (human)
ephrin receptor signaling pathwayCyclin-dependent kinase 5 activator 1Homo sapiens (human)
rhythmic processCyclin-dependent kinase 5 activator 1Homo sapiens (human)
regulation of dendritic spine morphogenesisCyclin-dependent kinase 5 activator 1Homo sapiens (human)
G1 to G0 transition involved in cell differentiationCyclin-dependent kinase 5 activator 1Homo sapiens (human)
positive regulation of protein targeting to membraneCyclin-dependent kinase 5 activator 1Homo sapiens (human)
regulation of synaptic vesicle cycleCyclin-dependent kinase 5 activator 1Homo sapiens (human)
positive regulation of translationELAV-like protein 1Homo sapiens (human)
mRNA stabilizationELAV-like protein 1Homo sapiens (human)
protein import into nucleusELAV-like protein 1Homo sapiens (human)
post-transcriptional gene silencingELAV-like protein 1Homo sapiens (human)
positive regulation of superoxide anion generationELAV-like protein 1Homo sapiens (human)
mRNA stabilizationELAV-like protein 1Homo sapiens (human)
protein homooligomerizationELAV-like protein 1Homo sapiens (human)
negative regulation of miRNA-mediated gene silencingELAV-like protein 1Homo sapiens (human)
mRNA destabilizationELAV-like protein 1Homo sapiens (human)
3'-UTR-mediated mRNA stabilizationELAV-like protein 1Homo sapiens (human)
regulation of stem cell population maintenanceELAV-like protein 1Homo sapiens (human)
B cell homeostasisSerine/threonine-protein kinase N1Homo sapiens (human)
B cell apoptotic processSerine/threonine-protein kinase N1Homo sapiens (human)
negative regulation of protein phosphorylationSerine/threonine-protein kinase N1Homo sapiens (human)
regulation of germinal center formationSerine/threonine-protein kinase N1Homo sapiens (human)
regulation of immunoglobulin productionSerine/threonine-protein kinase N1Homo sapiens (human)
renal system processSerine/threonine-protein kinase N1Homo sapiens (human)
chromatin remodelingSerine/threonine-protein kinase N1Homo sapiens (human)
regulation of transcription by RNA polymerase IISerine/threonine-protein kinase N1Homo sapiens (human)
protein phosphorylationSerine/threonine-protein kinase N1Homo sapiens (human)
hyperosmotic responseSerine/threonine-protein kinase N1Homo sapiens (human)
signal transductionSerine/threonine-protein kinase N1Homo sapiens (human)
epithelial cell migrationSerine/threonine-protein kinase N1Homo sapiens (human)
negative regulation of B cell proliferationSerine/threonine-protein kinase N1Homo sapiens (human)
post-translational protein modificationSerine/threonine-protein kinase N1Homo sapiens (human)
positive regulation of DNA-templated transcriptionSerine/threonine-protein kinase N1Homo sapiens (human)
spleen developmentSerine/threonine-protein kinase N1Homo sapiens (human)
regulation of androgen receptor signaling pathwaySerine/threonine-protein kinase N1Homo sapiens (human)
regulation of cell motilitySerine/threonine-protein kinase N1Homo sapiens (human)
peptidyl-serine phosphorylationSerine/threonine-protein kinase N1Homo sapiens (human)
intracellular signal transductionSerine/threonine-protein kinase N1Homo sapiens (human)
positive regulation of blood vessel endothelial cell migrationMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to lipopolysaccharideMitogen-activated protein kinase 14Homo sapiens (human)
DNA damage checkpoint signalingMitogen-activated protein kinase 14Homo sapiens (human)
cell morphogenesisMitogen-activated protein kinase 14Homo sapiens (human)
cartilage condensationMitogen-activated protein kinase 14Homo sapiens (human)
angiogenesisMitogen-activated protein kinase 14Homo sapiens (human)
osteoblast differentiationMitogen-activated protein kinase 14Homo sapiens (human)
placenta developmentMitogen-activated protein kinase 14Homo sapiens (human)
response to dietary excessMitogen-activated protein kinase 14Homo sapiens (human)
chondrocyte differentiationMitogen-activated protein kinase 14Homo sapiens (human)
negative regulation of inflammatory response to antigenic stimulusMitogen-activated protein kinase 14Homo sapiens (human)
glucose metabolic processMitogen-activated protein kinase 14Homo sapiens (human)
regulation of transcription by RNA polymerase IIMitogen-activated protein kinase 14Homo sapiens (human)
transcription by RNA polymerase IIMitogen-activated protein kinase 14Homo sapiens (human)
apoptotic processMitogen-activated protein kinase 14Homo sapiens (human)
chemotaxisMitogen-activated protein kinase 14Homo sapiens (human)
signal transductionMitogen-activated protein kinase 14Homo sapiens (human)
cell surface receptor signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
cell surface receptor protein serine/threonine kinase signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
skeletal muscle tissue developmentMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of gene expressionMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of myotube differentiationMitogen-activated protein kinase 14Homo sapiens (human)
peptidyl-serine phosphorylationMitogen-activated protein kinase 14Homo sapiens (human)
fatty acid oxidationMitogen-activated protein kinase 14Homo sapiens (human)
platelet activationMitogen-activated protein kinase 14Homo sapiens (human)
regulation of ossificationMitogen-activated protein kinase 14Homo sapiens (human)
osteoclast differentiationMitogen-activated protein kinase 14Homo sapiens (human)
stress-activated protein kinase signaling cascadeMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of cyclase activityMitogen-activated protein kinase 14Homo sapiens (human)
lipopolysaccharide-mediated signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
response to muramyl dipeptideMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of interleukin-12 productionMitogen-activated protein kinase 14Homo sapiens (human)
response to insulinMitogen-activated protein kinase 14Homo sapiens (human)
negative regulation of hippo signalingMitogen-activated protein kinase 14Homo sapiens (human)
intracellular signal transductionMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to vascular endothelial growth factor stimulusMitogen-activated protein kinase 14Homo sapiens (human)
response to muscle stretchMitogen-activated protein kinase 14Homo sapiens (human)
p38MAPK cascadeMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of protein import into nucleusMitogen-activated protein kinase 14Homo sapiens (human)
signal transduction in response to DNA damageMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of erythrocyte differentiationMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of myoblast differentiationMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIMitogen-activated protein kinase 14Homo sapiens (human)
glucose importMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of glucose importMitogen-activated protein kinase 14Homo sapiens (human)
vascular endothelial growth factor receptor signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
stem cell differentiationMitogen-activated protein kinase 14Homo sapiens (human)
striated muscle cell differentiationMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of muscle cell differentiationMitogen-activated protein kinase 14Homo sapiens (human)
stress-activated MAPK cascadeMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of cardiac muscle cell proliferationMitogen-activated protein kinase 14Homo sapiens (human)
bone developmentMitogen-activated protein kinase 14Homo sapiens (human)
3'-UTR-mediated mRNA stabilizationMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to lipoteichoic acidMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to tumor necrosis factorMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to ionizing radiationMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to UV-BMitogen-activated protein kinase 14Homo sapiens (human)
negative regulation of canonical Wnt signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of brown fat cell differentiationMitogen-activated protein kinase 14Homo sapiens (human)
cellular senescenceMitogen-activated protein kinase 14Homo sapiens (human)
stress-induced premature senescenceMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to virusMitogen-activated protein kinase 14Homo sapiens (human)
regulation of synaptic membrane adhesionMitogen-activated protein kinase 14Homo sapiens (human)
regulation of cytokine production involved in inflammatory responseMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of myoblast fusionMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to organic cyclic compoundCytochrome P450 1B1Homo sapiens (human)
angiogenesisCytochrome P450 1B1Homo sapiens (human)
trabecular meshwork developmentCytochrome P450 1B1Homo sapiens (human)
DNA modificationCytochrome P450 1B1Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1B1Homo sapiens (human)
nitric oxide biosynthetic processCytochrome P450 1B1Homo sapiens (human)
cell adhesionCytochrome P450 1B1Homo sapiens (human)
response to nutrientCytochrome P450 1B1Homo sapiens (human)
steroid metabolic processCytochrome P450 1B1Homo sapiens (human)
estrogen metabolic processCytochrome P450 1B1Homo sapiens (human)
negative regulation of cell population proliferationCytochrome P450 1B1Homo sapiens (human)
male gonad developmentCytochrome P450 1B1Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to oxidative stressCytochrome P450 1B1Homo sapiens (human)
toxin metabolic processCytochrome P450 1B1Homo sapiens (human)
positive regulation of vascular endothelial growth factor productionCytochrome P450 1B1Homo sapiens (human)
positive regulation of smooth muscle cell migrationCytochrome P450 1B1Homo sapiens (human)
sterol metabolic processCytochrome P450 1B1Homo sapiens (human)
arachidonic acid metabolic processCytochrome P450 1B1Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1B1Homo sapiens (human)
collagen fibril organizationCytochrome P450 1B1Homo sapiens (human)
adrenal gland developmentCytochrome P450 1B1Homo sapiens (human)
negative regulation of cell migrationCytochrome P450 1B1Homo sapiens (human)
negative regulation of NF-kappaB transcription factor activityCytochrome P450 1B1Homo sapiens (human)
response to follicle-stimulating hormoneCytochrome P450 1B1Homo sapiens (human)
response to estradiolCytochrome P450 1B1Homo sapiens (human)
negative regulation of cell adhesion mediated by integrinCytochrome P450 1B1Homo sapiens (human)
benzene-containing compound metabolic processCytochrome P450 1B1Homo sapiens (human)
retinol metabolic processCytochrome P450 1B1Homo sapiens (human)
retinal metabolic processCytochrome P450 1B1Homo sapiens (human)
positive regulation of apoptotic processCytochrome P450 1B1Homo sapiens (human)
blood vessel endothelial cell migrationCytochrome P450 1B1Homo sapiens (human)
endothelial cell migrationCytochrome P450 1B1Homo sapiens (human)
estrous cycleCytochrome P450 1B1Homo sapiens (human)
positive regulation of translationCytochrome P450 1B1Homo sapiens (human)
positive regulation of angiogenesisCytochrome P450 1B1Homo sapiens (human)
positive regulation of receptor signaling pathway via JAK-STATCytochrome P450 1B1Homo sapiens (human)
membrane lipid catabolic processCytochrome P450 1B1Homo sapiens (human)
response to arsenic-containing substanceCytochrome P450 1B1Homo sapiens (human)
blood vessel morphogenesisCytochrome P450 1B1Homo sapiens (human)
retinal blood vessel morphogenesisCytochrome P450 1B1Homo sapiens (human)
ganglion developmentCytochrome P450 1B1Homo sapiens (human)
cellular response to hydrogen peroxideCytochrome P450 1B1Homo sapiens (human)
cellular response to cAMPCytochrome P450 1B1Homo sapiens (human)
cellular response to tumor necrosis factorCytochrome P450 1B1Homo sapiens (human)
cellular response to luteinizing hormone stimulusCytochrome P450 1B1Homo sapiens (human)
cellular response to cortisol stimulusCytochrome P450 1B1Homo sapiens (human)
cellular response to progesterone stimulusCytochrome P450 1B1Homo sapiens (human)
response to dexamethasoneCytochrome P450 1B1Homo sapiens (human)
endothelial cell-cell adhesionCytochrome P450 1B1Homo sapiens (human)
response to indole-3-methanolCytochrome P450 1B1Homo sapiens (human)
cellular response to toxic substanceCytochrome P450 1B1Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1B1Homo sapiens (human)
response to 3-methylcholanthreneCytochrome P450 1B1Homo sapiens (human)
regulation of reactive oxygen species metabolic processCytochrome P450 1B1Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCytochrome P450 1B1Homo sapiens (human)
positive regulation of DNA biosynthetic processCytochrome P450 1B1Homo sapiens (human)
response to hypoxiaCarbonic anhydrase 9Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 9Homo sapiens (human)
response to xenobiotic stimulusCarbonic anhydrase 9Homo sapiens (human)
response to testosteroneCarbonic anhydrase 9Homo sapiens (human)
secretionCarbonic anhydrase 9Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 9Homo sapiens (human)
carbohydrate metabolic processProbable maltase-glucoamylase 2Homo sapiens (human)
protein phosphorylationCasein kinase II subunit alpha 3Homo sapiens (human)
positive regulation of cell population proliferationCasein kinase II subunit alpha 3Homo sapiens (human)
positive regulation of cell growthCasein kinase II subunit alpha 3Homo sapiens (human)
positive regulation of protein catabolic processCasein kinase II subunit alpha 3Homo sapiens (human)
peptidyl-threonine phosphorylationCasein kinase II subunit alpha 3Homo sapiens (human)
peptidyl-serine phosphorylationCasein kinase II subunit alpha 3Homo sapiens (human)
regulation of cell cycleCasein kinase II subunit alpha 3Homo sapiens (human)
inositol trisphosphate metabolic processInositol polyphosphate multikinaseHomo sapiens (human)
inositol phosphate metabolic processInositol polyphosphate multikinaseHomo sapiens (human)
phosphatidylinositol metabolic processInositol polyphosphate multikinaseHomo sapiens (human)
necroptotic processInositol polyphosphate multikinaseHomo sapiens (human)
inositol phosphate biosynthetic processInositol polyphosphate multikinaseHomo sapiens (human)
cell divisionG2/mitotic-specific cyclin-B3Homo sapiens (human)
meiotic cell cycleG2/mitotic-specific cyclin-B3Homo sapiens (human)
regulation of cyclin-dependent protein serine/threonine kinase activityG2/mitotic-specific cyclin-B3Homo sapiens (human)
mitotic cell cycle phase transitionG2/mitotic-specific cyclin-B3Homo sapiens (human)
xenobiotic metabolic processCanalicular multispecific organic anion transporter 1Homo sapiens (human)
xenobiotic transmembrane transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
negative regulation of gene expressionCanalicular multispecific organic anion transporter 1Homo sapiens (human)
bile acid and bile salt transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
bilirubin transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
heme catabolic processCanalicular multispecific organic anion transporter 1Homo sapiens (human)
xenobiotic export from cellCanalicular multispecific organic anion transporter 1Homo sapiens (human)
transmembrane transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
transepithelial transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
leukotriene transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
monoatomic anion transmembrane transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
transport across blood-brain barrierCanalicular multispecific organic anion transporter 1Homo sapiens (human)
xenobiotic transport across blood-brain barrierCanalicular multispecific organic anion transporter 1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIAurora kinase BHomo sapiens (human)
mitotic cell cycleAurora kinase BHomo sapiens (human)
mitotic cytokinesisAurora kinase BHomo sapiens (human)
negative regulation of B cell apoptotic processAurora kinase BHomo sapiens (human)
protein phosphorylationAurora kinase BHomo sapiens (human)
spindle organizationAurora kinase BHomo sapiens (human)
attachment of spindle microtubules to kinetochoreAurora kinase BHomo sapiens (human)
abscissionAurora kinase BHomo sapiens (human)
negative regulation of protein bindingAurora kinase BHomo sapiens (human)
positive regulation of telomere maintenance via telomeraseAurora kinase BHomo sapiens (human)
negative regulation of cytokinesisAurora kinase BHomo sapiens (human)
positive regulation of cytokinesisAurora kinase BHomo sapiens (human)
protein localization to kinetochoreAurora kinase BHomo sapiens (human)
cellular response to UVAurora kinase BHomo sapiens (human)
cleavage furrow formationAurora kinase BHomo sapiens (human)
post-translational protein modificationAurora kinase BHomo sapiens (human)
cell cycle G2/M phase transitionAurora kinase BHomo sapiens (human)
mitotic cytokinesis checkpoint signalingAurora kinase BHomo sapiens (human)
negative regulation of innate immune responseAurora kinase BHomo sapiens (human)
protein autophosphorylationAurora kinase BHomo sapiens (human)
mitotic spindle midzone assemblyAurora kinase BHomo sapiens (human)
positive regulation of telomerase activityAurora kinase BHomo sapiens (human)
regulation of chromosome segregationAurora kinase BHomo sapiens (human)
positive regulation of mitotic sister chromatid segregationAurora kinase BHomo sapiens (human)
positive regulation of mitotic cell cycle spindle assembly checkpointAurora kinase BHomo sapiens (human)
mitotic spindle assemblyAurora kinase BHomo sapiens (human)
negative regulation of cGAS/STING signaling pathwayAurora kinase BHomo sapiens (human)
regulation of signal transduction by p53 class mediatorAurora kinase BHomo sapiens (human)
positive regulation of mitotic sister chromatid separationAurora kinase BHomo sapiens (human)
positive regulation of attachment of mitotic spindle microtubules to kinetochoreAurora kinase BHomo sapiens (human)
positive regulation of mitotic cytokinesisAurora kinase BHomo sapiens (human)
positive regulation of telomere cappingAurora kinase BHomo sapiens (human)
positive regulation of lateral attachment of mitotic spindle microtubules to kinetochoreAurora kinase BHomo sapiens (human)
mitotic spindle organizationAurora kinase BHomo sapiens (human)
regulation of cytokinesisAurora kinase BHomo sapiens (human)
proteolysisChymotrypsin-CHomo sapiens (human)
intracellular calcium ion homeostasisChymotrypsin-CHomo sapiens (human)
proteolysisChymotrypsin-CHomo sapiens (human)
negative regulation of signaling receptor activityAngiotensin-converting enzyme 2 Homo sapiens (human)
symbiont entry into host cellAngiotensin-converting enzyme 2 Homo sapiens (human)
regulation of cytokine productionAngiotensin-converting enzyme 2 Homo sapiens (human)
angiotensin maturationAngiotensin-converting enzyme 2 Homo sapiens (human)
angiotensin-mediated drinking behaviorAngiotensin-converting enzyme 2 Homo sapiens (human)
regulation of systemic arterial blood pressure by renin-angiotensinAngiotensin-converting enzyme 2 Homo sapiens (human)
tryptophan transportAngiotensin-converting enzyme 2 Homo sapiens (human)
viral life cycleAngiotensin-converting enzyme 2 Homo sapiens (human)
receptor-mediated endocytosis of virus by host cellAngiotensin-converting enzyme 2 Homo sapiens (human)
regulation of vasoconstrictionAngiotensin-converting enzyme 2 Homo sapiens (human)
regulation of transmembrane transporter activityAngiotensin-converting enzyme 2 Homo sapiens (human)
regulation of cell population proliferationAngiotensin-converting enzyme 2 Homo sapiens (human)
symbiont entry into host cellAngiotensin-converting enzyme 2 Homo sapiens (human)
receptor-mediated virion attachment to host cellAngiotensin-converting enzyme 2 Homo sapiens (human)
negative regulation of smooth muscle cell proliferationAngiotensin-converting enzyme 2 Homo sapiens (human)
regulation of inflammatory responseAngiotensin-converting enzyme 2 Homo sapiens (human)
positive regulation of amino acid transportAngiotensin-converting enzyme 2 Homo sapiens (human)
maternal process involved in female pregnancyAngiotensin-converting enzyme 2 Homo sapiens (human)
positive regulation of cardiac muscle contractionAngiotensin-converting enzyme 2 Homo sapiens (human)
membrane fusionAngiotensin-converting enzyme 2 Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascadeAngiotensin-converting enzyme 2 Homo sapiens (human)
blood vessel diameter maintenanceAngiotensin-converting enzyme 2 Homo sapiens (human)
entry receptor-mediated virion attachment to host cellAngiotensin-converting enzyme 2 Homo sapiens (human)
positive regulation of gap junction assemblyAngiotensin-converting enzyme 2 Homo sapiens (human)
regulation of cardiac conductionAngiotensin-converting enzyme 2 Homo sapiens (human)
positive regulation of L-proline import across plasma membraneAngiotensin-converting enzyme 2 Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processAngiotensin-converting enzyme 2 Homo sapiens (human)
cytoskeleton organizationG-protein coupled receptor 35Homo sapiens (human)
G protein-coupled receptor signaling pathwayG-protein coupled receptor 35Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationG-protein coupled receptor 35Homo sapiens (human)
chemokine-mediated signaling pathwayG-protein coupled receptor 35Homo sapiens (human)
negative regulation of voltage-gated calcium channel activityG-protein coupled receptor 35Homo sapiens (human)
negative regulation of neuronal action potentialG-protein coupled receptor 35Homo sapiens (human)
positive regulation of Rho protein signal transductionG-protein coupled receptor 35Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayG-protein coupled receptor 35Homo sapiens (human)
protein phosphorylationSerine/threonine-protein kinase Nek6Homo sapiens (human)
apoptotic processSerine/threonine-protein kinase Nek6Homo sapiens (human)
mitotic spindle organizationSerine/threonine-protein kinase Nek6Homo sapiens (human)
chromosome segregationSerine/threonine-protein kinase Nek6Homo sapiens (human)
mitotic nuclear membrane disassemblySerine/threonine-protein kinase Nek6Homo sapiens (human)
regulation of mitotic cell cycleSerine/threonine-protein kinase Nek6Homo sapiens (human)
peptidyl-serine phosphorylationSerine/threonine-protein kinase Nek6Homo sapiens (human)
regulation of mitotic metaphase/anaphase transitionSerine/threonine-protein kinase Nek6Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionSerine/threonine-protein kinase Nek6Homo sapiens (human)
protein autophosphorylationSerine/threonine-protein kinase Nek6Homo sapiens (human)
spindle assemblySerine/threonine-protein kinase Nek6Homo sapiens (human)
cell divisionSerine/threonine-protein kinase Nek6Homo sapiens (human)
regulation of cellular senescenceSerine/threonine-protein kinase Nek6Homo sapiens (human)
cell morphogenesisNADPH oxidase 4Homo sapiens (human)
heart processNADPH oxidase 4Homo sapiens (human)
superoxide metabolic processNADPH oxidase 4Homo sapiens (human)
inflammatory responseNADPH oxidase 4Homo sapiens (human)
negative regulation of cell population proliferationNADPH oxidase 4Homo sapiens (human)
gene expressionNADPH oxidase 4Homo sapiens (human)
superoxide anion generationNADPH oxidase 4Homo sapiens (human)
bone resorptionNADPH oxidase 4Homo sapiens (human)
homocysteine metabolic processNADPH oxidase 4Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionNADPH oxidase 4Homo sapiens (human)
cardiac muscle cell differentiationNADPH oxidase 4Homo sapiens (human)
positive regulation of protein tyrosine kinase activityNADPH oxidase 4Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeNADPH oxidase 4Homo sapiens (human)
cellular response to glucose stimulusNADPH oxidase 4Homo sapiens (human)
reactive oxygen species biosynthetic processNADPH oxidase 4Homo sapiens (human)
positive regulation of DNA biosynthetic processNADPH oxidase 4Homo sapiens (human)
defense responseNADPH oxidase 4Homo sapiens (human)
positive regulation of myoblast differentiationHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
negative regulation of Notch signaling pathwayHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
negative regulation of DNA-templated transcriptionHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
positive regulation of vasculogenesisHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
proteolysisDipeptidyl peptidase 3Homo sapiens (human)
protein catabolic processDipeptidyl peptidase 3Homo sapiens (human)
negative regulation of cell growthInositol hexakisphosphate kinase 2Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylationInositol hexakisphosphate kinase 2Homo sapiens (human)
positive regulation of apoptotic processInositol hexakisphosphate kinase 2Homo sapiens (human)
inositol phosphate metabolic processInositol hexakisphosphate kinase 2Homo sapiens (human)
phosphatidylinositol phosphate biosynthetic processInositol hexakisphosphate kinase 2Homo sapiens (human)
protein stabilizationInositol hexakisphosphate kinase 2Homo sapiens (human)
cellular response to flavonoidInositol hexakisphosphate kinase 2Homo sapiens (human)
inositol phosphate biosynthetic processInositol hexakisphosphate kinase 2Homo sapiens (human)
calcium ion transportShort transient receptor potential channel 5Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationShort transient receptor potential channel 5Homo sapiens (human)
nervous system developmentShort transient receptor potential channel 5Homo sapiens (human)
positive regulation of cell population proliferationShort transient receptor potential channel 5Homo sapiens (human)
positive regulation of peptidyl-threonine phosphorylationShort transient receptor potential channel 5Homo sapiens (human)
neuron differentiationShort transient receptor potential channel 5Homo sapiens (human)
positive regulation of neuron differentiationShort transient receptor potential channel 5Homo sapiens (human)
positive regulation of axon extensionShort transient receptor potential channel 5Homo sapiens (human)
negative regulation of dendrite morphogenesisShort transient receptor potential channel 5Homo sapiens (human)
neuron apoptotic processShort transient receptor potential channel 5Homo sapiens (human)
calcium ion transmembrane transportShort transient receptor potential channel 5Homo sapiens (human)
phosphatidylserine exposure on apoptotic cell surfaceShort transient receptor potential channel 5Homo sapiens (human)
regulation of membrane hyperpolarizationShort transient receptor potential channel 5Homo sapiens (human)
regulation of cytosolic calcium ion concentrationShort transient receptor potential channel 5Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 14Homo sapiens (human)
protein autophosphorylationALK tyrosine kinase receptorHomo sapiens (human)
signal transductionALK tyrosine kinase receptorHomo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayALK tyrosine kinase receptorHomo sapiens (human)
phosphorylationALK tyrosine kinase receptorHomo sapiens (human)
hippocampus developmentALK tyrosine kinase receptorHomo sapiens (human)
adult behaviorALK tyrosine kinase receptorHomo sapiens (human)
swimming behaviorALK tyrosine kinase receptorHomo sapiens (human)
peptidyl-tyrosine autophosphorylationALK tyrosine kinase receptorHomo sapiens (human)
regulation of apoptotic processALK tyrosine kinase receptorHomo sapiens (human)
protein autophosphorylationALK tyrosine kinase receptorHomo sapiens (human)
neuron developmentALK tyrosine kinase receptorHomo sapiens (human)
negative regulation of lipid catabolic processALK tyrosine kinase receptorHomo sapiens (human)
positive regulation of NF-kappaB transcription factor activityALK tyrosine kinase receptorHomo sapiens (human)
regulation of dopamine receptor signaling pathwayALK tyrosine kinase receptorHomo sapiens (human)
response to environmental enrichmentALK tyrosine kinase receptorHomo sapiens (human)
energy homeostasisALK tyrosine kinase receptorHomo sapiens (human)
positive regulation of dendrite developmentALK tyrosine kinase receptorHomo sapiens (human)
regulation of neuron differentiationALK tyrosine kinase receptorHomo sapiens (human)
regulation of cell population proliferationALK tyrosine kinase receptorHomo sapiens (human)
multicellular organism developmentALK tyrosine kinase receptorHomo sapiens (human)
positive regulation of kinase activityALK tyrosine kinase receptorHomo sapiens (human)
lipid transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
organic anion transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
urate transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
biotin transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
sphingolipid biosynthetic processBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
riboflavin transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
urate metabolic processBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
transmembrane transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
transepithelial transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
renal urate salt excretionBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
export across plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
transport across blood-brain barrierBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
cellular detoxificationBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
xenobiotic transport across blood-brain barrierBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
response to bacteriumCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
glycoprotein catabolic processSialidase-2Homo sapiens (human)
ganglioside catabolic processSialidase-2Homo sapiens (human)
oligosaccharide catabolic processSialidase-2Homo sapiens (human)
glycosphingolipid catabolic processSialidase-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (536)

Processvia Protein(s)Taxonomy
iron ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
calcium ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
protein bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 13S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 8(S)-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 15-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 9S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytokine activityInterferon betaHomo sapiens (human)
cytokine receptor bindingInterferon betaHomo sapiens (human)
type I interferon receptor bindingInterferon betaHomo sapiens (human)
protein bindingInterferon betaHomo sapiens (human)
chloramphenicol O-acetyltransferase activityInterferon betaHomo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
signaling receptor bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
peptide antigen bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein-folding chaperone bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
glucose-6-phosphate dehydrogenase activityGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
protein bindingGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
glucose bindingGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
identical protein bindingGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
protein homodimerization activityGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
NADP bindingGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
endopeptidase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
metalloendopeptidase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
Notch bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
interleukin-6 receptor bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
integrin bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
protein bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
peptidase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
metallopeptidase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
SH3 domain bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cytokine bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
PDZ domain bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
tumor necrosis factor bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
metal ion bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
metalloendopeptidase activity involved in amyloid precursor protein catabolic processDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
inositol-1,3,4,5,6-pentakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol heptakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
protein bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
ATP bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 1-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 3-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol 5-diphosphate pentakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol diphosphate tetrakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
guanyl-nucleotide exchange factor activityRap guanine nucleotide exchange factor 3Homo sapiens (human)
protein bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
protein domain specific bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
cAMP bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
iron ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
calcium ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
protein bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 13S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 8(S)-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 15-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 9S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
serine-type endopeptidase activityTransmembrane protease serine 2Homo sapiens (human)
protein bindingTransmembrane protease serine 2Homo sapiens (human)
serine-type peptidase activityTransmembrane protease serine 2Homo sapiens (human)
ATP bindingATP-binding cassette sub-family C member 3Homo sapiens (human)
ABC-type xenobiotic transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
glucuronoside transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ABC-type glutathione S-conjugate transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ABC-type bile acid transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ATP hydrolysis activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ATPase-coupled transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
xenobiotic transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ATPase-coupled inorganic anion transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
icosanoid transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ABC-type transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
guanine nucleotide transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
protein bindingMultidrug resistance-associated protein 4Homo sapiens (human)
ATP bindingMultidrug resistance-associated protein 4Homo sapiens (human)
ABC-type xenobiotic transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
prostaglandin transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
urate transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
purine nucleotide transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ABC-type glutathione S-conjugate transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ABC-type bile acid transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
efflux transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
15-hydroxyprostaglandin dehydrogenase (NAD+) activityMultidrug resistance-associated protein 4Homo sapiens (human)
ATP hydrolysis activityMultidrug resistance-associated protein 4Homo sapiens (human)
glutathione transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ATPase-coupled transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
xenobiotic transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ATPase-coupled inorganic anion transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ABC-type transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
catalytic activityMaltase-glucoamylase, intestinalHomo sapiens (human)
glucan 1,4-alpha-glucosidase activityMaltase-glucoamylase, intestinalHomo sapiens (human)
alpha-1,4-glucosidase activityMaltase-glucoamylase, intestinalHomo sapiens (human)
protein bindingMaltase-glucoamylase, intestinalHomo sapiens (human)
amylase activityMaltase-glucoamylase, intestinalHomo sapiens (human)
carbohydrate bindingMaltase-glucoamylase, intestinalHomo sapiens (human)
maltose alpha-glucosidase activityMaltase-glucoamylase, intestinalHomo sapiens (human)
zinc ion bindingCarbonic anhydrase 12Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 12Homo sapiens (human)
p53 bindingNUAK family SNF1-like kinase 1Homo sapiens (human)
protein serine/threonine kinase activityNUAK family SNF1-like kinase 1Homo sapiens (human)
protein bindingNUAK family SNF1-like kinase 1Homo sapiens (human)
ATP bindingNUAK family SNF1-like kinase 1Homo sapiens (human)
metal ion bindingNUAK family SNF1-like kinase 1Homo sapiens (human)
protein serine kinase activityNUAK family SNF1-like kinase 1Homo sapiens (human)
telomeric DNA bindingLysine-specific histone demethylase 1AHomo sapiens (human)
p53 bindingLysine-specific histone demethylase 1AHomo sapiens (human)
chromatin bindingLysine-specific histone demethylase 1AHomo sapiens (human)
transcription coactivator activityLysine-specific histone demethylase 1AHomo sapiens (human)
protein bindingLysine-specific histone demethylase 1AHomo sapiens (human)
oxidoreductase activityLysine-specific histone demethylase 1AHomo sapiens (human)
enzyme bindingLysine-specific histone demethylase 1AHomo sapiens (human)
nuclear receptor coactivator activityLysine-specific histone demethylase 1AHomo sapiens (human)
demethylase activityLysine-specific histone demethylase 1AHomo sapiens (human)
histone demethylase activityLysine-specific histone demethylase 1AHomo sapiens (human)
histone H3K4 demethylase activityLysine-specific histone demethylase 1AHomo sapiens (human)
histone H3K9 demethylase activityLysine-specific histone demethylase 1AHomo sapiens (human)
identical protein bindingLysine-specific histone demethylase 1AHomo sapiens (human)
MRF bindingLysine-specific histone demethylase 1AHomo sapiens (human)
flavin adenine dinucleotide bindingLysine-specific histone demethylase 1AHomo sapiens (human)
nuclear androgen receptor bindingLysine-specific histone demethylase 1AHomo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingLysine-specific histone demethylase 1AHomo sapiens (human)
telomeric repeat-containing RNA bindingLysine-specific histone demethylase 1AHomo sapiens (human)
DNA-binding transcription factor bindingLysine-specific histone demethylase 1AHomo sapiens (human)
FAD-dependent H3K4me/H3K4me3 demethylase activityLysine-specific histone demethylase 1AHomo sapiens (human)
promoter-specific chromatin bindingLysine-specific histone demethylase 1AHomo sapiens (human)
transcription factor bindingLysine-specific histone demethylase 1AHomo sapiens (human)
protein bindingG2/mitotic-specific cyclin-B2Homo sapiens (human)
cadherin bindingG2/mitotic-specific cyclin-B2Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase regulator activityG2/mitotic-specific cyclin-B2Homo sapiens (human)
protein bindingBile salt export pumpHomo sapiens (human)
ATP bindingBile salt export pumpHomo sapiens (human)
ABC-type xenobiotic transporter activityBile salt export pumpHomo sapiens (human)
bile acid transmembrane transporter activityBile salt export pumpHomo sapiens (human)
canalicular bile acid transmembrane transporter activityBile salt export pumpHomo sapiens (human)
carbohydrate transmembrane transporter activityBile salt export pumpHomo sapiens (human)
ABC-type bile acid transporter activityBile salt export pumpHomo sapiens (human)
ATP hydrolysis activityBile salt export pumpHomo sapiens (human)
electron transfer activityGlutathione reductase, mitochondrialHomo sapiens (human)
NADP bindingGlutathione reductase, mitochondrialHomo sapiens (human)
glutathione-disulfide reductase (NADPH) activityGlutathione reductase, mitochondrialHomo sapiens (human)
flavin adenine dinucleotide bindingGlutathione reductase, mitochondrialHomo sapiens (human)
epidermal growth factor receptor activityEpidermal growth factor receptorHomo sapiens (human)
virus receptor activityEpidermal growth factor receptorHomo sapiens (human)
chromatin bindingEpidermal growth factor receptorHomo sapiens (human)
double-stranded DNA bindingEpidermal growth factor receptorHomo sapiens (human)
MAP kinase kinase kinase activityEpidermal growth factor receptorHomo sapiens (human)
protein tyrosine kinase activityEpidermal growth factor receptorHomo sapiens (human)
transmembrane receptor protein tyrosine kinase activityEpidermal growth factor receptorHomo sapiens (human)
transmembrane signaling receptor activityEpidermal growth factor receptorHomo sapiens (human)
epidermal growth factor receptor activityEpidermal growth factor receptorHomo sapiens (human)
integrin bindingEpidermal growth factor receptorHomo sapiens (human)
protein bindingEpidermal growth factor receptorHomo sapiens (human)
calmodulin bindingEpidermal growth factor receptorHomo sapiens (human)
ATP bindingEpidermal growth factor receptorHomo sapiens (human)
enzyme bindingEpidermal growth factor receptorHomo sapiens (human)
kinase bindingEpidermal growth factor receptorHomo sapiens (human)
protein kinase bindingEpidermal growth factor receptorHomo sapiens (human)
protein phosphatase bindingEpidermal growth factor receptorHomo sapiens (human)
protein tyrosine kinase activator activityEpidermal growth factor receptorHomo sapiens (human)
transmembrane receptor protein tyrosine kinase activator activityEpidermal growth factor receptorHomo sapiens (human)
ubiquitin protein ligase bindingEpidermal growth factor receptorHomo sapiens (human)
identical protein bindingEpidermal growth factor receptorHomo sapiens (human)
cadherin bindingEpidermal growth factor receptorHomo sapiens (human)
actin filament bindingEpidermal growth factor receptorHomo sapiens (human)
ATPase bindingEpidermal growth factor receptorHomo sapiens (human)
epidermal growth factor bindingEpidermal growth factor receptorHomo sapiens (human)
lipopolysaccharide bindingProthrombinHomo sapiens (human)
serine-type endopeptidase activityProthrombinHomo sapiens (human)
signaling receptor bindingProthrombinHomo sapiens (human)
calcium ion bindingProthrombinHomo sapiens (human)
protein bindingProthrombinHomo sapiens (human)
growth factor activityProthrombinHomo sapiens (human)
heparin bindingProthrombinHomo sapiens (human)
thrombospondin receptor activityProthrombinHomo sapiens (human)
serine-type endopeptidase activityProthrombin Bos taurus (cattle)
calcium ion bindingProthrombin Bos taurus (cattle)
protein bindingProthrombin Bos taurus (cattle)
fibrinogen bindingProthrombin Bos taurus (cattle)
serine-type endopeptidase activityUrokinase-type plasminogen activatorHomo sapiens (human)
protein bindingUrokinase-type plasminogen activatorHomo sapiens (human)
endopeptidase activityCationic trypsinBos taurus (cattle)
serine-type endopeptidase activityCationic trypsinBos taurus (cattle)
protein bindingCationic trypsinBos taurus (cattle)
metal ion bindingCationic trypsinBos taurus (cattle)
serpin family protein bindingCationic trypsinBos taurus (cattle)
protein bindingChymotrypsinogen ABos taurus (cattle)
serpin family protein bindingChymotrypsinogen ABos taurus (cattle)
beta-lactamase activityBeta-lactamaseEscherichia coli K-12
hydrolase activityBeta-lactamaseEscherichia coli K-12
arylesterase activityCarbonic anhydrase 1Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 1Homo sapiens (human)
protein bindingCarbonic anhydrase 1Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 1Homo sapiens (human)
hydro-lyase activityCarbonic anhydrase 1Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 1Homo sapiens (human)
arylesterase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 2Homo sapiens (human)
protein bindingCarbonic anhydrase 2Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 2Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 2Homo sapiens (human)
exo-alpha-sialidase activityNeuraminidaseInfluenza A virus (A/Puerto Rico/8/1934(H1N1))
peptidase activator activityNeuraminidaseInfluenza A virus (A/Puerto Rico/8/1934(H1N1))
endopeptidase activityInterstitial collagenaseHomo sapiens (human)
metalloendopeptidase activityInterstitial collagenaseHomo sapiens (human)
serine-type endopeptidase activityInterstitial collagenaseHomo sapiens (human)
peptidase activityInterstitial collagenaseHomo sapiens (human)
zinc ion bindingInterstitial collagenaseHomo sapiens (human)
phospholipase A2 activityPhospholipase A2Homo sapiens (human)
signaling receptor bindingPhospholipase A2Homo sapiens (human)
calcium ion bindingPhospholipase A2Homo sapiens (human)
bile acid bindingPhospholipase A2Homo sapiens (human)
calcium-dependent phospholipase A2 activityPhospholipase A2Homo sapiens (human)
phospholipid bindingPhospholipase A2Homo sapiens (human)
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
monooxygenase activityCytochrome P450 1A1Homo sapiens (human)
iron ion bindingCytochrome P450 1A1Homo sapiens (human)
protein bindingCytochrome P450 1A1Homo sapiens (human)
arachidonic acid monooxygenase activityCytochrome P450 1A1Homo sapiens (human)
oxidoreductase activityCytochrome P450 1A1Homo sapiens (human)
oxidoreductase activity, acting on diphenols and related substances as donorsCytochrome P450 1A1Homo sapiens (human)
flavonoid 3'-monooxygenase activityCytochrome P450 1A1Homo sapiens (human)
oxygen bindingCytochrome P450 1A1Homo sapiens (human)
enzyme bindingCytochrome P450 1A1Homo sapiens (human)
heme bindingCytochrome P450 1A1Homo sapiens (human)
Hsp70 protein bindingCytochrome P450 1A1Homo sapiens (human)
demethylase activityCytochrome P450 1A1Homo sapiens (human)
Hsp90 protein bindingCytochrome P450 1A1Homo sapiens (human)
aromatase activityCytochrome P450 1A1Homo sapiens (human)
vitamin D 24-hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
long-chain fatty acid omega-hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1A1Homo sapiens (human)
long-chain fatty acid omega-1 hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingAmyloid-beta precursor proteinHomo sapiens (human)
DNA bindingAmyloid-beta precursor proteinHomo sapiens (human)
serine-type endopeptidase inhibitor activityAmyloid-beta precursor proteinHomo sapiens (human)
signaling receptor bindingAmyloid-beta precursor proteinHomo sapiens (human)
protein bindingAmyloid-beta precursor proteinHomo sapiens (human)
heparin bindingAmyloid-beta precursor proteinHomo sapiens (human)
enzyme bindingAmyloid-beta precursor proteinHomo sapiens (human)
identical protein bindingAmyloid-beta precursor proteinHomo sapiens (human)
transition metal ion bindingAmyloid-beta precursor proteinHomo sapiens (human)
receptor ligand activityAmyloid-beta precursor proteinHomo sapiens (human)
PTB domain bindingAmyloid-beta precursor proteinHomo sapiens (human)
protein serine/threonine kinase bindingAmyloid-beta precursor proteinHomo sapiens (human)
signaling receptor activator activityAmyloid-beta precursor proteinHomo sapiens (human)
fibroblast growth factor bindingIntegrin beta-3Homo sapiens (human)
C-X3-C chemokine bindingIntegrin beta-3Homo sapiens (human)
insulin-like growth factor I bindingIntegrin beta-3Homo sapiens (human)
neuregulin bindingIntegrin beta-3Homo sapiens (human)
virus receptor activityIntegrin beta-3Homo sapiens (human)
fibronectin bindingIntegrin beta-3Homo sapiens (human)
protease bindingIntegrin beta-3Homo sapiens (human)
protein disulfide isomerase activityIntegrin beta-3Homo sapiens (human)
protein kinase C bindingIntegrin beta-3Homo sapiens (human)
platelet-derived growth factor receptor bindingIntegrin beta-3Homo sapiens (human)
integrin bindingIntegrin beta-3Homo sapiens (human)
protein bindingIntegrin beta-3Homo sapiens (human)
coreceptor activityIntegrin beta-3Homo sapiens (human)
enzyme bindingIntegrin beta-3Homo sapiens (human)
identical protein bindingIntegrin beta-3Homo sapiens (human)
vascular endothelial growth factor receptor 2 bindingIntegrin beta-3Homo sapiens (human)
metal ion bindingIntegrin beta-3Homo sapiens (human)
cell adhesion molecule bindingIntegrin beta-3Homo sapiens (human)
extracellular matrix bindingIntegrin beta-3Homo sapiens (human)
fibrinogen bindingIntegrin beta-3Homo sapiens (human)
chromatin bindingMyeloperoxidaseHomo sapiens (human)
peroxidase activityMyeloperoxidaseHomo sapiens (human)
protein bindingMyeloperoxidaseHomo sapiens (human)
heparin bindingMyeloperoxidaseHomo sapiens (human)
heme bindingMyeloperoxidaseHomo sapiens (human)
metal ion bindingMyeloperoxidaseHomo sapiens (human)
monooxygenase activityCytochrome P450 1A2Homo sapiens (human)
iron ion bindingCytochrome P450 1A2Homo sapiens (human)
protein bindingCytochrome P450 1A2Homo sapiens (human)
electron transfer activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 1A2Homo sapiens (human)
enzyme bindingCytochrome P450 1A2Homo sapiens (human)
heme bindingCytochrome P450 1A2Homo sapiens (human)
demethylase activityCytochrome P450 1A2Homo sapiens (human)
caffeine oxidase activityCytochrome P450 1A2Homo sapiens (human)
aromatase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1A2Homo sapiens (human)
phosphotyrosine residue bindingTyrosine-protein kinase LckHomo sapiens (human)
protein tyrosine kinase activityTyrosine-protein kinase LckHomo sapiens (human)
non-membrane spanning protein tyrosine kinase activityTyrosine-protein kinase LckHomo sapiens (human)
protein serine/threonine phosphatase activityTyrosine-protein kinase LckHomo sapiens (human)
protein bindingTyrosine-protein kinase LckHomo sapiens (human)
ATP bindingTyrosine-protein kinase LckHomo sapiens (human)
phospholipase activator activityTyrosine-protein kinase LckHomo sapiens (human)
protein kinase bindingTyrosine-protein kinase LckHomo sapiens (human)
protein phosphatase bindingTyrosine-protein kinase LckHomo sapiens (human)
SH2 domain bindingTyrosine-protein kinase LckHomo sapiens (human)
T cell receptor bindingTyrosine-protein kinase LckHomo sapiens (human)
CD4 receptor bindingTyrosine-protein kinase LckHomo sapiens (human)
CD8 receptor bindingTyrosine-protein kinase LckHomo sapiens (human)
identical protein bindingTyrosine-protein kinase LckHomo sapiens (human)
phospholipase bindingTyrosine-protein kinase LckHomo sapiens (human)
phosphatidylinositol 3-kinase bindingTyrosine-protein kinase LckHomo sapiens (human)
ATPase bindingTyrosine-protein kinase LckHomo sapiens (human)
signaling receptor bindingTyrosine-protein kinase LckHomo sapiens (human)
virus receptor activityCyclin-dependent kinase 1Homo sapiens (human)
chromatin bindingCyclin-dependent kinase 1Homo sapiens (human)
protein kinase activityCyclin-dependent kinase 1Homo sapiens (human)
protein serine/threonine kinase activityCyclin-dependent kinase 1Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activityCyclin-dependent kinase 1Homo sapiens (human)
protein bindingCyclin-dependent kinase 1Homo sapiens (human)
ATP bindingCyclin-dependent kinase 1Homo sapiens (human)
RNA polymerase II CTD heptapeptide repeat kinase activityCyclin-dependent kinase 1Homo sapiens (human)
kinase activityCyclin-dependent kinase 1Homo sapiens (human)
cyclin bindingCyclin-dependent kinase 1Homo sapiens (human)
Hsp70 protein bindingCyclin-dependent kinase 1Homo sapiens (human)
histone kinase activityCyclin-dependent kinase 1Homo sapiens (human)
cyclin-dependent protein kinase activityCyclin-dependent kinase 1Homo sapiens (human)
protein serine kinase activityCyclin-dependent kinase 1Homo sapiens (human)
purine nucleobase bindingGlycogen phosphorylase, liver formHomo sapiens (human)
protein bindingGlycogen phosphorylase, liver formHomo sapiens (human)
ATP bindingGlycogen phosphorylase, liver formHomo sapiens (human)
glucose bindingGlycogen phosphorylase, liver formHomo sapiens (human)
glycogen phosphorylase activityGlycogen phosphorylase, liver formHomo sapiens (human)
AMP bindingGlycogen phosphorylase, liver formHomo sapiens (human)
vitamin bindingGlycogen phosphorylase, liver formHomo sapiens (human)
bile acid bindingGlycogen phosphorylase, liver formHomo sapiens (human)
identical protein bindingGlycogen phosphorylase, liver formHomo sapiens (human)
linear malto-oligosaccharide phosphorylase activityGlycogen phosphorylase, liver formHomo sapiens (human)
SHG alpha-glucan phosphorylase activityGlycogen phosphorylase, liver formHomo sapiens (human)
pyridoxal phosphate bindingGlycogen phosphorylase, liver formHomo sapiens (human)
epoxide hydrolase activityEpoxide hydrolase 1 Homo sapiens (human)
protein bindingEpoxide hydrolase 1 Homo sapiens (human)
oxysterol bindingEpoxide hydrolase 1 Homo sapiens (human)
cis-stilbene-oxide hydrolase activityEpoxide hydrolase 1 Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 3Homo sapiens (human)
protein bindingCarbonic anhydrase 3Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 3Homo sapiens (human)
nickel cation bindingCarbonic anhydrase 3Homo sapiens (human)
serine-type endopeptidase activityTrypsin-1Homo sapiens (human)
metal ion bindingTrypsin-1Homo sapiens (human)
metalloendopeptidase activityTrypsin-2Homo sapiens (human)
serine-type endopeptidase activityTrypsin-2Homo sapiens (human)
calcium ion bindingTrypsin-2Homo sapiens (human)
protein bindingTrypsin-2Homo sapiens (human)
serine-type peptidase activityTrypsin-2Homo sapiens (human)
fibronectin bindingProcathepsin LHomo sapiens (human)
cysteine-type endopeptidase activityProcathepsin LHomo sapiens (human)
protein bindingProcathepsin LHomo sapiens (human)
collagen bindingProcathepsin LHomo sapiens (human)
cysteine-type peptidase activityProcathepsin LHomo sapiens (human)
histone bindingProcathepsin LHomo sapiens (human)
proteoglycan bindingProcathepsin LHomo sapiens (human)
serpin family protein bindingProcathepsin LHomo sapiens (human)
cysteine-type endopeptidase activator activity involved in apoptotic processProcathepsin LHomo sapiens (human)
phosphotyrosine residue bindingTyrosine-protein kinase YesHomo sapiens (human)
protein tyrosine kinase activityTyrosine-protein kinase YesHomo sapiens (human)
non-membrane spanning protein tyrosine kinase activityTyrosine-protein kinase YesHomo sapiens (human)
protein bindingTyrosine-protein kinase YesHomo sapiens (human)
ATP bindingTyrosine-protein kinase YesHomo sapiens (human)
enzyme bindingTyrosine-protein kinase YesHomo sapiens (human)
transmembrane transporter bindingTyrosine-protein kinase YesHomo sapiens (human)
signaling receptor bindingTyrosine-protein kinase YesHomo sapiens (human)
protein tyrosine kinase activityProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
transmembrane receptor protein tyrosine kinase activityProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
calcium ion bindingProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
protein bindingProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
ATP bindingProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
signaling receptor activityProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
G-protein alpha-subunit bindingInsulin-like growth factor 1 receptorHomo sapiens (human)
protein tyrosine kinase activityInsulin-like growth factor 1 receptorHomo sapiens (human)
insulin-like growth factor receptor activityInsulin-like growth factor 1 receptorHomo sapiens (human)
insulin receptor bindingInsulin-like growth factor 1 receptorHomo sapiens (human)
protein bindingInsulin-like growth factor 1 receptorHomo sapiens (human)
insulin-like growth factor bindingInsulin-like growth factor 1 receptorHomo sapiens (human)
ATP bindingInsulin-like growth factor 1 receptorHomo sapiens (human)
insulin-like growth factor I bindingInsulin-like growth factor 1 receptorHomo sapiens (human)
identical protein bindingInsulin-like growth factor 1 receptorHomo sapiens (human)
phosphatidylinositol 3-kinase bindingInsulin-like growth factor 1 receptorHomo sapiens (human)
insulin bindingInsulin-like growth factor 1 receptorHomo sapiens (human)
insulin receptor substrate bindingInsulin-like growth factor 1 receptorHomo sapiens (human)
protein-containing complex bindingInsulin-like growth factor 1 receptorHomo sapiens (human)
protein transporter activityInsulin-like growth factor 1 receptorHomo sapiens (human)
insulin receptor activityInsulin-like growth factor 1 receptorHomo sapiens (human)
protein bindingATP-dependent translocase ABCB1Homo sapiens (human)
ATP bindingATP-dependent translocase ABCB1Homo sapiens (human)
ABC-type xenobiotic transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
efflux transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
ATP hydrolysis activityATP-dependent translocase ABCB1Homo sapiens (human)
transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
ubiquitin protein ligase bindingATP-dependent translocase ABCB1Homo sapiens (human)
ATPase-coupled transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
carboxylic acid transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
phosphatidylcholine floppase activityATP-dependent translocase ABCB1Homo sapiens (human)
phosphatidylethanolamine flippase activityATP-dependent translocase ABCB1Homo sapiens (human)
ceramide floppase activityATP-dependent translocase ABCB1Homo sapiens (human)
floppase activityATP-dependent translocase ABCB1Homo sapiens (human)
protease bindingNeutrophil elastaseHomo sapiens (human)
transcription corepressor activityNeutrophil elastaseHomo sapiens (human)
endopeptidase activityNeutrophil elastaseHomo sapiens (human)
serine-type endopeptidase activityNeutrophil elastaseHomo sapiens (human)
protein bindingNeutrophil elastaseHomo sapiens (human)
heparin bindingNeutrophil elastaseHomo sapiens (human)
peptidase activityNeutrophil elastaseHomo sapiens (human)
cytokine bindingNeutrophil elastaseHomo sapiens (human)
fibronectin binding72 kDa type IV collagenaseHomo sapiens (human)
endopeptidase activity72 kDa type IV collagenaseHomo sapiens (human)
metalloendopeptidase activity72 kDa type IV collagenaseHomo sapiens (human)
serine-type endopeptidase activity72 kDa type IV collagenaseHomo sapiens (human)
protein binding72 kDa type IV collagenaseHomo sapiens (human)
metallopeptidase activity72 kDa type IV collagenaseHomo sapiens (human)
zinc ion binding72 kDa type IV collagenaseHomo sapiens (human)
endopeptidase activityStromelysin-1Homo sapiens (human)
metalloendopeptidase activityStromelysin-1Homo sapiens (human)
serine-type endopeptidase activityStromelysin-1Homo sapiens (human)
protein bindingStromelysin-1Homo sapiens (human)
peptidase activityStromelysin-1Homo sapiens (human)
metallopeptidase activityStromelysin-1Homo sapiens (human)
zinc ion bindingStromelysin-1Homo sapiens (human)
protein bindingIntegrin alpha-IIbHomo sapiens (human)
identical protein bindingIntegrin alpha-IIbHomo sapiens (human)
metal ion bindingIntegrin alpha-IIbHomo sapiens (human)
extracellular matrix bindingIntegrin alpha-IIbHomo sapiens (human)
molecular adaptor activityIntegrin alpha-IIbHomo sapiens (human)
fibrinogen bindingIntegrin alpha-IIbHomo sapiens (human)
integrin bindingIntegrin alpha-IIbHomo sapiens (human)
protein tyrosine kinase activityHepatocyte growth factor receptorHomo sapiens (human)
protein bindingHepatocyte growth factor receptorHomo sapiens (human)
ATP bindingHepatocyte growth factor receptorHomo sapiens (human)
semaphorin receptor activityHepatocyte growth factor receptorHomo sapiens (human)
protein phosphatase bindingHepatocyte growth factor receptorHomo sapiens (human)
identical protein bindingHepatocyte growth factor receptorHomo sapiens (human)
molecular function activator activityHepatocyte growth factor receptorHomo sapiens (human)
hepatocyte growth factor receptor activityHepatocyte growth factor receptorHomo sapiens (human)
monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
steroid bindingCytochrome P450 3A4Homo sapiens (human)
iron ion bindingCytochrome P450 3A4Homo sapiens (human)
protein bindingCytochrome P450 3A4Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
oxidoreductase activityCytochrome P450 3A4Homo sapiens (human)
oxygen bindingCytochrome P450 3A4Homo sapiens (human)
enzyme bindingCytochrome P450 3A4Homo sapiens (human)
heme bindingCytochrome P450 3A4Homo sapiens (human)
vitamin D3 25-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
caffeine oxidase activityCytochrome P450 3A4Homo sapiens (human)
quinine 3-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
aromatase activityCytochrome P450 3A4Homo sapiens (human)
vitamin D 24-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1,8-cineole 2-exo-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
G protein-coupled serotonin receptor activity5-hydroxytryptamine receptor 1AHomo sapiens (human)
protein binding5-hydroxytryptamine receptor 1AHomo sapiens (human)
receptor-receptor interaction5-hydroxytryptamine receptor 1AHomo sapiens (human)
neurotransmitter receptor activity5-hydroxytryptamine receptor 1AHomo sapiens (human)
serotonin binding5-hydroxytryptamine receptor 1AHomo sapiens (human)
DNA bindingHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
single-stranded DNA bindingHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
RNA bindingHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
single-stranded RNA bindingHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
protein bindingHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
protein domain specific bindingHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
miRNA bindingHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
pre-mRNA bindingHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
telomeric repeat-containing RNA bindingHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
G-rich strand telomeric DNA bindingHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
mRNA 3'-UTR bindingHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
arachidonate 5-lipoxygenase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
arachidonate 12(S)-lipoxygenase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
iron ion bindingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
protein bindingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
hydrolase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
arachidonate 8(S)-lipoxygenase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
enoyl-[acyl-carrier-protein] reductase (NADH) activityEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
protein bindingEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
oxidoreductase activityEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
identical protein bindingEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
NADH bindingEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
RNA-dependent RNA polymerase activityReplicase polyprotein 1aSevere acute respiratory syndrome-related coronavirus
cysteine-type endopeptidase activityReplicase polyprotein 1aSevere acute respiratory syndrome-related coronavirus
K63-linked deubiquitinase activityReplicase polyprotein 1aSevere acute respiratory syndrome-related coronavirus
K48-linked deubiquitinase activityReplicase polyprotein 1aSevere acute respiratory syndrome-related coronavirus
3'-5'-RNA exonuclease activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
RNA-dependent RNA polymerase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
cysteine-type endopeptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
mRNA 5'-cap (guanine-N7-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
mRNA (nucleoside-2'-O-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
5'-3' RNA helicase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
K63-linked deubiquitinase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
K48-linked deubiquitinase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
G protein-coupled adenosine receptor activityAdenosine receptor A3Homo sapiens (human)
calcium ion bindingCalmodulin-1Homo sapiens (human)
protein bindingCalmodulin-1Homo sapiens (human)
adenylate cyclase activator activityCalmodulin-1Homo sapiens (human)
calcium channel inhibitor activityCalmodulin-1Homo sapiens (human)
protein kinase bindingCalmodulin-1Homo sapiens (human)
titin bindingCalmodulin-1Homo sapiens (human)
protein serine/threonine kinase activator activityCalmodulin-1Homo sapiens (human)
transmembrane transporter bindingCalmodulin-1Homo sapiens (human)
calcium-dependent protein bindingCalmodulin-1Homo sapiens (human)
protein phosphatase activator activityCalmodulin-1Homo sapiens (human)
3'-5'-RNA exonuclease activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA-dependent RNA polymerase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
cysteine-type endopeptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA 5'-cap (guanine-N7-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA (nucleoside-2'-O-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA guanylyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA endonuclease activity, producing 3'-phosphomonoestersReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
ISG15-specific peptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
5'-3' RNA helicase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
protein guanylyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
alpha-amylase activityAlpha-amylase 1A Homo sapiens (human)
calcium ion bindingAlpha-amylase 1A Homo sapiens (human)
chloride ion bindingAlpha-amylase 1A Homo sapiens (human)
alpha-1,4-glucosidase activityLysosomal alpha-glucosidaseHomo sapiens (human)
carbohydrate bindingLysosomal alpha-glucosidaseHomo sapiens (human)
maltose alpha-glucosidase activityLysosomal alpha-glucosidaseHomo sapiens (human)
alpha-glucosidase activityLysosomal alpha-glucosidaseHomo sapiens (human)
monooxygenase activityCytochrome P450 2C8Homo sapiens (human)
iron ion bindingCytochrome P450 2C8Homo sapiens (human)
protein bindingCytochrome P450 2C8Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2C8Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 2C8Homo sapiens (human)
caffeine oxidase activityCytochrome P450 2C8Homo sapiens (human)
aromatase activityCytochrome P450 2C8Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 2C8Homo sapiens (human)
heme bindingCytochrome P450 2C8Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2C8Homo sapiens (human)
monooxygenase activityCytochrome P450 2D6Homo sapiens (human)
iron ion bindingCytochrome P450 2D6Homo sapiens (human)
oxidoreductase activityCytochrome P450 2D6Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2D6Homo sapiens (human)
heme bindingCytochrome P450 2D6Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 2D6Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 2D6Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 2D6Homo sapiens (human)
fructose transmembrane transporter activitySolute carrier family 2, facilitated glucose transporter member 2Homo sapiens (human)
galactose transmembrane transporter activitySolute carrier family 2, facilitated glucose transporter member 2Homo sapiens (human)
glucose transmembrane transporter activitySolute carrier family 2, facilitated glucose transporter member 2Homo sapiens (human)
hexose transmembrane transporter activitySolute carrier family 2, facilitated glucose transporter member 2Homo sapiens (human)
dehydroascorbic acid transmembrane transporter activitySolute carrier family 2, facilitated glucose transporter member 2Homo sapiens (human)
D-glucose transmembrane transporter activitySolute carrier family 2, facilitated glucose transporter member 2Homo sapiens (human)
protein serine/threonine kinase activitySerine/threonine-protein kinase pim-1Homo sapiens (human)
protein bindingSerine/threonine-protein kinase pim-1Homo sapiens (human)
ATP bindingSerine/threonine-protein kinase pim-1Homo sapiens (human)
transcription factor bindingSerine/threonine-protein kinase pim-1Homo sapiens (human)
manganese ion bindingSerine/threonine-protein kinase pim-1Homo sapiens (human)
ribosomal small subunit bindingSerine/threonine-protein kinase pim-1Homo sapiens (human)
protein serine kinase activitySerine/threonine-protein kinase pim-1Homo sapiens (human)
iron ion bindingAromataseHomo sapiens (human)
steroid hydroxylase activityAromataseHomo sapiens (human)
electron transfer activityAromataseHomo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenAromataseHomo sapiens (human)
oxygen bindingAromataseHomo sapiens (human)
heme bindingAromataseHomo sapiens (human)
aromatase activityAromataseHomo sapiens (human)
monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
iron ion bindingCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid 14,15-epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid 11,12-epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
oxidoreductase activityCytochrome P450 2C9 Homo sapiens (human)
(S)-limonene 6-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
(S)-limonene 7-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
caffeine oxidase activityCytochrome P450 2C9 Homo sapiens (human)
(R)-limonene 6-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
aromatase activityCytochrome P450 2C9 Homo sapiens (human)
heme bindingCytochrome P450 2C9 Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2C9 Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activityCyclin-dependent kinase 4Homo sapiens (human)
protein bindingCyclin-dependent kinase 4Homo sapiens (human)
ATP bindingCyclin-dependent kinase 4Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase regulator activityCyclin-dependent kinase 4Homo sapiens (human)
cyclin bindingCyclin-dependent kinase 4Homo sapiens (human)
protein serine kinase activityCyclin-dependent kinase 4Homo sapiens (human)
protein kinase activityProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
protein tyrosine kinase activityProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
non-membrane spanning protein tyrosine kinase activityProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
protein kinase C bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
signaling receptor bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
insulin receptor bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
integrin bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
protein bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
ATP bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
phospholipase activator activityProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
enzyme bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
heme bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
nuclear estrogen receptor bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
SH2 domain bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
phospholipase bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
transmembrane transporter bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cadherin bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
ephrin receptor bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
ATPase bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
phosphoprotein bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
BMP receptor bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
connexin bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
scaffold protein bindingProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
chloride channel activityCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
intracellularly ATP-gated chloride channel activityCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
protein bindingCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
ATP bindingCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
bicarbonate transmembrane transporter activityCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
chloride transmembrane transporter activityCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
isomerase activityCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
ATP hydrolysis activityCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
chloride channel regulator activityCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
chloride channel inhibitor activityCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
enzyme bindingCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
PDZ domain bindingCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
ATPase-coupled inorganic anion transmembrane transporter activityCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
protein-folding chaperone bindingCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
Sec61 translocon complex bindingCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
ABC-type transporter activityCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
ATPase-coupled transmembrane transporter activityCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
oligo-1,6-glucosidase activitySucrase-isomaltase, intestinalHomo sapiens (human)
sucrose alpha-glucosidase activitySucrase-isomaltase, intestinalHomo sapiens (human)
protein bindingSucrase-isomaltase, intestinalHomo sapiens (human)
carbohydrate bindingSucrase-isomaltase, intestinalHomo sapiens (human)
alpha-1,4-glucosidase activitySucrase-isomaltase, intestinalHomo sapiens (human)
patched bindingG2/mitotic-specific cyclin-B1Homo sapiens (human)
protein bindingG2/mitotic-specific cyclin-B1Homo sapiens (human)
protein kinase bindingG2/mitotic-specific cyclin-B1Homo sapiens (human)
ubiquitin-like protein ligase bindingG2/mitotic-specific cyclin-B1Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activator activityG2/mitotic-specific cyclin-B1Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase regulator activityG2/mitotic-specific cyclin-B1Homo sapiens (human)
tyrosinase activityTyrosinaseHomo sapiens (human)
copper ion bindingTyrosinaseHomo sapiens (human)
protein bindingTyrosinaseHomo sapiens (human)
identical protein bindingTyrosinaseHomo sapiens (human)
protein homodimerization activityTyrosinaseHomo sapiens (human)
endopeptidase activityMatrix metalloproteinase-9Homo sapiens (human)
metalloendopeptidase activityMatrix metalloproteinase-9Homo sapiens (human)
serine-type endopeptidase activityMatrix metalloproteinase-9Homo sapiens (human)
protein bindingMatrix metalloproteinase-9Homo sapiens (human)
collagen bindingMatrix metalloproteinase-9Homo sapiens (human)
peptidase activityMatrix metalloproteinase-9Homo sapiens (human)
metallopeptidase activityMatrix metalloproteinase-9Homo sapiens (human)
zinc ion bindingMatrix metalloproteinase-9Homo sapiens (human)
identical protein bindingMatrix metalloproteinase-9Homo sapiens (human)
small GTPase bindingSerine/threonine-protein kinase B-rafHomo sapiens (human)
protein kinase activitySerine/threonine-protein kinase B-rafHomo sapiens (human)
protein serine/threonine kinase activitySerine/threonine-protein kinase B-rafHomo sapiens (human)
MAP kinase kinase activitySerine/threonine-protein kinase B-rafHomo sapiens (human)
calcium ion bindingSerine/threonine-protein kinase B-rafHomo sapiens (human)
protein bindingSerine/threonine-protein kinase B-rafHomo sapiens (human)
ATP bindingSerine/threonine-protein kinase B-rafHomo sapiens (human)
mitogen-activated protein kinase kinase bindingSerine/threonine-protein kinase B-rafHomo sapiens (human)
identical protein bindingSerine/threonine-protein kinase B-rafHomo sapiens (human)
protein-containing complex bindingSerine/threonine-protein kinase B-rafHomo sapiens (human)
scaffold protein bindingSerine/threonine-protein kinase B-rafHomo sapiens (human)
protein serine kinase activitySerine/threonine-protein kinase B-rafHomo sapiens (human)
MAP kinase kinase kinase activitySerine/threonine-protein kinase B-rafHomo sapiens (human)
retinal dehydrogenase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
aldose reductase (NADPH) activityAldo-keto reductase family 1 member B1Homo sapiens (human)
protein bindingAldo-keto reductase family 1 member B1Homo sapiens (human)
electron transfer activityAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin H2 endoperoxidase reductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
glyceraldehyde oxidoreductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
allyl-alcohol dehydrogenase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
L-glucuronate reductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
glycerol dehydrogenase [NADP+] activityAldo-keto reductase family 1 member B1Homo sapiens (human)
all-trans-retinol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member B1Homo sapiens (human)
arachidonate 12(S)-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
iron ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
protein bindingPolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
phosphatidylinositol-4,5-bisphosphate bindingPolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
linoleate 13S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
arachidonate 15-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
retinal dehydrogenase activityAldo-keto reductase family 1 member B1Bos taurus (cattle)
prostaglandin H2 endoperoxidase reductase activityAldo-keto reductase family 1 member B1Bos taurus (cattle)
allyl-alcohol dehydrogenase activityAldo-keto reductase family 1 member B1Bos taurus (cattle)
glycerol dehydrogenase [NADP+] activityAldo-keto reductase family 1 member B1Bos taurus (cattle)
all-trans-retinol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member B1Bos taurus (cattle)
serine-type endopeptidase activityChymotrypsinogen BHomo sapiens (human)
RNA bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
zinc ion bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
enzyme bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
receptor tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cadherin bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
ephrin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein phosphatase 2A bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
arachidonate 12(S)-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
iron ion bindingPolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
protein bindingPolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
linoleate 13S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
hepoxilin-epoxide hydrolase activityPolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
arachidonate 15-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
protein serine/threonine kinase activityCasein kinase II subunit alpha'Homo sapiens (human)
protein bindingCasein kinase II subunit alpha'Homo sapiens (human)
ATP bindingCasein kinase II subunit alpha'Homo sapiens (human)
protein serine kinase activityCasein kinase II subunit alpha'Homo sapiens (human)
protein bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] A Bos taurus (cattle)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] A Bos taurus (cattle)
monoamine oxidase activityAmine oxidase [flavin-containing] A Bos taurus (cattle)
dopamine neurotransmitter receptor activity, coupled via Gi/GoD(4) dopamine receptorHomo sapiens (human)
dopamine neurotransmitter receptor activityD(4) dopamine receptorHomo sapiens (human)
protein bindingD(4) dopamine receptorHomo sapiens (human)
potassium channel regulator activityD(4) dopamine receptorHomo sapiens (human)
SH3 domain bindingD(4) dopamine receptorHomo sapiens (human)
dopamine bindingD(4) dopamine receptorHomo sapiens (human)
identical protein bindingD(4) dopamine receptorHomo sapiens (human)
metal ion bindingD(4) dopamine receptorHomo sapiens (human)
epinephrine bindingD(4) dopamine receptorHomo sapiens (human)
norepinephrine bindingD(4) dopamine receptorHomo sapiens (human)
G protein-coupled serotonin receptor activityD(4) dopamine receptorHomo sapiens (human)
neurotransmitter receptor activityD(4) dopamine receptorHomo sapiens (human)
serotonin bindingD(4) dopamine receptorHomo sapiens (human)
amyloid-beta bindingAcetylcholinesteraseHomo sapiens (human)
acetylcholinesterase activityAcetylcholinesteraseHomo sapiens (human)
cholinesterase activityAcetylcholinesteraseHomo sapiens (human)
protein bindingAcetylcholinesteraseHomo sapiens (human)
collagen bindingAcetylcholinesteraseHomo sapiens (human)
hydrolase activityAcetylcholinesteraseHomo sapiens (human)
serine hydrolase activityAcetylcholinesteraseHomo sapiens (human)
acetylcholine bindingAcetylcholinesteraseHomo sapiens (human)
protein homodimerization activityAcetylcholinesteraseHomo sapiens (human)
laminin bindingAcetylcholinesteraseHomo sapiens (human)
protein bindingCarbonic anhydrase 4Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 4Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 4Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 6Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 6Homo sapiens (human)
transcription corepressor activityG1/S-specific cyclin-D1Homo sapiens (human)
protein kinase activityG1/S-specific cyclin-D1Homo sapiens (human)
protein bindingG1/S-specific cyclin-D1Homo sapiens (human)
enzyme bindingG1/S-specific cyclin-D1Homo sapiens (human)
protein kinase bindingG1/S-specific cyclin-D1Homo sapiens (human)
histone deacetylase bindingG1/S-specific cyclin-D1Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activator activityG1/S-specific cyclin-D1Homo sapiens (human)
proline-rich region bindingG1/S-specific cyclin-D1Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase regulator activityG1/S-specific cyclin-D1Homo sapiens (human)
histone kinase activityCyclin-dependent kinase 2Homo sapiens (human)
magnesium ion bindingCyclin-dependent kinase 2Homo sapiens (human)
protein serine/threonine kinase activityCyclin-dependent kinase 2Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activityCyclin-dependent kinase 2Homo sapiens (human)
protein bindingCyclin-dependent kinase 2Homo sapiens (human)
ATP bindingCyclin-dependent kinase 2Homo sapiens (human)
protein domain specific bindingCyclin-dependent kinase 2Homo sapiens (human)
cyclin bindingCyclin-dependent kinase 2Homo sapiens (human)
cyclin-dependent protein kinase activityCyclin-dependent kinase 2Homo sapiens (human)
protein serine kinase activityCyclin-dependent kinase 2Homo sapiens (human)
interleukin-8 receptor activityC-X-C chemokine receptor type 1Homo sapiens (human)
G protein-coupled receptor activityC-X-C chemokine receptor type 1Homo sapiens (human)
chemokine receptor activityC-X-C chemokine receptor type 1Homo sapiens (human)
protein bindingC-X-C chemokine receptor type 1Homo sapiens (human)
interleukin-8 bindingC-X-C chemokine receptor type 1Homo sapiens (human)
C-C chemokine receptor activityC-X-C chemokine receptor type 1Homo sapiens (human)
C-C chemokine bindingC-X-C chemokine receptor type 1Homo sapiens (human)
protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
electron transfer activityAmine oxidase [flavin-containing] BHomo sapiens (human)
identical protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
virus receptor activityDipeptidyl peptidase 4Homo sapiens (human)
protease bindingDipeptidyl peptidase 4Homo sapiens (human)
aminopeptidase activityDipeptidyl peptidase 4Homo sapiens (human)
serine-type endopeptidase activityDipeptidyl peptidase 4Homo sapiens (human)
signaling receptor bindingDipeptidyl peptidase 4Homo sapiens (human)
protein bindingDipeptidyl peptidase 4Homo sapiens (human)
serine-type peptidase activityDipeptidyl peptidase 4Homo sapiens (human)
dipeptidyl-peptidase activityDipeptidyl peptidase 4Homo sapiens (human)
identical protein bindingDipeptidyl peptidase 4Homo sapiens (human)
protein homodimerization activityDipeptidyl peptidase 4Homo sapiens (human)
chemorepellent activityDipeptidyl peptidase 4Homo sapiens (human)
phosphotyrosine residue bindingPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
transmembrane receptor protein tyrosine kinase adaptor activityPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
insulin receptor bindingPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
insulin-like growth factor receptor bindingPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
neurotrophin TRKA receptor bindingPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
protein bindingPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
kinase activator activityPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
protein phosphatase bindingPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
phosphatidylinositol 3-kinase regulator activityPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
phosphatidylinositol 3-kinase regulatory subunit bindingPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
ErbB-3 class receptor bindingPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
phosphatidylinositol 3-kinase bindingPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
insulin bindingPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
insulin receptor substrate bindingPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
protein heterodimerization activityPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
phosphatidylinositol kinase activityPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
enzyme-substrate adaptor activityPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
phosphatidylinositol 3-kinase activator activityPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
1-phosphatidylinositol-3-kinase regulator activityPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
threonine-type endopeptidase activityProteasome subunit beta type-5Homo sapiens (human)
protein bindingProteasome subunit beta type-5Homo sapiens (human)
peptidase activityProteasome subunit beta type-5Homo sapiens (human)
endopeptidase activityProteasome subunit beta type-5Homo sapiens (human)
NAD+ nucleosidase activityADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
transferase activityADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
identical protein bindingADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
NAD+ nucleotidase, cyclic ADP-ribose generatingADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
phosphorus-oxygen lyase activityADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
vasopressin receptor activityVasopressin V2 receptorHomo sapiens (human)
protein bindingVasopressin V2 receptorHomo sapiens (human)
peptide bindingVasopressin V2 receptorHomo sapiens (human)
virus receptor activityTyrosine-protein kinase receptor UFOHomo sapiens (human)
phosphatidylserine bindingTyrosine-protein kinase receptor UFOHomo sapiens (human)
protein tyrosine kinase activityTyrosine-protein kinase receptor UFOHomo sapiens (human)
protein bindingTyrosine-protein kinase receptor UFOHomo sapiens (human)
ATP bindingTyrosine-protein kinase receptor UFOHomo sapiens (human)
myosin heavy chain bindingTyrosine-protein kinase receptor UFOHomo sapiens (human)
phosphatidylinositol 3-kinase bindingTyrosine-protein kinase receptor UFOHomo sapiens (human)
transmembrane receptor protein tyrosine kinase activityTyrosine-protein kinase receptor UFOHomo sapiens (human)
G protein-coupled adenosine receptor activityAdenosine receptor A2aRattus norvegicus (Norway rat)
protein kinase activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
protein serine/threonine kinase activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
protein serine/threonine/tyrosine kinase activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
protein bindingRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
calmodulin bindingRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
ATP bindingRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
phosphatidylinositol-3,4,5-trisphosphate bindingRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
kinase activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
enzyme bindingRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
protein kinase bindingRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
nitric-oxide synthase regulator activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
protein serine/threonine kinase inhibitor activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
identical protein bindingRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
protein homodimerization activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
phosphatidylinositol-3,4-bisphosphate bindingRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
14-3-3 protein bindingRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
potassium channel activator activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
protein serine kinase activityRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
ATP bindingMultidrug resistance-associated protein 1 Homo sapiens (human)
ABC-type vitamin B12 transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
ABC-type glutathione S-conjugate transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
efflux transmembrane transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
ATP hydrolysis activityMultidrug resistance-associated protein 1 Homo sapiens (human)
ATPase-coupled lipid transmembrane transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
glutathione transmembrane transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
ATPase-coupled transmembrane transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
xenobiotic transmembrane transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
ATPase-coupled inorganic anion transmembrane transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
sphingolipid transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
carboxylic acid transmembrane transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
ABC-type transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
ABC-type xenobiotic transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
magnesium ion bindingBifunctional epoxide hydrolase 2Homo sapiens (human)
epoxide hydrolase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
toxic substance bindingBifunctional epoxide hydrolase 2Homo sapiens (human)
phosphatase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
lipid phosphatase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
protein homodimerization activityBifunctional epoxide hydrolase 2Homo sapiens (human)
lysophosphatidic acid phosphatase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
serine-type endopeptidase activityTrypsin-3Homo sapiens (human)
calcium ion bindingTrypsin-3Homo sapiens (human)
protein bindingTrypsin-3Homo sapiens (human)
serine-type peptidase activityTrypsin-3Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
zinc ion bindingCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
peroxidase activityProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin-endoperoxide synthase activityProstaglandin G/H synthase 2Homo sapiens (human)
protein bindingProstaglandin G/H synthase 2Homo sapiens (human)
enzyme bindingProstaglandin G/H synthase 2Homo sapiens (human)
heme bindingProstaglandin G/H synthase 2Homo sapiens (human)
protein homodimerization activityProstaglandin G/H synthase 2Homo sapiens (human)
metal ion bindingProstaglandin G/H synthase 2Homo sapiens (human)
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygenProstaglandin G/H synthase 2Homo sapiens (human)
protein tyrosine kinase activityVascular endothelial growth factor receptor 2Homo sapiens (human)
transmembrane receptor protein tyrosine kinase activityVascular endothelial growth factor receptor 2Homo sapiens (human)
vascular endothelial growth factor receptor activityVascular endothelial growth factor receptor 2Homo sapiens (human)
integrin bindingVascular endothelial growth factor receptor 2Homo sapiens (human)
protein bindingVascular endothelial growth factor receptor 2Homo sapiens (human)
ATP bindingVascular endothelial growth factor receptor 2Homo sapiens (human)
coreceptor activityVascular endothelial growth factor receptor 2Homo sapiens (human)
growth factor bindingVascular endothelial growth factor receptor 2Homo sapiens (human)
vascular endothelial growth factor bindingVascular endothelial growth factor receptor 2Homo sapiens (human)
identical protein bindingVascular endothelial growth factor receptor 2Homo sapiens (human)
cadherin bindingVascular endothelial growth factor receptor 2Homo sapiens (human)
Hsp90 protein bindingVascular endothelial growth factor receptor 2Homo sapiens (human)
protein tyrosine kinase activityReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
transmembrane receptor protein tyrosine kinase activityReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
cytokine receptor activityReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
vascular endothelial growth factor receptor activityReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
protein bindingReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
ATP bindingReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
nuclear glucocorticoid receptor bindingReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
protein-containing complex bindingReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
phosphatidylinositol 3-kinase activator activityReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
growth factor bindingReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
estradiol 17-beta-dehydrogenase [NAD(P)] activity17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
testosterone dehydrogenase (NAD+) activity17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
fatty acid bindingAlpha-synucleinHomo sapiens (human)
phospholipase D inhibitor activityAlpha-synucleinHomo sapiens (human)
SNARE bindingAlpha-synucleinHomo sapiens (human)
magnesium ion bindingAlpha-synucleinHomo sapiens (human)
transcription cis-regulatory region bindingAlpha-synucleinHomo sapiens (human)
actin bindingAlpha-synucleinHomo sapiens (human)
protein kinase inhibitor activityAlpha-synucleinHomo sapiens (human)
copper ion bindingAlpha-synucleinHomo sapiens (human)
calcium ion bindingAlpha-synucleinHomo sapiens (human)
protein bindingAlpha-synucleinHomo sapiens (human)
phospholipid bindingAlpha-synucleinHomo sapiens (human)
ferrous iron bindingAlpha-synucleinHomo sapiens (human)
zinc ion bindingAlpha-synucleinHomo sapiens (human)
lipid bindingAlpha-synucleinHomo sapiens (human)
oxidoreductase activityAlpha-synucleinHomo sapiens (human)
kinesin bindingAlpha-synucleinHomo sapiens (human)
Hsp70 protein bindingAlpha-synucleinHomo sapiens (human)
histone bindingAlpha-synucleinHomo sapiens (human)
identical protein bindingAlpha-synucleinHomo sapiens (human)
alpha-tubulin bindingAlpha-synucleinHomo sapiens (human)
cysteine-type endopeptidase inhibitor activity involved in apoptotic processAlpha-synucleinHomo sapiens (human)
tau protein bindingAlpha-synucleinHomo sapiens (human)
phosphoprotein bindingAlpha-synucleinHomo sapiens (human)
molecular adaptor activityAlpha-synucleinHomo sapiens (human)
dynein complex bindingAlpha-synucleinHomo sapiens (human)
cuprous ion bindingAlpha-synucleinHomo sapiens (human)
core promoter sequence-specific DNA bindingMacrophage metalloelastaseHomo sapiens (human)
endopeptidase activityMacrophage metalloelastaseHomo sapiens (human)
metalloendopeptidase activityMacrophage metalloelastaseHomo sapiens (human)
serine-type endopeptidase activityMacrophage metalloelastaseHomo sapiens (human)
calcium ion bindingMacrophage metalloelastaseHomo sapiens (human)
collagen bindingMacrophage metalloelastaseHomo sapiens (human)
zinc ion bindingMacrophage metalloelastaseHomo sapiens (human)
sequence-specific DNA bindingMacrophage metalloelastaseHomo sapiens (human)
zinc ion bindingCarbonic anhydrase 7Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 7Homo sapiens (human)
phosphotyrosine residue bindingTyrosine-protein kinase SYKHomo sapiens (human)
protein kinase activityTyrosine-protein kinase SYKHomo sapiens (human)
protein serine/threonine kinase activityTyrosine-protein kinase SYKHomo sapiens (human)
protein tyrosine kinase activityTyrosine-protein kinase SYKHomo sapiens (human)
non-membrane spanning protein tyrosine kinase activityTyrosine-protein kinase SYKHomo sapiens (human)
signaling receptor bindingTyrosine-protein kinase SYKHomo sapiens (human)
integrin bindingTyrosine-protein kinase SYKHomo sapiens (human)
protein bindingTyrosine-protein kinase SYKHomo sapiens (human)
ATP bindingTyrosine-protein kinase SYKHomo sapiens (human)
interleukin-15 receptor bindingTyrosine-protein kinase SYKHomo sapiens (human)
kinase activityTyrosine-protein kinase SYKHomo sapiens (human)
protein kinase bindingTyrosine-protein kinase SYKHomo sapiens (human)
phosphatase bindingTyrosine-protein kinase SYKHomo sapiens (human)
Toll-like receptor bindingTyrosine-protein kinase SYKHomo sapiens (human)
SH2 domain bindingTyrosine-protein kinase SYKHomo sapiens (human)
phospholipase bindingTyrosine-protein kinase SYKHomo sapiens (human)
scaffold protein bindingTyrosine-protein kinase SYKHomo sapiens (human)
endopeptidase activityCollagenase 3Homo sapiens (human)
metalloendopeptidase activityCollagenase 3Homo sapiens (human)
serine-type endopeptidase activityCollagenase 3Homo sapiens (human)
calcium ion bindingCollagenase 3Homo sapiens (human)
collagen bindingCollagenase 3Homo sapiens (human)
zinc ion bindingCollagenase 3Homo sapiens (human)
oxidoreductase activity1-deoxy-D-xylulose 5-phosphate reductoisomeraseEscherichia coli K-12
manganese ion binding1-deoxy-D-xylulose 5-phosphate reductoisomeraseEscherichia coli K-12
1-deoxy-D-xylulose-5-phosphate reductoisomerase activity1-deoxy-D-xylulose 5-phosphate reductoisomeraseEscherichia coli K-12
identical protein binding1-deoxy-D-xylulose 5-phosphate reductoisomeraseEscherichia coli K-12
metal ion binding1-deoxy-D-xylulose 5-phosphate reductoisomeraseEscherichia coli K-12
NADPH binding1-deoxy-D-xylulose 5-phosphate reductoisomeraseEscherichia coli K-12
xanthine dehydrogenase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
xanthine oxidase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
iron ion bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
protein bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
protein homodimerization activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
molybdopterin cofactor bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
flavin adenine dinucleotide bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
2 iron, 2 sulfur cluster bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine dehydrogenase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine oxidase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
FAD bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
serine-type endopeptidase activityProlyl endopeptidaseHomo sapiens (human)
protein bindingProlyl endopeptidaseHomo sapiens (human)
serine-type peptidase activityProlyl endopeptidaseHomo sapiens (human)
oligopeptidase activityProlyl endopeptidaseHomo sapiens (human)
protein kinase activityPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
protein serine/threonine kinase activityPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
protein bindingPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
ATP bindingPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
kinase activityPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
1-phosphatidylinositol-3-kinase activityPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
1-phosphatidylinositol-4-phosphate 3-kinase activityPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
identical protein bindingPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
ephrin receptor bindingPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
1-phosphatidylinositol-4,5-bisphosphate 3-kinase activityPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
protein serine kinase activityPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
protein serine/threonine kinase activityGlycogen synthase kinase-3 alphaHomo sapiens (human)
signaling receptor bindingGlycogen synthase kinase-3 alphaHomo sapiens (human)
protein bindingGlycogen synthase kinase-3 alphaHomo sapiens (human)
ATP bindingGlycogen synthase kinase-3 alphaHomo sapiens (human)
protein kinase A catalytic subunit bindingGlycogen synthase kinase-3 alphaHomo sapiens (human)
tau protein bindingGlycogen synthase kinase-3 alphaHomo sapiens (human)
tau-protein kinase activityGlycogen synthase kinase-3 alphaHomo sapiens (human)
protein serine kinase activityGlycogen synthase kinase-3 alphaHomo sapiens (human)
protease bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
p53 bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
protein kinase activityGlycogen synthase kinase-3 betaHomo sapiens (human)
protein serine/threonine kinase activityGlycogen synthase kinase-3 betaHomo sapiens (human)
protein bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
ATP bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
beta-catenin bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
kinase activityGlycogen synthase kinase-3 betaHomo sapiens (human)
protein kinase bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
ubiquitin protein ligase bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
protein kinase A catalytic subunit bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
dynactin bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
tau protein bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
tau-protein kinase activityGlycogen synthase kinase-3 betaHomo sapiens (human)
NF-kappaB bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
protein serine kinase activityGlycogen synthase kinase-3 betaHomo sapiens (human)
chemokine receptor activityC-C chemokine receptor type 4Homo sapiens (human)
protein bindingC-C chemokine receptor type 4Homo sapiens (human)
C-C chemokine receptor activityC-C chemokine receptor type 4Homo sapiens (human)
C-C chemokine bindingC-C chemokine receptor type 4Homo sapiens (human)
protein kinase activitySerine/threonine-protein kinase Nek2Homo sapiens (human)
protein serine/threonine kinase activitySerine/threonine-protein kinase Nek2Homo sapiens (human)
protein bindingSerine/threonine-protein kinase Nek2Homo sapiens (human)
ATP bindingSerine/threonine-protein kinase Nek2Homo sapiens (human)
protein phosphatase bindingSerine/threonine-protein kinase Nek2Homo sapiens (human)
metal ion bindingSerine/threonine-protein kinase Nek2Homo sapiens (human)
protein serine kinase activitySerine/threonine-protein kinase Nek2Homo sapiens (human)
magnesium ion bindingSerine/threonine-protein kinase PLK1Homo sapiens (human)
protein kinase activitySerine/threonine-protein kinase PLK1Homo sapiens (human)
protein serine/threonine kinase activitySerine/threonine-protein kinase PLK1Homo sapiens (human)
protein bindingSerine/threonine-protein kinase PLK1Homo sapiens (human)
ATP bindingSerine/threonine-protein kinase PLK1Homo sapiens (human)
microtubule bindingSerine/threonine-protein kinase PLK1Homo sapiens (human)
anaphase-promoting complex bindingSerine/threonine-protein kinase PLK1Homo sapiens (human)
protein kinase bindingSerine/threonine-protein kinase PLK1Homo sapiens (human)
identical protein bindingSerine/threonine-protein kinase PLK1Homo sapiens (human)
protein serine kinase activitySerine/threonine-protein kinase PLK1Homo sapiens (human)
protein kinase activityDeath-associated protein kinase 1Homo sapiens (human)
protein serine/threonine kinase activityDeath-associated protein kinase 1Homo sapiens (human)
calmodulin-dependent protein kinase activityDeath-associated protein kinase 1Homo sapiens (human)
protein bindingDeath-associated protein kinase 1Homo sapiens (human)
calmodulin bindingDeath-associated protein kinase 1Homo sapiens (human)
ATP bindingDeath-associated protein kinase 1Homo sapiens (human)
GTP bindingDeath-associated protein kinase 1Homo sapiens (human)
syntaxin-1 bindingDeath-associated protein kinase 1Homo sapiens (human)
identical protein bindingDeath-associated protein kinase 1Homo sapiens (human)
protein serine kinase activityDeath-associated protein kinase 1Homo sapiens (human)
JUN kinase activityMitogen-activated protein kinase 10Homo sapiens (human)
MAP kinase kinase activityMitogen-activated protein kinase 10Homo sapiens (human)
protein bindingMitogen-activated protein kinase 10Homo sapiens (human)
ATP bindingMitogen-activated protein kinase 10Homo sapiens (human)
protein serine kinase activityMitogen-activated protein kinase 10Homo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] BBos taurus (cattle)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] BBos taurus (cattle)
monoamine oxidase activityAmine oxidase [flavin-containing] BBos taurus (cattle)
amyloid-beta bindingBeta-secretase 1Homo sapiens (human)
endopeptidase activityBeta-secretase 1Homo sapiens (human)
aspartic-type endopeptidase activityBeta-secretase 1Homo sapiens (human)
protein bindingBeta-secretase 1Homo sapiens (human)
peptidase activityBeta-secretase 1Homo sapiens (human)
beta-aspartyl-peptidase activityBeta-secretase 1Homo sapiens (human)
enzyme bindingBeta-secretase 1Homo sapiens (human)
protein serine/threonine kinase bindingBeta-secretase 1Homo sapiens (human)
protein bindingAnthrax toxin receptor 2Homo sapiens (human)
metal ion bindingAnthrax toxin receptor 2Homo sapiens (human)
transmembrane signaling receptor activityAnthrax toxin receptor 2Homo sapiens (human)
protein serine/threonine kinase activityCasein kinase II subunit betaHomo sapiens (human)
chromatin bindingCasein kinase II subunit betaHomo sapiens (human)
protein serine/threonine kinase activityCasein kinase II subunit betaHomo sapiens (human)
signaling receptor bindingCasein kinase II subunit betaHomo sapiens (human)
protein bindingCasein kinase II subunit betaHomo sapiens (human)
protein kinase regulator activityCasein kinase II subunit betaHomo sapiens (human)
protein domain specific bindingCasein kinase II subunit betaHomo sapiens (human)
protein-macromolecule adaptor activityCasein kinase II subunit betaHomo sapiens (human)
identical protein bindingCasein kinase II subunit betaHomo sapiens (human)
metal ion bindingCasein kinase II subunit betaHomo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCasein kinase II subunit betaHomo sapiens (human)
protein serine/threonine kinase activityCasein kinase II subunit alphaHomo sapiens (human)
protein bindingCasein kinase II subunit alphaHomo sapiens (human)
ATP bindingCasein kinase II subunit alphaHomo sapiens (human)
kinase activityCasein kinase II subunit alphaHomo sapiens (human)
identical protein bindingCasein kinase II subunit alphaHomo sapiens (human)
Hsp90 protein bindingCasein kinase II subunit alphaHomo sapiens (human)
protein serine kinase activityCasein kinase II subunit alphaHomo sapiens (human)
endopeptidase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
metalloendopeptidase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
Notch bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
interleukin-6 receptor bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
integrin bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
protein bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
peptidase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
metallopeptidase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
SH3 domain bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cytokine bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
PDZ domain bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
tumor necrosis factor bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
metal ion bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
metalloendopeptidase activity involved in amyloid precursor protein catabolic processDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
peroxidase activityLactoperoxidaseBos taurus (cattle)
calcium ion bindingLactoperoxidaseBos taurus (cattle)
heme bindingLactoperoxidaseBos taurus (cattle)
thiocyanate peroxidase activityLactoperoxidaseBos taurus (cattle)
lactoperoxidase activityLactoperoxidaseBos taurus (cattle)
xanthine dehydrogenase activityXanthine dehydrogenase/oxidaseBos taurus (cattle)
xanthine oxidase activityXanthine dehydrogenase/oxidaseBos taurus (cattle)
iron ion bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
molybdenum ion bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
protein homodimerization activityXanthine dehydrogenase/oxidaseBos taurus (cattle)
molybdopterin cofactor bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
flavin adenine dinucleotide bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
2 iron, 2 sulfur cluster bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
FAD bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
cyclin-dependent protein serine/threonine kinase activityCyclin-dependent kinase 6Homo sapiens (human)
protein bindingCyclin-dependent kinase 6Homo sapiens (human)
ATP bindingCyclin-dependent kinase 6Homo sapiens (human)
cyclin bindingCyclin-dependent kinase 6Homo sapiens (human)
FBXO family protein bindingCyclin-dependent kinase 6Homo sapiens (human)
protein serine kinase activityCyclin-dependent kinase 6Homo sapiens (human)
microtubule bindingCyclin-dependent-like kinase 5 Homo sapiens (human)
p53 bindingCyclin-dependent-like kinase 5 Homo sapiens (human)
protein kinase activityCyclin-dependent-like kinase 5 Homo sapiens (human)
protein serine/threonine kinase activityCyclin-dependent-like kinase 5 Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activityCyclin-dependent-like kinase 5 Homo sapiens (human)
ErbB-2 class receptor bindingCyclin-dependent-like kinase 5 Homo sapiens (human)
protein bindingCyclin-dependent-like kinase 5 Homo sapiens (human)
ATP bindingCyclin-dependent-like kinase 5 Homo sapiens (human)
kinase activityCyclin-dependent-like kinase 5 Homo sapiens (human)
acetylcholine receptor activator activityCyclin-dependent-like kinase 5 Homo sapiens (human)
ErbB-3 class receptor bindingCyclin-dependent-like kinase 5 Homo sapiens (human)
tau protein bindingCyclin-dependent-like kinase 5 Homo sapiens (human)
tau-protein kinase activityCyclin-dependent-like kinase 5 Homo sapiens (human)
Hsp90 protein bindingCyclin-dependent-like kinase 5 Homo sapiens (human)
protein serine kinase activityCyclin-dependent-like kinase 5 Homo sapiens (human)
transcription cis-regulatory region bindingHeat shock factor protein 1Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingHeat shock factor protein 1Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificHeat shock factor protein 1Homo sapiens (human)
RNA polymerase II intronic transcription regulatory region sequence-specific DNA bindingHeat shock factor protein 1Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificHeat shock factor protein 1Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificHeat shock factor protein 1Homo sapiens (human)
DNA bindingHeat shock factor protein 1Homo sapiens (human)
protein bindingHeat shock factor protein 1Homo sapiens (human)
protein kinase bindingHeat shock factor protein 1Homo sapiens (human)
heat shock protein bindingHeat shock factor protein 1Homo sapiens (human)
chromatin DNA bindingHeat shock factor protein 1Homo sapiens (human)
identical protein bindingHeat shock factor protein 1Homo sapiens (human)
sequence-specific DNA bindingHeat shock factor protein 1Homo sapiens (human)
protein heterodimerization activityHeat shock factor protein 1Homo sapiens (human)
Hsp90 protein bindingHeat shock factor protein 1Homo sapiens (human)
translation elongation factor bindingHeat shock factor protein 1Homo sapiens (human)
STAT family protein bindingHeat shock factor protein 1Homo sapiens (human)
sequence-specific single stranded DNA bindingHeat shock factor protein 1Homo sapiens (human)
general transcription initiation factor bindingHeat shock factor protein 1Homo sapiens (human)
sequence-specific double-stranded DNA bindingHeat shock factor protein 1Homo sapiens (human)
promoter-specific chromatin bindingHeat shock factor protein 1Homo sapiens (human)
DNA-binding transcription factor activityHeat shock factor protein 1Homo sapiens (human)
(R,R)-butanediol dehydrogenase activitySorbitol dehydrogenaseHomo sapiens (human)
L-iditol 2-dehydrogenase activitySorbitol dehydrogenaseHomo sapiens (human)
zinc ion bindingSorbitol dehydrogenaseHomo sapiens (human)
carbohydrate bindingSorbitol dehydrogenaseHomo sapiens (human)
identical protein bindingSorbitol dehydrogenaseHomo sapiens (human)
D-xylulose reductase activitySorbitol dehydrogenaseHomo sapiens (human)
D-sorbitol dehydrogenase (acceptor) activitySorbitol dehydrogenaseHomo sapiens (human)
ribitol 2-dehydrogenase activitySorbitol dehydrogenaseHomo sapiens (human)
NAD bindingSorbitol dehydrogenaseHomo sapiens (human)
protein kinase activityDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
protein serine/threonine kinase activityDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
MAP kinase kinase activityDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
protein serine/threonine/tyrosine kinase activityDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
protein tyrosine kinase activityDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
MAP-kinase scaffold activityDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
protein bindingDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
ATP bindingDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
protein kinase activator activityDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
protein serine/threonine kinase activator activityDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
scaffold protein bindingDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
protein serine kinase activityDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
lactoylglutathione lyase activityLactoylglutathione lyaseHomo sapiens (human)
protein bindingLactoylglutathione lyaseHomo sapiens (human)
zinc ion bindingLactoylglutathione lyaseHomo sapiens (human)
actin bindingFocal adhesion kinase 1Homo sapiens (human)
protein tyrosine kinase activityFocal adhesion kinase 1Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activityFocal adhesion kinase 1Homo sapiens (human)
protein tyrosine phosphatase activityFocal adhesion kinase 1Homo sapiens (human)
integrin bindingFocal adhesion kinase 1Homo sapiens (human)
protein bindingFocal adhesion kinase 1Homo sapiens (human)
ATP bindingFocal adhesion kinase 1Homo sapiens (human)
JUN kinase bindingFocal adhesion kinase 1Homo sapiens (human)
protein kinase bindingFocal adhesion kinase 1Homo sapiens (human)
protein phosphatase bindingFocal adhesion kinase 1Homo sapiens (human)
SH2 domain bindingFocal adhesion kinase 1Homo sapiens (human)
molecular function activator activityFocal adhesion kinase 1Homo sapiens (human)
actin bindingCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
protein bindingCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
ATP bindingCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
calcium-dependent protein serine/threonine kinase activityCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
identical protein bindingCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
protein homodimerization activityCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
protein serine kinase activityCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
calmodulin bindingCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
calmodulin-dependent protein kinase activityCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
protein bindingELAV-like protein 3Homo sapiens (human)
mRNA 3'-UTR AU-rich region bindingELAV-like protein 3Homo sapiens (human)
protease bindingCyclin-dependent kinase 5 activator 1Homo sapiens (human)
protein kinase activityCyclin-dependent kinase 5 activator 1Homo sapiens (human)
calcium ion bindingCyclin-dependent kinase 5 activator 1Homo sapiens (human)
protein bindingCyclin-dependent kinase 5 activator 1Homo sapiens (human)
kinase activityCyclin-dependent kinase 5 activator 1Homo sapiens (human)
protein kinase bindingCyclin-dependent kinase 5 activator 1Homo sapiens (human)
protein kinase activator activityCyclin-dependent kinase 5 activator 1Homo sapiens (human)
ionotropic glutamate receptor bindingCyclin-dependent kinase 5 activator 1Homo sapiens (human)
alpha-tubulin bindingCyclin-dependent kinase 5 activator 1Homo sapiens (human)
protein serine/threonine kinase activator activityCyclin-dependent kinase 5 activator 1Homo sapiens (human)
cadherin bindingCyclin-dependent kinase 5 activator 1Homo sapiens (human)
ephrin receptor bindingCyclin-dependent kinase 5 activator 1Homo sapiens (human)
beta-tubulin bindingCyclin-dependent kinase 5 activator 1Homo sapiens (human)
actin filament bindingCyclin-dependent kinase 5 activator 1Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activator activityCyclin-dependent kinase 5 activator 1Homo sapiens (human)
RNA bindingELAV-like protein 1Homo sapiens (human)
double-stranded RNA bindingELAV-like protein 1Homo sapiens (human)
mRNA bindingELAV-like protein 1Homo sapiens (human)
mRNA 3'-UTR bindingELAV-like protein 1Homo sapiens (human)
protein bindingELAV-like protein 1Homo sapiens (human)
protein kinase bindingELAV-like protein 1Homo sapiens (human)
miRNA bindingELAV-like protein 1Homo sapiens (human)
mRNA 3'-UTR AU-rich region bindingELAV-like protein 1Homo sapiens (human)
protein homodimerization activityELAV-like protein 1Homo sapiens (human)
lncRNA bindingELAV-like protein 1Homo sapiens (human)
chromatin bindingSerine/threonine-protein kinase N1Homo sapiens (human)
protein kinase activitySerine/threonine-protein kinase N1Homo sapiens (human)
protein serine/threonine kinase activitySerine/threonine-protein kinase N1Homo sapiens (human)
diacylglycerol-dependent serine/threonine kinase activitySerine/threonine-protein kinase N1Homo sapiens (human)
protein kinase C bindingSerine/threonine-protein kinase N1Homo sapiens (human)
protein bindingSerine/threonine-protein kinase N1Homo sapiens (human)
ATP bindingSerine/threonine-protein kinase N1Homo sapiens (human)
nuclear receptor coactivator activitySerine/threonine-protein kinase N1Homo sapiens (human)
small GTPase bindingSerine/threonine-protein kinase N1Homo sapiens (human)
histone H3T11 kinase activitySerine/threonine-protein kinase N1Homo sapiens (human)
histone bindingSerine/threonine-protein kinase N1Homo sapiens (human)
histone deacetylase bindingSerine/threonine-protein kinase N1Homo sapiens (human)
nuclear androgen receptor bindingSerine/threonine-protein kinase N1Homo sapiens (human)
protein serine kinase activitySerine/threonine-protein kinase N1Homo sapiens (human)
protein serine/threonine kinase activityMitogen-activated protein kinase 14Homo sapiens (human)
MAP kinase activityMitogen-activated protein kinase 14Homo sapiens (human)
MAP kinase kinase activityMitogen-activated protein kinase 14Homo sapiens (human)
protein bindingMitogen-activated protein kinase 14Homo sapiens (human)
ATP bindingMitogen-activated protein kinase 14Homo sapiens (human)
enzyme bindingMitogen-activated protein kinase 14Homo sapiens (human)
protein phosphatase bindingMitogen-activated protein kinase 14Homo sapiens (human)
mitogen-activated protein kinase p38 bindingMitogen-activated protein kinase 14Homo sapiens (human)
NFAT protein bindingMitogen-activated protein kinase 14Homo sapiens (human)
protein serine kinase activityMitogen-activated protein kinase 14Homo sapiens (human)
monooxygenase activityCytochrome P450 1B1Homo sapiens (human)
iron ion bindingCytochrome P450 1B1Homo sapiens (human)
protein bindingCytochrome P450 1B1Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 1B1Homo sapiens (human)
heme bindingCytochrome P450 1B1Homo sapiens (human)
aromatase activityCytochrome P450 1B1Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1B1Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1B1Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygenCytochrome P450 1B1Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 9Homo sapiens (human)
protein bindingCarbonic anhydrase 9Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 9Homo sapiens (human)
molecular function activator activityCarbonic anhydrase 9Homo sapiens (human)
glucan 1,4-alpha-glucosidase activityProbable maltase-glucoamylase 2Homo sapiens (human)
carbohydrate bindingProbable maltase-glucoamylase 2Homo sapiens (human)
alpha-1,4-glucosidase activityProbable maltase-glucoamylase 2Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 3Bos taurus (cattle)
protein serine/threonine kinase activityCasein kinase II subunit alpha 3Homo sapiens (human)
protein bindingCasein kinase II subunit alpha 3Homo sapiens (human)
ATP bindingCasein kinase II subunit alpha 3Homo sapiens (human)
protein serine kinase activityCasein kinase II subunit alpha 3Homo sapiens (human)
inositol-1,4,5-trisphosphate 6-kinase activityInositol polyphosphate multikinaseHomo sapiens (human)
inositol tetrakisphosphate 3-kinase activityInositol polyphosphate multikinaseHomo sapiens (human)
inositol tetrakisphosphate 6-kinase activityInositol polyphosphate multikinaseHomo sapiens (human)
protein bindingInositol polyphosphate multikinaseHomo sapiens (human)
ATP bindingInositol polyphosphate multikinaseHomo sapiens (human)
inositol-1,4,5-trisphosphate 3-kinase activityInositol polyphosphate multikinaseHomo sapiens (human)
metal ion bindingInositol polyphosphate multikinaseHomo sapiens (human)
1-phosphatidylinositol-4,5-bisphosphate 3-kinase activityInositol polyphosphate multikinaseHomo sapiens (human)
inositol tetrakisphosphate 5-kinase activityInositol polyphosphate multikinaseHomo sapiens (human)
flavonoid bindingInositol polyphosphate multikinaseHomo sapiens (human)
myo-inositol-1,2,3,4,6-heptakisphosphate 5-kinase activityInositol polyphosphate multikinaseHomo sapiens (human)
inositol tetrakisphosphate kinase activityInositol polyphosphate multikinaseHomo sapiens (human)
protein bindingG2/mitotic-specific cyclin-B3Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase regulator activityG2/mitotic-specific cyclin-B3Homo sapiens (human)
protein bindingCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ATP bindingCanalicular multispecific organic anion transporter 1Homo sapiens (human)
organic anion transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ABC-type xenobiotic transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
bilirubin transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ABC-type glutathione S-conjugate transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ATP hydrolysis activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ATPase-coupled transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
xenobiotic transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ATPase-coupled inorganic anion transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ABC-type transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
protein serine/threonine kinase activityAurora kinase BHomo sapiens (human)
protein serine/threonine kinase activityAurora kinase BHomo sapiens (human)
protein serine/threonine/tyrosine kinase activityAurora kinase BHomo sapiens (human)
protein bindingAurora kinase BHomo sapiens (human)
ATP bindingAurora kinase BHomo sapiens (human)
kinase bindingAurora kinase BHomo sapiens (human)
protein serine kinase activityAurora kinase BHomo sapiens (human)
protein bindingChymotrypsin-CHomo sapiens (human)
peptidase activityChymotrypsin-CHomo sapiens (human)
serine-type endopeptidase activityChymotrypsin-CHomo sapiens (human)
virus receptor activityAngiotensin-converting enzyme 2 Homo sapiens (human)
endopeptidase activityAngiotensin-converting enzyme 2 Homo sapiens (human)
carboxypeptidase activityAngiotensin-converting enzyme 2 Homo sapiens (human)
metallocarboxypeptidase activityAngiotensin-converting enzyme 2 Homo sapiens (human)
protein bindingAngiotensin-converting enzyme 2 Homo sapiens (human)
metallopeptidase activityAngiotensin-converting enzyme 2 Homo sapiens (human)
peptidyl-dipeptidase activityAngiotensin-converting enzyme 2 Homo sapiens (human)
zinc ion bindingAngiotensin-converting enzyme 2 Homo sapiens (human)
identical protein bindingAngiotensin-converting enzyme 2 Homo sapiens (human)
C-X-C chemokine receptor activityG-protein coupled receptor 35Homo sapiens (human)
G protein-coupled receptor activityG-protein coupled receptor 35Homo sapiens (human)
C-X-C chemokine receptor activityG-protein coupled receptor 35Homo sapiens (human)
magnesium ion bindingSerine/threonine-protein kinase Nek6Homo sapiens (human)
transcription corepressor bindingSerine/threonine-protein kinase Nek6Homo sapiens (human)
protein serine/threonine kinase activitySerine/threonine-protein kinase Nek6Homo sapiens (human)
protein bindingSerine/threonine-protein kinase Nek6Homo sapiens (human)
ATP bindingSerine/threonine-protein kinase Nek6Homo sapiens (human)
kinesin bindingSerine/threonine-protein kinase Nek6Homo sapiens (human)
protein kinase bindingSerine/threonine-protein kinase Nek6Homo sapiens (human)
ubiquitin protein ligase bindingSerine/threonine-protein kinase Nek6Homo sapiens (human)
protein serine kinase activitySerine/threonine-protein kinase Nek6Homo sapiens (human)
DNA-binding transcription factor bindingSerine/threonine-protein kinase Nek6Homo sapiens (human)
nucleotide bindingNADPH oxidase 4Homo sapiens (human)
protein bindingNADPH oxidase 4Homo sapiens (human)
electron transfer activityNADPH oxidase 4Homo sapiens (human)
NAD(P)H oxidase H2O2-forming activityNADPH oxidase 4Homo sapiens (human)
superoxide-generating NAD(P)H oxidase activityNADPH oxidase 4Homo sapiens (human)
oxygen sensor activityNADPH oxidase 4Homo sapiens (human)
heme bindingNADPH oxidase 4Homo sapiens (human)
flavin adenine dinucleotide bindingNADPH oxidase 4Homo sapiens (human)
modified amino acid bindingNADPH oxidase 4Homo sapiens (human)
superoxide-generating NADPH oxidase activityNADPH oxidase 4Homo sapiens (human)
NADPH oxidase H202-forming activityNADPH oxidase 4Homo sapiens (human)
protein tyrosine kinase bindingNADPH oxidase 4Homo sapiens (human)
transcription corepressor activityHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
Notch bindingHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
protein bindingHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
ferrous iron bindingHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
zinc ion bindingHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
oxygen sensor activityHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
carboxylic acid bindingHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
peptidyl-histidine dioxygenase activityHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
[protein]-asparagine 3-dioxygenase activityHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
protein homodimerization activityHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
NF-kappaB bindingHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
peptidyl-aspartic acid 3-dioxygenase activityHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
ankyrin repeat bindingHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
aminopeptidase activityDipeptidyl peptidase 3Homo sapiens (human)
protein bindingDipeptidyl peptidase 3Homo sapiens (human)
metalloexopeptidase activityDipeptidyl peptidase 3Homo sapiens (human)
dipeptidyl-peptidase activityDipeptidyl peptidase 3Homo sapiens (human)
zinc ion bindingDipeptidyl peptidase 3Homo sapiens (human)
inositol-1,3,4,5,6-pentakisphosphate kinase activityInositol hexakisphosphate kinase 2Homo sapiens (human)
inositol hexakisphosphate kinase activityInositol hexakisphosphate kinase 2Homo sapiens (human)
inositol heptakisphosphate kinase activityInositol hexakisphosphate kinase 2Homo sapiens (human)
inositol hexakisphosphate 5-kinase activityInositol hexakisphosphate kinase 2Homo sapiens (human)
protein bindingInositol hexakisphosphate kinase 2Homo sapiens (human)
ATP bindingInositol hexakisphosphate kinase 2Homo sapiens (human)
inositol 5-diphosphate pentakisphosphate 5-kinase activityInositol hexakisphosphate kinase 2Homo sapiens (human)
inositol diphosphate tetrakisphosphate kinase activityInositol hexakisphosphate kinase 2Homo sapiens (human)
flavonoid bindingInositol hexakisphosphate kinase 2Homo sapiens (human)
actin bindingShort transient receptor potential channel 5Homo sapiens (human)
calcium channel activityShort transient receptor potential channel 5Homo sapiens (human)
protein bindingShort transient receptor potential channel 5Homo sapiens (human)
clathrin bindingShort transient receptor potential channel 5Homo sapiens (human)
actinin bindingShort transient receptor potential channel 5Homo sapiens (human)
ATPase bindingShort transient receptor potential channel 5Homo sapiens (human)
store-operated calcium channel activityShort transient receptor potential channel 5Homo sapiens (human)
inositol 1,4,5 trisphosphate bindingShort transient receptor potential channel 5Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 14Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 14Homo sapiens (human)
protein tyrosine kinase activityALK tyrosine kinase receptorHomo sapiens (human)
transmembrane receptor protein tyrosine kinase activityALK tyrosine kinase receptorHomo sapiens (human)
protein bindingALK tyrosine kinase receptorHomo sapiens (human)
ATP bindingALK tyrosine kinase receptorHomo sapiens (human)
heparin bindingALK tyrosine kinase receptorHomo sapiens (human)
receptor signaling protein tyrosine kinase activator activityALK tyrosine kinase receptorHomo sapiens (human)
identical protein bindingALK tyrosine kinase receptorHomo sapiens (human)
protein bindingBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
ATP bindingBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
organic anion transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
ABC-type xenobiotic transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
urate transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
biotin transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
efflux transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
ATP hydrolysis activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
riboflavin transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
ATPase-coupled transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
identical protein bindingBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
protein homodimerization activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
xenobiotic transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
sphingolipid transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
zinc ion bindingCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
exo-alpha-sialidase activitySialidase-2Homo sapiens (human)
protein bindingSialidase-2Homo sapiens (human)
exo-alpha-(2->3)-sialidase activitySialidase-2Homo sapiens (human)
exo-alpha-(2->6)-sialidase activitySialidase-2Homo sapiens (human)
exo-alpha-(2->8)-sialidase activitySialidase-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (296)

Processvia Protein(s)Taxonomy
nucleusPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytosolPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytoskeletonPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
plasma membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
adherens junctionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
focal adhesionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
extracellular exosomePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
extracellular spaceInterferon betaHomo sapiens (human)
extracellular regionInterferon betaHomo sapiens (human)
Golgi membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
endoplasmic reticulumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
Golgi apparatusHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
cell surfaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
ER to Golgi transport vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
secretory granule membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
phagocytic vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
early endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
recycling endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular exosomeHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
lumenal side of endoplasmic reticulum membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
MHC class I protein complexHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular spaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
external side of plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
cytoplasmGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
cytosolGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
cytoplasmic side of plasma membraneGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
membraneGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
centriolar satelliteGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
intracellular membrane-bounded organelleGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
extracellular exosomeGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
cytosolGlucose-6-phosphate 1-dehydrogenaseHomo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
cell-cell junctionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
focal adhesionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
ruffle membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
Golgi membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cytoplasmDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
endoplasmic reticulum lumenDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cytosolDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
plasma membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cell surfaceDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
actin cytoskeletonDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
apical plasma membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
membrane raftDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
plasma membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
fibrillar centerInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
cytosolInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleusInositol hexakisphosphate kinase 1Homo sapiens (human)
cytoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
cortical actin cytoskeletonRap guanine nucleotide exchange factor 3Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
microvillusRap guanine nucleotide exchange factor 3Homo sapiens (human)
endomembrane systemRap guanine nucleotide exchange factor 3Homo sapiens (human)
membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
lamellipodiumRap guanine nucleotide exchange factor 3Homo sapiens (human)
filopodiumRap guanine nucleotide exchange factor 3Homo sapiens (human)
extracellular exosomeRap guanine nucleotide exchange factor 3Homo sapiens (human)
nucleusPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytosolPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytoskeletonPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
plasma membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
adherens junctionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
focal adhesionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
extracellular exosomePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
extracellular regionTransmembrane protease serine 2Homo sapiens (human)
nucleoplasmTransmembrane protease serine 2Homo sapiens (human)
plasma membraneTransmembrane protease serine 2Homo sapiens (human)
extracellular exosomeTransmembrane protease serine 2Homo sapiens (human)
plasma membraneATP-binding cassette sub-family C member 3Homo sapiens (human)
basal plasma membraneATP-binding cassette sub-family C member 3Homo sapiens (human)
basolateral plasma membraneATP-binding cassette sub-family C member 3Homo sapiens (human)
membraneATP-binding cassette sub-family C member 3Homo sapiens (human)
nucleolusMultidrug resistance-associated protein 4Homo sapiens (human)
Golgi apparatusMultidrug resistance-associated protein 4Homo sapiens (human)
plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
membraneMultidrug resistance-associated protein 4Homo sapiens (human)
basolateral plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
apical plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
platelet dense granule membraneMultidrug resistance-associated protein 4Homo sapiens (human)
external side of apical plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
plasma membraneMaltase-glucoamylase, intestinalHomo sapiens (human)
apical plasma membraneMaltase-glucoamylase, intestinalHomo sapiens (human)
extracellular exosomeMaltase-glucoamylase, intestinalHomo sapiens (human)
tertiary granule membraneMaltase-glucoamylase, intestinalHomo sapiens (human)
ficolin-1-rich granule membraneMaltase-glucoamylase, intestinalHomo sapiens (human)
plasma membraneCarbonic anhydrase 12Homo sapiens (human)
membraneCarbonic anhydrase 12Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 12Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 12Homo sapiens (human)
plasma membraneCarbonic anhydrase 12Homo sapiens (human)
fibrillar centerNUAK family SNF1-like kinase 1Homo sapiens (human)
nucleusNUAK family SNF1-like kinase 1Homo sapiens (human)
nucleoplasmNUAK family SNF1-like kinase 1Homo sapiens (human)
cytoplasmNUAK family SNF1-like kinase 1Homo sapiens (human)
microtubule cytoskeletonNUAK family SNF1-like kinase 1Homo sapiens (human)
chromatinLysine-specific histone demethylase 1AHomo sapiens (human)
nucleusLysine-specific histone demethylase 1AHomo sapiens (human)
chromosome, telomeric regionLysine-specific histone demethylase 1AHomo sapiens (human)
nucleusLysine-specific histone demethylase 1AHomo sapiens (human)
nucleoplasmLysine-specific histone demethylase 1AHomo sapiens (human)
transcription regulator complexLysine-specific histone demethylase 1AHomo sapiens (human)
protein-containing complexLysine-specific histone demethylase 1AHomo sapiens (human)
DNA repair complexLysine-specific histone demethylase 1AHomo sapiens (human)
centrosomeG2/mitotic-specific cyclin-B2Homo sapiens (human)
cytosolG2/mitotic-specific cyclin-B2Homo sapiens (human)
microtubule cytoskeletonG2/mitotic-specific cyclin-B2Homo sapiens (human)
membraneG2/mitotic-specific cyclin-B2Homo sapiens (human)
centrosomeG2/mitotic-specific cyclin-B2Homo sapiens (human)
cytoplasmG2/mitotic-specific cyclin-B2Homo sapiens (human)
cyclin-dependent protein kinase holoenzyme complexG2/mitotic-specific cyclin-B2Homo sapiens (human)
nucleusG2/mitotic-specific cyclin-B2Homo sapiens (human)
basolateral plasma membraneBile salt export pumpHomo sapiens (human)
Golgi membraneBile salt export pumpHomo sapiens (human)
endosomeBile salt export pumpHomo sapiens (human)
plasma membraneBile salt export pumpHomo sapiens (human)
cell surfaceBile salt export pumpHomo sapiens (human)
apical plasma membraneBile salt export pumpHomo sapiens (human)
intercellular canaliculusBile salt export pumpHomo sapiens (human)
intracellular canaliculusBile salt export pumpHomo sapiens (human)
recycling endosomeBile salt export pumpHomo sapiens (human)
recycling endosome membraneBile salt export pumpHomo sapiens (human)
extracellular exosomeBile salt export pumpHomo sapiens (human)
membraneBile salt export pumpHomo sapiens (human)
mitochondrial matrixGlutathione reductase, mitochondrialHomo sapiens (human)
cytosolGlutathione reductase, mitochondrialHomo sapiens (human)
external side of plasma membraneGlutathione reductase, mitochondrialHomo sapiens (human)
extracellular exosomeGlutathione reductase, mitochondrialHomo sapiens (human)
cytosolGlutathione reductase, mitochondrialHomo sapiens (human)
mitochondrionGlutathione reductase, mitochondrialHomo sapiens (human)
endosomeEpidermal growth factor receptorHomo sapiens (human)
plasma membraneEpidermal growth factor receptorHomo sapiens (human)
ruffle membraneEpidermal growth factor receptorHomo sapiens (human)
Golgi membraneEpidermal growth factor receptorHomo sapiens (human)
extracellular spaceEpidermal growth factor receptorHomo sapiens (human)
nucleusEpidermal growth factor receptorHomo sapiens (human)
cytoplasmEpidermal growth factor receptorHomo sapiens (human)
endosomeEpidermal growth factor receptorHomo sapiens (human)
endoplasmic reticulum membraneEpidermal growth factor receptorHomo sapiens (human)
plasma membraneEpidermal growth factor receptorHomo sapiens (human)
focal adhesionEpidermal growth factor receptorHomo sapiens (human)
cell surfaceEpidermal growth factor receptorHomo sapiens (human)
endosome membraneEpidermal growth factor receptorHomo sapiens (human)
membraneEpidermal growth factor receptorHomo sapiens (human)
basolateral plasma membraneEpidermal growth factor receptorHomo sapiens (human)
apical plasma membraneEpidermal growth factor receptorHomo sapiens (human)
cell junctionEpidermal growth factor receptorHomo sapiens (human)
clathrin-coated endocytic vesicle membraneEpidermal growth factor receptorHomo sapiens (human)
early endosome membraneEpidermal growth factor receptorHomo sapiens (human)
nuclear membraneEpidermal growth factor receptorHomo sapiens (human)
membrane raftEpidermal growth factor receptorHomo sapiens (human)
perinuclear region of cytoplasmEpidermal growth factor receptorHomo sapiens (human)
multivesicular body, internal vesicle lumenEpidermal growth factor receptorHomo sapiens (human)
intracellular vesicleEpidermal growth factor receptorHomo sapiens (human)
protein-containing complexEpidermal growth factor receptorHomo sapiens (human)
receptor complexEpidermal growth factor receptorHomo sapiens (human)
Shc-EGFR complexEpidermal growth factor receptorHomo sapiens (human)
basal plasma membraneEpidermal growth factor receptorHomo sapiens (human)
external side of plasma membraneProthrombinHomo sapiens (human)
collagen-containing extracellular matrixProthrombinHomo sapiens (human)
extracellular regionProthrombinHomo sapiens (human)
extracellular spaceProthrombinHomo sapiens (human)
endoplasmic reticulum lumenProthrombinHomo sapiens (human)
Golgi lumenProthrombinHomo sapiens (human)
plasma membraneProthrombinHomo sapiens (human)
extracellular exosomeProthrombinHomo sapiens (human)
blood microparticleProthrombinHomo sapiens (human)
collagen-containing extracellular matrixProthrombinHomo sapiens (human)
extracellular spaceProthrombinHomo sapiens (human)
extracellular regionUrokinase-type plasminogen activatorHomo sapiens (human)
extracellular spaceUrokinase-type plasminogen activatorHomo sapiens (human)
plasma membraneUrokinase-type plasminogen activatorHomo sapiens (human)
focal adhesionUrokinase-type plasminogen activatorHomo sapiens (human)
external side of plasma membraneUrokinase-type plasminogen activatorHomo sapiens (human)
cell surfaceUrokinase-type plasminogen activatorHomo sapiens (human)
specific granule membraneUrokinase-type plasminogen activatorHomo sapiens (human)
extracellular exosomeUrokinase-type plasminogen activatorHomo sapiens (human)
tertiary granule membraneUrokinase-type plasminogen activatorHomo sapiens (human)
serine protease inhibitor complexUrokinase-type plasminogen activatorHomo sapiens (human)
protein complex involved in cell-matrix adhesionUrokinase-type plasminogen activatorHomo sapiens (human)
serine-type endopeptidase complexUrokinase-type plasminogen activatorHomo sapiens (human)
extracellular spaceUrokinase-type plasminogen activatorHomo sapiens (human)
serine protease inhibitor complexCationic trypsinBos taurus (cattle)
extracellular regionChymotrypsinogen ABos taurus (cattle)
serine protease inhibitor complexChymotrypsinogen ABos taurus (cattle)
outer membrane-bounded periplasmic spaceBeta-lactamaseEscherichia coli K-12
periplasmic spaceBeta-lactamaseEscherichia coli K-12
cytosolCarbonic anhydrase 1Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 1Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
myelin sheathCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 2Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular regionNeuraminidaseInfluenza A virus (A/Puerto Rico/8/1934(H1N1))
plasma membraneNeuraminidaseInfluenza A virus (A/Puerto Rico/8/1934(H1N1))
extracellular regionInterstitial collagenaseHomo sapiens (human)
extracellular matrixInterstitial collagenaseHomo sapiens (human)
extracellular spaceInterstitial collagenaseHomo sapiens (human)
extracellular regionPhospholipase A2Homo sapiens (human)
extracellular spacePhospholipase A2Homo sapiens (human)
cell surfacePhospholipase A2Homo sapiens (human)
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
mitochondrial inner membraneCytochrome P450 1A1Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 1A1Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A1Homo sapiens (human)
extracellular spaceAmyloid-beta precursor proteinHomo sapiens (human)
dendriteAmyloid-beta precursor proteinHomo sapiens (human)
extracellular regionAmyloid-beta precursor proteinHomo sapiens (human)
extracellular spaceAmyloid-beta precursor proteinHomo sapiens (human)
nuclear envelope lumenAmyloid-beta precursor proteinHomo sapiens (human)
cytoplasmAmyloid-beta precursor proteinHomo sapiens (human)
mitochondrial inner membraneAmyloid-beta precursor proteinHomo sapiens (human)
endosomeAmyloid-beta precursor proteinHomo sapiens (human)
early endosomeAmyloid-beta precursor proteinHomo sapiens (human)
endoplasmic reticulumAmyloid-beta precursor proteinHomo sapiens (human)
endoplasmic reticulum lumenAmyloid-beta precursor proteinHomo sapiens (human)
smooth endoplasmic reticulumAmyloid-beta precursor proteinHomo sapiens (human)
Golgi apparatusAmyloid-beta precursor proteinHomo sapiens (human)
Golgi lumenAmyloid-beta precursor proteinHomo sapiens (human)
Golgi-associated vesicleAmyloid-beta precursor proteinHomo sapiens (human)
cytosolAmyloid-beta precursor proteinHomo sapiens (human)
plasma membraneAmyloid-beta precursor proteinHomo sapiens (human)
clathrin-coated pitAmyloid-beta precursor proteinHomo sapiens (human)
cell-cell junctionAmyloid-beta precursor proteinHomo sapiens (human)
synaptic vesicleAmyloid-beta precursor proteinHomo sapiens (human)
cell surfaceAmyloid-beta precursor proteinHomo sapiens (human)
membraneAmyloid-beta precursor proteinHomo sapiens (human)
COPII-coated ER to Golgi transport vesicleAmyloid-beta precursor proteinHomo sapiens (human)
axonAmyloid-beta precursor proteinHomo sapiens (human)
growth coneAmyloid-beta precursor proteinHomo sapiens (human)
platelet alpha granule lumenAmyloid-beta precursor proteinHomo sapiens (human)
neuromuscular junctionAmyloid-beta precursor proteinHomo sapiens (human)
endosome lumenAmyloid-beta precursor proteinHomo sapiens (human)
trans-Golgi network membraneAmyloid-beta precursor proteinHomo sapiens (human)
ciliary rootletAmyloid-beta precursor proteinHomo sapiens (human)
dendritic spineAmyloid-beta precursor proteinHomo sapiens (human)
dendritic shaftAmyloid-beta precursor proteinHomo sapiens (human)
perikaryonAmyloid-beta precursor proteinHomo sapiens (human)
membrane raftAmyloid-beta precursor proteinHomo sapiens (human)
apical part of cellAmyloid-beta precursor proteinHomo sapiens (human)
synapseAmyloid-beta precursor proteinHomo sapiens (human)
perinuclear region of cytoplasmAmyloid-beta precursor proteinHomo sapiens (human)
presynaptic active zoneAmyloid-beta precursor proteinHomo sapiens (human)
spindle midzoneAmyloid-beta precursor proteinHomo sapiens (human)
recycling endosomeAmyloid-beta precursor proteinHomo sapiens (human)
extracellular exosomeAmyloid-beta precursor proteinHomo sapiens (human)
receptor complexAmyloid-beta precursor proteinHomo sapiens (human)
early endosomeAmyloid-beta precursor proteinHomo sapiens (human)
membrane raftAmyloid-beta precursor proteinHomo sapiens (human)
cell surfaceAmyloid-beta precursor proteinHomo sapiens (human)
Golgi apparatusAmyloid-beta precursor proteinHomo sapiens (human)
plasma membraneAmyloid-beta precursor proteinHomo sapiens (human)
glutamatergic synapseIntegrin beta-3Homo sapiens (human)
nucleusIntegrin beta-3Homo sapiens (human)
nucleoplasmIntegrin beta-3Homo sapiens (human)
plasma membraneIntegrin beta-3Homo sapiens (human)
cell-cell junctionIntegrin beta-3Homo sapiens (human)
focal adhesionIntegrin beta-3Homo sapiens (human)
external side of plasma membraneIntegrin beta-3Homo sapiens (human)
cell surfaceIntegrin beta-3Homo sapiens (human)
apical plasma membraneIntegrin beta-3Homo sapiens (human)
platelet alpha granule membraneIntegrin beta-3Homo sapiens (human)
lamellipodium membraneIntegrin beta-3Homo sapiens (human)
filopodium membraneIntegrin beta-3Homo sapiens (human)
microvillus membraneIntegrin beta-3Homo sapiens (human)
ruffle membraneIntegrin beta-3Homo sapiens (human)
integrin alphav-beta3 complexIntegrin beta-3Homo sapiens (human)
melanosomeIntegrin beta-3Homo sapiens (human)
synapseIntegrin beta-3Homo sapiens (human)
postsynaptic membraneIntegrin beta-3Homo sapiens (human)
extracellular exosomeIntegrin beta-3Homo sapiens (human)
integrin alphaIIb-beta3 complexIntegrin beta-3Homo sapiens (human)
glycinergic synapseIntegrin beta-3Homo sapiens (human)
integrin complexIntegrin beta-3Homo sapiens (human)
protein-containing complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-PKCalpha complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-IGF-1-IGF1R complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-HMGB1 complexIntegrin beta-3Homo sapiens (human)
receptor complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-vitronectin complexIntegrin beta-3Homo sapiens (human)
alpha9-beta1 integrin-ADAM8 complexIntegrin beta-3Homo sapiens (human)
focal adhesionIntegrin beta-3Homo sapiens (human)
cell surfaceIntegrin beta-3Homo sapiens (human)
synapseIntegrin beta-3Homo sapiens (human)
extracellular regionMyeloperoxidaseHomo sapiens (human)
extracellular spaceMyeloperoxidaseHomo sapiens (human)
nucleusMyeloperoxidaseHomo sapiens (human)
nucleoplasmMyeloperoxidaseHomo sapiens (human)
lysosomeMyeloperoxidaseHomo sapiens (human)
secretory granuleMyeloperoxidaseHomo sapiens (human)
azurophil granule lumenMyeloperoxidaseHomo sapiens (human)
azurophil granuleMyeloperoxidaseHomo sapiens (human)
intracellular membrane-bounded organelleMyeloperoxidaseHomo sapiens (human)
extracellular exosomeMyeloperoxidaseHomo sapiens (human)
phagocytic vesicle lumenMyeloperoxidaseHomo sapiens (human)
extracellular spaceMyeloperoxidaseHomo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
pericentriolar materialTyrosine-protein kinase LckHomo sapiens (human)
immunological synapseTyrosine-protein kinase LckHomo sapiens (human)
cytosolTyrosine-protein kinase LckHomo sapiens (human)
plasma membraneTyrosine-protein kinase LckHomo sapiens (human)
membrane raftTyrosine-protein kinase LckHomo sapiens (human)
extracellular exosomeTyrosine-protein kinase LckHomo sapiens (human)
plasma membraneTyrosine-protein kinase LckHomo sapiens (human)
mitochondrial matrixCyclin-dependent kinase 1Homo sapiens (human)
chromosome, telomeric regionCyclin-dependent kinase 1Homo sapiens (human)
nucleusCyclin-dependent kinase 1Homo sapiens (human)
nucleoplasmCyclin-dependent kinase 1Homo sapiens (human)
mitochondrionCyclin-dependent kinase 1Homo sapiens (human)
endoplasmic reticulum membraneCyclin-dependent kinase 1Homo sapiens (human)
centrosomeCyclin-dependent kinase 1Homo sapiens (human)
cytosolCyclin-dependent kinase 1Homo sapiens (human)
spindle microtubuleCyclin-dependent kinase 1Homo sapiens (human)
membraneCyclin-dependent kinase 1Homo sapiens (human)
midbodyCyclin-dependent kinase 1Homo sapiens (human)
extracellular exosomeCyclin-dependent kinase 1Homo sapiens (human)
mitotic spindleCyclin-dependent kinase 1Homo sapiens (human)
cyclin A1-CDK1 complexCyclin-dependent kinase 1Homo sapiens (human)
cyclin A2-CDK1 complexCyclin-dependent kinase 1Homo sapiens (human)
cyclin B1-CDK1 complexCyclin-dependent kinase 1Homo sapiens (human)
cyclin-dependent protein kinase holoenzyme complexCyclin-dependent kinase 1Homo sapiens (human)
cytoplasmCyclin-dependent kinase 1Homo sapiens (human)
nucleusCyclin-dependent kinase 1Homo sapiens (human)
extracellular regionGlycogen phosphorylase, liver formHomo sapiens (human)
cytosolGlycogen phosphorylase, liver formHomo sapiens (human)
secretory granule lumenGlycogen phosphorylase, liver formHomo sapiens (human)
extracellular exosomeGlycogen phosphorylase, liver formHomo sapiens (human)
ficolin-1-rich granule lumenGlycogen phosphorylase, liver formHomo sapiens (human)
cytoplasmGlycogen phosphorylase, liver formHomo sapiens (human)
endoplasmic reticulum membraneEpoxide hydrolase 1 Homo sapiens (human)
cytosolCarbonic anhydrase 3Homo sapiens (human)
cytosolCarbonic anhydrase 3Homo sapiens (human)
cytoplasmCarbonic anhydrase 3Homo sapiens (human)
extracellular regionTrypsin-1Homo sapiens (human)
collagen-containing extracellular matrixTrypsin-1Homo sapiens (human)
blood microparticleTrypsin-1Homo sapiens (human)
extracellular spaceTrypsin-1Homo sapiens (human)
extracellular regionTrypsin-2Homo sapiens (human)
extracellular spaceTrypsin-2Homo sapiens (human)
extracellular matrixTrypsin-2Homo sapiens (human)
azurophil granule lumenTrypsin-2Homo sapiens (human)
extracellular spaceTrypsin-2Homo sapiens (human)
extracellular regionProcathepsin LHomo sapiens (human)
extracellular spaceProcathepsin LHomo sapiens (human)
nucleusProcathepsin LHomo sapiens (human)
lysosomeProcathepsin LHomo sapiens (human)
multivesicular bodyProcathepsin LHomo sapiens (human)
Golgi apparatusProcathepsin LHomo sapiens (human)
plasma membraneProcathepsin LHomo sapiens (human)
apical plasma membraneProcathepsin LHomo sapiens (human)
endolysosome lumenProcathepsin LHomo sapiens (human)
chromaffin granuleProcathepsin LHomo sapiens (human)
lysosomal lumenProcathepsin LHomo sapiens (human)
intracellular membrane-bounded organelleProcathepsin LHomo sapiens (human)
collagen-containing extracellular matrixProcathepsin LHomo sapiens (human)
extracellular exosomeProcathepsin LHomo sapiens (human)
endocytic vesicle lumenProcathepsin LHomo sapiens (human)
extracellular spaceProcathepsin LHomo sapiens (human)
lysosomeProcathepsin LHomo sapiens (human)
Golgi apparatusTyrosine-protein kinase YesHomo sapiens (human)
centrosomeTyrosine-protein kinase YesHomo sapiens (human)
cytosolTyrosine-protein kinase YesHomo sapiens (human)
actin filamentTyrosine-protein kinase YesHomo sapiens (human)
plasma membraneTyrosine-protein kinase YesHomo sapiens (human)
focal adhesionTyrosine-protein kinase YesHomo sapiens (human)
extracellular exosomeTyrosine-protein kinase YesHomo sapiens (human)
plasma membraneTyrosine-protein kinase YesHomo sapiens (human)
plasma membraneProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
early endosomeProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
plasma membraneProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
endosome membraneProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
dendriteProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
neuronal cell bodyProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
receptor complexProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
plasma membrane protein complexProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
axonProto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)
plasma membraneInsulin-like growth factor 1 receptorHomo sapiens (human)
caveolaInsulin-like growth factor 1 receptorHomo sapiens (human)
membraneInsulin-like growth factor 1 receptorHomo sapiens (human)
T-tubuleInsulin-like growth factor 1 receptorHomo sapiens (human)
neuronal cell bodyInsulin-like growth factor 1 receptorHomo sapiens (human)
intracellular membrane-bounded organelleInsulin-like growth factor 1 receptorHomo sapiens (human)
alphav-beta3 integrin-IGF-1-IGF1R complexInsulin-like growth factor 1 receptorHomo sapiens (human)
receptor complexInsulin-like growth factor 1 receptorHomo sapiens (human)
protein kinase complexInsulin-like growth factor 1 receptorHomo sapiens (human)
axonInsulin-like growth factor 1 receptorHomo sapiens (human)
plasma membraneInsulin-like growth factor 1 receptorHomo sapiens (human)
insulin receptor complexInsulin-like growth factor 1 receptorHomo sapiens (human)
cytoplasmATP-dependent translocase ABCB1Homo sapiens (human)
plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
cell surfaceATP-dependent translocase ABCB1Homo sapiens (human)
membraneATP-dependent translocase ABCB1Homo sapiens (human)
apical plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
extracellular exosomeATP-dependent translocase ABCB1Homo sapiens (human)
external side of apical plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
extracellular regionNeutrophil elastaseHomo sapiens (human)
extracellular spaceNeutrophil elastaseHomo sapiens (human)
cytoplasmNeutrophil elastaseHomo sapiens (human)
cytosolNeutrophil elastaseHomo sapiens (human)
cell surfaceNeutrophil elastaseHomo sapiens (human)
secretory granuleNeutrophil elastaseHomo sapiens (human)
azurophil granule lumenNeutrophil elastaseHomo sapiens (human)
specific granule lumenNeutrophil elastaseHomo sapiens (human)
phagocytic vesicleNeutrophil elastaseHomo sapiens (human)
collagen-containing extracellular matrixNeutrophil elastaseHomo sapiens (human)
extracellular exosomeNeutrophil elastaseHomo sapiens (human)
transcription repressor complexNeutrophil elastaseHomo sapiens (human)
extracellular spaceNeutrophil elastaseHomo sapiens (human)
collagen-containing extracellular matrix72 kDa type IV collagenaseHomo sapiens (human)
extracellular region72 kDa type IV collagenaseHomo sapiens (human)
extracellular space72 kDa type IV collagenaseHomo sapiens (human)
nucleus72 kDa type IV collagenaseHomo sapiens (human)
mitochondrion72 kDa type IV collagenaseHomo sapiens (human)
plasma membrane72 kDa type IV collagenaseHomo sapiens (human)
sarcomere72 kDa type IV collagenaseHomo sapiens (human)
collagen-containing extracellular matrix72 kDa type IV collagenaseHomo sapiens (human)
extracellular space72 kDa type IV collagenaseHomo sapiens (human)
extracellular regionStromelysin-1Homo sapiens (human)
nucleusStromelysin-1Homo sapiens (human)
mitochondrionStromelysin-1Homo sapiens (human)
cytosolStromelysin-1Homo sapiens (human)
extracellular matrixStromelysin-1Homo sapiens (human)
extracellular spaceStromelysin-1Homo sapiens (human)
plasma membraneIntegrin alpha-IIbHomo sapiens (human)
focal adhesionIntegrin alpha-IIbHomo sapiens (human)
cell surfaceIntegrin alpha-IIbHomo sapiens (human)
platelet alpha granule membraneIntegrin alpha-IIbHomo sapiens (human)
extracellular exosomeIntegrin alpha-IIbHomo sapiens (human)
integrin alphaIIb-beta3 complexIntegrin alpha-IIbHomo sapiens (human)
blood microparticleIntegrin alpha-IIbHomo sapiens (human)
integrin complexIntegrin alpha-IIbHomo sapiens (human)
external side of plasma membraneIntegrin alpha-IIbHomo sapiens (human)
extracellular regionHepatocyte growth factor receptorHomo sapiens (human)
plasma membraneHepatocyte growth factor receptorHomo sapiens (human)
basal plasma membraneHepatocyte growth factor receptorHomo sapiens (human)
cell surfaceHepatocyte growth factor receptorHomo sapiens (human)
membraneHepatocyte growth factor receptorHomo sapiens (human)
postsynapseHepatocyte growth factor receptorHomo sapiens (human)
basal plasma membraneHepatocyte growth factor receptorHomo sapiens (human)
plasma membraneHepatocyte growth factor receptorHomo sapiens (human)
receptor complexHepatocyte growth factor receptorHomo sapiens (human)
cytoplasmCytochrome P450 3A4Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 3A4Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 3A4Homo sapiens (human)
plasma membrane5-hydroxytryptamine receptor 1AHomo sapiens (human)
synapse5-hydroxytryptamine receptor 1AHomo sapiens (human)
plasma membrane5-hydroxytryptamine receptor 1AHomo sapiens (human)
dendrite5-hydroxytryptamine receptor 1AHomo sapiens (human)
nucleusHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
nucleoplasmHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
cytoplasmHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
cytosolHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
membraneHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
extracellular exosomeHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
spliceosomal complexHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
catalytic step 2 spliceosomeHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
ribonucleoprotein complexHeterogeneous nuclear ribonucleoprotein A1Homo sapiens (human)
extracellular regionPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
extracellular spacePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear envelopePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear envelope lumenPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nucleoplasmPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
cytosolPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear matrixPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear membranePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
secretory granule lumenPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
perinuclear region of cytoplasmPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
ficolin-1-rich granule lumenPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear envelopePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
cytosolEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
membraneEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
protein-containing complexEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
catalytic complexEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
double membrane vesicle viral factory outer membraneReplicase polyprotein 1aSevere acute respiratory syndrome-related coronavirus
double membrane vesicle viral factory outer membraneReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
plasma membraneAdenosine receptor A3Homo sapiens (human)
presynaptic membraneAdenosine receptor A3Homo sapiens (human)
Schaffer collateral - CA1 synapseAdenosine receptor A3Homo sapiens (human)
dendriteAdenosine receptor A3Homo sapiens (human)
plasma membraneAdenosine receptor A3Homo sapiens (human)
synapseAdenosine receptor A3Homo sapiens (human)
spindle poleCalmodulin-1Homo sapiens (human)
extracellular regionCalmodulin-1Homo sapiens (human)
nucleusCalmodulin-1Homo sapiens (human)
nucleoplasmCalmodulin-1Homo sapiens (human)
cytoplasmCalmodulin-1Homo sapiens (human)
centrosomeCalmodulin-1Homo sapiens (human)
cytosolCalmodulin-1Homo sapiens (human)
spindle microtubuleCalmodulin-1Homo sapiens (human)
plasma membraneCalmodulin-1Homo sapiens (human)
sarcomereCalmodulin-1Homo sapiens (human)
vesicleCalmodulin-1Homo sapiens (human)
myelin sheathCalmodulin-1Homo sapiens (human)
sperm midpieceCalmodulin-1Homo sapiens (human)
voltage-gated potassium channel complexCalmodulin-1Homo sapiens (human)
protein-containing complexCalmodulin-1Homo sapiens (human)
calcium channel complexCalmodulin-1Homo sapiens (human)
catalytic complexCalmodulin-1Homo sapiens (human)
cytoplasmCalmodulin-1Homo sapiens (human)
double membrane vesicle viral factory outer membraneReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
extracellular spaceAlpha-amylase 1A Homo sapiens (human)
extracellular exosomeAlpha-amylase 1A Homo sapiens (human)
extracellular spaceAlpha-amylase 1A Homo sapiens (human)
lysosomeLysosomal alpha-glucosidaseHomo sapiens (human)
lysosomal membraneLysosomal alpha-glucosidaseHomo sapiens (human)
plasma membraneLysosomal alpha-glucosidaseHomo sapiens (human)
membraneLysosomal alpha-glucosidaseHomo sapiens (human)
azurophil granule membraneLysosomal alpha-glucosidaseHomo sapiens (human)
lysosomal lumenLysosomal alpha-glucosidaseHomo sapiens (human)
intracellular membrane-bounded organelleLysosomal alpha-glucosidaseHomo sapiens (human)
extracellular exosomeLysosomal alpha-glucosidaseHomo sapiens (human)
tertiary granule membraneLysosomal alpha-glucosidaseHomo sapiens (human)
ficolin-1-rich granule membraneLysosomal alpha-glucosidaseHomo sapiens (human)
autolysosome lumenLysosomal alpha-glucosidaseHomo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2C8Homo sapiens (human)
plasma membraneCytochrome P450 2C8Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C8Homo sapiens (human)
cytoplasmCytochrome P450 2C8Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C8Homo sapiens (human)
mitochondrionCytochrome P450 2D6Homo sapiens (human)
endoplasmic reticulumCytochrome P450 2D6Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2D6Homo sapiens (human)
cytoplasmCytochrome P450 2D6Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2D6Homo sapiens (human)
cytoplasmSolute carrier family 2, facilitated glucose transporter member 2Homo sapiens (human)
plasma membraneSolute carrier family 2, facilitated glucose transporter member 2Homo sapiens (human)
cell-cell junctionSolute carrier family 2, facilitated glucose transporter member 2Homo sapiens (human)
membraneSolute carrier family 2, facilitated glucose transporter member 2Homo sapiens (human)
apical plasma membraneSolute carrier family 2, facilitated glucose transporter member 2Homo sapiens (human)
plasma membraneSolute carrier family 2, facilitated glucose transporter member 2Homo sapiens (human)
brush borderSolute carrier family 2, facilitated glucose transporter member 2Homo sapiens (human)
nucleusSerine/threonine-protein kinase pim-1Homo sapiens (human)
nucleoplasmSerine/threonine-protein kinase pim-1Homo sapiens (human)
nucleolusSerine/threonine-protein kinase pim-1Homo sapiens (human)
cytoplasmSerine/threonine-protein kinase pim-1Homo sapiens (human)
cytosolSerine/threonine-protein kinase pim-1Homo sapiens (human)
plasma membraneSerine/threonine-protein kinase pim-1Homo sapiens (human)
cytoplasmSerine/threonine-protein kinase pim-1Homo sapiens (human)
endoplasmic reticulumAromataseHomo sapiens (human)
endoplasmic reticulum membraneAromataseHomo sapiens (human)
membraneAromataseHomo sapiens (human)
endoplasmic reticulumAromataseHomo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2C9 Homo sapiens (human)
plasma membraneCytochrome P450 2C9 Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C9 Homo sapiens (human)
cytoplasmCytochrome P450 2C9 Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C9 Homo sapiens (human)
nucleusCyclin-dependent kinase 4Homo sapiens (human)
nucleoplasmCyclin-dependent kinase 4Homo sapiens (human)
nucleolusCyclin-dependent kinase 4Homo sapiens (human)
cytosolCyclin-dependent kinase 4Homo sapiens (human)
bicellular tight junctionCyclin-dependent kinase 4Homo sapiens (human)
nuclear membraneCyclin-dependent kinase 4Homo sapiens (human)
cyclin D1-CDK4 complexCyclin-dependent kinase 4Homo sapiens (human)
cyclin D2-CDK4 complexCyclin-dependent kinase 4Homo sapiens (human)
cyclin D3-CDK4 complexCyclin-dependent kinase 4Homo sapiens (human)
cyclin-dependent protein kinase holoenzyme complexCyclin-dependent kinase 4Homo sapiens (human)
chromatinCyclin-dependent kinase 4Homo sapiens (human)
transcription regulator complexCyclin-dependent kinase 4Homo sapiens (human)
nucleusCyclin-dependent kinase 4Homo sapiens (human)
cytoplasmCyclin-dependent kinase 4Homo sapiens (human)
podosomeProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
nucleoplasmProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cytoplasmProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
mitochondrionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
mitochondrial inner membraneProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
lysosomeProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
late endosomeProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cytosolProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
actin filamentProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
plasma membraneProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
caveolaProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
focal adhesionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
cell junctionProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
ruffle membraneProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
neuronal cell bodyProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
dendritic growth coneProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
membrane raftProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
perinuclear region of cytoplasmProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
extracellular exosomeProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
synaptic membraneProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
glutamatergic synapseProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
postsynaptic specialization, intracellular componentProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
dendritic filopodiumProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
plasma membraneProto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)
nucleusCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
cytoplasmCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
lysosomal membraneCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
early endosomeCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
endoplasmic reticulum membraneCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
cytosolCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
plasma membraneCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
cell surfaceCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
endosome membraneCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
membraneCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
apical plasma membraneCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
Golgi-associated vesicle membraneCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
clathrin-coated endocytic vesicle membraneCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
early endosome membraneCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
recycling endosomeCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
recycling endosome membraneCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
protein-containing complexCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
chloride channel complexCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
cytosolCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
plasma membraneCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
apical plasma membraneCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
Golgi apparatusSucrase-isomaltase, intestinalHomo sapiens (human)
plasma membraneSucrase-isomaltase, intestinalHomo sapiens (human)
brush borderSucrase-isomaltase, intestinalHomo sapiens (human)
apical plasma membraneSucrase-isomaltase, intestinalHomo sapiens (human)
extracellular exosomeSucrase-isomaltase, intestinalHomo sapiens (human)
mitochondrial matrixG2/mitotic-specific cyclin-B1Homo sapiens (human)
spindle poleG2/mitotic-specific cyclin-B1Homo sapiens (human)
nucleusG2/mitotic-specific cyclin-B1Homo sapiens (human)
nucleoplasmG2/mitotic-specific cyclin-B1Homo sapiens (human)
cytoplasmG2/mitotic-specific cyclin-B1Homo sapiens (human)
centrosomeG2/mitotic-specific cyclin-B1Homo sapiens (human)
cytosolG2/mitotic-specific cyclin-B1Homo sapiens (human)
membraneG2/mitotic-specific cyclin-B1Homo sapiens (human)
cyclin B1-CDK1 complexG2/mitotic-specific cyclin-B1Homo sapiens (human)
outer kinetochoreG2/mitotic-specific cyclin-B1Homo sapiens (human)
cytoplasmG2/mitotic-specific cyclin-B1Homo sapiens (human)
nucleusG2/mitotic-specific cyclin-B1Homo sapiens (human)
centrosomeG2/mitotic-specific cyclin-B1Homo sapiens (human)
cytoplasmTyrosinaseHomo sapiens (human)
lysosomeTyrosinaseHomo sapiens (human)
Golgi-associated vesicleTyrosinaseHomo sapiens (human)
melanosome membraneTyrosinaseHomo sapiens (human)
melanosomeTyrosinaseHomo sapiens (human)
intracellular membrane-bounded organelleTyrosinaseHomo sapiens (human)
perinuclear region of cytoplasmTyrosinaseHomo sapiens (human)
extracellular regionMatrix metalloproteinase-9Homo sapiens (human)
extracellular spaceMatrix metalloproteinase-9Homo sapiens (human)
collagen-containing extracellular matrixMatrix metalloproteinase-9Homo sapiens (human)
extracellular exosomeMatrix metalloproteinase-9Homo sapiens (human)
tertiary granule lumenMatrix metalloproteinase-9Homo sapiens (human)
ficolin-1-rich granule lumenMatrix metalloproteinase-9Homo sapiens (human)
extracellular spaceMatrix metalloproteinase-9Homo sapiens (human)
nucleusSerine/threonine-protein kinase B-rafHomo sapiens (human)
cytosolSerine/threonine-protein kinase B-rafHomo sapiens (human)
plasma membraneSerine/threonine-protein kinase B-rafHomo sapiens (human)
neuron projectionSerine/threonine-protein kinase B-rafHomo sapiens (human)
intracellular membrane-bounded organelleSerine/threonine-protein kinase B-rafHomo sapiens (human)
cell bodySerine/threonine-protein kinase B-rafHomo sapiens (human)
presynapseSerine/threonine-protein kinase B-rafHomo sapiens (human)
cytosolSerine/threonine-protein kinase B-rafHomo sapiens (human)
mitochondrionSerine/threonine-protein kinase B-rafHomo sapiens (human)
plasma membraneSerine/threonine-protein kinase B-rafHomo sapiens (human)
extracellular spaceAldo-keto reductase family 1 member B1Homo sapiens (human)
nucleoplasmAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B1Homo sapiens (human)
extracellular exosomeAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B1Homo sapiens (human)
lipid dropletPolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
cytosolPolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
plasma membranePolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
cytoplasmic side of plasma membranePolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
membranePolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
plasma membranePolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
cytosolPolyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)
extracellular regionChymotrypsinogen BHomo sapiens (human)
plasma membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial matrixTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial cristaTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endosome lumenTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
sorting endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmic side of endoplasmic reticulum membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein-containing complexTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmPolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
cytosolPolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
membranePolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
sarcolemmaPolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
extracellular exosomePolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
cytosolPolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
sarcolemmaPolyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)
cytosolGlycogen synthase kinase-3 betaRattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
PcG protein complexCasein kinase II subunit alpha'Homo sapiens (human)
acrosomal vesicleCasein kinase II subunit alpha'Homo sapiens (human)
nucleusCasein kinase II subunit alpha'Homo sapiens (human)
nucleoplasmCasein kinase II subunit alpha'Homo sapiens (human)
cytosolCasein kinase II subunit alpha'Homo sapiens (human)
protein kinase CK2 complexCasein kinase II subunit alpha'Homo sapiens (human)
chromatinCasein kinase II subunit alpha'Homo sapiens (human)
cytosolCasein kinase II subunit alpha'Homo sapiens (human)
nucleusCasein kinase II subunit alpha'Homo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] AHomo sapiens (human)
cytosolAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] A Bos taurus (cattle)
centrosomeD(4) dopamine receptorHomo sapiens (human)
plasma membraneD(4) dopamine receptorHomo sapiens (human)
membraneD(4) dopamine receptorHomo sapiens (human)
postsynapseD(4) dopamine receptorHomo sapiens (human)
glutamatergic synapseD(4) dopamine receptorHomo sapiens (human)
plasma membraneD(4) dopamine receptorHomo sapiens (human)
dendriteD(4) dopamine receptorHomo sapiens (human)
extracellular regionAcetylcholinesteraseHomo sapiens (human)
basement membraneAcetylcholinesteraseHomo sapiens (human)
extracellular spaceAcetylcholinesteraseHomo sapiens (human)
nucleusAcetylcholinesteraseHomo sapiens (human)
Golgi apparatusAcetylcholinesteraseHomo sapiens (human)
plasma membraneAcetylcholinesteraseHomo sapiens (human)
cell surfaceAcetylcholinesteraseHomo sapiens (human)
membraneAcetylcholinesteraseHomo sapiens (human)
neuromuscular junctionAcetylcholinesteraseHomo sapiens (human)
synaptic cleftAcetylcholinesteraseHomo sapiens (human)
synapseAcetylcholinesteraseHomo sapiens (human)
perinuclear region of cytoplasmAcetylcholinesteraseHomo sapiens (human)
side of membraneAcetylcholinesteraseHomo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 4Homo sapiens (human)
rough endoplasmic reticulumCarbonic anhydrase 4Homo sapiens (human)
endoplasmic reticulum-Golgi intermediate compartmentCarbonic anhydrase 4Homo sapiens (human)
Golgi apparatusCarbonic anhydrase 4Homo sapiens (human)
trans-Golgi networkCarbonic anhydrase 4Homo sapiens (human)
plasma membraneCarbonic anhydrase 4Homo sapiens (human)
external side of plasma membraneCarbonic anhydrase 4Homo sapiens (human)
cell surfaceCarbonic anhydrase 4Homo sapiens (human)
membraneCarbonic anhydrase 4Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 4Homo sapiens (human)
transport vesicle membraneCarbonic anhydrase 4Homo sapiens (human)
secretory granule membraneCarbonic anhydrase 4Homo sapiens (human)
brush border membraneCarbonic anhydrase 4Homo sapiens (human)
perinuclear region of cytoplasmCarbonic anhydrase 4Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 4Homo sapiens (human)
plasma membraneCarbonic anhydrase 4Homo sapiens (human)
extracellular regionCarbonic anhydrase 6Homo sapiens (human)
extracellular spaceCarbonic anhydrase 6Homo sapiens (human)
cytosolCarbonic anhydrase 6Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 6Homo sapiens (human)
extracellular spaceCarbonic anhydrase 6Homo sapiens (human)
nucleusG1/S-specific cyclin-D1Homo sapiens (human)
nucleoplasmG1/S-specific cyclin-D1Homo sapiens (human)
cytosolG1/S-specific cyclin-D1Homo sapiens (human)
bicellular tight junctionG1/S-specific cyclin-D1Homo sapiens (human)
nuclear membraneG1/S-specific cyclin-D1Homo sapiens (human)
cyclin D1-CDK4 complexG1/S-specific cyclin-D1Homo sapiens (human)
cyclin D1-CDK6 complexG1/S-specific cyclin-D1Homo sapiens (human)
cyclin-dependent protein kinase holoenzyme complexG1/S-specific cyclin-D1Homo sapiens (human)
transcription repressor complexG1/S-specific cyclin-D1Homo sapiens (human)
centrosomeG1/S-specific cyclin-D1Homo sapiens (human)
cytoplasmG1/S-specific cyclin-D1Homo sapiens (human)
nucleusG1/S-specific cyclin-D1Homo sapiens (human)
chromosome, telomeric regionCyclin-dependent kinase 2Homo sapiens (human)
condensed chromosomeCyclin-dependent kinase 2Homo sapiens (human)
X chromosomeCyclin-dependent kinase 2Homo sapiens (human)
Y chromosomeCyclin-dependent kinase 2Homo sapiens (human)
male germ cell nucleusCyclin-dependent kinase 2Homo sapiens (human)
nucleusCyclin-dependent kinase 2Homo sapiens (human)
nuclear envelopeCyclin-dependent kinase 2Homo sapiens (human)
nucleoplasmCyclin-dependent kinase 2Homo sapiens (human)
cytoplasmCyclin-dependent kinase 2Homo sapiens (human)
endosomeCyclin-dependent kinase 2Homo sapiens (human)
centrosomeCyclin-dependent kinase 2Homo sapiens (human)
cytosolCyclin-dependent kinase 2Homo sapiens (human)
Cajal bodyCyclin-dependent kinase 2Homo sapiens (human)
cyclin A1-CDK2 complexCyclin-dependent kinase 2Homo sapiens (human)
cyclin A2-CDK2 complexCyclin-dependent kinase 2Homo sapiens (human)
cyclin E1-CDK2 complexCyclin-dependent kinase 2Homo sapiens (human)
cyclin E2-CDK2 complexCyclin-dependent kinase 2Homo sapiens (human)
cyclin-dependent protein kinase holoenzyme complexCyclin-dependent kinase 2Homo sapiens (human)
transcription regulator complexCyclin-dependent kinase 2Homo sapiens (human)
cytoplasmCyclin-dependent kinase 2Homo sapiens (human)
nucleusCyclin-dependent kinase 2Homo sapiens (human)
plasma membraneC-X-C chemokine receptor type 1Homo sapiens (human)
secretory granule membraneC-X-C chemokine receptor type 1Homo sapiens (human)
external side of plasma membraneC-X-C chemokine receptor type 1Homo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial envelopeAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] BHomo sapiens (human)
dendriteAmine oxidase [flavin-containing] BHomo sapiens (human)
neuronal cell bodyAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
extracellular regionDipeptidyl peptidase 4Homo sapiens (human)
lysosomal membraneDipeptidyl peptidase 4Homo sapiens (human)
plasma membraneDipeptidyl peptidase 4Homo sapiens (human)
focal adhesionDipeptidyl peptidase 4Homo sapiens (human)
cell surfaceDipeptidyl peptidase 4Homo sapiens (human)
membraneDipeptidyl peptidase 4Homo sapiens (human)
apical plasma membraneDipeptidyl peptidase 4Homo sapiens (human)
lamellipodiumDipeptidyl peptidase 4Homo sapiens (human)
endocytic vesicleDipeptidyl peptidase 4Homo sapiens (human)
lamellipodium membraneDipeptidyl peptidase 4Homo sapiens (human)
membrane raftDipeptidyl peptidase 4Homo sapiens (human)
intercellular canaliculusDipeptidyl peptidase 4Homo sapiens (human)
extracellular exosomeDipeptidyl peptidase 4Homo sapiens (human)
plasma membraneDipeptidyl peptidase 4Homo sapiens (human)
nucleusPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
cytoplasmPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
cis-Golgi networkPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
cytosolPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
plasma membranePhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
cell-cell junctionPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
phosphatidylinositol 3-kinase complex, class IAPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
membranePhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
perinuclear region of cytoplasmPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
perinuclear endoplasmic reticulum membranePhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
phosphatidylinositol 3-kinase complexPhosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)
nucleusProteasome subunit beta type-5Homo sapiens (human)
cytoplasmProteasome subunit beta type-5Homo sapiens (human)
proteasome complexProteasome subunit beta type-5Homo sapiens (human)
nucleusProteasome subunit beta type-5Homo sapiens (human)
nucleoplasmProteasome subunit beta type-5Homo sapiens (human)
centrosomeProteasome subunit beta type-5Homo sapiens (human)
cytosolProteasome subunit beta type-5Homo sapiens (human)
extracellular exosomeProteasome subunit beta type-5Homo sapiens (human)
proteasome core complexProteasome subunit beta type-5Homo sapiens (human)
proteasome core complex, beta-subunit complexProteasome subunit beta type-5Homo sapiens (human)
cytosolProteasome subunit beta type-5Homo sapiens (human)
plasma membraneADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
cell surfaceADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
membraneADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
basolateral plasma membraneADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
nuclear membraneADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
extracellular exosomeADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
plasma membraneADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1Homo sapiens (human)
endosomeVasopressin V2 receptorHomo sapiens (human)
endoplasmic reticulumVasopressin V2 receptorHomo sapiens (human)
Golgi apparatusVasopressin V2 receptorHomo sapiens (human)
plasma membraneVasopressin V2 receptorHomo sapiens (human)
membraneVasopressin V2 receptorHomo sapiens (human)
endocytic vesicleVasopressin V2 receptorHomo sapiens (human)
clathrin-coated endocytic vesicle membraneVasopressin V2 receptorHomo sapiens (human)
perinuclear region of cytoplasmVasopressin V2 receptorHomo sapiens (human)
plasma membraneVasopressin V2 receptorHomo sapiens (human)
extracellular spaceTyrosine-protein kinase receptor UFOHomo sapiens (human)
plasma membraneTyrosine-protein kinase receptor UFOHomo sapiens (human)
cell surfaceTyrosine-protein kinase receptor UFOHomo sapiens (human)
actin cytoskeletonTyrosine-protein kinase receptor UFOHomo sapiens (human)
intracellular membrane-bounded organelleTyrosine-protein kinase receptor UFOHomo sapiens (human)
extracellular exosomeTyrosine-protein kinase receptor UFOHomo sapiens (human)
plasma membraneTyrosine-protein kinase receptor UFOHomo sapiens (human)
receptor complexTyrosine-protein kinase receptor UFOHomo sapiens (human)
Golgi membraneAdenosine receptor A2aRattus norvegicus (Norway rat)
cytoplasmRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
mitochondrial intermembrane spaceRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
membraneRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
nucleusRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
nucleoplasmRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cytoplasmRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
spindleRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cytosolRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
plasma membraneRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cell-cell junctionRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
cell cortexRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
microtubule cytoskeletonRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
lamellipodiumRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
vesicleRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
ciliary basal bodyRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
postsynapseRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
glutamatergic synapseRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
protein-containing complexRAC-alpha serine/threonine-protein kinaseHomo sapiens (human)
plasma membraneMultidrug resistance-associated protein 1 Homo sapiens (human)
basal plasma membraneMultidrug resistance-associated protein 1 Homo sapiens (human)
membraneMultidrug resistance-associated protein 1 Homo sapiens (human)
basolateral plasma membraneMultidrug resistance-associated protein 1 Homo sapiens (human)
apical plasma membraneMultidrug resistance-associated protein 1 Homo sapiens (human)
lateral plasma membraneMultidrug resistance-associated protein 1 Homo sapiens (human)
extracellular exosomeMultidrug resistance-associated protein 1 Homo sapiens (human)
basolateral plasma membraneMultidrug resistance-associated protein 1 Homo sapiens (human)
peroxisomeBifunctional epoxide hydrolase 2Homo sapiens (human)
peroxisomal matrixBifunctional epoxide hydrolase 2Homo sapiens (human)
cytosolBifunctional epoxide hydrolase 2Homo sapiens (human)
extracellular exosomeBifunctional epoxide hydrolase 2Homo sapiens (human)
peroxisomeBifunctional epoxide hydrolase 2Homo sapiens (human)
extracellular regionTrypsin-3Homo sapiens (human)
extracellular spaceTrypsin-3Homo sapiens (human)
tertiary granule lumenTrypsin-3Homo sapiens (human)
extracellular spaceTrypsin-3Homo sapiens (human)
mitochondrial matrixCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
mitochondrionCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
cytoplasmCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
mitochondrionCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
nuclear inner membraneProstaglandin G/H synthase 2Homo sapiens (human)
nuclear outer membraneProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulumProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum lumenProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum membraneProstaglandin G/H synthase 2Homo sapiens (human)
caveolaProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
protein-containing complexProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
extracellular regionVascular endothelial growth factor receptor 2Homo sapiens (human)
nucleusVascular endothelial growth factor receptor 2Homo sapiens (human)
endosomeVascular endothelial growth factor receptor 2Homo sapiens (human)
early endosomeVascular endothelial growth factor receptor 2Homo sapiens (human)
endoplasmic reticulumVascular endothelial growth factor receptor 2Homo sapiens (human)
Golgi apparatusVascular endothelial growth factor receptor 2Homo sapiens (human)
plasma membraneVascular endothelial growth factor receptor 2Homo sapiens (human)
external side of plasma membraneVascular endothelial growth factor receptor 2Homo sapiens (human)
cell junctionVascular endothelial growth factor receptor 2Homo sapiens (human)
membrane raftVascular endothelial growth factor receptor 2Homo sapiens (human)
anchoring junctionVascular endothelial growth factor receptor 2Homo sapiens (human)
sorting endosomeVascular endothelial growth factor receptor 2Homo sapiens (human)
plasma membraneVascular endothelial growth factor receptor 2Homo sapiens (human)
receptor complexVascular endothelial growth factor receptor 2Homo sapiens (human)
endoplasmic reticulumReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
endoplasmic reticulum lumenReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
plasma membraneReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
endosome membraneReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
receptor complexReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
plasma membraneReceptor-type tyrosine-protein kinase FLT3Homo sapiens (human)
endoplasmic reticulum membrane17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
intracellular membrane-bounded organelle17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
platelet alpha granule membraneAlpha-synucleinHomo sapiens (human)
extracellular regionAlpha-synucleinHomo sapiens (human)
extracellular spaceAlpha-synucleinHomo sapiens (human)
nucleusAlpha-synucleinHomo sapiens (human)
cytoplasmAlpha-synucleinHomo sapiens (human)
mitochondrionAlpha-synucleinHomo sapiens (human)
lysosomeAlpha-synucleinHomo sapiens (human)
cytosolAlpha-synucleinHomo sapiens (human)
plasma membraneAlpha-synucleinHomo sapiens (human)
cell cortexAlpha-synucleinHomo sapiens (human)
actin cytoskeletonAlpha-synucleinHomo sapiens (human)
membraneAlpha-synucleinHomo sapiens (human)
inclusion bodyAlpha-synucleinHomo sapiens (human)
axonAlpha-synucleinHomo sapiens (human)
growth coneAlpha-synucleinHomo sapiens (human)
synaptic vesicle membraneAlpha-synucleinHomo sapiens (human)
perinuclear region of cytoplasmAlpha-synucleinHomo sapiens (human)
postsynapseAlpha-synucleinHomo sapiens (human)
supramolecular fiberAlpha-synucleinHomo sapiens (human)
protein-containing complexAlpha-synucleinHomo sapiens (human)
cytoplasmAlpha-synucleinHomo sapiens (human)
axon terminusAlpha-synucleinHomo sapiens (human)
neuronal cell bodyAlpha-synucleinHomo sapiens (human)
extracellular regionMacrophage metalloelastaseHomo sapiens (human)
extracellular spaceMacrophage metalloelastaseHomo sapiens (human)
nucleusMacrophage metalloelastaseHomo sapiens (human)
cytoplasmMacrophage metalloelastaseHomo sapiens (human)
extracellular matrixMacrophage metalloelastaseHomo sapiens (human)
extracellular spaceMacrophage metalloelastaseHomo sapiens (human)
cytosolCarbonic anhydrase 7Homo sapiens (human)
cytoplasmCarbonic anhydrase 7Homo sapiens (human)
cytoplasmTyrosine-protein kinase SYKHomo sapiens (human)
nucleusTyrosine-protein kinase SYKHomo sapiens (human)
cytoplasmTyrosine-protein kinase SYKHomo sapiens (human)
cytosolTyrosine-protein kinase SYKHomo sapiens (human)
plasma membraneTyrosine-protein kinase SYKHomo sapiens (human)
early phagosomeTyrosine-protein kinase SYKHomo sapiens (human)
B cell receptor complexTyrosine-protein kinase SYKHomo sapiens (human)
protein-containing complexTyrosine-protein kinase SYKHomo sapiens (human)
T cell receptor complexTyrosine-protein kinase SYKHomo sapiens (human)
plasma membraneTyrosine-protein kinase SYKHomo sapiens (human)
extracellular regionCollagenase 3Homo sapiens (human)
extracellular matrixCollagenase 3Homo sapiens (human)
extracellular spaceCollagenase 3Homo sapiens (human)
Dxr protein complex1-deoxy-D-xylulose 5-phosphate reductoisomeraseEscherichia coli K-12
cytosolXanthine dehydrogenase/oxidaseHomo sapiens (human)
extracellular spaceXanthine dehydrogenase/oxidaseHomo sapiens (human)
peroxisomeXanthine dehydrogenase/oxidaseHomo sapiens (human)
cytosolXanthine dehydrogenase/oxidaseHomo sapiens (human)
sarcoplasmic reticulumXanthine dehydrogenase/oxidaseHomo sapiens (human)
extracellular spaceXanthine dehydrogenase/oxidaseHomo sapiens (human)
nucleusProlyl endopeptidaseHomo sapiens (human)
cytoplasmProlyl endopeptidaseHomo sapiens (human)
cytosolProlyl endopeptidaseHomo sapiens (human)
membraneProlyl endopeptidaseHomo sapiens (human)
cytosolProlyl endopeptidaseHomo sapiens (human)
cytoplasmPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
cytosolPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
plasma membranePhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
phosphatidylinositol 3-kinase complex, class IAPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
membranePhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
phosphatidylinositol 3-kinase complex, class IBPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
plasma membranePhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
cytoplasmPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)
mitochondrionGlycogen synthase kinase-3 alphaHomo sapiens (human)
cytosolGlycogen synthase kinase-3 alphaHomo sapiens (human)
beta-catenin destruction complexGlycogen synthase kinase-3 alphaHomo sapiens (human)
neuronal cell bodyGlycogen synthase kinase-3 alphaHomo sapiens (human)
apical dendriteGlycogen synthase kinase-3 alphaHomo sapiens (human)
postsynapseGlycogen synthase kinase-3 alphaHomo sapiens (human)
proximal dendriteGlycogen synthase kinase-3 alphaHomo sapiens (human)
cytoplasmGlycogen synthase kinase-3 alphaHomo sapiens (human)
nucleusGlycogen synthase kinase-3 alphaHomo sapiens (human)
axonGlycogen synthase kinase-3 alphaHomo sapiens (human)
cytosolGlycogen synthase kinase-3 alphaHomo sapiens (human)
glutamatergic synapseGlycogen synthase kinase-3 betaHomo sapiens (human)
nucleusGlycogen synthase kinase-3 betaHomo sapiens (human)
nucleoplasmGlycogen synthase kinase-3 betaHomo sapiens (human)
cytoplasmGlycogen synthase kinase-3 betaHomo sapiens (human)
mitochondrionGlycogen synthase kinase-3 betaHomo sapiens (human)
centrosomeGlycogen synthase kinase-3 betaHomo sapiens (human)
cytosolGlycogen synthase kinase-3 betaHomo sapiens (human)
plasma membraneGlycogen synthase kinase-3 betaHomo sapiens (human)
axonGlycogen synthase kinase-3 betaHomo sapiens (human)
dendriteGlycogen synthase kinase-3 betaHomo sapiens (human)
beta-catenin destruction complexGlycogen synthase kinase-3 betaHomo sapiens (human)
presynapseGlycogen synthase kinase-3 betaHomo sapiens (human)
postsynapseGlycogen synthase kinase-3 betaHomo sapiens (human)
Wnt signalosomeGlycogen synthase kinase-3 betaHomo sapiens (human)
cytosolGlycogen synthase kinase-3 betaHomo sapiens (human)
axonGlycogen synthase kinase-3 betaHomo sapiens (human)
nucleusGlycogen synthase kinase-3 betaHomo sapiens (human)
cytoplasmGlycogen synthase kinase-3 betaHomo sapiens (human)
plasma membraneC-C chemokine receptor type 4Homo sapiens (human)
neuronal cell bodyC-C chemokine receptor type 4Homo sapiens (human)
external side of plasma membraneC-C chemokine receptor type 4Homo sapiens (human)
kinetochoreSerine/threonine-protein kinase Nek2Homo sapiens (human)
kinetochoreSerine/threonine-protein kinase Nek2Homo sapiens (human)
condensed nuclear chromosomeSerine/threonine-protein kinase Nek2Homo sapiens (human)
spindle poleSerine/threonine-protein kinase Nek2Homo sapiens (human)
nucleoplasmSerine/threonine-protein kinase Nek2Homo sapiens (human)
nucleolusSerine/threonine-protein kinase Nek2Homo sapiens (human)
centrosomeSerine/threonine-protein kinase Nek2Homo sapiens (human)
cytosolSerine/threonine-protein kinase Nek2Homo sapiens (human)
microtubuleSerine/threonine-protein kinase Nek2Homo sapiens (human)
midbodySerine/threonine-protein kinase Nek2Homo sapiens (human)
protein-containing complexSerine/threonine-protein kinase Nek2Homo sapiens (human)
centrosomeSerine/threonine-protein kinase Nek2Homo sapiens (human)
cytoplasmSerine/threonine-protein kinase Nek2Homo sapiens (human)
nucleusSerine/threonine-protein kinase Nek2Homo sapiens (human)
spindle microtubuleSerine/threonine-protein kinase PLK1Homo sapiens (human)
kinetochoreSerine/threonine-protein kinase PLK1Homo sapiens (human)
synaptonemal complexSerine/threonine-protein kinase PLK1Homo sapiens (human)
spindle poleSerine/threonine-protein kinase PLK1Homo sapiens (human)
nucleusSerine/threonine-protein kinase PLK1Homo sapiens (human)
nucleoplasmSerine/threonine-protein kinase PLK1Homo sapiens (human)
centrosomeSerine/threonine-protein kinase PLK1Homo sapiens (human)
centrioleSerine/threonine-protein kinase PLK1Homo sapiens (human)
spindleSerine/threonine-protein kinase PLK1Homo sapiens (human)
cytosolSerine/threonine-protein kinase PLK1Homo sapiens (human)
microtubule cytoskeletonSerine/threonine-protein kinase PLK1Homo sapiens (human)
midbodySerine/threonine-protein kinase PLK1Homo sapiens (human)
centriolar satelliteSerine/threonine-protein kinase PLK1Homo sapiens (human)
spindle midzoneSerine/threonine-protein kinase PLK1Homo sapiens (human)
mitotic spindle poleSerine/threonine-protein kinase PLK1Homo sapiens (human)
chromatinSerine/threonine-protein kinase PLK1Homo sapiens (human)
outer kinetochoreSerine/threonine-protein kinase PLK1Homo sapiens (human)
nucleusSerine/threonine-protein kinase PLK1Homo sapiens (human)
centrosomeSerine/threonine-protein kinase PLK1Homo sapiens (human)
cytoplasmSerine/threonine-protein kinase PLK1Homo sapiens (human)
spindle poleSerine/threonine-protein kinase PLK1Homo sapiens (human)
kinetochoreSerine/threonine-protein kinase PLK1Homo sapiens (human)
cytoplasmDeath-associated protein kinase 1Homo sapiens (human)
plasma membraneDeath-associated protein kinase 1Homo sapiens (human)
postsynaptic densityDeath-associated protein kinase 1Homo sapiens (human)
actin cytoskeletonDeath-associated protein kinase 1Homo sapiens (human)
glutamatergic synapseDeath-associated protein kinase 1Homo sapiens (human)
DAPK1-calmodulin complexDeath-associated protein kinase 1Homo sapiens (human)
cytoplasmDeath-associated protein kinase 1Homo sapiens (human)
nucleusDeath-associated protein kinase 1Homo sapiens (human)
nucleoplasmMitogen-activated protein kinase 10Homo sapiens (human)
cytoplasmMitogen-activated protein kinase 10Homo sapiens (human)
mitochondrionMitogen-activated protein kinase 10Homo sapiens (human)
cytosolMitogen-activated protein kinase 10Homo sapiens (human)
plasma membraneMitogen-activated protein kinase 10Homo sapiens (human)
nucleusMitogen-activated protein kinase 10Homo sapiens (human)
cytoplasmMitogen-activated protein kinase 10Homo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BBos taurus (cattle)
mitochondrial outer membraneAmine oxidase [flavin-containing] BBos taurus (cattle)
lysosomeBeta-secretase 1Homo sapiens (human)
endosomeBeta-secretase 1Homo sapiens (human)
early endosomeBeta-secretase 1Homo sapiens (human)
late endosomeBeta-secretase 1Homo sapiens (human)
multivesicular bodyBeta-secretase 1Homo sapiens (human)
endoplasmic reticulum lumenBeta-secretase 1Homo sapiens (human)
Golgi apparatusBeta-secretase 1Homo sapiens (human)
trans-Golgi networkBeta-secretase 1Homo sapiens (human)
plasma membraneBeta-secretase 1Homo sapiens (human)
synaptic vesicleBeta-secretase 1Homo sapiens (human)
cell surfaceBeta-secretase 1Homo sapiens (human)
endosome membraneBeta-secretase 1Homo sapiens (human)
membraneBeta-secretase 1Homo sapiens (human)
axonBeta-secretase 1Homo sapiens (human)
dendriteBeta-secretase 1Homo sapiens (human)
neuronal cell bodyBeta-secretase 1Homo sapiens (human)
membrane raftBeta-secretase 1Homo sapiens (human)
recycling endosomeBeta-secretase 1Homo sapiens (human)
Golgi-associated vesicle lumenBeta-secretase 1Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseBeta-secretase 1Homo sapiens (human)
endosomeBeta-secretase 1Homo sapiens (human)
plasma membraneBeta-secretase 1Homo sapiens (human)
trans-Golgi networkBeta-secretase 1Homo sapiens (human)
extracellular regionAnthrax toxin receptor 2Homo sapiens (human)
endoplasmic reticulum membraneAnthrax toxin receptor 2Homo sapiens (human)
plasma membraneAnthrax toxin receptor 2Homo sapiens (human)
endosome membraneAnthrax toxin receptor 2Homo sapiens (human)
plasma membraneAnthrax toxin receptor 2Homo sapiens (human)
cell surfaceAnthrax toxin receptor 2Homo sapiens (human)
virion membraneSpike glycoproteinSevere acute respiratory syndrome-related coronavirus
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
plasma membraneCasein kinase II subunit betaHomo sapiens (human)
PcG protein complexCasein kinase II subunit betaHomo sapiens (human)
PML bodyCasein kinase II subunit betaHomo sapiens (human)
extracellular regionCasein kinase II subunit betaHomo sapiens (human)
nucleusCasein kinase II subunit betaHomo sapiens (human)
nucleoplasmCasein kinase II subunit betaHomo sapiens (human)
cytoplasmCasein kinase II subunit betaHomo sapiens (human)
cytosolCasein kinase II subunit betaHomo sapiens (human)
protein kinase CK2 complexCasein kinase II subunit betaHomo sapiens (human)
secretory granule lumenCasein kinase II subunit betaHomo sapiens (human)
extracellular exosomeCasein kinase II subunit betaHomo sapiens (human)
ficolin-1-rich granule lumenCasein kinase II subunit betaHomo sapiens (human)
chromatinCasein kinase II subunit betaHomo sapiens (human)
cytoplasmCasein kinase II subunit betaHomo sapiens (human)
PcG protein complexCasein kinase II subunit alphaHomo sapiens (human)
PML bodyCasein kinase II subunit alphaHomo sapiens (human)
nucleusCasein kinase II subunit alphaHomo sapiens (human)
nucleoplasmCasein kinase II subunit alphaHomo sapiens (human)
cytosolCasein kinase II subunit alphaHomo sapiens (human)
plasma membraneCasein kinase II subunit alphaHomo sapiens (human)
protein kinase CK2 complexCasein kinase II subunit alphaHomo sapiens (human)
Sin3-type complexCasein kinase II subunit alphaHomo sapiens (human)
cytosolCasein kinase II subunit alphaHomo sapiens (human)
nucleusCasein kinase II subunit alphaHomo sapiens (human)
cell-cell junctionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
focal adhesionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
ruffle membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
Golgi membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cytoplasmDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
endoplasmic reticulum lumenDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cytosolDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
plasma membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cell surfaceDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
actin cytoskeletonDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
apical plasma membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
membrane raftDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
plasma membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
extracellular spaceLactoperoxidaseBos taurus (cattle)
cytoplasmLactoperoxidaseBos taurus (cattle)
extracellular spaceXanthine dehydrogenase/oxidaseBos taurus (cattle)
peroxisomeXanthine dehydrogenase/oxidaseBos taurus (cattle)
xanthine dehydrogenase complexXanthine dehydrogenase/oxidaseBos taurus (cattle)
ruffleCyclin-dependent kinase 6Homo sapiens (human)
nucleusCyclin-dependent kinase 6Homo sapiens (human)
nucleoplasmCyclin-dependent kinase 6Homo sapiens (human)
cytoplasmCyclin-dependent kinase 6Homo sapiens (human)
centrosomeCyclin-dependent kinase 6Homo sapiens (human)
cytosolCyclin-dependent kinase 6Homo sapiens (human)
cyclin D1-CDK6 complexCyclin-dependent kinase 6Homo sapiens (human)
cyclin D3-CDK6 complexCyclin-dependent kinase 6Homo sapiens (human)
cyclin-dependent protein kinase holoenzyme complexCyclin-dependent kinase 6Homo sapiens (human)
cyclin D2-CDK6 complexCyclin-dependent kinase 6Homo sapiens (human)
cytoplasmCyclin-dependent kinase 6Homo sapiens (human)
nucleusCyclin-dependent kinase 6Homo sapiens (human)
microtubuleCyclin-dependent-like kinase 5 Homo sapiens (human)
cyclin-dependent protein kinase holoenzyme complexCyclin-dependent-like kinase 5 Homo sapiens (human)
nucleusCyclin-dependent-like kinase 5 Homo sapiens (human)
nucleoplasmCyclin-dependent-like kinase 5 Homo sapiens (human)
cytoplasmCyclin-dependent-like kinase 5 Homo sapiens (human)
cytosolCyclin-dependent-like kinase 5 Homo sapiens (human)
plasma membraneCyclin-dependent-like kinase 5 Homo sapiens (human)
postsynaptic densityCyclin-dependent-like kinase 5 Homo sapiens (human)
membraneCyclin-dependent-like kinase 5 Homo sapiens (human)
protein kinase 5 complexCyclin-dependent-like kinase 5 Homo sapiens (human)
lamellipodiumCyclin-dependent-like kinase 5 Homo sapiens (human)
cell junctionCyclin-dependent-like kinase 5 Homo sapiens (human)
filopodiumCyclin-dependent-like kinase 5 Homo sapiens (human)
axonCyclin-dependent-like kinase 5 Homo sapiens (human)
dendriteCyclin-dependent-like kinase 5 Homo sapiens (human)
growth coneCyclin-dependent-like kinase 5 Homo sapiens (human)
neuromuscular junctionCyclin-dependent-like kinase 5 Homo sapiens (human)
neuron projectionCyclin-dependent-like kinase 5 Homo sapiens (human)
neuronal cell bodyCyclin-dependent-like kinase 5 Homo sapiens (human)
perikaryonCyclin-dependent-like kinase 5 Homo sapiens (human)
presynapseCyclin-dependent-like kinase 5 Homo sapiens (human)
nucleusCyclin-dependent-like kinase 5 Homo sapiens (human)
cytoplasmCyclin-dependent-like kinase 5 Homo sapiens (human)
kinetochoreHeat shock factor protein 1Homo sapiens (human)
nucleusHeat shock factor protein 1Homo sapiens (human)
nucleoplasmHeat shock factor protein 1Homo sapiens (human)
cytoplasmHeat shock factor protein 1Homo sapiens (human)
centrosomeHeat shock factor protein 1Homo sapiens (human)
cytosolHeat shock factor protein 1Homo sapiens (human)
PML bodyHeat shock factor protein 1Homo sapiens (human)
perinuclear region of cytoplasmHeat shock factor protein 1Homo sapiens (human)
nuclear stress granuleHeat shock factor protein 1Homo sapiens (human)
mitotic spindle poleHeat shock factor protein 1Homo sapiens (human)
chromatinHeat shock factor protein 1Homo sapiens (human)
euchromatinHeat shock factor protein 1Homo sapiens (human)
heterochromatinHeat shock factor protein 1Homo sapiens (human)
protein folding chaperone complexHeat shock factor protein 1Homo sapiens (human)
ribonucleoprotein complexHeat shock factor protein 1Homo sapiens (human)
nucleusHeat shock factor protein 1Homo sapiens (human)
extracellular spaceSorbitol dehydrogenaseHomo sapiens (human)
cytosolSorbitol dehydrogenaseHomo sapiens (human)
membraneSorbitol dehydrogenaseHomo sapiens (human)
motile ciliumSorbitol dehydrogenaseHomo sapiens (human)
mitochondrial membraneSorbitol dehydrogenaseHomo sapiens (human)
extracellular exosomeSorbitol dehydrogenaseHomo sapiens (human)
nucleusDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
mitochondrionDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
early endosomeDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
late endosomeDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
endoplasmic reticulumDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
Golgi apparatusDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
centrosomeDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
cytosolDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
plasma membraneDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
focal adhesionDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
nucleoplasmLactoylglutathione lyaseHomo sapiens (human)
cytoplasmLactoylglutathione lyaseHomo sapiens (human)
cytosolLactoylglutathione lyaseHomo sapiens (human)
plasma membraneLactoylglutathione lyaseHomo sapiens (human)
extracellular exosomeLactoylglutathione lyaseHomo sapiens (human)
stress fiberFocal adhesion kinase 1Homo sapiens (human)
nucleusFocal adhesion kinase 1Homo sapiens (human)
cytoplasmFocal adhesion kinase 1Homo sapiens (human)
centrosomeFocal adhesion kinase 1Homo sapiens (human)
cytosolFocal adhesion kinase 1Homo sapiens (human)
cytoskeletonFocal adhesion kinase 1Homo sapiens (human)
plasma membraneFocal adhesion kinase 1Homo sapiens (human)
focal adhesionFocal adhesion kinase 1Homo sapiens (human)
cell cortexFocal adhesion kinase 1Homo sapiens (human)
ciliary basal bodyFocal adhesion kinase 1Homo sapiens (human)
intracellular membrane-bounded organelleFocal adhesion kinase 1Homo sapiens (human)
perinuclear region of cytoplasmFocal adhesion kinase 1Homo sapiens (human)
plasma membraneFocal adhesion kinase 1Homo sapiens (human)
focal adhesionFocal adhesion kinase 1Homo sapiens (human)
dendritic spineFocal adhesion kinase 1Homo sapiens (human)
nucleoplasmCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
centrosomeCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
cytosolCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
endocytic vesicle membraneCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
sarcoplasmic reticulum membraneCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
synapseCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
calcium- and calmodulin-dependent protein kinase complexCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
neuron projectionCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
cytoplasmCalcium/calmodulin-dependent protein kinase type II subunit betaHomo sapiens (human)
ribonucleoprotein complexELAV-like protein 3Homo sapiens (human)
cyclin-dependent protein kinase holoenzyme complexCyclin-dependent kinase 5 activator 1Homo sapiens (human)
nucleusCyclin-dependent kinase 5 activator 1Homo sapiens (human)
nucleoplasmCyclin-dependent kinase 5 activator 1Homo sapiens (human)
cytoplasmCyclin-dependent kinase 5 activator 1Homo sapiens (human)
cytosolCyclin-dependent kinase 5 activator 1Homo sapiens (human)
plasma membraneCyclin-dependent kinase 5 activator 1Homo sapiens (human)
postsynaptic densityCyclin-dependent kinase 5 activator 1Homo sapiens (human)
membraneCyclin-dependent kinase 5 activator 1Homo sapiens (human)
protein kinase 5 complexCyclin-dependent kinase 5 activator 1Homo sapiens (human)
axonCyclin-dependent kinase 5 activator 1Homo sapiens (human)
dendriteCyclin-dependent kinase 5 activator 1Homo sapiens (human)
growth coneCyclin-dependent kinase 5 activator 1Homo sapiens (human)
neuromuscular junctionCyclin-dependent kinase 5 activator 1Homo sapiens (human)
neuron projectionCyclin-dependent kinase 5 activator 1Homo sapiens (human)
neuronal cell bodyCyclin-dependent kinase 5 activator 1Homo sapiens (human)
dendritic spineCyclin-dependent kinase 5 activator 1Homo sapiens (human)
perikaryonCyclin-dependent kinase 5 activator 1Homo sapiens (human)
intracellular membrane-bounded organelleCyclin-dependent kinase 5 activator 1Homo sapiens (human)
contractile muscle fiberCyclin-dependent kinase 5 activator 1Homo sapiens (human)
perinuclear region of cytoplasmCyclin-dependent kinase 5 activator 1Homo sapiens (human)
presynapseCyclin-dependent kinase 5 activator 1Homo sapiens (human)
cytoplasmCyclin-dependent kinase 5 activator 1Homo sapiens (human)
growth coneCyclin-dependent kinase 5 activator 1Homo sapiens (human)
P-bodyELAV-like protein 1Homo sapiens (human)
nucleusELAV-like protein 1Homo sapiens (human)
nucleoplasmELAV-like protein 1Homo sapiens (human)
cytoplasmELAV-like protein 1Homo sapiens (human)
endoplasmic reticulumELAV-like protein 1Homo sapiens (human)
cytosolELAV-like protein 1Homo sapiens (human)
cytoplasmic stress granuleELAV-like protein 1Homo sapiens (human)
membraneELAV-like protein 1Homo sapiens (human)
sarcoplasmELAV-like protein 1Homo sapiens (human)
cytoplasmic vesicleELAV-like protein 1Homo sapiens (human)
postsynapseELAV-like protein 1Homo sapiens (human)
glutamatergic synapseELAV-like protein 1Homo sapiens (human)
ribonucleoprotein complexELAV-like protein 1Homo sapiens (human)
nucleusSerine/threonine-protein kinase N1Homo sapiens (human)
nucleoplasmSerine/threonine-protein kinase N1Homo sapiens (human)
cytoplasmSerine/threonine-protein kinase N1Homo sapiens (human)
endosomeSerine/threonine-protein kinase N1Homo sapiens (human)
cytosolSerine/threonine-protein kinase N1Homo sapiens (human)
midbodySerine/threonine-protein kinase N1Homo sapiens (human)
cleavage furrowSerine/threonine-protein kinase N1Homo sapiens (human)
protein-containing complexSerine/threonine-protein kinase N1Homo sapiens (human)
cytosolMitogen-activated protein kinase 14Homo sapiens (human)
spindle poleMitogen-activated protein kinase 14Homo sapiens (human)
extracellular regionMitogen-activated protein kinase 14Homo sapiens (human)
nucleusMitogen-activated protein kinase 14Homo sapiens (human)
nucleoplasmMitogen-activated protein kinase 14Homo sapiens (human)
cytoplasmMitogen-activated protein kinase 14Homo sapiens (human)
mitochondrionMitogen-activated protein kinase 14Homo sapiens (human)
cytosolMitogen-activated protein kinase 14Homo sapiens (human)
nuclear speckMitogen-activated protein kinase 14Homo sapiens (human)
secretory granule lumenMitogen-activated protein kinase 14Homo sapiens (human)
glutamatergic synapseMitogen-activated protein kinase 14Homo sapiens (human)
ficolin-1-rich granule lumenMitogen-activated protein kinase 14Homo sapiens (human)
nucleusMitogen-activated protein kinase 14Homo sapiens (human)
cytoplasmMitogen-activated protein kinase 14Homo sapiens (human)
mitochondrionCytochrome P450 1B1Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 1B1Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1B1Homo sapiens (human)
nucleolusCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
membraneCarbonic anhydrase 9Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 9Homo sapiens (human)
microvillus membraneCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
membraneProbable maltase-glucoamylase 2Homo sapiens (human)
nucleoplasmCasein kinase II subunit alpha 3Homo sapiens (human)
nucleusCasein kinase II subunit alpha 3Homo sapiens (human)
cytosolCasein kinase II subunit alpha 3Homo sapiens (human)
protein kinase CK2 complexCasein kinase II subunit alpha 3Homo sapiens (human)
nucleoplasmInositol polyphosphate multikinaseHomo sapiens (human)
nucleusInositol polyphosphate multikinaseHomo sapiens (human)
cytoplasmInositol polyphosphate multikinaseHomo sapiens (human)
nuclear speckG2/mitotic-specific cyclin-B3Homo sapiens (human)
cyclin-dependent protein kinase holoenzyme complexG2/mitotic-specific cyclin-B3Homo sapiens (human)
cytoplasmG2/mitotic-specific cyclin-B3Homo sapiens (human)
nucleusG2/mitotic-specific cyclin-B3Homo sapiens (human)
centrosomeG2/mitotic-specific cyclin-B3Homo sapiens (human)
plasma membraneCanalicular multispecific organic anion transporter 1Homo sapiens (human)
cell surfaceCanalicular multispecific organic anion transporter 1Homo sapiens (human)
apical plasma membraneCanalicular multispecific organic anion transporter 1Homo sapiens (human)
intercellular canaliculusCanalicular multispecific organic anion transporter 1Homo sapiens (human)
apical plasma membraneCanalicular multispecific organic anion transporter 1Homo sapiens (human)
kinetochoreAurora kinase BHomo sapiens (human)
condensed chromosome, centromeric regionAurora kinase BHomo sapiens (human)
nucleusAurora kinase BHomo sapiens (human)
nucleoplasmAurora kinase BHomo sapiens (human)
spindleAurora kinase BHomo sapiens (human)
cytosolAurora kinase BHomo sapiens (human)
chromocenterAurora kinase BHomo sapiens (human)
microtubule cytoskeletonAurora kinase BHomo sapiens (human)
midbodyAurora kinase BHomo sapiens (human)
chromosome passenger complexAurora kinase BHomo sapiens (human)
mitotic spindle poleAurora kinase BHomo sapiens (human)
mitotic spindle midzoneAurora kinase BHomo sapiens (human)
kinetochoreAurora kinase BHomo sapiens (human)
spindle pole centrosomeAurora kinase BHomo sapiens (human)
spindle microtubuleAurora kinase BHomo sapiens (human)
spindle midzoneAurora kinase BHomo sapiens (human)
plasma membraneAngiotensin-converting enzyme 2 Homo sapiens (human)
extracellular regionAngiotensin-converting enzyme 2 Homo sapiens (human)
extracellular spaceAngiotensin-converting enzyme 2 Homo sapiens (human)
endoplasmic reticulum lumenAngiotensin-converting enzyme 2 Homo sapiens (human)
plasma membraneAngiotensin-converting enzyme 2 Homo sapiens (human)
ciliumAngiotensin-converting enzyme 2 Homo sapiens (human)
cell surfaceAngiotensin-converting enzyme 2 Homo sapiens (human)
membraneAngiotensin-converting enzyme 2 Homo sapiens (human)
apical plasma membraneAngiotensin-converting enzyme 2 Homo sapiens (human)
endocytic vesicle membraneAngiotensin-converting enzyme 2 Homo sapiens (human)
brush border membraneAngiotensin-converting enzyme 2 Homo sapiens (human)
membrane raftAngiotensin-converting enzyme 2 Homo sapiens (human)
extracellular exosomeAngiotensin-converting enzyme 2 Homo sapiens (human)
extracellular spaceAngiotensin-converting enzyme 2 Homo sapiens (human)
plasma membraneG-protein coupled receptor 35Homo sapiens (human)
plasma membraneG-protein coupled receptor 35Homo sapiens (human)
centrosomeSerine/threonine-protein kinase Nek6Homo sapiens (human)
spindle poleSerine/threonine-protein kinase Nek6Homo sapiens (human)
nucleusSerine/threonine-protein kinase Nek6Homo sapiens (human)
nucleoplasmSerine/threonine-protein kinase Nek6Homo sapiens (human)
cytoplasmSerine/threonine-protein kinase Nek6Homo sapiens (human)
cytosolSerine/threonine-protein kinase Nek6Homo sapiens (human)
microtubuleSerine/threonine-protein kinase Nek6Homo sapiens (human)
nuclear speckSerine/threonine-protein kinase Nek6Homo sapiens (human)
centriolar satelliteSerine/threonine-protein kinase Nek6Homo sapiens (human)
protein-containing complexSerine/threonine-protein kinase Nek6Homo sapiens (human)
cytosolSerine/threonine-protein kinase Nek6Homo sapiens (human)
nucleusNADPH oxidase 4Homo sapiens (human)
nucleolusNADPH oxidase 4Homo sapiens (human)
mitochondrionNADPH oxidase 4Homo sapiens (human)
endoplasmic reticulumNADPH oxidase 4Homo sapiens (human)
endoplasmic reticulum membraneNADPH oxidase 4Homo sapiens (human)
plasma membraneNADPH oxidase 4Homo sapiens (human)
focal adhesionNADPH oxidase 4Homo sapiens (human)
membraneNADPH oxidase 4Homo sapiens (human)
perinuclear region of cytoplasmNADPH oxidase 4Homo sapiens (human)
perinuclear endoplasmic reticulumNADPH oxidase 4Homo sapiens (human)
plasma membraneNADPH oxidase 4Homo sapiens (human)
NADPH oxidase complexNADPH oxidase 4Homo sapiens (human)
nucleusHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
nucleoplasmHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
cytoplasmHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
cytosolHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
perinuclear region of cytoplasmHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
cytoplasmHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
cytosolDipeptidyl peptidase 3Homo sapiens (human)
extracellular exosomeDipeptidyl peptidase 3Homo sapiens (human)
cytoplasmDipeptidyl peptidase 3Homo sapiens (human)
fibrillar centerInositol hexakisphosphate kinase 2Homo sapiens (human)
nucleusInositol hexakisphosphate kinase 2Homo sapiens (human)
nucleoplasmInositol hexakisphosphate kinase 2Homo sapiens (human)
cell junctionInositol hexakisphosphate kinase 2Homo sapiens (human)
nucleusInositol hexakisphosphate kinase 2Homo sapiens (human)
cytoplasmInositol hexakisphosphate kinase 2Homo sapiens (human)
plasma membraneShort transient receptor potential channel 5Homo sapiens (human)
dendriteShort transient receptor potential channel 5Homo sapiens (human)
growth coneShort transient receptor potential channel 5Homo sapiens (human)
neuronal cell bodyShort transient receptor potential channel 5Homo sapiens (human)
calcium channel complexShort transient receptor potential channel 5Homo sapiens (human)
cation channel complexShort transient receptor potential channel 5Homo sapiens (human)
plasma membraneShort transient receptor potential channel 5Homo sapiens (human)
plasma membraneCarbonic anhydrase 14Homo sapiens (human)
membraneCarbonic anhydrase 14Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 14Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 14Homo sapiens (human)
plasma membraneCarbonic anhydrase 14Homo sapiens (human)
plasma membraneALK tyrosine kinase receptorHomo sapiens (human)
plasma membraneALK tyrosine kinase receptorHomo sapiens (human)
extracellular exosomeALK tyrosine kinase receptorHomo sapiens (human)
protein-containing complexALK tyrosine kinase receptorHomo sapiens (human)
receptor complexALK tyrosine kinase receptorHomo sapiens (human)
nucleoplasmBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
apical plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
brush border membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
mitochondrial membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
membrane raftBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
external side of apical plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
mitochondrionCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
mitochondrial matrixCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
mitochondrionCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
cytoplasmCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
cytosolSialidase-2Homo sapiens (human)
catalytic complexSialidase-2Homo sapiens (human)
lysosomeSialidase-2Homo sapiens (human)
membraneSialidase-2Homo sapiens (human)
cytoplasmSialidase-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2377)

Assay IDTitleYearJournalArticle
AID1347161Confirmatory screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347169Tertiary RLuc qRT-PCR qHTS assay for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347157Confirmatory screen GU Rhodamine qHTS for Zika virus inhibitors qHTS2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1508628Confirmatory qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1508627Counterscreen qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: GLuc-NoTag assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347149Furin counterscreen qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1508629Cell Viability qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347425Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347407qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347424RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1631834Antitrypanosomal activity against Trypanosoma brucei brucei Lister 427 bloodstream forms after 72 hrs by resazurin-based assay2016Journal of medicinal chemistry, 08-25, Volume: 59, Issue:16
Profiling of Flavonol Derivatives for the Development of Antitrypanosomatidic Drugs.
AID1757376Inhibition of G6PD (unknown origin) assessed as reduction in 6-phospho-D-glucono-1,5-lactone and NADPH production using glucose-6-phosphate and NADP+ as substrate incubated for 15 mins by UV absorption photometry assay2021Bioorganic & medicinal chemistry letters, 05-15, Volume: 40Discovery and characterization of a novel glucose-6-phosphate dehydrogenase (G6PD) inhibitor via high-throughput screening.
AID1631832Inhibition of Trypanosoma brucei PTR1 using H2B as substrate incubated for 10 mins followed by addition of NADPH measured for 10 to 50 mins2016Journal of medicinal chemistry, 08-25, Volume: 59, Issue:16
Profiling of Flavonol Derivatives for the Development of Antitrypanosomatidic Drugs.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID720501qHTS for Inhibitors of Polymerase Kappa: Confirmatory Assay for Cherry-picked Compounds2012PloS one, , Volume: 7, Issue:10
A comprehensive strategy to discover inhibitors of the translesion synthesis DNA polymerase κ.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1190381Inhibition of dengue virus 2 NS2B-NS3 serine protease assessed as reduction in hydrolysis of Boc-Gly-Arg-Arg-7-amino-4-methylcumarin substrate by Dixon plot2015Bioorganic & medicinal chemistry, Feb-01, Volume: 23, Issue:3
Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies.
AID705018Inhibition of Bacillus anthracis Protective antigen assessed as reduction in PA83 level in CHO C4 cells at 100 uM after 1 hr by Western blot analysis relative to untreated-control in presence of lethal factor2012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Small molecule inhibitors of Bacillus anthracis protective antigen proteolytic activation and oligomerization.
AID705031Inhibition of Bacillus anthracis Protective antigen assessed as reduction in PA63 level in CHO C4 cells at 100 uM after 1 hr by Western blot analysis relative to untreated-control2012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Small molecule inhibitors of Bacillus anthracis protective antigen proteolytic activation and oligomerization.
AID705223Inhibition of LF-induced Bacillus anthracis PA83 N645C mutant oligomerization expressed in Escherichia coli BL-21 cells at 100 uM over 40 mins by FRET assay2012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Small molecule inhibitors of Bacillus anthracis protective antigen proteolytic activation and oligomerization.
AID1190384Inhibition of dengue virus 3 NS2B-NS3 serine protease assessed as reduction in hydrolysis of Boc-Gly-Arg-Arg-7-amino-4-methylcumarin substrate by Dixon plot2015Bioorganic & medicinal chemistry, Feb-01, Volume: 23, Issue:3
Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies.
AID521220Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay2007Nature chemical biology, May, Volume: 3, Issue:5
Chemical genetics reveals a complex functional ground state of neural stem cells.
AID1190379Antiviral activity against dengue virus 2 infected in african green monkey Vero cells assessed as reduction in viral replication dosed after adsorption with 200 FFU of virus for 1 hour by foci forming unit reduction assay2015Bioorganic & medicinal chemistry, Feb-01, Volume: 23, Issue:3
Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies.
AID705025Inhibition of Bacillus anthracis Protective antigen-mediated cytotoxicity in HT1080 cells at 100 uM compound co-treated for 5 hrs with antigen measured after 48 hrs by MTT assay in presence of FP592012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Small molecule inhibitors of Bacillus anthracis protective antigen proteolytic activation and oligomerization.
AID705027Inhibition of Bacillus anthracis Protective antigen-mediated cytotoxicity in RAW264.7 cells at 100 uM compound co-treated for 5 hrs with antigen by MTT assay in presence of lethal factor2012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Small molecule inhibitors of Bacillus anthracis protective antigen proteolytic activation and oligomerization.
AID492140Antioxidant activity assessed as formazan formation induced absorbance changes at 25 ppm at 570 nm at 37 degC for 6 hrs by MTT assay2010Journal of natural products, Jul-23, Volume: 73, Issue:7
An efficient and economical MTT assay for determining the antioxidant activity of plant natural product extracts and pure compounds.
AID524794Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID705033Inhibition of Bacillus anthracis Protective antigen-mediated cytotoxicity in RAW264.7 cells by MTT assay in presence of fetal bovine serum2012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Small molecule inhibitors of Bacillus anthracis protective antigen proteolytic activation and oligomerization.
AID705017Inhibition of Bacillus anthracis PA U7 mutant assessed as reduction in PA83 level in CHO C4 cells at 100 uM after 1 hr by Western blot analysis relative to untreated-control in presence of lethal factor2012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Small molecule inhibitors of Bacillus anthracis protective antigen proteolytic activation and oligomerization.
AID705026Inhibition of Bacillus anthracis Protective antigen-mediated cytotoxicity in RAW264.7 cells at 100 uM compound co-treated for 5 hrs with antigen measured after 48 hrs by MTT assay in presence of FP592012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Small molecule inhibitors of Bacillus anthracis protective antigen proteolytic activation and oligomerization.
AID524796Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID524795Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID705024Inhibition of matrix metalloprotease activated Bacillus anthracis Protective antigen-mediated cytotoxicity in HT1080 cells at 100 uM compound co-treated for 5 hrs with antigen measured after 48 hrs by MTT assay in presence of FP592012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Small molecule inhibitors of Bacillus anthracis protective antigen proteolytic activation and oligomerization.
AID524790Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID705224Inhibition of Bacillus anthracis Protective antigen-mediated cytotoxicity in human HT1080 cells by MTT assay in presence of fetal bovine serum2012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Small molecule inhibitors of Bacillus anthracis protective antigen proteolytic activation and oligomerization.
AID705032Inhibition of Bacillus anthracis Protective antigen assessed as reduction in PA83 level in CHO C4 cells at 100 uM after 1 hr by Western blot analysis relative to untreated-control2012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Small molecule inhibitors of Bacillus anthracis protective antigen proteolytic activation and oligomerization.
AID524793Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID1190380Inhibition of dengue virus 2 NS2B-NS3 serine protease assessed as reduction in hydrolysis of Boc-Gly-Arg-Arg-7-amino-4-methylcumarin substrate2015Bioorganic & medicinal chemistry, Feb-01, Volume: 23, Issue:3
Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies.
AID1190385Binding affinity to NT-647-NHS fluorescent dye-labeled dengue virus 3 NS2B-NS3 serine protease incubated for 10 mins by microscale thermophoresis method2015Bioorganic & medicinal chemistry, Feb-01, Volume: 23, Issue:3
Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies.
AID1191756Inhibition of human purified MPG pre-incubated with compound for 10 mins followed by addition of 1,N6 ethenoadenine containing 32P-labeled duplex oligonucleotide substrates at 20 uM by gel-based excision activity assay2015Bioorganic & medicinal chemistry, Mar-01, Volume: 23, Issue:5
Naturally occurring polyphenol, morin hydrate, inhibits enzymatic activity of N-methylpurine DNA glycosylase, a DNA repair enzyme with various roles in human disease.
AID705029Inhibition of human furin-mediated Bacillus anthracis PA83 cleavage at 1 to 100 uM after 1 hr by Western blot analysis2012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Small molecule inhibitors of Bacillus anthracis protective antigen proteolytic activation and oligomerization.
AID524791Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID705030Inhibition of Bacillus anthracis Protective antigen assessed as reduction in SDS-resistant oligomer level in CHO C4 cells at 100 uM after 1 hr by Western blot analysis relative to untreated-control2012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Small molecule inhibitors of Bacillus anthracis protective antigen proteolytic activation and oligomerization.
AID524792Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay2009Nature chemical biology, Oct, Volume: 5, Issue:10
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
AID1190383Inhibition of dengue virus 3 NS2B-NS3 serine protease assessed as reduction in hydrolysis of Boc-Gly-Arg-Arg-7-amino-4-methylcumarin substrate2015Bioorganic & medicinal chemistry, Feb-01, Volume: 23, Issue:3
Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies.
AID705028Inhibition of human furin-mediated TGFalpha-PE38 cleavage at 1 to 100 uM after 1 hr by Western blot analysis2012Journal of medicinal chemistry, Sep-27, Volume: 55, Issue:18
Small molecule inhibitors of Bacillus anthracis protective antigen proteolytic activation and oligomerization.
AID1833873Antimicrobial activity against Staphylococcus aureus ATCC 25923 assessed as bacterial growth inhibition measured after 24 hrs by resazurin dye based broth microdilution method2021Bioorganic & medicinal chemistry, 12-15, Volume: 52Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition.
AID378682Inhibition of Rous sarcoma virus SRC2006Journal of natural products, Jan, Volume: 69, Issue:1
A common protein fold topology shared by flavonoid biosynthetic enzymes and therapeutic targets.
AID676986Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation at 1 uM by spectrophotometry based TBARS assay relative to untreated control2012Bioorganic & medicinal chemistry, Sep-01, Volume: 20, Issue:17
Synthesis, cytotoxic and antioxidant evaluations of amino derivatives from perezone.
AID1400538Activation of Nrf2 in mouse Heap1c1c7 cells assessed as induction of NAD(P)H:quinone reductase activity at 12.5 uM relative to control2018Bioorganic & medicinal chemistry, 10-01, Volume: 26, Issue:18
Discovery of natural flavonoids as activators of Nrf2-mediated defense system: Structure-activity relationship and inhibition of intracellular oxidative insults.
AID587319Antiinflammatory activity in human neutrophil assessed as inhibition of fMLP-induced neutrophil chemoattraction 10 nM after 2 hrs by Boyden chamber v2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID1224749Delta TM value showing the stabilisation of CAMK1D produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1239532Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 3 after 24 hrs by checkerboard assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID710230Antioxidant activity of the compound assessed as DPPH radical scavenging at 10 uM after 30 secs by spectrophotometry2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Carbamate derivatives of indolines as cholinesterase inhibitors and antioxidants for the treatment of Alzheimer's disease.
AID1597700Neuroprotective activity against H2O2-induced oxidative stress in human SH-SY5Y cells assessed as reduction in ROS generation at 100 uM preincubated for 1 hr followed by DCFH-DA addition for 30 mins and subsequent co-treatment with compound and H2O2 for 32019European journal of medicinal chemistry, Sep-01, Volume: 177Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease.
AID765682Cytotoxicity against human neutrophils assessed as cell viability at 100 uM after 1 hr by trypan blue exclusion assay2013European journal of medicinal chemistry, Sep, Volume: 67Modulation of human neutrophils' oxidative burst by flavonoids.
AID1224767Delta TM value showing the stabilisation of DAPK3 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID603363Antibacterial activity against vancomycin resistant Enterococcus NCTC 12201 after 24 hrs by microdilution method2011Journal of medicinal chemistry, Jun-09, Volume: 54, Issue:11
Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
AID596670Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 1 uM on day 8 relative to control2011Bioorganic & medicinal chemistry, May-01, Volume: 19, Issue:9
Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells.
AID512275Inhibition of rabbit MKK1 expressed in Escherichia coli at 20 uM2000The Biochemical journal, Oct-01, Volume: 351, Issue:Pt 1
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
AID1188614Anticancer activity against human HOP62 cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID1743178Antioxidant activity assessed as AAPH scavenging activity by measuring residual fluorescence at 10 uM measured at 1 min interval for 30 mins by ORAC fluorescein assay relative to control2020European journal of medicinal chemistry, Dec-15, Volume: 208Multiple biological active 4-aminopyrazoles containing trifluoromethyl and their 4-nitroso-precursors: Synthesis and evaluation.
AID347254Binding affinity to human recombinant carbonyl reductase 1 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in presence of NADPH2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1572025Inhibition of human IPMK using insP3 as substrate preincubated for 15 mins followed by substrate and measured after 30 mins by TR-FRET assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
AID1310992Antioxidant activity assessed as inhibition of allopurinol-xanthine oxidase system-mediated superoxide formation measured over 7 mins by lucigenin-based chemiluminescence analysis2016European journal of medicinal chemistry, Aug-25, Volume: 119On the vasoprotective mechanisms underlying novel β-phosphorylated nitrones: Focus on free radical characterization, scavenging and NO-donation in a biological model of oxidative stress.
AID663956Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay2012ACS medicinal chemistry letters, Feb-09, Volume: 3, Issue:2
Discovery of Natural Phenols as G Protein-Coupled Receptor-35 (GPR35) Agonists.
AID1102141Phytotoxicity in Bassia scoparia assessed as inhibition of seed germination at 250 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID1239526Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 7 by disk diffusion assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID365675Inhibition of DPP42008Bioorganic & medicinal chemistry, Aug-01, Volume: 16, Issue:15
Baicalin, a prodrug able to reach the CNS, is a prolyl oligopeptidase inhibitor.
AID404068In vivo antitumor activity against rat Walker 256 cells
AID1446228Inhibition of recombinant MPO (unknown origin) assessed as reduction in TMB peroxidation by measuring residual activity at 5 uM in absence of H2O2 incubated for 5 mins followed by 100 fold enzyme dilution relative to control2017Journal of medicinal chemistry, 08-10, Volume: 60, Issue:15
Discovery of Novel Potent Reversible and Irreversible Myeloperoxidase Inhibitors Using Virtual Screening Procedure.
AID455703Noncompetitive inhibition of recombinant influenza A virus rvH1N1 A/Bervig_Mission/1/18 neuraminidase2009Bioorganic & medicinal chemistry, Oct-01, Volume: 17, Issue:19
Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities.
AID641162Inhibition of PI3Kalpha H1047R mutant in human HCT116 cells assessed as inhibition of Akt Ser473 phosphorylation at 25 uM by immunoblot analysis2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Biological evaluation and docking studies of recently identified inhibitors of phosphoinositide-3-kinases.
AID670321Inhibition of human recombinant MMP13 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay2012Bioorganic & medicinal chemistry, Jul-01, Volume: 20, Issue:13
Natural products as a gold mine for selective matrix metalloproteinases inhibitors.
AID768912Inhibition of human thrombin assessed as inhibition of band decaying corresponding to fibrinogen gamma chains at IC50 after 30 mins by SDS-PAGE analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID1127226Antiproliferative activity against human HepG2 cells assessed as cell growth at 10'-4 ug/ml after 48 hrs by SRB assay relative to control2014European journal of medicinal chemistry, May-22, Volume: 79In-vitro anti-proliferative and anti-oxidant activity of galangin, fisetin and quercetin: role of localization and intermolecular interaction in model membrane.
AID1833874Antimicrobial activity against Staphylococcus aureus ATCC 25923 assessed as bacterial growth inhibition measured after 24 hrs by CLSI based agar dilution method2021Bioorganic & medicinal chemistry, 12-15, Volume: 52Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition.
AID1462061Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
3-O-Substituted-3',4',5'-trimethoxyflavonols: Synthesis and cell-based evaluation as anti-prostate cancer agents.
AID1654524Inhibition of LPS-induced NO production in mouse RAW264.7 cells by Griess reagent based assay
AID469935Antioxidant activity assessed as DPPH radical scavenging activity2009Journal of natural products, Aug, Volume: 72, Issue:8
Constituents of the leaves of Magnolia ovata.
AID1917220Cytotoxicity against rat PC-12 cells assessed as inhibition of cell viability at 20 to 50 uM incubated for 24 hrs by MTT assay2022Bioorganic & medicinal chemistry, 11-01, Volume: 73Synthesis and evaluation of glycosylated quercetin to enhance neuroprotective effects on cerebral ischemia-reperfusion.
AID578843Cytotoxicity against human A2780 cells assessed as intracellular ATP level at 10 uM after 72 hrs by luminometry2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
AID406716Photostability of compound assessed as sun protection factor after 120 mins2008Journal of natural products, Jun, Volume: 71, Issue:6
Quercetin and rutin as potential sunscreen agents: determination of efficacy by an in vitro method.
AID1917226Neuroprotective activity against middle cerebral artery occlusion induced cerebral ischemia reperfusion rat model assessed decrease in morphological changes in brain at 10 mg/kg, ip preincubated for 0.5 hrs followed by reperfusion and measured after 24 hr2022Bioorganic & medicinal chemistry, 11-01, Volume: 73Synthesis and evaluation of glycosylated quercetin to enhance neuroprotective effects on cerebral ischemia-reperfusion.
AID578564Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess method2011Bioorganic & medicinal chemistry letters, Mar-15, Volume: 21, Issue:6
A new ursane-type triterpenoid glycoside from Centella asiatica leaves modulates the production of nitric oxide and secretion of TNF-α in activated RAW 264.7 cells.
AID1224801Delta TM value showing the stabilisation of MST1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1246444Antioxidant activity assessed as ABTS cation radical scavenging activity measured after 6 mins2015European journal of medicinal chemistry, Sep-18, Volume: 102Potential of aryl-urea-benzofuranylthiazoles hybrids as multitasking agents in Alzheimer's disease.
AID1917227Neuroprotective activity against middle cerebral artery occlusion induced cerebral ischemia reperfusion rat model assessed decrease in neuronal loss in brain at 10 mg/kg, ip preincubated for 0.5 hrs followed by reperfusion and measured after 24 hrs by hem2022Bioorganic & medicinal chemistry, 11-01, Volume: 73Synthesis and evaluation of glycosylated quercetin to enhance neuroprotective effects on cerebral ischemia-reperfusion.
AID1194983Antioxidant activity assessed as FRAP values at 12.5 ug/ml incubated at 37 degC for 5 mins by FeSO4.7H2O calibration curve based method2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Cytotoxic and antioxidant constituents from the leaves of Psidium guajava.
AID347253Binding affinity to human recombinant carbonyl reductase 1 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in presence of NADP+2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID537629Selectivity ratio of IC50 for human recombinant CD38 to IC50 for Schistosoma mansoni recombinant NAD+ glycohydrolase2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Identification by high-throughput screening of inhibitors of Schistosoma mansoni NAD(+) catabolizing enzyme.
AID339144Inhibition of norepinephrine-induced Wistar rat thoracic aorta phasic contraction at 20 ug/mL after 15 mins1993Journal of natural products, Jun, Volume: 56, Issue:6
Antiplatelet effects and vasorelaxing action of some constituents of Formosan plants.
AID605035Cellular uptake in human HCT116 cells assessed a bright fluorescence light at 5 uM after 12 hrs by fluorescence microscopic analysis2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID1187101Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as reduction in nitric oxide production after 24 hrs by Griess method based ELISA2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Triterpene glycosides from red ginseng marc and their anti-inflammatory activities.
AID1450466Inhibition of ELAV1 (unknown origin)-ARE TNFalpha complex formation after 20 mins by liquid scintillation counting method2017Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20
Compounds Interfering with Embryonic Lethal Abnormal Vision (ELAV) Protein-RNA Complexes: An Avenue for Discovering New Drugs.
AID1446625Cytotoxicity against human A549 cells after 48 hrs by SRB assay2017Journal of natural products, 02-24, Volume: 80, Issue:2
Anti-Neurodegenerative Biflavonoid Glycosides from Impatiens balsamina.
AID1372149Inhibition of human CYP1A expressed in HEK293 cells by fluorescence assay
AID424718Activity at bovine xanthine oxidase at 10 uM2009Journal of natural products, Apr, Volume: 72, Issue:4
Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin.
AID681520TP_TRANSPORTER: RT-PCR in MCF-7 cells2002Toxicology, Feb-28, Volume: 171, Issue:2-3
Influence of redox-active compounds and PXR-activators on human MRP1 and MRP2 gene expression.
AID758733Cytotoxicity against human WM115 cells after 46 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Structure-cytotoxic activity relationship of 3-arylideneflavanone and chromanone (E,Z isomers) and 3-arylflavones.
AID731032Inhibition of intracellular A2E photooxidation in human ARPE19 cells at 20 uM after 18 days2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Synthesis of antioxidants for prevention of age-related macular degeneration.
AID587313Antiinflammatory activity in human neutrophil assessed as inhibition of LTB4-induced neutrophil chemoattraction 30 nM after 2 hrs by Boyden chamber v2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID1188610Anticancer activity against human NCI-H1792 cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID1761536Binding affinity to sensorchip-immobilized human His-tagged CFTR F508 deletion mutant by surface plasmon resonance analysis2021European journal of medicinal chemistry, Mar-05, Volume: 213In silico drug repositioning on F508del-CFTR: A proof-of-concept study on the AIFA library.
AID339143Inhibition of norepinephrine-induced Wistar rat thoracic aorta phasic contraction at 50 ug/mL after 15 mins1993Journal of natural products, Jun, Volume: 56, Issue:6
Antiplatelet effects and vasorelaxing action of some constituents of Formosan plants.
AID1176146Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated TNFalpha production at 10 uM by ELISA2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
Anti-inflammatory components of Chrysanthemum indicum flowers.
AID1191757Inhibition of MPG in human A549 cell extracts at 50 to 300 uM using 1,N6 ethenoadenine containing 32P-labeled duplex oligonucleotide substrates by gel-based excision activity assay2015Bioorganic & medicinal chemistry, Mar-01, Volume: 23, Issue:5
Naturally occurring polyphenol, morin hydrate, inhibits enzymatic activity of N-methylpurine DNA glycosylase, a DNA repair enzyme with various roles in human disease.
AID377664Effect on duration of immobility in CD1 mouse at 10 mg/kg, ip by forced swimming test relative to carboxy methyl cellulose2006Journal of natural products, Jun, Volume: 69, Issue:6
Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and computational study.
AID1063896Uncompetitive inhibition of soybean LOX-1 using linoleic acid as substrate preincubated for 5 mins followed by substrate addition by Lineweaver-Burk plot analysis2014European journal of medicinal chemistry, Jan-24, Volume: 72Inhibition of LOX by flavonoids: a structure-activity relationship study.
AID1888439Cytotoxicity against rat PC-12 cells assessed as cell viability at 25 uM incubated for 24 hrs by MTT assay relative to control2022European journal of medicinal chemistry, Jan-05, Volume: 227Design, synthesis, and biological evaluation of novel (4-(1,2,4-oxadiazol-5-yl)phenyl)-2-aminoacetamide derivatives as multifunctional agents for the treatment of Alzheimer's disease.
AID365082Vasorelaxant activity against phenylephrine-induced contraction in Sprague-Dawley rat aorta relative to phenylephrine2008Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17
Identification of SVM-based classification model, synthesis and evaluation of prenylated flavonoids as vasorelaxant agents.
AID512296Inhibition of PHK from rabbit skeletal muscle at 20 uM2000The Biochemical journal, Oct-01, Volume: 351, Issue:Pt 1
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
AID336952Inhibition of bovine thymocytes protein tyrosine kinase assessed as angiotensin 1 phosphorylation
AID670311Inhibition of human recombinant MMP2 catalytic domain incubated for 20 mins by fluorimetric assay2012Bioorganic & medicinal chemistry, Jul-01, Volume: 20, Issue:13
Natural products as a gold mine for selective matrix metalloproteinases inhibitors.
AID540210Clearance in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID779049Inhibition of PI3 kinase (unknown origin)2013Bioorganic & medicinal chemistry, Nov-01, Volume: 21, Issue:21
Discovery and characterization of synthetic 4'-hydroxyflavones-New CK2 inhibitors from flavone family.
AID1082357Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under light conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID587317Antiinflammatory activity in human neutrophil assessed as inhibition of CXCL8-induced neutrophil chemoattraction 10 nM after 2 hrs by Boyden chamber v2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID424728Inhibition of bovine xanthine oxidase assessed as reduction of cytochrome c at 20 uM2009Journal of natural products, Apr, Volume: 72, Issue:4
Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin.
AID277586Inhibition of Plasmodium falciparum ENR using crotonyl-CoA substrate2007Journal of medicinal chemistry, Feb-22, Volume: 50, Issue:4
Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR).
AID241206Inhibition of cyclin-dependent kinase 1/cyclinB2005Journal of medicinal chemistry, Feb-10, Volume: 48, Issue:3
Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin.
AID1743179Antioxidant activity assessed as AAPH scavenging activity by measuring residual fluorescence at 50 uM measured at 1 min interval for 30 mins by ORAC fluorescein assay relative to control2020European journal of medicinal chemistry, Dec-15, Volume: 208Multiple biological active 4-aminopyrazoles containing trifluoromethyl and their 4-nitroso-precursors: Synthesis and evaluation.
AID1102127Phytotoxicity in Triticum aestivum (wheat) assessed as inhibition of seed germination at 250 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID395150ABTS radical scavenging activity assessed as Trolox equivalent antioxidant capacity2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
QSAR study of antioxidant activity of wine polyphenols.
AID537733Binding affinity to Candida albicans CaCdr1p expressed in yeast AD1-8u2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
AID1484010Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as end-time for aggregation at 200 uM after 48 hrs by Thioflavin-T fluorescence assay (Rvb = 504.9 mins)2017Journal of natural products, 02-24, Volume: 80, Issue:2
Combined in Vitro Cell-Based/in Silico Screening of Naturally Occurring Flavonoids and Phenolic Compounds as Potential Anti-Alzheimer Drugs.
AID578844Cytotoxicity against human MCF7 cells assessed as intracellular ATP level at 10 uM after 72 hrs by luminometry2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
AID332706Inhibition of human plasma alternative complement system assessed as hemolysis of non-sensitized rabbit erythrocytes at 1000 uM1995Journal of natural products, Mar, Volume: 58, Issue:3
In vitro anticomplementary activity of constituents from Morinda morindoides.
AID195230Influence (5 uM) on transacetylase catalyzed time dependent activation of NADPH cytochrome C reductase at pre-incubation time being 20 mins2002Bioorganic & medicinal chemistry letters, Sep-16, Volume: 12, Issue:18
Comparison of the prevention of aflatoxin b(1)-induced genotoxicity by quercetin and quercetin pentaacetate.
AID1188609Anticancer activity against human H460 cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID1102134Phytotoxicity in Arabidopsis thaliana assessed as inhibition of shoot differentiation at 250 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID638569Cytotoxicity against MDCK cells after 4 days2012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Synthesis and antiviral activity of substituted quercetins.
AID487897Antidiabetic activity in STZ-induced Wistar rat assessed as reduction in blood glucose level at 50 mg/kg, ig after 2 day relative to control2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
A comparative study of flavonoid analogues on streptozotocin-nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11beta-hydroxysteroid dehydrogenase type 1 inhibition.
AID587326Inhibition of FLPR1 protein expression in human neutrophil at 100 nM after 30 mins by flow cytometry2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID1202778Antioxidant activity assessed as H2O2 scavenging activity after 15 mins2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Antioxidative compounds from Garcinia buchananii stem bark.
AID382346Inhibition of amyloid beta (1 to 40) aggregation assessed as emission of thioflavin T fluorescence in presence of 1,1,1,3,3,3-hexaflouro-2-propanol2008Bioorganic & medicinal chemistry, May-01, Volume: 16, Issue:9
Design, synthesis, and biological evaluation of glycine-based molecular tongs as inhibitors of Abeta1-40 aggregation in vitro.
AID1536966Inhibition of LPS-induced delay of apoptosis in human neutrophils assessed as early apoptotic cells at 2.5 uM preincubated for 1 hr followed by LPS stimulation and measured after 24 hrs by Annexin V-FITC/propidium iodide staining based flow cytometry (Rvb2019Journal of natural products, 02-22, Volume: 82, Issue:2
Eupatoriopicrin Inhibits Pro-inflammatory Functions of Neutrophils via Suppression of IL-8 and TNF-alpha Production and p38 and ERK 1/2 MAP Kinases.
AID641156Inhibition of PI3Kalpha in human HCT116 cells using [32P]ATP at 25 uM after 10 mins2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Biological evaluation and docking studies of recently identified inhibitors of phosphoinositide-3-kinases.
AID1896155Antiviral activity against HBV infected HepG2 2.2.15 cells assessed as reduction in HBsAg level at 50 microg/ml for 48 hrs by ELISA2022Journal of medicinal chemistry, 10-13, Volume: 65, Issue:19
Inhibiting Sodium Taurocholate Cotransporting Polypeptide in HBV-Related Diseases: From Biological Function to Therapeutic Potential.
AID605043Cellular uptake in human MCF7 cells assessed as compound remaining in culture media at 10 uM after 12 hrs by HPLC-mass spectrophotometric analysis2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID1656374Selectivity index, ratio of CC50 for dog MDCK cells to EC50 for Influenza A virus (H1N1) infected in dog MDCK cells2020Bioorganic & medicinal chemistry, 01-01, Volume: 28, Issue:1
Design, synthesis and biological evaluation of substituted flavones and aurones as potential anti-influenza agents.
AID351094Cytoprotective activity against H2O2-induced cell death in rat PC12 cells assessed as increase in cell viability at 16 ug/ml preincubated 2 hrs before H2O2 challenge measured after 4 hrs by MTT assay relative to control2009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
Preparation of two sets of 5,6,7-trioxygenated dihydroflavonol derivatives as free radical scavengers and neuronal cell protectors to oxidative damage.
AID1516856Antifungal activity against Candida glabrata 587 by microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID1080600Phytotoxic activity against Sinapis alba assessed as inhibition of hypocotyl growth at 22 +/-2 degC after 72 hr2009Journal of agricultural and food chemistry, Apr-08, Volume: 57, Issue:7
Level of catechin, myricetin, quercetin and isoquercitrin in buckwheat (Fagopyrum esculentum Moench), changes of their levels during vegetation and their effect on the growth of selected weeds.
AID1459578Inhibition of recombinant human MAO-A assessed as reduction in 4-hydroxyquinoline formation using kynuramine as substrate after 20 mins by fluorometric assay2016Journal of natural products, 10-28, Volume: 79, Issue:10
Isolation of Acacetin from Calea urticifolia with Inhibitory Properties against Human Monoamine Oxidase-A and -B.
AID758732Cytotoxicity against human NALM6 cells after 46 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Structure-cytotoxic activity relationship of 3-arylideneflavanone and chromanone (E,Z isomers) and 3-arylflavones.
AID467552Antinociceptive activity in Swiss mouse assessed as inhibition of carrageenan-induced mechanical hypernociception at 300 mg/kg, po dosed 30 mins before carrageenan challenge measured after 3 hrs by electronic pressure-meter test2009Journal of natural products, Nov, Volume: 72, Issue:11
Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production.
AID1226444Cytotoxicity against human BxPC3 cells assessed as cell growth inhibition after 72 hrs by MTT assay2015Journal of medicinal chemistry, May-28, Volume: 58, Issue:10
Selenium-containing chrysin and quercetin derivatives: attractive scaffolds for cancer therapy.
AID1188617Anticancer activity against human Calu1 cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID1434691Inhibition of sucrose loaded POPC/POPE/POPS/PtdIns(3,4,5)P3 (59:20:20:1) liposome binding to eGFP-fused PDK1 PH domain (unknown origin) expressed in Escherichia coli BL21 after 10 mins by fluorescence spectrophotometry based pull down assay2017Bioorganic & medicinal chemistry letters, 02-01, Volume: 27, Issue:3
Inhibitory potential of flavonoids on PtdIns(3,4,5)P3 binding with the phosphoinositide-dependent kinase 1 pleckstrin homology domain.
AID1316658Cytotoxicity against LPS-activated human BV2 cells assessed as cell viability at 1 uM after 24 hrs by MTT assay (Rvb = 98.03 to 98.84%)2016Bioorganic & medicinal chemistry letters, 10-15, Volume: 26, Issue:20
Bioactive phenols as potential neuroinflammation inhibitors from the leaves of Xanthoceras sorbifolia Bunge.
AID1070384Neuroprotective activity in mouse HT22 cells assessed as t-BOOH-induced toxicity at 40 uM preincubated for 3 hrs followed by t-BOOH induction measured after 9 hrs by MTT assay2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Flavonoids, flavonoid metabolites, and phenolic acids inhibit oxidative stress in the neuronal cell line HT-22 monitored by ECIS and MTT assay: a comparative study.
AID630145Antioxidant activity assessed as DPPH radical scavenging activity2011Bioorganic & medicinal chemistry, Nov-01, Volume: 19, Issue:21
Bioassay-guided identification of an anti-inflammatory prenylated acylphloroglucinol from Melicope ptelefolia and molecular insights into its interaction with 5-lipoxygenase.
AID1063047Inhibition of wild type MEK1 (unknown origin)2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Protein kinase and HDAC inhibitors from the endophytic fungus Epicoccum nigrum.
AID1172640Inhibition of cell proliferation of rat C6 cells assessed as cell viability at 100 uM after 72 hrs by sulforhodamine B assay2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Bioactive triterpenoid saponins and phenolic compounds against glioma cells.
AID710228Cytotoxicity against rat H9c2 cells assessed as cell viability in absence of H2O22012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Carbamate derivatives of indolines as cholinesterase inhibitors and antioxidants for the treatment of Alzheimer's disease.
AID1063041Inhibition of PIM1 (unknown origin)2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Protein kinase and HDAC inhibitors from the endophytic fungus Epicoccum nigrum.
AID403636Inhibition of COX2 mRNA expression in human DLD1 cells2005Journal of natural products, Jul, Volume: 68, Issue:7
Expanding the ChemGPS chemical space with natural products.
AID381802Inhibition of human recombinant His-tagged Glyoxalase 1 expressed in Sf21-Baculovirus system2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
Structure-activity relationship of human GLO I inhibitory natural flavonoids and their growth inhibitory effects.
AID512284Inhibition of His-tagged human MSK1 expressed in Sf9 cells at 20 uM2000The Biochemical journal, Oct-01, Volume: 351, Issue:Pt 1
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
AID703620Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay2012Journal of medicinal chemistry, Oct-25, Volume: 55, Issue:20
Flavonoid dimers as novel, potent antileishmanial agents.
AID1242169Inhibition of HSF1 in human ASB145 cells assessed as potentiation of geldanamycin-induced reduction in cell proliferation at 25 uM relative to geldanamycin alone2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Regulating the master regulator: Controlling heat shock factor 1 as a chemotherapy approach.
AID1416480Inhibition of B-Raf V600E mutant (unknown origin) using fluorescein-MAP2K1 as substrate after 1 hr by electrophoretic assay2017MedChemComm, Sep-01, Volume: 8, Issue:9
Integrating docking scores and key interaction profiles to improve the accuracy of molecular docking: towards novel B-Raf
AID1359849Neuroprotection against H2O2-induced cell death in rat PC12 cells assessed as cell viability at 1 uM preincubated for 3 hrs followed by H2O2 stimulation measured after 2 hrs by MTT assay (Rvb = 25.2 to 41.8%)2018European journal of medicinal chemistry, May-25, Volume: 152Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer's disease based on coumarin and lipoic acid scaffolds.
AID1294437Antioxidant activity assessed as inhibition of NO-induced oxidation of non-fluorescent DAF-2 to the fluorescent triazolofluorescein after 30 mins by fluorimetric method2016European journal of medicinal chemistry, Jun-10, Volume: 115Novel chromone and xanthone derivatives: Synthesis and ROS/RNS scavenging activities.
AID1381978Antitumor activity against human H22 cells xenografted in Kunming mouse assessed as tumor growth inhibition at 100 mg/kg, ig for 7 consecutive days measured on day 162018European journal of medicinal chemistry, Feb-25, Volume: 146The lead optimization of the polyamine conjugate of flavonoid with a naphthalene motif: Synthesis and biological evaluation.
AID1485277Potency index, ratio of allopurinol IC50 to compound IC50 for bovine milk xanthine oxidase2017European journal of medicinal chemistry, Jul-28, Volume: 135Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity.
AID1243355Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Isolation and structure elucidation of bioactive compounds from the roots of the Tunisian Ononis angustissima L.
AID289333Nitric oxide scavenging activity assessed as inhibition of DAF2 oxidation2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
2-Styrylchromones: novel strong scavengers of reactive oxygen and nitrogen species.
AID1515260Inhibition of LSD1 (unknown origin) by fluorescence assay2019Bioorganic & medicinal chemistry, 01-15, Volume: 27, Issue:2
Flavone-based natural product agents as new lysine-specific demethylase 1 inhibitors exhibiting cytotoxicity against breast cancer cells in vitro.
AID1555754Downregulation of ABCB1 gene expression in human EPG85-257RDB cells after 72 hrs by RT-PCR analysis2019European journal of medicinal chemistry, Aug-15, Volume: 176Natural products as multidrug resistance modulators in cancer.
AID191897Mutagenicity evaluated by calculating number of revertants using Salmonella Typhimurium strain TA 98 (0.25 mg/plate) without S9 mix from rat liver1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
4'-Hydroxy-3-methoxyflavones with potent antipicornavirus activity.
AID603837Effect on ERK1 protein level in human MDA-MB-231 cells at 20 uM up to 120 mins by Western blot analysis2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Rhamnetin production based on the rational design of the poplar O-methyltransferase enzyme and its biological activities.
AID1264954Cytotoxicity against human MSC assessed as cell viability at 5 uM treated for 3 days measured on day 4 by alamar blue assay (Rvb = 97 to 100%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID1871922Metal chelating activity assessed as compound-Cu2+ complex formation by measuring binding energy2022European journal of medicinal chemistry, Feb-05, Volume: 229Quercetin derivatives: Drug design, development, and biological activities, a review.
AID1224791Delta TM value showing the stabilisation of PRKACA produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1070391Neuroprotective activity in mouse HT22 cells assessed as reduction of t-BOOH-induced oxidative stress preincubated for 3 hrs followed by t-BOOH induction measured for 20 hrs by time-resolved ECIS analysis2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Flavonoids, flavonoid metabolites, and phenolic acids inhibit oxidative stress in the neuronal cell line HT-22 monitored by ECIS and MTT assay: a comparative study.
AID339150Inhibition of bovine thymus p56-LCK protein tyrosine kinase activity1993Journal of natural products, Jun, Volume: 56, Issue:6
Flavonoids from Koelreuteria henryi and other sources as protein-tyrosine kinase inhibitors.
AID1662292Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of NO production preincubated for 1 hr followed by LPS stimulation measured after 24 hrs by Griess reagent based assay2020Bioorganic & medicinal chemistry, 06-01, Volume: 28, Issue:11
Microbial transformation of glycyrrhetinic acid derivatives by Bacillus subtilis ATCC 6633 and Bacillus megaterium CGMCC 1.1741.
AID1175719Antimalarial activity against chloroquine /mefloquine/pyrimethamine-resistant Plasmodium falciparum C235 by malaria SYBR green 1-based fluorescence (MSF) assay2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
The synthesis, antimalarial activity and CoMFA analysis of novel aminoalkylated quercetin analogs.
AID1224803Delta TM value showing the stabilisation of PBK produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1625134Antioxidant activity assessed as DPPH radical scavenging activity incubated for 1.5 hrs under dark condition by spectrometric method2019Journal of natural products, 03-22, Volume: 82, Issue:3
Synthesis of Rosmarinic Acid Amides as Antioxidative and Hypoglycemic Agents.
AID1572033Inhibition of IP6K2 in [3H]-inositol-labelled HEK293 cells assessed as reduction in insp7 levels at 2.5 uM after 3.5 hrs by HPLC analysis relative to control2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
AID676965Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation at 5.62 uM by spectrophotometry based TBARS assay relative to untreated control2012Bioorganic & medicinal chemistry, Sep-01, Volume: 20, Issue:17
Synthesis, cytotoxic and antioxidant evaluations of amino derivatives from perezone.
AID1593917Inhibition of mushroom tyrosinase assessed as reduction in dopachrome formation using L-DOPA as substrate preincubated for 20 mins followed by substrate addition by spectrophotometry2019Bioorganic & medicinal chemistry, 06-15, Volume: 27, Issue:12
Veratric acid derivatives containing benzylidene-hydrazine moieties as promising tyrosinase inhibitors and free radical scavengers.
AID1171187Teratogenic effect in zebrafish assessed as developmental toxicity at 40 to 80 uM after 72 hrs by microscopy2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Delineation of the role of glycosylation in the cytotoxic properties of quercetin using novel assays in living vertebrates.
AID1370805Inhibition of alpha-glucosidase (unknown origin) using 4-Nitrophenyl-alpha-D-glucopyranoside as substrate incubated foe 5 mins followed by substrate addition measured after 15 mins2018Bioorganic & medicinal chemistry letters, 02-01, Volume: 28, Issue:3
In vitro and in silico evaluations of diarylpentanoid series as α-glucosidase inhibitor.
AID1470585Antioxidant activity assessed as DPPH free radical scavenging activity at 100 ppm after 30 mins in dark by spectrophotometric method relative to control2017European journal of medicinal chemistry, May-26, Volume: 132Recent synthetic and medicinal perspectives of dihydropyrimidinones: A review.
AID1711959Induction of ROS generation in human HepG2 cells at 80 uM after 48 hrs by DCFH-DA staining based assay2016European journal of medicinal chemistry, Oct-04, Volume: 121Synthesis and biological properties of polyamine modified flavonoids as hepatocellular carcinoma inhibitors.
AID710235Antioxidant activity assessed as scavenging of glucose oxidase-generated H2O2 and hydroxyl radicals by chemiluminescence assay2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Carbamate derivatives of indolines as cholinesterase inhibitors and antioxidants for the treatment of Alzheimer's disease.
AID289337Peroxynitrite scavenging activity assessed as inhibition of DHR oxidation2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
2-Styrylchromones: novel strong scavengers of reactive oxygen and nitrogen species.
AID600288Vasorelaxant activity in rat aortic ring assessed as inhibition of phenylephrine-induced contraction2009Bioorganic & medicinal chemistry letters, Jun-15, Volume: 19, Issue:12
Synthesis, biological evaluation of prenylflavonoids as vasorelaxant and neuroprotective agents.
AID771082Inhibition of Helicobacter pylori urease2013European journal of medicinal chemistry, Oct, Volume: 68Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.
AID1446628Cytotoxicity against human BT549 cells after 48 hrs by SRB assay2017Journal of natural products, 02-24, Volume: 80, Issue:2
Anti-Neurodegenerative Biflavonoid Glycosides from Impatiens balsamina.
AID378677Inhibition of PI3K2006Journal of natural products, Jan, Volume: 69, Issue:1
A common protein fold topology shared by flavonoid biosynthetic enzymes and therapeutic targets.
AID600289Neuroprotective activity against oxygen-glucose deprivation-induced cell injury in rat PC12 cells assessed as cell viability at 1 uM2009Bioorganic & medicinal chemistry letters, Jun-15, Volume: 19, Issue:12
Synthesis, biological evaluation of prenylflavonoids as vasorelaxant and neuroprotective agents.
AID309800Selectivity for 12h-LO over 15-hLO2007Bioorganic & medicinal chemistry, Dec-01, Volume: 15, Issue:23
Structure-activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2.
AID1185463Inhibition of xanthine oxidase (unknown origin) at 37 degC at ph 7..82014Journal of natural products, Jul-25, Volume: 77, Issue:7
X-ray crystal structure of a xanthine oxidase complex with the flavonoid inhibitor quercetin.
AID424727Inhibition of bovine xanthine oxidase assessed as reduction of cytochrome c at 10 uM2009Journal of natural products, Apr, Volume: 72, Issue:4
Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin.
AID1239527Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 8 by disk diffusion assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1224788Delta TM value showing the stabilisation of PIM3 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID690144Antioxidant activity in human HepG2 cells assessed as reduction of oleic acid-induced ROS generation incubated for 24 hrs by DHCF-DA based fluorimetric assay relative to untreated control2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Comparative study on antioxidant capacity of flavonoids and their inhibitory effects on oleic acid-induced hepatic steatosis in vitro.
AID1750468Inhibition of CK2 (unknown origin)
AID286229Inhibition of 15LOX in rabbit reticulocytes by EIA assay2007Journal of natural products, May, Volume: 70, Issue:5
Lipoxygenase inhibitory constituents of the fruits of noni (Morinda citrifolia) collected in Tahiti.
AID1224762Delta TM value showing the stabilisation of CLK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID676987Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation at 1.78 uM by spectrophotometry based TBARS assay relative to untreated control2012Bioorganic & medicinal chemistry, Sep-01, Volume: 20, Issue:17
Synthesis, cytotoxic and antioxidant evaluations of amino derivatives from perezone.
AID1743176Antioxidant activity assessed as trolox equivalent of ABTS radical scavenging activity measured after 1 hr by UV-vis spectrophotometric method2020European journal of medicinal chemistry, Dec-15, Volume: 208Multiple biological active 4-aminopyrazoles containing trifluoromethyl and their 4-nitroso-precursors: Synthesis and evaluation.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1593611GSH reactivity in pH 7.4 PBS assessed as GSH-adduct formation at 50 uM incubated for 10 mins in presence of HRP and H2O2 in presence of 40 uM GSH by HPLC-DAD and HPLC-MS/MS analysis relative to control2019Bioorganic & medicinal chemistry, 06-15, Volume: 27, Issue:12
Purification, structural elucidation, antioxidant capacity and neuroprotective potential of the main polyphenolic compounds contained in Achyrocline satureioides (Lam) D.C. (Compositae).
AID1871976Antifungal activity against Candida albicans 10/15 assessed as fungal growth inhibition measured after 24 hrs by microdilution assay2022European journal of medicinal chemistry, Feb-05, Volume: 229Quercetin derivatives: Drug design, development, and biological activities, a review.
AID346254Vasorelaxant activity in Sprague-Dawley rat aorta assessed as inhibition of phenylephrine-induced contraction after 15 to 20 mins relative to phenylephrine2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Synthesis, biological evaluation and quantitative structure-activities relationship of flavonoids as vasorelaxant agents.
AID203728Inhibition of sorbitol dehydrogenase from sheep liver (40 U/mg of protein)1996Journal of medicinal chemistry, Oct-25, Volume: 39, Issue:22
Synthesis, activity, and molecular modeling of a new series of tricyclic pyridazinones as selective aldose reductase inhibitors.
AID658253Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication after 72 hrs by EGFP assay2012European journal of medicinal chemistry, Jun, Volume: 52Discovery of flavonoid derivatives as anti-HCV agents via pharmacophore search combining molecular docking strategy.
AID1286207Cytotoxicity against human BV2 cells assessed as cell viability by MTT assay relative to control2016Journal of natural products, Jan-22, Volume: 79, Issue:1
Nitric Oxide Inhibitory Dimeric Sesquiterpenoids from Artemisia rupestris.
AID587316Antiinflammatory activity in human neutrophil assessed as inhibition of fMLP-induced neutrophil chemoattraction 100 nM after 2 hrs by Boyden chamber v2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID1151282Bactericidal activity against BacLight Green labeled Escherichia coli up to 30 ug/ml2014Journal of natural products, May-23, Volume: 77, Issue:5
Development of a fluorometric microplate antiadhesion assay using uropathogenic Escherichia coli and human uroepithelial cells.
AID213412Ability to inhibit protein-tyrosine kinase activity of p56lck (isolated from bovine thymus) in vitro.1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Synthesis and protein-tyrosine kinase inhibitory activities of flavonoid analogues.
AID1063043Inhibition of NEK6 (unknown origin)2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Protein kinase and HDAC inhibitors from the endophytic fungus Epicoccum nigrum.
AID191892Mutagenicity evaluated by calculating number of revertants using Salmonella Typhimurium strain TA 100 (0.25 mg/plate) without S9 mix from rat liver according to the plate incorporation assay.1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
4'-Hydroxy-3-methoxyflavones with potent antipicornavirus activity.
AID1514845Inhibition of MPO in human neutrophils at 10'4 M using H2O2 as substrate measured for 30 secs in presence of o-dianisidine hydrochloride by spectrophotometric method relative to control2019Bioorganic & medicinal chemistry letters, 01-01, Volume: 29, Issue:1
The development of myeloperoxidase inhibitors.
AID587310Inhibition of fMLP-induced neutrophil recruitment in Swiss mouse at 30 mg/kg, sc administered pre-inflammatory stimulus after 6 hrs by Newbauer chamber using Romanowsky stain2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID730326Cytotoxicity against human RS4:11 cells harboring wild type FLT3 after 72 hrs by tetrazolium based Ez CyTox cell viability assay2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
Flavonoids as receptor tyrosine kinase FLT3 inhibitors.
AID1220238Intrinsic clearance in human intestinal microsomes assessed UGT-mediated glucuronidation clearance2012Drug metabolism and disposition: the biological fate of chemicals, Sep, Volume: 40, Issue:9
Quantitative prediction of human intestinal glucuronidation effects on intestinal availability of UDP-glucuronosyltransferase substrates using in vitro data.
AID710227Prevention of apoptosis in rat H9c2 cells assessed as reduction in fall of mitochondrial membrane potential at 100 nM after 1 hr2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Carbamate derivatives of indolines as cholinesterase inhibitors and antioxidants for the treatment of Alzheimer's disease.
AID1873848Binding affinity to human MMP-1 catalytic domain (100 to 269 residues) expressed in Escherichia coli BL21 Star (DE3) by SPR analysis2022Bioorganic & medicinal chemistry, 08-15, Volume: 68Development of flavonoid probes and the binding mode of the target protein and quercetin derivatives.
AID1381987Toxicity in Kunming mouse xenografted with human H22 cells assessed as effect on spleen weight index at 100 mg/kg, ig administered for 7 consecutive days2018European journal of medicinal chemistry, Feb-25, Volume: 146The lead optimization of the polyamine conjugate of flavonoid with a naphthalene motif: Synthesis and biological evaluation.
AID587325Inhibition of BLT1 protein expression in human neutrophil at 100 nM after 30 mins by flow cytometry2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID1446256Selectivity ratio of IC50 for bovine milk LPO to IC50 for recombinant MPO (unknown origin)2017Journal of medicinal chemistry, 08-10, Volume: 60, Issue:15
Discovery of Novel Potent Reversible and Irreversible Myeloperoxidase Inhibitors Using Virtual Screening Procedure.
AID1210016Inhibition of CYP2C8 in human liver microsomes using paclitaxel as substrate after 8 mins by LC-MS/MS analysis2012Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
AID1763093Inhibition of soybean 15-LOX using arachidonic acid or linolenic acid as substrate in presence of hydrogen peroxide incubated for 5 mins by colorimetric analysis
AID1182104Antiaging activity in Caenorhabditis elegans Bristol isolate N2 assessed as lifespan at 10 uM2014European journal of medicinal chemistry, Aug-18, Volume: 83Microwave-assisted synthesis of 3,5-disubstituted isoxazoles and evaluation of their anti-ageing activity.
AID1462060Antiproliferative activity against human DU145 cells after 3 days by WST-1 assay2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
3-O-Substituted-3',4',5'-trimethoxyflavonols: Synthesis and cell-based evaluation as anti-prostate cancer agents.
AID1572035Down regulation of insp5 levels in [3H]-inositol-labelled HEK293 cells at 2.5 uM after 3.5 hrs by HPLC analysis2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
AID43125Inhibitory activity against Beta-lactamase from DMSO stock was determined2003Journal of medicinal chemistry, Sep-25, Volume: 46, Issue:20
A specific mechanism of nonspecific inhibition.
AID362988Inhibition of immune complex-stimulated neutrophil oxidative metabolism in New Zealand white rabbit neutrophils assessed as ROS generation after 30 mins by lucigenin enhanced chemiluminescence assay2008European journal of medicinal chemistry, May, Volume: 43, Issue:5
Inhibition of immune complex-mediated neutrophil oxidative metabolism: a pharmacophore model for 3-phenylcoumarin derivatives using GRIND-based 3D-QSAR and 2D-QSAR procedures.
AID1250696Cytotoxicity against human androgen-dependent LNCAP cells assessed as inhibition of cell viability after 3 days by WST-1 cell proliferation assay2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
A new class of hybrid anticancer agents inspired by the synergistic effects of curcumin and genistein: Design, synthesis, and anti-proliferative evaluation.
AID1264956Cytotoxicity against human MSC assessed as cell viability at 1 uM treated for 6 days measured on day 7 by alamar blue assay (Rvb = 96 to 101%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID1316659Cytotoxicity against LPS-activated human BV2 cells assessed as cell viability at 10 uM after 24 hrs by MTT assay (Rvb = 98.03 to 98.84%)2016Bioorganic & medicinal chemistry letters, 10-15, Volume: 26, Issue:20
Bioactive phenols as potential neuroinflammation inhibitors from the leaves of Xanthoceras sorbifolia Bunge.
AID1485278Inhibition of bovine milk xanthine oxidase assessed using xanthine as substrate after 10 mins by fluorometric assay2017European journal of medicinal chemistry, Jul-28, Volume: 135Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity.
AID449288Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by spectrophotometry2009Journal of medicinal chemistry, Dec-10, Volume: 52, Issue:23
Design, synthesis, and examination of neuron protective properties of alkenylated and amidated dehydro-silybin derivatives.
AID287079Inhibitory effect on TPA-induced Epstein-Barr Virus early antigen activation in Raji cells at 100 mol ratio/32 pmol TPA relative to TPA2007Journal of natural products, May, Volume: 70, Issue:5
Anti-inflammatory and potential cancer chemopreventive constituents of the fruits of Morinda citrifolia (Noni).
AID1355204Antiseptic activity in Balb/c mouse model of Escherichia coli K1 infection-induced sepsis assessed as increase in survival rate at 1 mg/kg, ip pretreated for 1 hr followed by Escherichia coli K1 infection measured over 72 hrs relative to control2018Journal of natural products, 06-22, Volume: 81, Issue:6
Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production.
AID729309Inhibition of vasopressin-stimulated vasopressin V2 receptor in human HTLA cells pre-incubated for 20 mins measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay2013Journal of medicinal chemistry, Mar-28, Volume: 56, Issue:6
Colloidal aggregation causes inhibition of G protein-coupled receptors.
AID1373931Induction of apoptosis in human HL60 cells assessed as necrotic cells at 50 uM after 24 hrs by Annexin-V-FITC/propidium iodide staining based flow cytometric analysis (Rvb = 1.96 +/- 0.33 %)2018Bioorganic & medicinal chemistry, 02-15, Volume: 26, Issue:4
Optimization of antimalarial, and anticancer activities of (E)-methyl 2-(7-chloroquinolin-4-ylthio)-3-(4-hydroxyphenyl) acrylate.
AID379094Stimulation of BALB/c mouse cloned 3T3/A31 cells growth at 0.01 to 0.1 ug/mL1999Journal of natural products, Mar, Volume: 62, Issue:3
Activities of plant-derived phenols in a fibroblast cell culture model
AID379094Stimulation of BALB/c mouse cloned 3T3/A31 cells growth at 0.01 to 0.1 ug/mL1999Journal of natural products, Mar, Volume: 62, Issue:3
Activities of plant-derived phenols in a fibroblast cell culture model.
AID605047Cellular uptake in human MCF7 cells assessed as formation of quercetin sulphate in cell lysates at 10 uM after 5 hrs by HPLC-mass spectrophotometric analysis2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID749999Binding affinity to recombinant paraoxonase-1 (unknown origin) expressed in Escherichia coli after 5 mins by Trp-fluorescence quenching method2013Bioorganic & medicinal chemistry, Jun-01, Volume: 21, Issue:11
The effects and mechanism of flavonoid-rePON1 interactions. Structure-activity relationship study.
AID69729Inhibition of epidermal growth factor (EGF) receptor from A431 cell membranes at 150 uM1994Journal of medicinal chemistry, May-27, Volume: 37, Issue:11
Structural studies on bioactive compounds. 23. Synthesis of polyhydroxylated 2-phenylbenzothiazoles and a comparison of their cytotoxicities and pharmacological properties with genistein and quercetin.
AID1161233Inhibition of PMA-induced oxidative burst in human neutrophils by amplex red assay2014European journal of medicinal chemistry, Oct-30, Volume: 86Synthesis of chlorinated flavonoids with anti-inflammatory and pro-apoptotic activities in human neutrophils.
AID402262Antioxidant activity assessed as trolox equivalent of ABTS radical scavenging activity by spectrophotometry2004Journal of natural products, May, Volume: 67, Issue:5
Antioxidative constituents from the leaves of Hypericum styphelioides.
AID1102137Phytotoxicity in Arabidopsis thaliana assessed as inhibition of seed germination at 250 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID1833876Antimicrobial activity against Staphylococcus aureus ATCC 25923 assessed as zone of inhibition at 250 ug/ml measured after 24 hrs by disc diffusion method2021Bioorganic & medicinal chemistry, 12-15, Volume: 52Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition.
AID1056591Antimicrobial activity against Aggregatibacter actinomycetemcomitans infected in Balb/c mouse measured per 10'6 colonies at 100 mg/kg, sc measured 14 days post-infection by Gram staining technique (Rvb = 6.41 +/- 0.96 No_unit)2013Journal of natural products, Dec-27, Volume: 76, Issue:12
Quercetin inhibits inflammatory bone resorption in a mouse periodontitis model.
AID1239538Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 9 after 24 hrs by checkerboard assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID334648Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-nitroflorene-induced mutation at 150 ug/plate after 72 hrs
AID1705068Inhibition of Influenza A virus (A/California/07/2009(H1N1)) neuraminidase at 400 uM by DNA-linked inhibitor antibody assay2020European journal of medicinal chemistry, Dec-15, Volume: 208Unraveling the anti-influenza effect of flavonoids: Experimental validation of luteolin and its congeners as potent influenza endonuclease inhibitors.
AID1711957Induction of mitochondrial membrane potential loss in human HepG2 cells at 80 uM after 48 hrs by Rh123 staining based assay2016European journal of medicinal chemistry, Oct-04, Volume: 121Synthesis and biological properties of polyamine modified flavonoids as hepatocellular carcinoma inhibitors.
AID1371456Cmax in mouse at 100 mg/kg, po by HPLC method2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID429249Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of IFN-gamma/LPS-stimulated nitric oxide production after 17 to 20 hrs by Griess assay2009European journal of medicinal chemistry, Aug, Volume: 44, Issue:8
Synthesis and biological evaluation of curcumin-like diarylpentanoid analogues for anti-inflammatory, antioxidant and anti-tyrosinase activities.
AID1634712Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production by Griess assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Eremophilane-Type Sesquiterpenoids from an Acremonium sp. Fungus Isolated from Deep-Sea Sediments.
AID1647704Inhibition of LPS-induced NO production in mouse RAW264.7 cells preincubated for 30 mins followed by LPS stimulation and measured after 24 hrs by Griess assay2020Journal of natural products, 02-28, Volume: 83, Issue:2
19-
AID1129462Cytotoxicity against mouse HT22 cells after 24 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Apr-01, Volume: 24, Issue:7
Functionalized acridin-9-yl phenylamines protected neuronal HT22 cells from glutamate-induced cell death by reducing intracellular levels of free radical species.
AID1250695Cytotoxicity against human androgen-independent DU145 cells assessed as inhibition of cell viability after 3 days by WST-1 cell proliferation assay2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
A new class of hybrid anticancer agents inspired by the synergistic effects of curcumin and genistein: Design, synthesis, and anti-proliferative evaluation.
AID624609Specific activity of expressed human recombinant UGT1A62000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1202775Antioxidant activity assessed as trolox equivalent of APPH radical scavenging activity preincubated for 30 mins followed by APPH addition measured after 90 mins by lipophilic-ORAC fluorescence assay2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Antioxidative compounds from Garcinia buchananii stem bark.
AID680150TP_TRANSPORTER: cell accumulation in MDR1-expressing MDCK cells2004Free radical biology & medicine, Mar-01, Volume: 36, Issue:5
Flavonoid permeability across an in situ model of the blood-brain barrier.
AID298197Inhibition of ALR1 in Sprague-Dawley Albino rat kidney2007Journal of medicinal chemistry, Oct-04, Volume: 50, Issue:20
Pyrido[1,2-a]pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity.
AID367705Inhibition of human recombinant ALR2 expressed in bacterial cell expression system2009Bioorganic & medicinal chemistry, Feb-01, Volume: 17, Issue:3
Correlation of binding constants and molecular modelling of inhibitors in the active sites of aldose reductase and aldehyde reductase.
AID1409607IC50 for antiviral activity against SARS-CoV-2 in the Vero E6 cell line at 48 h by immunofluorescence-based assay (detecting the viral NP protein in the nucleus of the Vero E6 cells).2020Nature, 07, Volume: 583, Issue:7816
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
AID1103947Antifeedant activity against third-instar Spodoptera litura assessed per cm2 leaf disk2009Bioresource technology, Jul, Volume: 100, Issue:14
Antifeedant activity of ethanolic extract from Flourensia oolepis and isolation of pinocembrin as its active principle compound.
AID455764Inhibition of human recombinant FIH12009Bioorganic & medicinal chemistry, Nov-15, Volume: 17, Issue:22
Structure-based virtual screening approach to the discovery of novel inhibitors of factor-inhibiting HIF-1: identification of new chelating groups for the active-site ferrous ion.
AID1502928Noncompetitive inhibition of human neutrophil elastase using varying levels of MeOSuc-AAPV-pNA as substrate measured after 30 mins by double-reciprocal Lineweaver-Burk plot analysis2017Journal of natural products, 10-27, Volume: 80, Issue:10
Potential Anti-inflammatory Effects of the Fruits of Paulownia tomentosa.
AID377661Effect on duration of immobility in CD1 mouse at 1 mg/kg, ip by forced swimming test relative to control2006Journal of natural products, Jun, Volume: 69, Issue:6
Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and computational study.
AID1500941Antioxidant activity assessed as inhibition rate constant for auto-oxidation of cumene initiated by AIMN in PhCl at 30 degC2017European journal of medicinal chemistry, Oct-20, Volume: 139Hydroxy-substituted trans-cinnamoyl derivatives as multifunctional tools in the context of Alzheimer's disease.
AID1161238Induction of apoptosis in human neutrophils assessed as viable cells at 50 uM after 4 hrs by Annexin-V-FLUOS staining based flow cytometry (Rvb = 89.8%)2014European journal of medicinal chemistry, Oct-30, Volume: 86Synthesis of chlorinated flavonoids with anti-inflammatory and pro-apoptotic activities in human neutrophils.
AID605036Permeability of the compound measured on donor plate of PAMPA membrane at 50 uM after 1 hr by HPLC analysis2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID511076Inhibition of CDK12010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Discovery of novel CDK1 inhibitors by combining pharmacophore modeling, QSAR analysis and in silico screening followed by in vitro bioassay.
AID681133TP_TRANSPORTER: inhibition of lactate uptake in Xenopus laevis oocytes1999The Biochemical journal, Aug-01, Volume: 341 ( Pt 3)Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes.
AID1083156Antifungal activity against Diplodia seriata LAT28 assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID1479735Activation of recombinant human ABCG2 ATPase activity expressed in baculovirus infected High five insect cell membranes after 20 mins by ascorbic acid ammonia molybdate reaction-based colorimetric method relative to control2018Journal of medicinal chemistry, 04-26, Volume: 61, Issue:8
New Inhibitors of Breast Cancer Resistance Protein (ABCG2) Containing a 2,4-Disubstituted Pyridopyrimidine Scaffold.
AID462345Inhibition of mushroom tyrosinase at 3 uM2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells.
AID1082349Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under dark conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1527604Anti-colitis activity in ICR mouse model of DSS-induced colitis assessed as inhibition of DSS-induced colorectum shortening at 6 mg, po for 14 days relative to control2020European journal of medicinal chemistry, Jan-01, Volume: 185Discovery of small-molecule candidates against inflammatory bowel disease.
AID1372153Inhibition of human CYP2D6 expressed in HEK293 cells by fluorescence assay
AID1693699Antimigratory activity against human MDA-MB-231 cells assessed as minimum effective concentration by light microscopy2021Bioorganic & medicinal chemistry, 01-15, Volume: 30In vitro and in vivo effects of inhibitors on actin and myosin.
AID455704Cytotoxicity against MDCK cells after 48 hrs by MTT assay2009Bioorganic & medicinal chemistry, Oct-01, Volume: 17, Issue:19
Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities.
AID1555995Neuroprotective activity against H2O2 induced cytotoxicity in rat PC12 cells assessed as cell viability at 1 uM pretreated for 3 hrs followed by H2O2 challenge measured after 24 hrs by MTT assay (Rvb = 35.69 to 50.26%)2019European journal of medicinal chemistry, Sep-01, Volume: 177Design, synthesis, and biological evaluation of rutacecarpine derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease.
AID450612Antitumor initiating activity in human Chang cells assessed as ratio of inhibition of cellular transformation in presence of NOR1 to compound and NOR1 at 350 nmol treated 1 min before NOR1 addition measured after 1 hr by light microscopy2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Anti-tumor-initiating effects of phenolic compounds isolated from the bark of Picea jezoensis var. jezoensis.
AID483707Inhibition of human recombinant BACE1 after 60 mins by FRET assay2010Bioorganic & medicinal chemistry letters, Jun-01, Volume: 20, Issue:11
Molecular docking studies of phlorotannins from Eisenia bicyclis with BACE1 inhibitory activity.
AID506935Inhibition of HSP90-mediated antiapoptotic activity in human MCF7 cells assessed as induction of PARP cleavage at 200 uM after 24 hrs by Western blot analysis2007Nature chemical biology, Aug, Volume: 3, Issue:8
Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer.
AID492140Antioxidant activity assessed as formazan formation induced absorbance changes at 25 ppm at 570 nm at 37 degC for 6 hrs by MTT assay2010Journal of natural products, Jul-23, Volume: 73, Issue:7
An efficient and economical MTT assay for determining the antioxidant activity of plant natural product extracts and pure compounds.
AID690145Cytotoxicity against human HepG2 cells incubated for 24 hrs by MTT assay2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Comparative study on antioxidant capacity of flavonoids and their inhibitory effects on oleic acid-induced hepatic steatosis in vitro.
AID450964Antioxidant activity assessed as DPPH radical scavenging activity at 100 ug/mL after 30 mins2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Preparation of C-23 esterified silybin derivatives and evaluation of their lipid peroxidation inhibitory and DNA protective properties.
AID1784508Neuroprotective activity against glutamate induced neuronal death in mouse HT-22 cells assessed as increase in cell viability at 25 uM by MTT assay2021European journal of medicinal chemistry, Dec-05, Volume: 225From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects.
AID512295Inhibition of His-tagged human CK2 expressed in Sf9 cells at 20 uM2000The Biochemical journal, Oct-01, Volume: 351, Issue:Pt 1
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
AID1572041Inhibition of IPMK in human [3H]-inositol-labelled HCT116 cells assessed as reduction in insp5 levels at 2.5 uM up to 200 mins by HPLC analysis relative to control2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
AID690143Inhibition of oleic acid-induced triglyceride over-accumulation in human HepG2 cells incubated for 24 hrs relative to untreated control2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Comparative study on antioxidant capacity of flavonoids and their inhibitory effects on oleic acid-induced hepatic steatosis in vitro.
AID592413Antioxidant activity assessed as DPPH radical scavenging activity2011Journal of natural products, Mar-25, Volume: 74, Issue:3
Epiafzelechin from the root bark of Cassia sieberiana: detection by DART mass spectrometry, spectroscopic characterization, and antioxidant properties.
AID1168861Inhibition of soybean 15-LOX incubated for 4 mins before linoleic acid substrate addition by spectrophotometry2014European journal of medicinal chemistry, Nov-24, Volume: 87Imidazo[2,1-b]thiazole derivatives as new inhibitors of 15-lipoxygenase.
AID441664Cytotoxicity against human HepG2 cells upto 200 umol/L after 24 hrs by MTS assay2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase.
AID1845530Binding affinity to human c-MYC G-quadruplex (Pu24T) DNA assessed as first order binding constant by fluorescence spectroscopy2021Journal of medicinal chemistry, 01-14, Volume: 64, Issue:1
Recent Update on Targeting
AID596671Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 3 uM on day 8 relative to control2011Bioorganic & medicinal chemistry, May-01, Volume: 19, Issue:9
Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells.
AID95258In vitro inhibitory activity against L-Hexonate Dehydrogenase from rat kidney1991Journal of medicinal chemistry, Nov, Volume: 34, Issue:11
Spiro[fluoreneisothiazolidin]one dioxides: new aldose reductase and L-hexonate dehydrogenase inhibitors.
AID1080609Phytotoxic activity against Lolium perenne (perennial ryegrass) assessed as inhibition of root growth at 22 +/-2 degC after 72 hr2009Journal of agricultural and food chemistry, Apr-08, Volume: 57, Issue:7
Level of catechin, myricetin, quercetin and isoquercitrin in buckwheat (Fagopyrum esculentum Moench), changes of their levels during vegetation and their effect on the growth of selected weeds.
AID1082325Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under light conditions measured 72 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1063042Inhibition of PLK1 (unknown origin)2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Protein kinase and HDAC inhibitors from the endophytic fungus Epicoccum nigrum.
AID762914Antileishmanial activity against promastigotes of Leishmania amazonensis MHOM/BR/75/LTB0016 infected in Swiss mouse peritoneal macrophages assessed as reduction of infection index after 72 hrs2013Journal of natural products, Aug-23, Volume: 76, Issue:8
Reactive oxygen species production by quercetin causes the death of Leishmania amazonensis intracellular amastigotes.
AID1126478Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 18 hrs by griess reaction analysis2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID450966Antioxidant activity assessed as ferrous ion chelating activity after 30 mins by spectrophotometry2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Preparation of C-23 esterified silybin derivatives and evaluation of their lipid peroxidation inhibitory and DNA protective properties.
AID587301Inhibition of CXCL5-induced neutrophil recruitment in Swiss mouse at 100 mg/kg, sc administered pre-inflammatory stimulus after 6 hrs by Newbauer chamber using Romanowsky stain2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID1371434Cytotoxicity against human BxPC3 cells assessed as cell viability at 14 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1334868Inhibition of LPS-stimulated nitric oxide production in ddy mouse peritoneal macrophages measured after 20 hrs by Greiss method2017Bioorganic & medicinal chemistry, 01-15, Volume: 25, Issue:2
Structure-activity relationship of the inhibitory effects of flavonoids on nitric oxide production in RAW264.7 cells.
AID1491171Inhibition of yeast alpha-glucosidase at 1.5 uM using p-nitrophenyl-alpha-glucopyranoside as substrate measured after 30 mins relative to control
AID1336847Inhibition of P-gp in human MES-SA/Dx5 cells assessed as potentiation of paclitaxel-induced cytotoxicity by measuring fold reduction in paclitaxel EC50 at 5 uM after 72 hrs by MTT assay relative to untreated control2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Quercetin-glutamic acid conjugate with a non-hydrolysable linker; a novel scaffold for multidrug resistance reversal agents through inhibition of P-glycoprotein.
AID379089Growth inhibition of BALB/c mouse cloned 3T3/A31 cells after 72 hrs by nigrosin assay1999Journal of natural products, Mar, Volume: 62, Issue:3
Activities of plant-derived phenols in a fibroblast cell culture model
AID379089Growth inhibition of BALB/c mouse cloned 3T3/A31 cells after 72 hrs by nigrosin assay1999Journal of natural products, Mar, Volume: 62, Issue:3
Activities of plant-derived phenols in a fibroblast cell culture model.
AID377662Effect on duration of immobility in CD1 mouse at 1 mg/kg, ip by forced swimming test relative to carboxy methyl cellulose2006Journal of natural products, Jun, Volume: 69, Issue:6
Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and computational study.
AID286230Inhibition of human recombinant COX2 expressed in insect Sf21 cells by EIA assay2007Journal of natural products, May, Volume: 70, Issue:5
Lipoxygenase inhibitory constituents of the fruits of noni (Morinda citrifolia) collected in Tahiti.
AID641164Induction of apoptosis in human HCT116 cells assessed DNA fragmentation at 25 uM after 48 hrs by ELISA relative to control2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Biological evaluation and docking studies of recently identified inhibitors of phosphoinositide-3-kinases.
AID1683181Induction of apoptosis in human HCT-116 cells assessed as early apoptosis measured after 48 hrs by annexinV-FITC/propidium iodide staining based by flow cytometry (Rvb = 3.42 %)2021Bioorganic & medicinal chemistry, 01-01, Volume: 29Synthesis and anticancer activity of new coumarin-3-carboxylic acid derivatives as potential lactatetransportinhibitors.
AID441660Inhibition of human recombinant AChE by Ellman's method2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase.
AID379054Inhibition of TNFalpha expression in LPS-stimulated human monocytes treated 30 mins before LPS challenge measured after 14 hrs by ELISA1999Journal of natural products, Mar, Volume: 62, Issue:3
Polymethoxylated flavones derived from citrus suppress tumor necrosis factor-alpha expression by human monocytes.
AID1516857Antifungal activity against Candida glabrata 510 by microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID1516854Antifungal activity against Candida glabrata 507 by microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID1209973Inhibition of CYP2D6 in human liver microsomes using dextromethorphan as substrate after 8 mins by LC-MS/MS analysis2012Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
AID1175716Aqueous solubility of the compound at 1 mM by UV spectroscopic assay2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
The synthesis, antimalarial activity and CoMFA analysis of novel aminoalkylated quercetin analogs.
AID418378Inhibition of Pim12009Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7
Hit to lead account of the discovery of a new class of inhibitors of Pim kinases and crystallographic studies revealing an unusual kinase binding mode.
AID1323132Antioxidant activity assessed as DPPH free radical scavenging activity by measuring remaining DPPH at 5 uM after 15 to 60 mins relative to trolox2016Journal of natural products, 07-22, Volume: 79, Issue:7
Effects of Functional Groups and Sugar Composition of Quercetin Derivatives on Their Radical Scavenging Properties.
AID332642Binding affinity to Escherichia coli pUC8 DNA assessed as production of linear DNA at 100 ug/ml after 30 mins by agarose gel electrophoresis1995Journal of natural products, Feb, Volume: 58, Issue:2
Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships.
AID512288Inhibition of His-tagged human PDK1 expressed in Sf21 cells at 20 uM2000The Biochemical journal, Oct-01, Volume: 351, Issue:Pt 1
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
AID1128732Inhibition of bovine COX-1 assessed as PGF2-alpha formation using arachidonic acid as substrate at 20 uM by enzyme immunoassay2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Design of novel potent antihyperlipidemic agents with antioxidant/anti-inflammatory properties: exploiting phenothiazine's strong antioxidant activity.
AID441659Inhibition of human plasma BChE by Ellman's method2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase.
AID424729Inhibition of bovine xanthine oxidase assessed as reduction of cytochrome c at 50 uM2009Journal of natural products, Apr, Volume: 72, Issue:4
Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin.
AID1264953Cytotoxicity against human MSC assessed as cell viability at 1 uM treated for 3 days measured on day 4 by alamar blue assay (Rvb = 97 to 100%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID449298Neuroprotective activity against H2O2-induced injury in rat PC12 cells assessed as increase in cell viability at 50 uM treated 2 hrs before H2O2 challenge measured after 4 hrs by MTT assay2009Journal of medicinal chemistry, Dec-10, Volume: 52, Issue:23
Design, synthesis, and examination of neuron protective properties of alkenylated and amidated dehydro-silybin derivatives.
AID1171186Teratogenic effect in zebrafish assessed as abnormal development of yolk sac at 160 uM after 72 hrs by microscopy2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Delineation of the role of glycosylation in the cytotoxic properties of quercetin using novel assays in living vertebrates.
AID1592997Inhibition of soya bean 15-LOX by colorimetric lipoxygenase inhibitor screening assay kit method2019European journal of medicinal chemistry, Apr-01, Volume: 167Shooting three inflammatory targets with a single bullet: Novel multi-targeting anti-inflammatory glitazones.
AID253005Tested for vasorelaxant activity in rat thoracic aorta rings against PE-induced contractions2004Bioorganic & medicinal chemistry letters, Aug-02, Volume: 14, Issue:15
Synthesis and biological evaluation of flavonoids as vasorelaxant agents.
AID501419Antimicrobial activity against methicillin-resistant Staphylococcus aureus COL after 24 hrs by microdilution assay2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Design, synthesis, and biological evaluation of a novel series of quercetin diacylglucosides as potent anti-MRSA and anti-VRE agents.
AID624608Specific activity of expressed human recombinant UGT1A42000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1254801Antiinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-stimulated nitric oxide production after 24 hrs by Griess assay2015Journal of natural products, Oct-23, Volume: 78, Issue:10
Nitrogen Oxide Inhibitory Trimeric and Dimeric Carbazole Alkaloids from Murraya tetramera.
AID1370804Inhibition of alpha-glucosidase (unknown origin) at 50 uM using 4-Nitrophenyl-alpha-D-glucopyranoside as substrate incubated foe 5 mins followed by substrate addition measured after 15 mins relative to control2018Bioorganic & medicinal chemistry letters, 02-01, Volume: 28, Issue:3
In vitro and in silico evaluations of diarylpentanoid series as α-glucosidase inhibitor.
AID333525Cytotoxicity against human A549 cells at 20 mcg/mL after 3 days by SRB assay2004Journal of natural products, Nov, Volume: 67, Issue:11
Prenylated benzophenones and xanthones from Hypericum scabrum.
AID1102132Phytotoxicity in Linaria genistifolia subsp. dalmatica assessed as inhibition of shoot differentiation at 250 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID377666Increase in duration of immobility in CD1 mouse at 1 mg/kg, ip by forced swimming test relative to carboxy methyl cellulose2006Journal of natural products, Jun, Volume: 69, Issue:6
Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and computational study.
AID1290223Neuroprotective activity against glutamate-induced oxycytotic cell death in mouse HT22 cells assessed as cell viability at 25 uM after 24 hrs by MTT assay2016Journal of medicinal chemistry, Mar-10, Volume: 59, Issue:5
Discovery of Highly Selective and Nanomolar Carbamate-Based Butyrylcholinesterase Inhibitors by Rational Investigation into Their Inhibition Mode.
AID494830Inhibition of Plasmodium falciparum FabI2010Bioorganic & medicinal chemistry letters, Aug-15, Volume: 20, Issue:16
Integrated ligand and structure based studies of flavonoids as fatty acid biosynthesis inhibitors of Plasmodium falciparum.
AID735304Inhibition of iNOS-mediated nitric oxide production in LPS-stimulated mouse RAW264.7 cells after 24 hrs by Griess reaction analysis2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Anti-inflammatory lanostanoids and lactone derivatives from Antrodia camphorata.
AID404692Inhibition of human salivary alpha-amylase2008Journal of medicinal chemistry, Jun-26, Volume: 51, Issue:12
Flavonoids for controlling starch digestion: structural requirements for inhibiting human alpha-amylase.
AID550024Inhibition of human recombinant calmodulin assessed as inhibition of calmodulin-sensitive cAMP phosphodiesterase activation after 15 mins by spectrophotometric analysis2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Vasorelaxant effect of flavonoids through calmodulin inhibition: Ex vivo, in vitro, and in silico approaches.
AID462338Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells after 72 hrs2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells.
AID1063044Inhibition of wild type MET (unknown origin)2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Protein kinase and HDAC inhibitors from the endophytic fungus Epicoccum nigrum.
AID587299Inhibition of CXCL1-induced neutrophil recruitment in Swiss mouse at 100 mg/kg, sc administered pre-inflammatory stimulus after 6 hrs by Newbauer chamber using Romanowsky stain2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID456188Inhibition of beta amyloid (1 to 40) fibril formation by thioflavin T staining-based binding assay2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Carboxymethylated-kappa-casein: a convenient tool for the identification of polyphenolic inhibitors of amyloid fibril formation.
AID288326Inhibition of 5-LO activity in ionophore A23187 and arachidonic-stimulated human intact PMNL2007Journal of medicinal chemistry, May-31, Volume: 50, Issue:11
Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening.
AID681181TP_TRANSPORTER: increase in mitoxantrone intracellular accumulation (Mitoxantrone: 20 uM, Quercetin: 50 uM) in BCRP-expressing NCI-H460 cells2004Molecular pharmacology, May, Volume: 65, Issue:5
Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport.
AID242481Inhibition of human cyclin-dependent kinase 6 complex with a virus-encoded cyclin from herpesvirus saimiri (Vcyclin)2005Journal of medicinal chemistry, Feb-10, Volume: 48, Issue:3
Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin.
AID1210013Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control2012Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
AID1516855Antifungal activity against Candida glabrata 531 by microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID1515374Antioxidant activity assessed as ABTS radical scavenging activity after 16 hrs by spectrophotometric analysis2019Bioorganic & medicinal chemistry, 01-15, Volume: 27, Issue:2
Synthesis, Antioxidant Activity and Cytotoxicity of N-Functionalized Organotellurides.
AID1385702Antiinflammatory activity against f-MLP-stimulated human neutrophils assessed as reduction in ROS production incubated for 40 mins measured at intervals of 2 mins by luminol-dependent chemiluminescence assay2018Journal of natural products, 08-24, Volume: 81, Issue:8
Anti-inflammatory Potential of Flavonoids from the Aerial Parts of Corispermum marschallii.
AID512285Inhibition of His-tagged human PRAK expressed in Sf9 cells at 20 uM2000The Biochemical journal, Oct-01, Volume: 351, Issue:Pt 1
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
AID1083162Antifungal activity against Neofusicoccum parvum Bp0014 assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID214874Inhibitory concentration of the compounds against Bovine trypsin enzyme.1997Journal of medicinal chemistry, Dec-05, Volume: 40, Issue:25
Assessment of solvation effects on calculated binding affinity differences: trypsin inhibition by flavonoids as a model system for congeneric series.
AID604942Chemical stability of the compound in PBS buffer at pH 7.4 assessed as half life by HPLC analysis2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID435140Relative inhibition of I174A-mutated CK2 holoenzyme compared to wild-type2003The Biochemical journal, Sep-15, Volume: 374, Issue:Pt 3
Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).
AID1082347Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under dark conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID501413Antimicrobial activity against vancomycin-resistant Enterococcus FN-1 after 24 hrs by microdilution assay2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Design, synthesis, and biological evaluation of a novel series of quercetin diacylglucosides as potent anti-MRSA and anti-VRE agents.
AID729314Inhibition of CCL22-stimulated CCR4 in human HTLA cells pre-incubated for 20 mins with centrifuged compound solution measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay2013Journal of medicinal chemistry, Mar-28, Volume: 56, Issue:6
Colloidal aggregation causes inhibition of G protein-coupled receptors.
AID729315Inhibition of CCL22-stimulated CCR4 in human HTLA cells pre-incubated for 20 mins measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay2013Journal of medicinal chemistry, Mar-28, Volume: 56, Issue:6
Colloidal aggregation causes inhibition of G protein-coupled receptors.
AID334643Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of benzo[a]pyrene-induced mutation at 600 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID1242167Inhibition of HSF1 in human HeLa cells assessed as potentiation of 17-DMAG-induced increase in cell death at 30 uM relative to 17-DMAG alone2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Regulating the master regulator: Controlling heat shock factor 1 as a chemotherapy approach.
AID1711980Toxicity in Kunming mouse implanted with mouse H22 cells assessed as change in mouse body weight at 100 mg/kg, iv administered for 7 consecutive days starting from day 8 post inoculation and measured after 16 days (Rvb = 21 %)2016European journal of medicinal chemistry, Oct-04, Volume: 121Synthesis and biological properties of polyamine modified flavonoids as hepatocellular carcinoma inhibitors.
AID1127225Antiproliferative activity against human K562 cells assessed as cell growth at 10'-4 ug/ml after 48 hrs by SRB assay relative to control2014European journal of medicinal chemistry, May-22, Volume: 79In-vitro anti-proliferative and anti-oxidant activity of galangin, fisetin and quercetin: role of localization and intermolecular interaction in model membrane.
AID1473738Inhibition of human BSEP overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-taurocholate in presence of ATP measured after 15 to 20 mins by membrane vesicle transport assay2013Toxicological sciences : an official journal of the Society of Toxicology, Nov, Volume: 136, Issue:1
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
AID1484017Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as lag time at 200 uM after 48 hrs by Thioflavin-T fluorescence assay (Rvb = 64.4 mins)2017Journal of natural products, 02-24, Volume: 80, Issue:2
Combined in Vitro Cell-Based/in Silico Screening of Naturally Occurring Flavonoids and Phenolic Compounds as Potential Anti-Alzheimer Drugs.
AID1871977Antifungal activity against Candida albicans 13/15 assessed as fungal growth inhibition measured after 24 hrs by microdilution assay2022European journal of medicinal chemistry, Feb-05, Volume: 229Quercetin derivatives: Drug design, development, and biological activities, a review.
AID596673Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 30 uM on day 8 relative to control2011Bioorganic & medicinal chemistry, May-01, Volume: 19, Issue:9
Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells.
AID435888Relative inhibition of V66A-mutated CK2 holoenzyme compared to wild-type2003The Biochemical journal, Sep-15, Volume: 374, Issue:Pt 3
Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).
AID1510604Inhibition of Enterobacter cloacae beta-lactamase incubated for 10 mins followed by nitrocefin substrate challenge and measured for 5 mins in presence of Triton X-100 by spectrophotometric analysis2019ACS medicinal chemistry letters, Jun-13, Volume: 10, Issue:6
DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors.
AID400266Inhibition of rat fetal brain CDK5 assessed as phosphorylated histone H1 levels by immuno-precipitation2004Journal of natural products, Mar, Volume: 67, Issue:3
Effects of natural flavones and flavonols on the kinase activity of Cdk5.
AID1310994Inhibition of xanthine oxidase (unknown origin) using xanthine as substrate assessed as inhibition of uric acid formation after 30 mins by spectrophotometric method2016European journal of medicinal chemistry, Aug-25, Volume: 119On the vasoprotective mechanisms underlying novel β-phosphorylated nitrones: Focus on free radical characterization, scavenging and NO-donation in a biological model of oxidative stress.
AID456191Inhibition of reduced carboxymethylated kappa-casein fibril formation assessed as formation of shorter and stunted fibrils at 1 uM by transmission electron microscopy2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Carboxymethylated-kappa-casein: a convenient tool for the identification of polyphenolic inhibitors of amyloid fibril formation.
AID1102131Phytotoxicity in Linaria genistifolia subsp. dalmatica assessed as inhibition of seed germination at 250 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID424724Ratio of kcat to km for bovine xanthine oxidase at 50 uM2009Journal of natural products, Apr, Volume: 72, Issue:4
Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin.
AID603832Increase in Egr-1 protein expression in human MDA-MB-231 cells at 20 uM within 30 mins by Western blot analysis2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Rhamnetin production based on the rational design of the poplar O-methyltransferase enzyme and its biological activities.
AID1102143Phytotoxicity in Centaurea maculosa assessed as inhibition of root differentiation at 250 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID1082351Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under dark conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1313603Antiinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced NO production incubated for 24 hrs measured after 15 mins by Griess assay2016Bioorganic & medicinal chemistry letters, 08-01, Volume: 26, Issue:15
Lanostane triterpenoids from Ganoderma curtisii and their NO production inhibitory activities of LPS-induced microglia.
AID1572027Inhibition of IP6K2 in human [3H]-inositol-labelled HCT116 cells assessed as reduction in insp7 levels after 3.5 hrs by HPLC analysis2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
AID502473Inhibition of human CYP1A2 by EROD assay2010Bioorganic & medicinal chemistry, Sep-01, Volume: 18, Issue:17
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.
AID1174275Neuroprotective activity against H2O2-induced cell death in rat PC12 cells assessed as cell viability at 10 uM after 24 hrs by MTT assay relative to control2015European journal of medicinal chemistry, Jan-07, Volume: 89New tetracyclic tacrine analogs containing pyrano[2,3-c]pyrazole: efficient synthesis, biological assessment and docking simulation study.
AID265762Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K12006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.
AID598341Inhibition of CYP1A1 EROD activity assessed as inhibition of deethylation of 7-ethoxyresorufin to resorufin2011Bioorganic & medicinal chemistry, May-01, Volume: 19, Issue:9
Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.
AID289317Superoxide radical scavenging activity by NBT reduction assay2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
2-Styrylchromones: novel strong scavengers of reactive oxygen and nitrogen species.
AID359633Antiviral activity against HSV1 in african green monkey Vero cells assessed as log reduction of virus titer at 60.4 ug/ml1992Journal of natural products, Dec, Volume: 55, Issue:12
Synergistic effect of flavones and flavonols against herpes simplex virus type 1 in cell culture. Comparison with the antiviral activity of propolis.
AID1063904Inhibition of 5-LOX-mediated LTB4 production in human neutrophils using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 8 mins by enzyme immunoassay2014European journal of medicinal chemistry, Jan-24, Volume: 72Inhibition of LOX by flavonoids: a structure-activity relationship study.
AID1545063Neuroprotective activity in rat PC12 cells assessed as protection against H2O2-induced cytotoxicity at 10 uM pre-incubated for 3 hrs before H2O2 addition and measured after 12 hrs by MTT assay2019Bioorganic & medicinal chemistry, 07-01, Volume: 27, Issue:13
Design, synthesis, and biological evaluation of novel 4-oxobenzo[d]1,2,3-triazin-benzylpyridinum derivatives as potent anti-Alzheimer agents.
AID663959Agonist activity at GPR35 receptor in human HT-29 cells at 32 uM after 10 mins by dynamic mass redistribution assay in the presence of SPB051422012ACS medicinal chemistry letters, Feb-09, Volume: 3, Issue:2
Discovery of Natural Phenols as G Protein-Coupled Receptor-35 (GPR35) Agonists.
AID450963Antioxidant activity assessed as superoxide anion scavenging activity after 5 mins by NBT reduction assay2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Preparation of C-23 esterified silybin derivatives and evaluation of their lipid peroxidation inhibitory and DNA protective properties.
AID603834Effect on JNK2 protein level in human MDA-MB-231 cells at 20 uM up to 120 mins by Western blot analysis2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Rhamnetin production based on the rational design of the poplar O-methyltransferase enzyme and its biological activities.
AID1434705Cytotoxicity against LPS-induced mouse N9 cells assessed as decrease in cell viability at 1 to 100 ug/ml after 24 hrs by MTT assay2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Natural potential neuroinflammatory inhibitors from Alhagi sparsifolia Shap.
AID1239533Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 4 after 24 hrs by checkerboard assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID218689The effect of 10-fold increase in enzyme concentration on beta-lactamase inhibition.2002Journal of medicinal chemistry, Apr-11, Volume: 45, Issue:8
A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.
AID377785Antioxidant activity assessed as reduction of F3+/ferricyanide complex after 20 mins2005Journal of natural products, Apr, Volume: 68, Issue:4
Antioxidant phenolic glycosides from Moricandia arvensis.
AID1063732Cytotoxicity against HUVEC assessed as cell viability at 10 to 50 uM after 24 to 72 hrs by WST-1 assay relative to untreated control2014European journal of medicinal chemistry, Jan-24, Volume: 72A novel 2,3-diphenyl-4H-pyrido[1,2-a]pyrimidin-4-one derivative inhibits endothelial cell dysfunction and smooth muscle cell proliferation/activation.
AID1711941Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation at 30 uM measured after 48 hrs by MTT assay relative to control2016European journal of medicinal chemistry, Oct-04, Volume: 121Synthesis and biological properties of polyamine modified flavonoids as hepatocellular carcinoma inhibitors.
AID1815679Antineuroinflammatory activity against mouse BV-2 cells assessed as inhibition of LPS-induced NO production incubated for 24 hrs by Griess assay2022Journal of natural products, 01-28, Volume: 85, Issue:1
Structurally Diverse Sesquiterpenoid Glycoside Esters from
AID1888437Neuroprotective activity against H202-induced cell death in rat PC-12 cells assessed as cell viability at 5 uM pretreated for 3 hrs followed by H2O2 stimulation and measured after 24 hrs by MTT assay relative to control2022European journal of medicinal chemistry, Jan-05, Volume: 227Design, synthesis, and biological evaluation of novel (4-(1,2,4-oxadiazol-5-yl)phenyl)-2-aminoacetamide derivatives as multifunctional agents for the treatment of Alzheimer's disease.
AID293297Antioxidant activity assessed as DPPH radical scavenging activity after 20 min2007Bioorganic & medicinal chemistry, Feb-15, Volume: 15, Issue:4
Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems.
AID462346Inhibition of mushroom tyrosinase at 10 uM2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells.
AID729310Inhibition of CX3CL1-stimulated CX3CR1 in human HTLA cells pre-incubated for 20 mins with Tween-80-treated compound solution measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay2013Journal of medicinal chemistry, Mar-28, Volume: 56, Issue:6
Colloidal aggregation causes inhibition of G protein-coupled receptors.
AID696432Activation of bovine kidney LMW-PTPase at 400 uM using pNPP substrate2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Low molecular weight phosphotyrosine protein phosphatases as emerging targets for the design of novel therapeutic agents.
AID406996Inhibition of human recombinant 17beta-HSD2 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol at 40 uM2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
Discovery of nonsteroidal 17beta-hydroxysteroid dehydrogenase 1 inhibitors by pharmacophore-based screening of virtual compound libraries.
AID277109Inhibition of fMLP-induced ROS production in human mononuclear leukocytes2006Bioorganic & medicinal chemistry letters, Dec-15, Volume: 16, Issue:24
Total synthesis and biological evaluation of viscolin, a 1,3-diphenylpropane as a novel potent anti-inflammatory agent.
AID1185177Inhibition of PI3Kgamma (unknown origin) assessed as decrease in fluorescence intensity using phosphorylated substrate2014European journal of medicinal chemistry, Sep-12, Volume: 84Discovery of nanomolar phosphoinositide 3-kinase gamma (PI3Kγ) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis.
AID1555998Neuroprotective activity against H2O2 induced cytotoxicity in rat PC12 cells assessed as cell viability at 30 uM pretreated for 3 hrs followed by H2O2 challenge measured after 24 hrs by MTT assay (Rvb = 35.69 to 50.26%)2019European journal of medicinal chemistry, Sep-01, Volume: 177Design, synthesis, and biological evaluation of rutacecarpine derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease.
AID501414Antimicrobial activity against vancomycin-resistant Enterococcus NCTC 12201 after 24 hrs by microdilution assay2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Design, synthesis, and biological evaluation of a novel series of quercetin diacylglucosides as potent anti-MRSA and anti-VRE agents.
AID768888Inhibition of urokinase amidolytic activity (unknown origin)2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID1888438Neuroprotective activity against H202-induced cell death in rat PC-12 cells assessed as cell viability at 20 uM pretreated for 3 hrs followed by H2O2 stimulation and measured after 24 hrs by MTT assay relative to control2022European journal of medicinal chemistry, Jan-05, Volume: 227Design, synthesis, and biological evaluation of novel (4-(1,2,4-oxadiazol-5-yl)phenyl)-2-aminoacetamide derivatives as multifunctional agents for the treatment of Alzheimer's disease.
AID1711986Antimetastatic activity against mouse H22 cells implanted in Kunming mouse assessed as number of metastatic focus at 100 mg/kg, iv administered for 7 consecutive days starting from day 11 post inoculation and measured after 18 days (Rvb = 5.73 +/- 14.6 No2016European journal of medicinal chemistry, Oct-04, Volume: 121Synthesis and biological properties of polyamine modified flavonoids as hepatocellular carcinoma inhibitors.
AID1764181Hypolipidemic activity against oleic acid/palmitic acid-induced hyperlipidemia in human HepG2 cells assessed as reduction in triglycerides content2021Bioorganic & medicinal chemistry letters, 09-01, Volume: 47Phenolic compounds from the leaves of Crataegus pinnatifida Bge. var. major N.E.Br. And their lipid-lowering effects.
AID1371431Cytotoxicity against human COLO201 cells assessed as cell viability at 14 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1572042Inhibition of IP6K2 in human [3H]-inositol-labelled HCT116 cells assessed as reduction in insp7 levels at 2.5 uM after 3.5 hrs by HPLC analysis relative to control2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
AID1536967Inhibition of LPS-induced delay of apoptosis in human neutrophils assessed as late apoptotic cells at 2.5 uM preincubated for 1 hr followed by LPS stimulation and measured after 24 hrs by Annexin V-FITC/propidium iodide staining based flow cytometry (Rvb 2019Journal of natural products, 02-22, Volume: 82, Issue:2
Eupatoriopicrin Inhibits Pro-inflammatory Functions of Neutrophils via Suppression of IL-8 and TNF-alpha Production and p38 and ERK 1/2 MAP Kinases.
AID353599Inhibition of CAMK2 assessed as level of ATP utilized by luciferase-based bioluminescence assay2009Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7
Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives.
AID676985Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation at 0.56 uM by spectrophotometry based TBARS assay relative to untreated control2012Bioorganic & medicinal chemistry, Sep-01, Volume: 20, Issue:17
Synthesis, cytotoxic and antioxidant evaluations of amino derivatives from perezone.
AID218565Increase in inhibition of beta-lactamase due to the effect of incubation2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
Kinase inhibitors: not just for kinases anymore.
AID1082331Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under light conditions measured 72 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1224773Delta TM value showing the stabilisation of ASK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224758Delta TM value showing the stabilisation of CDK6 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1063048Inhibition of FAK (unknown origin)2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Protein kinase and HDAC inhibitors from the endophytic fungus Epicoccum nigrum.
AID671217Inhibition of androgen receptor expression in human 22Rv1 cells assessed as AR protein level at 10 uM after 72 hrs by densitometry relative to untreated control2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and biological evaluation of novel flavonols as potential anti-prostate cancer agents.
AID399341Antioxidant activity assessed as superoxide-scavenging activity by nitrite method1998Journal of natural products, Jan, Volume: 61, Issue:1
Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers.
AID730328Inhibition of recombinant FLT3 (unknown origin) by TR-FRET assay2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
Flavonoids as receptor tyrosine kinase FLT3 inhibitors.
AID336178Antiviral activity against Potato virus X in half leaf of Chenopodium quinoa at 9.3 mg/mL after 10 days2002Journal of natural products, Oct, Volume: 65, Issue:10
Bioactive constituents from Iryanthera megistophylla.
AID1220257Ratio of drug level in blood to plasma in human2012Drug metabolism and disposition: the biological fate of chemicals, Sep, Volume: 40, Issue:9
Quantitative prediction of human intestinal glucuronidation effects on intestinal availability of UDP-glucuronosyltransferase substrates using in vitro data.
AID1264955Cytotoxicity against human MSC assessed as cell viability at 10 uM treated for 3 days measured on day 4 by alamar blue assay (Rvb = 97 to 100%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID1056594Antiperiodontitic activity in Aggregatibacter actinomycetemcomitans infected Balb/c mouse model assessed as downregulation of ICAM-1 expression at 100 mg/kg, sc for 15 days post Aggregatibacter actinomycetemcomitans-challenge by Western blotting analysis2013Journal of natural products, Dec-27, Volume: 76, Issue:12
Quercetin inhibits inflammatory bone resorption in a mouse periodontitis model.
AID195229Influence (5 uM) on transacetylase catalyzed time dependent activation of NADPH cytochrome C reductase at pre-incubation time being 10 mins2002Bioorganic & medicinal chemistry letters, Sep-16, Volume: 12, Issue:18
Comparison of the prevention of aflatoxin b(1)-induced genotoxicity by quercetin and quercetin pentaacetate.
AID1239530Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 1 after 24 hrs by checkerboard assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1294432Antioxidant activity assessed as inhibition of H2O2 induced lucigenin oxidation at 37 degC2016European journal of medicinal chemistry, Jun-10, Volume: 115Novel chromone and xanthone derivatives: Synthesis and ROS/RNS scavenging activities.
AID1226447Cytotoxicity against human A431 cells assessed as cell growth inhibition after 72 hrs by MTT assay2015Journal of medicinal chemistry, May-28, Volume: 58, Issue:10
Selenium-containing chrysin and quercetin derivatives: attractive scaffolds for cancer therapy.
AID671219Inhibition of prostate specific antigen expression in human 22Rv1 cells assessed as PSA protein level at 10 uM after 72 hrs by densitometry relative to untreated control2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and biological evaluation of novel flavonols as potential anti-prostate cancer agents.
AID1385704Antiinflammatory activity against LPS-stimulated human neutrophils assessed as reduction in TNFalpha production incubated for 1 hr followed by LPS stimulation measured after 18 to 24 hrs by ELISA2018Journal of natural products, 08-24, Volume: 81, Issue:8
Anti-inflammatory Potential of Flavonoids from the Aerial Parts of Corispermum marschallii.
AID1161232Inhibition of PMA-induced oxidative burst in human neutrophils by chemiluminescence assay2014European journal of medicinal chemistry, Oct-30, Volume: 86Synthesis of chlorinated flavonoids with anti-inflammatory and pro-apoptotic activities in human neutrophils.
AID1127219Binding affinity DPPC multilamellar vesicles assessed as main transition temperature at 1:5 compound/lipid ratio after 2 hrs by differential scanning calorimetry method (Rvb = 41.98 degC)2014European journal of medicinal chemistry, May-22, Volume: 79In-vitro anti-proliferative and anti-oxidant activity of galangin, fisetin and quercetin: role of localization and intermolecular interaction in model membrane.
AID1080598Phytotoxic activity against Trifolium repens assessed as inhibition of hypocotyl growth at 22 +/-2 degC after 72 hr2009Journal of agricultural and food chemistry, Apr-08, Volume: 57, Issue:7
Level of catechin, myricetin, quercetin and isoquercitrin in buckwheat (Fagopyrum esculentum Moench), changes of their levels during vegetation and their effect on the growth of selected weeds.
AID605056Antiproliferative activity against human HCT116 cells after 24 hrs by MTT assay2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID1083167Induction of Eutypa lata BX1-10 growth at 500 uM2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID339148Inhibition of norepinephrine-induced Wistar rat thoracic aorta tonic contraction at 20 ug/mL after 15 mins1993Journal of natural products, Jun, Volume: 56, Issue:6
Antiplatelet effects and vasorelaxing action of some constituents of Formosan plants.
AID480503Inhibition of aldose reductase from calf lense by AR assay2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Synthesis, characterization and vasculoprotective effects of nitric oxide-donating derivatives of chrysin.
AID1408298Antiproliferative activity against human LNCAP cells after 3 days by WST-1 assay2018European journal of medicinal chemistry, Sep-05, Volume: 157Structure-activity relationship and pharmacokinetic studies of 3-O-substitutedflavonols as anti-prostate cancer agents.
AID1082436Inhibition of fruit-infesting behavior of Cydia pomonella (codling moth) neonates infested in apple fruit plugs assessed as feeding deterrence index at 1 mg/mL2011Journal of agricultural and food chemistry, Oct-26, Volume: 59, Issue:20
Effects of Ginkgo biloba constituents on fruit-infesting behavior of codling moth (Cydia pomonella) in apples.
AID402483Inhibition of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality treated with drug after 2 hrs of TNFalpha treatment1997Journal of natural products, Aug, Volume: 60, Issue:8
Flavonoids as inhibitors or enhancers of the cytotoxicity of tumor necrosis factor-alpha in L-929 tumor cells.
AID1311090Antioxidant activity assessed as inhibition of peroxynitrite-induced oxidation of DHR to rhodamine-123 measured after 2 mins in presence of NaHCO3 by fluorimetric analysis2016European journal of medicinal chemistry, Aug-25, Volume: 119New polyhydroxylated flavon-3-ols and 3-hydroxy-2-styrylchromones: synthesis and ROS/RNS scavenging activities.
AID365674Inhibition of human brain prolyl oligopeptidase expressed in Escherichia coli2008Bioorganic & medicinal chemistry, Aug-01, Volume: 16, Issue:15
Baicalin, a prodrug able to reach the CNS, is a prolyl oligopeptidase inhibitor.
AID1501277Activation of ABCG2 ATPase activity (unknown origin) expressed in baculovirus infected high5 cell membranes after 20 mins by ascorbic acid ammonia molybdate reaction based colorimetric assay2017European journal of medicinal chemistry, Oct-20, Volume: 139Synthesis and biological investigation of 2,4-substituted quinazolines as highly potent inhibitors of breast cancer resistance protein (ABCG2).
AID605033Solubility of the compound in cell-free DMEM media assessed as forward light scattering by compound by microplate neplhelometric analysis in presence of FBS2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID310884Solubility in Hanks balanced salt solution at 1 mg after 24 hrs2007Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2
Ester-based precursors to increase the bioavailability of quercetin.
AID1833884Ratio of MIC for antimicrobial activity against Staphylococcus aureus ATCC 25923 to IC50 for inhibition of Staphylococcus aureus sortase A using Abz-LPETGK(Dnp)-NH2 fluorescent peptide as substrate2021Bioorganic & medicinal chemistry, 12-15, Volume: 52Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition.
AID1220236Oral clearance in human2012Drug metabolism and disposition: the biological fate of chemicals, Sep, Volume: 40, Issue:9
Quantitative prediction of human intestinal glucuronidation effects on intestinal availability of UDP-glucuronosyltransferase substrates using in vitro data.
AID1371371Cytotoxicity against human COLO201 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1233228Cytotoxicity against mouse B16-4A5 cells assessed as cell viability at 3 uM after 70 hrs by WST-8 assay relative to control2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID512276Inhibition of His-tagged human MAPK2/ERK2 expressed in Escherichia coli at 20 uM2000The Biochemical journal, Oct-01, Volume: 351, Issue:Pt 1
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
AID641161Inhibition of PI3Kalpha in human HCT116 cells assessed as inhibition of Akt Ser473 phosphorylation at 25 uM by immunoblot analysis2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Biological evaluation and docking studies of recently identified inhibitors of phosphoinositide-3-kinases.
AID1327470Increase in glucose uptake in serum-starved mouse 3T3L1 adipocytes at 10 uM pretreated followed by glucose addition measured under basal condition by glucose oxidase peroxidase method2016European journal of medicinal chemistry, Oct-21, Volume: 122Total synthesis of 8-(6″-umbelliferyl)-apigenin and its analogs as anti-diabetic reagents.
AID1127221Binding affinity DPPC multilamellar vesicles assessed as chemical shift at 1:5 compound/lipid ratio at 323 K by nuclear magnetic resonance analysis2014European journal of medicinal chemistry, May-22, Volume: 79In-vitro anti-proliferative and anti-oxidant activity of galangin, fisetin and quercetin: role of localization and intermolecular interaction in model membrane.
AID1082348Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under dark conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1224761Delta TM value showing the stabilisation of CLK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1224804Delta TM value showing the stabilisation of VRK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1220240Unbound fraction during CYP4500-mediated metabolism in human intestinal microsomes2012Drug metabolism and disposition: the biological fate of chemicals, Sep, Volume: 40, Issue:9
Quantitative prediction of human intestinal glucuronidation effects on intestinal availability of UDP-glucuronosyltransferase substrates using in vitro data.
AID1866002Antioxidant activity assessed as free radical scavenging activity incubated for 30 mins by DPPH assay2022Bioorganic & medicinal chemistry, 01-15, Volume: 54Isolation and biological activity of azocine and azocane alkaloids.
AID1373927Induction of apoptosis in human Jurkat E6-1 cells assessed as early apoptotic cells at 50 uM after 24 hrs by Annexin-V-FITC/propidium iodide staining based flow cytometric analysis (Rvb = 0.5 +/- 0.07 %)2018Bioorganic & medicinal chemistry, 02-15, Volume: 26, Issue:4
Optimization of antimalarial, and anticancer activities of (E)-methyl 2-(7-chloroquinolin-4-ylthio)-3-(4-hydroxyphenyl) acrylate.
AID1485954Cytotoxicity against rat PC12 cells assessed as reduction in cell viability at 100 uM after 48 hrs in presence of up to 2 uM amyloid beta (1 to 42) by MTT assay2017Bioorganic & medicinal chemistry, 07-15, Volume: 25, Issue:14
Structure-activity relationships for flavone interactions with amyloid β reveal a novel anti-aggregatory and neuroprotective effect of 2',3',4'-trihydroxyflavone (2-D08).
AID587322Antiinflammatory activity in human neutrophil assessed as inhibition of LTB4-induced neutrophil chemoattraction 300 to 1000 nM after 2 hrs by Boyden chamber v2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID641163Inhibition of Akt expression in human HCT116 cells at 10 uM by immunoblot analysis2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Biological evaluation and docking studies of recently identified inhibitors of phosphoinositide-3-kinases.
AID603835Effect on JNK1 protein level in human MDA-MB-231 cells at 20 uM up to 120 mins by Western blot analysis2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Rhamnetin production based on the rational design of the poplar O-methyltransferase enzyme and its biological activities.
AID630873Inhibition of soybean arachidonate 15-lipoxygenase2011European journal of medicinal chemistry, Nov, Volume: 46, Issue:11
Recent progress in synthesis and bioactivity studies of indolizines.
AID1851410Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation at 10 uM incubated for 2 hrs by ThT fluorescence assay
AID510243Inhibition of NOX4 expressed in HEK293 FS cells at 10 uM assessed as H2O2 production by H2O2/Tyr/LPO assay2010Journal of medicinal chemistry, Sep-23, Volume: 53, Issue:18
Small-molecule inhibitors of NADPH oxidase 4.
AID768925Inhibition of human thrombin assessed as inhibition of fibrinogen polymerization at 50 uM preincubated for 10 mins followed by fibrionogen addition measured for 20 mins2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID1777359Antiviral activity against SARS-CoV-2 NCCP43326 infected in African green monkey Vero cells assessed as inhibition of plaque formation at 1 to 25 ug/ml treated with compound for 1 hr post-infection followed by drug wash-out and measured at 72 hrs post-inf2021Bioorganic & medicinal chemistry, 09-01, Volume: 45Potent antiviral activity of Agrimonia pilosa, Galla rhois, and their components against SARS-CoV-2.
AID1419294Antioxidant activity assessed as ferric ion reducing activity at 20 to 320 umol after 20 mins by FRAP assay2018Bioorganic & medicinal chemistry, 12-01, Volume: 26, Issue:22
Synthesis and in vitro antitumor activity of novel alkenyl derivatives of pyridoxine, bioisosteric analogs of feruloyl methane.
AID366284Inhibition of Influenza A Jinan/15/90 H3N2 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay2008Bioorganic & medicinal chemistry, Aug-01, Volume: 16, Issue:15
Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities.
AID677268Antioxidant activity against APPH radical assessed as trolox equivalent incubated for 15 mins prior to APPH addition measured every 1 min by 120 mins by fluorescein-based ORAC method2012Bioorganic & medicinal chemistry letters, Sep-01, Volume: 22, Issue:17
Antitrypanosomal and antioxidant properties of 4-hydroxycoumarins derivatives.
AID1713247Inhibition of ovine COX-1 assessed as appearance of oxidized TMPD level by EIA method2016European journal of medicinal chemistry, Nov-10, Volume: 123Novel N-substituted indole Schiff bases as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes: Synthesis, biological activities in vitro and docking study.
AID1288181Antioxidant activity in human HepG2 cells assessed as decrease in fluorescence level after 2.5 hrs measured every 5 mins for 1 hr by DCFH-DA staining based fluorescence assay2016European journal of medicinal chemistry, May-23, Volume: 114Protective effects of kaempferol against reactive oxygen species-induced hemolysis and its antiproliferative activity on human cancer cells.
AID1695729Inhibition of human alpha-synuclein filament formation expressed in Escherichia coli BL21(DE3) cells incubated for 72 hrs by thioflavin S based fluorescence assay2019European journal of medicinal chemistry, Apr-01, Volume: 167Toward the discovery and development of effective modulators of α-synuclein amyloid aggregation.
AID1226439Antioxidant activity assessed as DPPH radical scavenging activity after 1 hr2015Journal of medicinal chemistry, May-28, Volume: 58, Issue:10
Selenium-containing chrysin and quercetin derivatives: attractive scaffolds for cancer therapy.
AID34969Inhibitory concentration to aldose reductase (ALR-2) obtained from rat lens2001Journal of medicinal chemistry, Dec-06, Volume: 44, Issue:25
[1,2,4]Triazino[4,3-a]benzimidazole acetic acid derivatives: a new class of selective aldose reductase inhibitors.
AID749997Activation of recombinant paraoxonase-1 (unknown origin) expressed in Escherichia coli assessed as delaying of Cu2+-induced LDL oxidation time after 15 mins by UV ELISA2013Bioorganic & medicinal chemistry, Jun-01, Volume: 21, Issue:11
The effects and mechanism of flavonoid-rePON1 interactions. Structure-activity relationship study.
AID75438In vitro inhibitory activity against glutathione reductase (GR) from bakers yeast2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
Novel, highly potent aldose reductase inhibitors: cyano(2-oxo-2,3-dihydroindol-3-yl)acetic acid derivatives.
AID510246Inhibition of NOX4 expressed in HEK293 FS cells at 10 uM assessed as H2O2 production by H2O2/Tyr/LPO assay substituted with 3 uM H2O22010Journal of medicinal chemistry, Sep-23, Volume: 53, Issue:18
Small-molecule inhibitors of NADPH oxidase 4.
AID1446939Inhibition of CYP1B1 (unknown origin)2017European journal of medicinal chemistry, Apr-21, Volume: 130Quinazoline derivatives as selective CYP1B1 inhibitors.
AID1194982Antioxidant activity assessed as ABTS radical scavenging activity after 15 mins2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Cytotoxic and antioxidant constituents from the leaves of Psidium guajava.
AID424719Activity at bovine xanthine oxidase at 25 uM2009Journal of natural products, Apr, Volume: 72, Issue:4
Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin.
AID1656377Non-competitive inhibition of Influenza A virus (H1N1) neuraminidase by Lineweaver-Burk plot analysis2020Bioorganic & medicinal chemistry, 01-01, Volume: 28, Issue:1
Design, synthesis and biological evaluation of substituted flavones and aurones as potential anti-influenza agents.
AID429128Agonist activity at androgen receptor in human MDA-kb2 cells assessed as stimulation of luciferase activity at 100 uM by luciferase reporter gene assay2009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Effect of flavonoids on androgen and glucocorticoid receptors based on in vitro reporter gene assay.
AID732542Activation of Nrf2 in mouse RAW264.7 cells assessed as nuclear accumulation at 50 uM after 3 hrs by Western blotting analysis2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
A novel semisynthetic flavonoid 7-O-galloyltaxifolin upregulates heme oxygenase-1 in RAW264.7 cells via MAPK/Nrf2 pathway.
AID467856Analgesic activity in Swiss mouse assessed as reaction time taken to jump or lick paw at 100 mg/kg, ip after 30 mins of administration by hot plate test2009Journal of natural products, Nov, Volume: 72, Issue:11
Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production.
AID1264957Cytotoxicity against human MSC assessed as cell viability at 5 uM treated for 6 days measured on day 7 by alamar blue assay (Rvb = 96 to 101%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID1845532Thermal stabilization of human c-MYC G-quadruplex (Pu24T) DNA assessed as change in melting temperature at 1:2 ratio by circular dichroism spectroscopy2021Journal of medicinal chemistry, 01-14, Volume: 64, Issue:1
Recent Update on Targeting
AID333524Cytotoxicity against human MCF7 cells after 3 days by SRB assay2004Journal of natural products, Nov, Volume: 67, Issue:11
Prenylated benzophenones and xanthones from Hypericum scabrum.
AID1194978Cytotoxicity against human SGC7901 cells by MTT assay2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Cytotoxic and antioxidant constituents from the leaves of Psidium guajava.
AID454617Inhibition of trypsin at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-15, Volume: 20, Issue:2
Synthesis and biological evaluation of nitrogen-containing chalcones as possible anti-inflammatory and antioxidant agents.
AID366285Inhibition of Influenza A PR/8/34 H1N1 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay2008Bioorganic & medicinal chemistry, Aug-01, Volume: 16, Issue:15
Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities.
AID1224766Delta TM value showing the stabilisation of CK1G3 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID494832Antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF542010Bioorganic & medicinal chemistry letters, Aug-15, Volume: 20, Issue:16
Integrated ligand and structure based studies of flavonoids as fatty acid biosynthesis inhibitors of Plasmodium falciparum.
AID1172639Inhibition of cell proliferation of human U251 cells assessed as cell viability at 100 uM after 72 hrs by sulforhodamine B assay2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Bioactive triterpenoid saponins and phenolic compounds against glioma cells.
AID1359850Neuroprotection against H2O2-induced cell death in rat PC12 cells assessed as cell viability at 5 uM preincubated for 3 hrs followed by H2O2 stimulation measured after 2 hrs by MTT assay (Rvb = 25.2 to 41.8%)2018European journal of medicinal chemistry, May-25, Volume: 152Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer's disease based on coumarin and lipoic acid scaffolds.
AID1188607Anticancer activity against human A549 cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID351096Cytoprotective activity against H2O2-induced cell death in rat PC12 cells assessed as increase in cell viability preincubated 2 hrs before H2O2 challenge measured after 4 hrs by MTT assay2009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
Preparation of two sets of 5,6,7-trioxygenated dihydroflavonol derivatives as free radical scavengers and neuronal cell protectors to oxidative damage.
AID456187Inhibition of reduced carboxymethylated kappa-casein fibril formation measured every 5 mins after 1000 mins by thioflavin T staining-based binding assay2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Carboxymethylated-kappa-casein: a convenient tool for the identification of polyphenolic inhibitors of amyloid fibril formation.
AID355888Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 after 36 hrs under aerobic condition by microdilution method2003Journal of natural products, May, Volume: 66, Issue:5
Sesquiterpene lactones from Anthemis altissima and their anti-Helicobacter pylori activity.
AID358174Inhibition of p56 lck1992Journal of natural products, Nov, Volume: 55, Issue:11
Protein-tyrosine kinase inhibition: mechanism-based discovery of antitumor agents.
AID578565Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha secretion after 18 hrs2011Bioorganic & medicinal chemistry letters, Mar-15, Volume: 21, Issue:6
A new ursane-type triterpenoid glycoside from Centella asiatica leaves modulates the production of nitric oxide and secretion of TNF-α in activated RAW 264.7 cells.
AID377786Antioxidant activity assessed as DPPH radical scavenging activity at 15 ug/mL after 30 to 45 mins2005Journal of natural products, Apr, Volume: 68, Issue:4
Antioxidant phenolic glycosides from Moricandia arvensis.
AID334637Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-aminoanthracene-induced mutation at 600 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID1516858Antifungal activity against Candida glabrata 493 by microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID1233244Inhibition of plasmin (unknown origin) at 100 uM after 18 hrs by arianor mahogany dye-based fibrin plate assay relative to control2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID1668636Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production incubated for 12 hrs by Griess reagent based assay2020Journal of natural products, 05-22, Volume: 83, Issue:5
Cucurbitane-Type Triterpenoids from the Vines of
AID1188620Anticancer activity against human M14 cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID287076Inhibition of TPA-induced inflammation in mouse assessed per ear by edema assay2007Journal of natural products, May, Volume: 70, Issue:5
Anti-inflammatory and potential cancer chemopreventive constituents of the fruits of Morinda citrifolia (Noni).
AID203731In vitro inhibitory activity against sorbitol dehydrogenase (SD) from sheep liver2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
Novel, highly potent aldose reductase inhibitors: cyano(2-oxo-2,3-dihydroindol-3-yl)acetic acid derivatives.
AID310882Inhibition of HIV1 replication2007Bioorganic & medicinal chemistry letters, Mar-01, Volume: 17, Issue:5
Simple criterion for selection of flavonoid compounds with anti-HIV activity.
AID1903080Antiproliferative activity against human HT-29 cells over expressing GLUT1 assessed as reduction in cell viability at 50 uM measured after 48 hrs by MTT assay2022Bioorganic & medicinal chemistry, 03-15, Volume: 58Design, synthesis and biological evaluation of colchicine glycoconjugates as tubulin polymerization inhibitors.
AID462344Inhibition of mushroom tyrosinase at 1 uM2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells.
AID758734Cytotoxicity against human HL60 cells after 46 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Structure-cytotoxic activity relationship of 3-arylideneflavanone and chromanone (E,Z isomers) and 3-arylflavones.
AID666853Cytotoxicity against human LCC-6 cells after 5 days by MTS assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis of methylated quercetin derivatives and their reversal activities on P-gp- and BCRP-mediated multidrug resistance tumour cells.
AID449299Neuroprotective activity against H2O2-induced injury in rat PC12 cells treated 2 hrs before H2O2 challenge measured after 4 hrs by MTT assay2009Journal of medicinal chemistry, Dec-10, Volume: 52, Issue:23
Design, synthesis, and examination of neuron protective properties of alkenylated and amidated dehydro-silybin derivatives.
AID587329Inhibition of fMLP-induced actin polymerization in human neutrophil at 100 nM after 30 mins by DAPI staining based immunofluorescence2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID745311Inhibition of Helicobacter pylori ATCC 43504 urease-mediated ammonia production preincubated for 1.5 hrs by indophenol method2013European journal of medicinal chemistry, May, Volume: 63Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.
AID315610Effect on cell morphology in human BGC823 cells assessed as chromosomal condensations at 50 uM2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
Studies on the chemical constituents and anticancer activity of Saxifraga stolonifera (L) Meeb.
AID1371435Cytotoxicity against human PANC1 cells assessed as cell viability at 14 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID395151Antioxidant activity in Wistar rat liver microsomes assessed as inhibition of lipid peroxidation by TBA assay2009European journal of medicinal chemistry, Jan, Volume: 44, Issue:1
QSAR study of antioxidant activity of wine polyphenols.
AID1408296Antiproliferative activity against human PC3 cells after 3 days by WST-1 assay2018European journal of medicinal chemistry, Sep-05, Volume: 157Structure-activity relationship and pharmacokinetic studies of 3-O-substitutedflavonols as anti-prostate cancer agents.
AID1572032Inhibition of IP6K2 in human [3H]-inositol-labelled HCT116 cells assessed as reduction in insp7 levels at 2.5 uM after 30 mins by HPLC analysis2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
AID351095Cytoprotective activity against H2O2-induced cell death in rat PC12 cells assessed as increase in cell viability at 32 ug/ml preincubated 2 hrs before H2O2 challenge measured after 4 hrs by MTT assay relative to control2009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
Preparation of two sets of 5,6,7-trioxygenated dihydroflavonol derivatives as free radical scavengers and neuronal cell protectors to oxidative damage.
AID681162TP_TRANSPORTER: drug resistance (vincristine) in AML-2/D100 cells2004Biochemical and biophysical research communications, Jul-30, Volume: 320, Issue:3
Reversal of P-glycoprotein-mediated MDR by 5,7,3',4',5'-pentamethoxyflavone and SAR.
AID1459579Inhibition of recombinant human MAO-B assessed as reduction in 4-hydroxyquinoline formation using kynuramine as substrate after 20 mins by fluorometric assay2016Journal of natural products, 10-28, Volume: 79, Issue:10
Isolation of Acacetin from Calea urticifolia with Inhibitory Properties against Human Monoamine Oxidase-A and -B.
AID1152251Antiviral activity against HIV-1 3B infected in human C8166 cells assessed as inhibition of virus-induced cytopathogenicity by measuring syncytial cell number after 3 days by inverted microscopic analysis2014Bioorganic & medicinal chemistry, Jun-15, Volume: 22, Issue:12
Design and discovery of flavonoid-based HIV-1 integrase inhibitors targeting both the active site and the interaction with LEDGF/p75.
AID378674Inhibition of thymocyte protein tyrosine kinase2006Journal of natural products, Jan, Volume: 69, Issue:1
A common protein fold topology shared by flavonoid biosynthetic enzymes and therapeutic targets.
AID402267Antioxidant activity against ABTS radical assessed as TEAC units2004Journal of natural products, May, Volume: 67, Issue:5
Yucca schidigera bark: phenolic constituents and antioxidant activity.
AID309798Inhibition of 12-hLO2007Bioorganic & medicinal chemistry, Dec-01, Volume: 15, Issue:23
Structure-activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2.
AID605049Cellular uptake in human MCF7 cells assessed as formation of methylated quercetin in cell lysates at 10 uM after 5 hrs by HPLC-mass spectrophotometric analysis2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID347256Binding affinity to human recombinant carbonyl reductase 3 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in presence of NADP+2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID587304Inhibition of LTB4-induced neutrophil recruitment in Swiss mouse at 300 mg/kg, sc administered pre-inflammatory stimulus after 6 hrs by Newbauer chamber using Romanowsky stain2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID359632Antiviral activity against HSV1 in african green monkey Vero cells assessed as log reduction of virus titer at 48.3 ug/ml1992Journal of natural products, Dec, Volume: 55, Issue:12
Synergistic effect of flavones and flavonols against herpes simplex virus type 1 in cell culture. Comparison with the antiviral activity of propolis.
AID232928Selectivity as ratio of IC50 for rat lens and kidney aldose reductase1991Journal of medicinal chemistry, Nov, Volume: 34, Issue:11
Spiro[fluoreneisothiazolidin]one dioxides: new aldose reductase and L-hexonate dehydrogenase inhibitors.
AID1536965Inhibition of LPS-induced delay of apoptosis in human neutrophils assessed as viable cells at 2.5 uM preincubated for 1 hr followed by LPS stimulation and measured after 24 hrs by Annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 75.4 +2019Journal of natural products, 02-22, Volume: 82, Issue:2
Eupatoriopicrin Inhibits Pro-inflammatory Functions of Neutrophils via Suppression of IL-8 and TNF-alpha Production and p38 and ERK 1/2 MAP Kinases.
AID703474Selectivity ratio of IC50 for Leishmania donovani promastigote to IC50 for SSG-resistant Leishmania donovani 39 amastigote infected in mouse peritoneal macrophages2012Journal of medicinal chemistry, Oct-25, Volume: 55, Issue:20
Flavonoid dimers as novel, potent antileishmanial agents.
AID357254Antifungal activity against Candida albicans ATCC 900282002Journal of natural products, Dec, Volume: 65, Issue:12
Fatty acid synthase inhibitors from plants: isolation, structure elucidation, and SAR studies.
AID402568Inhibition of XOD at 125 uM relative to control2004Journal of natural products, Jun, Volume: 67, Issue:6
Geranylgeraniol-type diterpenoids, boletinins A-J, from Boletinus cavipes as inhibitors of superoxide anion generation in macrophage cells.
AID1224756Delta TM value showing the stabilisation of CAMKK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID402708Antioxidant activity assessed as inhibition of copper-induced lipid peroxidation by Fe3(CN)6 method at 300 uM2005Journal of natural products, Jul, Volume: 68, Issue:7
A labdane diterpene glucoside from the rhizomes of Curcuma mangga.
AID1102356Antioxidant activity assessed as DPPH free radical scavenging activity at 5 to 100 uM after 30 min by spectrophotometric analysis2003Journal of agricultural and food chemistry, May-07, Volume: 51, Issue:10
Herbicidal, plant growth inhibitory, and cytotoxic activities of bismuthines containing aromatic heterocycles.
AID1286206Inhibition of LPS-induced nitric oxide production in human BV2 cells after 24 hrs by Griess assay2016Journal of natural products, Jan-22, Volume: 79, Issue:1
Nitric Oxide Inhibitory Dimeric Sesquiterpenoids from Artemisia rupestris.
AID353593Inhibition of HSF1 binding to heat shock element DNA assessed as HSF1/HSE complex formation in human Jurkat cells at 50 ug/mL treated for 1 hr before heat induction2009Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7
Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives.
AID1572040Down regulation of insp5 levels in human [3H]-inositol-labelled HCT116 cells at 2.5 uM up to 200 mins by HPLC analysis2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
AID710226Prevention of apoptosis in rat H9c2 cells assessed as protection against oxidative stress-induced cytotoxicity at 100 nM pM by Alamar blue assay2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Carbamate derivatives of indolines as cholinesterase inhibitors and antioxidants for the treatment of Alzheimer's disease.
AID346253Vasorelaxant activity in Sprague-Dawley rat aorta assessed as inhibition of phenylephrine-induced contraction after 15 to 20 mins2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Synthesis, biological evaluation and quantitative structure-activities relationship of flavonoids as vasorelaxant agents.
AID1599344Antiviral activity against DENV2 infected in BHK-21 cells2019European journal of medicinal chemistry, Aug-15, Volume: 176Recent update on anti-dengue drug discovery.
AID338748Inhibition of phosphatidylinositol 4-kinase in human A431 cell membrane by liquid scintillation counting
AID603840Increase in ERK2 phosphorylation in human MDA-MB-231 cells at 20 uM by Western blot analysis2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Rhamnetin production based on the rational design of the poplar O-methyltransferase enzyme and its biological activities.
AID1572031Inhibition of IP6K2 in human [3H]-inositol-labelled HCT116 cells assessed as reduction in insp7 levels at 2.5 uM up to 3.5 hrs by HPLC analysis relative to control2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
AID762908Induction of intracellular RPS production in promastigotes of Leishmania amazonensis MHOM/BR/75/LTB0016 infected Swiss mouse peritoneal macrophages at 12 uM after 72 hrs by spectrofluorometric analysis relative to control2013Journal of natural products, Aug-23, Volume: 76, Issue:8
Reactive oxygen species production by quercetin causes the death of Leishmania amazonensis intracellular amastigotes.
AID1188621Anticancer activity against human SKBR cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID101295Ex vivo inhibition of LTB4 production was measured in dog blood1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Indazolinones, a new series of redox-active 5-lipoxygenase inhibitors with built-in selectivity and oral activity.
AID1239528Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 9 by disk diffusion assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1311085Antioxidant activity assessed as inhibition of HOCl-induced oxidation of non-fluorescent DHR to fluorescent rhodamine-123 by fluorescence-based assay2016European journal of medicinal chemistry, Aug-25, Volume: 119New polyhydroxylated flavon-3-ols and 3-hydroxy-2-styrylchromones: synthesis and ROS/RNS scavenging activities.
AID1533714Inhibition of human liver microsomes CYP1A1 expressed in Escherichia coli DH5alpha cell membranes coexpressing human NADPH-cytochrome P450 reductase using 7-Ethoxyresorufin as substrate preincubated for 3 mins followed by NADPH addition measured after 10 2019European journal of medicinal chemistry, Feb-01, Volume: 163Phytoestrogens and their synthetic analogues as substrate mimic inhibitors of CYP1B1.
AID1226458Selectivity index, ratio of IC50 for HEK293 cells to IC50 for human MCF7 cells2015Journal of medicinal chemistry, May-28, Volume: 58, Issue:10
Selenium-containing chrysin and quercetin derivatives: attractive scaffolds for cancer therapy.
AID429129Agonist activity at glucocorticoid receptor in human MDA-kb2 cells assessed as stimulation of luciferase activity at 100 uM by luciferase reporter gene assay2009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Effect of flavonoids on androgen and glucocorticoid receptors based on in vitro reporter gene assay.
AID1871975Antifungal activity against Candida albicans 527/14 assessed as fungal growth inhibition measured after 24 hrs by microdilution assay2022European journal of medicinal chemistry, Feb-05, Volume: 229Quercetin derivatives: Drug design, development, and biological activities, a review.
AID1871969Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins under dark condition2022European journal of medicinal chemistry, Feb-05, Volume: 229Quercetin derivatives: Drug design, development, and biological activities, a review.
AID598342Inhibition of CYP1B1 EROD activity assessed as inhibition of deethylation of 7-ethoxyresorufin to resorufin2011Bioorganic & medicinal chemistry, May-01, Volume: 19, Issue:9
Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.
AID1204217Inhibition of porcine pancreatic lipase using p-nitrophenylbutyrate as substrate assessed as formation of p-nitrophenol preincubated for 15 mins followed by substrate addition measured after 15 mins2015Bioorganic & medicinal chemistry letters, Jun-01, Volume: 25, Issue:11
Pancreatic lipase inhibitory constituents from Morus alba leaves and optimization for extraction conditions.
AID603463Inhibition of Escherichia coli DNA topoisomerase 4 subunit ParC/DNA topoisomerase 4 subunit ParE-mediated decatenation of kDNA by densitometry2011Journal of medicinal chemistry, Jun-09, Volume: 54, Issue:11
Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
AID338750Inhibition of bovine thymus p56LCK-catalyzed phosphorylation of angiotensin 1 by SDS-PAGE
AID336446Antileishmanial activity against Leishmania donovani (MHOM/ET/67/L82) promastigotes2002Journal of natural products, Oct, Volume: 65, Issue:10
Assessment of the antiprotozoal activity of Galphimia glauca and the isolation of new nor-secofriedelanes and nor-friedelanes.
AID701064Inhibition of SYK in human mast cells assessed as reduction in mast cell degranulation2012Journal of medicinal chemistry, Apr-26, Volume: 55, Issue:8
Discovery and development of spleen tyrosine kinase (SYK) inhibitors.
AID1564980Antioxidant activity assessed as APPH-induced radical scavenging activity preincubated for 30 mins followed by AAPH addition and measured every minute for 2 hrs by ORAC fluorescein assay relative to trolox2019European journal of medicinal chemistry, Nov-15, Volume: 182Novel multi target-directed ligands targeting 5-HT
AID1485956Inhibition of human amyloid beta (1 to 42) assessed as neuroprotective activity against amyloid beta (1 to 42)-induced toxicity in rat PC12 cells by measuring reduction in cell viability at 50 to 100 uM incubated 15 mins prior to amyloid beta (1 to 42) ad2017Bioorganic & medicinal chemistry, 07-15, Volume: 25, Issue:14
Structure-activity relationships for flavone interactions with amyloid β reveal a novel anti-aggregatory and neuroprotective effect of 2',3',4'-trihydroxyflavone (2-D08).
AID337692Antibacterial activity against Bacillus subtilis ATCC 6633 after 48 hrs by silica gel plate-based INT-formazan method
AID768915Inhibition of human thrombin assessed as inhibition of fibrinogen gamma-gamma chain formation at IC50 after 5 mins by SDS-PAGE analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID1233222Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells at 3 uM after 72 hrs by microplate reader analysis relative to control2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID1127227Antiproliferative activity against human MCF7 cells assessed as cell growth at 10'-4 ug/ml after 48 hrs by SRB assay relative to control2014European journal of medicinal chemistry, May-22, Volume: 79In-vitro anti-proliferative and anti-oxidant activity of galangin, fisetin and quercetin: role of localization and intermolecular interaction in model membrane.
AID1555996Neuroprotective activity against H2O2 induced cytotoxicity in rat PC12 cells assessed as cell viability at 5 uM pretreated for 3 hrs followed by H2O2 challenge measured after 24 hrs by MTT assay (Rvb = 35.69 to 50.26%)2019European journal of medicinal chemistry, Sep-01, Volume: 177Design, synthesis, and biological evaluation of rutacecarpine derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease.
AID678024Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation by spectrophotometry based TBARS assay2012Bioorganic & medicinal chemistry, Sep-01, Volume: 20, Issue:17
Synthesis, cytotoxic and antioxidant evaluations of amino derivatives from perezone.
AID1409613Selectivity ratio: ratio of AUC (viral infection %) of SARS-CoV-2 in the Vero E6 cell line compared to AUC (cytotoxicity %) of compound against Vero E6 cells by MTT assay.2020Nature, 07, Volume: 583, Issue:7816
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
AID427748Inhibition of MRP1 transfected in human HeLa cells assessed as inhibition of [3H]LTC4 transport by rapid filtration assay2009Journal of medicinal chemistry, Sep-10, Volume: 52, Issue:17
Modulation of multidrug resistance protein 1 (MRP1/ABCC1)-mediated multidrug resistance by bivalent apigenin homodimers and their derivatives.
AID241232Inhibition of Cyclin-dependent kinase 5-p25nck5a2005Journal of medicinal chemistry, Feb-10, Volume: 48, Issue:3
Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin.
AID398393Inhibition of bovine pancreas trypsin1995Journal of natural products, Jun, Volume: 58, Issue:6
Flavonoid inhibitors of trypsin and leucine aminopeptidase: a proposed mathematical model for IC50 estimation.
AID1102138Phytotoxicity in Centaurea diffusa assessed as inhibition of root differentiation at 250 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID265761Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum NF542006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.
AID512290Inhibition of His-tagged human SGK expressed in Sf9 cells at 20 uM2000The Biochemical journal, Oct-01, Volume: 351, Issue:Pt 1
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
AID587323Inhibition of CXCR1 protein expression in human neutrophil at 100 nM after 30 mins by flow cytometry2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID603362Antibacterial activity against vancomycin resistant Enterococcus FN-1 after 24 hrs by microdilution method2011Journal of medicinal chemistry, Jun-09, Volume: 54, Issue:11
Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
AID362986Inhibition of immune complex-stimulated neutrophil oxidative metabolism in New Zealand white rabbit neutrophils assessed as ROS generation at 50 uM after 30 mins by lucigenin enhanced chemiluminescence assay2008European journal of medicinal chemistry, May, Volume: 43, Issue:5
Inhibition of immune complex-mediated neutrophil oxidative metabolism: a pharmacophore model for 3-phenylcoumarin derivatives using GRIND-based 3D-QSAR and 2D-QSAR procedures.
AID483708Noncompetitive inhibition of human recombinant BACE1 after 60 mins by Dixon plot analysis2010Bioorganic & medicinal chemistry letters, Jun-01, Volume: 20, Issue:11
Molecular docking studies of phlorotannins from Eisenia bicyclis with BACE1 inhibitory activity.
AID250527Antiproliferative effect against human colonic cell line (HT-29) after 6 hr at a concentration of 50 uM2005Journal of medicinal chemistry, Apr-21, Volume: 48, Issue:8
Effects of flavonoids on cell proliferation and caspase activation in a human colonic cell line HT29: an SAR study.
AID638570Therapeutic index, ratio of TD50 for MDCK cells to ED50 for influenza A virus (A/swine/OH/511445/2007(H1N1)) Oh72012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Synthesis and antiviral activity of substituted quercetins.
AID779048Inhibition of phospholipase A2 (unknown origin)2013Bioorganic & medicinal chemistry, Nov-01, Volume: 21, Issue:21
Discovery and characterization of synthetic 4'-hydroxyflavones-New CK2 inhibitors from flavone family.
AID231882Compound was tested for Ratio of IC50(ALR1)/(ALR2)1999Journal of medicinal chemistry, Jun-03, Volume: 42, Issue:11
1-Benzopyran-4-one antioxidants as aldose reductase inhibitors.
AID501421Inhibition of Escherichia coli DNA gyraseB assessed as inhibition of pBR322 supercoiling by densitometry2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Design, synthesis, and biological evaluation of a novel series of quercetin diacylglucosides as potent anti-MRSA and anti-VRE agents.
AID424736Inhibition of bovine xanthine oxidase assessed as reduction in free enzyme turnover at 50 uM relative to control2009Journal of natural products, Apr, Volume: 72, Issue:4
Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin.
AID1656372Cytotoxicity against dog MDCK cells assessed as reduction in cell viability by MTT assay2020Bioorganic & medicinal chemistry, 01-01, Volume: 28, Issue:1
Design, synthesis and biological evaluation of substituted flavones and aurones as potential anti-influenza agents.
AID1516901Antifungal activity against Trichophyton rubrum deltaTruMDR2 by CLSI-based microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID356714Antiinflammatory activity against TPA-induced ear edema in mouse assessed inhibition of edema at 0.05 mg/ear2001Journal of natural products, Jul, Volume: 64, Issue:7
Antiinflammatory constituents from Heterotheca inuloides.
AID1372152Inhibition of human CYP3A4 expressed in HEK293 cells by fluorescence assay
AID1301297Antioxidant activity assessed as ABTS radical scavenging activity after 60 mins2016Bioorganic & medicinal chemistry letters, 07-01, Volume: 26, Issue:13
Enantioselective synthesis and antioxidant activity of 3,4,5-substituted piperidine derivatives.
AID1224781Delta TM value showing the stabilisation of PAK4 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1083163Antifungal activity against Botryosphaeria dothidea OGE14 assessed as growth inhibition measured after 1 to 10 days relative to control2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID1479734Activation of recombinant human ABCG2 ATPase activity expressed in baculovirus infected High five insect cell membranes after 20 mins by ascorbic acid ammonia molybdate reaction-based colorimetric method2018Journal of medicinal chemistry, 04-26, Volume: 61, Issue:8
New Inhibitors of Breast Cancer Resistance Protein (ABCG2) Containing a 2,4-Disubstituted Pyridopyrimidine Scaffold.
AID445114Antioxidant activity assessed as protection against AAPH-induced pBR322 plasmid DNA strand open circular form at <5 uM after 4 hrs by agarose gel electrophoresis2009Bioorganic & medicinal chemistry letters, Nov-15, Volume: 19, Issue:22
Synthesis and antioxidant properties of dendritic polyphenols.
AID439368Agonist activity at human PPARgamma expressed in HEK293 cells co-transfected with PPRE assessed as beta-galactosidase signal at 25 uM after 48 hrs by reporter gene assay relative to control2009Journal of medicinal chemistry, Nov-12, Volume: 52, Issue:21
7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists.
AID1510609Inhibition of bovine pancreas alpha-chymotrypsin at concentration of 6 uM using SPpNA as substrate treated with enzyme for 30 mins following enzyme incubation with 0.7 to 2.1 M DMSO for 5 mins followed by substrate addition and measured for 12 mins by DMS2019ACS medicinal chemistry letters, Jun-13, Volume: 10, Issue:6
DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors.
AID1239568Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 at 1.69 mM after 5 hrs by time kill assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1226440Antioxidant activity assessed as DPPH radical scavenging activity at 1 mM after 1 hr2015Journal of medicinal chemistry, May-28, Volume: 58, Issue:10
Selenium-containing chrysin and quercetin derivatives: attractive scaffolds for cancer therapy.
AID1328664Neuroprotective activity in mouse HT22 cells assessed as decrease in glutamate-induced reduction of full-length Bid level at 5 uM pretreated for 12 hrs prior to glutamate-challenge measured after 12 hrs by Western blotting assay (Rvb = 0.9 +/- 0.05 No_uni2016Bioorganic & medicinal chemistry letters, 12-01, Volume: 26, Issue:23
The comparison of neuroprotective effects of isoliquiritigenin and its Phase I metabolites against glutamate-induced HT22 cell death.
AID1082326Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under light conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1501278Activation of ABCG2 ATPase activity (unknown origin) expressed in baculovirus infected high5 cell membranes assessed as enzyme activity after 20 mins by ascorbic acid ammonia molybdate reaction based colorimetric assay relative to control2017European journal of medicinal chemistry, Oct-20, Volume: 139Synthesis and biological investigation of 2,4-substituted quinazolines as highly potent inhibitors of breast cancer resistance protein (ABCG2).
AID398957Antimicrobial activity against Staphylococcus aureus
AID332650Inhibition of calf thymus DNA topoisomerase 1 catalytic domain-mediated supercoiled Escherichia coli pUC8 DNA relaxation at 100 uM after 30 mins by agarose gel electrophoresis1995Journal of natural products, Feb, Volume: 58, Issue:2
Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships.
AID1899561Inhibition of LPS induced NO production in mouse BV-2 cells by Griess reagent based analysis2022European journal of medicinal chemistry, Jan-15, Volume: 228Imidazolylacetophenone oxime-based multifunctional neuroprotective agents: Discovery and structure-activity relationships.
AID1224792Delta TM value showing the stabilisation of RIOK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID378807Antioxidant activity assessed as inhibition of hydroxyl radical generation by fluorescence spectroscopy2006Journal of natural products, Oct, Volume: 69, Issue:10
Antioxidative phenolics from the fresh leaves of Ternstroemia japonica.
AID1668635Cytotoxicity against mouse RAW264.7 cells assessed as cell viability at 15 ug/ml after 24 hrs by alamarBlue assay relative to control2020Journal of natural products, 05-22, Volume: 83, Issue:5
Cucurbitane-Type Triterpenoids from the Vines of
AID515377Antioxidant activity assessed as singlet oxygen scavenging activity by spectrophotometry2010Bioorganic & medicinal chemistry, Sep-15, Volume: 18, Issue:18
2,3-diarylxanthones as strong scavengers of reactive oxygen and nitrogen species: a structure-activity relationship study.
AID680498TP_TRANSPORTER: inhibition of Hoechst 33342 efflux (Hoechst 33342: 25 uM, Quercetin: 25 uM) in purified and reconstituted P-gp, flow cytometry1997Biochemical pharmacology, Feb-21, Volume: 53, Issue:4
Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein.
AID1187092Cytotoxicity against LPS-stimulated mouse RAW264.7 cells assessed as cell viability at 1.5 uM after 24 hrs by MTT assay (Rvb = 100%)2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Triterpene glycosides from red ginseng marc and their anti-inflammatory activities.
AID1185433Neuroprotective activity in mouse HT22 cells assessed as reduction in glutamate-induced cytotoxicity at 25 uM by MTT assay2014Bioorganic & medicinal chemistry, Sep-01, Volume: 22, Issue:17
Cyclic acyl guanidines bearing carbamate moieties allow potent and dirigible cholinesterase inhibition of either acetyl- or butyrylcholinesterase.
AID1063899Activity at soybean LOX-1 using linoleic acid as substrate at 25 uM preincubated for 5 mins followed by substrate addition by Michaelis-Menten plot analysis2014European journal of medicinal chemistry, Jan-24, Volume: 72Inhibition of LOX by flavonoids: a structure-activity relationship study.
AID385353Inhibition of rat lens aldose reductase2008Journal of natural products, Apr, Volume: 71, Issue:4
Erigeroflavanone, a flavanone derivative from the flowers of Erigeron annuus with protein glycation and aldose reductase inhibitory activity.
AID1336846Inhibition of P-gp in human MES-SA/Dx5 cells assessed as potentiation of vinblastine-induced cytotoxicity by measuring fold reduction in vinblastine EC50 at 5 uM after 72 hrs by MTT assay relative to untreated control2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Quercetin-glutamic acid conjugate with a non-hydrolysable linker; a novel scaffold for multidrug resistance reversal agents through inhibition of P-glycoprotein.
AID1127220Binding affinity DPPC multilamellar vesicles assessed as main transition temperature at 1:2 compound/lipid ratio after 2 hrs by differential scanning calorimetry method (Rvb = 41.98 degC)2014European journal of medicinal chemistry, May-22, Volume: 79In-vitro anti-proliferative and anti-oxidant activity of galangin, fisetin and quercetin: role of localization and intermolecular interaction in model membrane.
AID467853Inhibition of CXCL1-induced neutrophil recruitment in Swiss mouse subcutaneous plantar tissue assessed as myeloperoxidase activity at 100 mg/kg, ip dosed 30 mins before CXCL1 challenge measured after 3 hrs by spectrophotometry2009Journal of natural products, Nov, Volume: 72, Issue:11
Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production.
AID587309Inhibition of LTB4-induced neutrophil recruitment in Swiss mouse at 30 mg/kg, sc administered pre-inflammatory stimulus after 6 hrs by Newbauer chamber using Romanowsky stain2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID603364Antibacterial activity against vancomycin-intermediate Staphylococcus aureus Mu50 after 24 hrs by microdilution method2011Journal of medicinal chemistry, Jun-09, Volume: 54, Issue:11
Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
AID512292Inhibition of His-tagged human GSK3b expressed in Sf21 cells at 20 uM2000The Biochemical journal, Oct-01, Volume: 351, Issue:Pt 1
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
AID469266Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced nitrite accumulation after 24 hrs by Griess reagent method2009Journal of natural products, Sep, Volume: 72, Issue:9
Triterpenoids and flavonoids from celery (Apium graveolens).
AID512448Inhibition of His-tagged bovine PI3K expressed in Sf9 cells at 20 uM2000The Biochemical journal, Oct-01, Volume: 351, Issue:Pt 1
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
AID504290Antioxidant activity assessed as superoxide radical scavenging activity by NBT method2010Journal of natural products, Sep-24, Volume: 73, Issue:9
Chlorinated iridoid glucosides from Veronica longifolia and their antioxidant activity.
AID587328Inhibition of LTB4-induced actin polymerization in human neutrophil at 100 nM after 30 mins by DAPI staining based immunofluorescence2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID512283Inhibition of His-tagged human MAPKAPK2 expressed in Escherichia coli at 20 uM2000The Biochemical journal, Oct-01, Volume: 351, Issue:Pt 1
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
AID578759Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
AID311925Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells2007Journal of natural products, Dec, Volume: 70, Issue:12
Kadsuralignans H-K from Kadsura coccinea and their nitric oxide production inhibitory effects.
AID1083159Antifungal activity against Diplodia mutila BRA08 assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID161024In vitro for prostaglandin G/H synthase inhibitory activity against rat basophil leukemia type 1 cell homogenates, by measuring the radioactivity of [14C]-PGD21990Journal of medicinal chemistry, Oct, Volume: 33, Issue:10
Penta- and hexadienoic acid derivatives: a novel series of 5-lipoxygenase inhibitors.
AID1083171Antifungal activity against Togninia minima SO21 assessed as susceptibility at 500 uM measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID1210017Inhibition of CYP2C9 in human liver microsomes using diclofenac as substrate after 8 mins by LC-MS/MS analysis2012Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
AID1186044Cytotoxicity against human HL60 cells assessed as cell survival at 50 uM after 72 hrs by CCK8 assay2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Phytochemical analysis and antileukemic activity of polyphenolic constituents of Toona sinensis.
AID1674246Inhibition of BACE1 (unknown origin) at 10 uM measured after 60 mins by FRET assay2020Journal of natural products, 07-24, Volume: 83, Issue:7
Neuroprotective Effects of Triterpenoids from
AID406995Inhibition of human recombinant 17beta-HSD1 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
Discovery of nonsteroidal 17beta-hydroxysteroid dehydrogenase 1 inhibitors by pharmacophore-based screening of virtual compound libraries.
AID277108Inhibition of PMA-induced ROS production in human mononuclear leukocytes2006Bioorganic & medicinal chemistry letters, Dec-15, Volume: 16, Issue:24
Total synthesis and biological evaluation of viscolin, a 1,3-diphenylpropane as a novel potent anti-inflammatory agent.
AID1083161Antifungal activity against Neofusicoccum parvum PER20 assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID467851Antinociceptive activity in Swiss mouse assessed as inhibition of CXCL1-induced mechanical hypernociception at 100 mg/kg, ip dosed 30 mins before CXCL1 challenge measured after 3 hrs by electronic pressure-meter test2009Journal of natural products, Nov, Volume: 72, Issue:11
Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production.
AID1224759Delta TM value showing the stabilisation of CDKL1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1654169Induction of cell proliferation in human Gingival fibroblast at 0.5 to 10 uM after 72 hrs by MTS assay2020Journal of natural products, 03-27, Volume: 83, Issue:3
Antioxidant Activity of Compounds Isolated from
AID512294Inhibition of rat liver AMPK at 20 uM2000The Biochemical journal, Oct-01, Volume: 351, Issue:Pt 1
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
AID356713Antiinflammatory activity against TPA-induced ear edema in mouse assessed inhibition of edema at 0.10 mg/ear2001Journal of natural products, Jul, Volume: 64, Issue:7
Antiinflammatory constituents from Heterotheca inuloides.
AID1250230Inhibition of aromatase (unknown origin)2015European journal of medicinal chemistry, Sep-18, Volume: 102Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer.
AID1446624Cytotoxicity against rat C6 cells assessed as cell viability at 20 uM after 24 hrs by MTT assay relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Anti-Neurodegenerative Biflavonoid Glycosides from Impatiens balsamina.
AID34885Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells1996Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
Interactions of flavonoids and other phytochemicals with adenosine receptors.
AID1713539Inhibition of diphenolase activity of mushroom tyrosinase using L-DOPA substrate2016Bioorganic & medicinal chemistry, 11-15, Volume: 24, Issue:22
ArgTX-636, a polyamine isolated from spider venom: A novel class of melanogenesis inhibitors.
AID218683inhibitory activity against Beta-lactamase2002Journal of medicinal chemistry, Apr-11, Volume: 45, Issue:8
A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.
AID402230Antioxidant activity in Wistar rat liver microsomes assessed as inhibition of hydroxyl radical-induced lipid peroxidation by TBARS assay2004Journal of natural products, May, Volume: 67, Issue:5
Hypoglycemic effect and antioxidant potential of kaempferol-3,7-O-(alpha)-dirhamnoside from Bauhinia forficata leaves.
AID1693692Inhibition of rabbit skeletal muscle myosin-2 ATPase at 1 to 10 uM incubated for 20 mins followed by ATP addition and measured after 20 mins2021Bioorganic & medicinal chemistry, 01-15, Volume: 30In vitro and in vivo effects of inhibitors on actin and myosin.
AID670310Inhibition of human recombinant MMP1 catalytic domain incubated for 20 mins by fluorimetric assay2012Bioorganic & medicinal chemistry, Jul-01, Volume: 20, Issue:13
Natural products as a gold mine for selective matrix metalloproteinases inhibitors.
AID353598Inhibition of CK2 assessed as level of ATP utilized by luciferase-based bioluminescence assay2009Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7
Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives.
AID1833878Antimicrobial activity against Staphylococcus aureus MRSA ATCC 43300 assessed as bacterial growth inhibition measured after 24 hrs by resazurin dye based broth microdilution method2021Bioorganic & medicinal chemistry, 12-15, Volume: 52Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition.
AID1336867Inhibition of amyloid beta (1 to 42) aggregation (unknown origin)2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Neuritogenic activity of bi-functional bis-tryptoline triazole.
AID527150Reduction of MuRF-1 mRNA expression in gastrocnemius muscle of C57BL/6 mouse tail suspension model at 2.5 pmol administered in gastrocnemius muscle qd for 10 days by RT-PCR analysis2010Journal of natural products, Oct-22, Volume: 73, Issue:10
Quercetin prevents unloading-derived disused muscle atrophy by attenuating the induction of ubiquitin ligases in tail-suspension mice.
AID587327Inhibition of CXCL8-induced actin polymerization in human neutrophil at 100 nM after 30 mins by DAPI staining based immunofluorescence2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID179757In vitro inhibition of LTB4 production was measured in rat blood1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Indazolinones, a new series of redox-active 5-lipoxygenase inhibitors with built-in selectivity and oral activity.
AID379312Antioxidant scavenging activity against 2,2'-azobis-amidinopropane-induced peroxyl radicals assessed as total oxyradical scavenging capacity relative to Trolox2000Journal of natural products, Mar, Volume: 63, Issue:3
Evaluation of the total peroxyl radical-scavenging capacity of flavonoids: structure-activity relationships.
AID677748Antioxidant activity assessed as inhibition of DPPH radical at 5 mM after 15 mins2012Bioorganic & medicinal chemistry letters, Sep-01, Volume: 22, Issue:17
Two novel bioactive glucosinolates from Broccoli (Brassica oleracea L. var. italica) florets.
AID398374Inhibition of mushroom tyrosinase assessed as L-3,4-dihydroxyphenylalanine oxidation1995Journal of natural products, May, Volume: 58, Issue:5
Tyrosinase inhibitors from Bolivian medicinal plants.
AID605052Cellular uptake in human HuH7 cells assessed as intracellular accumulation at 10 uM after 12 hrs by HPLC-mass spectrophotometric analysis2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID1224748Delta TM value showing the stabilisation of AMPKA2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID762909Induction of intracellular RPS production in promastigotes of Leishmania amazonensis MHOM/BR/75/LTB0016 infected Swiss mouse peritoneal macrophages after 72 hrs by spectrofluorometric analysis2013Journal of natural products, Aug-23, Volume: 76, Issue:8
Reactive oxygen species production by quercetin causes the death of Leishmania amazonensis intracellular amastigotes.
AID1536973Inhibition of LPS-stimulated TNFalpha production in human neutrophils at 50 uM after 24 hrs by ELISA2019Journal of natural products, 02-22, Volume: 82, Issue:2
Eupatoriopicrin Inhibits Pro-inflammatory Functions of Neutrophils via Suppression of IL-8 and TNF-alpha Production and p38 and ERK 1/2 MAP Kinases.
AID768920Inhibition of human thrombin assessed as inhibition of fibrinogen alpha-polymer formation at 15 uM after 5 mins by SDS-PAGE analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID480946Inhibition of Clostridium perfringens neuraminidase assessed as inhibition of 4-MU-NANA hydrolysis at 20 ug/mL after 10 mins by spectrofluorimetry2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Prenylated pterocarpans as bacterial neuraminidase inhibitors.
AID1516909Antifungal activity against FLC-resistant Candida tropicalis2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID403340Inhibition of COX22005Journal of natural products, Jul, Volume: 68, Issue:7
Expanding the ChemGPS chemical space with natural products.
AID402233Antioxidant activity in asolectin liposome assessed as inhibition of ascorbyl radical-induced lipid peroxidation by TBARS assay2004Journal of natural products, May, Volume: 67, Issue:5
Hypoglycemic effect and antioxidant potential of kaempferol-3,7-O-(alpha)-dirhamnoside from Bauhinia forficata leaves.
AID1683186Reduction of lactate production in human HeLa cells at IC50 after 8 hrs by colorimetric assay2021Bioorganic & medicinal chemistry, 01-01, Volume: 29Synthesis and anticancer activity of new coumarin-3-carboxylic acid derivatives as potential lactatetransportinhibitors.
AID504291Antioxidant activity assessed as nitric oxide scavenging activity after 150 mins by Griess assay2010Journal of natural products, Sep-24, Volume: 73, Issue:9
Chlorinated iridoid glucosides from Veronica longifolia and their antioxidant activity.
AID1470586Antioxidant activity assessed as DPPH free radical scavenging activity at 12.5 ppm after 30 mins in dark by spectrophotometric method relative to control2017European journal of medicinal chemistry, May-26, Volume: 132Recent synthetic and medicinal perspectives of dihydropyrimidinones: A review.
AID332929Antiviral activity against HIV1 3B infected in human H9 cells assessed as inhibition of viral replication after 3 days by p24 antigen capture assay1994Journal of natural products, Jan, Volume: 57, Issue:1
Anti-AIDS agents, 10. Acacetin-7-O-beta-D-galactopyranoside, an anti-HIV principle from Chrysanthemum morifolium and a structure-activity correlation with some related flavonoids.
AID1467075Renoprotective activity in pig LLC-PK1 cells assessed as inhibition of cisplatin-induced damage by measuring increase in cell viability at 10 to 100 uM preincubated for 2 hrs followed by cisplatin addition after 24 hrs by Ez-Cytox reagent based assay2017Bioorganic & medicinal chemistry letters, 07-01, Volume: 27, Issue:13
Protective effect of lanostane triterpenoids from the sclerotia of Poria cocos Wolf against cisplatin-induced apoptosis in LLC-PK1 cells.
AID367703Inhibition of human recombinant ALR2 expressed in bacterial cell expression system by Uncompetitive inhibition based Lineweaver-Burke plot2009Bioorganic & medicinal chemistry, Feb-01, Volume: 17, Issue:3
Correlation of binding constants and molecular modelling of inhibitors in the active sites of aldose reductase and aldehyde reductase.
AID1336845Inhibition of P-gp in human MES-SA/Dx5 cells assessed as potentiation of actinomycin D-induced cytotoxicity by measuring fold reduction in actinomycin D EC50 at 5 uM after 72 hrs by MTT assay relative to untreated control2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Quercetin-glutamic acid conjugate with a non-hydrolysable linker; a novel scaffold for multidrug resistance reversal agents through inhibition of P-glycoprotein.
AID406717Photostability of compound assessed as protection factor-UVA after 120 mins2008Journal of natural products, Jun, Volume: 71, Issue:6
Quercetin and rutin as potential sunscreen agents: determination of efficacy by an in vitro method.
AID1485945Inhibition of human amyloid beta (1 to 42) assessed as reduction in fibrillisation AUC in cell-free solution at 100 uM measured every 10 mins for 48 hrs by Thioflavin T based fluorescence assay2017Bioorganic & medicinal chemistry, 07-15, Volume: 25, Issue:14
Structure-activity relationships for flavone interactions with amyloid β reveal a novel anti-aggregatory and neuroprotective effect of 2',3',4'-trihydroxyflavone (2-D08).
AID1432767Enhancement of GLUT4 translocation at plasma membrane of rat L6 cells expressing pIRAP-mOrange at 10 uM after 30 mins by fluorescence assay relative to control2017Bioorganic & medicinal chemistry letters, 03-15, Volume: 27, Issue:6
Chemical constituents from Sophora tonkinensis and their glucose transporter 4 translocation activities.
AID624611Specific activity of expressed human recombinant UGT1A82000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID703621Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay2012Journal of medicinal chemistry, Oct-25, Volume: 55, Issue:20
Flavonoid dimers as novel, potent antileishmanial agents.
AID1239522Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 3 by disk diffusion assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1371378Cytotoxicity against human U87 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID568209Inhibition of aldose reductase by spectrophotometric analysis2011Bioorganic & medicinal chemistry letters, Feb-15, Volume: 21, Issue:4
Furoxan nitric oxide donor coupled chrysin derivatives: synthesis and vasculoprotection.
AID1056595Antiinflammatory activity in Aggregatibacter actinomycetemcomitans infected Balb/c mouse model assessed as inhibition of IL-17 production at 100 mg/kg, sc for 15 days post Aggregatibacter actinomycetemcomitans-challenge by ELISA2013Journal of natural products, Dec-27, Volume: 76, Issue:12
Quercetin inhibits inflammatory bone resorption in a mouse periodontitis model.
AID671220Inhibition of prostate specific antigen expression in human 22Rv1 cells assessed as PSA protein level at 20 uM after 72 hrs by densitometry relative to untreated control2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and biological evaluation of novel flavonols as potential anti-prostate cancer agents.
AID397122Inhibition of HIV1 RT
AID1234240Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production incubated for 24 hrs by Griess reagent based assay2015Journal of natural products, Jul-24, Volume: 78, Issue:7
Antioxidant and Anti-Inflammatory Phenolic Glycosides from Clematis tashiroi.
AID624613Specific activity of expressed human recombinant UGT1A102000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1189228Inhibition of methylglucose uptake in rat adipocytes2015Journal of medicinal chemistry, Jan-08, Volume: 58, Issue:1
Small molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseases.
AID641152Growth inhibition of human HCT116 cells overexpressing PI3Kalpha after 48 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Biological evaluation and docking studies of recently identified inhibitors of phosphoinositide-3-kinases.
AID768929Inhibition of human thrombin amidolytic activity using D-Phe-Pip-Arg-pNA as substrate preincubated for 10 mins followed by substrate addition measured every 12 secs for 10 mins by spectrophotometric analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID1372142Inhibition of recombinant human CYP1A1 expressed in yeast microsomal membranes at 10 uM by fluorescence assay relative to control
AID504289Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins2010Journal of natural products, Sep-24, Volume: 73, Issue:9
Chlorinated iridoid glucosides from Veronica longifolia and their antioxidant activity.
AID537734Antifungal activity against yeast AD1-8u expressing Candida albicans CaMdr1p by agar disk diffusion assay2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
AID462340Toxicity in mouse B16-4A5 cells assessed as inhibition of cell proliferation at 3 uM in presence of 1 mM theophylline after 72 hrs by WST8 dye reduction assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells.
AID1294436Antioxidant activity assessed as inhibition of peroxyl radical induced oxidation of fluorescein measured as trolox equivalents at 37 degC by ORAC assay2016European journal of medicinal chemistry, Jun-10, Volume: 115Novel chromone and xanthone derivatives: Synthesis and ROS/RNS scavenging activities.
AID353595Inhibition of of heat-induced increase in nuclear HSF1 protein level in human HeLa cells at 50 ug/mL treated for 1 hr before heat induction by Western blot2009Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7
Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives.
AID1239525Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 6 by disk diffusion assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1359877Antioxidant activity assessed as ferric ion reducing activity by measuring Fe2+ levels at 10 uM using Fe2+-TPTZ after 15 mins by FRAP assay2018European journal of medicinal chemistry, May-25, Volume: 152Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer's disease based on coumarin and lipoic acid scaffolds.
AID1063045Inhibition of NEK2 (unknown origin)2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Protein kinase and HDAC inhibitors from the endophytic fungus Epicoccum nigrum.
AID1316657Antineuroinflammatory activity in human BV2 cells assessed as inhibition of LPS-induced NO production after 24 hrs in presence of LPS by Griess reaction2016Bioorganic & medicinal chemistry letters, 10-15, Volume: 26, Issue:20
Bioactive phenols as potential neuroinflammation inhibitors from the leaves of Xanthoceras sorbifolia Bunge.
AID1224793Delta TM value showing the stabilisation of RSK2a produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID729307Inhibition of vasopressin-stimulated vasopressin V2 receptor in human HTLA cells pre-incubated for 20 mins with Tween-80-treated compound solution measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay2013Journal of medicinal chemistry, Mar-28, Volume: 56, Issue:6
Colloidal aggregation causes inhibition of G protein-coupled receptors.
AID1635056Antiproliferative activity against bFGF-stimulated BBEC by Coulter particle counter method2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Effects of 2,3-Dehydrosilybin and Its Galloyl Ester and Methyl Ether Derivatives on Human Umbilical Vein Endothelial Cells.
AID179759In vitro inhibition of PGE-2 production was measured in rat blood1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Indazolinones, a new series of redox-active 5-lipoxygenase inhibitors with built-in selectivity and oral activity.
AID1711970Antitumor activity against mouse H22 cells implanted in Kunming mouse assessed as reduction in tumor weight at 100 mg/kg, iv administered for 7 consecutive days starting from day 8 post inoculation and measured after 16 days (Rvb = 2.15 +/- 0.51 g)2016European journal of medicinal chemistry, Oct-04, Volume: 121Synthesis and biological properties of polyamine modified flavonoids as hepatocellular carcinoma inhibitors.
AID388742Inhibition of cataracted human eye lens aldose reductase2008Bioorganic & medicinal chemistry, Dec-01, Volume: 16, Issue:23
Inhibition of aldose reductase from cataracted eye lenses by finger millet (Eleusine coracana) polyphenols.
AID74123Inhibition constant of compound against binding of Yeast Glyoxalase I1988Journal of medicinal chemistry, Jul, Volume: 31, Issue:7
The hypothetical active site lattice. An approach to modelling active sites from data on inhibitor molecules.
AID69727Inhibition of epidermal growth factor (EGF) receptor from A431 cell membranes at 150 uM1994Journal of medicinal chemistry, May-27, Volume: 37, Issue:11
Structural studies on bioactive compounds. 23. Synthesis of polyhydroxylated 2-phenylbenzothiazoles and a comparison of their cytotoxicities and pharmacological properties with genistein and quercetin.
AID467544Inhibition of carrageenan-induced IL1-beta production in Swiss mouse subcutaneous plantar tissue at 100 mg/kg, ip dosed 30 mins before carrageenan challenge measured after 3 hrs by ELISA2009Journal of natural products, Nov, Volume: 72, Issue:11
Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production.
AID1143308Neuroprotection against glutamate challenged mouse HT22 cells assessed as reduction in cell viability at 5 uM after 48 hrs by MTT assay2014European journal of medicinal chemistry, Jun-23, Volume: 81Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine.
AID420262Inhibition of EGFR2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Discovering novel quercetin-3-O-amino acid-esters as a new class of Src tyrosine kinase inhibitors.
AID1617250Anti-austerity activity against nutrient-deprived human PANC1 cells assessed as cell death incubated for 24 hrs by WST-8 assay
AID502475Inhibition of human CYP1B1 by EROD assay2010Bioorganic & medicinal chemistry, Sep-01, Volume: 18, Issue:17
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.
AID455706Antiviral activity against influenza A virus H9N2 A/Chicken/Korea/MS96/96 infected in MDCK cells assessed as reduction in virus-induced cytopathic effect2009Bioorganic & medicinal chemistry, Oct-01, Volume: 17, Issue:19
Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities.
AID450967Inhibition of FeSO4-induced lipid peroxidation in Sprague-Dawley rat liver homogenate assessed as decrease in malondialdehyde level after 1 hr by TBA assay2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Preparation of C-23 esterified silybin derivatives and evaluation of their lipid peroxidation inhibitory and DNA protective properties.
AID1833881Inhibition of Staphylococcus aureus sortase A using Abz-LPETGK(Dnp)-NH2 fluorescent peptide as a substrate assessed as substrate cleavage measured over 60 mins by FRET assay2021Bioorganic & medicinal chemistry, 12-15, Volume: 52Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition.
AID1634713Cytotoxicity against mouse RAW264.7 cells assessed as reduction in cell viability after 24 hrs by MTT assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Eremophilane-Type Sesquiterpenoids from an Acremonium sp. Fungus Isolated from Deep-Sea Sediments.
AID1056597Antiperiodontitic activity in Aggregatibacter actinomycetemcomitans infected Balb/c mouse model assessed as inhibition of alveolar bone loss at 100 mg/kg, sc for 15 days post Aggregatibacter actinomycetemcomitans-challenge by methylene blue staining-based2013Journal of natural products, Dec-27, Volume: 76, Issue:12
Quercetin inhibits inflammatory bone resorption in a mouse periodontitis model.
AID449296Iron chelating activity assessed as inhibition of ferrozine-Fe2+ complex formation after 10 mins by spectrophotometry2009Journal of medicinal chemistry, Dec-10, Volume: 52, Issue:23
Design, synthesis, and examination of neuron protective properties of alkenylated and amidated dehydro-silybin derivatives.
AID681614TP_TRANSPORTER: inhibition of Saquinavir transepithelial transport (basal to apical) in Caco-2 cells1999British journal of clinical pharmacology, Oct, Volume: 48, Issue:4
Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components.
AID510245Cytotoxicity against human free style HEK293 cells after 72 hrs2010Journal of medicinal chemistry, Sep-23, Volume: 53, Issue:18
Small-molecule inhibitors of NADPH oxidase 4.
AID1155653Neuroprotective activity against H2O2-induced rat differentiated PC12 cell death assessed as increase in cell viability at 5 uM after 24 hrs by MTT assay2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis, biological evaluation and docking study of 3-aroyl-1-(4-sulfamoylphenyl)thiourea derivatives as 15-lipoxygenase inhibitors.
AID501422Antimicrobial activity against Pseudomonas aeruginosa PAO1 after 24 hrs by microdilution assay2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Design, synthesis, and biological evaluation of a novel series of quercetin diacylglucosides as potent anti-MRSA and anti-VRE agents.
AID1233237Downregulation of tyrosinase mRNA expression in theophylline-stimulated mouse B16-4A5 cells assessed as ratio of tyrosinase mRNA to beta-actin mRNA level at 30 uM after 72 hrs by qPCR analysis2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID1165539Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of lipopolysaccharide-induced nitric oxide production incubated for 24 hrs by Griess reagent based assay2014Journal of natural products, Oct-24, Volume: 77, Issue:10
Anti-inflammatory ursane- and oleanane-type triterpenoids from Vitex negundo var. cannabifolia.
AID1176143Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated nitric oxide production at 10 uM after 24 hrs by Griess assay2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
Anti-inflammatory components of Chrysanthemum indicum flowers.
AID191899Mutagenicity evaluated by calculating number of revertants using Salmonella Typhimurium strain TA 98 (2.5 mg/plate) without S9 mix from rat liver according to the plate incorporation assay; Toxic concentration1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
4'-Hydroxy-3-methoxyflavones with potent antipicornavirus activity.
AID670312Inhibition of human recombinant MMP3 catalytic domain incubated for 20 mins by fluorimetric assay2012Bioorganic & medicinal chemistry, Jul-01, Volume: 20, Issue:13
Natural products as a gold mine for selective matrix metalloproteinases inhibitors.
AID1616106Inhibition of ATP synthase in Escherichia coli relative to control2019European journal of medicinal chemistry, Nov-15, Volume: 182Recent advancements in mechanistic studies and structure activity relationship of F
AID377657Induction of behavioral effects in CD1 mouse at 1 mg/kg, ip by forced swimming test relative to control2006Journal of natural products, Jun, Volume: 69, Issue:6
Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and computational study.
AID1365686Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control2017Bioorganic & medicinal chemistry letters, 11-01, Volume: 27, Issue:21
Flavonoids and their derivatives with β-amyloid aggregation inhibitory activity from the leaves and twigs of Pithecellobium clypearia Benth.
AID401236Inhibition of superoxide production in PMNCs by NBT reduction assay2004Journal of natural products, Apr, Volume: 67, Issue:4
Madhucosides A and B, protobassic acid glycosides from Madhuca indica with inhibitory activity on free radical release from phagocytes.
AID1336862Neuritogenic activity in mouse P19 derived neurons assessed as increase in neurite length at 1 nM after 18 hrs by phase contrast microscopic method relative to control2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Neuritogenic activity of bi-functional bis-tryptoline triazole.
AID1151281Inhibition of BacLight Green labeled Escherichia coli adherence to human UEC at 0.1 ug/ml after 1 hr by flow cytometry analysis2014Journal of natural products, May-23, Volume: 77, Issue:5
Development of a fluorometric microplate antiadhesion assay using uropathogenic Escherichia coli and human uroepithelial cells.
AID1706450Neuroprotective activity against H2O2-induced cytotoxicity in rat PC12 cells assessed as increase in cell viability at 10 uM preincubated for 3 hrs followed by H2O2 addition and measured after 24 hrs by MTT assay (Rvb = 24.8 to 41.7%)2021European journal of medicinal chemistry, Jan-01, Volume: 209Design and synthesis of 3-(4-pyridyl)-5-(4-sulfamido-phenyl)-1,2,4-oxadiazole derivatives as novel GSK-3β inhibitors and evaluation of their potential as multifunctional anti-Alzheimer agents.
AID436312Antioxidant activity assessed as ratio of drug concentration to DPPH concentration causing 50% DPPH radical scavenging activity by TLC assay2008Journal of natural products, Nov, Volume: 71, Issue:11
Antioxidant C-glucosylxanthones from the leaves of Arrabidaea patellifera.
AID1662293Cytotoxicity against mouse RAW264.7 cells assessed as cell viability2020Bioorganic & medicinal chemistry, 06-01, Volume: 28, Issue:11
Microbial transformation of glycyrrhetinic acid derivatives by Bacillus subtilis ATCC 6633 and Bacillus megaterium CGMCC 1.1741.
AID439367Agonist activity at human PPARgamma expressed in HEK293 cells co-transfected with PPRE assessed as beta-galactosidase signal at 5 uM after 48 hrs by reporter gene assay relative to control2009Journal of medicinal chemistry, Nov-12, Volume: 52, Issue:21
7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists.
AID488645Antioxidant activity assessed as trolox equivalents of peroxyl radical scavenging activity by ORAC assay2010Journal of natural products, Jun-25, Volume: 73, Issue:6
Alkaloids from the bark of Guatteria hispida and their evaluation as antioxidant and antimicrobial agents.
AID1171190Drug metabolism assessed as zebrafish intestinal beta-glucosidase-mediated deglycosylation of compound at 80 uM after 2.5 hrs by resorufin-beta-D-glucopyranoside-based fluorescence assay2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Delineation of the role of glycosylation in the cytotoxic properties of quercetin using novel assays in living vertebrates.
AID729313Inhibition of CCL22-stimulated CCR4 in human HTLA cells pre-incubated for 20 mins with Tween-80-treated compound solution measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay2013Journal of medicinal chemistry, Mar-28, Volume: 56, Issue:6
Colloidal aggregation causes inhibition of G protein-coupled receptors.
AID1090647Antifungal activity against Verticillium dahliae assessed as inhibition of mycelial radial growth measured after 350 hr2007Journal of agricultural and food chemistry, May-02, Volume: 55, Issue:9
Dysfunctionality of the xylem in Olea europaea L. Plants associated with the infection process by Verticillium dahliae Kleb. Role of phenolic compounds in plant defense mechanism.
AID1247842Inhibition of recombinant human CK2 expressed in Escherichia coli using RRRADDSDDDDD as substrate after 10 mins2015Journal of medicinal chemistry, Sep-24, Volume: 58, Issue:18
Structural Insight into the Interactions between Death-Associated Protein Kinase 1 and Natural Flavonoids.
AID1516850Antifungal activity against Candida albicans 501 by microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID298693Inhibition of CDK22007Bioorganic & medicinal chemistry letters, Mar-01, Volume: 17, Issue:5
3-Hydroxychromones as cyclin-dependent kinase inhibitors: synthesis and biological evaluation.
AID1070455Antioxidant activity in human HepG2 cells assessed as inhibition of ABAP-induced intracellular peroxyl radical scavenging activity by measuring ROS production measured every 5 mins for 1 hr by absorbance assay2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Octulosonic acid derivatives from Roman chamomile (Chamaemelum nobile) with activities against inflammation and metabolic disorder.
AID1127134Antiinflammatory activity in human BV2 cells assessed as inhibition of LPS-induced nitric oxide production by Griess assay2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Anti-inflammatory labdane diterpenoids from Lagopsis supina.
AID603318Inhibition of human CD38 using 20 uM 1, N6-etheno NAD+ as substrate by continuous fluorimetric method2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Flavonoids as inhibitors of human CD38.
AID1693698Antimigratory activity against human MDA-MB-231 cells assessed as cell migration at 2.5 uM by light microscopy relative to control2021Bioorganic & medicinal chemistry, 01-15, Volume: 30In vitro and in vivo effects of inhibitors on actin and myosin.
AID277584Inhibition of Escherichia coli ENR2007Journal of medicinal chemistry, Feb-22, Volume: 50, Issue:4
Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR).
AID1220239Unbound intrinsic clearance in human intestinal microsomes assessed UGT-mediated glucuronidation clearance2012Drug metabolism and disposition: the biological fate of chemicals, Sep, Volume: 40, Issue:9
Quantitative prediction of human intestinal glucuronidation effects on intestinal availability of UDP-glucuronosyltransferase substrates using in vitro data.
AID1233235Downregulation of tyrosinase mRNA expression in theophylline-stimulated mouse B16-4A5 cells assessed as ratio of tyrosinase mRNA to beta-actin mRNA level at 3 uM after 72 hrs by qPCR analysis2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID587308Inhibition of CXCL5-induced neutrophil recruitment in Swiss mouse at 30 mg/kg, sc administered pre-inflammatory stimulus after 6 hrs by Newbauer chamber using Romanowsky stain2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID257905Inhibition of glutamate-induced oxytosis of mouse hippocampal HT22 cells2006Journal of medicinal chemistry, Jan-12, Volume: 49, Issue:1
Chroman/catechol hybrids: synthesis and evaluation of their activity against oxidative stress induced cellular damage.
AID1739494Inhibition of soya bean 15-LOX2020European journal of medicinal chemistry, Aug-15, Volume: 200Expanding the anticancer potential of 1,2,3-triazoles via simultaneously targeting Cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases.
AID402473Inhibition of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality preincubated for 15 mins before TNFalpha addition measured after 24 hrs by crystal violet staining1997Journal of natural products, Aug, Volume: 60, Issue:8
Flavonoids as inhibitors or enhancers of the cytotoxicity of tumor necrosis factor-alpha in L-929 tumor cells.
AID219998Inhibition of rat brain cytosolic cAMP phosphodiesterase1982Journal of medicinal chemistry, Oct, Volume: 25, Issue:10
Pentasubstituted quercetin analogues as selective inhibitors of particulate 3':5'-cyclic-AMP phosphodiesterase from rat brain.
AID1730603Antioxidant activity assessed as trolox equivalent of AAPH radical scavenging activity measured every 5 mins for 180 mins by ORAC-FL assay2021European journal of medicinal chemistry, Mar-05, Volume: 213Design, synthesis, and biological evaluation of novel xanthone-alkylbenzylamine hybrids as multifunctional agents for the treatment of Alzheimer's disease.
AID1126476Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha secretion at 10 uM after 18 hrs by sandwich ELISA2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID1239540Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by checkerboard assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID467550Antinociceptive activity in ip dosed Swiss mouse assessed as inhibition of carrageenan-induced mechanical hypernociception administered 30 mins before carrageenan challenge measured after 3 hrs by electronic pressure-meter test2009Journal of natural products, Nov, Volume: 72, Issue:11
Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production.
AID700818Increase of SIRT1 mRNA expression in mouse brain at 25 mg/kg qd for 7 days by RT-PCR analysis2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
SIRT1 modulation as a novel approach to the treatment of diseases of aging.
AID654746Inhibition of GST-tagged Human papillomavirus 16 protein E6 interaction with His-tagged human caspase 8 expressed in Escherichia coli after 1 hr incubation followed by overnight incubation by Alpha screening technique2012Bioorganic & medicinal chemistry letters, Mar-01, Volume: 22, Issue:5
Small molecule inhibitors of the HPV16-E6 interaction with caspase 8.
AID1446938Inhibition of CYP1A1 (unknown origin)2017European journal of medicinal chemistry, Apr-21, Volume: 130Quinazoline derivatives as selective CYP1B1 inhibitors.
AID1654172Antioxidant activity in human Gingival fibroblast assessed as reduction in intracellular ROS level at 1 uM after 72 hrs by H2DCFDA staining based fluorescence method2020Journal of natural products, 03-27, Volume: 83, Issue:3
Antioxidant Activity of Compounds Isolated from
AID603475Antibacterial activity against methicillin-susceptible Staphylococcus aureus 209P after 24 hrs by microdilution method2011Journal of medicinal chemistry, Jun-09, Volume: 54, Issue:11
Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
AID1470594Antioxidant activity assessed as cupric ion reducing activity by measuring increase in absorbance at 100 ppm by CUPRAC assay2017European journal of medicinal chemistry, May-26, Volume: 132Recent synthetic and medicinal perspectives of dihydropyrimidinones: A review.
AID351091Antioxidant activity assessed as DPPH free radical scavenging activity by spectrophotometry2009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
Preparation of two sets of 5,6,7-trioxygenated dihydroflavonol derivatives as free radical scavengers and neuronal cell protectors to oxidative damage.
AID1373919Induction of apoptosis in human Jurkat E6-1 cells assessed as necrotic cells at 50 uM after 24 hrs by Annexin-V-FITC/propidium iodide staining based flow cytometric analysis (Rvb = 1.26 +/- 0.24 %)2018Bioorganic & medicinal chemistry, 02-15, Volume: 26, Issue:4
Optimization of antimalarial, and anticancer activities of (E)-methyl 2-(7-chloroquinolin-4-ylthio)-3-(4-hydroxyphenyl) acrylate.
AID1125770Antioxidant activity assessed as superoxide anion radical scavenging activity by non-enzymatic phenazine methosulfate NADH-system2014Bioorganic & medicinal chemistry, Apr-15, Volume: 22, Issue:8
Quinolone-benzylpiperidine derivatives as novel acetylcholinesterase inhibitor and antioxidant hybrids for Alzheimer disease.
AID1310991Antioxidant activity assessed as AAPH free radical scavenging activity measured as trolox equivalent by TRAP assay2016European journal of medicinal chemistry, Aug-25, Volume: 119On the vasoprotective mechanisms underlying novel β-phosphorylated nitrones: Focus on free radical characterization, scavenging and NO-donation in a biological model of oxidative stress.
AID605129Antiproliferative activity against human DU145 cells after 24 hrs by MTT assay2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID1594769Cytotoxicity against human HeLa cells assessed as reduction in cell viability at 12.5 to 100 ug/ml measured after 12 hrs by crystal violet staining based assay2019Journal of natural products, 06-28, Volume: 82, Issue:6
Inhibitory Effects of Phenylpropanoid Derivatives from Oenanthe javanica on Antigen-Stimulated Degranulation in RBL-2H3 Cells.
AID462333Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 30 uM after 72 hrs2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells.
AID605046Cellular uptake in human MCF7 cells assessed as formation of quercetin glucuronide in cell lysates at 10 uM after 5 hrs by HPLC-mass spectrophotometric analysis2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID605053Cellular uptake in human HuH7 cells assessed as quercetin-sulphate accumulation at 10 uM after 12 hrs by HPLC-mass spectrophotometric analysis2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID91308Inhibition of PDGF-induced mitogenesis in human foreskin fibroblasts1994Journal of medicinal chemistry, May-27, Volume: 37, Issue:11
Structural studies on bioactive compounds. 23. Synthesis of polyhydroxylated 2-phenylbenzothiazoles and a comparison of their cytotoxicities and pharmacological properties with genistein and quercetin.
AID506949Inhibition of HSP70-mediated antiapoptotic activity in human NCI-H526 cells assessed as induction of PARP cleavage after 24 hrs by Western blot analysis2007Nature chemical biology, Aug, Volume: 3, Issue:8
Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer.
AID441665Cytotoxicity against human A549 cells upto 200 umol/L after 24 hrs by MTS assay2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase.
AID1605044Inhibition of porcine cerebellar microsomes SERCA2b preincubated for 10 mins followed by addition of ATP and measured after 40 mins2020Journal of medicinal chemistry, 03-12, Volume: 63, Issue:5
Sarco/Endoplasmic Reticulum Calcium ATPase Inhibitors: Beyond Anticancer Perspective.
AID377654Inhibition of bovine MAO-A by fluorimetric method2006Journal of natural products, Jun, Volume: 69, Issue:6
Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and computational study.
AID630874Inhibition of rabbit reticulocytes arachidonate 15-lipoxygenase2011European journal of medicinal chemistry, Nov, Volume: 46, Issue:11
Recent progress in synthesis and bioactivity studies of indolizines.
AID1484014Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as nucleation constant at 200 uM after 48 hrs by Thioflavin-T fluorescence assay (Rvb = 580.7 10'6/min)2017Journal of natural products, 02-24, Volume: 80, Issue:2
Combined in Vitro Cell-Based/in Silico Screening of Naturally Occurring Flavonoids and Phenolic Compounds as Potential Anti-Alzheimer Drugs.
AID501209Antiviral activity against HSV1 infected african green monkey Vero cells assessed as reduction of plaque formation after 3 days by using crystal violet stain2010Journal of natural products, Feb-26, Volume: 73, Issue:2
Phloroglucinol glycosides from the fresh fruits of Eucalyptus maideni.
AID754153Antioxidant activity assessed as hydroxyl radical scavenging activity2013Journal of natural products, Jun-28, Volume: 76, Issue:6
Steviol glycosides: chemical diversity, metabolism, and function.
AID462272Inhibition of human CA3 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID604941Chemical stability of the compound in buffer at pH 2 assessed as half life by HPLC analysis2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID703482Therapeutic index, ratio of IC50 for mouse Peritoneal macrophages to IC50 for pentamidine-resistant Leishmania donovani AG83PentR50 promastigote2012Journal of medicinal chemistry, Oct-25, Volume: 55, Issue:20
Flavonoid dimers as novel, potent antileishmanial agents.
AID1239520Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 1 by disk diffusion assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID356646Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins2003Journal of natural products, Nov, Volume: 66, Issue:11
New bioactive polyphenols from Theobroma grandiflorum ("cupuaçu").
AID230227Inhibitory ratio at 1.0 mg/ear1995Journal of medicinal chemistry, Oct-13, Volume: 38, Issue:21
Alkane-6,8-diol: inhibitor of tumor promotion in two-stage carcinogenesis in mouse skin.
AID315614Induction of apoptosis in human BGC823 cells assessed as increase in DNA fragmentation by DNA ladder assay2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
Studies on the chemical constituents and anticancer activity of Saxifraga stolonifera (L) Meeb.
AID710231Antioxidant activity assessed as scavenging of morpholino sydononimine based nitric oxide release by chemiluminescence assay2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Carbamate derivatives of indolines as cholinesterase inhibitors and antioxidants for the treatment of Alzheimer's disease.
AID1498663Cytoprotective activity against 100 uM t-BHP-induced oxidative stress in human HepG2 cells assessed as cell viability preincubated for 1 hr followed by t-BHP addition measured after 3 hrs by CCK-8 assay (Rvb = 22%)2018Bioorganic & medicinal chemistry letters, 08-01, Volume: 28, Issue:14
Synthesis of coumarin derivatives and their cytoprotective effects on t-BHP-induced oxidative damage in HepG2 cells.
AID354858Inhibition of DNA topoisomerase 11996Journal of natural products, Jul, Volume: 59, Issue:7
DNA topoisomerase I inhibitors: cytotoxic flavones from Lethedon tannaensis.
AID1316661Cytotoxicity against LPS-activated human BV2 cells assessed as cell viability at 100 uM after 24 hrs by MTT assay (Rvb = 98.03 to 98.84%)2016Bioorganic & medicinal chemistry letters, 10-15, Volume: 26, Issue:20
Bioactive phenols as potential neuroinflammation inhibitors from the leaves of Xanthoceras sorbifolia Bunge.
AID1536943Anti-inflammatory activity in human PMN assessed as inhibition of fMLP/cytochalasin A-induced CD11b/CD18 expression at 2.5 uM preincubated for 30 mins followed by fMLP/cytochalasin A addition and measured after 30 mins by flow cytometry2019Journal of natural products, 02-22, Volume: 82, Issue:2
Eupatoriopicrin Inhibits Pro-inflammatory Functions of Neutrophils via Suppression of IL-8 and TNF-alpha Production and p38 and ERK 1/2 MAP Kinases.
AID69720Cytotoxic effect on EGF-receptor overexpressing HN5 squamous carcinoma cells1994Journal of medicinal chemistry, May-27, Volume: 37, Issue:11
Structural studies on bioactive compounds. 23. Synthesis of polyhydroxylated 2-phenylbenzothiazoles and a comparison of their cytotoxicities and pharmacological properties with genistein and quercetin.
AID752787Inhibition of porcine pancreatic lipase using para-nitrophenyl butyrate as substrate at 100 uM by ELISA2013Bioorganic & medicinal chemistry letters, Jun-15, Volume: 23, Issue:12
Chemical constituents from Nelumbo nucifera leaves and their anti-obesity effects.
AID455705Antiviral activity against influenza A virus H1N1 A/PR/8/34 infected in MDCK cells assessed as reduction in virus-induced cytopathic effect2009Bioorganic & medicinal chemistry, Oct-01, Volume: 17, Issue:19
Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities.
AID768893Inhibition of human thrombin assessed as equilibrium association constant at 50 to 1000 uM by BIAcore analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID332930Cytotoxicity against human H9 cells after 3 days1994Journal of natural products, Jan, Volume: 57, Issue:1
Anti-AIDS agents, 10. Acacetin-7-O-beta-D-galactopyranoside, an anti-HIV principle from Chrysanthemum morifolium and a structure-activity correlation with some related flavonoids.
AID671261Inhibition of Saccharomyces cerevisiae alpha-glucosidase using p-nitrophenyl-alpha-D-glucopyranoside as substrate preincubated for 5 mins prior to substrate addition measured after 35 mins by spectrophotocolorimetric assay2012Journal of natural products, May-25, Volume: 75, Issue:5
α-glucosidase inhibitors from Brickellia cavanillesii.
AID1316797Inhibition of wild type His-tagged translin/trax E126A mutant (unknown origin) coexpressed in Escherichia coli BL21 cells using RNase Alert as substrate at 30 uM incubated for 10 mins prior to substrate addition monitored over 60 mins by fluorescence assa2016Bioorganic & medicinal chemistry letters, 10-15, Volume: 26, Issue:20
A druggable target for rescuing microRNA defects.
AID1330798Inhibition of soybean 15-LOX type 1B assessed as reduction in conversion of linoleic acid to 13-hydroperoxylinoleic acid incubated for 5 mins followed by substrate addition measured for 1 min by spectrophotometric analysis2016European journal of medicinal chemistry, Nov-10, Volume: 123Synthesis and structure-activity relationship study of tacrine-based pyrano[2,3-c]pyrazoles targeting AChE/BuChE and 15-LOX.
AID462336Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 1 uM after 72 hrs2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells.
AID1352204Antioxidant activity assessed as superoxide dismutase-like activity by measuring inhibition of xanthine oxidase-induced superoxide anion level measured ever 30 secs for 5 mins by NBT reduction assay2018European journal of medicinal chemistry, Feb-10, Volume: 145Design, synthesis, biological evaluation and docking studies of new 3-(4,5-dihydro-1H-pyrazol/isoxazol-5-yl)-2-phenyl-1H-indole derivatives as potent antioxidants and 15-lipoxygenase inhibitors.
AID1202780Antioxidant activity assessed as trolox equivalent of APPH radical scavenging activity preincubated for 30 mins followed by APPH addition measured every 1.14 mins for 120 mins by lipophilic-ORAC fluorescence assay2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Antioxidative compounds from Garcinia buchananii stem bark.
AID1693690Inhibition of rabbit muscle G-actin polymerization assessed as polymerized G-actin level at 25 uM incubated for 15 mins by spectrophotometric analysis (Rvb = 100 %)2021Bioorganic & medicinal chemistry, 01-15, Volume: 30In vitro and in vivo effects of inhibitors on actin and myosin.
AID1242165Inhibition of HSF1 in human ASB244 cells assessed as potentiation of 17-DMAG-induced reduction in cell proliferation at 20 uM relative to 17-DMAG alone2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Regulating the master regulator: Controlling heat shock factor 1 as a chemotherapy approach.
AID144650In vitro cytotoxic potency against NCI-60 human tumor cell line1998Journal of medicinal chemistry, Jun-18, Volume: 41, Issue:13
Structure-activity requirements for flavone cytotoxicity and binding to tubulin.
AID551409Antioxidant activity assessed as hydroxyl radical scavenging activity at 50 uM after 2 hrs by benzoic acid method2011Bioorganic & medicinal chemistry, Jan-15, Volume: 19, Issue:2
Synthesis, structure, theoretical and experimental in vitro antioxidant/pharmacological properties of α-aryl, N-alkyl nitrones, as potential agents for the treatment of cerebral ischemia.
AID216458Cytotoxic effect on WiDr human colon cells1994Journal of medicinal chemistry, May-27, Volume: 37, Issue:11
Structural studies on bioactive compounds. 23. Synthesis of polyhydroxylated 2-phenylbenzothiazoles and a comparison of their cytotoxicities and pharmacological properties with genistein and quercetin.
AID1188612Anticancer activity against human H266 cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID1330796Inhibition of human recombinant BChE using butyrylthiocholine iodide as substrate incubated for 5 mins followed by substrate addition measured for 1 min by Ellman's method2016European journal of medicinal chemistry, Nov-10, Volume: 123Synthesis and structure-activity relationship study of tacrine-based pyrano[2,3-c]pyrazoles targeting AChE/BuChE and 15-LOX.
AID605131Antiproliferative activity against human HCT116 cells after 24 hrs by MTT assay in presence of antioxidative stabilizer ascorbic acid2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID1359852Neuroprotection against H2O2-induced cell death in rat PC12 cells assessed as cell viability at 20 uM preincubated for 3 hrs followed by H2O2 stimulation measured after 2 hrs by MTT assay (Rvb = 25.2 to 41.8%)2018European journal of medicinal chemistry, May-25, Volume: 152Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer's disease based on coumarin and lipoic acid scaffolds.
AID551408Antioxidant activity assessed as trolox equivalents of peroxyl radical scavenging activity by ORAC assay2011Bioorganic & medicinal chemistry, Jan-15, Volume: 19, Issue:2
Synthesis, structure, theoretical and experimental in vitro antioxidant/pharmacological properties of α-aryl, N-alkyl nitrones, as potential agents for the treatment of cerebral ischemia.
AID506923Inhibition of HSP90-mediated antiapoptotic activity in human SKBR3 cells assessed as induction of PARP cleavage at 200 uM after 24 hrs by Western blot analysis2007Nature chemical biology, Aug, Volume: 3, Issue:8
Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer.
AID1102128Phytotoxicity in Triticum aestivum (wheat) assessed as inhibition of root differentiation at 250 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID540209Volume of distribution at steady state in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID34976In vitro inhibitory activity against Aldose reductase from rat lens1991Journal of medicinal chemistry, Nov, Volume: 34, Issue:11
Spiro[fluoreneisothiazolidin]one dioxides: new aldose reductase and L-hexonate dehydrogenase inhibitors.
AID218564Decrease in inhibition of beta-lactamase due to 10-fold increase in enzyme concentration2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
Kinase inhibitors: not just for kinases anymore.
AID220162Inhibition of rat brain particulate cGMP phosphodiesterase1982Journal of medicinal chemistry, Oct, Volume: 25, Issue:10
Pentasubstituted quercetin analogues as selective inhibitors of particulate 3':5'-cyclic-AMP phosphodiesterase from rat brain.
AID388743Antioxidant activity assessed as DPPH radical scavenging activity after 20 mins2008Bioorganic & medicinal chemistry, Dec-01, Volume: 16, Issue:23
Inhibition of aldose reductase from cataracted eye lenses by finger millet (Eleusine coracana) polyphenols.
AID1239576Antibacterial activity against vancomycin-intermediate resistant Staphylococcus aureus Mu50 at 1.69 mM after 4 hrs by time kill assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1162624Inhibition of cell migration of PMA-stimulated human MDA-MB-231 cells2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID603461Inhibition of Escherichia coli DNA gyrase assessed as inhibition of pBR322 supercoiling by densitometry2011Journal of medicinal chemistry, Jun-09, Volume: 54, Issue:11
Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
AID1372151Inhibition of human CYP1A2 expressed in HEK293 cells by fluorescence assay
AID1424435Cytotoxicity in human A375 cells2017European journal of medicinal chemistry, Dec-15, Volume: 142Recent discoveries of anticancer flavonoids.
AID462335Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 3 uM after 72 hrs2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells.
AID462274Inhibition of human CA5A by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID1634892Binding affinity to human C-terminally His-tagged p38 expressed in Escherichia coli BL21 by fluorescence quenching based spectrofluorometric analysis2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Antituberculosis Activity of a Naturally Occurring Flavonoid, Isorhamnetin.
AID1264950Cytotoxicity against human MSC assessed as cell viability at 1 uM measured on day 1 by alamar blue assay (Rvb = 97 to 101%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID1355205Antiseptic activity in Balb/c mouse model of Escherichia coli K1 infection-induced sepsis assessed as reduction in bacterial count in lungs at 50 mg/kg, ip pretreated for 1 hr followed by Escherichia coli K1 infection measured after 12 hrs2018Journal of natural products, 06-22, Volume: 81, Issue:6
Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production.
AID1777361Antiviral activity against SARS-CoV-2 NCCP43326 infected in African green monkey Vero cells assessed as reduction in spike protein production at 1 to 25 ug/ml treated with compound for 1 hr post-infection followed by drug wash-out and measured at 72 hrs p2021Bioorganic & medicinal chemistry, 09-01, Volume: 45Potent antiviral activity of Agrimonia pilosa, Galla rhois, and their components against SARS-CoV-2.
AID1516900Antifungal activity against Trichophyton rubrum ATCC MYA3108 by CLSI-based microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID1515373Antioxidant activity of the compound assessed as DPPH radical scavenging activity after 30 mins by spectrophotometric method2019Bioorganic & medicinal chemistry, 01-15, Volume: 27, Issue:2
Synthesis, Antioxidant Activity and Cytotoxicity of N-Functionalized Organotellurides.
AID1226457Selectivity index, ratio of IC50 for HEK293 cells to IC50 for human BxPC3 cells2015Journal of medicinal chemistry, May-28, Volume: 58, Issue:10
Selenium-containing chrysin and quercetin derivatives: attractive scaffolds for cancer therapy.
AID1699040Inhibition of quorum sensing system in Escherichia coli O157:H72020Bioorganic & medicinal chemistry, 11-01, Volume: 28, Issue:21
Next generation quorum sensing inhibitors: Accounts on structure activity relationship studies and biological activities.
AID605045Cellular uptake in human MCF7 cells assessed as compound remaining in cell lysates at 10 uM after 12 hr by HPLC-mass spectrophotometric analysis2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID1224776Delta TM value showing the stabilisation of ERK3 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1082328Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under dark conditions measured 72 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID692831Neuroprotective activity against glutamate-induced oxidative stress in mouse HT22 cells assessed as reduction of intracellular ROS formation at 25 uM after 24 hrs by MTT assay2012ACS medicinal chemistry letters, Nov-08, Volume: 3, Issue:11
Neuroprotective Tri- and Tetracyclic BChE Inhibitors Releasing Reversible Inhibitors upon Carbamate Transfer.
AID673631Inhibition of heat shock-induced HSP70 expression in human Jurkat cells at 145 uM treated 2 hrs before beat shock challenge measured after 8 hrs by Western blotting2011Bioorganic & medicinal chemistry, Aug-15, Volume: 19, Issue:16
Biotinylated quercetin as an intrinsic photoaffinity proteomics probe for the identification of quercetin target proteins.
AID768916Inhibition of human thrombin assessed as inhibition of band decaying corresponding to fibrinogen gamma chains at 15 uM after 5 mins by SDS-PAGE analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID1711962Induction of apoptosis in human HepG2 cells assessed as activation of caspase 8 at 80 uM measured after 48 hrs by immunofluorescence assay2016European journal of medicinal chemistry, Oct-04, Volume: 121Synthesis and biological properties of polyamine modified flavonoids as hepatocellular carcinoma inhibitors.
AID578760Inhibition of BCRP expressed in MCF-7 MX cells using Hoechst 33342 staining2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
AID1303557Inhibition of LPS-induced NO production in mouse RAW264.7 cells after 24 hrs by Griess assay2016Bioorganic & medicinal chemistry letters, 07-01, Volume: 26, Issue:13
Natural nitric oxide (NO) inhibitors from Chloranthus japonicus.
AID1719072Cytotoxicity against mouse C2C12 cells assessed as reduction in cell viability by MTT assay2021Bioorganic & medicinal chemistry letters, 03-01, Volume: 35Flavonoids from Sophora alopecuroides L. improve palmitate-induced insulin resistance by inhibiting PTP1B activity in vitro.
AID587311Antiinflammatory activity in human neutrophil assessed as inhibition of CXCL8-induced neutrophil chemoattraction 30 nM after 2 hrs by Boyden chamber v2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID287080Inhibitory effect on TPA-induced Epstein-Barr Virus early antigen activation in Raji cells at 10 mol ratio/32 pmol TPA relative to TPA2007Journal of natural products, May, Volume: 70, Issue:5
Anti-inflammatory and potential cancer chemopreventive constituents of the fruits of Morinda citrifolia (Noni).
AID1433309Antioxidant activity assessed as DPPH radical scavenging activity incubated for 30 mins under dark conditions by spectrophotometry2016European journal of medicinal chemistry, Nov-29, Volume: 124Synthesis and evaluation of xanthine oxidase inhibitory and antioxidant activities of 2-arylbenzo[b]furan derivatives based on salvianolic acid C.
AID592728Antioxidant activity in rat liver microsomes assessed as inhibition of lipid peroxidation after 30 mins2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
In vitro and QSAR studies of cucurbitacins on HepG2 and HSC-T6 liver cell lines.
AID1473740Inhibition of human MRP3 overexpressed in Sf9 insect cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 10 mins by membrane vesicle transport assay2013Toxicological sciences : an official journal of the Society of Toxicology, Nov, Volume: 136, Issue:1
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
AID673630Inhibition of CAMK2 using autocamtide-2 as substrate after 30 mins by PKLight assay2011Bioorganic & medicinal chemistry, Aug-15, Volume: 19, Issue:16
Biotinylated quercetin as an intrinsic photoaffinity proteomics probe for the identification of quercetin target proteins.
AID257904Activity against hydrogen peroxide induced DNA damage in Jurkat T cells2006Journal of medicinal chemistry, Jan-12, Volume: 49, Issue:1
Chroman/catechol hybrids: synthesis and evaluation of their activity against oxidative stress induced cellular damage.
AID1830872Inhibition of alpha-glucosidase (unknown origin) using p-nitrophenyl-alpha-D-glucopyranoside as substrate incubated for 50 mins by microplate reader analysis2021Bioorganic & medicinal chemistry letters, 12-01, Volume: 53Germacrane sesquiterpenes from leaves of Eupatorium chinense inhibit protein tyrosine phosphatase.
AID277583Inhibition of Plasmodium falciparum ENR2007Journal of medicinal chemistry, Feb-22, Volume: 50, Issue:4
Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR).
AID455702Inhibition of Clostridium perfringens neuraminidase2009Bioorganic & medicinal chemistry, Oct-01, Volume: 17, Issue:19
Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities.
AID550020Vasorelaxant activity in Wistar rat endothelium-intact thoracic aortic ring assessed as inhibition of noradrenaline-induced contraction treated after noradrenaline challenge measured after 60 mins2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Vasorelaxant effect of flavonoids through calmodulin inhibition: Ex vivo, in vitro, and in silico approaches.
AID1172641Inhibition of cell proliferation of human U251 cells assessed as cell viability after 72 hrs by sulforhodamine B assay2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Bioactive triterpenoid saponins and phenolic compounds against glioma cells.
AID1220259Oral absorption in human2012Drug metabolism and disposition: the biological fate of chemicals, Sep, Volume: 40, Issue:9
Quantitative prediction of human intestinal glucuronidation effects on intestinal availability of UDP-glucuronosyltransferase substrates using in vitro data.
AID441661Stability in phosphate buffer at pH 7.4 after 90 mins by spectrophotometry2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase.
AID1194981Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by microplate reader based assay2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Cytotoxic and antioxidant constituents from the leaves of Psidium guajava.
AID402566Cytotoxicity against CD mouse macrophages assessed as cell viability at 50 uM by trypan blue exclusion test2004Journal of natural products, Jun, Volume: 67, Issue:6
Geranylgeraniol-type diterpenoids, boletinins A-J, from Boletinus cavipes as inhibitors of superoxide anion generation in macrophage cells.
AID311148Inhibition of PIM1 kinase2007Bioorganic & medicinal chemistry, Oct-01, Volume: 15, Issue:19
Comparative molecular field analysis of flavonoid inhibitors of the PIM-1 kinase.
AID402563Radical scavenging activity in CD mouse macrophages assessed as inhibition of superoxide anion generation at 25 uM relative to control2004Journal of natural products, Jun, Volume: 67, Issue:6
Geranylgeraniol-type diterpenoids, boletinins A-J, from Boletinus cavipes as inhibitors of superoxide anion generation in macrophage cells.
AID1552787Neuroprotective activity against TBHP-induced cellular damage in rat PC12 cells assessed as cell viability at 10 uM pretreated for 1 hr followed by TBHP addition and measured after 3 hrs by CCK8 assay (Rvb = 27.3%)2019Bioorganic & medicinal chemistry letters, 09-01, Volume: 29, Issue:17
Comparative analysis of stilbene and benzofuran neolignan derivatives as acetylcholinesterase inhibitors with neuroprotective and anti-inflammatory activities.
AID315611Induction of apoptotic bodies in human BGC823 cells at 50 uM after 48 hrs2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
Studies on the chemical constituents and anticancer activity of Saxifraga stolonifera (L) Meeb.
AID1372145Inhibition of human CYP1B1 expressed in yeast microsomal membranes using 7-ethoxyresorufin as substrate by fluorescence assay
AID354608Inhibition of pig lens aldose reductase by spectrophotometry1996Journal of natural products, Apr, Volume: 59, Issue:4
Effect of Polygonum hydropiper sulfated flavonoids on lens aldose reductase and related enzymes.
AID1353952Protection against thermal stress in Caenorhabditis elegans N2 assessed as increase in mean survival time at 100 uM at 37 degC measured every 1 hr post treatment relative to control2018European journal of medicinal chemistry, Mar-25, Volume: 148Marine derived xyloketal derivatives exhibit anti-stress and anti-ageing effects through HSF pathway in Caenorhabditis elegans.
AID654478Inhibition of lipoxygenase using linoleic acid as substrate after 10 mins preincubation2012Bioorganic & medicinal chemistry, Apr-15, Volume: 20, Issue:8
Synthesis of new sulfonamides as lipoxygenase inhibitors.
AID1683175Cytotoxicity against human HCT-116 cells overexpressing MCT-1 assessed as reduction in cell viability measured after 72 hrs by MTT assay2021Bioorganic & medicinal chemistry, 01-01, Volume: 29Synthesis and anticancer activity of new coumarin-3-carboxylic acid derivatives as potential lactatetransportinhibitors.
AID550022Vasorelaxant activity in Wistar rat endothelium-intact thoracic aortic ring assessed as inhibition of noradrenaline-induced contraction treated after noradrenaline challenge measured after 60 mins relative to control2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Vasorelaxant effect of flavonoids through calmodulin inhibition: Ex vivo, in vitro, and in silico approaches.
AID512287Inhibition of His-tagged human PKCalpha expressed in Escherichia coli at 20 uM2000The Biochemical journal, Oct-01, Volume: 351, Issue:Pt 1
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
AID731031Inhibition of A2E photooxidation at 100 uM after 5 mins by reversed-phase HPLC analysis2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Synthesis of antioxidants for prevention of age-related macular degeneration.
AID1128737In vivo antidyslipidemic activity against Triton WR 1339-induced hyperlipidemic Wistar rat model assessed as decrease in total cholesterol level in plasma at 56 umol/kg, ip administered as single dose 1 hr after Triton WR 1339 challenge measured after 24 2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Design of novel potent antihyperlipidemic agents with antioxidant/anti-inflammatory properties: exploiting phenothiazine's strong antioxidant activity.
AID1596712Inhibition of 5-LOX in polymorphonuclear leucocytes (unknown origin)2019European journal of medicinal chemistry, Aug-01, Volume: 175Structure-activity relationship and synthetic methodologies of α-santonin derivatives with diverse bioactivities: A mini-review.
AID333311Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins2004Journal of natural products, Sep, Volume: 67, Issue:9
Iridoid glycosides from Eremostachys glabra.
AID1484012Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 200 uM after 48 hrs by Thioflavin-T fluorescence assay relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Combined in Vitro Cell-Based/in Silico Screening of Naturally Occurring Flavonoids and Phenolic Compounds as Potential Anti-Alzheimer Drugs.
AID1371374Cytotoxicity against human BxPC3 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1242170Inhibition of HSF1 in human ASB244 cells assessed as potentiation of geldanamycin-induced reduction in cell proliferation at 25 uM relative to geldanamycin alone2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Regulating the master regulator: Controlling heat shock factor 1 as a chemotherapy approach.
AID540213Half life in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID1188611Anticancer activity against human NCI-H1944 cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID1385998Cytotoxicity against LPS-induced mouse BV2 cells assessed as cell viability after 24 hrs by MTT assay2018Journal of natural products, 09-28, Volume: 81, Issue:9
Ansamycins with Antiproliferative and Antineuroinflammatory Activity from Moss-Soil-Derived Streptomyces cacaoi subsp. asoensis H2S5.
AID775750Inhibition of supercoiling activity of calf thymus topoisomerase 1 using relaxed pBR322 as substrate after 15 mins by ethidium bromide staining2013Bioorganic & medicinal chemistry letters, Nov-01, Volume: 23, Issue:21
Flavone-based analogues inspired by the natural product simocyclinone D8 as DNA gyrase inhibitors.
AID1151279Inhibition of BacLight Green labeled Escherichia coli adherence to human UEC after 1 hr by flow cytometry analysis2014Journal of natural products, May-23, Volume: 77, Issue:5
Development of a fluorometric microplate antiadhesion assay using uropathogenic Escherichia coli and human uroepithelial cells.
AID481717Inhibition of Influenza A PR/8/34 H1N1 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
QSAR study of flavonoids and biflavonoids as influenza H1N1 virus neuraminidase inhibitors.
AID517391Cytotoxicity against mouse 3T3L1 cells at 20 uM after 24 hrs2010Bioorganic & medicinal chemistry letters, Oct-15, Volume: 20, Issue:20
The selected flavonol glycoside derived from Sophorae Flos improves glucose uptake and inhibits adipocyte differentiation via activation AMPK in 3T3-L1 cells.
AID1083154Antifungal activity against Diplodia seriata BoF98-1 assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID1683174Cytotoxicity against human NCM460 cells harboring low MCT1 expression incubated for 72 hrs by MTT assay2021Bioorganic & medicinal chemistry, 01-01, Volume: 29Synthesis and anticancer activity of new coumarin-3-carboxylic acid derivatives as potential lactatetransportinhibitors.
AID191896Mutagenicity evaluated by calculating number of revertants using Salmonella Typhimurium strain TA 100 (2.5 mg/plate) without S9 mix from rat liver; Toxic concentration1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
4'-Hydroxy-3-methoxyflavones with potent antipicornavirus activity.
AID1226449Cytotoxicity against human 2008 cells assessed as cell growth inhibition after 72 hrs by MTT assay2015Journal of medicinal chemistry, May-28, Volume: 58, Issue:10
Selenium-containing chrysin and quercetin derivatives: attractive scaffolds for cancer therapy.
AID436271Cytotoxicity against african green monkey Vero cells by MTT assay2008Journal of natural products, Nov, Volume: 71, Issue:11
Bioactive diterpenes and other constituents of Croton steenkampianus.
AID1447895Activation of ABCG2 (unknown origin) ATPase activity expressed in baculovirus infected high five cell membranes by ascorbic acid/ammonia molybdate reaction-based colorimetric analysis2017Journal of medicinal chemistry, 05-25, Volume: 60, Issue:10
4-Anilino-2-pyridylquinazolines and -pyrimidines as Highly Potent and Nontoxic Inhibitors of Breast Cancer Resistance Protein (ABCG2).
AID1102125Phytotoxicity in Solanum lycopersicum (tomato) assessed as inhibition of root differentiation at 250 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID1204902Antioxidant activity assessed as DPPH free radical scavenging activity measured as decoloration of a MeOH solution after 10 mins by spectrophotometry2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Iridoid glycosides from Barleria lupulina.
AID1592010Antioxidant activity assessed as DPPH free radical scavenging activity at 0.25 mM relative to untreated control
AID649085Inhibition of soybean lipoxygenase using arachidonic acid as substrate at 4 uM2012Bioorganic & medicinal chemistry, Mar-15, Volume: 20, Issue:6
Discovery of new orally effective analgesic and anti-inflammatory hybrid furoxanyl N-acylhydrazone derivatives.
AID1082333Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under light conditions measured 72 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1371458Renal toxicity in patient assessed as decrease in glomerular flow rate at 1400 mg/m'2, iv administered as bolus dose measured after 24 hrs relative to control2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID402564Radical scavenging activity in CD mouse macrophages assessed as inhibition of superoxide anion generation at 50 uM relative to control2004Journal of natural products, Jun, Volume: 67, Issue:6
Geranylgeraniol-type diterpenoids, boletinins A-J, from Boletinus cavipes as inhibitors of superoxide anion generation in macrophage cells.
AID1209974Inhibition of CYP3A4 in human liver microsomes using midazolam as substrate after 8 mins by LC-MS/MS analysis2012Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
AID537123Inhibition of SARS coronavirus 3C-like protease after 60 mins by FRET assay2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition.
AID1706452Cytotoxicity against rat PC-12 cells assessed as cell viability at 30 uM by MTT assay relative to control2021European journal of medicinal chemistry, Jan-01, Volume: 209Design and synthesis of 3-(4-pyridyl)-5-(4-sulfamido-phenyl)-1,2,4-oxadiazole derivatives as novel GSK-3β inhibitors and evaluation of their potential as multifunctional anti-Alzheimer agents.
AID1103942Antifeedant activity against third-instar Xanthogaleruca luteola assessed per cm2 leaf disk after 24 hr by leaf-disk choice test2009Bioresource technology, Jul, Volume: 100, Issue:14
Antifeedant activity of ethanolic extract from Flourensia oolepis and isolation of pinocembrin as its active principle compound.
AID336484ABTS radical scavenging activity assessed as Trolox equivalent antioxidant capacity at 1 mM by spectrophotometry2002Journal of natural products, Nov, Volume: 65, Issue:11
Antioxidant and free-radical scavenging activity of constituents of the leaves of Tachigalia paniculata.
AID1082356Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under light conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID293299Antioxidant activity in BALB/c mouse BM cells assessed as inhibition of ROS production2007Bioorganic & medicinal chemistry, Feb-15, Volume: 15, Issue:4
Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems.
AID1572647Inhibition of PKC in rat brain homogenate at 50 uM using FKKSFKL-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 5 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis relative to control2019Bioorganic & medicinal chemistry, 03-01, Volume: 27, Issue:5
A review on flavones targeting serine/threonine protein kinases for potential anticancer drugs.
AID378809Antioxidant activity assessed as peroxynitrite scavenging activity by fluorescence spectroscopy2006Journal of natural products, Oct, Volume: 69, Issue:10
Antioxidative phenolics from the fresh leaves of Ternstroemia japonica.
AID1409611AUC (cytotoxicity %) of compound against Vero E6 cells by MTT assay.2020Nature, 07, Volume: 583, Issue:7816
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
AID1126477Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha secretion at 0.4 uM after 18 hrs by sandwich ELISA2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID397831Antioxidant activity assessed as DPPH radical scavenging activity after 20 mins by UV-visible spectrophotometry2002Journal of natural products, Dec, Volume: 65, Issue:12
An extract of Tagetes lucida and its phenolic constituents as antioxidants.
AID1226455Selectivity index, ratio of IC50 for HEK293 cells to IC50 for human A375 cells2015Journal of medicinal chemistry, May-28, Volume: 58, Issue:10
Selenium-containing chrysin and quercetin derivatives: attractive scaffolds for cancer therapy.
AID1226454Cytotoxicity against HEK293 cells assessed as cell growth inhibition after 72 hrs by MTT assay2015Journal of medicinal chemistry, May-28, Volume: 58, Issue:10
Selenium-containing chrysin and quercetin derivatives: attractive scaffolds for cancer therapy.
AID735837Inhibition of LPS-induced NO production in mouse RAW264.7 cells after 24 hrs2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Antioxidant lignans and chromone glycosides from Eurya japonica.
AID358170Inhibition of Rous sarcoma virus p60 v-src1992Journal of natural products, Nov, Volume: 55, Issue:11
Protein-tyrosine kinase inhibition: mechanism-based discovery of antitumor agents.
AID603836Effect on ERK2 protein level in human MDA-MB-231 cells at 20 uM up to 120 mins by Western blot analysis2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Rhamnetin production based on the rational design of the poplar O-methyltransferase enzyme and its biological activities.
AID289327Singlet oxygen scavenging activity by assessed as inhibition of DHR oxidation2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
2-Styrylchromones: novel strong scavengers of reactive oxygen and nitrogen species.
AID315606Growth inhibition of human BGC823 cells at 5 uM after 72 hrs by MTT assay relative to control2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
Studies on the chemical constituents and anticancer activity of Saxifraga stolonifera (L) Meeb.
AID1437339Inhibition of CYP2C8 in human liver microsomes using paclitaxel as substrate after 5 to 15 mins
AID1126473Cytotoxicity against mouse RAW264.7 cells assessed as cell viability at 50 uM after 18 hrs by MTT assay in presence of LPS2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID1242172Inhibition of HSF1 in human HeLa cells assessed as potentiation of radicicol and heat-induced increase in cell death at 30 uM relative to radicicol and heat alone2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Regulating the master regulator: Controlling heat shock factor 1 as a chemotherapy approach.
AID311864Induction of mouse osteoclast apoptosis2007Journal of natural products, Dec, Volume: 70, Issue:12
Inhibitors of osteoclast differentiation from Cephalotaxus koreana.
AID517390Inhibition of PPAR-gamma-mediated adipocyte differentiation in mouse 3T3L1 cells2010Bioorganic & medicinal chemistry letters, Oct-15, Volume: 20, Issue:20
The selected flavonol glycoside derived from Sophorae Flos improves glucose uptake and inhibits adipocyte differentiation via activation AMPK in 3T3-L1 cells.
AID449295Iron chelating activity assessed as inhibition of ferrozine-Fe2+ complex formation at 150 uM after 10 mins by spectrophotometry2009Journal of medicinal chemistry, Dec-10, Volume: 52, Issue:23
Design, synthesis, and examination of neuron protective properties of alkenylated and amidated dehydro-silybin derivatives.
AID1372157Inhibition of human CYP1A1 transfected in HEK293 cells assessed as protection against CYP1A1 mediated B[a]P toxicity by measuring B[a]P EC50 at 20 uM by MTT assay (Rvb =1.2+/- 0.3 uM)
AID1381983Toxicity in Kunming mouse xenografted with human H22 cells assessed as effect on body weight at 100 mg/kg, ig administered for 7 consecutive days2018European journal of medicinal chemistry, Feb-25, Volume: 146The lead optimization of the polyamine conjugate of flavonoid with a naphthalene motif: Synthesis and biological evaluation.
AID1485943Inhibition of human amyloid beta (1 to 42) assessed as neuroprotective activity against amyloid beta (1 to 42)-induced toxicity in rat PC12 cells by measuring reduction in cell viability at 10 uM incubated 15 mins prior to amyloid beta (1 to 42) addition 2017Bioorganic & medicinal chemistry, 07-15, Volume: 25, Issue:14
Structure-activity relationships for flavone interactions with amyloid β reveal a novel anti-aggregatory and neuroprotective effect of 2',3',4'-trihydroxyflavone (2-D08).
AID1711991Antimetastatic activity against mouse H22 cells implanted in Kunming mouse assessed as inhibition of metastasis at 100 mg/kg, iv administered for 7 consecutive days starting from day 11 post inoculation and measured after 18 days relative to control2016European journal of medicinal chemistry, Oct-04, Volume: 121Synthesis and biological properties of polyamine modified flavonoids as hepatocellular carcinoma inhibitors.
AID74513Inhibitory activity against glucose transporter isoform 2 (GLUT2)2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
Kinase inhibitors: not just for kinases anymore.
AID1102124Phytotoxicity in Solanum lycopersicum (tomato) assessed as inhibition of seed germination at 250 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID1446623Neuroprotective activity in rat C6 cells assessed as NGF secretion at 20 uM after 24 hrs by ELISA relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Anti-Neurodegenerative Biflavonoid Glycosides from Impatiens balsamina.
AID402234Antioxidant activity in asolectin liposome assessed as inhibition of ascorbyl hydroxyl-induced lipid peroxidation by TBARS assay2004Journal of natural products, May, Volume: 67, Issue:5
Hypoglycemic effect and antioxidant potential of kaempferol-3,7-O-(alpha)-dirhamnoside from Bauhinia forficata leaves.
AID680911TP_TRANSPORTER: cell accumulation of colchicine in the presence of Quercetin at a concentration of 100uM in MDR1-expressing MDCK cells2004Free radical biology & medicine, Mar-01, Volume: 36, Issue:5
Flavonoid permeability across an in situ model of the blood-brain barrier.
AID1082437Inhibition of fruit-infesting behavior of Cydia pomonella (codling moth) neonates infested in apple fruit plugs assessed as feeding deterrence index at 10 mg/mL2011Journal of agricultural and food chemistry, Oct-26, Volume: 59, Issue:20
Effects of Ginkgo biloba constituents on fruit-infesting behavior of codling moth (Cydia pomonella) in apples.
AID1224750Delta TM value showing the stabilisation of CAMK1G produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID456192Selectivity ratio of IC50 for reduced carboxymethylated kappa-casein fibril formation to IC50 for beta amyloid (1 to 40) fibril formation2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Carboxymethylated-kappa-casein: a convenient tool for the identification of polyphenolic inhibitors of amyloid fibril formation.
AID1102144Phytotoxicity in Centaurea maculosa assessed as inhibition of shoot differentiation at 250 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID1668219Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins2020Bioorganic & medicinal chemistry, 05-15, Volume: 28, Issue:10
Acylhydrazones as isoniazid derivatives with multi-target profiles for the treatment of Alzheimer's disease: Radical scavenging, myeloperoxidase/acetylcholinesterase inhibition and biometal chelation.
AID1202779Antioxidant activity assessed as trolox equivalent of ABTS radical scavenging activity measured for 1 to 6 mins by lipophilic-TEAC fluorescence assay2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Antioxidative compounds from Garcinia buchananii stem bark.
AID480947Inhibition of Vibrio cholerae neuraminidase assessed as inhibition of 4-MU-NANA hydrolysis after 30 mins by spectrofluorimetry2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Prenylated pterocarpans as bacterial neuraminidase inhibitors.
AID478694Binding affinity to dopamine D4 receptor2010Journal of natural products, May-28, Volume: 73, Issue:5
Lessons learned from herbal medicinal products: the example of St. John's Wort (perpendicular).
AID1239523Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 4 by disk diffusion assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1125769Antioxidant activity assessed as DPPH radical scavenging activity after 2 hrs by absorbance analysis2014Bioorganic & medicinal chemistry, Apr-15, Volume: 22, Issue:8
Quinolone-benzylpiperidine derivatives as novel acetylcholinesterase inhibitor and antioxidant hybrids for Alzheimer disease.
AID527149Reduction of atrogin-1 mRNA expression in gastrocnemius muscle of C57BL/6 mouse tail suspension model at 2.5 pmol administered in gastrocnemius muscle qd for 10 days by RT-PCR analysis2010Journal of natural products, Oct-22, Volume: 73, Issue:10
Quercetin prevents unloading-derived disused muscle atrophy by attenuating the induction of ubiquitin ligases in tail-suspension mice.
AID1239529Antibacterial activity against methicillin-resistant Staphylococcus aureus NCTC 12493 after 24 hrs by checkerboard assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1627949Antiproliferative activity against human LNCAP cells after 3 days by WST1 assay2016Bioorganic & medicinal chemistry letters, 09-01, Volume: 26, Issue:17
A new class of flavonol-based anti-prostate cancer agents: Design, synthesis, and evaluation in cell models.
AID1228058Induction of intracellular ROS generation in Leishmania amazonensis MHOM/BR/75/LTB0016 promastigotes at 96 uM incubated for 48 hrs by H2DCFDA dye based assay2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Effect of Apigenin on Leishmania amazonensis Is Associated with Reactive Oxygen Species Production Followed by Mitochondrial Dysfunction.
AID462276Inhibition of human CA6 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID310888Permeability from apical to basolateral side of human Caco-2 cell monolayer assessed as intact drug level in basolateral compartment after 6 hrs2007Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2
Ester-based precursors to increase the bioavailability of quercetin.
AID1395903Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 4 secs followed by substrate addition and measured after 30 mins by luminescence assay2018European journal of medicinal chemistry, May-10, Volume: 151Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
AID1063051Inhibition of ARK5 (unknown origin)2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Protein kinase and HDAC inhibitors from the endophytic fungus Epicoccum nigrum.
AID1371433Cytotoxicity against human NCI-H460 cells assessed as cell viability at 14 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID461575Inhibition of rat ecto-5'-nucleotidase expressed in Sf9 cells by capillary electrophoresis method2010Journal of medicinal chemistry, Mar-11, Volume: 53, Issue:5
Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffold.
AID517387Induction of AMPK phosphorylation in mouse 3T3L1 cells at 10 uM by Western blotting2010Bioorganic & medicinal chemistry letters, Oct-15, Volume: 20, Issue:20
The selected flavonol glycoside derived from Sophorae Flos improves glucose uptake and inhibits adipocyte differentiation via activation AMPK in 3T3-L1 cells.
AID551407Antioxidant activity of the compound assessed as DPPH radical scavenging activity at 15 mM after 2 hrs2011Bioorganic & medicinal chemistry, Jan-15, Volume: 19, Issue:2
Synthesis, structure, theoretical and experimental in vitro antioxidant/pharmacological properties of α-aryl, N-alkyl nitrones, as potential agents for the treatment of cerebral ischemia.
AID528480Antioxidant activity assessed as DPPH radical scavenging activity by spectrophotometric analysis2010Journal of medicinal chemistry, Nov-25, Volume: 53, Issue:22
Phenolic bis-styrylbenzenes as β-amyloid binding ligands and free radical scavengers.
AID1243356Antioxidant activity assessed as ABTS radical scavenging activity after 6 mins2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Isolation and structure elucidation of bioactive compounds from the roots of the Tunisian Ononis angustissima L.
AID355885Antimicrobial activity against Helicobacter pylori isolates after 36 hrs under aerobic condition by microdilution method2003Journal of natural products, May, Volume: 66, Issue:5
Sesquiterpene lactones from Anthemis altissima and their anti-Helicobacter pylori activity.
AID729308Inhibition of vasopressin-stimulated vasopressin V2 receptor in human HTLA cells pre-incubated for 20 mins with centrifuged compound solution measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay2013Journal of medicinal chemistry, Mar-28, Volume: 56, Issue:6
Colloidal aggregation causes inhibition of G protein-coupled receptors.
AID332649Inhibition of human DNA topoisomerase 2 catalytic domain-mediated knotted bacteriophage P4Virl dell0 DNA unknotting at 100 uM by agarose gel electrophoresis1995Journal of natural products, Feb, Volume: 58, Issue:2
Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships.
AID1224787Delta TM value showing the stabilisation of PIM2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1525239Antioxidant activity in Wistar rat brain homogenate assessed as inhibition of FeCl2-induced lipid peroxidation by measuring reduction in TBARS level preincubated for 30 mins followed by FeCl2/ascorbic acid addition and measured after 1 hr2019Journal of natural products, 05-24, Volume: 82, Issue:5
Structure and Absolute Configuration of Abietane Diterpenoids from Salvia clinopodioides: Antioxidant, Antiprotozoal, and Antipropulsive Activities.
AID277107Inhibition of fMLP-induced ROS production in human PMN2006Bioorganic & medicinal chemistry letters, Dec-15, Volume: 16, Issue:24
Total synthesis and biological evaluation of viscolin, a 1,3-diphenylpropane as a novel potent anti-inflammatory agent.
AID1063897Activity at soybean LOX-1 using linoleic acid as substrate at 100 uM preincubated for 5 mins followed by substrate addition by Michaelis-Menten plot analysis2014European journal of medicinal chemistry, Jan-24, Volume: 72Inhibition of LOX by flavonoids: a structure-activity relationship study.
AID201080Minimum inhibitory concentration, that inhibits growth of Staphylococcus aureus in the presence of subinhibitory (30 ug/mL) Berberine; Inactive2001Journal of medicinal chemistry, Jan-18, Volume: 44, Issue:2
Flavonolignan and flavone inhibitors of a Staphylococcus aureus multidrug resistance pump: structure-activity relationships.
AID33222The compound was evaluated for in Vitro binding of AFB1 to DNA in rat liver microsomes; Pre-incubation time being 20 mins2002Bioorganic & medicinal chemistry letters, Sep-16, Volume: 12, Issue:18
Comparison of the prevention of aflatoxin b(1)-induced genotoxicity by quercetin and quercetin pentaacetate.
AID1446226Inhibition of recombinant MPO (unknown origin) assessed as reduction in taurine chloramine production preincubated with enzyme and taurine followed by H2O2 addition measured after 5 mins2017Journal of medicinal chemistry, 08-10, Volume: 60, Issue:15
Discovery of Novel Potent Reversible and Irreversible Myeloperoxidase Inhibitors Using Virtual Screening Procedure.
AID1082352Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under dark conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID377592Increase in duration of immobility in CD1 mouse at 10 mg/kg, ip by forced swimming test relative to carboxy methyl cellulose2006Journal of natural products, Jun, Volume: 69, Issue:6
Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and computational study.
AID402009Antioxidant activity assessed as ABAP free radical scavenging measured at 3.2 mM by TRAP assay2005Journal of natural products, May, Volume: 68, Issue:5
Benzophenones from Hypericum carinatum.
AID1171180Teratogenic effect in zebrafish assessed as delayed hatching at 160 uM after 72 hrs by microscopy2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Delineation of the role of glycosylation in the cytotoxic properties of quercetin using novel assays in living vertebrates.
AID1161234Inhibition of PMA-induced oxidative burst in human neutrophils by APF assay2014European journal of medicinal chemistry, Oct-30, Volume: 86Synthesis of chlorinated flavonoids with anti-inflammatory and pro-apoptotic activities in human neutrophils.
AID1083160Antifungal activity against Neofusicoccum luteum CBS110299 assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID679336TP_TRANSPORTER: inhibition of LTC4 uptake in membrane vesicle from MRP1-expressing HeLa cells2001Molecular pharmacology, May, Volume: 59, Issue:5
Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and atpase activities by interaction with dietary flavonoids.
AID732550Activation of Nrf2 in mouse RAW264.7 cells assessed as upregulation of Hmox1 gene expression at 50 uM after 6 hrs by real-time PCR analysis relative to GAPDH mRNA expression2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
A novel semisynthetic flavonoid 7-O-galloyltaxifolin upregulates heme oxygenase-1 in RAW264.7 cells via MAPK/Nrf2 pathway.
AID1446627Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB assay2017Journal of natural products, 02-24, Volume: 80, Issue:2
Anti-Neurodegenerative Biflavonoid Glycosides from Impatiens balsamina.
AID1188619Anticancer activity against human LOXIMVI cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID1239575Antibacterial activity against methicillin-resistant Staphylococcus aureus NCTC 12493 at 1.69 mM after 4 hrs by time kill assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1102140Phytotoxicity in Bassia scoparia assessed as inhibition of root differentiation at 250 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID1614066Inhibition of recombinant human CYP2C82019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Evaluation of Amides, Carbamates, Sulfonamides, and Ureas of 4-Prop-2-ynylidenecycloalkylamine as Potent, Selective, and Bioavailable Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5.
AID624606Specific activity of expressed human recombinant UGT1A12000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1224807Delta TM value showing the stabilisation of YSK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1359848Neuroprotection against H2O2-induced cell death in rat PC12 cells assessed as cell viability at 0.1 uM preincubated for 3 hrs followed by H2O2 stimulation measured after 2 hrs by MTT assay (Rvb = 25.2 to 41.8%)2018European journal of medicinal chemistry, May-25, Volume: 152Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer's disease based on coumarin and lipoic acid scaffolds.
AID587306Inhibition of fMLP-induced neutrophil recruitment in Swiss mouse at 300 mg/kg, sc administered pre-inflammatory stimulus after 6 hrs by Newbauer chamber using Romanowsky stain2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID666857Reversal of BCRP-mediated drug resistant in human HEK293/R2 cells assessed as potentiation of topotecan-induced cytotoxicity at 1 uM after 5 days by MTS assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis of methylated quercetin derivatives and their reversal activities on P-gp- and BCRP-mediated multidrug resistance tumour cells.
AID315617Induction of apoptosis in human BGC823 cells at 100 uM after 36 hrs by flow cytometry2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
Studies on the chemical constituents and anticancer activity of Saxifraga stolonifera (L) Meeb.
AID697064Inhibition of duck liver FASN2011Journal of medicinal chemistry, Aug-25, Volume: 54, Issue:16
The lipogenesis pathway as a cancer target.
AID1777360Antiviral activity against SARS-CoV-2 NCCP43326 infected in African green monkey Vero cells assessed as inhibition of plaque formation at 25 ug/ml treated with compound for 1 hr post-infection followed by drug wash-out and measured at 72 hrs post-infectio2021Bioorganic & medicinal chemistry, 09-01, Volume: 45Potent antiviral activity of Agrimonia pilosa, Galla rhois, and their components against SARS-CoV-2.
AID512282Inhibition of MAPKAPK1b from rabbit skeletal muscle at 20 uM2000The Biochemical journal, Oct-01, Volume: 351, Issue:Pt 1
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
AID265759Inhibition of FabI2006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.
AID501423Antimicrobial activity against Escherichia coli K-12 after 24 hrs by microdilution assay2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Design, synthesis, and biological evaluation of a novel series of quercetin diacylglucosides as potent anti-MRSA and anti-VRE agents.
AID1372144Inhibition of recombinant human CYP1A1 expressed in yeast microsomal membranes by fluorescence assay
AID1126472Inhibition of sEH (unknown origin) assessed as substrate PHOME hydrolysis after 1 hr by fluorescence method2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID502476Competitive inhibition of Clostridium perfringens neuraminidase by fluorimetry2010Bioorganic & medicinal chemistry, Sep-01, Volume: 18, Issue:17
Xanthones with neuraminidase inhibitory activity from the seedcases of Garcinia mangostana.
AID603366Antibacterial activity against methicillin-resistant Staphylococcus aureus OM584 after 24 hrs by microdilution method2011Journal of medicinal chemistry, Jun-09, Volume: 54, Issue:11
Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
AID378676Inhibition of CK22006Journal of natural products, Jan, Volume: 69, Issue:1
A common protein fold topology shared by flavonoid biosynthetic enzymes and therapeutic targets.
AID1294643Antioxidant activity assessed as nitric oxide radical scavenging activity at 40 uM after 3 hrs by Griess assay2016European journal of medicinal chemistry, May-23, Volume: 114Novel benzylidenephenylpyrrolizinones with pleiotropic activities potentially useful in Alzheimer's disease treatment.
AID1152249Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis2014Bioorganic & medicinal chemistry, Jun-15, Volume: 22, Issue:12
Design and discovery of flavonoid-based HIV-1 integrase inhibitors targeting both the active site and the interaction with LEDGF/p75.
AID506922Inhibition of HSP90-mediated antiapoptotic activity in human SKBR3 cells assessed as induction of caspase-9 cleavage at 200 uM after 24 hrs by Western blot analysis2007Nature chemical biology, Aug, Volume: 3, Issue:8
Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer.
AID666854Cytotoxicity against multidrug resistant human LCC-6 cells after 5 days by MTS assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis of methylated quercetin derivatives and their reversal activities on P-gp- and BCRP-mediated multidrug resistance tumour cells.
AID1082335Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1917216n-Octanol-water partition coefficient, logP of the compound at 1 mg and measured after 2 hrs by HPLC analysis2022Bioorganic & medicinal chemistry, 11-01, Volume: 73Synthesis and evaluation of glycosylated quercetin to enhance neuroprotective effects on cerebral ischemia-reperfusion.
AID1080605Phytotoxic activity against Trifolium repens assessed as inhibition of root growth at 22 +/-2 degC after 72 hr2009Journal of agricultural and food chemistry, Apr-08, Volume: 57, Issue:7
Level of catechin, myricetin, quercetin and isoquercitrin in buckwheat (Fagopyrum esculentum Moench), changes of their levels during vegetation and their effect on the growth of selected weeds.
AID765677Inhibition of oxidative burst in PMA-stimulated human neutrophils assessed as inhibition of H2O2-induced oxidation of amplex red incubated for 5 mins prior to PMA challenge by fluorescence assay2013European journal of medicinal chemistry, Sep, Volume: 67Modulation of human neutrophils' oxidative burst by flavonoids.
AID1242164Inhibition of HSF1 in human ASB145 cells assessed as potentiation of 17-DMAG-induced reduction in cell proliferation at 20 uM relative to 17-DMAG alone2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Regulating the master regulator: Controlling heat shock factor 1 as a chemotherapy approach.
AID339147Inhibition of norepinephrine-induced Wistar rat thoracic aorta tonic contraction at 50 ug/mL after 15 mins1993Journal of natural products, Jun, Volume: 56, Issue:6
Antiplatelet effects and vasorelaxing action of some constituents of Formosan plants.
AID293618Cytotoxicity against Vero cells2007European journal of medicinal chemistry, May, Volume: 42, Issue:5
Novel and versatile methodology for synthesis of cyclic imides and evaluation of their cytotoxic, DNA binding, apoptotic inducing activities and molecular modeling study.
AID603365Antibacterial activity against methicillin-resistant Staphylococcus aureus OM481 after 24 hrs by microdilution method2011Journal of medicinal chemistry, Jun-09, Volume: 54, Issue:11
Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
AID1485944Inhibition of human amyloid beta (1 to 42) fibrillisation in cell-free solution at 100 uM measured every 10 mins up to 48 hrs by Thioflavin T based fluorescence assay2017Bioorganic & medicinal chemistry, 07-15, Volume: 25, Issue:14
Structure-activity relationships for flavone interactions with amyloid β reveal a novel anti-aggregatory and neuroprotective effect of 2',3',4'-trihydroxyflavone (2-D08).
AID417656Inhibition of Clostridium perfringens neuraminidase by fluorimetry2009Bioorganic & medicinal chemistry, Apr-01, Volume: 17, Issue:7
Characteristic of neuraminidase inhibitory xanthones from Cudrania tricuspidata.
AID1593608Antioxidant activity in Sprague-Dawley rat brain homogenates assessed as inhibition of lipoperoxidation incubated for 40 mins by fluorescence based assay2019Bioorganic & medicinal chemistry, 06-15, Volume: 27, Issue:12
Purification, structural elucidation, antioxidant capacity and neuroprotective potential of the main polyphenolic compounds contained in Achyrocline satureioides (Lam) D.C. (Compositae).
AID1683193Inhibition of lactate transport in human HeLa cells assessed as increase in intracellular lactate level at IC50 measured after 8 to 24 hrs by colorimetric assay2021Bioorganic & medicinal chemistry, 01-01, Volume: 29Synthesis and anticancer activity of new coumarin-3-carboxylic acid derivatives as potential lactatetransportinhibitors.
AID424720Activity at bovine xanthine oxidase at 50 uM2009Journal of natural products, Apr, Volume: 72, Issue:4
Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin.
AID467547Antinociceptive activity in ip dosed Swiss mouse assessed as inhibition of phenyl-p-benzoquinone-induced writhing response administered 30 mins before phenyl-p-benzoquinone challenge measured for 20 mins2009Journal of natural products, Nov, Volume: 72, Issue:11
Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production.
AID681320TP_TRANSPORTER: increase in Daunomycin intracellular accumulation (Daunomycin: 0.05 uM, Quercetin: 100 uM) in PANC-1 cells2003Journal of pharmaceutical sciences, Feb, Volume: 92, Issue:2
Effect of flavonoids on MRP1-mediated transport in Panc-1 cells.
AID1226462Selectivity index, ratio of IC50 for HEK293 cells to IC50 for human 2008 cells2015Journal of medicinal chemistry, May-28, Volume: 58, Issue:10
Selenium-containing chrysin and quercetin derivatives: attractive scaffolds for cancer therapy.
AID354609Inhibition of pig kidney aldehyde reductase by spectrophotometry1996Journal of natural products, Apr, Volume: 59, Issue:4
Effect of Polygonum hydropiper sulfated flavonoids on lens aldose reductase and related enzymes.
AID380503Displacement of [3H]8-OH-DPAT from human recombinant 5HT1A receptor expressed in CHO cells2006Journal of natural products, Mar, Volume: 69, Issue:3
Alkaloids from Eschscholzia californica and their capacity to inhibit binding of [3H]8-Hydroxy-2-(di-N-propylamino)tetralin to 5-HT1A receptors in Vitro.
AID1191756Inhibition of human purified MPG pre-incubated with compound for 10 mins followed by addition of 1,N6 ethenoadenine containing 32P-labeled duplex oligonucleotide substrates at 20 uM by gel-based excision activity assay2015Bioorganic & medicinal chemistry, Mar-01, Volume: 23, Issue:5
Naturally occurring polyphenol, morin hydrate, inhibits enzymatic activity of N-methylpurine DNA glycosylase, a DNA repair enzyme with various roles in human disease.
AID466939Selectivity for Trypanosoma cruzi trans-sialidase mutant over human Neu22010Bioorganic & medicinal chemistry, Feb-15, Volume: 18, Issue:4
Potent inhibitor scaffold against Trypanosoma cruzi trans-sialidase.
AID325654Inhibition of PI3K2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID641165Induction of apoptosis in human HCT116 cells overexpressing PI3Kalpha assessed DNA fragmentation at 25 uM after 48 hrs by ELISA relative to control2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Biological evaluation and docking studies of recently identified inhibitors of phosphoinositide-3-kinases.
AID1371430Cytotoxicity against human HT-29 cells assessed as cell viability at 14 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID605055Antiproliferative activity against human MCF7 cells after 24 hrs by MTT assay2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID1311082Antioxidant activity assessed as inhibition of superoxide-induced NBT reduction measured during 2 mins by spectrophotometric analysis2016European journal of medicinal chemistry, Aug-25, Volume: 119New polyhydroxylated flavon-3-ols and 3-hydroxy-2-styrylchromones: synthesis and ROS/RNS scavenging activities.
AID1408297Antiproliferative activity against human DU145 cells after 3 days by WST-1 assay2018European journal of medicinal chemistry, Sep-05, Volume: 157Structure-activity relationship and pharmacokinetic studies of 3-O-substitutedflavonols as anti-prostate cancer agents.
AID462342Toxicity in mouse B16-4A5 cells assessed as inhibition of cell proliferation at 30 uM in presence of 1 mM theophylline after 72 hrs by WST8 dye reduction assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells.
AID1713248Inhibition of ovine COX-2 assessed as appearance of oxidized TMPD level by EIA method2016European journal of medicinal chemistry, Nov-10, Volume: 123Novel N-substituted indole Schiff bases as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes: Synthesis, biological activities in vitro and docking study.
AID332647Enhancement of human DNA topoisomerase 2-mediated Escherichia coli pUC8 DNA cleavage after 30 mins by agarose gel electrophoresis1995Journal of natural products, Feb, Volume: 58, Issue:2
Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships.
AID1082324Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under dark conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID52780Inhibitory activity against chymotrypsinogen2002Journal of medicinal chemistry, Apr-11, Volume: 45, Issue:8
A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.
AID681338TP_TRANSPORTER: inhibition of glibenclamide uptake (glibenclamide: 10nM) in OATP2B1-expressing HEK293 cells2005Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 33, Issue:4
Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B.
AID587300Inhibition of CXCL1-induced neutrophil recruitment in Swiss mouse at 300 mg/kg, sc administered pre-inflammatory stimulus after 6 hrs by Newbauer chamber using Romanowsky stain2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID1668634Cytotoxicity against mouse RAW264.7 cells assessed as reduction in cell viability after 24 hrs by alamarBlue assay2020Journal of natural products, 05-22, Volume: 83, Issue:5
Cucurbitane-Type Triterpenoids from the Vines of
AID334645Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of benzo[a]pyrene-induced mutation at 150 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID1484011Inhibition of amyloid beta (1 to 42) aggregation in Escherichia coli competent cells BL21 (DE3) at 200 uM after overnight incubation by Thioflavin-S steady-state fluorescence assay2017Journal of natural products, 02-24, Volume: 80, Issue:2
Combined in Vitro Cell-Based/in Silico Screening of Naturally Occurring Flavonoids and Phenolic Compounds as Potential Anti-Alzheimer Drugs.
AID1446626Cytotoxicity against human SKOV3 cells after 48 hrs by SRB assay2017Journal of natural products, 02-24, Volume: 80, Issue:2
Anti-Neurodegenerative Biflavonoid Glycosides from Impatiens balsamina.
AID334635Toxicity in Salmonella Typhimurium T98 at 300 ug/plate after 72 hrs by Ames assay in presence of Ames S-9 fraction
AID487900Antidiabetic activity in STZ-induced Wistar rat assessed as reduction in blood glucose level at 50 mg/kg, ig after 5 day relative to control2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
A comparative study of flavonoid analogues on streptozotocin-nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11beta-hydroxysteroid dehydrogenase type 1 inhibition.
AID43268Percentage inhibition of Beta-lactamase at KPi (Potassium Phosphate) stock concentration of 5.9 uM2003Journal of medicinal chemistry, Sep-25, Volume: 46, Issue:20
A specific mechanism of nonspecific inhibition.
AID165000The inhibitory activity tested against human Protein-tyrosine phosphatase 1B enzyme2002Bioorganic & medicinal chemistry letters, Dec-02, Volume: 12, Issue:23
Natural PTP1B inhibitors from Broussonetia papyrifera.
AID454616Antioxidant activity assessed as DPPH radical scavenging activity at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-15, Volume: 20, Issue:2
Synthesis and biological evaluation of nitrogen-containing chalcones as possible anti-inflammatory and antioxidant agents.
AID462339Toxicity in mouse B16-4A5 cells assessed as inhibition of cell proliferation at 1 uM in presence of 1 mM theophylline after 72 hrs by WST8 dye reduction assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells.
AID537628Inhibition of human recombinant CD38 expressed in Pichia pastoris by continuous fluorometric method2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Identification by high-throughput screening of inhibitors of Schistosoma mansoni NAD(+) catabolizing enzyme.
AID265758Inhibition of FabZ2006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.
AID1102130Phytotoxicity in Bassia scoparia assessed as inhibition of shoot differentiation at 250 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID466938Inhibition of human Neu2 assessed as MuNANA substrate hydrolysis in presence of 0.1% Triton X-100 by discontinuous fluorimetric assay2010Bioorganic & medicinal chemistry, Feb-15, Volume: 18, Issue:4
Potent inhibitor scaffold against Trypanosoma cruzi trans-sialidase.
AID487737Antidiabetic activity in Wistar rat assessed as change in blood glucose level at 50 mg/kg, ig after 5 hrs (RVb = -1.17% +/- 8.77%)2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
A comparative study of flavonoid analogues on streptozotocin-nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11beta-hydroxysteroid dehydrogenase type 1 inhibition.
AID1656440Inhibition of Escherichia coli K-12 beta-glucuronidase using PNPG as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins2020European journal of medicinal chemistry, Feb-01, Volume: 187Therapeutic significance of β-glucuronidase activity and its inhibitors: A review.
AID603462Inhibition of Staphylococcus aureus DNA Topoisomerase 4-mediated decatenation of kDNA after 30 mins by densitometry2011Journal of medicinal chemistry, Jun-09, Volume: 54, Issue:11
Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
AID1224757Delta TM value showing the stabilisation of CDK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID502474Inhibition of human CYP1A1 by EROD assay2010Bioorganic & medicinal chemistry, Sep-01, Volume: 18, Issue:17
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.
AID1771177Inhibition of CYP2C8 (unknown origin) assessed as activity at 10 uM relative to control2021Journal of medicinal chemistry, 09-09, Volume: 64, Issue:17
Discovery of
AID1083155Antifungal activity against Diplodia seriata BoF99-1 assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID1593607Antioxidant activity in pH 7.4 PBS assessed as ABTS+ radical scavenger activity incubated under absence of light for 16 hrs2019Bioorganic & medicinal chemistry, 06-15, Volume: 27, Issue:12
Purification, structural elucidation, antioxidant capacity and neuroprotective potential of the main polyphenolic compounds contained in Achyrocline satureioides (Lam) D.C. (Compositae).
AID1220237Unbound fraction during UGT-mediated glucuronidation in human intestinal microsomes2012Drug metabolism and disposition: the biological fate of chemicals, Sep, Volume: 40, Issue:9
Quantitative prediction of human intestinal glucuronidation effects on intestinal availability of UDP-glucuronosyltransferase substrates using in vitro data.
AID1226442Cytotoxicity against human A375 cells assessed as cell growth inhibition after 72 hrs by MTT assay2015Journal of medicinal chemistry, May-28, Volume: 58, Issue:10
Selenium-containing chrysin and quercetin derivatives: attractive scaffolds for cancer therapy.
AID424735Inhibition of bovine xanthine oxidase assessed as reduction in free enzyme turnover at 25 uM relative to control2009Journal of natural products, Apr, Volume: 72, Issue:4
Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin.
AID1706453Cytotoxicity against rat PC-12 cells assessed as cell viability at 50 uM by MTT assay relative to control2021European journal of medicinal chemistry, Jan-01, Volume: 209Design and synthesis of 3-(4-pyridyl)-5-(4-sulfamido-phenyl)-1,2,4-oxadiazole derivatives as novel GSK-3β inhibitors and evaluation of their potential as multifunctional anti-Alzheimer agents.
AID17283Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex1997Journal of medicinal chemistry, Dec-05, Volume: 40, Issue:25
Assessment of solvation effects on calculated binding affinity differences: trypsin inhibition by flavonoids as a model system for congeneric series.
AID1175718Antimalarial activity against chloroquine-sensitive/mefloquine-resistant Plasmodium falciparum D6 by malaria SYBR green 1-based fluorescence (MSF) assay2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
The synthesis, antimalarial activity and CoMFA analysis of novel aminoalkylated quercetin analogs.
AID402565Cytotoxicity against CD mouse macrophages assessed as cell viability at 25 uM by trypan blue exclusion test2004Journal of natural products, Jun, Volume: 67, Issue:6
Geranylgeraniol-type diterpenoids, boletinins A-J, from Boletinus cavipes as inhibitors of superoxide anion generation in macrophage cells.
AID487732Hypoglycemic activity in Wistar rat assessed as change in blood glucose level at 50 mg/kg, ig after 5 hrs (RVb = 1.21+/- 3.64 %)2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
A comparative study of flavonoid analogues on streptozotocin-nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11beta-hydroxysteroid dehydrogenase type 1 inhibition.
AID596753Cytotoxicity against human HepG2(2.2.15) cells after 8 days by MTT assay2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Homoflavonoid glucosides from Ophioglossum pedunculosum and their anti-HBV activity.
AID1743177Antioxidant activity assessed as ABTS radical scavenging activity measured after 1 hr by UV-vis spectrophotometric method2020European journal of medicinal chemistry, Dec-15, Volume: 208Multiple biological active 4-aminopyrazoles containing trifluoromethyl and their 4-nitroso-precursors: Synthesis and evaluation.
AID1161237Induction of apoptosis in human neutrophils assessed as early apoptotic cells at 50 uM after 4 hrs by Annexin-V-FLUOS staining based flow cytometry (Rvb = 9.7%)2014European journal of medicinal chemistry, Oct-30, Volume: 86Synthesis of chlorinated flavonoids with anti-inflammatory and pro-apoptotic activities in human neutrophils.
AID298196Inhibition of ALR2 in Sprague-Dawley Albino rat lens2007Journal of medicinal chemistry, Oct-04, Volume: 50, Issue:20
Pyrido[1,2-a]pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity.
AID682124TP_TRANSPORTER: Immunoblot analysis in Caco-2 cells2000Biochemical pharmacology, Mar-01, Volume: 59, Issue:5
Coordinate induction by antioxidants of UDP-glucuronosyltransferase UGT1A6 and the apical conjugate export pump MRP2 (multidrug resistance protein 2) in Caco-2 cells.
AID435763Inhibitory constant against Zea mays CK2alpha2003The Biochemical journal, Sep-15, Volume: 374, Issue:Pt 3
Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).
AID1224805Delta TM value showing the stabilisation of VRK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID754357Cytotoxicity against human MCF7 cells at 1 to 100 uM after 12 hrs by MTT assay2013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
Quercetin-POC conjugates: Differential stability and bioactivity profiles between breast cancer (MCF-7) and colorectal carcinoma (HCT116) cell lines.
AID339141Inhibition of K(+)/Ca(2+)-induced Wistar rat thoracic aorta contraction at 100 ug/mL after 15 mins1993Journal of natural products, Jun, Volume: 56, Issue:6
Antiplatelet effects and vasorelaxing action of some constituents of Formosan plants.
AID1171182Teratogenic effect in zebrafish assessed as abnormal heart at 160 uM after 72 hrs by microscopy2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Delineation of the role of glycosylation in the cytotoxic properties of quercetin using novel assays in living vertebrates.
AID1224771Delta TM value showing the stabilisation of MEK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID34338Inhibition of ALR2 (aldose reductase) of bovine lens1999Journal of medicinal chemistry, Jun-03, Volume: 42, Issue:11
1-Benzopyran-4-one antioxidants as aldose reductase inhibitors.
AID265760Inhibition of FabG2006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.
AID666769Inhibition of thrombin in New Zealand rabbit plasma assessed as prothrombin time at 100 uM by coagulometry2012European journal of medicinal chemistry, Aug, Volume: 54Metabolism-based synthesis, biologic evaluation and SARs analysis of O-methylated analogs of quercetin as thrombin inhibitors.
AID1593609Antioxidant activity in pH 7.4 PBS assessed as H2O2 oxidation at 50 uM incubated for 10 mins in presence of HRP and H2O2 by UV spectroscopy and HPLC analysis relative to control2019Bioorganic & medicinal chemistry, 06-15, Volume: 27, Issue:12
Purification, structural elucidation, antioxidant capacity and neuroprotective potential of the main polyphenolic compounds contained in Achyrocline satureioides (Lam) D.C. (Compositae).
AID277587Inhibition of Plasmodium falciparum ENR in presence of triclosan2007Journal of medicinal chemistry, Feb-22, Volume: 50, Issue:4
Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR).
AID7096In vitro inhibition of 5-lipoxygenase (5-lo) from the 20000 g supernatant of RBI-1 cells1991Journal of medicinal chemistry, Jul, Volume: 34, Issue:7
4-hydroxythiazole inhibitors of 5-lipoxygenase.
AID338025Inhibition of rat liver mitochondrial ATPase assessed per mg of protein
AID1769285Inhibition of BCRP (unknown origin) expressed in HEK293/R2 cells assessed as conformational change by measuring increase in 5D3 shift at 10 uM preincubated for 15 mins followed by FITC mouse antihuman BCRP antibody addition measured after 30 mins by flow 2021Journal of medicinal chemistry, 10-14, Volume: 64, Issue:19
Flavonoid Monomers as Potent, Nontoxic, and Selective Modulators of the Breast Cancer Resistance Protein (ABCG2).
AID367707Selectivity ratio of IC50 for pig ALR1 to IC50 for human recombinant ALR22009Bioorganic & medicinal chemistry, Feb-01, Volume: 17, Issue:3
Correlation of binding constants and molecular modelling of inhibitors in the active sites of aldose reductase and aldehyde reductase.
AID1210015Inhibition of CYP1A2 in human liver microsomes using phenacetin as substrate after 8 mins by LC-MS/MS analysis2012Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
AID768911Inhibition of human thrombin assessed as inhibition of band decaying corresponding to fibrinogen Aalpha chains at IC50 after 30 mins by SDS-PAGE analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID676984Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation at 0.32 uM by spectrophotometry based TBARS assay relative to untreated control2012Bioorganic & medicinal chemistry, Sep-01, Volume: 20, Issue:17
Synthesis, cytotoxic and antioxidant evaluations of amino derivatives from perezone.
AID1385997Inhibition of LPS-induced nitric oxide production in mouse BV2 cells after 24 hrs by Griess assay2018Journal of natural products, 09-28, Volume: 81, Issue:9
Ansamycins with Antiproliferative and Antineuroinflammatory Activity from Moss-Soil-Derived Streptomyces cacaoi subsp. asoensis H2S5.
AID355887Antimicrobial activity against Proteus mirabilis isolates after 36 hrs under aerobic condition by microdilution method2003Journal of natural products, May, Volume: 66, Issue:5
Sesquiterpene lactones from Anthemis altissima and their anti-Helicobacter pylori activity.
AID376367Antioxidant activity in brain homogenate assessed as drug level require to inhibit 50% of spontaneous lipid peroxidation relative to control1999Journal of natural products, Nov, Volume: 62, Issue:11
Dihydrochalcones and flavonolignans from Iryanthera lancifolia.
AID467852Inhibition of TNF-alpha-induced neutrophil recruitment in Swiss mouse subcutaneous plantar tissue assessed as myeloperoxidase activity at 100 mg/kg, ip dosed 30 mins before TNFalpha challenge measured after 3 hrs by spectrophotometry2009Journal of natural products, Nov, Volume: 72, Issue:11
Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production.
AID1264945Induction of osteogenic differentiation in human MSC assessed as increase in ALP activity at 1 uM using p-NPP as substrate after 9 days by colorimetric method relative to control2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID218679Inhibition of beta-lactamase from Escherichia coli2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
Kinase inhibitors: not just for kinases anymore.
AID351090Antioxidant activity assessed as superoxide radical scavenging activity by spectrophotometry2009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
Preparation of two sets of 5,6,7-trioxygenated dihydroflavonol derivatives as free radical scavengers and neuronal cell protectors to oxidative damage.
AID1202777Antioxidant activity assessed as trolox equivalent of ABTS radical scavenging activity after 10 mins by lipophilic-TEAC fluorescence assay2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Antioxidative compounds from Garcinia buchananii stem bark.
AID1355206Antiseptic activity in Balb/c mouse model of Escherichia coli K1 infection-induced sepsis assessed as reduction in bacterial count in kidneys at 50 mg/kg, ip pretreated for 1 hr followed by Escherichia coli K1 infection measured after 12 hrs2018Journal of natural products, 06-22, Volume: 81, Issue:6
Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production.
AID1224775Delta TM value showing the stabilisation of ERK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1525242Antioxidant activity assessed as DPPH radical scavenging activity measured after 30 mins2019Journal of natural products, 05-24, Volume: 82, Issue:5
Structure and Absolute Configuration of Abietane Diterpenoids from Salvia clinopodioides: Antioxidant, Antiprotozoal, and Antipropulsive Activities.
AID729305Inhibition of vasopressin V2 receptor (unknown origin) assessed as change in intracellular calcium levels incubated with compound treated with Tween-80 by fluorometric analysis2013Journal of medicinal chemistry, Mar-28, Volume: 56, Issue:6
Colloidal aggregation causes inhibition of G protein-coupled receptors.
AID477795Inhibition of amyloid beta (1 to 40) aggregation assessed as inhibition of fibril formation by thioflavin T fluorescent dye assay2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Design, synthesis and biological evaluation of indane-2-arylhydrazinylmethylene-1,3-diones and indol-2-aryldiazenylmethylene-3-ones as beta-amyloid aggregation inhibitors.
AID1082358Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under light conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID681519TP_TRANSPORTER: Western blot, MCF-7 cells2002Toxicology, Feb-28, Volume: 171, Issue:2-3
Influence of redox-active compounds and PXR-activators on human MRP1 and MRP2 gene expression.
AID34804In vitro inhibitory activity against aldose reductase (ALR2) from rat lens extraction.2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
Novel, highly potent aldose reductase inhibitors: cyano(2-oxo-2,3-dihydroindol-3-yl)acetic acid derivatives.
AID1129464Ratio of EC50 for cytotoxicity against mouse HT22 cells to EC50 for neuroprotective activity in glutamate-induced mouse HT22 cells2014Bioorganic & medicinal chemistry letters, Apr-01, Volume: 24, Issue:7
Functionalized acridin-9-yl phenylamines protected neuronal HT22 cells from glutamate-induced cell death by reducing intracellular levels of free radical species.
AID605037Permeability of the compound measured on donor plate of PAMPA membrane at 50 uM after 5 hrs by HPLC analysis2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID1516847Antifungal activity against Candida parapsilosis 96 by microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID402229Antioxidant activity in Wistar rat liver microsomes assessed as inhibition of ascorbyl radical-induced lipid peroxidation by TBARS assay2004Journal of natural products, May, Volume: 67, Issue:5
Hypoglycemic effect and antioxidant potential of kaempferol-3,7-O-(alpha)-dirhamnoside from Bauhinia forficata leaves.
AID1246445Antioxidant activity assessed as cupric reducing antioxidant capacity measured after 1 hr2015European journal of medicinal chemistry, Sep-18, Volume: 102Potential of aryl-urea-benzofuranylthiazoles hybrids as multitasking agents in Alzheimer's disease.
AID1485951Inhibition of human amyloid beta (1 to 42) assessed as neuroprotective activity up to 2 uM of amyloid beta (1 to 42)-induced toxicity in rat PC12 cells by measuring reduction in cell viability at 100 uM incubated 15 mins prior to amyloid beta (1 to 42) ad2017Bioorganic & medicinal chemistry, 07-15, Volume: 25, Issue:14
Structure-activity relationships for flavone interactions with amyloid β reveal a novel anti-aggregatory and neuroprotective effect of 2',3',4'-trihydroxyflavone (2-D08).
AID605038Permeability of the compound measured on acceptor plate of PAMPA membrane at 50 uM after 1 hr by HPLC analysis2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1359851Neuroprotection against H2O2-induced cell death in rat PC12 cells assessed as cell viability at 10 uM preincubated for 3 hrs followed by H2O2 stimulation measured after 2 hrs by MTT assay (Rvb = 25.2 to 41.8%)2018European journal of medicinal chemistry, May-25, Volume: 152Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer's disease based on coumarin and lipoic acid scaffolds.
AID1372143Inhibition of human CYP1B1 expressed in yeast microsomal membranes at 10 uM using 7-ethoxyresorufin as substrate by fluorescence assay relative to control
AID1515372Antioxidant activity assessed as ferric ion reducing activity by measuring trolox equivalents after 40 mins by FRAP assay2019Bioorganic & medicinal chemistry, 01-15, Volume: 27, Issue:2
Synthesis, Antioxidant Activity and Cytotoxicity of N-Functionalized Organotellurides.
AID436039Inhibition of I174A-mutated CK2 holoenzyme2003The Biochemical journal, Sep-15, Volume: 374, Issue:Pt 3
Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).
AID1359853Neuroprotection against H2O2-induced cell death in rat PC12 cells assessed as cell viability at 50 uM preincubated for 3 hrs followed by H2O2 stimulation measured after 2 hrs by MTT assay (Rvb = 25.2 to 41.8%)2018European journal of medicinal chemistry, May-25, Volume: 152Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer's disease based on coumarin and lipoic acid scaffolds.
AID1233232Inhibition of mushroom tyrosinase using L-DOPA as substrate assessed as dopaquinone production at 10 uM after 5 mins by microplate reader analysis relative to control2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID449291Inhibition of lipid peroxidation in Sprague-Dawley rat liver homogenate assessed as malondialdehyde formation after 1 hr by TBARS assay2009Journal of medicinal chemistry, Dec-10, Volume: 52, Issue:23
Design, synthesis, and examination of neuron protective properties of alkenylated and amidated dehydro-silybin derivatives.
AID639825Inhibition of human recombinant aldose reductase using D-glyceraldehyde as substrate preincubated for 10 mins before substrate addition measured for every 10 secs for 50 mins by spectrophotometry2012Bioorganic & medicinal chemistry, Feb-01, Volume: 20, Issue:3
Construction of an Indonesian herbal constituents database and its use in Random Forest modelling in a search for inhibitors of aldose reductase.
AID401616Inhibition of human muscle recombinant aldose reductase by spectrophotometry2005Journal of natural products, Apr, Volume: 68, Issue:4
Structures and aldose reductase inhibitory effects of bromophenols from the red alga Symphyocladia latiuscula.
AID1248069Inhibition of baker's yeast alpha-glucosidase using p-nitrophenyl-alpha-D-glucopyranoside as substrate after 30 mins by spectrophotometric analysis2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Synthesis, α-glucosidase inhibitory and molecular docking studies of prenylated and geranylated flavones, isoflavones and chalcones.
AID1871921Metal chelating activity assessed as Zn2+-compound complex formation by measuring binding energy2022European journal of medicinal chemistry, Feb-05, Volume: 229Quercetin derivatives: Drug design, development, and biological activities, a review.
AID1330797Selectivity index, ratio of IC50 for electric eel AChE to IC50 for human recombinant BChE2016European journal of medicinal chemistry, Nov-10, Volume: 123Synthesis and structure-activity relationship study of tacrine-based pyrano[2,3-c]pyrazoles targeting AChE/BuChE and 15-LOX.
AID729306Inhibition of vasopressin V2 receptor (unknown origin) assessed as change in intracellular calcium levels treated with centrifuged compound solution by fluorometric analysis2013Journal of medicinal chemistry, Mar-28, Volume: 56, Issue:6
Colloidal aggregation causes inhibition of G protein-coupled receptors.
AID1082342Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID295378Decrease in androgen receptor protein expression in LNCaP cells by Western blotting2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
First pharmacophore-based identification of androgen receptor down-regulating agents: discovery of potent anti-prostate cancer agents.
AID456193Selectivity ratio of IC50 for reduced carboxymethylated kappa-casein fibril formation to IC50 for beta amyloid (1 to 42) fibril formation2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Carboxymethylated-kappa-casein: a convenient tool for the identification of polyphenolic inhibitors of amyloid fibril formation.
AID703476Therapeutic index, ratio of IC50 for mouse Peritoneal macrophages to IC50 for SSG-resistant Leishmania donovani 39 amastigote infected in mouse peritoneal macrophages2012Journal of medicinal chemistry, Oct-25, Volume: 55, Issue:20
Flavonoid dimers as novel, potent antileishmanial agents.
AID1771176Inhibition of CYP2C8 (unknown origin) assessed as activity at 1 uM relative to control2021Journal of medicinal chemistry, 09-09, Volume: 64, Issue:17
Discovery of
AID1371436Cytotoxicity against human MML1 cells assessed as cell viability at 14 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID587314Antiinflammatory activity in human neutrophil assessed as inhibition of LTB4-induced neutrophil chemoattraction 100 nM after 2 hrs by Boyden chamber v2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID1171181Teratogenic effect in zebrafish assessed as skeletal deformities at 160 uM after 72 hrs by microscopy2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Delineation of the role of glycosylation in the cytotoxic properties of quercetin using novel assays in living vertebrates.
AID315608Growth inhibition of human BGC823 cells at 50 uM after 72 hrs by MTT assay relative to control2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
Studies on the chemical constituents and anticancer activity of Saxifraga stolonifera (L) Meeb.
AID353594Inhibition of of heat-induced increase in nuclear HSF1 protein level in human Jurkat cells at 50 ug/mL treated for 1 hr before heat induction by Western blot2009Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7
Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives.
AID423636Cytotoxicity against human HeLa cells by MTT assay2009Journal of natural products, Apr, Volume: 72, Issue:4
Cytotoxic constituents of chinese propolis.
AID462341Toxicity in mouse B16-4A5 cells assessed as inhibition of cell proliferation at 10 uM in presence of 1 mM theophylline after 72 hrs by WST8 dye reduction assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells.
AID309802Reductive inhibition of 15-hLO12007Bioorganic & medicinal chemistry, Dec-01, Volume: 15, Issue:23
Structure-activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2.
AID603831Increase in c-Fos protein expression in human MDA-MB-231 cells at 20 uM within 30 mins by Western blot analysis2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Rhamnetin production based on the rational design of the poplar O-methyltransferase enzyme and its biological activities.
AID1667490Inhibition of soybean 15-LOX using arachidonic acid or linoleic acid as substrate preincubated for 5 mins followed by substrate addition and measured after 10 mins by colorimetric assay2020Bioorganic & medicinal chemistry, 04-01, Volume: 28, Issue:7
Novel class of benzimidazole-thiazole hybrids: The privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes.
AID191752Compound was evaluated for the mutagenicity by calculating number of revertants using Salmonella Typhimurium strain TA 98 (0.25 mg/plate) with S9 mix from rat liver; Toxic concentration1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
4'-Hydroxy-3-methoxyflavones with potent antipicornavirus activity.
AID106657Inhibitory activity against malate dehydrogenase (MDH) from Thermus flavus2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
Kinase inhibitors: not just for kinases anymore.
AID257081Inhibitory activity against PIM12005Journal of medicinal chemistry, Dec-01, Volume: 48, Issue:24
Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM-1) kinase.
AID605034Cellular uptake in human HCT116 cells assessed a bright fluorescence light at 5 uM after 1 hr by fluorescence microscopic analysis2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID464264Cytotoxicity against mouse RAW264.7 cells assessed as cell viability at 1 to 20 uM after 24 hrs by MTT assay relative to control2010Journal of natural products, Feb-26, Volume: 73, Issue:2
Flavanone and diphenylpropane glycosides and glycosidic acyl esters from Viscum articulatum.
AID603843Induction of apoptosis in human MDA-MB-231 cells assessed as cleaved caspase-7 accumulation at 20 uM after 12 hrs by Western blot analysis2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Rhamnetin production based on the rational design of the poplar O-methyltransferase enzyme and its biological activities.
AID33936Affinity at Adenosine A2A receptor in rat striatal membranes by [3H]- CGS 21680 displacement.1996Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
Interactions of flavonoids and other phytochemicals with adenosine receptors.
AID666771Inhibition of thrombin in New Zealand rabbit plasma assessed as fibrinogen level at 100 uM by coagulometry2012European journal of medicinal chemistry, Aug, Volume: 54Metabolism-based synthesis, biologic evaluation and SARs analysis of O-methylated analogs of quercetin as thrombin inhibitors.
AID1161235Induction of apoptosis in human neutrophils assessed as necrotic cells at 50 uM after 4 hrs by Annexin-V-FLUOS staining based flow cytometry (Rvb = 0.1%)2014European journal of medicinal chemistry, Oct-30, Volume: 86Synthesis of chlorinated flavonoids with anti-inflammatory and pro-apoptotic activities in human neutrophils.
AID1394724Inhibition of recombinant human VEGFR2 using peptide as substrate by fluorimetric analysis2018European journal of medicinal chemistry, Apr-25, Volume: 150Challenging clinically unresponsive medullary thyroid cancer: Discovery and pharmacological activity of novel RET inhibitors.
AID624616Specific activity of expressed human recombinant UGT2B152000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID469283Antiviral activity against HSV1 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by crystal violet staining2009Journal of natural products, Sep, Volume: 72, Issue:9
Eucalmaidins A-E, (+)-oleuropeic acid derivatives from the fresh leaves of Eucalyptus maideni.
AID1498666Antioxidant activity assessed as DPPH radical scavenging activity measured after 30 mins2018Bioorganic & medicinal chemistry letters, 08-01, Volume: 28, Issue:14
Synthesis of coumarin derivatives and their cytoprotective effects on t-BHP-induced oxidative damage in HepG2 cells.
AID1533715Inhibition of human liver microsomes CYP1A2 expressed in Escherichia coli DH5alpha cell membranes coexpressing human NADPH-cytochrome P450 reductase using 7-Ethoxyresorufin as substrate preincubated for 3 mins followed by NADPH addition measured after 10 2019European journal of medicinal chemistry, Feb-01, Volume: 163Phytoestrogens and their synthetic analogues as substrate mimic inhibitors of CYP1B1.
AID1186051Retention time of the compound by UPLC analysis2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Phytochemical analysis and antileukemic activity of polyphenolic constituents of Toona sinensis.
AID1859367Inhibition of recombinant HIV-1 reverse transcriptase at 200 ug/ml by ELISA relative to control2022European journal of medicinal chemistry, Apr-05, Volume: 233Natural products and synthetic analogues against HIV: A perspective to develop new potential anti-HIV drugs.
AID1485274Inhibition of butter milk xanthine oxidase (unknown origin) assessed as reduction in uric acid formation using xanthine as substrate by spectrophotometric assay2017European journal of medicinal chemistry, Jul-28, Volume: 135Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity.
AID1171178Cytotoxicity against human HCT116 cells at 1.25 to 20 uM after 96 hrs by MTT assay2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Delineation of the role of glycosylation in the cytotoxic properties of quercetin using novel assays in living vertebrates.
AID456190Inhibition of beta amyloid (1 to 42) fibril formation at 50 ug/mL by thioflavin T staining-based binding assay2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Carboxymethylated-kappa-casein: a convenient tool for the identification of polyphenolic inhibitors of amyloid fibril formation.
AID1224789Delta TM value showing the stabilisation of PLK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1871924Antioxidant activity assessed as ABTS radical scavenging activity at 5 wt% incubated for 6 mins in presence of Si and PCL50 by UV spectrophotometer analysis relative to control2022European journal of medicinal chemistry, Feb-05, Volume: 229Quercetin derivatives: Drug design, development, and biological activities, a review.
AID1572034Inhibition of IPMK in [3H]-inositol-labelled HEK293 cells assessed as reduction in insp5 levels at 2.5 uM after 3.5 hrs by HPLC analysis relative to control2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
AID487730Hypoglycemic activity in Wistar rat assessed as change in blood glucose level at 50 mg/kg, ig after 1 hr (RVb = 10.96 +/- 3.67 %)2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
A comparative study of flavonoid analogues on streptozotocin-nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11beta-hydroxysteroid dehydrogenase type 1 inhibition.
AID332708Inhibition of guinea pig classical complement system assessed as hemolysis of sensitized sheep erythrocytes1995Journal of natural products, Mar, Volume: 58, Issue:3
In vitro anticomplementary activity of constituents from Morinda morindoides.
AID424722Ratio of kcat to km for bovine xanthine oxidase at 10 uM2009Journal of natural products, Apr, Volume: 72, Issue:4
Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin.
AID1082330Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under dark conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1917223Neuroprotective activity in rat PC12 cells assessed as reduction in H2O2-induced ROS generation at 20 to 100 uM preincubated for 2 hrs followed by H2O2 stimulation and measured after 2 hrs by by DCFH-DA staining based fluorescence microscopic analysis2022Bioorganic & medicinal chemistry, 11-01, Volume: 73Synthesis and evaluation of glycosylated quercetin to enhance neuroprotective effects on cerebral ischemia-reperfusion.
AID467546Antinociceptive activity in ip dosed Swiss mouse assessed as inhibition of acetic acid-induced writhing response administered 30 mins before acetic acid challenge measured for 20 mins2009Journal of natural products, Nov, Volume: 72, Issue:11
Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production.
AID336445Cytotoxicity against human KB cells2002Journal of natural products, Oct, Volume: 65, Issue:10
Assessment of the antiprotozoal activity of Galphimia glauca and the isolation of new nor-secofriedelanes and nor-friedelanes.
AID1871936Antioxidant activity assessed as DPPH radical scavenging activity up to 2 mM relative to control2022European journal of medicinal chemistry, Feb-05, Volume: 229Quercetin derivatives: Drug design, development, and biological activities, a review.
AID1510602Inhibition of Enterobacter cloacae beta-lactamase incubated for 10 mins followed by nitrocefin substrate challenge and measured for 5 mins by spectrophotometric analysis2019ACS medicinal chemistry letters, Jun-13, Volume: 10, Issue:6
DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors.
AID701372Inhibition of myeloperoxidase2012Journal of medicinal chemistry, Aug-23, Volume: 55, Issue:16
Evaluation of new scaffolds of myeloperoxidase inhibitors by rational design combined with high-throughput virtual screening.
AID1381985Toxicity in Kunming mouse xenografted with human H22 cells assessed as effect on heart weight index at 100 mg/kg, ig administered for 7 consecutive days2018European journal of medicinal chemistry, Feb-25, Volume: 146The lead optimization of the polyamine conjugate of flavonoid with a naphthalene motif: Synthesis and biological evaluation.
AID445113Antioxidant activity assessed as protection against AAPH-induced pBR322 plasmid DNA strand open circular form at 11 to 45 uM after 4 hrs by agarose gel electrophoresis2009Bioorganic & medicinal chemistry letters, Nov-15, Volume: 19, Issue:22
Synthesis and antioxidant properties of dendritic polyphenols.
AID1555997Neuroprotective activity against H2O2 induced cytotoxicity in rat PC12 cells assessed as cell viability at 10 uM pretreated for 3 hrs followed by H2O2 challenge measured after 24 hrs by MTT assay (Rvb = 35.69 to 50.26%)2019European journal of medicinal chemistry, Sep-01, Volume: 177Design, synthesis, and biological evaluation of rutacecarpine derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease.
AID1152250Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis2014Bioorganic & medicinal chemistry, Jun-15, Volume: 22, Issue:12
Design and discovery of flavonoid-based HIV-1 integrase inhibitors targeting both the active site and the interaction with LEDGF/p75.
AID1516974Antifungal activity against Cryptococcus neoformans by CLSI-based microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID1224794Delta TM value showing the stabilisation of RSK2b produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID725981Inhibition of CMG2 (40 to 217) C175A and R40C double mutant (unknown origin) interaction to full length PA E733C mutant expressed in Escherichia coli by FRET assay2013Journal of medicinal chemistry, Mar-14, Volume: 56, Issue:5
1,2,3,4,6-Penta-O-galloyl-β-D-glucopyranose inhibits angiogenesis via inhibition of capillary morphogenesis gene 2.
AID512289Inhibition of human PKBalpha expressed in SF9 cells at 20 uM2000The Biochemical journal, Oct-01, Volume: 351, Issue:Pt 1
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
AID779050Inhibition of CK2 (unknown origin)2013Bioorganic & medicinal chemistry, Nov-01, Volume: 21, Issue:21
Discovery and characterization of synthetic 4'-hydroxyflavones-New CK2 inhibitors from flavone family.
AID445116Prooxidant effect on Cu2+-induced pBR322 DNA damage at 3 to 45 uM after 1 hr2009Bioorganic & medicinal chemistry letters, Nov-15, Volume: 19, Issue:22
Synthesis and antioxidant properties of dendritic polyphenols.
AID730327Cytotoxicity against human MV4-11 cells harboring FLT3 mutation after 72 hrs by tetrazolium based Ez CyTox cell viability assay2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
Flavonoids as receptor tyrosine kinase FLT3 inhibitors.
AID1164705Antioxidant activity assessed as DPPH scavenging activity after 30 mins by spectrophotometry2014Journal of natural products, Sep-26, Volume: 77, Issue:9
Flemingins G-O, cytotoxic and antioxidant constituents of the leaves of Flemingia grahamiana.
AID398958Antimicrobial activity against Escherichia coli
AID1224806Delta TM value showing the stabilisation of VRK3 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID377665Increase in duration of immobility in CD1 mouse at 1 mg/kg, ip by forced swimming test relative to control2006Journal of natural products, Jun, Volume: 69, Issue:6
Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and computational study.
AID462280Inhibition of mouse CA13 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID1711937Antiproliferative activity against human SMMC-7221 cells assessed as inhibition of cell proliferation at 30 uM measured after 48 hrs by MTT assay relative to control2016European journal of medicinal chemistry, Oct-04, Volume: 121Synthesis and biological properties of polyamine modified flavonoids as hepatocellular carcinoma inhibitors.
AID1224800Delta TM value showing the stabilisation of MST4 (2) produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1070497Antioxidant activity in human neutrophils assessed as inhibition of oxidative burst-induced ROS production by chemiluminescence assay2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Biologically active eremophilane-type sesquiterpenes from Camarops sp., an endophytic fungus isolated from Alibertia macrophylla.
AID337693Antibacterial activity against Escherichia coli ATCC 25922 after 48 hrs by silica gel plate-based INT-formazan method
AID690148Reducing activity assessed as chlorogenic acid equivalent per mmol standard at 37 degC for 30 mins by Folin-Ciocalteu reagent assay assay2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Comparative study on antioxidant capacity of flavonoids and their inhibitory effects on oleic acid-induced hepatic steatosis in vitro.
AID1248049Antioxidant activity assessed as inhibition of AAPH-induced lipid peroxidation after 3 hrs by TBA-MDA test2015Bioorganic & medicinal chemistry, Oct-01, Volume: 23, Issue:19
Synthesis, electronic properties, antioxidant and antibacterial activity of some new benzimidazoles.
AID768913Inhibition of human thrombin assessed as inhibition of fibrinogen alpha polymer formation at IC50 after 15 mins by SDS-PAGE analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID375989Antioxidant activity assessed as superoxide anion scavenging activity by xanthine oxidase oxidation system relative to control2006Journal of natural products, Apr, Volume: 69, Issue:4
Vanillic acid glycoside and quinic acid derivatives from Gardeniae Fructus.
AID1233223Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells at 10 uM after 72 hrs by microplate reader analysis relative to control2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID1239535Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 6 after 24 hrs by checkerboard assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1505137Antioxidant activity assessed as DPPH radical scavenging activity measured after 30 mins incubation under dark condition2018Journal of natural products, 01-26, Volume: 81, Issue:1
Isolation of Flavonoids and Flavonoid Glycosides from Myrsine africana and Their Inhibitory Activities against Mushroom Tyrosinase.
AID325766Inhibition of phospholipase A22007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1491172Inhibition of yeast alpha-glucosidase using p-nitrophenyl-alpha-glucopyranoside as substrate measured after 30 mins
AID487899Antidiabetic activity in STZ-induced Wistar rat assessed as reduction in blood glucose level at 50 mg/kg, ig after 4 day relative to control2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
A comparative study of flavonoid analogues on streptozotocin-nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11beta-hydroxysteroid dehydrogenase type 1 inhibition.
AID403628Inhibition of COX1 at 2.5 ug/mL2005Journal of natural products, Jul, Volume: 68, Issue:7
Expanding the ChemGPS chemical space with natural products.
AID1083158Antifungal activity against Diplodia seriata PLU03 assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID1188616Anticancer activity against human 292G cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID588151Permeability across MDCK cells from apical to basolateral side assessed as relative permeation rate at 10 to 100 uM after 1 hr2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Increased bioavailability of tricin-amino acid derivatives via a prodrug approach.
AID700819Increase of SIRT1 mRNA expression in mouse brain at 12.5 mg/kg qd for 7 days by RT-PCR analysis2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
SIRT1 modulation as a novel approach to the treatment of diseases of aging.
AID71640Inhibition of EGF-induced mitogenesis in human foreskin fibroblasts1994Journal of medicinal chemistry, May-27, Volume: 37, Issue:11
Structural studies on bioactive compounds. 23. Synthesis of polyhydroxylated 2-phenylbenzothiazoles and a comparison of their cytotoxicities and pharmacological properties with genistein and quercetin.
AID1226456Selectivity index, ratio of IC50 for HEK293 cells to IC50 for human HCT15 cells2015Journal of medicinal chemistry, May-28, Volume: 58, Issue:10
Selenium-containing chrysin and quercetin derivatives: attractive scaffolds for cancer therapy.
AID1162608Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated COX2 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method relative to untreated control2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID1220252Drug absorption in po dosed human2012Drug metabolism and disposition: the biological fate of chemicals, Sep, Volume: 40, Issue:9
Quantitative prediction of human intestinal glucuronidation effects on intestinal availability of UDP-glucuronosyltransferase substrates using in vitro data.
AID729311Inhibition of CX3CL1-stimulated CX3CR1 in human HTLA cells pre-incubated for 20 mins with centrifuged compound solution measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay2013Journal of medicinal chemistry, Mar-28, Volume: 56, Issue:6
Colloidal aggregation causes inhibition of G protein-coupled receptors.
AID1224802Delta TM value showing the stabilisation of TNIK produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID605042Cellular uptake in human MCF7 cells assessed as compound remaining in culture media at 10 uM after 1 hr by HPLC-mass spectrophotometric analysis2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID435640Inhibition of wild-type CK2 holoenzyme2003The Biochemical journal, Sep-15, Volume: 374, Issue:Pt 3
Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).
AID425006Antioxidant activity assessed as protection against peroxyl radical-induced alkaline phosphatase activity loss by microplate assay2009Journal of natural products, May-22, Volume: 72, Issue:5
Antioxidant phenylethanoid glycosides and a neolignan from Jacaranda caucana.
AID681196TP_TRANSPORTER: increase in mitoxantrone intracellular accumulation (Mitoxantrone: 100 uM, Quercetin: 50 uM) in BCRP-expressing MCF-7 cells2004Molecular pharmacology, May, Volume: 65, Issue:5
Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport.
AID1080610Phytotoxic activity against Echinochloa crus-galli (barnyard grass) assessed as inhibition of root growth at 22 +/-2 degC after 72 hr2009Journal of agricultural and food chemistry, Apr-08, Volume: 57, Issue:7
Level of catechin, myricetin, quercetin and isoquercitrin in buckwheat (Fagopyrum esculentum Moench), changes of their levels during vegetation and their effect on the growth of selected weeds.
AID379092Growth inhibition of BALB/c mouse cloned 3T3/A31 cells at 10 to 100 ug/mL after 72 hrs by nigrosin assay1999Journal of natural products, Mar, Volume: 62, Issue:3
Activities of plant-derived phenols in a fibroblast cell culture model
AID379092Growth inhibition of BALB/c mouse cloned 3T3/A31 cells at 10 to 100 ug/mL after 72 hrs by nigrosin assay1999Journal of natural products, Mar, Volume: 62, Issue:3
Activities of plant-derived phenols in a fibroblast cell culture model.
AID450965Antioxidant activity assessed as superoxide anion scavenging activity at 100 ug/mL after 5 mins by NBT reduction assay2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Preparation of C-23 esterified silybin derivatives and evaluation of their lipid peroxidation inhibitory and DNA protective properties.
AID1224779Delta TM value showing the stabilisation of NEK6 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID338024Inhibition of beef heart mitochondrial succinoxidase assessed as specific activity at 0.35 mM preincubated for 15 mins relative to control
AID1656373Antiviral activity against Influenza A virus (H1N1) infected in dog MDCK cells assessed as reduction in log2HA titer incubated for 3 to 4 days by CPE assay2020Bioorganic & medicinal chemistry, 01-01, Volume: 28, Issue:1
Design, synthesis and biological evaluation of substituted flavones and aurones as potential anti-influenza agents.
AID1242168Inhibition of HSF1 in human HeLa cells assessed as potentiation of 17-DMAG and heat-induced increase in cell death at 30 uM relative to 17-DMAG and heat alone2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Regulating the master regulator: Controlling heat shock factor 1 as a chemotherapy approach.
AID1172642Inhibition of cell proliferation of rat C6 cells assessed as cell viability after 72 hrs by sulforhodamine B assay2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Bioactive triterpenoid saponins and phenolic compounds against glioma cells.
AID1373935Induction of apoptosis in human HL60 cells assessed as late apoptotic cells at 50 uM after 24 hrs by Annexin-V-FITC/propidium iodide staining based flow cytometric analysis (Rvb = 0.85 +/- 0.13 %)2018Bioorganic & medicinal chemistry, 02-15, Volume: 26, Issue:4
Optimization of antimalarial, and anticancer activities of (E)-methyl 2-(7-chloroquinolin-4-ylthio)-3-(4-hydroxyphenyl) acrylate.
AID537735Binding affinity to Candida albicans CaMdr1p expressed in yeast AD1-8u2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
AID506950Inhibition of HSP70-mediated antiapoptotic activity in human NCI-H526 cells assessed as release of Apaf-1 from chaperon complex after 24 hrs by Western blot analysis2007Nature chemical biology, Aug, Volume: 3, Issue:8
Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer.
AID1336863Neuritogenic activity in mouse P19 derived neurons assessed as increase in neurite number at 1 nM after 18 hrs by phase contrast microscopic method relative to control2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Neuritogenic activity of bi-functional bis-tryptoline triazole.
AID762907Induction of intracellular RPS production in Swiss mouse peritoneal macrophages up to 12 uM after 72 hrs by spectrofluorometric analysis2013Journal of natural products, Aug-23, Volume: 76, Issue:8
Reactive oxygen species production by quercetin causes the death of Leishmania amazonensis intracellular amastigotes.
AID377591Increase in duration of immobility in CD1 mouse at 10 mg/kg, ip by forced swimming test relative to control2006Journal of natural products, Jun, Volume: 69, Issue:6
Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and computational study.
AID1056593Antiperiodontitic activity in Aggregatibacter actinomycetemcomitans infected Balb/c mouse model assessed as downregulation of RANKL expression at 100 mg/kg, sc for 15 days post Aggregatibacter actinomycetemcomitans-challenge by Western blotting analysis2013Journal of natural products, Dec-27, Volume: 76, Issue:12
Quercetin inhibits inflammatory bone resorption in a mouse periodontitis model.
AID603841Increase in JNK1 phosphorylation in human MDA-MB-231 cells at 20 uM by Western blot analysis2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Rhamnetin production based on the rational design of the poplar O-methyltransferase enzyme and its biological activities.
AID195232Influence (5 uM) on transacetylase catalyzed time dependent activation of NADPH cytochrome C reductase at pre-incubation time being 5 mins2002Bioorganic & medicinal chemistry letters, Sep-16, Volume: 12, Issue:18
Comparison of the prevention of aflatoxin b(1)-induced genotoxicity by quercetin and quercetin pentaacetate.
AID362989Inhibition of immune complex-stimulated neutrophil oxidative metabolism in New Zealand white rabbit neutrophils assessed as ROS generation after 30 mins by luminol enhanced chemiluminescence assay2008European journal of medicinal chemistry, May, Volume: 43, Issue:5
Inhibition of immune complex-mediated neutrophil oxidative metabolism: a pharmacophore model for 3-phenylcoumarin derivatives using GRIND-based 3D-QSAR and 2D-QSAR procedures.
AID1265118Inhibition of recombinant human N-terminal His6-tagged AKR1B10 expressed in Escherichia coli BL21 cells using all-trans-retinal as substrate at 20 uM incubated for 15 mins by HPLC method2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Flavones Inhibit the Activity of AKR1B10, a Promising Therapeutic Target for Cancer Treatment.
AID1110806Inhibition of xanthine oxidase assessed as conversion of xanthine to uric acid incubated for 3 min2005Phytochemistry, Jan, Volume: 66, Issue:2
Bioactive ellagitannins from Cunonia macrophylla, an endemic Cunoniaceae from New Caledonia.
AID1294430Antioxidant activity assessed as inhibition of superoxide induced reduction of NBT measured for 2 mins by UV-visible spectrophotometric method2016European journal of medicinal chemistry, Jun-10, Volume: 115Novel chromone and xanthone derivatives: Synthesis and ROS/RNS scavenging activities.
AID1845529Binding affinity to human c-MYC G-quadruplex (Pu24T) DNA assessed as second order binding constant by isothermal titration calorimetry method2021Journal of medicinal chemistry, 01-14, Volume: 64, Issue:1
Recent Update on Targeting
AID1372148Inhibition of recombinant human CYP2D6 expressed in yeast microsomal membranes by fluorescence assay
AID603839Increase in JNK2 phosphorylation in human MDA-MB-231 cells at 20 uM by Western blot analysis2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Rhamnetin production based on the rational design of the poplar O-methyltransferase enzyme and its biological activities.
AID1194986Antioxidant activity assessed as FRAP values at 100 ug/ml incubated at 37 degC for 5 mins by FeSO4.7H2O calibration curve based method2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Cytotoxic and antioxidant constituents from the leaves of Psidium guajava.
AID527148Reduction of gastrocnemius muscle weight loss in C57BL/6 mouse tail suspension model at 2.5 pmol administered in gastrocnemius muscle qd for 10 days relative to whole body weight2010Journal of natural products, Oct-22, Volume: 73, Issue:10
Quercetin prevents unloading-derived disused muscle atrophy by attenuating the induction of ubiquitin ligases in tail-suspension mice.
AID1683176Cytotoxicity against human HeLa cells overexpressing MCT-1 assessed as reduction in cell viability measured after 72 hrs by MTT assay2021Bioorganic & medicinal chemistry, 01-01, Volume: 29Synthesis and anticancer activity of new coumarin-3-carboxylic acid derivatives as potential lactatetransportinhibitors.
AID429252Inhibition of tyrosinase2009European journal of medicinal chemistry, Aug, Volume: 44, Issue:8
Synthesis and biological evaluation of curcumin-like diarylpentanoid analogues for anti-inflammatory, antioxidant and anti-tyrosinase activities.
AID1917229Neuroprotective activity against middle cerebral artery occlusion induced cerebral ischemia reperfusion rat model assessed as decrease in brain MDA level at 10 mg/kg, ip preincubated for 0.5 hrs followed by reperfusion and measured after 24 hrs2022Bioorganic & medicinal chemistry, 11-01, Volume: 73Synthesis and evaluation of glycosylated quercetin to enhance neuroprotective effects on cerebral ischemia-reperfusion.
AID429251Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins2009European journal of medicinal chemistry, Aug, Volume: 44, Issue:8
Synthesis and biological evaluation of curcumin-like diarylpentanoid analogues for anti-inflammatory, antioxidant and anti-tyrosinase activities.
AID1871967Competitive inhibition of xanthine oxidase (unknown origin) at 0.4 uM using xanthine as substrate preincubated with substrate for 1 min followed by compound addition by double beam spectrophotometer analysis relative to control2022European journal of medicinal chemistry, Feb-05, Volume: 229Quercetin derivatives: Drug design, development, and biological activities, a review.
AID755045Antioxidant activity assessed as DPPH radical scavenging activity measured at 10 mins by ESR spectrometric analysis2013Bioorganic & medicinal chemistry, Jul-01, Volume: 21, Issue:13
Remarkable antioxidant properties of a series of hydroxy-3-arylcoumarins.
AID1294434Antioxidant activity assessed as inhibition of HOCl-induced oxidation of DHR to rhodamine 123 at 37 degC by fluorimetric method2016European journal of medicinal chemistry, Jun-10, Volume: 115Novel chromone and xanthone derivatives: Synthesis and ROS/RNS scavenging activities.
AID1188615Anticancer activity against human H1299 cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID1867187Antiinflammatory activity in mouse RAW264.7 assessed as inhibition of LPS-induced NO production preincubated for 30 mins followed by LPS stimulation measured after 24 hrs by Griess reagent based assay relative to control2022Journal of natural products, 04-22, Volume: 85, Issue:4
Polysubstituted Cyclopentene Benzamides and Dianthramide Alkaloids from
AID1668220Inhibition of rat bone marrow myeloperoxidase using H2O2 as substrate at 10 uM after 20 mins by TMB based method (Rvb = - 1.4 +/- 12.7%)2020Bioorganic & medicinal chemistry, 05-15, Volume: 28, Issue:10
Acylhydrazones as isoniazid derivatives with multi-target profiles for the treatment of Alzheimer's disease: Radical scavenging, myeloperoxidase/acetylcholinesterase inhibition and biometal chelation.
AID1706451Neuroprotective activity against H2O2-induced cytotoxicity in rat PC12 cells assessed as increase in cell viability at 30 uM preincubated for 3 hrs followed by H2O2 addition and measured after 24 hrs by MTT assay (Rvb = 24.8 to 41.7%)2021European journal of medicinal chemistry, Jan-01, Volume: 209Design and synthesis of 3-(4-pyridyl)-5-(4-sulfamido-phenyl)-1,2,4-oxadiazole derivatives as novel GSK-3β inhibitors and evaluation of their potential as multifunctional anti-Alzheimer agents.
AID1434704Antineuroinflammatory activity in mouse N9 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess assay2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Natural potential neuroinflammatory inhibitors from Alhagi sparsifolia Shap.
AID1162612Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated MMP9 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID1713249Selectivity index, ratio of IC50 for ovine COX-1 to IC50 for ovine COX-22016European journal of medicinal chemistry, Nov-10, Volume: 123Novel N-substituted indole Schiff bases as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes: Synthesis, biological activities in vitro and docking study.
AID1516853Antifungal activity against Candida albicans ATCC 10231 by microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID501210Cytotoxicity against african green monkey Vero cells after 3 days by MTT assay2010Journal of natural products, Feb-26, Volume: 73, Issue:2
Phloroglucinol glycosides from the fresh fruits of Eucalyptus maideni.
AID638568Antiviral activity against influenza A virus (A/swine/OH/511445/2007(H1N1)) Oh7 infected in MDCK cells assessed as inhibition of viral replication after 4 days by quantitative RT-PCR2012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Synthesis and antiviral activity of substituted quercetins.
AID366286Inhibition of Influenza A Jiangsu/10/2003 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay2008Bioorganic & medicinal chemistry, Aug-01, Volume: 16, Issue:15
Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities.
AID605048Cellular uptake in human MCF7 cells assessed as formation of oxidised quercetin in cell lysates at 10 uM after 5 hrs by HPLC-mass spectrophotometric analysis2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID578664Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as TNF-alpha level at 1 to 100 uM after 18 hrs2011Bioorganic & medicinal chemistry letters, Mar-15, Volume: 21, Issue:6
A new ursane-type triterpenoid glycoside from Centella asiatica leaves modulates the production of nitric oxide and secretion of TNF-α in activated RAW 264.7 cells.
AID1128739In vivo antidyslipidemic activity against Triton WR 1339-induced hyperlipidemic Wistar rat model assessed as decrease in triglyceride level in plasma at 56 umol/kg, ip administered as single dose 1 hr after Triton WR 1339 challenge measured after 24 hrs2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Design of novel potent antihyperlipidemic agents with antioxidant/anti-inflammatory properties: exploiting phenothiazine's strong antioxidant activity.
AID1239713Anti-platelet activity in rat platelet rich plasma assessed as inhibition of ADP and calcium-induced platelet aggregation at 100 uM pre-incubated at 37 degC for 10 mins and measured 30 mins after ADP and calcium addition2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Potential therapeutic agents for circulatory diseases from Bauhinia glauca Benth.subsp. pernervosa. (Da Ye Guan Men).
AID487735Antidiabetic activity in Wistar rat assessed as change in blood glucose level at 50 mg/kg, ig after 3 hrs (RVb = -9.83 % +/- 5.67%)2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
A comparative study of flavonoid analogues on streptozotocin-nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11beta-hydroxysteroid dehydrogenase type 1 inhibition.
AID1871968Non-competitive inhibition of xanthine oxidase (unknown origin) at 0.4 uM using xanthine as substrate preincubated with substrate for 1 min followed by compound addition by double beam spectrophotometer analysis relative to control2022European journal of medicinal chemistry, Feb-05, Volume: 229Quercetin derivatives: Drug design, development, and biological activities, a review.
AID362990Cytotoxicity against New Zealand white rabbit neutrophils assessed as cell viability at 50 uM after 30 mins by trypan blue exclusion test2008European journal of medicinal chemistry, May, Volume: 43, Issue:5
Inhibition of immune complex-mediated neutrophil oxidative metabolism: a pharmacophore model for 3-phenylcoumarin derivatives using GRIND-based 3D-QSAR and 2D-QSAR procedures.
AID670319Inhibition of human recombinant MMP9 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay2012Bioorganic & medicinal chemistry, Jul-01, Volume: 20, Issue:13
Natural products as a gold mine for selective matrix metalloproteinases inhibitors.
AID1247840Displacement of ANS from DAPK1 catalytic domain (1 to 285) (unknown origin) after 30 mins by fluorescence assay2015Journal of medicinal chemistry, Sep-24, Volume: 58, Issue:18
Structural Insight into the Interactions between Death-Associated Protein Kinase 1 and Natural Flavonoids.
AID1572028Inhibition of IP6K2 in human [3H]-inositol-labelled HCT116 cells assessed as reduction in insp7 levels at 10 uM after 3.5 hrs by HPLC analysis relative to control2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
AID467545Muscle relaxant activity in Swiss mouse assessed as motor response at 100 mg/kg, ip after 3 hrs 30 mins by rotarod test2009Journal of natural products, Nov, Volume: 72, Issue:11
Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production.
AID1711975Antitumor activity against mouse H22 cells implanted in Kunming mouse assessed as tumor growth inhibition at 100 mg/kg, iv administered for 7 consecutive days starting from day 8 post inoculation and measured after 16 days relative to control2016European journal of medicinal chemistry, Oct-04, Volume: 121Synthesis and biological properties of polyamine modified flavonoids as hepatocellular carcinoma inhibitors.
AID615921Binding affinity to ABCB1 nucleotide binding domain 22011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Docking and 3D-QSAR (quantitative structure activity relationship) studies of flavones, the potent inhibitors of p-glycoprotein targeting the nucleotide binding domain.
AID1224777Delta TM value showing the stabilisation of MST4(1) produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1311084Antioxidant activity assessed as inhibition of hydrogen peroxide-induced lucigenin oxidation at 1000 uM by chemiluminescence-based assay2016European journal of medicinal chemistry, Aug-25, Volume: 119New polyhydroxylated flavon-3-ols and 3-hydroxy-2-styrylchromones: synthesis and ROS/RNS scavenging activities.
AID1264949Cytotoxicity against human MSC assessed as decrease in cell number at 1 to 10 uM after 9 days by methylene blue staining based microscopy relative to control2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID355891Antimicrobial activity against Bacillus cereus isolate after 36 hrs under aerobic condition by microdilution method2003Journal of natural products, May, Volume: 66, Issue:5
Sesquiterpene lactones from Anthemis altissima and their anti-Helicobacter pylori activity.
AID1082425Stimulation of fruit-infesting behavior of Cydia pomonella (codling moth) neonates infested in apple fruit plugs assessed as feeding deterrence index at 30 mg/mL2011Journal of agricultural and food chemistry, Oct-26, Volume: 59, Issue:20
Effects of Ginkgo biloba constituents on fruit-infesting behavior of codling moth (Cydia pomonella) in apples.
AID1226461Selectivity index, ratio of IC50 for HEK293 cells to IC50 for cisplatin-resistant human A431 cells2015Journal of medicinal chemistry, May-28, Volume: 58, Issue:10
Selenium-containing chrysin and quercetin derivatives: attractive scaffolds for cancer therapy.
AID334639Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-aminoanthracene-induced mutation at 150 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID339145Inhibition of norepinephrine-induced Wistar rat thoracic aorta phasic contraction at 10 ug/mL after 15 mins1993Journal of natural products, Jun, Volume: 56, Issue:6
Antiplatelet effects and vasorelaxing action of some constituents of Formosan plants.
AID487901Inhibition of human 11beta HSD1 in HEK293 cells at 10 uM2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
A comparative study of flavonoid analogues on streptozotocin-nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11beta-hydroxysteroid dehydrogenase type 1 inhibition.
AID1316677Binding affinity to [d(T2AG3T)]4 G-quadruplex DNA (unknown origin) containing human telomeric repeat assessed as increase in melting temperature by NMR spectroscopic analysis2016Bioorganic & medicinal chemistry letters, 10-15, Volume: 26, Issue:20
Nuclear magnetic resonance studies reveal stabilization of parallel G-quadruplex DNA [d(T
AID512298Inhibition of His-tagged human CHK1 expressed in Escherichia coli at 20 uM2000The Biochemical journal, Oct-01, Volume: 351, Issue:Pt 1
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
AID1399730Cytotoxicity against LPS-treated mouse BV2 cells assessed as cell viability after 24 hrs by SRB assay relative to control2018Bioorganic & medicinal chemistry, 09-01, Volume: 26, Issue:16
Synthesis and bioactivities evaluation of l-pyroglutamic acid analogues from natural product lead.
AID1224752Delta TM value showing the stabilisation of CAMK2B produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1452994Inhibition of CYP1B1 (unknown origin)2017European journal of medicinal chemistry, Jul-28, Volume: 135Inhibitors of cytochrome P450 (CYP) 1B1.
AID1056592Effect on OPG expression in Aggregatibacter actinomycetemcomitans infected Balb/c mouse model at 100 mg/kg, sc for 15 days post Aggregatibacter actinomycetemcomitans-challenge by Western blotting analysis2013Journal of natural products, Dec-27, Volume: 76, Issue:12
Quercetin inhibits inflammatory bone resorption in a mouse periodontitis model.
AID252875Caspase 3/7 activity is expressed as ratio of caspase activation in treated human colonic cell line (HT-29) to that of untreated control cells after 5 hr2005Journal of medicinal chemistry, Apr-21, Volume: 48, Issue:8
Effects of flavonoids on cell proliferation and caspase activation in a human colonic cell line HT29: an SAR study.
AID1176148Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated TNFalpha production at 0.4 to 2 uM by ELISA2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
Anti-inflammatory components of Chrysanthemum indicum flowers.
AID1224760Delta TM value showing the stabilisation of CHEK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1462059Antiproliferative activity against human PC3 cells after 3 days by WST-1 assay2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
3-O-Substituted-3',4',5'-trimethoxyflavonols: Synthesis and cell-based evaluation as anti-prostate cancer agents.
AID729312Inhibition of CX3CL1-stimulated CX3CR1 in human HTLA cells pre-incubated for 20 mins measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay2013Journal of medicinal chemistry, Mar-28, Volume: 56, Issue:6
Colloidal aggregation causes inhibition of G protein-coupled receptors.
AID1176150Inhibition of COX2 protein expression in LPS-stimulated mouse RAW264.7 cells by Western blot analysis2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
Anti-inflammatory components of Chrysanthemum indicum flowers.
AID353592Inhibition of HSF1 binding to heat shock element DNA assessed as HSF1/HSE complex formation in human HeLa cells at 50 ug/mL treated for 1 hr before heat induction2009Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7
Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives.
AID1655303Growth inhibition of human A2780 cells incubated for 72 hrs by trypan blue assay2020ACS medicinal chemistry letters, May-14, Volume: 11, Issue:5
Synthesis, Antiproliferative Effect, and Topoisomerase II Inhibitory Activity of 3-Methyl-2-phenyl-1
AID362991Cytotoxicity against New Zealand white rabbit neutrophils assessed as LDH release at 50 uM after 30 mins by spectrophotometry2008European journal of medicinal chemistry, May, Volume: 43, Issue:5
Inhibition of immune complex-mediated neutrophil oxidative metabolism: a pharmacophore model for 3-phenylcoumarin derivatives using GRIND-based 3D-QSAR and 2D-QSAR procedures.
AID768895Inhibition of human thrombin assessed as response unit at 1000 uM by BIAcore analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID1224795Delta TM value showing the stabilisation of SLK produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1102142Phytotoxicity in Centaurea maculosa assessed as inhibition of seed germination at 250 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID1705065Inhibition of biotinylated 5-(4-((Z)-3-Carboxy-3-hydroxyacryloyl)-4-(4-chlorobenzyl)piperidine-1-carbonyl)-2-((13,35-dioxo-39-((3aR,4R,6aS)-2-oxohexahydro-1H-thieno[3,4-d]imidazole-4-yl)-3,6,9,16,19,22,25,28,31-nonaoxa-12,34-diazanonatriacontyl)oxy)benzoi2020European journal of medicinal chemistry, Dec-15, Volume: 208Unraveling the anti-influenza effect of flavonoids: Experimental validation of luteolin and its congeners as potent influenza endonuclease inhibitors.
AID666855Cytotoxicity against mouse L929 cells after 5 days by MTS assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis of methylated quercetin derivatives and their reversal activities on P-gp- and BCRP-mediated multidrug resistance tumour cells.
AID155518Inhibition of phosphatidylinositol 3-kinase2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
Kinase inhibitors: not just for kinases anymore.
AID663957Partial agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay2012ACS medicinal chemistry letters, Feb-09, Volume: 3, Issue:2
Discovery of Natural Phenols as G Protein-Coupled Receptor-35 (GPR35) Agonists.
AID1063053Inhibition of ALK (unknown origin)2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Protein kinase and HDAC inhibitors from the endophytic fungus Epicoccum nigrum.
AID1224784Delta TM value showing the stabilisation of PCTK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID315616Induction of apoptosis in human BGC823 cells at 100 uM after 24 hrs by flow cytometry2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
Studies on the chemical constituents and anticancer activity of Saxifraga stolonifera (L) Meeb.
AID706714Competitive inhibition of PIM1 in presence of ATP2012Journal of medicinal chemistry, Oct-11, Volume: 55, Issue:19
Potential use of selective and nonselective Pim kinase inhibitors for cancer therapy.
AID240981Inhibition of glycogen synthase kinase 32005Journal of medicinal chemistry, Feb-10, Volume: 48, Issue:3
Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin.
AID293619Apoptotic activity in human blood neutrophils after 24 hrs2007European journal of medicinal chemistry, May, Volume: 42, Issue:5
Novel and versatile methodology for synthesis of cyclic imides and evaluation of their cytotoxic, DNA binding, apoptotic inducing activities and molecular modeling study.
AID1224768Delta TM value showing the stabilisation of DMPK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID195231Influence (5 uM) on transacetylase catalyzed time dependent activation of NADPH cytochrome C reductase at pre-incubation time being 30 mins2002Bioorganic & medicinal chemistry letters, Sep-16, Volume: 12, Issue:18
Comparison of the prevention of aflatoxin b(1)-induced genotoxicity by quercetin and quercetin pentaacetate.
AID34785Antiallergic agent with Aldose reductase Inhibitory Activity at 10E-6 M concentration1980Journal of medicinal chemistry, Nov, Volume: 23, Issue:11
Synthesis and aldose reductase inhibitory activity of 7-sulfamoylxanthone-2-carboxylic acids.
AID1324834Protective effect against H2O2-induced cell death in rat PC12 cells at 5 uM preincubated for 2 hrs followed by H2O2 addition for 24 hrs by MTT assay2016European journal of medicinal chemistry, Oct-21, Volume: 122Design, synthesis and evaluation of 4-dimethylamine flavonoid derivatives as potential multifunctional anti-Alzheimer agents.
AID1425891Competitive inhibition of GLUT4 in Wistar rat adipocytes assessed as reduction in insulin-stimulated 3-O-[3H]methyl-D-glucose uptake measured for 30 secs by Lineweaver-Burk plot analysis2016MedChemComm, Sep-01, Volume: 7, Issue:9
Anticancer agents interacting with membrane glucose transporters.
AID1373923Induction of apoptosis in human Jurkat E6-1 cells assessed as late apoptotic cells at 50 uM after 24 hrs by Annexin-V-FITC/propidium iodide staining based flow cytometric analysis (Rvb = 0.73 +/- 0.14 %)2018Bioorganic & medicinal chemistry, 02-15, Volume: 26, Issue:4
Optimization of antimalarial, and anticancer activities of (E)-methyl 2-(7-chloroquinolin-4-ylthio)-3-(4-hydroxyphenyl) acrylate.
AID1516849Antifungal activity against Candida krusei 168 by microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID1191758Inhibition of MPG in human HeLa cell extracts at 50 to 300 uM using 1,N6 ethenoadenine containing 32P-labeled duplex oligonucleotide substrates by gel-based excision activity assay2015Bioorganic & medicinal chemistry, Mar-01, Volume: 23, Issue:5
Naturally occurring polyphenol, morin hydrate, inhibits enzymatic activity of N-methylpurine DNA glycosylase, a DNA repair enzyme with various roles in human disease.
AID287078Inhibitory effect on TPA-induced Epstein-Barr Virus early antigen activation in Raji cells at 500 mol ratio/32 pmol TPA relative to TPA2007Journal of natural products, May, Volume: 70, Issue:5
Anti-inflammatory and potential cancer chemopreventive constituents of the fruits of Morinda citrifolia (Noni).
AID1129472Antioxidant activity assessed as trolox equivalent of ABTS radical scavenging activity2014Bioorganic & medicinal chemistry letters, Apr-01, Volume: 24, Issue:7
Functionalized acridin-9-yl phenylamines protected neuronal HT22 cells from glutamate-induced cell death by reducing intracellular levels of free radical species.
AID550021Vasorelaxant activity in Wistar rat endothelium-denuded thoracic aortic ring assessed as inhibition of noradrenaline-induced contraction treated after noradrenaline challenge measured after 60 mins2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Vasorelaxant effect of flavonoids through calmodulin inhibition: Ex vivo, in vitro, and in silico approaches.
AID1224796Delta TM value showing the stabilisation of LOK produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID353591Enhancement of HSP27 Ser78 phosphorylation in human HeLa cells at 50 ug/mL treated for 1 hr2009Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7
Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives.
AID1527605Anti-colitis activity in ICR mouse model of DSS-induced colitis assessed as reduction in DSS-induced body weight loss at 6 mg, po for 14 days relative to control2020European journal of medicinal chemistry, Jan-01, Volume: 185Discovery of small-molecule candidates against inflammatory bowel disease.
AID1717775Inhibition of SARS-CoV 3C-like protease (3241 to 3546 residues) expressed in Pichia pastoris GS115 using Dabcyl-KTSAVLQSGFRKME-Edans fluorogenic peptide as substrate measured for 18 mins by fluorescence method2020Journal of medicinal chemistry, 11-25, Volume: 63, Issue:22
Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
AID1683180Induction of apoptosis in human HeLa cells assessed as late apoptotic cells measured after 48 hrs by annexinV-FITC/propidium iodide staining based by flow cytometry (Rvb = 3.85 %)2021Bioorganic & medicinal chemistry, 01-01, Volume: 29Synthesis and anticancer activity of new coumarin-3-carboxylic acid derivatives as potential lactatetransportinhibitors.
AID1371370Cytotoxicity against human HT-29 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID673629Inhibition of CK2 using RRRADDSDDDDD as substrate after 30 mins by PKLight assay2011Bioorganic & medicinal chemistry, Aug-15, Volume: 19, Issue:16
Biotinylated quercetin as an intrinsic photoaffinity proteomics probe for the identification of quercetin target proteins.
AID370284Effect on CYP2C8/CYP2C9 in human liver assessed as tolubutamide methylhydroxylation at 100 uM relative to control2006PLoS medicine, Nov, Volume: 3, Issue:11
OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice.
AID34658In vitro inhibitory activity against recombinant human aldose reductase (ALR2) was determined2003Journal of medicinal chemistry, Nov-20, Volume: 46, Issue:24
Synthesis, activity, and molecular modeling studies of novel human aldose reductase inhibitors based on a marine natural product.
AID33150Ability to displace [3H]-CGS- 21680 binding from adenosine A2A receptor.1998Journal of medicinal chemistry, Jan-01, Volume: 41, Issue:1
Flavonoid derivatives as adenosine receptor antagonists: a comparison of the hypothetical receptor binding site based on a comparative molecular field analysis model.
AID1536972Inhibition of LPS-stimulated TNFalpha production in human neutrophils at 2.5 uM after 24 hrs by ELISA2019Journal of natural products, 02-22, Volume: 82, Issue:2
Eupatoriopicrin Inhibits Pro-inflammatory Functions of Neutrophils via Suppression of IL-8 and TNF-alpha Production and p38 and ERK 1/2 MAP Kinases.
AID399340Inhibition of xanthine oxidase assessed as decrease in uric acid production by spectrophotometry1998Journal of natural products, Jan, Volume: 61, Issue:1
Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers.
AID317335Effect on doxorubicin metabolism in human liver cytosolic fractions assessed as inhibition of formation of doxorubicinol2008Bioorganic & medicinal chemistry, Feb-15, Volume: 16, Issue:4
The effect of flavonoid derivatives on doxorubicin transport and metabolism.
AID624612Specific activity of expressed human recombinant UGT1A92000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1303189Induction of vanadate-sensitive ATPase activity of recombinant human ABCG2 expressed in baculovirus infected Sf9 cell membrane assessed as increase in inorganic phosphate production at 1 uM after 20 mins by colorimetry2016European journal of medicinal chemistry, Jul-19, Volume: 117The combination of quinazoline and chalcone moieties leads to novel potent heterodimeric modulators of breast cancer resistance protein (BCRP/ABCG2).
AID365954Inhibition of Cdk1/cyclin B2008Bioorganic & medicinal chemistry, Aug-01, Volume: 16, Issue:15
Nitrogen-containing flavonoid analogues as CDK1/cyclin B inhibitors: synthesis, SAR analysis, and biological activity.
AID338026Inhibition of rat liver mitochondrial ATPase assessed as specific activity at 0.42 mM relative to control
AID1233242Downregulation of TRP-2 mRNA expression in theophylline-stimulated mouse B16-4A5 cells assessed as ratio of TRP-2 mRNA to beta-actin mRNA level at 10 uM after 72 hrs by qPCR analysis2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID1381991Toxicity in Kunming mouse xenografted with human H22 cells assessed as effect on kidney weight index at 100 mg/kg, ig administered for 7 consecutive days2018European journal of medicinal chemistry, Feb-25, Volume: 146The lead optimization of the polyamine conjugate of flavonoid with a naphthalene motif: Synthesis and biological evaluation.
AID1365687Neuroprotective activity against H2O2-induced cell death in human SH-SY5Y cells assessed as increase in cell viability at 100 uM pretreated for 12 hrs followed by H2O2 challenge measured after 3 hrs by MTT assay2017Bioorganic & medicinal chemistry letters, 11-01, Volume: 27, Issue:21
Flavonoids and their derivatives with β-amyloid aggregation inhibitory activity from the leaves and twigs of Pithecellobium clypearia Benth.
AID132224In vivo inhibition of AA induced ear oedema in mice following topical administration.1990Journal of medicinal chemistry, Oct, Volume: 33, Issue:10
Penta- and hexadienoic acid derivatives: a novel series of 5-lipoxygenase inhibitors.
AID1070388Neuroprotective activity in mouse HT22 cells assessed as reduction of t-BOOH-induced oxidative stress at 40 uM preincubated for 3 hrs followed by t-BOOH induction measured after 20 hrs by MTT assay2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Flavonoids, flavonoid metabolites, and phenolic acids inhibit oxidative stress in the neuronal cell line HT-22 monitored by ECIS and MTT assay: a comparative study.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID359635Antiviral activity against HSV1 in african green monkey Vero cells assessed as log reduction of virus titer at 5 ug/ml1992Journal of natural products, Dec, Volume: 55, Issue:12
Synergistic effect of flavones and flavonols against herpes simplex virus type 1 in cell culture. Comparison with the antiviral activity of propolis.
AID467859Analgesic activity in Swiss mouse assessed as reaction time taken to jump or lick paw at 8 mg/kg, ip after 60 mins of administration by hot plate test2009Journal of natural products, Nov, Volume: 72, Issue:11
Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production.
AID1446231Inhibition of recombinant MPO (unknown origin) assessed as reduction in LDL oxidation in presence of H2O2 and HCl after 5 mins by ELISA2017Journal of medicinal chemistry, 08-10, Volume: 60, Issue:15
Discovery of Novel Potent Reversible and Irreversible Myeloperoxidase Inhibitors Using Virtual Screening Procedure.
AID1705066Inhibition of endonuclease activity of Influenza A virus (A/California/07/2009(H1N1)) N-terminal GST-tagged polymerase acidic subunit N-terminal domain expressed in Escherichia coli BL21 (DE3) RIL cells at 0.01 to 100 uM using single-stranded circular DNA2020European journal of medicinal chemistry, Dec-15, Volume: 208Unraveling the anti-influenza effect of flavonoids: Experimental validation of luteolin and its congeners as potent influenza endonuclease inhibitors.
AID309801Inhibition of 15-hLO22007Bioorganic & medicinal chemistry, Dec-01, Volume: 15, Issue:23
Structure-activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2.
AID1082341Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1156027Neuroprotective activity in rat PC12 cells assessed as inhibition H2O2-induced reduction of cell viability at 5 uM after 24 hrs by MTT assay2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis and anti-cholinesterase activity of new 7-hydroxycoumarin derivatives.
AID277106Inhibition of PMA-induced ROS production in human PMN2006Bioorganic & medicinal chemistry letters, Dec-15, Volume: 16, Issue:24
Total synthesis and biological evaluation of viscolin, a 1,3-diphenylpropane as a novel potent anti-inflammatory agent.
AID375992Inhibition of HIV1 recombinant integrase expressed in Escherichia coli2006Journal of natural products, Apr, Volume: 69, Issue:4
Vanillic acid glycoside and quinic acid derivatives from Gardeniae Fructus.
AID1871935Induction of apoptosis in human MCF7 cells assessed as early apoptotic cells at 50 uM measured after 12 hrs by annexin V-FITC/propidium iodide staining based flow cytometry relative to control2022European journal of medicinal chemistry, Feb-05, Volume: 229Quercetin derivatives: Drug design, development, and biological activities, a review.
AID1879371Binding affinity to triplex DNA1 containing 15 nucleotide-long triplex-forming region (unknown origin) assessed as change in melting temperature at 10 uM by UV based assay2022Bioorganic & medicinal chemistry letters, 04-01, Volume: 615-Substituted 3, 3', 4', 7-tetramethoxyflavonoids - A novel class of potent DNA triplex specific binding ligands.
AID1126475Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production at 0.4 uM after 18 hrs by griess reaction analysis2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID1743180Antioxidant activity in human erythrocytes assessed as protection against AAPH-induced hemolysis at 50 uM preincubated for 20 mins followed by AAPH addition and measured after 2 hrs by spectrophotometric method relative to control2020European journal of medicinal chemistry, Dec-15, Volume: 208Multiple biological active 4-aminopyrazoles containing trifluoromethyl and their 4-nitroso-precursors: Synthesis and evaluation.
AID1410098Antioxidant activity in human HepG2 cells assessed as inhibition of cumene hydroperoxide-mediated lipid peroxidation incubated for 60 mins followed by cumOOH addition for 60 mins measured for 60 mins by C11-BODIPY probe based fluorescence assay2018Journal of natural products, 04-27, Volume: 81, Issue:4
Synthesis, Biological Investigation, and Structural Revision of Sielboldianin A.
AID1514098Antileishmanial activity against Leishmania donovani promastigotes infected in golden hamster assessed as reduction in parasitic load in spleen at 14 mg/kg, po administered 2 times a week for 4 weeks starting at 4 days post-infection measured 1 week post 2018European journal of medicinal chemistry, Dec-05, Volume: 160Leishmania treatment and prevention: Natural and synthesized drugs.
AID1533713Inhibition of human liver microsomes CYP1B1 expressed in Escherichia coli DH5alpha cell membranes coexpressing human NADPH-cytochrome P450 reductase using 7-Ethoxyresorufin as substrate preincubated for 3 mins followed by NADPH addition measured after 10 2019European journal of medicinal chemistry, Feb-01, Volume: 163Phytoestrogens and their synthetic analogues as substrate mimic inhibitors of CYP1B1.
AID1152254Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay2014Bioorganic & medicinal chemistry, Jun-15, Volume: 22, Issue:12
Design and discovery of flavonoid-based HIV-1 integrase inhibitors targeting both the active site and the interaction with LEDGF/p75.
AID1381989Toxicity in Kunming mouse xenografted with human H22 cells assessed as effect on lung weight index at 100 mg/kg, ig administered for 7 consecutive days2018European journal of medicinal chemistry, Feb-25, Volume: 146The lead optimization of the polyamine conjugate of flavonoid with a naphthalene motif: Synthesis and biological evaluation.
AID1683179Induction of apoptosis in human HeLa cells assessed as early apoptosis measured after 48 hrs by annexinV-FITC/propidium iodide staining based by flow cytometry (Rvb = 2.94 %)2021Bioorganic & medicinal chemistry, 01-01, Volume: 29Synthesis and anticancer activity of new coumarin-3-carboxylic acid derivatives as potential lactatetransportinhibitors.
AID592417Inhibition of H2O2-induced lipid peroxidation in rat liver homogenates assessed as malondialdehyde level after 4 hrs2011Journal of natural products, Mar-25, Volume: 74, Issue:3
Epiafzelechin from the root bark of Cassia sieberiana: detection by DART mass spectrometry, spectroscopic characterization, and antioxidant properties.
AID1130099Inhibition of human aromatase using androstenedione as substrate assessed as remaining estrone level at 10 uM after 30 mins by LC-MS/MS analysis relative to control2014Bioorganic & medicinal chemistry letters, Apr-01, Volume: 24, Issue:7
Inhibitory effect of Rhus verniciflua Stokes extract on human aromatase activity; butin is its major bioactive component.
AID517389Inhibition of AMPK-mediated adipocyte differentiation in mouse 3T3L1 cells2010Bioorganic & medicinal chemistry letters, Oct-15, Volume: 20, Issue:20
The selected flavonol glycoside derived from Sophorae Flos improves glucose uptake and inhibits adipocyte differentiation via activation AMPK in 3T3-L1 cells.
AID1767576Inhibition of MMP9 (unknown origin) by colorimetric assay2021European journal of medicinal chemistry, Oct-15, Volume: 222Halting colorectal cancer metastasis via novel dual nanomolar MMP-9/MAO-A quinoxaline-based inhibitors; design, synthesis, and evaluation.
AID1510607Inhibition of alpha-chymotrypsin in bovine pancreas using SPpNA as substrate pretreated with enzyme for 30 mins followed by substrate addition and measured for 12 mins in presence of Triton X-100 by spectrophotometric analysis2019ACS medicinal chemistry letters, Jun-13, Volume: 10, Issue:6
DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors.
AID1171184Teratogenic effect in zebrafish assessed as slow heartbeat at 160 uM after 72 hrs by microscopy2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Delineation of the role of glycosylation in the cytotoxic properties of quercetin using novel assays in living vertebrates.
AID1854435Antioxidant activity assessed as DPPH radical scavenging activity2022European journal of medicinal chemistry, Oct-05, Volume: 240The untapped potential of spermidine alkaloids: Sources, structures, bioactivities and syntheses.
AID1194980Cytotoxicity against human HeLa cells by MTT assay2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Cytotoxic and antioxidant constituents from the leaves of Psidium guajava.
AID1233221Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells at 1 uM after 72 hrs by microplate reader analysis relative to control2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID462279Inhibition of human CA12 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID6855In vitro inhibition of 5-lipoxygenase in rat (peritoneal assay)1990Journal of medicinal chemistry, Oct, Volume: 33, Issue:10
Penta- and hexadienoic acid derivatives: a novel series of 5-lipoxygenase inhibitors.
AID322409Inhibition of mouse recombinant AKR1C212008Bioorganic & medicinal chemistry, Mar-15, Volume: 16, Issue:6
Inhibition of 3(17)alpha-hydroxysteroid dehydrogenase (AKR1C21) by aldose reductase inhibitors.
AID1894486Antioxidant activity of the compound by DPPH assay2021Journal of natural products, 03-26, Volume: 84, Issue:3
Freshwater Fungi as a Source of Chemical Diversity: A Review.
AID603367Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 after 24 hrs by microdilution method2011Journal of medicinal chemistry, Jun-09, Volume: 54, Issue:11
Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
AID749998Binding affinity to recombinant paraoxonase-1 (unknown origin) expressed in Escherichia coli2013Bioorganic & medicinal chemistry, Jun-01, Volume: 21, Issue:11
The effects and mechanism of flavonoid-rePON1 interactions. Structure-activity relationship study.
AID1371429Cytotoxicity against human T47D cells assessed as cell viability at 14 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1372146Inhibition of recombinant human CYP1A2 expressed in yeast microsomal membranes by fluorescence assay
AID1233238Downregulation of TRP-1 mRNA expression in theophylline-stimulated mouse B16-4A5 cells assessed as ratio of TRP-1 mRNA to beta-actin mRNA level at 3 uM after 72 hrs by qPCR analysis2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID502478Inhibition of Clostridium perfringens neuraminidase by fluorimetry2010Bioorganic & medicinal chemistry, Sep-01, Volume: 18, Issue:17
Xanthones with neuraminidase inhibitory activity from the seedcases of Garcinia mangostana.
AID670320Inhibition of human recombinant MMP12 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay2012Bioorganic & medicinal chemistry, Jul-01, Volume: 20, Issue:13
Natural products as a gold mine for selective matrix metalloproteinases inhibitors.
AID1162605Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated MMP9 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method relative to untreated control2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID1224769Delta TM value showing the stabilisation of GSK3B produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1082435Inhibition of fruit-infesting behavior of Cydia pomonella (codling moth) neonates infested in apple fruit plugs assessed as feeding deterrence index at 0.1 mg/mL2011Journal of agricultural and food chemistry, Oct-26, Volume: 59, Issue:20
Effects of Ginkgo biloba constituents on fruit-infesting behavior of codling moth (Cydia pomonella) in apples.
AID75433Inhibition of Glutathione reductase1996Journal of medicinal chemistry, Oct-25, Volume: 39, Issue:22
Synthesis, activity, and molecular modeling of a new series of tricyclic pyridazinones as selective aldose reductase inhibitors.
AID462349Inhibition of mushroom tyrosinase2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells.
AID1065977Inhibition of human ABCG2 ATPase activity expressed in Sf9 insect cell membranes at 2 uM after 30 mins by colorimetric analysis relative to basal control in presence of sodium orthovanadate2013Journal of medicinal chemistry, Dec-27, Volume: 56, Issue:24
Structure-activity relationships of chromone derivatives toward the mechanism of interaction with and inhibition of breast cancer resistance protein ABCG2.
AID436313Antioxidant activity assessed as protection against peroxyl radical-induced alkaline phosphatase oxidation by fluorimetric assay2008Journal of natural products, Nov, Volume: 71, Issue:11
Antioxidant C-glucosylxanthones from the leaves of Arrabidaea patellifera.
AID356717Antiinflammatory activity against TPA-induced ear edema in mouse assessed inhibition of edema at 0.50 mg/ear2001Journal of natural products, Jul, Volume: 64, Issue:7
Antiinflammatory constituents from Heterotheca inuloides.
AID765679Inhibition of oxidative burst in PMA-stimulated human neutrophils assessed as inhibition of superoxide anion radical-induced lucigenin oxidation incubated for 5 mins prior to PMA challenge by chemiluminescence assay2013European journal of medicinal chemistry, Sep, Volume: 67Modulation of human neutrophils' oxidative burst by flavonoids.
AID426319Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess reagent assay2009Journal of natural products, Jun, Volume: 72, Issue:6
Labdane diterpenoid glycosides from Alpinia densespicata and their nitric oxide inhibitory activities in macrophages.
AID1385703Antiinflammatory activity against LPS-stimulated human neutrophils assessed as reduction in IL-8 production incubated for 1 hr followed by LPS stimulation measured after 18 to 24 hrs by ELISA2018Journal of natural products, 08-24, Volume: 81, Issue:8
Anti-inflammatory Potential of Flavonoids from the Aerial Parts of Corispermum marschallii.
AID1355203Inhibition of LPS-induced immune response in C57BL/6 mouse BMDC assessed as increase in IL10 secretion at 25 uM pretreated for 30 mins followed by LPS-challenge measured after 6 hrs by ELISA2018Journal of natural products, 06-22, Volume: 81, Issue:6
Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production.
AID475505Binding affinity to amyloid beta (1 to 42) oligomers by change in fluorescence at 100 uM after 10 mins2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta.
AID1175717Antimalarial activity against chloroquine-resistant/mefloquine-sensitive Plasmodium falciparum W2 by malaria SYBR green 1-based fluorescence (MSF) assay2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
The synthesis, antimalarial activity and CoMFA analysis of novel aminoalkylated quercetin analogs.
AID54030Inhibitory activity against cyclin-dependent kinase 4-cyclin D12000Bioorganic & medicinal chemistry letters, May-15, Volume: 10, Issue:10
Structure-activity relationship studies of flavopiridol analogues.
AID1408300Cytotoxicity against human PWR-1E cells assessed as decrease in cell viability after 3 days by WST-1 assay2018European journal of medicinal chemistry, Sep-05, Volume: 157Structure-activity relationship and pharmacokinetic studies of 3-O-substitutedflavonols as anti-prostate cancer agents.
AID334647Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-nitroflorene-induced mutation at 300 ug/plate after 72 hrs
AID1382195Neuroprotective activity against glutamate-induced mouse HT22 cells assessed as cell survival at 25 uM cotreated with glutamate measured after 24 hrs by MTT assay relative to control2018European journal of medicinal chemistry, Feb-25, Volume: 146Regioselective synthesis of 7-O-esters of the flavonolignan silibinin and SARs lead to compounds with overadditive neuroprotective effects.
AID387406Inhibition of PLK12008Bioorganic & medicinal chemistry letters, Sep-15, Volume: 18, Issue:18
Pharmacophore modeling and virtual screening for designing potential PLK1 inhibitors.
AID317347Effect on [14C]DOX efflux in human NCI-ADR-RES cells2008Bioorganic & medicinal chemistry, Feb-15, Volume: 16, Issue:4
The effect of flavonoid derivatives on doxorubicin transport and metabolism.
AID1485279Inhibition of butter milk xanthine oxidase (unknown origin) assessed as reduction in uric acid formation using xanthine as substrate by double beam spectrophotometric assay2017European journal of medicinal chemistry, Jul-28, Volume: 135Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity.
AID462348Inhibition of mushroom tyrosinase at 100 uM2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells.
AID515157Antimutagenic activity in Salmonella Typhimurium TA98 assessed as inhibition of 3-nitrofluoranthene-induced mutation by Ames test2010European journal of medicinal chemistry, Oct, Volume: 45, Issue:10
Multivariate QSAR study on the antimutagenic activity of flavonoids against 3-NFA on Salmonella typhimurium TA98.
AID1224755Delta TM value showing the stabilisation of CAMK4 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID338023Inhibition of beef heart mitochondrial NADH oxidase assessed as specific activity at 0.35 mM preincubated for 15 mins relative to control
AID1371368Cytotoxicity against human MDA-MB-231 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID333523Cytotoxicity against human A549 cells after 3 days by SRB assay2004Journal of natural products, Nov, Volume: 67, Issue:11
Prenylated benzophenones and xanthones from Hypericum scabrum.
AID512297Inhibition of His-tagged human LCK expressed in Sf9 cells at 20 uM2000The Biochemical journal, Oct-01, Volume: 351, Issue:Pt 1
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
AID1186739Inhibition of glycogen phosphorylase a (unknown origin)2014Bioorganic & medicinal chemistry, Sep-01, Volume: 22, Issue:17
Structure based inhibitor design targeting glycogen phosphorylase B. Virtual screening, synthesis, biochemical and biological assessment of novel N-acyl-β-d-glucopyranosylamines.
AID1129463Neuroprotective activity in mouse HT22 cells assessed as protection against glutamate-induced oxidative damage after 24 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Apr-01, Volume: 24, Issue:7
Functionalized acridin-9-yl phenylamines protected neuronal HT22 cells from glutamate-induced cell death by reducing intracellular levels of free radical species.
AID716425Neuroprotective activity against glutamate induced oxidative stress in mouse hippocampal HT22 cells assessed as cell viability at 25 uM after 24 hrs by MTT assay2012Journal of medicinal chemistry, Jun-14, Volume: 55, Issue:11
Tacrine-silibinin codrug shows neuro- and hepatoprotective effects in vitro and pro-cognitive and hepatoprotective effects in vivo.
AID336485Inhibition of xanthine oxidase-mediated formation of uric acid by spectrophotometry2002Journal of natural products, Nov, Volume: 65, Issue:11
Antioxidant and free-radical scavenging activity of constituents of the leaves of Tachigalia paniculata.
AID765681Inhibition of oxidative burst in PMA-stimulated human neutrophils assessed as inhibition of ROS-induced luminol oxidation incubated for 5 mins prior to PMA challenge by chemiluminescence assay2013European journal of medicinal chemistry, Sep, Volume: 67Modulation of human neutrophils' oxidative burst by flavonoids.
AID693702Inhibition of amyloid beta (1-42) aggregation at 100 uM measured at 8 hrs and 24 hrs by thioflavin T fluorescence method2012European journal of medicinal chemistry, Dec, Volume: 58Design, synthesis and biological evaluation of benzo[e][1,2,4]triazin-7(1H)-one and [1,2,4]-triazino[5,6,1-jk]carbazol-6-one derivatives as dual inhibitors of beta-amyloid aggregation and acetyl/butyryl cholinesterase.
AID1871940Inhibition of Helicobacter pylori urease assessed as measuring ammonia production incubated for 1.5 hr by indophenol method2022European journal of medicinal chemistry, Feb-05, Volume: 229Quercetin derivatives: Drug design, development, and biological activities, a review.
AID218575Inhibitory activity against beta-lactamase2002Journal of medicinal chemistry, Apr-11, Volume: 45, Issue:8
A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.
AID424721Activity at bovine xanthine oxidase at 25 uM preincubated for 10 mins2009Journal of natural products, Apr, Volume: 72, Issue:4
Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin.
AID456316ABTS radical scavenging activity assessed as trolox equivalent antioxidant capacity2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID1171183Teratogenic effect in zebrafish assessed as abnormal head at 160 uM after 72 hrs by microscopy2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Delineation of the role of glycosylation in the cytotoxic properties of quercetin using novel assays in living vertebrates.
AID1082323Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under dark conditions measured 72 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1486117Inhibition of recombinant human BACE1 using Rh-EVNLDAEFK-Quencher as substrate after 60 mins by FRET assay2017Bioorganic & medicinal chemistry, 08-01, Volume: 25, Issue:15
BACE1 inhibitory activity and molecular docking analysis of meroterpenoids from Sargassum serratifolium.
AID1668221Inhibition of rat bone marrow myeloperoxidase using H2O2 as substrate after 20 mins by TMB based method2020Bioorganic & medicinal chemistry, 05-15, Volume: 28, Issue:10
Acylhydrazones as isoniazid derivatives with multi-target profiles for the treatment of Alzheimer's disease: Radical scavenging, myeloperoxidase/acetylcholinesterase inhibition and biometal chelation.
AID670313Inhibition of human recombinant MMP9 catalytic domain incubated for 20 mins by fluorimetric assay2012Bioorganic & medicinal chemistry, Jul-01, Volume: 20, Issue:13
Natural products as a gold mine for selective matrix metalloproteinases inhibitors.
AID426989Cytotoxicity against human HepG2 cells by MTT assay2009Journal of natural products, Jul, Volume: 72, Issue:7
Anti-inflammatory flavonoids from the rhizomes of Helminthostachys zeylanica.
AID587307Inhibition of CXCL1-induced neutrophil recruitment in Swiss mouse at 30 mg/kg, sc administered pre-inflammatory stimulus after 6 hrs by Newbauer chamber using Romanowsky stain2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID257082Binding affinity to non phosphorylated PIM12005Journal of medicinal chemistry, Dec-01, Volume: 48, Issue:24
Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM-1) kinase.
AID1845533Cytotoxicity against human HeLa cells assessed as inhibition of cell viability incubated for 48 hrs by MTT assay2021Journal of medicinal chemistry, 01-14, Volume: 64, Issue:1
Recent Update on Targeting
AID332652Inhibition of human DNA topoisomerase 2 catalytic domain-mediated knotted bacteriophage P4Virl dell0 DNA unknotting by agarose gel electrophoresis1995Journal of natural products, Feb, Volume: 58, Issue:2
Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships.
AID1233227Cytotoxicity against mouse B16-4A5 cells assessed as cell viability at 1 uM after 70 hrs by WST-8 assay relative to control2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID487734Antidiabetic activity in Wistar rat assessed as change in blood glucose level at 50 mg/kg, ig after 1 hr (RVb = 20.18 % +/- 8.49%)2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
A comparative study of flavonoid analogues on streptozotocin-nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11beta-hydroxysteroid dehydrogenase type 1 inhibition.
AID250567Antiproliferative effect against human colonic cell line (HT-29) after 24 hr at a concentration of 50 uM2005Journal of medicinal chemistry, Apr-21, Volume: 48, Issue:8
Effects of flavonoids on cell proliferation and caspase activation in a human colonic cell line HT29: an SAR study.
AID1224778Delta TM value showing the stabilisation of NEK2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID334638Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-aminoanthracene-induced mutation at 300 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID1264946Induction of osteogenic differentiation in human MSC assessed as increase in ALP activity at 5 uM using p-NPP as substrate after 9 days by colorimetric method relative to control2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID293298Antioxidant activity assessed as inhibition of superoxide production by xanthine/xanthine oxidase method2007Bioorganic & medicinal chemistry, Feb-15, Volume: 15, Issue:4
Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems.
AID1063712Cytotoxicity against HUVEC assessed as cell viability at 10 uM after 24 to 72 hrs by WST-1 assay relative to untreated control2014European journal of medicinal chemistry, Jan-24, Volume: 72A novel 2,3-diphenyl-4H-pyrido[1,2-a]pyrimidin-4-one derivative inhibits endothelial cell dysfunction and smooth muscle cell proliferation/activation.
AID1514844Inhibition of MPO in human neutrophils using H2O2 as substrate measured after 1 hr by fluorescence based HPLC analysis2019Bioorganic & medicinal chemistry letters, 01-01, Volume: 29, Issue:1
The development of myeloperoxidase inhibitors.
AID1505136Inhibition of mushroom tyrosinase using L-tyrosine as substrate pretreated for 5 mins followed by substrate addition measured over 30 mins by spectrophotometric method2018Journal of natural products, 01-26, Volume: 81, Issue:1
Isolation of Flavonoids and Flavonoid Glycosides from Myrsine africana and Their Inhibitory Activities against Mushroom Tyrosinase.
AID417659Competitive inhibition of Clostridium perfringens neuraminidase by Lineweaver-Burke plot and Dixon plot2009Bioorganic & medicinal chemistry, Apr-01, Volume: 17, Issue:7
Characteristic of neuraminidase inhibitory xanthones from Cudrania tricuspidata.
AID1264947Induction of osteogenic differentiation in human MSC assessed as increase in ALP activity at 10 uM using p-NPP as substrate after 9 days by colorimetric method relative to control2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID1220241Intrinsic clearance in human intestinal microsomes assessed CYP450-mediated glucuronidation clearance2012Drug metabolism and disposition: the biological fate of chemicals, Sep, Volume: 40, Issue:9
Quantitative prediction of human intestinal glucuronidation effects on intestinal availability of UDP-glucuronosyltransferase substrates using in vitro data.
AID681123TP_TRANSPORTER: inhibition of lactate uptake in Xenopus laevis oocytes1999The Biochemical journal, Aug-01, Volume: 341 ( Pt 3)Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes.
AID456317Antioxidant activity assessed as trolox equivalent by TEAC assay2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID402484Potentiation of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality treated with drug after 2 hrs of TNFalpha treatment1997Journal of natural products, Aug, Volume: 60, Issue:8
Flavonoids as inhibitors or enhancers of the cytotoxicity of tumor necrosis factor-alpha in L-929 tumor cells.
AID1394718Inhibition of wild type recombinant human RET using peptide as substrate by fluorimetric analysis2018European journal of medicinal chemistry, Apr-25, Volume: 150Challenging clinically unresponsive medullary thyroid cancer: Discovery and pharmacological activity of novel RET inhibitors.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1311089Antioxidant activity assessed as inhibition of peroxynitrite-induced oxidation of DHR to rhodamine-123 measured after 2 mins by fluorimetric analysis2016European journal of medicinal chemistry, Aug-25, Volume: 119New polyhydroxylated flavon-3-ols and 3-hydroxy-2-styrylchromones: synthesis and ROS/RNS scavenging activities.
AID289341Peroxynitrite scavenging activity assessed as inhibition of DHR oxidation in presence of NaHCo32007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
2-Styrylchromones: novel strong scavengers of reactive oxygen and nitrogen species.
AID641154Growth inhibition of human HCT116 cells after 48 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Biological evaluation and docking studies of recently identified inhibitors of phosphoinositide-3-kinases.
AID605039Permeability of the compound measured on acceptor plate of PAMPA membrane at 50 uM after 5 hrs by HPLC analysis2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID426990Cytotoxicity against human MCF7 cells by MTT assay2009Journal of natural products, Jul, Volume: 72, Issue:7
Anti-inflammatory flavonoids from the rhizomes of Helminthostachys zeylanica.
AID489318Cytoprotective activity against H2O2-induced cell injury in HUVEC cells2010Bioorganic & medicinal chemistry letters, Jul-15, Volume: 20, Issue:14
Synthesis and biological activity of halophenols as potent antioxidant and cytoprotective agents.
AID1479742Induction of conformational changes in ABCG2 in human PLB-985 cells assessed as increase in 5D3 antibody binding to protein at 10 uM preincubated for 5 mins followed by antibody addition measured after 30 mins by flow cytometric method2018Journal of medicinal chemistry, 04-26, Volume: 61, Issue:8
New Inhibitors of Breast Cancer Resistance Protein (ABCG2) Containing a 2,4-Disubstituted Pyridopyrimidine Scaffold.
AID332651Inhibition of calf thymus DNA topoisomerase 1 catalytic domain-mediated supercoiled Escherichia coli pUC8 DNA relaxation after 30 mins by agarose gel electrophoresis1995Journal of natural products, Feb, Volume: 58, Issue:2
Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships.
AID1242166Inhibition of HSF1 in human HNE1 cells assessed as potentiation of 17-DMAG and heat-induced increase in apoptosis at 100 uM relative to 17-DMAG and heat alone2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Regulating the master regulator: Controlling heat shock factor 1 as a chemotherapy approach.
AID398376Competitive inhibition of mushroom tyrosinase assessed as L-3,4-dihydroxyphenylalanine oxidation1995Journal of natural products, May, Volume: 58, Issue:5
Tyrosinase inhibitors from Bolivian medicinal plants.
AID605130Antiproliferative activity against human HS27 cells after 24 hrs by MTT assay2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID1668637Inhibition of human liver FBP1 at 200 uM incubated for 5 mins by fluorescence method relative to control2020Journal of natural products, 05-22, Volume: 83, Issue:5
Structural Specificity of Flavonoids in the Inhibition of Human Fructose 1,6-Bisphosphatase.
AID52462Inhibitory activity against Chymotrypsinogen from Thermus flavus2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
Kinase inhibitors: not just for kinases anymore.
AID1617366Inhibition of human CYP2C8 by fluorescence method2019Journal of medicinal chemistry, 11-27, Volume: 62, Issue:22
Development of Robust 17(
AID616482Antioxidant activity assessed as DPPH free radical scavenging activity2011Bioorganic & medicinal chemistry letters, Sep-15, Volume: 21, Issue:18
Synthesis and antioxygenic activities of seabuckthorn flavone-3-ols and analogs.
AID755047Antioxidant activity assessed as inhibition of AAPH-induced peroxyl radical formation by ORAC-FL assay relative to trolox2013Bioorganic & medicinal chemistry, Jul-01, Volume: 21, Issue:13
Remarkable antioxidant properties of a series of hydroxy-3-arylcoumarins.
AID1265115Inhibition of recombinant human AKR1B10 expressed in human HCT116 cells assessed as reduction in daunorubicinol production using daunorubicin as substrate at 20 uM incubated for 4 to 8 hrs by UHPLC based transient transfection assay2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Flavones Inhibit the Activity of AKR1B10, a Promising Therapeutic Target for Cancer Treatment.
AID587302Inhibition of CXCL5-induced neutrophil recruitment in Swiss mouse at 300 mg/kg, sc administered pre-inflammatory stimulus after 6 hrs by Newbauer chamber using Romanowsky stain2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID1082334Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under light conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID424730Inhibition of bovine xanthine oxidase assessed as reduction of cytochrome c at 25 uM preincubated for 10 mins2009Journal of natural products, Apr, Volume: 72, Issue:4
Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin.
AID480945Inhibition of Clostridium perfringens neuraminidase assessed as inhibition of 4-MU-NANA hydrolysis after 10 mins by spectrofluorimetry2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Prenylated pterocarpans as bacterial neuraminidase inhibitors.
AID1126471Inhibition of sEH (unknown origin) assessed as substrate PHOME hydrolysis at 25 uM after 1 hr by fluorescence method2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID603459Antibacterial activity against Escherichia coli K-12 after 24 hrs by microdilution method2011Journal of medicinal chemistry, Jun-09, Volume: 54, Issue:11
Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
AID666770Inhibition of thrombin in New Zealand rabbit plasma assessed as activated partial thromboplastin time at 100 uM after 3 mins by coagulometry2012European journal of medicinal chemistry, Aug, Volume: 54Metabolism-based synthesis, biologic evaluation and SARs analysis of O-methylated analogs of quercetin as thrombin inhibitors.
AID1536960Inhibition of fMLP/cytochalasin A-stimulated elastase release in human neutrophils assessed as elastase level at 2.5 uM preincubated for 15 mins followed by fMLP/cytochalasin A stimulation and measured after 15 mins by SAAVNA substrate based spectrophotom2019Journal of natural products, 02-22, Volume: 82, Issue:2
Eupatoriopicrin Inhibits Pro-inflammatory Functions of Neutrophils via Suppression of IL-8 and TNF-alpha Production and p38 and ERK 1/2 MAP Kinases.
AID1355207Antiseptic activity in Balb/c mouse model of Escherichia coli K1 infection-induced sepsis assessed as reduction in serum endotoxin level at 50 mg/kg, ip pretreated for 1 hr followed by Escherichia coli K1 infection measured after 12 hrs by chromogenic ass2018Journal of natural products, 06-22, Volume: 81, Issue:6
Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production.
AID351097Inhibition of xanthine oxidase assessed as formation of formazan after 2 hrs by spectrophotometry2009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
Preparation of two sets of 5,6,7-trioxygenated dihydroflavonol derivatives as free radical scavengers and neuronal cell protectors to oxidative damage.
AID1603991Growth inhibition of human HL60 cells after 72 hrs by MTT assay2019European journal of medicinal chemistry, Nov-01, Volume: 181The Mediterranean Diet as source of bioactive compounds with multi-targeting anti-cancer profile.
AID1220242Unbound intrinsic clearance in human intestinal microsomes assessed CYP450-mediated glucuronidation clearance2012Drug metabolism and disposition: the biological fate of chemicals, Sep, Volume: 40, Issue:9
Quantitative prediction of human intestinal glucuronidation effects on intestinal availability of UDP-glucuronosyltransferase substrates using in vitro data.
AID1082350Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under dark conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1176149Inhibition of iNOS protein expression in LPS-stimulated mouse RAW264.7 cells by Western blot analysis2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
Anti-inflammatory components of Chrysanthemum indicum flowers.
AID768889Inhibition of trypsin amidolytic activity (unknown origin)2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID467848Inhibition of carrageenan-induced TNFalpha production in Swiss mouse subcutaneous plantar tissue at 100 mg/kg, ip dosed 30 mins before carrageenan challenge measured after 3 hrs by ELISA2009Journal of natural products, Nov, Volume: 72, Issue:11
Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production.
AID768894Inhibition of human thrombin assessed as equilibrium dissociation constant at 50 to 1000 uM by BIAcore analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID1172643Inhibition of cell proliferation of human U87MG cells assessed as cell viability after 72 hrs by sulforhodamine B assay2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Bioactive triterpenoid saponins and phenolic compounds against glioma cells.
AID1891160Inhibition of tyrosinase (unknown origin)2022Bioorganic & medicinal chemistry letters, 06-01, Volume: 65Polyphenolic compounds: Synthesis, assessment of antimicrobial effect and enzymes inhibition against important medicinal enzymes with computational details.
AID1311086Antioxidant activity assessed as inhibition of singlet oxygen-induced oxidation of DHR to fluorescent rhodamine-123 measured after 30 mins by fluorescence microplate screening assay2016European journal of medicinal chemistry, Aug-25, Volume: 119New polyhydroxylated flavon-3-ols and 3-hydroxy-2-styrylchromones: synthesis and ROS/RNS scavenging activities.
AID347252Binding affinity to human recombinant carbonyl reductase 1 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in absence of cofactor2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1536968Inhibition of LPS-induced delay of apoptosis in human neutrophils assessed as necrotic cells at 2.5 uM preincubated for 1 hr followed by LPS stimulation and measured after 24 hrs by Annexin V-FITC/propidium iodide staining based flow cytometry (Rvb = 2.1 2019Journal of natural products, 02-22, Volume: 82, Issue:2
Eupatoriopicrin Inhibits Pro-inflammatory Functions of Neutrophils via Suppression of IL-8 and TNF-alpha Production and p38 and ERK 1/2 MAP Kinases.
AID605133Cell cycle arrest in human MCF7 cells assessed as increase in accumulation at S phase at 50 uM after 14 hrs by propidium iodide staining based flow cytometric analysis relative to untreated control2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID768914Inhibition of human thrombin assessed as inhibition of fibrinogen alpha-polymer formation at IC50 after 5 mins by SDS-PAGE analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID1616105Inhibition of ATP synthase in Escherichia coli2019European journal of medicinal chemistry, Nov-15, Volume: 182Recent advancements in mechanistic studies and structure activity relationship of F
AID462347Inhibition of mushroom tyrosinase at 30 uM2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells.
AID420260Inhibition of Src2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Discovering novel quercetin-3-O-amino acid-esters as a new class of Src tyrosine kinase inhibitors.
AID467554Antinociceptive activity in Swiss mouse assessed as inhibition of carrageenan-induced mechanical hypernociception at 100 mg/kg, ip dosed 3 hrs before carrageenan challenge measured after 3 hrs by electronic pressure-meter test2009Journal of natural products, Nov, Volume: 72, Issue:11
Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production.
AID506944Inhibition of HSP70-mediated antiapoptotic activity in human SKBR3 cells assessed as increase in caspase-3 activity after 24 hrs by Western blot analysis2007Nature chemical biology, Aug, Volume: 3, Issue:8
Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer.
AID1126474Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production at 10 uM after 18 hrs by griess reaction analysis2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID361175Cytotoxicity against human CEM cells after 3 days by MTT assay2001Journal of natural products, Jun, Volume: 64, Issue:6
Chemical constituents from Lippia sidoides and cytotoxic activity.
AID1226443Cytotoxicity against human HCT15 cells assessed as cell growth inhibition after 72 hrs by MTT assay2015Journal of medicinal chemistry, May-28, Volume: 58, Issue:10
Selenium-containing chrysin and quercetin derivatives: attractive scaffolds for cancer therapy.
AID1683178Antiproliferative activity against human HCT-116 cells assessed as reduction in cell proliferation at IC50 incubated for 6 days and measured on day 6 by MTS assay2021Bioorganic & medicinal chemistry, 01-01, Volume: 29Synthesis and anticancer activity of new coumarin-3-carboxylic acid derivatives as potential lactatetransportinhibitors.
AID1264958Cytotoxicity against human MSC assessed as cell viability at 10 uM treated for 6 days measured on day 7 by alamar blue assay (Rvb = 96 to 101%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID1711942Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation at 100 uM measured after 48 hrs by MTT assay relative to control2016European journal of medicinal chemistry, Oct-04, Volume: 121Synthesis and biological properties of polyamine modified flavonoids as hepatocellular carcinoma inhibitors.
AID1063052Inhibition of AKT1 (unknown origin)2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Protein kinase and HDAC inhibitors from the endophytic fungus Epicoccum nigrum.
AID550023Vasorelaxant activity in Wistar rat endothelium-denuded thoracic aortic ring assessed as inhibition of noradrenaline-induced contraction treated after noradrenaline challenge measured after 60 mins relative to control2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Vasorelaxant effect of flavonoids through calmodulin inhibition: Ex vivo, in vitro, and in silico approaches.
AID361173Cytotoxicity against human HL60 cells after 3 days by MTT assay2001Journal of natural products, Jun, Volume: 64, Issue:6
Chemical constituents from Lippia sidoides and cytotoxic activity.
AID587305Inhibition of fMLP-induced neutrophil recruitment in Swiss mouse at 100 mg/kg, sc administered pre-inflammatory stimulus after 6 hrs by Newbauer chamber using Romanowsky stain2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID1917222Neuroprotective activity against H2O2-induced cytotoxicity in rat PC12 cells assessed as increase in cell viability at 2.5 to 100 uM preincubated for 2 hrs followed by H2O2 stimulation and measured after 2 hrs by MTT assay2022Bioorganic & medicinal chemistry, 11-01, Volume: 73Synthesis and evaluation of glycosylated quercetin to enhance neuroprotective effects on cerebral ischemia-reperfusion.
AID601455Inhibition of xanthine oxidase assessed as reduction of uric acid production from xanthine at 10 to 50 uM preincubated for 15 mins measured after 30 mins by spectrophotometry2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Evaluation of antioxidant and antimicrobial activities of Bergenin and its derivatives obtained by chemoenzymatic synthesis.
AID759070Cytotoxicity against human HCT116 cells assessed as cell viability at 30 uM after 48 hrs by MTT assay relative to control2013European journal of medicinal chemistry, Jul, Volume: 65Superior anticancer activity of halogenated chalcones and flavonols over the natural flavonol quercetin.
AID703484Cytotoxicity against mouse Peritoneal macrophages cells after 72 hrs by MTS assay2012Journal of medicinal chemistry, Oct-25, Volume: 55, Issue:20
Flavonoid dimers as novel, potent antileishmanial agents.
AID1202776Antioxidant activity assessed as trolox equivalent of ABTS radical scavenging activity after 10 mins by hydrophilic-TEAC fluorescence assay2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Antioxidative compounds from Garcinia buchananii stem bark.
AID596672Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 10 uM on day 8 relative to control2011Bioorganic & medicinal chemistry, May-01, Volume: 19, Issue:9
Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells.
AID43253Percentage inhibition against beta-Lactamase in the absence of detergent Triton X-100 was determined at a concentration of 25 uM2003Journal of medicinal chemistry, Sep-25, Volume: 46, Issue:20
A specific mechanism of nonspecific inhibition.
AID1272001Inhibition of Saccharomyces cerevisiae alpha-Glucosidase using p-nitrophenyl-alpha-D-glucopyranoside as substrate assessed as formation of para-nitrophenol preincubated for 5 mins followed by addition of substrate measured after 15 mins by microplate read2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Polyketide butenolide, diphenyl ether, and benzophenone derivatives from the fungus Aspergillus flavipes PJ03-11.
AID195382Effect of compound on AFB1-induced micronuclei formation in rat bone marrow cells (Activity: Micronucleated cells/1000 cells)2002Bioorganic & medicinal chemistry letters, Sep-16, Volume: 12, Issue:18
Comparison of the prevention of aflatoxin b(1)-induced genotoxicity by quercetin and quercetin pentaacetate.
AID191891Mutagenicity evaluated by calculating number of revertants using Salmonella Typhimurium strain TA 100 (0.25 mg/plate) with S9 mix from rat liver; Toxic concentration1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
4'-Hydroxy-3-methoxyflavones with potent antipicornavirus activity.
AID1720813Inhibition of quorum sensing in violacein-negative Chromobacterium violaceum CV026 mini-Tn5 mutant assessed as quorum quenching by measuring violacein production at 400 uM in presence of C6-HSL relative to control2020Bioorganic & medicinal chemistry letters, 08-15, Volume: 30, Issue:16
Chloroquine fumardiamides as novel quorum sensing inhibitors.
AID332640Enhancement of human DNA topoisomerase 2-mediated Escherichia coli pUC8 DNA cleavage assessed as production of linear DNA at 100 ug/ml after 30 mins by agarose gel electrophoresis relative to control1995Journal of natural products, Feb, Volume: 58, Issue:2
Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships.
AID487896Antidiabetic activity in STZ-induced Wistar rat assessed as reduction in blood glucose level at 50 mg/kg, ig after 1 day relative to control2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
A comparative study of flavonoid analogues on streptozotocin-nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11beta-hydroxysteroid dehydrogenase type 1 inhibition.
AID605054Cellular uptake in human HuH7 cells assessed as methyl-quercetin accumulation at 10 uM after 12 hrs by HPLC-mass spectrophotometric analysis2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID1917230Neuroprotective activity against middle cerebral artery occlusion induced cerebral ischemia reperfusion rat model assessed as increase in brain GSH level at 10 mg/kg, ip preincubated for 0.5 hrs followed by reperfusion and measured after 24 hrs2022Bioorganic & medicinal chemistry, 11-01, Volume: 73Synthesis and evaluation of glycosylated quercetin to enhance neuroprotective effects on cerebral ischemia-reperfusion.
AID353590Inhibition of heat-induced HSP70 expression in human Jurkat cells at 50 ug/mL treated for 1 hr before heat induction by Western blot2009Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7
Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives.
AID309799Inhibition of 15-hLO12007Bioorganic & medicinal chemistry, Dec-01, Volume: 15, Issue:23
Structure-activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2.
AID1194985Antioxidant activity assessed as FRAP values at 50 ug/ml incubated at 37 degC for 5 mins by FeSO4.7H2O calibration curve based method2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Cytotoxic and antioxidant constituents from the leaves of Psidium guajava.
AID1683187Decrease in glucose consumption in human HCT-116 cells at IC50 after 4 to 24 hrs by glucose oxidase based colorimetric assay2021Bioorganic & medicinal chemistry, 01-01, Volume: 29Synthesis and anticancer activity of new coumarin-3-carboxylic acid derivatives as potential lactatetransportinhibitors.
AID147515Inhibition of neutral endopeptidase (NEP/CD13) at 0.3*10e-3 M compound concentration2003Journal of medicinal chemistry, Aug-28, Volume: 46, Issue:18
Synthesis and biological evaluation of novel flavone-8-acetic acid derivatives as reversible inhibitors of aminopeptidase N/CD13.
AID1720811Inhibition of quorum sensing system in Chromobacterium violaceum ATCC 31532 assessed as reduction in violacein production at 400 uM relative to control2020Bioorganic & medicinal chemistry letters, 08-15, Volume: 30, Issue:16
Chloroquine fumardiamides as novel quorum sensing inhibitors.
AID1239537Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 8 after 24 hrs by checkerboard assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1668222Inhibition of Electrophorus electricus AChE at 100 uM using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 10 mins by Ellman's method (Rvb = 7 +/- 7.1%)2020Bioorganic & medicinal chemistry, 05-15, Volume: 28, Issue:10
Acylhydrazones as isoniazid derivatives with multi-target profiles for the treatment of Alzheimer's disease: Radical scavenging, myeloperoxidase/acetylcholinesterase inhibition and biometal chelation.
AID1152253Therapeutic index, ratio of CC50 for human C8166 cells to EC50 for HIV-1 3B infected in human C8166 cells2014Bioorganic & medicinal chemistry, Jun-15, Volume: 22, Issue:12
Design and discovery of flavonoid-based HIV-1 integrase inhibitors targeting both the active site and the interaction with LEDGF/p75.
AID752786Antiobesity activity in mouse 3T3L1 cells assessed as reduction of fat accumulation at 100 uM by oil Red O staining-based ELISA2013Bioorganic & medicinal chemistry letters, Jun-15, Volume: 23, Issue:12
Chemical constituents from Nelumbo nucifera leaves and their anti-obesity effects.
AID1516859Antifungal activity against Candida glabrata 482 by microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID1510605Inhibition of alpha-chymotrypsin in bovine pancreas using SPpNA as substrate pretreated with enzyme for 30 mins followed by substrate addition and measured for 12 mins by spectrophotometric analysis2019ACS medicinal chemistry letters, Jun-13, Volume: 10, Issue:6
DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors.
AID735123Inhibition of baker's yeast alpha-glucosidase2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Mexican antidiabetic herbs: valuable sources of inhibitors of α-glucosidases.
AID605031Aqueous solubility of the compound in PBS assessed as forward light scattering by compound by microplate neplhelometric analysis2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID339146Inhibition of norepinephrine-induced Wistar rat thoracic aorta tonic contraction at 100 ug/mL after 15 mins1993Journal of natural products, Jun, Volume: 56, Issue:6
Antiplatelet effects and vasorelaxing action of some constituents of Formosan plants.
AID1233230Cytotoxicity against mouse B16-4A5 cells assessed as cell viability at 30 uM after 70 hrs by WST-8 assay relative to control2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID540212Mean residence time in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID1371375Cytotoxicity against human PANC1 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID754415Permeability of the compound after 1 hr by PAMPA assay2013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
Quercetin-POC conjugates: Differential stability and bioactivity profiles between breast cancer (MCF-7) and colorectal carcinoma (HCT116) cell lines.
AID317345Cytotoxicity against human MDA-MB-435 cells at 10 uM after 96 hrs by MTT assay2008Bioorganic & medicinal chemistry, Feb-15, Volume: 16, Issue:4
The effect of flavonoid derivatives on doxorubicin transport and metabolism.
AID512280Inhibition of His-tagged human SAPK3/p38gamma expressed in Escherichia coli at 20 uM2000The Biochemical journal, Oct-01, Volume: 351, Issue:Pt 1
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
AID527151Increase of lipid peroxidation in gastrocnemius muscle of C57BL/6 mouse tail suspension model assessed as decrease of thiobarbituric acid-reactive substance level at 2.5 pmol administered in gastrocnemius muscle qd for 10 days by RT-PCR analysis2010Journal of natural products, Oct-22, Volume: 73, Issue:10
Quercetin prevents unloading-derived disused muscle atrophy by attenuating the induction of ubiquitin ligases in tail-suspension mice.
AID1336835Antioxidant activity assessed as DPPH radical scavenging activity2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Quercetin-glutamic acid conjugate with a non-hydrolysable linker; a novel scaffold for multidrug resistance reversal agents through inhibition of P-glycoprotein.
AID467854Antinociceptive activity in Swiss mouse assessed as inhibition of PGE2-induced mechanical hypernociception at 100 mg/kg, ip dosed 30 mins before PGE2 challenge measured after 3 hrs by electronic pressure-meter test2009Journal of natural products, Nov, Volume: 72, Issue:11
Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production.
AID462275Inhibition of human CA5B by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID670318Inhibition of human recombinant MMP3 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay2012Bioorganic & medicinal chemistry, Jul-01, Volume: 20, Issue:13
Natural products as a gold mine for selective matrix metalloproteinases inhibitors.
AID1655304Growth inhibition of human MSTO-211H cells incubated for 72 hrs by trypan blue assay2020ACS medicinal chemistry letters, May-14, Volume: 11, Issue:5
Synthesis, Antiproliferative Effect, and Topoisomerase II Inhibitory Activity of 3-Methyl-2-phenyl-1
AID1917228Neuroprotective activity against middle cerebral artery occlusion induced cerebral ischemia reperfusion rat model assessed as decrease in brain SOD level at 10 mg/kg, ip preincubated for 0.5 hrs followed by reperfusion and measured after 24 hrs2022Bioorganic & medicinal chemistry, 11-01, Volume: 73Synthesis and evaluation of glycosylated quercetin to enhance neuroprotective effects on cerebral ischemia-reperfusion.
AID1711938Antiproliferative activity against human SMMC-7221 cells assessed as inhibition of cell proliferation at 100 uM measured after 48 hrs by MTT assay relative to control2016European journal of medicinal chemistry, Oct-04, Volume: 121Synthesis and biological properties of polyamine modified flavonoids as hepatocellular carcinoma inhibitors.
AID1224799Delta TM value showing the stabilisation of NDR1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID377663Effect on duration of immobility in CD1 mouse at 10 mg/kg, ip by forced swimming test relative to control2006Journal of natural products, Jun, Volume: 69, Issue:6
Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and computational study.
AID1233240Downregulation of TRP-1 mRNA expression in theophylline-stimulated mouse B16-4A5 cells assessed as ratio of TRP-1 mRNA to beta-actin mRNA level at 30 uM after 72 hrs by qPCR analysis2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID1183093Cytotoxicity against human HL60 cells after 72 hrs by MTT assay2014European journal of medicinal chemistry, Sep-12, Volume: 84Synthesis and effects on cell viability of flavonols and 3-methyl ether derivatives on human leukemia cells.
AID1311088Antioxidant activity assessed as inhibition of nitric oxide-induced oxidation of DAF-2 to DAF-2T measured after 30 mins by fluorimetric analysis2016European journal of medicinal chemistry, Aug-25, Volume: 119New polyhydroxylated flavon-3-ols and 3-hydroxy-2-styrylchromones: synthesis and ROS/RNS scavenging activities.
AID1633138Inhibition of chymotrypsin-like activity of human 26S proteasome in human Jurkat cells assessed as decrease in AMC hydrolysis using Z-Gly-Gly-Leu-AMC as substrate after 24 hrs by fluorescence based method2019European journal of medicinal chemistry, Apr-01, Volume: 167Another look at phenolic compounds in cancer therapy the effect of polyphenols on ubiquitin-proteasome system.
AID1102133Phytotoxicity in Linaria genistifolia subsp. dalmatica assessed as inhibition of root differentiation at 250 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID1224798Delta TM value showing the stabilisation of DRAK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID377040Hepatoprotective activity against H2O2-induced hepatotoxicity in Wistar rat hepatocytes assessed as reduction in glutamic pyruvate transaminase release after 1 hr relative to control2005Journal of natural products, Jan, Volume: 68, Issue:1
Two new hepatoprotective stilbene glycosides from Acer mono leaves.
AID1783637Inhibition of LPS-induced NO production in mouse BV-2 cells incubated for 24 hrs by Griess reagent based assay2021European journal of medicinal chemistry, Nov-15, Volume: 2241,10-Seco-Eudesmane sesquiterpenoids as a new type of anti-neuroinflammatory agents by suppressing TLR4/NF-κB/MAPK pathways.
AID1330795Inhibition of electric eel AChE using acetylthiocholine iodide as substrate incubated for 5 mins followed by substrate addition measured for 1 min by Ellman's method2016European journal of medicinal chemistry, Nov-10, Volume: 123Synthesis and structure-activity relationship study of tacrine-based pyrano[2,3-c]pyrazoles targeting AChE/BuChE and 15-LOX.
AID578765Inhibition of P-gp expressed in A2780adr cells at 10 uM by calcein AM accumulation assay relative to verapamil2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
AID467951Induction of CYP1A1 expression in human MCF7 cells at 0.5 uM to 10 uM after 24 hrs by RT PCR and DNA electrophoresis2009Journal of natural products, Aug, Volume: 72, Issue:8
The methoxylated flavones eupatorin and cirsiliol induce CYP1 enzyme expression in MCF7 cells.
AID1220243Activity of human UGT1A3 expressed in insect cells assessed as reduction in compound level after 30 mins2012Drug metabolism and disposition: the biological fate of chemicals, Sep, Volume: 40, Issue:9
Quantitative prediction of human intestinal glucuronidation effects on intestinal availability of UDP-glucuronosyltransferase substrates using in vitro data.
AID1239531Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 2 after 24 hrs by checkerboard assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1871923Metal chelating activity assessed as compound-Fe2+ complex formation by measuring binding energy2022European journal of medicinal chemistry, Feb-05, Volume: 229Quercetin derivatives: Drug design, development, and biological activities, a review.
AID678023Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation at 10 uM by spectrophotometry based TBARS assay relative to untreated control2012Bioorganic & medicinal chemistry, Sep-01, Volume: 20, Issue:17
Synthesis, cytotoxic and antioxidant evaluations of amino derivatives from perezone.
AID603368Antibacterial activity against methicillin-resistant Staphylococcus aureus COL after 24 hrs by microdilution method2011Journal of medicinal chemistry, Jun-09, Volume: 54, Issue:11
Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
AID1161379Inhibition of human recombinant aldose reductase using DL-glyceraldehyde, HRAR and beta-NADPH incubated for 10 mins by spectrophotometry2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
20(S)-Ginsenoside Rh2 as aldose reductase inhibitor from Panax ginseng.
AID93508IC50 was measured as concentration required to inhibit 50% of HIV-integrase integration1995Journal of medicinal chemistry, Mar-17, Volume: 38, Issue:6
Three-dimensional quantitative structure-activity relationship (QSAR) of HIV integrase inhibitors: a comparative molecular field analysis (CoMFA) study.
AID596755Antiviral activity against HBV transfected in human HepG2(2.2.15) cells assessed as inhibition of HBsAg secretion at nontoxic concentration by ELISA2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Homoflavonoid glucosides from Ophioglossum pedunculosum and their anti-HBV activity.
AID1226445Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 72 hrs by MTT assay2015Journal of medicinal chemistry, May-28, Volume: 58, Issue:10
Selenium-containing chrysin and quercetin derivatives: attractive scaffolds for cancer therapy.
AID1593613Neuroprotective activity in Sprague-Dawley rat CGN cells assessed as protection against H2O2-induced cytotoxicity by measuring increase in cell viability at 5 to 100 uM pre-incubated for 24 hrs before H2O2 stimulation for 24 hrs by MTT assay2019Bioorganic & medicinal chemistry, 06-15, Volume: 27, Issue:12
Purification, structural elucidation, antioxidant capacity and neuroprotective potential of the main polyphenolic compounds contained in Achyrocline satureioides (Lam) D.C. (Compositae).
AID289322Hypochlorous acid scavenging activity assessed as inhibition of DHR oxidation2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
2-Styrylchromones: novel strong scavengers of reactive oxygen and nitrogen species.
AID257903Antioxidant potency assessed chemically2006Journal of medicinal chemistry, Jan-12, Volume: 49, Issue:1
Chroman/catechol hybrids: synthesis and evaluation of their activity against oxidative stress induced cellular damage.
AID220159Inhibition of rat brain cytosolic cGMP phosphodiesterase1982Journal of medicinal chemistry, Oct, Volume: 25, Issue:10
Pentasubstituted quercetin analogues as selective inhibitors of particulate 3':5'-cyclic-AMP phosphodiesterase from rat brain.
AID670315Inhibition of human recombinant MMP13 catalytic domain incubated for 20 mins by fluorimetric assay2012Bioorganic & medicinal chemistry, Jul-01, Volume: 20, Issue:13
Natural products as a gold mine for selective matrix metalloproteinases inhibitors.
AID400607Inhibition of procoagulant activity in monocyte from human blood assessed as counteraction of IL1-induced tissue factor expression at 10 uM after 18 hrs measured as microunits of tissue factor/10'5 cells1996Journal of natural products, Mar, Volume: 59, Issue:3
Ability of different flavonoids to inhibit the procoagulant activity of adherent human monocytes.
AID334646Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-nitroflorene-induced mutation at 600 ug/plate after 72 hrs
AID512293Inhibition of rat ROCK2 expressed in Sf9 cells at 20 uM2000The Biochemical journal, Oct-01, Volume: 351, Issue:Pt 1
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
AID1597706Inhibition of HFIP treated amyloid beta (1 to 40) (unknown origin) self-induced aggregation at 100 uM measured after 2 hrs by Thioflavin T fluorescence assay2019European journal of medicinal chemistry, Sep-01, Volume: 177Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease.
AID1224763Delta TM value showing the stabilisation of CLK3 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID334644Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of benzo[a]pyrene-induced mutation at 300 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID367708Inhibition of pig ALR1 by Uncompetitive inhibition based Lineweaver-Burke plot2009Bioorganic & medicinal chemistry, Feb-01, Volume: 17, Issue:3
Correlation of binding constants and molecular modelling of inhibitors in the active sites of aldose reductase and aldehyde reductase.
AID454619Inhibition of beta-glucuronidase at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-15, Volume: 20, Issue:2
Synthesis and biological evaluation of nitrogen-containing chalcones as possible anti-inflammatory and antioxidant agents.
AID587303Inhibition of LTB4-induced neutrophil recruitment in Swiss mouse at 100 mg/kg, sc administered pre-inflammatory stimulus after 6 hrs by Newbauer chamber using Romanowsky stain2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID762911Selectivity index, ratio of IC50 for Swiss mouse peritoneal macrophages to IC50 for promastigotes of Leishmania amazonensis MHOM/BR/75/LTB00162013Journal of natural products, Aug-23, Volume: 76, Issue:8
Reactive oxygen species production by quercetin causes the death of Leishmania amazonensis intracellular amastigotes.
AID404028Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells2005Journal of natural products, Dec, Volume: 68, Issue:12
Sesquiterpene chromones from Ferula fukanensis and their nitric oxide production inhibitory effects.
AID402231Antioxidant activity in 1-alpha-phosphatidylcholine liposome assessed as inhibition of ascorbyl radical-induced lipid peroxidation by TBARS assay2004Journal of natural products, May, Volume: 67, Issue:5
Hypoglycemic effect and antioxidant potential of kaempferol-3,7-O-(alpha)-dirhamnoside from Bauhinia forficata leaves.
AID1572030Inhibition of IPMK in human [3H]-inositol-labelled HCT116 cells assessed as reduction in insp5 levels at 10 uM after 3.5 hrs by HPLC analysis relative to control2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
AID1833879Antimicrobial activity against Escherichia coli ATCC 25922 assessed as bacterial growth inhibition measured after 24 hrs by resazurin dye based broth microdilution method2021Bioorganic & medicinal chemistry, 12-15, Volume: 52Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition.
AID1220244Activity of human UGT1A1 expressed in insect cells assessed as reduction in compound level after 30 mins2012Drug metabolism and disposition: the biological fate of chemicals, Sep, Volume: 40, Issue:9
Quantitative prediction of human intestinal glucuronidation effects on intestinal availability of UDP-glucuronosyltransferase substrates using in vitro data.
AID430218Antileishmanial activity against extracellular Leishmania braziliensis promastigotes after 72 hrs2009Journal of natural products, Jun, Volume: 72, Issue:6
Antileishmaniasis activity of flavonoids from Consolida oliveriana.
AID624607Specific activity of expressed human recombinant UGT1A32000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID768890Inhibition of thrombin (unknown origin) assessed as hydrolysis of N-benzoyl-phenylalanylvalyl-arginine-paranitroanilide2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID1633137Inhibition of chymotrypsin-like activity of purified human 20S proteasome expressed in human Jurkat cells assessed as decrease in AMC hydrolysis using Suc-Leu-Leu-Val-Tyr-AMC as substrate incubated for 2 hrs by fluorescence based method2019European journal of medicinal chemistry, Apr-01, Volume: 167Another look at phenolic compounds in cancer therapy the effect of polyphenols on ubiquitin-proteasome system.
AID768927Inhibition of human thrombin assessed as inhibition of fibrinogen polymerization preincubated for 10 mins followed by fibrionogen addition measured for 20 mins2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID1446235Inhibition of bovine milk LPO assessed as reduction in NaOSCN production in presence of H2O2/NaSCN after 5 mins2017Journal of medicinal chemistry, 08-10, Volume: 60, Issue:15
Discovery of Novel Potent Reversible and Irreversible Myeloperoxidase Inhibitors Using Virtual Screening Procedure.
AID1063040Inhibition of PRK1 (unknown origin)2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Protein kinase and HDAC inhibitors from the endophytic fungus Epicoccum nigrum.
AID1128731Inhibition of squalene synthase in rat liver microsomes assessed as decrease in conversion of [3H]FPP to squalene2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Design of novel potent antihyperlipidemic agents with antioxidant/anti-inflammatory properties: exploiting phenothiazine's strong antioxidant activity.
AID125798Evaluated for the antioxidant property by measuring the inhibition of microsomal lipid peroxidation2001Bioorganic & medicinal chemistry letters, Jan-22, Volume: 11, Issue:2
Synthesis and evaluation of caffeic acid amides as antioxidants.
AID1485947Inhibition of human amyloid beta (1 to 42) aggregation assessed as loosely attached/thin fibrils at 100 uM after 48 hrs by transmission electron microscopic analysis2017Bioorganic & medicinal chemistry, 07-15, Volume: 25, Issue:14
Structure-activity relationships for flavone interactions with amyloid β reveal a novel anti-aggregatory and neuroprotective effect of 2',3',4'-trihydroxyflavone (2-D08).
AID1712014Toxicity in Kunming mouse implanted with mouse H22 cells assessed as mouse mortality at 100 mg/kg, iv administered for 7 consecutive days starting from day 8 post inoculation and measured after 16 days2016European journal of medicinal chemistry, Oct-04, Volume: 121Synthesis and biological properties of polyamine modified flavonoids as hepatocellular carcinoma inhibitors.
AID34337The compound was tested for Inhibitory effect against ALR1 in bovine kidneys1999Journal of medicinal chemistry, Jun-03, Volume: 42, Issue:11
1-Benzopyran-4-one antioxidants as aldose reductase inhibitors.
AID293621Apoptotic activity in human blood neutrophils after 72 hrs2007European journal of medicinal chemistry, May, Volume: 42, Issue:5
Novel and versatile methodology for synthesis of cyclic imides and evaluation of their cytotoxic, DNA binding, apoptotic inducing activities and molecular modeling study.
AID1371372Cytotoxicity against human A549 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1474812Inhibition of LPS-induced NO production in mouse RAW264.7 cells preincubated for 1 hr followed by LPS stimulation measured after 24 hrs by Griess assay2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
New derivatives of ursolic acid through the biotransformation by Bacillus megaterium CGMCC 1.1741 as inhibitors on nitric oxide production.
AID699540Inhibition of human liver OATP1B3 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E17-betaG uptake at 20 uM incubated for 5 mins by scintillation counting2012Journal of medicinal chemistry, May-24, Volume: 55, Issue:10
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
AID1082430Inhibition of fruit-infesting behavior of Cydia pomonella (codling moth) neonates infested in apple fruit plugs assessed as feeding deterrence index at 30 mg/mL2011Journal of agricultural and food chemistry, Oct-26, Volume: 59, Issue:20
Effects of Ginkgo biloba constituents on fruit-infesting behavior of codling moth (Cydia pomonella) in apples.
AID467555Antiinflammatory activity in Swiss mouse assessed as inhibition of carrageenan-induced paw edema at 100 mg/kg, ip dosed 30 mins before carrageenan challenge measured after 0.5 to 3 hrs2009Journal of natural products, Nov, Volume: 72, Issue:11
Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production.
AID1425889Inhibition of human GLUT2 expressed in Xenopus laevis oocytes assessed as reduction in [3H] 2-deoxyglucose uptake by scintillation spectrometric method2016MedChemComm, Sep-01, Volume: 7, Issue:9
Anticancer agents interacting with membrane glucose transporters.
AID506945Inhibition of HSP70-mediated antiapoptotic activity in human SKBR3 cells assessed as induction of caspase-3 cleavage after 24 hrs by Western blot analysis2007Nature chemical biology, Aug, Volume: 3, Issue:8
Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer.
AID1162607Inhibition of basal NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in COX2 mRNA expression at 25 uM by quantitative RT-PCR method relative to untreated control2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID402232Antioxidant activity in 1-alpha-phosphatidylcholine liposome assessed as inhibition of ascorbyl hydroxyl-induced lipid peroxidation by TBARS assay2004Journal of natural products, May, Volume: 67, Issue:5
Hypoglycemic effect and antioxidant potential of kaempferol-3,7-O-(alpha)-dirhamnoside from Bauhinia forficata leaves.
AID1265123Inhibition of recombinant human AKR1B10 expressed in human HCT116 cells assessed as reduction in daunorubicinol production using daunorubicin as substrate at 10 uM incubated for 4 to 8 hrs by UHPLC based transient transfection assay2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Flavones Inhibit the Activity of AKR1B10, a Promising Therapeutic Target for Cancer Treatment.
AID378681Inhibition of LCK2006Journal of natural products, Jan, Volume: 69, Issue:1
A common protein fold topology shared by flavonoid biosynthetic enzymes and therapeutic targets.
AID1447896Activation of ABCG2 (unknown origin) ATPase activity expressed in baculovirus infected high five cell membranes assessed as protein Vmax by ascorbic acid/ammonia molybdate reaction-based colorimetric analysis relative to basal control2017Journal of medicinal chemistry, 05-25, Volume: 60, Issue:10
4-Anilino-2-pyridylquinazolines and -pyrimidines as Highly Potent and Nontoxic Inhibitors of Breast Cancer Resistance Protein (ABCG2).
AID351093Cytoprotective activity against H2O2-induced cell death in rat PC12 cells assessed as increase in cell viability at 8 ug/ml preincubated 2 hrs before H2O2 challenge measured after 4 hrs by MTT assay relative to control2009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
Preparation of two sets of 5,6,7-trioxygenated dihydroflavonol derivatives as free radical scavengers and neuronal cell protectors to oxidative damage.
AID353597Inhibition of of heat-induced increase in nuclear HSF1 protein phosphorylation in human HeLa cells assessed as decrease in protein mobility at 50 ug/mL treated for 1 hr before heat induction by EMSA2009Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7
Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives.
AID1627948Antiproliferative activity against human PC3 cells after 3 days by WST1 assay2016Bioorganic & medicinal chemistry letters, 09-01, Volume: 26, Issue:17
A new class of flavonol-based anti-prostate cancer agents: Design, synthesis, and evaluation in cell models.
AID1635055Antimigratory activity in rhesus monkey RF/6A cells measured after 24 hrs by wound assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Effects of 2,3-Dehydrosilybin and Its Galloyl Ester and Methyl Ether Derivatives on Human Umbilical Vein Endothelial Cells.
AID506946Inhibition of HSP70-mediated antiapoptotic activity in human SKBR3 cells assessed as induction of PARP cleavage after 24 hrs by Western blot analysis2007Nature chemical biology, Aug, Volume: 3, Issue:8
Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer.
AID347257Binding affinity to human recombinant carbonyl reductase 3 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in presence of NADPH2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID404008Cytotoxicity against human KB cells
AID357035Antioxidant activity assessed as radical scavenging activity in FMLP-stimulated human PMNC by chemiluminescence assay2001Journal of natural products, Jul, Volume: 64, Issue:7
Flavonoid, iridoid, and lignan glycosides from Putoria calabrica.
AID1198740Inhibition of Saccharomyces cerevisiae alpha-glucosidase using 4-NPGP substrate assessed as reduction in 4-nitrophenol release pre-incubated for 10 mins before substrate addition by microplate reader based assay2015European journal of medicinal chemistry, Mar-26, Volume: 93Antioxidant activity and inhibition of α-glucosidase by hydroxyl-functionalized 2-arylbenzo[b]furans.
AID216252In vitro inhibitory activity against the growth of WISH cell derived from human cervical carcinoma was determined; slight effect2004Bioorganic & medicinal chemistry letters, Jan-05, Volume: 14, Issue:1
Antiproliferative activity of various flavonoids and related compounds: additive effect of interferon-alpha2b.
AID1204216Inhibition of porcine pancreatic lipase using p-nitrophenylbutyrate as substrate assessed as formation of p-nitrophenol at 100 uM preincubated for 15 mins followed by substrate addition measured after 15 mins relative to control2015Bioorganic & medicinal chemistry letters, Jun-01, Volume: 25, Issue:11
Pancreatic lipase inhibitory constituents from Morus alba leaves and optimization for extraction conditions.
AID754355Cytotoxicity against human HCT116 cells at 1 to 100 uM after 12 hrs by MTT assay2013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
Quercetin-POC conjugates: Differential stability and bioactivity profiles between breast cancer (MCF-7) and colorectal carcinoma (HCT116) cell lines.
AID35134Evaluated for inhibition of Aldose reductase 21996Journal of medicinal chemistry, Oct-25, Volume: 39, Issue:22
Synthesis, activity, and molecular modeling of a new series of tricyclic pyridazinones as selective aldose reductase inhibitors.
AID1328668Neuroprotective activity in mouse HT22 cells assessed as decrease of glutamate-induced ROS production at 10 uM pretreated for 12 hrs prior to glutamate-challenge measured after 12 hrs by CM-H2CDFDA staining-based flow cytometry (Rvb = 3.95 +/- 0.01 No_uni2016Bioorganic & medicinal chemistry letters, 12-01, Volume: 26, Issue:23
The comparison of neuroprotective effects of isoliquiritigenin and its Phase I metabolites against glutamate-induced HT22 cell death.
AID1224774Delta TM value showing the stabilisation of p38beta produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID462334Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 10 uM after 72 hrs2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells.
AID257079Inhibitory activity against PIM1 at 1 uM2005Journal of medicinal chemistry, Dec-01, Volume: 48, Issue:24
Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM-1) kinase.
AID1239574Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 at 1.69 mM after 4 hrs by time kill assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1162602Inhibition of basal NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in MMP9 mRNA expression at 25 uM by quantitative RT-PCR method relative to untreated control2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID1394726Inhibition of recombinant human EGFR using peptide as substrate by fluorimetric analysis2018European journal of medicinal chemistry, Apr-25, Volume: 150Challenging clinically unresponsive medullary thyroid cancer: Discovery and pharmacological activity of novel RET inhibitors.
AID339149Inhibition of norepinephrine-induced Wistar rat thoracic aorta tonic contraction at 10 ug/mL after 15 mins1993Journal of natural products, Jun, Volume: 56, Issue:6
Antiplatelet effects and vasorelaxing action of some constituents of Formosan plants.
AID462277Inhibition of human CA7 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID315615Induction of apoptosis in human BGC823 cells at 100 uM after 12 hrs by flow cytometry2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
Studies on the chemical constituents and anticancer activity of Saxifraga stolonifera (L) Meeb.
AID676963Antioxidant activity in Wistar rat brain homogenates assessed as inhibition of lipid peroxidation at 3.16 uM by spectrophotometry based TBARS assay relative to untreated control2012Bioorganic & medicinal chemistry, Sep-01, Volume: 20, Issue:17
Synthesis, cytotoxic and antioxidant evaluations of amino derivatives from perezone.
AID1103943Antifeedant activity against third-instar Epilachna paenulata measured assessed per cm2 leaf disk after 24 hr by leaf disk choice test2009Bioresource technology, Jul, Volume: 100, Issue:14
Antifeedant activity of ethanolic extract from Flourensia oolepis and isolation of pinocembrin as its active principle compound.
AID587315Antiinflammatory activity in human neutrophil assessed as inhibition of fMLP-induced neutrophil chemoattraction 30 nM after 2 hrs by Boyden chamber v2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID701071Inhibition of SYK2012Journal of medicinal chemistry, Apr-26, Volume: 55, Issue:8
Discovery and development of spleen tyrosine kinase (SYK) inhibitors.
AID1080607Phytotoxic activity against Sinapis alba assessed as inhibition of root growth at 22 +/-2 degC after 72 hr2009Journal of agricultural and food chemistry, Apr-08, Volume: 57, Issue:7
Level of catechin, myricetin, quercetin and isoquercitrin in buckwheat (Fagopyrum esculentum Moench), changes of their levels during vegetation and their effect on the growth of selected weeds.
AID1063733Cytotoxicity against HUVEC assessed as cell detachment at 10 to 50 uM after 72 hrs by phase-contrast microscopy2014European journal of medicinal chemistry, Jan-24, Volume: 72A novel 2,3-diphenyl-4H-pyrido[1,2-a]pyrimidin-4-one derivative inhibits endothelial cell dysfunction and smooth muscle cell proliferation/activation.
AID370563Inhibition of Escherichia coli D-alanine-D-alanine ligase B assessed as residual activity at 2 mM preincubated for 30 mins by malachite green assay2009Bioorganic & medicinal chemistry, Feb-01, Volume: 17, Issue:3
ATP competitive inhibitors of D-alanine-D-alanine ligase based on protein kinase inhibitor scaffolds.
AID43262Percentage inhibition against beta-Lactamase in the presence of detergent 0.01% Triton X-100 was determined at a concentration of 25 uM2003Journal of medicinal chemistry, Sep-25, Volume: 46, Issue:20
A specific mechanism of nonspecific inhibition.
AID1372147Inhibition of recombinant human CYP3A4 expressed in yeast microsomal membranes by fluorescence assay
AID703481Therapeutic index, ratio of IC50 for mouse Peritoneal macrophages to IC50 for SSG-resistant Leishmania donovani 39 promastigote2012Journal of medicinal chemistry, Oct-25, Volume: 55, Issue:20
Flavonoid dimers as novel, potent antileishmanial agents.
AID467849Inhibition of carrageenan-induced CXCL1 production in Swiss mouse subcutaneous plantar tissue at 100 mg/kg, ip dosed 30 mins before carrageenan challenge measured after 3 hrs by ELISA2009Journal of natural products, Nov, Volume: 72, Issue:11
Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production.
AID1654170Growth inhibition of human Gingival fibroblast at 50 uM after 72 hrs by MTS assay2020Journal of natural products, 03-27, Volume: 83, Issue:3
Antioxidant Activity of Compounds Isolated from
AID1371453Tmax in mouse at 10 mg/kg, iv by LC-MS/MS method2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID161176Inhibition of Prostaglandin G/H synthase activity in sheep seminal vesicle was determined 10E-4 uM1993Journal of medicinal chemistry, Nov-26, Volume: 36, Issue:24
3,4-Dihydroxychalcones as potent 5-lipoxygenase and cyclooxygenase inhibitors.
AID336443Antiprotozoal activity against Plasmodium falciparum K12002Journal of natural products, Oct, Volume: 65, Issue:10
Assessment of the antiprotozoal activity of Galphimia glauca and the isolation of new nor-secofriedelanes and nor-friedelanes.
AID1917221Cytotoxicity against mouse BEND3 cells assessed as inhibition of cell viability at 20 to 50 uM incubated for 24 hrs by MTT assay2022Bioorganic & medicinal chemistry, 11-01, Volume: 73Synthesis and evaluation of glycosylated quercetin to enhance neuroprotective effects on cerebral ischemia-reperfusion.
AID622872Non-competitive inhibition of Clostridium perfringens neuraminidase using 4-methylumbelliferyl-alpha-D-N-acetylneuraminic acid as substrate by Lineweaver-Burk plot analysis2011Bioorganic & medicinal chemistry letters, Oct-15, Volume: 21, Issue:20
Potent inhibition of bacterial neuraminidase activity by pterocarpans isolated from the roots of Lespedeza bicolor.
AID1572039Inhibition of IP6K2 in mouse 3T3-L1 cells assessed as AKT phosphorylation at T308 at 1 uM after 3 hrs by Western blot analysis2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
AID1617255Cytotoxicity against nutrient-rich DMEM cultured human PANC1 cells at PC50 incubated for 24 hrs by WST-8 assay
AID467858Analgesic activity in Swiss mouse assessed as reaction time taken to jump or lick paw at 8 mg/kg, ip after 30 mins of administration by hot plate test2009Journal of natural products, Nov, Volume: 72, Issue:11
Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production.
AID605032Solubility of the compound in DMEM media assessed as forward light scattering by compound by microplate neplhelometric analysis2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID760688Inhibition of bovine lens aldose reductase using DL-glyceraldehyde as substrate assessed as NADPH oxidation measured for 10 mins by spectrophotometric analysis2013Bioorganic & medicinal chemistry, Jul-15, Volume: 21, Issue:14
Synthesis of organic nitrates of luteolin as a novel class of potent aldose reductase inhibitors.
AID1209972Inhibition of CYP2C19 in human liver microsomes using S-mephenytoin as substrate after 8 mins by LC-MS/MS analysis2012Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
AID1564979Antioxidant activity assessed as DPPH radical scavenging activity measured after 120 mins2019European journal of medicinal chemistry, Nov-15, Volume: 182Novel multi target-directed ligands targeting 5-HT
AID1367970Antiinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-stimulated nitric oxide production by Griess reagent based spectrophotometric analysis2017Bioorganic & medicinal chemistry letters, 12-15, Volume: 27, Issue:24
New terpenoids and thiophene derivatives from the aerial parts of Artemisia sieversiana.
AID1187100Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as reduction in nitric oxide production at 3 uM after 24 hrs by Griess method based ELISA (Rvb = 52.4 +/- 0.9 uM)2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Triterpene glycosides from red ginseng marc and their anti-inflammatory activities.
AID359634Antiviral activity against HSV1 in african green monkey Vero cells assessed as log reduction of virus titer at 72.5 ug/ml1992Journal of natural products, Dec, Volume: 55, Issue:12
Synergistic effect of flavones and flavonols against herpes simplex virus type 1 in cell culture. Comparison with the antiviral activity of propolis.
AID71641Inhibition of EGF-induced mitogenesis in human foreskin fibroblasts1994Journal of medicinal chemistry, May-27, Volume: 37, Issue:11
Structural studies on bioactive compounds. 23. Synthesis of polyhydroxylated 2-phenylbenzothiazoles and a comparison of their cytotoxicities and pharmacological properties with genistein and quercetin.
AID1446621Antiinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced nitrite production after 24 hrs by Griess assay2017Journal of natural products, 02-24, Volume: 80, Issue:2
Anti-Neurodegenerative Biflavonoid Glycosides from Impatiens balsamina.
AID770924Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins2013European journal of medicinal chemistry, Oct, Volume: 68Polyoxygenated cinnamoylcoumarins as conformationally constrained analogs of cytotoxic diarylpentanoids: synthesis and biological activity.
AID430217Antileishmanial activity against extracellular Leishmania peruviana promastigotes after 72 hrs2009Journal of natural products, Jun, Volume: 72, Issue:6
Antileishmaniasis activity of flavonoids from Consolida oliveriana.
AID395316Inhibition of Trypanosoma cruzi recombinant glycosomal GAPDH expressed in Escherichia coli by spectrophotometry2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Discovery of novel Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase inhibitors.
AID315609Growth inhibition of human BGC823 cells at 100 uM after 72 hrs by MTT assay relative to control2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
Studies on the chemical constituents and anticancer activity of Saxifraga stolonifera (L) Meeb.
AID1505144Antiinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by griess assay2018Journal of natural products, 01-26, Volume: 81, Issue:1
Anti-Inflammatory Prenylated Phenylpropenols and Coumarin Derivatives from Murraya exotica.
AID681309TP_TRANSPORTER: increase in Vinblastine intracellular accumulation (Vinblastine: 0.05 uM, Quercetin: 100 uM) in PANC-1 cells2003Journal of pharmaceutical sciences, Feb, Volume: 92, Issue:2
Effect of flavonoids on MRP1-mediated transport in Panc-1 cells.
AID710229Antioxidant activity of the compound assessed as DHR radical scavenging activity at 10 uM by fluorescence assay2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Carbamate derivatives of indolines as cholinesterase inhibitors and antioxidants for the treatment of Alzheimer's disease.
AID1845531Binding affinity to human c-MYC G-quadruplex (Pu24T) DNA assessed as second order binding constant by fluorescence spectroscopy2021Journal of medicinal chemistry, 01-14, Volume: 64, Issue:1
Recent Update on Targeting
AID768892Competitive inhibition of human thrombin using D-Phe-Pip-Arg-pNA as substrate preincubated for 10 mins followed by substrate addition measured every 12 secs for 10 mins by Lineweaver-Burk plot analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID1371437Cytotoxicity against human SK-MEL-2 cells assessed as cell viability at 14 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID762875Antioxidant activity assessed as peroxyl radical scavenging activity by ORAC assay relative to trolox2013Journal of medicinal chemistry, Aug-08, Volume: 56, Issue:15
Synthesis and electrochemical and biological studies of novel coumarin-chalcone hybrid compounds.
AID1127218Binding affinity DPPC multilamellar vesicles assessed as main transition temperature at 1:20 compound/lipid ratio after 2 hrs by differential scanning calorimetry method (Rvb = 41.98 degC)2014European journal of medicinal chemistry, May-22, Volume: 79In-vitro anti-proliferative and anti-oxidant activity of galangin, fisetin and quercetin: role of localization and intermolecular interaction in model membrane.
AID1443980Inhibition of human BSEP expressed in fall armyworm sf9 cell plasma membrane vesicles assessed as reduction in vesicle-associated [3H]-taurocholate transport preincubated for 10 mins prior to ATP addition measured after 15 mins in presence of [3H]-tauroch2010Toxicological sciences : an official journal of the Society of Toxicology, Dec, Volume: 118, Issue:2
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
AID1080602Phytotoxic activity against Lolium perenne (perennial ryegrass) assessed as inhibition of hypocotyl growth at 22 +/-2 degC after 72 hr2009Journal of agricultural and food chemistry, Apr-08, Volume: 57, Issue:7
Level of catechin, myricetin, quercetin and isoquercitrin in buckwheat (Fagopyrum esculentum Moench), changes of their levels during vegetation and their effect on the growth of selected weeds.
AID1230141Inhibition of human recombinant BACE1 by fluorescence resonance energy transfer (FRET) assay2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Isolation of cholinesterase and β-secretase 1 inhibiting compounds from Lycopodiella cernua.
AID34784Antiallergic agent with Aldose reductase Inhibitory Activity at 10E-5 M concentration1980Journal of medicinal chemistry, Nov, Volume: 23, Issue:11
Synthesis and aldose reductase inhibitory activity of 7-sulfamoylxanthone-2-carboxylic acids.
AID1845528Binding affinity to human c-MYC G-quadruplex (Pu24T) DNA assessed as first order binding constant by isothermal titration calorimetry method2021Journal of medicinal chemistry, 01-14, Volume: 64, Issue:1
Recent Update on Targeting
AID1516852Antifungal activity against Candida albicans 53 by microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID315618Induction of apoptosis in human BGC823 cells at 100 uM after 48 hrs by flow cytometry2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
Studies on the chemical constituents and anticancer activity of Saxifraga stolonifera (L) Meeb.
AID1683188Reduction of lactate production in human HCT-116 cells at IC50 after 4 to 24 hrs by colorimetric assay2021Bioorganic & medicinal chemistry, 01-01, Volume: 29Synthesis and anticancer activity of new coumarin-3-carboxylic acid derivatives as potential lactatetransportinhibitors.
AID429250Antioxidant activity assessed as nitric oxide scavenging activity after 60 min by Griess assay2009European journal of medicinal chemistry, Aug, Volume: 44, Issue:8
Synthesis and biological evaluation of curcumin-like diarylpentanoid analogues for anti-inflammatory, antioxidant and anti-tyrosinase activities.
AID762913Antileishmanial activity against promastigotes of Leishmania amazonensis MHOM/BR/75/LTB0016 infected in Swiss mouse peritoneal macrophages assessed as parasite growth inhibition at 12 uM after 72 hrs2013Journal of natural products, Aug-23, Volume: 76, Issue:8
Reactive oxygen species production by quercetin causes the death of Leishmania amazonensis intracellular amastigotes.
AID1294438Antioxidant activity assessed as inhibition of peroxynitrite induced oxidation of the non-fluorescent dihydrorhodamine 123 to the fluorescent rhodamine 123 after 2 mins by fluorimetric method2016European journal of medicinal chemistry, Jun-10, Volume: 115Novel chromone and xanthone derivatives: Synthesis and ROS/RNS scavenging activities.
AID1239521Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 2 by disk diffusion assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1102139Phytotoxicity in Centaurea diffusa assessed as inhibition of shoot differentiation at 250 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID357255Antifungal activity against Cryptococcus neoformans ATCC 901132002Journal of natural products, Dec, Volume: 65, Issue:12
Fatty acid synthase inhibitors from plants: isolation, structure elucidation, and SAR studies.
AID703486Antimicrobial activity against SSG-resistant Leishmania donovani 39 amastigote infected in mouse peritoneal macrophages assessed as inhibition of parasite growth after 72 hrs by Giemsa staining method2012Journal of medicinal chemistry, Oct-25, Volume: 55, Issue:20
Flavonoid dimers as novel, potent antileishmanial agents.
AID1484024Inhibition of amyloid beta (1 to 42) aggregation in Escherichia coli competent cells BL21 (DE3) after overnight incubation by Thioflavin-S steady-state fluorescence assay2017Journal of natural products, 02-24, Volume: 80, Issue:2
Combined in Vitro Cell-Based/in Silico Screening of Naturally Occurring Flavonoids and Phenolic Compounds as Potential Anti-Alzheimer Drugs.
AID1376931Antiplasmodial activity against asexual erythrocyte stage of chloroquine-sensitive Plasmodium falciparum 3D7 infected in human red blood cells after 48 hrs by lactate dehydrogenase assay2017Journal of natural products, 06-23, Volume: 80, Issue:6
Antimalarial Activities of Alkyl Cyclohexenone Derivatives Isolated from the Leaves of Poupartia borbonica.
AID336444Antitrypanosomal activity against Trypanosoma brucei brucei S427 blood stream trypomastigotes2002Journal of natural products, Oct, Volume: 65, Issue:10
Assessment of the antiprotozoal activity of Galphimia glauca and the isolation of new nor-secofriedelanes and nor-friedelanes.
AID1082329Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under dark conditions measured 72 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1371457Tmax in mouse at 100 mg/kg, po by HPLC method2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1917217Stability of compound in phosphate buffer assessed as parent compound remaining after 48 hrs by HPLC analysis2022Bioorganic & medicinal chemistry, 11-01, Volume: 73Synthesis and evaluation of glycosylated quercetin to enhance neuroprotective effects on cerebral ischemia-reperfusion.
AID38383Inhibition of cell surface aminopeptidase N (APN/CD13) at 0.3*10e-3 M compound concentration2003Journal of medicinal chemistry, Aug-28, Volume: 46, Issue:18
Synthesis and biological evaluation of novel flavone-8-acetic acid derivatives as reversible inhibitors of aminopeptidase N/CD13.
AID603838Increase in p38 kinase phosphorylation in human MDA-MB-231 cells at 20 uM by Western blot analysis2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Rhamnetin production based on the rational design of the poplar O-methyltransferase enzyme and its biological activities.
AID1294435Antioxidant activity assessed as inhibition of singlet oxygen induced oxidation of non-fluorescent DHR to fluorescent rhodamine 123 at 37 degC measured after 30 mins by fluorimetric method2016European journal of medicinal chemistry, Jun-10, Volume: 115Novel chromone and xanthone derivatives: Synthesis and ROS/RNS scavenging activities.
AID1328666Inhibition of glutamate-induced increase in ERK phosphorylation in mouse HT22 cells at 5 uM pretreated for 12 hrs followed by glutamate-challenge measured after 12 hrs by Western blotting assay (Rvb = 3.01 +/- 0.3 No_unit)2016Bioorganic & medicinal chemistry letters, 12-01, Volume: 26, Issue:23
The comparison of neuroprotective effects of isoliquiritigenin and its Phase I metabolites against glutamate-induced HT22 cell death.
AID1056596Antiinflammatory activity in Aggregatibacter actinomycetemcomitans infected Balb/c mouse model assessed as inhibition of TNFalpha production at 100 mg/kg, sc for 15 days post Aggregatibacter actinomycetemcomitans-challenge by ELISA2013Journal of natural products, Dec-27, Volume: 76, Issue:12
Quercetin inhibits inflammatory bone resorption in a mouse periodontitis model.
AID1082359Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under light conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID622873Inhibition of Clostridium perfringens neuraminidase using 4-methylumbelliferyl-alpha-D-N-acetylneuraminic acid as substrate by fluorimetry2011Bioorganic & medicinal chemistry letters, Oct-15, Volume: 21, Issue:20
Potent inhibition of bacterial neuraminidase activity by pterocarpans isolated from the roots of Lespedeza bicolor.
AID1202774Antioxidant activity assessed as trolox equivalent of APPH radical scavenging activity preincubated for 30 mins followed by APPH addition measured after 90 mins by hydrophilic-ORAC fluorescence assay2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Antioxidative compounds from Garcinia buchananii stem bark.
AID1328669Neuroprotective activity against glutamate-induced oxidative stress in mouse HT22 cells assessed as ROS level at 10 uM pretreated for 12 hrs prior to glutamate-challenge measured after 12 hrs (Rvb = 241.63 +/- 7.98%)2016Bioorganic & medicinal chemistry letters, 12-01, Volume: 26, Issue:23
The comparison of neuroprotective effects of isoliquiritigenin and its Phase I metabolites against glutamate-induced HT22 cell death.
AID34198In vitro inhibitory activity against aldehyde reductase 1 (ALR1) from rat kidney.2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
Novel, highly potent aldose reductase inhibitors: cyano(2-oxo-2,3-dihydroindol-3-yl)acetic acid derivatives.
AID1224790Delta TM value showing the stabilisation of PLK4 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID322413Inhibition of human recombinant aldose reductase2008Bioorganic & medicinal chemistry, Mar-15, Volume: 16, Issue:6
Inhibition of 3(17)alpha-hydroxysteroid dehydrogenase (AKR1C21) by aldose reductase inhibitors.
AID334641Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of acetylaminofluorene-induced mutation at 300 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID332648Enhancement of human DNA topoisomerase 2-mediated Escherichia coli pUC8 DNA cleavage assessed as production of linear DNA at 100 ug/ml after 30 mins by agarose gel electrophoresis relative to total DNA1995Journal of natural products, Feb, Volume: 58, Issue:2
Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships.
AID293620Apoptotic activity in human blood neutrophils after 48 hrs2007European journal of medicinal chemistry, May, Volume: 42, Issue:5
Novel and versatile methodology for synthesis of cyclic imides and evaluation of their cytotoxic, DNA binding, apoptotic inducing activities and molecular modeling study.
AID732547Activation of Nrf2 in mouse RAW264.7 cells assessed as upregulation of HO1 protein expression at 50 uM after 6 hrs by Western blotting analysis2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
A novel semisynthetic flavonoid 7-O-galloyltaxifolin upregulates heme oxygenase-1 in RAW264.7 cells via MAPK/Nrf2 pathway.
AID1128738In vivo antidyslipidemic activity against Triton WR 1339-induced hyperlipidemic Wistar rat model assessed as decrease in LDL-cholesterol level in plasma at 56 umol/kg, ip administered as single dose 1 hr after Triton WR 1339 challenge measured after 24 hr2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Design of novel potent antihyperlipidemic agents with antioxidant/anti-inflammatory properties: exploiting phenothiazine's strong antioxidant activity.
AID1323133Antioxidant activity assessed as DPPH free radical scavenging activity at 5 uM after 15 to 60 mins in presence of CuSO4.5H2O2016Journal of natural products, 07-22, Volume: 79, Issue:7
Effects of Functional Groups and Sugar Composition of Quercetin Derivatives on Their Radical Scavenging Properties.
AID1434690Inhibition of sucrose loaded POPC/POPE/POPS/PtdIns(3,4,5)P3 (59:20:20:1) liposome binding to eGFP-fused PDK1 PH domain (unknown origin) expressed in Escherichia coli BL21 at 20 uM after 10 mins by fluorescence spectrophotometry based pull down assay relat2017Bioorganic & medicinal chemistry letters, 02-01, Volume: 27, Issue:3
Inhibitory potential of flavonoids on PtdIns(3,4,5)P3 binding with the phosphoinositide-dependent kinase 1 pleckstrin homology domain.
AID1187903Inhibition of LPS-stimulated NO production in human BV2 cells after 24 hrs by Griess assay2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Rupestonic acids B-G, NO inhibitory sesquiterpenoids from Artemisia rupestris.
AID663955Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay2012ACS medicinal chemistry letters, Feb-09, Volume: 3, Issue:2
Discovery of Natural Phenols as G Protein-Coupled Receptor-35 (GPR35) Agonists.
AID1171179Induction of apoptosis in human HCT116 cells assessed as PARP cleavage at 20 uM after 72 hrs by immunoblotting2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Delineation of the role of glycosylation in the cytotoxic properties of quercetin using novel assays in living vertebrates.
AID361174Cytotoxicity against human SW1573 cells after 3 days by MTT assay2001Journal of natural products, Jun, Volume: 64, Issue:6
Chemical constituents from Lippia sidoides and cytotoxic activity.
AID1526862Neuroprotection against glutamate-induced cell death in mouse HT22 cells assessed as increase in cell viability at 25 uM measured after 24 hrs by MTT assay2019Journal of medicinal chemistry, 10-24, Volume: 62, Issue:20
Highly Selective Butyrylcholinesterase Inhibitors with Tunable Duration of Action by Chemical Modification of Transferable Carbamate Units Exhibit Pronounced Neuroprotective Effect in an Alzheimer's Disease Mouse Model.
AID1066694Inhibition of Leishmania amazonensis recombinant arginase expressed in Escherichia coli Rosetta (DE3) pLysS using L-arginine as substrate incubated for 10 mins prior to substrate addition measured after 10 mins by colorimetry2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Isolation of arginase inhibitors from the bioactivity-guided fractionation of Byrsonima coccolobifolia leaves and stems.
AID754420Half life of the compound in DMEM cell-free cell culture medium at 50 uM by HPLC analysis2013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
Quercetin-POC conjugates: Differential stability and bioactivity profiles between breast cancer (MCF-7) and colorectal carcinoma (HCT116) cell lines.
AID1871925Antioxidant activity assessed as ABTS radical scavenging activity at 10 wt% incubated for 6 mins in presence of Si and PCL50 by UV spectrophotometer analysis relative to control2022European journal of medicinal chemistry, Feb-05, Volume: 229Quercetin derivatives: Drug design, development, and biological activities, a review.
AID467855Antinociceptive activity in Swiss mouse assessed as inhibition of dopamine-induced mechanical hypernociception at 100 mg/kg, ip dosed 30 mins before dopamine challenge measured after 3 hrs by electronic pressure-meter test2009Journal of natural products, Nov, Volume: 72, Issue:11
Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production.
AID1871926Antioxidant activity assessed as ABTS radical scavenging activity at 15 wt% incubated for 6 mins in presence of Si and PCL50 by UV spectrophotometer analysis relative to control2022European journal of medicinal chemistry, Feb-05, Volume: 229Quercetin derivatives: Drug design, development, and biological activities, a review.
AID289320Hydrogen peroxide scavenging activity by assessed as inhibition of lucigenin oxidation2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
2-Styrylchromones: novel strong scavengers of reactive oxygen and nitrogen species.
AID605132Cell cycle arrest in human MCF7 cells assessed as decrease in accumulation at G0/G1 phase at 50 uM after 12 hrs by propidium iodide staining based flow cytometric analysis relative to untreated control2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID1082339Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 2% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1194979Cytotoxicity against human A549 cells by MTT assay2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Cytotoxic and antioxidant constituents from the leaves of Psidium guajava.
AID1172632Antioxidant activity assessed as DPPH radical scavenging activity after 10 mins2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
New silibinin glyco-conjugates: synthesis and evaluation of antioxidant properties.
AID1371452Cmax in mouse at 10 mg/kg, iv by LC-MS/MS method2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID351092Antioxidant activity against FeSO4-induced lipid peroxidation in rat liver homogenate assessed as inhibition of malondialdehyde release after 1 hr by thiobarbituric acid assay2009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
Preparation of two sets of 5,6,7-trioxygenated dihydroflavonol derivatives as free radical scavengers and neuronal cell protectors to oxidative damage.
AID1711961Induction of apoptosis in human HepG2 cells assessed as activation of caspase 3 at 80 uM measured after 48 hrs by immunofluorescence assay2016European journal of medicinal chemistry, Oct-04, Volume: 121Synthesis and biological properties of polyamine modified flavonoids as hepatocellular carcinoma inhibitors.
AID456319ABTS radical scavenging activity assessed as vitamin C equivalent antioxidant capacity2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID666859Reversal of MRP1-mediated drug resistant in human 2008/MRP1 cells assessed as potentiation of doxorubicin-induced cytotoxicity at 1 uM after 5 days by MTS assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis of methylated quercetin derivatives and their reversal activities on P-gp- and BCRP-mediated multidrug resistance tumour cells.
AID424723Ratio of kcat to km for bovine xanthine oxidase at 25 uM2009Journal of natural products, Apr, Volume: 72, Issue:4
Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin.
AID454618Inhibition of ovine COX2 at 1 mM by colorimetric assay2010Bioorganic & medicinal chemistry letters, Jan-15, Volume: 20, Issue:2
Synthesis and biological evaluation of nitrogen-containing chalcones as possible anti-inflammatory and antioxidant agents.
AID1649932Inhibition of YES (unknown origin)2019European journal of medicinal chemistry, Mar-15, Volume: 166Pharmacological urate-lowering approaches in chronic kidney disease.
AID1063039Inhibition of SRC (unknown origin)2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Protein kinase and HDAC inhibitors from the endophytic fungus Epicoccum nigrum.
AID1188613Anticancer activity against human NCI-H522 cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID1356521Inhibition of elastase (unknown origin) using N-succinyl-Ala-Ala-Ala-p-nitroanilide as substrate pretreated for 25 mins followed by substrate addition2018Journal of natural products, 08-24, Volume: 81, Issue:8
A Bioactive Resveratrol Trimer from the Stem Bark of the Sri Lankan Endemic Plant Vateria copallifera.
AID663962Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay relative to control2012ACS medicinal chemistry letters, Feb-09, Volume: 3, Issue:2
Discovery of Natural Phenols as G Protein-Coupled Receptor-35 (GPR35) Agonists.
AID1502927Inhibition of human neutrophil elastase using MeOSuc-AAPV-pNA as substrate measured after 30 mins by spectrometric method2017Journal of natural products, 10-27, Volume: 80, Issue:10
Potential Anti-inflammatory Effects of the Fruits of Paulownia tomentosa.
AID452853Antioxidant activity assessed as hydrogen peroxide scavenging activity by peroxyoxalate chemiluminescent method2009Bioorganic & medicinal chemistry, Dec-01, Volume: 17, Issue:23
Natural and synthetic 2'-hydroxy-chalcones and aurones: synthesis, characterization and evaluation of the antioxidant and soybean lipoxygenase inhibitory activity.
AID1224786Delta TM value showing the stabilisation of PIM1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID770923Antioxidant activity assessed as ferric ion reducing ability after 20 mins by FRAP assay2013European journal of medicinal chemistry, Oct, Volume: 68Polyoxygenated cinnamoylcoumarins as conformationally constrained analogs of cytotoxic diarylpentanoids: synthesis and biological activity.
AID377659Induction of behavioral effects in CD1 mouse at 10 mg/kg, ip by forced swimming test relative to control2006Journal of natural products, Jun, Volume: 69, Issue:6
Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and computational study.
AID1537234Antiallergic activity in CD-1 mouse model of IgE/DNP-BSA-stimulated passive cutaneous anaphylaxis assessed as inhibition of vascular permeability at 0.02%, iv administered immediately after sensitization by Evans blue extravasation assay relative to contr2019Journal of natural products, 02-22, Volume: 82, Issue:2
In Vivo Anti-inflammatory and Antiallergic Activity of Pure Naringenin, Naringenin Chalcone, and Quercetin in Mice.
AID1484013Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay2017Journal of natural products, 02-24, Volume: 80, Issue:2
Combined in Vitro Cell-Based/in Silico Screening of Naturally Occurring Flavonoids and Phenolic Compounds as Potential Anti-Alzheimer Drugs.
AID732560Cytotoxicity against mouse RAW264.7 cells assessed as decreased cell viability at 10 uM after 6 hrs by MTT assay2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
A novel semisynthetic flavonoid 7-O-galloyltaxifolin upregulates heme oxygenase-1 in RAW264.7 cells via MAPK/Nrf2 pathway.
AID1220258Renal clearance in human2012Drug metabolism and disposition: the biological fate of chemicals, Sep, Volume: 40, Issue:9
Quantitative prediction of human intestinal glucuronidation effects on intestinal availability of UDP-glucuronosyltransferase substrates using in vitro data.
AID191754Compound was evaluated for the mutagenicity by calculating number of revertants using Salmonella Typhimurium strain TA 98 (2.5 mg/plate) with S9 mix from rat liver; Toxic concentration1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
4'-Hydroxy-3-methoxyflavones with potent antipicornavirus activity.
AID332931Therapeutic index, ratio of IC50 for human H9 cells to EC50 for HIV1 3B1994Journal of natural products, Jan, Volume: 57, Issue:1
Anti-AIDS agents, 10. Acacetin-7-O-beta-D-galactopyranoside, an anti-HIV principle from Chrysanthemum morifolium and a structure-activity correlation with some related flavonoids.
AID1833883Cytotoxicity against HEK293 cells assessed as reduction in cell viability at 62.5 to 2000 ug/ml measured after 24 hrs by resazurin dye based cell viability assay2021Bioorganic & medicinal chemistry, 12-15, Volume: 52Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition.
AID1371432Cytotoxicity against human A549 cells assessed as cell viability at 14 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1233236Downregulation of tyrosinase mRNA expression in theophylline-stimulated mouse B16-4A5 cells assessed as ratio of tyrosinase mRNA to beta-actin mRNA level at 10 uM after 72 hrs by qPCR analysis2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID1185460Inhibition of bovine milk xanthine oxidoreductase by spectrophotometry2014Journal of natural products, Jul-25, Volume: 77, Issue:7
X-ray crystal structure of a xanthine oxidase complex with the flavonoid inhibitor quercetin.
AID1239569Antibacterial activity against methicillin-resistant Staphylococcus aureus NCTC 12493 at 1.69 mM after 5 hrs by time kill assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID406997Inhibition of human recombinant 17beta-HSD2 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
Discovery of nonsteroidal 17beta-hydroxysteroid dehydrogenase 1 inhibitors by pharmacophore-based screening of virtual compound libraries.
AID641158Inhibition of PI3Kalpha H1047R mutant in human HCT116 cells using [32P]ATP at 25 uM after 10 mins2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Biological evaluation and docking studies of recently identified inhibitors of phosphoinositide-3-kinases.
AID332233Antiinflammatory activity against ICR mouse assessed as inhibition of TPA-induced ear edema compound administered topically preincubated 30 mins before TPA challenge2002Journal of natural products, Feb, Volume: 65, Issue:2
Anti-inflammatory and anti-tumor-promoting effects of cucurbitane glycosides from the roots of Bryonia dioica.
AID312786Inhibition of NADH-induced lipid peroxidation in rat brain microsome2008Journal of medicinal chemistry, Feb-14, Volume: 51, Issue:3
Synthesis and evaluation of 2'-hydroxyethyl trans-apovincaminate derivatives as antioxidant and cognitive enhancer agents.
AID1888440Cytotoxicity against rat PC-12 cells assessed as cell viability at 50 uM incubated for 24 hrs by MTT assay relative to control2022European journal of medicinal chemistry, Jan-05, Volume: 227Design, synthesis, and biological evaluation of novel (4-(1,2,4-oxadiazol-5-yl)phenyl)-2-aminoacetamide derivatives as multifunctional agents for the treatment of Alzheimer's disease.
AID1224785Delta TM value showing the stabilisation of PDK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1187904Cytotoxicity against LPS-stimulated human BV2 cells assessed as cell viability at 40 uM by MTT assay2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Rupestonic acids B-G, NO inhibitory sesquiterpenoids from Artemisia rupestris.
AID332704Inhibition of guinea pig classical complement system assessed as hemolysis of sensitized sheep erythrocytes at 1000 uM1995Journal of natural products, Mar, Volume: 58, Issue:3
In vitro anticomplementary activity of constituents from Morinda morindoides.
AID1198742Antioxidant activity assessed as DPPH radical scavenging activity incubated for for 5 mins by microplate spectrophotometry2015European journal of medicinal chemistry, Mar-26, Volume: 93Antioxidant activity and inhibition of α-glucosidase by hydroxyl-functionalized 2-arylbenzo[b]furans.
AID1871979Antiproliferative activity against human MCF7 assessed as reduction in cell viability incubated for 48 hrs by MTT assay2022European journal of medicinal chemistry, Feb-05, Volume: 229Quercetin derivatives: Drug design, development, and biological activities, a review.
AID512279Inhibition of His-tagged human SAPK2b/p38b2 expressed in Escherichia coli at 20 uM2000The Biochemical journal, Oct-01, Volume: 351, Issue:Pt 1
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
AID1693689Inhibition of rabbit muscle F-actin depolymerization incubated for 15 mins by spectrophotometric analysis2021Bioorganic & medicinal chemistry, 01-15, Volume: 30In vitro and in vivo effects of inhibitors on actin and myosin.
AID481170Selectivity ratio of IC50 for Leishmania donovani DNA topoisomerase 1 treated simultaneously with DNA to IC50 for Leishmania donovani DNA topoisomerase 1 pretreated before addition of DNA2010Bioorganic & medicinal chemistry letters, May-01, Volume: 20, Issue:9
Cytotoxicity and inhibition of DNA topoisomerase I of polyhydroxylated triterpenoids and triterpenoid glycosides.
AID34200Inhibition of Aldehyde reductase 21996Journal of medicinal chemistry, Oct-25, Volume: 39, Issue:22
Synthesis, activity, and molecular modeling of a new series of tricyclic pyridazinones as selective aldose reductase inhibitors.
AID1634891Binding affinity to human ERK1 expressed in Escherichia coli BL21 by fluorescence quenching based spectrofluorometric analysis2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Antituberculosis Activity of a Naturally Occurring Flavonoid, Isorhamnetin.
AID1224765Delta TM value showing the stabilisation of CK1G2 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID404304Effect on human MRP2-mediated estradiol-17-beta-glucuronide transport in Sf9 cells inverted membrane vesicles relative to control2008Journal of medicinal chemistry, Jun-12, Volume: 51, Issue:11
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
AID462278Inhibition of human CA9 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID501420Antimicrobial activity against methicillin-sensitive Staphylococcus aureus 209P after 24 hrs by microdilution assay2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Design, synthesis, and biological evaluation of a novel series of quercetin diacylglucosides as potent anti-MRSA and anti-VRE agents.
AID33223The compound was evaluated for in Vitro binding of AFB1 to DNA in rat liver microsomes; Pre-incubation time being 30 mins2002Bioorganic & medicinal chemistry letters, Sep-16, Volume: 12, Issue:18
Comparison of the prevention of aflatoxin b(1)-induced genotoxicity by quercetin and quercetin pentaacetate.
AID1224764Delta TM value showing the stabilisation of CK1G1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID257080Inhibitory activity against PIM1 at 10 uM2005Journal of medicinal chemistry, Dec-01, Volume: 48, Issue:24
Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM-1) kinase.
AID353596Inhibition of of heat-induced increase in nuclear HSF1 protein phosphorylation in human Jurkat cells assessed as decrease in protein mobility at 50 ug/mL treated for 1 hr before heat induction by EMSA2009Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7
Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives.
AID1537233Anti-inflammatory activity in tetradecanoylphorbol-13-acetate-induced CD-1 mouse ear edema model assessed as inhibition of ear edema thickness at 1.3% administered topically immediately after tetradecanoylphorbol-13-acetate treatment and measured 4 hrs po2019Journal of natural products, 02-22, Volume: 82, Issue:2
In Vivo Anti-inflammatory and Antiallergic Activity of Pure Naringenin, Naringenin Chalcone, and Quercetin in Mice.
AID103902Cytotoxic effect on MCF-7 human breast carcinoma cells1994Journal of medicinal chemistry, May-27, Volume: 37, Issue:11
Structural studies on bioactive compounds. 23. Synthesis of polyhydroxylated 2-phenylbenzothiazoles and a comparison of their cytotoxicities and pharmacological properties with genistein and quercetin.
AID1372154Inhibition of human CYP1B1 expressed in MDA-MB-468 cells assessed as cell toxicity
AID540211Fraction unbound in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID132112In vivo inhibition of ear oedema in mice following p.o. administration.1990Journal of medicinal chemistry, Oct, Volume: 33, Issue:10
Penta- and hexadienoic acid derivatives: a novel series of 5-lipoxygenase inhibitors.
AID1845534Cytotoxicity against human HEK cells assessed as inhibition of cell viability incubated for 48 hrs by MTT assay2021Journal of medicinal chemistry, 01-14, Volume: 64, Issue:1
Recent Update on Targeting
AID1572646Inhibition of human recombinant CK2 expressed in Escherichia coli using RRRADDSDDDDD as substrate after 10 mins in presence of [gamma-32P]ATP2019Bioorganic & medicinal chemistry, 03-01, Volume: 27, Issue:5
A review on flavones targeting serine/threonine protein kinases for potential anticancer drugs.
AID699541Inhibition of human liver OATP2B1 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E3S uptake at 20 uM incubated for 5 mins by scintillation counting2012Journal of medicinal chemistry, May-24, Volume: 55, Issue:10
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
AID220001Inhibition of rat brain cytosolic cAMP phosphodiesterase1982Journal of medicinal chemistry, Oct, Volume: 25, Issue:10
Pentasubstituted quercetin analogues as selective inhibitors of particulate 3':5'-cyclic-AMP phosphodiesterase from rat brain.
AID641166Induction of apoptosis in human HCT116 cells overexpressing PI3Kalpha H1047R mutant assessed DNA fragmentation at 25 uM after 48 hrs by ELISA relative to control2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Biological evaluation and docking studies of recently identified inhibitors of phosphoinositide-3-kinases.
AID1261709Antineuroinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-stimulated NO production after 24 hrs by Griess assay2015Journal of medicinal chemistry, Nov-12, Volume: 58, Issue:21
Design, Synthesis, and Evaluation of Orally Available Clioquinol-Moracin M Hybrids as Multitarget-Directed Ligands for Cognitive Improvement in a Rat Model of Neurodegeneration in Alzheimer's Disease.
AID1224753Delta TM value showing the stabilisation of CAMK2D produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID762910Cytotoxicity against Swiss mouse peritoneal macrophages after 72 hrs by AlamarBlue assay2013Journal of natural products, Aug-23, Volume: 76, Issue:8
Reactive oxygen species production by quercetin causes the death of Leishmania amazonensis intracellular amastigotes.
AID1634854Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated for 7 days by resazurin assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Antituberculosis Activity of a Naturally Occurring Flavonoid, Isorhamnetin.
AID356716Antiinflammatory activity against TPA-induced ear edema in mouse assessed inhibition of edema2001Journal of natural products, Jul, Volume: 64, Issue:7
Antiinflammatory constituents from Heterotheca inuloides.
AID512291Inhibition of His-tagged human S6K1 expressed in Escherichia coli at 20 uM2000The Biochemical journal, Oct-01, Volume: 351, Issue:Pt 1
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
AID1371377Cytotoxicity against human SK-MEL-2 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1171185Teratogenic effect in zebrafish assessed as heart sac edema at 160 uM after 72 hrs by microscopy2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Delineation of the role of glycosylation in the cytotoxic properties of quercetin using novel assays in living vertebrates.
AID501416Antimicrobial activity against methicillin-resistant Staphylococcus aureus OM481 after 24 hrs by microdilution assay2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Design, synthesis, and biological evaluation of a novel series of quercetin diacylglucosides as potent anti-MRSA and anti-VRE agents.
AID220006Relative inhibition of cAMP and cGMP hydrolysis by particulate phosphodiesterase1982Journal of medicinal chemistry, Oct, Volume: 25, Issue:10
Pentasubstituted quercetin analogues as selective inhibitors of particulate 3':5'-cyclic-AMP phosphodiesterase from rat brain.
AID1425890Inhibition of human GLUT2 expressed in Xenopus laevis oocytes assessed as reduction in [14C]fructose uptake by scintillation spectrometric method2016MedChemComm, Sep-01, Volume: 7, Issue:9
Anticancer agents interacting with membrane glucose transporters.
AID603844Stability of the compound in DMEM media assessed as compound degradation at 25 ppm after 3 hrs by HPLC2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Rhamnetin production based on the rational design of the poplar O-methyltransferase enzyme and its biological activities.
AID347255Binding affinity to human recombinant carbonyl reductase 3 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in absence of cofactor2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1239524Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 5 by disk diffusion assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID339057Inhibition of Moloney murine leukemia virus reverse transcriptase using (ribocytidylic acid)n(deoxyguanylic acid)12-18 as template primer by liquid scintillation counting1992Journal of natural products, Feb, Volume: 55, Issue:2
Inhibitory effects of flavonoids on Moloney murine leukemia virus reverse transcriptase activity.
AID1879364Stabilization of [poly(dA).poly(dT)] triplex DNA (unknown origin) assessed as change in melting temperature at 10 uM by UV based assay2022Bioorganic & medicinal chemistry letters, 04-01, Volume: 615-Substituted 3, 3', 4', 7-tetramethoxyflavonoids - A novel class of potent DNA triplex specific binding ligands.
AID467857Analgesic activity in Swiss mouse assessed as reaction time taken to jump or lick paw at 100 mg/kg, ip after 60 mins of administration by hot plate test2009Journal of natural products, Nov, Volume: 72, Issue:11
Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production.
AID670314Inhibition of human recombinant MMP12 catalytic domain incubated for 20 mins by fluorimetric assay2012Bioorganic & medicinal chemistry, Jul-01, Volume: 20, Issue:13
Natural products as a gold mine for selective matrix metalloproteinases inhibitors.
AID604943Chemical stability of the compound in cell-free DMEM culture media assessed as half life by HPLC analysis in presence of FBS2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID1593610Antioxidant activity in pH 7.4 PBS assessed as reactivity against GSH at 50 uM incubated for 10 mins in presence of HRP and H2O2 in presence of 40 uM GSH by HPLC-DAD and HPLC-MS/MS analysis relative to control2019Bioorganic & medicinal chemistry, 06-15, Volume: 27, Issue:12
Purification, structural elucidation, antioxidant capacity and neuroprotective potential of the main polyphenolic compounds contained in Achyrocline satureioides (Lam) D.C. (Compositae).
AID1371455Plasma concentration in mouse at 10 mg/kg, iv at 60 mins by LC-MS/MS method2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID3342Cytotoxic effect on 3T3 cells1994Journal of medicinal chemistry, May-27, Volume: 37, Issue:11
Structural studies on bioactive compounds. 23. Synthesis of polyhydroxylated 2-phenylbenzothiazoles and a comparison of their cytotoxicities and pharmacological properties with genistein and quercetin.
AID1127215Binding affinity DPPC multilamellar vesicles after 2 hrs by centrifugation method2014European journal of medicinal chemistry, May-22, Volume: 79In-vitro anti-proliferative and anti-oxidant activity of galangin, fisetin and quercetin: role of localization and intermolecular interaction in model membrane.
AID1233243Downregulation of TRP-2 mRNA expression in theophylline-stimulated mouse B16-4A5 cells assessed as ratio of TRP-2 mRNA to beta-actin mRNA level at 30 uM after 72 hrs by qPCR analysis2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID1656375Inhibition of Influenza A virus (H1N1) neuraminidase2020Bioorganic & medicinal chemistry, 01-01, Volume: 28, Issue:1
Design, synthesis and biological evaluation of substituted flavones and aurones as potential anti-influenza agents.
AID1592009Antioxidant activity assessed as DPPH free radical scavenging activity at 0.5 mM relative to untreated control
AID461722Inhibition of human MAOB2010Bioorganic & medicinal chemistry, Feb, Volume: 18, Issue:3
A new series of flavones, thioflavones, and flavanones as selective monoamine oxidase-B inhibitors.
AID1082344Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1063050Inhibition of AXL (unknown origin)2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Protein kinase and HDAC inhibitors from the endophytic fungus Epicoccum nigrum.
AID658255Cytotoxicity against human Huh7.5.1 cells by MTT assay2012European journal of medicinal chemistry, Jun, Volume: 52Discovery of flavonoid derivatives as anti-HCV agents via pharmacophore search combining molecular docking strategy.
AID310889Displacement of fluorescent quercetin from Escherichia coli BL21 (DE3) recombinant DNA gyrase B G242007Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2
Green tea catechins inhibit bacterial DNA gyrase by interaction with its ATP binding site.
AID1082346Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 5% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1917225Neuroprotective activity against middle cerebral artery occlusion induced cerebral ischemia reperfusion rat model assessed infarct volume volume at 10 mg/kg, ip preincubated for 0.5 hrs followed by reperfusion and measured after 24 hrs by TTC staining bas2022Bioorganic & medicinal chemistry, 11-01, Volume: 73Synthesis and evaluation of glycosylated quercetin to enhance neuroprotective effects on cerebral ischemia-reperfusion.
AID1484015Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as apparent elongation constant at 200 uM after 48 hrs by Thioflavin-T fluorescence assay (Rvb = 1657.7 /M/min)2017Journal of natural products, 02-24, Volume: 80, Issue:2
Combined in Vitro Cell-Based/in Silico Screening of Naturally Occurring Flavonoids and Phenolic Compounds as Potential Anti-Alzheimer Drugs.
AID671218Inhibition of androgen receptor expression in human 22Rv1 cells assessed as AR protein level at 20 uM after 72 hrs by densitometry relative to untreated control2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and biological evaluation of novel flavonols as potential anti-prostate cancer agents.
AID1410099Cytotoxicity against human K562 cells assessed as inhibition of cell growth after 5 days by MTT assay2018Journal of natural products, 04-27, Volume: 81, Issue:4
Synthesis, Biological Investigation, and Structural Revision of Sielboldianin A.
AID768922Inhibition of human thrombin assessed as inhibition of fibrinogen gamma-gamma chain formation at 15 uM after 5 mins by SDS-PAGE analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID314064Inhibition of LPS-induced NO production in mouse BV2 cells2008Bioorganic & medicinal chemistry letters, Feb-15, Volume: 18, Issue:4
In vitro anti-inflammatory activity of 3-O-methyl-flavones isolated from Siegesbeckia glabrescens.
AID1408299Cytotoxicity against human MCF10A cells assessed as decrease in cell viability after 3 days by WST-1 assay2018European journal of medicinal chemistry, Sep-05, Volume: 157Structure-activity relationship and pharmacokinetic studies of 3-O-substitutedflavonols as anti-prostate cancer agents.
AID315607Growth inhibition of human BGC823 cells at 10 uM after 72 hrs by MTT assay relative to control2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
Studies on the chemical constituents and anticancer activity of Saxifraga stolonifera (L) Meeb.
AID1446230Inhibition of recombinant MPO (unknown origin) assessed as reduction in TMB peroxidation by measuring residual activity at 5 uM in presence of H2O2 and NaCl incubated for 5 mins followed by 100 fold enzyme dilution relative to control2017Journal of medicinal chemistry, 08-10, Volume: 60, Issue:15
Discovery of Novel Potent Reversible and Irreversible Myeloperoxidase Inhibitors Using Virtual Screening Procedure.
AID1220256Total clearance in human2012Drug metabolism and disposition: the biological fate of chemicals, Sep, Volume: 40, Issue:9
Quantitative prediction of human intestinal glucuronidation effects on intestinal availability of UDP-glucuronosyltransferase substrates using in vitro data.
AID1220255Apparent permeability by PAMPA method2012Drug metabolism and disposition: the biological fate of chemicals, Sep, Volume: 40, Issue:9
Quantitative prediction of human intestinal glucuronidation effects on intestinal availability of UDP-glucuronosyltransferase substrates using in vitro data.
AID1324836Antioxidant activity in rat PC12 cells assessed as decrease of H2O2-induced ROS production at 2.5 uM preincubated for 2 hrs followed by H2O2 addition for 24 hrs by DCFH-DA /DAPI-based fluorescence assay2016European journal of medicinal chemistry, Oct-21, Volume: 122Design, synthesis and evaluation of 4-dimethylamine flavonoid derivatives as potential multifunctional anti-Alzheimer agents.
AID1188618Anticancer activity against human M4E cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID462281Inhibition of human CA14 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID294159Inhibition of diphenolase activity of mushroom tyrosinase at 0.051 mM2007Bioorganic & medicinal chemistry, Apr-01, Volume: 15, Issue:7
Identification of tyrosinase inhibitors from Marrubium velutinum and Marrubium cylleneum.
AID1082338Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID467553Antinociceptive activity in Swiss mouse assessed as inhibition of carrageenan-induced mechanical hypernociception at 100 mg/kg, ip dosed 30 mins before carrageenan challenge measured after 1 to 5 hrs by electronic pressure-meter test2009Journal of natural products, Nov, Volume: 72, Issue:11
Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production.
AID512286Inhibition of bovine heart PKA at 20 uM2000The Biochemical journal, Oct-01, Volume: 351, Issue:Pt 1
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
AID501415Antimicrobial activity against vancomycin intermediate-resistant Staphylococcus aureus Mu50 after 24 hrs by microdilution assay2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Design, synthesis, and biological evaluation of a novel series of quercetin diacylglucosides as potent anti-MRSA and anti-VRE agents.
AID768918Inhibition of human thrombin assessed as inhibition of band decaying corresponding to fibrinogen Aalpha chains at 15 uM after 5 mins by SDS-PAGE analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID768923Inhibition of human thrombin assessed as inhibition of fibrinogen gamma-gamma chain formation at IC50 after 15 mins by SDS-PAGE analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID671213Antiproliferative activity against human 22Rv1 cells incubated up to 144 hrs by Coulter particle count and size analyzer2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and biological evaluation of novel flavonols as potential anti-prostate cancer agents.
AID1917224Antioxidant activity in rat PC12 cells assessed as reduction in H2O2-induced ROS level at 20 to 100 uM preincubated for 2 hrs followed by H2O2 stimulation and measured after 2 hrs by by DCFH-DA staining based fow cytometry2022Bioorganic & medicinal chemistry, 11-01, Volume: 73Synthesis and evaluation of glycosylated quercetin to enhance neuroprotective effects on cerebral ischemia-reperfusion.
AID332234Antiinflammatory activity against ICR mouse assessed as inhibition ratio of TPA-induced ear edema at 1 mg/ear, topically preincubated 30 mins before TPA challenge relative to TPA2002Journal of natural products, Feb, Volume: 65, Issue:2
Anti-inflammatory and anti-tumor-promoting effects of cucurbitane glycosides from the roots of Bryonia dioica.
AID765674Inhibition of oxidative burst in PMA-stimulated human neutrophils assessed as inhibition of HOCl-induced oxidation of APF after 6 mins by fluorescence assay2013European journal of medicinal chemistry, Sep, Volume: 67Modulation of human neutrophils' oxidative burst by flavonoids.
AID53359Inhibition of Cyclin-dependent kinase 1-cyclin B12000Bioorganic & medicinal chemistry letters, May-15, Volume: 10, Issue:10
Structure-activity relationship studies of flavopiridol analogues.
AID354610Inhibition of bovine liver NADH oxidase1996Journal of natural products, Apr, Volume: 59, Issue:4
Effect of Polygonum hydropiper sulfated flavonoids on lens aldose reductase and related enzymes.
AID1572029Down regulation of insp5 levels in human [3H]-inositol-labelled HCT116 cells at 10 uM after 3.5 hrs by HPLC analysis2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
AID1572044Inhibition of IPMK in human [3H]-inositol-labelled HCT116 cells assessed as reduction in insp5 levels at 2.5 uM after 3.5 hrs by HPLC analysis relative to control2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
AID1372158Inhibition of human CYP1A1 transfected in HEK293 cells assessed as cell toxicity
AID1188608Anticancer activity against human NCI-H157 cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID33221The compound was evaluated for in Vitro binding of AFB1 to DNA in rat liver microsomes; Pre-incubation time being 10 mins2002Bioorganic & medicinal chemistry letters, Sep-16, Volume: 12, Issue:18
Comparison of the prevention of aflatoxin b(1)-induced genotoxicity by quercetin and quercetin pentaacetate.
AID1704260Inhibition of SARS-CoV 3C-like protease (3241 to 3546 residues) expressed in Pichia pastoris GS115 using Dabcyl-KTSAVLQSGFRKME-Edans fluorogenic peptide as substrate measured for 18 mins by fluorescence method2020European journal of medicinal chemistry, Nov-15, Volume: 206The development of Coronavirus 3C-Like protease (3CL
AID663856Antioxidant activity against ABTS radical assessed as trolox equivalents by TEAC assay2012Journal of natural products, Apr-27, Volume: 75, Issue:4
HPLC-ESIMS(n) profiling, isolation, structural elucidation, and evaluation of the antioxidant potential of phenolics from Paepalanthus geniculatus.
AID1127223Binding affinity DPPC multilamellar vesicles assessed as chemical shift at 1:5 compound/lipid ratio at 333 K by nuclear magnetic resonance analysis2014European journal of medicinal chemistry, May-22, Volume: 79In-vitro anti-proliferative and anti-oxidant activity of galangin, fisetin and quercetin: role of localization and intermolecular interaction in model membrane.
AID311641Antioxidant activity assessed as ABTS radical scavenging activity after 15 mins by TEAC assay2007Journal of natural products, Oct, Volume: 70, Issue:10
Antioxidant flavonoid glycosides from aerial parts of the fern Abacopteris penangiana.
AID487898Antidiabetic activity in STZ-induced Wistar rat assessed as reduction in blood glucose level at 50 mg/kg, ig after 3 day relative to control2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
A comparative study of flavonoid analogues on streptozotocin-nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11beta-hydroxysteroid dehydrogenase type 1 inhibition.
AID1187093Cytotoxicity against LPS-stimulated mouse RAW264.7 cells assessed as cell viability at 3 uM after 24 hrs by MTT assay (Rvb = 100%)2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Triterpene glycosides from red ginseng marc and their anti-inflammatory activities.
AID1162595Inhibition of PMA-stimulated NF-kappaB signaling (unknown origin) expressed in MDA-MB-231 cells at 5 uM incubated for 16 hrs by luciferase reporter gene assay2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID356212Antioxidant activity assessed as trolox equivalents of ABTS radical scavenging activity by TEAC assay2003Journal of natural products, Aug, Volume: 66, Issue:8
Antioxidant chalcone glycosides and flavanones from Maclura (Chlorophora) tinctoria.
AID430139Inhibition of ATPase activity of SARS coronavirus helicase assessed as phosphate release by malachite green assay2009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Investigation of the pharmacophore space of Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) NTPase/helicase by dihydroxychromone derivatives.
AID1372155Inhibition of human CYP1B1 expressed in MDA-MB-468 cells assessed as potentiation of cisplatin-induced cytotoxicity by measuring cisplatin EC50 at 6.6 uM (Rvb = 6.70+/- 0.7 uM)
AID362787Inhibition of human recombinant PDE5A1 expressed in COS7 cells at 10 uM2008Journal of natural products, Sep, Volume: 71, Issue:9
Potent inhibition of human phosphodiesterase-5 by icariin derivatives.
AID506933Inhibition of HSP90-mediated antiapoptotic activity in human MCF7 cells assessed as induction of caspase-3 cleavage at 200 uM after 24 hrs by Western blot analysis2007Nature chemical biology, Aug, Volume: 3, Issue:8
Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer.
AID338027Inhibition of beef heart mitochondrial NADH oxidase assessed per mg of protein
AID469284Cytotoxicity against african green monkey Vero cells after 3 days by MTT assay2009Journal of natural products, Sep, Volume: 72, Issue:9
Eucalmaidins A-E, (+)-oleuropeic acid derivatives from the fresh leaves of Eucalyptus maideni.
AID1572037Inhibition of IP6K2 in human HCT116 cells assessed as AKT phosphorylation at T308 at 10 uM after 3 hrs by Western blot analysis2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
AID732559Cytotoxicity against mouse RAW264.7 cells assessed as decreased cell viability at 50 uM after 6 hrs by MTT assay2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
A novel semisynthetic flavonoid 7-O-galloyltaxifolin upregulates heme oxygenase-1 in RAW264.7 cells via MAPK/Nrf2 pathway.
AID592419Inhibition of H2O2-induced lipid peroxidation in rat liver homogenates assessed as malondialdehyde level at 32 ug/ml after 4 hrs2011Journal of natural products, Mar-25, Volume: 74, Issue:3
Epiafzelechin from the root bark of Cassia sieberiana: detection by DART mass spectrometry, spectroscopic characterization, and antioxidant properties.
AID1399729Antiinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess assay2018Bioorganic & medicinal chemistry, 09-01, Volume: 26, Issue:16
Synthesis and bioactivities evaluation of l-pyroglutamic acid analogues from natural product lead.
AID466937Inhibition of Trypanosoma cruzi trans-sialidase containing catalytic domain (N58F, R200K) and lectin-like domain (S495 K, V496G, E520K, D593G, I597D, H599R) mutation expressed in Escherichia coli JM109 assessed as MuNANA substrate hydrolysis in presence o2010Bioorganic & medicinal chemistry, Feb-15, Volume: 18, Issue:4
Potent inhibitor scaffold against Trypanosoma cruzi trans-sialidase.
AID1063046Inhibition of IGF1R (unknown origin)2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Protein kinase and HDAC inhibitors from the endophytic fungus Epicoccum nigrum.
AID1381965Toxicity in Kunming mouse xenografted with human H22 cells assessed as effect on liver weight index at 100 mg/kg, ig administered for 7 consecutive days2018European journal of medicinal chemistry, Feb-25, Volume: 146The lead optimization of the polyamine conjugate of flavonoid with a naphthalene motif: Synthesis and biological evaluation.
AID1082355Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under light conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1446622Cytotoxicity against mouse BV2 cells assessed as cell viability at 20 uM after 24 hrs by MTT assay relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Anti-Neurodegenerative Biflavonoid Glycosides from Impatiens balsamina.
AID1127214Binding affinity to 0.5 mg/ml of DPPC multilamellar vesicles at 100 uM after 2 hrs by centrifugation method2014European journal of medicinal chemistry, May-22, Volume: 79In-vitro anti-proliferative and anti-oxidant activity of galangin, fisetin and quercetin: role of localization and intermolecular interaction in model membrane.
AID1242158Inhibition of HSF1 (unknown origin)2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Regulating the master regulator: Controlling heat shock factor 1 as a chemotherapy approach.
AID587324Inhibition of CXCR2 protein expression in human neutrophil at 100 nM after 30 mins by flow cytometry2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID1634855Lipophilicity, logP of the compound2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Antituberculosis Activity of a Naturally Occurring Flavonoid, Isorhamnetin.
AID377660Induction of behavioral effects in CD1 mouse at 10 mg/kg, ip by forced swimming test relative to carboxy methyl cellulose2006Journal of natural products, Jun, Volume: 69, Issue:6
Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and computational study.
AID1242171Inhibition of HSF1 in human ASB244 cells assessed as potentiation of geldanamycin-induced reduction in cell migration at 20 uM relative to geldanamycin alone2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Regulating the master regulator: Controlling heat shock factor 1 as a chemotherapy approach.
AID772993Antioxidant activity assessed as trolox equivalents of ABTS radical scavenging activity at pH 7.4 by spectrophotometry2013European journal of medicinal chemistry, Oct, Volume: 68Chemopreventive and antioxidant activity of 6-substituted imidazo[2,1-b]thiazoles.
AID501418Antimicrobial activity against methicillin-resistant Staphylococcus aureus N315 after 24 hrs by microdilution assay2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Design, synthesis, and biological evaluation of a novel series of quercetin diacylglucosides as potent anti-MRSA and anti-VRE agents.
AID1127224Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins2014European journal of medicinal chemistry, May-22, Volume: 79In-vitro anti-proliferative and anti-oxidant activity of galangin, fisetin and quercetin: role of localization and intermolecular interaction in model membrane.
AID1612327Metal chelating activity assessed as compound-Fe2+ complex formation by measuring chelated ferrous ion at 0.18 umol/ml preincubated with Mohr's salt followed by ferozine addition and measured after 10 mins2018Journal of natural products, 10-26, Volume: 81, Issue:10
Phytosterol and γ-Oryzanol Conjugates: Synthesis and Evaluation of their Antioxidant, Antiproliferative, and Anticholesterol Activities.
AID479369Inhibition of human placental microsome CYP192010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19).
AID666856Reversal of p-glycoprotein-mediated drug resistant in human LCC-6/MDR cells assessed as potentiation of paclitaxel-induced cytotoxicity at 1 uM after 5 days by MTS assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis of methylated quercetin derivatives and their reversal activities on P-gp- and BCRP-mediated multidrug resistance tumour cells.
AID603842Increase in ERK1 phosphorylation in human MDA-MB-231 cells at 20 uM by Western blot analysis2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Rhamnetin production based on the rational design of the poplar O-methyltransferase enzyme and its biological activities.
AID1233224Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells at 30 uM after 72 hrs by microplate reader analysis relative to control2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID467551Antinociceptive activity in Swiss mouse assessed as inhibition of carrageenan-induced mechanical hypernociception at 3 to 100 mg/kg, ip administered 30 mins before carrageenan challenge measured after 3 hrs by electronic pressure-meter test2009Journal of natural products, Nov, Volume: 72, Issue:11
Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production.
AID1605043Inhibition of rabbit skeletal muscle microsomes SERCA1a preincubated for 10 mins followed by addition of ATP and measured after 40 mins2020Journal of medicinal chemistry, 03-12, Volume: 63, Issue:5
Sarco/Endoplasmic Reticulum Calcium ATPase Inhibitors: Beyond Anticancer Perspective.
AID480667Inhibition of anti-DNP-IgE-induced degranulation in rat RBL2H3 cells assessed as betahexosaminidase released at 10 uM after 20 mins by microplate reader assay2010Bioorganic & medicinal chemistry letters, May-01, Volume: 20, Issue:9
Inhibition of antigen-induced degranulation by aryl compounds isolated from the bark of Betula platyphylla in RBL-2H3 cells.
AID1250694Cytotoxicity against human androgen-independent PC3 cells assessed as cell cell viability after 3 days by WST-1 cell proliferation assay2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
A new class of hybrid anticancer agents inspired by the synergistic effects of curcumin and genistein: Design, synthesis, and anti-proliferative evaluation.
AID578568Cytotoxicity against mouse RAW264.7 cells assessed as cell viability by MTT assay2011Bioorganic & medicinal chemistry letters, Mar-15, Volume: 21, Issue:6
A new ursane-type triterpenoid glycoside from Centella asiatica leaves modulates the production of nitric oxide and secretion of TNF-α in activated RAW 264.7 cells.
AID587312Antiinflammatory activity in human neutrophil assessed as inhibition of CXCL8-induced neutrophil chemoattraction 100 nM after 2 hrs by Boyden chamber v2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID550025Ratio of chlorpromazine IC50 to compound IC50 for human recombinant calmodulin2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Vasorelaxant effect of flavonoids through calmodulin inhibition: Ex vivo, in vitro, and in silico approaches.
AID1603728Inhibition of human PMNL 5-LOX using arachidonic acid as substrate after 5 mins by HPLC method2019Bioorganic & medicinal chemistry, 09-01, Volume: 27, Issue:17
5-Lipoxygenase as a drug target: A review on trends in inhibitors structural design, SAR and mechanism based approach.
AID666768Inhibition of thrombin in New Zealand rabbit plasma assessed as thrombin time at 100 uM after 3 mins by coagulometry2012European journal of medicinal chemistry, Aug, Volume: 54Metabolism-based synthesis, biologic evaluation and SARs analysis of O-methylated analogs of quercetin as thrombin inhibitors.
AID537627Inhibition of Schistosoma mansoni recombinant NAD+ glycohydrolase expressed in Pichia pastoris by continuous fluorometric method2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Identification by high-throughput screening of inhibitors of Schistosoma mansoni NAD(+) catabolizing enzyme.
AID506921Inhibition of HSP90-mediated antiapoptotic activity in human SKBR3 cells assessed as induction of caspase-3 cleavage at 200 uM after 24 hrs by Western blot analysis2007Nature chemical biology, Aug, Volume: 3, Issue:8
Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer.
AID220005Relative inhibition of cAMP and cGMP hydrolysis by cytosolic phosphodiesterase1982Journal of medicinal chemistry, Oct, Volume: 25, Issue:10
Pentasubstituted quercetin analogues as selective inhibitors of particulate 3':5'-cyclic-AMP phosphodiesterase from rat brain.
AID456318DPPH radical scavenging activity assessed as trolox equivalent antioxidant capacity2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID700825Increase of SIRT1 mRNA expression in mouse soleus muscle at 12.5 to 25 mg/kg qd for 7 days by RT-PCR analysis2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
SIRT1 modulation as a novel approach to the treatment of diseases of aging.
AID1879363Binding affinity to duplex DNA (unknown origin) assessed as effect on melting temperature at 10 uM by UV based assay2022Bioorganic & medicinal chemistry letters, 04-01, Volume: 615-Substituted 3, 3', 4', 7-tetramethoxyflavonoids - A novel class of potent DNA triplex specific binding ligands.
AID425005DPPH radical scavenging activity assessed as ratio of antioxidant concentration to drug level causing 50% decrease in DPPH level at steady state at 100 ug by TLC autographic assay2009Journal of natural products, May-22, Volume: 72, Issue:5
Antioxidant phenylethanoid glycosides and a neolignan from Jacaranda caucana.
AID501417Antimicrobial activity against methicillin-resistant Staphylococcus aureus OM584 after 24 hrs by microdilution assay2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Design, synthesis, and biological evaluation of a novel series of quercetin diacylglucosides as potent anti-MRSA and anti-VRE agents.
AID683739Antioxidant activity assessed as DPPH radical scavenging activity at 15 uM after 2 hrs by spectrophotometric analysis2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Α-aryl-N-alkyl nitrones, as potential agents for stroke treatment: synthesis, theoretical calculations, antioxidant, anti-inflammatory, neuroprotective, and brain-blood barrier permeability properties.
AID424734Inhibition of bovine xanthine oxidase assessed as reduction in free enzyme turnover at 10 uM relative to control2009Journal of natural products, Apr, Volume: 72, Issue:4
Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin.
AID587318Antiinflammatory activity in human neutrophil assessed as inhibition of LTB4-induced neutrophil chemoattraction 10 nM after 2 hrs by Boyden chamber v2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID340664Antioxidant activity assessed as trolox equivalents at 0.2 to 0.6 uM by ORAC-fluorescein assay2008Journal of natural products, Jul, Volume: 71, Issue:7
Synthesis, cytotoxicity, and antioxidative activity of minor prenylated chalcones from Humulus lupulus.
AID277585Inhibition of Plasmodium falciparum ENR using NADH substrate2007Journal of medicinal chemistry, Feb-22, Volume: 50, Issue:4
Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR).
AID339142Inhibition of norepinephrine-induced Wistar rat thoracic aorta phasic contraction at 100 ug/mL after 15 mins1993Journal of natural products, Jun, Volume: 56, Issue:6
Antiplatelet effects and vasorelaxing action of some constituents of Formosan plants.
AID1484016Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation assessed as half life for aggregation at 200 uM after 48 hrs by Thioflavin-T fluorescence assay (Rvb = 284.7 mins)2017Journal of natural products, 02-24, Volume: 80, Issue:2
Combined in Vitro Cell-Based/in Silico Screening of Naturally Occurring Flavonoids and Phenolic Compounds as Potential Anti-Alzheimer Drugs.
AID1102126Phytotoxicity in Solanum lycopersicum (tomato) assessed as inhibition of shoot differentiation at 250 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID487733Hypoglycemic activity in Wistar rat assessed as change in blood glucose level at 50 mg/kg, ig after 7 hrs (RVb = -3.59 +/- 2.65 %)2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
A comparative study of flavonoid analogues on streptozotocin-nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11beta-hydroxysteroid dehydrogenase type 1 inhibition.
AID1233233Inhibition of mushroom tyrosinase using L-DOPA as substrate assessed as dopaquinone production at 100 uM after 5 mins by microplate reader analysis relative to control2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID1264952Cytotoxicity against human MSC assessed as cell viability at 10 uM measured on day 1 by alamar blue assay (Rvb = 97 to 101%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID1082360Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under light conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1082345Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 2% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID31746Cytotoxic effect on v-abl transformed murine ANN-1 cells1994Journal of medicinal chemistry, May-27, Volume: 37, Issue:11
Structural studies on bioactive compounds. 23. Synthesis of polyhydroxylated 2-phenylbenzothiazoles and a comparison of their cytotoxicities and pharmacological properties with genistein and quercetin.
AID1239565Antibacterial activity against methicillin-resistant Staphylococcus aureus NCTC 12493 assessed as log reduction of bacterial growth after 9 hrs2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID377658Induction of behavioral effects in CD1 mouse at 1 mg/kg, ip by forced swimming test relative to carboxy methyl cellulose2006Journal of natural products, Jun, Volume: 69, Issue:6
Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and computational study.
AID218566Preincubated with beta-lactamase, inhibitory activity expressed as fold decrease in IC50(ie. improved activity)2002Journal of medicinal chemistry, Apr-11, Volume: 45, Issue:8
A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.
AID402263Antioxidant activity assessed as trolox equivalent of free radical scavenging activity by chemiluminescence assay2004Journal of natural products, May, Volume: 67, Issue:5
Antioxidative constituents from the leaves of Hypericum styphelioides.
AID1409608AUC (viral infection %) for SARS-CoV-2 in the Vero E6 cell line at 48 h by immunofluorescence-based assay (detecting the viral NP protein in the nucleus of the Vero E6 cells).2020Nature, 07, Volume: 583, Issue:7816
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
AID398394Inhibition of pig kidney cytosolic Leucyl aminopeptidase1995Journal of natural products, Jun, Volume: 58, Issue:6
Flavonoid inhibitors of trypsin and leucine aminopeptidase: a proposed mathematical model for IC50 estimation.
AID1224770Delta TM value showing the stabilisation of JAK1~B produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID339009Cytotoxicity against mouse P388 cells
AID682234TP_TRANSPORTER: inhibition of Fexofenadine uptake (Fexofenadine: 1? uM, Quercetin: 5 uM) in Oatp3-expressing HeLa cells2002Clinical pharmacology and therapeutics, Jan, Volume: 71, Issue:1
Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine.
AID1239536Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 7 after 24 hrs by checkerboard assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID461721Inhibition of human MAOA2010Bioorganic & medicinal chemistry, Feb, Volume: 18, Issue:3
A new series of flavones, thioflavones, and flavanones as selective monoamine oxidase-B inhibitors.
AID1224780Delta TM value showing the stabilisation of OSR1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID7079Iin vitro inhibition of 5-lipoxygenase activity in rat basophil leukemia type 1(RBL1) cell homogenates, (reduction of [14C]-5-HETE formation)1990Journal of medicinal chemistry, Oct, Volume: 33, Issue:10
Penta- and hexadienoic acid derivatives: a novel series of 5-lipoxygenase inhibitors.
AID475504Binding affinity to amyloid beta (1 to 42) fibrils by change in fluorescence at 100 uM after 10 mins2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta.
AID1194984Antioxidant activity assessed as FRAP values at 25 ug/ml incubated at 37 degC for 5 mins by FeSO4.7H2O calibration curve based method2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Cytotoxic and antioxidant constituents from the leaves of Psidium guajava.
AID1371379Cytotoxicity against human LN229 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID33196Ability to displace [125I]AB-MECA binding from adenosine A3 receptor.1998Journal of medicinal chemistry, Jan-01, Volume: 41, Issue:1
Flavonoid derivatives as adenosine receptor antagonists: a comparison of the hypothetical receptor binding site based on a comparative molecular field analysis model.
AID1082332Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under light conditions measured 72 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1226452Resistance factor, ratio of IC50 for cisplatin-resistant human A431 cells to IC50 for human A431 cells2015Journal of medicinal chemistry, May-28, Volume: 58, Issue:10
Selenium-containing chrysin and quercetin derivatives: attractive scaffolds for cancer therapy.
AID462270Inhibition of human CA1 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID1171188Antitumor activity against human HCT116 cells xenografted in 48 hpf zebrafish embryo assessed as inhibition of cancer cell proliferation at 80 uM treated for 4 days2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Delineation of the role of glycosylation in the cytotoxic properties of quercetin using novel assays in living vertebrates.
AID480948Inhibition of Vibrio cholerae neuraminidase assessed as inhibition of 4-MU-NANA hydrolysis at 30 ug/mL after 10 mins by spectrofluorimetry2010Bioorganic & medicinal chemistry, May-01, Volume: 18, Issue:9
Prenylated pterocarpans as bacterial neuraminidase inhibitors.
AID1336844Inhibition of P-gp in human MES-SA/Dx5 cells assessed as potentiation of doxorubicin-induced cytotoxicity by measuring fold reduction in doxorubicin EC50 at 5 uM after 72 hrs by MTT assay relative to untreated control2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Quercetin-glutamic acid conjugate with a non-hydrolysable linker; a novel scaffold for multidrug resistance reversal agents through inhibition of P-glycoprotein.
AID1292310Antioxidant activity assessed as DPPH radical scavenging activity incubated for 20 mins2016Bioorganic & medicinal chemistry, 05-15, Volume: 24, Issue:10
Synthesis and molecular docking of N'-arylidene-5-(4-chlorophenyl)-1-(3,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carbohydrazides as novel hypoglycemic and antioxidant dual agents.
AID1473741Inhibition of human MRP4 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay2013Toxicological sciences : an official journal of the Society of Toxicology, Nov, Volume: 136, Issue:1
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
AID1082343Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID512281Inhibition of His-tagged human SAPK4/p38delta expressed in Escherichia coli at 20 uM2000The Biochemical journal, Oct-01, Volume: 351, Issue:Pt 1
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
AID1102135Phytotoxicity in Arabidopsis thaliana assessed as inhibition of root differentiation at 250 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID1537236Antiallergic activity in mouse model of picryl-chloride-induced type 1 allergy at 0.8 mg/kg, po for 5 days relative to control2019Journal of natural products, 02-22, Volume: 82, Issue:2
In Vivo Anti-inflammatory and Antiallergic Activity of Pure Naringenin, Naringenin Chalcone, and Quercetin in Mice.
AID315613Induction of apoptosis in human BGC823 cells assessed as increase in DNA fragmentation at 100 uM after 48 hrs2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
Studies on the chemical constituents and anticancer activity of Saxifraga stolonifera (L) Meeb.
AID464265Antiinflammatory activity against mouse RAW264.7 cells assessed as Inhibition of LPS-induced nitric oxide production after 24 hrs by ELISA2010Journal of natural products, Feb-26, Volume: 73, Issue:2
Flavanone and diphenylpropane glycosides and glycosidic acyl esters from Viscum articulatum.
AID1371454Plasma concentration in mouse at 100 mg/kg, po at 60 mins by LC-MS/MS method2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1311087Antioxidant activity assessed as inhibition of peroxyl radical-induced oxidation of fluorescein measured as trolox equivalent by ORAC assay2016European journal of medicinal chemistry, Aug-25, Volume: 119New polyhydroxylated flavon-3-ols and 3-hydroxy-2-styrylchromones: synthesis and ROS/RNS scavenging activities.
AID1473739Inhibition of human MRP2 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay2013Toxicological sciences : an official journal of the Society of Toxicology, Nov, Volume: 136, Issue:1
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
AID317346Decrease in [14C]DOX accumulation in human NCI-ADR-RES cells at 30 uM after 120 mins2008Bioorganic & medicinal chemistry, Feb-15, Volume: 16, Issue:4
The effect of flavonoid derivatives on doxorubicin transport and metabolism.
AID429118Antagonist activity at glucocorticoid receptor in human MDA-kb2 cells assessed as inhibition of Dex-induced luciferase activity by luciferase reporter gene assay2009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Effect of flavonoids on androgen and glucocorticoid receptors based on in vitro reporter gene assay.
AID1161236Induction of apoptosis in human neutrophils assessed as late apoptotic cells at 50 uM after 4 hrs by Annexin-V-FLUOS staining based flow cytometry (Rvb = 0.5%)2014European journal of medicinal chemistry, Oct-30, Volume: 86Synthesis of chlorinated flavonoids with anti-inflammatory and pro-apoptotic activities in human neutrophils.
AID1182100Inhibition of H2O2-induced oxidative stress in human HLF1 cells assessed as increase in cell viability at 2 to 5 uM pretreated for 24 hrs followed by addition of 300 uM H2O2 for 2.5 hrs2014European journal of medicinal chemistry, Aug-18, Volume: 83Microwave-assisted synthesis of 3,5-disubstituted isoxazoles and evaluation of their anti-ageing activity.
AID1783638Cytotoxicity against LPS-stimulated mouse BV-2 cells assessed as reduction in cell viability at 20 uM measured after 24 hrs by MTT assay relative to control2021European journal of medicinal chemistry, Nov-15, Volume: 2241,10-Seco-Eudesmane sesquiterpenoids as a new type of anti-neuroinflammatory agents by suppressing TLR4/NF-κB/MAPK pathways.
AID1102129Phytotoxicity in Triticum aestivum (wheat) assessed as inhibition of shoot differentiation at 250 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID603457Antibacterial activity against Streptococcus pneumoniae R6 after 24 hrs by microdilution method2011Journal of medicinal chemistry, Jun-09, Volume: 54, Issue:11
Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
AID1310990Antioxidant activity assessed as DPPH scavenging activity measured after 3 mins by spectrophotometric method2016European journal of medicinal chemistry, Aug-25, Volume: 119On the vasoprotective mechanisms underlying novel β-phosphorylated nitrones: Focus on free radical characterization, scavenging and NO-donation in a biological model of oxidative stress.
AID1264951Cytotoxicity against human MSC assessed as cell viability at 5 uM measured on day 1 by alamar blue assay (Rvb = 97 to 101%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID696769Cytotoxicity against human HepG2 cells by MTT assay2011Journal of medicinal chemistry, Aug-25, Volume: 54, Issue:16
The lipogenesis pathway as a cancer target.
AID1709241Antioxidant activity assessed as inhibition of DPPH radical activity at 100 uM incubated for 20 mins by spectrophotometric method relative to control2021Bioorganic & medicinal chemistry, 04-15, Volume: 36The natural-based optimization of kojic acid conjugated to different thio-quinazolinones as potential anti-melanogenesis agents with tyrosinase inhibitory activity.
AID502292Antioxidant activity assessed as DDPH radical scavenging activity2010Bioorganic & medicinal chemistry letters, Sep-15, Volume: 20, Issue:18
Relationships between structures of hydroxyflavones and their antioxidative effects.
AID1593918Antioxidant activity assessed as DPPH radical scavenging activity incubated for 30 mins under dark condition2019Bioorganic & medicinal chemistry, 06-15, Volume: 27, Issue:12
Veratric acid derivatives containing benzylidene-hydrazine moieties as promising tyrosinase inhibitors and free radical scavengers.
AID406994Inhibition of human recombinant 17beta-HSD1 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol at 20 uM2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
Discovery of nonsteroidal 17beta-hydroxysteroid dehydrogenase 1 inhibitors by pharmacophore-based screening of virtual compound libraries.
AID1233229Cytotoxicity against mouse B16-4A5 cells assessed as cell viability at 10 uM after 70 hrs by WST-8 assay relative to control2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID1128733Inhibition of human recombinant COX-2 assessed as PGF2-alpha formation using arachidonic acid as substrate at 20 uM by enzyme immunoassay2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Design of novel potent antihyperlipidemic agents with antioxidant/anti-inflammatory properties: exploiting phenothiazine's strong antioxidant activity.
AID1516910Antifungal activity against FLC-resistant Candida tropicalis in presence of FLC2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID435764Inhibition of V66A-mutated CK2 holoenzyme2003The Biochemical journal, Sep-15, Volume: 374, Issue:Pt 3
Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).
AID1224782Delta TM value showing the stabilisation of PAK5 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID768901Inhibition of human thrombin assessed as decrease in platelet aggregation at 50 uM preincubated for 10 mins measured for 10 mins by dual channel chrono-log aggregometric analysis relative to control2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID30342Ability to displace [3H]N6-phenylisopropyladenosine binding from adenosine A1 receptor.1998Journal of medicinal chemistry, Jan-01, Volume: 41, Issue:1
Flavonoid derivatives as adenosine receptor antagonists: a comparison of the hypothetical receptor binding site based on a comparative molecular field analysis model.
AID467847Inhibition of carrageenan-induced neutrophil recruitment in Swiss mouse subcutaneous plantar tissue assessed as myeloperoxidase activity at 100 mg/kg, ip dosed 30 mins before carrageenan challenge measured after 3 hrs by spectrophotometry2009Journal of natural products, Nov, Volume: 72, Issue:11
Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production.
AID43124Inhibitory activity against Amp C beta-Lactamase2003Journal of medicinal chemistry, Sep-25, Volume: 46, Issue:20
A specific mechanism of nonspecific inhibition.
AID467549Antinociceptive activity against formalin-induced pain in Swiss mouse assessed as inhibition of paw licking response during second phase at 100 mg/kg, ip dosed 30 mins before formalin challenge measured for 0 to 30 mins2009Journal of natural products, Nov, Volume: 72, Issue:11
Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production.
AID1896156Antiviral activity against HBV infected HepG2 2.2.15 cells assessed as reduction in HBeAg level at 50 microg/ml for 48 hrs by ELISA2022Journal of medicinal chemistry, 10-13, Volume: 65, Issue:19
Inhibiting Sodium Taurocholate Cotransporting Polypeptide in HBV-Related Diseases: From Biological Function to Therapeutic Potential.
AID1683190Decrease in intracellular glucose level in human HeLa cells at IC50 after 4 hrs by colorimetric assay2021Bioorganic & medicinal chemistry, 01-01, Volume: 29Synthesis and anticancer activity of new coumarin-3-carboxylic acid derivatives as potential lactatetransportinhibitors.
AID430311Cytotoxicity against BALB/c mouse J774.2 cells after 72 hrs by trypan blue assay2009Journal of natural products, Jun, Volume: 72, Issue:6
Antileishmaniasis activity of flavonoids from Consolida oliveriana.
AID1873847Inhibition of MMP-1 (unknown origin) using FRET substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by fluorescence assay2022Bioorganic & medicinal chemistry, 08-15, Volume: 68Development of flavonoid probes and the binding mode of the target protein and quercetin derivatives.
AID1100871Antifeedant activity against Spodoptera litura in compound treated cork borer from fresh sweet potato leaves by Choice Leaf-Disk Bioassay2000Journal of agricultural and food chemistry, May, Volume: 48, Issue:5
Insect antifeedant flavonoids from Gnaphalium affine D. Don.
AID395317Antitrypanosomal activity against Trypanosoma cruzi amastigote forms2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Discovery of novel Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase inhibitors.
AID1155651Inhibition of soybean 15-LOX1 by UV spectrophotometric analysis2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis, biological evaluation and docking study of 3-aroyl-1-(4-sulfamoylphenyl)thiourea derivatives as 15-lipoxygenase inhibitors.
AID1162613Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated COX2 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID6820In vitro inhibition against 5-lipoxygenase in RBL-1 cells was determined1993Journal of medicinal chemistry, Nov-26, Volume: 36, Issue:24
3,4-Dihydroxychalcones as potent 5-lipoxygenase and cyclooxygenase inhibitors.
AID703483Therapeutic index, ratio of IC50 for mouse PEM cells to IC50 for wild-type Leishmania donovani AG83 promastigote2012Journal of medicinal chemistry, Oct-25, Volume: 55, Issue:20
Flavonoid dimers as novel, potent antileishmanial agents.
AID487736Antidiabetic activity in Wistar rat assessed as change in blood glucose level at 50 mg/kg, ig after 7 hrs (RVb = -10.51% +/- 5.53%)2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
A comparative study of flavonoid analogues on streptozotocin-nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11beta-hydroxysteroid dehydrogenase type 1 inhibition.
AID1572024Inhibition of human IP6K2 using insP6 as substrate preincubated for 15 mins followed by substrate and measured after 30 mins by TR-FRET assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
AID365081Vasorelaxant activity against phenylephrine-induced contraction in Sprague-Dawley rat aorta2008Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17
Identification of SVM-based classification model, synthesis and evaluation of prenylated flavonoids as vasorelaxant agents.
AID1371428Cytotoxicity against human MDA-MB-231 cells assessed as cell viability at 14 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1328661Neuroprotective activity against glutamate-induced cell death in mouse HT22 cells assessed as cell viability at 10 uM pretreated for 12 hrs prior to glutamate-challenge measured after 12 hrs by MTT assay (Rvb = 43.35 +/- 1.48%)2016Bioorganic & medicinal chemistry letters, 12-01, Volume: 26, Issue:23
The comparison of neuroprotective effects of isoliquiritigenin and its Phase I metabolites against glutamate-induced HT22 cell death.
AID1833872Solubility of the compound in 5% DMSO in MHB assessed as precipitation at up to 500 ug/ml measured over 24 hrs2021Bioorganic & medicinal chemistry, 12-15, Volume: 52Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition.
AID506948Inhibition of HSP70-mediated antiapoptotic activity in human NCI-H526 cells assessed as induction of caspase-3 cleavage after 24 hrs by Western blot analysis2007Nature chemical biology, Aug, Volume: 3, Issue:8
Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer.
AID287077Inhibitory effect on TPA-induced Epstein-Barr Virus early antigen activation in Raji cells at 1000 mol ratio/32 pmol TPA relative to TPA2007Journal of natural products, May, Volume: 70, Issue:5
Anti-inflammatory and potential cancer chemopreventive constituents of the fruits of Morinda citrifolia (Noni).
AID1572043Down regulation of insp5 levels in human [3H]-inositol-labelled HCT116 cells at 2.5 uM after 3.5 hrs by HPLC analysis2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
AID375988Antioxidant activity assessed as DPPH free radical scavenging activity relative to control2006Journal of natural products, Apr, Volume: 69, Issue:4
Vanillic acid glycoside and quinic acid derivatives from Gardeniae Fructus.
AID1655302Growth inhibition of human HeLa cells incubated for 72 hrs by trypan blue assay2020ACS medicinal chemistry letters, May-14, Volume: 11, Issue:5
Synthesis, Antiproliferative Effect, and Topoisomerase II Inhibitory Activity of 3-Methyl-2-phenyl-1
AID424725Ratio of kcat to km for bovine xanthine oxidase at 25 uM preincubated for 10 mins2009Journal of natural products, Apr, Volume: 72, Issue:4
Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin.
AID1833880Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 assessed as bacterial growth inhibition measured after 24 hrs by resazurin dye based broth microdilution method2021Bioorganic & medicinal chemistry, 12-15, Volume: 52Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition.
AID1371373Cytotoxicity against human NCI-H460 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID375991Antioxidant activity assessed as inhibition of 2,2'-azobis(2-amidinopropane)dihydrochloride-induced lipid peroxidation at 3.125 ug/ml by ferric thiocyanate system relative to control2006Journal of natural products, Apr, Volume: 69, Issue:4
Vanillic acid glycoside and quinic acid derivatives from Gardeniae Fructus.
AID681339TP_TRANSPORTER: inhibition of Estrone-3-sulfate uptake (Estrone-3-sulfate: 10nM) in OATP2B1-expressing HEK293 cells2005Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 33, Issue:4
Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B.
AID1871974Antifungal activity against Candida albicans 475/15 assessed as fungal growth inhibition measured after 24 hrs by microdilution assay2022European journal of medicinal chemistry, Feb-05, Volume: 229Quercetin derivatives: Drug design, development, and biological activities, a review.
AID310886Permeability from apical to basolateral side of dog MDCK1 cell monolayer assessed as intact drug level in basolateral compartment after 6 hrs2007Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2
Ester-based precursors to increase the bioavailability of quercetin.
AID1578735Inhibition of human TRPC5 expressed in HEK293 cells assessed as reduction in gadolinium-induced calcium entry after 30 mins by fluo-4 dye based fluorescence assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Review of Transient Receptor Potential Canonical (TRPC5) Channel Modulators and Diseases.
AID1372150Inhibition of human CYP1B1 expressed in HEK293 cells by fluorescence assay
AID195383Effect of compound on AFB1-induced micronuclei formation in rat bone marrow cells in the presence of AFB1 (Activity: Micronucleated cells/1000 cells)2002Bioorganic & medicinal chemistry letters, Sep-16, Volume: 12, Issue:18
Comparison of the prevention of aflatoxin b(1)-induced genotoxicity by quercetin and quercetin pentaacetate.
AID357253Inhibition of Saccharomyces cerevisiae fatty acid synthase2002Journal of natural products, Dec, Volume: 65, Issue:12
Fatty acid synthase inhibitors from plants: isolation, structure elucidation, and SAR studies.
AID1127222Binding affinity DPPC multilamellar vesicles assessed as chemical shift at 1:5 compound/lipid ratio at 303 K by nuclear magnetic resonance analysis2014European journal of medicinal chemistry, May-22, Volume: 79In-vitro anti-proliferative and anti-oxidant activity of galangin, fisetin and quercetin: role of localization and intermolecular interaction in model membrane.
AID467543Antioxidant activity in ip dosed Swiss mouse assessed as inhibition of carrageenan-induced reduction in GSH level dosed 30 mins before carrageenan challenge measured after 3 hrs by fluorescence spectrophotometry2009Journal of natural products, Nov, Volume: 72, Issue:11
Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production.
AID1352198Antioxidant activity assessed as inhibition of DPPH radical formation after 30 mins2018European journal of medicinal chemistry, Feb-10, Volume: 145Design, synthesis, biological evaluation and docking studies of new 3-(4,5-dihydro-1H-pyrazol/isoxazol-5-yl)-2-phenyl-1H-indole derivatives as potent antioxidants and 15-lipoxygenase inhibitors.
AID334642Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of acetylaminofluorene-induced mutation at 150 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID641153Growth inhibition of human HCT116 cells overexpressing PI3Kalpha H1047R mutant after 48 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Biological evaluation and docking studies of recently identified inhibitors of phosphoinositide-3-kinases.
AID378808Antioxidant activity assessed as inhibition of total reactive oxygen species generation in Wistar rat kidney by 2',7'-dichlorofluorescein based fluorescence spectroscopy2006Journal of natural products, Oct, Volume: 69, Issue:10
Antioxidative phenolics from the fresh leaves of Ternstroemia japonica.
AID1364654Inhibition of human 17beta-HSD2 expressed in HEK293 cell lysates incubated for 10 mins using [2,4,6,7-3H]-estradiol and NAD+ by scintillation counting method2017Journal of natural products, 04-28, Volume: 80, Issue:4
Potential Antiosteoporotic Natural Product Lead Compounds That Inhibit 17β-Hydroxysteroid Dehydrogenase Type 2.
AID1082336Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1668218Antioxidant activity assessed as DPPH radical scavenging activity at 100 uM after 30 mins (Rvb = 1.9 +/- 1.2%)2020Bioorganic & medicinal chemistry, 05-15, Volume: 28, Issue:10
Acylhydrazones as isoniazid derivatives with multi-target profiles for the treatment of Alzheimer's disease: Radical scavenging, myeloperoxidase/acetylcholinesterase inhibition and biometal chelation.
AID457184Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production by Griess reagent method2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
Quiquelignan A-H, eight new lignoids from the rattan palm Calamus quiquesetinervius and their antiradical, anti-inflammatory and antiplatelet aggregation activities.
AID1233241Downregulation of TRP-2 mRNA expression in theophylline-stimulated mouse B16-4A5 cells assessed as ratio of TRP-2 mRNA to beta-actin mRNA level at 3 uM after 72 hrs by qPCR analysis2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID1176142Cytotoxicity against mouse RAW264.7 cells at 50 uM by MTT assay2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
Anti-inflammatory components of Chrysanthemum indicum flowers.
AID1238320Inhibition of xanthine oxidase (unknown origin) using xanthine as substrate at 33 to 100 umol/L after 10 mins by HPLC method relative to control2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
An oxidative coupling product of luteolin with cysteine ester and its enhanced inhibitory activity for xanthine oxidase.
AID1269368Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay2016Bioorganic & medicinal chemistry, Jan-15, Volume: 24, Issue:2
Structural insights into mechanisms for inhibiting amyloid β42 aggregation by non-catechol-type flavonoids.
AID1369961Cytoprotective activity against H2O2-induced oxidative stress in mouse RAW264.7 cells assessed as increase in cell viability at 1 pM incubated for 2 hrs prior to H2O2 addition measured after 24 hrs by MTT assay2018Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9
Synthesis and Biological Evaluation of Derivatives of Indoline as Highly Potent Antioxidant and Anti-inflammatory Agents.
AID455707Selectivity index, ratio of CC50 for MDCK cells to EC50 for influenza virus H1N1 A/PR/8/342009Bioorganic & medicinal chemistry, Oct-01, Volume: 17, Issue:19
Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities.
AID339056Inhibition of Moloney murine leukemia virus reverse transcriptase using (riboadenylic acid)n(deoxythymidylic acid)12-18 as template primer by liquid scintillation counting1992Journal of natural products, Feb, Volume: 55, Issue:2
Inhibitory effects of flavonoids on Moloney murine leukemia virus reverse transcriptase activity.
AID680281TP_TRANSPORTER: increase in Calcein-AM intracellular accumulation (Calcein-AM: 0.5 uM, Quercetin: 200 uM) in MDR1-expressing NIH-3T3 cells2004Biochemical and biophysical research communications, Mar-19, Volume: 315, Issue:4
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
AID1484022n-octanol-water partition coefficient, log P of the compound2017Journal of natural products, 02-24, Volume: 80, Issue:2
Combined in Vitro Cell-Based/in Silico Screening of Naturally Occurring Flavonoids and Phenolic Compounds as Potential Anti-Alzheimer Drugs.
AID367704Inhibition of pig ALR12009Bioorganic & medicinal chemistry, Feb-01, Volume: 17, Issue:3
Correlation of binding constants and molecular modelling of inhibitors in the active sites of aldose reductase and aldehyde reductase.
AID430140Inhibition of SARS coronavirus helicase assessed as duplex-DNA unwinding by FRET based assay2009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Investigation of the pharmacophore space of Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) NTPase/helicase by dihydroxychromone derivatives.
AID1198741Inhibition of Saccharomyces cerevisiae alpha-glucosidase2015European journal of medicinal chemistry, Mar-26, Volume: 93Antioxidant activity and inhibition of α-glucosidase by hydroxyl-functionalized 2-arylbenzo[b]furans.
AID400516Inhibition of LPS and INF-gamma-induced NO production in mouse RAW264.7 cells2004Journal of natural products, Mar, Volume: 67, Issue:3
Sesquiterpene coumarins from Ferula fukanensis and nitric oxide production inhibitory effects.
AID1352200Inhibition of soybean 15-LOX using arachidonic acid or linoleic acid as substrate preincubated with enzyme followed by substrate addition up to 5 mins by chromogenic method2018European journal of medicinal chemistry, Feb-10, Volume: 145Design, synthesis, biological evaluation and docking studies of new 3-(4,5-dihydro-1H-pyrazol/isoxazol-5-yl)-2-phenyl-1H-indole derivatives as potent antioxidants and 15-lipoxygenase inhibitors.
AID1572038Activation of AKT activity in mouse 3T3-L1 cells assessed as increase in AKT phosphorylation at T308 residues at 2.5 uM after 3 hrs by Western blot analysis2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
AID1711996Toxicity in Kunming mouse implanted with mouse H22 cells assessed as change in body weight at 100 mg/kg, iv administered for 7 consecutive days starting from day 11 post inoculation and measured after 18 days (Rvb = 5.2 %)2016European journal of medicinal chemistry, Oct-04, Volume: 121Synthesis and biological properties of polyamine modified flavonoids as hepatocellular carcinoma inhibitors.
AID506943Inhibition of HSP70-mediated antiapoptotic activity in human SKBR3 cells assessed as induction of cell growth arrest after 72 hrs by propidium iodide staining-based flow cytometry2007Nature chemical biology, Aug, Volume: 3, Issue:8
Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer.
AID467850Antinociceptive activity in Swiss mouse assessed as inhibition of TNF-alpha-induced mechanical hypernociception at 100 mg/kg, ip dosed 30 mins before TNFalpha challenge measured after 3 hrs by electronic pressure-meter test2009Journal of natural products, Nov, Volume: 72, Issue:11
Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production.
AID1226453Resistance factor, ratio of IC50 for cisplatin-resistant human C13 cells to IC50 for human 2008 cells2015Journal of medicinal chemistry, May-28, Volume: 58, Issue:10
Selenium-containing chrysin and quercetin derivatives: attractive scaffolds for cancer therapy.
AID732541Activation of Nrf2 in mouse RAW264.7 cells assessed as cytosolic accumulation at 50 uM after 3 hrs by Western blotting analysis2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
A novel semisynthetic flavonoid 7-O-galloyltaxifolin upregulates heme oxygenase-1 in RAW264.7 cells via MAPK/Nrf2 pathway.
AID1167300Antioxidant activity assessed as DPPH radical scavenging activity incubated at room temperature for 20 mins by UV-visible spectrophotometry2014Bioorganic & medicinal chemistry letters, Nov-01, Volume: 24, Issue:21
Design, synthesis and exploring the quantitative structure-activity relationship of some antioxidant flavonoid analogues.
AID424726Inhibition of bovine xanthine oxidase2009Journal of natural products, Apr, Volume: 72, Issue:4
Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin.
AID359636Antiviral activity against HSV1 in african green monkey Vero cells assessed as log reduction of virus titer at 10.1 ug/ml1992Journal of natural products, Dec, Volume: 55, Issue:12
Synergistic effect of flavones and flavonols against herpes simplex virus type 1 in cell culture. Comparison with the antiviral activity of propolis.
AID1239534Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 5 after 24 hrs by checkerboard assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID356718Antiinflammatory activity against TPA-induced ear edema in mouse assessed inhibition of edema at 1 mg/ear2001Journal of natural products, Jul, Volume: 64, Issue:7
Antiinflammatory constituents from Heterotheca inuloides.
AID1537229Anti-inflammatory activity in arachidonic acid-induced CD-1 mouse ear edema model assessed as inhibition of ear edema thickness at 1.3% administered topically immediately after arachidonic acid treatment and measured 1 hr post arachidonic acid treatment2019Journal of natural products, 02-22, Volume: 82, Issue:2
In Vivo Anti-inflammatory and Antiallergic Activity of Pure Naringenin, Naringenin Chalcone, and Quercetin in Mice.
AID402567Inhibition of XOD at 25 uM relative to control2004Journal of natural products, Jun, Volume: 67, Issue:6
Geranylgeraniol-type diterpenoids, boletinins A-J, from Boletinus cavipes as inhibitors of superoxide anion generation in macrophage cells.
AID663961Agonist activity at GPR35 receptor in human HT-29 cells assessed as shift in resonant wavelength of biosensor stimulation after 10 mins by dynamic mass redistribution assay relative to control2012ACS medicinal chemistry letters, Feb-09, Volume: 3, Issue:2
Discovery of Natural Phenols as G Protein-Coupled Receptor-35 (GPR35) Agonists.
AID1593916Inhibition of mushroom tyrosinase assessed as reduction in dopachrome formation at 50 uM using L-DOPA as substrate preincubated for 20 mins followed by substrate addition by spectrophotometry relative to untreated control2019Bioorganic & medicinal chemistry, 06-15, Volume: 27, Issue:12
Veratric acid derivatives containing benzylidene-hydrazine moieties as promising tyrosinase inhibitors and free radical scavengers.
AID317348Drug level in human plasma2008Bioorganic & medicinal chemistry, Feb-15, Volume: 16, Issue:4
The effect of flavonoid derivatives on doxorubicin transport and metabolism.
AID1063038Inhibition of VEGFR2 (unknown origin)2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Protein kinase and HDAC inhibitors from the endophytic fungus Epicoccum nigrum.
AID512277Inhibition of His-tagged human JNK1a1/SAPK1c expressed in Escherichia coli at 20 uM2000The Biochemical journal, Oct-01, Volume: 351, Issue:Pt 1
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
AID1128712Antioxidant activity in rat liver microsome membrane assessed as inhibition of lipid peroxidation after 45 mins by TBARS-based spectrophotometric assay2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Design of novel potent antihyperlipidemic agents with antioxidant/anti-inflammatory properties: exploiting phenothiazine's strong antioxidant activity.
AID603458Antibacterial activity against Pseudomonas aeruginosa PAO1 after 24 hrs by microdilution method2011Journal of medicinal chemistry, Jun-09, Volume: 54, Issue:11
Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
AID1224751Delta TM value showing the stabilisation of CAMK2A produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1210014Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control2012Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
AID754413Permeability of the compound after 5 hrs by PAMPA assay2013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
Quercetin-POC conjugates: Differential stability and bioactivity profiles between breast cancer (MCF-7) and colorectal carcinoma (HCT116) cell lines.
AID1371438Cytotoxicity against human U87 cells assessed as cell viability at 14 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1711945Cytotoxicity against human QSG7701 cells assessed as inhibition of cell proliferation at 30 uM measured after 48 hrs by MTT assay relative to control2016European journal of medicinal chemistry, Oct-04, Volume: 121Synthesis and biological properties of polyamine modified flavonoids as hepatocellular carcinoma inhibitors.
AID402361Activity at human estrogen receptor expressed in transgenic Arabidopsis plant at 400 uM by pER8-GFP reporter assay2005Journal of natural products, Jul, Volume: 68, Issue:7
The transgenic Arabidopsis plant system, pER8-GFP, as a powerful tool in searching for natural product estrogen-agonists/antagonists.
AID1226463Selectivity index, ratio of IC50 for HEK293 cells to IC50 for human C13 cells2015Journal of medicinal chemistry, May-28, Volume: 58, Issue:10
Selenium-containing chrysin and quercetin derivatives: attractive scaffolds for cancer therapy.
AID1572026Selectivity ratio of IC50 for human IPMK to IC50 for human IP6K22019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
AID1080603Phytotoxic activity against Echinochloa crus-galli (barnyard grass) assessed as inhibition of hypocotyl growth at 22 +/-2 degC after 72 hr2009Journal of agricultural and food chemistry, Apr-08, Volume: 57, Issue:7
Level of catechin, myricetin, quercetin and isoquercitrin in buckwheat (Fagopyrum esculentum Moench), changes of their levels during vegetation and their effect on the growth of selected weeds.
AID462367Inhibition of mushroom tyrosinase assessed as inhibition of melanin production from dopachrome by autoxidation at 100 uM2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells.
AID381804Antiproliferative activity against human HL60 cells at 30 uM after 48 hrs by MTS assay2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
Structure-activity relationship of human GLO I inhibitory natural flavonoids and their growth inhibitory effects.
AID1162631Induction apoptosis in PMA-stimulated human MDA-MB-231 cells assessed as mitochondrial disruption 3.125 to 25 uM uM after 48 hrs by JC1 staining based fluorescence assay2014Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19
Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
AID191894Mutagenicity evaluated by calculating number of revertants using Salmonella Typhimurium strain TA 100 (2.5 mg/plate) with S9 mix from rat liver; Toxic concentration1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
4'-Hydroxy-3-methoxyflavones with potent antipicornavirus activity.
AID403627Inhibition of COX2 at 2.5 ug/mL2005Journal of natural products, Jul, Volume: 68, Issue:7
Expanding the ChemGPS chemical space with natural products.
AID512278Inhibition of His-tagged human SAPK2a/p38 expressed in Escherichia coli at 20 uM2000The Biochemical journal, Oct-01, Volume: 351, Issue:Pt 1
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
AID54410Binding affinity towards cytochrome P450 2C92004Journal of medicinal chemistry, Feb-12, Volume: 47, Issue:4
Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.
AID1316660Cytotoxicity against LPS-activated human BV2 cells assessed as cell viability at 30 uM after 24 hrs by MTT assay (Rvb = 98.03 to 98.84%)2016Bioorganic & medicinal chemistry letters, 10-15, Volume: 26, Issue:20
Bioactive phenols as potential neuroinflammation inhibitors from the leaves of Xanthoceras sorbifolia Bunge.
AID287081Cell viability of Raji cells at 1000 mol ratio/32 pmol TPA relative to TPA2007Journal of natural products, May, Volume: 70, Issue:5
Anti-inflammatory and potential cancer chemopreventive constituents of the fruits of Morinda citrifolia (Noni).
AID1224783Delta TM value showing the stabilisation of PAK6 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID334640Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of acetylaminofluorene-induced mutation at 600 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID1224797Delta TM value showing the stabilisation of MPSK1 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID1187099Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as reduction in nitric oxide production at 1.5 uM after 24 hrs by Griess method based ELISA (Rvb = 52.4 +/- 0.9 uM)2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Triterpene glycosides from red ginseng marc and their anti-inflammatory activities.
AID362987Inhibition of immune complex-stimulated neutrophil oxidative metabolism in New Zealand white rabbit neutrophils assessed as ROS generation at 50 uM after 30 mins by luminol enhanced chemiluminescence assay2008European journal of medicinal chemistry, May, Volume: 43, Issue:5
Inhibition of immune complex-mediated neutrophil oxidative metabolism: a pharmacophore model for 3-phenylcoumarin derivatives using GRIND-based 3D-QSAR and 2D-QSAR procedures.
AID666858Reversal of BCRP-mediated drug resistant in human MCF7-MX100 cells assessed as potentiation of topotecan-induced cytotoxicity at 1 uM after 5 days by MTS assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis of methylated quercetin derivatives and their reversal activities on P-gp- and BCRP-mediated multidrug resistance tumour cells.
AID1233226Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells after 72 hrs by microplate reader analysis2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID334634Toxicity in Salmonella Typhimurium T98 at 600 ug/plate after 72 hrs by Ames assay in presence of Ames S-9 fraction
AID379313Antioxidant scavenging activity against 2,2'-azobis-amidinopropane-induced peroxyl radicals assessed as total oxyradical scavenging capacity2000Journal of natural products, Mar, Volume: 63, Issue:3
Evaluation of the total peroxyl radical-scavenging capacity of flavonoids: structure-activity relationships.
AID467548Antinociceptive activity against formalin-induced pain in Swiss mouse assessed as inhibition of hind paw flinching response during second phase of response at 100 mg/kg, ip dosed 30 mins before formalin challenge measured for 0 to 30 mins2009Journal of natural products, Nov, Volume: 72, Issue:11
Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production.
AID1056598Antiinflammatory activity in Aggregatibacter actinomycetemcomitans infected Balb/c mouse model assessed as inhibition of IL-1beta production at 100 mg/kg, sc for 15 days post Aggregatibacter actinomycetemcomitans-challenge by ELISA2013Journal of natural products, Dec-27, Volume: 76, Issue:12
Quercetin inhibits inflammatory bone resorption in a mouse periodontitis model.
AID257315Inhibitory activity against baker's yeast alpha glucosidase at 200 uM2005Bioorganic & medicinal chemistry letters, Dec-15, Volume: 15, Issue:24
Sulfonamide chalcone as a new class of alpha-glucosidase inhibitors.
AID578570Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as nitrite level at 1 to 100 uM after 24 hrs by Griess method2011Bioorganic & medicinal chemistry letters, Mar-15, Volume: 21, Issue:6
A new ursane-type triterpenoid glycoside from Centella asiatica leaves modulates the production of nitric oxide and secretion of TNF-α in activated RAW 264.7 cells.
AID1713250Inhibition of potato 5-LOX assessed as reduction in hydroperoxide level by EIA method2016European journal of medicinal chemistry, Nov-10, Volume: 123Novel N-substituted indole Schiff bases as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes: Synthesis, biological activities in vitro and docking study.
AID642414Estrogenic activity at ERalpha in human MVLN cells at 100 ug/mL after 24 hrs by luciferase reporter gene assay relative to E22012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Discovery of estrogen receptor α modulators from natural compounds in Si-Wu-Tang series decoctions using estrogen-responsive MCF-7 breast cancer cells.
AID703485Cytotoxicity against mouse RAW264.7 cells after 72 hrs by MTS assay2012Journal of medicinal chemistry, Oct-25, Volume: 55, Issue:20
Flavonoid dimers as novel, potent antileishmanial agents.
AID1720812Bactericidal activity against Chromobacterium violaceum ATCC 31532 at 400 uM by resazurin dye based assay relative to control2020Bioorganic & medicinal chemistry letters, 08-15, Volume: 30, Issue:16
Chloroquine fumardiamides as novel quorum sensing inhibitors.
AID436267Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum D62008Journal of natural products, Nov, Volume: 71, Issue:11
Bioactive diterpenes and other constituents of Croton steenkampianus.
AID489317Antioxidant activity assessed as DPPH scavenging activity after 4 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, Jul-15, Volume: 20, Issue:14
Synthesis and biological activity of halophenols as potent antioxidant and cytoprotective agents.
AID1683182Induction of apoptosis in human HCT-116 cells assessed as late apoptotic cells measured after 48 hrs by annexinV-FITC/propidium iodide staining based by flow cytometry (Rvb = 2.78 %)2021Bioorganic & medicinal chemistry, 01-01, Volume: 29Synthesis and anticancer activity of new coumarin-3-carboxylic acid derivatives as potential lactatetransportinhibitors.
AID462271Inhibition of human CA2 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID456183Inhibition of reduced carboxymethylated kappa-casein fibril formation at 50 ug/mL measured every 5 mins after 1000 mins by thioflavin T staining-based binding assay2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Carboxymethylated-kappa-casein: a convenient tool for the identification of polyphenolic inhibitors of amyloid fibril formation.
AID1625135Antioxidant activity assessed as trolox equivalents of AAPH radical scavenging activity at 50 uM preincubated for 10 mins followed by AAPH addition and measured every min for 30 mins by ORAC-FL assay2019Journal of natural products, 03-22, Volume: 82, Issue:3
Synthesis of Rosmarinic Acid Amides as Antioxidative and Hypoglycemic Agents.
AID338028Inhibition of beef heart mitochondrial succinoxidase assessed per mg of protein
AID1525245Antidiarrheal activity in po dosed Sprague-Dawley rat assessed as inhibition of charcoal-gum acacia-induced hyperperistalsis by measuring reduction in distance travelled by charcoal from pylorus to cecum pretreated for 20 mins followed by charcoal meal st2019Journal of natural products, 05-24, Volume: 82, Issue:5
Structure and Absolute Configuration of Abietane Diterpenoids from Salvia clinopodioides: Antioxidant, Antiprotozoal, and Antipropulsive Activities.
AID1188622Anticancer activity against human HeLa cells by HTS assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer.
AID1693703Cardiotoxicity in medaka embryo post hatching 24 hrs assessed as reduction in heart beat at 25 uM measured after 1 hr2021Bioorganic & medicinal chemistry, 01-15, Volume: 30In vitro and in vivo effects of inhibitors on actin and myosin.
AID1198743Antioxidant activity assessed as DPPH radical scavenging activity2015European journal of medicinal chemistry, Mar-26, Volume: 93Antioxidant activity and inhibition of α-glucosidase by hydroxyl-functionalized 2-arylbenzo[b]furans.
AID1693695Induction of cell morphological changes in human MDA-MB-231 cells assessed as membrane blebbing by inverted microscopy2021Bioorganic & medicinal chemistry, 01-15, Volume: 30In vitro and in vivo effects of inhibitors on actin and myosin.
AID383193Antioxidant activity assessed as trolox equivalent at 0.2 to 0.6 uM by ORAC-fluorescein assay2008Bioorganic & medicinal chemistry, Apr-15, Volume: 16, Issue:8
Natural and non-natural prenylated chalcones: synthesis, cytotoxicity and anti-oxidative activity.
AID504311Antioxidant activity assessed as trolox equivalent of ABTS radical scavenging activity after 12 to 16 hrs by spectrophotometry2010Journal of natural products, Sep-24, Volume: 73, Issue:9
Antioxidant flavone glycosides from the leaves of Fargesia robusta.
AID1379226Neuroprotective activity in rat PC12 cells assessed as decrease in H2O2 mediated apoptosis at 10 uM preincubated for 3 hrs followed by H2O2 challenge measured after 24 hrs by MTT assay2017European journal of medicinal chemistry, Oct-20, Volume: 139New racemic annulated pyrazolo[1,2-b]phthalazines as tacrine-like AChE inhibitors with potential use in Alzheimer's disease.
AID663960Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins2012ACS medicinal chemistry letters, Feb-09, Volume: 3, Issue:2
Discovery of Natural Phenols as G Protein-Coupled Receptor-35 (GPR35) Agonists.
AID359646Cytotoxicity against african green monkey Vero cells1992Journal of natural products, Dec, Volume: 55, Issue:12
Synergistic effect of flavones and flavonols against herpes simplex virus type 1 in cell culture. Comparison with the antiviral activity of propolis.
AID1635054Antiproliferative activity in rhesus monkey RF/6A cells measured after 24 to 72 hrs by MTT assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Effects of 2,3-Dehydrosilybin and Its Galloyl Ester and Methyl Ether Derivatives on Human Umbilical Vein Endothelial Cells.
AID1313604Cytotoxicity against LPS-induced mouse BV2 cells assessed as cell viability after 24 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, 08-01, Volume: 26, Issue:15
Lanostane triterpenoids from Ganoderma curtisii and their NO production inhibitory activities of LPS-induced microglia.
AID414643Inhibition of PTP1B2009Bioorganic & medicinal chemistry, Apr-01, Volume: 17, Issue:7
Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors.
AID1156024Antioxidant activity assessed as ferric ion reducing activity using fe3+-TPTZ measured per gram of protein by FRAP assay2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis and anti-cholinesterase activity of new 7-hydroxycoumarin derivatives.
AID1063049Inhibition of aurora-B (unknown origin)2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Protein kinase and HDAC inhibitors from the endophytic fungus Epicoccum nigrum.
AID690149Reducing activity by cyclic voltammetry2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Comparative study on antioxidant capacity of flavonoids and their inhibitory effects on oleic acid-induced hepatic steatosis in vitro.
AID1871934Inhibition of LPS-induced NO production in mouse J774.A1 cells pre-incubated with compound for 1 hr followed by LPS stimulation for 24 hrs by ELISA assay2022European journal of medicinal chemistry, Feb-05, Volume: 229Quercetin derivatives: Drug design, development, and biological activities, a review.
AID1510617Inhibition of Enterobacter cloacae beta-lactamase incubated for 10 mins followed by nitrocefin substrate challenge and measured for 5 mins in presence of 1 mM DTT by spectrophotometric analysis2019ACS medicinal chemistry letters, Jun-13, Volume: 10, Issue:6
DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors.
AID587321Antiinflammatory activity in human neutrophil assessed as inhibition of fMLP-induced neutrophil chemoattraction 300 to 1000 nM after 2 hrs by Boyden chamber v2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID1234555Antioxidant activity in soybean large unilamellar vesicles assessed as inhibition of AAPH-induced lipid peroxidation compound added prior to AAPH induction measured after 90 mins by UV-visible absorption spectrometric analysis2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Lipocarbazole, an efficient lipid peroxidation inhibitor anchored in the membrane.
AID1537238Antiallergic activity in CD-1 mouse model of IgE/DNP-BSA-stimulated passive cutaneous anaphylaxis assessed as inhibition of vascular permeability at 2% administered topically immediately after sensitization by Evans blue extravasation assay relative to co2019Journal of natural products, 02-22, Volume: 82, Issue:2
In Vivo Anti-inflammatory and Antiallergic Activity of Pure Naringenin, Naringenin Chalcone, and Quercetin in Mice.
AID456189Inhibition of beta amyloid (1 to 42) fibril formation by thioflavin T staining-based binding assay2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Carboxymethylated-kappa-casein: a convenient tool for the identification of polyphenolic inhibitors of amyloid fibril formation.
AID398959Antimicrobial activity against Candida albicans
AID1248048Antioxidant activity assessed as inhibition of AAPH-induced lipid peroxidation at 200 ug/ml after 3 hrs by TBA-MDA test2015Bioorganic & medicinal chemistry, Oct-01, Volume: 23, Issue:19
Synthesis, electronic properties, antioxidant and antibacterial activity of some new benzimidazoles.
AID1539764Inhibition of CK2alpha (unknown origin)2019European journal of medicinal chemistry, Nov-01, Volume: 181Small molecule modulators targeting protein kinase CK1 and CK2.
AID1446252Cytotoxicity against NHDF assessed as reduction in cell viability after 72 hrs by MTT assay2017Journal of medicinal chemistry, 08-10, Volume: 60, Issue:15
Discovery of Novel Potent Reversible and Irreversible Myeloperoxidase Inhibitors Using Virtual Screening Procedure.
AID377655Inhibition of bovine MAO-B by fluorimetric method2006Journal of natural products, Jun, Volume: 69, Issue:6
Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and computational study.
AID1446229Inhibition of recombinant MPO (unknown origin) assessed as reduction in TMB peroxidation by measuring residual activity at 5 uM in presence of H2O2 incubated for 5 mins followed by 100 fold enzyme dilution relative to control2017Journal of medicinal chemistry, 08-10, Volume: 60, Issue:15
Discovery of Novel Potent Reversible and Irreversible Myeloperoxidase Inhibitors Using Virtual Screening Procedure.
AID1555999Neuroprotective activity against H2O2 induced cytotoxicity in rat PC12 cells assessed as cell viability at 50 uM pretreated for 3 hrs followed by H2O2 challenge measured after 24 hrs by MTT assay (Rvb = 35.69 to 50.26%)2019European journal of medicinal chemistry, Sep-01, Volume: 177Design, synthesis, and biological evaluation of rutacecarpine derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease.
AID1082327Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under dark conditions measured 72 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID504312Antioxidant activity against AAPH-induced lipid peroxidation assessed as trolox equivalent of peroxy radical scavenging activity after 10 mins by ORAC assay2010Journal of natural products, Sep-24, Volume: 73, Issue:9
Antioxidant flavone glycosides from the leaves of Fargesia robusta.
AID1226448Cytotoxicity against cisplatin-resistant human A431 cells assessed as cell growth inhibition after 72 hrs by MTT assay2015Journal of medicinal chemistry, May-28, Volume: 58, Issue:10
Selenium-containing chrysin and quercetin derivatives: attractive scaffolds for cancer therapy.
AID1409609Cytotoxicity of compound against Vero E6 cells by MTT assay.2020Nature, 07, Volume: 583, Issue:7816
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
AID1516851Antifungal activity against Candida albicans 498 by microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID1777362Antiviral activity against SARS-CoV-2 NCCP43326 infected in African green monkey Vero cells assessed as reduction in spike protein production at 1 to 25 ug/ml cells were infected with virus for 1 hr followed by wash-out period and later treated with compo2021Bioorganic & medicinal chemistry, 09-01, Volume: 45Potent antiviral activity of Agrimonia pilosa, Galla rhois, and their components against SARS-CoV-2.
AID354859Inhibition of DNA topoisomerase 21996Journal of natural products, Jul, Volume: 59, Issue:7
DNA topoisomerase I inhibitors: cytotoxic flavones from Lethedon tannaensis.
AID768903Inhibition of human thrombin assessed as decrease in platelet aggregation preincubated for 10 mins measured for 10 mins by dual channel chrono-log aggregometric analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID1128714Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Design of novel potent antihyperlipidemic agents with antioxidant/anti-inflammatory properties: exploiting phenothiazine's strong antioxidant activity.
AID517388Induction of AMPK-mediated ACC phosphorylation in mouse 3T3L1 cells at 10 uM by Western blotting2010Bioorganic & medicinal chemistry letters, Oct-15, Volume: 20, Issue:20
The selected flavonol glycoside derived from Sophorae Flos improves glucose uptake and inhibits adipocyte differentiation via activation AMPK in 3T3-L1 cells.
AID462273Inhibition of human CA4 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID1751496Antibiofilm activity against Pseudomonas aeruginosa assessed as inhibition of biofilm formation at 100 uM2021Bioorganic & medicinal chemistry letters, 09-15, Volume: 48Discovery of non-proteinogenic amino acids inhibiting biofilm formation by S. aureus and methicillin-resistant S. aureus.
AID1516848Antifungal activity against Candida tropicalis 166 by microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID1371369Cytotoxicity against human T47D cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1593612GSH reactivity in pH 7.4 PBS assessed as hydroxylated quercetin formation at 50 uM incubated for 10 mins in presence of HRP and H2O2 in presence of 40 uM GSH by HPLC-DAD and HPLC-MS/MS analysis relative to control2019Bioorganic & medicinal chemistry, 06-15, Volume: 27, Issue:12
Purification, structural elucidation, antioxidant capacity and neuroprotective potential of the main polyphenolic compounds contained in Achyrocline satureioides (Lam) D.C. (Compositae).
AID537736Antifungal activity against yeast AD1-8u expressing Candida albicans CaCdr1p by agar disk diffusion assay2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
AID257317Inhibitory activity against barley beta amylase at 200 uM2005Bioorganic & medicinal chemistry letters, Dec-15, Volume: 15, Issue:24
Sulfonamide chalcone as a new class of alpha-glucosidase inhibitors.
AID1899560Cytotoxicity against LPS induced mouse BV-2 cells assessed as inhibition in cell viability at 20 uM measured by MTT assay2022European journal of medicinal chemistry, Jan-15, Volume: 228Imidazolylacetophenone oxime-based multifunctional neuroprotective agents: Discovery and structure-activity relationships.
AID487731Hypoglycemic activity in Wistar rat assessed as change in blood glucose level at 50 mg/kg, ig after 3 hrs (RVb = 1.39 +/- 5.895 %)2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
A comparative study of flavonoid analogues on streptozotocin-nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11beta-hydroxysteroid dehydrogenase type 1 inhibition.
AID1226450Cytotoxicity against human C13 cells assessed as cell growth inhibition after 72 hrs by MTT assay2015Journal of medicinal chemistry, May-28, Volume: 58, Issue:10
Selenium-containing chrysin and quercetin derivatives: attractive scaffolds for cancer therapy.
AID455708Selectivity index, ratio of CC50 for MDCK cells to EC50 for influenza virus H9N2 A/Chicken/Korea/MS96/962009Bioorganic & medicinal chemistry, Oct-01, Volume: 17, Issue:19
Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities.
AID1711946Cytotoxicity against human QSG7701 cells assessed as inhibition of cell proliferation at 100 uM measured after 48 hrs by MTT assay relative to control2016European journal of medicinal chemistry, Oct-04, Volume: 121Synthesis and biological properties of polyamine modified flavonoids as hepatocellular carcinoma inhibitors.
AID1572036Effect on AKT activity in human HCT116 cells assessed as AKT phosphorylation at T308 residues at 2.5 uM after 3 hrs by Western blot analysis2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
AID605044Cellular uptake in human MCF7 cells assessed as compound remaining in cell lysates at 10 uM after 1 hr by HPLC-mass spectrophotometric analysis2010Journal of medicinal chemistry, Dec-23, Volume: 53, Issue:24
Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.
AID377784Antioxidant activity assessed as ABTS radical scavenging activity after 15 mins by TEAC method2005Journal of natural products, Apr, Volume: 68, Issue:4
Antioxidant phenolic glycosides from Moricandia arvensis.
AID1308027Inhibition of CYP2C8 in human liver microsomes at 10 uM incubated for 5 mins followed by NADPH addition by LC-MS/MS analysis relative to control2016Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibition by Optimization of the 2-Aminopyridine-Based Scaffold with a Pyridine Linker.
AID445119Antioxidant activity assessed as protection against AAPH-induced pBR322 plasmid DNA strand open circular form at 5 uM after 4 hrs by agarose electrophoresis2009Bioorganic & medicinal chemistry letters, Nov-15, Volume: 19, Issue:22
Synthesis and antioxidant properties of dendritic polyphenols.
AID1711958Induction of lysosomal impairment in human HepG2 cells at 80 uM after 48 hrs by Lyso-tracker Red staining based assay2016European journal of medicinal chemistry, Oct-04, Volume: 121Synthesis and biological properties of polyamine modified flavonoids as hepatocellular carcinoma inhibitors.
AID1070383Neuroprotective activity in mouse HT22 cells assessed as t-BOOH-induced toxicity at 40 uM preincubated for 3 hrs followed by t-BOOH induction measured after 4.5 hrs by MTT assay2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Flavonoids, flavonoid metabolites, and phenolic acids inhibit oxidative stress in the neuronal cell line HT-22 monitored by ECIS and MTT assay: a comparative study.
AID1233239Downregulation of TRP-1 mRNA expression in theophylline-stimulated mouse B16-4A5 cells assessed as ratio of TRP-1 mRNA to beta-actin mRNA level at 10 uM after 72 hrs by qPCR analysis2015Bioorganic & medicinal chemistry letters, Jul-01, Volume: 25, Issue:13
Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna).
AID257316Inhibitory activity against Bacillus licheniformis alpha amylase at 200 uM2005Bioorganic & medicinal chemistry letters, Dec-15, Volume: 15, Issue:24
Sulfonamide chalcone as a new class of alpha-glucosidase inhibitors.
AID436268Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Dd22008Journal of natural products, Nov, Volume: 71, Issue:11
Bioactive diterpenes and other constituents of Croton steenkampianus.
AID1352202Antioxidant activity in PBS buffer assessed as NO scavenging activity after 90 mins in presence of sodium nitroprusside by Griess assay2018European journal of medicinal chemistry, Feb-10, Volume: 145Design, synthesis, biological evaluation and docking studies of new 3-(4,5-dihydro-1H-pyrazol/isoxazol-5-yl)-2-phenyl-1H-indole derivatives as potent antioxidants and 15-lipoxygenase inhibitors.
AID426324Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by ELISA2009Journal of natural products, Jun, Volume: 72, Issue:6
Labdane diterpenoid glycosides from Alpinia densespicata and their nitric oxide inhibitory activities in macrophages.
AID587344Inhibition of recombinant human CK2 activity assessed as [gamma-32P]ATP incorporation into substrate peptide after 20 mins in presence of 50 uM ATP2011European journal of medicinal chemistry, Mar, Volume: 46, Issue:3
Synthesis and biological evaluation of substituted (thieno[2,3-d]pyrimidin-4-ylthio)carboxylic acids as inhibitors of human protein kinase CK2.
AID754421Half life of the compound in PBS buffer at pH 7.4 at 50 uM by HPLC analysis2013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
Quercetin-POC conjugates: Differential stability and bioactivity profiles between breast cancer (MCF-7) and colorectal carcinoma (HCT116) cell lines.
AID1239539Antibacterial activity against vancomycin-intermediate resistant Staphylococcus aureus Mu50 after 24 hrs by checkerboard assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID587320Antiinflammatory activity in human neutrophil assessed as inhibition of CXCL8-induced neutrophil chemoattraction 300 to 1000 nM after 2 hrs by Boyden chamber v2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization.
AID339058Selectivity for Moloney murine leukemia virus reverse transcriptase over Escherichia coli DNA polymerase 11992Journal of natural products, Feb, Volume: 55, Issue:2
Inhibitory effects of flavonoids on Moloney murine leukemia virus reverse transcriptase activity.
AID1371439Cytotoxicity against human LN229 cells assessed as cell viability at 14 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1751495Antibiofilm activity against Staphylococcus aureus assessed as inhibition of biofilm formation at 66 uM2021Bioorganic & medicinal chemistry letters, 09-15, Volume: 48Discovery of non-proteinogenic amino acids inhibiting biofilm formation by S. aureus and methicillin-resistant S. aureus.
AID506934Inhibition of HSP90-mediated antiapoptotic activity in human MCF7 cells assessed as induction of caspase-9 cleavage at 200 uM after 24 hrs by Western blot analysis2007Nature chemical biology, Aug, Volume: 3, Issue:8
Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer.
AID93507IC50 was measured as concentration required to inhibit 50% of HIV-integrase cleavage1995Journal of medicinal chemistry, Mar-17, Volume: 38, Issue:6
Three-dimensional quantitative structure-activity relationship (QSAR) of HIV integrase inhibitors: a comparative molecular field analysis (CoMFA) study.
AID449290Antioxidant activity assessed as superoxide anion scavenging activity after 5 mins by spectrophotometry2009Journal of medicinal chemistry, Dec-10, Volume: 52, Issue:23
Design, synthesis, and examination of neuron protective properties of alkenylated and amidated dehydro-silybin derivatives.
AID1373939Induction of apoptosis in human HL60 cells assessed as early apoptotic cells at 50 uM after 24 hrs by Annexin-V-FITC/propidium iodide staining based flow cytometric analysis (Rvb = 0.36 +/- 0.02 %)2018Bioorganic & medicinal chemistry, 02-15, Volume: 26, Issue:4
Optimization of antimalarial, and anticancer activities of (E)-methyl 2-(7-chloroquinolin-4-ylthio)-3-(4-hydroxyphenyl) acrylate.
AID1152252Cytotoxicity against human C8166 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay2014Bioorganic & medicinal chemistry, Jun-15, Volume: 22, Issue:12
Design and discovery of flavonoid-based HIV-1 integrase inhibitors targeting both the active site and the interaction with LEDGF/p75.
AID379055Cytotoxicity against human monocytes assessed as depletion of cellular LDH activity1999Journal of natural products, Mar, Volume: 62, Issue:3
Polymethoxylated flavones derived from citrus suppress tumor necrosis factor-alpha expression by human monocytes.
AID377656Selectivity index, IC50 for bovine MAO-B to IC50 for bovine MAO-A2006Journal of natural products, Jun, Volume: 69, Issue:6
Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and computational study.
AID311924Inhibition of LPS and INF-alpha-induced nitric oxide production in mouse RAW264.7 cells after 16 hrs2007Journal of natural products, Dec, Volume: 70, Issue:12
Kadsuralignans H-K from Kadsura coccinea and their nitric oxide production inhibitory effects.
AID1711963Induction of apoptosis in human HepG2 cells assessed as activation of caspase 9 at 80 uM measured after 48 hrs by immunofluorescence assay2016European journal of medicinal chemistry, Oct-04, Volume: 121Synthesis and biological properties of polyamine modified flavonoids as hepatocellular carcinoma inhibitors.
AID1558602Neuroprotective activity at mouse HT22 cells assessed as reduction in glutamate-induced oxidative stress by measuring cell viability at 25 uM incubated for 24 hrs by MTT assay2019Journal of medicinal chemistry, 10-24, Volume: 62, Issue:20
Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo.
AID1226460Selectivity index, ratio of IC50 for HEK293 cells to IC50 for human A431 cells2015Journal of medicinal chemistry, May-28, Volume: 58, Issue:10
Selenium-containing chrysin and quercetin derivatives: attractive scaffolds for cancer therapy.
AID1720814Bactericidal activity against violacein-negative Chromobacterium violaceum CV026 mini-Tn5 mutant at 400 uM by resazurin dye based assay relative to control2020Bioorganic & medicinal chemistry letters, 08-15, Volume: 30, Issue:16
Chloroquine fumardiamides as novel quorum sensing inhibitors.
AID312787Inhibition of Fe2+-induced lipid peroxidation in rat brain homogenate2008Journal of medicinal chemistry, Feb-14, Volume: 51, Issue:3
Synthesis and evaluation of 2'-hydroxyethyl trans-apovincaminate derivatives as antioxidant and cognitive enhancer agents.
AID1510610Inhibition of bovine pancreas alpha-chymotrypsin at concentration of 6 nM using SAAPPpNA as substrate treated with enzyme for 30 mins following enzyme incubation with 0.7 to 2.1 M DMSO for 5 mins followed by substrate addition and measured for 12 mins by 2019ACS medicinal chemistry letters, Jun-13, Volume: 10, Issue:6
DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors.
AID1294439Antioxidant activity assessed as inhibition of peroxynitrite induced oxidation of the non-fluorescent dihydrorhodamine 123 to the fluorescent rhodamine-123 in presence of NaHCO3 after 2 mins by fluorimetric method2016European journal of medicinal chemistry, Jun-10, Volume: 115Novel chromone and xanthone derivatives: Synthesis and ROS/RNS scavenging activities.
AID402475Inhibition of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality preincubated for 15 mins before TNFalpha addition measured after 24 hrs by [methyl-3H]thymidine incorporation assay1997Journal of natural products, Aug, Volume: 60, Issue:8
Flavonoids as inhibitors or enhancers of the cytotoxicity of tumor necrosis factor-alpha in L-929 tumor cells.
AID1485952Cytotoxicity against rat PC12 cells assessed as reduction in cell viability at 100 uM after 48 hrs by MTT assay2017Bioorganic & medicinal chemistry, 07-15, Volume: 25, Issue:14
Structure-activity relationships for flavone interactions with amyloid β reveal a novel anti-aggregatory and neuroprotective effect of 2',3',4'-trihydroxyflavone (2-D08).
AID603833Effect on p38 kinase protein level in human MDA-MB-231 cells at 20 uM up to 120 mins by Western blot analysis2011Bioorganic & medicinal chemistry letters, Jul-01, Volume: 21, Issue:13
Rhamnetin production based on the rational design of the poplar O-methyltransferase enzyme and its biological activities.
AID1224754Delta TM value showing the stabilisation of CAMK2G produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID450962Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Preparation of C-23 esterified silybin derivatives and evaluation of their lipid peroxidation inhibitory and DNA protective properties.
AID1127213Binding affinity DPPC multilamellar vesicles assessed as main transition temperature at 1:10 compound/lipid ratio after 2 hrs by differential scanning calorimetry method (Rvb = 41.98 degC)2014European journal of medicinal chemistry, May-22, Volume: 79In-vitro anti-proliferative and anti-oxidant activity of galangin, fisetin and quercetin: role of localization and intermolecular interaction in model membrane.
AID32357Displacement of specific [3H]PIA binding from adenosine A1 receptor in rat brain membranes.1996Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
Interactions of flavonoids and other phytochemicals with adenosine receptors.
AID310887Permeability from apical to basolateral side of dog MDCK2 cell monolayer assessed as intact drug level in basolateral compartment after 6 hrs2007Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2
Ester-based precursors to increase the bioavailability of quercetin.
AID1743181Antioxidant activity in human erythrocytes assessed as protection against AAPH-induced hemolysis at 400 uM preincubated for 20 mins followed by AAPH addition and measured after 2 hrs by spectrophotometric method relative to control2020European journal of medicinal chemistry, Dec-15, Volume: 208Multiple biological active 4-aminopyrazoles containing trifluoromethyl and their 4-nitroso-precursors: Synthesis and evaluation.
AID510244Inhibition of NOX4 expressed in HEK293 FS cells assessed as H2O2 production by H2O2/Tyr/LPO assay2010Journal of medicinal chemistry, Sep-23, Volume: 53, Issue:18
Small-molecule inhibitors of NADPH oxidase 4.
AID1083157Antifungal activity against Lasiodiplodia theobromae CBS116460 assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID1082337Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1102136Phytotoxicity in Centaurea diffusa assessed as inhibition of seed germination at 250 ug/mL measured on day 14 relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Structure-dependent phytotoxicity of catechins and other flavonoids: flavonoid conversions by cell-free protein extracts of Centaurea maculosa (spotted knapweed) roots.
AID600292Vasorelaxant activity in rat aortic ring assessed as inhibition of phenylephrine-induced contraction relative to control2009Bioorganic & medicinal chemistry letters, Jun-15, Volume: 19, Issue:12
Synthesis, biological evaluation of prenylflavonoids as vasorelaxant and neuroprotective agents.
AID1510611Drug metabolism in DMSO-d6/potassium phosphate buffer assessed as drug recovery with small amount of metabolite formation by 1H-NMR analysis2019ACS medicinal chemistry letters, Jun-13, Volume: 10, Issue:6
DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors.
AID112434Inhibition of TPA-induced inflammatory ear edema in mice(compound was applied 30 min before TPA (1 mg),Ear thickness was determined 6 hr after TPA treatment)1995Journal of medicinal chemistry, Oct-13, Volume: 38, Issue:21
Alkane-6,8-diol: inhibitor of tumor promotion in two-stage carcinogenesis in mouse skin.
AID1371376Cytotoxicity against human MML1 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1082340Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 5% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID315612Induction of apoptosis in human BGC823 cells assessed as increase in DNA fragmentation at 50 uM after 48 hrs2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
Studies on the chemical constituents and anticancer activity of Saxifraga stolonifera (L) Meeb.
AID504308Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as inhibition of NO production after 24 hrs2010Journal of natural products, Sep-24, Volume: 73, Issue:9
Antioxidant and anti-inflammatory phenylpropanoid derivatives from Calamus quiquesetinervius.
AID1450465Inhibition of ELAV3 (unknown origin)-artificial ARE complex formation after 30 mins in the presence of biotin-labeled RNA probe by chemiluminescence nucleic acid detection method2017Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20
Compounds Interfering with Embryonic Lethal Abnormal Vision (ELAV) Protein-RNA Complexes: An Avenue for Discovering New Drugs.
AID1161231Cytotoxicity against human neutrophils assessed as cell viability at 50 uM after 4 hrs by trypan blue assay2014European journal of medicinal chemistry, Oct-30, Volume: 86Synthesis of chlorinated flavonoids with anti-inflammatory and pro-apoptotic activities in human neutrophils.
AID1410097Antioxidant activity in human HepG2 cells assessed as inhibition of ABAP-induced peroxyl radical generation incubated for 60 mins measured for 60 mins by DCFH-DA probe based fluorescence assay2018Journal of natural products, 04-27, Volume: 81, Issue:4
Synthesis, Biological Investigation, and Structural Revision of Sielboldianin A.
AID699539Inhibition of human liver OATP1B1 expressed in HEK293 Flp-In cells assessed as reduction in E17-betaG uptake at 20 uM by scintillation counting2012Journal of medicinal chemistry, May-24, Volume: 55, Issue:10
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
AID6809In vitro inhibitory activity against RBL-1 5-LO1987Journal of medicinal chemistry, Mar, Volume: 30, Issue:3
Hydroxamic acid inhibitors of 5-lipoxygenase.
AID1224772Delta TM value showing the stabilisation of MAP2K6 produced by compound binding2007Proceedings of the National Academy of Sciences of the United States of America, Dec-18, Volume: 104, Issue:51
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
AID286228Inhibition of 5LOX in human PBMC by EIA assay2007Journal of natural products, May, Volume: 70, Issue:5
Lipoxygenase inhibitory constituents of the fruits of noni (Morinda citrifolia) collected in Tahiti.
AID670317Inhibition of human recombinant MMP2 catalytic domain at 10 uM incubated for 20 mins by fluorimetric assay2012Bioorganic & medicinal chemistry, Jul-01, Volume: 20, Issue:13
Natural products as a gold mine for selective matrix metalloproteinases inhibitors.
AID1235034Antioxidant activity assessed as DPPH radical scavenging activity2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Structure-based development of nitroxoline derivatives as potential multifunctional anti-Alzheimer agents.
AID642415Estrogenic activity at ERalpha in human MVLN cells at 20 ug/mL after 24 hrs by luciferase reporter gene assay relative to E22012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Discovery of estrogen receptor α modulators from natural compounds in Si-Wu-Tang series decoctions using estrogen-responsive MCF-7 breast cancer cells.
AID703487Antimicrobial activity against pentamidine-resistant Leishmania donovani AG83PentR50 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay2012Journal of medicinal chemistry, Oct-25, Volume: 55, Issue:20
Flavonoid dimers as novel, potent antileishmanial agents.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID1508627Counterscreen qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: GLuc-NoTag assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1508628Confirmatory qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1508629Cell Viability qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID686947qHTS for small molecule inhibitors of Yes1 kinase: Primary Screen2013Bioorganic & medicinal chemistry letters, Aug-01, Volume: 23, Issue:15
Identification of potent Yes1 kinase inhibitors using a library screening approach.
AID1347411qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Mechanism Interrogation Plate v5.0 (MIPE) Libary2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347156DAPI mCherry counterscreen qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347158ZIKV-mCherry secondary qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1796664Kinase Inhibition Assay from Article 10.1042/BJ20030674: \\Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).\\2003The Biochemical journal, Sep-15, Volume: 374, Issue:Pt 3
Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).
AID1799639Kinase Assay from Article 10.1002/cbic.201000487: \\Biological evaluation and structural determinants of p38u00CEu00B1 mitogen-activated-protein kinase and c-Jun-N-terminal kinase 3 inhibition by flavonoids.\\2010Chembiochem : a European journal of chemical biology, Dec-10, Volume: 11, Issue:18
Biological evaluation and structural determinants of p38α mitogen-activated-protein kinase and c-Jun-N-terminal kinase 3 inhibition by flavonoids.
AID1805801Various Assay from Article 10.1021/acs.jmedchem.1c00409: \\Perspectives on SARS-CoV-2 Main Protease Inhibitors.\\2021Journal of medicinal chemistry, 12-09, Volume: 64, Issue:23
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
AID1803140Esterase Activity Assay from Article 10.3109/14756366.2011.643303: \\Carbonic anhydrase inhibitors: in vitro inhibition of a isoforms (hCA I, hCA II, bCA III, hCA IV) by flavonoids.\\2013Journal of enzyme inhibition and medicinal chemistry, Apr, Volume: 28, Issue:2
Carbonic anhydrase inhibitors: in vitro inhibition of α isoforms (hCA I, hCA II, bCA III, hCA IV) by flavonoids.
AID1796044Kinase Inhibition Assay from Article 10.1021/jm049353p: \\Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin.\\2005Journal of medicinal chemistry, Feb-10, Volume: 48, Issue:3
Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin.
AID1803286cd-MMP-1 Activity Assay from Article 10.3109/14756366.2012.681650: \\The efficient expression of human fibroblast collagenase in Escherichia coli and the discovery of flavonoid inhibitors.\\2013Journal of enzyme inhibition and medicinal chemistry, Aug, Volume: 28, Issue:4
The efficient expression of human fibroblast collagenase in Escherichia coli and the discovery of flavonoid inhibitors.
AID1802643DPP III Enzyme Activity Assay from Article 10.1111/cbdd.12887: \\Validation of flavonoids as potential dipeptidyl peptidase III inhibitors: Experimental and computational approach.\\2017Chemical biology & drug design, 04, Volume: 89, Issue:4
Validation of flavonoids as potential dipeptidyl peptidase III inhibitors: Experimental and computational approach.
AID1802891Surface Plasmon Resonance (SPR) Assay from Article 10.1074/jbc.M114.553248: \\Chemical proteomics identifies heterogeneous nuclear ribonucleoprotein (hnRNP) A1 as the molecular target of quercetin in its anti-cancer effects in PC-3 cells.\\2014The Journal of biological chemistry, Aug-08, Volume: 289, Issue:32
Chemical proteomics identifies heterogeneous nuclear ribonucleoprotein (hnRNP) A1 as the molecular target of quercetin in its anti-cancer effects in PC-3 cells.
AID1798320In Vitro alpha-Amylase Activity Assay from Article 10.1021/jm800115x: \\Flavonoids for controlling starch digestion: structural requirements for inhibiting human alpha-amylase.\\2008Journal of medicinal chemistry, Jun-26, Volume: 51, Issue:12
Flavonoids for controlling starch digestion: structural requirements for inhibiting human alpha-amylase.
AID1801043DXR Inhibition Assay from Article 10.1016/j.bioorg.2015.02.008: \\Flavonoids: true or promiscuous inhibitors of enzyme? The case of deoxyxylulose phosphate reductoisomerase.\\2015Bioorganic chemistry, Apr, Volume: 59Flavonoids: true or promiscuous inhibitors of enzyme? The case of deoxyxylulose phosphate reductoisomerase.
AID1803131Enzyme Assay from Article 10.3109/14756366.2010.616860: \\Polyphenol fatty acid esters as serine protease inhibitors: a quantum-chemical QSAR analysis.\\2012Journal of enzyme inhibition and medicinal chemistry, Dec, Volume: 27, Issue:6
Polyphenol fatty acid esters as serine protease inhibitors: a quantum-chemical QSAR analysis.
AID1798717Solid-Phase ELISA Kinase Assay from Article 10.1158/1535-7163.MCT-06-0397: \\Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinase.\\2007Molecular cancer therapeutics, Jan, Volume: 6, Issue:1
Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinase.
AID1797363Fluorescence Assays for Determination of Binding Affinity. from Article 10.1016/s1097-2765(05)00089-4: \\Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine.\\2000Molecular cell, Oct, Volume: 6, Issue:4
Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine.
AID1804126No assay is provided from Article 10.1021/acs.jmedchem.5b01461: \\An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy.\\2016Journal of medicinal chemistry, 07-28, Volume: 59, Issue:14
An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy.
AID1799599Esterase Activity Assay from Article 10.1111/j.1747-0285.2010.00965.x: \\Carbonic anhydrase inhibitors: Inhibition of human erythrocyte isozymes I and II with a series of phenolic acids.\\2010Chemical biology & drug design, May, Volume: 75, Issue:5
Carbonic anhydrase inhibitors: Inhibition of human erythrocyte isozymes I and II with a series of phenolic acids.
AID1802376Thioflavin-T (Th-T) Fluorescence Assay from Article 10.1074/jbc.M113.464222: \\Site-specific inhibitory mechanism for amyloid u00DF42 aggregation by catechol-type flavonoids targeting the Lys residues.\\2013The Journal of biological chemistry, Aug-09, Volume: 288, Issue:32
Site-specific inhibitory mechanism for amyloid β42 aggregation by catechol-type flavonoids targeting the Lys residues.
AID1804127No assay is provided from Article 10.1002/med.21724: \\The recent outbreaks of human coronaviruses: A medicinal chemistry perspective.\\2021Medicinal research reviews, 01, Volume: 41, Issue:1
The recent outbreaks of human coronaviruses: A medicinal chemistry perspective.
AID1801097Aurora B Kinase Assay from Article 10.1111/cbdd.12445: \\Plant-derived flavones as inhibitors of aurora B kinase and their quantitative structure-activity relationships.\\2015Chemical biology & drug design, May, Volume: 85, Issue:5
Plant-derived flavones as inhibitors of aurora B kinase and their quantitative structure-activity relationships.
AID1803217Esterase Activity Assay from Article 10.3109/14756366.2011.651464: \\Analysis of saponins and phenolic compounds as inhibitors of a-carbonic anhydrase isoenzymes.\\2013Journal of enzyme inhibition and medicinal chemistry, Apr, Volume: 28, Issue:2
Analysis of saponins and phenolic compounds as inhibitors of α-carbonic anhydrase isoenzymes.
AID1800258AR Activity from Article 10.1016/j.bioorg.2014.02.002: \\Development of novel pyrazolone derivatives as inhibitors of aldose reductase: an eco-friendly one-pot synthesis, experimental screening and in silico analysis.\\2014Bioorganic chemistry, Apr, Volume: 53Development of novel pyrazolone derivatives as inhibitors of aldose reductase: an eco-friendly one-pot synthesis, experimental screening and in silico analysis.
AID504836Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation2002The Journal of biological chemistry, Apr-19, Volume: 277, Issue:16
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347049Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot screen2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588378qHTS for Inhibitors of ATXN expression: Validation
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347050Natriuretic polypeptide receptor (hNpr2) antagonism - Pilot subtype selectivity assay2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347045Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot counterscreen GloSensor control cell line2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID588349qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay
AID1347157Confirmatory screen GU Rhodamine qHTS for Zika virus inhibitors qHTS2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347169Tertiary RLuc qRT-PCR qHTS assay for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347149Furin counterscreen qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347161Confirmatory screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
AID1347410qHTS for inhibitors of adenylyl cyclases using a fission yeast platform: a pilot screen against the NCATS LOPAC library2019Cellular signalling, 08, Volume: 60A fission yeast platform for heterologous expression of mammalian adenylyl cyclases and high throughput screening.
AID1347059CD47-SIRPalpha protein protein interaction - Alpha assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347057CD47-SIRPalpha protein protein interaction - LANCE assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347058CD47-SIRPalpha protein protein interaction - HTRF assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347405qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS LOPAC collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347151Optimization of GU AMC qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID1347164384 well plate NINDS Rhodamine confirmatory qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347163384 well plate NINDS AMC confirmatory qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID977608Experimentally measured binding affinity data (IC50) for protein-ligand complexes derived from PDB2014Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, May, Volume: 67Biochemical and biological assessment of the inhibitory potency of extracts from vinification byproducts of Vitis vinifera extracts against glycogen phosphorylase.
AID493017Wombat Data for BeliefDocking1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Indazolinones, a new series of redox-active 5-lipoxygenase inhibitors with built-in selectivity and oral activity.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2008Protein science : a publication of the Protein Society, Nov, Volume: 17, Issue:11
Three flavonoids targeting the beta-hydroxyacyl-acyl carrier protein dehydratase from Helicobacter pylori: crystal structure characterization with enzymatic inhibition assay.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2011Chemistry & biology, Dec-23, Volume: 18, Issue:12
A small molecule discrimination map of the antibiotic resistance kinome.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11,993)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990566 (4.72)18.7374
1990's825 (6.88)18.2507
2000's2642 (22.03)29.6817
2010's5334 (44.48)24.3611
2020's2626 (21.90)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 60.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index60.60 (24.57)
Research Supply Index9.44 (2.92)
Research Growth Index5.10 (4.65)
Search Engine Demand Index213.73 (26.88)
Search Engine Supply Index3.91 (0.95)

This Compound (60.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Trials239 (1.93%)5.53%
Reviews0 (0.00%)6.00%
Reviews0 (0.00%)6.00%
Reviews601 (4.85%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Case Studies12 (0.10%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Observational3 (0.02%)0.25%
Other14 (100.00%)84.16%
Other12 (100.00%)84.16%
Other11,548 (93.11%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (69)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Nasal Potential Studies Utilizing CFTR Modulators (UAB Center for Clinical and Translational Science) [NCT01348204]Phase 232 participants (Actual)Interventional2010-03-31Completed
Evaluation of the Efficacy of Natural Senolytic Agents and NLRP3 Inhibitors in Treatment of Osteoarthritis: Randomized, Double Blinded ,Placebo Controlled Trial [NCT05276895]60 participants (Anticipated)Interventional2022-07-01Suspended(stopped due to unavailability of drugs)
Phase II Clinical Trial to Evaluate the Safety and Feasibility of Senolytic Therapy in Alzheimer's Disease [NCT04685590]Phase 248 participants (Anticipated)Interventional2021-12-22Recruiting
[NCT01375101]Phase 130 participants (Anticipated)Interventional2010-04-30Recruiting
The Effectiveness of Phytotherapy in the Treatment of SARS-COV2 (COVID-19) [NCT04851821]Phase 180 participants (Actual)Interventional2021-01-04Completed
Hypoxia-inducible Transcription Factor 1 (HIF-1) in Vascular Aging [NCT01376011]Early Phase 1106 participants (Actual)Interventional2009-06-30Completed
Effectiveness of Quercetin In The Treatment of SARS-COV 2 [NCT04853199]Early Phase 1200 participants (Actual)Interventional2021-06-01Completed
Senescence, Frailty, and Mesenchymal Stem Cell Functionality in Chronic Kidney Disease: Effect of Senolytic Agents [NCT02848131]Phase 230 participants (Anticipated)Interventional2016-07-31Enrolling by invitation
Single Nuclei RNA-sequencing to Map Adipose Cellular Populations and Senescent Cells in Older Subjects [NCT05653258]Phase 2/Phase 3160 participants (Anticipated)Interventional2023-09-30Not yet recruiting
Phase II Trial of Tislelizumab, an Anti-PD-1 Monoclonal Antibody, in Combination With Dasatinib and Quercetin, as a Novel Neoadjuvant Pre-Surgical Therapy for Head and Neck Squamous Cell Carcinoma [NCT05724329]Phase 224 participants (Anticipated)Interventional2023-02-05Recruiting
The Ability of Antistax® to Improve Chronic Venous Insufficiency (CVI) I and II in Male and Female Patients: a Dose Response Study [NCT02191280]Phase 2260 participants (Actual)Interventional1998-04-30Completed
An Open-Label, Randomized, Double Arm, Phase 2 Study to Evaluate the Safety and Efficacy of C and RQC for Preventing Progression in Age-Related Macular Degeneration [NCT05062486]Phase 2150 participants (Anticipated)Interventional2021-07-22Recruiting
Evaluation of a Computational Model That Predicts the Effects of Quercetin on Metabolic Health Using Biological Age and Other Lipid-related Blood Metrics [NCT05297032]5 participants (Actual)Interventional2022-03-24Terminated(stopped due to Labs ordering channel is no longer available. Indena (collaborator) opted not to increase funding for an alternative, terminated study.)
Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD? [NCT02226484]Phase 126 participants (Actual)Interventional2014-08-31Completed
Serum Concentration and Gene Expression of Sirtuin-1 and Advanced Glycation End-products in Postmenopausal Women With Atherosclerotic Coronary Disease After Administration of Atorvastatin and Supplementation With Quercetin: Randomized Trial [NCT03943459]Phase 360 participants (Anticipated)Interventional2019-08-02Recruiting
GRAPe Seed Extract and Ventriculovascular Investigation in Normal Ejection-Fraction Heart Failure [NCT01185067]Phase 115 participants (Actual)Interventional2010-10-31Completed
Effect of Combined Exercise, Heat, and Quercetin Supplementation on Whole Body Stress Response [NCT01168739]9 participants (Actual)Interventional2009-09-30Completed
SEN-SURVIVORS: An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer [NCT04733534]Phase 260 participants (Anticipated)Interventional2022-06-06Recruiting
Serum Concentration of Endogenous Estrogens and Sirtuin-1 in Postmenopausal Women With Atherosclerotic Coronary Heart Disease After Administration of Atorvastatin and Supplementation With Quercetin: a Randomized Study [NCT05877235]60 participants (Anticipated)Interventional2021-10-03Recruiting
Randomized, Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Masitinib Combined With Isoquercetin, and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19 [NCT04622865]Phase 2200 participants (Anticipated)Interventional2020-06-01Recruiting
Targeting Cellular Senescence With Senolytics to Improve Skeletal Health in Older Humans: A Phase 2, Single-Center, 20-week, Open-Label, Randomized Controlled Trial. [NCT04313634]Phase 2120 participants (Anticipated)Interventional2020-06-09Active, not recruiting
Effect of Quercetin Supplementation on Glycemic Status, Lipid Profile, Oxidative Stress, Inflammation, Growth Factor, Adiponectin, Sex Hormones and Anthropometric Indices in Women With Endometriosis [NCT05983224]50 participants (Anticipated)Interventional2023-08-15Recruiting
Senolytics To Alleviate Mobility Issues and Neurological Impairment in Aging [NCT05422885]Phase 1/Phase 212 participants (Actual)Interventional2022-05-20Active, not recruiting
A Prospective, Randomized, Open-labelled, Controlled Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With Diagnosis of COVID-19. [NCT04578158]Phase 3152 participants (Actual)Interventional2020-09-29Completed
Pilot Study to Test the Safety and Efficacy of Metformin, Dasatinib, Rapamycin and Nutritional Supplements (Bio-quercetin; Bio-fisetin; Glucosamine; Nicotinamide Riboside; Trans-resveratrol) in Reducing Clinical Measures of Aging in Older Adults [NCT04994561]Phase 10 participants (Actual)Interventional2022-06-30Withdrawn(stopped due to Study was withdrawn)
SENolytics to Improve Osteoporosis Therapy: a Randomised Controlled Clinical Trial The SENIOR Trial [NCT06018467]Phase 2120 participants (Anticipated)Interventional2023-09-06Recruiting
Study to Investigate the Benefits of Dietary Supplement Quercetin for Early Symptoms of COVID-19 [NCT04861298]100 participants (Actual)Interventional2021-01-11Completed
Quercetin for Cardio-Skeletal Muscle Health and Estrogen Deficiency (QUICKENED) Feasibility Study in Older Women [NCT04258410]Phase 40 participants (Actual)Interventional2022-09-30Withdrawn(stopped due to "Per PI: Never went to IRB Never recruited anyone Never resubmitted the score NIH application I am leaving the institution")
The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism [NCT05680662]Early Phase 1200 participants (Anticipated)Interventional2023-01-01Not yet recruiting
A Double-Blind, Cross-Over, Placebo-Controlled Study Evaluating the Effect of Quercetin 500 mg Tablets on Blood Uric Acid in Healthy Males [NCT01881919]Early Phase 122 participants (Actual)Interventional2013-02-28Completed
A Phase I Randomized, Double-Blind, Placebo-Controlled Two-Arm Study of Quercetin and Green Tea to Enhance the Bioavailability of Green Tea Polyphenols in Men Scheduled for Prostatectomy [NCT01912820]Phase 132 participants (Actual)Interventional2014-01-01Completed
Pilot Study to Investigate the Safety and Feasibility of Senolytic Therapy to Modulate Progression of Alzheimer's Disease (SToMP-AD) [NCT04063124]Phase 1/Phase 25 participants (Actual)Interventional2020-02-14Completed
Impact of Quercetin on Inflammatory and Oxidative Stress Markers in COPD [NCT03989271]Phase 1/Phase 229 participants (Anticipated)Interventional2019-10-01Recruiting
Targeted Removal of Pro-Inflammatory Cells: An Open Label Human Pilot Study in Idiopathic Pulmonary Fibrosis [NCT02874989]Phase 126 participants (Actual)Interventional2016-12-16Completed
[NCT01847521]Phase 250 participants (Actual)Interventional2011-12-31Completed
Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders [NCT05838560]Phase 240 participants (Anticipated)Interventional2023-07-01Recruiting
The Possible Effect of Quercetin on Prophylaxis and Treatment of COVID-19 [NCT04377789]447 participants (Actual)Interventional2020-03-20Completed
Randomized, Placebo-controlled Clinical Trial to Evaluate the Efficacy of an Oral Nutritional Supplement Based on Quercetin in the Prevention of Covid-19 Infection for a Duration of 3 Months [NCT05037240]80 participants (Actual)Interventional2021-01-12Completed
Effects of Quercetin on the Oxidative Stress and Inflammatory Markers in COPD Phase II [NCT06003270]Phase 230 participants (Anticipated)Interventional2023-09-30Not yet recruiting
Open Label,Crossover,Pilot Study to Assess the Efficacy & Safety of Perispinal Admin.of Etanercept(Enbrel®) in Comb.w/Nutritional Supplements vs. Nutritional Supplements Alone in Subj. w/Mild to Mod. Alzheimer's Disease Receiving Std. Care. [NCT01716637]Phase 112 participants (Anticipated)Interventional2010-02-28Completed
Dietary Intervention in Stage III/IV Follicular Lymphoma. Impact on Markers of Cell Proliferation, Apoptosis, Host Immune Cell Infiltrate and Oxidative Stress. [NCT00455416]Phase 245 participants (Anticipated)Interventional2007-04-30Recruiting
The Effect of Quercetin on the Increased Inflammatory and Decreased Antioxidant Status in Sarcoidosis [NCT00402623]18 participants (Actual)Interventional2006-01-31Completed
Clinical Trial on the Effectiveness of the Flavonoids Genistein and Quercetin in Men With Rising Prostate-specific Antigen [NCT01538316]60 participants (Anticipated)Interventional2012-03-31Recruiting
Advancing Niacin by Inhibiting FLUSHing: (ANTI-FLUSH) [NCT00913081]Phase 417 participants (Actual)Interventional2009-02-28Completed
Phase I Study to Determine the Safety of Quercetin in COPD Patients [NCT01708278]Phase 19 participants (Actual)Interventional2014-02-28Completed
Randomized, Placebo-controlled, Double-blind Phase II/III Trial of Oral Isoquercetin to Prevent Venous Thromboembolic Events in Cancer Patients. [NCT02195232]Phase 2/Phase 364 participants (Actual)Interventional2015-01-31Completed
Effectiveness of a 3-months Dietary Supplementation Based on Quercetin Phytosome®) for the Treatment of Chronic Fatigue Syndrome [NCT05730660]80 participants (Actual)Interventional2022-09-01Completed
Therapeutic Efficacy of Quercetin Versus Its Encapsulated Nanoparticle on Tongue Squamous Cell Carcinoma Cell Line [NCT05456022]Phase 21,000,000 participants (Anticipated)Interventional2022-07-31Not yet recruiting
Hematopoietic Stem Cell Transplant Survivors Study (HTSS Study) [NCT02652052]10 participants (Anticipated)Interventional2016-03-01Recruiting
Study on the Effects of Epicatechin and Quercetin Supplementation on Vascular Function and Blood Pressure in Untreated (Pre)Hypertensive Subjects [NCT01691404]38 participants (Actual)Interventional2012-09-30Completed
Effect of Quercetin in Prevention and Treatment of Chemotherapy Induced Oral Mucositis in Blood Dyscrasias [NCT01732393]Phase 1/Phase 220 participants (Actual)Interventional2010-01-31Completed
Inhibition of Intestinal Glucose Absorption by the Bioflavonoid Quercetin in the Obese and in Obese Type 2 Diabetics [NCT00065676]Phase 224 participants (Actual)Interventional2010-04-30Completed
Comparing the Pharmacological Profile of Different Quercetin Formulations in Healthy Volunteers [NCT05611827]10 participants (Actual)Interventional2022-01-31Completed
Evaluation of Quercetin in Type 2 Diabetes: Impact on Glucose Tolerance and Postprandial Endothelial Function. [NCT01839344]Phase 219 participants (Actual)Interventional2013-05-31Completed
Ivermectin Will be Used as an Outpatient Treatment Option for COVID-19 Patients. [NCT05045937]1,000 participants (Anticipated)Observational [Patient Registry]2022-05-01Recruiting
A Phase 1 Study of Quercetin in Patients With Hepatitis C [NCT01438320]Phase 134 participants (Actual)Interventional2011-07-31Completed
Dasatinib and Quercetin, a Combination of Senolytics to Treat Fibrotic Non-alcoholic Fatty Liver Disease - the TRUTH Study [NCT05506488]Phase 1/Phase 230 participants (Anticipated)Interventional2023-03-01Recruiting
Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia [NCT03476330]Phase 248 participants (Actual)Interventional2018-05-08Active, not recruiting
Three New Ideas to Protect Special Forces From the Stress of High Altitude [NCT02463357]Phase 4148 participants (Actual)Interventional2015-08-31Completed
The Safety and Effectivness of Quercetin and Dasatinib on the Epigenetic Aging Rates in Healthy Individuals [NCT04946383]Phase 225 participants (Anticipated)Interventional2020-12-16Active, not recruiting
ALSENLITE: An Open-Label Pilot Study of Senolytics for Alzheimer's Disease [NCT04785300]Phase 1/Phase 220 participants (Anticipated)Interventional2022-07-06Enrolling by invitation
Prospective Open Labeled Pilot Trial of Quercetin in the Treatment and Prevention of Chemotherapy-induced Neuropathic Pain in Cancer Patients [NCT02989129]Early Phase 10 participants (Actual)Interventional2018-04-30Withdrawn(stopped due to FDA IND Approval)
The Efficacy of Quercetin Supplementation on Bone Turnover Markers, Inflammatory Markers, Body Composition, and Physical Function in Post-Menopausal Women [NCT05371340]33 participants (Actual)Interventional2019-08-27Completed
Pharmacokinetic and Pharmacodynamic Study of Oral Quercetin and Isoquercetin in Healthy Adults and Patients With Hypercoagulable States. [NCT01722669]Early Phase 138 participants (Actual)Interventional2012-05-31Completed
Efficacy of Quercetin Nanoemulgel as Adjunct Local Delivery Drug in Non-surgical Treatment of Periodontitis [NCT05928546]Phase 120 participants (Anticipated)Interventional2023-10-20Not yet recruiting
The Effect of Plant Phenolic Compounds on Human Colon Epithelial Cells [NCT00003365]0 participants Interventional1996-08-31Terminated(stopped due to Study completed)
The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19 [NCT04468139]Phase 460 participants (Anticipated)Interventional2020-06-20Recruiting
Étude randomisée contrôlée Par Placebo de Phase II Visant à Mesurer l'Effet Anti-inflammatoire et Anti-sénescence de la quercétine Lors d'Une Chirurgie Cardiaque [NCT04907253]Phase 2100 participants (Anticipated)Interventional2021-06-04Active, not recruiting
Quercetin in Children With Fanconi Anemia; a Pilot Study [NCT01720147]Phase 130 participants (Actual)Interventional2012-07-31Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

TrialOutcome
NCT00913081 (1) [back to overview]Whether Quercetin Dose-dependently Reduces Laser Doppler Flux Index Primary Peak Following Immediate-release Niacin
NCT01708278 (1) [back to overview]Participants Who Experienced Safety Concerns, Where Safety Concerns of Quercetin Supplementation is Indicated by Significant Change From Baseline Measures of Tests Indicated Below in Outcome Measure Description
NCT01722669 (3) [back to overview]AUC
NCT01722669 (3) [back to overview]Platelet-induced Thrombin Generation (U/mL)
NCT01722669 (3) [back to overview]Reductase Activity of PDI Using Dieosin Glutathione Disulfide
NCT02195232 (3) [back to overview]Cumulative Incidence of VTE at 56 Days
NCT02195232 (3) [back to overview]Number of Participants With Hemorrhage
NCT02195232 (3) [back to overview]Percent Change in D-dimer Value
NCT02463357 (5) [back to overview]Change in Uphill Hike at High Altitude
NCT02463357 (5) [back to overview]Change in Army Physical Fitness Test (APFT) at High Altitude
NCT02463357 (5) [back to overview]Change in Defense Automated Neurobehavioral Assessment (DANA) Reaction Time at High Altitude
NCT02463357 (5) [back to overview]Change in Environmental Symptoms Questionnaire at High Altitude
NCT02463357 (5) [back to overview]Change in Lake Louise AMS Scoring System at High Altitude
NCT04063124 (6) [back to overview]Alzheimer's Disease Marker - CSF Amyloid Beta
NCT04063124 (6) [back to overview]Alzheimer's Disease Marker - CSF Tau
NCT04063124 (6) [back to overview]Brain Penetrance of Dasatinib (D)
NCT04063124 (6) [back to overview]Brain Penetrance of Quercetin (Q)
NCT04063124 (6) [back to overview]Montreal Cognitive Assessment (MoCA)
NCT04063124 (6) [back to overview]Senescence Marker IL-6 in CSF

Whether Quercetin Dose-dependently Reduces Laser Doppler Flux Index Primary Peak Following Immediate-release Niacin

Laser Doppler flowmetry at the malar eminence measures blood flow quantitatively as red blood cell flux. Flux index is the fold-change in flux over baseline. Flux index primary peak is the maximum flux index between 0-4 hours after niacin. (NCT00913081)
Timeframe: 8 hour period

InterventionFold change over baseline (Mean)
Quercetin 500 mg9.9
Quercetin 1000 mg9.4
Quercetin 2000 mg7.7
Placebo8.9

[back to top]

Participants Who Experienced Safety Concerns, Where Safety Concerns of Quercetin Supplementation is Indicated by Significant Change From Baseline Measures of Tests Indicated Below in Outcome Measure Description

"Note: If values for any of the measures indicated here were found, the participant would be indicated as a participant with a safety concern, and values for that particular measure would be posted specifically, but since none of the participants experienced these outlying values, results of all tests are expressed here as a composite function.~PULMONARY FUNCTION TEST:~FEV1% of predicted: decline by >20% from baseline COMPLETE BLOOD COUNTS: WBC (cells)/mm3 : <2000, Platelets (cells)/mm3: <25,000, Hemoglobin (g/dL): <7.0 COMPREHENSIVE METABOLIC PROFILE (study drug related):Sodium (mmol/L): <125 or >148, Potassium (mmol/L): < 3.0 or > 6.0, Calcium (mmol/L): <7.4 or > 11.5, LIVER FUNCTION TESTS INCREASE BY FACTOR: Enzymes ALT, AST, and Alkaline phosphate, Total bilirubin: for any of these a value >3X upper limit of normal" (NCT01708278)
Timeframe: One week in Phase I safety study

InterventionParticipants (Count of Participants)
Sugar Chew- Cohort 10
Quercetin 1-Cohort 10
Quercetin 2-Cohort 20
Quercetin 3-Cohort 30
Sugar Chew-Cohort 20
Sugar Chew-Cohort 30

[back to top]

AUC

AUC 0-24 hours of measured plasma quercetin aglycone for Arms A1, B1, A2, B2, C Collected at timepoints: baseline and 1, 2, 4, 6, 8, and 24 hours after dose. PK and PDI samples were not measured for Arm D (anti-phospholipid antibody cohort) (NCT01722669)
Timeframe: 24 hours

InterventionuM hr/L (Mean)
Quercetin 500 mg (ARM A1)4.78
Isoquercetin 500 mg (ARM B1)15.00
Quercetin 500 mg + Ascorbic Acid (ARM A2)5.41
Isoquercetin 500 mg + Ascorbic Acid (ARM B2)16.34
Isoquercetin 1000 mg + Ascorbic Acid (ARM C)40.3

[back to top]

Platelet-induced Thrombin Generation (U/mL)

Thrombin induced thrombin generation measured in patient plasma (NCT01722669)
Timeframe: 4 hours

InterventionU/mL (Mean)
Isoquercetin 1000 mg + Ascorbic Acid (ARM C)0.30
Antiphospholipid Antibody (ARM D)1.40

[back to top]

Reductase Activity of PDI Using Dieosin Glutathione Disulfide

Measurement of protein disulfide inhibition in plasma using a fluorescent PDI substrate (dieosin glutathione disulfide) (NCT01722669)
Timeframe: 2 hours. Not measured in D

InterventionPercent inhibition (Mean)
Quercetin 500 mg (ARM A1)31.9
Isoquercetin 500 mg (ARM B1)63.2
Quercetin 500 mg + Ascorbic Acid (ARM A2)16
Isoquercetin 500 mg + Ascorbic Acid (ARM B2)8.3
Isoquercetin 1000 mg + Ascorbic Acid (ARM C)38

[back to top]

Cumulative Incidence of VTE at 56 Days

To investigate the cumulative incidence of VTE according to tissue factor bearing microparticle status (and isoquercetin randomization). (NCT02195232)
Timeframe: 56 days

Interventionparticipants (Number)
Cohort A - Isoquercetin0
Cohort B - Isoquercetin0

[back to top]

Number of Participants With Hemorrhage

Investigating the safety of isoquercetin in cancer patients (NCT02195232)
Timeframe: study visits until day 56

InterventionParticipants (Count of Participants)
Cohort A (Isoquercetin 500 mg)2
Cohort B (Isoquercetin 1000 mg)2

[back to top]

Percent Change in D-dimer Value

D-dimer concentrations will be compared for each patient at day 0 and day 56 by a paired-t test analysis. Analysis will be performed on an intention to treat basis for patients who undergo randomization and completed the baseline and day 56 D-dimer assessments. (NCT02195232)
Timeframe: Baseline, 56 Day

Interventionpercent change (Median)
Cohort A (Isoquercetin 500 mg)9.9
Cohort B (Isoquercetin 1000 mg)-21.9

[back to top]

Change in Uphill Hike at High Altitude

Timed 3.1 mile uphill run/hike, with weighted back-pack (NCT02463357)
Timeframe: 2nd day at altitude

Interventionseconds (Mean)
Quercetin4685
Nifedipine+Methazolamide4993
Metformin5005
Placebo4819
Nitrite4953

[back to top]

Change in Army Physical Fitness Test (APFT) at High Altitude

"Timed 2 mile run, push-ups, sit-ups, and pull-ups. The Army Physical Fitness Test (APFT) measures physical fitness. Higher scores indicate a better outcome. A score of 60 is considered minimum passing score. The maximum possible score is 300, indicating the highest level of physical fitness." (NCT02463357)
Timeframe: Baseline, 1st day at high altitude

,,,,
Interventionscore on a scale (Mean)
BaselineChange at Day 1
Metformin254.1-32.9
Nifedipine+Methazolamide251.0-59.2
Nitrite252.1-26.1
Placebo251.5-23.0
Quercetin247.2-27.5

[back to top]

Change in Defense Automated Neurobehavioral Assessment (DANA) Reaction Time at High Altitude

Battery of nine cognitive function tests. The Defense Automated Neurobehavioral Assessment (DANA) measures cognitive function and was used to measure mean reaction time. Possible scores range from 180 to 500 milliseconds, with lower scores indicating a better outcome. (NCT02463357)
Timeframe: Baseline and and 1st day at high altitude

,,,,
Interventionmilliseconds (Mean)
BaselineChange from baseline at day 1
Metformin312.3-8.3
Nifedipine+Methazolamide302.214.2
Nitrite310.7-4.6
Placebo333.90.5
Quercetin308.0-0.5

[back to top]

Change in Environmental Symptoms Questionnaire at High Altitude

Self-reported assessment of AMS symptoms (headache, lightheaded, dizzy, etc.). The 11-item Environmental Symptoms Questionnaire measures Acute Mountain Sickness symptoms (nausea, weakness, lightheadedness, dizziness, headache, etc.). Possible scores range from 0 to 55 (0-5 per item), with higher scores indicating a better outcome. (NCT02463357)
Timeframe: Baseline and during high altitude exposure (3 days, AM/PM)

,,,,
Interventionscore on a scale (Mean)
BaselineChange at 3 days
Metformin0.0800.128
Nifedipine+Methazolamide0.122-0.073
Nitrite0.1210.044
Placebo0.0690.035
Quercetin0.132-0.088

[back to top]

Change in Lake Louise AMS Scoring System at High Altitude

Self-reported assessment of AMS symptoms (headache, nausea, vomiting, dizziness, fatigue and difficultly sleeping). The Lake Louise AMS Scoring System measures symptoms of altitude sickness. Possible scores range from 0 to 16, with higher scores indicating a worse outcome. (NCT02463357)
Timeframe: Baseline and during high altitude exposure (3 days, AM/PM)

,,,,
Interventionscore on a scale (Mean)
BaselineChange at Day 3
Metformin0.1500.750
Nifedipine+Methazolamide0.1500.150
Nitrite0.2500.474
Placebo0.000.632
Quercetin0.000.053

[back to top]

Alzheimer's Disease Marker - CSF Amyloid Beta

Cerebrospinal Fluid collected by lumbar puncture analyzed for level of amyloid beta proteins present in CSF (NCT04063124)
Timeframe: Change from 0 to 12 weeks

Interventionpg/ml (Mean)
Intermittent D+Q78

[back to top]

Alzheimer's Disease Marker - CSF Tau

Cerebrospinal Fluid collected by lumbar puncture analyzed for level of tau proteins present in CSF (NCT04063124)
Timeframe: Change from 0 to 12 weeks

Interventionpg/ml (Mean)
Intermittent D+Q-21

[back to top]

Brain Penetrance of Dasatinib (D)

Cerebrospinal Fluid (CSF) collected by lumbar puncture before and after 12 weeks of treatment to determine levels of drug that reach the central nervous system will be measured by high performance liquid chromatography/mass spectrometry (HPLC/MS) (NCT04063124)
Timeframe: Change from 0 to 12 weeks

Interventionng/ml (Mean)
Intermittent D+Q0.27

[back to top]

Brain Penetrance of Quercetin (Q)

CSF collected by lumbar puncture before and after 12 weeks of treatment to determine levels of drug that reach the central nervous system using HPLC/MS (NCT04063124)
Timeframe: Change from 0 to 12 weeks

Interventionng/ml (Mean)
Intermittent D+Q0

[back to top]

Montreal Cognitive Assessment (MoCA)

A test which scores the participant with score ranges between 0 and 30. A score of 26 or over is considered normal. Individuals with mild cognitive impairment score lower and individuals with Alzheimer's disease score even lower. (NCT04063124)
Timeframe: Change from 0 to 12 weeks

Interventionpoints (Mean)
Intermittent D+Q-0.20

[back to top]

Senescence Marker IL-6 in CSF

Laboratory measure of level of IL-6 found in CSF collected pre and post treatment (NCT04063124)
Timeframe: Change from 0 to 12 weeks

Interventionpg/ml (Mean)
Intermittent D+Q0.37

[back to top]